BEL-ID	BEL original	Sentence	Sentence ID	PMID
BEL:20000010	tscript(p(MGI:Cebpb)) increases p(MGI:Pparg)	Induction of C/EBP beta DNA-binding activity in NIH-3T3 beta 2 cells exposed to dexamethasone in the presence of insulin and fetal bovine serum activates the expression of an adipocyte-specific nuclear hormone receptor, PPAR gamma, that stimulates the conversion of these fibroblasts into committed preadipocytes	SEN:10000006	7557387
BEL:20000014	a(CHEBI:glucocorticoid) decreases p(MGI:Pomc)	Pulse-chase biosynthetic labeling studies showed that AtT-20 cells expressed much less RESP18 than the endogenous prohormone, POMC, but that glucocorticoid treatment lowered POMC and raised RESP18 biosynthetic rates so that they were nearly equimolar.	SEN:10000010	7988462
BEL:20000016	a(CHEBI:glucocorticoid) increases p(MGI:Resp18)	Pulse-chase biosynthetic labeling studies showed that AtT-20 cells expressed much less RESP18 than the endogenous prohormone, POMC, but that glucocorticoid treatment lowered POMC and raised RESP18 biosynthetic rates so that they were nearly equimolar.	SEN:10000010	7988462
BEL:20000030	a(CHEBI:lipopolysaccharide) increases p(MGI:Il1rn)	interleukin 1 receptor antagonist (IL-1ra) is induced in mouse liver after lipopolysaccharide (LPS) or recombinant interleukin 1.	SEN:10000020	9112333
BEL:20000042	cat(p(HGNC:CASP3)) directlyIncreases kin(p(HGNC:PAK2))	P21-activated protein kinase gamma-PAK (Pak2, PAK I) is cleaved by CPP32 (caspase 3) during apoptosis and plays a key role in regulation of cell death. 	SEN:10000026	9786869
BEL:20000068	cat(p(HGNC:AGTR1)) increases p(HGNC:OLR1)	Importantly, the increase in LOX-1 mRNA expression in response to Ang II was completely blocked by losartan, a specific AT1 blocker, but not by PD123319, a specific AT2 blocker (n56, Figure 5). 	SEN:10000044	10325241
BEL:20000070	cat(p(HGNC:F2R)) increases p(HGNC:IL6)	Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-kappa B activation 	SEN:10000046	10343541
BEL:20000072	cat(p(HGNC:F2R)) increases p(HGNC:CSF3)	Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-kappa B activation 	SEN:10000046	10343541
BEL:20000074	a(CHEBI:lipopolysaccharide) increases p(MGI:Nos2)	"A basal expression of NOS II mRNA and protein was detected in skeletal muscle from untreated wild-type mice; expression increased when mice were treated with bacterial lipopolysaccharide (LPS)."	SEN:10000048	10359657
BEL:20000080	cat(p(HGNC:IL6R)) increases tscript(p(HGNC:STAT3))	Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase. 	SEN:10000052	10409724
BEL:20000096	complex(p(HGNC:PDGFA),p(HGNC:PDGFB)) increases bp(GOBP:mitosis)	The finding that PDGF-AB gives stronger mitogenic and chemotactic effects on cells expressing both alpha - and beta -receptors (179, 401) suggests that the heterodimeric alpha beta -receptor complex may have unique properties.	SEN:10000060	10508235
BEL:20000108	cat(p(HGNC:CASP3)) directlyIncreases cat(p(HGNC:GAS2))	Treatment with increasing amounts of caspase-3 for 30 minutes at 37�C specifically cleaved Gas2, thus producing a band showing similar electrophoretic mobility (����31 kDa) with respect to Gas2 as detected in extracts of apoptotic cells.	SEN:10000068	10564664
BEL:20000110	cat(p(HGNC:CASP3)) directlyIncreases cat(p(HGNC:GAS2))	In summary we can conclude that Gas2 is a direct substrate of caspase-3 and that the aspartic residue 279 is critical both for its in vitro and in vivo proteolytic processing.	SEN:10000070	10564664
BEL:20000112	p(MGI:Fdft1) increases a(CHEBI:dolichol)	it was found that a 6-fold increase in Fdft1 activity compared with that of the wild-type did not cause significant changes in HmgCoA reductase activity, while the amounts of synthesized dolichols and ergosterols increased by 80 and 32 percent respectively.	SEN:10000072	10623644
BEL:20000116	a(CHEBI:androgen) directlyIncreases complex(p(HGNC:AR),p(HGNC:PIAS1))	Binding of PIAS1 to human AR DNA+ligand binding domains was androgen dependent in the yeast liquid beta-galactosidase assay. 	SEN:10000076	10628744
BEL:20000118	a(CHEBI:androgen) directlyIncreases complex(p(HGNC:AR),p(HGNC:PIAS1))	PIAS1 binding to full-length human AR in a reversed yeast two hybrid system was also androgen dependent.	SEN:10000078	10628744
BEL:20000144	cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:FOS))	UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.	SEN:10000092	10760570
BEL:20000146	cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:MYC))	UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.	SEN:10000092	10760570
BEL:20000148	cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:TP53))	UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.	SEN:10000092	10760570
BEL:20000162	p(MGI:Apc) decreases path(MESHD:Adenoma)	These animals bear a germline mutation in the Apc gene and spontaneously develop numerous intestinal adenomas by 15 weeks of age.	SEN:10000102	10783313
BEL:20000172	cat(p(HGNC:PRDX2)) increases deg(a(CHEBI:"lipid hydroperoxide"))	Human TSA1 exhibited high catalytic activity for the reduction of the fatty acid hydroperoxide as indicated by K(m) and V(max) (89.9 microM for linoleic acid hydroperoxide, 28.64 micromol(-1) min(-1) mg(-1), respectively)	SEN:10000108	10841776
BEL:20000178	kin(p(MGI:Chek1)) decreases path(MESHD:Neoplasms)	Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression	SEN:10000114	10859164
BEL:20000180	p(HGNC:TLR2) increases cat(p(HGNC:CASP1))	Interestingly, BLP also activates caspase 1 through TLR2, resulting in proteolysis and secretion of mature IL-1beta.	SEN:10000116	10880445
BEL:20000182	cat(p(HGNC:CASP1)) increases p(HGNC:IL1B)	Interestingly, BLP also activates caspase 1 through TLR2, resulting in proteolysis and secretion of mature IL-1beta.	SEN:10000116	10880445
BEL:20000184	cat(p(HGNC:MYD88)) increases bp(GOBP:"apoptotic process")	Here we show that the adaptor molecule, myeloid differentiation factor 88 (MyD88), mediates both apoptosis and nuclear factor-kappaB (NF-kappaB) activation by BLP-stimulated TLR2.	SEN:10000118	10880445
BEL:20000186	cat(p(HGNC:TLR2)) increases cat(p(HGNC:MYD88))	Here we show that the adaptor molecule, myeloid differentiation factor 88 (MyD88), mediates both apoptosis and nuclear factor-kappaB (NF-kappaB) activation by BLP-stimulated TLR2.	SEN:10000118	10880445
BEL:20000192	a(CHEBI:galangin) decreases complex(a(CHEBI:"2,3,7,8-tetrachlorodibenzodioxine"),p(MGI:Ahr))	The ability of galangin to inhibit binding of TCDD, a high-affinity AhR ligand, to the AhR demonstrates that galangin is able to bind to the AhR.	SEN:10000124	10953044
BEL:20000194	a(CHEBI:galangin) increases tscript(p(MGI:Ahr))	"60 or 90 ?M galangin induced AhR nuclear translocation in both cell types (Fig. 11A, lanes 7, 8; Fig. 11B, lane 6)."	SEN:10000126	10953044
BEL:20000200	cat(p(HGNC:FAS)) increases bp(GOBP:"apoptotic process")	Interleukin-1beta (IL-1beta) is a pro-inflammatory cytokine that inhibits beta cell function and promotes Fas-triggered apoptosis.	SEN:10000130	10967112
BEL:20000202	bp(GOBP:"MAPK cascade") increases cat(p(MGI:Tnks))	"Tankyrase is a novel signaling target of mitogen-activated protein kinase (MAPK); it is stoichiometrically phosphorylated upon insulin stimulation. "	SEN:10000132	10988299
BEL:20000204	bp(GOBP:"MAPK cascade") directlyIncreases p(MGI:Tnks,pmod(P))	"Tankyrase is a novel signaling target of mitogen-activated protein kinase (MAPK); it is stoichiometrically phosphorylated upon insulin stimulation. "	SEN:10000132	10988299
BEL:20000210	bp(GOBP:"response to hypoxia") increases deg(p(HGNC:CREB1))	Ambient hypoxia resulted in temporally sequential CREB serine phosphorylation, ubiquitination, and degradation (in vitro and in vivo).	SEN:10000138	11035795
BEL:20000212	bp(GOBP:"response to hypoxia") increases deg(p(HGNC:CREB1))	Thus, hypoxia establishes conditions that target CREB to proteasomal degradation.	SEN:10000140	11035795
BEL:20000214	bp(GOBP:"response to hypoxia") increases p(HGNC:CREB1,pmod(P,S))	Ambient hypoxia resulted in temporally sequential CREB serine phosphorylation, ubiquitination, and degradation (in vitro and in vivo).	SEN:10000138	11035795
BEL:20000226	cat(p(HGNC:IL2)) increases kin(p(HGNC:LYN))	The association of lyn with IL-2Rbeta was markedly elevated by IL-2 stimulation. Furthermore the activity of lyn kinase, evaluated by an in vitro kinase assay with enolase as a substrate, increased following IL-2 stimulation.	SEN:10000150	11131153
BEL:20000228	cat(p(HGNC:IL2)) increases complex(p(HGNC:LYN), p(HGNC:IL2RB))	The association of lyn with IL-2Rbeta was markedly elevated by IL-2 stimulation. Furthermore the activity of lyn kinase, evaluated by an in vitro kinase assay with enolase as a substrate, increased following IL-2 stimulation.	SEN:10000150	11131153
BEL:20000234	a(CHEBI:wortmannin) decreases p(MGI:Ddit3)	Both of the PI3K inhibitors inhibited the induction of CHOP in a dose-dependent manner, with wortmannin producing maximal inhibition at 100 nM and LY294002 producing maximal inhibition at 5μ M (Fig.3)	SEN:10000154	11145585
BEL:20000236	a(CHEBI:LY294002) decreases p(MGI:Ddit3)	Both of the PI3K inhibitors inhibited the induction of CHOP in a dose-dependent manner, with wortmannin producing maximal inhibition at 100 nM and LY294002 producing maximal inhibition at 5μ M (Fig.3)	SEN:10000154	11145585
BEL:20000238	a(CHEBI:lipopolysaccharide) increases a(CHEBI:"nitric oxide")	LPS-induced NO synthesis feedback regulates itself through up-regulation of OPN promoter activity and gene transcription.	SEN:10000156	11145688
BEL:20000242	kin(p(MGI:Src)) decreases path(MESHD:Osteopetrosis)	Expression of a truncated Src mutant lacking the kinase domain induced osteopetrosis in wildtype and Src +/- mice and worsened osteopetrosis in Src -/- mice by increased osteoclast apoptosis.	SEN:10000158	11157779
BEL:20000244	kin(p(MGI:Src)) increases bp(GOBP:"apoptotic process")	Expression of a truncated Src mutant lacking the kinase domain induced osteopetrosis in wildtype and Src +/- mice and worsened osteopetrosis in Src -/- mice by increased osteoclast apoptosis.	SEN:10000158	11157779
BEL:20000246	kin(p(MGI:Src)) decreases path(MESHD:Osteopetrosis)	Mutant src(-/-) mice have osteopetrosis resulting from defective osteoclasts (increased apoptosis). 	SEN:10000160	11157779
BEL:20000252	p(HGNC:PTGER1) increases bp(GOBP:"wound healing")	Figure 5 shows that both the EP1 receptor antagonist AH-6809 and the EP4 receptor antagonist AH-23848B significantly inhibited wound repair compared with that in untreated control monolayers.	SEN:10000164	11159024
BEL:20000254	p(HGNC:PTGER4) increases bp(GOBP:"wound healing")	 Figure 5 shows that both the EP1 receptor antagonist AH-6809 and the EP4 receptor antagonist AH-23848B significantly inhibited wound repair compared with that in untreated control monolayers.	SEN:10000166	11159024
BEL:20000260	complex(p(HGNC:PLAU),p(HGNC:PLAUR)) directlyIncreases cat(p(HGNC:PLAUR))	"The interaction of uPA with its receptor concentrates the enzyme activity to the so-called \"focal attachment sites\" on the cell surface and stimulates signal transduction through the uPAR, leading to induction of cell migration and invasion (19)."	SEN:10000172	11172729
BEL:20000274	p(HGNC:DCC) increases cat(p(HGNC:CASP9))	Moreover, we demonstrate that DCC interacts with both caspase-3 and caspase-9 and drives the activation of caspase-3 through caspase-9 without a requirement for cytochrome c or Apaf-1.	SEN:10000182	11248093
BEL:20000278	p(MGI:Aifm1) increases bp(GOBP:"cell death")	Thus, extramitochondrially targeted AIF is a dominant cell death inducer.	SEN:10000184	11259394
BEL:20000282	bp(GOBP:"apoptotic process") increases deg(p(HGNC:EIF4B))	Eukaryotic initiation factor (eIF) 4B interacts with several components of the initiation pathway and is targeted for cleavage during apoptosis.	SEN:10000188	11274152
BEL:20000284	bp(GOBP:"apoptotic process") decreases complex(p(HGNC:EIF4B),p(HGNC:PABPN1))	Similarly, the association of eIF4B with the poly(A)-binding protein in vivo is reduced when cells are induced to undergo apoptosis.	SEN:10000190	11274152
BEL:20000286	cat(p(HGNC:CASP3)) increases deg(p(HGNC:EIF4B))	In a cell-free system, cleavage of eIF4B by caspase-3 coincides with a general inhibition of protein synthetic activity.	SEN:10000192	11274152
BEL:20000292	bp(GOBP:"response to ionizing radiation") increases p(HGNC:JUN)	In the absence of CdCl2 pretreatment, ionizing radiation increased both expression (Fig. 3A) and phosphorylation (Fig. 3B) of c-Jun in MRC5CV1 cells but not in AT5BIVA cells.	SEN:10000196	11278277
BEL:20000310	a(CHEBI:fenofibrate) increases p(MGI:Pltp)	Significant rises in plasma PLTP activity were observed after 2 weeks of fenofibrate treatment.	SEN:10000210	11342537
BEL:20000318	complex(p(HGNC:DFFA), p(HGNC:DFFB)) decreases cat(p(HGNC:DFFB))	Caspase-activated DNase (CAD) is a deoxyribonuclease that causes DNA fragmentation during apoptosis. In proliferating cells, CAD is complexed with ICAD (inhibitor of CAD) and its DNase activity is suppressed	SEN:10000216	11361146
BEL:20000320	cat(p(HGNC:DFFA)) decreases cat(p(HGNC:DFFB))	Caspase-activated DNase (CAD) is a deoxyribonuclease that causes DNA fragmentation during apoptosis. In proliferating cells, CAD is complexed with ICAD (inhibitor of CAD) and its DNase activity is suppressed	SEN:10000216	11361146
BEL:20000322	cat(p(MGI:Ednrb)) increases cat(p(MGI:Slc9a3))	In conclusion, metabolic acidosis increases ET-1 expression, which increases NHE3 activity via the ET(B) receptor.	SEN:10000218	11413164
BEL:20000324	complex(p(MGI:Edn1),p(MGI:Ednrb)) increases cat(p(MGI:Slc9a3))	In conclusion, metabolic acidosis increases ET-1 expression, which increases NHE3 activity via the ET(B) receptor.	SEN:10000218	11413164
BEL:20000356	a(CHEBI:"Ro 31-8220") decreases kin(p(MGI:Prkd1))	As illustrated in Fig. 2B, the increase in PKD activity induced by these stimuli was markedly attenuated by treatment with either Ro 31-8220 or GF I.	SEN:10000230	11514571
BEL:20000368	a(CHEBI:vasopressin) increases p(MGI:Prkd1,pmod(P,S,916))	Stimulation with either vasopressin or PDBu also induced a marked increase in PKD activity within cells as shown by Ser916 phosphorylation (Fig. 3B).	SEN:10000236	11514571
BEL:20000372	a(CHEBI:"cholic acid") increases r(MGI:Apoc2)	hepatic expression of both apoC2 and phospholipid transfer protein mRNAs increases when mice are fed diets supplemented with cholic acid, an Fxr ligand, and this induction is attenuated in Fxr null mice	SEN:10000240	11579204
BEL:20000374	a(CHEBI:"cholic acid") increases r(MGI:Pltp)	hepatic expression of both apoC2 and phospholipid transfer protein mRNAs increases when mice are fed diets supplemented with cholic acid, an Fxr ligand, and this induction is attenuated in Fxr null mice	SEN:10000240	11579204
BEL:20000376	p(HGNC:PARP1) decreases cat(p(HGNC:DNASE1L3))	caspase-3 prevented the inhibition of DNAS1L3 endonuclease activity by wild-type PARP-1	SEN:10000242	11694507
BEL:20000380	cat(p(HGNC:CASP3)) decreases p(HGNC:PARP1)	caspase-3 prevented the inhibition of DNAS1L3 endonuclease activity by wild-type PARP-1	SEN:10000242	11694507
BEL:20000392	p(MGI:Mst1) increases cat(p(MGI:Mst1r))	macrophage-stimulating protein (MSP), through activation of its receptor RON, negatively regulates NO production in response to IFN-gamma and LPS by inhibiting the expression of inducible NO synthase (iNOS).	SEN:10000252	11777982
BEL:20000394	cat(p(MGI:Mst1r)) decreases r(MGI:Nos2)	macrophage-stimulating protein (MSP), through activation of its receptor RON, negatively regulates NO production in response to IFN-gamma and LPS by inhibiting the expression of inducible NO synthase (iNOS).	SEN:10000252	11777982
BEL:20000396	cat(p(MGI:Mst1r)) decreases a(CHEBI:"nitric oxide")	macrophage-stimulating protein (MSP), through activation of its receptor RON, negatively regulates NO production in response to IFN-gamma and LPS by inhibiting the expression of inducible NO synthase (iNOS).	SEN:10000252	11777982
BEL:20000398	p(MGI:Apoa1) increases complex(a(CHEBI:"high-density lipoprotein"),a(CHEBI:cholesterol))	Recent studies have demonstrated in humans that fibrates increase plasma HDL cholesterol in humans, at least in part, through induction of the expression of the human apoa1 ans apoa2 genes.	SEN:10000254	11788127
BEL:20000400	p(MGI:Apoa2) increases complex(a(CHEBI:"high-density lipoprotein"),a(CHEBI:cholesterol))	Recent studies have demonstrated in humans that fibrates increase plasma HDL cholesterol in humans, at least in part, through induction of the expression of the human apoa1 ans apoa2 genes.	SEN:10000254	11788127
BEL:20000418	cat(p(HGNC:IL6ST)) directlyIncreases kin(p(HGNC:JAK2))	binding of Il6 to Il6R induces homodimerization ofgp130, activating JAK associated with gp130 at Box1.	SEN:10000268	12110143
BEL:20000426	cat(p(HGNC:FADD)) increases cat(p(HGNC:CASP8))	Thus, FADD is not only necessary for recruitment and activation of caspase-8, but also for recruitment and activation of caspase-10 at the TRAIL and the CD95 DISCs.	SEN:10000276	12198154
BEL:20000428	cat(p(HGNC:FADD)) increases cat(p(HGNC:CASP10))	Thus, FADD is not only necessary for recruitment and activation of caspase-8, but also for recruitment and activation of caspase-10 at the TRAIL and the CD95 DISCs.	SEN:10000276	12198154
BEL:20000430	bp(GOBP:"apoptotic process") increases cat(p(MGI:Pla2g4a))	Both Pla2g6 and cPLA2 are activated during apoptosis. 	SEN:10000278	12208880
BEL:20000432	bp(GOBP:"apoptotic process") increases cat(p(MGI:Pla2g6))	Both Pla2g6 and cPLA2 are activated during apoptosis. 	SEN:10000278	12208880
BEL:20000442	cat(p(HGNC:MMP12)) increases deg(p(HGNC:ELN))	It has also become apparent that macrophage-derived metalloproteases, including gelatinase A (MMP-2), gelatinase B (MMP-9), matrilysin MMP-7), and macrophage metalloelastase (MMP-12), can degrade elastin and collagen (11, 13, 14).	SEN:10000286	12522030
BEL:20000444	cat(p(HGNC:MMP2)) increases deg(p(HGNC:ELN))	It has also become apparent that macrophage-derived metalloproteases, including gelatinase A (MMP-2), gelatinase B (MMP-9), matrilysin MMP-7), and macrophage metalloelastase (MMP-12), can degrade elastin and collagen (11, 13, 14).	SEN:10000286	12522030
BEL:20000446	cat(p(HGNC:MMP7)) increases deg(p(HGNC:ELN))	It has also become apparent that macrophage-derived metalloproteases, including gelatinase A (MMP-2), gelatinase B (MMP-9), matrilysin MMP-7), and macrophage metalloelastase (MMP-12), can degrade elastin and collagen (11, 13, 14).	SEN:10000286	12522030
BEL:20000448	cat(p(HGNC:MMP9)) increases deg(p(HGNC:ELN))	It has also become apparent that macrophage-derived metalloproteases, including gelatinase A (MMP-2), gelatinase B (MMP-9), matrilysin MMP-7), and macrophage metalloelastase (MMP-12), can degrade elastin and collagen (11, 13, 14).	SEN:10000286	12522030
BEL:20000454	cat(p(HGNC:DOCK1)) directlyIncreases gtp(p(HGNC:RAC1))	FA-CRKL induced cotranslocation of a Rac1 activator, Dock1, to focal adhesions. 	SEN:10000292	12665586
BEL:20000464	cat(p(HGNC:ADAM17)) increases p(HGNC:AREG)	Data show that in squamous cell carcinoma cells, stimulation with G protein-coupled receptor agonists specifically results in cleavage and release of amphiregulin (AR) by TACE.	SEN:10000300	12743035
BEL:20000466	complex(p(MGI:Yy1),p(MGI:Rb1)) decreases tscript(p(MGI:Yy1))	These observations suggest that the interaction of YY1 with hypophosphorylated Rb in resting B cells prevents interaction of YY1 with DNA. 	SEN:10000302	12759432
BEL:20000468	cat(p(HGNC:MMP9)) increases p(HGNC:VEGFA)	The matrix metalloproteinase (MMP)-9 was also found to be a component of the angiogenic switch. By releasing sequestered VEGF, this proteinase makes VEGF available for interaction with its receptors45.	SEN:10000304	12778130
BEL:20000480	p(MGI:Cry1) increases bp(GOBP:"cell cycle")	 Therefore, the cell cycle progression from S to M phase was impaired during liver regeneration in Cry-deficient mice	SEN:10000314	12934012
BEL:20000482	cat(p(HGNC:HIF1AN)) directlyDecreases complex(p(HGNC:HIF1A),p(HGNC:EP300))	O2-dependent hydroxylation of asparagine (N) residue 803 in HIF-1a by the enzyme FIH-1 (factor inhibiting HIF-1) blocks the binding of p300 and CBP to HIF-1a and therefore inhibits HIF-1-mediated gene transcription.	SEN:10000316	13130303
BEL:20000484	cat(p(HGNC:HIF1AN)) directlyDecreases complex(p(HGNC:HIF1A),p(HGNC:CREBBP))	O2-dependent hydroxylation of asparagine (N) residue 803 in HIF-1a by the enzyme FIH-1 (factor inhibiting HIF-1) blocks the binding of p300 and CBP to HIF-1a and therefore inhibits HIF-1-mediated gene transcription.	SEN:10000316	13130303
BEL:20000486	cat(p(HGNC:HIF1AN)) directlyDecreases tscript(p(HGNC:HIF1A))	O2-dependent hydroxylation of asparagine (N) residue 803 in HIF-1a by the enzyme FIH-1 (factor inhibiting HIF-1) blocks the binding of p300 and CBP to HIF-1a and therefore inhibits HIF-1-mediated gene transcription.	SEN:10000316	13130303
BEL:20000492	path(MESHD:Hyperoxia) decreases sec(p(MGI:Vegfa))	In the developing retina, hyperoxia-induced vessel regression has been correlated with inhibition of glial VEGF release (5).	SEN:10000322	14657001
BEL:20000520	cat(p(MGI:Icmt)) increases bp(GOBP:"cell growth")	Inactivation of Icmt inhibited cell growth and K-Ras-induced oncogenic transformation, both in soft agar assays and in a nude mice model.	SEN:10000336	14966563
BEL:20000532	cat(p(MGI:Entpd1)) decreases path(MESHD:Ischemia)	In mutant mice null or deficient for cd39, ischemia reperfusion-related death occurred in 80% of animals.	SEN:10000342	14983235
BEL:20000542	cat(p(MGI:Lgals12)) increases bp(GOBP:"fat cell differentiation")	Here, we show that the galectin-12 gene is expressed in mouse preadipocytes and is up-regulated when preadipocytes undergo cell cycle arrest, concomitant with acquisition of the competence to undergo differentiation in response to adipogenic hormone stimulation. 	SEN:10000348	15131127
BEL:20000544	cat(p(MGI:Lgals12)) increases r(MGI:Cebpa)	Down-regulation of endogenous galectin-12 expression by RNA interference greatly reduced the expression of the adipogenic transcription factors CCAAT/enhancer-binding protein-beta and -alpha and peroxisome proliferator-activated receptor-gamma and severely suppressed adipocyte differentiation as a result of defective adipogenic signaling.	SEN:10000350	15131127
BEL:20000546	cat(p(MGI:Lgals12)) increases r(MGI:Cebpb)	Down-regulation of endogenous galectin-12 expression by RNA interference greatly reduced the expression of the adipogenic transcription factors CCAAT/enhancer-binding protein-beta and -alpha and peroxisome proliferator-activated receptor-gamma and severely suppressed adipocyte differentiation as a result of defective adipogenic signaling.	SEN:10000350	15131127
BEL:20000548	cat(p(MGI:Lgals12)) increases r(MGI:Pparg)	Down-regulation of endogenous galectin-12 expression by RNA interference greatly reduced the expression of the adipogenic transcription factors CCAAT/enhancer-binding protein-beta and -alpha and peroxisome proliferator-activated receptor-gamma and severely suppressed adipocyte differentiation as a result of defective adipogenic signaling.	SEN:10000350	15131127
BEL:20000550	cat(p(MGI:Lgals12)) increases bp(GOBP:"fat cell differentiation")	 Down-regulation of endogenous galectin-12 expression by RNA interference greatly reduced the expression of the adipogenic transcription factors CCAAT/enhancer-binding protein-beta and -alpha and peroxisome proliferator-activated receptor-gamma and severely suppressed adipocyte differentiation as a result of defective adipogenic signaling.	SEN:10000352	15131127
BEL:20000564	cat(p(HGNC:CASP8)) directlyIncreases cat(p(HGNC:CASP3))	When initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10000364	15286739
BEL:20000566	cat(p(HGNC:CASP9)) directlyIncreases cat(p(HGNC:CASP3))	When initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10000364	15286739
BEL:20000568	cat(p(HGNC:CASP9)) directlyIncreases cat(p(HGNC:CASP6))	When initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10000364	15286739
BEL:20000570	cat(p(HGNC:CASP9)) directlyIncreases cat(p(HGNC:CASP7))	When initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10000364	15286739
BEL:20000586	path(MESHD:Hyperoxia) increases kin(p(MGI:Mapk1))	hyperoxia stimulated ERK-1 and ERK-2 phosphorylation	SEN:10000378	15292179
BEL:20000590	path(MESHD:Hyperoxia) increases kin(p(MGI:Mapk3))	hyperoxia stimulated ERK-1 and ERK-2 phosphorylation	SEN:10000378	15292179
BEL:20000592	path(MESHD:Hyperoxia) increases p(MGI:Nfe2l2,pmod(P))	As was seen for wild-type MEFs, hyperoxia enhanced the phosphorylation of endogenous Nrf2 (lane 6) when compared with room air-exposed controls (lane 5).	SEN:10000382	15292179
BEL:20000594	path(MESHD:Hyperoxia) increases p(MGI:Nfe2l2,pmod(P))	In ERK-1+/+ MEFs, hyperoxia stimulated phosphorylation of Nrf2 (lane 4), when compared with room air-exposed controls (lane 3).	SEN:10000384	15292179
BEL:20000602	a(CHEBI:aldosterone) directlyIncreases tscript(p(HGNC:NR3C2))	The AT2 cells treated with aldosterone had increased Na,K-ATPase beta1-subunit mRNA and protein, which was associated with a 4-fold increase in the Na,K-ATPase hydrolytic activity and the ouabain-sensitive (86)Rb(+) uptake.	SEN:10000392	10673201
BEL:20000606	a(CHEBI:ATP) decreases bp(GOBP:"necrotic cell death")	Activation of poly(ADP-ribose) polymerase (PARP) by DNA breaks catalyzes poly(ADP-ribosyl)ation and results in depletion of NAD+ and ATP, which is thought to induce necrosis. 	SEN:10000396	10373561
BEL:20000608	a(CHEBI:bilirubin) decreases a(CHEBI:"reactive oxygen species")	Bilirubin is a potent antioxidant that we show can protect cells from a 10,000-fold excess of H2O2. We report that bilirubin is a major physiologic antioxidant cytoprotectant.	SEN:10000398	12456881
BEL:20000620	a(CHEBI:ceramide) increases a(CHEBI:"reactive oxygen species")	Ceramide triggers the generation of ROS and increases oxidative stress in many mammalian cells and animal models.	SEN:10000408	20502003
BEL:20000630	a(CHEBI:curcumin) decreases cat(p(HGNC:CYP2B6))	Curcumin showed a competitive type of inhibition towards CYP1A2, CYP3A4 and CYP2B6. Curcumin inhibited CYP1A2 (IC(50), 40.0 microM), CYP3A4 (IC(50), 16.3 microM), CYP2D6 (IC(50), 50.3 microM), CYP2C9 (IC(50), 4.3 microM) and CYP2B6 (IC(50), 24.5 microM). 	SEN:10000418	17433521
BEL:20000632	a(CHEBI:curcumin) increases cat(p(HGNC:SIRT1))	Naturally occurring dietary polyphenols, such as resveratrol, curcumin, quercetin, and catechins, have antioxidant and anti-inflammatory properties via modulating different pathways, such as NF-kappaB- and mitogen activated protein kinase-dependent signaling pathways. In addition, these polyphenols have also been shown to activate SIRT1 directly or indirectly in a variety of models. 	SEN:10000420	20450879
BEL:20000634	a(CHEBI:curcumin) increases p(HGNC:NFE2L2)	Dietary curcumin led to increase in NF-E2-related factor-2 (Nrf2) protein levels and enhanced its nuclear translocation in liver and lungs of mice as compared with controls.	SEN:10000422	18321868
BEL:20000636	a(CHEBI:curcumin) increases tloc(p(MGI:Nfe2l2),GOCCID:0005737,GOCCID:0005634)	Dietary curcumin led to increase in NF-E2-related factor-2 (Nrf2) protein levels and enhanced its nuclear translocation in liver and lungs of mice as compared with controls.	SEN:10000422	18321868
BEL:20000638	a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))	The capacity of GR to transactivate the native angiotensinogen glucocorticoid-responsive element (GRE) using chromatin-IP was not impaired.	SEN:10000424	12414793
BEL:20000650	a(CHEBI:"hyaluronic acid") increases p(HGNC:CD44)	The requirement for CD44 binding and hyaluronan internalization could be bypassed by intracellular administration of hyaluronan oligosaccharides (10-18-mer) in lipopolysaccharide-primed macrophages	SEN:10000436	19258328
BEL:20000666	a(CHEBI:"leukotriene B4") directlyIncreases tscript(p(HGNC:PPARA))	Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.	SEN:10000450	16313356
BEL:20000668	a(CHEBI:"leukotriene B4") directlyIncreases tscript(p(HGNC:PPARA))	Leukotriene B4, a potent chemotactic agent that initiates, coordinates, sustains and amplifies the inflammatory response, is shown to be an activating ligand for the transcription factor PPARalpha.	SEN:10000452	8900274
BEL:20000672	a(CHEBI:lipopolysaccharide) directlyIncreases cat(p(HGNC:TLR4))	In response to lipopolysaccharide (LPS) exposure, macrophages activate the transcription of a large number of pro-inflammatory genes by way of signaling pathways downstream of the LPS receptor, Toll-Like Receptor 4.	SEN:10000456	15107417
BEL:20000674	a(CHEBI:lipopolysaccharide) directlyIncreases cat(p(HGNC:TLR4))	LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappaB-dependent pathway	SEN:10000458	17952090
BEL:20000686	a(CHEBI:ozone) increases a(CHEBI:"reactive oxygen species")	Ozone and oxysterols induced apoptosis and cytotoxicity in ATI-like cells. They also generated reactive oxygen species and DNA damage. 	SEN:10000470	20219673
BEL:20000688	a(CHEBI:quercetin) increases cat(p(HGNC:SIRT1))	Naturally occurring dietary polyphenols, such as resveratrol, curcumin, quercetin, and catechins, have antioxidant and anti-inflammatory properties via modulating different pathways, such as NF-kappaB- and mitogen activated protein kinase-dependent signaling pathways. In addition, these polyphenols have also been shown to activate SIRT1 directly or indirectly in a variety of models. 	SEN:10000420	20450879
BEL:20000706	a(CHEBI:"reactive oxygen species") increases cat(p(HGNC:ADAM17))	We conclude that HNE induces MUC5AC mucin expression via a cascade involving PKC-ROS-TACE in human airway epithelial cells.	SEN:10000488	16148149
BEL:20000716	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAP3K5))	Treatment with PM2.5 resulted in the ROS-mediated activation of the oxidant-sensitive kinase ASK1 and its downstream kinase JNK.	SEN:10000498	19033436
BEL:20000718	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAPK1))	In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,	SEN:10000500	16987002
BEL:20000724	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAPK3))	In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,	SEN:10000500	16987002
BEL:20000750	a(CHEBI:"reactive oxygen species") increases p(HGNC:CCL3)	Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS)	SEN:10000522	19293939
BEL:20000752	a(CHEBI:"reactive oxygen species") increases p(HGNC:CXCL2)	Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS)	SEN:10000522	19293939
BEL:20000764	a(CHEBI:resveratrol) increases cat(p(HGNC:SIRT1))	Pre-treatment of endothelial cells with resveratrol significantly attenuated the CSE- and oxidant-mediated SIRT1 levels and eNOS acetylation. 	SEN:10000532	20102704
BEL:20000766	a(CHEBI:"sphingosine 1-phosphate") decreases bp(GOBP:"apoptotic process")	We demonstrate that inactivation of the S1P producing enzyme, sphingosine kinase, leads to cell death in cardiac tissue which is rescued by exogenous S1P treatment.	SEN:10000534	16434032
BEL:20000772	a(CHEBI:thapsigargin) increases bp(GOBP:"response to endoplasmic reticulum stress")	selective hypersensitivity to apoptosis induced by ER stress agents (thapsigargin, tunicamycin, brefeldin A), but not to stimulators of mitochondrial or TNF/Fas-death receptor apoptosis pathways.	SEN:10000540	15304216
BEL:20000774	a(CHEBI:thapsigargin) increases bp(GOBP:"response to endoplasmic reticulum stress")	Thapsigargin, an endoplasmic reticulum (ER) stress-inducing agent, significantly decreased threonine32-phosphorylation of FOXO3a, and increased nuclear and decreased cytosolic FOXO3a, suggesting that thapsigargin activates FOXO3a.	SEN:10000542	15207915
BEL:20000776	a(CHEBI:"thromboxane A2") increases bp(GOBP:"macrophage activation")	These observations suggested that the inverse gene expression of PGIS and TXS in macrophages contributes to immune responses by modulating the relative levels of prostacyclin and thromboxane A2.	SEN:10000544	9202154
BEL:20000936	bp(GOBP:"cell migration") increases bp(GOBP:"wound healing")	Wound healing is a complex process requiring the collaborative efforts of different tissues and cell lineages, and involving the coordinated interplay of several phases of proliferation, migration, matrix synthesis and contraction.	SEN:10000686	15642097
BEL:20000938	bp(GOBP:"hyperosmotic response") increases kin(p(HGNC:MAPK14))	RNA interference (RNAi) demonstrates that MEKK3 and the scaffold protein are required for p38 activation in response to sorbitol-induced hyperosmolarity.	SEN:10000688	14634666
BEL:20000942	bp(GOBP:"hyperosmotic response") increases p(HGNC:NRG1)	We investigated upstream components of the response to hypertonicity in lung epithelial cells and found that before extracellular signal-regulated kinase activation and aquaporin synthesis, the membrane-bound prohormone neuregulin 1-beta is cleaved and binds to human epidermal growth factor receptor 3 (HER3). 	SEN:10000692	15498868
BEL:20000944	bp(GOBP:"hyperosmotic response") increases tscript(p(HGNC:HIF1A))	Cotransfections of AQP5-luciferase with HIF-1alpha and HIF-1beta expression plasmids in MLE-15 cells led to dose-dependent transcriptional enhancement, which was partially abrogated by mutagenesis of putative HIF-1alpha binding sites in the proximal AQP5 promoter.Importantly, hypertonic induction of AQP5 was significantly inhibited by preventing HIF-1alpha induction with small interfering RNA. 	SEN:10000694	17108010
BEL:20000966	bp(GOBP:"mast cell activation") increases p(HGNC:IL13)	In the light of recent reports that strongly support critical roles for IL-9 and IL-13 in allergic lung inflammation, our results emphasize the potential clinical importance of LPS as an enhancer of mast cell-derived IL-9 and IL-13 production in the course of inflammatory reactions and allergic diseases.	SEN:10000710	11254693
BEL:20000968	bp(GOBP:"mast cell activation") increases p(HGNC:IL9)	In the light of recent reports that strongly support critical roles for IL-9 and IL-13 in allergic lung inflammation, our results emphasize the potential clinical importance of LPS as an enhancer of mast cell-derived IL-9 and IL-13 production in the course of inflammatory reactions and allergic diseases.	SEN:10000710	11254693
BEL:20000970	bp(GOBP:"necrotic cell death") increases p(HGNC:HMGB1)	HMGB1 protein is not released by apoptotic cells but is passively released by necrotic or damaged somatic and immune cells and it functions as a major stimulus of necrosis-induced inflammation. 	SEN:10000712	15387080
BEL:20000978	bp(GOBP:"cellular response to DNA damage stimulus") increases kin(p(HGNC:ATR))	 Treatment with estrogen can block DNA damage-induced senescence. Moreover, WRN is suppressed by ATR that is activated by DNA damage, whereas WRN can be induced by ATR elimination. 	SEN:10000720	20395656
BEL:20000982	bp(GOBP:"cellular response to DNA damage stimulus") increases kin(p(HGNC:CHEK1))	We have shown recently that DNA damage effector kinase Chk1 is phosphorylated in vitro by protein kinase B/Akt (PKB/Akt) on serine 280. Activation of Chk1 by DNA damage in vivo is suppressed in presence of activated PKB. In this study we show that Chk1 is phosphorylated by PKB in vivo, and that increased phosphorylation by PKB on serine 280 correlates with impairment of Chk1 activation by DNA damage.	SEN:10000724	15107605
BEL:20001000	bp(GOBP:"response to endoplasmic reticulum stress") increases tscript(p(HGNC:ATF6))	These results suggest that specific ER stress signaling transmitted by ATF6 leads to naturally occurring apoptosis during muscle development.	SEN:10000742	15897261
BEL:20001012	bp(GOBP:"response to hypoxia") increases bp(GOBP:glycolysis)	The incubation of activated monocytes with oligomycin, an inhibitor of oxidative phosphorylation, or under hypoxic conditions activated AMPK and further increased iPFK-2 activity, fructose 2,6-bisphosphate content, and glycolysis.	SEN:10000752	12065600
BEL:20001026	bp(GOBP:"response to hypoxia") increases p(HGNC:EDN1)	Plasma and lung endothelin-1 levels were increased by chronic hypoxia, but these levels were not significantly different between the 2 genotypes.	SEN:10000766	11230292
BEL:20001036	bp(GOBP:"response to hypoxia") increases p(HGNC:VEGFA)	Both glucose and pH significantly affected VEGF production induced by low oxygen.	SEN:10000776	9746434
BEL:20001050	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	Our results suggest that activation of HIF-1alpha by hypoxia decreases HDAC2 levels, resulting in amplified inflammation	SEN:10000790	19880520
BEL:20001052	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	These results suggest the dependence of G6PD gene expression on HIF	SEN:10000792	15225644
BEL:20001056	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	To examine whether this up-regulation of Met was directly induced by HIF-1alpha, we performed the chromatin immunoprecipitation assay, which revealed that HIF-1alpha binds to the promoter region of the Met gene under low-oxygen tension.	SEN:10000796	16099863
BEL:20001058	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	Up-regulation of NPM is hypoxia-inducible factor-1 (HIF-1)-dependent. The NPM promoter encodes a functional HIF-1-responsive element that can be activated by hypoxia or forced expression of HIF-1alpha.	SEN:10000798	15310764
BEL:20001060	bp(GOBP:"response to ionizing radiation") increases gtp(p(HGNC:RHOB))	The increase in RhoB activity after genotoxic stress is associated with increased activity of the nuclear guanine nucleotide exchange factors (GEFs), Ect2 and Net1, but not the cytoplasmic GEFs p115 RhoGEF or Vav2.	SEN:10000800	21373644
BEL:20001074	bp(GOBP:"response to oxidative stress") increases kin(p(HGNC:MAP3K5))	Taken together, glucose deprivation-induced metabolic oxidative stress may activate ASK1 through two different pathways: glutathione-dependent GRX-ASK1 and glutathione-independent TRX-ASK1 pathways.	SEN:10000812	12723971
BEL:20001080	bp(GOBP:"response to UV") increases bp(GOBP:"cellular response to DNA damage stimulus")	This type of radiation generates reactive oxygen species and consequently induces DNA damage.	SEN:10000818	11750059
BEL:20001108	cat(complex(p(HGNC:TSC1),p(HGNC:TSC2))) directlyDecreases gtp(p(HGNC:RHEB))	TSC2 is a GTPase-activating protein (GAP) toward Rheb, a Ras family GTPase	SEN:10000844	12869586
BEL:20001116	cat(p(HGNC:ADAM17)) increases p(HGNC:MUC5AC)	We conclude that HNE induces MUC5AC mucin expression via a cascade involving PKC-ROS-TACE in human airway epithelial cells.	SEN:10000488	16148149
BEL:20001118	cat(p(HGNC:ADAM17)) increases p(HGNC:TGFA)	HNE induces MUC5AC mucin production involving reactive oxygen species (ROS) generation and TGF-alpha-dependent epidermal growth factor receptor (EGFR) activation in human airway epithelial cells. However, the molecular mechanisms involved in these responses are not defined. TNF-alpha-converting enzyme (TACE) cleaves pro-TGF-alpha into soluble TGF-alpha and can be activated by ROS	SEN:10000852	16148149
BEL:20001120	cat(p(HGNC:ADORA2A)) increases p(HGNC:VEGFA)	We propose a novel signaling pathway in murine macrophages involving synergy between TLRs 2, 4, 7, and 9 and A(2A)Rs, that up-regulates VEGF and down-regulates TNFalpha expression, thus acting as an angiogenic switch	SEN:10000854	12875990
BEL:20001128	cat(p(HGNC:AGTR1)) increases p(HGNC:TGFB1)	Collagen synthesis is activated via the angiotensin II type 1 (AT1) receptor. We demonstrate that transforming growth factor-beta1, a major product of stimulated AT1 receptor, does not activate solely collagen synthesis but synergistically the synthesis of hnRNP A1, E1, and K as well.	SEN:10000860	15514164
BEL:20001150	cat(p(HGNC:BAD)) increases cat(p(HGNC:BAK1))	BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X(L) to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1.	SEN:10000880	17115033
BEL:20001152	cat(p(HGNC:BAD)) increases cat(p(HGNC:BAX))	BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X(L) to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1.	SEN:10000880	17115033
BEL:20001154	cat(p(HGNC:BAX)) increases bp(GOBP:"apoptotic process")	JNK is essential for UV-stimulated apoptosis mediated by the mitochondrial pathway by a Bax/Bak-dependent mechanism	SEN:10000882	12591950
BEL:20001164	cat(p(HGNC:BCL2L11)) increases bp(GOBP:"apoptotic process")	JNK phosphorylates two members of the BH3-only subgroup of Bcl2-related proteins (Bim and Bmf)	SEN:10000892	12591950
BEL:20001174	cat(p(HGNC:CASP3)) directlyIncreases kin(p(HGNC:PAK2))	p21-activated protein kinase gamma-PAK (Pak2, PAK I) is cleaved by CPP32 (caspase 3) during apoptosis and plays a key role in regulation of cell death. In vitro, CPP32 cleaves recombinant gamma-PAK into two peptides; 1-212 contains the majority of the regulatory domain whereas 213-524 contains 34 amino acids of the regulatory domain plus the entire catalytic domain.	SEN:10000902	9786869
BEL:20001178	cat(p(HGNC:CASP3)) increases bp(GOBP:"apoptotic process")	apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema. 	SEN:10000906	15944319
BEL:20001180	cat(p(HGNC:CASP3)) increases bp(GOBP:"apoptotic process")	Exposure of hBEC to CS or CS extract (CSE) caused expression of endogenous ER stress markers GRP78 and CHOP and induction of apoptosis evidenced by nuclear condensation, membrane blebbing, and activation of caspase-3 and caspase-4	SEN:10000908	18394432
BEL:20001182	cat(p(HGNC:CASP3)) increases bp(GOBP:"apoptotic process")	Preincubation with the caspase-9 inhibitor z-LEHD-fmk, the caspase-3 inhibitor z-DEVD-fmk, or the specific pan-caspase inhibitor Q-VD-oph decreased the percentage of propidium iodide-positive neurons	SEN:10000910	19235896
BEL:20001190	cat(p(HGNC:CASP4)) increases bp(GOBP:"apoptotic process")	Exposure of hBEC to CS or CS extract (CSE) caused expression of endogenous ER stress markers GRP78 and CHOP and induction of apoptosis evidenced by nuclear condensation, membrane blebbing, and activation of caspase-3 and caspase-4	SEN:10000908	18394432
BEL:20001196	cat(p(HGNC:CASP8)) increases cat(p(HGNC:BID))	Apo2L/TRAIL-induced apoptosis involves caspase-8-mediated cleavage of BID.	SEN:10000922	12154014
BEL:20001198	cat(p(HGNC:CASP8)) increases cat(p(HGNC:BID))	BACKGROUND: Following cleavage by caspase 8, the C-terminus of Bid translocates from the cytosol to the mitochondria that is dependent upon structures formed by the mitochondrial-specific lipid cardiolipin. Once associated with mitochondria, truncated Bid (tBid) causes the potent release of cytochrome c, endonuclease G, and smac.	SEN:10000924	11716782
BEL:20001222	cat(p(HGNC:CCR7)) increases kin(p(HGNC:MAP2K4))	CCL19 also increased interaction between phospho-JNK and phospho-mitogen-activated protein kinase kinase (MKK) 4 but not phospho-MKK7 in mature DCs, suggesting that the JNK activation is mediated via MKK4	SEN:10000948	16027136
BEL:20001226	cat(p(HGNC:CCR7)) increases kin(p(HGNC:MAPK1))	We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.	SEN:10000952	15778365
BEL:20001230	cat(p(HGNC:CCR7)) increases kin(p(HGNC:MAPK3))	We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.	SEN:10000952	15778365
BEL:20001234	cat(p(HGNC:CD40)) increases p(HGNC:TNFSF13)	dendritic cells up-regulate BLyS and APRIL upon exposure to interferon-alpha, interferon-gamma or CD40 ligand.	SEN:10000954	12154359
BEL:20001258	cat(p(HGNC:CYP1A1)) increases a(CHEBI:"reactive oxygen species")	Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)	SEN:10000976	16877260
BEL:20001260	cat(p(HGNC:CYP1A2)) increases a(CHEBI:"reactive oxygen species")	Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)	SEN:10000976	16877260
BEL:20001262	cat(p(HGNC:CYP1B1)) increases a(CHEBI:"reactive oxygen species")	Generally, induction of CYP1A1, CYP1A2, and CYP1B1 is considered cardiotoxic through generating reactive oxygen species (ROS)	SEN:10000976	16877260
BEL:20001276	cat(p(HGNC:EGLN1)) increases deg(p(HGNC:HIF1A))	Cellular iron is needed for cell survival and hydroxylation of hypoxia-inducible factor-1alpha (HIF-alpha) by prolyl hydroxylases (PHD). One mechanism of iron uptake is mediated by the cell surface transferrin receptor (TfR). Because iron is required for cell growth and suppression of HIF-alpha levels	SEN:10000988	16510596
BEL:20001278	cat(p(HGNC:EGLN2)) increases deg(p(HGNC:HIF1A))	Cellular iron is needed for cell survival and hydroxylation of hypoxia-inducible factor-1alpha (HIF-alpha) by prolyl hydroxylases (PHD). One mechanism of iron uptake is mediated by the cell surface transferrin receptor (TfR). Because iron is required for cell growth and suppression of HIF-alpha levels	SEN:10000988	16510596
BEL:20001280	cat(p(HGNC:EP300)) directlyIncreases p(HGNC:WRN)	Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect.	SEN:10000990	20428248
BEL:20001302	cat(p(HGNC:FPR1)) increases bp(GOBP:"neutrophil chemotaxis")	The peptide FMLP is an active component of CS. FMLP interacts on the neutrophil and macrophage membranes with a high-affinity receptor subtype (FPR1) and with a low-affinity subtype FPRL1, promoting a chemotactic response, superoxide anion production, and degranulation.	SEN:10000652	22461430
BEL:20001306	cat(p(HGNC:G6PD)) increases a(CHEBI:NADPH)	G6PD activity and expression level, providing NADPH	SEN:10001004	12475221
BEL:20001318	cat(p(HGNC:GRPR)) increases kin(p(HGNC:EGFR))	Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells	SEN:10001016	15967120
BEL:20001322	cat(p(HGNC:GSR)) increases a(CHEBI:glutathione)	Nrf2(-/-) MEFs exhibited greater accumulation of glutathione disulfide and cytotoxicity compared to Nrf2(+/+) MEFs in response to t-butylhydroquinone, which was rescued by restoring GSR	SEN:10001020	19028565
BEL:20001326	cat(p(HGNC:IL1R1)) increases cat(p(HGNC:TRAF6))	IL-1 treatment of 293 cells induces the association of TRAF6 with IRAK, a serine/threonine kinase that is rapidly recruited  to the IL-1 receptor  after IL-1 induction	SEN:10001024	8837778
BEL:20001342	cat(p(HGNC:ITGAM)) increases bp(GOBP:"cell adhesion")	Neutralization with Ab showed that this adhesion was mediated by Mac-1	SEN:10001038	12626582
BEL:20001344	cat(p(HGNC:ITGAM)) increases bp(GOBP:"cell adhesion")	The neutrophil cytoplasmic protein S100A8/A9 (along with S100A8 and S100A9) is chemotactic and stimulates neutrophil adhesion by activating the beta2-integrin CD11b/CD18.	SEN:10001040	15107458
BEL:20001350	cat(p(HGNC:MBTPS1)) increases tscript(p(HGNC:ATF6))	Upon ER stress, transcription factor ATF6 translocates from the ER to Golgi, where it is sequentially cleaved by site 1 and site 2 proteases, S1P and S2P, to a 50-kDa form that activates transcription of ERSE genes	SEN:10001046	18287014
BEL:20001354	cat(p(HGNC:MBTPS2)) increases tscript(p(HGNC:ATF6))	Upon ER stress, transcription factor ATF6 translocates from the ER to Golgi, where it is sequentially cleaved by site 1 and site 2 proteases, S1P and S2P, to a 50-kDa form that activates transcription of ERSE genes	SEN:10001046	18287014
BEL:20001356	cat(p(HGNC:MDM2)) directlyDecreases p(HGNC:TP53)	p16(INK4a) is a critical component in retinoblastoma protein (Rb)-mediated growth regulatory pathway, p14(ARF) plays a pivotal role in the activation of p53 upon oncogenic stress signals. 	SEN:10001048	17297463
BEL:20001364	cat(p(HGNC:MYD88)) directlyIncreases tscript(p(HGNC:IRF5))	We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6	SEN:10001056	15665823
BEL:20001370	cat(p(HGNC:NOS1)) directlyIncreases a(CHEBI:"nitric oxide")	OS exists in three distinct isoforms: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). NO derived from the constitutive isoforms of NOS (nNOS and eNOS) and other NO-adduct molecules (nitrosothiols) have been shown to be modulators of bronchomotor tone.	SEN:10001062	15269335
BEL:20001372	cat(p(HGNC:NOS2)) directlyIncreases a(CHEBI:"nitric oxide")	NADPH is an obligatory cosubstrate for iNOS synthesis of NO	SEN:10001064	12475221
BEL:20001374	cat(p(HGNC:NOS2)) directlyIncreases a(CHEBI:"nitric oxide")	Vascular endothelium participates in the control of vascular tone and function via the release of nitric oxide (NO) by the endothelial-type NO synthase (eNOS). Inducible NO synthase (iNOS) expression in endothelial cells occurs in many clinical conditions following induction by lipopolysaccharide or cytokines and generates large quantities of NO that result in endothelial cell activation and dysfunction.	SEN:10001066	11474579
BEL:20001378	cat(p(HGNC:NOS3)) directlyIncreases a(CHEBI:"nitric oxide")	OS exists in three distinct isoforms: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). NO derived from the constitutive isoforms of NOS (nNOS and eNOS) and other NO-adduct molecules (nitrosothiols) have been shown to be modulators of bronchomotor tone.	SEN:10001062	15269335
BEL:20001380	cat(p(HGNC:NOS3)) directlyIncreases a(CHEBI:"nitric oxide")	Vascular endothelium participates in the control of vascular tone and function via the release of nitric oxide (NO) by the endothelial-type NO synthase (eNOS). Inducible NO synthase (iNOS) expression in endothelial cells occurs in many clinical conditions following induction by lipopolysaccharide or cytokines and generates large quantities of NO that result in endothelial cell activation and dysfunction.	SEN:10001066	11474579
BEL:20001382	cat(p(HGNC:NOS3)) increases bp(GOBP:angiogenesis)	Whereas angiopoietin 2 (Ang2) was exclusively regulated by Foxo1, eNOS, which is essential for postnatal neovascularization, was regulated by Foxo1 and Foxo3a. Consistent with these findings, constitutively active Foxo1 and Foxo3a repressed eNOS protein expression and bound to the eNOS promoter.	SEN:10001070	16100571
BEL:20001384	cat(p(HGNC:NOX1)) increases a(CHEBI:"reactive oxygen species")	In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,	SEN:10000500	16987002
BEL:20001388	cat(p(HGNC:NOX1)) increases a(CHEBI:"reactive oxygen species")	Rac1 GTPase is essential for the activation of the NAD(P)H oxidase complex	SEN:10001072	12493759
BEL:20001396	cat(p(HGNC:NQO1)) decreases a(CHEBI:"reactive oxygen species")	However the cardioprotective properties of NQO1 and GSTA1 are mainly attributed to the antioxidant effect by decreasing ROS and increasing the levels of endogenous antioxidants. 	SEN:10001074	16877260
BEL:20001400	cat(p(HGNC:PARP1)) decreases a(CHEBI:ATP)	Activation of poly(ADP-ribose) polymerase (PARP) by DNA breaks catalyzes poly(ADP-ribosyl)ation and results in depletion of NAD+ and ATP, which is thought to induce necrosis. 	SEN:10000396	10373561
BEL:20001426	cat(p(HGNC:PTGS2)) decreases a(CHEBI:"arachidonic acid")	FACL4 and COX-2 synergistically inhibit apoptosis by reducing the intracellular level of free arachidonic acid. Here, we report that expression of FACL4 is significantly increased in colon adenocarcinoma	SEN:10001096	11731423
BEL:20001436	cat(p(HGNC:RAD50)) increases bp(GOBP:"double-strand break repair")	In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.	SEN:10001104	17024177
BEL:20001438	cat(p(HGNC:SHC1)) increases kin(p(HGNC:MAPK1))	stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA	SEN:10001106	9171350
BEL:20001440	cat(p(HGNC:SHC1)) increases kin(p(HGNC:MAPK3))	stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA	SEN:10001106	9171350
BEL:20001442	cat(p(HGNC:SIRT1)) directlyDecreases p(HGNC:WRN)	Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect.	SEN:10000990	20428248
BEL:20001452	cat(p(HGNC:SMPD1)) increases a(CHEBI:ceramide)	Moreover, inhibition of ROS generating enzymes or treatment of antioxidants impairs sphingomyelinase activation and ceramide production	SEN:10001112	20502003
BEL:20001454	cat(p(HGNC:SMPD2)) increases a(CHEBI:ceramide)	Moreover, inhibition of ROS generating enzymes or treatment of antioxidants impairs sphingomyelinase activation and ceramide production	SEN:10001112	20502003
BEL:20001460	cat(p(HGNC:TBXAS1)) increases a(CHEBI:"thromboxane A2")	These observations suggested that the inverse gene expression of PGIS and TXS in macrophages contributes to immune responses by modulating the relative levels of prostacyclin and thromboxane A2.	SEN:10000544	9202154
BEL:20001468	cat(p(HGNC:TIMP1)) decreases cat(p(HGNC:MMP7))	TIMP-1 also inhibited matrilysin-mediated cell migration and spreading in vitro	SEN:10001124	18385523
BEL:20001474	cat(p(HGNC:TLR2)) increases cat(p(HGNC:MYD88))	Both interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) signal via the adapter molecule MyD88.	SEN:10001130	16413919
BEL:20001482	cat(p(HGNC:TLR2)) increases p(HGNC:IL6)	In TLR2 agonist, heat-killed Listeria monocytogenes-activated human monocytes, NA reduced secretion of TNF-? (by 48.6±7.1%), interleukin-6 (by 60.9±1.6%), and monocyte chemoattractant protein-1 (by 59.3±5.3%)	SEN:10001138	22267479
BEL:20001484	cat(p(HGNC:TLR2)) increases p(HGNC:IL8)	Airway epithelium expresses the highest levels of TLR2, TLR3, TLR5, and TLR6, and here we found that ligands for these TLRs increased IL-8 and VEGF production in normal human bronchial epithelial cells. 	SEN:10001140	18375743
BEL:20001486	cat(p(HGNC:TLR2)) increases p(HGNC:VEGFA)	We propose a novel signaling pathway in murine macrophages involving synergy between TLRs 2, 4, 7, and 9 and A(2A)Rs, that up-regulates VEGF and down-regulates TNFalpha expression, thus acting as an angiogenic switch	SEN:10000854	12875990
BEL:20001500	cat(p(HGNC:TLR4)) increases p(HGNC:IL6)	We tested if human coronary artery endothelial cells (HCAEC) may become a source of cytokine and adhesion molecule expression when stimulated with bacterial lipopolysaccharide (LPS). Analysis of HCAEC supernatants by ELISA identified enhanced secretion of IL-6, IL-8, and MCP-1 while	SEN:10001150	12237173
BEL:20001502	cat(p(HGNC:TLR4)) increases p(HGNC:SELE)	IL-1beta and TNF-alpha but not IL-10. FACS analysis showed an LPS-induced upregulation of ICAM-1, VCAM, and ELAM-1.	SEN:10001152	12237173
BEL:20001506	cat(p(HGNC:TLR4)) increases p(HGNC:VEGFA)	We propose a novel signaling pathway in murine macrophages involving synergy between TLRs 2, 4, 7, and 9 and A(2A)Rs, that up-regulates VEGF and down-regulates TNFalpha expression, thus acting as an angiogenic switch	SEN:10000854	12875990
BEL:20001516	cat(p(HGNC:TLR7)) increases p(HGNC:VEGFA)	We propose a novel signaling pathway in murine macrophages involving synergy between TLRs 2, 4, 7, and 9 and A(2A)Rs, that up-regulates VEGF and down-regulates TNFalpha expression, thus acting as an angiogenic switch	SEN:10000854	12875990
BEL:20001520	cat(p(HGNC:TLR9)) increases p(HGNC:VEGFA)	We propose a novel signaling pathway in murine macrophages involving synergy between TLRs 2, 4, 7, and 9 and A(2A)Rs, that up-regulates VEGF and down-regulates TNFalpha expression, thus acting as an angiogenic switch	SEN:10000854	12875990
BEL:20001522	cat(p(HGNC:TNFRSF1A)) increases cat(p(HGNC:TRADD))	We found that TRADD is required for TNFR1 to induce NF-kappaB activation and caspase-8-dependent apoptosis but is dispensable for TNFR1-initiated, RIP1-dependent necrosis.	SEN:10001160	16611992
BEL:20001526	cat(p(HGNC:TNFRSF1A)) increases kin(p(HGNC:RIPK1))	The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumour necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3)	SEN:10001164	20823910
BEL:20001528	cat(p(HGNC:TNFRSF1A)) increases kin(p(HGNC:RIPK3))	The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumour necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3)	SEN:10001164	20823910
BEL:20001536	cat(p(HGNC:TNFRSF1B)) increases kin(p(HGNC:SRC))	We therefore conclude that TNFR2 activates a novel Src-regulated pathway involving FAK tyrosine phosphorylation that enhances migration of intestinal epithelial cells	SEN:10001170	12466150
BEL:20001560	cat(p(HGNC:XDH)) increases a(CHEBI:"reactive oxygen species")	During ischemia, there appears to be a calcium-triggered, protease-dependent conversion of the native xanthine dehydrogenase to a superoxide-producing xanthine oxidase. The catabolic degradation of ATP during ischemia provides an oxidizable substrate, hypoxanthine	SEN:10001192	2982206
BEL:20001574	cat(p(HGNC:XIAP)) decreases cat(p(HGNC:CASP7))	Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments.	SEN:10001206	14512414
BEL:20001578	cat(p(HGNC:XIAP)) decreases cat(p(HGNC:CASP9))	Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments.	SEN:10001206	14512414
BEL:20001588	cat(p(MGI:P2rx7)) increases cat(p(HGNC:CASP1))	.....rapid export of caspase-1-processed IL-1 beta from monocytes/macrophages in response to activation of P2X7 receptors (P2X7R) by extracellular ATP.	SEN:10001214	17641058
BEL:20001614	complex(p(HGNC:ERBB4),p(HGNC:ERBB2)) directlyIncreases kin(p(HGNC:ERBB2))	Furthermore, our data indicate that the HRG-induced ErbB2.ErbB4 complexes stimulate ErbB2 tyrosine kinase, which induces both ERK phosphorylation and kinase activity.  The activated ERK then increases the phosphorylation of HAS1, HAS2, and HAS3.  Consequently, all three HAS isozymes are activated resulting in hyaluronan (HA) production. 	SEN:10001240	17493932
BEL:20001618	complex(p(HGNC:ETV6),p(HGNC:CTBP1)) increases bp(GOBP:"patterning of blood vessels")	Tel orchestrates endothelial sprouting by binding to the generic co-repressor, CtBP	SEN:10001242	20835243
BEL:20001622	complex(p(HGNC:IL12B),p(HGNC:IL23A)) directlyIncreases cat(p(HGNC:IL12RB1))	Like IL-12, IL-23 binds to the IL-12R subunit IL-12Rbeta1.	SEN:10001246	12023369
BEL:20001632	complex(p(HGNC:ITGAV),p(HGNC:ITGB6)) increases p(HGNC:TGFB1)	alpha v beta 6-expressing cells induce spatially restricted activation of TGF beta 1	SEN:10001256	10025398
BEL:20001640	complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) increases bp(GOBP:"double-strand break repair")	The Mre11/Rad50/NBS1 (MRN) complex is mutated in inherited genomic instability syndromes featuring cancer predisposition, mental retardation and immunodeficiency.  It functions both in DNA double-strand break repair and in controlling the ataxia telangiectasia mutated (ATM) kinase during the response to these lesions	SEN:10001262	16087684
BEL:20001650	complex(p(HGNC:SERPINA1),p(HGNC:IL8)) directlyDecreases cat(p(EGID:3579))	We demonstrated that glycosylated AAT can bind to IL-8 (a ligand for CXCR1) and that AAT-IL-8 complex formation prevented IL-8 interaction with CXCR1.	SEN:10001272	21060150
BEL:20001658	complex(p(HGNC:TXN),p(HGNC:MAP3K5)) decreases kin(p(HGNC:MAP3K5))	Redox-sensing molecules such as thioredoxin (TRX) and glutaredoxin (GRX) bind to apoptosis signal-regulating kinase 1 (ASK1) and suppress its activation	SEN:10001280	12723971
BEL:20001924	gtp(p(HGNC:KRAS)) increases cat(p(HGNC:PTGS2))	COX-2 protein and activity measured as prostaglandin E(2) level were up-regulated in cells expressing mutant K-ras(V12);	SEN:10001506	15284181
BEL:20001938	gtp(p(HGNC:RAC1)) increases p(HGNC:STAT3,pmod(P,S,727))	Induction of STAT3 Tyr705 and Ser727 phosphorylations by Galpha(s)QL was suppressed by inhibition of protein kinase A, Janus kinase 2/3, Rac1, c-Jun N-terminal kinase (JNK), or phosphatidylinositol 3-kinase, and a similar profile was observed in response to beta2-adrenergic receptor stimulation	SEN:10001518	17008315
BEL:20001940	gtp(p(HGNC:RAC1)) increases p(HGNC:STAT3,pmod(P,Y,705))	Induction of STAT3 Tyr705 and Ser727 phosphorylations by Galpha(s)QL was suppressed by inhibition of protein kinase A, Janus kinase 2/3, Rac1, c-Jun N-terminal kinase (JNK), or phosphatidylinositol 3-kinase, and a similar profile was observed in response to beta2-adrenergic receptor stimulation	SEN:10001518	17008315
BEL:20001946	gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:TIAM1))	Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation	SEN:10000610	17493609
BEL:20001950	gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:VAV2))	Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation	SEN:10000610	17493609
BEL:20001964	gtp(p(HGNC:RHOA)) increases bp(GOBP:"cell migration")	However, the molecular mechanism by which KDR mediates EC migration is not clear yet. Here we show for the first time that activation of RhoA and Rac1 is fully and partially required for KDR-mediated human umbilical vein endothelial cell (HUVEC) migration, respectively, and that CDC42, however, is not involved.	SEN:10001532	12244099
BEL:20001966	gtp(p(HGNC:RHOA)) increases bp(GOBP:"cell migration")	Matrigel invasion assay using the ovarian cancer cell line, SKOV3, showed that up-regulation and activation after treatment with lysophosphatidic acid was associated with enhanced invasion of the cancer cells. This increase in invasiveness was suppressed by the addition of C3, a specific inhibitor of Rho.	SEN:10001534	12808121
BEL:20002004	kin(p(HGNC:ACVRL1)) increases tscript(p(HGNC:SMAD1))	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20002006	kin(p(HGNC:ACVRL1)) increases tscript(p(HGNC:SMAD5))	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20002008	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:GSK3B,pmod(P,S,9))	GSK-3 activity is inhibited through phosphorylation of serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta. These serine residues of GSK-3 have been previously identified as targets of protein kinase B (PKB/Akt), a serine/threonine kinase located downstream of phosphatidylinositol 3-kinase.      	SEN:10001570	11035810
BEL:20002010	kin(p(HGNC:AKT1)) increases bp(GOBP:"cell migration")	Mechanistically, the loss of Akt1 reduces the basal phosphorylation of several Akt substrates, the migration of fibroblasts and ECs, and NO release. 	SEN:10001572	16075056
BEL:20002020	kin(p(HGNC:AKT2)) directlyDecreases kin(p(HGNC:MAP3K5))	AKT2 interacts with and phosphorylates ASK1 at Ser-83 resulting in inhibition of its kinase activity.	SEN:10001582	12697749
BEL:20002026	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))	Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.	SEN:10001586	15107605
BEL:20002028	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:EP300,pmod(P,S,106))	. ATM-phosphorylated p300 in vitro and in vivo, in response to DNA damage. Phosphorylation of p300 proteins was observed upon gamma-irradiation in ATM(+) cells but not ATM(-) cells.	SEN:10001588	20471956
BEL:20002030	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))	Highly purified ATM phosphorylated PHAS-I, the 32-kDa subunit of RPA, serine 15 of p53, and Chk2 in vitro.	SEN:10001590	10713094
BEL:20002034	kin(p(HGNC:ATM)) increases kin(p(HGNC:CHEK1))	 Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation	SEN:10001594	19416980
BEL:20002038	kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))	ATM and Rad3-related (ATR) is a regulatory kinase that, when activated by hydroxyurea, UV, or human immunodeficiency virus-1 Vpr, causes cell cycle arrest through Chk1-Ser(345) phosphorylation.	SEN:10001598	17210576
BEL:20002040	kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))	Consistently, the RNAi-mediated ablation of Claspin selectively abrogated ATR's ability to phosphorylate Chk1 but not other ATR targets.	SEN:10001600	16880517
BEL:20002042	kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))	Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.	SEN:10001586	15107605
BEL:20002050	kin(p(HGNC:AURKA)) directlyIncreases p(HGNC:CDC25B,pmod(P,S,353))	In this report, we demonstrate that the CDC25B phosphatase, an activator of cyclin dependent kinases at mitosis, is phosphorylated both in vitro and in vivo by Aurora-A on serine 353 and that this phosphorylated form of CDC25B is located at the centrosome during mitosis.	SEN:10001604	15128871
BEL:20002070	kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,20))	Two peptides derived from the DNA-binding domain of p53 bind to CHK2 and stimulate phosphorylation of full-length p53 at Thr 18 and Ser 20, thus identifying CHK2-docking sites. 	SEN:10001618	12897801
BEL:20002072	kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:TP53,pmod(P,T,18))	Two peptides derived from the DNA-binding domain of p53 bind to CHK2 and stimulate phosphorylation of full-length p53 at Thr 18 and Ser 20, thus identifying CHK2-docking sites. 	SEN:10001618	12897801
BEL:20002074	kin(p(HGNC:CSNK1D)) increases p(HGNC:PER2,pmod(P))	both hCKIdelta and hCKIepsilon phosphorylated and caused protein instability of human period 2 protein (hPER2)	SEN:10001456	11165242
BEL:20002076	kin(p(HGNC:CSNK1E)) increases p(HGNC:PER1,pmod(P))	Casein kinase Iepsilon (CKIepsilon), a central component of the circadian clock, interacts with and phosphorylates human period protein 1 (hPER1)	SEN:10001620	11165242
BEL:20002078	kin(p(HGNC:CSNK1E)) increases p(HGNC:PER2,pmod(P))	both hCKIdelta and hCKIepsilon phosphorylated and caused protein instability of human period 2 protein (hPER2)	SEN:10001456	11165242
BEL:20002082	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	GRP induced rapid activation of p44/42 MAPK in lung cancer cells through EGFR.	SEN:10001624	15967120
BEL:20002088	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line	SEN:10001630	12618892
BEL:20002090	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK3))	GRP induced rapid activation of p44/42 MAPK in lung cancer cells through EGFR.	SEN:10001624	15967120
BEL:20002094	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK3))	The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line	SEN:10001630	12618892
BEL:20002098	kin(p(HGNC:EGFR)) increases tscript(p(HGNC:STAT3))	The stimulatory EGFR signal is insensitive to inhibition of JAKs and appears to involve Src kinases and STAT proteins as shown by inhibition through overexpression of C-terminal Src kinase (Csk) and transdominant negative STAT3, respectively	SEN:10001634	10462375
BEL:20002110	kin(p(HGNC:GSK3B)) decreases tscript(p(HGNC:CTNNB1))	beta-Catenin is efficiently phosphorylated by glycogen synthase kinase-3beta in the Axin complex in the cytoplasm, resulting in the down-regulation.	SEN:10001646	10921920
BEL:20002112	kin(p(HGNC:GSK3B)) increases p(HGNC:FYN,pmod(P,T))	The activated GSK-3beta phosphorylates Fyn at threonine residue(s). Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. 	SEN:10001648	17403689
BEL:20002126	kin(p(HGNC:IRAK1)) increases kin(p(HGNC:MAP3K7))	Our results show that IRAK is required for the IL-1-induced phosphorylation of TAK1, TAB1, and TAB2.	SEN:10001662	11518704
BEL:20002144	kin(p(HGNC:JAK2)) increases tscript(p(HGNC:STAT1))	This IFNg-stimulated expression of T-bet is dependent on signaling through JAK2 and signal transducers and activators of transcription 1 (STAT1) and activates T-bet-dependent DNA binding activity	SEN:10001678	21239533
BEL:20002146	kin(p(HGNC:JAK2)) increases tscript(p(HGNC:STAT5A))	Furthermore, GH induced rapid, time- and dose-dependent signaling events in LNCaP cells, including phosphorylation of JAK2 tyrosine kinase, of GHR itself and of STAT5A (JAK2-STAT5A pathway), of p42/p44 MAPK and of Akt/PKB.	SEN:10001680	15196705
BEL:20002168	kin(p(HGNC:MAP2K1)) directlyIncreases kin(p(HGNC:MAPK1))	The dual phosphorylation of Thr-183 and Tyr-185 in ERK2 is catalyzed by MAPK/ERK kinase 1 (MEK1).	SEN:10001700	12082107
BEL:20002174	kin(p(HGNC:MAP2K1)) directlyIncreases p(HGNC:MAPK1,pmod(P,Y,187))	The dual phosphorylation of Thr-183 and Tyr-185 in ERK2 is catalyzed by MAPK/ERK kinase 1 (MEK1).	SEN:10001700	12082107
BEL:20002178	kin(p(HGNC:MAP2K4)) directlyIncreases p(HGNC:MAPK8,pmod(P,Y,185))	Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183) in three SAPK1/JNK1 isoforms tested (JNK1 alpha 1, JNK2 alpha 2 and JNK3 alpha 1)	SEN:10001706	11062067
BEL:20002180	kin(p(HGNC:MAP2K4)) directlyIncreases p(HGNC:MAPK9,pmod(P,Y,185))	Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183) in three SAPK1/JNK1 isoforms tested (JNK1 alpha 1, JNK2 alpha 2 and JNK3 alpha 1)	SEN:10001706	11062067
BEL:20002184	kin(p(HGNC:MAP2K7)) directlyIncreases p(HGNC:MAPK8,pmod(P,T,183))	Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183) in three SAPK1/JNK1 isoforms tested (JNK1 alpha 1, JNK2 alpha 2 and JNK3 alpha 1)	SEN:10001706	11062067
BEL:20002186	kin(p(HGNC:MAP2K7)) directlyIncreases p(HGNC:MAPK9,pmod(P,T,183))	Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183) in three SAPK1/JNK1 isoforms tested (JNK1 alpha 1, JNK2 alpha 2 and JNK3 alpha 1)	SEN:10001706	11062067
BEL:20002204	kin(p(HGNC:MAP3K5)) increases bp(GOBP:"apoptotic process")	In this study, we found that H-Ras interacted with ASK1 to cause the inhibition of both ASK1 activity and ASK1-induced apoptosis in vivo	SEN:10001726	15115616
BEL:20002212	kin(p(HGNC:MAP3K5)) increases bp(GOBP:"apoptotic process")	Redox-sensing molecules such as thioredoxin (TRX) and glutaredoxin (GRX) bind to apoptosis signal-regulating kinase 1 (ASK1) and suppress its activation	SEN:10001280	12723971
BEL:20002226	kin(p(HGNC:MAP3K7)) directlyIncreases kin(p(HGNC:MAP3K14))	Activated TAK1 phosphorylates NIK, which stimulates IKK-alpha activity.	SEN:10001746	10094049
BEL:20002228	kin(p(HGNC:MAPK14)) decreases bp(GOBP:"cell proliferation")	deletion of p38alpha mitogen-activated protein (MAP) kinase in adult mice results in increased proliferation	SEN:10001748	17468755
BEL:20002230	kin(p(HGNC:MAPK14)) decreases kin(p(HGNC:EGFR))	In addition, p38alpha controls self-renewal of the lung stem and progenitor cell population by inhibiting proliferation-inducing signals, most notably epidermal growth factor receptor	SEN:10001750	17468755
BEL:20002234	kin(p(HGNC:MAPK14)) increases bp(GOBP:"cell differentiation")	We found that p38alpha positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation.	SEN:10001754	17468755
BEL:20002248	kin(p(HGNC:MAPK1)) increases bp(GOBP:"cell proliferation")	Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways	SEN:10001760	11408560
BEL:20002250	kin(p(HGNC:MAPK1)) increases bp(GOBP:"cell proliferation")	hyperactivation of the extracellular signal-regulated kinase (ERK) via the hematopoietic-specific Rho GTPase, Rac2, directly contributes to the hyperproliferation of Nf1-deficient mast cells in vitro and in vivo	SEN:10001762	11435472
BEL:20002252	kin(p(HGNC:MAPK1)) increases bp(GOBP:"cell proliferation")	We conclude that TNFalpha and IGF-I may additively contribute to fibrosis during intestinal inflammation. TNFR2 is a primary mediator of fibrogenic actions of TNFalpha acting through ERK1/2 to stimulate proliferation and through STAT3 to stimulate TIMP-1 and inhibit collagen degradation.	SEN:10001764	16141211
BEL:20002256	kin(p(HGNC:MAPK1)) increases bp(GOBP:"neutrophil chemotaxis")	These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.	SEN:10001768	16903868
BEL:20002262	kin(p(HGNC:MAPK1)) increases p(HGNC:MUC5B)	Leptin-induced MUC5B expression was blocked by the ERK1/2 and p38 pathway inhibitors, but not by the JAK2/STAT3 pathway inhibitor.	SEN:10001770	20497020
BEL:20002272	kin(p(HGNC:MAPK3)) increases bp(GOBP:"cell proliferation")	Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways	SEN:10001760	11408560
BEL:20002280	kin(p(HGNC:MAPK3)) increases bp(GOBP:"neutrophil chemotaxis")	These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.	SEN:10001768	16903868
BEL:20002286	kin(p(HGNC:MAPK3)) increases p(HGNC:MUC5B)	Leptin-induced MUC5B expression was blocked by the ERK1/2 and p38 pathway inhibitors, but not by the JAK2/STAT3 pathway inhibitor.	SEN:10001770	20497020
BEL:20002302	kin(p(HGNC:MET)) increases kin(p(HGNC:MAPK1))	We also show that both Cbl and Gab1 enhance Met-induced activation of another MAP kinase cascade, the ERK pathway, in a Crk-independent manner. Taken together, our studies demonstrate a previously unidentified functional role for Cbl in Met signaling and suggest that Met utilizes at least two docking proteins, Gab1 and Cbl, to activate downstream signaling pathways. 	SEN:10001788	10962563
BEL:20002314	kin(p(HGNC:PDGFRA)) increases cat(p(HGNC:PTGS2))	The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.	SEN:10001800	7574691
BEL:20002330	kin(p(HGNC:PRKAA1)) increases bp(GOBP:"blood vessel development")	AMPKalpha1 plays an essential role in VEGF-induced angiogenesis in vitro (tube formation and sprouting from spheroids) and in vivo (Matrigel plug assay)	SEN:10001812	20129920
BEL:20002338	kin(p(HGNC:PRKCD)) decreases bp(GOBP:"mast cell activation")	 Altogether, our data suggest that PKC-delta is a negative regulator of antigen-induced mast cell degranulation.	SEN:10001814	12024011
BEL:20002340	kin(p(HGNC:PRKCD)) directlyIncreases p(HGNC:PRKD1,pmod(P,S,738))	Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.	SEN:10001816	15024053
BEL:20002342	kin(p(HGNC:PRKCD)) directlyIncreases p(HGNC:PRKD1,pmod(P,S,742))	Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.	SEN:10001816	15024053
BEL:20002350	kin(p(HGNC:PTK2B)) decreases cat(p(HGNC:CFL1))	Interference with Rho or Pyk2 inhibited cofilin inactivation and the migratory speed of DCs, but did not affect chemotaxis.	SEN:10001824	15778365
BEL:20002368	kin(p(HGNC:RAF1)) increases kin(p(HGNC:ROCK2))	This Raf-1-mediated fine tuning of Rok-a signaling allows the activation of junctional myosin and the timely maturation of AJ essential for maintaining cell cohesion during sprouting angiogenesis	SEN:10001840	22209329
BEL:20002378	kin(p(HGNC:RIPK1)) increases bp(GOBP:"necrotic cell death")	The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumour necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3)	SEN:10001164	20823910
BEL:20002380	kin(p(HGNC:RIPK3)) increases bp(GOBP:"necrotic cell death")	The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumour necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3)	SEN:10001164	20823910
BEL:20002386	kin(p(HGNC:RIPK3)) increases bp(GOBP:"necrotic cell death")	We identified the protein kinase receptor-interacting protein 3 (RIP3) as a molecular switch between TNF-induced apoptosis and necrosis in NIH 3T3 cells and found that RIP3 was required for necrosis in other cells	SEN:10001852	19498109
BEL:20002388	kin(p(HGNC:ROCK2)) increases bp(GOBP:"patterning of blood vessels")	This Raf-1-mediated fine tuning of Rok-a signaling allows the activation of junctional myosin and the timely maturation of AJ essential for maintaining cell cohesion during sprouting angiogenesis	SEN:10001840	22209329
BEL:20002390	kin(p(HGNC:RPS6KA1)) decreases cat(p(HGNC:BAD))	Thus, AR and IGF1 cooperate to prevent apoptosis by activating a specific PKC-p90(rsk)-dependent pathway, which leads to Bad and Bax inactivation	SEN:10001854	15767261
BEL:20002392	kin(p(HGNC:RPS6KB1)) increases p(HGNC:GSK3B,pmod(P,S))	GSK3 is inhibited by serine phosphorylation in response to insulin or growth factors and in vitro by either MAP kinase-activated protein (MAPKAP) kinase-1 (also known as p90rsk) or p70 ribosomal S6 kinase (p70S6k).	SEN:10001856	8524413
BEL:20002394	kin(p(HGNC:RPS6KB1)) increases p(HGNC:RPS6KB1,pmod(P,T,389))	Consistent with this, epidermal growth factor-induced Thr(389) phosphorylation in wild type S6K1 persisted for up to 120 min, whereas kinase-inactive mutants of S6K1 displayed only a reduced and transient increase in Thr(389) phosphorylation.	SEN:10001858	12183455
BEL:20002396	kin(p(HGNC:SRC)) directlyIncreases p(HGNC:CTNNB1,pmod(P,Y,654))	The binding of beta-catenin to these partners is regulated by phosphorylation of at least three critical tyrosine residues. Each of these residues is targeted by one or more specific kinases: Y142 by Fyn, Fer and cMet; Y489 by Abl; and Y654 by Src and the epidermal growth factor receptor.	SEN:10001860	16099633
BEL:20002400	kin(p(HGNC:SRC)) increases cat(p(HGNC:PLCG1))	Adhesion to fibronectin induced PLC-gamma1 tyrosine phosphorylation that was inhibited by a Src-kinase inhibitor	SEN:10001862	15657076
BEL:20002402	kin(p(HGNC:SRC)) increases kin(p(HGNC:EGFR))	PTPD1 activates src tyrosine kinase and increases the magnitude and duration of epidermal growth factor (EGF) signaling. EGF receptor phosphorylation and downstream activation of ERK 1/2 and Elk1-dependent gene transcription are enhanced by PTPD1.	SEN:10001864	15143158
BEL:20002408	kin(p(HGNC:SRC)) increases kin(p(HGNC:MAPK1))	Pretreatment with PP2, a specific inhibitor of Src family tyrosine kinase, completely blocked the NHERF2-dependent increase of the phosphorylation of ERK and Akt, suggesting that NHERF2 up-regulates Erk phosphorylation through a Src family kinase-dependent pathway.	SEN:10001868	15115658
BEL:20002414	kin(p(HGNC:SRC)) increases kin(p(HGNC:MAPK3))	Pretreatment with PP2, a specific inhibitor of Src family tyrosine kinase, completely blocked the NHERF2-dependent increase of the phosphorylation of ERK and Akt, suggesting that NHERF2 up-regulates Erk phosphorylation through a Src family kinase-dependent pathway.	SEN:10001868	15115658
BEL:20002416	kin(p(HGNC:SRC)) increases kin(p(HGNC:MAPK8))	pp60v-src expression strongly activates c-Jun N-terminal kinase (JNK1) enzyme activity.	SEN:10001870	7499226
BEL:20002418	kin(p(HGNC:SRC)) increases kin(p(HGNC:MAPK8))	pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.	SEN:10001872	10066798
BEL:20002422	kin(p(HGNC:SRC)) increases kin(p(HGNC:MAPK9))	pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.	SEN:10001872	10066798
BEL:20002442	kin(p(HGNC:TGFBR1)) directlyIncreases p(HGNC:SMAD2,pmod(P))	Activated TbetaRI phosphorylates Smad2	SEN:10001888	10505717
BEL:20002444	kin(p(HGNC:TGFBR1)) increases p(HGNC:IL6)	Unexpectedly, TGF-beta treatment also induced increased IL-6 production by pDC.	SEN:10001890	21518970
BEL:20002446	kin(p(HGNC:TGFBR2)) increases kin(p(HGNC:ACVRL1))	Through binding to the TGF-beta type II receptor, TGF-beta can activate two distinct type I receptors (ALK1 and ALK5) in endothelial cells	SEN:10001892	16595794
BEL:20002448	kin(p(HGNC:TGFBR2)) increases tscript(p(HGNC:SMAD2))	TGFbeta markedly and specifically decreases both mRNA and protein levels of a HIF-1alpha-associated prolyl hydroxylase (PHD), PHD2, through the Smad signaling pathway.	SEN:10001894	16815840
BEL:20002592	path(MESHD:Ischemia) increases a(CHEBI:"reactive oxygen species")	Recent studies have established a major role for oxygen-derived free radicals in post ischemic tissue injury to the intestine.	SEN:10001988	2982206
BEL:20002594	path(MESHD:Ischemia) increases p(HGNC:SELP)	These results indicate that I/R induces a time-dependent platelet-endothelial adhesion response in postcapillary venules via a mechanism that involves PSGL-1 and both platelet and endothelial P-selectin, with platelet P-selectin playing a greater role.	SEN:10001990	12736150
BEL:20002630	p(EGID:2475,pmod(P,S,2481)) directlyIncreases kin(p(EGID:2475))	Phosphorylation of wild-type but not kinase-inactive FRAP occurs at Ser-2481 in vivo, suggesting that Ser-2481 phosphorylation is a marker of FRAP autokinase activity in cells.	SEN:10002022	10702316
BEL:20002636	p(EGID:9776) increases bp(GOBP:autophagy)	 Atg13 localizes on the autophagic isolation membrane and is essential for autophagosome formation... 	SEN:10002028	19211835
BEL:20002640	p(HGNC:ADAM17) increases p(HGNC:TNF)	Besides regulating the systemic availability of the proinflammatory cytokine TNF, our results demonstrate that ADAM17 is needed for vital regenerative activities during the immune response	SEN:10002032	20603312
BEL:20002672	p(HGNC:ATF2,pmod(P,T,69)) directlyIncreases tscript(p(HGNC:ATF2))	pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.	SEN:10001872	10066798
BEL:20002674	p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))	pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.	SEN:10001872	10066798
BEL:20002684	p(HGNC:ATG5) increases bp(GOBP:autophagy)	knockdown of ATG5 and beclin 1 blocked clinical grade IL-2-induced autophagy	SEN:10002062	23195496
BEL:20002688	p(HGNC:ATG7) increases bp(GOBP:autophagy)	Autophagic death required the genes ATG7 and beclin 1 and was induced by caspase-8 inhibition.	SEN:10002066	15131264
BEL:20002696	p(HGNC:BAX) increases bp(GOBP:"apoptotic process")	Co-immunoprecipitation analysis confirmed that Bis interacted with Bcl-2 in vivo. DNA transfection experiments indicated that Bis itself exerted only weak anti-apoptotic activity, but was synergistic with Bcl-2 in preventing Bax-induced and Fas-mediated apoptosis.	SEN:10002070	10597216
BEL:20002700	p(HGNC:BAX) increases bp(GOBP:"apoptotic process")	SIRT1 deacetylates the DNA repair factor Ku70, causing it to sequester the proapoptotic factor Bax away from mitochondria, thereby inhibiting stress-induced apoptotic cell death.	SEN:10002074	15205477
BEL:20002708	p(HGNC:BCL2A1) decreases bp(GOBP:"apoptotic process")	We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1	SEN:10002080	8752150
BEL:20002732	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1	SEN:10002080	8752150
BEL:20002746	p(HGNC:BCL2L1) decreases bp(GOBP:"apoptotic process")	We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1	SEN:10002080	8752150
BEL:20002748	p(HGNC:BECN1) increases bp(GOBP:autophagy)	Autophagic death required the genes ATG7 and beclin 1 and was induced by caspase-8 inhibition.	SEN:10002066	15131264
BEL:20002758	p(HGNC:BRCA1) increases tscript(p(HGNC:NFE2L2))	Finally, BRCA1 stimulated antioxidant response element-driven transcriptional activity and enhanced the activity of the antioxidant response transcription factor nuclear factor erythroid-derived 2 like 2 [also called NRF2 (NFE2L2)]. 	SEN:10002114	15520196
BEL:20002762	p(HGNC:CASP3) increases bp(GOBP:"apoptotic process")	Importantly, apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema. 	SEN:10002118	15944319
BEL:20002766	p(HGNC:CASP9,pmod(P,T,125)) directlyDecreases cat(p(HGNC:CASP9))	Here, we show that the apoptotic initiator protease caspase-9 is regulated during the cell cycle through periodic phosphorylation at an inhibitory site, Thr125. 	SEN:10002122	17466630
BEL:20002780	p(HGNC:CCL2) increases p(HGNC:IFNG)	Development of secondary pulmonary granulomata in response to Schistosoma mansoni eggs was blunted in MCP-1(-/-) mice, as was expression of IL-4, IL-5, and interferon gamma in splenocytes.	SEN:10002132	9463410
BEL:20002810	p(HGNC:CCND1) decreases bp(GOBP:"macrophage differentiation")	overexpressions of cyclin D1 or bcl-2 inhibited only differentiation or apoptosis, respectively	SEN:10002154	10666199
BEL:20002820	p(HGNC:CCND1) increases bp(GOBP:"cell proliferation")	SOX2 promotes cell proliferation and tumorigenesis by facilitating the G(1)/S transition and through its transcription regulation of the CCND1 gene in breast cancer cells. 	SEN:10002160	18456656
BEL:20002848	p(HGNC:CDC25B,pmod(P,S,353)) directlyIncreases phos(p(HGNC:CDC25B))	In this report, we demonstrate that the CDC25B phosphatase, an activator of cyclin dependent kinases at mitosis, is phosphorylated both in vitro and in vivo by Aurora-A on serine 353 and that this phosphorylated form of CDC25B is located at the centrosome during mitosis.	SEN:10001604	15128871
BEL:20002852	p(HGNC:CDKN1A) directlyDecreases kin(p(HGNC:CDK2))	The cyclin-dependent kinase 2 (Cdk2) inhibitors p21(CIP1) and p27(KIP1) are negatively regulated by anchorage during cell proliferation, but it is unclear how integrin signaling may affect these Cdk2 inhibitors.	SEN:10002184	12052868
BEL:20002854	p(HGNC:CDKN1A) directlyDecreases kin(p(HGNC:CDK4))	hese results indicate that glucocorticoid inhibition of fibroblast proliferation is due to induction of p21Cip1, which binds to and inactivates cyclinD/Cdk4 complexes.	SEN:10002186	9139801
BEL:20002858	p(HGNC:CDKN1B) directlyDecreases kin(p(HGNC:CDK2))	The cyclin-dependent kinase 2 (Cdk2) inhibitors p21(CIP1) and p27(KIP1) are negatively regulated by anchorage during cell proliferation, but it is unclear how integrin signaling may affect these Cdk2 inhibitors.	SEN:10002184	12052868
BEL:20002874	p(HGNC:CFLAR) decreases bp(GOBP:"apoptotic process")	Silencing FLIP expression significantly increased human sarcoma cells to both FasL-induced and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, and ectopic expression of IRF8 also significantly increased the sensitivity of these human sarcoma cells to FasL- and TRAIL-induced apoptosis.	SEN:10002200	19155307
BEL:20002876	p(HGNC:CFTR) decreases p(HGNC:NFKBIA)	This was accompanied by reduced lung caspase-3 activity and defective degradation of NF-kappaB inhibitor IkappaB-alpha.	SEN:10002202	18372427
BEL:20002884	p(HGNC:COL18A1) decreases kin(p(HGNC:KDR))	Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells	SEN:10002206	12029087
BEL:20002886	p(HGNC:COL18A1) decreases kin(p(HGNC:MAPK1))	Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells	SEN:10002206	12029087
BEL:20002888	p(HGNC:COL18A1) decreases kin(p(HGNC:MAPK3))	Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells	SEN:10002206	12029087
BEL:20002892	p(HGNC:COL18A1) decreases kin(p(HGNC:PTK2))	Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells	SEN:10002206	12029087
BEL:20002906	p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))	Protein kinase A phosphorylation of CREB at serine 133 facilitates transcription from cellular CREs by recruiting CBP/p300 via its KIX domain. 	SEN:10002216	17449469
BEL:20002922	p(HGNC:CSF3) increases bp(GOBP:"inflammatory response")	In conclusion, 67LR up-regulation in G-CSF-mobilized HSCs correlates with their successful mobilization and reflects its increase in marrow HSCs, which contributes to the egress from bone marrow by mediating laminin-dependent cell adhesion and transendothelial migration.	SEN:10002224	16788104
BEL:20002924	p(HGNC:CSF3) increases bp(GOBP:"neutrophil chemotaxis")	NCA was inhibited by leukotriene B4 receptor antagonist and anti-IL-8 and G-CSF Abs. 	SEN:10002226	10229865
BEL:20002928	p(HGNC:CSF3) increases kin(p(HGNC:MAPK1))	These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.	SEN:10001768	16903868
BEL:20002930	p(HGNC:CSF3) increases kin(p(HGNC:MAPK3))	These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.	SEN:10001768	16903868
BEL:20002932	p(HGNC:CTNNB1) decreases p(HGNC:PER2)	Here we report that increased beta-catenin destabilizes PER2 clock protein	SEN:10002230	19106159
BEL:20002936	p(HGNC:CTNNB1,pmod(P)) directlyIncreases deg(p(HGNC:CTNNB1))	Here we demonstrate that cyclin-dependent kinase 2 (CDK2) in association with cyclin A or cyclin E directly binds to beta-catenin.  In vivo and in vitro kinase assays with cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin via the beta-TrCP-mediated proteasome pathway.	SEN:10002234	14985333
BEL:20002940	p(HGNC:CTNNB1,pmod(P,S,33)) directlyIncreases deg(p(HGNC:CTNNB1))	beta-Catenin phosphorylation at serine 45 (Ser45), threonine 41 (Thr41), Ser37, and Ser33 is critical for beta-catenin degradation, and regulation of beta-catenin phosphorylation is a central part of the canonical Wnt signaling pathway.	SEN:10002236	16618120
BEL:20002942	p(HGNC:CTNNB1,pmod(P,S,33)) directlyIncreases deg(p(HGNC:CTNNB1))	Serine-33 and -37 of beta-catenin are GSK3 phosphorylation sites that serve as recognition sites for the beta-TRCP-ubiquitin ligase complex, which ultimately triggers beta-catenin degradation.	SEN:10001360	12417018
BEL:20002944	p(HGNC:CTNNB1,pmod(P,S,37)) directlyIncreases deg(p(HGNC:CTNNB1))	beta-Catenin phosphorylation at serine 45 (Ser45), threonine 41 (Thr41), Ser37, and Ser33 is critical for beta-catenin degradation, and regulation of beta-catenin phosphorylation is a central part of the canonical Wnt signaling pathway.	SEN:10002236	16618120
BEL:20002946	p(HGNC:CTNNB1,pmod(P,S,37)) directlyIncreases deg(p(HGNC:CTNNB1))	Serine-33 and -37 of beta-catenin are GSK3 phosphorylation sites that serve as recognition sites for the beta-TRCP-ubiquitin ligase complex, which ultimately triggers beta-catenin degradation.	SEN:10001360	12417018
BEL:20002948	p(HGNC:CTNNB1,pmod(P,S,45)) directlyIncreases deg(p(HGNC:CTNNB1))	beta-Catenin phosphorylation at serine 45 (Ser45), threonine 41 (Thr41), Ser37, and Ser33 is critical for beta-catenin degradation, and regulation of beta-catenin phosphorylation is a central part of the canonical Wnt signaling pathway.	SEN:10002236	16618120
BEL:20002950	p(HGNC:CTNNB1,pmod(P,S,45)) increases p(HGNC:CTNNB1,pmod(P,S,33))	It is established that Ser45 phosphorylation by casein kinase I (CKI) initiates phosphorylation at Thr41, Ser37, and Ser33 by glycogen synthase kinase 3 (GSK3) and that phosphorylated Ser37 and Ser33 are recognized by the F-box protein beta-TrCP, a component of a ubiquitin ligase complex that mediates beta-catenin degradation.	SEN:10002238	16618120
BEL:20002952	p(HGNC:CTNNB1,pmod(P,S,45)) increases p(HGNC:CTNNB1,pmod(P,S,37))	It is established that Ser45 phosphorylation by casein kinase I (CKI) initiates phosphorylation at Thr41, Ser37, and Ser33 by glycogen synthase kinase 3 (GSK3) and that phosphorylated Ser37 and Ser33 are recognized by the F-box protein beta-TrCP, a component of a ubiquitin ligase complex that mediates beta-catenin degradation.	SEN:10002238	16618120
BEL:20002954	p(HGNC:CTNNB1,pmod(P,S,45)) increases p(HGNC:CTNNB1,pmod(P,T,41))	It is established that Ser45 phosphorylation by casein kinase I (CKI) initiates phosphorylation at Thr41, Ser37, and Ser33 by glycogen synthase kinase 3 (GSK3) and that phosphorylated Ser37 and Ser33 are recognized by the F-box protein beta-TrCP, a component of a ubiquitin ligase complex that mediates beta-catenin degradation.	SEN:10002238	16618120
BEL:20002956	p(HGNC:CTNNB1,pmod(P,T,41)) directlyIncreases deg(p(HGNC:CTNNB1))	beta-Catenin phosphorylation at serine 45 (Ser45), threonine 41 (Thr41), Ser37, and Ser33 is critical for beta-catenin degradation, and regulation of beta-catenin phosphorylation is a central part of the canonical Wnt signaling pathway.	SEN:10002236	16618120
BEL:20002972	p(HGNC:CXCL2) increases bp(GOBP:"neutrophil chemotaxis")	MIP-2 mRNA expression was observed in lung tissue after CLP and numerous neutrophils were accumulated in the lung under those conditions. Anti-MIP-2 antibody contributed to the inhibition of the CD11b expression and chemotaxis of pulmonary neutrophils, lung edema, and thus the reduction in peritonitis-related mortality.	SEN:10002252	11855919
BEL:20002974	p(HGNC:CXCL2) increases bp(GOBP:"neutrophil chemotaxis")	the neutrophil chemotactic factor, macrophage inflammatory protein 2 (MIP-2)	SEN:10002254	8480341
BEL:20002990	p(HGNC:DDIT4) decreases kin(p(EGID:2475))	We observed that two stress-induced proteins, RTP801/Redd1 and RTP801L/Redd2, potently inhibit signaling through mTOR.	SEN:10002264	15632201
BEL:20002992	p(HGNC:DDIT4L) decreases kin(p(EGID:2475))	We observed that two stress-induced proteins, RTP801/Redd1 and RTP801L/Redd2, potently inhibit signaling through mTOR.	SEN:10002264	15632201
BEL:20003004	p(HGNC:DNAJC3) directlyDecreases kin(p(HGNC:EIF2AK2))	P58(IPK) is an Hsp40 family member known to inhibit the interferon (IFN)-induced, double-stranded RNA-activated, eukaryotic initiation factor 2alpha (eIF2alpha) protein kinase R (PKR) by binding to its kinase domain.	SEN:10002276	12446838
BEL:20003006	p(HGNC:DNAJC3) directlyDecreases kin(p(HGNC:EIF2AK3))	We find that the stress of unfolded proteins in the endoplasmic reticulum (ER) activates P58(IPK) gene transcription through an ER stress-response element in its promoter region. P58(IPK) interacts with and inhibits the PKR-like ER-localized eIF2alpha kinase PERK, which is normally activated during the ER-stress response to protect cells from ER stress by attenuating protein synthesis and reducing ER client protein load.	SEN:10002278	12446838
BEL:20003022	p(HGNC:EGF) directlyIncreases kin(p(HGNC:EGFR))	EGF stabilizes the short-lived Smad transcriptional corepressor TG-interacting factor (TGIF) via EGFR	SEN:10002292	18441095
BEL:20003032	p(HGNC:EGF) increases p(HGNC:EGFR,pmod(P,Y))	EGF increased the tyrosine phosphorylation of several proteins (the EGF receptor,insulin receptor substrate (IRS)-1, IRS-2, and Grb2-associated binder 1)	SEN:10002302	12138086
BEL:20003036	p(HGNC:EGF) increases p(HGNC:EGFR,pmod(P,Y))	We used mass spectrometry-based proteomics to comprehensively compare proteins that were tyrosine phosphorylated in response to EGF and PDGF and their associated partners. More than 90% of these signaling proteins were used by both ligands, whereas the phosphatidylinositol 3-kinase (PI3K) pathway was exclusively activated by PDGF,	SEN:10002306	15933201
BEL:20003038	p(HGNC:EGF) increases p(HGNC:PLCG1,pmod(P,Y))	We used mass spectrometry-based proteomics to comprehensively compare proteins that were tyrosine phosphorylated in response to EGF and PDGF and their associated partners. More than 90% of these signaling proteins were used by both ligands, whereas the phosphatidylinositol 3-kinase (PI3K) pathway was exclusively activated by PDGF,	SEN:10002306	15933201
BEL:20003042	p(HGNC:EGFR,pmod(P)) directlyIncreases kin(p(HGNC:EGFR))	PTPD1 activates src tyrosine kinase and increases the magnitude and duration of epidermal growth factor (EGF) signaling. EGF receptor phosphorylation and downstream activation of ERK 1/2 and Elk1-dependent gene transcription are enhanced by PTPD1.	SEN:10001864	15143158
BEL:20003060	p(HGNC:EP300,pmod(P,S,106)) increases p(HGNC:NBN)	Importantly, expression of nonphosphorylatable serine to alanine form of p300 (S106A) destabilized both p300 and NBS1 proteins, after DNA damage. These data demonstrate that ATM transduces a DNA damage signal to p300, and that ATM-dependent phosphorylation of p300 is required for stabilization of NBS1 proteins in response to DNA damage.	SEN:10002318	20471956
BEL:20003076	p(HGNC:F2) increases bp(GOBP:"neutrophil chemotaxis")	In addition, we show that thrombin, fragment 1 and fragment 2 induce human neutrophil chemotaxis. 	SEN:10002330	17951099
BEL:20003086	p(HGNC:FASLG) directlyIncreases cat(p(HGNC:FAS))	The protein Daxx promotes Fas-mediated cell death through activation of apoptosis signal-regulating kinase 1, leading to the activation of the MAPKs JNK and p38.	SEN:10002340	17082815
BEL:20003126	p(HGNC:FOXO1,pmod(P,S,256)) directlyDecreases tscript(p(HGNC:FOXO1))	Insulin disrupts IRS-dependent transactivation by FKHR, and phosphorylation of Ser-256 by PKB is necessary and sufficient to mediate this effect.	SEN:10002368	10358076
BEL:20003128	p(HGNC:FYN,pmod(P,T)) increases kin(p(HGNC:FYN))	The activated GSK-3beta phosphorylates Fyn at threonine residue(s). Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. 	SEN:10001648	17403689
BEL:20003132	p(HGNC:GABARAP) increases bp(GOBP:autophagy)	The GABARAP family members (GABARAP, GABARAPL1 and GABARAPL2) and their close homologs (LC3 and Atg8) are not only involved in the transport of proteins or vesicles but are also implicated in various mechanisms such as autophagy, cell death, cell proliferation and tumor progression.	SEN:10002372	21597319
BEL:20003136	p(HGNC:GABARAPL1) increases bp(GOBP:autophagy)	The GABARAP family members (GABARAP, GABARAPL1 and GABARAPL2) and their close homologs (LC3 and Atg8) are not only involved in the transport of proteins or vesicles but are also implicated in various mechanisms such as autophagy, cell death, cell proliferation and tumor progression.	SEN:10002372	21597319
BEL:20003148	p(HGNC:GAS6) directlyIncreases kin(p(HGNC:AXL))	The current study evaluated the contribution of each of the three known Gas6 receptors (Axl, Sky and Mer) in human and mouse platelet function.	SEN:10002382	15733062
BEL:20003150	p(HGNC:GAS6) directlyIncreases kin(p(HGNC:MERTK))	The current study evaluated the contribution of each of the three known Gas6 receptors (Axl, Sky and Mer) in human and mouse platelet function.	SEN:10002382	15733062
BEL:20003154	p(HGNC:GSK3B,pmod(P,S,9)) directlyDecreases kin(p(HGNC:GSK3B))	GSK-3 activity is inhibited through phosphorylation of serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta. These serine residues of GSK-3 have been previously identified as targets of protein kinase B (PKB/Akt), a serine/threonine kinase located downstream of phosphatidylinositol 3-kinase.      	SEN:10001570	11035810
BEL:20003156	p(HGNC:GSK3B,pmod(P,S,9)) directlyDecreases kin(p(HGNC:GSK3B))	In mammals GSK3 is present in two isoforms, alpha and beta regulated by phosphorylation: phosphorylation of Ser9 in GSK3beta or Ser21 in GSK3alpha leads to inactivation while phosphorylation of Tyr216 in GSK3beta or Tyr279 in GSK3alpha leads to activation.	SEN:10002386	15265592
BEL:20003164	p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))	In mammals GSK3 is present in two isoforms, alpha and beta regulated by phosphorylation: phosphorylation of Ser9 in GSK3beta or Ser21 in GSK3alpha leads to inactivation while phosphorylation of Tyr216 in GSK3beta or Tyr279 in GSK3alpha leads to activation.	SEN:10002386	15265592
BEL:20003172	p(HGNC:HGF) directlyIncreases kin(p(HGNC:MET))	A CD44 isoform containing variant exon v6 sequences is strictly required for c-Met activation by HGF/SF in rat and human carcinoma cells, in established cell lines as well as in primary keratinocytes. 	SEN:10002394	12464636
BEL:20003184	p(HGNC:HGF) increases kin(p(HGNC:MAPK1))	SSB-1 also enhanced HGF-induced Erk phosphorylation	SEN:10002406	15713673
BEL:20003190	p(HGNC:HGF) increases kin(p(HGNC:MAPK3))	SSB-1 also enhanced HGF-induced Erk phosphorylation	SEN:10002406	15713673
BEL:20003200	p(HGNC:HOXA9) increases bp(GOBP:"cell proliferation")	Retroviral transduction with a Hoxa-9 expression vector dramatically enhanced the cytokine-driven proliferation and in vivo engraftment of Hoxa-9-/- marrow cells.	SEN:10002414	16091451
BEL:20003218	p(HGNC:ICAM1) increases bp(GOBP:"endothelial cell activation")	glucosamine is likely to suppress endothelial cell activation (TNF-alpha-induced ICAM-1 and MCP-1 expression) possibly by affecting p38MAPK and NF-kappaB signaling via O-GlcNAc modification.	SEN:10002428	19020780
BEL:20003224	p(HGNC:IFNG) increases a(CHEBI:calcitriol)	It has been demonstrated that macrophages can produce 1alpha,25(OH)2D3 on activation with interferon gamma (IFN-gamma)	SEN:10002434	16118315
BEL:20003250	p(HGNC:IL13) increases p(HGNC:CD40)	Interestingly, IL-13 increased the expression of CD40 on peripheral blood B cells, providing a possible mechanism for the observed synergy.	SEN:10002460	9192766
BEL:20003254	p(HGNC:IL13) increases tscript(p(HGNC:STAT6))	IL-4 and IL-13 induced phosphorylation of STAT6 in mtCC cells, which binds to the proximal STAT-binding element (SBE) in the Ugrp2 gene promoter, leading to transcriptional activation of this gene. 	SEN:10002464	16237061
BEL:20003350	p(HGNC:IL33) increases cat(p(HGNC:IL1RL1))	Transfection of ST2 small interference RNA into both endothelial and epithelial cells significantly reduced the IL-33-dependent upregulation of IL-8, suggesting that IL-33-mediated responses in these cells occur via the ST2 receptor.	SEN:10002536	20926795
BEL:20003354	p(HGNC:IL4) decreases p(HGNC:C3AR1)	In the present study we investigated the impact of GM-CSF, IL-4, and IFN-gamma on anaphylatoxin receptor expression in monocytes and dendritic cells (DC). IL-4 was identified as the strongest down-regulator of the receptors for C5a and C3a in monocytes and monocyte-derived DC (MoDC).	SEN:10002538	12626590
BEL:20003356	p(HGNC:IL4) decreases p(HGNC:C5AR1)	In the present study we investigated the impact of GM-CSF, IL-4, and IFN-gamma on anaphylatoxin receptor expression in monocytes and dendritic cells (DC). IL-4 was identified as the strongest down-regulator of the receptors for C5a and C3a in monocytes and monocyte-derived DC (MoDC).	SEN:10002538	12626590
BEL:20003358	p(HGNC:IL4) increases kin(p(HGNC:MAPK14))	Immunoblotting analysis using a specific Ab against phosphorylated p38 MAP kinase (Thr(180)/Tyr(182)) showed that IL-4 induced phosphorylation of p38 MAP kinase in human dermal fibroblasts.  Furthermore, the p38 MAP kinase assay showed that IL-4 induces p38 MAPK activation in human dermal fibroblasts. 	SEN:10002540	11823524
BEL:20003360	p(HGNC:IL4) increases p(HGNC:IL1RL1)	Importantly, Th2 cytokines, such as IL-4, further enhanced ST2 expression and function in both endothelial and epithelial cells	SEN:10002542	20926795
BEL:20003372	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	IL-4 and IL-13 induced phosphorylation of STAT6 in mtCC cells, which binds to the proximal STAT-binding element (SBE) in the Ugrp2 gene promoter, leading to transcriptional activation of this gene. 	SEN:10002464	16237061
BEL:20003378	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	These results suggest that IL-4 inhibition of IFN-gamma-induced CD40 gene expression is mediated by direct STAT-6 binding to the CD40 promoter.	SEN:10002556	11086058
BEL:20003388	p(HGNC:IL6) increases p(HGNC:CCL3)	Treatment of bleomycin-challenged mice with soluble TNF receptor (sTNFr) or anti-IL-6 antibodies significantly decreased MIP-1alpha protein expression in the lungs.	SEN:10002564	9766634
BEL:20003394	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	A tetrameric Stat3 complex was found to be essential in transfection experiments for maximal interleukin-6-inducible activation of alpha2-macroglobulin gene promoter.	SEN:10002568	11438543
BEL:20003400	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	IL-6 family cytokines (Interleukin-6 and Oncostatin M (OSM))-increase STAT3 phosphorylation (pSTAT3), increase CCAAT enhancer binding protein delta (C/EBPdelta) gene expression	SEN:10002572	15389879
BEL:20003406	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program.	SEN:10002578	15507530
BEL:20003408	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	Signal transducer and activator of transcription 3 (STAT3) is activated by the IL-6 family of cytokines and growth factors. STAT3 requires phosphorylation on Ser-727, in addition to tyrosine phosphorylation on Tyr-705, to be transcriptionally active.	SEN:10002580	15764709
BEL:20003416	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	The mouse tumors mimic molecular hallmarks of their human tumor counterparts, including elevated IL-6/Stat3/Bcl-X(L) signaling. The newly developed mouse strains may provide a good preclinical research tool for the design and testing of new approaches to target IL-6 in treatment and prevention of human PCNs.	SEN:10002588	20018915
BEL:20003424	p(HGNC:IL6ST) increases tscript(p(HGNC:STAT3))	gp130-mediated Stat1/3 activation is required to maintain the normal balance of hematopoietic progenitors during fetal and adult hematopoiesis	SEN:10002596	12423677
BEL:20003428	p(HGNC:IL7) directlyIncreases cat(p(HGNC:IL7R))	There are 2 known ligands for IL-7Ralpha: IL-7 itself and thymic stromal lymphopoietin (TSLP).	SEN:10002600	18664628
BEL:20003444	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	By blocking CXCL8, CXCL5, CXCL7 and Pan GRO (CXCL1, CXCL2, CXCL3), we observed that CXCL8/interleukin-8 might be the chemokine that induced the PMNL chemotactic activity in the CS of untreated and TNF-alpha-treated moDC.	SEN:10002612	15720439
BEL:20003448	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	NCA was inhibited by leukotriene B4 receptor antagonist and anti-IL-8 and G-CSF Abs. 	SEN:10002226	10229865
BEL:20003450	p(HGNC:ILK) increases p(HGNC:AKT1,pmod(P,S,473))	Knock-down of ILK by small, interfering RNA (siRNA) attenuated Akt phosphorylation in response to ligation of beta1 integrin by collagen or activating antibody and enhanced fibroblast apoptosis in response to collagen contraction. Kinase dead ILK attenuated Akt phosphorylation and enhanced fibroblast apoptosis, whereas hyperactive and wild type ILK augmented Akt phosphorylation and protected fibroblasts from apoptosis. 	SEN:10002616	15905178
BEL:20003502	p(HGNC:MAP3K5,pmod(P,S,83)) directlyDecreases kin(p(HGNC:MAP3K5))	AKT2 interacts with and phosphorylates ASK1 at Ser-83 resulting in inhibition of its kinase activity.	SEN:10001582	12697749
BEL:20003506	p(HGNC:MAPK14,pmod(P,T,180)) directlyIncreases kin(p(HGNC:MAPK14))	Immunoblotting analysis using a specific Ab against phosphorylated p38 MAP kinase (Thr(180)/Tyr(182)) showed that IL-4 induced phosphorylation of p38 MAP kinase in human dermal fibroblasts.  Furthermore, the p38 MAP kinase assay showed that IL-4 induces p38 MAPK activation in human dermal fibroblasts. 	SEN:10002540	11823524
BEL:20003510	p(HGNC:MAPK14,pmod(P,Y,182)) directlyIncreases kin(p(HGNC:MAPK14))	Immunoblotting analysis using a specific Ab against phosphorylated p38 MAP kinase (Thr(180)/Tyr(182)) showed that IL-4 induced phosphorylation of p38 MAP kinase in human dermal fibroblasts.  Furthermore, the p38 MAP kinase assay showed that IL-4 induces p38 MAPK activation in human dermal fibroblasts. 	SEN:10002540	11823524
BEL:20003516	p(HGNC:MAPK1,pmod(P)) directlyIncreases kin(p(HGNC:MAPK1))	EGF and thrombin triggered a rapid activation of the EGF receptor, followed by the phosphorylation and activation of the extracellular signal-regulated protein kinase (ERK)	SEN:10002658	11948693
BEL:20003518	p(HGNC:MAPK1,pmod(P)) directlyIncreases kin(p(HGNC:MAPK1))	ERK1/2 and JNK inactivation was associated with Ets-like transcription factor-1 (ELK-1) dephosphorylation.	SEN:10002660	15590693
BEL:20003522	p(HGNC:MAPK1,pmod(P)) directlyIncreases kin(p(HGNC:MAPK1))	SSB-1 also enhanced HGF-induced Erk phosphorylation	SEN:10002406	15713673
BEL:20003524	p(HGNC:MAPK1,pmod(P,T,185)) directlyIncreases kin(p(HGNC:MAPK1))	Additionally, genistein enhanced RA-induced neuronal differentiation by increasing the activation of extracellular signal-related kinase 1/2 (ERK1/2) via phosphorylation at Thr183 and Tyr185 in 3-7 days. 	SEN:10002664	16149052
BEL:20003528	p(HGNC:MAPK1,pmod(P,Y,187)) directlyIncreases kin(p(HGNC:MAPK1))	Additionally, genistein enhanced RA-induced neuronal differentiation by increasing the activation of extracellular signal-related kinase 1/2 (ERK1/2) via phosphorylation at Thr183 and Tyr185 in 3-7 days. 	SEN:10002664	16149052
BEL:20003534	p(HGNC:MAPK3,pmod(P)) directlyIncreases kin(p(HGNC:MAPK3))	ERK1/2 and JNK inactivation was associated with Ets-like transcription factor-1 (ELK-1) dephosphorylation.	SEN:10002660	15590693
BEL:20003536	p(HGNC:MAPK3,pmod(P)) directlyIncreases kin(p(HGNC:MAPK3))	SSB-1 also enhanced HGF-induced Erk phosphorylation	SEN:10002406	15713673
BEL:20003546	p(HGNC:MAPK8,pmod(P,T,183)) directlyIncreases kin(p(HGNC:MAPK8))	JNKs are activated by phosphorylation on two critical residues, the threonine 183 and tyrosine 185, within the TPY motif. The activated JNKs, in turn, phosphorylate the nuclear protein c-Jun, a major component of the transcription factor AP1.	SEN:10002674	9830038
BEL:20003550	p(HGNC:MAPK8,pmod(P,Y,185)) directlyIncreases kin(p(HGNC:MAPK8))	JNKs are activated by phosphorylation on two critical residues, the threonine 183 and tyrosine 185, within the TPY motif. The activated JNKs, in turn, phosphorylate the nuclear protein c-Jun, a major component of the transcription factor AP1.	SEN:10002674	9830038
BEL:20003554	p(HGNC:MAPK9,pmod(P,T,183)) directlyIncreases kin(p(HGNC:MAPK9))	JNKs are activated by phosphorylation on two critical residues, the threonine 183 and tyrosine 185, within the TPY motif. The activated JNKs, in turn, phosphorylate the nuclear protein c-Jun, a major component of the transcription factor AP1.	SEN:10002674	9830038
BEL:20003558	p(HGNC:MAPK9,pmod(P,Y,185)) directlyIncreases kin(p(HGNC:MAPK9))	JNKs are activated by phosphorylation on two critical residues, the threonine 183 and tyrosine 185, within the TPY motif. The activated JNKs, in turn, phosphorylate the nuclear protein c-Jun, a major component of the transcription factor AP1.	SEN:10002674	9830038
BEL:20003562	p(HGNC:MDM2) directlyIncreases deg(p(HGNC:TP53))	In concert with these results, Lyn reverses Mdm2-mediated degradation of p53 and increases p53-dependent apoptosis. Our findings support a previously undefined role for nuclear Lyn in both activation and Mdm2-mediated regulation of p53.	SEN:10001470	12642697
BEL:20003582	p(HGNC:MYC) increases bp(GOBP:"cell proliferation")	The c-Myc oncoprotein functions as a transcription factor that can transform normal cells into tumor cells, as well as playing a direct role in normal cell proliferation.	SEN:10002686	11839798
BEL:20003584	p(HGNC:MYC) increases bp(GOBP:"cell proliferation")	The c-Myc oncoprotein induces cell proliferation	SEN:10002688	10207076
BEL:20003590	p(HGNC:NBN) increases bp(GOBP:"double-strand break repair")	In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.	SEN:10001104	17024177
BEL:20003604	p(HGNC:NFKBIA,pmod(P,S)) directlyIncreases deg(p(HGNC:NFKBIA))	Activation of NF-kappaB mainly occurs via IkappaB kinase (IKK)-mediated phosphorylation of inhibitory molecules, including IkappaBalpha	SEN:10001414	15653325
BEL:20003606	p(HGNC:NFKBIA,pmod(P,S)) directlyIncreases deg(p(HGNC:NFKBIA))	CHUK specifically phosphorylates IkappaB-alpha on both serine 32 and serine 36, modifications that are required for targeted degradation of IkappaB-alpha via the ubiquitin-proteasome pathway	SEN:10001416	9244310
BEL:20003608	p(HGNC:NFKBIA,pmod(P,S)) directlyIncreases deg(p(HGNC:NFKBIA))	The functional relevance of this observation is supported by the fact that the turnover of free IkappaBalpha in resting cells is S293-dependent.	SEN:10002700	10764587
BEL:20003612	p(HGNC:NIN) increases bp(GOBP:"blood vessel development")	siRNA-dependent silencing of ninein in endothelial cells inhibited tubular morphogenesis	SEN:10002704	18772498
BEL:20003622	p(HGNC:NRG1) increases cat(p(HGNC:ERBB3))	We investigated upstream components of the response to hypertonicity in lung epithelial cells and found that before extracellular signal-regulated kinase activation and aquaporin synthesis, the membrane-bound prohormone neuregulin 1-beta is cleaved and binds to human epidermal growth factor receptor 3 (HER3). 	SEN:10000692	15498868
BEL:20003638	p(HGNC:PLCG1,pmod(P,Y)) directlyIncreases cat(p(HGNC:PLCG1))	Based on these results, we propose that CD148 negatively regulates TCR signaling by interfering with the phosphorylation and function of PLCgamma1 and LAT.	SEN:10002718	11259588
BEL:20003642	p(HGNC:PRKAA1,pmod(P,T,183)) directlyIncreases kin(p(HGNC:PRKAA1))	Essential to activation of AMPK is its phosphorylation at Thr-172 by an upstream kinase, AMPKK, whose identity in mammalian cells has remained elusive.	SEN:10002722	14985505
BEL:20003644	p(HGNC:PRKCD,pmod(P,Y)) directlyIncreases kin(p(HGNC:PRKCD))	together, these data indicate that CD45 inhibits PMA-dependent PKCdelta activation by impeding PMA-dependent PKCdelta tyrosine phosphorylation.	SEN:10002724	11124968
BEL:20003646	p(HGNC:PRKD1,pmod(P,S,738)) directlyIncreases kin(p(HGNC:PRKD1))	Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.	SEN:10001816	15024053
BEL:20003648	p(HGNC:PRKD1,pmod(P,S,742)) directlyIncreases kin(p(HGNC:PRKD1))	Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.	SEN:10001816	15024053
BEL:20003654	p(HGNC:PTGS2) increases p(HGNC:IL1B)	Inhibition of COX2 markedly reduced both IL-1 beta and IL-6 release.	SEN:10002728	19580863
BEL:20003656	p(HGNC:PTGS2) increases p(HGNC:IL6)	Inhibition of COX2 markedly reduced both IL-1 beta and IL-6 release.	SEN:10002728	19580863
BEL:20003672	p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))	Pak3 phosphorylates Raf-1 on serine 338 in vitro and in vivo. The p21-activated protein kinases are regulated by the Rho-family GTPases Rac and Cdc42.	SEN:10002738	9823899
BEL:20003674	p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))	PKA also decreased Raf-1 serine 338 phosphorylation of Raf-1, previously shown to be required for Raf-1 activation. 	SEN:10001966	11971957
BEL:20003690	p(HGNC:RIPK1) increases p(HGNC:TRAF2)	Although TRAF2 levels remained constant in TNF-treated wild-type cells, TNF stimulation of RIPK1(-/-) cells caused TRAF2 and cIAP1 to be rapidly degraded by the proteasome, which led to an increase in NIK levels.	SEN:10002746	21339290
BEL:20003692	p(HGNC:RPS6KA1,pmod(P,S,380)) directlyIncreases kin(p(HGNC:RPS6KA1))	Increased phosphorylation of two sites essential for RSK1 kinase activity (Ser(380) and Ser(363)) in RSK1S154A compared with RSK1 wild type, demonstrated that 14-3-3 interferes with RSK1 phosphorylation.	SEN:10002748	12618428
BEL:20003694	p(HGNC:RPS6KB1,pmod(P,S,424)) directlyDecreases kin(p(HGNC:RPS6KB1))	conditional inactivation of Cdc2 reduces phosphorylation of S6K1 at S/TP sites while simultaneously increasing phosphorylation of Thr(389) and of the S6K1 substrate, RPS6.	SEN:10002750	12586835
BEL:20003696	p(HGNC:RPS6KB1,pmod(P,T,389)) directlyIncreases kin(p(HGNC:RPS6KB1))	conditional inactivation of Cdc2 reduces phosphorylation of S6K1 at S/TP sites while simultaneously increasing phosphorylation of Thr(389) and of the S6K1 substrate, RPS6.	SEN:10002750	12586835
BEL:20003698	p(HGNC:RPS6KB1,pmod(P,T,412)) directlyIncreases kin(p(HGNC:RPS6KB1))	We report here that a mammalian recombinant p70alpha polypeptide, extracted in an inactive form from rapamycin-treated cells, can be directly phosphorylated by the mTOR kinase in vitro predominantly at the rapamycin-sensitive site Thr-412. 	SEN:10002752	10567431
BEL:20003700	p(HGNC:S100A8) directlyIncreases cat(p(HGNC:TLR4))	The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.	SEN:10002754	20473308
BEL:20003702	p(HGNC:S100A9) directlyIncreases cat(p(HGNC:TLR4))	The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.	SEN:10002754	20473308
BEL:20003708	p(HGNC:SFN) decreases p(HGNC:MDM2)	In studying the molecular mechanism of this increased stabilization of p53, we found that 14-3-3 sigma antagonized the biological functions of Mdm2 by blocking Mdm2-mediated p53 ubiquitination and nuclear export. In addition, we found that 14-3-3 sigma facilitated the oligomerization of p53 and enhanced p53's transcriptional activity.	SEN:10002758	14517281
BEL:20003712	p(HGNC:SHH) increases bp(GOBP:"cell proliferation")	Shh overexpression results in increased mesenchymal and epithelial cell proliferation	SEN:10002762	9006067
BEL:20003718	p(HGNC:SMAD2,pmod(P)) directlyIncreases tscript(p(HGNC:SMAD2))	TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation	SEN:10002766	15494412
BEL:20003722	p(HGNC:SMAD3) increases a(CHEBI:hydroxyproline)	Mice deficient in Smad3 demonstrated suppressed type I procollagen mRNA expression and reduced hydroxyproline content in the lungs compared with wild-type mice treated with bleomycin	SEN:10002770	11839555
BEL:20003726	p(HGNC:SMAD3,pmod(P)) directlyIncreases tscript(p(HGNC:SMAD3))	TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation	SEN:10002766	15494412
BEL:20003734	p(HGNC:SOCS1) decreases tscript(p(HGNC:STAT6))	IFN-gamma-induced inhibition of STAT6 phosphorylation and eotaxin production were mediated by SOCS-1 induced in STAT1-dependent manner.	SEN:10002780	14733929
BEL:20003740	p(HGNC:SOCS3) decreases tscript(p(HGNC:STAT3))	We demonstrated that SOCS3 deletion in the liver resulted in hyperactivation of STAT3 and promoted ConA- and chemical-induced liver fibrosis.	SEN:10002786	16474852
BEL:20003748	p(HGNC:STAT1,pmod(P,S,727)) directlyIncreases tscript(p(HGNC:STAT1))	Biochemical analysis illustrated that the mechanism of this transcriptional synergy involves interaction between BRCA1 aa 502-802 and the C-terminal transcriptional activation domain of STAT1 including Ser-727 whose phosphorylation is crucial for transcriptional activation.	SEN:10002792	10792030
BEL:20003754	p(HGNC:STAT1,pmod(P,Y,701)) directlyIncreases tscript(p(HGNC:STAT1))	We found that the Tyr701 phosphorylation kinetics of Stat1 mediated by IFN stimulation was higher when cells were incubated with IFN-alpha5 than when using IFN-alpha2. Similarly, Tyr(1054/1055) phosphorylation kinetics of Tyk2 were more intense after exposure to IFN-alpha5 than when using IFN-alpha2. Concomitantly, Tyr705 phosphorylation of Stat3 was higher after stimulation with IFN-alpha5 than with IFN-alpha2.	SEN:10002798	15320963
BEL:20003758	p(HGNC:STAT3,pmod(P,S,727)) directlyIncreases tscript(p(HGNC:STAT3))	LIGHT, a member of tumor necrosis factor superfamily, activates Stat3 in cancer cells. LIGHT induces dose-dependent activation of Stat3 by phosphorylation at both the tyrosine 705 and serine 727 residues.	SEN:10002802	17543278
BEL:20003760	p(HGNC:STAT3,pmod(P,S,727)) directlyIncreases tscript(p(HGNC:STAT3))	Signal transducer and activator of transcription 3 (STAT3) is activated by the IL-6 family of cytokines and growth factors. STAT3 requires phosphorylation on Ser-727, in addition to tyrosine phosphorylation on Tyr-705, to be transcriptionally active.	SEN:10002580	15764709
BEL:20003766	p(HGNC:STAT3,pmod(P,Y,705)) directlyIncreases tscript(p(HGNC:STAT3))	LIGHT, a member of tumor necrosis factor superfamily, activates Stat3 in cancer cells. LIGHT induces dose-dependent activation of Stat3 by phosphorylation at both the tyrosine 705 and serine 727 residues.	SEN:10002802	17543278
BEL:20003768	p(HGNC:STAT3,pmod(P,Y,705)) directlyIncreases tscript(p(HGNC:STAT3))	Signal transducer and activator of transcription 3 (STAT3) is activated by the IL-6 family of cytokines and growth factors. STAT3 requires phosphorylation on Ser-727, in addition to tyrosine phosphorylation on Tyr-705, to be transcriptionally active.	SEN:10002580	15764709
BEL:20003770	p(HGNC:STAT3,pmod(P,Y,705)) directlyIncreases tscript(p(HGNC:STAT3))	Stat3 is activated by phosphorylation on Tyr-705, which leads to dimer formation, nuclear translocation, and regulation of gene expression.	SEN:10002808	10446219
BEL:20003772	p(HGNC:STAT3,pmod(P,Y,705)) directlyIncreases tscript(p(HGNC:STAT3))	We found that the Tyr701 phosphorylation kinetics of Stat1 mediated by IFN stimulation was higher when cells were incubated with IFN-alpha5 than when using IFN-alpha2. Similarly, Tyr(1054/1055) phosphorylation kinetics of Tyk2 were more intense after exposure to IFN-alpha5 than when using IFN-alpha2. Concomitantly, Tyr705 phosphorylation of Stat3 was higher after stimulation with IFN-alpha5 than with IFN-alpha2.	SEN:10002798	15320963
BEL:20003782	p(HGNC:SYK,pmod(P)) directlyIncreases kin(p(HGNC:SYK))	phosphorylation of syk and PLC gamma2 by collagen	SEN:10002818	9028946
BEL:20003784	p(HGNC:TGFA) directlyIncreases kin(p(HGNC:EGFR))	Transforming growth factor (TGF)-alpha is a ligand for the epidermal growth factor receptor (EGFR).	SEN:10002820	19244201
BEL:20003786	p(HGNC:TGFB1) decreases p(HGNC:ATF1,pmod(P))	The TGF-beta1-induced down-regulation of cyclin A promoter activity appeared to be mediated via the activating transcription factor (ATF) site, because mutation of this site abolished down-regulation.	SEN:10002822	9268374
BEL:20003802	p(HGNC:TGFB1) increases p(HGNC:CD80)	TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.	SEN:10002836	16517699
BEL:20003804	p(HGNC:TGFB1) increases p(HGNC:CTLA4)	TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.	SEN:10002836	16517699
BEL:20003828	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD1))	Both SMAD2 and SMAD1/5 were activated upon exposure to TGF-beta1	SEN:10002858	19270180
BEL:20003830	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	Blocking TGF-beta1 signaling pathway by knocking down Smad2 significantly blunted the aldosterone induced fibronectin production. 	SEN:10002860	16876110
BEL:20003832	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	Both SMAD2 and SMAD1/5 were activated upon exposure to TGF-beta1	SEN:10002858	19270180
BEL:20003836	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine	SEN:10002864	15972691
BEL:20003838	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation	SEN:10002766	15494412
BEL:20003840	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	C/EBPbeta and C/EBPdelta were found to physically interact with Smad3 and Smad4, and Smad3 cooperated with Smad4 and TGF-beta signaling to repress the transcriptional activity of C/EBPs. Thus, repression of the activity of C/EBPs by Smad3/4 at C/EBP binding sites inhibited transcription from the PPARgamma2 and leptin promoters.	SEN:10002866	12524424
BEL:20003842	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	Here we report that epidermal growth factor (EGF) potentializes transforming growth factor beta (TGF-beta)-induced Smad3 transactivation in rat hepatocytes, an effect abrogated by TAM-67, a dominant negative mutant of AP-1	SEN:10002868	11134003
BEL:20003846	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	Neutralizing Ab to TGF-beta1 eliminated TMEV-induced IL-23 production and SMAD-3 activation in RAW264.7 cells, BMM, and SPM.	SEN:10002872	18802055
BEL:20003848	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine	SEN:10002864	15972691
BEL:20003854	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation	SEN:10002766	15494412
BEL:20003860	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD5))	Both SMAD2 and SMAD1/5 were activated upon exposure to TGF-beta1	SEN:10002858	19270180
BEL:20003868	p(HGNC:TGFBR1,pmod(P)) directlyIncreases kin(p(HGNC:TGFBR1))	Smad7 interacts with growth arrest and DNA damage protein, GADD34, a regulatory subunit of the protein phosphatase 1 (PP1) holoenzyme, which subsequently recruits catalytic subunit of PP1 (PP1c) to dephosphorylate TbetaRI.	SEN:10002884	14718519
BEL:20003872	p(HGNC:TGM1) increases bp(GOBP:"wound healing")	Similar injuries to TGase 1 knockout mouse skins grafted on athymic nude mice showed substantial delays in wound healing concomitant with sustained K6alpha mRNA induction.	SEN:10002886	11106560
BEL:20003886	p(HGNC:THPO) directlyIncreases cat(p(HGNC:MPL))	Thrombopoietin is the cytokine involved in megakaryopoiesis and its receptor (c-Mpl) is considered to regulate development of megakaryocyte. 	SEN:10002898	21174945
BEL:20003892	p(HGNC:TIMP1) decreases path(MESHD:Fibrosis)	TIMP-1 knockout mice also displayed greater degree of liver fibrosis after chronic CCl4 injection when compared with wild-type mice.	SEN:10002900	21711826
BEL:20003898	p(HGNC:TLR2) decreases p(EGID:3579)	TLR2 deficiency prevented the down-regulation of CXCR2 and failure of neutrophil migration. 	SEN:10002906	19234125
BEL:20003902	p(HGNC:TNF) increases bp(GOBP:"endothelial cell activation")	Modulation of TNF-alpha-induced endothelial cell activation by glucosamine, a naturally occurring amino monosaccharide.	SEN:10002910	19020780
BEL:20003904	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	Mice carrying a deletion in the tumor necrosis factor (TNF) AU-rich elements (ARE) are reported as a model for human CD and are characterized by elevated TNF-alpha levels and inflammations in the terminal ileum	SEN:10002912	18266230
BEL:20003906	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	Tumor necrosis factor (TNF) alpha has defined proinflammatory	SEN:10002914	16141211
BEL:20003922	p(HGNC:TNF) increases p(HGNC:CCL3)	Treatment of bleomycin-challenged mice with soluble TNF receptor (sTNFr) or anti-IL-6 antibodies significantly decreased MIP-1alpha protein expression in the lungs.	SEN:10002564	9766634
BEL:20003934	p(HGNC:TNF) increases p(HGNC:TP53)	TNF-alpha treatment resulted in accumulation of p53 in LNCaP and upregulation of p21/WAF1.	SEN:10002934	10773886
BEL:20004012	p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))	PRPK phosphorylates serine-15 residue of p53 and enhances transcriptional activity.	SEN:10002990	16600182
BEL:20004014	p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))	The intrinsic transcriptional activity of p53 was up-regulated by a transient transfection of PRPK to COS-7 cells. PRPK was shown to bind to p53 and to phosphorylate p53 at Ser-15.	SEN:10002992	11546806
BEL:20004030	p(HGNC:TP53,pmod(P,T,18)) directlyIncreases tscript(p(HGNC:TP53))	Endogenous p53 is also phosphorylated in Thr18 by VRK2B, promoting its stabilization and transcriptional activation in A549 cells	SEN:10003004	16704422
BEL:20004034	p(HGNC:TSLP) directlyIncreases cat(p(HGNC:IL7R))	There are 2 known ligands for IL-7Ralpha: IL-7 itself and thymic stromal lymphopoietin (TSLP).	SEN:10002600	18664628
BEL:20004048	p(HGNC:TYK2,pmod(P,Y,1054)) directlyIncreases kin(p(HGNC:TYK2))	We found that the Tyr701 phosphorylation kinetics of Stat1 mediated by IFN stimulation was higher when cells were incubated with IFN-alpha5 than when using IFN-alpha2. Similarly, Tyr(1054/1055) phosphorylation kinetics of Tyk2 were more intense after exposure to IFN-alpha5 than when using IFN-alpha2. Concomitantly, Tyr705 phosphorylation of Stat3 was higher after stimulation with IFN-alpha5 than with IFN-alpha2.	SEN:10002798	15320963
BEL:20004050	p(HGNC:TYK2,pmod(P,Y,1055)) directlyIncreases kin(p(HGNC:TYK2))	We found that the Tyr701 phosphorylation kinetics of Stat1 mediated by IFN stimulation was higher when cells were incubated with IFN-alpha5 than when using IFN-alpha2. Similarly, Tyr(1054/1055) phosphorylation kinetics of Tyk2 were more intense after exposure to IFN-alpha5 than when using IFN-alpha2. Concomitantly, Tyr705 phosphorylation of Stat3 was higher after stimulation with IFN-alpha5 than with IFN-alpha2.	SEN:10002798	15320963
BEL:20004056	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:FLT1))	VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).	SEN:10003014	16336962
BEL:20004058	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:KDR))	Pharmacological intervention with a VEGFR-2-neutralizing Ab (anti-Flk1 mAb) abolished the production of IL-6 (but not IL-12p70) and the subsequent development of allergen-specific Th17 cell response.	SEN:10003016	20921519
BEL:20004060	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:KDR))	VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).	SEN:10003014	16336962
BEL:20004062	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	AMPKalpha1 plays an essential role in VEGF-induced angiogenesis in vitro (tube formation and sprouting from spheroids) and in vivo (Matrigel plug assay)	SEN:10001812	20129920
BEL:20004084	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	Together, our results suggest that Dll4-Notch1 signalling between the endothelial cells within the angiogenic sprout serves to restrict tip-cell formation in response to VEGF, thereby establishing the adequate ratio between tip and stalk cells required for correct sprouting and branching patterns	SEN:10003036	17259973
BEL:20004110	p(HGNC:VEGFC) directlyIncreases kin(p(HGNC:FLT4))	VEGFR3, a receptor for the lymphatic growth factors VEGF-C and VEGF-D, but not for VEGF-A, regulates vascular and lymphatic endothelial cell function during embryogenesis.	SEN:10003060	16336962
BEL:20004124	p(HGNC:VIP) increases cat(p(HGNC:VIPR1))	We synthesized a VIP analog that combines mutations that decrease the affinity for the VPAC1 receptor but maintain a high affinity for the VPAC2 receptor with an amino-terminal hexanoylation that increases the affinity for the VPAC2 receptor with a limited decrease in the affinity of the VPAC1 receptor. 	SEN:10003066	15063009
BEL:20004128	p(HGNC:VIP) increases cat(p(HGNC:VIPR2))	We synthesized a VIP analog that combines mutations that decrease the affinity for the VPAC1 receptor but maintain a high affinity for the VPAC2 receptor with an amino-terminal hexanoylation that increases the affinity for the VPAC2 receptor with a limited decrease in the affinity of the VPAC1 receptor. 	SEN:10003066	15063009
BEL:20004146	p(HGNC:WRN) decreases bp(GOBP:"replicative cell aging")	 To identify cellular events that are specifically vulnerable to WRN deficiency, we used RNA interference (RNAi) to knockdown WRN or BLM (the RecQ helicase mutated in Bloom syndrome) expression in primary human fibroblasts. Withdrawal of WRN or BLM produced accelerated cellular senescence phenotype and DNA damage response in normal fibroblasts, as evidenced by induction of gammaH2AX and 53BP1 nuclear foci. 	SEN:10003086	16287861
BEL:20004164	phos(p(HGNC:PTEN)) decreases p(HGNC:MMP9)	Modulation of miR-21 altered focal adhesion kinase phosphorylation and expression of matrix metalloproteases 2 and 9, both downstream mediators of PTEN involved in cell migration and invasion.	SEN:10003100	17681183
BEL:20004270	tscript(p(HGNC:ARNT)) directlyIncreases tscript(p(HGNC:HIF1A))	HIF-1 alpha can then translocate to the nucleus and facilitate transcription of numerous target genes, the majority of which are involved in glycolysis and angiogenesis via heterodimerisation with the beta subunit (HIF-1 beta/ARNT).	SEN:10003166	12054621
BEL:20004278	tscript(p(HGNC:FLI1)) increases tscript(p(HGNC:GATA1))	Transcriptional output by the GATA-1-FOG-1 complex is determined by the hematopoietic Ets protein Fli-1 that binds to an adjacent Ets element. 	SEN:10003172	12356738
BEL:20004284	tscript(p(HGNC:FOXO1)) decreases bp(GOBP:"cell migration")	Here, we show that Foxo1 and Foxo3a are the most abundant Foxo isoforms in mature endothelial cells and that overexpression of constitutively active Foxo1 or Foxo3a, but not Foxo4, significantly inhibits endothelial cell migration and tube formation in vitro.	SEN:10003178	16100571
BEL:20004286	tscript(p(HGNC:FOXO3)) decreases bp(GOBP:"cell migration")	Here, we show that Foxo1 and Foxo3a are the most abundant Foxo isoforms in mature endothelial cells and that overexpression of constitutively active Foxo1 or Foxo3a, but not Foxo4, significantly inhibits endothelial cell migration and tube formation in vitro.	SEN:10003178	16100571
BEL:20004292	tscript(p(HGNC:GATA3)) increases bp(GOBP:"T-helper 2 cell differentiation")	In vitro deletion of Gata3 diminished both interleukin 4 (IL-4)-dependent and IL-4-independent T(H)2 cell differentiation; without GATA-3, T(H)1 differentiation occurred in the absence of IL-12 and interferon-gamma. 	SEN:10003184	15475959
BEL:20004304	tscript(p(HGNC:IRF3)) increases p(HGNC:IFNB1)	we demonstrate that overexpression of IRF-3 significantly enhances virus-mediated transcription of the IFNA and IFNB genes in infected cells as well as IFN synthesis	SEN:10003194	9707562
BEL:20004310	tscript(p(HGNC:JUN)) increases bp(GOBP:"wound healing")	These results demonstrate that activin B promotes epithelial wound closure in vivo through the RhoA-Rock-JNK-cJun signaling pathway	SEN:10001536	21949871
BEL:20004312	tscript(p(HGNC:MEOX2)) decreases bp(GOBP:"cell proliferation")	constitutive Gax expression inhibits cell proliferation in a p21(WAF/CIP)-dependent manner	SEN:10003200	9649428
BEL:20004316	tscript(p(HGNC:MYCN)) increases bp(GOBP:"cell cycle")	Third, HBP1 can function as a transcriptional repressor of the promoter for N-MYC, which is a critical cell cycle and developmental gene. Fourth, because the activation of the N-MYC promoter in cycling cells required the E2F transcription factor, we show that E2F-1 and HBP1 represent opposite transcriptional signals that can be integrated within the N-MYC promoter.	SEN:10003204	9030690
BEL:20004320	tscript(p(HGNC:NFE2)) increases bp(GOBP:"megakaryocyte differentiation")	Several transcription factors have also been implicated in megakaryopoiesis including, GATA-1, friend of GATA-1 (FOG-1), nuclear factor-erythroid 2 (NF-E2), and Fli-1.	SEN:10003208	17127443
BEL:20004332	tscript(p(HGNC:PPARA)) decreases p(HGNC:IL10)	Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.	SEN:10000450	16313356
BEL:20004334	tscript(p(HGNC:PPARA)) decreases p(HGNC:IL12B)	Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.	SEN:10000450	16313356
BEL:20004346	tscript(p(HGNC:SMAD1)) increases bp(GOBP:"cell migration")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004348	tscript(p(HGNC:SMAD1)) increases bp(GOBP:"cell proliferation")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004350	tscript(p(HGNC:SMAD2)) decreases bp(GOBP:"cell migration")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004352	tscript(p(HGNC:SMAD2)) decreases bp(GOBP:"cell proliferation")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004354	tscript(p(HGNC:SMAD3)) decreases bp(GOBP:"cell migration")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004356	tscript(p(HGNC:SMAD3)) decreases bp(GOBP:"cell proliferation")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004360	tscript(p(HGNC:SMAD5)) increases bp(GOBP:"cell migration")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004362	tscript(p(HGNC:SMAD5)) increases bp(GOBP:"cell proliferation")	ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration	SEN:10001568	15664386
BEL:20004366	tscript(p(HGNC:SMAD7)) decreases tscript(p(HGNC:SMAD2))	Smad7 expression inhibited both Smad2- and Smad3-mediated TGF-beta signaling in podocytes	SEN:10003232	12397035
BEL:20004372	tscript(p(HGNC:SMAD7)) decreases tscript(p(HGNC:SMAD3))	Smad7 expression inhibited both Smad2- and Smad3-mediated TGF-beta signaling in podocytes	SEN:10003232	12397035
BEL:20004378	tscript(p(HGNC:SOX2)) increases bp(GOBP:"epithelial cell differentiation")	Sox2 is required for proliferation and differentiation of Clara cells that serve as the progenitor cells from which Clara, ciliated, and goblet cells are derived.	SEN:10003240	20011520
BEL:20004382	tscript(p(HGNC:SPI1)) increases bp(GOBP:"macrophage differentiation")	Rb promotes differentiation of macrophages by opposing the inhibitory functions of Id2 on the transcription factor PU.1, a master regulator of macrophage differentiation.	SEN:10003242	15616565
BEL:20004394	tscript(p(HGNC:TBX21)) increases bp(GOBP:"T-helper 1 cell differentiation")	Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.	SEN:10003254	10761931
BEL:20004396	tscript(p(HGNC:TFDP1)) increases tscript(p(HGNC:E2F1))	DP1, the DNA binding partner of the E2F family of factors (E2Fs)	SEN:10003256	16135794
BEL:20004398	tscript(p(HGNC:TFDP1)) increases tscript(p(HGNC:E2F2))	DP1, the DNA binding partner of the E2F family of factors (E2Fs)	SEN:10003256	16135794
BEL:20004400	tscript(p(HGNC:TFDP1)) increases tscript(p(HGNC:E2F3))	DP1, the DNA binding partner of the E2F family of factors (E2Fs)	SEN:10003256	16135794
BEL:20004430	a(CHEBI:alcohol) decreases p(MGI:Eif4ebp1,pmod(P))	Phosphorylation of 4E-BP1, S6k1(Thr(389)), and Erk 1/2 was reduced 2 h following IP injection of alcohol.	SEN:10003272	18317950
BEL:20004432	a(CHEBI:alcohol) decreases p(MGI:Mapk1,pmod(P))	Phosphorylation of 4E-BP1, S6k1(Thr(389)), and Erk 1/2 was reduced 2 h following IP injection of alcohol.	SEN:10003272	18317950
BEL:20004434	a(CHEBI:alcohol) decreases p(MGI:Mapk3,pmod(P))	Phosphorylation of 4E-BP1, S6k1(Thr(389)), and Erk 1/2 was reduced 2 h following IP injection of alcohol.	SEN:10003272	18317950
BEL:20004436	a(CHEBI:alcohol) decreases p(MGI:Rps6ka1,pmod(P,T,389))	Phosphorylation of 4E-BP1, S6k1(Thr(389)), and Erk 1/2 was reduced 2 h following IP injection of alcohol.	SEN:10003272	18317950
BEL:20004454	a(CHEBI:atropine) decreases p(HGNC:TNK2,pmod(P,Y))	Incubation of cells with the cholinergic agonist oxotremorine-M (Oxo-M) induced an approximately 6-fold increase in the tyrosine phosphorylation of ACK-1 which was inhibited by atropine.	SEN:10003286	11087735
BEL:20004524	a(CHEBI:corticotropin) increases p(MGI:Sik1,pmod(P,S,577))	The level of phosphorylation at Ser577, a canonical PKA-phosphorylation site, was elevated by ACTH treatment. The disruption of the serine residue inhibited the nuclear export and enhanced the transcription repression activity of SIK.	SEN:10003346	12530631
BEL:20004534	a(CHEBI:"cytochalasin D") increases p(HGNC:TNK2,pmod(P,Y))	In contrast, disruption of the actin cytoskeleton with cytochalasin D stimulated ACK-1 phosphorylation, and moreover, addition of Oxo-M to cells preincubated with this agent elicited a further increase in phosphorylation, indicating that an intact cytoskeleton is not required for mAChR signaling to ACK-1.	SEN:10003352	11087735
BEL:20004556	a(CHEBI:dopamine) decreases p(HGNC:PPP1R1B,pmod(P,T,75))	We report here that dopamine, in slices, and acute cocaine, in whole animals, decreases the state of phosphorylation of striatal DARPP-32 at Thr-75 and thereby removes this inhibitory constraint.	SEN:10003366	11050161
BEL:20004568	a(CHEBI:estradiol) increases p(MGI:Mapk1,pmod(P,Y,204))	We demonstrated that lung myofibroblasts, incubated in the presence of E2, showed a rapid phosphorylation on serine-259 of Raf1 and tyrosine-204 of ERK1/2 MAP kinase at 15 min, by approximately 3- and 5-fold, respectively	SEN:10003378	11341776
BEL:20004570	a(CHEBI:estradiol) increases p(MGI:Mapk3,pmod(P,Y,205))	We demonstrated that lung myofibroblasts, incubated in the presence of E2, showed a rapid phosphorylation on serine-259 of Raf1 and tyrosine-204 of ERK1/2 MAP kinase at 15 min, by approximately 3- and 5-fold, respectively	SEN:10003378	11341776
BEL:20004574	a(CHEBI:estradiol) increases p(MGI:Raf1,pmod(P,S,259))	We demonstrated that lung myofibroblasts, incubated in the presence of E2, showed a rapid phosphorylation on serine-259 of Raf1 and tyrosine-204 of ERK1/2 MAP kinase at 15 min, by approximately 3- and 5-fold, respectively	SEN:10003378	11341776
BEL:20004642	a(CHEBI:imatinib) decreases p(MGI:Abl1,pmod(P,Y,245))	Using the specific Abl tyrosine kinase inhibitor STI 571, we purified unphosphorylated murine type IV c-Abl	SEN:10003428	10964922
BEL:20004644	a(CHEBI:imatinib) decreases p(MGI:Abl1,pmod(P,Y,412))	Using the specific Abl tyrosine kinase inhibitor STI 571, we purified unphosphorylated murine type IV c-Abl	SEN:10003428	10964922
BEL:20004670	a(CHEBI:"kainic acid") decreases p(MGI:Aatk,pmod(P))	However, LK-induced hyperphosphorylation of AATYK at multiple sites was blocked by kainate, lithium, and protein kinase C-delta inhibitor.	SEN:10003446	16100393
BEL:20004768	a(CHEBI:"okadaic acid") increases p(MGI:Myl9,pmod(P))	Whereas the phosphorylation level of troponin I was not changed by 3 microM okadaic acid, that of MLC2 was significantly increased by the same dose of okadaic acid	SEN:10003522	12002261
BEL:20004776	a(CHEBI:"oxotremorine M") increases p(HGNC:TNK2,pmod(P,Y))	Incubation of cells with the cholinergic agonist oxotremorine-M (Oxo-M) induced an approximately 6-fold increase in the tyrosine phosphorylation of ACK-1 which was inhibited by atropine.	SEN:10003286	11087735
BEL:20004928	a(CHEBI:staurosporine) decreases p(MGI:Ptpn14,pmod(P,S))	Staurosporine and ML-9, which inhibited the phosphorylation of PTP36 in vivo, induced the translocation of PTP36 too.	SEN:10003612	10400706
BEL:20005576	bp(GOBP:"cell adhesion") increases p(MGI:Ptpn14,pmod(P,S))	In mouse fibroblasts adhered to substrates, PTP36 was phosphorylated on serine residues. PTP36 was found to make complexes with serine/threonine kinase(s), which phosphorylated PTP36 in vitro. PTP36 was dephosphorylated rapidly when the cell-substrate adhesion was disrupted and it was phosphorylated again along with the reattachment of the cells to fibronectin.	SEN:10004050	10400706
BEL:20005578	bp(GOBP:"cell adhesion") increases p(MGI:Vav1,pmod(P,Y))	% Integrin regulation of neutrophils is essential for appropriate adhesion and transmigration into tissues. Vav proteins are Rho family guanine nucleotide exchange factors that become tyrosine phosphorylated in response to adhesion.	SEN:10004052	15249579
BEL:20005580	bp(GOBP:"cell adhesion") increases p(MGI:Vav3,pmod(P,Y))	% Integrin regulation of neutrophils is essential for appropriate adhesion and transmigration into tissues. Vav proteins are Rho family guanine nucleotide exchange factors that become tyrosine phosphorylated in response to adhesion.	SEN:10004052	15249579
BEL:20005600	bp(GOBP:"cellular response to DNA damage stimulus") increases p(HGNC:BRCA1,pmod(P))	The BRCA1 protein has been implicated in the DNA damage response, as DNA damage induces the phosphorylation of BRCA1 and causes its recruitment into nuclear foci that contain DNA repair proteins.	SEN:10004068	11114888
BEL:20005644	bp(GOBP:"MAPK cascade") directlyIncreases p(HGNC:ESR1,pmod(P))	Mitogen-activated protein (MAP) kinases phosphorylate the estrogen receptor and activate transcription from estrogen receptor-regulated genes.	SEN:10000050	10373563
BEL:20005646	bp(GOBP:"MAPK cascade") increases p(MGI:Cebpb,pmod(P,T,188))	Immunoblotting with antiphosphopeptide antibodies specific for Thr(188/37) of C/EBPbeta (anti-P-C/EBPbeta) shows that GH rapidly and transiently promotes phosphorylation of mLAP and mLIP on the MAPK site. MEK inhibitors prevent this GH-promoted phosphorylation of LAP and LIP, suggesting that such phosphorylation depends on GH-activated MAPK signaling.	SEN:10004102	12213825
BEL:20005648	bp(GOBP:"MAPK cascade") increases p(MGI:Cebpb,pmod(P,T,37))	Immunoblotting with antiphosphopeptide antibodies specific for Thr(188/37) of C/EBPbeta (anti-P-C/EBPbeta) shows that GH rapidly and transiently promotes phosphorylation of mLAP and mLIP on the MAPK site. MEK inhibitors prevent this GH-promoted phosphorylation of LAP and LIP, suggesting that such phosphorylation depends on GH-activated MAPK signaling.	SEN:10004102	12213825
BEL:20005650	bp(GOBP:"MAPK cascade") directlyIncreases p(MGI:Gata1,pmod(P,S,26))	Here we report that, upon interleukin-3 stimulation of Ba/F3 cells, the transcription factor GATA-1 is strongly phosphorylated at residue serine 26 by a MAPK-dependent pathway.	SEN:10004104	15967790
BEL:20005654	bp(GOBP:"MAPK cascade") directlyIncreases p(MGI:Tnks,pmod(P))	Tankyrase is a novel signaling target of mitogen-activated protein kinase (MAPK); it is stoichiometrically phosphorylated upon insulin stimulation. Phosphorylation enhances the poly(ADP-ribose) polymerase activity of tankyrase	SEN:10004100	10988299
BEL:20005810	cat(complex(p(HGNC:CREBBP),p(HGNC:EP300))) increases p(HGNC:KLF1,pmod(A))	The coactivators CBP and P300 interact with, acetylate, and enhance its activity, helping to explain its role as a transcription activator.	SEN:10004208	11287616
BEL:20005984	cat(p(HGNC:CREBBP)) directlyIncreases p(HGNC:HNF4A,pmod(A,K))	Here, it is shown that CBP can acetylate hepatocyte nuclear factor-4 (HNF-4), a member of the nuclear hormone receptor family, at lysine residues within the nuclear localization sequence.	SEN:10004320	10882110
BEL:20006082	cat(p(HGNC:FAS)) increases p(HGNC:RB1,pmod(P))	Fas stimulation of Jurkat cells is known to induce p38 kinase and we find a pronounced increase in Rb phosphorylation within 30 min of Fas stimulation	SEN:10000032	10075927
BEL:20006590	cat(p(MGI:Crebbp)) increases p(MGI:Mef2d,pmod(A,K))	Importantly, HDAC4 promotes sumoylation on a lysine residue that is also subject to acetylation by a MEF2 coactivator, the acetyltransferase CBP,	SEN:10004682	16166628
BEL:20007356	cat(p(MGI:Spp1)) decreases p(MGI:Stat1,pmod(U))	In this current study, using a system of LPS-treated RAW264.7 macrophages, we go on to demonstrate that OPN increases STAT1 ubiquitination and subsequent 26s proteasome-mediated degradation to inhibit STAT1 dependent iNOS promoter activity, transcription, and protein expression.	SEN:10005138	17237438
BEL:20007500	complex(a(CHEBI:estradiol),p(HGNC:GPER1)) increases p(HGNC:SHC1,pmod(P,Y,317))	Consistent with acting through a G protein-coupled receptor, estradiol signaling to Erk-1/-2 occurred via a Gbetagamma-dependent, pertussis toxin-sensitive pathway that required Src-related tyrosine kinase activity and tyrosine phosphorylation of tyrosine 317 of the Shc adapter protein.	SEN:10005226	11043579
BEL:20007752	complex(p(MGI:Ccnd3),p(MGI:Cdk4)) increases p(MGI:Cebpa,pmod(P,S,193))	Cyclin D3-cdk4/cdk6 specifically phosphorylate C/EBPalpha at Ser193 in vitro and in the liver and support growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.	SEN:10005400	16537903
BEL:20007772	complex(p(MGI:Cdk6),p(MGI:Ccnd3)) increases p(MGI:Cebpa,pmod(P,S,193))	Cyclin D3-cdk4/cdk6 specifically phosphorylate C/EBPalpha at Ser193 in vitro and in the liver and support growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.	SEN:10005400	16537903
BEL:20007790	complex(p(MGI:Crebbp),p(MGI:Ep300)) increases p(MGI:Myod1,pmod(A))	MyoD acetylation by CBP/p300 (as well as by PCAF) increases its activity on a muscle-specific promoter, as assessed by microinjection experiments.	SEN:10005424	10944526
BEL:20007856	complex(p(MGI:Il12a),p(MGI:Il12b)) increases p(MGI:Stat4,pmod(P,S,721))	Here we show that IL-12 induces STAT4 phosphorylation on serine 721 and that mutation of serine 721 interferes with STAT4 transcriptional activity.	SEN:10005480	10961885
BEL:20007916	complex(p(MGI:Irs1),p(MGI:Prkcz)) directlyIncreases p(MGI:Irs1,pmod(P,S))	In rat adipose cells, endogenous IRS-1 coimmunoprecipitated with endogenous PKC-zeta, and this association was increased 2-fold upon insulin stimulation.	SEN:10005516	11063744
BEL:20008322	gtp(p(MGI:Kras)) increases p(MGI:Ctnnb1,pmod(P,Y))	Activated KRAS is known to induce tyrosine phosphorylation of beta-catenin, leading to its release from E-cadherin at the adherens junction	SEN:10005428	17030180
BEL:20008440	kin(p(EGID:12534)) directlyIncreases p(MGI:Btg1,pmod(P,S,159))	in vitro the hCAF-1/BTG1 complex formation was dependent on the phosphorylation of a putative p34cdc2 kinase site on BTG1 (Ser-159).	SEN:10005840	9820826
BEL:20008442	kin(p(EGID:279561)) directlyIncreases p(MGI:Slc12a4,pmod(P))	Wild-type WNK3 activates Na-(K)-Cl cotransporters by increasing their phosphorylation, and catalytically inactive kinase inhibits Na-(K)-Cl cotransporters by decreasing their phosphorylation, such that our data suggest that WNK3 is a crucial component of the kinase/phosphatase signaling pathway that coordinately regulates the Cl- influx and efflux branches of the SLC12A cotransporter family.	SEN:10005842	16446421
BEL:20008444	kin(p(EGID:279561)) increases p(MGI:Slc12a4,pmod(P))	Wild-type WNK3 activates Na-(K)-Cl cotransporters by increasing their phosphorylation, and catalytically inactive kinase inhibits Na-(K)-Cl cotransporters by decreasing their phosphorylation, such that our data suggest that WNK3 is a crucial component of the kinase/phosphatase signaling pathway that coordinately regulates the Cl- influx and efflux branches of the SLC12A cotransporter family.	SEN:10005842	16446421
BEL:20008452	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:FOXO1,pmod(P,S,256))	Insulin disrupts IRS-dependent transactivation by FKHR, and phosphorylation of Ser-256 by PKB is necessary and sufficient to mediate this effect.	SEN:10002368	10358076
BEL:20008458	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P))	Highly purified ATM phosphorylated PHAS-I, the 32-kDa subunit of RPA, serine 15 of p53, and Chk2 in vitro.	SEN:10001590	10713094
BEL:20008460	kin(p(HGNC:ATM)) increases p(HGNC:EIF4EBP1,pmod(P))	Highly purified ATM phosphorylated PHAS-I, the 32-kDa subunit of RPA, serine 15 of p53, and Chk2 in vitro.	SEN:10001590	10713094
BEL:20008462	kin(p(HGNC:ATM)) increases p(HGNC:RPA2,pmod(P))	Highly purified ATM phosphorylated PHAS-I, the 32-kDa subunit of RPA, serine 15 of p53, and Chk2 in vitro.	SEN:10001590	10713094
BEL:20008498	kin(p(HGNC:CSNK1D)) directlyIncreases p(HGNC:TP53,pmod(P,T,18))	In this paper, we identify threonine 18 of p53, a key site in regulating the interaction between p53 and its regulatory partner MDM2, as a novel site phosphorylated in vitro by purified recombinant casein kinase 1 (CK1) delta. Strikingly, phosphorylation of threonine 18 is dependent upon prior phosphorylation of serine 15	SEN:10005872	10606744
BEL:20008508	kin(p(HGNC:DYRK1A)) directlyIncreases p(HGNC:MAPT,pmod(P,T,212))	The DYRK isoforms also phosphorylate human microtubule-associated protein tau at Thr(212) in vitro, a residue that is phosphorylated in foetal tau and hyperphosphorylated in filamentous tau from Alzheimer's-disease brain. Phosphorylation of Thr(212) primes tau for phosphorylation by GSK3 at Ser(208) in vitro, suggesting a more general role for DYRK isoforms in priming phosphorylation of GSK3 substrates.	SEN:10005878	11311121
BEL:20008516	kin(p(HGNC:EGFR)) directlyIncreases p(HGNC:GAB1,pmod(P,Y,657))	Recently, we identified a similar cohort of tyrosine phosphorylation sites for the epidermal growth factor receptor (EGFR) with a predominant phosphorylation of tyrosine residue Y657 and binding of Syp [Lehr, S. et al. (1999) Biochemistry 38, 151-159].	SEN:10005880	10978177
BEL:20008526	kin(p(HGNC:EPHA3)) increases p(HGNC:STAM2,pmod(P,Y))	STAM2 is downstream of the Jak family of kinases since coexpression of STAM2 with Jak1 or Jak2 but not an unrelated Tec family kinase, Etk, resulted in its tyrosine phosphorylation.	SEN:10005890	10993906
BEL:20008534	kin(p(HGNC:FER)) directlyIncreases p(HGNC:STAT3,pmod(P,Y))	When combined with immunoprecipitation analysis, this assay showed that p94(fer) can lead to the tyrosine phosphorylation and activation of Stat3 but not of Stat1 or Stat2.	SEN:10005894	10878010
BEL:20008540	kin(p(HGNC:FLT3)) increases p(HGNC:GAB1,pmod(P,Y))	In this study, we show that both Gab1 and Gab2 are rapidly tyrosine phosphorylated after Flt3 ligand stimulation of Flt3 ligand-responsive cells.	SEN:10005896	11027663
BEL:20008542	kin(p(HGNC:FLT3)) increases p(HGNC:GAB2,pmod(P,Y))	In this study, we show that both Gab1 and Gab2 are rapidly tyrosine phosphorylated after Flt3 ligand stimulation of Flt3 ligand-responsive cells.	SEN:10005896	11027663
BEL:20008552	kin(p(HGNC:GSK3B)) directlyIncreases p(HGNC:CTNNB1,pmod(P,S))	Axin, a Wnt signal negative regulator, enhances glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of beta-catenin and stimulates the degradation of beta-catenin.	SEN:10001338	10488109
BEL:20008554	kin(p(HGNC:GSK3B)) directlyIncreases p(HGNC:MAPT,pmod(P,S,208))	The DYRK isoforms also phosphorylate human microtubule-associated protein tau at Thr(212) in vitro, a residue that is phosphorylated in foetal tau and hyperphosphorylated in filamentous tau from Alzheimer's-disease brain. Phosphorylation of Thr(212) primes tau for phosphorylation by GSK3 at Ser(208) in vitro, suggesting a more general role for DYRK isoforms in priming phosphorylation of GSK3 substrates.	SEN:10005878	11311121
BEL:20008562	kin(p(HGNC:IKBKE)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,36))	Although recombinant IKKepsilon directly phosphorylates only serine 36 of IKBalpha, the PMA-activated endogenous IKKepsilon complex phosphorylates both critical serine residues.	SEN:10005904	10882136
BEL:20008566	kin(p(HGNC:INSR)) increases p(HGNC:GAB1,pmod(P,Y))	Accordingly, pull down assays with human HepG2 cell lysates showed that IR-specific phosphorylation of wild-type hGab-1 strongly enhanced PI-3 kinase binding.	SEN:10005906	10978177
BEL:20008574	kin(p(HGNC:JAK1)) increases p(HGNC:STAM2,pmod(P,Y))	STAM2 is downstream of the Jak family of kinases since coexpression of STAM2 with Jak1 or Jak2 but not an unrelated Tec family kinase, Etk, resulted in its tyrosine phosphorylation.	SEN:10005890	10993906
BEL:20008578	kin(p(HGNC:JAK2)) increases p(HGNC:STAM2,pmod(P,Y))	STAM2 is downstream of the Jak family of kinases since coexpression of STAM2 with Jak1 or Jak2 but not an unrelated Tec family kinase, Etk, resulted in its tyrosine phosphorylation.	SEN:10005890	10993906
BEL:20008588	kin(p(HGNC:KIT)) directlyIncreases p(HGNC:KIT,pmod(P,Y,703))	In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail. We furthermore demonstrate that the adapter protein Grb2 is a specific binding partner for both phosphorylated Tyr-703 and phosphorylated Tyr-936,	SEN:10005918	10377264
BEL:20008590	kin(p(HGNC:KIT)) directlyIncreases p(HGNC:KIT,pmod(P,Y,936))	In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail. We furthermore demonstrate that the adapter protein Grb2 is a specific binding partner for both phosphorylated Tyr-703 and phosphorylated Tyr-936,	SEN:10005918	10377264
BEL:20008600	kin(p(HGNC:LIMK1)) increases p(HGNC:CFL1,pmod(P,S,3))	Overexpression of LIMK1 in cultured cells results in accumulation of filamentous (F-) actin. LIMK1 phosphorylates cofilin, an actin depolymerisation factor, which is then unable to bind and depolymerise F-actin.	SEN:10005926	10224665
BEL:20008620	kin(p(HGNC:MAP3K11)) increases p(HGNC:MAP2K1,pmod(P,S,218))	In support of these data, we also show that MEK1 is highly phosphorylated in vivo on Ser 217/221 in MLK3-transformed fibroblasts	SEN:10005936	10232608
BEL:20008622	kin(p(HGNC:MAP3K11)) increases p(HGNC:MAP2K1,pmod(P,S,222))	In support of these data, we also show that MEK1 is highly phosphorylated in vivo on Ser 217/221 in MLK3-transformed fibroblasts	SEN:10005936	10232608
BEL:20008640	kin(p(HGNC:MAPK14)) increases p(HGNC:KRT19,pmod(P,Y))	However, K8/19 tyrosine phosphorylation is independent of EGF signaling or ERK activation while inhibition of p38 kinase activity blocks pervanadate-induced K8/19 tyrosine phosphorylation	SEN:10005946	10362538
BEL:20008642	kin(p(HGNC:MAPK14)) increases p(HGNC:KRT8,pmod(P,Y))	However, K8/19 tyrosine phosphorylation is independent of EGF signaling or ERK activation while inhibition of p38 kinase activity blocks pervanadate-induced K8/19 tyrosine phosphorylation	SEN:10005946	10362538
BEL:20008652	kin(p(HGNC:MAPK1)) directlyIncreases p(HGNC:MYC,pmod(P,S,62))	We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK.	SEN:10005952	11018017
BEL:20008656	kin(p(HGNC:MAPK1)) directlyIncreases p(HGNC:STAT3,pmod(P,S,727))	Recently, serine phosphorylation of Stat3 on Ser-727 by ERK has been identified in response to epidermal growth factor (EGF).	SEN:10005954	10521505
BEL:20008662	kin(p(HGNC:MAPK3)) directlyIncreases p(HGNC:MYC,pmod(P,S,62))	We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK.	SEN:10005952	11018017
BEL:20008674	kin(p(HGNC:MAPK9)) increases p(HGNC:ATF2,pmod(U,K))	Activation of SAPK by forced expression of DeltaMEKK1 increased overall ATF2 ubiquitination, presumably because of the enhanced dimerization of ATF2.	SEN:10005940	10777545
BEL:20008688	kin(p(HGNC:MKNK1)) increases p(HGNC:PLA2G4A,pmod(P,S,727))	Expression of a dominant negative form of MNK1 in HEK293 cells leads to significant inhibition of cPLA2-mediated arachidonate release.	SEN:10005968	10978317
BEL:20008690	kin(p(HGNC:MKNK2)) directlyIncreases p(HGNC:EIF4E,pmod(P,S,209))	The cap-binding translation initiation factor eukaryotic initiation factor 4E (eIF4E) is phosphorylated in vivo at Ser209 in response to a variety of stimuli. In this paper, we show that the mitogen-activated protein kinase (MAPK) signal-integrating kinase Mnk2 phosphorylates eIF4E at this residue.	SEN:10005970	11154262
BEL:20008692	kin(p(HGNC:MTOR)) directlyIncreases p(HGNC:MTOR,pmod(P,S,2481))	Phosphorylation of wild-type but not kinase-inactive FRAP occurs at Ser-2481 in vivo, suggesting that Ser-2481 phosphorylation is a marker of FRAP autokinase activity in cells.	SEN:10002022	10702316
BEL:20008720	kin(p(HGNC:PDK2)) directlyIncreases p(HGNC:PDHA1,pmod(P))	By using human components, we have evaluated how binding to the lipoyl domains of the dihydrolipoyl acetyltransferase (E2) produces the predominant changes in the rates of phosphorylation of the pyruvate dehydrogenase (E1) component by PDK2 and PDK3	SEN:10005986	10748134
BEL:20008722	kin(p(HGNC:PDK3)) directlyIncreases p(HGNC:PDHA1,pmod(P))	By using human components, we have evaluated how binding to the lipoyl domains of the dihydrolipoyl acetyltransferase (E2) produces the predominant changes in the rates of phosphorylation of the pyruvate dehydrogenase (E1) component by PDK2 and PDK3	SEN:10005986	10748134
BEL:20008736	kin(p(HGNC:PDPK1)) directlyIncreases p(HGNC:PRKCZ,pmod(P,T,410))	Activation of protein kinase C-zeta (PKC-zeta) by insulin requires phosphatidylinositol (PI) 3-kinase-dependent increases in phosphatidylinositol-3,4,5-(PO(4))(3) (PIP(3)) and phosphorylation of activation loop and autophosphorylation sites	SEN:10003898	11141077
BEL:20008748	kin(p(HGNC:PRKCD)) directlyIncreases p(HGNC:STAT3,pmod(P,S,727))	Here, we report that Stat3 was specifically associated with PKC delta in vivo in an IL-6-dependent manner in several cell types. Furthermore, Stat3 was phosphorylated by PKC delta in vivo on Ser-727,	SEN:10005996	10446219
BEL:20008754	kin(p(HGNC:PRKCI)) directlyIncreases p(HGNC:IKBKB,pmod(P))	The two members of the atypical protein kinase C (aPKC) subfamily of isozymes (zetaPKC and lambda/iotaPKC) are involved in the control of nuclear factor kappaB (NF-kappaB) through IKKbeta activation.	SEN:10006002	10356400
BEL:20008756	kin(p(HGNC:PRKCZ)) directlyIncreases p(HGNC:IKBKB,pmod(P))	The two members of the atypical protein kinase C (aPKC) subfamily of isozymes (zetaPKC and lambda/iotaPKC) are involved in the control of nuclear factor kappaB (NF-kappaB) through IKKbeta activation.	SEN:10006002	10356400
BEL:20008758	kin(p(HGNC:PRKCZ)) directlyIncreases p(HGNC:PRKCZ,pmod(P,T,560))	Activation of protein kinase C-zeta (PKC-zeta) by insulin requires phosphatidylinositol (PI) 3-kinase-dependent increases in phosphatidylinositol-3,4,5-(PO(4))(3) (PIP(3)) and phosphorylation of activation loop and autophosphorylation sites	SEN:10003898	11141077
BEL:20008762	kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:HOXC4,pmod(P))	Ku binding allowed the recruitment of the homeodomain to DNA ends and dramatically enhanced the phosphorylation of homeodomain-containing proteins by DNA-PK.	SEN:10005374	11279128
BEL:20008764	kin(p(HGNC:PRKDC)) increases p(HGNC:TOMM7,pmod(P))	It has 1 site (-SQ-) for DNA-dependent protein kinase (DNA-PK) phosphorylation and 2 sites of myristilation.	SEN:10006006	10647823
BEL:20008772	kin(p(HGNC:PTK2B)) directlyIncreases p(HGNC:PTK2,pmod(P,Y))	Interestingly, CADTK tyrosine-phosphorylated FAK when both were transiently expressed, but FAK did not phosphorylate CADTK. Biochemical experiments confirmed direct CADTK phosphorylation of FAK.	SEN:10006010	10085136
BEL:20008784	kin(p(HGNC:ROCK1)) increases p(HGNC:DES,pmod(P,T,16))	treatment of the interphase cells with calyculin A revealed phosphorylation at all the three sites of desmin. We also found that an antibody, which specifically recognizes vimentin phosphorylated at Ser-71 by Rho kinase, became immunoreactive after calyculin A treatment.	SEN:10006016	10574968
BEL:20008786	kin(p(HGNC:ROCK1)) increases p(HGNC:DES,pmod(P,T,75))	treatment of the interphase cells with calyculin A revealed phosphorylation at all the three sites of desmin. We also found that an antibody, which specifically recognizes vimentin phosphorylated at Ser-71 by Rho kinase, became immunoreactive after calyculin A treatment.	SEN:10006016	10574968
BEL:20008788	kin(p(HGNC:ROCK1)) increases p(HGNC:DES,pmod(P,T,76))	treatment of the interphase cells with calyculin A revealed phosphorylation at all the three sites of desmin. We also found that an antibody, which specifically recognizes vimentin phosphorylated at Ser-71 by Rho kinase, became immunoreactive after calyculin A treatment.	SEN:10006016	10574968
BEL:20008790	kin(p(HGNC:ROCK1)) increases p(HGNC:VIM,pmod(P,S,71))	treatment of the interphase cells with calyculin A revealed phosphorylation at all the three sites of desmin. We also found that an antibody, which specifically recognizes vimentin phosphorylated at Ser-71 by Rho kinase, became immunoreactive after calyculin A treatment.	SEN:10006016	10574968
BEL:20008802	kin(p(HGNC:RPS6KA1)) increases p(HGNC:BAD,pmod(P,S))	Rsk1 directly phosphorylated the pro-apoptotic protein Bad at the serine %residues that, when phosphorylated, abrogate Bad's pro-apoptotic function.	SEN:10000878	10679322
BEL:20008806	kin(p(HGNC:RPS6KA3)) increases p(HGNC:BAD,pmod(P,S,112))	Ser(112) is reported to be phosphorylated by mitogen-activated protein (MAP)kinase-activated protein kinase-1 (MAPKAP-K1, also called RSK) and by cAMP-dependent protein kinase (PKA)	SEN:10006022	10880354
BEL:20008812	kin(p(HGNC:RPS6KA3)) increases p(HGNC:RPS6KA3,pmod(P,S,386))	The C-terminal kinase of RSK2 is activated by ERK-type MAP kinases, leading to autophosphorylation of RSK2 at Ser386 in a hydrophobic motif.	SEN:10006028	10856237
BEL:20008824	kin(p(HGNC:SRC)) increases p(HGNC:BMX,pmod(P,Y,566))	Coexpression of v-Src and Etk led to a transphosphorylation on tyrosine 566 of Etk and subsequent autophosphorylation. These events correlated with a substantial increase in the kinase activity of Etk.	SEN:10006036	10688651
BEL:20008844	kin(p(HGNC:SYK)) increases p(HGNC:FCGR2B,pmod(P))	Inhibition of p72(Syk) by piceatannol resulted in partial or total inhibition of FcgammaRII phosphorylation, after immunological activation or addition of thrombin, respectively, suggesting that p72(Syk) participates in FcgammaRII phosphorylation.	SEN:10006044	10704823
BEL:20008846	kin(p(HGNC:SYK)) increases p(HGNC:SHC1,pmod(P))	More recent studies have suggested that tyrosine kinase (syk)-mediated phosphorylation of shc is responsible for the ras-ERK cascade via the formation of shc-Grb2-Sos2 following stimulation with anti-IgE antibody, but not FMLP, in human basophils	SEN:10006046	10979966
BEL:20008848	kin(p(HGNC:SYK)) increases p(HGNC:VAV1,pmod(P,Y))	Inhibition of Syk activity by piceatannol prevents both in vitro and in vivo Vav tyrosine phosphorylation, its association with the regulatory subunit of phosphoinositide 3-kinase, and the nuclear modifications typically observed during granulocytic differentiation of this cell line.	SEN:10006048	11331248
BEL:20008854	kin(p(HGNC:TESK1)) increases p(HGNC:CFL1,pmod(P,S,3))	Expression of a kinase-negative TESK1 suppressed cofilin phosphorylation and formation of stress fibers and focal adhesions induced in cells plated on fibronectin.	SEN:10006050	11294912
BEL:20008856	kin(p(HGNC:TGFBR1)) increases p(HGNC:SMAD2,pmod(P))	TGF-beta-mediated activation of TGF-beta type I receptor stimulates the phosphorylation of Smad2 and Smad3 and subsequent heteromeric complex formation with Smad4.	SEN:10006052	11058129
BEL:20008858	kin(p(HGNC:TGFBR1)) increases p(HGNC:SMAD3,pmod(P))	TGF-beta-mediated activation of TGF-beta type I receptor stimulates the phosphorylation of Smad2 and Smad3 and subsequent heteromeric complex formation with Smad4.	SEN:10006052	11058129
BEL:20008866	kin(p(MGI:Abl1)) directlyIncreases p(MGI:Abl1,pmod(P,Y,245))	The autophosphorylation rate was dependent on Abl protein concentration consistent with an intermolecular reaction.	SEN:10006058	10964922
BEL:20008868	kin(p(MGI:Abl1)) directlyIncreases p(MGI:Abl1,pmod(P,Y,412))	The autophosphorylation rate was dependent on Abl protein concentration consistent with an intermolecular reaction.	SEN:10006058	10964922
BEL:20008878	kin(p(MGI:Adrbk2)) increases p(MGI:Oprk1,pmod(P))	The result suggests that tolerance to kappa agonists includes phosphorylation of serine 369 within KOR by GRK3	SEN:10006062	14597630
BEL:20008926	kin(p(MGI:Cdk2)) increases p(MGI:Bard1,pmod(P))	CDK2-cyclin A1/E1 and CDK1-cyclin B1 phosphorylate BARD1 on its NH(2) terminus in vivo and in vitro.	SEN:10005396	15665273
BEL:20008934	kin(p(MGI:Cdk5)) increases p(MGI:Pparg,pmod(P,S,273))	Obesity induced in mice by high-fat feeding activates the protein kinase Cdk5 (cyclin-dependent kinase 5) in adipose tissues. This results in phosphorylation of the nuclear receptor PPARgamma (peroxisome proliferator-activated receptor gamma), a dominant regulator of adipogenesis and fat cell gene expression, at serine 273.	SEN:10006092	20651683
BEL:20008942	kin(p(MGI:Chek1)) directlyIncreases p(MGI:Bad,pmod(P,S,155))	Our results suggest that Chk1 associates with BAD and phosphorylates the BAD protein at serine-155	SEN:10006098	15736430
BEL:20008944	kin(p(MGI:Chek1)) directlyIncreases p(MGI:Cdc25c,pmod(P,S,123))	Furthermore, Chk1 also phosphorylates Cdc25A on serine 123 which accelerates its degradation through the ubiquitin-proteasome pathway and arrests cells in late G2-phase after DNA damage.	SEN:10006100	15736430
BEL:20008948	kin(p(MGI:Chuk)) directlyIncreases p(MGI:Rela,pmod(P,S,276))	Coexpression of catalytically inactive mutants of the catalytic subunit of protein kinase A/mitogen- and stress-activated kinase 1 or IKK1/IKK2, which phosphorylate RelA on serine 276 or serine 536, respectively, sharply inhibited RelA acetylation on lysine 310.	SEN:10006104	16135789
BEL:20008968	kin(p(MGI:Egfr)) increases p(MGI:Prkcd,pmod(P,Y))	Treatment of keratinocytes expressing a normal epidermal growth factor receptor (EGFR) with TGFalpha or epidermal growth factor for 5 min induced PKCdelta tyrosine phosphorylation.	SEN:10006116	8621384
BEL:20008970	kin(p(MGI:Egfr)) increases p(MGI:Scamp1,pmod(P,Y))	A search for SCAMP kinase activities has shown that SCAMPs 1 and 3, but not SCAMP2, are tyrosine phosphorylated in EGF-stimulated murine fibroblasts overexpressing the EGF receptor (EGFR).	SEN:10006118	9658162
BEL:20008972	kin(p(MGI:Egfr)) increases p(MGI:Scamp3,pmod(P,Y))	A search for SCAMP kinase activities has shown that SCAMPs 1 and 3, but not SCAMP2, are tyrosine phosphorylated in EGF-stimulated murine fibroblasts overexpressing the EGF receptor (EGFR).	SEN:10006118	9658162
BEL:20008990	kin(p(MGI:Eif2ak3)) increases p(MGI:Eif2s1,pmod(P))	This response centers on the phosphorylation state of eukaryotic initiation factor (eIF)-2 alpha, which is induced by kinases like protein kinase R-like ER kinase (PERK) and GCN2 to suppress translation and is later reversed so translation resumes.	SEN:10006126	12840028
BEL:20008994	kin(p(MGI:Eif2ak4)) increases p(MGI:Eif2s1,pmod(P))	This response centers on the phosphorylation state of eukaryotic initiation factor (eIF)-2 alpha, which is induced by kinases like protein kinase R-like ER kinase (PERK) and GCN2 to suppress translation and is later reversed so translation resumes.	SEN:10006126	12840028
BEL:20009010	kin(p(MGI:Fgfr1)) directlyIncreases p(MGI:Frs3,pmod(P,Y))	We demonstrate that siRNA targeting ULK2 in mouse P19 cells results in elevated FGFR1 mediated FRS3 and SHP2 tyrosyl phosphorylation.	SEN:10006142	16887332
BEL:20009012	kin(p(MGI:Fgfr1)) directlyIncreases p(MGI:Ptpn11,pmod(P,Y))	We demonstrate that siRNA targeting ULK2 in mouse P19 cells results in elevated FGFR1 mediated FRS3 and SHP2 tyrosyl phosphorylation.	SEN:10006142	16887332
BEL:20009028	kin(p(MGI:Fyn)) directlyIncreases p(MGI:Agap2,pmod(P,Y))	Employing fyn-deficient mouse embryonic fibroblast cells and tissues, we demonstrate that fyn is essential for phosphorylating PIKE-A and protects it from apoptotic cleavage. Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues.	SEN:10006152	16841086
BEL:20009038	kin(p(MGI:Fyn)) increases p(MGI:Nfe2l2,pmod(P,Y,576))	Further experiments with small interfering RNA revealed that Fyn phosphorylated Nrf 2Y568 leading to nuclear export and degradation of Nrf 2.	SEN:10006156	16513647
BEL:20009042	kin(p(MGI:Fyn)) increases p(MGI:Skap2,pmod(P,Y))	Transient expression of mSKAP55R in COS cells demonstrated that tyrosine 260 was the predominant site of phosphorylation by FYN kinase. Furthermore, this phosphotyrosine was essential for coimmunoprecipitation of FYN with mSKAP55R	SEN:10006154	11063873
BEL:20009084	kin(p(MGI:Ikbkb)) directlyIncreases p(MGI:Rela,pmod(P,S,536))	Coexpression of catalytically inactive mutants of the catalytic subunit of protein kinase A/mitogen- and stress-activated kinase 1 or IKK1/IKK2, which phosphorylate RelA on serine 276 or serine 536, respectively, sharply inhibited RelA acetylation on lysine 310.	SEN:10006104	16135789
BEL:20009086	kin(p(MGI:Ikbke)) increases p(MGI:Nfkbia,pmod(P,S,32))	Overexpression of wild-type IKK-i phosphorylated serine residues Ser32 and Ser36 of IkappaB-alpha (preferentially Ser36), and significantly stimulated NF-kappaB activation.	SEN:10006184	10421793
BEL:20009088	kin(p(MGI:Ikbke)) directlyIncreases p(MGI:Nfkbia,pmod(P,S,36))	Overexpression of wild-type IKK-i phosphorylated serine residues Ser32 and Ser36 of IkappaB-alpha (preferentially Ser36), and significantly stimulated NF-kappaB activation.	SEN:10006184	10421793
BEL:20009090	kin(p(MGI:Ikbke)) directlyIncreases p(MGI:Stat1,pmod(P))	We demonstrate that IKKepsilon is activated by IFNbeta and that IKKepsilon directly phosphorylates signal transducer and activator of transcription 1 (STAT1), a component of ISGF3.	SEN:10006186	17332413
BEL:20009098	kin(p(MGI:Insr)) increases p(MGI:Cblb,pmod(P,Y))	Cbl-b also undergoes tyrosine phosphorylation and membrane translocation in response to insulin in 3T3-L1 adipocytes.	SEN:10006192	12842890
BEL:20009108	kin(p(MGI:Irak1)) increases p(MGI:Irak1,pmod(P))	IRAK-1 itself, an endogenous substrate with an apparent molecular weight of 24kDa (p24), and exogenous substrates like histone and myelin basic protein are phosphorylated by nuclear located IRAK-1.	SEN:10006198	15896328
BEL:20009112	kin(p(MGI:Irak1)) increases p(MGI:Mbp,pmod(P))	IRAK-1 itself, an endogenous substrate with an apparent molecular weight of 24kDa (p24), and exogenous substrates like histone and myelin basic protein are phosphorylated by nuclear located IRAK-1.	SEN:10006198	15896328
BEL:20009132	kin(p(MGI:Jak2)) directlyIncreases p(MGI:Slc12a2,pmod(P,Y))	PRL enhanced tyrosine phosphorylation of NKCC1, and this effect was attenuated by the JAK2 inhibitor AG490.	SEN:10006206	11117534
BEL:20009168	kin(p(MGI:Map2k1)) directlyIncreases p(MGI:Mapk1,pmod(P,T,183))	Mitogen-activated protein (MAP) kinase is central to a signal transduction pathway that triggers cell proliferation or differentiation. Activation of the p42mapk isoform requires its phosphorylation at two residues, Thr 183 and Tyr 185, and this phosphorylation is catalysed by MAP kinase kinase (MAPKK).	SEN:10006222	7780739
BEL:20009170	kin(p(MGI:Map2k1)) directlyIncreases p(MGI:Mapk1,pmod(P,Y,185))	Mitogen-activated protein (MAP) kinase is central to a signal transduction pathway that triggers cell proliferation or differentiation. Activation of the p42mapk isoform requires its phosphorylation at two residues, Thr 183 and Tyr 185, and this phosphorylation is catalysed by MAP kinase kinase (MAPKK).	SEN:10006222	7780739
BEL:20009184	kin(p(MGI:Map3k11)) decreases p(MGI:Cebpb,pmod(P,S,64))	MLK3 appears to activate C/EBP-beta in response to IFN-gamma by a mechanism involving decreased phosphorylation of a specific phosphoacceptor residue, Ser(64), within the transactivation domain.	SEN:10006232	15878863
BEL:20009226	kin(p(MGI:Mapk14)) increases p(MGI:Cryab,pmod(P))	PDGF-BB induces phosphorylation of alphaB-crystallin via p38 MAP kinase during myocardial infarction	SEN:10006254	15907784
BEL:20009230	kin(p(MGI:Mapk14)) increases p(MGI:Nfatc4,pmod(P,S))	Here we demonstrate that NFATc4 is phosphorylated by p38 mitogen-activated protein (MAP) kinase but not by JNK. The p38 MAP kinase phosphorylates multiple residues, including Ser(168) and Ser(170), in the NFAT homology domain of NFATc4.	SEN:10006256	11997522
BEL:20009308	kin(p(MGI:Mapk8)) increases p(MGI:Pax2,pmod(P))	The activation domain of Pax2 is phosphorylated by the c-Jun N-terminal kinase (JNK) to enhance Pax2-dependent transcription.	SEN:10006290	14532124
BEL:20009316	kin(p(MGI:Mapk9)) increases p(MGI:Msr1,pmod(P))	JNK2-dependent phosphorylation of SR-A promotes uptake of lipids in macrophages, thereby regulating foam cell formation, a critical step in atherogenesis	SEN:10006292	15567863
BEL:20009318	kin(p(MGI:Mapk9)) increases p(MGI:Pax2,pmod(P))	The activation domain of Pax2 is phosphorylated by the c-Jun N-terminal kinase (JNK) to enhance Pax2-dependent transcription.	SEN:10006290	14532124
BEL:20009350	kin(p(MGI:Ntrk1)) increases p(MGI:Frs2,pmod(P,Y))	we demonstrated that the ShcY317F mutant exerts an inhibitory effect on TRK-T3 transforming activity.	SEN:10006314	12237775
BEL:20009352	kin(p(MGI:Ntrk1)) increases p(MGI:Shc1,pmod(P,Y,317))	we demonstrated that the ShcY317F mutant exerts an inhibitory effect on TRK-T3 transforming activity.	SEN:10006314	12237775
BEL:20009422	kin(p(MGI:Prkcz)) directlyIncreases p(MGI:Llgl1,pmod(P,S))	Here we identify direct physiological interactions between mammalian aPKC, murine Par-6C (mPar-6C) and Mlgl, the mammalian orthologue of the Drosophila melanogaster tumour suppressor Lethal (2) giant larvae. In cultured cell lines and in mouse brain, aPKC, mPar-6C and Mlgl form a multiprotein complex in which Mlgl is targeted for phosphorylation on conserved serine residues.	SEN:10005568	12629547
BEL:20009424	kin(p(MGI:Prkcz)) directlyIncreases p(MGI:Rela,pmod(P,S,311))	Here we demonstrate that Ser311 accounts for zetaPKC phosphorylation of RelA and that this site is phosphorylated in vivo in response to TNF-alpha.	SEN:10006346	12881425
BEL:20009434	kin(p(MGI:Ptk2b)) increases p(MGI:Ptk2b,pmod(P,Y))	In addition, autophosphorylation of proline-rich tyrosine kinase 2 (Pyk2), a tyrosine kinase linked to NMDAR signaling, was also reduced in PTPalpha-deficient synaptosomes.	SEN:10006350	16899073
BEL:20009442	kin(p(MGI:Ptk6)) directlyIncreases p(MGI:Khdrbs1,pmod(P,Y))	Only a few substrates have been identified for BRK/Sik, including the KH domain containing RNA-binding protein Sam68 and the novel adaptor protein BKS	SEN:10006356	15471878
BEL:20009444	kin(p(MGI:Ptk6)) directlyIncreases p(MGI:Stap2,pmod(P,Y))	Only a few substrates have been identified for BRK/Sik, including the KH domain containing RNA-binding protein Sam68 and the novel adaptor protein BKS	SEN:10006356	15471878
BEL:20009476	kin(p(MGI:Rock2)) increases p(MGI:Cd44,pmod(P))	ROK-alpha promoted CD44 surface expression through phosphorylation of CD44 and ezrin-radixin-moesin (ERM) proteins.	SEN:10006374	12730217
BEL:20009488	kin(p(MGI:Rps6ka4)) increases p(MGI:Hmgn1,pmod(P))	Further more, we show that histone H3 and HMG-14 phosphorylation is severely reduced or abolished in mice lacking MSK1 and MSK2	SEN:10006380	12773393
BEL:20009492	kin(p(MGI:Rps6ka5)) increases p(MGI:Hmgn1,pmod(P))	Further more, we show that histone H3 and HMG-14 phosphorylation is severely reduced or abolished in mice lacking MSK1 and MSK2	SEN:10006380	12773393
BEL:20009506	kin(p(MGI:Sik2)) increases p(MGI:Crtc2,pmod(P,S,171))	Activated SIK2 in turn stimulated the Ser 171 phosphorylation and cytoplasmic translocation of TORC2. Phosphorylated TORC2 was degraded by the 26S proteasome during re-feeding through an association with COP1, a substrate receptor for an E3 ligase complex that promoted TORC2 ubiquitination at Lys 628.	SEN:10006386	17805301
BEL:20009516	kin(p(MGI:Src)) directlyIncreases p(MGI:Cdh1,pmod(P,Y))	However, phosphorylation by src kinase decreased the affinity constant from approximately 260 nM to 4 microM. Interestingly, phosphorylation of E-cadherin by CK1 or CK2 prevented the inhibition of beta-catenin binding by src phosphorylation.	SEN:10006108	16945320
BEL:20009526	kin(p(MGI:Srpk1)) increases p(EGID:110809,pmod(P))	Northern blotting revealed the ubiquitous expression of mSRPK1 in all tissues examined and the tissue-specific expression of mSRPK2 in testis, lung, and brain. Both kinases phosphorylated SF2/ASF, a member of SR proteins in vitro and the phosphopeptide mappings were identical, indicating that these kinases phosphorylate the same site of SF2/ASF.	SEN:10006396	9446799
BEL:20009528	kin(p(MGI:Srpk2)) increases p(EGID:110809,pmod(P))	Northern blotting revealed the ubiquitous expression of mSRPK1 in all tissues examined and the tissue-specific expression of mSRPK2 in testis, lung, and brain. Both kinases phosphorylated SF2/ASF, a member of SR proteins in vitro and the phosphopeptide mappings were identical, indicating that these kinases phosphorylate the same site of SF2/ASF.	SEN:10006396	9446799
BEL:20009534	kin(p(MGI:Syk)) directlyIncreases p(MGI:Sh3bp2,pmod(P,Y,174))	3BP2 was predominantly phosphorylated on Tyr174, Tyr183, and Tyr446 when it was coexpressed with Syk.	SEN:10006400	12709437
BEL:20009536	kin(p(MGI:Syk)) directlyIncreases p(MGI:Sh3bp2,pmod(P,Y,183))	3BP2 was predominantly phosphorylated on Tyr174, Tyr183, and Tyr446 when it was coexpressed with Syk.	SEN:10006400	12709437
BEL:20009538	kin(p(MGI:Syk)) directlyIncreases p(MGI:Sh3bp2,pmod(P,Y,446))	3BP2 was predominantly phosphorylated on Tyr174, Tyr183, and Tyr446 when it was coexpressed with Syk.	SEN:10006400	12709437
BEL:20009556	kin(p(MGI:Tssk6)) directlyIncreases p(MGI:H1f0,pmod(P))	SSTK phosphorylated histones H1, H2A, H2AX, and H3 but not H2B or H4 or transition protein 1 in vitro.	SEN:10006412	15870294
BEL:20009558	kin(p(MGI:Tssk6)) directlyIncreases p(MGI:H2afx,pmod(P,S,140))	SSTK phosphorylated histones H1, H2A, H2AX, and H3 but not H2B or H4 or transition protein 1 in vitro.	SEN:10006412	15870294
BEL:20009560	kin(p(MGI:Tssk6)) directlyIncreases p(MGI:H3f3a,pmod(P))	SSTK phosphorylated histones H1, H2A, H2AX, and H3 but not H2B or H4 or transition protein 1 in vitro.	SEN:10006412	15870294
BEL:20009562	kin(p(MGI:Tssk6)) directlyIncreases p(MGI:Hist3h2a,pmod(P))	SSTK phosphorylated histones H1, H2A, H2AX, and H3 but not H2B or H4 or transition protein 1 in vitro.	SEN:10006412	15870294
BEL:20009758	p(EGID:103968,pmod(P,S,517)) increases cat(p(MGI:Pnpla2))	These results provide the first demonstration that Peri A regulates ATGL-dependent lipolysis and identify serine 517 as the Peri A PKA site essential for this regulation.	SEN:10006520	17114792
BEL:20009798	p(HGNC:ACP1,pmod(P,Y,132)) directlyIncreases complex(p(HGNC:ACP1),p(HGNC:GRB2))	Tyr131 phosphorylation is followed by a strong (about 25-fold) increase of the enzyme specific activity, whereas phosphorylation at Tyr132 leads to Grb2 recruitment. These differing effects are discussed on the light of the enzyme structure.	SEN:10006032	10452533
BEL:20009800	p(HGNC:ACP1,pmod(P,Y,132)) directlyIncreases phos(p(HGNC:ACP1))	Tyr131 phosphorylation is followed by a strong (about 25-fold) increase of the enzyme specific activity, whereas phosphorylation at Tyr132 leads to Grb2 recruitment. These differing effects are discussed on the light of the enzyme structure.	SEN:10006032	10452533
BEL:20009884	p(HGNC:ATP2B1,pmod(P,Y)) directlyDecreases tport(p(HGNC:ATP2B1))	More recently, we discovered that PMCA is phosphorylated on tyrosine residues during thrombin-stimulated platelet aggregation and that this phosphorylation causes inhibition of PMCA activity.	SEN:10006600	10642282
BEL:20009892	p(HGNC:BAD,pmod(P,S)) directlyDecreases cat(p(HGNC:BAD))	Rsk1 directly phosphorylated the pro-apoptotic protein Bad at the serine %residues that, when phosphorylated, abrogate Bad's pro-apoptotic function.	SEN:10000878	10679322
BEL:20009944	p(HGNC:BMX,pmod(P,Y,566)) directlyIncreases kin(p(HGNC:BMX))	Coexpression of v-Src and Etk led to a transphosphorylation on tyrosine 566 of Etk and subsequent autophosphorylation. These events correlated with a substantial increase in the kinase activity of Etk.	SEN:10006036	10688651
BEL:20009996	p(HGNC:CBL,pmod(P,Y)) directlyIncreases complex(p(HGNC:CBL),p(HGNC:CRKL))	During treatment of NB-4 human cells with IFN-gamma, c-cbl protooncogene product is rapidly phosphorylated on tyrosine and provides a docking site for the src homology 2 domain of CrkL, which also undergoes IFN-gamma-dependent tyrosine phosphorylation.	SEN:10006672	10657627
BEL:20010052	p(HGNC:CDC6,pmod(U,K)) directlyIncreases deg(p(HGNC:CDC6))	Furthermore, APC, in association with CDH1, ubiquitinates CDC6 in vitro, and both APC and CDH1 are required and limiting for CDC6 proteolysis in vivo.	SEN:10006710	10995389
BEL:20010070	p(HGNC:CDKN1B,pmod(P,T,187)) directlyIncreases deg(p(HGNC:CDKN1B))	Degradation of p27 is initiated by phosphorylation of p27 at Thr-187, which marks the protein for ubiquitination by SCF(Skp2) and subsequent proteolysis by the 26S proteasome.	SEN:10004498	10781063
BEL:20010078	p(HGNC:CDKN2A) decreases p(HGNC:RB1,pmod(P))	Whereas cdk4/cdk6 inhibition and Rb dephosphorylation are expected on p16Ink4a expression, we have also observed indirect cdk2 inhibition.	SEN:10002192	11063124
BEL:20010088	p(HGNC:CFL1,pmod(P,S,3)) increases tloc(p(HGNC:CFL1),GOCCID:0005634,GOCCID:0005737)	In unstimulated human peripheral blood T lymphocytes cofilin is phosphorylated and localized in the cytoplasm	SEN:10006730	11093160
BEL:20010108	p(HGNC:CNTF) increases p(HGNC:STAT3,pmod(P,S,727))	We found that CNTF-induced phosphorylation of Ser727 was inhibited by the mTOR inhibitor rapamycin, but not by inhibitors of MAPK and protein kinase C (PKC) activation.	SEN:10003930	10660304
BEL:20010116	p(HGNC:COPS2) increases p(HGNC:IRF8,pmod(P,S))	We show that in vitro association of ICSBP with the CSN leads to phosphorylation of ICSBP at a unique serine residue within its IAD.	SEN:10006750	10991940
BEL:20010180	p(HGNC:CTNNB1,pmod(P,S)) directlyIncreases deg(p(HGNC:CTNNB1))	We identified a human F-box/WD40 repeats protein (HOS), which is homologous to Slimb/h betaTrCP. Being a part of SCF complex with Skp1 and Cullin1, HOS specifically interacted with the phosphorylated IkappaB and beta-catenin, targeting these proteins for proteasome-dependent degradation in vivo.	SEN:10001364	10321728
BEL:20010182	p(HGNC:CTNNB1,pmod(P,S)) directlyIncreases deg(p(HGNC:CTNNB1))	Axin, a Wnt signal negative regulator, enhances glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of beta-catenin and stimulates the degradation of beta-catenin.	SEN:10001338	10488109
BEL:20010268	p(HGNC:EGF) increases p(HGNC:STAM2,pmod(P,Y))	Tyrosine phosphorylation of STAM2 is induced by growth factors such as epidermal growth factor and platelet-derived growth factor as well as by cytokines like IL-3.	SEN:10006852	10993906
BEL:20010272	p(HGNC:EGF) increases p(HGNC:TGIF1,pmod(P))	epidermal growth factor (EGF) signaling via the Ras-Mek pathway causes the phosphorylation of TGIF at two Erk MAP kinase sites, leading to TGIF stabilization	SEN:10006844	11226163
BEL:20010308	p(HGNC:ELK1,sub(F,378,A)) directlyDecreases tscript(p(HGNC:ELK1))	Mutation to alanine of S383, F378 or W379, which virtually abolishes transcriptional activation by Elk-1, does not affect phosphorylation of any sites tested.	SEN:10006876	10637505
BEL:20010310	p(HGNC:ELK1,sub(S,383,A)) directlyDecreases tscript(p(HGNC:ELK1))	Mutation to alanine of S383, F378 or W379, which virtually abolishes transcriptional activation by Elk-1, does not affect phosphorylation of any sites tested.	SEN:10006876	10637505
BEL:20010312	p(HGNC:ELK1,sub(W,379,A)) directlyDecreases tscript(p(HGNC:ELK1))	Mutation to alanine of S383, F378 or W379, which virtually abolishes transcriptional activation by Elk-1, does not affect phosphorylation of any sites tested.	SEN:10006876	10637505
BEL:20010340	p(HGNC:ERBB2,pmod(P,Y,1144)) increases tscript(p(HGNC:ETS2))	Here, we demonstrate that these transformation-competent neu mutants activate extracellular signal-regulated kinases and stimulate Ets-2-dependent transcription.	SEN:10006894	11238891
BEL:20010344	p(HGNC:ERBB2,pmod(P,Y,1201)) increases tscript(p(HGNC:ETS2))	Here, we demonstrate that these transformation-competent neu mutants activate extracellular signal-regulated kinases and stimulate Ets-2-dependent transcription.	SEN:10006894	11238891
BEL:20010348	p(HGNC:ERBB2,pmod(P,Y,1227)) increases tscript(p(HGNC:ETS2))	Here, we demonstrate that these transformation-competent neu mutants activate extracellular signal-regulated kinases and stimulate Ets-2-dependent transcription.	SEN:10006894	11238891
BEL:20010352	p(HGNC:ERBB2,pmod(P,Y,1253)) increases tscript(p(HGNC:ETS2))	Here, we demonstrate that these transformation-competent neu mutants activate extracellular signal-regulated kinases and stimulate Ets-2-dependent transcription.	SEN:10006894	11238891
BEL:20010356	p(HGNC:ESR1,pmod(P)) directlyIncreases tscript(p(HGNC:ESR1))	Mitogen-activated protein (MAP) kinases phosphorylate the estrogen receptor and activate transcription from estrogen receptor-regulated genes.	SEN:10000050	10373563
BEL:20010368	p(HGNC:F2) increases p(HGNC:ATP2B1,pmod(P,Y))	More recently, we discovered that PMCA is phosphorylated on tyrosine residues during thrombin-stimulated platelet aggregation and that this phosphorylation causes inhibition of PMCA activity.	SEN:10006600	10642282
BEL:20010392	p(HGNC:FCGR2B,pmod(P)) directlyIncreases cat(p(HGNC:FCGR2B))	Inhibition of p72(Syk) by piceatannol resulted in partial or total inhibition of FcgammaRII phosphorylation, after immunological activation or addition of thrombin, respectively, suggesting that p72(Syk) participates in FcgammaRII phosphorylation.	SEN:10006044	10704823
BEL:20010460	p(HGNC:GAB1,pmod(P,Y,627)) directlyIncreases complex(p(HGNC:GAB1),p(HGNC:PTPN11))	We found that both Tyr-627 and Tyr-659 of Gab1 were required for SHP2 binding to Gab1 and for ERK2 activation by EGF.	SEN:10006960	11323411
BEL:20010462	p(HGNC:GAB1,pmod(P,Y,627)) directlyIncreases phos(p(HGNC:PTPN11))	We found that both Tyr-627 and Tyr-659 of Gab1 were required for SHP2 binding to Gab1 and for ERK2 activation by EGF.	SEN:10006960	11323411
BEL:20010464	p(HGNC:GAB1,pmod(P,Y,657)) directlyIncreases complex(p(HGNC:GAB1),p(HGNC:SYP))	Recently, we identified a similar cohort of tyrosine phosphorylation sites for the epidermal growth factor receptor (EGFR) with a predominant phosphorylation of tyrosine residue Y657 and binding of Syp [Lehr, S. et al. (1999) Biochemistry 38, 151-159].	SEN:10005880	10978177
BEL:20010466	p(HGNC:GAB1,pmod(P,Y,659)) directlyIncreases complex(p(HGNC:GAB1),p(HGNC:PTPN11))	We found that both Tyr-627 and Tyr-659 of Gab1 were required for SHP2 binding to Gab1 and for ERK2 activation by EGF.	SEN:10006960	11323411
BEL:20010468	p(HGNC:GAB1,pmod(P,Y,659)) directlyIncreases phos(p(HGNC:PTPN11))	We found that both Tyr-627 and Tyr-659 of Gab1 were required for SHP2 binding to Gab1 and for ERK2 activation by EGF.	SEN:10006960	11323411
BEL:20010470	p(HGNC:GAB1,pmod(P,Y)) directlyIncreases complex(p(HGNC:GAB1),p(HGNC:PIK3R1))	Accordingly, pull down assays with human HepG2 cell lysates showed that IR-specific phosphorylation of wild-type hGab-1 strongly enhanced PI-3 kinase binding.	SEN:10005906	10978177
BEL:20010550	p(HGNC:HNF4A,pmod(A,K)) increases complex(p(HGNC:CREBBP),p(HGNC:HNF4A))	Acetylation also increases HNF-4 DNA binding activity and its affinity of interaction with CBP itself and is required for target gene activation.	SEN:10007008	10882110
BEL:20010554	p(HGNC:HNF4A,pmod(A,K)) directlyIncreases tscript(p(HGNC:HNF4A))	Acetylation also increases HNF-4 DNA binding activity and its affinity of interaction with CBP itself and is required for target gene activation.	SEN:10007008	10882110
BEL:20010612	p(HGNC:IFNG) increases p(HGNC:CBL,pmod(P,Y))	During treatment of NB-4 human cells with IFN-gamma, c-cbl protooncogene product is rapidly phosphorylated on tyrosine and provides a docking site for the src homology 2 domain of CrkL, which also undergoes IFN-gamma-dependent tyrosine phosphorylation.	SEN:10006672	10657627
BEL:20010614	p(HGNC:IFNG) increases p(HGNC:CRKL,pmod(P,Y))	During treatment of NB-4 human cells with IFN-gamma, c-cbl protooncogene product is rapidly phosphorylated on tyrosine and provides a docking site for the src homology 2 domain of CrkL, which also undergoes IFN-gamma-dependent tyrosine phosphorylation.	SEN:10006672	10657627
BEL:20010618	p(HGNC:IFNG) increases p(HGNC:STAT3,pmod(P,Y,705))	TSH induced phosphorylation of both Y705 and S727 in STAT3, while IFN-gamma phosphorylated only the Y705.	SEN:10003990	10707961
BEL:20010720	p(HGNC:IKBKB,pmod(P)) directlyIncreases kin(p(HGNC:IKBKB))	PKC-theta acts directly or indirectly to stimulate phosphorylation of IKKbeta, leading to activation of this enzyme	SEN:10007122	10733597
BEL:20010880	p(HGNC:IL3) decreases p(HGNC:STAM2,pmod(P,Y))	Tyrosine phosphorylation of STAM2 is induced by growth factors such as epidermal growth factor and platelet-derived growth factor as well as by cytokines like IL-3.	SEN:10006852	10993906
BEL:20011076	p(HGNC:KIT,pmod(P,Y,703)) directlyIncreases complex(p(HGNC:KIT),p(HGNC:GRB2))	In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail. We furthermore demonstrate that the adapter protein Grb2 is a specific binding partner for both phosphorylated Tyr-703 and phosphorylated Tyr-936,	SEN:10005918	10377264
BEL:20011078	p(HGNC:KIT,pmod(P,Y,936)) directlyIncreases complex(p(HGNC:KIT),p(HGNC:GRB2))	In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail. We furthermore demonstrate that the adapter protein Grb2 is a specific binding partner for both phosphorylated Tyr-703 and phosphorylated Tyr-936,	SEN:10005918	10377264
BEL:20011080	p(HGNC:KLF1,pmod(A)) directlyIncreases tscript(p(HGNC:KLF1))	The coactivators CBP and P300 interact with, acetylate, and enhance its activity, helping to explain its role as a transcription activator.	SEN:10004208	11287616
BEL:20011106	p(HGNC:LYN,pmod(P,Y)) directlyIncreases kin(p(HGNC:LYN))	CD45 selectively dephosphorylates the Src-family protein tyrosine kinase Lyn and inhibits its kinase activity.	SEN:10007368	10415030
BEL:20011130	p(HGNC:MAPK14) decreases p(HGNC:NFKBIA,pmod(P,S))	ASK1/p38 silences the Fas promoter by inhibition of IkappaBalpha phosphorylation - thereby limiting NF-kappaB activity.	SEN:10005950	10871852
BEL:20011144	p(HGNC:MCAM) increases p(HGNC:PTK2,pmod(P,Y))	These results indicate that CD146 is coupled to a FYN-dependent pathway that triggers Ca(2+) flux via phospholipase C-gamma activation leading subsequently to the tyrosine phosphorylation of downstream targets such as Pyk2, p130(Cas), FAK, and paxillin.	SEN:10007384	11036077
BEL:20011146	p(HGNC:MCAM) increases p(HGNC:PXN,pmod(P,Y))	These results indicate that CD146 is coupled to a FYN-dependent pathway that triggers Ca(2+) flux via phospholipase C-gamma activation leading subsequently to the tyrosine phosphorylation of downstream targets such as Pyk2, p130(Cas), FAK, and paxillin.	SEN:10007384	11036077
BEL:20011162	p(HGNC:MTOR,pmod(P,S,2481)) directlyIncreases kin(p(HGNC:MTOR))	Phosphorylation of wild-type but not kinase-inactive FRAP occurs at Ser-2481 in vivo, suggesting that Ser-2481 phosphorylation is a marker of FRAP autokinase activity in cells.	SEN:10002022	10702316
BEL:20011168	p(HGNC:MYC,pmod(P,S,62)) directlyDecreases deg(p(HGNC:MYC))	We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK.	SEN:10005952	11018017
BEL:20011260	p(HGNC:NTRK1,pmod(P,Y,490)) directlyIncreases complex(p(HGNC:NTRK1),p(HGNC:FRS2))	While FGFR1 interacts with FRS2 constitutively, independent of ligand stimulation and tyrosine phosphorylation, NGF receptor (TrkA) binding to FRS2 is strongly dependent on receptor activation. Complex formation with TrkA is dependent on phosphorylation of Y490, a canonical PTB domain binding site that also functions as a binding site for Shc (NPXpY).	SEN:10007444	10629055
BEL:20011282	p(HGNC:PBK,pmod(P)) directlyIncreases kin(p(HGNC:PBK))	PBK and hDlg are phosphorylated at mitosis in HeLa cells, and the mitotic phosphorylation of PBK is required for its kinase activity.	SEN:10007462	10779557
BEL:20011322	p(HGNC:PPP1R14B,pmod(P)) directlyIncreases cat(p(HGNC:PPP1R14B))	Recombinant tagged PHI-1 was phosphorylated by protein kinase C at two sites, one a Ser and one a Thr; phosphorylation enhanced inhibitory potency 50-fold.	SEN:10006460	10606530
BEL:20011330	p(HGNC:PRKCQ) increases p(HGNC:IKBKB,pmod(P))	PKC-theta acts directly or indirectly to stimulate phosphorylation of IKKbeta, leading to activation of this enzyme	SEN:10007122	10733597
BEL:20011410	p(HGNC:RASGRF1,pmod(P,Y)) increases gtp(p(HGNC:HRAS))	GEF activity of Ras-GRF1 toward Ha-Ras, as defined by in vitro GDP binding and release assays, was augmented after tyrosine phosphorylation by ACK1.	SEN:10004484	10882715
BEL:20011412	p(HGNC:RASGRF1,pmod(P,Y)) increases gtp(p(HGNC:RAC1))	Ras-GRF1 acts as a GEF for Rac when tyrosine-phosphorylated following G protein-coupled receptor stimulation.	SEN:10004486	10882715
BEL:20011414	p(HGNC:RB1,pmod(P)) directlyDecreases tscript(p(HGNC:RB1))	Fas stimulation of Jurkat cells is known to induce p38 kinase and we find a pronounced increase in Rb phosphorylation within 30 min of Fas stimulation	SEN:10000032	10075927
BEL:20011440	p(HGNC:REM1,pmod(P)) directlyIncreases complex(p(HGNC:REM1),p(HGNC:YWHAE))	Rem interacts with a series of 14-3-3 isoforms (epsilon, eta, theta, and zeta). Rem is phosphorylated in vivo, and binding of Rem to 14-3-3zeta is abolished by pretreating Rem with protein phosphatase 1. Thus, the association of Rem and 14-3-3zeta is phosphorylation-dependent.	SEN:10007542	10441394
BEL:20011442	p(HGNC:REM1,pmod(P)) directlyIncreases complex(p(HGNC:REM1),p(HGNC:YWHAH))	Rem interacts with a series of 14-3-3 isoforms (epsilon, eta, theta, and zeta). Rem is phosphorylated in vivo, and binding of Rem to 14-3-3zeta is abolished by pretreating Rem with protein phosphatase 1. Thus, the association of Rem and 14-3-3zeta is phosphorylation-dependent.	SEN:10007542	10441394
BEL:20011444	p(HGNC:REM1,pmod(P)) directlyIncreases complex(p(HGNC:REM1),p(HGNC:YWHAQ))	Rem interacts with a series of 14-3-3 isoforms (epsilon, eta, theta, and zeta). Rem is phosphorylated in vivo, and binding of Rem to 14-3-3zeta is abolished by pretreating Rem with protein phosphatase 1. Thus, the association of Rem and 14-3-3zeta is phosphorylation-dependent.	SEN:10007542	10441394
BEL:20011446	p(HGNC:REM1,pmod(P)) directlyIncreases complex(p(HGNC:REM1),p(HGNC:YWHAZ))	Rem interacts with a series of 14-3-3 isoforms (epsilon, eta, theta, and zeta). Rem is phosphorylated in vivo, and binding of Rem to 14-3-3zeta is abolished by pretreating Rem with protein phosphatase 1. Thus, the association of Rem and 14-3-3zeta is phosphorylation-dependent.	SEN:10007542	10441394
BEL:20011450	p(HGNC:RPS6KB1,pmod(P,T,412)) directlyIncreases kin(p(HGNC:RPS6KB1))	We report here that a mammalian recombinant p70alpha polypeptide, extracted in an inactive form from rapamycin-treated cells, can be directly phosphorylated by the mTOR kinase in vitro predominantly at the rapamycin-sensitive site Thr-412.	SEN:10005838	10567431
BEL:20011500	p(HGNC:SHC1,pmod(P)) directlyIncreases cat(p(HGNC:SHC1))	More recent studies have suggested that tyrosine kinase (syk)-mediated phosphorylation of shc is responsible for the ras-ERK cascade via the formation of shc-Grb2-Sos2 following stimulation with anti-IgE antibody, but not FMLP, in human basophils	SEN:10006046	10979966
BEL:20011538	p(HGNC:SOCS3) decreases p(HGNC:PTPN11,pmod(P))	Inhibition of SHP2 activation leads to increased SOCS3-mRNA levels, whereas increased expression of SOCS3 results in a reduction of SHP2 phosphorylation after activation of the interleukin-6 signal transduction pathway.	SEN:10007596	10777583
BEL:20011570	p(HGNC:STAT1,pmod(P,S,727)) directlyIncreases complex(p(HGNC:BRCA1),p(HGNC:STAT1))	Biochemical analysis illustrated that the mechanism of this transcriptional synergy involves interaction between BRCA1 aa 502-802 and the C-terminal transcriptional activation domain of STAT1 including Ser-727 whose phosphorylation is crucial for transcriptional activation.	SEN:10002792	10792030
BEL:20011572	p(HGNC:STAT3,pmod(P,Y,705)) increases complex(p(HGNC:STAT3),p(HGNC:STAT3))	Stat3 is activated by phosphorylation on Tyr-705, which leads to dimer formation, nuclear translocation, and regulation of gene expression.	SEN:10002808	10446219
BEL:20011574	p(HGNC:STAT3,pmod(P,Y,705)) increases tloc(p(HGNC:STAT3),GOCCID:0005737,GOCCID:0005634)	Stat3 is activated by phosphorylation on Tyr-705, which leads to dimer formation, nuclear translocation, and regulation of gene expression.	SEN:10002808	10446219
BEL:20011576	p(HGNC:STAT5A,pmod(P,Y,694)) increases complex(p(HGNC:STAT5A),p(HGNC:STAT5A))	Introduction of an additional mutation (Y694F) to STAT5A-N642H, which disrupted critical tyrosine 694 required for dimerization of STAT5, abolished all the activities manifested by the mutant STAT5A-N642H, which indicates that dimerization is required for the activity of STAT5A-N642H as was the case for the wild-type STAT5A. T	SEN:10005366	10823841
BEL:20011610	p(HGNC:TGFA) increases p(HGNC:KRT18,pmod(P))	its immunoreactivity with RS-11 is up-regulated by malignant transformation or stimulation with either epidermal growth factor or transforming growth factor alpha.	SEN:10007630	10801882
BEL:20011612	p(HGNC:TGFA) increases p(HGNC:KRT8,pmod(P))	its immunoreactivity with RS-11 is up-regulated by malignant transformation or stimulation with either epidermal growth factor or transforming growth factor alpha.	SEN:10007630	10801882
BEL:20011694	p(HGNC:TGIF1,pmod(P)) increases p(HGNC:TGIF1)	epidermal growth factor (EGF) signaling via the Ras-Mek pathway causes the phosphorylation of TGIF at two Erk MAP kinase sites, leading to TGIF stabilization	SEN:10006844	11226163
BEL:20011736	p(HGNC:TNF) increases p(HGNC:STMN1,pmod(P,S,16))	These findings indicate that TNF-induced MT stabilization is mediated by hyperphosphorylation of Op18 and that this promotes cell death.	SEN:10007686	10913145
BEL:20011738	p(HGNC:TNF) increases p(HGNC:STMN1,pmod(P,S,25))	These findings indicate that TNF-induced MT stabilization is mediated by hyperphosphorylation of Op18 and that this promotes cell death.	SEN:10007686	10913145
BEL:20011740	p(HGNC:TNF) increases p(HGNC:STMN1,pmod(P,S,38))	These findings indicate that TNF-induced MT stabilization is mediated by hyperphosphorylation of Op18 and that this promotes cell death.	SEN:10007686	10913145
BEL:20011742	p(HGNC:TNF) increases p(HGNC:STMN1,pmod(P,S,63))	These findings indicate that TNF-induced MT stabilization is mediated by hyperphosphorylation of Op18 and that this promotes cell death.	SEN:10007686	10913145
BEL:20011830	p(HGNC:TP53,pmod(P,T,81)) directlyIncreases tscript(p(HGNC:TP53))	Forced expression of MKP5, a JNK phosphatase, in JNK kinase-expressing cells decreased T81 phosphorylation while reducing p53 transcriptional activity and p53-mediated apoptosis.	SEN:10005962	11283254
BEL:20011866	p(HGNC:VAV1,pmod(P,Y)) directlyIncreases cat(p(HGNC:VAV1))	Inhibition of Syk activity by piceatannol prevents both in vitro and in vivo Vav tyrosine phosphorylation, its association with the regulatory subunit of phosphoinositide 3-kinase, and the nuclear modifications typically observed during granulocytic differentiation of this cell line.	SEN:10006048	11331248
BEL:20011966	phos(p(HGNC:CDC14A)) directlyDecreases p(HGNC:TP53,pmod(P,S,315))	Furthermore, the hCdc14 phosphatases were found to dephosphorylate p53 specifically at the p34(Cdc2)/clb phosphorylation site (p53-phosphor-Ser(315)).	SEN:10007794	10644693
BEL:20011968	phos(p(HGNC:CDC14B)) directlyDecreases p(HGNC:TP53,pmod(P,S,315))	Furthermore, the hCdc14 phosphatases were found to dephosphorylate p53 specifically at the p34(Cdc2)/clb phosphorylation site (p53-phosphor-Ser(315)).	SEN:10007794	10644693
BEL:20011992	phos(p(HGNC:PPM1B)) decreases p(HGNC:MSN,pmod(P,T))	Phosphorylation of Thr(558) is necessary for F-actin binding of moesin in vitro. The purified enzyme, as well as bacterially made PP2Calpha and PP2Cbeta, efficiently dephosphorylate(s) highly purified platelet phospho-moesin.	SEN:10007808	10480873
BEL:20012018	phos(p(HGNC:PTEN)) decreases p(HGNC:FOXO1,pmod(P))	Here we show that Forkhead transcription factors FKHRL1 and FKHR, substrates of the Akt kinase, are aberrantly localized to the cytoplasm and cannot activate transcription in PTEN-deficient cells. Restoration of PTEN function restores FKHR to the nucleus and restores transcriptional activation.	SEN:10007826	11073996
BEL:20012020	phos(p(HGNC:PTEN)) decreases p(HGNC:FOXO3,pmod(P))	Here we show that Forkhead transcription factors FKHRL1 and FKHR, substrates of the Akt kinase, are aberrantly localized to the cytoplasm and cannot activate transcription in PTEN-deficient cells. Restoration of PTEN function restores FKHR to the nucleus and restores transcriptional activation.	SEN:10007826	11073996
BEL:20012022	phos(p(HGNC:PTEN)) decreases p(HGNC:IRS1,pmod(P,S))	The latter was accompanied by a decrease in the phosphorylation of insulin receptor substrate 1 (IRS-1) and the association of IRS-1 with Grb2/Sos	SEN:10007824	11230180
BEL:20012036	phos(p(HGNC:PTPN11)) directlyDecreases p(HGNC:GAB1,pmod(P,Y))	Consistently, substrate-trapping experiments with a SHP2 catalytic inactive mutant suggested that Gab1 was a SHP2 PTPase substrate in the cells. Therefore, Gab1 not only is a SHP2 activator but also is a target of its PTPase.	SEN:10001008	11323411
BEL:20012054	phos(p(HGNC:PTPRB)) directlyDecreases p(HGNC:CTNNB1,pmod(P,Y))	Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta	SEN:10007508	10706604
BEL:20012064	phos(p(HGNC:PTPRC)) decreases p(HGNC:LYN,pmod(P,Y))	CD45 selectively dephosphorylates the Src-family protein tyrosine kinase Lyn and inhibits its kinase activity.	SEN:10007368	10415030
BEL:20012066	phos(p(HGNC:PTPRC)) decreases p(HGNC:PRKCD,pmod(P,Y))	together, these data indicate that CD45 inhibits PMA-dependent PKCdelta activation by impeding PMA-dependent PKCdelta tyrosine phosphorylation.	SEN:10002724	11124968
BEL:20012074	phos(p(HGNC:PTPRF)) decreases p(HGNC:FRS2,pmod(P,Y))	The specific effect of LAR on FGF-induced MAPK activation appeared to be mediated by specific inhibition of the phosphorylation of two signal transducers that act downstream of the FGF receptor, FRS2 and a 180 kDa protein, and by prevention of their interaction with the adaptor protein GRB2.	SEN:10007838	10822386
BEL:20012080	phos(p(HGNC:PTPRZ1)) directlyDecreases p(HGNC:CTNNB1,pmod(P,Y))	Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta	SEN:10007508	10706604
BEL:20012104	phos(p(MGI:Ppp1cc)) decreases p(MGI:Eif2s1,pmod(P))	GADD34 was recently identified as the factor that activates the type 1 protein serine/threonine phosphatase (PP1), which dephosphorylates eIF-2 alpha during cellular stresses.	SEN:10007854	12840028
BEL:20012116	phos(p(MGI:Ptpn11)) directlyDecreases p(MGI:Stat1,pmod(P,S))	SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei	SEN:10007862	12270932
BEL:20012118	phos(p(MGI:Ptpn11)) directlyDecreases p(MGI:Stat1,pmod(P,Y))	SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei	SEN:10007862	12270932
BEL:20012126	phos(p(MGI:Ptpra)) directlyDecreases p(MGI:Src,pmod(P,Y,527))	Protein tyrosine phosphatase alpha (PTPalpha) is believed to dephosphorylate physiologically the Src proto-oncogene at phosphotyrosine (pTyr)527, a critical negative-regulatory residue. It thereby activates Src	SEN:10007866	10698938
BEL:20012128	phos(p(MGI:Ptprc)) decreases p(MGI:Lck,pmod(P,Y,505))	we have found that the C-terminal tyrosine of Lck (Y505) is markedly hyperphosphorylated in total thymocytes from CD45-deficient mice compared with control animals.	SEN:10007868	17277109
BEL:20012142	p(MGI:A2m) increases p(MGI:Cd2bp2,pmod(P))	We further demonstrate that phosphorylation of Lin-11, Isl-1, Mec-3 (LIM) kinase and cofilin is promoted by treating macrophages with alpha2M*.	SEN:10007882	16081825
BEL:20012144	p(MGI:A2m) increases p(MGI:Cfl1,pmod(P))	We further demonstrate that phosphorylation of Lin-11, Isl-1, Mec-3 (LIM) kinase and cofilin is promoted by treating macrophages with alpha2M*.	SEN:10007882	16081825
BEL:20012146	p(MGI:A2m) increases p(MGI:Isl1,pmod(P))	We further demonstrate that phosphorylation of Lin-11, Isl-1, Mec-3 (LIM) kinase and cofilin is promoted by treating macrophages with alpha2M*.	SEN:10007882	16081825
BEL:20012148	p(MGI:A2m) increases p(MGI:Limk1,pmod(P))	We further demonstrate that phosphorylation of Lin-11, Isl-1, Mec-3 (LIM) kinase and cofilin is promoted by treating macrophages with alpha2M*.	SEN:10007882	16081825
BEL:20012186	p(MGI:Acss2,pmod(A,K,661)) directlyDecreases cat(p(MGI:Acss2))	SIRT1 expression also led to a pronounced increase in AceCS1-dependent fatty-acid synthesis from acetate.	SEN:10005098	16790548
BEL:20012418	p(MGI:Axin1,pmod(P)) increases deg(p(MGI:Ctnnb1))	In the absence of Cdc42, degradation of beta-catenin was increased corresponding to a decreased phosphorylation of GSK3beta at Ser 9 and an increased phosphorylation of axin, which is known to be required for binding of beta-catenin to the degradation machinery	SEN:10008056	16510873
BEL:20012434	p(MGI:Bad,pmod(P,S,155)) decreases complex(p(MGI:Bcl2l1),p(MGI:Bad))	BAD is sequestered by 14-3-3 through serine 136 phosphorylation and is dissociated from BCL-X(L) through serine 155 phosphorylation.	SEN:10008064	12944463
BEL:20012466	p(MGI:Bcl2) decreases p(MGI:Ptk2,pmod(P,Y))	We have previously shown that B cell lymphoma/leukemia-2 (bcl-2) -/- mice develop cystic kidneys and exhibit sustained phosphorylation of FAK and paxillin.	SEN:10008080	11832424
BEL:20012468	p(MGI:Bcl2) decreases p(MGI:Pxn,pmod(P,Y))	We have previously shown that B cell lymphoma/leukemia-2 (bcl-2) -/- mice develop cystic kidneys and exhibit sustained phosphorylation of FAK and paxillin.	SEN:10008080	11832424
BEL:20012602	p(MGI:Btg1,pmod(P,S,159)) directlyIncreases complex(p(MGI:Cnot7),p(MGI:Btg1))	formation of the hCAF-1/BTG1 complex is driven by phosphorylation at BTG1 (Ser-159) and implicates this complex in the signalling events of cell division that lead to changes in cellular proliferation associated with cell-cell contact.	SEN:10005420	9820826
BEL:20012666	p(MGI:Cav2,pmod(P,Y,19)) decreases complex(p(MGI:Cav1),p(MGI:Cav2))	Our results indicate that phosphocaveolin-2 (Tyr(P)(19)) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1	SEN:10008192	12091389
BEL:20012668	p(MGI:Cav2,pmod(P,Y,19)) increases complex(p(MGI:Cav2),p(MGI:Ptk2))	During integrin ligation, phosphocaveolin-2 (Tyr(P)(19)) co-localizes with activated FAK at focal adhesions.	SEN:10008194	12091389
BEL:20012682	p(MGI:Cblb,pmod(P,Y)) directlyIncreases complex(p(MGI:Cblb),p(MGI:Sorbs1))	Like c-Cbl, Cbl-b associates constitutively with CAP and interacts with Crk upon insulin stimulation.	SEN:10008202	12842890
BEL:20012786	p(MGI:Cdc25a,pmod(P,S,123)) directlyDecreases phos(p(MGI:Cdc25a))	Furthermore, Chk1 also phosphorylates Cdc25A on serine 123 which accelerates its degradation through the ubiquitin-proteasome pathway and arrests cells in late G2-phase after DNA damage.	SEN:10006100	15736430
BEL:20012792	p(MGI:Cdc42) decreases p(MGI:Axin1,pmod(P))	In the absence of Cdc42, degradation of beta-catenin was increased corresponding to a decreased phosphorylation of GSK3beta at Ser 9 and an increased phosphorylation of axin, which is known to be required for binding of beta-catenin to the degradation machinery	SEN:10008056	16510873
BEL:20012794	p(MGI:Cdc42) increases p(MGI:Gsk3b,pmod(P,S,9))	In the absence of Cdc42, degradation of beta-catenin was increased corresponding to a decreased phosphorylation of GSK3beta at Ser 9 and an increased phosphorylation of axin, which is known to be required for binding of beta-catenin to the degradation machinery	SEN:10008056	16510873
BEL:20012802	p(MGI:Cdh1,pmod(P,Y)) directlyDecreases complex(p(MGI:Ctnnb1),p(MGI:Cdh1))	However, phosphorylation by src kinase decreased the affinity constant from approximately 260 nM to 4 microM. Interestingly, phosphorylation of E-cadherin by CK1 or CK2 prevented the inhibition of beta-catenin binding by src phosphorylation.	SEN:10006108	16945320
BEL:20012830	p(MGI:Cebpb,pmod(P,S,64)) directlyIncreases tscript(p(MGI:Cebpb))	MLK3 appears to activate C/EBP-beta in response to IFN-gamma by a mechanism involving decreased phosphorylation of a specific phosphoacceptor residue, Ser(64), within the transactivation domain.	SEN:10006232	15878863
BEL:20012998	p(MGI:Crtc2,pmod(P,S,171)) directlyIncreases deg(p(MGI:Crtc2))	Activated SIK2 in turn stimulated the Ser 171 phosphorylation and cytoplasmic translocation of TORC2. Phosphorylated TORC2 was degraded by the 26S proteasome during re-feeding through an association with COP1, a substrate receptor for an E3 ligase complex that promoted TORC2 ubiquitination at Lys 628.	SEN:10006386	17805301
BEL:20013086	p(MGI:Ctnnb1,pmod(P,S,45)) decreases bp(GOBP:"Wnt receptor signaling pathway")	This phosphorylation creates a priming site for glycogen synthase kinase 3beta (GSK3beta) and is both necessary and sufficient to initiate the beta-catenin phosphorylation-degradation cascade	SEN:10008446	17208333
BEL:20013088	p(MGI:Ctnnb1,pmod(P,S,45)) directlyIncreases deg(p(MGI:Ctnnb1))	This phosphorylation creates a priming site for glycogen synthase kinase 3beta (GSK3beta) and is both necessary and sufficient to initiate the beta-catenin phosphorylation-degradation cascade	SEN:10008446	17208333
BEL:20013090	p(MGI:Ctnnb1,pmod(P,S,45)) decreases p(MGI:Ctnnb1)	This phosphorylation creates a priming site for glycogen synthase kinase 3beta (GSK3beta) and is both necessary and sufficient to initiate the beta-catenin phosphorylation-degradation cascade	SEN:10008446	17208333
BEL:20013092	p(MGI:Ctnnb1,pmod(P,S)) decreases bp(GOBP:"Wnt receptor signaling pathway")	This phosphorylation creates a priming site for glycogen synthase kinase 3beta (GSK3beta) and is both necessary and sufficient to initiate the beta-catenin phosphorylation-degradation cascade	SEN:10008446	17208333
BEL:20013094	p(MGI:Ctnnb1,pmod(P,Y)) decreases complex(p(MGI:Ctnnb1),p(MGI:Cdh1))	Activated KRAS is known to induce tyrosine phosphorylation of beta-catenin, leading to its release from E-cadherin at the adherens junction	SEN:10005428	17030180
BEL:20013096	p(MGI:Ctnnb1,pmod(P,Y)) directlyDecreases complex(p(MGI:Met),p(MGI:Ctnnb1))	We have previously reported that beta-catenin forms a complex with c-Met (HGF receptor) that undergoes dissociation because of beta-catenin tyrosine phosphorylation on stimulation by HGF.	SEN:10008448	17006939
BEL:20013300	p(MGI:Efna1) increases p(MGI:Epha2,pmod(P))	Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes.	SEN:10008564	11336673
BEL:20013314	p(MGI:Egf) increases p(MGI:Mapk1,pmod(P))	Similarly, EGF but not IL-4 strongly activated phosphorylation of p42/p44 extracellular regulated kinase isoforms, a reaction blocked by the mitogen-activated protein kinase (MAPK) inhibitor, PD98059.	SEN:10003864	11277615
BEL:20013316	p(MGI:Egf) increases p(MGI:Mapk3,pmod(P))	Similarly, EGF but not IL-4 strongly activated phosphorylation of p42/p44 extracellular regulated kinase isoforms, a reaction blocked by the mitogen-activated protein kinase (MAPK) inhibitor, PD98059.	SEN:10003864	11277615
BEL:20013356	p(MGI:Eif2s1,pmod(P)) decreases bp(GOBP:"protein metabolic process")	Phosphorylation of eIF2alpha in mouse embryo fibroblast (MEF) cells subjected to proteasome inhibition leads to a significant reduction in protein synthesis, concomitant with induced expression of the bZIP transcription regulator, ATF4, and its target gene CHOP/GADD153	SEN:10008592	15684420
BEL:20013358	p(MGI:Eif2s1,pmod(P)) increases r(MGI:Atf4)	Phosphorylation of eIF2alpha in mouse embryo fibroblast (MEF) cells subjected to proteasome inhibition leads to a significant reduction in protein synthesis, concomitant with induced expression of the bZIP transcription regulator, ATF4, and its target gene CHOP/GADD153	SEN:10008592	15684420
BEL:20013404	p(MGI:Epo) increases p(MGI:Crkl,pmod(P,Y))	The present study demonstrates that erythropoietin (Epo) and IL-3 induce tyrosine phosphorylation of the SH2/SH3-containing adapter protein CrkL and its transient association with tyrosine-phosphorylated SHP-2, Shc, and Cbl in a murine IL-3-dependent cell line, 32D, expressing the Epo receptor (EpoR).	SEN:10008622	9344843
BEL:20013714	p(MGI:Gadd45a) decreases p(MGI:Gsk3b,pmod(P,S))	We show that Gadd45a not only directly associates with two components of the APC complex, namely protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta) but also promotes GSK3beta dephosphorylation at Ser9, which is essential for GSK3beta activation, and resultant activation of the APC destruction complex.	SEN:10008794	14647429
BEL:20013716	p(MGI:Gata1,pmod(P,S,26)) directlyIncreases r(MGI:Nfil3)	Phosphorylation of GATA-1 increases GATA-1-mediated transcription of the E4bp4 survival gene without significantly changing the DNA-binding affinity of GATA-1.	SEN:10008796	15967790
BEL:20013718	p(MGI:Gata1,pmod(P,S,26)) directlyIncreases tscript(p(MGI:Gata1))	Phosphorylation of GATA-1 increases GATA-1-mediated transcription of the E4bp4 survival gene without significantly changing the DNA-binding affinity of GATA-1.	SEN:10008796	15967790
BEL:20013758	p(MGI:Gh) increases p(MGI:Cebpb,pmod(P,T,188))	Immunoblotting with antiphosphopeptide antibodies specific for Thr(188/37) of C/EBPbeta (anti-P-C/EBPbeta) shows that GH rapidly and transiently promotes phosphorylation of mLAP and mLIP on the MAPK site. MEK inhibitors prevent this GH-promoted phosphorylation of LAP and LIP, suggesting that such phosphorylation depends on GH-activated MAPK signaling.	SEN:10004102	12213825
BEL:20013760	p(MGI:Gh) increases p(MGI:Cebpb,pmod(P,T,37))	Immunoblotting with antiphosphopeptide antibodies specific for Thr(188/37) of C/EBPbeta (anti-P-C/EBPbeta) shows that GH rapidly and transiently promotes phosphorylation of mLAP and mLIP on the MAPK site. MEK inhibitors prevent this GH-promoted phosphorylation of LAP and LIP, suggesting that such phosphorylation depends on GH-activated MAPK signaling.	SEN:10004102	12213825
BEL:20013814	p(MGI:Gmfb,pmod(P)) increases kin(p(MGI:Mapk14))	PKA-phosphorylated GMF strongly enhances the activity of a related but distinct subfamily of MAP kinase, the p38 MAP kinase, showing an increase of 60-fold over baseline and an EC50 of 7 nM.	SEN:10008862	8798479
BEL:20013816	p(MGI:Gmfb,pmod(P)) decreases kin(p(MGI:Mapk1))	endogenous GMF is rapidly phosphorylated upon stimulation of astrocytes by phorbol 12-myristate 13-acetate We further observed that protein kinase A (PKA)-phosphorylated GMF is a potent inhibitor (IC50 = 3 nM) of the ERK1/ERK2 (p44/p42) subfamily of mitogen-activated protein (MAP) kinase.	SEN:10003974	8798479
BEL:20013818	p(MGI:Gmfb,pmod(P)) decreases kin(p(MGI:Mapk3))	endogenous GMF is rapidly phosphorylated upon stimulation of astrocytes by phorbol 12-myristate 13-acetate We further observed that protein kinase A (PKA)-phosphorylated GMF is a potent inhibitor (IC50 = 3 nM) of the ERK1/ERK2 (p44/p42) subfamily of mitogen-activated protein (MAP) kinase.	SEN:10003974	8798479
BEL:20013842	p(MGI:Gpi1) increases p(MGI:Rb1,pmod(P))	PGI-overexpressing cells also exhibited elevated expression of Skp2 involved in p27Kip1 ubiquitination and elevation in the levels of retinoblastoma protein hyperphosphorylation.	SEN:10008872	12783864
BEL:20013886	p(MGI:Gsk3b,pmod(P,S)) directlyDecreases kin(p(MGI:Gsk3b))	We show that Gadd45a not only directly associates with two components of the APC complex, namely protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta) but also promotes GSK3beta dephosphorylation at Ser9, which is essential for GSK3beta activation, and resultant activation of the APC destruction complex.	SEN:10008794	14647429
BEL:20013964	p(MGI:Hgf) increases p(MGI:Ctnnb1,pmod(P,Y))	We have previously reported that beta-catenin forms a complex with c-Met (HGF receptor) that undergoes dissociation because of beta-catenin tyrosine phosphorylation on stimulation by HGF.	SEN:10008448	17006939
BEL:20014080	p(MGI:Hras,sub(G,12,V)) directlyIncreases gtp(p(MGI:Hras))	Germline expression of the endogenous H-RasG12V oncogene, even in homozygosis, resulted in hyperplasia of the mammary gland.	SEN:10009006	18483625
BEL:20014084	p(MGI:Hras,sub(G,12,V)) increases path(MESHD:Hyperplasia)	Germline expression of the endogenous H-RasG12V oncogene, even in homozygosis, resulted in hyperplasia of the mammary gland.	SEN:10009006	18483625
BEL:20014390	p(MGI:Il17rd) decreases p(MGI:Fgfr1,pmod(P,Y))	Overexpression of mSef in NIH3T3 cells results in a decrease in FGF-induced cell proliferation associated with a decrease in Tyr phosphorylation of FGFR1 and FRS2. As a consequence, there is a reduction in the phosphorylation of Raf-1 at Ser(338), MEK1/2 at Ser(217) and Ser(221), and ERK1/2 at Thr(202) and Tyr(204).	SEN:10009184	12604616
BEL:20014392	p(MGI:Il17rd) decreases p(MGI:Frs2,pmod(P,Y))	Overexpression of mSef in NIH3T3 cells results in a decrease in FGF-induced cell proliferation associated with a decrease in Tyr phosphorylation of FGFR1 and FRS2. As a consequence, there is a reduction in the phosphorylation of Raf-1 at Ser(338), MEK1/2 at Ser(217) and Ser(221), and ERK1/2 at Thr(202) and Tyr(204).	SEN:10009184	12604616
BEL:20014394	p(MGI:Il17rd) decreases p(MGI:Map2k1,pmod(P,S,218))	Overexpression of mSef in NIH3T3 cells results in a decrease in FGF-induced cell proliferation associated with a decrease in Tyr phosphorylation of FGFR1 and FRS2. As a consequence, there is a reduction in the phosphorylation of Raf-1 at Ser(338), MEK1/2 at Ser(217) and Ser(221), and ERK1/2 at Thr(202) and Tyr(204).	SEN:10009184	12604616
BEL:20014396	p(MGI:Il17rd) decreases p(MGI:Map2k1,pmod(P,S,222))	Overexpression of mSef in NIH3T3 cells results in a decrease in FGF-induced cell proliferation associated with a decrease in Tyr phosphorylation of FGFR1 and FRS2. As a consequence, there is a reduction in the phosphorylation of Raf-1 at Ser(338), MEK1/2 at Ser(217) and Ser(221), and ERK1/2 at Thr(202) and Tyr(204).	SEN:10009184	12604616
BEL:20014442	p(MGI:Il1b) increases p(MGI:Irs1,pmod(P,S))	Importantly, endogenous mPLK/IRAK was activated in response to TNF-alpha or interleukin 1 treatment of primary adipose cells.	SEN:10009192	15849359
BEL:20014522	p(MGI:Il3) increases p(MGI:Bcl2,pmod(P))	High concentrations of stauro of up to 1 microM only partially inhibit IL-3-stimulated Bcl2 phosphorylation but completely block PKC-mediated Bcl2 phosphorylation in vitro	SEN:10003614	10677502
BEL:20014524	p(MGI:Il3) increases p(MGI:Crkl,pmod(P,Y))	The present study demonstrates that erythropoietin (Epo) and IL-3 induce tyrosine phosphorylation of the SH2/SH3-containing adapter protein CrkL and its transient association with tyrosine-phosphorylated SHP-2, Shc, and Cbl in a murine IL-3-dependent cell line, 32D, expressing the Epo receptor (EpoR).	SEN:10008622	9344843
BEL:20014716	p(MGI:Irs3) decreases p(MGI:Irs1,pmod(P,Y))	However, IRS-3- or IRS-4-expressing cells also showed a marked decrease in IRS-1 and IRS-2 phosphorylation compared to the host cells.	SEN:10009356	11113178
BEL:20014718	p(MGI:Irs3) decreases p(MGI:Irs2,pmod(P,Y))	However, IRS-3- or IRS-4-expressing cells also showed a marked decrease in IRS-1 and IRS-2 phosphorylation compared to the host cells.	SEN:10009356	11113178
BEL:20014726	p(MGI:Irs4) decreases p(MGI:Irs1,pmod(P,Y))	However, IRS-3- or IRS-4-expressing cells also showed a marked decrease in IRS-1 and IRS-2 phosphorylation compared to the host cells.	SEN:10009356	11113178
BEL:20014728	p(MGI:Irs4) decreases p(MGI:Irs2,pmod(P,Y))	However, IRS-3- or IRS-4-expressing cells also showed a marked decrease in IRS-1 and IRS-2 phosphorylation compared to the host cells.	SEN:10009356	11113178
BEL:20014792	p(MGI:Kat2b) increases p(MGI:Myod1,pmod(A))	MyoD acetylation by CBP/p300 (as well as by PCAF) increases its activity on a muscle-specific promoter, as assessed by microinjection experiments.	SEN:10005424	10944526
BEL:20014818	p(MGI:Khdrbs2,pmod(P)) directlyDecreases cat(p(MGI:Khdrbs2))	The phosphorylation of SLM-1 and SLM-2 has functional relevance and leads to inhibition of their RNA-binding abilities	SEN:10006354	15471878
BEL:20014820	p(MGI:Khdrbs3,pmod(P)) directlyDecreases cat(p(MGI:Khdrbs3))	The phosphorylation of SLM-1 and SLM-2 has functional relevance and leads to inhibition of their RNA-binding abilities	SEN:10006354	15471878
BEL:20014838	p(MGI:Kras,sub(G,12,V)) increases cat(p(MGI:Ptgs2))	COX-2 protein and activity measured as prostaglandin E(2) level were up-regulated in cells expressing mutant K-ras(V12);	SEN:10001506	15284181
BEL:20015030	p(MGI:Map2k1,pmod(P)) directlyIncreases kin(p(MGI:Map2k1))	MEK1 and MEK2 can also be activated by autophosphorylation. Autophosphorylation of MEKs correlates with their ability to phosphorylate and activate ERKs.	SEN:10009532	8226933
BEL:20015070	p(MGI:Mapk1,pmod(P,T,183)) directlyIncreases kin(p(MGI:Mapk1))	Mitogen-activated protein (MAP) kinase is central to a signal transduction pathway that triggers cell proliferation or differentiation. Activation of the p42mapk isoform requires its phosphorylation at two residues, Thr 183 and Tyr 185, and this phosphorylation is catalysed by MAP kinase kinase (MAPKK).	SEN:10006222	7780739
BEL:20015072	p(MGI:Mapk1,pmod(P,Y,185)) directlyIncreases kin(p(MGI:Mapk1))	Mitogen-activated protein (MAP) kinase is central to a signal transduction pathway that triggers cell proliferation or differentiation. Activation of the p42mapk isoform requires its phosphorylation at two residues, Thr 183 and Tyr 185, and this phosphorylation is catalysed by MAP kinase kinase (MAPKK).	SEN:10006222	7780739
BEL:20015112	p(MGI:Mef2d,pmod(A,K)) directlyIncreases tscript(p(MGI:Mef2d))	acetylation is correlated with MEF2 activation and dynamically induced upon muscle cell differentiation, while sumoylation inhibits MEF2 transcriptional activity	SEN:10009576	16166628
BEL:20015144	p(MGI:Msr1,pmod(P)) directlyIncreases cat(p(MGI:Msr1))	JNK2-dependent phosphorylation of SR-A promotes uptake of lipids in macrophages, thereby regulating foam cell formation, a critical step in atherogenesis	SEN:10006292	15567863
BEL:20015258	p(MGI:Nfe2l2,pmod(P,Y,576)) directlyIncreases deg(p(MGI:Nfe2l2))	Further experiments with small interfering RNA revealed that Fyn phosphorylated Nrf 2Y568 leading to nuclear export and degradation of Nrf 2.	SEN:10006156	16513647
BEL:20015260	p(MGI:Nfe2l2,pmod(P,Y,576)) increases tloc(p(MGI:Nfe2l2),GOCCID:0005634,GOCCID:0005737)	Further experiments with small interfering RNA revealed that Fyn phosphorylated Nrf 2Y568 leading to nuclear export and degradation of Nrf 2.	SEN:10006156	16513647
BEL:20015358	p(MGI:Nos3,pmod(P)) directlyIncreases cat(p(MGI:Nos3))	Our results suggest that shear stress activates AMPK in ECs, which contributes to elevated eNOS activity	SEN:10005810	16601232
BEL:20015360	p(MGI:Nos3,pmod(P,S,633)) directlyIncreases cat(p(MGI:Nos3))	Expression of gain-/loss-of-function eNOS mutants revealed that Ser633 phosphorylation is important for NO production.	SEN:10009722	19131647
BEL:20015510	p(MGI:Oprk1,pmod(P)) directlyDecreases cat(p(MGI:Oprk1))	The result suggests that tolerance to kappa agonists includes phosphorylation of serine 369 within KOR by GRK3	SEN:10006062	14597630
BEL:20015556	p(MGI:Pax2,pmod(P)) directlyIncreases tscript(p(MGI:Pax2))	The activation domain of Pax2 is phosphorylated by the c-Jun N-terminal kinase (JNK) to enhance Pax2-dependent transcription.	SEN:10006290	14532124
BEL:20015586	p(MGI:Pdgfb) increases p(MGI:Cryab,pmod(P,S))	PDGF-BB induces phosphorylation of alphaB-crystallin via p38 MAP kinase during myocardial infarction	SEN:10006254	15907784
BEL:20015618	p(MGI:Pfkfb3,pmod(U)) directlyIncreases deg(p(MGI:Pfkfb3))	the expression of the pfkfb3 gene in C2C12 cells and its downregulation during myogenic cell differentiation. We also show that the decrease of ubiquitous 6-phosphofructo-2-kinase isozyme levels, product of pfkfb3 gene, is due to its enhanced degradation through the ubiquitin-proteasome proteolytic pathway.	SEN:10005732	12935880
BEL:20015620	p(MGI:Pfkfb3,pmod(U)) decreases r(MGI:Pfkfb3)	the expression of the pfkfb3 gene in C2C12 cells and its downregulation during myogenic cell differentiation. We also show that the decrease of ubiquitous 6-phosphofructo-2-kinase isozyme levels, product of pfkfb3 gene, is due to its enhanced degradation through the ubiquitin-proteasome proteolytic pathway.	SEN:10005732	12935880
BEL:20015662	p(MGI:Polr2a,pmod(P)) directlyIncreases deg(p(MGI:Polr2a))	The elongating hyperphosphorylated Rpb1 is subject to ubiquitination, particularly in response to UV radiation and DNA-damaging agents.	SEN:10004174	12604794
BEL:20015674	p(MGI:Pparg,pmod(P,S,273)) increases path(MESHD:"Insulin Resistance")	All these findings strongly suggest that Cdk5-mediated phosphorylation of PPARgamma may be involved in the pathogenesis of insulin-resistance	SEN:10006090	20651683
BEL:20015676	p(MGI:Pparg,pmod(P,S,273)) decreases r(MGI:Adipoq)	This modification of PPARgamma does not alter its adipogenic capacity, but leads to dysregulation of a large number of genes whose expression is altered in obesity, including a reduction in the expression of the insulin-sensitizing adipokine, adiponectin	SEN:10009896	20651683
BEL:20015706	p(MGI:Prkaa1,pmod(P,T,172)) directlyIncreases kin(p(MGI:Prkaa1))	Essential to activation of AMPK is its phosphorylation at Thr-172 by an upstream kinase, AMPKK, whose identity in mammalian cells has remained elusive.	SEN:10002722	14985505
BEL:20015708	p(MGI:Prkaa1,pmod(P,T,183)) increases cat(p(MGI:Nos3))	Our results suggest that shear stress activates AMPK in ECs, which contributes to elevated eNOS activity	SEN:10005810	16601232
BEL:20015716	p(MGI:Prkcd) increases p(MGI:Aatk,pmod(P))	However, LK-induced hyperphosphorylation of AATYK at multiple sites was blocked by kainate, lithium, and protein kinase C-delta inhibitor.	SEN:10003446	16100393
BEL:20015718	p(MGI:Prkcd,pmod(P,Y)) directlyDecreases kin(p(MGI:Prkcd))	Taken together, these results indicate that PKCdelta activity is inhibited by tyrosine phosphorylation in response to EGFR-mediated signaling and activation of a member of the Src kinase family may be the proximal tyrosine kinase acting on PKCdelta in keratinocytes.	SEN:10009912	8621384
BEL:20015734	p(MGI:Prmt1) increases p(MGI:Nfatc2ip,pmod(M))	T cell receptor signaling increased expression of the protein arginine methyltransferase PRMT1, which in turn methylated the nuclear factor of activated T cells (NFAT) cofactor protein, NIP45.	SEN:10009920	15327772
BEL:20015778	p(MGI:Ptpn11) decreases p(MGI:Stat1,pmod(P,S,727))	In SHP-2-/- mouse fibroblast cells, Stat1 phosphorylation at both the tyrosine residue Tyr(701) and the serine residue Ser(727) by IFNgamma was enhanced and prolonged.	SEN:10009942	12270932
BEL:20015780	p(MGI:Ptpn11) decreases p(MGI:Stat1,pmod(P,Y,701))	In SHP-2-/- mouse fibroblast cells, Stat1 phosphorylation at both the tyrosine residue Tyr(701) and the serine residue Ser(727) by IFNgamma was enhanced and prolonged.	SEN:10009942	12270932
BEL:20015782	p(MGI:Ptpn11,pmod(P,Y,546)) directlyIncreases complex(p(MGI:Grb2),p(MGI:Ptpn11))	Immunoblot analyses confirm that Tyr-542 and Tyr-580 are the major sites of Shp2 tyrosyl phosphorylation and that Tyr-542 is the major Grb2 binding site.	SEN:10009944	12923167
BEL:20015784	p(MGI:Ptpn14,pmod(P,S)) directlyDecreases phos(p(MGI:Ptpn14))	In mouse fibroblasts adhered to substrates, PTP36 was phosphorylated on serine residues. PTP36 was found to make complexes with serine/threonine kinase(s), which phosphorylated PTP36 in vitro. PTP36 was dephosphorylated rapidly when the cell-substrate adhesion was disrupted and it was phosphorylated again along with the reattachment of the cells to fibronectin.	SEN:10004050	10400706
BEL:20015790	p(MGI:Ptpra,pmod(P,Y,789)) directlyIncreases complex(p(MGI:Ptpra),p(MGI:Grb2))	pTyr789 in PTPalpha is constitutively phosphorylated and binds Grb2, an interaction that may inhibit PTPalpha activity. We show here that this phosphorylation also specifically enables PTPalpha to dephosphorylate pTyr527	SEN:10009950	10698938
BEL:20015792	p(MGI:Ptpra,pmod(P,Y,789)) directlyIncreases phos(p(MGI:Ptpra))	pTyr789 in PTPalpha is constitutively phosphorylated and binds Grb2, an interaction that may inhibit PTPalpha activity. We show here that this phosphorylation also specifically enables PTPalpha to dephosphorylate pTyr527	SEN:10009950	10698938
BEL:20015798	p(MGI:Pxn,pmod(P,Y,118)) decreases gtp(p(MGI:Rhoa))	Tyr31/118-phosphorylated paxillin serves as a template for the localized suppression of RhoA activity	SEN:10009956	12446743
BEL:20015800	p(MGI:Pxn,pmod(P,Y,31)) decreases gtp(p(MGI:Rhoa))	Tyr31/118-phosphorylated paxillin serves as a template for the localized suppression of RhoA activity	SEN:10009956	12446743
BEL:20015826	p(MGI:Rasgrf1,pmod(P,S,916)) directlyIncreases cat(p(MGI:Rasgrf1))	Activation of G protein-coupled receptors stimulates an increase in the phosphorylation of Ras-GRF1 at certain serine residues. The first of these sites to be identified, Ser(916) in the mouse sequence (equivalent to Ser(898) in the rat sequence), is required for full activation of the Ras exchange factor activity of Ras-GRF1 by muscarinic receptors.	SEN:10009978	12538592
BEL:20015828	p(MGI:Rasgrf1,pmod(P,S,916)) directlyIncreases cat(p(MGI:Rasgrf1))	Indirect confocal immunofluorescence of transfected PC12 cells using antibody 2152 demonstrated reactivity only under conditions in which Ras-GRF1 was phosphorylated at Ser(916/898).	SEN:10009980	12538592
BEL:20015854	p(MGI:Rela,pmod(P,S,276)) decreases p(MGI:"Rela",pmod(A,K,310))	Coexpression of catalytically inactive mutants of the catalytic subunit of protein kinase A/mitogen- and stress-activated kinase 1 or IKK1/IKK2, which phosphorylate RelA on serine 276 or serine 536, respectively, sharply inhibited RelA acetylation on lysine 310.	SEN:10006104	16135789
BEL:20015856	p(MGI:Rela,pmod(P,S,311)) directlyIncreases complex(p(MGI:Crebbp),p(MGI:Rela))	Also, an inactivating mutation of that residue severely impairs RelA transcriptional activity, blocks its anti-apoptotic function and abrogates the interaction of RelA with the co-activator CBP as well as its recruitment, and that of RNA polymerase II (Pol II) with the interleukin-6 (IL-6) promoter.	SEN:10009992	12881425
BEL:20015860	p(MGI:Rela,pmod(P,S,311)) directlyIncreases tscript(p(MGI:Rela))	Also, an inactivating mutation of that residue severely impairs RelA transcriptional activity, blocks its anti-apoptotic function and abrogates the interaction of RelA with the co-activator CBP as well as its recruitment, and that of RNA polymerase II (Pol II) with the interleukin-6 (IL-6) promoter.	SEN:10009992	12881425
BEL:20015862	p(MGI:Rela,pmod(P,S,536)) decreases p(MGI:Rela,pmod(A,K,310))	Coexpression of catalytically inactive mutants of the catalytic subunit of protein kinase A/mitogen- and stress-activated kinase 1 or IKK1/IKK2, which phosphorylate RelA on serine 276 or serine 536, respectively, sharply inhibited RelA acetylation on lysine 310.	SEN:10006104	16135789
BEL:20016076	p(MGI:Sik1,pmod(P,S,577)) decreases tloc(p(MGI:Sik1),GOCCID:0005634,GOCCID:0005737)	The level of phosphorylation at Ser577, a canonical PKA-phosphorylation site, was elevated by ACTH treatment. The disruption of the serine residue inhibited the nuclear export and enhanced the transcription repression activity of SIK.	SEN:10003346	12530631
BEL:20016112	p(MGI:Skap2,pmod(P,Y)) directlyIncreases kin(p(MGI:Skap2))	Transient expression of mSKAP55R in COS cells demonstrated that tyrosine 260 was the predominant site of phosphorylation by FYN kinase. Furthermore, this phosphotyrosine was essential for coimmunoprecipitation of FYN with mSKAP55R	SEN:10006154	11063873
BEL:20016336	p(MGI:Spry1,pmod(P,Y,53)) decreases cat(p(MGI:Sos1))	Next, they bind to the adaptor protein Grb2 and inhibit the recruitment of the Grb2-Sos complex either to the fibroblast growth factor receptor (FGFR) docking adaptor protein FRS2 or to Shp2. Membrane translocation of Spry is necessary for its phosphorylation, which is essential for its inhibitor activity.	SEN:10010224	12402043
BEL:20016344	p(MGI:Spry2,pmod(P,Y,55)) decreases cat(p(MGI:Sos1))	Next, they bind to the adaptor protein Grb2 and inhibit the recruitment of the Grb2-Sos complex either to the fibroblast growth factor receptor (FGFR) docking adaptor protein FRS2 or to Shp2. Membrane translocation of Spry is necessary for its phosphorylation, which is essential for its inhibitor activity.	SEN:10010224	12402043
BEL:20016368	p(MGI:Src,pmod(P,Y,527)) directlyDecreases kin(p(MGI:Src))	Protein tyrosine phosphatase alpha (PTPalpha) is believed to dephosphorylate physiologically the Src proto-oncogene at phosphotyrosine (pTyr)527, a critical negative-regulatory residue. It thereby activates Src	SEN:10007866	10698938
BEL:20016400	p(MGI:Stat1,pmod(U)) increases deg(p(MGI:Stat1))	In this current study, using a system of LPS-treated RAW264.7 macrophages, we go on to demonstrate that OPN increases STAT1 ubiquitination and subsequent 26s proteasome-mediated degradation to inhibit STAT1 dependent iNOS promoter activity, transcription, and protein expression.	SEN:10005138	17237438
BEL:20016402	p(MGI:Stat2) decreases p(MGI:Stat1,pmod(P))	Impairment in the expression of this important negative regulator led to a striking prolongation in IFN-I-dependent Stat1 activation, as well as enhanced expression of the target gene, IFN-regulatory factor-1	SEN:10010256	17579067
BEL:20016420	p(MGI:Stat3,pmod(P,S,727)) directlyIncreases tscript(p(MGI:Stat3))	PKCepsilon interaction with Stat3 was PKCepsilon isoform specific and was not observed with other protein kinases. As observed in vitro with immunocomplex kinase assay with immunopurified PKCepsilon and Stat3, PKCepsilon phosphorylated Stat3 at the serine 727 residue. PKCepsilon depletion prevented Stat3Ser727 phosphorylation, Stat3 DNA binding, and transcriptional activity	SEN:10010268	17583567
BEL:20016440	p(MGI:Stk11,pmod(P,S,431)) decreases bp(GOBP:"cell proliferation")	The reintroduction of wild-type LKB1 into a cancer cell line that lacks LKB1 suppressed growth, but mutants of LKB1 in which Ser(431) was mutated to Ala to prevent phosphorylation of LKB1 were ineffective in inhibiting growth.	SEN:10006398	11297520
BEL:20016442	p(MGI:Stk11,pmod(P,S,431)) directlyIncreases kin(p(MGI:Stk11))	The reintroduction of wild-type LKB1 into a cancer cell line that lacks LKB1 suppressed growth, but mutants of LKB1 in which Ser(431) was mutated to Ala to prevent phosphorylation of LKB1 were ineffective in inhibiting growth.	SEN:10006398	11297520
BEL:20016524	p(MGI:Tgfa) increases p(MGI:Rps6kb1,pmod(P))	Using a doxycycline-regulatable transgenic mouse model of lung-specific TGF-alpha expression, we observed increased PCNA protein and phosphorylation of Akt and p70S6K in whole lung homogenates in association with induction of TGF-alpha. Induction in the lung of TGF-alpha caused progressive pulmonary fibrosis over a 7-week period.	SEN:10010312	19244201
BEL:20016652	p(MGI:Tgfb3) increases p(MGI:Smad2,pmod(P))	This finding suggests that TGF-beta3 is required for inhibiting MEE proliferation during palatal fusion. The inhibition of MEE proliferation may be mediated by TGF-beta3-dependent phosphorylation of SMAD2	SEN:10010376	12815624
BEL:20016820	p(MGI:Tnf) increases p(MGI:Irs1,pmod(P,S))	Importantly, endogenous mPLK/IRAK was activated in response to TNF-alpha or interleukin 1 treatment of primary adipose cells.	SEN:10009192	15849359
BEL:20016822	p(MGI:Tnf) increases p(MGI:Irs1,pmod(P,S,307))	Tumor necrosis factor-alpha (TNF-alpha) signaling through the IkappaB kinase (IKK) complex attenuates insulin action via the phosphorylation of insulin receptor substrate 1 (IRS-1) at Ser307.	SEN:10010454	16754954
BEL:20016824	p(MGI:Tnf) increases p(MGI:Mapk1,pmod(P))	TNFalpha, but not IGF-I, induced tissue inhibitor of metalloproteinase-1 (TIMP-1) expression and reduced matrix metalloproteinases-2 activity and collagen degradation. TNFalpha also activated ERK1/2.	SEN:10010448	16141211
BEL:20016830	p(MGI:Tnf) increases p(MGI:Rela,pmod(P,S,311))	Here we demonstrate that Ser311 accounts for zetaPKC phosphorylation of RelA and that this site is phosphorylated in vivo in response to TNF-alpha.	SEN:10006346	12881425
BEL:20016836	p(MGI:Tnf) increases p(MGI:Trp53,pmod(A))	Our results also demonstrate that TNFalpha-induced acetylation of p53 attenuated its transcriptional activation via CBP depletion.	SEN:10010470	12165799
BEL:20016940	p(MGI:Tnks,pmod(P)) directlyIncreases cat(p(MGI:Tnks))	Tankyrase is a novel signaling target of mitogen-activated protein kinase (MAPK); it is stoichiometrically phosphorylated upon insulin stimulation. Phosphorylation enhances the poly(ADP-ribose) polymerase activity of tankyrase	SEN:10004100	10988299
BEL:20017002	p(MGI:Trp53,pmod(A)) directlyDecreases tscript(p(MGI:Trp53))	Our results also demonstrate that TNFalpha-induced acetylation of p53 attenuated its transcriptional activation via CBP depletion.	SEN:10010470	12165799
BEL:20017060	p(MGI:Txndc5) decreases p(MGI:Eif2s1,pmod(P,S,52))	In addition, reduced expression of ERp46 by siRNA increased the expression of CHOP and peIF2a, indicating development of ER stress.	SEN:10010576	19622788
BEL:20017350	tloc(p(MGI:Spry1),GOCCID:0005737,GOCCID:0005886) increases p(MGI:Spry1,pmod(P,Y,53))	Here we show that after stimulation by growth factors Spry1 and Spry2 translocate to the plasma membrane and become phosphorylated on a conserved tyrosine.	SEN:10004190	12402043
BEL:20017352	tloc(p(MGI:Spry1),GOCCID:0005737,GOCCID:0005886) increases p(MGI:Spry1,pmod(P,Y,55))	Here we show that after stimulation by growth factors Spry1 and Spry2 translocate to the plasma membrane and become phosphorylated on a conserved tyrosine.	SEN:10004190	12402043
BEL:20023362	a(CHEBI:"5,6,7,8-tetrahydrobiopterin") increases cat(p(MGI:Nos1))	BH4 is a cofactor for three pteridine-requiring monooxygenases that hydroxylate aromatic L-amino acids, i.e., tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and phenylalanine hydroxylase (PAH), as well as for nitric oxide synthase (NOS)	SEN:10003264	10321973
BEL:20023366	a(CHEBI:"5,6,7,8-tetrahydrobiopterin") increases cat(p(MGI:Th))	BH4 is a cofactor for three pteridine-requiring monooxygenases that hydroxylate aromatic L-amino acids, i.e., tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and phenylalanine hydroxylase (PAH), as well as for nitric oxide synthase (NOS)	SEN:10003264	10321973
BEL:20023368	a(CHEBI:"5,6,7,8-tetrahydrobiopterin") increases cat(p(MGI:Tph1))	BH4 is a cofactor for three pteridine-requiring monooxygenases that hydroxylate aromatic L-amino acids, i.e., tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and phenylalanine hydroxylase (PAH), as well as for nitric oxide synthase (NOS)	SEN:10003264	10321973
BEL:20023430	a(CHEBI:acrolein) increases cat(p(MGI:Casp3))	Figure 7. Increased active caspase3 is greater in the lungs of wild-type compared to Cd8(?/?) mice exposed to acrolein	SEN:10015390	17950725
BEL:20023432	a(CHEBI:acrolein) decreases cat(p(MGI:Casp3))	As expected, treatment of mouse bone marrow-derived neutrophils with acrolein similarly suppressed caspase-3 activation, inhibited constitutive apoptosis, and increased necrosis	SEN:10015392	18566440
BEL:20023434	a(CHEBI:acrolein) decreases cat(p(MGI:Mmp2))	Figure 6. MMP-2 and MMP-9 activity were increased in the lungs of wild-type, but not Cd8(?/?) mice, exposed to acrolein (by gelatin zymography)	SEN:10015394	17950725
BEL:20023436	a(CHEBI:acrolein) decreases cat(p(MGI:Mmp9))	Figure 6. MMP-2 and MMP-9 activity were increased in the lungs of wild-type, but not Cd8(?/?) mice, exposed to acrolein (by gelatin zymography)	SEN:10015394	17950725
BEL:20023438	a(CHEBI:acrolein) increases cat(p(MGI:Mmp9))	our present study also showed that acrolein increased MMP-9 production with an increased MMP-9 activity in murine macrophages in a concentration- and timedependent manners (Figs. 1C and D).	SEN:10015396	20153347
BEL:20023440	a(CHEBI:acrolein) increases kin(p(MGI:Egfr))	Upon exposure of J774A.1 cells to acrolein, EGFR phosphorylation increased significantly within minutes, and further increased up to 10 min (Fig. 6A), confirming a direct effect of acrolein on the activation of the EGFR pathway.	SEN:10015398	20153347
BEL:20023442	a(CHEBI:acrolein) increases kin(p(MGI:Mapk1))	As shown in Figs. 3A and B, acrolein (10 uM) was able to induce phosphorylation of ERK, but not JNK and p38 MAPK, in a timedependent manner up to 120 min.	SEN:10015400	20153347
BEL:20023446	a(CHEBI:acrolein) increases p(MGI:Alox5)	As shown in Fig. 2A, acrolein induced 5-LO mRNA and protein expression in a concentration-dependent manner.	SEN:10015404	20153347
BEL:20023450	a(CHEBI:acrolein) increases p(MGI:Hmox1)	Experimental studies confirmed that HO-1 was induced by many factors such as cigarette smoke exposure (84), aqueous CSE (156), acrolein (354), crude diesel exhaust particles (DEP), aromatic and polar DEP fractions, and benzo(a)pyrene quinine (187), ultra fine particulate (PM0.1) (186), and 4-HNE (127) in a variety of cell lines.	SEN:10015408	17615396
BEL:20023452	a(CHEBI:acrolein) increases p(MGI:Mmp9)	our present study also showed that acrolein increased MMP-9 production with an increased MMP-9 activity in murine macrophages in a concentration- and timedependent manners (Figs. 1C and D).	SEN:10015396	20153347
BEL:20023468	a(CHEBI:aldosterone) increases cat(p(MGI:Fxyd4))	Corticosteroid hormone induced factor (CHIF) is a small epithelial-specific protein regulated by aldosterone and K+ intake.	SEN:10003276	14976412
BEL:20023478	a(CHEBI:androgen) directlyIncreases complex(p(HGNC:AR),p(HGNC:PIAS1))	Binding of PIAS1 to human AR DNA+ligand binding domains was androgen dependent in the yeast liquid beta-galactosidase assay. PIAS1 binding to full-length human AR in a reversed yeast two hybrid system was also androgen dependent.	SEN:10015420	10628744
BEL:20023488	a(CHEBI:"angiotensin II") increases cat(p(MGI:Parp1))	Angiotensin II infusion significantly increased heart weight-to-tibia length ratio, myocyte cross-sectional area, and interstitial fibrosis in PARP(+/+) but not in PARP(-/-) mice.	SEN:10003282	16632544
BEL:20023492	a(CHEBI:"angiotensin II") increases p(HGNC:OLR1)	Incubation of HCAECs with Ang II markedly increased LOX-1 mRNA (RT-PCR) and protein (Western blot) expression.	SEN:10015428	10325241
BEL:20023494	a(CHEBI:"angiotensin II") increases p(HGNC:STAT1,pmod(P,S))	Angiotensin II induces the tyrosine and serine phosphorylation of Stat1 and Stat3. Under High Glucose condition both the extent and the duration of phosphorylation of Stat1 and Stat3 was increased.	SEN:10015430	10542280
BEL:20023496	a(CHEBI:"angiotensin II") increases p(HGNC:STAT1,pmod(P,Y))	Angiotensin II induces the tyrosine and serine phosphorylation of Stat1 and Stat3. Under High Glucose condition both the extent and the duration of phosphorylation of Stat1 and Stat3 was increased.	SEN:10015430	10542280
BEL:20023498	a(CHEBI:"angiotensin II") increases p(HGNC:STAT3,pmod(P,S))	Angiotensin II induces the tyrosine and serine phosphorylation of Stat1 and Stat3. Under High Glucose condition both the extent and the duration of phosphorylation of Stat1 and Stat3 was increased.	SEN:10015430	10542280
BEL:20023500	a(CHEBI:"angiotensin II") increases p(HGNC:STAT3,pmod(P,Y))	Angiotensin II induces the tyrosine and serine phosphorylation of Stat1 and Stat3. Under High Glucose condition both the extent and the duration of phosphorylation of Stat1 and Stat3 was increased.	SEN:10015430	10542280
BEL:20023506	a(CHEBI:"angiotensin II") increases p(MGI:Cdkn1a)	Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97	SEN:10015436	18155543
BEL:20023508	a(CHEBI:"angiotensin II") increases p(MGI:Cdkn1a)	Furthermore, angiotensin II increased the proportion of senescent VSMCs and induced the expression of proinflammatory molecules, as well as p21, in aortic atherosclerotic lesions in a mouse model of atherosclerosis.33	SEN:10015438	18762784
BEL:20023510	a(CHEBI:"angiotensin II") increases p(MGI:Eif4ebp1,pmod(P))	Phosphorylation of 4E-BPs is also induced by growth factors, hormones such as angiotensin II, and cytokines (94).	SEN:10015440	12588811
BEL:20023524	a(CHEBI:"angiotensin II") increases p(MGI:Trp53)	Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97	SEN:10015436	18155543
BEL:20023536	a(CHEBI:"arachidonic acid") increases p(MGI:Cd36)	As shown in Fig. 6A, we found that AA and EPA, from 1 to 250 microM, mildly induced TR4-mediated and PPARgamma/RXR-mediated CD36 expression.	SEN:10015456	19666541
BEL:20023540	a(CHEBI:"arachidonic acid") increases tscript(p(MGI:Ppara))	The best natural Ppara agonists are long-chain polyunsaturated fatty acids such as arachidonic acid and linoleic acid.	SEN:10015460	12088279
BEL:20023546	a(CHEBI:atorvastatin) increases p(MGI:Hmox1)	As shown in Fig. 1A, treatment with atorvastatin induced a significant increase in HO-1 expression in murine aortic endothelium at a site with low probability of developing atherosclerotic lesions (27).	SEN:10015466	19457866
BEL:20023550	a(CHEBI:ATP) directlyIncreases cat(p(MGI:P2rx7))	.....rapid export of caspase-1-processed IL-1 beta from monocytes/macrophages in response to activation of P2X7 receptors (P2X7R) by extracellular ATP.	SEN:10001214	17641058
BEL:20023560	a(CHEBI:baicalein) decreases p(MGI:Cldn5)	Brain endothelial cells were protected against hypoxia and H(2)O(2) by the lipoxygenase inhibitor baicalein. After focal ischemia, 12/15-LOX was increased in neurons and endothelial cells. The vascular tight junction protein claudin-5 underwent extensive degradation in the peri-infarct area, which was partially prevented by the lipoxygenase inhibitor baicalein.	SEN:10003288	18635843
BEL:20023564	a(CHEBI:berberine) increases cat(p(MGI:Pde3b))	Stimulation of adipocytes with berberine increased phosphodiesterase (PDE) 3B and PDE4 activity measured by hydrolysis of (3)[H]cAMP	SEN:10003290	20969954
BEL:20023566	a(CHEBI:bezafibrate) decreases cat(p(MGI:Pemt))	We have shown that bezafibrate and clofibric acid, known hypolipidemic agents, are potent inhibitors of PE methylation	SEN:10003292	8944747
BEL:20023568	a(CHEBI:bezafibrate) decreases sec(p(MGI:Apoe))	In hepatocytes incubated with ethanolamine, which maintained cellular PE levels and PE methylation activity, bezafibrate (200 microM) decreased the secretion of triacylglycerol (TG), PC, apolipoproteins B48, and E in VLDL by 50-75%.	SEN:10003294	8944747
BEL:20023578	a(CHEBI:"bile salt") increases tscript(p(MGI:Nr0b2))	Mice were sacrificed 12 h after fasting, and the livers were removed for Northern blot analysis. Bile acid homeostasis is tightly controlled by the feedback mechanism in which an atypical orphan nuclear receptor (NR) small heterodimer partner (SHP) inactivates several NRs such as liver receptor homologue-1 and hepatocyte nuclear factor 4.	SEN:10015474	15047713
BEL:20023588	a(CHEBI:bleomycin) increases cat(p(MGI:Mmp2))	MMP-2 (76 kDa) activity was elevated only at day 11 in C57BL/6 mice but not in MyD88–/– and IL-1R1–/– mice (Figure 4B).	SEN:10015480	17992263
BEL:20023590	a(CHEBI:bleomycin) increases cat(p(MGI:Mmp9))	MMP-9 activity was significantly upregulated in BALF at day 1 in C57BL/6 mice but not in MyD88–/– mice, and only partially in IL-1R1–/– mice (Figure 4A).	SEN:10015482	17992263
BEL:20023592	a(CHEBI:bleomycin) increases p(HGNC:CCL2)	The concentrations of IL-8, G-CSF, monocyte chemoattractant protein-1, GM-CSF, and TGF-beta in the supernatant fluids significantly increased in response to bleomycin.	SEN:10003300	10229865
BEL:20023594	a(CHEBI:bleomycin) increases p(HGNC:CSF3)	The concentrations of IL-8, G-CSF, monocyte chemoattractant protein-1, GM-CSF, and TGF-beta in the supernatant fluids significantly increased in response to bleomycin.	SEN:10003300	10229865
BEL:20023596	a(CHEBI:bleomycin) increases p(HGNC:TGFB1)	The concentrations of IL-8, G-CSF, monocyte chemoattractant protein-1, GM-CSF, and TGF-beta in the supernatant fluids significantly increased in response to bleomycin.	SEN:10003300	10229865
BEL:20023600	a(CHEBI:bleomycin) increases p(MGI:Mmp12)	The former studies demonstrate that TGF-1 and bleomycin are potent stimulators of the propeptide and mature forms of MMP-12 (Fig. 10,Aand B).	SEN:10015486	17209037
BEL:20023602	a(CHEBI:bleomycin) increases p(MGI:Tgfb1)	Latent TGF-?1 was detected after activation in BALF from WT mice 7 days after BLM administration, but was not detected in BALF from MyD88- or IL-1R1–deficient mice (Figure 5G)	SEN:10015488	17992263
BEL:20023608	a(CHEBI:"brefeldin A") increases tloc(p(MGI:Stk16),GOCCID:0005794,GOCCID:0005634)	When cells were treated with brefeldin A (BFA) or nocodazole, drugs that promote Golgi disorganization, we observed STK16 translocation to the nuclear compartment.	SEN:10003304	16310770
BEL:20023618	a(CHEBI:caffeine) decreases kin(p(HGNC:ATM))	As shown in Fig. 6A, ATM immunoprecipitated from irradiated cells was more active than that from unirradiated cells, and both the basal and radiationinduced ATM activities were inhibited by caffeine with an IC50 at around 200 M.	SEN:10015498	10744722
BEL:20023624	a(CHEBI:calcitriol) decreases cat(complex(p(MGI:Ifngr1),p(MGI:Ifngr2)))	We show here that 1alpha,25(OH)2D3 can selectively suppress key effector functions of IFN-gamma-activated macrophages.	SEN:10003306	16118315
BEL:20023628	a(CHEBI:calcitriol) increases cat(p(MGI:Npr3))	The present study examined the 1,25(OH)2D3-mediated regulation of natriuretic peptide receptor-C (NPR-C) expression in osteoblasts. 1,25(OH)2D3 treatment significantly increased NPR-C-dependent atrial natriuretic peptide-binding activity and synthesis of the NPR-C protein in mouse osteoblastic cells in a cell-specific manner.	SEN:10003310	9843738
BEL:20023634	a(CHEBI:calcitriol) increases p(MGI:Npr3)	Western blot analysis also demonstrated that 1, 25(OH)2D3 upregulated expression of NPR-C protein in slow kinetics.	SEN:10015504	9843738
BEL:20023654	a(CHEBI:"carbon monoxide") decreases p(MGI:F3)	Addition of LPS strongly increased TF expression, which was significantly suppressed (by 72.7%, 57.1%, and 51.9% after 5, 9, and 15 hr, respectively) (Figure 4B) in cells exposed to CO.	SEN:10015516	16713977
BEL:20023656	a(CHEBI:"carbon monoxide") increases p(MGI:Hspa1b)	Exogenous CO exposure (250 ppm) acutely induced the expression of Hsp70 in mLEC, which lasted up to 8 h and declined by 24 h (Fig. 1A).	SEN:10015520	16081837
BEL:20023658	a(CHEBI:"carbon monoxide") increases tloc(p(MGI:Hsf1),GOCCID:0005737,GOCCID:0005634)	The mLEC treated with TNF-a/Act D in the presence of CO showed increased nuclear translocation of HSF-1 relative to cells treated with TNF-a/Act D in the absence of CO (Fig. 4A).	SEN:10015522	16081837
BEL:20023660	a(CHEBI:"carbon monoxide") decreases tscript(p(MGI:Elk1))	Because LPS induces Egr-1 activation via phosphorylation of the transcription factor Elk-1 (Guha et al., 2001), we investigated whether PPARgamma modulates LPS-induced Elk-1 phosphorylation. Phosphorylation of Elk-1 was barely detectable in untreated cells; addition of LPS resulted in a rapid increase in nuclear Elk-1 phosphorylation. This increase was inhibited an average of 36% in the presence of CO (Figures 3A?3C).	SEN:10015518	16713977
BEL:20023666	a(CHEBI:castanospermine) decreases complex(p(MGI:Asgr2),p(MGI:Pdia3))	Preincubation with a low concentration (15 microg/ml) of the glucosidase inhibitor castanospermine prevented the association of H2a to ERp57 but not to calnexin.	SEN:10000340	14978212
BEL:20023672	a(CHEBI:castanospermine) increases deg(p(MGI:Asgr2))	This low concentration of castanospermine accelerated the degradation of H2a, suggesting that ERp57 protects the glycoprotein from degradation and not calnexin.	SEN:10003318	14978212
BEL:20023676	a(CHEBI:ceramide) decreases cat(p(MGI:Pde3b))	Incubation of adipocytes with 100 micromol/l C(2)-ceramide (N-acetyl-sphingosine) resulted in a time-dependent decrease of PDE3B activity, accompanied by decreased PDE3B protein expression.	SEN:10015530	11872660
BEL:20023678	a(CHEBI:ceramide) increases complex(p(MGI:Prkcz),p(MGI:Pawr))	We have reported that ceramide mediates binding of atypical protein kinase C (PKC) zeta to its inhibitor protein, PAR-4 (prostate apoptosis response-4), thereby inducing apoptosis in differentiating embryonic stem cells.	SEN:10003320	15901738
BEL:20023680	a(CHEBI:ceramide) increases kin(p(MGI:Prkcz))	Ceramide and its analogs activated PKCzeta prior to binding to PAR-4, as determined by increased levels of phosphorylated PKCzeta and glycogen synthase kinase-3beta and emergence of a PAR-4-to-phosphorylated PKCzeta fluorescence resonance energy transfer signal that co-localizes with ceramide.	SEN:10015532	15901738
BEL:20023682	a(CHEBI:ceramide) increases kin(p(MGI:Prkcz))	Ceramides are the core structures of naturally occurring sphingolipids. They lead to inhibition of the classical PKC subtypes as well as inhibition of NFkB activity [52], and to activation of the atypical PKC subtype z [53].	SEN:10015534	16568236
BEL:20023684	a(CHEBI:ceramide) decreases p(MGI:Pde3b)	Incubation of adipocytes with 100 micromol/l C(2)-ceramide (N-acetyl-sphingosine) resulted in a time-dependent decrease of PDE3B activity, accompanied by decreased PDE3B protein expression.	SEN:10015530	11872660
BEL:20023686	a(CHEBI:ceramide) increases p(MGI:Prkcz,pmod(P))	Ceramide and its analogs activated PKCzeta prior to binding to PAR-4, as determined by increased levels of phosphorylated PKCzeta and glycogen synthase kinase-3beta and emergence of a PAR-4-to-phosphorylated PKCzeta fluorescence resonance energy transfer signal that co-localizes with ceramide.	SEN:10015532	15901738
BEL:20023706	a(CHEBI:cholesterol) increases p(MGI:Abcg1)	Initial studies of the ABCG1 transporter demonstrated that the transporter is upregulated in response to cholesterol loading in the macrophage.26–28	SEN:10015546	12679197
BEL:20023708	a(CHEBI:cholesterol) increases p(MGI:Ero1l)	Using the lipoprotein-cholesterol model, we found an approximately twofold increase in Ero1a mRNA and an ~50% increase in ERO1-alpha protein (Fig. 1 a).	SEN:10015548	19752026
BEL:20023722	a(CHEBI:"cholic acid") increases tscript(p(MGI:Nr1h4))	observed decreased plasma triglyceride levels in mice fed cholic acid-containing diets Fxr and its ligands lower plasma triglyeride levels	SEN:10015554	11579204
BEL:20023726	a(CHEBI:choline) increases sec(p(MGI:Apob))	other examples of apoB degradation that appear to occur post-ER include regulation by choline deficiency, dexamethasone, and the interaction of newly assembled apoB lipoproteins with LDL receptors in the secretory pathway or at the cell surface cell surface heparin sulfate proteoglycans may also serve an LDL receptor-like function	SEN:10015558	12006608
BEL:20023734	a(CHEBI:ciprofibrate) increases tscript(p(MGI:Ppara))	The overall commonality of expression between AOX-/- and ciprofibrate-induced liver tumors but not with DENA-induced tumors strongly implicates the activation of PPARalpha.	SEN:10003334	12771043
BEL:20023736	a(CHEBI:cisplatin) increases cat(p(MGI:Endog))	At day 4 after cisplatin injection mRNA, protein levels and enzyme activity of proapoptotic renal endonuclease G (Endo G) were increased compared with saline-treated mice. % In situ hybridization and immunohistochemical studies localized the increased expression of Endo G mRNA to the cytosolic compartment and Endo G protein to the nuclear compartment of proximal tubules in cisplatin-treated mice	SEN:10015560	15280156
BEL:20023738	a(CHEBI:cisplatin) increases kin(p(HGNC:MAPK14))	Treatment of cells with cisplatin induces a sustained activation of the stress activated protein kinase SAPK/JNK and the mitogen-activated protein kinase p38.	SEN:10003336	11064451
BEL:20023740	a(CHEBI:cisplatin) increases kin(p(HGNC:MAPK8))	Treatment of cells with cisplatin induces a sustained activation of the stress activated protein kinase SAPK/JNK and the mitogen-activated protein kinase p38.	SEN:10003336	11064451
BEL:20023742	a(CHEBI:cisplatin) increases p(MGI:Endog)	At day 4 after cisplatin injection mRNA, protein levels and enzyme activity of proapoptotic renal endonuclease G (Endo G) were increased compared with saline-treated mice. % In situ hybridization and immunohistochemical studies localized the increased expression of Endo G mRNA to the cytosolic compartment and Endo G protein to the nuclear compartment of proximal tubules in cisplatin-treated mice	SEN:10015560	15280156
BEL:20023746	a(CHEBI:cisplatin) decreases tscript(complex(p(MGI:Ppara),p(MGI:Rxra)))	DNA-protein binding studies demonstrated that exposure to cisplatin reduces PPARalpha/retinoid X receptor (RXRalpha) binding activity.	SEN:10003338	12234291
BEL:20023750	a(CHEBI:clofibrate) decreases cat(p(MGI:Pemt))	We have shown that bezafibrate and clofibric acid, known hypolipidemic agents, are potent inhibitors of PE methylation	SEN:10003292	8944747
BEL:20023752	a(CHEBI:clofibrate) increases p(MGI:Abcc3)	Western blot analysis confirmed that CFB enhances protein expression of liver Bcrp, Mrp3, and Mrp4 in CD-1 mice.	SEN:10015564	16467456
BEL:20023754	a(CHEBI:clofibrate) increases p(MGI:Abcc4)	Western blot analysis confirmed that CFB enhances protein expression of liver Bcrp, Mrp3, and Mrp4 in CD-1 mice.	SEN:10015564	16467456
BEL:20023756	a(CHEBI:clofibrate) increases p(MGI:Abcg2)	Western blot analysis confirmed that CFB enhances protein expression of liver Bcrp, Mrp3, and Mrp4 in CD-1 mice.	SEN:10015564	16467456
BEL:20023760	a(CHEBI:clofibrate) directlyIncreases tscript(p(MGI:Ppara))	Hepatic transporters play a vital role in the disposition of endogenous compounds and xenobiotics in the liver. The current study investigates the expression and regulation of hepatic efflux transporters in response to treatment with the peroxisome proliferator-activated receptor (PPAR)alpha agonist clofibrate (CFB).	SEN:10003340	16467456
BEL:20023768	a(CHEBI:corticosterone) decreases cat(p(MGI:Hsd11b1))	the effect of dexamethasone was mimicked by both cortisol and corticosterone but blocked by the glucocorticoid receptor antagonist RU486. (From full text: We showed that both steroids were equally effective in reducing 11?-HSD1 activity as dexamethasone)	SEN:10015570	18467433
BEL:20023776	a(CHEBI:curcumin) increases p(MGI:Nfe2l2)	Dietary curcumin led to increase in NF-E2-related factor-2 (Nrf2) protein levels and enhanced its nuclear translocation in liver and lungs of mice as compared with controls.	SEN:10000422	18321868
BEL:20023782	a(CHEBI:cycloheximide) decreases cat(p(MGI:Casp1))	Treatment of macrophages with the protein synthesis inhibitor cycloheximide dose responsively led to reduced caspase-1 activation obtained by the combination of LPS and ATP indicating that protein de novo synthesis was functionally limiting in mouse macrophages (Fig. 3A).	SEN:10015576	19570822
BEL:20023790	a(CHEBI:cycloheximide) decreases p(HGNC:EIF6)	However, protein levels were unaffected ( Fig. 3b). Cycloheximide treatment (10 ?g/ml) was performed for 24 h. In FG2 cell lines the levels of p27BBP mRNA and protein were totally unchanged (Fig. 3a,b). In contrast, in HaCaT cells the levels of p27BBP mRNA were similar to the control, but protein levels were significantly decreased.	SEN:10015582	11290417
BEL:20023800	a(CHEBI:cycloheximide) decreases p(MGI:Eif2ak3,pmod(P,T,980))	Importantly, cycloheximide treatment also completely suppressed PERK (Thr980) phosphorylation in both Tsc1-/- and Tsc2-/- cells (Figure S1C), supporting the hypothesis that increased protein synthesis is likely the underlying mechanism for activation of UPR in TSC1- and TSC2-deficient cells.	SEN:10015590	18342602
BEL:20023814	a(CHEBI:"cytochalasin D") increases phos(p(MGI:Ptpn14))	Rephosphorylation of PTP36 seemed to depend on actin polymerization since it was inhibited by cytochalasin D.	SEN:10015600	10400706
BEL:20023816	a(CHEBI:"cytochalasin D") decreases p(MGI:Ptpn14,pmod(P,S))	Rephosphorylation of PTP36 seemed to depend on actin polymerization since it was inhibited by cytochalasin D.	SEN:10015600	10400706
BEL:20023818	a(CHEBI:"cytochalasin D") increases tloc(p(MGI:Ptpn14),GOCCID:0005737,GOCCID:0005856)	Rephosphorylation of PTP36 seemed to depend on actin polymerization since it was inhibited by cytochalasin D.	SEN:10015600	10400706
BEL:20023822	a(CHEBI:"dermatan sulfate") decreases complex(p(HGNC:VCAN),p(HGNC:SELL))	The binding of versican to L- and P-selectin was inhibited by CS B, CS E, and heparan sulfate (HS)	SEN:10003354	10950950
BEL:20023824	a(CHEBI:"dermatan sulfate") decreases complex(p(HGNC:VCAN),p(HGNC:SELP))	The binding of versican to L- and P-selectin was inhibited by CS B, CS E, and heparan sulfate (HS)	SEN:10003354	10950950
BEL:20023826	a(CHEBI:desipramine) increases tscript(p(MGI:Crem))	Using real-time quantitative PCR, we establish that hypothalamic CRF expression is significantly reduced after swim exposure in DMI-treated wild-type mice, however DMI is unable to blunt hypothalamic CRF expression in ICER-deficient mice.	SEN:10003356	14985439
BEL:20023830	a(CHEBI:dexamethasone) increases cat(p(MGI:Gpd1))	Both activation of glycerophosphate dehydrogenase and stimulation of insulin-dependent 2-deoxyglucose uptake induced by hormones/IBMX were enhanced in protein kinase C-depleted cells exposed to phorbol 12-myristate 13-acetate (PMA)	SEN:10015606	7981246
BEL:20023832	a(CHEBI:dexamethasone) decreases cat(p(MGI:Hsd11b1))	insulin stimulated whereas dexamethasone inhibited 11beta-HSD1 activity and expression in a time- and concentration-dependent manner	SEN:10015608	18467433
BEL:20023834	a(CHEBI:dexamethasone) increases cat(p(MGI:Lpl))	Inhibition of LPL activity by Wy-14643 did not reduce the ability of insulin plus dexamethasone to stimulate cellular and heparin-releasable LPL activities. A similar inhibitory effect on cellular and heparin-releasable LPL activity was observed when cardiomyocytes were cultured with 60 microM linoleic acid.	SEN:10015610	11454595
BEL:20023848	a(CHEBI:dexamethasone) decreases p(MGI:Rb1,pmod(P))	pRb from dexamethasone-treated cells was much less polymorphic and tended to migrate more rapidly than some of the pRb species that were detected in extracts from untreated mid-log phase cells. These properties are consistent with the conclusion that the state of pRb phosphorylation is reduced in glucocorticoid treated L929 cells.	SEN:10015620	9139801
BEL:20023852	a(CHEBI:dexamethasone) decreases sec(p(MGI:Apob))	other examples of apoB degradation that appear to occur post-ER include regulation by choline deficiency, dexamethasone, and the interaction of newly assembled apoB lipoproteins with LDL receptors in the secretory pathway or at the cell surface cell surface heparin sulfate proteoglycans may also serve an LDL receptor-like function	SEN:10015558	12006608
BEL:20023856	a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))	Lysyl oxidase transcription was stimulated by dexamethasone treatment of cells, but this effect could not be assigned within the approximately 3 kb region tested in reporter gene constructs.	SEN:10015624	10391127
BEL:20023860	a(CHEBI:dexamethasone) increases tscript(p(MGI:Cebpb))	Induction of C/EBP beta DNA-binding activity in NIH-3T3 beta 2 cells exposed to dexamethasone in the presence of insulin and fetal bovine serum activates the expression of an adipocyte-specific nuclear hormone receptor, PPAR gamma, that stimulates the conversion of these fibroblasts into committed preadipocytes	SEN:10000006	7557387
BEL:20023868	a(CHEBI:"D-fructose 1,6-bisphosphate") increases kin(p(MGI:Pfkm))	In addition, we show that this interaction is (i) highly regulated by the extracellular concentration of glucose and (ii) can be stabilized by a number of relevant intracellular metabolites, such as fructose 1,6-bisphosphate and fructose 2,6-bisphosphate, which are known allosteric activators of PFK	SEN:10015630	9252390
BEL:20023888	a(CHEBI:"double-stranded DNA") increases cat(p(MGI:Myd88))	Finally, we determined that bacterial DNA stimulated CD11b up-regulation in TLR9(-/-) but not in MyD88(-/-) mouse neutrophils, supporting that bacterial DNA induces neutrophil activation through a TLR9-independent and MyD88-dependent pathway.	SEN:10015644	16951367
BEL:20023902	a(CHEBI:estradiol) decreases p(HGNC:ERBB2)	In oestrogen receptor (ER) positive breast epithelial cells oestrogens reduce ERBB2 mRNA and protein levels, an effect that is reversed in the presence of anti-oestrogens such as tamoxifen and ICI 182780	SEN:10003374	10698518
BEL:20023904	a(CHEBI:estradiol) increases p(MGI:Fgf7)	The vaginae cultured with 5 microg/ml E2 or 5 microg/ml KGF had a cornified thick epithelium, while the epithelium of the vehicle-treated controls stayed thin. The E2 effect was blocked by concurrent treatment with anti-KGF antibody or KGFR inhibitory peptide.	SEN:10003376	15480797
BEL:20023922	a(CHEBI:estradiol) decreases tport(p(MGI:Slc6a4))	beta-Estradiol (E2) exhibited noncompetitive, and possibly allosteric, inhibition of both radiolabeled serotonin ([3H]5-HT) transport by, and radiolabeled cocaine congener ([3H]CFT) binding to, this system....Assessments of covalent conjugates of E2 suggested that E2 interacts with the transporter protein at allosteric site(s) inaccessible from the extracellular domain.	SEN:10015658	10076044
BEL:20023932	a(CHEBI:estradiol) increases tscript(p(HGNC:ESR1))	Treatment with cycloheximide indicated that ER directly controls GREB1 expression...The pattern of expression suggests a critical role for these two genes in the response of tissues and tumors to beta-estradiol.	SEN:10015666	11103799
BEL:20023940	a(CHEBI:estriol) decreases tport(p(MGI:Slc6a4))	Beyond E2, preliminary examination of other steroid metabolites and synthetic steroid receptor agonists/antagonists revealed that inhibition of 5-HT transport is additionally attributable only to estriol (E3, an E2 metabolite) and tamoxifen (a nonsteroidal, E2 receptor antagonist).	SEN:10003388	10076044
BEL:20023956	a(CHEBI:fenofibrate) increases p(MGI:Pltp)	Significant rises in plasma PLTP activity were observed after 2 weeks of fenofibrate treatment...Simultaneously, hepatic PLTP mRNA levels increased in a dose-dependent fashion.	SEN:10015674	11342537
BEL:20023962	a(CHEBI:fenofibrate) directlyIncreases tscript(p(MGI:Ppara))	Two peroxisome proliferator-activated receptor a agonsists: Wy-14643 and a marketed fribrate drug, fenofibrate	SEN:10015678	11798191
BEL:20023968	a(CHEBI:formaldehyde) increases p(MGI:Camk2a)	Both CaMKIIalpha mRNA and protein expression were increased in a time-dependent manner in the spinal cords of wild-type mice after formalin injection.	SEN:10003394	15082179
BEL:20023970	a(CHEBI:fructose) increases cat(p(MGI:Fbp1))	In the intestinal mucosa, ketohexokinase, aldolase, triokinase, fructose-diphosphatase, and glucose-6-phosphatase specific activities were still entirely or partially stimulated on the 15th day after return to the standard diet.	SEN:10003396	1725750
BEL:20023972	a(CHEBI:fructose) increases cat(p(MGI:G6pc))	In the intestinal mucosa, ketohexokinase, aldolase, triokinase, fructose-diphosphatase, and glucose-6-phosphatase specific activities were still entirely or partially stimulated on the 15th day after return to the standard diet.	SEN:10003396	1725750
BEL:20023974	a(CHEBI:fructose) decreases deg(p(MGI:Apob))	there are also animal models of post-transcriptional regulation of apoB secretion hamsters fed a high fructose diet had increased assembly and secretion of VLDL apoB with no change in apoB mRNA levels but with decreased non-proteasomal degradation of apoB	SEN:10015682	12006608
BEL:20023976	a(CHEBI:fructose) increases kin(p(MGI:Khk))	In the intestinal mucosa, ketohexokinase, aldolase, triokinase, fructose-diphosphatase, and glucose-6-phosphatase specific activities were still entirely or partially stimulated on the 15th day after return to the standard diet.	SEN:10003396	1725750
BEL:20023978	a(CHEBI:fructose) increases sec(p(MGI:Apob))	there are also animal models of post-transcriptional regulation of apoB secretion hamsters fed a high fructose diet had increased assembly and secretion of VLDL apoB with no change in apoB mRNA levels but with decreased non-proteasomal degradation of apoB	SEN:10015682	12006608
BEL:20023980	a(CHEBI:fulvestrant) increases p(HGNC:NDRG1)	It was increased in mammary carcinoma MCF-7 cells treated by retinoids and by the anti-estrogen ICI 182,780 but not by 4-hydroxytamoxifen.	SEN:10015684	10395947
BEL:20023994	a(CHEBI:galangin) increases tscript(p(MGI:Ahr))	60 or 90 ?M galangin induced AhR nuclear translocation in both cell types (Fig. 11A, lanes 7, 8; Fig. 11B, lane 6).	SEN:10015690	10953044
BEL:20024014	a(CHEBI:glucocorticoid) increases cat(p(MGI:Gpd1))	Both activation of glycerophosphate dehydrogenase and stimulation of insulin-dependent 2-deoxyglucose uptake induced by hormones/IBMX were enhanced in protein kinase C-depleted cells exposed to phorbol 12-myristate 13-acetate (PMA)	SEN:10015606	7981246
BEL:20024016	a(CHEBI:glucocorticoid) increases p(MGI:Il10)	Glucocorticoids and IL-10 stimulated the production of GILZ by macrophages both in vitro and in vivo.	SEN:10015708	12393603
BEL:20024018	a(CHEBI:glucocorticoid) increases p(MGI:Mif)	Calandra et al. [32] demonstrated that MIF expression can be induced by glucocorticoid release. ....MIF counteracts steroid-induced induction of MAP kinase phosphatase [29] .	SEN:10015710	18791328
BEL:20024020	a(CHEBI:glucocorticoid) decreases p(MGI:Pomc)	Pulse-chase biosynthetic labeling studies showed that AtT-20 cells expressed much less RESP18 than the endogenous prohormone, POMC, but that glucocorticoid treatment lowered POMC and raised RESP18 biosynthetic rates so that they were nearly equimolar. Surprisingly, RESP18 was not processed to smaller peptides to any significant extent, nor was RESP18 or any smaller peptide secreted.	SEN:10015712	7988462
BEL:20024022	a(CHEBI:glucocorticoid) increases p(MGI:Resp18)	Pulse-chase biosynthetic labeling studies showed that AtT-20 cells expressed much less RESP18 than the endogenous prohormone, POMC, but that glucocorticoid treatment lowered POMC and raised RESP18 biosynthetic rates so that they were nearly equimolar. Surprisingly, RESP18 was not processed to smaller peptides to any significant extent, nor was RESP18 or any smaller peptide secreted.	SEN:10015712	7988462
BEL:20024024	a(CHEBI:glucocorticoid) decreases p(MGI:Tnxb)	We have identified glucocorticoids as physiological inhibitors of tenascin-X and suggest that glucocorticoids may in part participate in the downregulation of tenascin-X in fibroblasts in vivo.	SEN:10000018	8856503
BEL:20024026	a(CHEBI:glucocorticoid) increases p(MGI:Tsc22d3)	Glucocorticoids and IL-10 stimulated the production of GILZ by macrophages both in vitro and in vivo.	SEN:10015708	12393603
BEL:20024028	a(CHEBI:glucocorticoid) increases sec(p(MGI:Mif))	Physiological concentrations of glucocorticoids increase MIF secretion from murine macrophages [32]	SEN:10015714	18791328
BEL:20024032	a(CHEBI:glucosamine) increases p(HGNC:IRS1,pmod(G,S))	We also demonstrated that glucosamine % infusion results in O-linked N-acetylglucosamine modification of IRS-1 and % IRS-2.	SEN:10015718	10426374
BEL:20024036	a(CHEBI:glutathione) decreases p(HGNC:NFKBIA,pmod(P,S))	Under reducing conditions, such as an increase in intracellular GSH following treatment with N-acetyl-L-cysteine (NAC), the phosphorylation of serine groups on IkB-a following TNF-a treatment is inhibited, leading to the downregulation of NF-kB in endothelial cells (fig. 2) [53].	SEN:10015722	11028671
BEL:20024044	a(CHEBI:heme) directlyDecreases tscript(p(MGI:Bach1))	Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements.	SEN:10015726	14747657
BEL:20024046	a(CHEBI:hemin) increases deg(p(MGI:Bach1))	As shown in Fig. ?Fig.3A,3A, FLAG-Bach1 was rather stable in the absence of hemin, but it disappeared more rapidly in the presence of hemin. Its half-life was shortened less than 1 h by the presence of hemin (Fig. ?(Fig.3B).3B). We conclude that heme induces degradation of Bach1 in vivo.	SEN:10015728	17682061
BEL:20024048	a(CHEBI:hemin) increases p(MGI:Bach1,pmod(U,K))	An immunoblotting analysis of the precipitates with an anti-HA antibody revealed that polyubiquitination of FLAG-Bach1 or FLAG-MafK was not apparent under normal conditions (Fig. 4A and B). In contrast, it significantly increased when the cells expressing FLAG-Bach1 (Fig. ?(Fig.4A,4A, lane 3) or FLAG-Bach1 and FLAG-MafK (Fig. ?(Fig.4B,4B, anti-HA blot, lane 5) were treated with hemin	SEN:10015730	17682061
BEL:20024050	a(CHEBI:hemin) increases p(MGI:Bach2,pmod(U,K))	We next compared Bach2 and Nrf2 and found that Bach2 was also polyubiquitinated in response to hemin treatment (Fig. ?(Fig.5B).5B).	SEN:10015732	17682061
BEL:20024056	a(CHEBI:heparin) increases cat(p(HGNC:CMA1))	The tight binding of chymase to heparin PG results in increased activity of the protease toward certain substrates, e.g., thrombin and MeO-Suc-Arg-Pro-Tyr-pNA (S-2586).	SEN:10003404	10508424
BEL:20024070	a(CHEBI:heparin) decreases sec(p(MGI:Apob))	other examples of apoB degradation that appear to occur post-ER include regulation by choline deficiency, dexamethasone, and the interaction of newly assembled apoB lipoproteins with LDL receptors in the secretory pathway or at the cell surface cell surface heparin sulfate proteoglycans may also serve an LDL receptor-like function	SEN:10015558	12006608
BEL:20024072	a(CHEBI:histamine) increases cat(p(HGNC:HRH2))	histamine suppresses gene expression and synthesis of tumor necrosis factor alpha (TNF-alpha) induced by lipopolysaccharide (LPS)	SEN:10003410	10818238
BEL:20024074	a(CHEBI:histamine) increases cat(p(HGNC:HRH2))	activation of the human H(2) receptor (hH(2)R) leads to an increase in c-fos transcription and cell proliferation	SEN:10003412	10837353
BEL:20024092	a(CHEBI:histamine) increases p(MGI:Fgf2)	The amount of basic fibroblast growth factor (bFGF) in protein level at the wound edge was higher in HDC(+/+) mice, especially on the 3rd and 5th day of wound healing compared to those in HDC(-/-) mice.	SEN:10015744	16543894
BEL:20024100	a(CHEBI:"hyaluronic acid") increases cat(p(MGI:Tlr4))	freezing or disruption of the matrix by subcutaneous sterile bead injection, induce the release of fragments of HA that in turn stimulates a TLR4-dependent increase in CXCL2 chemokines	SEN:10015746	19258328
BEL:20024104	a(CHEBI:"hyaluronic acid") increases p(MGI:Cd44)	The requirement for CD44 binding and hyaluronan internalization could be bypassed by intracellular administration of hyaluronan oligosaccharides (10-18-mer) in lipopolysaccharide-primed macrophages	SEN:10000436	19258328
BEL:20024108	a(CHEBI:"hyaluronic acid") increases sec(p(MGI:Il1b))	we next examined whether HA can directly induce IL-1beta release. Peritoneal macrophages of WT mice, but not cryopyrin null mice (Nlrp3-/-), showed a large increase in IL-1beta release	SEN:10015752	19258328
BEL:20024116	a(CHEBI:"hydrogen peroxide") increases cat(p(HGNC:ALOX5))	It was found that 5-LO in the Epstein-Barr virus-transformed B-lymphocytic cell line BL41-E95-A is activated by addition of hydrogen peroxide or xanthine/xanthine oxidase and after increasing the oxidative state of the cell	SEN:10003424	10691962
BEL:20024124	a(CHEBI:"hydrogen peroxide") increases complex(p(HGNC:PRKCD),p(HGNC:ABL1))	The present studies demonstrate that treatment of cells with hydrogen peroxide (H(2)O(2)) induces binding of the PKCdelta isoform and the c-Abl protein-tyrosine kinase. The results show that c-Abl phosphorylates PKCdelta in the H(2)O(2) response. We also show that PKCdelta phosphorylates and activates c-Abl in vitro.	SEN:10015764	10713049
BEL:20024128	a(CHEBI:"hydrogen peroxide") decreases deg(p(MGI:Nfkbia))	In neutrophils challenged with LPS, IkB-a underwent time-dependent degradation (Fig. 8C). However, in neutrophils incubated with both LPS and H2O2, no degradation of IkB-a was apparent.	SEN:10015754	14656721
BEL:20024130	a(CHEBI:"hydrogen peroxide") increases gtp(p(MGI:Hras))	3) H(2)O(2) rapidly activated Ras (peak at 2-5 min), which preceded p90RSK activation (peak at 20 min).	SEN:10015768	10636870
BEL:20024132	a(CHEBI:"hydrogen peroxide") increases kin(p(HGNC:MAP2K1))	which are dual-specificity (serine/threonine and tyrosine) kinases that regulate downstream responses to a broad range of mitogenic, apoptotic, and differentiation-inducing stimuli [368-372]. Interestingly, MEK1 but not MEK2 is stimulated by H2O2 treatment, suggesting that only MEK1 is redox-sensitive [154].	SEN:10015770	10699758
BEL:20024136	a(CHEBI:"hydrogen peroxide") increases kin(p(MGI:Jak2))	JAK-2 activation and phosphorylation have been demonstrated in response to exogenous H2O2 in fibroblasts and VSMCs, respectively (27,63).	SEN:10015774	17406055
BEL:20024138	a(CHEBI:"hydrogen peroxide") increases kin(p(MGI:Mapk14))	a part of the phosphorylation of Sap-1a upon stimulation with H2O2 is due to p38 MAPK, while the rest can most likely be attributed to JNKs that are also inducible by H2O2.	SEN:10015776	9130707
BEL:20024144	a(CHEBI:"hydrogen peroxide") directlyDecreases phos(p(MGI:Pten))	This assay allowed us to show that addition of exogenous hydrogen peroxide to Swiss 3T3 cells could completely inactivate cellular PTEN	SEN:10015782	15046604
BEL:20024146	a(CHEBI:"hydrogen peroxide") decreases phos(p(MGI:Ptpn11))	in view of the ability of H2O2 to inhibit protein tyrosine phosphatases (PTPases), such as PTP-1B (68), and SH-2 domain-containing tyrosine phosphatase (SHP)-2 (69),	SEN:10015784	17406055
BEL:20024148	a(CHEBI:"hydrogen peroxide") decreases phos(p(MGI:Ptpn1))	in view of the ability of H2O2 to inhibit protein tyrosine phosphatases (PTPases), such as PTP-1B (68), and SH-2 domain-containing tyrosine phosphatase (SHP)-2 (69),	SEN:10015784	17406055
BEL:20024154	a(CHEBI:"hydrogen peroxide") increases p(MGI:Ddit3)	the induction of CHOP by H2O2 was inhibited by both LY294002 and rapamycin (Fig. 5), suggesting that the PI3K/mTOR pathway is also involved in H2O2 signaling.	SEN:10015790	11145585
BEL:20024156	a(CHEBI:"hydrogen peroxide") increases p(MGI:Elk4,pmod(P))	Therefore, we also analyzed NIH 3T3 cells that were serum deprived and then stimulated with either H2O2, anisomycin or UV light. All of these stimuli resulted in increased phosphorylation of Myc–Sap-1a, most prominently seen with H2O2 (Figure 8B)	SEN:10015792	9130707
BEL:20024160	a(CHEBI:"hydrogen peroxide") increases p(MGI:Mapk1,pmod(P,T,183))	As was the case for p38, ERK1/2 was both rapidly and persistently activated in neutrophils exposed to H2O2 (Fig. 2A).	SEN:10015794	14656721
BEL:20024162	a(CHEBI:"hydrogen peroxide") increases p(MGI:Mapk1,pmod(P,Y,185))	As was the case for p38, ERK1/2 was both rapidly and persistently activated in neutrophils exposed to H2O2 (Fig. 2A).	SEN:10015794	14656721
BEL:20024164	a(CHEBI:"hydrogen peroxide") increases p(MGI:Mapk3,pmod(P,T,202))	As was the case for p38, ERK1/2 was both rapidly and persistently activated in neutrophils exposed to H2O2 (Fig. 2A).	SEN:10015794	14656721
BEL:20024166	a(CHEBI:"hydrogen peroxide") increases p(MGI:Mapk3,pmod(P,Y,204))	As was the case for p38, ERK1/2 was both rapidly and persistently activated in neutrophils exposed to H2O2 (Fig. 2A).	SEN:10015794	14656721
BEL:20024168	a(CHEBI:"hydrogen peroxide") increases p(MGI:Mapk8,pmod(P,T,183))	Similar to the patterns seen with ERK1/2 and p38, JNK activation in neutrophils exposed to H2O2 was both rapid and persistent (Fig. 2B).	SEN:10015796	14656721
BEL:20024170	a(CHEBI:"hydrogen peroxide") increases p(MGI:Mapk8,pmod(P,Y,185))	Similar to the patterns seen with ERK1/2 and p38, JNK activation in neutrophils exposed to H2O2 was both rapid and persistent (Fig. 2B).	SEN:10015796	14656721
BEL:20024184	a(CHEBI:hydroxyurea) increases p(HGNC:BRCA1,pmod(P,S,1423))	Increased expression of ATR enhanced the phosphorylation of BRCA1 on Ser 1423 following cellular exposure to HU or UV light, whereas doxycycline-induced expression of a kinase-inactive ATR mutant protein inhibited HU- or UV light-induced Ser 1423 phosphorylation in GM847 fibroblasts, and partially suppressed the phosphorylation of this site in response to IR.	SEN:10015806	11114888
BEL:20024188	a(CHEBI:"icosapentaenoic acid") increases p(MGI:Cd36)	As shown in Fig. 6A, we found that AA and EPA, from 1 to 250 microM, mildly induced TR4-mediated and PPARgamma/RXR-mediated CD36 expression.	SEN:10015456	19666541
BEL:20024192	a(CHEBI:imatinib) directlyDecreases kin(p(MGI:Abl1))	Using the specific Abl tyrosine kinase inhibitor STI 571, we purified unphosphorylated murine type IV c-Abl	SEN:10003428	10964922
BEL:20024200	a(CHEBI:indometacin) decreases cat(p(MGI:Cntf))	Ciliary neurotrophic factor (CNTF) supports the differentiation and survival of central and peripheral neurons.	SEN:10003430	8378338
BEL:20024202	a(CHEBI:indometacin) decreases cat(p(MGI:Cyp1a2))	Treatment of the LPS-sensitive mice with intraperitoneal indomethacin (5 mg/kg per day, 3 days) significantly decreased enzyme activities for CYP3A11, CYP2D9 and CYP1A2 but not CYP2E1.	SEN:10003432	12927920
BEL:20024204	a(CHEBI:indometacin) decreases cat(p(MGI:Cyp2d9))	Treatment of the LPS-sensitive mice with intraperitoneal indomethacin (5 mg/kg per day, 3 days) significantly decreased enzyme activities for CYP3A11, CYP2D9 and CYP1A2 but not CYP2E1.	SEN:10003432	12927920
BEL:20024206	a(CHEBI:indometacin) decreases cat(p(MGI:Cyp2e1))	Treatment of the LPS-sensitive mice with intraperitoneal indomethacin (5 mg/kg per day, 3 days) significantly decreased enzyme activities for CYP3A11, CYP2D9 and CYP1A2 but not CYP2E1.	SEN:10003432	12927920
BEL:20024208	a(CHEBI:indometacin) decreases cat(p(MGI:Cyp3a11))	Treatment of the LPS-sensitive mice with intraperitoneal indomethacin (5 mg/kg per day, 3 days) significantly decreased enzyme activities for CYP3A11, CYP2D9 and CYP1A2 but not CYP2E1.	SEN:10003432	12927920
BEL:20024214	a(CHEBI:indometacin) decreases p(HGNC:PTGS1)	we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin. Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells	SEN:10015812	11159024
BEL:20024216	a(CHEBI:indometacin) decreases p(HGNC:PTGS2)	we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin. Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells	SEN:10015812	11159024
BEL:20024220	p(HGNC:INS) increases cat(p(MGI:Hsd11b1))	insulin stimulated whereas dexamethasone inhibited 11beta-HSD1 activity and expression in a time- and concentration-dependent manner	SEN:10015608	18467433
BEL:20024230	p(HGNC:INS) decreases complex(p(MGI:Ppargc1a),p(MGI:Foxo1))	Insulin signaling inhibits gluconeogenesis by disrupting this interaction between FoxO1 and PGC-1 and/or by inhibiting PGC-1 (Schilling et al., 2006; Li et al., 2007b).	SEN:10015820	18391970
BEL:20024232	p(HGNC:INS) increases complex(p(MGI:Ppp1r13b),p(MGI:Socs6))	In contrast, SOCS-6-associated p85 was not degraded and could be recruited to the newly synthesized SOCS-6 molecules in the presence of insulin, suggesting that SOCS-6 expression and its interaction with p85, but not the degradation, is regulated by insulin.	SEN:10003438	15123678
BEL:20024234	p(HGNC:INS) increases gtp(p(MGI:Rab4a))	(i) insulin signaling stimulates Rab4 activity, the association of Rab4 with kinesin, and the interaction of KIF3 with microtubules and (ii) this process is mediated by insulin-induced PI3-kinase-dependent PKC-lambda activation and participates in GLUT4 exocytosis in 3T3-L1 adipocytes.	SEN:10003440	12832475
BEL:20024242	p(HGNC:INS) increases kin(p(MGI:Rps6kb1))	Whereas treatment of wild type MEFs with insulin induced a marked increase in S6K1 activity, the basal activity of S6K1 isolated from Tsc1- and Tsc2-null MEFs was high and was not increased further by insulin (Fig. 1B).	SEN:10015826	14993219
BEL:20024254	p(HGNC:INS) increases p(MGI:Akt1,pmod(P,S,473))	Figure 3a shows that while 5 min of insulin treatment resulted in rapid and substantive phosphorylation of Akt, 5 min visfatin treatment alone failed to induce Akt Ser472 phosphorylation, compared to control.	SEN:10015832	19898975
BEL:20024268	p(HGNC:INS) increases p(MGI:Stat3,pmod(P,S))	Insulin reduces the tyrosine phosphorylation and increases the serine phosphorylation of STAT3, thereby reducing its nuclear localization and transcriptional activity	SEN:10015842	17267401
BEL:20024270	p(HGNC:INS) decreases p(MGI:Stat3,pmod(P,Y))	Insulin reduces the tyrosine phosphorylation and increases the serine phosphorylation of STAT3, thereby reducing its nuclear localization and transcriptional activity	SEN:10015842	17267401
BEL:20024272	p(HGNC:INS) increases surf(p(HGNC:SOCS3))	Second, using confocal microscopy, we show that insulin induces translocation of SOCS-3 from an intracellular compartment to the cell membrane, leading to colocalization of SOCS-3 with the insulin receptor. This colocalization is dependent upon phosphorylation of insulin receptor tyrosine 960.	SEN:10015844	10821852
BEL:20024274	p(HGNC:INS) increases tloc(p(MGI:Inppl1),GOCCID:0005737,GOCCID:0005886)	insulin specifically stimulates the redistribution of SHIP2 from the cytosol to the PM independent of 5'-phosphatase activity, thereby regulating the insulin-induced translocation and phosphorylation of Akt2 at the PM.	SEN:10015846	14744864
BEL:20024278	p(HGNC:INS) decreases tscript(p(MGI:Ppargc1a))	Insulin signaling inhibits gluconeogenesis by disrupting this interaction between FoxO1 and PGC-1 and/or by inhibiting PGC-1 (Schilling et al., 2006; Li et al., 2007b).	SEN:10015820	18391970
BEL:20024284	a(CHEBI:"kainic acid") increases p(MGI:Aifm1)	These mutant cells exhibit extended neuroprotection against DNA damage, as well as glutamate-induced excitotoxicity. Specifically, AIF is involved in NMDA- and kainic acid- but not AMPA-induced excitotoxicity. In vivo excitotoxic studies using kainic acid-induced seizure showed that Hq mice had significantly less hippocampal damage than wild-type littermates.	SEN:10015850	15703386
BEL:20024296	a(CHEBI:"leukotriene B4") directlyIncreases cat(p(HGNC:LTB4R2))	A binding assay using membrane fractions from HEK 293 cells exogenously transfected with the receptor cDNA showed that BLT2 is a low-affinity receptor for LTB4	SEN:10015858	10934230
BEL:20024300	a(CHEBI:"leukotriene B4") directlyIncreases cat(p(MGI:Ltb4r1))	A selective inhibitor of leukotriene synthesis MK886 as well as an antagonist of the high affinity LTB(4) receptor (BLT(1)) U-75302 slightly inhibited zymosan-, but not LPS-stimulated interleukin (IL)-10 release from BM-DCs.	SEN:10015862	16313356
BEL:20024304	a(CHEBI:"leukotriene B4") increases p(MGI:Il10)	A selective inhibitor of leukotriene synthesis MK886 as well as an antagonist of the high affinity LTB(4) receptor (BLT(1)) U-75302 slightly inhibited zymosan-, but not LPS-stimulated interleukin (IL)-10 release from BM-DCs.	SEN:10015862	16313356
BEL:20024306	a(CHEBI:"leukotriene B4") decreases p(MGI:Il10)	Consistent with the effects of leukotriene antagonists, exogenous LTB(4) enhanced LPS-stimulated IL-10 release by approximately 39% and inhibited IL-12 p40 release by approximately 22%	SEN:10015866	16313356
BEL:20024308	a(CHEBI:"leukotriene B4") decreases p(MGI:Il12b)	Consistent with the effects of leukotriene antagonists, exogenous LTB(4) enhanced LPS-stimulated IL-10 release by approximately 39% and inhibited IL-12 p40 release by approximately 22%	SEN:10015866	16313356
BEL:20024314	a(CHEBI:"leukotriene B4") directlyIncreases tscript(p(MGI:Ppara))	hypolipidemic fibrates and eicosanoids such as leukotriene B4 and 8(S)-hydroxyeicosatetraenoic acid (8(S)-HETE) are synthetic and natural ligands respectively for PPARa.	SEN:10015870	11852057
BEL:20024316	a(CHEBI:"leukotriene B4") directlyIncreases tscript(p(MGI:Ppara))	Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.	SEN:10000450	16313356
BEL:20024318	a(CHEBI:"linoleic acid") increases tscript(p(MGI:Ppara))	Recently we reported that LPL acts on lipoproteins to generate endogenous PPARa ligand generation and limit inflammation.	SEN:10015872	12878589
BEL:20024326	a(CHEBI:lipid) increases p(MGI:Spp1)	accumulation of fat in hepatocytes is thought to be an important early event in the progression to NASH. Our findings suggest that alterations in hepatocyte metabolism and/or accumulation of microvesicular fat may contribute to the early increase in OPN...We did not observe any significant changes in OPN mRNA levels	SEN:10015878	15044174
BEL:20024328	a(CHEBI:lipid) increases sec(p(MGI:Apob))	increased fatty acid flux to the liver increases apoB secretion in VLDL hyperinsulinemia can acutely inhibit VLDL apoB secretion in normal subjects but not in insulin-resistant subjects	SEN:10015880	12006608
BEL:20024334	a(CHEBI:lipopolysaccharide) increases cat(p(MGI:Mmp9))	(MMP-9) activity in BALFs of LPS-exposed mice was markedly induced compared with control mice (Fig. 3, top; lanes D and E in comparison with lane A; saline-exposed mice),	SEN:10015884	11907182
BEL:20024340	a(CHEBI:lipopolysaccharide) increases cat(p(MGI:Mmp9))	At 24 h post-LPS, unlike TNF-, MMP-9 activity in BAL fluid (Fig. 3B, right) and lung homogenates (Fig. 3C, right) further increased. Pre or posttreatment with PP1 inhibited LPS-induced MMP-9 activity in BAL fluid at 4 and 24 h (by 82 and 96% vs LPS, respectively) (Fig. 3B). Similarly, PP1 inhibited this activity in the lung homogenates by 55 and 43% at 4 and 24 h, respectively (Fig. 3C).	SEN:10015890	17982091
BEL:20024342	a(CHEBI:lipopolysaccharide) increases cat(p(MGI:Nos2))	Because IFN-g is known to induce NOS2, an important mediator of inflammation and host defense, we also analyzed effects of acrolein exposure on LPS-mediated induction of NOS2 (28) and observed a strong trend toward reduced NOS2 expression after acrolein exposure	SEN:10015386	18566440
BEL:20024348	a(CHEBI:lipopolysaccharide) increases cat(p(MGI:Pde4b))	LPS stimulation of mouse peripheral leukocytes induced PDE4B mRNA accumulation and increased PDE4 activity	SEN:10003454	12032334
BEL:20024360	a(CHEBI:lipopolysaccharide) directlyIncreases cat(p(MGI:Tlr4))	LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappaB-dependent pathway	SEN:10000458	17952090
BEL:20024362	a(CHEBI:lipopolysaccharide) directlyIncreases cat(p(MGI:Tlr4))	Lipopolysaccharides (LPS), which activate Toll-like receptor 4 (TLR4), reduced PPARgamma expression and function in peritoneal macrophages and macrophage cell lines	SEN:10015902	18422969
BEL:20024368	a(CHEBI:lipopolysaccharide) increases complex(p(MGI:Myd88),p(MGI:Tlr4))	LPS significantly increased the formation of the TRL4-MyD88 complex compared with control, and this interaction was not blocked by cotreatment with lutein or apocynin (Fig. 5H).	SEN:10015908	18620044
BEL:20024370	a(CHEBI:lipopolysaccharide) increases deg(p(MGI:Nfkbia))	In neutrophils challenged with LPS, IkB-a underwent time-dependent degradation (Fig. 8C). However, in neutrophils incubated with both LPS and H2O2, no degradation of IkB-a was apparent.	SEN:10015754	14656721
BEL:20024372	a(CHEBI:lipopolysaccharide) increases deg(p(MGI:Nfkbia))	To confirm that antioxidants also affected functional, downstream effects of IKK activation, we examined cytoplasmic levels of IkBa in neutrophils treated with LPS alone or with LPS plus NAC or alphaTOC. In neutrophils challenged with LPS, IkBa underwent time-dependent degradation (Fig. 3B). However, in neutrophils incubated with LPS and either antioxidant, no degradation of IkBa was apparent.	SEN:10015356	14764725
BEL:20024378	a(CHEBI:lipopolysaccharide) increases kin(p(MGI:Chuk))	Stimulation of neutrophils with LPS primarily resulted in increased activation of IKKb (Fig. 4A), although late increases in IKKa activity also appeared to be present (Fig. 4B).	SEN:10015910	14764725
BEL:20024380	a(CHEBI:lipopolysaccharide) increases kin(p(MGI:Ikbkb))	Stimulation of neutrophils with LPS primarily resulted in increased activation of IKKb (Fig. 4A), although late increases in IKKa activity also appeared to be present (Fig. 4B).	SEN:10015910	14764725
BEL:20024384	a(CHEBI:lipopolysaccharide) increases kin(p(MGI:Map3k8))	Thus, LPS-stimulated Tpl2(-/-) macrophages express low levels of COX-2 and PGE2, compared with wild-type Tpl2(+/+) cells. {Tpl2 Official Gene Symbol: MAP3K8}	SEN:10015914	12234923
BEL:20024386	a(CHEBI:lipopolysaccharide) increases kin(p(MGI:Mapk1))	Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).	SEN:10015916	18620044
BEL:20024388	a(CHEBI:lipopolysaccharide) increases kin(p(MGI:Mapk3))	Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).	SEN:10015916	18620044
BEL:20024390	a(CHEBI:lipopolysaccharide) increases kin(p(MGI:Ptk2))	Stimulation by LPS resulted in an increasing amount of phosphorylated FAK (Fig. 4A), which was detectable within 5 min and remained elevated for at least 30 min. Similar FAK phosphorylation was obtained after LPS stimulation of human FLSs (Fig. 4B). Thus, LPS induced FAK phosphorylation in murine and human primary cells.	SEN:10015918	15905587
BEL:20024392	a(CHEBI:lipopolysaccharide) increases p(HGNC:CXCL5)	Progesterone, lipopolysaccharide, tumour necrosis factor-alpha, and interleukin-1beta significantly stimulated the expression of ENA-78 by ESC. ....The expression of ENA-78 was also detected in cyclic endometrium by immunohistochemistry.	SEN:10015920	11331668
BEL:20024398	a(CHEBI:lipopolysaccharide) increases p(MGI:Aebp1)	Subsequently, whole cell protein extracts were isolated from LPS-treated J774 macrophages and subjected to SDS-PAGE followed by immunoblotting (Fig. 2A). A histogram illustrating relative protein levels of AEBP1 normalized based on actin expression is shown in Fig. 2B. Clearly, LPS induces AEBP1 expression in J774 macrophages in a time-dependent manner, with maximum induction (?12 folds) 48 h post treatment (Fig.2Aand B)	SEN:10015924	19166963
BEL:20024400	a(CHEBI:lipopolysaccharide) increases p(MGI:Atf2,pmod(P))	where the ability of p38 to phosphorylate the substrate ATF-2 was determined directly. Pre or posttreatment with PP1 had little effect on LPS-induced p38 MAP kinase activation at 4 or 24 h post-LPS, respectively (Fig. 1B).	SEN:10015926	17982091
BEL:20024402	a(CHEBI:lipopolysaccharide) decreases p(MGI:Atf4)	from full text - Despite stable levels of ATF4 mRNA, the incorporation of [35S]methionine-cysteine into ATF4 protein after a 20-min labeling period was markedly reduced when exposure to tunicamycin was preceded by LPS (Fig. 1i). Given the brevity of the labeling period, this observation suggests that LPS affects rates of ATF4 translation and not protein stability.	SEN:10015928	19855386
BEL:20024406	a(CHEBI:lipopolysaccharide) increases p(MGI:Creb1,pmod(P,S,133))	whereas exposure of neutrophils to LPS or TNF-a resulted in increased levels of the transcriptionally active serine 133-phosphorylated form of CREB	SEN:10015930	14656721
BEL:20024408	a(CHEBI:lipopolysaccharide) increases p(MGI:Csf2)	AEC grown on Matrigel:collagen matrix, thereby maintained in the \"classical\" type II phenotype until Day 3 of culture ... similarly expressed and released GM-CSF on LPS stimulation in the coculture and responded to GM-CSF stimulation with enhanced proliferation (Figure E2), further supporting the concept that the proliferative response to GM-CSF is related to the type II AEC phenotype.	SEN:10015932	19590023
BEL:20024410	a(CHEBI:lipopolysaccharide) increases p(MGI:Cxcl1)	4 h after exposure to LPS, which corresponds to the peak in KC levels in our model (43). Intravascular KC levels are increased in PAI-1-deficient mice compared with C57BL/6J wt controls	SEN:10015934	16148154
BEL:20024414	a(CHEBI:lipopolysaccharide) increases p(MGI:Egr1)	In RAW 267.4 mouse macrophages, LPS induced maximum Egr-1 mRNA expression 1 hour after treatment (data not shown). Maximum Egr-1 protein expression and DNA binding activity occurred 2 hours after treatment (data not shown).	SEN:10015938	16037570
BEL:20024416	a(CHEBI:lipopolysaccharide) decreases p(MGI:Elk3)	LPS administration to macrophages led to a dose-dependent decrease in endogenous Elk-3 mRNA levels, and this decrease in Elk-3 preceded the induction of NOS2 mRNA.	SEN:10015940	12896968
BEL:20024422	a(CHEBI:lipopolysaccharide) increases p(MGI:F3)	Addition of LPS strongly increased TF expression, which was significantly suppressed (by 72.7%, 57.1%, and 51.9% after 5, 9, and 15 hr, respectively) (Figure 4B) in cells exposed to CO.	SEN:10015516	16713977
BEL:20024424	a(CHEBI:lipopolysaccharide) increases p(MGI:Hoxc4)	HoxC4 was 'preferentially' expressed in germinal center B cells and was upregulated by engagement of CD40 by CD154, as well as by lipopolysaccharide and interleukin 4.	SEN:10003464	19363484
BEL:20024426	a(CHEBI:lipopolysaccharide) increases p(MGI:Ifng)	LPS-induced production of Th1 cytokines, especially IFN-g, again appeared to be reduced by acrolein exposure (Fig. 6C), although no statistically significant effects were seen on LPS-induced induction of mRNA of these cytokines (data not shown).	SEN:10015388	18566440
BEL:20024428	a(CHEBI:lipopolysaccharide) increases p(MGI:Il10)	As shown in Fig. 2, LPS exposure led to a significant decrease in the IL-10 BALF level. This decrease was significantly reversed by a 30 mg/kg RP 73-401 pretreatment (P 0.05).	SEN:10015944	11907182
BEL:20024430	a(CHEBI:lipopolysaccharide) increases p(MGI:Il10)	A selective inhibitor of leukotriene synthesis MK886 as well as an antagonist of the high affinity LTB(4) receptor (BLT(1)) U-75302 slightly inhibited zymosan-, but not LPS-stimulated interleukin (IL)-10 release from BM-DCs.	SEN:10015862	16313356
BEL:20024432	a(CHEBI:lipopolysaccharide) increases p(MGI:Il10)	After being treated with different concentrations of LPS for 24h, tumor supernatants of LLC cells were obtained and TGFb1 and IL-10 concentrations were detected by ELISA. The results showed that with increasing concentrations of LPS, the levels of TGFb1 and IL-10 protein were also increased	SEN:10015946	24211974
BEL:20024438	a(CHEBI:lipopolysaccharide) increases p(MGI:Il1b)	We further found that LPS stimulation led to both NLRP3 and pro-IL-1b protein induction in a dose- and time-dependent manner (Fig. 3E, F).	SEN:10015948	19570822
BEL:20024440	a(CHEBI:lipopolysaccharide) increases p(MGI:Il1rn)	interleukin 1 receptor antagonist (IL-1ra) is induced in mouse liver after lipopolysaccharide (LPS) or recombinant interleukin 1 (IL-1	SEN:10015950	9112333
BEL:20024444	a(CHEBI:lipopolysaccharide) increases p(MGI:Il6)	LPS stimulation resulted in a significant increase of IL-6 production (approximately 3-fold) in wild-type mice aortas, in agreement with previous observations (26). However, this increase was much greater in aortas isolated from the PPARa 2/2 mice (12-fold, p , 0.03).	SEN:10015954	10542237
BEL:20024446	a(CHEBI:lipopolysaccharide) increases p(MGI:Il6)	A) Increase in IL-6 production from baseline in WT, tlr4/, myd88/, and trif/ alveolar macrophages treated with LPS, BAL fluid from normal control, or BAL fluid from acid-treated WT mice. **p < 0.01. Data are from four separate experiments.	SEN:10015956	18423196
BEL:20024448	a(CHEBI:lipopolysaccharide) increases p(MGI:Il6)	By contrast, LPS-induced IL-6 production in alveolar macrophages was dependent on TLR4, MyD88, and TRIF (Figure 3A).	SEN:10015958	18423196
BEL:20024450	a(CHEBI:lipopolysaccharide) increases p(MGI:Il6)	In vivo production of VEGF and Th1- and Th17-polarizing cytokines (IL-12p70 and IL-6, respectively) were upregulated by airway exposure to LPS.	SEN:10003466	20921519
BEL:20024452	a(CHEBI:lipopolysaccharide) increases p(MGI:Itgam)	PMNs incubated with LOS for 30 min increased surface expression of cyt b558 by 128 ± 40.3%, whereas NFA-treated PMNs showed virtually no increase after LOS (Fig. 5A). CD11b expression was similarly affected (Fig. 5B).	SEN:10015960	17908687
BEL:20024454	a(CHEBI:lipopolysaccharide) increases p(MGI:Jak2,pmod(P,Y))	We used a murine macrophage-like cell line, RAW264.7, to demonstrate that Janus kinase (JAK)2 is tyrosine phosphorylated immediately after LPS stimulation. Anti-Toll-like receptor (TLR)4 neutralization antibody inhibits the phosphorylation of JAK2 and the c-Jun NH2-terminal protein kinase (JNK).	SEN:10015962	12686512
BEL:20024456	a(CHEBI:lipopolysaccharide) increases p(MGI:Lamp1)	In RAW264.7 cells, LPS promoted LAMP1 expression and the maturation of autophagosomes as evidenced by an increase in the co-localization of GFP-LC3 with LAMP1 (Data not shown).	SEN:10015964	17658277
BEL:20024458	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk14,pmod(P,T,180))	Exposure of neutrophils to LPS resulted in persistence of p38 activation that was similar to that produced by H2O2, but the increase in phosphorylated p38 was less rapid, rising above baseline values more than 5 min after LPS was added to the neutrophils.	SEN:10015966	14656721
BEL:20024460	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk14,pmod(P,Y,182))	Exposure of neutrophils to LPS resulted in persistence of p38 activation that was similar to that produced by H2O2, but the increase in phosphorylated p38 was less rapid, rising above baseline values more than 5 min after LPS was added to the neutrophils.	SEN:10015966	14656721
BEL:20024462	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk1,pmod(P,T,183))	Phosphorylation of ERK1/2 after exposure of neutrophils with LPS was only apparent after 20-min incubation and was less intense than that produced by stimulation of neutrophils with H2O2.	SEN:10015968	14656721
BEL:20024464	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk1,pmod(P,Y,185))	Phosphorylation of ERK1/2 after exposure of neutrophils with LPS was only apparent after 20-min incubation and was less intense than that produced by stimulation of neutrophils with H2O2.	SEN:10015968	14656721
BEL:20024466	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk3,pmod(P,T,202))	Phosphorylation of ERK1/2 after exposure of neutrophils with LPS was only apparent after 20-min incubation and was less intense than that produced by stimulation of neutrophils with H2O2.	SEN:10015968	14656721
BEL:20024468	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk3,pmod(P,Y,204))	Phosphorylation of ERK1/2 after exposure of neutrophils with LPS was only apparent after 20-min incubation and was less intense than that produced by stimulation of neutrophils with H2O2.	SEN:10015968	14656721
BEL:20024470	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk8,pmod(P,T,183))	JNK activation induced by LPS only became apparent 20 min after LPS was added to the cells and was of a lesser degree than that induced by H2O2 at all time points.	SEN:10015970	14656721
BEL:20024472	a(CHEBI:lipopolysaccharide) increases p(MGI:Mapk8,pmod(P,Y,185))	JNK activation induced by LPS only became apparent 20 min after LPS was added to the cells and was of a lesser degree than that induced by H2O2 at all time points.	SEN:10015970	14656721
BEL:20024474	a(CHEBI:lipopolysaccharide) increases p(MGI:Mif)	The notion of MIF as a proinflammatory protein was further evaluated using a mouse model of septic shock [28] . After applying LPS, a potent activator of the innate immune system, MIF secretion and production measured by mRNA and protein synthesis increased compared to controls.	SEN:10015972	18791328
BEL:20024478	a(CHEBI:lipopolysaccharide) increases p(MGI:Mmp9)	PP1 was also observed to have an inhibitory effect on MMP-9 expression in BAL fluid at 4 and 24 h (Fig. 3D, upper and lower).	SEN:10015976	17982091
BEL:20024482	a(CHEBI:lipopolysaccharide) increases p(MGI:Muc5ac)	Pseudomonas LPS induced MUC5AC expression, associated with neutrophil infiltration (359), and metalloproteinase (MMP)-9 expression (152).	SEN:10015978	17615396
BEL:20024484	a(CHEBI:lipopolysaccharide) increases p(MGI:Nfkbia,pmod(P,S,32))	RAW264.7 cells treated with LPS promoted the phosphorylation of the serine 32 residue of IkBa and its subsequent degradation, and these increases were attenuated by cotreatment with lutein (Fig. 4A).	SEN:10015980	18620044
BEL:20024486	a(CHEBI:lipopolysaccharide) increases p(MGI:Nos2)	A basal expression of NOS II mRNA and protein was detected in skeletal muscle from untreated wild-type mice; expression increased when mice were treated with bacterial lipopolysaccharide (LPS).	SEN:10003470	10359657
BEL:20024488	a(CHEBI:lipopolysaccharide) increases p(MGI:Nos2)	A significant dose-dependent increase in the inducible nitric oxide synthase (NOS2) expression and NO production were observed by various concentrations of TNF-alpha (1, 5, and 10 ng/mL) and LPS (1 and 5 microg/mL) which was completely inhibited by a NOS2 inhibitor, L-N6-(1-iminoethyl) lysine (L-NIL) (1 mM).	SEN:10003472	17588258
BEL:20024490	a(CHEBI:lipopolysaccharide) decreases p(MGI:Nr1h3)	As shownin Fig.2Aand B, LPS-inducedup-regulation of AEBP1 expression is accompanied by significant inhibition of PPAR1 and LXR expression where their levels drop by 5 and 3 folds, respectively, 24 h post LPS treatment.	SEN:10015982	19166963
BEL:20024494	a(CHEBI:lipopolysaccharide) decreases p(MGI:Pparg)	The LPS reduced both PPAR? mRNA and protein in a concentration-dependent and time-dependent manner.	SEN:10015986	18422969
BEL:20024496	a(CHEBI:lipopolysaccharide) decreases p(MGI:Pparg)	As shownin Fig.2Aand B, LPS-inducedup-regulation of AEBP1 expression is accompanied by significant inhibition of PPAR1 and LXR expression where their levels drop by 5 and 3 folds, respectively, 24 h post LPS treatment.	SEN:10015982	19166963
BEL:20024504	a(CHEBI:lipopolysaccharide) increases p(MGI:Src,pmod(P,Y,418))	The phosphorylation of c-Src in lung tissue was found to be enhanced by 2.1-fold 4 h after LPS treatment (post-LPS) (Fig. 1A, left). The level of phosphorylation of this kinase was slightly decreased 24 h post-LPS (Fig. 1A, right).	SEN:10015994	17982091
BEL:20024506	a(CHEBI:lipopolysaccharide) increases p(MGI:Srf)	In contrast, there was weak induction of SRF expression after 15 minutes LPS stimulation, which was not inhibited by IL-10 pretreatment (Figure 6B).	SEN:10015996	16037570
BEL:20024508	a(CHEBI:lipopolysaccharide) increases p(MGI:Tgfb1)	Similarly, LPS exposure induced a significant enhancement in the TGF- level in BALFs compared with saline-exposed mice (Fig. 4). This increase was significantly attenuated by a 30 mg/kg RP 73-401 pretreatment.	SEN:10015998	11907182
BEL:20024510	a(CHEBI:lipopolysaccharide) increases p(MGI:Tgfb1)	After being treated with different concentrations of LPS for 24h, tumor supernatants of LLC cells were obtained and TGFb1 and IL-10 concentrations were detected by ELISA. The results showed that with increasing concentrations of LPS, the levels of TGFb1 and IL-10 protein were also increased	SEN:10015946	24211974
BEL:20024514	a(CHEBI:lipopolysaccharide) increases p(MGI:Tlr4)	The results indicated that the expression of TLR4 protein in 10 g/mL of LPS group was significantly enhanced compared with untreated group (P < 0.05), as shown in Fig.4.	SEN:10016002	24211974
BEL:20024518	a(CHEBI:lipopolysaccharide) increases p(MGI:Tnf)	The TNF-a level was markedly increased after LPS challenge compared with saline-exposed mice (P 0.05). This increase was significantly and dose-dependently reduced when LPS-exposed mice were pretreated by RP 73-401 (1–30 mg/kg).	SEN:10016004	11907182
BEL:20024520	a(CHEBI:lipopolysaccharide) increases p(MGI:Tnf)	A profound BAL neutrophilia and impressive levels of BAL TNF were noted 6 h after LPS administration to transgene () mice (Fig. 2). IL-10 inhibited these responses in an impressive fashion.	SEN:10016006	12107190
BEL:20024522	a(CHEBI:lipopolysaccharide) increases p(MGI:Tnf)	Further evidence comes from in vitro studies using peritoneal macrophages stimulated with LPS that show an induction of the proinflammatory cytokine TNF- (23).	SEN:10016008	17601796
BEL:20024524	a(CHEBI:lipopolysaccharide) increases p(MGI:Tnf)	As shown in Fig. 3A, at 4 or 24 h post-LPS, TNF- levels increased 71- and 7.6-fold that of the saline treated controls, respectively. Moreover, these increases were significantly reduced by the pre or posttreatment with PP1 at 4 or 24 h post-LPS (by 71 and 81% vs LPS, respectively, p 0.05).	SEN:10016010	17982091
BEL:20024530	a(CHEBI:lipopolysaccharide) increases p(MGI:Vegfa)	In vivo production of VEGF and Th1- and Th17-polarizing cytokines (IL-12p70 and IL-6, respectively) were upregulated by airway exposure to LPS.	SEN:10003466	20921519
BEL:20024532	a(CHEBI:lipopolysaccharide) increases sec(p(HGNC:CSF2))	In PBMC, LPS significantly induced G-CSF and interleukin (IL)-1, an inducer of G-CSF. Both were partly inhibited by IL-4, IL-6 and IL-10.	SEN:10003474	10564547
BEL:20024534	a(CHEBI:lipopolysaccharide) increases sec(p(HGNC:IL10))	In smokers and in controls, LPS increased the release of both TNF-alpha and IL-10 (Figure 4), with the increase in TNF-alpha being greater than the increase in IL-10. IL-1beta had no effect on TNF-alpha and IL-10 levels in smokers, whereas in nonsmokers this cytokine increased the production of TNF-alpha but not that of IL-10, although TNF-alpha levels remained very low.	SEN:10016016	11029344
BEL:20024536	a(CHEBI:lipopolysaccharide) increases sec(p(HGNC:TNF))	In smokers and in controls, LPS increased the release of both TNF-alpha and IL-10 (Figure 4), with the increase in TNF-alpha being greater than the increase in IL-10. IL-1beta had no effect on TNF-alpha and IL-10 levels in smokers, whereas in nonsmokers this cytokine increased the production of TNF-alpha but not that of IL-10, although TNF-alpha levels remained very low.	SEN:10016016	11029344
BEL:20024538	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Cxcl2))	As expected, concentrations of TNF-a, IL-1b, and MIP-2 were increased in supernatants of neutrophils stimulated with LPS (Fig. 2).	SEN:10016018	14764725
BEL:20024540	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Il1b))	As expected, concentrations of TNF-a, IL-1b, and MIP-2 were increased in supernatants of neutrophils stimulated with LPS (Fig. 2).	SEN:10016018	14764725
BEL:20024542	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Il1b))	he most effective in vitro concentration of 1 mg/ml is less than the normal plasma concentration of A1AT, and thus is probably achievable locally (i.e., microscopically) in areas of cigarette smoke–induced leakage of plasma (15, 16) into the lung. Fairly similar concentrations have been shown to inhibit LPS-induced TNF-{alpha} and IL-1beta release (10).	SEN:10016020	17395890
BEL:20024544	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Il6))	Our analyses using epiregulin-deficient mice with mixed and inbred genetic backgrounds revealed that epiregulin deficiency results in the reduction of IL-6 production levels in both cell types upon peptidoglycan stimulation, and that the extent of this reduction is more evident under the BALB/c background compared with the C57BL/6J background.	SEN:10003476	16182244
BEL:20024546	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Lrp1))	In this study, we show that LPS and IFN-G induce shedding of LRP1 from RAW 264.7 cells and BMMs in vitro.	SEN:10016022	20610799
BEL:20024548	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Mif))	Since macrophages activated by lipopolysaccharide, tumor necrosis factor (TNF)-?, and interferon-? have been shown to secret substantial amounts of preformed MIF [17], it is reasonable to assume that macrophage-derived MIF could be involved in atherogenesis.	SEN:10016024	18385967
BEL:20024550	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Mif))	The notion of MIF as a proinflammatory protein was further evaluated using a mouse model of septic shock [28] . After applying LPS, a potent activator of the innate immune system, MIF secretion and production measured by mRNA and protein synthesis increased compared to controls.	SEN:10015972	18791328
BEL:20024558	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Tnf))	LPS induction of tumor necrosis factor-alpha secretion by circulating leukocytes was decreased by approximately 90% in mice deficient in PDE4B but not in mice lacking PDE4D	SEN:10003478	12032334
BEL:20024562	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Tnf))	neutrophils stimulated with LPS demonstrated increased TNF-a secretion (Fig. 6A). The response was significantly attenuated by concurrent incubation of neutrophils with H2O2.	SEN:10015758	14656721
BEL:20024564	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Tnf))	As expected, concentrations of TNF-a, IL-1b, and MIP-2 were increased in supernatants of neutrophils stimulated with LPS (Fig. 2).	SEN:10016018	14764725
BEL:20024566	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Tnf))	he most effective in vitro concentration of 1 mg/ml is less than the normal plasma concentration of A1AT, and thus is probably achievable locally (i.e., microscopically) in areas of cigarette smoke–induced leakage of plasma (15, 16) into the lung. Fairly similar concentrations have been shown to inhibit LPS-induced TNF-{alpha} and IL-1beta release (10).	SEN:10016020	17395890
BEL:20024572	a(CHEBI:lipopolysaccharide) increases sec(p(MGI:Ucn))	In addition, the secretion of Ucn I from HL-1 cardiomyocytes was stimulated by LPS and TNF-alpha.	SEN:10016036	19318426
BEL:20024574	a(CHEBI:lipopolysaccharide) increases tloc(p(MGI:Nfkb1),GOCCID:0005737,GOCCID:0005634)	The results indicate that unstimulated RAW264.7 cells express low constitutive levels of nuclear NF-nB p50 and p65 (Fig. 3). As expected, LPS was a powerful inducer of both p50 and p65 nuclear localization.	SEN:10016038	12757742
BEL:20024576	a(CHEBI:lipopolysaccharide) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	The results indicate that unstimulated RAW264.7 cells express low constitutive levels of nuclear NF-nB p50 and p65 (Fig. 3). As expected, LPS was a powerful inducer of both p50 and p65 nuclear localization.	SEN:10016038	12757742
BEL:20024578	a(CHEBI:lipopolysaccharide) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	LPS treatment decreased the cytosolic p65 subunit level, resulting in an increase in the nuclear p65 level, while this subunit was located mainly in the cytoplasm of control cells (Figs. 3B and C).	SEN:10016040	18620044
BEL:20024582	a(CHEBI:lipopolysaccharide) increases tscript(p(MGI:Cebpb))	Treatment of cells with C2 notably increased LPS-inducible CCAAT/enhancer binding protein (C/EBP) DNA binding	SEN:10003480	12606757
BEL:20024586	a(CHEBI:lipopolysaccharide) increases tscript(p(MGI:Egr1))	In RAW 267.4 mouse macrophages, LPS induced maximum Egr-1 mRNA expression 1 hour after treatment (data not shown). Maximum Egr-1 protein expression and DNA binding activity occurred 2 hours after treatment (data not shown).	SEN:10015938	16037570
BEL:20024588	a(CHEBI:lipopolysaccharide) increases tscript(p(MGI:Elk1))	Phosphorylation of Elk-1 after LPS treatment was induced in a time-dependent manner,showing maximum phosphorylation after 30 minutes (data not shown).	SEN:10016044	16037570
BEL:20024590	a(CHEBI:lipopolysaccharide) increases tscript(p(MGI:Elk1))	Because LPS induces Egr-1 activation via phosphorylation of the transcription factor Elk-1 (Guha et al., 2001), we investigated whether PPARgamma modulates LPS-induced Elk-1 phosphorylation. Phosphorylation of Elk-1 was barely detectable in untreated cells; addition of LPS resulted in a rapid increase in nuclear Elk-1 phosphorylation. This increase was inhibited an average of 36% in the presence of CO (Figures 3A?3C).	SEN:10015518	16713977
BEL:20024594	a(CHEBI:lipopolysaccharide) increases tscript(p(MGI:Maz))	Serum amyloid A-activating factor-1 (SAF-1) is a zinc finger transcription factor that is activated by many mediators of inflammation including IL-1, IL-6, and bacterial LPS.	SEN:10003486	11490023
BEL:20024596	a(CHEBI:lipopolysaccharide) decreases tscript(p(MGI:Nr1h2))	Nuclear hormone receptors that heterodimerize with retinoid X receptor (RXR), such as thyroid receptors, peroxisome proliferator-activated receptors, and liver X receptors, modulate lipid metabolism. We recently demonstrated that these nuclear hormone receptors are repressed during the acute phase response induced by lipopolysaccharide (LPS), consistent with the known decreases in genes that they regulate.	SEN:10016046	12519762
BEL:20024598	a(CHEBI:lipopolysaccharide) decreases tscript(p(MGI:Nr1h3))	Nuclear hormone receptors that heterodimerize with retinoid X receptor (RXR), such as thyroid receptors, peroxisome proliferator-activated receptors, and liver X receptors, modulate lipid metabolism. We recently demonstrated that these nuclear hormone receptors are repressed during the acute phase response induced by lipopolysaccharide (LPS), consistent with the known decreases in genes that they regulate.	SEN:10016046	12519762
BEL:20024600	a(CHEBI:lipopolysaccharide) decreases tscript(p(MGI:Ppara))	Nuclear hormone receptors that heterodimerize with retinoid X receptor (RXR), such as thyroid receptors, peroxisome proliferator-activated receptors, and liver X receptors, modulate lipid metabolism. We recently demonstrated that these nuclear hormone receptors are repressed during the acute phase response induced by lipopolysaccharide (LPS), consistent with the known decreases in genes that they regulate.	SEN:10016046	12519762
BEL:20024602	a(CHEBI:lipopolysaccharide) decreases tscript(p(MGI:Pparg))	Nuclear hormone receptors that heterodimerize with retinoid X receptor (RXR), such as thyroid receptors, peroxisome proliferator-activated receptors, and liver X receptors, modulate lipid metabolism. We recently demonstrated that these nuclear hormone receptors are repressed during the acute phase response induced by lipopolysaccharide (LPS), consistent with the known decreases in genes that they regulate.	SEN:10016046	12519762
BEL:20024608	a(CHEBI:lipopolysaccharide) decreases tscript(p(MGI:Rxra))	We sought to determine if Rosiglitazone (Rosi), a peroxisome proliferator activated receptor gamma (PPARgamma) agonist with anti-inflammatory properties, can attenuate LPS and cytokine-induced molecular suppression of RXRalpha-regulated genes	SEN:10003488	17107731
BEL:20024610	a(CHEBI:lipopolysaccharide) increases tscript(p(MGI:Smad2))	Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine	SEN:10002864	15972691
BEL:20024612	a(CHEBI:lipopolysaccharide) increases tscript(p(MGI:Smad3))	Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine	SEN:10002864	15972691
BEL:20024614	a(CHEBI:"lipoteichoic acid") directlyIncreases cat(p(MGI:Tlr2))	In vitro, the TLR2 agonist lipoteichoic acid (LTA) down-regulated CXCR2 expression and markedly inhibited the neutrophil chemotaxis and actin polymerization induced by CXCL2.	SEN:10003490	19234125
BEL:20024616	a(CHEBI:"lipoteichoic acid") increases p(MGI:Adrbk1)	We found significant up-regulation of GRK2 protein expression in LTA-treated neutrophils compared with control cells (Fig. 5 C and D).	SEN:10016050	19234125
BEL:20024622	a(CHEBI:"lithocholic acid") increases tscript(p(MGI:Nr1i2))	and the secondary bile acid, lithocholic acid and its metabolite 3-keto-lithocholic acid as activators of Pxr	SEN:10000256	11792716
BEL:20024624	a(CHEBI:losartan) decreases cat(p(MGI:Casp3))	Co-administration of LOS abrogated BLEO-induced increases in total lung caspase 3 activity detected 6 hours after in vivo administration and reduced by 57% BLEO-induced caspase 3 activity in blood-depleted lung explants exposed to BLEO ex vivo (both P < 0.05).	SEN:10016056	14633624
BEL:20024626	a(CHEBI:losartan) increases sec(p(MGI:Adipoq))	telmisartan, and to a lesser extent, losartan, increased production and secretion of adiponectin from 3T3-L1 adipocytes compared to the other antihypertensive drugs	SEN:10003492	19730415
BEL:20024630	a(CHEBI:lovastatin) increases cat(p(HGNC:PARP1))	Lovastatin also stimulated proteolytic cleavage of poly-(ADP-ribose) polymerase (PARP), and followed by the appearance of caspase activity and DNA fragmentation.	SEN:10016060	10728920
BEL:20024646	a(CHEBI:melatonin) increases tscript(p(HGNC:RORA))	An electrophoretic mobility shift assay showed that melatonin stimulates the DNA-binding activity of activator protein-1 (AP-1) as well as retinoid Z receptor/retinoid receptor-related orphan receptor alpha (RZR/RORalpha).	SEN:10016068	10515588
BEL:20024664	a(CHEBI:mifepristone) decreases tscript(p(MGI:Pgr))	Treatment with RU486, a progesterone receptor antagonist, blocked progesterone-induced galectin-1 mRNA level in uterine tissues of ovariectomized mouse.	SEN:10000022	9291476
BEL:20024670	a(CHEBI:"N-acetylsphingosine") increases tscript(p(MGI:Cebpb))	In LPS-treated cells, C2 enhanced both the nuclear translocation and the expression of LPS-inducible C/EBP beta with an increase in AP-1 DNA binding activity.	SEN:10003502	12606757
BEL:20024682	a(CHEBI:nicotine) increases p(HGNC:FAS)	In addition, we found that in vitro brief treatment with nicotine induces and/or enhances FasL mRNA and protein expression of lymphocytes from normal donors without smoking.	SEN:10003504	10066346
BEL:20024696	a(CHEBI:"nitric oxide") increases cat(p(MGI:Bak1))	To determine if BAX and BAK are activated in response to NO, wild type MEFs were treated with DETA-NO for 24 hours and BAX and BAK activation was determined using antibodies that specifically recognize the activated form of these proteins [20], [23]. Indeed, BAX and BAK are activated in response to NO treatment indicating that both of these proteins regulate NO-mediated apoptosis (Figure 1E/FFigure 1).	SEN:10016094	19768117
BEL:20024698	a(CHEBI:"nitric oxide") increases cat(p(MGI:Bax))	To determine if BAX and BAK are activated in response to NO, wild type MEFs were treated with DETA-NO for 24 hours and BAX and BAK activation was determined using antibodies that specifically recognize the activated form of these proteins [20], [23]. Indeed, BAX and BAK are activated in response to NO treatment indicating that both of these proteins regulate NO-mediated apoptosis (Figure 1E/FFigure 1).	SEN:10016094	19768117
BEL:20024700	a(CHEBI:"nitric oxide") increases deg(p(MGI:Irs1))	Here we demonstrate that exposure to NO donor or iNOS transfection reduced insulin receptor substrate (IRS)-1 protein expression without altering the mRNA level in cultured skeletal muscle cells. NO donor increased IRS-1 ubiquitination, and proteasome inhibitors blocked NO donor-induced reduction in IRS-1 expression in cultured skeletal muscle cells.	SEN:10003508	15805118
BEL:20024702	a(CHEBI:"nitric oxide") decreases kin(p(HGNC:MAPK1))	NO modulation of the signaling pathway was shown by its inhibitory effect on shear stress-induced ERK1/ERK2 phosphorylation and activity.	SEN:10003510	10436166
BEL:20024704	a(CHEBI:"nitric oxide") decreases kin(p(HGNC:MAPK3))	NO modulation of the signaling pathway was shown by its inhibitory effect on shear stress-induced ERK1/ERK2 phosphorylation and activity.	SEN:10003510	10436166
BEL:20024712	a(CHEBI:"nitric oxide") increases kin(p(MGI:Mapk8))	To determine if NO activates JNK upstream of BAX and BAK, we treated Bax?/?/Bak?/? MEFs with DETA-NO and assessed JNK activity by measuring expression of phoshpo-cJun, a downstream target of JNK. NO activates JNK as early as 8 hours after exposure to NO, and this activation was sustained to 24 hours (Figure 6AFigure 6).	SEN:10016100	19768117
BEL:20024714	a(CHEBI:"nitric oxide") directlyIncreases kin(p(MGI:Src))	These results suggest that the NO/N(2)O(3)-provoked S-nitrosylation/S-S bond formation destabilizes the Src structure for Tyr-416 autophosphorylation-associated activation	SEN:10003512	10464322
BEL:20024728	a(CHEBI:"nitric oxide") increases p(MGI:Jun,pmod(P))	To determine if NO activates JNK upstream of BAX and BAK, we treated Bax?/?/Bak?/? MEFs with DETA-NO and assessed JNK activity by measuring expression of phoshpo-cJun, a downstream target of JNK. NO activates JNK as early as 8 hours after exposure to NO, and this activation was sustained to 24 hours (Figure 6AFigure 6).	SEN:10016100	19768117
BEL:20024732	a(CHEBI:"nitric oxide") decreases p(MGI:Thbs1)	The addition of an NO donor prevented the glucose-dependent increase in TSP1 mRNA, protein, and TGF-beta bioactivity.	SEN:10003514	11784717
BEL:20024738	a(CHEBI:"nitric oxide") decreases tscript(p(MGI:Hnrnpab))	S-nitrosylation of hnRNP inhibits its activity as a constitutive repressor of the OPN promoter and results in enhanced OPN expression.	SEN:10003516	14722087
BEL:20024740	a(CHEBI:nocodazole) increases tloc(p(MGI:Stk16),GOCCID:0005794,GOCCID:0005634)	When cells were treated with brefeldin A (BFA) or nocodazole, drugs that promote Golgi disorganization, we observed STK16 translocation to the nuclear compartment.	SEN:10003304	16310770
BEL:20024746	a(CHEBI:octreotide) decreases p(MGI:Gh)	Administration of the somatostatin analogue octreotide to pituitary intact rats in a manner previously shown to acutely suppress the GH/IGF-I axis, up-regulated mammary gland MDGI expression	SEN:10003520	9683796
BEL:20024748	a(CHEBI:octreotide) decreases p(MGI:Igf1)	Administration of the somatostatin analogue octreotide to pituitary intact rats in a manner previously shown to acutely suppress the GH/IGF-I axis, up-regulated mammary gland MDGI expression	SEN:10003520	9683796
BEL:20024750	a(CHEBI:octreotide) decreases sec(p(MGI:Gh))	A potent, long-acting somatostatin octapeptide analog which has a wide range of physiological actions. It inhibits growth hormone secretion,	SEN:10016116	9683796
BEL:20024756	a(CHEBI:"okadaic acid") decreases phos(p(MGI:Ptpn14))	On the contrary, when the dephosphorylation of PTP36 was inhibited by okadaic acid, no translocation of PTP36 was induced by the cell detachment	SEN:10016120	10400706
BEL:20024758	a(CHEBI:"okadaic acid") increases p(MGI:Mmp9)	OA (40 nmol·L?1) increased MMP-9 protein and on combination with isoprenaline, this effect was inhibited (P < 0.05; Figure 2C).	SEN:10016122	21718298
BEL:20024762	a(CHEBI:"okadaic acid") increases p(MGI:Myl9,pmod(P))	Okadaic acid, a protein phosphatase inhibitor, induced a delayed but massive cell shortening preceded by a large increase in MHC and LC20 phosphorylation.	SEN:10016124	1421576
BEL:20024764	a(CHEBI:"okadaic acid") increases p(MGI:Ptpn14,pmod(P,S))	On the contrary, when the dephosphorylation of PTP36 was inhibited by okadaic acid, no translocation of PTP36 was induced by the cell detachment	SEN:10016120	10400706
BEL:20024768	a(CHEBI:"okadaic acid") decreases tloc(p(MGI:Ptpn14),GOCCID:0005856,GOCCID:0005737)	On the contrary, when the dephosphorylation of PTP36 was inhibited by okadaic acid, no translocation of PTP36 was induced by the cell detachment	SEN:10016120	10400706
BEL:20024780	a(CHEBI:oxysterol) decreases tscript(p(MGI:Srebf2))	oxysterols selectively suppress the nuclear levels of Srebp2, as compared to Srebbp1 as a result, Srebp2-dependent genes are repressed by oxysterols whereas hepatic Srebp1c-dependent genes are activated	SEN:10000258	11792716
BEL:20024790	a(CHEBI:paclitaxel) increases cat(p(MGI:Tlr4))	The expression of MD-2, which associates with Toll-like receptor (TLR) 4 on the cell surface, confers LPS and LPS-mimetic Taxol responsiveness on TLR4.	SEN:10003528	12496426
BEL:20024804	a(CHEBI:"palmitic acid") decreases sec(p(MGI:Lpl))	our results on the effects of PPAR on reduction of macrophage LPL secretion and activity appear in contrast with previous observations published while this work was in progress [46], demonstrating an increase of extra- and intracellular LPL mass and activity in murine J774 macrophages after treatment with natural fatty acid-derived PPAR activators, such as palmitic acid, stearic acid and linoleic acid	SEN:10016138	11852057
BEL:20024818	a(CHEBI:peptidoglycan) increases complex(p(MGI:Cebpa),p(MGI:Elk1))	C/EBPa expression in Elk-1 antibody-immunoprecipitated proteins was also increased after PGN (Fig. 8A, lanes 1 and 2), but no expression was evident in the rabbit IgG and negative control immunoprecipitates (Fig. 8A, lanes 3 and 4).	SEN:10016146	20348279
BEL:20024820	a(CHEBI:peptidoglycan) increases p(MGI:Cebpa)	C/EBPa expression in the cell extracts, before IP, was increased after exposure to PGN (Fig. 8A, lanes 5 and 6).	SEN:10016148	20348279
BEL:20024822	a(CHEBI:peptidoglycan) increases p(MGI:Hmox1)	We found that PGN increased HO-1 protein and mRNA levels in a dose-dependent manner (with a dose as low as 0.5 ug/ml and up to 5 ug/ml, data not shown) in mouse macrophages (RAW 264.7 cells).	SEN:10016150	20348279
BEL:20024824	a(CHEBI:peptidoglycan) increases sec(p(MGI:Il6))	Our analyses using epiregulin-deficient mice with mixed and inbred genetic backgrounds revealed that epiregulin deficiency results in the reduction of IL-6 production levels in both cell types upon peptidoglycan stimulation, and that the extent of this reduction is more evident under the BALB/c background compared with the C57BL/6J background.	SEN:10003476	16182244
BEL:20024826	a(CHEBI:peptidoglycan) increases tscript(p(MGI:Cebpa))	This revealed that the C/EBPa antibody disrupted the 3rd DNAprotein complex (Fig. 7C, “”) and supershifted the complex (Fig. 7C, arrow), whereas rabbit IgG had no effect. These results indicated that the binding of C/EBPa to the C/EBP binding site on the HO-1 promoter is specific and increased by PGN.	SEN:10016152	20348279
BEL:20024828	a(CHEBI:peptidoglycan) increases tscript(p(MGI:Elk1))	In the presence of PGN (Fig. 5, filled bars), Elk-1 and Ets-2 further increased HO-1 promoter activity by 12.2- and 7.5-fold, respectively, compared with baseline pCI control (P 0.05; Fig. 5A).	SEN:10016154	20348279
BEL:20024830	a(CHEBI:peptidoglycan) increases tscript(p(MGI:Ets2))	In the presence of PGN (Fig. 5, filled bars), Elk-1 and Ets-2 further increased HO-1 promoter activity by 12.2- and 7.5-fold, respectively, compared with baseline pCI control (P 0.05; Fig. 5A).	SEN:10016154	20348279
BEL:20024836	a(CHEBI:peroxynitrite) increases cat(p(MGI:Bdnf))	Several receptor tyrosine kinases exhibit stimulated activity upon peroxynitrite exposure, triggering downstream phosphotyrosine-dependent signalling, as shown for the platelet-derived growth factor receptor (PDGFR) and the receptor for brain-derived neurotrophic factor (TrkB) in murine fibroblasts (24,25), as well as the Epidermal Growth Factor Receptor (EGFR) in rat lung myofibroblasts (26).	SEN:10016158	19273391
BEL:20024838	a(CHEBI:peroxynitrite) increases kin(p(MGI:Mapk8))	Peroxynitrite-mediated JNK activation has been associated with apoptotic cell death in murine alveolar C10 cells, in which JNK was activated upon the oxidation of the death receptor Fas.	SEN:10016160	19273391
BEL:20024840	a(CHEBI:peroxynitrite) decreases p(MGI:Irs1)	Nomiyama et al, who reported that peroxynitrite inhibited insulin-stimulated glucose uptake in preadipocyte-derived 3T3-L1 cells by reducing insulin receptor substrate-1 (IRS-1) protein levels and associated PI3K activity, upstream of Akt/PKB (122).	SEN:10016162	19273391
BEL:20024846	a(CHEBI:phenobarbital) increases tscript(p(MGI:Nr1i3))	induction of Mrp2 by phenobarbital, an activator of Car, was comparable in wild-type and Pxr null mice	SEN:10016166	11706036
BEL:20024848	a(CHEBI:phenobarbital) increases tscript(p(MGI:Nr1i3))	CAR activators [phenobarbital, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, and diallyl sulfide] decreased Oatp1a1 mRNA expression.	SEN:10016168	15919853
BEL:20024852	a(CHEBI:pioglitazone) decreases deg(p(MGI:Ctnnb1))	In PIO-treated embryos, the levels of beta-catenin and c-MYC in the kidneys at E16.5 were similar in Pkd1-/- and wild-type	SEN:10016170	12095915
BEL:20024854	a(CHEBI:pioglitazone) decreases deg(p(MGI:Myc))	In PIO-treated embryos, the levels of beta-catenin and c-MYC in the kidneys at E16.5 were similar in Pkd1-/- and wild-type	SEN:10016170	12095915
BEL:20024872	a(CHEBI:"pirinixic acid") decreases complex(p(MGI:Nr1h2),p(MGI:Rxra))	in the liver nuclei, addition of Ppara agonist enhanced binding of Ppara to Rxr, decreased the amount of Lxr/Rxr heterodimers, leading to suppression of Lxr ligand-activated Srebf1c expresssion	SEN:10016186	12730331
BEL:20024874	a(CHEBI:"pirinixic acid") decreases complex(p(MGI:Nr1h3),p(MGI:Rxra))	in the liver nuclei, addition of Ppara agonist enhanced binding of Ppara to Rxr, decreased the amount of Lxr/Rxr heterodimers, leading to suppression of Lxr ligand-activated Srebf1c expresssion	SEN:10016186	12730331
BEL:20024876	a(CHEBI:"pirinixic acid") increases complex(p(MGI:Ppara),p(MGI:Rxra))	in the liver nuclei, addition of Ppara agonist enhanced binding of Ppara to Rxr, decreased the amount of Lxr/Rxr heterodimers, leading to suppression of Lxr ligand-activated Srebf1c expresssion	SEN:10016186	12730331
BEL:20024882	a(CHEBI:"pirinixic acid") directlyIncreases tscript(p(MGI:Ppara))	Two peroxisome proliferator-activated receptor a agonsists: Wy-14643 and a marketed fribrate drug, fenofibrate	SEN:10015678	11798191
BEL:20024884	a(CHEBI:"pirinixic acid") increases tscript(p(MGI:Ppara))	In addition to its activation in response to peroxisome proliferators such as Wy14,643, Ppara is also activated by a variety of medium and long-chain fatty acids and has been shown to stimulate lipid metabolism by teh induction of peroxisomal B-oxidation and faty acid w-hydroxylation.	SEN:10016192	11867749
BEL:20024900	a(CHEBI:"polyunsaturated fatty acid") decreases p(HGNC:F3)	dietary intake of PUFAs in humans reduces TF activity in unstimulated and LPS-stimulated monocytes.13	SEN:10016196	11208679
BEL:20024916	a(CHEBI:progesterone) increases p(HGNC:CXCL5)	Progesterone, lipopolysaccharide, tumour necrosis factor-alpha, and interleukin-1beta significantly stimulated the expression of ENA-78 by ESC. ....The expression of ENA-78 was also detected in cyclic endometrium by immunohistochemistry.	SEN:10015920	11331668
BEL:20024918	a(CHEBI:progesterone) decreases tport(p(MGI:Abcb1a))	multiple drug resistance P-glycoproteins are plasma membrane proteins implicated in the movement of drugs and lipids across membranes their functions are inhibited by progesterone, which has been shown to alter cellular cholesterol homeostasis and has implicated P-glycoproteins in the movement of cholesterol to the endoplasmic reticulum	SEN:10016204	11984826
BEL:20024922	a(CHEBI:"prostaglandin D2") decreases p(MGI:Adipoq)	PGD(2) induced a reduction in adiponectin and leptin mRNA, and the secretion of these adipokines was also inhibited, the effect being greater with leptin (up to 10-fold) than with adiponectin (twofold).	SEN:10003554	16924534
BEL:20024924	a(CHEBI:"prostaglandin D2") decreases p(MGI:Lep)	PGD(2) induced a reduction in adiponectin and leptin mRNA, and the secretion of these adipokines was also inhibited, the effect being greater with leptin (up to 10-fold) than with adiponectin (twofold).	SEN:10003554	16924534
BEL:20024926	a(CHEBI:"prostaglandin D2") increases sec(p(MGI:Ccl2))	In contrast, PGD(2) induced a marked stimulation of IL-6 and MCP-1 expression; with IL-6, this was rapid, the mRNA level increasing by >50-fold by 1 h. The rise in mRNA was accompanied by an increase in IL-6 and MCP-1 release (up to 100- and 6.5-fold, respectively).	SEN:10016206	16924534
BEL:20024928	a(CHEBI:"prostaglandin D2") increases sec(p(MGI:Il6))	In contrast, PGD(2) induced a marked stimulation of IL-6 and MCP-1 expression; with IL-6, this was rapid, the mRNA level increasing by >50-fold by 1 h. The rise in mRNA was accompanied by an increase in IL-6 and MCP-1 release (up to 100- and 6.5-fold, respectively).	SEN:10016206	16924534
BEL:20024930	a(CHEBI:"prostaglandin G2") increases tscript(p(MGI:Pparg))	PGD2 metabolites inhibit NF-B (224–226) and IKK2 (227), and activate peroxisome proliferator-activated receptor (PPAR) (228), reducing inflammatory response.	SEN:10016208	16046792
BEL:20024938	a(CHEBI:quinidine) decreases p(HGNC:CCND1)	Quinidine-treated MCF-7 cells showed elevated p21(WAF1), hypophosphorylation and suppression of retinoblastoma protein, and down-regulation of cyclin D1, similar to the cell cycle response observed with cells induced to differentiate by histone deacetylase inhibitors, trichostatin A, and trapoxin.	SEN:10016214	10938272
BEL:20024940	a(CHEBI:quinidine) increases p(HGNC:CDKN1A)	Quinidine-treated MCF-7 cells showed elevated p21(WAF1), hypophosphorylation and suppression of retinoblastoma protein, and down-regulation of cyclin D1, similar to the cell cycle response observed with cells induced to differentiate by histone deacetylase inhibitors, trichostatin A, and trapoxin.	SEN:10016214	10938272
BEL:20024942	a(CHEBI:quinidine) decreases p(HGNC:RB1)	Quinidine-treated MCF-7 cells showed elevated p21(WAF1), hypophosphorylation and suppression of retinoblastoma protein, and down-regulation of cyclin D1, similar to the cell cycle response observed with cells induced to differentiate by histone deacetylase inhibitors, trichostatin A, and trapoxin.	SEN:10016214	10938272
BEL:20024944	a(CHEBI:quinidine) decreases p(HGNC:RB1,pmod(P))	Quinidine-treated MCF-7 cells showed elevated p21(WAF1), hypophosphorylation and suppression of retinoblastoma protein, and down-regulation of cyclin D1, similar to the cell cycle response observed with cells induced to differentiate by histone deacetylase inhibitors, trichostatin A, and trapoxin.	SEN:10016214	10938272
BEL:20024948	a(CHEBI:"reactive oxygen species") increases cat(p(HGNC:ALOX5))	Generation of endogenous ROS from mitochondria by antimycin A also lead to a threefold upregulation of 5-LO activity in B-cells	SEN:10003556	10691962
BEL:20024950	a(CHEBI:"reactive oxygen species") increases cat(p(HGNC:ALOX5))	It was found that 5-LO in the Epstein-Barr virus-transformed B-lymphocytic cell line BL41-E95-A is activated by addition of hydrogen peroxide or xanthine/xanthine oxidase and after increasing the oxidative state of the cell	SEN:10003424	10691962
BEL:20024952	a(CHEBI:"reactive oxygen species") increases cat(p(HGNC:MMP9))	This is of interest, since ROS have been shown to activate MMP-9 through transformation of the proenzyme into the active enzyme (33).	SEN:10016218	11029344
BEL:20024958	a(CHEBI:"reactive oxygen species") increases cat(p(MGI:Parp1))	Poly(ADP-ribose) polymerase-1 (PARP), a chromatin-bound enzyme, is activated by cell oxidative stress.	SEN:10003558	16632544
BEL:20024964	a(CHEBI:"reactive oxygen species") increases gtp(p(MGI:Hras))	3) H(2)O(2) rapidly activated Ras (peak at 2-5 min), which preceded p90RSK activation (peak at 20 min).	SEN:10015768	10636870
BEL:20024966	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAP2K1))	which are dual-specificity (serine/threonine and tyrosine) kinases that regulate downstream responses to a broad range of mitogenic, apoptotic, and differentiation-inducing stimuli [368-372]. Interestingly, MEK1 but not MEK2 is stimulated by H2O2 treatment, suggesting that only MEK1 is redox-sensitive [154].	SEN:10015770	10699758
BEL:20024970	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:SYK))	Moreover, intracellular reactive oxygen species were involved in mediating osmotic stress-induced Syk activation	SEN:10003560	10448097
BEL:20024972	a(CHEBI:"reactive oxygen species") increases kin(p(MGI:Map3k5))	Treatment with PM2.5 resulted in the ROS-mediated activation of the oxidant-sensitive kinase ASK1 and its downstream kinase JNK.	SEN:10000498	19033436
BEL:20024976	a(CHEBI:"reactive oxygen species") increases kin(p(MGI:Mapk1))	In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,	SEN:10000500	16987002
BEL:20024980	a(CHEBI:"reactive oxygen species") increases kin(p(MGI:Mapk3))	In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,	SEN:10000500	16987002
BEL:20024982	a(CHEBI:"reactive oxygen species") decreases kin(p(MGI:Sphk1))	MAO-A can promote apoptosis through ROS-dependent sphingosine kinase inhibition that results in the accumulation of ceramide [64].	SEN:10016226	19307700
BEL:20024986	a(CHEBI:"reactive oxygen species") increases p(MGI:Ccl3)	Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS)	SEN:10000522	19293939
BEL:20024988	a(CHEBI:"reactive oxygen species") increases p(MGI:Cxcl2)	Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS)	SEN:10000522	19293939
BEL:20024992	a(CHEBI:"reactive oxygen species") decreases sec(p(MGI:Adipoq))	Secretion levels of adipokines were also changed by oxidative stress in parallel with mRNA expression levels.	SEN:10003564	16310164
BEL:20024994	a(CHEBI:"reactive oxygen species") decreases sec(p(MGI:Lep))	Secretion levels of adipokines were also changed by oxidative stress in parallel with mRNA expression levels.	SEN:10003564	16310164
BEL:20024996	a(CHEBI:"reactive oxygen species") decreases sec(p(MGI:Retn))	Secretion levels of adipokines were also changed by oxidative stress in parallel with mRNA expression levels.	SEN:10003564	16310164
BEL:20024998	a(CHEBI:"reactive oxygen species") increases sec(p(MGI:Serpine1))	Secretion levels of adipokines were also changed by oxidative stress in parallel with mRNA expression levels.	SEN:10003564	16310164
BEL:20025006	a(CHEBI:"reactive oxygen species") increases tscript(p(MGI:Nfe2l2))	Taken together, these observations strongly support a role for NADPH oxidase-generated ROS in mediating hyperoxia-induced Nrf2 activation in pulmonary epithelial cells.	SEN:10016234	15292179
BEL:20025008	a(CHEBI:"reactive oxygen species") increases tscript(p(MGI:Nfe2l2))	Nrf2 is a transcription factor that is activated by increased ROS, which induces the transcription of several antioxidant and detoxification enzymes including several classes of GST	SEN:10016236	18372916
BEL:20025020	a(CHEBI:resveratrol) decreases kin(p(MGI:Mtor))	Some of the most highly downregulated pathways in the resveratrol-fed group are... insulin signaling, IGF-1 and mTOR signaling, oxidative phosphorylation and electron transport.	SEN:10016240	17086191
BEL:20025022	a(CHEBI:resveratrol) decreases p(MGI:Igf1)	Resveratrol produces changes associated with longer lifespan, including increased insulin sensitivity, reduced insulin-like growth factor-1 (IGF-I) levels, increased AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) activity, increased mitochondrial number	SEN:10003570	17086191
BEL:20025024	a(CHEBI:resveratrol) increases tscript(p(MGI:Ppargc1a))	Resveratrol produces changes associated with longer lifespan, including increased insulin sensitivity, reduced insulin-like growth factor-1 (IGF-I) levels, increased AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) activity, increased mitochondrial number	SEN:10003570	17086191
BEL:20025036	a(CHEBI:"Ro 31-8220") increases p(MGI:Prkd1,pmod(P,S,744))	we developed novel phosphorylation state-specific antibodies directed against Ser744 and Ser748 in the PKD activation loop (52). By using these antibodies, we demonstrate here that PKD Ser744/Ser748 phosphorylation is rapidly triggered in Swiss 3T3-PKD.GFP cells by stimulation of cells with either bombesin or PDBu (Fig. 3E).	SEN:10016246	11514571
BEL:20025038	a(CHEBI:"Ro 31-8220") increases p(MGI:Prkd1,pmod(P,S,748))	we developed novel phosphorylation state-specific antibodies directed against Ser744 and Ser748 in the PKD activation loop (52). By using these antibodies, we demonstrate here that PKD Ser744/Ser748 phosphorylation is rapidly triggered in Swiss 3T3-PKD.GFP cells by stimulation of cells with either bombesin or PDBu (Fig. 3E).	SEN:10016246	11514571
BEL:20025048	a(CHEBI:rolipram) decreases p(MGI:Ccl3)	Marimastat (100 mg/kg), dexamethasone (10 mg/kg) and rolipram (0.3 mg/kg) reduced significantly IL-6, KC/CXCL1, MIP-1alpha/CCL3 and MMP-9 levels in bronchoalveolar lavage fluid.	SEN:10003578	17234180
BEL:20025050	a(CHEBI:rolipram) decreases p(MGI:Ifng)	Our results suggest that rolipram and amrinone decrease the immune activation in endotoxemia through inhibition of the production of pro-inflammatory mediators IL-12, IFN-gamma, TNF-alpha and NO.	SEN:10003580	9521054
BEL:20025060	a(CHEBI:rolipram) decreases p(MGI:Il4)	Administration of rolipram, in a dose-dependent manner, significantly prevented both changes in RL and Cdyn, as well as eosinophil, lymphocyte, and neutrophil accumulation in the BALF; IL-4 and IL-5 levels in BALF were also significantly reduced.	SEN:10003588	11208644
BEL:20025062	a(CHEBI:rolipram) decreases p(MGI:Il5)	Administration of rolipram, in a dose-dependent manner, significantly prevented both changes in RL and Cdyn, as well as eosinophil, lymphocyte, and neutrophil accumulation in the BALF; IL-4 and IL-5 levels in BALF were also significantly reduced.	SEN:10003588	11208644
BEL:20025066	a(CHEBI:rolipram) decreases p(MGI:Il6)	Marimastat (100 mg/kg), dexamethasone (10 mg/kg) and rolipram (0.3 mg/kg) reduced significantly IL-6, KC/CXCL1, MIP-1alpha/CCL3 and MMP-9 levels in bronchoalveolar lavage fluid.	SEN:10003578	17234180
BEL:20025070	a(CHEBI:rolipram) decreases p(MGI:Mmp9)	Marimastat (100 mg/kg), dexamethasone (10 mg/kg) and rolipram (0.3 mg/kg) reduced significantly IL-6, KC/CXCL1, MIP-1alpha/CCL3 and MMP-9 levels in bronchoalveolar lavage fluid.	SEN:10003578	17234180
BEL:20025078	a(CHEBI:rolipram) decreases p(MGI:Tnf)	Our results suggest that rolipram and amrinone decrease the immune activation in endotoxemia through inhibition of the production of pro-inflammatory mediators IL-12, IFN-gamma, TNF-alpha and NO.	SEN:10003580	9521054
BEL:20025082	a(CHEBI:rosiglitazone) increases cat(p(MGI:Cs))	Citrate synthase, localized exclusively to the mitochondrial matrix, catalyzes the conversion of acetyl-CoA to citrate, the initial step in the TCA cycle. The activity in inguinal adipose tissue from db/db mice was significantly lower than that from db/ mice (Fig. 5B). RSG dosedependently increased the activity, reaching a plateau at 3 and 10 mg/kg.	SEN:10016254	17456854
BEL:20025092	a(CHEBI:rosiglitazone) decreases p(MGI:Pparg,pmod(P,S,273))	The phosphorylation of PPARgamma by Cdk5 is blocked by anti-diabetic PPARgamma ligands, such as rosiglitazone and MRL24	SEN:10016260	20651683
BEL:20025096	a(CHEBI:rosiglitazone) increases tscript(p(MGI:Pparg))	we treated Zucker diabetic fatty rats (ZDF) for 15 days with a PPAR-alpha-specific compound, fenofibrate, a PPAR-gamma-specific ligand, rosiglitazone, and a PPAR-alpha/-gamma coagonist, GW2331, and measured the levels of several messenger RNAs (mRNAs) in liver by real-time polymerase chain reaction.	SEN:10003594	11474486
BEL:20025098	a(CHEBI:rosiglitazone) increases tscript(p(MGI:Pparg))	Furthermore, it has been shown that activation of PPARg by the thiozolidinedione, rosiglitazaone, decreased scavenger receptor class A expresion.	SEN:10016262	11557774
BEL:20025100	a(CHEBI:rosiglitazone) increases tscript(p(MGI:Pparg))	important effect of rosiglitazone in adipose tissue is based on activation of PPAR-gamma in preexisting preadipocytes found among the mature adipocytes, resulting in subsequent adipocyte differentiation.	SEN:10016264	11916924
BEL:20025106	a(CHEBI:"saturated fatty acid") decreases cat(p(MGI:Dnpep))	However, Sol AspAP and Sol pGluAP progressively decreased with the degree of saturation of the fatty acid used in the diet	SEN:10003598	11903661
BEL:20025108	a(CHEBI:"saturated fatty acid") increases cat(p(MGI:Enpep))	M-B GluAP progressively increased with the degree of saturation of the fatty acid used in the diet	SEN:10003600	11903661
BEL:20025110	a(CHEBI:"saturated fatty acid") decreases cat(p(MGI:Trhde))	However, Sol AspAP and Sol pGluAP progressively decreased with the degree of saturation of the fatty acid used in the diet	SEN:10003598	11903661
BEL:20025112	a(CHEBI:selegiline) decreases cat(p(MGI:Maob))	MAO-A, which preferentially catalyzes the oxidative deamination of norepinephrine (NE) and serotonin (5-HT), is inhibited by low concentrations of clorgyline. In contrast, MAO-B, which has a higher affinity for phenylethylamine and benzylamine, is inhibited by selegiline [79].	SEN:10016268	19307700
BEL:20025132	a(CHEBI:simvastatin) decreases cat(p(MGI:Hmgcr))	In vitro treatment with a pharmacological dose of simvastatin, a potent pro-drug of a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, stimulates bone formation.	SEN:10003608	14973129
BEL:20025134	a(CHEBI:simvastatin) decreases gtp(p(MGI:Rhoa))	Of note, simvastatin, a 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor, blocked the development of cigarette smoke-induced emphysema (183), probably through the inhibition of RhoA (224).	SEN:10016276	17615396
BEL:20025136	a(CHEBI:simvastatin) increases p(MGI:Scarb1)	As shown in Fig. 11A, the statin treatment clearly increased the SR-BI expression in the whole aortas, whereas the endothelium-removed aortas showed a marginal expression of SR-BI regardless of the statin treatment.	SEN:10016278	18981156
BEL:20025142	a(CHEBI:"S-nitrosoglutathione") increases deg(p(MGI:Irs1))	Here we demonstrate that exposure to NO donor or iNOS transfection reduced insulin receptor substrate (IRS)-1 protein expression without altering the mRNA level in cultured skeletal muscle cells. NO donor increased IRS-1 ubiquitination, and proteasome inhibitors blocked NO donor-induced reduction in IRS-1 expression in cultured skeletal muscle cells.	SEN:10003508	15805118
BEL:20025148	a(CHEBI:"sodium chloride") increases p(MGI:Ptpn6,pmod(P,S,591))	High NaCl-induced increase of phosphorylation of SHP-1 at S591 occurs within 15 min and lasts for at least 16 h (Fig. 6B).	SEN:10016286	20351292
BEL:20025154	a(CHEBI:spironolactone) increases tscript(p(MGI:Nr1i2))	Two PXR ligands [pregnenolone-16alpha-carbonitrile (PCN) and spironolactone] increased Oatp1a4 mRNA expression in liver,	SEN:10016292	15919853
BEL:20025162	a(CHEBI:staurosporine) increases deg(p(HGNC:PARG))	recombinant caspase-3 efficiently cleaved PARG in vitro, suggesting the involvement of this protease in PARG processing in vivo caspase-3-deficient MCF-7 cells did not show any PARG cleavage in response to staurosporine treatment	SEN:10016298	11053413
BEL:20025172	a(CHEBI:staurosporine) increases phos(p(MGI:Ptpn14))	Staurosporine and ML-9, which inhibited the phosphorylation of PTP36 in vivo, induced the translocation of PTP36 too.	SEN:10003612	10400706
BEL:20025176	a(CHEBI:staurosporine) decreases p(MGI:Hist1h1d,pmod(P))	The protein kinase inhibitor staurosporine, shown to dephosphorylate histone H1 and down-regulate MMTV in cultured cells, appears only to completely dephosphorylate the H1.3 isoform.	SEN:10000226	11479299
BEL:20025180	a(CHEBI:staurosporine) decreases p(MGI:Myl9,pmod(P))	Staurosporine, a kinase inhibitor known to effect dissolution but not contraction of stress fibers, immediately caused an increase in MHC and LC20 phosphorylation followed within minutes by the dephosphorylation of LC20 to a level below that of untreated cells.	SEN:10016306	1421576
BEL:20025184	a(CHEBI:staurosporine) increases tloc(p(MGI:Ptpn14),GOCCID:0005737,GOCCID:0005856)	Staurosporine and ML-9, which inhibited the phosphorylation of PTP36 in vivo, induced the translocation of PTP36 too.	SEN:10003612	10400706
BEL:20025188	a(CHEBI:sterol) decreases tscript(p(HGNC:SREBF1))	cellular sterol deprivation results in 2 sequential proteolytic cleavages of Srebp and the release of a mature 68-kDa amino-terminal domain of the protein from the endoplasmic reticulum mature Srebp enters the nucleus and activates transcription of target genes by a process that is dependent upon the binding of Srebp and either Nfy and/or Sp1 to the proximal promoters of these genes	SEN:10016308	10318878
BEL:20025190	a(CHEBI:sterol) decreases tscript(p(HGNC:SREBF2))	cellular sterol deprivation results in 2 sequential proteolytic cleavages of Srebp and the release of a mature 68-kDa amino-terminal domain of the protein from the endoplasmic reticulum mature Srebp enters the nucleus and activates transcription of target genes by a process that is dependent upon the binding of Srebp and either Nfy and/or Sp1 to the proximal promoters of these genes	SEN:10016308	10318878
BEL:20025192	a(CHEBI:suramin) decreases cat(p(MGI:Entpd2))	In RAW 264.7 cells, suramin and reactive blue, but not PPADS, competitively inhibited the UTP response, with pA2 values of 4.8 +/- 0.5 and 5.8 +/- 0.7, respectively.	SEN:10003616	8982511
BEL:20025194	a(CHEBI:suramin) decreases p(MGI:Fgf2)	Finally, the addition of FGF-2 to suramin-treated cells completely reversed suramin stimulation of lysyl oxidase mRNA levels.	SEN:10016310	12788924
BEL:20025196	a(CHEBI:tamoxifen) increases p(MGI:Tgfb1)	Conversely, apolipoprotein E deficient-atherosclerotic prone mice that were treated with tamoxifen had decreased atheroma lesion size and increased TGF-?1 levels.23	SEN:10016312	16462725
BEL:20025198	a(CHEBI:tamoxifen) decreases tport(p(MGI:Slc6a4))	Beyond E2, preliminary examination of other steroid metabolites and synthetic steroid receptor agonists/antagonists revealed that inhibition of 5-HT transport is additionally attributable only to estriol (E3, an E2 metabolite) and tamoxifen (a nonsteroidal, E2 receptor antagonist).	SEN:10003388	10076044
BEL:20025206	a(CHEBI:telmisartan) increases sec(p(MGI:Adipoq))	telmisartan, and to a lesser extent, losartan, increased production and secretion of adiponectin from 3T3-L1 adipocytes compared to the other antihypertensive drugs	SEN:10003492	19730415
BEL:20025224	a(CHEBI:thapsigargin) increases complex(p(MGI:Ripk1),p(MGI:Ern1),p(MGI:Tnfrsf1a))	Both RIP and IRE1a were coprecipitated with TNFR1 in response to Tg treatment, indicating that TNFR1, IRE1a and RIP might form a complex in cells under ER stress.	SEN:10016324	16680093
BEL:20025226	a(CHEBI:thapsigargin) increases complex(p(MGI:Tnfrsf1a),p(MGI:Ern1))	As shown in Fig 4B, Flag-tagged IRE1a was co-immunoprecipitated with GFP–TNFR1 and the treatment of Tg increased the interaction between IRE1a and TNFR1.	SEN:10016326	16680093
BEL:20025228	a(CHEBI:thapsigargin) increases kin(p(HGNC:ERN1))	Endogenous IRE1alpha was recovered in the TRAF2 immunoprecipitates only when the cells were treated with an agent that causes ER stress (Fig. 3B). These results suggest that ER stress-induced activation of IRE1 kinase activity is important for TRAF2 recruitment, whereas endonuclease activity of IRE1 is dispensable.	SEN:10016328	10650002
BEL:20025230	a(CHEBI:thapsigargin) increases kin(p(MGI:Eif2ak3))	RT-PCR analysis of the mRNA levels of selected IE genes such as egr-1 and c-myc confirmed that their expression was induced by thapsigargin in a PERK-dependent manner (Figure 1A).	SEN:10016330	16124869
BEL:20025232	a(CHEBI:thapsigargin) increases kin(p(MGI:Eif2ak3))	The level of phosphorylated p38 MAPK was increased 2–3 fold in Perk+/+ but not in Perk-/- MEFs after thapsigargin treatment (Figure 4), indicating that activation of the p38 MAPK signal pathway by thapsigargin is PERK-dependent.	SEN:10016332	16124869
BEL:20025234	a(CHEBI:thapsigargin) increases kin(p(MGI:Ern1))	ER stress led to a twofold increase in JNK activity in wild-type fibroblasts, whereas in the IRE1alpha-^sup 1^- fibroblasts JNK activity was decreased by ER stress (Fig. 2B).	SEN:10016334	10650002
BEL:20025236	a(CHEBI:thapsigargin) increases kin(p(MGI:Mapk8))	WT fibroblasts were treated with thapsigargin (Tg) or tunicamycin (Tu), which induce ER stress by the depletion of ER Ca2þ stores or inhibition of protein glycosylation, respectively, JNK activity, measured by in vitro kinase assay (Liu et al, 1996), is elevated.	SEN:10016336	16680093
BEL:20025240	a(CHEBI:thapsigargin) increases p(MGI:Atf3)	The ATF4 target genes ATF3 and CHOP were not induced by hypertonic stress at the protein level but were induced by thapsigargin, which triggers the UPR (supplemental Fig. 3A).	SEN:10016338	20338999
BEL:20025244	a(CHEBI:thapsigargin) increases p(MGI:Ddit3)	The ATF4 target genes ATF3 and CHOP were not induced by hypertonic stress at the protein level but were induced by thapsigargin, which triggers the UPR (supplemental Fig. 3A).	SEN:10016338	20338999
BEL:20025256	a(CHEBI:thapsigargin) increases p(MGI:Hspa5)	Although the rates of BiP synthesis before ER stress were comparable in the two MEFs, BiP protein induction during the course of ER stress was almost completely abolished in cells lacking ATF4 expression (Fig. 3D).	SEN:10016350	12840028
BEL:20025260	a(CHEBI:thapsigargin) increases p(MGI:Jun,pmod(P,S,73))	Furthermore, phosphorylation of c-Jun, one target of JNK, increased in response to TG treatment in c-Jun Re cells (Fig. 5D).	SEN:10016354	18641051
BEL:20025262	a(CHEBI:thapsigargin) increases tloc(p(MGI:Tnfrsf1a),GOCCID:0005886,GOCCID:0005783)	As shown in Fig 4C, there is a small amount of TNFR1 localized at ER before Tg treatment. But the level of TNFR1 at ER is markedly increased after Tg treatment.	SEN:10016356	16680093
BEL:20025272	a(CHEBI:thioredoxin) increases p(MGI:Hif1a)	The redox regulator thioredoxin-1 also exerts a positive effect on HIF-1a expression. Thioredoxin inhibitors block HIF-1a expression and xenograft growth.	SEN:10016362	13130303
BEL:20025288	a(CHEBI:"trichostatin A") decreases tscript(p(MGI:Pou2f1))	Hdac inhibitors disrupt Oct1 binding to the octamer element Oct1 interacts with the H2A octamer element with a high efficiency and represses Ifng-inducible H2A promtoer activation in Rb-defective tumor cell lines the reduction in binding activity seen for Oct1 was specific, as 2 other proteins, Nfy and Yy1, were not affected in their ability to bind DNA following treatment of the cells with Hdac inhibitors	SEN:10016370	11533238
BEL:20025290	a(CHEBI:trifluoperazine) decreases cat(p(MGI:Calm1))	Okadaic acid over 3 microM enhanced Ca2+-activated force, which was inhibited by 50 microM trifluoperazine, a calmodulin antagonist.	SEN:10003632	12002261
BEL:20025292	a(CHEBI:troglitazone) increases sec(p(MGI:Adipoq))	Treatment of 3T3-L1 adipocytes with the PPAR{gamma} ligand troglitazone significantly increases the amount of secreted HMW adiponectin and attenuates secretion of adipsin, whereas T0070907, a PPAR{gamma} antagonist, has the opposite effect (Fig. 3A and B). Interestingly, activation of PPAR{gamma} induces expression of SIRT1 (Fig. 3A), consistent with the fact that SIRT1 expression is enhanced during adipogenesis (26).	SEN:10016372	17452443
BEL:20025294	a(CHEBI:troglitazone) decreases sec(p(MGI:Cfd))	Treatment of 3T3-L1 adipocytes with the PPAR{gamma} ligand troglitazone significantly increases the amount of secreted HMW adiponectin and attenuates secretion of adipsin, whereas T0070907, a PPAR{gamma} antagonist, has the opposite effect (Fig. 3A and B). Interestingly, activation of PPAR{gamma} induces expression of SIRT1 (Fig. 3A), consistent with the fact that SIRT1 expression is enhanced during adipogenesis (26).	SEN:10016372	17452443
BEL:20025296	a(CHEBI:troglitazone) increases tscript(p(MGI:Pparg))	Furthermore, activation of Sirt1 prevented the increase in adipocytes caused by the PPARgamma-agonist troglitazone.	SEN:10003634	16813520
BEL:20025298	a(CHEBI:"UDP-N-acetyl-D-galactosamine") increases p(HGNC:IRS1,pmod(G,S))	We also demonstrated that glucosamine % infusion results in O-linked N-acetylglucosamine modification of IRS-1 and % IRS-2.	SEN:10015718	10426374
BEL:20025302	a(CHEBI:"uric acid") increases sec(p(MGI:Pdgfa))	Finally, uric acid, which is the by-product of xanthine oxidase-dependent xanthine metabolism, has also been reported to mediate autocrine growth (257). Exposure of VSMC to uric acid stimulated accumulation of PDGF-A mRNA and secretion of PDGF-like material in conditioned medium (>10-fold at 24 h). Thus uric acid stimulates VSMC growth via an autocrine mechanism involving PDGF-A	SEN:10016376	11427690
BEL:20025304	a(CHEBI:"ursolic acid") increases cat(p(MGI:Mpo))	In addition, i.p. administration of UA increased the levels of IL-1beta secretion and MPO activity in colonic mucosa of ICR mice.	SEN:10003636	17404266
BEL:20025306	a(CHEBI:"ursolic acid") increases p(MGI:Il1b)	As shown in Fig. 3, A and B, IL-1B mRNA and proIL-1B protein were detected in a constitutive manner at low levels in nontreated pMphi. Those treated with 4 microM UA for 3 and 6 h were markedly up-regulated, whereas, intriguingly, the levels diminished after 12 h.	SEN:10016378	17404266
BEL:20025308	a(CHEBI:"ursolic acid") increases sec(p(MGI:Il1b))	UA increased the protein release of IL-1beta, IL-6, and MIF, but not of TNF-alpha, in dose- and time-dependent manners.	SEN:10003638	17404266
BEL:20025310	a(CHEBI:"ursolic acid") increases sec(p(MGI:Il6))	UA increased the protein release of IL-1beta, IL-6, and MIF, but not of TNF-alpha, in dose- and time-dependent manners.	SEN:10003638	17404266
BEL:20025312	a(CHEBI:"ursolic acid") increases sec(p(MGI:Mif))	UA increased the protein release of IL-1beta, IL-6, and MIF, but not of TNF-alpha, in dose- and time-dependent manners.	SEN:10003638	17404266
BEL:20025316	a(CHEBI:vasopressin) increases p(MGI:Prkd1,pmod(P,S,916))	Bombesin stimulation induced a dramatic increase in the immunoreactivity of the PKD band indicative of phosphorylation at Ser916 (Fig. 3A). Stimulation with either vasopressin or PDBu also induced a marked increase in PKD activity within cells as shown by Ser916 phosphorylation (Fig. 3B).	SEN:10016380	11514571
BEL:20025320	a(CHEBI:verapamil) decreases tport(p(MGI:Abcb1a))	mice lacking Abcb1a developed significantly fewer intestinal polyps inhibitors of p-glycoprotein, verapamil, and cyclosporin A had a suppressive effect on the polypoid growth	SEN:10016382	12615699
BEL:20025356	a(CHEBI:"zinc protoporphyrin") decreases cat(p(MGI:Hmox1))	NO-mediated increase in MnSOD activity was partly abolished by HO-1 inhibitor Zn(II) protoporphyrin IX (ZnPP)	SEN:10003644	15993853
BEL:20025358	a(CHEBI:"zinc protoporphyrin") directlyDecreases cat(p(MGI:Hmox1))	ZnPP attenuated the protective effect of eckol on H2O2-induced cytotoxicity (Fig. 4A), and siHO-1-transfected cells exhibited similar results (Fig. 4B).....Therefore, the cytoprotective effect of eckol is likely to be mediated through HO-1 induction.	SEN:10016400	19931411
BEL:20028348	bp(GOBP:"cell adhesion") increases kin(p(HGNC:KDR))	Cell adhesion is critical for receptor activation based on two experimental observations: (i) VEGF-A165-dependent VEGFR-2 phosphorylation was strongly activated in adherent cell, but showed a substantially reduced response in suspended cells; and	SEN:10017960	10022831
BEL:20028350	bp(GOBP:"cell adhesion") decreases phos(p(MGI:Ptpn14))	In mouse fibroblasts adhered to substrates, PTP36 was phosphorylated on serine residues. PTP36 was found to make complexes with serine/threonine kinase(s), which phosphorylated PTP36 in vitro. PTP36 was dephosphorylated rapidly when the cell-substrate adhesion was disrupted and it was phosphorylated again along with the reattachment of the cells to fibronectin.	SEN:10004050	10400706
BEL:20028362	bp(GOBP:"cell differentiation") decreases complex(p(HGNC:ALDOA),p(HGNC:EIF4G2))	We demonstrate that the binding between AldA-NRE and p97 decreases during differentiation of human Caco-2 cells and is inversely correlated with L-type mRNA expression.	SEN:10004056	10413096
BEL:20028364	bp(GOBP:"cell differentiation") increases tscript(p(MGI:Tlx3))	In undifferentiated ES cells, there was no significant difference in gene expression in the presence or absence of Tlx3, even after ES cells were cultured for an extensive time period. In contrast, expression levels of Mash1, Ngn1, and NeuroD were significantly higher in Tlx3-expressing cells after neural induction for 4 days compared with those in cells expressing the control vector.	SEN:10004058	18391221
BEL:20028366	bp(GOBP:"cell growth") increases p(MGI:Cdkn1a)	During onset of irreversible growth arrest associated with terminal differentiation, the level of p21 declined with a concomitant, dramatic increase in p18 and a sustained level of p27.	SEN:10004060	10358062
BEL:20028368	bp(GOBP:"cell growth") decreases p(MGI:Cdkn2c)	During onset of irreversible growth arrest associated with terminal differentiation, the level of p21 declined with a concomitant, dramatic increase in p18 and a sustained level of p27.	SEN:10004060	10358062
BEL:20028374	bp(GOBP:"cell proliferation") increases tloc(p(HGNC:PTPN14),GOCCID:0005737,GOCCID:0005634)	Vascular endothelial cells normally exist as a quiescent confluent monolayer but become proliferative during angiogenesis or upon vascular injury. Using a 'wound' assay to mimic these events in vitro, Pez was found to be nuclear in the cells that had migrated and were proliferative at the 'wound' edge.	SEN:10000120	10934049
BEL:20028378	bp(GOBP:"cellular response to DNA damage stimulus") increases cat(p(MGI:Parp1))	Activation of poly(ADP-ribose) polymerase (PARP) by DNA breaks catalyzes poly(ADP-ribosyl)ation and results in depletion of NAD+ and ATP, which is thought to induce necrosis.	SEN:10004064	10373561
BEL:20028380	bp(GOBP:"cellular response to DNA damage stimulus") increases complex(p(HGNC:ABL1),p(HGNC:TP53))	<A4> c-Abl binds to p53 in response to 1-b-d-arabinofuransylcytosine or methylmethanesulfonate (Yuan et al., 1996); this interaction does not require c-Abl kinase activity. Moreover, c-Abl kinase activity does not require p53. Binding of c-Abl to p53 inhibits the Mdm2-mediated degradation of p53 (Sionov et al., 1999).	SEN:10017968	10436023
BEL:20028416	bp(GOBP:"fat cell differentiation") increases cat(p(HGNC:PDE3B))	Following differentiation into adipocytes, however, PDE3B activity is markedly increased in cell particulate fractions	SEN:10017986	10952971
BEL:20028446	bp(GOBP:"hyperosmotic response") increases p(MGI:Hif1a)	Hybridization of proteins from sorbitol-treated cells to a transcription factor DNA array demonstrated induction of hypoxia-inducible factor-1alpha (HIF-1alpha) by hypertonicity, which was confirmed by quantitative RT-PCR.	SEN:10004078	17108010
BEL:20028450	bp(GOBP:"hyperosmotic response") increases p(MGI:Nfat5)	Also consistent with previous reports (12,28), significant inductions of OREBP protein became apparent at 2 h and reached peak levels by 6-8 h (Figure 1B and C) after high NaCl exposure.	SEN:10018002	20852262
BEL:20028454	bp(GOBP:"hyperosmotic response") increases tscript(p(MGI:Hif1a))	Cotransfections of AQP5-luciferase with HIF-1alpha and HIF-1beta expression plasmids in MLE-15 cells led to dose-dependent transcriptional enhancement, which was partially abrogated by mutagenesis of putative HIF-1alpha binding sites in the proximal AQP5 promoter.Importantly, hypertonic induction of AQP5 was significantly inhibited by preventing HIF-1alpha induction with small interfering RNA.	SEN:10004082	17108010
BEL:20028456	bp(GOBP:"inflammatory response") increases complex(p(HGNC:PDGFRB),p(HGNC:PDGFRB))	D. Expression of PDGF Receptors Importantly, the level of PDGF receptor expression on cells is not constant. For instance, the expression of beta -receptors on connective tissue cells in vivo is low but increases during inflammation (400) or after explantation into tissue culture (465).	SEN:10018004	10508235
BEL:20028466	bp(GOBP:"insulin receptor signaling pathway") decreases kin(p(MGI:Gsk3b))	GSK3-beta is also phosphorylated in response to hormonal stimuli not involving mechanical stress, such as insulin28; this pathway, however, was unaffected in the melusin-null background.	SEN:10018008	12496958
BEL:20028472	bp(GOBP:"integrin-mediated signaling pathway") increases kin(p(HGNC:ABL1))	The FAK and Fyn/Shc pathways. Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Srcfamily kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (4, 7).	SEN:10018010	10446041
BEL:20028474	bp(GOBP:"integrin-mediated signaling pathway") increases kin(p(HGNC:ILK))	The FAK and Fyn/Shc pathways. Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Srcfamily kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (4, 7).	SEN:10018010	10446041
BEL:20028476	bp(GOBP:"integrin-mediated signaling pathway") increases kin(p(HGNC:KDR))	Cell adhesion is critical for receptor activation based on two experimental observations: (i) VEGF-A165-dependent VEGFR-2 phosphorylation was strongly activated in adherent cell, but showed a substantially reduced response in suspended cells; and	SEN:10017960	10022831
BEL:20028484	bp(GOBP:"integrin-mediated signaling pathway") increases kin(p(HGNC:PTK2))	The FAK and Fyn/Shc pathways. Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Srcfamily kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (4, 7).	SEN:10018010	10446041
BEL:20028492	bp(GOBP:"integrin-mediated signaling pathway") decreases p(HGNC:CDKN1A)	(38). Integrins also stimulate the p70 S6- kinase, which may promote cyclin D1 translation (39). Finally, anchorage to the ECM is necessary for the down-regulation of the Cdk 2 inhibitors p21 and p27 and, thus, the activation of cyclin E-Cdk 2	SEN:10018016	10446041
BEL:20028494	bp(GOBP:"integrin-mediated signaling pathway") decreases p(HGNC:CDKN1B)	(38). Integrins also stimulate the p70 S6- kinase, which may promote cyclin D1 translation (39). Finally, anchorage to the ECM is necessary for the down-regulation of the Cdk 2 inhibitors p21 and p27 and, thus, the activation of cyclin E-Cdk 2	SEN:10018016	10446041
BEL:20028496	bp(GOBP:"integrin-mediated signaling pathway") increases phos(p(HGNC:PTPN12))	PTP-PEST has a COOH-terminal extension that anchors it to the cytosolic aspect of the endoplasmic reticulum. Integrin-mediated adhesion activates calpain, a protease that cleaves this extension and allows the phosphatase to relocate to focal adhesions (21).	SEN:10018018	10446041
BEL:20028498	bp(GOBP:"integrin-mediated signaling pathway") increases tloc(p(MGI:Thbs2),GOCCID:0005576,GOCCID:0005622)	Consistent with this hypothesis, MKs take up recombinant TSP2 in an integrin-dependent manner when it is supplied in the culture medium.	SEN:10018020	12732502
BEL:20028502	bp(GOBP:"lipid biosynthetic process") increases kin(p(MGI:Ikbkb))	These findings indicate that lipid accumulation in the liver leads to subacute hepatic 'inflammation' through NF-kappaB activation and downstream cytokine production. This causes insulin resistance both locally in liver and systemically.	SEN:10004092	15685173
BEL:20028508	bp(GOBP:"macrophage activation") increases cat(p(MGI:Ptgs2))	Macrophage activation promotes the secretion of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta), and of secondary mediators (through activation of Cox2), leukotrienes and prostaglandins (PGs) such as PGE2.	SEN:10018024	12234923
BEL:20028520	bp(GOBP:"macrophage activation") increases sec(p(MGI:Cxcl13))	This induced production is enhanced after in vitro maturation of the monocytes toward macrophages but markedly decreased after maturation toward dendritic cells.	SEN:10004096	15284119
BEL:20028522	bp(GOBP:"macrophage differentiation") increases cat(p(MGI:Pon2))	PON2 expression (mRNA and protein) and activity gradually increased during monocyte/macrophage differentiation	SEN:10004098	15544923
BEL:20028524	bp(GOBP:"macrophage differentiation") increases p(MGI:Pon2)	PON2 expression (mRNA and protein) and activity gradually increased during monocyte/macrophage differentiation	SEN:10004098	15544923
BEL:20028536	bp(GOBP:"MAPK cascade") increases cat(p(MGI:Tnks))	Tankyrase is a novel signaling target of mitogen-activated protein kinase (MAPK); it is stoichiometrically phosphorylated upon insulin stimulation. Phosphorylation enhances the poly(ADP-ribose) polymerase activity of tankyrase	SEN:10004100	10988299
BEL:20028540	bp(GOBP:"MAPK cascade") increases kin(p(HGNC:RPS6KA1))	Rsk1 directly phosphorylated the pro-apoptotic protein Bad at the serine %residues that, when phosphorylated, abrogate Bad's pro-apoptotic function. kinase Rsk1, a downstream target of the MEK-MAP kinase signaling pathway	SEN:10018038	10679322
BEL:20028542	bp(GOBP:"MAPK cascade") increases p(HGNC:CDKN1A)	Upregulation of p21(WAF1/CIP1) cyclin-dependent kinase inhibitor protein was observed in a manner dependent on PKC or MAP kinase.	SEN:10000208	11313866
BEL:20028550	bp(GOBP:"MAPK cascade") increases p(MGI:Cebpb,pmod(P))	In response to IFN-gamma, C/EBP-beta undergoes phosphorylation at a critical ERK1/2 phosphorylation motif.	SEN:10018042	15879117
BEL:20028564	bp(GOBP:"MAPK cascade") decreases surf(p(MGI:Slc12a3))	Although inhibitors of PKC had no effect on this suppression, MAPK inhibitors completely prevented the TPA effect. RasGRP1 activates the MAPK pathway through activation of the small G protein H-Ras.	SEN:10004108	18077438
BEL:20028566	bp(GOBP:"MAPK cascade") increases tscript(p(HGNC:ESR1))	Mitogen-activated protein (MAP) kinases phosphorylate the estrogen receptor and activate transcription from estrogen receptor-regulated genes.	SEN:10000050	10373563
BEL:20028568	bp(GOBP:"MAPK cascade") increases tscript(p(MGI:Cebpb))	The hsp90beta gene promoter contains binding sites for the transcription factors nuclear factor IL-6 (\"NF-IL6\") and signal transducer and activator of transcription 3 (STAT-3), which are activated respectively by the mitogen-activated-protein-kinase and Jak-kinase pathways following IL-6 treatment.	SEN:10018046	9461509
BEL:20028576	bp(GOBP:"mast cell activation") increases p(HGNC:IL4)	Using immunocytochemistry, Bradding et al. [1±4] reported that interleukin (IL)-4, IL-5, IL-6, and tumour necrosis factor (TNF)-a were present within mast cells in nasal and bronchial mucosa taken from both normal subjects and patients with allergic perennial rhinitis,	SEN:10018052	10971465
BEL:20028578	bp(GOBP:"mast cell activation") increases p(HGNC:IL5)	Jaffe et al. [22,23] reported IL-5 and IL-13 production from human lung mast cells following IgE-mediated activation.	SEN:10018050	10971465
BEL:20028582	bp(GOBP:"mast cell activation") increases p(HGNC:IL6)	Using immunocytochemistry, Bradding et al. [1±4] reported that interleukin (IL)-4, IL-5, IL-6, and tumour necrosis factor (TNF)-a were present within mast cells in nasal and bronchial mucosa taken from both normal subjects and patients with allergic perennial rhinitis,	SEN:10018052	10971465
BEL:20028588	bp(GOBP:"mast cell activation") increases p(HGNC:TNF)	Using immunocytochemistry, Bradding et al. [1±4] reported that interleukin (IL)-4, IL-5, IL-6, and tumour necrosis factor (TNF)-a were present within mast cells in nasal and bronchial mucosa taken from both normal subjects and patients with allergic perennial rhinitis,	SEN:10018052	10971465
BEL:20028590	bp(GOBP:"mast cell activation") increases p(MGI:Il13)	In the light of recent reports that strongly support critical roles for IL-9 and IL-13 in allergic lung inflammation, our results emphasize the potential clinical importance of LPS as an enhancer of mast cell-derived IL-9 and IL-13 production in the course of inflammatory reactions and allergic diseases.	SEN:10000710	11254693
BEL:20028592	bp(GOBP:"mast cell activation") increases p(MGI:Il9)	In the light of recent reports that strongly support critical roles for IL-9 and IL-13 in allergic lung inflammation, our results emphasize the potential clinical importance of LPS as an enhancer of mast cell-derived IL-9 and IL-13 production in the course of inflammatory reactions and allergic diseases.	SEN:10000710	11254693
BEL:20028594	bp(GOBP:"mast cell activation") increases p(MGI:Tnf)	IL-4 inhibited immunoglobulin E-induced TNF-alpha production and neutrophil recruitment in the peritoneal cavity in wild-type mice but not in signal transducers and activators of transcription 6 (Stat6)-deficient mice... IL-4 also inhibited TNF-alpha production in cultured mast cells by a Stat6-dependent mechanism.	SEN:10018054	14638848
BEL:20028596	bp(GOBP:"mast cell activation") increases sec(complex(a(CHEBI:heparin),p(HGNC:CMA1)))	Chymases are highly basic chymotrypsin-like serine proteases expressed exclusively by mast cells. Large amounts of chymases complexed with heparin proteoglycan (PG) are released in vivo during mast cell activation.	SEN:10004112	10508424
BEL:20028598	bp(GOBP:"mast cell activation") increases sec(p(HGNC:CMA1))	Chymases are highly basic chymotrypsin-like serine proteases expressed exclusively by mast cells. Large amounts of chymases complexed with heparin proteoglycan (PG) are released in vivo during mast cell activation.	SEN:10004112	10508424
BEL:20028600	bp(GOBP:"mast cell activation") increases sec(p(HGNC:IFNG))	When HMC-1 cells were stimulated with PMA (100 nmol/L) for periods of 0-3 days, the cells released IFN-gamma protein, peaking on day 1.	SEN:10004114	10233311
BEL:20028604	bp(GOBP:mitosis) increases complex(p(HGNC:AKAP8),p(HGNC:PRKAR1A))	In a cytosolic extract derived from mitotic cells, AKAP95 recruits the RIIalpha regulatory subunit of PKA onto chromatin.	SEN:10018058	10601332
BEL:20028606	bp(GOBP:mitosis) increases p(HGNC:PTK2,pmod(P,S))	Whereas FAK is phosphorylated on tyrosine upon assembly of focal adhesions, it becomes phosphorylated on serine and disassociates from Src and p130CAS during mitosis (14). These events may loosen cell-substrate contacts and allow cells to divide and move apart.	SEN:10018060	10446041
BEL:20028624	bp(GOBP:"myeloid dendritic cell activation") decreases sec(p(MGI:Cxcl13))	This induced production is enhanced after in vitro maturation of the monocytes toward macrophages but markedly decreased after maturation toward dendritic cells.	SEN:10004096	15284119
BEL:20028642	bp(GOBP:"neutrophil activation") increases cat(p(MGI:Mpo))	In both BALB/c and C57BL/6 mice, a neutrophil infiltration was observed after the sequential application of lipopolysaccharide and N-Formyl-Met-Leu-Phe. However, 5 times less neutrophil was found in C57BL/6 mice when compared to BALB/c mice. This was reflected in the neutrophil activation parameters measured (myeloperoxidase and elastase activities).	SEN:10018072	11806755
BEL:20028646	bp(GOBP:"neutrophil activation") increases sec(p(MGI:Ccl20))	In the mouse system, Toxoplasma Gondii-stimulated neutrophils secrete CCL3, CCL4, CCL5 and CCL20 chemokines	SEN:10018076	19273148
BEL:20028648	bp(GOBP:"neutrophil activation") increases sec(p(MGI:Ccl3))	In the mouse system, Toxoplasma Gondii-stimulated neutrophils secrete CCL3, CCL4, CCL5 and CCL20 chemokines	SEN:10018076	19273148
BEL:20028650	bp(GOBP:"neutrophil activation") increases sec(p(MGI:Ccl4))	In the mouse system, Toxoplasma Gondii-stimulated neutrophils secrete CCL3, CCL4, CCL5 and CCL20 chemokines	SEN:10018076	19273148
BEL:20028652	bp(GOBP:"neutrophil activation") increases sec(p(MGI:Ccl5))	In the mouse system, Toxoplasma Gondii-stimulated neutrophils secrete CCL3, CCL4, CCL5 and CCL20 chemokines	SEN:10018076	19273148
BEL:20028690	bp(GOBP:"response to endoplasmic reticulum stress") increases cat(p(MGI:Ero1l))	These data indicate that ERO1-alpha plays an important role in ER stressed–induced, CHOP-dependent apoptosis in macrophages.	SEN:10018094	19752026
BEL:20028692	bp(GOBP:"response to endoplasmic reticulum stress") increases complex(p(MGI:Atf1),p(MGI:Creb1))	ER stress induces CREB1 phosphorylation and ATF1/CREB1 binding to the Grp78 promoter. Through the use of adenoviral vector expression systems, we provide evidence that when ATF4 function is suppressed and its binding partners are not able to compensate for its function, Grp78 induction by Tg and Tu is partially inhibited.	SEN:10018096	12871976
BEL:20028696	bp(GOBP:"response to endoplasmic reticulum stress") increases complex(p(MGI:Tnfrsf1a),p(MGI:Ern1))	We also found that TNFR1 functions downstream of IRE1 and that IRE1 is present in the same complex with TNFR1 under ER stress condition. Therefore, our study shows a novel role of TNFR1 in mediating ER stress-induced JNK activation.	SEN:10004132	16680093
BEL:20028698	bp(GOBP:"response to endoplasmic reticulum stress") increases kin(p(MGI:Mapk8))	In this study, we report that TNFR1 has a crucial role in endoplasmic reticulum (ER) stress-induced Jun amino-terminal kinase (JNK) activation.	SEN:10018098	16680093
BEL:20028700	bp(GOBP:"response to endoplasmic reticulum stress") increases kin(p(MGI:Ripk1))	As shown in Fig 1C, ER stressinduced JNK activation was recovered in RIP-reconstituted RIP-/- cells, even though the protein level of RIP was much lower in RIP-reconstituted cells than in WT cells (Fig 1B). These results indicate that RIP, like TRAF2, is essential for JNK activation in response to ER stress.	SEN:10018100	16680093
BEL:20028702	bp(GOBP:"response to endoplasmic reticulum stress") increases phos(p(MGI:Ppp1r15a))	Recently, Novoa et al. (29, 31) demonstrated that GADD34, also known as Myd116 in mouse, promotes the dephosphorylation of eIF-2alpha and is induced by both ER stress and amino acid deprivation.	SEN:10018102	12840028
BEL:20028706	bp(GOBP:"response to endoplasmic reticulum stress") increases p(MGI:Creb1,pmod(P))	ER stress induces CREB1 phosphorylation and ATF1/CREB1 binding to the Grp78 promoter. Through the use of adenoviral vector expression systems, we provide evidence that when ATF4 function is suppressed and its binding partners are not able to compensate for its function, Grp78 induction by Tg and Tu is partially inhibited.	SEN:10018096	12871976
BEL:20028708	bp(GOBP:"response to endoplasmic reticulum stress") decreases p(MGI:Eif2s1,pmod(P,S,52))	Recently, Novoa et al. (29, 31) demonstrated that GADD34, also known as Myd116 in mouse, promotes the dephosphorylation of eIF-2alpha and is induced by both ER stress and amino acid deprivation.	SEN:10018102	12840028
BEL:20028710	bp(GOBP:"response to endoplasmic reticulum stress") decreases p(MGI:Hp)	Iron induced a dramatic post-transcriptional decrease of liver and serum haptoglobin in C57BL/6 mice...We assumed that the oxidative stress induced by iron in C57BL/6 mice altered the endoplasmic reticulum (ER) environment, leading to the incorrect folding of haptoglobin and its subsequent degradation.	SEN:10016964	17644369
BEL:20028712	bp(GOBP:"response to endoplasmic reticulum stress") increases p(MGI:Msr1)	Insr(-/-) macrophages showed diminished Akt phosphorylation and an augmented ER stress response, leading to induction of scavenger receptor A and increased apoptosis when challenged with cholesterol loading or nutrient deprivation.	SEN:10004134	16581003
BEL:20028716	bp(GOBP:"response to endoplasmic reticulum stress") increases tloc(p(HGNC:ATF6),GOCCID:0005737,GOCCID:0005634)	ATF6 has been implicated in the endoplasmic reticulum (ER) stress response pathway since it can activate expression of GRP78 and other genes induced by the ER stress response. ER stress appears to activate ATF6 by cleavage from the ER membrane and translocation to the nucleus	SEN:10018104	10856300
BEL:20028722	bp(GOBP:"response to endoplasmic reticulum stress") increases tscript(p(MGI:Atf6))	These results suggest that specific ER stress signaling transmitted by ATF6 leads to naturally occurring apoptosis during muscle development.	SEN:10000742	15897261
BEL:20028754	bp(GOBP:"response to hypoxia") decreases cat(complex(p(MGI:Tsc1),p(MGI:Tsc2)))	Here we show that mTOR inhibition by hypoxia requires the TSC1/TSC2 tumor suppressor complex and the hypoxia-inducible gene REDD1/RTP801. Disruption of the TSC1/TSC2 complex through loss of TSC1 or TSC2 blocks the effects of hypoxia on mTOR, as measured by changes in the mTOR targets S6K and 4EBP1, and results in abnormal accumulation of Hypoxia-inducible factor (HIF).	SEN:10018116	15545625
BEL:20028762	bp(GOBP:"response to hypoxia") increases deg(p(HGNC:CREB1))	Ambient hypoxia resulted in temporally sequential CREB serine phosphorylation, ubiquitination, and degradation (in vitro and in vivo)....Thus, hypoxia establishes conditions that target CREB to proteasomal degradation.	SEN:10018120	11035795
BEL:20028764	bp(GOBP:"response to hypoxia") increases kin(p(HGNC:MAPK1))	In addition, our results demonstrate that the p42/p44 MAPK protein kinases are activated by hypoxia.	SEN:10000178	11207433
BEL:20028766	bp(GOBP:"response to hypoxia") increases kin(p(HGNC:MAPK3))	In addition, our results demonstrate that the p42/p44 MAPK protein kinases are activated by hypoxia.	SEN:10000178	11207433
BEL:20028774	bp(GOBP:"response to hypoxia") decreases kin(p(MGI:Insr))	In 3T3-L1 adipocytes, this inhibition of insulin receptor phosphorylation is followed by a decrease in the phosphorylation state of protein kinase B and AS160, as well as an inhibition of glucose transport in response to insulin.	SEN:10018122	18984735
BEL:20028776	bp(GOBP:"response to hypoxia") increases kin(p(MGI:Prkaa2))	AMPK transmits a portion of the signal by which muscle contraction increases glucose uptake, but other AMPK-independent pathways also contribute to the response.	SEN:10004144	11389854
BEL:20028778	bp(GOBP:"response to hypoxia") increases p(HGNC:CREB1,pmod(P,S))	Ambient hypoxia resulted in temporally sequential CREB serine phosphorylation, ubiquitination, and degradation (in vitro and in vivo)....Thus, hypoxia establishes conditions that target CREB to proteasomal degradation.	SEN:10018120	11035795
BEL:20028780	bp(GOBP:"response to hypoxia") increases p(HGNC:CREB1,pmod(U))	Ambient hypoxia resulted in temporally sequential CREB serine phosphorylation, ubiquitination, and degradation (in vitro and in vivo)....Thus, hypoxia establishes conditions that target CREB to proteasomal degradation.	SEN:10018120	11035795
BEL:20028790	bp(GOBP:"response to hypoxia") increases p(MGI:Cdkn1a)	In contrast to HIF-1alpha, the maximal inducibility of p21WAF1 in hypoxia was achieved in MEF WT cells (Figure 2B).	SEN:10018126	20072654
BEL:20028798	bp(GOBP:"response to hypoxia") increases p(MGI:Edn1)	Plasma and lung endothelin-1 levels were increased by chronic hypoxia, but these levels were not significantly different between the 2 genotypes.	SEN:10000766	11230292
BEL:20028802	bp(GOBP:"response to hypoxia") increases p(MGI:Epas1)	In hypoxia, HIF-1A expression by densitometry was significantly (P < 0.005) reduced in hypoxic lungs and tumors. HIF-2A expression was 2-fold higher in hypoxic lungs and 2.7-fold higher in tumors from hypoxic mice compared with those in normoxia (P = 0.05; Fig. 2A and C).	SEN:10018134	22700853
BEL:20028804	bp(GOBP:"response to hypoxia") increases p(MGI:Ero1l)	upregulation of Ero1-La by hypoxia was demonstrated in a variety of tumor cell lines, as well as in nontransformed, primary cells, including hepatocellular carcinoma, C6 glioblastoma, transformed mouse embryonic fibrobalsts, primary MEFs and embryonic stem cells.	SEN:10018136	15592500
BEL:20028810	bp(GOBP:"response to hypoxia") increases p(MGI:Hif1a)	As shown in Fig. 1A, robust HIF-1 stabilization was observed following exposure to hypoxia and to DMOG.	SEN:10018138	17545479
BEL:20028818	bp(GOBP:"response to hypoxia") decreases p(MGI:Hif1a)	In hypoxia, HIF-1A expression by densitometry was significantly (P < 0.005) reduced in hypoxic lungs and tumors. HIF-2A expression was 2-fold higher in hypoxic lungs and 2.7-fold higher in tumors from hypoxic mice compared with those in normoxia (P = 0.05; Fig. 2A and C).	SEN:10018134	22700853
BEL:20028820	bp(GOBP:"response to hypoxia") increases p(MGI:Hmox1)	As seen in Fig. 2A, exposure to hypoxia resulted in 3.8-fold induction in HO-1 mRNA expression and 2.7-fold induction of iNOS mRNA as assessed by QPCR (P 0.001 vs. control). ...Western blot analysis showed significant increases in HO-1 and iNOS protein expression (Fig. 2B).	SEN:10018144	17545479
BEL:20028822	bp(GOBP:"response to hypoxia") increases p(MGI:Il6)	Hypoxia exposure of IL-6+/+ mice led to marked increases in IL-6 mRNA and protein levels within the first week, with positive IL-6 immunostaining in the pulmonary vessel walls ...In vitro studies of cultured human pulmonary-artery smooth-muscle-cells (PA-SMCs) and microvascular endothelial cells revealed prominent synthesis of IL-6 by PA-SMCs, with further stimulation by hypoxia.	SEN:10018146	19173740
BEL:20028828	bp(GOBP:"response to hypoxia") decreases p(MGI:Mdm2)	Mdm2, was decreased in all cell lines independent of eIF2alpha phosphorylation levels (Figure 3B).	SEN:10018150	20072654
BEL:20028830	bp(GOBP:"response to hypoxia") increases p(MGI:Myc)	We examined expression of c-Myc and as shown in Fig. 2A, expression was higher in urethane-treated lungs (P < 0.005) and tumors under hypoxia (P < 0.05).	SEN:10018152	22700853
BEL:20028832	bp(GOBP:"response to hypoxia") increases p(MGI:Nos2)	As seen in Fig. 2A, exposure to hypoxia resulted in 3.8-fold induction in HO-1 mRNA expression and 2.7-fold induction of iNOS mRNA as assessed by QPCR (P 0.001 vs. control). ...Western blot analysis showed significant increases in HO-1 and iNOS protein expression (Fig. 2B).	SEN:10018144	17545479
BEL:20028836	bp(GOBP:"response to hypoxia") increases p(MGI:Ptch1)	Here, we demonstrate that hypoxia per se is able to induce a rapid systemic hedgehog response in adult mice, as evident from expression of the pathway ligand, Sonic hedgehog, as well as the pathway activity marker Patched1 in various organs.	SEN:10004148	18774959
BEL:20028840	bp(GOBP:"response to hypoxia") increases p(MGI:Shh)	Here, we demonstrate that hypoxia per se is able to induce a rapid systemic hedgehog response in adult mice, as evident from expression of the pathway ligand, Sonic hedgehog, as well as the pathway activity marker Patched1 in various organs.	SEN:10004148	18774959
BEL:20028842	bp(GOBP:"response to hypoxia") increases p(MGI:Snai1)	In addition, exposure of hepatocytes to hypoxia increased levels of Snail mRNA (Fig. 2A) and protein (Fig. 2B and D).	SEN:10018158	20158611
BEL:20028844	bp(GOBP:"response to hypoxia") increases p(MGI:Stat5a,pmod(P))	Here we showed that STAT5a was phosphorylated 10 min after desferrioxamine (DFO) treatment, and reached a maximum induction at 4 h in mammary epithelial cells (HC11) and transfected COS-7 cells. Under hypoxic conditions (2% O2), a maximal phosphorylation of STAT5a was observed within 6 h. These results showed that DFO or hypoxia induces tyrosine phosphorylation of STAT5a.	SEN:10016778	14646587
BEL:20028846	bp(GOBP:"response to hypoxia") increases p(MGI:Tgfb1)	Collectively, these results demonstrate that hypoxic hepatocytes activate latent TGF-beta1 and that this stimulates hepatocyte EMT.	SEN:10018160	20158611
BEL:20028850	bp(GOBP:"response to hypoxia") increases sec(p(MGI:Vegfa))	As evident from Figure 1a, the 10-fold increase in VEGF mRNA induced in mouse embryonic fibroblasts under hypoxia was not matched by a similar increase in the amount of secreted protein, which was merely two-fold.	SEN:10018162	15592500
BEL:20028852	bp(GOBP:"response to hypoxia") decreases tport(complex(p(MGI:Kcns3),p(MGI:Kcnb1)))	Kv2.1/Kv9.3 heteromeric channels are inhibited by hypoxia in the voltage range of the PA VSMC E(M). Thus, these heteromeric channels are strong candidates for the K(+) channel isoforms initiating hypoxic pulmonary vasoconstriction.	SEN:10004150	10488051
BEL:20028856	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:EPAS1))	We further show that p42/p44 MAPK is critical for the hypoxia-induced transactivation of endothelial PAS-domain protein 1 (EPAS1),	SEN:10018164	11207433
BEL:20028864	bp(GOBP:"response to hypoxia") increases tscript(p(MGI:Hif1a))	Thus hypoxia or DMOG exposure potently stabilizes HIF-1 and induces HIF-1-dependent transactivation in HL-1 cardiomyocytes.	SEN:10018168	17545479
BEL:20028866	bp(GOBP:"response to hypoxia") increases tscript(p(MGI:Hif1a))	Under hypoxic condition, HIF proteins enhance this transcriptional activation response by co-occupying Notch target genes together with Notch ICD[30] (Fig. 2).	SEN:10018170	17885420
BEL:20028870	bp(GOBP:"response to hypoxia") increases tscript(p(MGI:Hif1a))	The MEFs that were positive for HIF-1? were capable of inducing miR-210, which is in contrast to the MEFs that were deficient in HIF-1? ( Fig. 2B, top). In parallel, the hypoxia-inducible gene DEC1 was seen to be up-regulated only in the HIF-1??expressing MEFs ( Fig. 2B, bottom).	SEN:10018174	19141645
BEL:20028876	bp(GOBP:"response to hypoxia") increases tscript(p(MGI:Stat5a))	EMSA (electrophoretic mobility shift assay) showed that DFO or hypoxia enhanced the binding activities of STAT5a DNA to beta-casein gene promoter in mammary epithelial cells (HC11) and transfected COS-7 cells. (taof is inferred from increased phosphorylation and increased promoter binding)	SEN:10016780	14646587
BEL:20028882	bp(GOBP:"response to ionizing radiation") decreases deg(p(MGI:Trp53))	In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis.	SEN:10004158	12192050
BEL:20028888	bp(GOBP:"response to ionizing radiation") increases kin(p(HGNC:CHEK2))	As shown in Fig. 3A in normal cells, IR causes activation of Chk2/Cds1 (lane 2), and this activation is inhibited by prior treatment of cells with caffeine (lane 4).	SEN:10015494	10744722
BEL:20028894	bp(GOBP:"response to ionizing radiation") increases p(HGNC:CDC25C,pmod(P,S,216))	Immediately after IR, an increase in serine 216-phosphorylated Cdc25C was observed in the nuclear fraction (Fig. 1B, lane 2), and prior treatment of cells with caffeine inhibited this increase (Fig. 1B, lane 4).	SEN:10015496	10744722
BEL:20028896	bp(GOBP:"response to ionizing radiation") increases p(HGNC:CHEK2,pmod(P,T,68))	As shown in Fig. 5B, immediately after -irradiation, the amount of threonine 68- phosphorylated Chk2 increased (lane 2), and prior treatment of cells with caffeine markedly reduced this increase (lane 4).	SEN:10000088	10744722
BEL:20028898	bp(GOBP:"response to ionizing radiation") increases p(HGNC:CHEK2,pmod(P,T,68))	Substitution of Thr68 with Ala reduced the amount of fully phosphorylated Chk2 by 50%, and Ala substitution at all seven SQyTQ motifs abolished the mobility shift altogether, indicating that phosphorylation of Thr68 is not solely responsible for the shift in electrophoretic mobility after IR (Fig. 6A).	SEN:10018182	10973490
BEL:20028900	bp(GOBP:"response to ionizing radiation") increases p(HGNC:JUN,pmod(P,S,73))	In the absence of CdCl2 pretreatment, ionizing radiation increased both expression (Fig. 3A) and phosphorylation (Fig. 3B) of c-Jun in MRC5CV1 cells but not in AT5BIVA cells.	SEN:10000196	11278277
BEL:20028902	bp(GOBP:"response to ionizing radiation") increases p(HGNC:TP53)	ATM is mutated in the human genetic disorder ataxia telangiectasia, which is characterized by ataxia, immune defects, and cancer predisposition. Cells that lack ATM exhibit delayed up-regulation of p53 in response to ionizing radiation.	SEN:10004160	10713094
BEL:20028910	bp(GOBP:"response to osmotic stress") increases p(MGI:Atf4)	Hypertonic stress increased ATF4 levels in S/S cells and induced mRNA levels for the downstream targets of ATF4: ATF3, and CHOP (supplemental Fig. 3A and data not shown).	SEN:10018186	20338999
BEL:20028912	bp(GOBP:"response to osmotic stress") increases p(MGI:Eef2,pmod(P,T,57))	We found that treatment with hypertonic medium induced elongation factor 2 phosphorylation (Fig. 1B) and dephosphorylation of 4EBP1 (supplemental Fig. 1A) to similar extents in S/S and A/A cells.	SEN:10018188	20338999
BEL:20028914	bp(GOBP:"response to osmotic stress") increases p(MGI:Eif2s1,pmod(P,S,52))	Mouse embryonic fibroblasts (MEFs) from C57BL/6 mice (S/S) treated for 1 h with hypertonic media showed increased eIF2a phosphorylation with increasing stress intensity, without a change in total eIF2A (Fig. 1A). As shown in earlier studies, osmotic stress reduced the phosphorylation of ribosomal protein S6 and 4EBP1 consistent with the inhibition of the mammalian target of rapamycin pathway (25).	SEN:10018190	20338999
BEL:20028916	bp(GOBP:"response to osmotic stress") decreases p(MGI:Eif4ebp1,pmod(P))	Mouse embryonic fibroblasts (MEFs) from C57BL/6 mice (S/S) treated for 1 h with hypertonic media showed increased eIF2a phosphorylation with increasing stress intensity, without a change in total eIF2A (Fig. 1A). As shown in earlier studies, osmotic stress reduced the phosphorylation of ribosomal protein S6 and 4EBP1 consistent with the inhibition of the mammalian target of rapamycin pathway (25).	SEN:10018190	20338999
BEL:20028918	bp(GOBP:"response to osmotic stress") decreases p(MGI:Eif4g2)	Osmotic stress caused a decrease in DAP5 protein levels in both S/S and A/A cells (Fig. 3A), in agreement with the decreased translation of DAP5 mRNA (Fig. 3C).	SEN:10018192	20338999
BEL:20028920	bp(GOBP:"response to osmotic stress") increases p(MGI:Hnrnpa1)	hnRNP A1 levels increased in the cytoplasm of stressed S/S, but not A/A cells (Fig. 4A), showing that the cytoplasmic accumulation of hnRNP A1 during osmotic stress requires eIF2a phosphorylation.	SEN:10018194	20338999
BEL:20028922	bp(GOBP:"response to osmotic stress") decreases p(MGI:Rps6,pmod(P,S,235))	Mouse embryonic fibroblasts (MEFs) from C57BL/6 mice (S/S) treated for 1 h with hypertonic media showed increased eIF2a phosphorylation with increasing stress intensity, without a change in total eIF2A (Fig. 1A). As shown in earlier studies, osmotic stress reduced the phosphorylation of ribosomal protein S6 and 4EBP1 consistent with the inhibition of the mammalian target of rapamycin pathway (25).	SEN:10018190	20338999
BEL:20028924	bp(GOBP:"response to osmotic stress") decreases p(MGI:Rps6,pmod(P,S,236))	Mouse embryonic fibroblasts (MEFs) from C57BL/6 mice (S/S) treated for 1 h with hypertonic media showed increased eIF2a phosphorylation with increasing stress intensity, without a change in total eIF2A (Fig. 1A). As shown in earlier studies, osmotic stress reduced the phosphorylation of ribosomal protein S6 and 4EBP1 consistent with the inhibition of the mammalian target of rapamycin pathway (25).	SEN:10018190	20338999
BEL:20028926	bp(GOBP:"response to osmotic stress") increases tloc(p(MGI:Cycs),GOCCID:0005739,GOCCID:0005737)	As expected, hypertonic stress caused cytochrome c release from mitochondria in S/S but not in A/A cells (supplemental Fig. 1B) consistent with the increase in mitochondria-induced apoptosis in the former cells.	SEN:10018196	20338999
BEL:20028928	bp(GOBP:"response to osmotic stress") increases tloc(p(MGI:Nfat5),GOCCID:0005829,GOCCID:0005634)	Treatment of S/S and A/A cells with hypertonic medium increased both extracellular signal-regulated kinase (ERK) phosphorylation and TonEBP nuclear translocation (supplemental Fig. 2, A and B).	SEN:10018198	20338999
BEL:20028934	bp(GOBP:"response to oxidative stress") increases cat(p(HGNC:ALOX5))	It was found that 5-LO in the Epstein-Barr virus-transformed B-lymphocytic cell line BL41-E95-A is activated by addition of hydrogen peroxide or xanthine/xanthine oxidase and after increasing the oxidative state of the cell	SEN:10003424	10691962
BEL:20028942	bp(GOBP:"response to oxidative stress") increases complex(p(MGI:Foxo3),p(MGI:Sirt1))	SIRT1 and the FOXO transcription factor FOXO3 formed a complex in cells in response to oxidative stress	SEN:10004166	14976264
BEL:20028944	bp(GOBP:"response to oxidative stress") decreases complex(p(MGI:Keap1),p(MGI:Nfe2l2))	oxidative and electrophilic stresses induce the nuclear accumulation of Nrf2 by affecting the Keap1-mediated rapid turnover of Nrf2	SEN:10018204	16354693
BEL:20028950	bp(GOBP:"response to oxidative stress") increases p(MGI:Foxo3,pmod(A))	We have shown that FOXO3 and p53 are acetylated when SIRT1 is reduced in response to oxidants/CS exposure in mouse lung and in lung epithelial cells [39] and [158] S. Rajendrasozhan, S.R. Yang, S. Caito and I. Rahman, Am. J. Respir. Crit. Care Med. 177 (2008), p. A266.[158]	SEN:10018206	20450879
BEL:20028954	bp(GOBP:"response to oxidative stress") increases p(MGI:Trp53,pmod(A))	We have shown that FOXO3 and p53 are acetylated when SIRT1 is reduced in response to oxidants/CS exposure in mouse lung and in lung epithelial cells [39] and [158] S. Rajendrasozhan, S.R. Yang, S. Caito and I. Rahman, Am. J. Respir. Crit. Care Med. 177 (2008), p. A266.[158]	SEN:10018206	20450879
BEL:20028958	bp(GOBP:"response to oxidative stress") increases tscript(p(MGI:Bach2))	Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies.	SEN:10004170	11923289
BEL:20028960	bp(GOBP:"response to oxidative stress") increases tscript(p(MGI:Nfe2l2))	oxidative and electrophilic stresses induce the nuclear accumulation of Nrf2 by affecting the Keap1-mediated rapid turnover of Nrf2	SEN:10018204	16354693
BEL:20028964	bp(GOBP:"response to oxidative stress") increases tscript(p(MGI:Trp53))	These results suggest that Bach1 is a negative regulator of the p53-mediated senescence program in response to oxidative stress, although Bach1 could be either parallel or upstream to p53 in this process.	SEN:10018212	19011633
BEL:20029016	bp(GOBP:"response to UV") increases deg(p(MGI:Polr2a))	The elongating hyperphosphorylated Rpb1 is subject to ubiquitination, particularly in response to UV radiation and DNA-damaging agents.	SEN:10004174	12604794
BEL:20029022	bp(GOBP:"response to UV") increases kin(p(MGI:Ern1))	ER stress led to a twofold increase in JNK activity in wild-type fibroblasts, whereas in the IRE1alpha-^sup 1^- fibroblasts JNK activity was decreased by ER stress (Fig. 2B).	SEN:10016334	10650002
BEL:20029024	bp(GOBP:"response to UV") increases kin(p(MGI:Mapk8))	Whereas UV treatment led to robust JNK activation in both WT and TNFR1-/- cells, TNF activates JNK only in WT and not in TNFR1-/- cells.	SEN:10018248	16680093
BEL:20029026	bp(GOBP:"response to UV") increases kin(p(MGI:Mapk8))	Elk-1 is phosphorylated by both kinases (MAPK8 and MAPK9) , each of which is strongly stimulated by pre-treatment of cells with ultraviolet light.	SEN:10018250	8548291
BEL:20029028	bp(GOBP:"response to UV") increases kin(p(MGI:Mapk9))	Elk-1 is phosphorylated by both kinases (MAPK8 and MAPK9) , each of which is strongly stimulated by pre-treatment of cells with ultraviolet light.	SEN:10018250	8548291
BEL:20029030	bp(GOBP:"response to UV") increases p(HGNC:BRCA1,pmod(P,S,1423))	Increased expression of ATR enhanced the phosphorylation of BRCA1 on Ser 1423 following cellular exposure to HU or UV light, whereas doxycycline-induced expression of a kinase-inactive ATR mutant protein inhibited HU- or UV light-induced Ser 1423 phosphorylation in GM847 fibroblasts, and partially suppressed the phosphorylation of this site in response to IR.	SEN:10015806	11114888
BEL:20029032	bp(GOBP:"response to UV") increases p(MGI:Ccnd1)	UV exposure strongly induced cyclin D expression with a maximum at 24 h in wild-type skin. In Egfr-null skin, in contrast, no induction of cyclin D expression was detected (Figure 3D).	SEN:10018252	16123117
BEL:20029034	bp(GOBP:"response to UV") increases p(MGI:Cdkn1a)	p53 and p21 expression was increased by 2- and 5-fold, respectively, 3 days post-UV in Egfr-wild-type skin when compared with sham-irradiated controls (Figure 5). Both p21 and p53 expression were elevated several fold in Egfr-null compared with wild-type skin at both 24 and 48 h post-UV (Figure 5).	SEN:10018254	16123117
BEL:20029036	bp(GOBP:"response to UV") increases p(MGI:Elk4,pmod(P))	Therefore, we also analyzed NIH 3T3 cells that were serum deprived and then stimulated with either H2O2, anisomycin or UV light. All of these stimuli resulted in increased phosphorylation of Myc–Sap-1a, most prominently seen with H2O2 (Figure 8B)	SEN:10015792	9130707
BEL:20029042	bp(GOBP:"response to UV") increases p(MGI:Trp53)	p53 and p21 expression was increased by 2- and 5-fold, respectively, 3 days post-UV in Egfr-wild-type skin when compared with sham-irradiated controls (Figure 5). Both p21 and p53 expression were elevated several fold in Egfr-null compared with wild-type skin at both 24 and 48 h post-UV (Figure 5).	SEN:10018254	16123117
BEL:20029058	bp(GOBP:"T cell activation") increases p(MGI:Il17a)	Interleukin (IL)-17 is a pro-inflammatory cytokine that is produced by activated T cells. We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion. IL-23 also induced expression of the related cytokine IL-17F.IL-23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles.	SEN:10018268	12417590
BEL:20029060	bp(GOBP:"T cell activation") increases p(MGI:Il17f)	Interleukin (IL)-17 is a pro-inflammatory cytokine that is produced by activated T cells. We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion. IL-23 also induced expression of the related cytokine IL-17F.IL-23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles.	SEN:10018268	12417590
BEL:20029062	bp(GOBP:"T cell activation") increases p(MGI:Maf)	To examine mechanisms of VPAC(2) promotion of the Th2 phenotype, we analyzed controls of IL-4 transcription in CD4 T cells from T cell-targeted VPAC(2) transgenic (Tg), VPAC(2) knockout, and wild-type (WT) mice. c-maf and junB mRNA, protein, and activity were significantly up-regulated to a higher level in TCR-stimulated CD4 T cells from Tg mice compared with those from knockout and WT C57BL/6 mice.	SEN:10004184	15187104
BEL:20029070	bp(GOBP:"T cell activation") increases tscript(p(MGI:Irf8))	Taken together, these results indicate that IRF8 is induced during T-cell activation, and that TH17-cell differentiation is enhanced in cells deficient in IRF8.	SEN:10018270	21587231
BEL:20029072	bp(GOBP:"T cell activation") increases tscript(p(MGI:Junb))	To examine mechanisms of VPAC(2) promotion of the Th2 phenotype, we analyzed controls of IL-4 transcription in CD4 T cells from T cell-targeted VPAC(2) transgenic (Tg), VPAC(2) knockout, and wild-type (WT) mice. c-maf and junB mRNA, protein, and activity were significantly up-regulated to a higher level in TCR-stimulated CD4 T cells from Tg mice compared with those from knockout and WT C57BL/6 mice.	SEN:10004184	15187104
BEL:20029088	bp(GOBP:"Wnt receptor signaling pathway") decreases kin(p(MGI:Gsk3b))	The accumulation of beta-catenin results from the inhibition of the GSK3b kinase, which normally would phosphorylate beta-catenin as a degradation signal.	SEN:10018280	15225871
BEL:20029090	bp(GOBP:"Wnt receptor signaling pathway") increases p(MGI:Ctnnb1)	As shown in Fig. 4, the essential event in Wnt signaling is the accumulation of b-catenin and the subsequent transcriptional activation by a complex of b-catenin and TCF/LEF transcription factors.	SEN:10018282	15225871
BEL:20029092	bp(GOBP:"wound healing") increases p(MGI:Ifna2)	pDCs were found to rapidly infiltrate both murine and human skin wounds and to transiently produce type I IFNs via TLR7- and TLR9-dependent recognition of nucleic acids.	SEN:10004192	21115688
BEL:20029102	bp(GOBP:"apoptotic process") increases cat(p(MGI:Pla2g4a))	both Pla2g6 and cPLA2 are activated during apoptosis Pla2g6 is involved in the hydrolysis of plasma membrane phospholipids and exposure of the epitope recognized by IgM	SEN:10018288	12208880
BEL:20029104	bp(GOBP:"apoptotic process") increases cat(p(MGI:Pla2g6))	both Pla2g6 and cPLA2 are activated during apoptosis Pla2g6 is involved in the hydrolysis of plasma membrane phospholipids and exposure of the epitope recognized by IgM	SEN:10018288	12208880
BEL:20029108	bp(GOBP:"apoptotic process") increases deg(p(HGNC:EIF4B))	Eukaryotic initiation factor (eIF) 4B interacts with several components of the initiation pathway and is targeted for cleavage during apoptosis. In a cell-free system, cleavage of eIF4B by caspase-3 coincides with a general inhibition of protein synthetic activity.	SEN:10018286	11274152
BEL:20029128	bp(GOBP:"necrotic cell death") increases sec(p(HGNC:CALR))	Necrotic but not apoptotic cell death leads to release of HSP gp96, calreticulin, hsp90 and hsp70.	SEN:10018300	11058573
BEL:20029130	bp(GOBP:"necrotic cell death") increases sec(p(HGNC:HSP90AA1))	Necrotic but not apoptotic cell death leads to release of HSP gp96, calreticulin, hsp90 and hsp70.	SEN:10018300	11058573
BEL:20029132	bp(GOBP:"necrotic cell death") increases sec(p(HGNC:HSP90B1))	Necrotic but not apoptotic cell death leads to release of HSP gp96, calreticulin, hsp90 and hsp70.	SEN:10018300	11058573
BEL:20029184	cat(complex(p(HGNC:CREBBP),p(HGNC:EP300))) increases tscript(p(HGNC:KLF1))	The coactivators CBP and P300 interact with, acetylate, and enhance its activity, helping to explain its role as a transcription activator.	SEN:10004208	11287616
BEL:20029186	cat(complex(p(HGNC:ITGA6),p(HGNC:ITGB1))) decreases p(HGNC:PXN)	Certain integrins may regulate proliferation by additional mechanisms. For example, the a6b1 integrin may in part promote exit from the cell cycle in myoblasts, because the cytoplasmic domain of a6 inhibits paxillin signaling (44).	SEN:10018334	10446041
BEL:20029190	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) increases bp(GOBP:"cell migration")	Second, such activation appears to be the result of affinity modulation because VEGF165-stimulated cells acquired the capacity to bind the soluble monovalent ligand- mimetic anti-aVb3 antibody, WOW-1 Fab. Fourth, a particularly relevant functional consequence of VEGF165 activation of aVb3 is the augmentation of cell migration.	SEN:10018338	11090623
BEL:20029198	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) increases kin(p(HGNC:EGFR))	Alternatively, this integrin complex can interact with tenascin-C, thus favoring the clustering of EGF receptors and EGF-dependent growth (Jones et al., 1997).	SEN:10018346	10022831
BEL:20029200	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) increases kin(p(HGNC:PDGFRA))	For example, avb3 associates with the PDGF receptor, and fibroblasts show greater proliferation in response to PDGFb when adhering to the avb3 ligand vitronectin than when they adhere to the b1 integrin ligand collagen (26).	SEN:10018348	10446041
BEL:20029202	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) increases kin(p(HGNC:PDGFRB))	For example, avb3 associates with the PDGF receptor, and fibroblasts show greater proliferation in response to PDGFb when adhering to the avb3 ligand vitronectin than when they adhere to the b1 integrin ligand collagen (26).	SEN:10018348	10446041
BEL:20029210	cat(complex(p(MGI:Itga8),p(MGI:Itgb1))) increases bp(GOBP:"cell adhesion")	These results suggest that POEM is a novel ligand for alpha(8)beta(1) integrin and that POEM may be involved in the development and function of various tissues, such as kidney, bone, muscles, and endocrine organs.	SEN:10004212	11546798
BEL:20029216	cat(complex(p(MGI:Itgad),p(MGI:Itgb2))) increases cat(p(MGI:Vtn))	To examine whether D2 can support leukocyte migration, we have examined the ability of vitronectin, as a representative ECM protein, to mediate migration of IC-21 cells. As shown in Figure 5B, cells efficiently migrated toward vitronectin and this process depended on both D2 and M2 because anti-D polyclonal antibody and anti-M mAb M1/70 blocked the response.	SEN:10018354	16239428
BEL:20029218	cat(complex(p(MGI:Itgam),p(MGI:Itgb2))) increases cat(p(MGI:Vtn))	To examine whether D2 can support leukocyte migration, we have examined the ability of vitronectin, as a representative ECM protein, to mediate migration of IC-21 cells. As shown in Figure 5B, cells efficiently migrated toward vitronectin and this process depended on both D2 and M2 because anti-D polyclonal antibody and anti-M mAb M1/70 blocked the response.	SEN:10018354	16239428
BEL:20029220	cat(complex(p(MGI:Itgav),p(MGI:Itgb3))) increases bp(GOBP:"cell adhesion")	In this study, we show that purified Fisp12 (mCTGF) protein promotes the adhesion of microvascular endothelial cells through the integrin receptor alphavbeta3.	SEN:10018356	10082563
BEL:20029222	cat(complex(p(MGI:Itgav),p(MGI:Itgb3))) increases bp(GOBP:"cell migration")	Furthermore, Fisp12 stimulates the migration of microvascular endothelial cells in culture, also through an integrin-alphavbeta3-dependent mechanism.	SEN:10004218	10082563
BEL:20029266	cat(p(EGID:104263)) decreases tscript(p(MGI:Etv2))	Furthermore, TSGA impairs the ability of ER71 to activate transcription from the matrix metalloproteinase-1 promoter.	SEN:10004230	16619273
BEL:20029268	cat(p(MGI:Il1a)) increases kin(p(MGI:Irak1))	Interleukin-1 receptor-associated kinase, IRAK, has been shown to activate NFkappaB in response to interleukin-1.	SEN:10001664	10446393
BEL:20029270	cat(p(EGID:116816)) increases kin(p(MGI:Mapk1))	In addition to chemotaxis, Fprs also mediate neutrophil activation by Listeria lysate as shown by increased phosphorylation of extracellular regulatory kinase (Erk) 1/2 in WT mouse neutrophils, which was reduced by Fpr1 or Fpr2 antagonist.	SEN:10018374	23139859
BEL:20029272	cat(p(EGID:116816)) increases kin(p(MGI:Mapk3))	In addition to chemotaxis, Fprs also mediate neutrophil activation by Listeria lysate as shown by increased phosphorylation of extracellular regulatory kinase (Erk) 1/2 in WT mouse neutrophils, which was reduced by Fpr1 or Fpr2 antagonist.	SEN:10018374	23139859
BEL:20029274	cat(p(EGID:116817)) increases kin(p(MGI:Mapk1))	In addition to chemotaxis, Fprs also mediate neutrophil activation by Listeria lysate as shown by increased phosphorylation of extracellular regulatory kinase (Erk) 1/2 in WT mouse neutrophils, which was reduced by Fpr1 or Fpr2 antagonist.	SEN:10018374	23139859
BEL:20029276	cat(p(EGID:116817)) increases kin(p(MGI:Mapk3))	In addition to chemotaxis, Fprs also mediate neutrophil activation by Listeria lysate as shown by increased phosphorylation of extracellular regulatory kinase (Erk) 1/2 in WT mouse neutrophils, which was reduced by Fpr1 or Fpr2 antagonist.	SEN:10018374	23139859
BEL:20029282	cat(p(EGID:330914)) directlyDecreases gtp(p(MGI:Cdc42))	RICS is mainly expressed in the brain and functions as a RhoGAP protein for Cdc42 and Rac1 in vitro.	SEN:10004232	16716191
BEL:20029284	cat(p(EGID:330914)) decreases gtp(p(MGI:Cdc42))	RICS knockout mice developed normally and were fertile. However, when cultured in vitro, Cdc42 activity in RICS(-/-) neurons was higher than that in wild-type neurons.	SEN:10004234	16716191
BEL:20029286	cat(p(EGID:330914)) directlyDecreases gtp(p(MGI:Rac1))	RICS is mainly expressed in the brain and functions as a RhoGAP protein for Cdc42 and Rac1 in vitro.	SEN:10004232	16716191
BEL:20029288	cat(p(EGID:3577)) increases complex(p(HGNC:FGR),p(HGNC:AP2B1))	Interleukin 8 (IL-8) activation of the chemokine receptor CXCRI was found to stimulate rapid formation of beta-arrestin complexes with Hck or c-Fgr. Formation of beta-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions.	SEN:10004236	10973280
BEL:20029290	cat(p(EGID:3577)) increases complex(p(HGNC:HCK),p(HGNC:AP2B1))	Interleukin 8 (IL-8) activation of the chemokine receptor CXCRI was found to stimulate rapid formation of beta-arrestin complexes with Hck or c-Fgr. Formation of beta-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions.	SEN:10004236	10973280
BEL:20029302	cat(p(HGNC:ACSL4)) decreases bp(GOBP:"apoptotic process")	% Exogenous arachidonic acid caused apoptosis in colon cancer and other cell lines, as did triacsin C, a FACL inhibitor. In addition, indomethacin and sulindac significantly enhanced the apoptosis-inducing effect of triacsin C.	SEN:10004008	11005842
BEL:20029304	cat(p(HGNC:ADAM12)) increases deg(p(HGNC:IGFBP3))	ADAM 12-S has IGFBP-3 protease activity, and it may contribute to the IGFBP-3 protease activity present in pregnancy serum.	SEN:10004242	10849447
BEL:20029318	cat(p(HGNC:AGTR1)) increases p(HGNC:OLR1)	Importantly, the increase in LOX-1 mRNA expression in response to Ang II was completely blocked by losartan, a specific AT1 blocker, but not by PD123319, a specific AT2 blocker (n56, Figure 5). The increased LOX-1 protein expression in response to Ang II was also blocked by pretreatment of HCAECs with losartan, but not with PD123319 (n56, Figure 6).	SEN:10018384	10325241
BEL:20029322	cat(p(HGNC:AGTR1)) increases r(HGNC:OLR1)	Importantly, the increase in LOX-1 mRNA expression in response to Ang II was completely blocked by losartan, a specific AT1 blocker, but not by PD123319, a specific AT2 blocker (n56, Figure 5). The increased LOX-1 protein expression in response to Ang II was also blocked by pretreatment of HCAECs with losartan, but not with PD123319 (n56, Figure 6).	SEN:10018384	10325241
BEL:20029342	cat(p(HGNC:ALOX5)) increases bp(GOBP:"cell proliferation")	Inhibitors of the enzyme 5-lipoxygenase reduce proliferation and initiate programmed cell death in many different types of malignantly transformed cells	SEN:10000128	10953307
BEL:20029346	cat(p(HGNC:ANXA2)) increases bp(GOBP:"osteoclast differentiation")	We have recently identified two novel stimulators of OCL osteoclast formation, annexin II and osteoclast stimulatory factor (3), and an inhibitor of OCL formation,human ScaI	SEN:10018392	10488118
BEL:20029352	cat(p(HGNC:APC)) decreases p(HGNC:CTNNB1)	The mutational inactivation of a tumor suppressor gene, adenomatous polyposis coli (APC), results in the accumulation of cytoplasmic beta-catenin protein and the activation of T-cell factor (TCF)/lymphoid enhancer factor transcriptional factors.	SEN:10018394	10987283
BEL:20029354	cat(p(HGNC:APC)) decreases tscript(p(HGNC:LEF1))	The mutational inactivation of a tumor suppressor gene, adenomatous polyposis coli (APC), results in the accumulation of cytoplasmic beta-catenin protein and the activation of T-cell factor (TCF)/lymphoid enhancer factor transcriptional factors.	SEN:10018394	10987283
BEL:20029380	cat(p(HGNC:ATXN1)) decreases bp(GOBP:"osteoclast differentiation")	We have recently identified two novel stimulators of OCL osteoclast formation, annexin II and osteoclast stimulatory factor (3), and an inhibitor of OCL formation,human ScaI	SEN:10018392	10488118
BEL:20029386	cat(p(HGNC:BAD)) increases bp(GOBP:"apoptotic process")	Rsk1 directly phosphorylated the pro-apoptotic protein Bad at the serine %residues that, when phosphorylated, abrogate Bad's pro-apoptotic function.	SEN:10000878	10679322
BEL:20029394	cat(p(HGNC:BCL2L11)) directlyIncreases complex(p(HGNC:BCL2),p(HGNC:BCL2L11))	This freed Bim to translocate together with LC8 to Bcl-2 and to neutralize its antiapoptotic activity.	SEN:10018408	10198631
BEL:20029406	cat(p(HGNC:BDKRB1)) increases r(HGNC:COL1A1)	We examined human embryonic lung fibroblasts that constitutively express the B1 receptor and report that engagement of the B1 receptor by des-Arg(10)-kallidin stabilized connective tissue growth factor (CTGF) mRNA, stimulated an increase in alpha1(I) collagen mRNA, and stimulated type I collagen production.	SEN:10018414	10777533
BEL:20029422	cat(p(HGNC:BTRC)) increases deg(p(HGNC:CTNNB1))	In contrast, a dominant-negative mutant form of FWD1 inhibited the ubiquitination process and stabilized beta-catenin.	SEN:10000042	10228155
BEL:20029428	cat(p(HGNC:C3AR1)) increases r(HGNC:CCL4)	transient expression of C3a receptors in HMC-1 cells rendered the cells responsive to C3a for sustained Ca(2+) mobilization and MIP-1ss production.	SEN:10018416	11120854
BEL:20029432	cat(p(HGNC:CALM1)) decreases complex(p(HGNC:MEF2A),p(HGNC:HDAC4))	Because Cabin-1 also associates with mSin3a and histone deacetylases 1 and 2 (HDAC1/2), its dissociation from MEF2 may replace a repressing complex with an activating complex (51). In a like manner, MEF2 binds and is repressed by HDAC4 but is released by Ca2+/CaM binding to HDAC4 (52).	SEN:10000142	11096122
BEL:20029446	cat(p(HGNC:CASP3)) decreases cat(p(HGNC:BCL2))	Caspase-3 cleaves Bcl-2 and Bcl-XL, which destroys the anti-apoptotic function of these proteins and releases C-terminal fragments that are pro-apoptotic.	SEN:10018422	10400609
BEL:20029450	cat(p(HGNC:CASP3)) decreases cat(p(HGNC:BCL2L1))	Caspase-3 cleaves Bcl-2 and Bcl-XL, which destroys the anti-apoptotic function of these proteins and releases C-terminal fragments that are pro-apoptotic.	SEN:10018422	10400609
BEL:20029454	cat(p(HGNC:CASP3)) increases cat(p(HGNC:DFFA))	caspase-3 cleaves ICAD, prompting release of active CAD, which then cleaves DNA and promotes chromatin condensation.	SEN:10018426	10400609
BEL:20029456	cat(p(HGNC:CASP3)) decreases cat(p(HGNC:DFFA))	Following FAS stimulation, caspase-8 activates caspase-3, which in turn activates the caspase-activated DNAse (CAD) by proteolysis of its inhibitor (ICAD)	SEN:10004290	11004695
BEL:20029458	cat(p(HGNC:CASP3)) increases cat(p(HGNC:DFFB))	Following FAS stimulation, caspase-8 activates caspase-3, which in turn activates the caspase-activated DNAse (CAD) by proteolysis of its inhibitor (ICAD)	SEN:10004290	11004695
BEL:20029462	cat(p(HGNC:CASP3)) directlyIncreases cat(p(HGNC:GAS2))	Treatment with increasing amounts of caspase-3 for 30 minutes at 37°C specifically cleaved Gas2, thus producing a band showing similar electrophoretic mobility (Å31 kDa) with respect to Gas2 as detected in extracts of apoptotic cells...In summary we can conclude that Gas2 is a direct substrate of caspase-3 and that the aspartic residue 279 is critical both for its in vitro and in vivo proteolytic processing.	SEN:10018430	10564664
BEL:20029464	cat(p(HGNC:CASP3)) increases cat(p(HGNC:GSN))	Caspase-3 also cleaves and activates gelsolin, a protein that regulates actin dynamics. Interestingly, activated gelsolin promotes both cytoplasmic and nuclear apoptosis, including DNA fragmentation.	SEN:10018432	10400609
BEL:20029470	cat(p(HGNC:CASP3)) directlyIncreases deg(p(HGNC:ADD1))	Cleavage of the actin-capping protein alpha -adducin at Asp-Asp-Ser-Asp633-Ala by caspase-3 is preceded by its phosphorylation on serine 726 in cisplatin- induced apoptosis of renal epithelial cells.	SEN:10004296	10823823
BEL:20029474	cat(p(HGNC:CASP3)) directlyIncreases deg(p(HGNC:CTNNB1))	Cleavage of beta-catenin was found to be caspase-dependent. Five cleavage products of beta-catenin were identified in vivo and after in vitro cleavage by caspase-3 . . . Functional analysis revealed that beta-catenin deletion constructs resembling the observed proteolytic fragments show a strongly reduced transcription activation potential when analyzed in gene reporter assays.	SEN:10018436	10748026
BEL:20029476	cat(p(HGNC:CASP3)) increases deg(p(HGNC:EIF4B))	Eukaryotic initiation factor (eIF) 4B interacts with several components of the initiation pathway and is targeted for cleavage during apoptosis. In a cell-free system, cleavage of eIF4B by caspase-3 coincides with a general inhibition of protein synthetic activity.	SEN:10018286	11274152
BEL:20029478	cat(p(HGNC:CASP3)) increases deg(p(HGNC:PARG))	recombinant caspase-3 efficiently cleaved PARG in vitro, suggesting the involvement of this protease in PARG processing in vivo caspase-3-deficient MCF-7 cells did not show any PARG cleavage in response to staurosporine treatment	SEN:10016298	11053413
BEL:20029490	cat(p(HGNC:CASP6)) directlyIncreases deg(p(HGNC:LMNB1))	While lamin B is cleaved by caspase 6, the protease responsible for the cleavage of LAP2 and Nup153 was probably caspase 3, since (1) cleavage of both proteins was specifically prevented by in vivo addition of caspase 3 inhibitor Ac-DEVD-CHO and (2) consensus sites for these caspases are present in both proteins.	SEN:10004300	10318766
BEL:20029492	cat(p(HGNC:CASP7)) increases bp(GOBP:"apoptotic process")	These results suggest that PKC eta protects MCF-7 cells against TNF-induced cell death by preventing the activation of caspases.	SEN:10000920	11112424
BEL:20029494	cat(p(HGNC:CASP7)) directlyIncreases cat(p(HGNC:GAS2))	In vitro translated Gas2 was incubated with increasing amounts of purified caspase-7 for 90 minutes at 37°C. As shown in Fig. 5, 200 ng of caspase-7 were required for the full processing of Gas2 while partial Gas2 processing was observed after incubation with 20 ng of caspase-7.	SEN:10018442	10564664
BEL:20029498	cat(p(HGNC:CASP8)) increases bp(GOBP:"apoptotic process")	These results suggest that PKC eta protects MCF-7 cells against TNF-induced cell death by preventing the activation of caspases.	SEN:10000920	11112424
BEL:20029500	cat(p(HGNC:CASP8)) increases cat(p(HGNC:CASP3))	Following FAS stimulation, caspase-8 activates caspase-3, which in turn activates the caspase-activated DNAse (CAD) by proteolysis of its inhibitor (ICAD)	SEN:10004290	11004695
BEL:20029510	cat(p(HGNC:CASP9)) directlyIncreases cat(p(HGNC:CASP3))	Moreover, we demonstrate that DCC interacts with both caspase-3 and caspase-9 and drives the activation of caspase-3 through caspase-9 without a requirement for cytochrome c or Apaf-1.	SEN:10000182	11248093
BEL:20029516	cat(p(HGNC:CBL)) increases p(HGNC:EGFR,pmod(U,K))	Ligation of ubiquitin to EGFR was followed by either labeling of the receptor (with a radioactive phosphate) or by using a radioactive ubiquitin. As we previously reported, bacterially expressed c-Cbl fused to glutathione S-transferase (GST–Cbl) enabled receptor ubiquitination ( Figure 2A).	SEN:10018450	10635327
BEL:20029520	cat(p(HGNC:CCL4)) increases kin(p(HGNC:SYK))	Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation.	SEN:10002144	10747947
BEL:20029530	cat(p(HGNC:CD40)) decreases bp(GOBP:"cell growth")	Following exposure to either CD40-specific mAbs or the soluble trimeric ligand (sCD40L), high responder (HR) lines showed rapid aggregation, activation of NF-kappa B, up-regulation of cell surface markers ICAM-1/CD54 and Fas/CD95, and growth inhibition	SEN:10000958	10092782
BEL:20029534	cat(p(HGNC:CD40)) increases p(HGNC:CCL2)	Importantly, CD40 ligation enhanced the sensitivity of airway epithelial cells to the effects of TNF-alpha and/or IL-1beta on expression of RANTES, MCP-1, IL-8, and VCAM-1. In contrast, neither IL-4 nor IL-13 modified the effects of CD40 engagement on the expression of RANTES, MCP-1, IL-8, or VCAM-1; however, both IL-4 and IL-13 attenuated the effects of CD40 cross-linking on ICAM-1 expression	SEN:10018458	10925309
BEL:20029536	cat(p(HGNC:CD40)) increases p(HGNC:CCL5)	Importantly, CD40 ligation enhanced the sensitivity of airway epithelial cells to the effects of TNF-alpha and/or IL-1beta on expression of RANTES, MCP-1, IL-8, and VCAM-1. In contrast, neither IL-4 nor IL-13 modified the effects of CD40 engagement on the expression of RANTES, MCP-1, IL-8, or VCAM-1; however, both IL-4 and IL-13 attenuated the effects of CD40 cross-linking on ICAM-1 expression	SEN:10018458	10925309
BEL:20029538	cat(p(HGNC:CD40)) increases p(HGNC:ICAM1)	Importantly, CD40 ligation enhanced the sensitivity of airway epithelial cells to the effects of TNF-alpha and/or IL-1beta on expression of RANTES, MCP-1, IL-8, and VCAM-1. In contrast, neither IL-4 nor IL-13 modified the effects of CD40 engagement on the expression of RANTES, MCP-1, IL-8, or VCAM-1; however, both IL-4 and IL-13 attenuated the effects of CD40 cross-linking on ICAM-1 expression	SEN:10018458	10925309
BEL:20029544	cat(p(HGNC:CD40)) increases p(HGNC:IL8)	Importantly, CD40 ligation enhanced the sensitivity of airway epithelial cells to the effects of TNF-alpha and/or IL-1beta on expression of RANTES, MCP-1, IL-8, and VCAM-1. In contrast, neither IL-4 nor IL-13 modified the effects of CD40 engagement on the expression of RANTES, MCP-1, IL-8, or VCAM-1; however, both IL-4 and IL-13 attenuated the effects of CD40 cross-linking on ICAM-1 expression	SEN:10018458	10925309
BEL:20029550	cat(p(HGNC:CD40)) increases r(HGNC:BIRC3)	As expected, CD40-induced cIAP2 protein expression in DCs could be blocked by SB203580 (Fig. 5 , C and D ).	SEN:10018462	10570261
BEL:20029552	cat(p(HGNC:CD40)) increases r(HGNC:CCL5)	SB203580 strongly blocked CD40-induced IL-12 p40 production in DCs at both mRNA and protein levels, while having minimal effect on CD40-induced expression of the chemokine RANTES.	SEN:10004310	10570261
BEL:20029554	cat(p(HGNC:CD40)) increases r(HGNC:FAS)	Following exposure to either CD40-specific mAbs or the soluble trimeric ligand (sCD40L), high responder (HR) lines showed rapid aggregation, activation of NF-kappa B, up-regulation of cell surface markers ICAM-1/CD54 and Fas/CD95, and growth inhibition	SEN:10000958	10092782
BEL:20029556	cat(p(HGNC:CD40)) increases r(HGNC:ICAM1)	Following exposure to either CD40-specific mAbs or the soluble trimeric ligand (sCD40L), high responder (HR) lines showed rapid aggregation, activation of NF-kappa B, up-regulation of cell surface markers ICAM-1/CD54 and Fas/CD95, and growth inhibition	SEN:10000958	10092782
BEL:20029574	cat(p(HGNC:CMA1)) increases deg(p(HGNC:SERPINA1))	Importantly, the heparin proteoglycan-bound chymase, but not unbound chymase, degraded its inhibitor (alpha1-antitrypsin) in the presence of its substrate (HDL3).	SEN:10018466	11223430
BEL:20029578	cat(p(HGNC:CMA1)) increases sec(p(HGNC:KITLG))	Although overnight incubation of the eosinophils in either culture medium or in phorbol 12-myristate 13-acetate-calcium ionophore did not cause the secretion of SCF, the addition of chymase induced SCF release.	SEN:10004318	11159541
BEL:20029596	cat(p(HGNC:CTSB)) increases cat(p(HGNC:PLAU))	uPA is secreted as an inactive single-chain proenzyme. Secreted pro-uPA binds to the uPA receptor (uPAR) present on many different cell types. Cleavage of pro-uPA by plasmin, Factor XIIa or cathepsin B yields the active enzyme consisting of two disulfide-linked chains (17).	SEN:10018476	11172729
BEL:20029640	cat(p(HGNC:EIF4E)) directlyIncreases p(HGNC:CCND1)	Thus, mTOR also controls eIF4E function, which is particularly important in the translation of mRNAs containing a highly structured 5' untranslated region (UTR), such as the transcripts encoding cyclin D1 and the c-myc oncogene ([82]).	SEN:10018490	11057898
BEL:20029642	cat(p(HGNC:EIF4E)) directlyIncreases p(HGNC:MYC)	Thus, mTOR also controls eIF4E function, which is particularly important in the translation of mRNAs containing a highly structured 5' untranslated region (UTR), such as the transcripts encoding cyclin D1 and the c-myc oncogene ([82]).	SEN:10018490	11057898
BEL:20029648	cat(p(HGNC:EP300)) increases r(HGNC:AHR)	Cotransfection of an AhR promoter-luciferase reporter plasmid with a vector expressing the E1A(12s) oncoprotein, a negative regulator of p300, a protein with histone acetylase activity, decreased AhR promoter activity fivefold.	SEN:10004340	10666294
BEL:20029652	cat(p(HGNC:EPO)) decreases cat(p(HGNC:CASP3))	IFN-gamma induced Fas expression of the cells without the activation of caspase8 or caspase3 during 16 hours of incubation, while deprivation of EPO induced expression of Fas and the activation of both caspase8 and caspase3	SEN:10004342	10845905
BEL:20029654	cat(p(HGNC:EPO)) decreases cat(p(HGNC:CASP8))	IFN-gamma induced Fas expression of the cells without the activation of caspase8 or caspase3 during 16 hours of incubation, while deprivation of EPO induced expression of Fas and the activation of both caspase8 and caspase3	SEN:10004342	10845905
BEL:20029656	cat(p(HGNC:EPO)) decreases r(HGNC:FAS)	IFN-gamma induced Fas expression of the cells without the activation of caspase8 or caspase3 during 16 hours of incubation, while deprivation of EPO induced expression of Fas and the activation of both caspase8 and caspase3	SEN:10004342	10845905
BEL:20029662	cat(p(HGNC:F12)) increases cat(p(HGNC:PLAU))	uPA is secreted as an inactive single-chain proenzyme. Secreted pro-uPA binds to the uPA receptor (uPAR) present on many different cell types. Cleavage of pro-uPA by plasmin, Factor XIIa or cathepsin B yields the active enzyme consisting of two disulfide-linked chains (17).	SEN:10018476	11172729
BEL:20029674	cat(p(HGNC:F2)) increases cat(p(HGNC:F2R))	Stimulation of human platelets with thrombin or thrombin receptor agonist peptide (TRAP/ Ser-Phe-Leu-Leu-Arg-Asn) resulted in phosphorylation of the protease-activated receptor 1 (PAR1)	SEN:10000096	10780327
BEL:20029676	cat(p(HGNC:F2)) increases kin(p(HGNC:STK33))	The results showed that treatment of platelets with thrombin induced about 10- fold increase in the activity of the 33-kDa Ser/Thr protein kinase	SEN:10004352	10780327
BEL:20029678	cat(p(HGNC:F2)) increases p(HGNC:F2R,pmod(P))	Stimulation of human platelets with thrombin or thrombin receptor agonist peptide (TRAP/ Ser-Phe-Leu-Leu-Arg-Asn) resulted in phosphorylation of the protease-activated receptor 1 (PAR1)	SEN:10000096	10780327
BEL:20029696	cat(p(HGNC:F2)) increases r(HGNC:CYR61)	Activation of cell- associated prothrombin by Ecarin induced Cyr61 expression, which was completely inhibited by hirudin.	SEN:10018502	11342437
BEL:20029698	cat(p(HGNC:F2)) increases r(HGNC:EDN1)	As previously described,9 thrombin significantly induced ET-1 mRNA levels (Figure 4Down) This induction was totally abolished in the presence of both PPAR{alpha} (Wy-14643) and PPAR{gamma} (BRL49653) activators	SEN:10016182	10473669
BEL:20029704	cat(p(HGNC:F2R)) increases p(HGNC:IL6)	Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-êB activation	SEN:10018504	10343541
BEL:20029714	cat(p(HGNC:F2)) increases sec(p(HGNC:EDN1))	In endothelial cells, ET-1 secretion is detectable under basal conditions, whereas thrombin induces its secretion.	SEN:10018506	10473669
BEL:20029730	cat(p(HGNC:FAS)) increases bp(GOBP:"apoptotic process")	Previously, we have reported that interferon-gamma (IFN-gamma) sensitizes human ovarian carcinoma cell lines to Fas-mediated apoptosis	SEN:10004372	10329044
BEL:20029742	cat(p(HGNC:FAS)) increases bp(GOBP:"apoptotic process")	Fas-associated phosphatase-1 (FAP-1) is a protein that has been shown to interact with the negative regulatory domain of Fas and block Fas-mediated apoptosis in FAP-1 transfected Jurkat cells	SEN:10004378	10537175
BEL:20029748	cat(p(HGNC:FAS)) increases bp(GOBP:"apoptotic process")	Moreover, cord blood T cells cultured with IGF-1 and PHA had a higher resistance to anti-Fas-induced apoptosis as compared with PHA-activated cord blood T cells. IGF-1 also significantly inhibited PHA-induced Fas expression on cord blood T cells	SEN:10004380	10903734
BEL:20029750	cat(p(HGNC:FAS)) increases bp(GOBP:"apoptotic process")	Interleukin-1beta (IL-1beta) is a pro-inflammatory cytokine that inhibits beta cell function and promotes Fas-triggered apoptosis	SEN:10004382	10967112
BEL:20029752	cat(p(HGNC:FAS)) increases bp(GOBP:"apoptotic process")	Here, we show that 12-O-tetradecanoylphorbol-13-acetate (TPA) prevents Fas-induced apoptosis in T lymphocytes	SEN:10003970	10976111
BEL:20029754	cat(p(HGNC:FAS)) increases bp(GOBP:"apoptotic process")	We have shown previously that mitogen-activated protein kinase (MAPK or ERK) signaling suppresses CD95-mediated apoptosis in different cellular systems	SEN:10000136	11032809
BEL:20029762	cat(p(HGNC:FAS)) increases kin(p(HGNC:MAPK1))	phosphorylation of extracellular signal-regulated kinase (ERK), but not of c-Jun NH2-terminal kinase or p38, was induced by cross-linking of Fas	SEN:10018516	10749152
BEL:20029764	cat(p(HGNC:FAS)) increases kin(p(HGNC:MAPK14))	Fas stimulation of Jurkat cells is known to induce p38 kinase and we find a pronounced increase in Rb phosphorylation within 30 min of Fas stimulation	SEN:10000032	10075927
BEL:20029772	cat(p(HGNC:FAS)) increases r(HGNC:CASP8)	Analysis of apoptosis regulators indicated that caspase-8 mRNA and protein levels were up-regulated in both of the cell lines after treatment with IFN-gamma	SEN:10004384	11059759
BEL:20029776	cat(p(HGNC:FAS)) increases r(HGNC:CCL3)	ligation of Fas induces expression of the chemokines macrophage inflammatory protein-1beta (MIP-1beta), MIP-1alpha, and MIP-2	SEN:10004386	10640741
BEL:20029778	cat(p(HGNC:FAS)) increases r(HGNC:CCL4)	ligation of Fas induces expression of the chemokines macrophage inflammatory protein-1beta (MIP-1beta), MIP-1alpha, and MIP-2	SEN:10004386	10640741
BEL:20029782	cat(p(HGNC:FAS)) increases r(HGNC:CXCL2)	ligation of Fas induces expression of the chemokines macrophage inflammatory protein-1beta (MIP-1beta), MIP-1alpha, and MIP-2	SEN:10004386	10640741
BEL:20029794	cat(p(HGNC:FAS)) decreases tscript(p(HGNC:RB1))	Fas stimulation of Jurkat cells is known to induce p38 kinase and we find a pronounced increase in Rb phosphorylation within 30 min of Fas stimulation	SEN:10000032	10075927
BEL:20029812	cat(p(HGNC:FPR1)) increases cat(p(HGNC:GNAI1))	fMLP-induced chemokine production was blocked by pertussis toxin, PD98059, and cyclosporin A, which respectively inhibit G(i)alpha activation, mitgen-activated protein kinase kinase-mediated ERK phosphorylation, and calcineurin-mediated activation of NFAT.	SEN:10018536	11120854
BEL:20029820	cat(p(HGNC:FPR1)) increases r(HGNC:CCL2)	We found that fMLP, ... induced macrophage inflammatory protein (MIP)-1ss (CCL4) and monocyte chemoattractant protein-1 (CCL2) mRNA and protein.	SEN:10018538	11120854
BEL:20029822	cat(p(HGNC:FPR1)) increases r(HGNC:CCL4)	We found that fMLP, ... induced macrophage inflammatory protein (MIP)-1ss (CCL4) and monocyte chemoattractant protein-1 (CCL2) mRNA and protein.	SEN:10018538	11120854
BEL:20029832	cat(p(HGNC:GAB1)) directlyIncreases phos(p(HGNC:PTPN11))	Consistently, substrate-trapping experiments with a SHP2 catalytic inactive mutant suggested that Gab1 was a SHP2 PTPase substrate in the cells. Therefore, Gab1 not only is a SHP2 activator but also is a target of its PTPase.	SEN:10001008	11323411
BEL:20029874	cat(p(HGNC:GSN)) increases bp(GOBP:"apoptotic process")	Caspase-3 also cleaves and activates gelsolin, a protein that regulates actin dynamics. Interestingly, activated gelsolin promotes both cytoplasmic and nuclear apoptosis, including DNA fragmentation.	SEN:10018432	10400609
BEL:20029884	cat(p(HGNC:HDAC1)) decreases r(HGNC:MAZ)	Ecpotic expression of HDAC1 repressed the activity of the MAZ promoter, and such repression was overcome in the presence of TSA (Fig. 7 A ), indicating that histone deacetylases might be involved in repression by MAZ .	SEN:10018562	11259406
BEL:20029888	cat(p(HGNC:HDAC4)) decreases tscript(p(HGNC:JUN))	Furthermore, HDAC4 and MEF2C individually upregulate but together downmodulate c-jun promoter activity.	SEN:10004410	10523670
BEL:20029890	cat(p(HGNC:HDAC4)) directlyDecreases tscript(p(HGNC:MEF2A))	In the nucleus, HDAC4 associates with the myocyte enhancer factor MEF2A. Binding of HDAC4 to MEF2A results in the repression of MEF2A transcriptional activation, a function that requires the deacetylase domain of HDAC4.	SEN:10004412	10487761
BEL:20029900	cat(p(HGNC:HRH2)) increases bp(GOBP:"cell proliferation")	activation of the human H(2) receptor (hH(2)R) leads to an increase in c-fos transcription and cell proliferation	SEN:10003412	10837353
BEL:20029906	cat(p(HGNC:HRH2)) increases r(HGNC:FOS)	activation of the human H(2) receptor (hH(2)R) leads to an increase in c-fos transcription and cell proliferation	SEN:10003412	10837353
BEL:20029916	cat(p(HGNC:HRH2)) increases r(HGNC:JUN)	Histamine induced an increase in c-jun mRNA in human embryonic kidney cells stably transfected with the hH(2)R	SEN:10004424	10837353
BEL:20029932	cat(p(HGNC:IGF2R)) increases bp(GOBP:"cell growth")	The mannose 6-phosphate/IGF2 receptor (M6P/IGF2R) plays a key role in regulating cell growth, by ensuring the clearance and inactivation of IGF-II and facilitating activation of the growth inhibitor, transforming growth factor beta (TGFbeta1).	SEN:10018568	11182753
BEL:20029934	cat(p(HGNC:IGF2R)) decreases bp(GOBP:"cell proliferation")	Evidence for an antiproliferative role of M6P/IGF2R is also provided by its frequent involvement in carcinogenesis.	SEN:10018570	11182753
BEL:20029936	cat(p(HGNC:IL18R1)) increases p(HGNC:IFNG)	The suppressive effect of IL-18 on PGE(2) production was mediated by interferon (IFN)-gamma because anti-human IFN-gamma-antibody prevented IL-18-induced reduction in PGE(2).	SEN:10018572	10681439
BEL:20029946	cat(p(HGNC:IL2RB)) increases kin(p(HGNC:LYN))	the association of lyn with IL-2Rbeta was markedly elevated by IL-2 stimulation. Furthermore the activity of lyn kinase, evaluated by an in vitro kinase assay with enolase as a substrate, increased following IL-2 stimulation.	SEN:10001026	11131153
BEL:20029956	cat(p(HGNC:IL6R)) increases tscript(p(HGNC:STAT3))	Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.	SEN:10018580	10409724
BEL:20029968	cat(p(HGNC:ITGAV)) increases kin(p(HGNC:FYN))	In addition to activating FAK, some b1 and av integrins also activate the tyrosine kinase Fyn and, through it, the adapter protein Shc (4).	SEN:10018586	10446041
BEL:20029970	cat(p(HGNC:ITGB1)) increases bp(GOBP:"myoblast differentiation")	The degree of FAK activation during myogenesis by b1A-integrin signaling can regulate myoblast progression through proliferation and differentiation (52).	SEN:10018588	10642399
BEL:20029976	cat(p(HGNC:ITGB1)) increases bp(GOBP:"protein metabolic process")	DOWNSTREAM OF INTEGRIN-MEDIATED SIGNALING Integrin interaction with the extracellular matrix and the subsequent formation of focal adhesion complexes can directly alter transcription (29) and translation (42).	SEN:10018590	10642399
BEL:20029978	cat(p(HGNC:ITGB1)) increases kin(p(HGNC:FYN))	In addition to activating FAK, some b1 and av integrins also activate the tyrosine kinase Fyn and, through it, the adapter protein Shc (4).	SEN:10018586	10446041
BEL:20029980	cat(p(HGNC:ITGB1)) increases kin(p(HGNC:PTK2))	Downstream Signaling Mediator: FAK FAK is recruited to focal adhesion complexes. The clustering of integrins and formation of the focal adhesion complex can induce tyrosine phosphorylation of FAK, as can other stimuli (32, 54).	SEN:10018592	10642399
BEL:20029986	cat(p(HGNC:ITGB1)) increases p(HGNC:PTK2,pmod(P,Y))	Downstream Signaling Mediator: FAK FAK is recruited to focal adhesion complexes. The clustering of integrins and formation of the focal adhesion complex can induce tyrosine phosphorylation of FAK, as can other stimuli (32, 54).	SEN:10018592	10642399
BEL:20029990	cat(p(HGNC:KLK3)) directlyDecreases p(HGNC:IGFBP3)	These results indicate that human insulin-like growth factor binding protein-3 is specifically cleaved at Tyr-159 by prostate specific antigen.	SEN:10018598	10218588
BEL:20029992	cat(p(HGNC:LEPR)) increases cat(p(HGNC:HSD11B1))	Leptin treatment did not alter 11betaHSD1 activity in human hepatocytes, but increased activity in omental ASC [135.8 +/- 14.1% (leptin, 100 ng/ml); P = 0.08 vs. control (100%)].	SEN:10018600	11316764
BEL:20029994	cat(p(HGNC:LGALS12)) decreases bp(GOBP:"cell cycle")	Ectopic expression of galectin-12 in cancer cells causes cell cycle arrest at the G(1) phase and cell growth suppression. We conclude that galectin-12 is a novel regulator of cellular homeostasis.	SEN:10018602	11283015
BEL:20029996	cat(p(HGNC:LGALS12)) decreases bp(GOBP:"cell growth")	Ectopic expression of galectin-12 in cancer cells causes cell cycle arrest at the G(1) phase and cell growth suppression. We conclude that galectin-12 is a novel regulator of cellular homeostasis.	SEN:10018602	11283015
BEL:20029998	cat(p(HGNC:LIG3)) increases bp(GOBP:"base-excision repair")	POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates.	SEN:10018604	10583946
BEL:20030012	cat(p(HGNC:MDM2)) increases deg(p(HGNC:TP53))	<p30> p53 is rapidly degraded by the process of ubiquitiation and proteasome. <p31> mdm2 stimulates p53 degradation	SEN:10018610	10436023
BEL:20030014	cat(p(HGNC:MDM2)) increases deg(p(HGNC:TP53))	In vitro sumoylation of Mdm2 abrogates its self-ubiquitination and increases its ubiquitin ligase activity toward p53	SEN:10001474	10892746
BEL:20030018	cat(p(HGNC:MMP13)) increases deg(p(HGNC:COL2A1))	Figure 2. Inhibition by doxycycline (DOXY) of digestion of type II collagen by collagenases 1, 2, or 3.	SEN:10018612	10366106
BEL:20030022	cat(p(HGNC:MMP1)) increases deg(p(HGNC:COL2A1))	Figure 2. Inhibition by doxycycline (DOXY) of digestion of type II collagen by collagenases 1, 2, or 3.	SEN:10018612	10366106
BEL:20030030	cat(p(HGNC:MMP3)) directlyIncreases cat(p(HGNC:MMP9))	The activated MMP-3 becomes a potent activator of the 92-kDa pro-MMP-9, yielding an 82-kDa species that is enzymatically active in solution and represents up to 50-75% conversion of the zymogen.	SEN:10018616	10224058
BEL:20030032	cat(p(HGNC:MMP8)) increases deg(p(HGNC:COL2A1))	Figure 2. Inhibition by doxycycline (DOXY) of digestion of type II collagen by collagenases 1, 2, or 3.	SEN:10018612	10366106
BEL:20030040	cat(p(HGNC:MSR1)) increases a(CHEBI:"cholesterol ester")	Predominant induction of SR-A type II mRNA parallels the increased accumulation of cholesteryl esters under these conditions	SEN:10018618	11348881
BEL:20030048	cat(p(HGNC:MYD88)) increases kin(p(HGNC:IRAK1))	MyD88 initiates a signaling pathway which sequentially involves IL-1R-associated kinase 1 (IRAK1), tumor necrosis factor-{alpha} receptor (TNFR)-associated factor 6 (TRAF6) and nuclear factor (NF)-{kappa}B-inducing kinase (NIK) (Medzhitov et al., 1998; Muzio et al., 1998a; O'Neill and Greene, 1998; Kopp and Medzhitov, 1999; Yang et al., 1999; Zhang et al., 1999).	SEN:10018620	10880445
BEL:20030052	cat(p(HGNC:NCOA1)) decreases cat(p(HGNC:NR2F6))	Using reporter systems, we found that both the basal activation and the T3-dependent activation mediated by TRbeta1 were repressed by Ear-2 in CV1 cells. The repression effect of Ear-2 was reversed by steroid hormone receptor coactivator 1.	SEN:10018624	10713182
BEL:20030056	cat(p(HGNC:NET1)) increases gtp(p(HGNC:RHOA))	NET1 is a guanine nucleotide exchange factor for RhoA NET1 is important for the increase of Rho activity	SEN:10018626	11278519
BEL:20030062	cat(p(HGNC:NOS2)) increases a(CHEBI:"nitric oxide")	These findings demonstrate that sensitization of human ovarian carcinoma cell lines to Fas-mediated apoptosis by IFN-gamma can be due, in part, to the induction of iNOS and the subsequent upregulation of Fas gene expression by reactive nitrogen intermediates	SEN:10018632	10329044
BEL:20030066	cat(p(HGNC:NOS2)) increases r(HGNC:FAS)	These findings demonstrate that sensitization of human ovarian carcinoma cell lines to Fas-mediated apoptosis by IFN-gamma can be due, in part, to the induction of iNOS and the subsequent upregulation of Fas gene expression by reactive nitrogen intermediates	SEN:10018632	10329044
BEL:20030068	cat(p(HGNC:NOS3)) decreases kin(p(HGNC:MAPK1))	NO modulation of the signaling pathway was shown by its inhibitory effect on shear stress-induced ERK1/ERK2 phosphorylation and activity.	SEN:10003510	10436166
BEL:20030070	cat(p(HGNC:NOS3)) decreases kin(p(HGNC:MAPK3))	NO modulation of the signaling pathway was shown by its inhibitory effect on shear stress-induced ERK1/ERK2 phosphorylation and activity.	SEN:10003510	10436166
BEL:20030072	cat(p(HGNC:NOS3)) decreases r(HGNC:EGR1)	Treatment of ECs with an NO donor, S-nitroso-N-acetylpenicillamine (SNAP) or 3-morpholinosydnonimine (SIN-1), inhibited this shear stress-induced Egr-1 expression.	SEN:10018636	10436166
BEL:20030080	cat(p(HGNC:NR0B2)) directlyDecreases tscript(p(HGNC:HNF4A))	Here we show that SHP inhibits transactivation by the orphan receptor hepatocyte nuclear factor 4 (HNF-4) and the retinoid X receptor (RXR)	SEN:10004458	10594021
BEL:20030084	cat(p(HGNC:NR2F6)) decreases cat(p(HGNC:THRB))	Using reporter systems, we found that both the basal activation and the T3-dependent activation mediated by TRbeta1 were repressed by Ear-2 in CV1 cells. The repression effect of Ear-2 was reversed by steroid hormone receptor coactivator 1.	SEN:10018624	10713182
BEL:20030088	cat(p(HGNC:NRP2)) directlyIncreases kin(p(HGNC:FLT1))	Our experiments therefore indicate that Np-2, and possibly also Np-1, associate with VEGFR-1 and that such complexes may be part of a cell membrane-associated signaling complex.	SEN:10018640	11278319
BEL:20030110	cat(p(HGNC:PDE3B)) decreases p(HGNC:LIPE,pmod(P))	Moreover, the phosphorylation and activation of PDE3B correlates with the inactivation of PKA and the dephosphorylation of HSL	SEN:10018648	10976911
BEL:20030116	cat(p(HGNC:PLAU)) directlyIncreases complex(p(HGNC:PLAU),p(HGNC:PLAUR))	The interaction of uPA with its receptor concentrates the enzyme activity to the so-called \"focal attachment sites\" on the cell surface and stimulates signal transduction through the uPAR, leading to induction of cell migration and invasion (19).	SEN:10000170	11172729
BEL:20030118	cat(p(HGNC:PLAUR)) increases bp(GOBP:"cell migration")	The interaction of uPA with its receptor concentrates the enzyme activity to the so-called \"focal attachment sites\" on the cell surface and stimulates signal transduction through the uPAR, leading to induction of cell migration and invasion (19).	SEN:10000170	11172729
BEL:20030126	cat(p(HGNC:PLG)) increases cat(p(HGNC:MMP1))	In addition, plasmin may activate several matrix metalloproteinases such as MMP-1, MMP-3 and MMP-9 (163).	SEN:10018652	11172729
BEL:20030128	cat(p(HGNC:PLG)) directlyIncreases cat(p(HGNC:MMP3))	Plasmin, however, is very efficient at generating active MMP-3 (stromelysin-1) from exogenously added pro-MMP-3.	SEN:10018654	10224058
BEL:20030130	cat(p(HGNC:PLG)) increases cat(p(HGNC:MMP3))	In addition, plasmin may activate several matrix metalloproteinases such as MMP-1, MMP-3 and MMP-9 (163).	SEN:10018652	11172729
BEL:20030132	cat(p(HGNC:PLG)) increases cat(p(HGNC:MMP9))	In addition, plasmin may activate several matrix metalloproteinases such as MMP-1, MMP-3 and MMP-9 (163).	SEN:10018652	11172729
BEL:20030134	cat(p(HGNC:PLG)) increases cat(p(HGNC:PLAU))	uPA is secreted as an inactive single-chain proenzyme. Secreted pro-uPA binds to the uPA receptor (uPAR) present on many different cell types. Cleavage of pro-uPA by plasmin, Factor XIIa or cathepsin B yields the active enzyme consisting of two disulfide-linked chains (17).	SEN:10018476	11172729
BEL:20030136	cat(p(HGNC:POLB)) increases bp(GOBP:"base-excision repair")	POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates.	SEN:10018604	10583946
BEL:20030138	cat(p(HGNC:POLB)) directlyIncreases complex(p(HGNC:XRCC1),p(HGNC:LIG3))	POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates.	SEN:10018604	10583946
BEL:20030152	cat(p(HGNC:PRDX2)) decreases a(CHEBI:"lipid hydroperoxide")	Human TSA1 exhibited high catalytic activity for the reduction of the fatty acid hydroperoxide as indicated by K(m) and V(max) (89.9 microM for linoleic acid hydroperoxide, 28.64 micromol(-1) min(-1) mg(-1), respectively)	SEN:10000108	10841776
BEL:20030162	cat(p(HGNC:PROC)) increases cat(p(HGNC:MMP2))	APC induced the fully active form of gelatinase A in a dose (100-300 nM)- and time (4-24 h)-responsive manner.	SEN:10004476	10734039
BEL:20030166	cat(p(HGNC:PTAFR)) increases a(CHEBI:"reactive oxygen species")	Eosinophils Human Superoxide production Human Transmigration through epithelial cells Human Transmigration through Matrigel Human CD11b/CD18 (Mac-1) translocation, degranulation Human IL-8 release	SEN:10018666	10729607
BEL:20030168	cat(p(HGNC:PTAFR)) increases p(HGNC:IL8)	Eosinophils Human Superoxide production Human Transmigration through epithelial cells Human Transmigration through Matrigel Human CD11b/CD18 (Mac-1) translocation, degranulation Human IL-8 release	SEN:10018666	10729607
BEL:20030182	cat(p(HGNC:PTGS2)) decreases bp(GOBP:"apoptotic process")	Nonsteroidal antiinflammatory drugs, which inhibit COX-2, prevent colon cancer and cause apoptosis.	SEN:10004480	11005842
BEL:20030184	cat(p(HGNC:PTGS2)) increases r(HGNC:MSR1)	Conversely, calcium ionophore greatly enhanced SR-A up-regulation This enhancement was dependent upon concurrent up-regulation of SMC cyclooxygenase-2 expression and activity and was blocked by the cyclooxygenase-2 inhibitors NS-398 and Resveratrol	SEN:10018672	10837497
BEL:20030188	cat(p(HGNC:PTN)) increases p(HGNC:CTNNB1,pmod(P,Y))	We also have found that an active site-containing domain of RPTP beta zeta both binds beta-catenin and functionally reduces its levels of tyrosine phosphorylation Finally, in parallel to its ability to inactivate endogenous RPTP beta zeta, PTN sharply increases tyrosine phosphorylation of beta-catenin in PTN-treated cells	SEN:10018674	10706604
BEL:20030200	cat(p(HGNC:RASGRF1)) increases gtp(p(HGNC:HRAS))	GEF activity of Ras-GRF1 toward Ha-Ras, as defined by in vitro GDP binding and release assays, was augmented after tyrosine phosphorylation by ACK1.	SEN:10004484	10882715
BEL:20030202	cat(p(HGNC:RASGRF1)) increases gtp(p(HGNC:RAC1))	Ras-GRF1 acts as a GEF for Rac when tyrosine-phosphorylated following G protein-coupled receptor stimulation.	SEN:10004486	10882715
BEL:20030204	cat(p(HGNC:RASGRP2)) directlyIncreases gtp(p(HGNC:RAP1A))	RasGRP2 also catalyzes nucleotide exchange on Rap1, but this RapGEF activity is less potent than that associated with CalDAG-GEFI.	SEN:10004488	10918068
BEL:20030206	cat(p(HGNC:RASGRP2)) directlyIncreases gtp(p(HGNC:RAP1B))	RasGRP2 also catalyzes nucleotide exchange on Rap1, but this RapGEF activity is less potent than that associated with CalDAG-GEFI.	SEN:10004488	10918068
BEL:20030222	cat(p(HGNC:SERPINA1)) decreases cat(p(HGNC:CMA1))	Importantly, the heparin proteoglycan-bound chymase, but not unbound chymase, degraded its inhibitor (alpha1-antitrypsin) in the presence of its substrate (HDL3).	SEN:10018466	11223430
BEL:20030228	cat(p(HGNC:SH3BGRL3)) decreases p(HGNC:TNF)	TNF-sensitive cells, when exposed to 4-10 microg/ml concentrations of TIP-B1 prior to the addition of TNF, are completely protected from TNF-induced lysis. Furthermore, TIP-B1 protects cells from apoptotic lysis induced by TNF.	SEN:10018684	10554026
BEL:20030242	cat(p(HGNC:SMURF2)) directlyIncreases deg(p(HGNC:SMAD1))	Ectopic expression of Smurf2 was sufficient to reduce the steady-state levels of Smad1 and Smad2 but not Smad3 or Smad4	SEN:10004502	11016919
BEL:20030244	cat(p(HGNC:SMURF2)) directlyIncreases deg(p(HGNC:SMAD2))	Ectopic expression of Smurf2 was sufficient to reduce the steady-state levels of Smad1 and Smad2 but not Smad3 or Smad4	SEN:10004502	11016919
BEL:20030250	cat(p(HGNC:SPN)) increases r(HGNC:CD40LG)	In this study we show that CD43 ligation on human normal peripheral T cells was sufficient to induce interleukin-2, CD69, and CD40-L gene expression, without requiring signals provided by additional receptor molecules.	SEN:10004504	10908570
BEL:20030252	cat(p(HGNC:SPN)) increases r(HGNC:CD69)	In this study we show that CD43 ligation on human normal peripheral T cells was sufficient to induce interleukin-2, CD69, and CD40-L gene expression, without requiring signals provided by additional receptor molecules.	SEN:10004504	10908570
BEL:20030254	cat(p(HGNC:SPN)) increases r(HGNC:IL2)	In this study we show that CD43 ligation on human normal peripheral T cells was sufficient to induce interleukin-2, CD69, and CD40-L gene expression, without requiring signals provided by additional receptor molecules.	SEN:10004504	10908570
BEL:20030260	cat(p(HGNC:SPN)) increases tscript(p(HGNC:FOS))	AP-1 complexes bound to the AP-1 sequence contained c-Jun, and those bound to the NF-AT-AP-1 composite site contained c-Jun and Fos.	SEN:10004506	10908570
BEL:20030262	cat(p(HGNC:SPN)) increases tscript(p(HGNC:JUN))	AP-1 complexes bound to the AP-1 sequence contained c-Jun, and those bound to the NF-AT-AP-1 composite site contained c-Jun and Fos.	SEN:10004506	10908570
BEL:20030278	cat(p(HGNC:TIMP2)) decreases cat(p(HGNC:MMP2))	The reactive site-modified TIMP-2 also prevented an accumulation of active gelatinase A on the cell surface.	SEN:10000036	10187841
BEL:20030280	cat(p(HGNC:TIMP3)) decreases cat(p(HGNC:ADAMTS4))	We show here that the N-terminal inhibitory domain of TIMP-3, a member of the TIMP family that has functional properties distinct from other TIMPs, is a strong inhibitor of human aggrecanases 1 and 2, with K(i) values in the subnanomolar range.	SEN:10018698	11278243
BEL:20030282	cat(p(HGNC:TIMP3)) decreases cat(p(HGNC:ADAMTS5))	We show here that the N-terminal inhibitory domain of TIMP-3, a member of the TIMP family that has functional properties distinct from other TIMPs, is a strong inhibitor of human aggrecanases 1 and 2, with K(i) values in the subnanomolar range.	SEN:10018698	11278243
BEL:20030284	cat(p(HGNC:TLR2)) increases gtp(p(HGNC:CDC42))	Here we show that TLR2 stimulation by Staphylococcus aureus induces a fast and transient activation of the Rho GTPases Rac1 and Cdc42 in the human monocytic cell line THP-1 and in 293 cells expressing TLR2.	SEN:10004510	11101877
BEL:20030286	cat(p(HGNC:TLR2)) increases gtp(p(HGNC:RAC1))	Here we show that TLR2 stimulation by Staphylococcus aureus induces a fast and transient activation of the Rho GTPases Rac1 and Cdc42 in the human monocytic cell line THP-1 and in 293 cells expressing TLR2.	SEN:10004510	11101877
BEL:20030290	cat(p(HGNC:TLR2)) increases p(HGNC:IL1B)	These data indicate that TLR2 is a novel 'death receptor' that engages the apoptotic machinery without a conventional cytoplasmic death domain. Through TLR2, BLP induces the synthesis of the precursor of the pro-inflammatory cytokine interleukin-1beta (IL-1beta).	SEN:10004514	10880445
BEL:20030302	cat(p(HGNC:TNFRSF10A)) increases cat(p(HGNC:TRAF2))	Here we show that TRAIL-R1-, TRAIL-R2-, and TRAIL-R4-induced NF-kappaB activation are mediated by a TRAF2-NIK-IkappaB kinase alpha/beta signaling cascade but is MEKK1 independent.	SEN:10018702	10521444
BEL:20030304	cat(p(HGNC:TNFRSF10B)) increases cat(p(HGNC:TRAF2))	Here we show that TRAIL-R1-, TRAIL-R2-, and TRAIL-R4-induced NF-kappaB activation are mediated by a TRAF2-NIK-IkappaB kinase alpha/beta signaling cascade but is MEKK1 independent.	SEN:10018702	10521444
BEL:20030310	cat(p(HGNC:TNFRSF1A)) decreases r(HGNC:PPARG)	Adipocyte precursor cells exposed to the 60-kDa TNF receptor (p60-TNFR)-specific TNF(R32W-S86T) showed a marked decrease in the percentage of differentiating cells in response to adipogenic factors as well as a reduction in peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) messenger RNA (mRNA) and glycerophosphate dehydrogenase (GPDH) activity, but increased endogenous TNF mRNA expression	SEN:10018706	10875261
BEL:20030314	cat(p(HGNC:TNFRSF1B)) increases r(HGNC:PPARG)	When cells were incubated with the p80-TNFR-specific TNF(D143N-A145R), adipogenesis and PPARgamma2 mRNA expression were stimulated, GPDH activity was unchanged, and TNF mRNA was completely suppressed	SEN:10004522	10875261
BEL:20030322	cat(p(HGNC:TRAF6)) directlyIncreases kin(p(HGNC:MAP3K7))	Here we show that the MAPKK kinase TAK1 acts upstream of NIK in the IL-1-activated signalling pathway and that TAK1 associates with TRAF6 during IL-1 signalling.	SEN:10001178	10094049
BEL:20030338	cat(p(HGNC:UBE2D3)) directlyIncreases p(HGNC:SMAD2,pmod(U,K))	Lo and Massagué1 found that the ubiquitination of Smad2 was achieved by certain E2 enzymes, including UbcH5b or UbcH5c and, to a lesser extent, Ubc3, but not by others, such as E2-20K.	SEN:10018716	10587654
BEL:20030340	cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:FOS))	% UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.	SEN:10001404	10760570
BEL:20030342	cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:MYC))	% UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.	SEN:10001404	10760570
BEL:20030344	cat(p(HGNC:UBE2L3)) increases deg(p(HGNC:TP53))	% UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.	SEN:10001404	10760570
BEL:20030352	cat(p(HGNC:UGT2B17)) decreases a(CHEBI:androgen)	The human UDP glucuronosyltransferase UGT2B17, glucuronidates androgens and is expressed in the liver and the prostate.	SEN:10004530	11191885
BEL:20030354	cat(p(HGNC:UGT2B17)) increases deg(a(CHEBI:androgen))	The human UDP glucuronosyltransferase UGT2B17, glucuronidates androgens and is expressed in the liver and the prostate.	SEN:10004530	11191885
BEL:20030366	cat(p(HGNC:XDH)) increases cat(p(HGNC:ALOX5))	It was found that 5-LO in the Epstein-Barr virus-transformed B-lymphocytic cell line BL41-E95-A is activated by addition of hydrogen peroxide or xanthine/xanthine oxidase and after increasing the oxidative state of the cell	SEN:10003424	10691962
BEL:20030368	cat(p(HGNC:XDH)) increases p(HGNC:IL6)	An XO enzyme activity of 5.0 mU/ml led to a twofold increase in IL-6 secretion in NHBE cells. And incubation of HS-24 cells with XO (20 mU/ml) induced a 1.8-fold increase in IL-6 production	SEN:10018726	10362713
BEL:20030370	cat(p(HGNC:XDH)) increases sec(p(HGNC:IL6))	An XO enzyme activity of 5.0 mU/ml led to a twofold increase in IL-6 secretion in NHBE cells. And incubation of HS-24 cells with XO (20 mU/ml) induced a 1.8-fold increase in IL-6 production	SEN:10018726	10362713
BEL:20030378	cat(p(MGI:Acacb)) decreases bp(GOBP:"fatty acid oxidation")	Interestingly, in addition to increased fatty acid oxidation, we also observed increased glucose oxidation in adipocytes of Acc2-/- mutant mice compared with that of WT mice.	SEN:10004536	15677334
BEL:20030386	cat(p(MGI:Acacb)) decreases r(MGI:Slc2a4)	The mRNA level of glucose transporter 4 (GLUT4) decreased several fold in the adipose tissue of WT mice fed a HF/HC diet; however, in the adipose tissue of Acc2-/- mutant mice, it was 7-fold higher. Moreover, lipolysis activity was higher in adipocytes of Acc2-/- mutant mice compared with that in WT mice.	SEN:10018730	15677334
BEL:20030406	cat(p(MGI:Adipor1)) increases bp(GOBP:"fatty acid oxidation")	AdipoR1 and AdipoR2 are able to mediate the binding of globular and full-length adiponectin, as well as increases in PPAR-a ligand activity and fatty-acid oxidation by globular and full-length adiponectin in C2C12 myocytes	SEN:10018742	12802337
BEL:20030408	cat(p(MGI:Adipor1)) increases cat(p(MGI:Acaca))	Expression of AdipoR1 in C2C12 myocytes was associated with increased phosphorylation of AMPK, ACC and p38 MAPK on stimulation with globular adiponectin	SEN:10018744	12802337
BEL:20030414	cat(p(MGI:Adipor1)) increases tscript(p(MGI:Ppara))	AdipoR1 and AdipoR2 are able to mediate the binding of globular and full-length adiponectin, as well as increases in PPAR-a ligand activity and fatty-acid oxidation by globular and full-length adiponectin in C2C12 myocytes	SEN:10018742	12802337
BEL:20030416	cat(p(MGI:Adipor1)) increases tscript(p(MGI:Ppara))	Expression of AdipoR1 or AdipoR2 alone or in combination made it possible for globular adiponectin to bind to hepatocytes (Supplementary Fig. 3e) and further increased fulllength adiponectin binding to hepatocytes (Supplementary Fig. 3f), both of which were associated with increases in PPAR-a ligand activity	SEN:10018746	12802337
BEL:20030422	cat(p(MGI:Adipor2)) increases bp(GOBP:"fatty acid oxidation")	AdipoR1 and AdipoR2 are able to mediate the binding of globular and full-length adiponectin, as well as increases in PPAR-a ligand activity and fatty-acid oxidation by globular and full-length adiponectin in C2C12 myocytes	SEN:10018742	12802337
BEL:20030424	cat(p(MGI:Adipor2)) increases tscript(p(MGI:Ppara))	AdipoR1 and AdipoR2 are able to mediate the binding of globular and full-length adiponectin, as well as increases in PPAR-a ligand activity and fatty-acid oxidation by globular and full-length adiponectin in C2C12 myocytes	SEN:10018742	12802337
BEL:20030426	cat(p(MGI:Adipor2)) increases tscript(p(MGI:Ppara))	Expression of AdipoR1 or AdipoR2 alone or in combination made it possible for globular adiponectin to bind to hepatocytes (Supplementary Fig. 3e) and further increased fulllength adiponectin binding to hepatocytes (Supplementary Fig. 3f), both of which were associated with increases in PPAR-a ligand activity	SEN:10018746	12802337
BEL:20030428	cat(p(MGI:Adora1)) increases tscript(p(MGI:Stat1))	Pretreatment with CCPA (A1 receptor agonist), NECA (non-specific A1 and A2 receptor agonist), and CGS21680 (A2A receptor agonist) all resulted in a 14- to 15-fold increase in STAT1 activity over control cells, levels comparable to what was observed in cells treated with IFN-gamma alone (Fig. 6, A?C)	SEN:10018750	19846878
BEL:20030442	cat(p(MGI:Adora2a)) increases tscript(p(MGI:Stat1))	Pretreatment with CCPA (A1 receptor agonist), NECA (non-specific A1 and A2 receptor agonist), and CGS21680 (A2A receptor agonist) all resulted in a 14- to 15-fold increase in STAT1 activity over control cells, levels comparable to what was observed in cells treated with IFN-gamma alone (Fig. 6, A?C)	SEN:10018750	19846878
BEL:20030448	cat(p(MGI:Adra2c)) increases a(CHEBI:corticosterone)	In addition, alpha2C-KO was associated with attenuated elevation of plasma corticosterone after different stressors, and overexpression of alpha2C-ARs was linked with increased corticosterone levels after repeated stress.	SEN:10018760	10523817
BEL:20030450	cat(p(MGI:Adra2c)) decreases r(MGI:Fos)	Moreover, the brain dopamine and serotonin balance, but not norepinephrine turnover, was dependent on alpha2C-AR expression, and the expression of c-fos and junB mRNA was increased in alpha2C-KO mice.	SEN:10004542	10523817
BEL:20030452	cat(p(MGI:Adra2c)) decreases r(MGI:Junb)	Moreover, the brain dopamine and serotonin balance, but not norepinephrine turnover, was dependent on alpha2C-AR expression, and the expression of c-fos and junB mRNA was increased in alpha2C-KO mice.	SEN:10004542	10523817
BEL:20030460	cat(p(MGI:Adrb1)) increases r(MGI:Ucp1)	beta(3)-AR is required for leptin-mediated regulation of ob mRNA expression in WAT, but is interchangeable with the beta(1)/beta(2)-ARs in mediating leptin's effect on UCP1 mRNA expression in brown adipose tissue	SEN:10004544	10938091
BEL:20030466	cat(p(MGI:Adrb2)) increases r(MGI:Ucp1)	beta(3)-AR is required for leptin-mediated regulation of ob mRNA expression in WAT, but is interchangeable with the beta(1)/beta(2)-ARs in mediating leptin's effect on UCP1 mRNA expression in brown adipose tissue	SEN:10004544	10938091
BEL:20030470	cat(p(MGI:Adrb3)) increases r(MGI:Azgp1)	Zinc-alpha2-glycoprotein also increased its own expression and this was attenuated by SR59230A, suggesting that it was mediated through the beta3-AR	SEN:10004548	15714206
BEL:20030474	cat(p(MGI:Adrb3)) increases r(MGI:Ucp1)	beta(3)-AR is required for leptin-mediated regulation of ob mRNA expression in WAT, but is interchangeable with the beta(1)/beta(2)-ARs in mediating leptin's effect on UCP1 mRNA expression in brown adipose tissue	SEN:10004544	10938091
BEL:20030486	cat(p(MGI:Ager)) decreases bp(GOBP:angiogenesis)	AGE-treated wild-type mice showed a significant increase in inner retinal ischemia and a reduction in neovascularization compared with non-AGE controls (P < 0.001). However, ablation of galectin-3 abolished the AGE-mediated increase in retinal ischemia and restored the neovascular response to that seen in controls. AGE:AGER^ischemia; occursInTissue; retina	SEN:10018770	15734857
BEL:20030494	cat(p(MGI:Ager)) increases path(MESHD:Ischemia)	AGE-treated wild-type mice showed a significant increase in inner retinal ischemia and a reduction in neovascularization compared with non-AGE controls (P < 0.001). However, ablation of galectin-3 abolished the AGE-mediated increase in retinal ischemia and restored the neovascular response to that seen in controls. AGE:AGER^ischemia; occursInTissue; retina	SEN:10018770	15734857
BEL:20030522	cat(p(MGI:Aifm1)) increases bp(GOBP:"cell death")	Neurons carrying double mutations for Hq/Apaf1-/- (apoptosis proteases-activating factor) are impaired in both caspase-dependent and AIF-mediated mitochondrial cell death pathways.	SEN:10018782	15703386
BEL:20030532	cat(p(MGI:Akr1b8)) increases path(MESHD:Atherosclerosis)	\"Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.\" Mice in which diabetes was induced through streptozotocin (STZ) treatment, but not nondiabetic mice, expressing human AR (hAR) crossed with LDL receptor-deficient (Ldlr-/-) C57BL/6 male mice had increased aortic atherosclerosis.	SEN:10018784	16127462
BEL:20030534	cat(p(MGI:Akr1b8)) increases p(MGI:Msr1)	macrophages from hAR-transgenic mice expressed more scavenger receptors and had greater accumulation of modified lipoproteins than macrophages from nontransgenic mice.	SEN:10004564	16127462
BEL:20030536	cat(p(MGI:Akr1c6)) increases deg(a(CHEBI:progesterone))	Prostaglandin F(2)alpha (PGF(2)alpha) binding to its receptor on the rat corpus luteum triggers various signal transduction pathways that lead to the activation of a steroidogenic enzyme, 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD), which in turn catabolizes progesterone	SEN:10003762	10973968
BEL:20030558	cat(p(MGI:Alox12)) increases bp(GOBP:"inflammatory response")	We conclude that macrophage 12/15-LO plays a dominant role in the development of atherosclerosis by promoting endothelial inflammation and foam cell formation	SEN:10004572	15451785
BEL:20030560	cat(p(MGI:Alox12)) increases path(MESHD:Atherosclerosis)	We conclude that macrophage 12/15-LO plays a dominant role in the development of atherosclerosis by promoting endothelial inflammation and foam cell formation	SEN:10004572	15451785
BEL:20030572	cat(p(MGI:Alox15)) increases bp(GOBP:"inflammatory response")	We conclude that macrophage 12/15-LO plays a dominant role in the development of atherosclerosis by promoting endothelial inflammation and foam cell formation	SEN:10004572	15451785
BEL:20030574	cat(p(MGI:Alox15)) increases path(MESHD:Atherosclerosis)	We conclude that macrophage 12/15-LO plays a dominant role in the development of atherosclerosis by promoting endothelial inflammation and foam cell formation	SEN:10004572	15451785
BEL:20030576	cat(p(MGI:Alox5ap)) increases a(CHEBI:"leukotriene B4")	We demonstrate that IL-10 suppresses the production of LTB4 from DC by inhibiting FLAP protein expression without any effect on 5-LO and cytosolic phospholipase A2.	SEN:10018790	12496393
BEL:20030590	cat(p(MGI:Ank)) decreases bp(GOBP:"cell proliferation")	By light microscopy, the earliest synovial lesion was inflammatory followed by synovial proliferation and cartilage erosions.	SEN:10004576	2541245
BEL:20030592	cat(p(MGI:Ank)) decreases bp(GOBP:"inflammatory response")	By light microscopy, the earliest synovial lesion was inflammatory followed by synovial proliferation and cartilage erosions.	SEN:10004576	2541245
BEL:20030594	cat(p(MGI:Ank)) decreases path(MESHD:Hypertrophy)	synovial cell proliferation and hypertrophy with collagen deposition was seen before the appearance of intracellular and extracellular hydroxyapatite crystals. These pathologic changes are the same as those found in the human spondyloarthropathies.	SEN:10004578	2541245
BEL:20030606	cat(p(MGI:App)) directlyIncreases tscript(p(MGI:Kat5))	the LrpICD is translocated to the nucleus, where it co-localizes in the nucleus with a transcription modulator, Tip60, which is known to interact with Fe65 and with the APP-derived intracellular domain, AICD LrpICD has a close interaction with Tip60 in the nucleus	SEN:10018798	12888553
BEL:20030622	cat(p(MGI:Atg7)) increases bp(GOBP:autophagy)	Abundant autophagosomes in K-rasG12D/+;atg7+/+ but not in K-rasG12D/+;atg7 -/- tumors were confirmed by electron microscopy (Fig. 2B).	SEN:10018804	23824538
BEL:20030624	cat(p(MGI:Atg7)) increases bp(GOBP:autophagy)	these data show that Atg7 deletion is sufficient to block autophagy in Braf V600E -driven lung tumors	SEN:10018806	23965987
BEL:20030626	cat(p(MGI:Atg7)) increases bp(GOBP:"cell proliferation")	Reduction of atg7-deficient tumor burden was coincident with reduced proliferation (Ki67) and decreased levels of phospho-MEK1/2 (P-MEK1/2) and P-ERK1/2 and p53 and p21 induction, compared with wild-type tumors (Fig. 1I; Supplemental Figs. S4A–C, S5A–C), suggesting that inhibition of tumor cell proliferation upon atg7 deletion is the main cause of reduced tumor burden.	SEN:10018808	23824538
BEL:20030630	cat(p(MGI:Atg7)) decreases p(MGI:Cdkn1a)	Reduction of atg7-deficient tumor burden was coincident with reduced proliferation (Ki67) and decreased levels of phospho-MEK1/2 (P-MEK1/2) and P-ERK1/2 and p53 and p21 induction, compared with wild-type tumors (Fig. 1I; Supplemental Figs. S4A–C, S5A–C), suggesting that inhibition of tumor cell proliferation upon atg7 deletion is the main cause of reduced tumor burden.	SEN:10018808	23824538
BEL:20030634	cat(p(MGI:Atg7)) decreases p(MGI:Map1lc3a)	atg7 deficiency in tumors prevented LC3-I processing to LC3-II and caused accumulation of LC3-I and autophagy substrate p62 in large aggregates apparent at 6 wk that increased throughout tumorigenesis	SEN:10018812	23824538
BEL:20030636	cat(p(MGI:Atg7)) decreases p(MGI:Nfe2l2)	induction of NRF2 was observed in Atg7 -deficient tumors both by IHC examining levels of nuclear NRF2 and by Western blotting of tumor lysates	SEN:10018814	23965987
BEL:20030638	cat(p(MGI:Atg7)) decreases p(MGI:Sqstm1)	atg7 deficiency in tumors prevented LC3-I processing to LC3-II and caused accumulation of LC3-I and autophagy substrate p62 in large aggregates apparent at 6 wk that increased throughout tumorigenesis	SEN:10018812	23824538
BEL:20030640	cat(p(MGI:Atg7)) decreases p(MGI:Sqstm1)	the accumulation of the autophagy substrate p62 was accelerated in Braf V600E /+ ; Atg7 -/- tumors	SEN:10018816	23965987
BEL:20030644	cat(p(MGI:Atg7)) decreases tscript(p(MGI:Trp53))	Reduction of atg7-deficient tumor burden was coincident with reduced proliferation (Ki67) and decreased levels of phospho-MEK1/2 (P-MEK1/2) and P-ERK1/2 and p53 and p21 induction, compared with wild-type tumors (Fig. 1I; Supplemental Figs. S4A–C, S5A–C), suggesting that inhibition of tumor cell proliferation upon atg7 deletion is the main cause of reduced tumor burden.	SEN:10018808	23824538
BEL:20030646	cat(p(MGI:Atg7)) decreases tscript(p(MGI:Trp53))	loss of ATG7 causes premature p53 induction in Braf V600E lung tumors that suppresses proliferation and tumor growth	SEN:10018818	23965987
BEL:20030666	cat(p(MGI:Azgp1)) decreases path(MESHD:Obesity)	Loss of adipose tissue in cancer cachexia in mice bearing the MAC16 tumour arises from an increased lipid mobilisation through increased expression of zinc-alpha2-glycoprotein (ZAG) in white (WAT) and brown (BAT) adipose tissue	SEN:10004596	15714206
BEL:20030668	cat(p(MGI:Azgp1)) increases cat(p(MGI:Adrb3))	Zinc-alpha2-glycoprotein also increased its own expression and this was attenuated by SR59230A, suggesting that it was mediated through the beta3-AR	SEN:10004548	15714206
BEL:20030678	cat(p(MGI:Azgp1)) increases r(MGI:Azgp1)	Zinc-alpha2-glycoprotein also increased its own expression and this was attenuated by SR59230A, suggesting that it was mediated through the beta3-AR	SEN:10004548	15714206
BEL:20030680	cat(p(MGI:Bad)) increases cat(p(MGI:Bak1))	BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X(L) to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1.	SEN:10000880	17115033
BEL:20030682	cat(p(MGI:Bad)) increases cat(p(MGI:Bax))	BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X(L) to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1.	SEN:10000880	17115033
BEL:20030684	cat(p(MGI:Bax)) increases cat(p(MGI:Aifm1))	Our results demonstrate an important role for AIF in both BAX-dependent and BAX-independent mechanisms of neuronal injury.	SEN:10004602	15703386
BEL:20030690	cat(p(MGI:Bcl2)) directlyIncreases complex(p(MGI:Bcl2),p(MGI:Bid))	BCL-2 interacts with BID. This interaction was modelled on a demonstrated interaction between mouse BCL-2 and human BID.	SEN:10018830	12242151
BEL:20030696	cat(p(MGI:Bid)) increases tport(p(MGI:Mtch2))	These results implicate Mtch2 as a mitochondrial target of tBID and raise the possibility that the Mtch2-resident complex participates in the mitochondrial apoptotic program.	SEN:10004604	15899861
BEL:20030706	cat(p(MGI:Btrc)) increases deg(p(MGI:Gli2))	The hyperphosphorylation of Gli2 protein creates binding sites for beta-TrCP, which in turn conjugates the multiple ubiquitin molecules onto the Gli2 protein and triggers the proteasome-mediated protein degradation.	SEN:10018834	16611981
BEL:20030724	cat(p(MGI:Capn2)) increases cat(p(MGI:Casp12))	It has been proposed that m-calpain, a cysteine protease activated by calcium ions (see above), processes procaspase-12 (Nakagawa and Yuan 2000). Although this would potentially provide a mechanism for coupling ER stress through Ca2+ release to caspase-12 activation	SEN:10016660	14561771
BEL:20030750	cat(p(MGI:Casp1)) increases sec(p(MGI:Il1b))	.....rapid export of caspase-1-processed IL-1 beta from monocytes/macrophages in response to activation of P2X7 receptors (P2X7R) by extracellular ATP.	SEN:10001214	17641058
BEL:20030752	cat(p(MGI:Casp1)) increases sec(p(MGI:Il1b))	Additionally, the cleaved form of IL-1b, produced from pro IL-1b by the action of activated caspase-1, was increased in the cell lysates and culture medium of Map1lc3b-/- macrophages (Fig. 1a).	SEN:10018854	21151103
BEL:20030754	cat(p(MGI:Casp2)) increases bp(GOBP:"apoptotic process")	we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3beta inhibitors lithium chloride and SB216763, and by GSK-3beta knockdown using short interfering RNA.	SEN:10018856	17666435
BEL:20030758	cat(p(MGI:Casp3)) increases bp(GOBP:"apoptotic process")	apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema.	SEN:10004620	15944319
BEL:20030760	cat(p(MGI:Casp3)) increases bp(GOBP:"apoptotic process")	The anti-caspase-3 effect of A1AT was further tested in vivo in the mouse lung...intramuscular administration of hA1AT-AAV serotype 5, which leads to persistent hA1AT expression,(27) inhibited apoptotic airspace destruction and oxidative stress (measured by catalase activity assay) caused by subsequent direct instillation of active caspase-3 into the mouse lung28 (Figure 7, a? d).	SEN:10018860	17003475
BEL:20030762	cat(p(MGI:Casp3)) increases bp(GOBP:"apoptotic process")	Preincubation with the caspase-9 inhibitor z-LEHD-fmk, the caspase-3 inhibitor z-DEVD-fmk, or the specific pan-caspase inhibitor Q-VD-oph decreased the percentage of propidium iodide-positive neurons	SEN:10000910	19235896
BEL:20030764	cat(p(MGI:Casp3)) increases bp(GOBP:"apoptotic process")	Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice.	SEN:10018862	19570263
BEL:20030770	cat(p(MGI:Casp3)) increases cat(p(MGI:Cat))	The anti-caspase-3 effect of A1AT was further tested in vivo in the mouse lung...intramuscular administration of hA1AT-AAV serotype 5, which leads to persistent hA1AT expression,(27) inhibited apoptotic airspace destruction and oxidative stress (measured by catalase activity assay) caused by subsequent direct instillation of active caspase-3 into the mouse lung28 (Figure 7, a? d).	SEN:10018860	17003475
BEL:20030774	cat(p(MGI:Casp3)) increases deg(p(MGI:Tax1bp1))	TXBP151 was indeed found to be specifically cleaved in vitro by members of the caspase-3-like subfamily, viz. caspase-3, caspase-6 and caspase-7	SEN:10000056	10435631
BEL:20030776	cat(p(MGI:Casp3)) increases kin(p(MGI:Rock1))	Two potential sites of caspase cleavage, resembling the prototypical caspase-3 cleavage sequence DEVD, are situated in this region in both human and mouse ROCK I, at positions 1110-1113 (DETD) and 1155-1158 (DEQD), respectively.	SEN:10018868	11283606
BEL:20030780	cat(p(MGI:Casp3)) increases path(MESHD:Emphysema)	Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice.	SEN:10018862	19570263
BEL:20030784	cat(p(MGI:Casp6)) increases deg(p(MGI:Tax1bp1))	TXBP151 was indeed found to be specifically cleaved in vitro by members of the caspase-3-like subfamily, viz. caspase-3, caspase-6 and caspase-7	SEN:10000056	10435631
BEL:20030786	cat(p(MGI:Casp7)) increases deg(p(MGI:Tax1bp1))	TXBP151 was indeed found to be specifically cleaved in vitro by members of the caspase-3-like subfamily, viz. caspase-3, caspase-6 and caspase-7	SEN:10000056	10435631
BEL:20030792	cat(p(MGI:Casp8)) increases cat(p(MGI:Bid))	The activation of caspase 8 led to the cleavage of Bid in wild-type mice under various regimes (Fig. 3 C and data not shown).	SEN:10018872	11369777
BEL:20030794	cat(p(MGI:Casp8)) directlyDecreases cat(p(MGI:Parp2))	caspase-8 is relocated into the nucleus of apoptotic neurons, where it cleaves PARP-2 Activity assays confirm that cleavage of PARP-2 results in inactivation of its poly(ADP-ribosylation) property, proportional to the efficiency of the cleavage.	SEN:10018874	12065591
BEL:20030796	cat(p(MGI:Casp8)) directlyIncreases deg(p(MGI:Parp2))	caspase-8 is relocated into the nucleus of apoptotic neurons, where it cleaves PARP-2 Activity assays confirm that cleavage of PARP-2 results in inactivation of its poly(ADP-ribosylation) property, proportional to the efficiency of the cleavage.	SEN:10018874	12065591
BEL:20030802	cat(p(MGI:Casp9)) increases bp(GOBP:"apoptotic process")	Preincubation with the caspase-9 inhibitor z-LEHD-fmk, the caspase-3 inhibitor z-DEVD-fmk, or the specific pan-caspase inhibitor Q-VD-oph decreased the percentage of propidium iodide-positive neurons	SEN:10000910	19235896
BEL:20030828	cat(p(MGI:Cbs)) increases cat(p(MGI:Acaa1a))	The activity of thiolase, a key enzyme in beta-oxidation of fatty acids, was significantly impaired in CBS(-/-) mouse liver.	SEN:10018886	15466479
BEL:20030840	cat(p(MGI:Ccr1)) decreases r(MGI:Ccl17)	peritoneal CXCL10, CCL6, and CCL17 expression in CCR1-/- mice was significantly increased over WT expression	SEN:10018894	15557190
BEL:20030842	cat(p(MGI:Ccr1)) decreases r(MGI:Ccl6)	peritoneal CXCL10, CCL6, and CCL17 expression in CCR1-/- mice was significantly increased over WT expression	SEN:10018894	15557190
BEL:20030844	cat(p(MGI:Ccr1)) decreases r(MGI:Cxcl10)	peritoneal CXCL10, CCL6, and CCL17 expression in CCR1-/- mice was significantly increased over WT expression	SEN:10018894	15557190
BEL:20030848	cat(p(MGI:Ccr2)) increases p(MGI:Ifng)	At days 8, 11, 20, 23, and 26 after disease induction, splenocytes from CCR2-deficient mice also proliferated less robustly to Ag and secreted lower levels of IFN-{gamma} and IL-6 than splenocytes from wild-type controls	SEN:10018896	11015448
BEL:20030850	cat(p(MGI:Ccr2)) increases p(MGI:Il6)	At days 8, 11, 20, 23, and 26 after disease induction, splenocytes from CCR2-deficient mice also proliferated less robustly to Ag and secreted lower levels of IFN-{gamma} and IL-6 than splenocytes from wild-type controls	SEN:10018896	11015448
BEL:20030876	cat(p(MGI:Cd28)) decreases cat(p(MGI:Ctla4))	CTLA-4 delivers signals that inhibit selection, indicating that CTLA-4 and CD28 have opposing functions in thymic development.	SEN:10018912	12759417
BEL:20030880	cat(p(MGI:Cd36)) increases cat(p(MGI:Tlr2))	Notably, a CD36 peptide blocked oxLDL-induced foam cell formation and macrophage activation. However, the activating mCD36 mAb induced macrophage activation was not inhibited by CD36 peptide. Further, activating mCD36 mAb enhanced oxLDL- or TLR2- or TLR4-mediated inflammatory responses.	SEN:10018914	21281677
BEL:20030882	cat(p(MGI:Cd36)) increases cat(p(MGI:Tlr4))	Notably, a CD36 peptide blocked oxLDL-induced foam cell formation and macrophage activation. However, the activating mCD36 mAb induced macrophage activation was not inhibited by CD36 peptide. Further, activating mCD36 mAb enhanced oxLDL- or TLR2- or TLR4-mediated inflammatory responses.	SEN:10018914	21281677
BEL:20030884	cat(p(MGI:Cd36)) increases kin(p(MGI:Mapk9))	We found markedly higher levels of activation of JNK2 in WT and SRA-/- macrophages compared to CD36-/- cells (Fig. 2A). These finding suggest that oxLDL-mediated activation of JNK2 occurs in vivo in the hyperlipidemic pro-atherogenic mice and that is primarily dependent on CD36 expression.	SEN:10018916	16950138
BEL:20030894	cat(p(MGI:Cd40)) increases bp(GOBP:autophagy)	The autophagy pathway was required for CD40-induced anti-T. gondii activity in microglia because CD40 stimulation caused recruitment of the autophagy marker LC3 around the parasite (Figure 3B) and silencing of Beclin 1 using siRNA ablated CD40-induced anti-T. gondii activity (p,0.01) (Figure 3C).	SEN:10018924	21217818
BEL:20030908	cat(p(MGI:Cd40)) increases p(MGI:Atg5)	CD40 stimulation also caused an apparently less pronounced upregulation of the Atg5 expression (average 1.7-fold) but did not appear to affect expression of Atg7 (Figure 4A).	SEN:10018928	21217818
BEL:20030910	cat(p(MGI:Cd40)) increases p(MGI:Becn1)	As shown in Figure 4A, CD40 stimulation caused a rapid increase in Beclin 1 protein expression in primary microglia (2.8-fold increase on average; n= 4).	SEN:10018930	21217818
BEL:20030912	cat(p(MGI:Cd40)) decreases p(MGI:Cdkn1a)	CD40 stimulation of primary microglia and BV-2 cells caused a rapid decrease in p21 levels (Figure 5A).	SEN:10018932	21217818
BEL:20030916	cat(p(MGI:Cd40)) increases p(MGI:Hoxc4)	HoxC4 was 'preferentially' expressed in germinal center B cells and was upregulated by engagement of CD40 by CD154, as well as by lipopolysaccharide and interleukin 4.	SEN:10003464	19363484
BEL:20030940	cat(p(MGI:Cd44)) decreases r(MGI:"mt-Co1")	mitochondrial protein, CCOI, is significantly decreased in the setting of OPN stimulation. This effect is blocked by the CD44 competitive ligand,	SEN:10004664	12943672
BEL:20030948	cat(p(MGI:Cd80)) increases r(MGI:Foxp3)	TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.	SEN:10002836	16517699
BEL:20030960	cat(p(MGI:Cela2a)) increases bp(GOBP:"neutrophil extravasation")	whereas regulation of the expression of alpha6 integrins and NE occur via different adhesive mechanisms, these molecules might act in a cooperative manner in mediating neutrophil migration through venular walls, in particular the perivascular basement membrane.	SEN:10018952	15840647
BEL:20030982	cat(p(MGI:Cpt1a)) increases bp(GOBP:"fatty acid beta-oxidation")	Increased Mitochondrial Fatty Acid Oxidation in Mice with Disruptions in SCD1. A fall in malonyl-CoA would be expected to result in increased activities of CPT1 and CPT2, enzymes responsible for activated fatty acid transport into mitochondria for b-oxidation. CPT1 activity was 63% higher in SCD1-/- mice relative to wild-type controls. CPT2 activity was also higher in SCD1-/- mice relative to wild-type controls.	SEN:10018956	15096593
BEL:20030984	cat(p(MGI:Cpt1b)) increases r(MGI:Ppara)	Etomoxir treatment for 24 h resulted in a down-regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) mRNA expression	SEN:10004678	11792699
BEL:20030986	cat(p(MGI:Cpt2)) increases bp(GOBP:"fatty acid beta-oxidation")	Increased Mitochondrial Fatty Acid Oxidation in Mice with Disruptions in SCD1. A fall in malonyl-CoA would be expected to result in increased activities of CPT1 and CPT2, enzymes responsible for activated fatty acid transport into mitochondria for b-oxidation. CPT1 activity was 63% higher in SCD1-/- mice relative to wild-type controls. CPT2 activity was also higher in SCD1-/- mice relative to wild-type controls.	SEN:10018956	15096593
BEL:20030994	cat(p(MGI:Crebbp)) increases tscript(p(MGI:Runx1))	Histone acetyltransferases (HATs) p300 and CREB-binding protein (CBP) function as co-activators for a variety of sequence-specific transcription factors, including AML1.	SEN:10018960	16917507
BEL:20030996	cat(p(MGI:Crkl)) increases bp(GOBP:"integrin-mediated signaling pathway")	FA-CRKL induced cotranslocation of a Rac1 activator, Dock1, to focal adhesions. These results therefore indicate a role for CrkL in mediating Src signaling by activating small G proteins at focal adhesions. Furthermore, MEFs lacking CrkL show impaired integrin-induced migration despite expression of a closely related protein, Crk-II, in these cells.	SEN:10018962	12665586
BEL:20030998	cat(p(MGI:Crk)) increases p(MGI:Bcar1,pmod(P,Y))	Transient expression of v-Crk induced elevation of the Cas-associated kinase activity in all of these cell lines except the primary culture of Fyn-/- fibroblasts.	SEN:10018964	9136985
BEL:20031026	cat(p(MGI:Ctla4)) decreases cat(p(MGI:Cd28))	CTLA-4 delivers signals that inhibit selection, indicating that CTLA-4 and CD28 have opposing functions in thymic development.	SEN:10018912	12759417
BEL:20031040	cat(p(MGI:Ctsl)) increases cat(p(MGI:Plau))	Extracellular CTSL is also able to activate other proteases such as urokinase-type plasminogen activators	SEN:10018988	11972068
BEL:20031052	cat(p(MGI:Cx3cl1)) increases r(MGI:Ifng)	Furthermore, treatment with anti-CX3CL1 mAb down-regulated the mRNA expression of TNF-alpha, IFN-gamma, and perforin in the muscles.	SEN:10018996	16272359
BEL:20031054	cat(p(MGI:Cx3cl1)) increases r(MGI:Prf1)	Furthermore, treatment with anti-CX3CL1 mAb down-regulated the mRNA expression of TNF-alpha, IFN-gamma, and perforin in the muscles.	SEN:10018996	16272359
BEL:20031056	cat(p(MGI:Cx3cl1)) increases r(MGI:Tnf)	Furthermore, treatment with anti-CX3CL1 mAb down-regulated the mRNA expression of TNF-alpha, IFN-gamma, and perforin in the muscles.	SEN:10018996	16272359
BEL:20031058	cat(p(MGI:Cx3cr1)) decreases bp(GOBP:"apoptotic process")	CX3CR1 may also be of importance as it confers a survival signal, which prevents cell death of monocytes and foam cells [52].	SEN:10018998	19238385
BEL:20031062	cat(p(MGI:Cxcr3)) increases bp(GOBP:"T cell proliferation")	neutralization of CXCR3 reduced MIG/CXCL9-induced T lymphocyte proliferation and the number of IFN-gamma-positive spots	SEN:10000968	15187119
BEL:20031086	cat(p(MGI:Cyld)) directlyDecreases p(MGI:Ripk1,pmod(U,K))	However, when K63-ubiquitination of RIP1 is removed by the deubiquitinases CYLD (cylindromatosis) or A20 (44, 45), RIP1 and RIP3 are recruited to a complex containing TRADD, Fas-associated death domain protein (FADD), and caspase-8, in which RIP1 and RIP3 are cleaved (42)	SEN:10019010	20354226
BEL:20031104	cat(p(MGI:Cysltr1)) increases p(MGI:Muc5ac)	The LTD4-ra MK-571 also dose dependently inhibited MUC5AC (Fig. 6, A and B) and mucus accumulation in epithelial cells as verified morphologically (Fig. 7D and Table 1), as did the LTB4-ra PH-163 72 h after challenge with Ova (Figs. 6, A and B, 7E; Table 1).	SEN:10019018	12794006
BEL:20031106	cat(p(MGI:Cyth1)) increases cat(p(MGI:Itgb2))	knockdown of cytohesin-1, a PI3K-regulated adaptor molecule for beta(2) integrin activation, specifically abrogated CD14-regulated CR3 ingestion of BCG consistent with the observation of physical association between CR3 and cytohesin-1 in cells stimulated with mycobacterial surface components.	SEN:10004704	15778383
BEL:20031140	cat(p(MGI:Dnmt1)) increases bp(GOBP:"cell differentiation")	It has been reported that DNA methyltransferase 1-deficient (Dnmt1-/-) embryonic stem (ES) cells are hypomethylated (20% CpG methylation) and die through apoptosis when induced to differentiate. Here, we show that Dnmt[3a-/-,3b-/-] ES cells with just 0.6% of their CpG dinucleotides behave differently: the majority of cells within the culture are partially or completely blocked in their ability to initiate differentiation	SEN:10019036	15456861
BEL:20031150	cat(p(MGI:Dnmt3a)) increases bp(GOBP:"cell differentiation")	It has been reported that DNA methyltransferase 1-deficient (Dnmt1-/-) embryonic stem (ES) cells are hypomethylated (20% CpG methylation) and die through apoptosis when induced to differentiate. Here, we show that Dnmt[3a-/-,3b-/-] ES cells with just 0.6% of their CpG dinucleotides behave differently: the majority of cells within the culture are partially or completely blocked in their ability to initiate differentiation	SEN:10019036	15456861
BEL:20031152	cat(p(MGI:Dnmt3b)) increases bp(GOBP:"cell differentiation")	It has been reported that DNA methyltransferase 1-deficient (Dnmt1-/-) embryonic stem (ES) cells are hypomethylated (20% CpG methylation) and die through apoptosis when induced to differentiate. Here, we show that Dnmt[3a-/-,3b-/-] ES cells with just 0.6% of their CpG dinucleotides behave differently: the majority of cells within the culture are partially or completely blocked in their ability to initiate differentiation	SEN:10019036	15456861
BEL:20031154	cat(p(MGI:Dock1)) directlyIncreases gtp(p(MGI:Rac1))	FA-CRKL induced cotranslocation of a Rac1 activator, Dock1, to focal adhesions. These results therefore indicate a role for CrkL in mediating Src signaling by activating small G proteins at focal adhesions. Furthermore, MEFs lacking CrkL show impaired integrin-induced migration despite expression of a closely related protein, Crk-II, in these cells.	SEN:10018962	12665586
BEL:20031166	cat(p(MGI:Ednra)) increases a(CHEBI:"reactive oxygen species")	These findings demonstrate that ET-1 activation of ET(A) receptors mediates an increase in ROS that is associated with cardiac hypertrophy in AhR null mice. In addition, the ET-1-mediated increase in ROS appears to be initiated via increased NAD(P)H oxidase activity.	SEN:10019040	16107552
BEL:20031172	cat(p(MGI:Ednrb)) increases cat(p(MGI:Slc9a3))	In cultured renal epithelial cells, activation of the endothelin-B (ET(B)) receptor increases NHE3 activity.	SEN:10019042	11413164
BEL:20031184	cat(p(MGI:Egr1)) increases r(MGI:Gad1)	nuclear factor-kappa B activation through oxidative stress can up-regulate GAD67 expression [36], and the early growth response factor 1-related pathway also mediates GAD67 up-regulation [37].	SEN:10019046	21034448
BEL:20031200	cat(p(MGI:Entpd1)) increases bp(GOBP:"endothelial cell activation")	CD39 (ecto-nucleoside triphosphate diphosphohydrolase-1; E-NTPDase-1), is highly expressed on quiescent vascular endothelial cells and efficiently hydrolyzes extracellular ATP and ADP to AMP and ultimately adenosine. This action blocks extracellular nucleotide-dependent platelet aggregation and abrogates endothelial cell activation.	SEN:10004736	14983235
BEL:20031204	cat(p(MGI:Entpd1)) decreases path(MESHD:Ischemia)	In wild-type animals, ischemia reperfusion injury resulted in 60% mortality within 48 hours. In mutant mice null or deficient for cd39, ischemia reperfusion-related death occurred in 80% of animals.	SEN:10004738	14983235
BEL:20031208	cat(p(MGI:Ep300)) directlyIncreases p(MGI:Rela,pmod(A,K,310))	Furthermore, phosphorylation of RelA on serine 276 or serine 536 increased assembly of phospho-RelA with p300, which enhanced acetylation on lysine 310.	SEN:10019052	16135789
BEL:20031210	cat(p(MGI:Ep300)) increases p(MGI:Rela,pmod(A,K,310))	Using anti-acetylated lysine 310 RelA antibodies, we detected p300-mediated acetylation of RelA in vitro and in vivo after stimulation of cells with tumor necrosis factor alpha (TNF-alpha).	SEN:10019054	16135789
BEL:20031212	cat(p(MGI:Ep300)) directlyIncreases p(MGI:Rela,pmod(A,K,310))	We show here in vitro and in vivo acetylation of RelA/p65 by p300 on lysine 314 and 315, two novel acetylation sites. Additionally, we confirmed the acetylation on lysine 310 shown previously.	SEN:10019056	18263619
BEL:20031214	cat(p(MGI:Ep300)) directlyIncreases p(MGI:Rela,pmod(A,K,314))	We show here in vitro and in vivo acetylation of RelA/p65 by p300 on lysine 314 and 315, two novel acetylation sites. Additionally, we confirmed the acetylation on lysine 310 shown previously.	SEN:10019056	18263619
BEL:20031216	cat(p(MGI:Ep300)) directlyIncreases p(MGI:Rela,pmod(A,K,315))	We show here in vitro and in vivo acetylation of RelA/p65 by p300 on lysine 314 and 315, two novel acetylation sites. Additionally, we confirmed the acetylation on lysine 310 shown previously.	SEN:10019056	18263619
BEL:20031220	cat(p(MGI:Ep300)) increases r(MGI:Dmp1)	Intrinsic histone acetyltransferase activity of p300 also plays a critical role in regulating DMP1 gene expression.	SEN:10004740	15308641
BEL:20031224	cat(p(MGI:Ep300)) increases tscript(p(MGI:Runx1))	Histone acetyltransferases (HATs) p300 and CREB-binding protein (CBP) function as co-activators for a variety of sequence-specific transcription factors, including AML1.	SEN:10018960	16917507
BEL:20031264	cat(p(MGI:F2)) increases cat(p(MGI:F2r))	exogenously applied serine proteases thrombin, plasmin, and tissue plasminogen activator can activate PAR1 signaling in brain tissue	SEN:10004760	14559973
BEL:20031276	cat(p(MGI:F2rl1)) decreases bp(GOBP:"regulation of vascular permeability")	However, an agonist for another endothelial cell Gi-coupled receptor, Par2, did protect wild-type mice from PAF-induced vascular leak, and systemic treatment with pertussis toxin prevented rescue by Par2 agonist and sensitized wild-type mice to leak-inducing stimuli in a manner that resembled the loss of plasma S1P.	SEN:10019064	19603543
BEL:20031296	cat(p(MGI:Fadd)) increases r(MGI:Ifnb1)	Wild-type MEFs induced Ifnb, Tnfa, and Il-6 in response to poly(I:C) {an viral mimetic activator of FADD signaling-SE}, whereas the induction was severely impaired in FADD-deficient MEFs as examined by RT-PCR analyses (Fig. 1A).	SEN:10018258	16585540
BEL:20031298	cat(p(MGI:Fadd)) increases r(MGI:Il6)	Wild-type MEFs induced Ifnb, Tnfa, and Il-6 in response to poly(I:C) {an viral mimetic activator of FADD signaling-SE}, whereas the induction was severely impaired in FADD-deficient MEFs as examined by RT-PCR analyses (Fig. 1A).	SEN:10018258	16585540
BEL:20031300	cat(p(MGI:Fadd)) increases r(MGI:Tnf)	Wild-type MEFs induced Ifnb, Tnfa, and Il-6 in response to poly(I:C) {an viral mimetic activator of FADD signaling-SE}, whereas the induction was severely impaired in FADD-deficient MEFs as examined by RT-PCR analyses (Fig. 1A).	SEN:10018258	16585540
BEL:20031310	cat(p(MGI:Fap)) increases bp(GOBP:"cell differentiation")	We therefore conclude that FAP enzymatic activity regulates recruitment, proliferation, survival, or differentiation of myofibroblasts	SEN:10019076	19920354
BEL:20031312	cat(p(MGI:Fap)) increases bp(GOBP:"cell proliferation")	We therefore conclude that FAP enzymatic activity regulates recruitment, proliferation, survival, or differentiation of myofibroblasts	SEN:10019076	19920354
BEL:20031316	cat(p(MGI:Farp1)) directlyIncreases gtp(p(MGI:Rhoa))	The dissociation of [3H]GDP from RhoA was stimulated dose-dependently by Sf9 cell lysates containing the CDEP peptide. CDEP is a novel GEF for Rho family GTPases with the transforming activity.	SEN:10019080	11680691
BEL:20031324	cat(p(MGI:Fas)) increases bp(GOBP:"apoptotic process")	These results suggest that IL-1beta suppresses Fas-mediated hepatocyte apoptosis by inducing molecule(s) that suppress the apoptosis control machinery upstream of caspase 3	SEN:10004766	10464143
BEL:20031326	cat(p(MGI:Fas)) increases bp(GOBP:"apoptotic process")	Silica induced Fas ligand expression in lung macrophages in vitro and in vivo, and promoted Fas ligand-dependent macrophage apoptosis.	SEN:10019086	11457890
BEL:20031332	cat(p(MGI:Fas)) increases bp(GOBP:"apoptotic process")	FAF1 potentiates Fas-induced cell killing and is a candidate signal transducing molecule in the regulation of apoptosis	SEN:10004770	8524870
BEL:20031336	cat(p(MGI:Fas)) increases cat(p(MGI:Casp3))	These results suggest that IL-1beta suppresses Fas-mediated hepatocyte apoptosis by inducing molecule(s) that suppress the apoptosis control machinery upstream of caspase 3	SEN:10004766	10464143
BEL:20031338	cat(p(MGI:Fas)) increases cat(p(MGI:Casp3))	We further found that expression of the Fas gene was repressed, resulting in abrogation of the Fas-mediated induction of apoptosis both in Mssp-knockout mice and primary thymocytes. it was found that cytochrome C was not released in the cytosol and that activations of caspase 8 and caspase 3 occurred in primary fibroblasts from MSSP (+/+) cells but not from MSSP (-/-) cells.	SEN:10019082	16211301
BEL:20031340	cat(p(MGI:Fas)) increases cat(p(MGI:Casp8))	We further found that expression of the Fas gene was repressed, resulting in abrogation of the Fas-mediated induction of apoptosis both in Mssp-knockout mice and primary thymocytes. it was found that cytochrome C was not released in the cytosol and that activations of caspase 8 and caspase 3 occurred in primary fibroblasts from MSSP (+/+) cells but not from MSSP (-/-) cells.	SEN:10019082	16211301
BEL:20031342	cat(p(MGI:Fas)) increases cat(p(MGI:Fadd))	Fas-induced apoptosis was completely blocked in FADD -/- MEFs, indicating that there are no redundant Fas apoptotic pathways	SEN:10019092	9521326
BEL:20031354	cat(p(MGI:Fas)) decreases r(MGI:Dusp1)	mRNA of mitogen-activated protein kinase phosphatase-1 (MKP-1), an inactivator of JNK, was up-regulated by FA alone, but not by FA+AD or AD alone.	SEN:10016774	12176128
BEL:20031358	cat(p(MGI:Fbxl20)) directlyIncreases deg(p(MGI:Rims1))	In neurons from Scrapper-knockout (SCR-KO) mice, RIM1 had a longer half-life with significant reduction in ubiquitination, indicating that SCRAPPER is the predominant ubiquitin ligase that mediates RIM1 degradation.	SEN:10004772	17803915
BEL:20031368	cat(p(MGI:Fcgr2b)) decreases bp(GOBP:"cell proliferation")	FcgammaRs, FcgammaRIIb, is thought to contribute to protection from autoimmune disease by down-regulation of B-cell responsiveness and myeloid cell activation	SEN:10004776	12937154
BEL:20031422	cat(p(MGI:Fpr1)) decreases bp(GOBP:"neutrophil chemotaxis")	agonist for Fpr1 and Fpr2 induced cross-desensitization in neutrophils and attenuated neutrophil migration into the airways	SEN:10004792	21039475
BEL:20031424	cat(p(MGI:Fpr2)) decreases bp(GOBP:"neutrophil chemotaxis")	agonist for Fpr1 and Fpr2 induced cross-desensitization in neutrophils and attenuated neutrophil migration into the airways	SEN:10004792	21039475
BEL:20031430	cat(p(MGI:Furin)) increases cat(p(MGI:Tgfb1))	Moreover, inhibition of the TGFbeta1 converting enzyme, furin, resulted in increased PHD2 expression, and decreased basal HIF-1alpha and VEGF levels, suggesting that endogenous production of bioactive TGFbeta1 efficiently regulates HIF-1-targeted genes.	SEN:10019116	16815840
BEL:20031436	cat(p(MGI:G6pdx)) increases bp(GOBP:"fat cell differentiation")	In 3T3-L1 cells, G6PD overexpression stimulated the expression of most adipocyte marker genes and elevated the levels of cellular free fatty acids, triglyceride, and FFA release. Consistently, G6PD knockdown via small interfering RNA attenuated adipocyte differentiation	SEN:10019120	15923630
BEL:20031438	cat(p(MGI:G6pdx)) increases path(MESHD:"Insulin Resistance")	overexpression of G6PD impaired insulin signaling and suppressed insulin-dependent glucose uptake in adipocytes	SEN:10004794	15923630
BEL:20031444	cat(p(MGI:G6pdx)) decreases r(MGI:Adipoq)	Surprisingly, the expression of certain adipocytokines such as tumor necrosis factor alpha and resistin was increased, whereas that of adiponectin was decreased in G6PD overexpressed adipocytes	SEN:10004796	15923630
BEL:20031446	cat(p(MGI:G6pdx)) increases r(MGI:Retn)	Surprisingly, the expression of certain adipocytokines such as tumor necrosis factor alpha and resistin was increased, whereas that of adiponectin was decreased in G6PD overexpressed adipocytes	SEN:10004796	15923630
BEL:20031448	cat(p(MGI:G6pdx)) increases r(MGI:Tnf)	Surprisingly, the expression of certain adipocytokines such as tumor necrosis factor alpha and resistin was increased, whereas that of adiponectin was decreased in G6PD overexpressed adipocytes	SEN:10004796	15923630
BEL:20031456	cat(p(MGI:Gab2)) increases phos(p(MGI:Ptpn11))	PTP? is required for SCF-induced c-Kit and Fyn activation, and in this way regulates a Fyn-based c-Kit signaling axis (Fyn/Gab2/Shp2/Vav/PAK/Rac/JNK) that mediates mast cell migration.	SEN:10019126	20944008
BEL:20031458	cat(p(MGI:Galc)) decreases a(CHEBI:psychosine)	This was associated with a decrease in the abnormal accumulation of the GALC substrate psychosine, which is thought to play a pivotal role in disease pathology	SEN:10004798	15987783
BEL:20031460	cat(p(MGI:Galc)) decreases a(CHEBI:psychosine)	Globoid cell leukodystrophy (GLD) is a disorder of the central and peripheral nervous systems caused by the deficiency of the lysosomal enzyme galactocerebrosidase (GALC). The pathological changes associated with the disease include accumulation of globoid cells and loss of myelin due to production of psychosine,	SEN:10004800	16169269
BEL:20031464	cat(p(MGI:Galc)) increases deg(a(CHEBI:psychosine))	The death of oligodendrocytes is accompanied by accumulation of psychosine, which is also a substrate for the GALC enzyme.	SEN:10004804	15039117
BEL:20031490	cat(p(MGI:Ghrhr)) decreases r(MGI:Fabp3)	In the mammary gland of growth hormone releasing hormone receptor mutant (Ghrhrlit/Ghrhrlit) mice, the MDGI gene was overexpressed.	SEN:10019136	9683796
BEL:20031492	cat(p(MGI:Ghr)) increases kin(p(MGI:Jak2))	\"Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.\"	SEN:10019138	10842184
BEL:20031494	cat(p(MGI:Ghr)) increases p(MGI:Apoa4)	apolipoprotein A-IV, the lung content of which was reduced by approximately 73% in these mice. [GHR KO mice]	SEN:10019140	16287172
BEL:20031496	cat(p(MGI:Ghr)) increases p(MGI:Etfa)	Proteasome 26S ATPase subunit 4, a protein involved in the non-lysosomal degradation of intracellular proteins, and electron flavoprotein alpha subunit , involved in intracellular metabolism, were also reduced in content in the lungs of the GHR (-/-) mice (by approximately 70% and 49%, respectively).	SEN:10019142	16287172
BEL:20031498	cat(p(MGI:Ghr)) increases p(MGI:Idh1)	Three proteins involved in oxidative protection [SH3 domain-binding glutamic acid-rich-like protein, peroxiredoxin 6 (Prdx6), and isocitrate dehydrogenase 1] were also of lower content in the GHR (-/-) lungs (by approximately 88%, 81% and 70%, respectively).	SEN:10019144	16287172
BEL:20031500	cat(p(MGI:Ghr)) increases p(MGI:Prdx6)	Three proteins involved in oxidative protection [SH3 domain-binding glutamic acid-rich-like protein, peroxiredoxin 6 (Prdx6), and isocitrate dehydrogenase 1] were also of lower content in the GHR (-/-) lungs (by approximately 88%, 81% and 70%, respectively).	SEN:10019144	16287172
BEL:20031502	cat(p(MGI:Ghr)) increases p(MGI:Sh3bgrl)	Three proteins involved in oxidative protection [SH3 domain-binding glutamic acid-rich-like protein, peroxiredoxin 6 (Prdx6), and isocitrate dehydrogenase 1] were also of lower content in the GHR (-/-) lungs (by approximately 88%, 81% and 70%, respectively).	SEN:10019144	16287172
BEL:20031504	cat(p(MGI:Ghr)) increases p(MGI:Vim)	Vimentin, a protein involved in cellular proliferation, was reduced in content by approximately 75% in the lungs of the GHR (-/-) mice.	SEN:10004812	16287172
BEL:20031508	cat(p(MGI:Gipc1)) decreases r(MGI:Rin3)	Rin3, a novel Rab 5 guanine exchange factor, was identified by microarray analysis to be expressed at higher basal levels in synectin -/- cells than synectin +/+ cells and this is confirmed by PCR.	SEN:10019148	16940428
BEL:20031510	cat(p(MGI:Gja1)) increases bp(GOBP:"blood vessel development")	Mice lacking both connexin37 (Cx37) and connexin40 (Cx40), gap junction proteins expressed in vascular endothelium, die perinatally with pronounced vascular abnormalities.	SEN:10004814	14681045
BEL:20031512	cat(p(MGI:Gja5)) increases bp(GOBP:"blood vessel development")	Mice lacking both connexin37 (Cx37) and connexin40 (Cx40), gap junction proteins expressed in vascular endothelium, die perinatally with pronounced vascular abnormalities.	SEN:10004814	14681045
BEL:20031520	cat(p(MGI:Glud1)) increases a(CHEBI:"reactive oxygen species")	Depletion of PYGL, GLUL, and GLUD1 by means of siRNA reduced TNF+zVAD–induced accumulation of ROS (Fig. 4C and fig. S11), which correlated with cell death (Fig. 3F and figs. S7D and S8D).	SEN:10019152	19498109
BEL:20031522	cat(p(MGI:Glud1)) increases a(CHEBI:"reactive oxygen species")	Importantly, knockdown of PYGL, GLUL, or GLUD1 partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells	SEN:10019154	19632174
BEL:20031524	cat(p(MGI:Glul)) increases a(CHEBI:"reactive oxygen species")	Depletion of PYGL, GLUL, and GLUD1 by means of siRNA reduced TNF+zVAD–induced accumulation of ROS (Fig. 4C and fig. S11), which correlated with cell death (Fig. 3F and figs. S7D and S8D).	SEN:10019152	19498109
BEL:20031526	cat(p(MGI:Glul)) increases a(CHEBI:"reactive oxygen species")	Importantly, knockdown of PYGL, GLUL, or GLUD1 partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells	SEN:10019154	19632174
BEL:20031532	cat(p(MGI:Got1)) increases bp(GOBP:gluconeogenesis)	cytosolic aspartate aminotransferase, a housekeeping gene that participates in gluconeogenesis in the liver.	SEN:10004820	7846052
BEL:20031540	cat(p(MGI:Gpr64)) increases bp(GOBP:spermatogenesis)	Targeted disruption of the epididymis-specific HE6/Gpr64 receptor gene in mice led to male infertility.	SEN:10004822	17034053
BEL:20031560	cat(p(MGI:Gsr)) increases a(CHEBI:glutathione)	Nrf2(-/-) MEFs exhibited greater accumulation of glutathione disulfide and cytotoxicity compared to Nrf2(+/+) MEFs in response to t-butylhydroquinone, which was rescued by restoring GSR	SEN:10001020	19028565
BEL:20031566	cat(p(MGI:Gsr)) decreases bp(GOBP:"cell death")	Nrf2(-/-) MEFs exhibited greater accumulation of glutathione disulfide and cytotoxicity compared to Nrf2(+/+) MEFs in response to t-butylhydroquinone, which was rescued by restoring GSR	SEN:10001020	19028565
BEL:20031572	cat(p(MGI:Gstp1)) decreases kin(p(MGI:Mapk1))	Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways	SEN:10001760	11408560
BEL:20031574	cat(p(MGI:Gstp1)) decreases kin(p(MGI:Mapk3))	Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways	SEN:10001760	11408560
BEL:20031576	cat(p(MGI:Gstp1)) decreases kin(p(MGI:Mapk8))	title := \"Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus.\"	SEN:10019170	11279197
BEL:20031586	cat(p(MGI:Hdac1)) directlyDecreases tscript(p(MGI:Trp53))	These results suggest that Bach1 impedes p53-mediated transactivation by binding to a subset of target genes along with p53 and by recruiting Hdac1.	SEN:10019176	19011633
BEL:20031590	cat(p(MGI:Hdac3)) decreases r(MGI:Gdf11)	A comprehensive survey of human HDACs revealed that HDAC3 is necessary and sufficient for the repression of gdf11 promoter activity.	SEN:10004832	15169878
BEL:20031596	cat(p(MGI:Hdac4)) decreases tscript(p(MGI:Mef2d))	HDAC4 is believed to repress MEF2 transcriptional activity by binding to MEF2 and catalyzing local histone deacetylation.	SEN:10004836	16166628
BEL:20031610	cat(p(MGI:Hells)) decreases r(MGI:Cdkn1c)	We report here that loss of Lsh specifically alters expression of the Cdkn1c gene The reactivation of the silenced paternal Cdkn1c allele correlates closely with a loss of CpG methylation at the 5' DMR at the Cdkn1c promoter Chromatin immunoprecipitations demonstrate a direct association of Lsh with the 5' DMR at the Cdkn1c promoter	SEN:10019184	15647320
BEL:20031632	cat(p(MGI:Hrh1)) increases r(MGI:C3)	However, via H1 receptor a considerably up-regulation of C3 gene expression and biosynthesis was demonstrated.	SEN:10019188	3221881
BEL:20031636	cat(p(MGI:Hrh2)) decreases r(MGI:C2)	Measuring the quantity of specific mRNAs and biosynthetically labelled proteins a down-regulation of the biosynthesis of C2, factor B and C3 via H2 receptor was found.	SEN:10004858	3221881
BEL:20031638	cat(p(MGI:Hrh2)) decreases r(MGI:C3)	Measuring the quantity of specific mRNAs and biosynthetically labelled proteins a down-regulation of the biosynthesis of C2, factor B and C3 via H2 receptor was found.	SEN:10004858	3221881
BEL:20031640	cat(p(MGI:Hrh2)) decreases r(MGI:Cfb)	Measuring the quantity of specific mRNAs and biosynthetically labelled proteins a down-regulation of the biosynthesis of C2, factor B and C3 via H2 receptor was found.	SEN:10004858	3221881
BEL:20031644	cat(p(MGI:Hrh3)) increases r(MGI:Ucp1)	The expression of UCP1 in brown adipose tissue and of UCP3 in brown adipose tissue, white adipose tissue, and skeletal muscle is decreased in H3(-/-) mutants, and the anorexigenic activity of thioperamide is not observed.	SEN:10004860	12488429
BEL:20031646	cat(p(MGI:Hrh3)) increases r(MGI:Ucp3)	The expression of UCP1 in brown adipose tissue and of UCP3 in brown adipose tissue, white adipose tissue, and skeletal muscle is decreased in H3(-/-) mutants, and the anorexigenic activity of thioperamide is not observed.	SEN:10004860	12488429
BEL:20031668	cat(p(MGI:Hsd11b1)) increases path(MESHD:"Insulin Resistance")	Overexpression of 11beta-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)alpha overexpression, central obesity, and insulin resistance	SEN:10004866	15356040
BEL:20031670	cat(p(MGI:Hsd11b1)) increases path(MESHD:"Insulin Resistance")	In mice, overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose or liver causes obesity or insulin resistance, respectively	SEN:10004868	18622204
BEL:20031674	cat(p(MGI:Hsd11b1)) increases path(MESHD:Obesity)	Overexpression of 11beta-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)alpha overexpression, central obesity, and insulin resistance	SEN:10004866	15356040
BEL:20031680	cat(p(MGI:Hsd11b1)) increases path(MESHD:Obesity)	In mice, overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose or liver causes obesity or insulin resistance, respectively	SEN:10004868	18622204
BEL:20031684	cat(p(MGI:Hsd11b1)) decreases r(MGI:Adipoq)	AdipoQ (23), has been suggested to serve as an insulin-sensitizing factor (24). The mRNA level in mesenteric fat from Tg mice was markedly decreased	SEN:10019202	15793228
BEL:20031686	cat(p(MGI:Hsd11b1)) increases r(MGI:Agt)	Angiotensinogen mRNA, which is up-regulated by glucocorticoids (26), was substantially increased in Tg mice.	SEN:10019204	15793228
BEL:20031694	cat(p(MGI:Hsd11b1)) increases r(MGI:Nr3c1)	Overexpression of 11beta-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)alpha overexpression, central obesity, and insulin resistance	SEN:10004866	15356040
BEL:20031696	cat(p(MGI:Hsd11b1)) decreases r(MGI:Retn)	The mRNA for resistin, which has been suggested to be involved in glucose homeostasis (25), was significantly decreased in Tg mice.	SEN:10019208	15793228
BEL:20031700	cat(p(MGI:Hsd11b1)) increases sec(p(MGI:Tnf))	model. Tumor necrosis factor- alpha (TNF-a), a fat cell- derived cytokine that can cause insulin resistance (3, 22), was significantly elevated in serum of Tg mice	SEN:10019210	15793228
BEL:20031728	cat(p(MGI:Icmt)) directlyIncreases gtp(p(MGI:Hras))	In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.	SEN:10004878	14966563
BEL:20031732	cat(p(MGI:Icmt)) directlyIncreases gtp(p(MGI:Kras))	In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.	SEN:10004878	14966563
BEL:20031744	cat(p(MGI:Icmt)) decreases p(MGI:Cdkn1a)	levels of RhoA were greatly reduced as a consequence of accelerated protein turnover. In addition, there was a large Ras/Erk1/2-dependent increase in p21(Cip1), which was probably a consequence of the reduced levels of RhoA. Deletion of p21(Cip1) restored the ability of K-Ras-Icmt(Delta/Delta) fibroblasts to grow in soft agar.	SEN:10004882	14966563
BEL:20031746	cat(p(MGI:Icmt)) increases p(MGI:Rhoa)	levels of RhoA were greatly reduced as a consequence of accelerated protein turnover. In addition, there was a large Ras/Erk1/2-dependent increase in p21(Cip1), which was probably a consequence of the reduced levels of RhoA. Deletion of p21(Cip1) restored the ability of K-Ras-Icmt(Delta/Delta) fibroblasts to grow in soft agar.	SEN:10004882	14966563
BEL:20031750	cat(p(MGI:Ids)) increases deg(a(CHEBI:"dermatan sulfate"))	The lysosomal enzyme iduronate-2-sulfatase (IDS) is expressed in pancreatic islets and is responsible for degradation of proteoglycans, such as perlecan and dermatan sulfate.	SEN:10004886	15149955
BEL:20031752	cat(p(MGI:Ids)) increases deg(a(CHEBI:proteoglycan))	The lysosomal enzyme iduronate-2-sulfatase (IDS) is expressed in pancreatic islets and is responsible for degradation of proteoglycans, such as perlecan and dermatan sulfate.	SEN:10004886	15149955
BEL:20031760	cat(p(MGI:Igf2r)) decreases bp(GOBP:"cell growth")	Consistent with this, overexpression of Igf2r in a tissue-specific manner was shown to cause a local reduction in organ size	SEN:10019224	11311167
BEL:20031762	cat(p(MGI:Igf2r)) decreases p(MGI:Igfbp3)	IGF2R/IGF-II-deficient mice have elevated levels of circulating IGF binding protein (IGFBP)-3 and show a strong IGFBP-6 immunoreactivity in all pancreatic islet cells	SEN:10019226	10226807
BEL:20031764	cat(p(MGI:Il10ra)) decreases bp(GOBP:"apoptotic process")	Here we show that IL-10 directly affects progenitor myeloid cells by protecting them from death following the removal of growth factors.	SEN:10019228	11591769
BEL:20031774	cat(p(MGI:Il13)) increases p(MGI:Ccl2)	eotaxin protein levels in both lung tissue and BAL were also reduced when IL-13 was blocked in the supernatant (Fig. 5B); in lung tissue, where higher concentrations of eotaxin were detected, the levels of eotaxin protein were also reduced close to the control levels (Fig. 5B).	SEN:10019234	10072486
BEL:20031776	cat(p(MGI:Il13)) increases r(MGI:Ccl11)	Addition of anti-IL-13 Ab to the Th2 supernatant effectively blocked the induction of eotaxin mRNA, with levels equivalent to those in control mice (Fig. 5A).	SEN:10019236	10072486
BEL:20031778	cat(p(MGI:Il17ra)) increases bp(GOBP:"macrophage chemotaxis")	Lung tumor tissues attracted migration of mouse RAW264.7 macrophages and primary peritoneal macrophages through IL-17, which was mediated by IL-17RA and IL-17RC.	SEN:10004890	22534817
BEL:20031780	cat(p(MGI:Il17rc)) increases bp(GOBP:"macrophage chemotaxis")	Lung tumor tissues attracted migration of mouse RAW264.7 macrophages and primary peritoneal macrophages through IL-17, which was mediated by IL-17RA and IL-17RC.	SEN:10004890	22534817
BEL:20031782	cat(p(MGI:Il1r1)) increases cat(p(MGI:Myd88))	Both interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) signal via the adapter molecule MyD88.	SEN:10001130	16413919
BEL:20031784	cat(p(MGI:Il1rl1)) increases p(MGI:Ccr3)	These results indicate that the endogenous IL-33/ST2 signaling pathway enhances the expression of CCR3 on eosinophils.	SEN:10019238	20693421
BEL:20031786	cat(p(MGI:Il1rl1)) increases sec(p(MGI:Ccl17))	IL-33 triggered the production of IL-13 and IL-6 and strongly increased the production of CCL17 and TGF-b from WT eosinophils, but not ST2-/- eosinophils, in a dosedependent manner (Fig. 5A).	SEN:10019240	20693421
BEL:20031788	cat(p(MGI:Il1rl1)) increases sec(p(MGI:Il13))	IL-33 triggered the production of IL-13 and IL-6 and strongly increased the production of CCL17 and TGF-b from WT eosinophils, but not ST2-/- eosinophils, in a dosedependent manner (Fig. 5A).	SEN:10019240	20693421
BEL:20031790	cat(p(MGI:Il1rl1)) increases sec(p(MGI:Il6))	IL-33 triggered the production of IL-13 and IL-6 and strongly increased the production of CCL17 and TGF-b from WT eosinophils, but not ST2-/- eosinophils, in a dosedependent manner (Fig. 5A).	SEN:10019240	20693421
BEL:20031792	cat(p(MGI:Il1rl1)) increases sec(p(MGI:Tgfb1))	IL-33 triggered the production of IL-13 and IL-6 and strongly increased the production of CCL17 and TGF-b from WT eosinophils, but not ST2-/- eosinophils, in a dosedependent manner (Fig. 5A).	SEN:10019240	20693421
BEL:20031796	cat(p(MGI:Il2rb)) directlyIncreases kin(p(MGI:Jak1))	IL-2-mediated hetero-dimerization of its receptor triggers a rapid increase in the recruitment of Jak3 and activation of both Jak1 and Jak3	SEN:10019244	10851055
BEL:20031798	cat(p(MGI:Il2rb)) directlyIncreases kin(p(MGI:Jak3))	IL-2-mediated hetero-dimerization of its receptor triggers a rapid increase in the recruitment of Jak3 and activation of both Jak1 and Jak3	SEN:10019244	10851055
BEL:20031818	cat(p(MGI:Il6st)) increases bp(GOBP:"MAPK cascade")	The interleukin-6 (IL6) family of cytokines signals through the common receptor subunit gp130, and subsequently activates Stat3, MAPK, and PI3K.	SEN:10019252	15292206
BEL:20031822	cat(p(MGI:Il6st)) directlyIncreases kin(p(MGI:Hck))	identification of an acidic domain of gp130 as a binding region for Hck, which mediates proliferative signaling the deletion of this region of gp130 resulted in a significant reduction of Hck kinase activity and cell proliferation upon stimulation of gp130 compared to wild-type gp130	SEN:10019254	11689697
BEL:20031826	cat(p(MGI:Il6st)) increases tscript(p(MGI:Stat3))	The interleukin-6 (IL6) family of cytokines signals through the common receptor subunit gp130, and subsequently activates Stat3, MAPK, and PI3K.	SEN:10019252	15292206
BEL:20031832	cat(p(MGI:Impa1)) directlyIncreases a(CHEBI:inositol)	ISYNA1 is an isomerase that catalyzes the conversion of glucose-6-phoshate to myo-inositol-1-phosphate. IMPA1 then hydrolyzes the phosphate group to produce myo-inositol.	SEN:10004898	14613899
BEL:20031844	cat(p(MGI:Itgam)) increases bp(GOBP:"cell adhesion")	we used an alternative strategy of inhibiting leukocyte recruitment by activating CD11b/CD18 with small-molecule agonists, which we term leukadherins. These compounds increased the extent of CD11b/CD18-dependent cell adhesion of transfected cells and of primary human and mouse neutrophils	SEN:10019262	21900205
BEL:20031846	cat(p(MGI:Itgav)) decreases r(EGID:12096)	an RGD peptidomimetic compound, designed to block interaction of ligands to the alpha(v) integrin subunit, increases osteocalcin expression and inhibits collagenase-3 expression,	SEN:10004902	11964409
BEL:20031848	cat(p(MGI:Itgav)) increases r(MGI:Mmp13)	an RGD peptidomimetic compound, designed to block interaction of ligands to the alpha(v) integrin subunit, increases osteocalcin expression and inhibits collagenase-3 expression,	SEN:10004902	11964409
BEL:20031850	cat(p(MGI:Itgb1bp2)) increases kin(p(MGI:Ptk2))	but did not substantially affect phosphorylation of p38 and ERK 1/2. In addition, phosphorylation of AKT was greatly impaired in aortic-banded heart of melusin-null mice.	SEN:10019264	12496958
BEL:20031852	cat(p(MGI:Itgb1bp2)) increases p(MGI:Gsk3b,pmod(P,S))	Analysis of intracellular signaling events induced by pressure overload indicated that phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) was specifically blunted in melusin-null hearts.	SEN:10019266	12496958
BEL:20031858	cat(p(MGI:Itpr1)) increases bp(GOBP:"insulin secretion")	Mice heterozygous for the annexin A7 (Anx7) gene have a profound reduction in IP3 receptor function in pancreatic islets along with defective insulin secretion.	SEN:10004904	15590065
BEL:20031884	cat(p(MGI:Ldlr)) decreases path(MESHD:Atherosclerosis)	\"Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.\" Mice in which diabetes was induced through streptozotocin (STZ) treatment, but not nondiabetic mice, expressing human AR (hAR) crossed with LDL receptor-deficient (Ldlr-/-) C57BL/6 male mice had increased aortic atherosclerosis.	SEN:10018784	16127462
BEL:20031890	cat(p(MGI:Lgals12)) decreases bp(GOBP:"cell cycle")	We previously showed that galectin-12 is induced by cell cycle block at the G(1) phase and causes G(1) arrest when overexpressed (Yang, R.-Y., Hsu, D. K., Yu, L., Ni, J., and Liu, F.-T. (2001) J. Biol. Chem. 276, 20252-20260)	SEN:10019280	15131127
BEL:20031930	cat(p(MGI:Lipe)) increases r(EGID:103968)	expression of adipose differentiation markers, such as ALBP and perilipin, was suppressed 50-80% (P < 0.01; Fig. 7, A and B). Expression of lipoprotein lipase (LPL) was also suppressed 30-40% (P < 0.05) in WAT of HSL-/- mice (Fig. 7C), with greater reductions observed in male mice.	SEN:10019288	12954598
BEL:20031932	cat(p(MGI:Lipe)) increases r(MGI:Cebpa)	in parallel with the suppression of adipogenic transcription factors PPAR{gamma} and C/EBP{alpha} in WAT of HSL-/- mice,	SEN:10019290	12954598
BEL:20031934	cat(p(MGI:Lipe)) increases r(MGI:Fabp4)	expression of adipose differentiation markers, such as ALBP and perilipin, was suppressed 50-80% (P < 0.01; Fig. 7, A and B). Expression of lipoprotein lipase (LPL) was also suppressed 30-40% (P < 0.05) in WAT of HSL-/- mice (Fig. 7C), with greater reductions observed in male mice.	SEN:10019288	12954598
BEL:20031936	cat(p(MGI:Lipe)) increases r(MGI:Lpl)	expression of adipose differentiation markers, such as ALBP and perilipin, was suppressed 50-80% (P < 0.01; Fig. 7, A and B). Expression of lipoprotein lipase (LPL) was also suppressed 30-40% (P < 0.05) in WAT of HSL-/- mice (Fig. 7C), with greater reductions observed in male mice.	SEN:10019288	12954598
BEL:20031938	cat(p(MGI:Lipe)) increases r(MGI:Pparg)	in parallel with the suppression of adipogenic transcription factors PPAR{gamma} and C/EBP{alpha} in WAT of HSL-/- mice,	SEN:10019290	12954598
BEL:20031942	cat(p(MGI:Lox)) decreases tloc(p(MGI:Fgf2),GOCCID:0005737,GOCCID:0005634)	Both the mitogenic potential and the nuclear localization of bFGF were markedly inhibited in the Swiss 3T3 cells upon its oxidation by LO.	SEN:10000284	12461785
BEL:20031952	cat(p(MGI:Lrp1)) decreases tscript(p(MGI:Kat5))	LrpICD dramatically inhibits AICD/Fe65 transactivation mediated by Tip60 LrpICD has a novel signaling function, negatively impacting transcriptional activity of the APP, Fe65 and Tip60 complex in the nucleus	SEN:10019296	12888553
BEL:20031962	cat(p(MGI:Ltb4r1)) increases a(CHEBI:"reactive oxygen species")	At low concentrations of immune complexes, loss of PI3K beta alone substantially inhibited the production of reactive oxygen species (ROS) by neutrophils... Activation of PI3Kbeta by immune complexes involved cooperation between FcgammaRs and BLT1, the receptor for the endogenous proinflammatory lipid leukotriene B4.	SEN:10019302	21487107
BEL:20031970	cat(p(MGI:Ltb4r1)) increases p(MGI:Ccl2)	Blocking the LTB4 receptor in mice results in reduced lesions, accompanied by reduced monocyte chemoattractant protein-1 (MCP- 1) (242).	SEN:10019306	16046792
BEL:20031972	cat(p(MGI:Ltb4r1)) increases p(MGI:Il12b)	A selective inhibitor of leukotriene synthesis MK886 as well as an antagonist of the high affinity LTB(4) receptor (BLT(1)) U-75302 slightly inhibited zymosan-, but not LPS-stimulated interleukin (IL)-10 release from BM-DCs. In contrast, U-75302 increased zymosan-stimulated release of IL-12 p40 by approximately 23%	SEN:10019308	16313356
BEL:20031976	cat(p(MGI:Ltb4r1)) increases p(MGI:Muc5ac)	The LTD4-ra MK-571 also dose dependently inhibited MUC5AC (Fig. 6, A and B) and mucus accumulation in epithelial cells as verified morphologically (Fig. 7D and Table 1), as did the LTB4-ra PH-163 72 h after challenge with Ova (Figs. 6, A and B, 7E; Table 1).	SEN:10019018	12794006
BEL:20031984	cat(p(MGI:Maoa)) decreases a(CHEBI:serotonin)	MAO-A, which preferentially catalyzes the oxidative deamination of norepinephrine (NE) and serotonin (5-HT), is inhibited by low concentrations of clorgyline. In contrast, MAO-B, which has a higher affinity for phenylethylamine and benzylamine, is inhibited by selegiline [79].	SEN:10016268	19307700
BEL:20031990	cat(p(MGI:March7)) increases deg(p(MGI:Lifr))	we found that IL6 effectively inhibited LIF signalling, repressing transcription of the LIF receptor gp190, and strongly inducing axotrophin/MARCH-7, a novel E3 ubitquitin ligase that we discovered to be active in degradation of gp190 protein.	SEN:10019318	19342884
BEL:20031992	cat(p(MGI:March7)) increases p(MGI:Lifr,pmod(U,K))	we found that IL6 effectively inhibited LIF signalling, repressing transcription of the LIF receptor gp190, and strongly inducing axotrophin/MARCH-7, a novel E3 ubitquitin ligase that we discovered to be active in degradation of gp190 protein.	SEN:10019318	19342884
BEL:20031998	cat(p(MGI:Mc1r)) increases bp(GOBP:"inflammatory response")	from full text - As demonstrated in mice with a nonfunctional MC1R, this receptor in particular is important for maintaining mucosal homeostasis and for preventing intestinal inflammation. 77	SEN:10019322	17075348
BEL:20032012	cat(p(MGI:Mmp12)) increases deg(p(MGI:Eln))	The most upregulated gene in the smoke group (MMP12, increased 18.2-fold in the smoke group, 5.1- fold in the LPS group, and 4.5-fold in the smoke–LPS group) is a matrix metalloproteinase that preferentially degrades elastin and has been implicated in COPD development	SEN:10019330	16717027
BEL:20032016	cat(p(MGI:Mmp12)) increases p(MGI:Tnf)	Figure 4. Whole-lung TNF protein levels. In MMP-12 +/+ mice (top), there is a sustained increase in TNF over 24 hours after smoke exposure; in MMP-12 -/- mice (bottom), smoke has no effect at any time.	SEN:10019334	12522030
BEL:20032018	cat(p(MGI:Mmp12)) increases sec(p(MGI:Tnf))	These findings suggest that, acutely, MMP-12 mediates smoke-induced inflammation by releasing TNF-alpha from macrophages, with subsequent endothelial activation, neutrophil influx, and proteolytic matrix breakdown caused by neutrophil-derived proteases.	SEN:10004924	12522030
BEL:20032024	cat(p(MGI:Mmp14)) increases cat(p(MGI:Mmp2))	PDK1 mediates its effect in part by MT1-MMP induction, which in turn activates MMP-2 and modulates the ECM proteins decorin and collagen	SEN:10004928	16551362
BEL:20032062	cat(p(MGI:Mmp9)) increases p(MGI:Col4a3)	Mice deficient in matrix metalloproteinase-9, which cleaves tumstatin efficiently from Col IValpha3, have decreased circulating tumstatin and accelerated growth of tumor.	SEN:10019352	12842087
BEL:20032076	cat(p(MGI:Mpl)) increases tscript(p(MGI:Stat3))	In contrast, enhanced thrombopoietin signaling, conferred by enforced expression of constitutively active JAK2 or c-MPL, induced phosphorylation of STAT3 and STAT5, but not STAT1, and failed to rescue megakaryocyte maturation.	SEN:10001688	18060035
BEL:20032112	cat(p(MGI:"mt-Co2")) increases r(MGI:C1qb)	We report that overexpression of human (h) cyclooxygenase-2 h(COX-2) in the brain of a transgenic mouse line leads to selective induction of endogenous complement component C1qB expression in neurons Chronic treatment of mice with the selective COX-2 inhibitor nimesulide reduced the hCOX-2-mediated induction of hippocampal C1qB mRNA expression.	SEN:10019368	11810182
BEL:20032114	cat(p(MGI:Myd88)) decreases bp(GOBP:"insulin receptor signaling pathway")	RNA interference-mediated inhibition of TLR2 and MyD88 expression in C2C12 muscle cells resulted in a near complete inhibition of palmitate-induced insulin resistance and IL-6 production.	SEN:10004954	16798732
BEL:20032116	cat(p(MGI:Myd88)) increases path(MESHD:"Insulin Resistance")	RNA interference-mediated inhibition of TLR2 and MyD88 expression in C2C12 muscle cells resulted in a near complete inhibition of palmitate-induced insulin resistance and IL-6 production.	SEN:10004954	16798732
BEL:20032120	cat(p(MGI:Myd88)) increases kin(p(MGI:Akt1))	Pretreatment of PMN with MyD88 inhibitor prevented HMGB1-induced activation of both Akt and p38 MAPK (Fig. 6, C and D), indicating that the activation of both Akt and p38 MAPK are downstream events that depend on MyD88 activation.	SEN:10019372	17475888
BEL:20032122	cat(p(MGI:Myd88)) increases kin(p(MGI:Irak4))	Next, the role of IRAK4 in MyD88 signaling was examined by evaluating IRAK4 activity in the PMN. We found that HMGB1 induced a 6-fold increase in IRAK4 activity in TLR4 WT PMN compared with the non-HMGB1-treated WT PMN (p < 0.01; Fig. 5B)....Pretreatment with MyD88 inhibitor decreased IRAK4 activity by 91% in WT PMN (Fig. 5B).	SEN:10019374	17475888
BEL:20032130	cat(p(MGI:Myd88)) increases tscript(p(MGI:Irf7))	TLR9 primarily induces ISRE gene expression through IRF7...TLR9, which exclusively couples to the MyD88-dependent pathway	SEN:10019378	16143103
BEL:20032144	cat(p(MGI:Net1)) increases tscript(p(MGI:Srf))	In NIH 3T3 cells, activated mNET1 induces formation of actin stress fibres and potentiates activity of the transcription factor serum response factor	SEN:10019382	9670022
BEL:20032146	cat(p(MGI:Nfkbia)) decreases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	Interestingly, Par-4 expression blocks inhibitory kappaB protein (IkappaB) kinase activity, which leads to the inhibition of IkappaB phosphorylation and degradation, in a manner that is dependent on its ability to inhibit lambda/iotaPKC.	SEN:10004962	10391896
BEL:20032148	cat(p(MGI:Niacr1)) decreases bp(GOBP:"macrophage differentiation")	nicotinic acid strongly reduced the relative fluorescence intensity of arginase-2 versus CD68 levels in a GPR109A-dependent manner (Figure 6C), indicating that nicotinic acid induces reduced M1-like differentiation via GPR109A.	SEN:10019384	21317532
BEL:20032152	cat(p(MGI:Niacr1)) decreases p(MGI:Arg2)	nicotinic acid strongly reduced the relative fluorescence intensity of arginase-2 versus CD68 levels in a GPR109A-dependent manner (Figure 6C), indicating that nicotinic acid induces reduced M1-like differentiation via GPR109A.	SEN:10019384	21317532
BEL:20032154	cat(p(MGI:Niacr1)) increases r(MGI:Abcg1)	In macrophages from WT mice, but not from GPR109A-deficient animals, nicotinic acid induced expression of the cholesterol transporter ABCG1 and promoted cholesterol efflux.	SEN:10003836	21317532
BEL:20032160	cat(p(MGI:Nod1)) increases bp(GOBP:autophagy)	Travassos et al. (2010) also found that stimulation with both Nod1 and Nod2 triggers the induction of autophagy in mouse embryonic fibroblasts (MEFs), mouse macrophages, human lymphoblasts, and human cell lines (Fig. 3).	SEN:10019386	20548099
BEL:20032164	cat(p(MGI:Nod2)) increases bp(GOBP:autophagy)	Travassos et al. (2010) also found that stimulation with both Nod1 and Nod2 triggers the induction of autophagy in mouse embryonic fibroblasts (MEFs), mouse macrophages, human lymphoblasts, and human cell lines (Fig. 3).	SEN:10019386	20548099
BEL:20032170	cat(p(MGI:Nos2)) increases a(CHEBI:"nitric oxide")	In addition, we found that, endogenously via iNOS, synthesized NO increases the constitutive mRNA expression of both MT-1 and MT-2 genes and that nitrosative stress exogenously applied via an NO donor increases constitutive MT mRNA expression via intracellular Zn2+ release.	SEN:10019388	14617770
BEL:20032172	cat(p(MGI:Nos2)) increases a(CHEBI:"reactive oxygen species")	PDGF stimulates nitric oxide synthase activity in NIH3T3 cells, but not in the superoxide dismutase-expressing clones.	SEN:10019390	7574691
BEL:20032178	cat(p(MGI:Nos2)) increases r(MGI:Bnip3)	Expression of BNIP3 was also induced in macrophages by LPS/IFN-gamma, and the induction was blocked by a NOS2 inhibitor, S-methyl-isothiourea	SEN:10004968	15358175
BEL:20032180	cat(p(MGI:Nos3)) directlyIncreases a(CHEBI:"nitric oxide")	Akt, a serine/threonine kinase that is a major target of phosphatidylinositol 3-kiniase (PI3K), phosphorylates eNOS at Ser1177, and this phosphorylation enhances eNOS activity and increases NO production in vascular endothelial cells.	SEN:10019394	17000928
BEL:20032182	cat(p(MGI:Nos3)) increases a(CHEBI:"nitric oxide")	endothelin-1 failed to stimulate NO production by tubules from NOS3–/– mice (?= 0.38 ± 0.22 fluorescence units/min; p < 0.001 versus wild-type mice; n = 4) (Fig. 1A).	SEN:10019396	19033447
BEL:20032200	cat(p(MGI:Nox1)) increases a(CHEBI:"reactive oxygen species")	NOXO1...is an organizer protein that activates NADPH oxidase (NOX1)...NADPH oxidase is a major source of reactive oxygen species, and oxidative stress is considered to play an important role in the pathogenesis of COPD	SEN:10019400	16717027
BEL:20032202	cat(p(MGI:Nox1)) increases a(CHEBI:"reactive oxygen species")	In cycling cells, the effects of Nox1 were dose dependent: levels of Nox1 that induced 3- to 10-fold increases in ROS promoted phosphorylation of ERK1/2 and expression of cyclin D1,	SEN:10000500	16987002
BEL:20032204	cat(p(MGI:Nox1)) increases a(CHEBI:"reactive oxygen species")	Hyperoxia-dependent ROS production was strongly reduced in lung sections, in isolated epithelial type II cells, and lung endothelial cells from NOX1-deficient mice.	SEN:10019402	19661248
BEL:20032208	cat(p(MGI:Noxo1)) increases cat(p(MGI:Nox1))	Exposure of mice to cigarette smoke and/or LPS was found to result in increased lung expression of NOXO1, an activator of NOX1 (214), but the potential significance for cigarette smoke-induced emphysema or lung cancer is unclear.	SEN:10019406	18164271
BEL:20032242	cat(p(MGI:Osmr)) increases bp(GOBP:"inflammatory response")	overexpression of Osm in lungs of mice resulted in a vigorous inflammatory response strongly supports a role of Osm in lung inflammatory responses that involve eosinophil infiltration	SEN:10019422	12496442
BEL:20032244	cat(p(MGI:Osmr)) increases r(MGI:Ccl11)	Osm stimluated eotaxin protein prudction and mRNA levels in fibroblasts Il6 could regulate a small induction of eotaxin, but other Il6/Lif cytokines [Lif, cariotrophin-1] had no effect	SEN:10019424	12496442
BEL:20032246	cat(p(MGI:P2rx7)) increases cat(p(MGI:Casp1))	.....rapid export of caspase-1-processed IL-1 beta from monocytes/macrophages in response to activation of P2X7 receptors (P2X7R) by extracellular ATP.	SEN:10001214	17641058
BEL:20032254	cat(p(MGI:Parp1)) decreases a(CHEBI:ATP)	Activation of poly(ADP-ribose) polymerase (PARP) by DNA breaks catalyzes poly(ADP-ribosyl)ation and results in depletion of NAD+ and ATP, which is thought to induce necrosis.	SEN:10004064	10373561
BEL:20032256	cat(p(MGI:Parp1)) decreases a(CHEBI:ATP)	The activation of PARP-1 also leads to ATP depletion, a condition that is permissive for necrosis (81, 82).	SEN:10019430	20354226
BEL:20032264	cat(p(MGI:Parp1)) increases bp(GOBP:"cell death")	When cells were treated with cell death-inducing doses of angiotensin II (10-20 microM), robust myocyte cell death was observed in PARP(+/+) but not in PARP(-/-) myocytes.	SEN:10019436	16632544
BEL:20032276	cat(p(MGI:Pcsk6)) increases cat(p(MGI:Mmp14))	Two transgenic mouse lines were designed by targeting PACE4 to the epidermal basal keratinocytes. Transgenic keratinocytes showed increased processing of MT1-MMP and MT2-MMP resulting in collagenase IV activation and collagen type IV degradation.	SEN:10019444	16103082
BEL:20032278	cat(p(MGI:Pcsk6)) increases cat(p(MGI:Mmp15))	Two transgenic mouse lines were designed by targeting PACE4 to the epidermal basal keratinocytes. Transgenic keratinocytes showed increased processing of MT1-MMP and MT2-MMP resulting in collagenase IV activation and collagen type IV degradation.	SEN:10019444	16103082
BEL:20032288	cat(p(MGI:Pdia3)) increases cat(p(MGI:Cpt1a))	the association of carnitine palmitoyltransferase, CPT, activity with Grp58 expression of Grp58 led to an increase in assayable and immunoreactive CPT activity	SEN:10019446	7998951
BEL:20032290	cat(p(MGI:Pdia3)) increases cat(p(MGI:Cpt1b))	the association of carnitine palmitoyltransferase, CPT, activity with Grp58 expression of Grp58 led to an increase in assayable and immunoreactive CPT activity	SEN:10019446	7998951
BEL:20032292	cat(p(MGI:Pdia3)) increases cat(p(MGI:Cpt1c))	the association of carnitine palmitoyltransferase, CPT, activity with Grp58 expression of Grp58 led to an increase in assayable and immunoreactive CPT activity	SEN:10019446	7998951
BEL:20032294	cat(p(MGI:Pdia3)) increases cat(p(MGI:Cpt2))	the association of carnitine palmitoyltransferase, CPT, activity with Grp58 expression of Grp58 led to an increase in assayable and immunoreactive CPT activity	SEN:10019446	7998951
BEL:20032316	cat(p(MGI:Pgm1)) increases a(CHEBI:glycogen)	Glycogen content was increased proportionately to the expression of the transgene, reaching a 40% increase in high-expression transgenic mice	SEN:10019454	15543936
BEL:20032330	cat(p(MGI:Plat)) increases bp(GOBP:"apoptotic process")	We have previously shown that excitotoxic neuronal degeneration elicited through exogenous insults (e.g. excitotoxins, stroke) is promoted by an extracellular cascade involving the serine protease tissue plasminogen activator (tPA). Partial rescue of neural apoptosis in the Lurcher mutant mouse through elimination of tissue plasminogen activator	SEN:10019460	11934869
BEL:20032344	cat(p(MGI:Plg)) increases cat(p(MGI:F2r))	exogenously applied serine proteases thrombin, plasmin, and tissue plasminogen activator can activate PAR1 signaling in brain tissue	SEN:10004760	14559973
BEL:20032378	cat(p(MGI:Prdx1)) increases bp(GOBP:"cell growth")	Pag overexpression promotes a marked increase in cell size and enhances apoptosis, thus mimicking two previously described c-Myc phenotypes.	SEN:10019472	12196529
BEL:20032380	cat(p(MGI:Prdx1)) increases bp(GOBP:"apoptotic process")	Pag overexpression promotes a marked increase in cell size and enhances apoptosis, thus mimicking two previously described c-Myc phenotypes.	SEN:10019472	12196529
BEL:20032382	cat(p(MGI:Prdx1)) directlyDecreases kin(p(MGI:Abl1))	Pag, also known as MSP23 and peroxiredoxin-1 Pag, a member of the peroxiredoxin family, has been reported previously to bind to and inhibit the cytostatic properties of the c-Abl oncoprotein.	SEN:10019474	12196529
BEL:20032386	cat(p(MGI:Prdx1)) decreases tscript(p(MGI:Myc))	The consequences of this interaction include effects on cellular growth, transformation, apoptosis, response to oxidative stress, and c-Myc target gene transcription.	SEN:10019476	12196529
BEL:20032400	cat(p(MGI:Prdx6)) decreases a(CHEBI:"reactive oxygen species")	PRDX6, a member of the peroxiredoxins (PRDXs) family, is a key player in the removal of reactive oxygen species (ROS)	SEN:10005028	15818411
BEL:20032410	cat(p(MGI:Prdx6)) decreases r(MGI:Acta2)	PRDX6-depleted LECs displayed phenotypic alterations and elevated alpha-smooth muscle actin and betaig-h3 expression	SEN:10005034	15818411
BEL:20032412	cat(p(MGI:Prdx6)) decreases r(MGI:Tgfbi)	PRDX6-depleted LECs displayed phenotypic alterations and elevated alpha-smooth muscle actin and betaig-h3 expression	SEN:10005034	15818411
BEL:20032422	cat(p(MGI:Ptafr)) increases kin(p(MGI:Fyn))	Activation of tyrosine kinases Fyn and Lyn, but not Lck, also occurred within 2 min after PAF stimulation in the cells	SEN:10019486	10729607
BEL:20032424	cat(p(MGI:Ptafr)) increases kin(p(MGI:Lyn))	Activation of tyrosine kinases Fyn and Lyn, but not Lck, also occurred within 2 min after PAF stimulation in the cells	SEN:10019486	10729607
BEL:20032426	cat(p(MGI:Ptafr)) increases kin(p(MGI:Mapk1))	PAFR promoter 2 contained AP-2 and Sp-1 binding sites we demonstrated that PAF activates p44ERK1/p42ERK2 in CHO cells stably expressing PAF receptor	SEN:10019488	10729607
BEL:20032428	cat(p(MGI:Ptafr)) increases kin(p(MGI:Mapk3))	PAFR promoter 2 contained AP-2 and Sp-1 binding sites we demonstrated that PAF activates p44ERK1/p42ERK2 in CHO cells stably expressing PAF receptor	SEN:10019488	10729607
BEL:20032430	cat(p(MGI:Ptafr)) increases kin(p(MGI:Ptk2))	PAF induced tyrosine phosphorylation and activation of focal adhesion kinase (FAK) in human endothelial cells derived from vein umbilical cord	SEN:10019490	10729607
BEL:20032436	cat(p(MGI:Ptafr)) increases tloc(p(MGI:Prkca),GOCCID:0005737,GOCCID:0005886)	These results are consistent with our previous data showing that PAF is able to translocate PKCa and PKCe from cytosol to plasma membrane	SEN:10000086	10729607
BEL:20032438	cat(p(MGI:Ptafr)) increases tloc(p(MGI:Prkce),GOCCID:0005737,GOCCID:0005886)	These results are consistent with our previous data showing that PAF is able to translocate PKCa and PKCe from cytosol to plasma membrane	SEN:10000086	10729607
BEL:20032442	cat(p(MGI:Ptger2)) increases r(MGI:Il10)	Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNFalpha production, but up-regulation on the IL-10 production	SEN:10005038	11301049
BEL:20032448	cat(p(MGI:Ptger2)) decreases r(MGI:Tnf)	Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNFalpha production, but up-regulation on the IL-10 production	SEN:10005038	11301049
BEL:20032476	cat(p(MGI:Ptgfr)) increases r(MGI:Akr1c6)	Prostaglandin F(2)alpha (PGF(2)alpha) binding to its receptor on the rat corpus luteum triggers various signal transduction pathways that lead to the activation of a steroidogenic enzyme, 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD), which in turn catabolizes progesterone	SEN:10003762	10973968
BEL:20032482	cat(p(MGI:Ptgs1)) increases a(CHEBI:"prostaglandin G2")	On the other hand, the mRNA for cyclooxygenase-2, which produces PGH2 and participates in the production of prostanoids in inflammation, was expressed in both the resident and BCG-elicited macrophages but barely in the casein-elicited cells.	SEN:10005050	9202154
BEL:20032484	cat(p(MGI:Ptgs1)) increases a(CHEBI:"prostaglandin H2")	On the other hand, the mRNA for cyclooxygenase-2, which produces PGH2 and participates in the production of prostanoids in inflammation, was expressed in both the resident and BCG-elicited macrophages but barely in the casein-elicited cells.	SEN:10005050	9202154
BEL:20032486	cat(p(MGI:Ptgs1)) decreases r(MGI:Il13)	There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.	SEN:10019504	11956061
BEL:20032488	cat(p(MGI:Ptgs1)) decreases r(MGI:Il5)	There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.	SEN:10019504	11956061
BEL:20032492	cat(p(MGI:Ptgs2)) increases a(CHEBI:"reactive oxygen species")	In conclusion, the results suggest that ROS generation, through COX-2 up-regulation, may contribute to the active oncogenicity of mutant K-ras in the lung as a result of DNA damage	SEN:10019506	15284181
BEL:20032506	cat(p(MGI:Ptgs2)) decreases r(MGI:Il13)	There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.	SEN:10019504	11956061
BEL:20032508	cat(p(MGI:Ptgs2)) decreases r(MGI:Il5)	There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.	SEN:10019504	11956061
BEL:20032516	cat(p(MGI:Pygl)) increases a(CHEBI:"reactive oxygen species")	Depletion of PYGL, GLUL, and GLUD1 by means of siRNA reduced TNF+zVAD–induced accumulation of ROS (Fig. 4C and fig. S11), which correlated with cell death (Fig. 3F and figs. S7D and S8D).	SEN:10019152	19498109
BEL:20032518	cat(p(MGI:Pygl)) increases a(CHEBI:"reactive oxygen species")	Importantly, knockdown of PYGL, GLUL, or GLUD1 partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells	SEN:10019154	19632174
BEL:20032522	cat(p(MGI:Ralgds)) increases r(MGI:St6gal1)	Results obtained with H-RasV12 partial loss of function mutants H-RasV12S35 (Raf signal only), H-RasV12C40 (PI3-kinase signal only) and H-RasV12G37 (RalGEFs signal only) suggest that the H-Ras induction of the mouse ST6Gal I gene (Siat1) transcription is primarily routed through RalGEFs.	SEN:10019518	15355339
BEL:20032528	cat(p(MGI:Rap1a)) increases bp(GOBP:"cell adhesion")	proposed a novel role for the Chat-Cas complex in controlling cell adhesion via the activation of Rap1	SEN:10019522	12432078
BEL:20032530	cat(p(MGI:Rapgef3)) increases bp(GOBP:"cell adhesion")	Epac1, on the contrary, strongly promoted cell adhesion, which was decreased upon cotransfection of the receptor (Figure 8C, D).	SEN:10019524	17203972
BEL:20032532	cat(p(MGI:Rapgef3)) increases gtp(p(MGI:Rap1a))	The data in Figs. 1 and 2 provide strong evidence that the Epac/Rap/PLCepsilon pathway contributes to betaAR signaling in the heart.	SEN:10019526	17178726
BEL:20032546	cat(p(MGI:Rasgrf1)) increases gtp(p(MGI:Hras))	The Ras-GRF1 exchange factor, which is regulated by increases in intracellular calcium and the release of G beta gamma subunits from heterotrimeric G proteins, plays a critical role in the activation of neuronal Ras.	SEN:10016662	12538592
BEL:20032552	cat(p(MGI:Rasgrp1)) increases gtp(p(MGI:Hras))	Although inhibitors of PKC had no effect on this suppression, MAPK inhibitors completely prevented the TPA effect. RasGRP1 activates the MAPK pathway through activation of the small G protein H-Ras.	SEN:10004108	18077438
BEL:20032554	cat(p(MGI:Rbck1)) increases p(MGI:Bach1,pmod(U,K))	As shown in Fig. ?Fig.7A,7A, HOIL-1 stimulated polyubiquitination of Bach1 only in the presence of both E1 and E2 enzymes.	SEN:10019534	17682061
BEL:20032568	cat(p(MGI:Rnf128)) decreases bp(GOBP:"T cell activation")	Retroviral transduction of hemopoietic stem cells from TCR transgenic mice and subsequent reconstitution of syngeneic mice to express the E3 ubiquitin ligase, gene related to anergy in lymphocytes (GRAIL), or an enzymatically inactive form, H2N2 GRAIL, allowed analysis of the role of GRAIL in T cell anergy in vivo.	SEN:10019540	15210761
BEL:20032578	cat(p(MGI:Rpsa)) increases bp(GOBP:"cell migration")	The 67-kDa laminin receptor (67LR) is a nonintegrin cell-surface receptor with high affinity for laminin, which plays a key role in tumor invasion and metastasis.	SEN:10005062	16788104
BEL:20032598	cat(p(MGI:S100a6)) increases r(MGI:Alpl)	Overexpression of calcyclin cDNA stimulated both the proliferation and expression of alkaline phosphatase mRNA significantly, without exposure to simvastatin in MC3T3-E1 cells.	SEN:10005064	14973129
BEL:20032604	cat(p(MGI:S1pr1)) increases bp(GOBP:"regulation of vascular permeability")	Increased leak was associated with increased interendothelial cell gaps in venules and was reversed by transfusion with wild-type erythrocytes (which restored plasma S1P levels) and by acute treatment with an agonist for the S1P receptor 1 (S1pr1).	SEN:10019550	19603543
BEL:20032618	cat(p(MGI:Scd1)) increases a(CHEBI:ceramide)	% we show that SCD1 deficiency reduced the total ceramide content in oxidative skeletal muscles (soleus and red gastrocnemius) by approximately 40%.	SEN:10005066	15562249
BEL:20032620	cat(p(MGI:Scd1)) increases a(CHEBI:"oleic acid")	flk is a novel allele of the stearoyl coenzyme A desaturase 1 gene (Scd1). flake homozygotes show reduced sebum production and are unable to synthesize the monounsaturated fatty acids (MUFA) palmitoleate (C(16:1)) and oleate (C(18:1)),	SEN:10005068	16040962
BEL:20032622	cat(p(MGI:Scd1)) increases a(CHEBI:"palmitoleic acid")	flk is a novel allele of the stearoyl coenzyme A desaturase 1 gene (Scd1). flake homozygotes show reduced sebum production and are unable to synthesize the monounsaturated fatty acids (MUFA) palmitoleate (C(16:1)) and oleate (C(18:1)),	SEN:10005068	16040962
BEL:20032628	cat(p(MGI:Scd1)) decreases bp(GOBP:"fatty acid beta-oxidation")	The activity and mRNA levels of carnitine palmitoyltransferase I (CPT I) and the rate of beta-oxidation were increased in oxidative muscles of SCD1-/- mice.	SEN:10019558	15562249
BEL:20032630	cat(p(MGI:Scd1)) increases path(MESHD:"Insulin Resistance")	Lack of SCD1 function significantly increases insulin sensitivity in skeletal muscles and corrects the hypometabolic phenotype of leptin-deficient ob/ob mice,	SEN:10005072	15562249
BEL:20032632	cat(p(MGI:Scd1)) decreases cat(p(MGI:Cpt1b))	The activity and mRNA levels of carnitine palmitoyltransferase I (CPT I) and the rate of beta-oxidation were increased in oxidative muscles of SCD1-/- mice.	SEN:10019558	15562249
BEL:20032634	cat(p(MGI:Scd1)) increases cat(p(MGI:Sptlc1))	The mRNA levels and activity of serine palmitoyltransferase (SPT), a key enzyme in ceramide synthesis, as well as the incorporation of [14C]palmitate into ceramide were decreased by approximately 50% in red muscles of SCD1-/- mice.	SEN:10019556	15562249
BEL:20032642	cat(p(MGI:Scd1)) decreases r(MGI:Cpt1b)	The activity and mRNA levels of carnitine palmitoyltransferase I (CPT I) and the rate of beta-oxidation were increased in oxidative muscles of SCD1-/- mice.	SEN:10019558	15562249
BEL:20032644	cat(p(MGI:Scd1)) increases r(MGI:Sptlc1)	The mRNA levels and activity of serine palmitoyltransferase (SPT), a key enzyme in ceramide synthesis, as well as the incorporation of [14C]palmitate into ceramide were decreased by approximately 50% in red muscles of SCD1-/- mice.	SEN:10019556	15562249
BEL:20032652	cat(p(MGI:Serpine1)) increases bp(GOBP:"neutrophil chemotaxis")	Exogenous PAI-1 (50 µg) restored the LPS-induced neutrophil recruitment to the alveolar space in PAI-1-deficient mice	SEN:10019564	16148154
BEL:20032654	cat(p(MGI:Serpine1)) decreases cat(p(MGI:Plat))	The most upregulated gene identified encodes plasminogen activator inhibitor 1 (PAI-1, Serpine 1), a protease inhibitor that blocks urokinase plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) activity.	SEN:10005078	16250054
BEL:20032656	cat(p(MGI:Serpine1)) decreases cat(p(MGI:Plau))	The most upregulated gene identified encodes plasminogen activator inhibitor 1 (PAI-1, Serpine 1), a protease inhibitor that blocks urokinase plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) activity.	SEN:10005078	16250054
BEL:20032658	cat(p(MGI:Serpine1)) decreases kin(p(MGI:Met))	This was further supported by elevated levels of c-Met and Akt phosphorylation in PAI-1-/- mice after BDL.	SEN:10005080	16250054
BEL:20032660	cat(p(MGI:Serpine1)) decreases p(MGI:Hgf)	% Furthermore, PAI-1-/- mice had higher levels of tPA activation and mature hepatocyte growth factor (HGF) after BDL than WT mice,	SEN:10005082	16250054
BEL:20032670	cat(p(MGI:Shh)) decreases r(EGID:387202)	qPCR analysis showed that Gli1 and Patched1 mRNA levels were increased in the mutant lung (Fig. 4D), confirming hyperactive Shh signaling. miR-206 levels were significantly reduced by 3-fold in these mutant lungs compared to Rosa(SmoM2) controls (Fig. 4D), providing evidence that Shh signaling blocks miR-206 expression in vivo.	SEN:10019566	22031887
BEL:20032682	cat(p(MGI:Sirt1)) decreases bp(GOBP:"fat cell differentiation")	Treatment with the plant polyphenol resveratrol as well as isonicotinamide, both of which activate Sirt1, blocked adipocyte development and increased the expression of osteoblast markers.	SEN:10005090	16813520
BEL:20032684	cat(p(MGI:Sirt1)) decreases bp(GOBP:"fat cell differentiation")	In contrast, a SIRT1 inhibitory compound showed a stimulatory activity on the differentiation of adipocytes	SEN:10005092	17099246
BEL:20032686	cat(p(MGI:Sirt1)) decreases bp(GOBP:"inflammatory response")	In addition, the same compounds have anti-inflammatory properties, as became evident by the reduction of the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha)	SEN:10019572	17099246
BEL:20032688	cat(p(MGI:Sirt1)) increases bp(GOBP:"osteoblast differentiation")	Treatment with the plant polyphenol resveratrol as well as isonicotinamide, both of which activate Sirt1, blocked adipocyte development and increased the expression of osteoblast markers.	SEN:10005090	16813520
BEL:20032694	cat(p(MGI:Sirt1)) increases cat(p(MGI:Acss2))	SIRT1 expression also led to a pronounced increase in AceCS1-dependent fatty-acid synthesis from acetate.	SEN:10005098	16790548
BEL:20032696	cat(p(MGI:Sirt1)) increases cat(p(MGI:Ctsb))	expression of exogenous human (h) SIRT1 in the brain of hSIRT1 transgenics also resulted in decreased ROCK1 expression and elevated alpha-secretase activity in vivo	SEN:10005100	16751189
BEL:20032702	cat(p(MGI:Sirt1)) increases complex(p(MGI:Foxo1),p(MGI:Cebpa))	SIRT1 increases adiponectin transcription in adipocytes by activating Foxo1 and enhancing Foxo1 and C/EBPa interaction.	SEN:10019574	17090532
BEL:20032708	cat(p(MGI:Sirt1)) decreases p(MGI:Acss2,pmod(A,K,661))	Site-specific acetylation of mouse AceCS1 on Lys-661 was identified by using mass spectrometry and a specific anti-acetyl-AceCS antibody. SIRT1 was the only member of seven human Sir2 homologues capable of deacetylating AceCS1	SEN:10019578	16790548
BEL:20032716	cat(p(MGI:Sirt1)) decreases p(MGI:Tnf)	In addition, the same compounds have anti-inflammatory properties, as became evident by the reduction of the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha)	SEN:10019572	17099246
BEL:20032722	cat(p(MGI:Sirt1)) increases r(MGI:Acadm)	from full text - As expected, fasting induced gene expression of fatty acid oxidation enzymes medium chain acyl-CoA deyhydrogenase (MCAD) and carnitine palmitoyltransferase- 1a (CPT-1a) (Fig. 4A). Notably, mice with hepatic SIRT1 knockdown displayed lower expression of these enzymes compared with control mice.	SEN:10019584	17646659
BEL:20032728	cat(p(MGI:Sirt1)) increases r(MGI:Cpt1a)	from full text - As expected, fasting induced gene expression of fatty acid oxidation enzymes medium chain acyl-CoA deyhydrogenase (MCAD) and carnitine palmitoyltransferase- 1a (CPT-1a) (Fig. 4A). Notably, mice with hepatic SIRT1 knockdown displayed lower expression of these enzymes compared with control mice.	SEN:10019584	17646659
BEL:20032730	cat(p(MGI:Sirt1)) increases r(MGI:Cyp7a1)	from full text - A rate-limiting enzyme involved in bile acid synthesis, Cyp7A1, was decreased in fasted livers of SIRT1 shRNA mice (Fig. 4D) and induced by SIRT1 overexpression in the fasted state	SEN:10019586	17646659
BEL:20032732	cat(p(MGI:Sirt1)) increases r(MGI:Dgat2)	from full text - Expression of DGAT2, an enzyme involved in fatty acid esterification to glycerol, was markedly reduced in SIRT1 knockdown mice	SEN:10019588	17646659
BEL:20032734	cat(p(MGI:Sirt1)) increases r(MGI:G6pc)	from full text - As shown in Fig. 2A, infection with SIRT1 shRNA resulted in reduced expression of the gluconeogenic G6Pase and Pepck	SEN:10019590	17646659
BEL:20032738	cat(p(MGI:Sirt1)) increases r(MGI:Nr1h3)	from full text - SIRT1 knockdown caused a slight yet highly significant decrease in LXRalpha expression in both fed and fasted livers. However, SIRT1 knockdown decreased expression of PGC-1beta only the fasted state	SEN:10019592	17646659
BEL:20032740	cat(p(MGI:Sirt1)) increases r(MGI:Pck1)	from full text - As shown in Fig. 2A, infection with SIRT1 shRNA resulted in reduced expression of the gluconeogenic G6Pase and Pepck	SEN:10019590	17646659
BEL:20032742	cat(p(MGI:Sirt1)) increases r(MGI:Ppargc1b)	from full text - SIRT1 knockdown caused a slight yet highly significant decrease in LXRalpha expression in both fed and fasted livers. However, SIRT1 knockdown decreased expression of PGC-1beta only the fasted state	SEN:10019592	17646659
BEL:20032744	cat(p(MGI:Sirt1)) decreases r(MGI:Rock1)	expression of exogenous human (h) SIRT1 in the brain of hSIRT1 transgenics also resulted in decreased ROCK1 expression and elevated alpha-secretase activity in vivo	SEN:10005100	16751189
BEL:20032746	cat(p(MGI:Sirt1)) decreases r(MGI:Ucp2)	beta cell-specific Sirt1-overexpressing (BESTO) transgenic mice. Microarray analyses of beta cell lines reveal that Sirt1 regulates genes involved in insulin secretion, including uncoupling protein 2 (Ucp2). Isolated BESTO islets also have reduced Ucp2, increased ATP production, and enhanced insulin secretion during glucose and KCl stimulation.	SEN:10019568	16098828
BEL:20032748	cat(p(MGI:Sirt1)) increases sec(p(HGNC:INS))	beta cell-specific Sirt1-overexpressing (BESTO) transgenic mice. Microarray analyses of beta cell lines reveal that Sirt1 regulates genes involved in insulin secretion, including uncoupling protein 2 (Ucp2). Isolated BESTO islets also have reduced Ucp2, increased ATP production, and enhanced insulin secretion during glucose and KCl stimulation.	SEN:10019568	16098828
BEL:20032750	cat(p(MGI:Sirt1)) increases sec(p(HGNC:INS))	Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose- stimulated insulin secretion in mice.	SEN:10005114	16098828
BEL:20032752	cat(p(MGI:Sirt1)) decreases sec(p(MGI:Adipoq))	Figure 2A demonstrates that activation of SIRT1 reduces the secretion of adiponectin (external) without significantly affecting synthesis of the protein (intracellular) or without affecting secretion of adipsin.	SEN:10019594	17452443
BEL:20032760	cat(p(MGI:Sirt1)) increases tscript(p(MGI:Cebpa))	SIRT1 increases adiponectin transcription in adipocytes by activating Foxo1 and enhancing Foxo1 and C/EBPa interaction.	SEN:10019574	17090532
BEL:20032762	cat(p(MGI:Sirt1)) increases tscript(p(MGI:Foxo1))	SIRT1 increases adiponectin transcription in adipocytes by activating Foxo1 and enhancing Foxo1 and C/EBPa interaction.	SEN:10019574	17090532
BEL:20032764	cat(p(MGI:Sirt1)) directlyDecreases tscript(p(MGI:Jun))	Here, we show that SIRT1 associated with c-JUN in co-immunoprecipitation of whole cell lysate, and inhibited the transcriptional activity of c-JUN in the mammalian two hybridization system.	SEN:10005120	18823944
BEL:20032772	cat(p(MGI:Sirt3)) increases cat(p(MGI:Acss1))	specifically deacetylated by mitochondrial SIRT3 AceCS2 was completely inactivated upon acetylation and was rapidly reactivated by SIRT3 deacetylation	SEN:10019600	16790548
BEL:20032774	cat(p(MGI:Sirt3)) decreases p(MGI:Acss1,pmod(A,K,635))	specifically deacetylated by mitochondrial SIRT3 AceCS2 was completely inactivated upon acetylation and was rapidly reactivated by SIRT3 deacetylation	SEN:10019600	16790548
BEL:20032792	cat(p(MGI:Smurf1)) increases deg(p(MGI:Smad1))	Thus overexpression of Smurf1 specifically promotes Smad1 and Smad5 ubiquitination and degradation in embryonic lung epithelium, thereby modulating the effects of BMP4 on embryonic lung growth.	SEN:10019610	14711801
BEL:20032794	cat(p(MGI:Smurf1)) increases deg(p(MGI:Smad5))	Thus overexpression of Smurf1 specifically promotes Smad1 and Smad5 ubiquitination and degradation in embryonic lung epithelium, thereby modulating the effects of BMP4 on embryonic lung growth.	SEN:10019610	14711801
BEL:20032812	cat(p(MGI:Sod1)) decreases cat(p(MGI:Nos2))	These results indicate that superoxide dismutase overexpression blocks the PDGF-induced release of PGE2 by blocking induction of nitric oxide synthase.	SEN:10005128	7574691
BEL:20032820	cat(p(MGI:Sod2)) decreases a(CHEBI:"reactive oxygen species")	These results indicate that the increase in mitochondrial reactive oxygen species from knockout of SOD2 activity can result in biochemical aberrations with features reminiscent of mitochondrial myopathy	SEN:10000028	9927656
BEL:20032838	cat(p(MGI:Spn)) increases bp(GOBP:"cell adhesion")	These results identify CD43 as a T cell counterreceptor for sialoadhesin and suggest that in addition to its anti-adhesive role CD43 may promote cell-cell interactions.	SEN:10005136	11238599
BEL:20032844	cat(p(MGI:Sptlc1)) increases a(CHEBI:ceramide)	Analysis showed that, compared with WT mice, Sptlc1(+/-) and Sptlc2(+/-) mice had: decreased liver SPT activity by 45% and 60% (P<0.01, respectively); decreased liver ceramide (22% and 39%, P<0.05 and P<0.01, respectively) and sphingosine levels (22% and 31%, P<0.05 and P<0.01, respectively);	SEN:10019622	16216550
BEL:20032846	cat(p(MGI:Sptlc1)) increases a(CHEBI:sphingosine)	Analysis showed that, compared with WT mice, Sptlc1(+/-) and Sptlc2(+/-) mice had: decreased liver SPT activity by 45% and 60% (P<0.01, respectively); decreased liver ceramide (22% and 39%, P<0.05 and P<0.01, respectively) and sphingosine levels (22% and 31%, P<0.05 and P<0.01, respectively);	SEN:10019622	16216550
BEL:20032848	cat(p(MGI:Sptlc2)) increases a(CHEBI:ceramide)	Analysis showed that, compared with WT mice, Sptlc1(+/-) and Sptlc2(+/-) mice had: decreased liver SPT activity by 45% and 60% (P<0.01, respectively); decreased liver ceramide (22% and 39%, P<0.05 and P<0.01, respectively) and sphingosine levels (22% and 31%, P<0.05 and P<0.01, respectively);	SEN:10019622	16216550
BEL:20032850	cat(p(MGI:Sptlc2)) increases a(CHEBI:sphingosine)	Analysis showed that, compared with WT mice, Sptlc1(+/-) and Sptlc2(+/-) mice had: decreased liver SPT activity by 45% and 60% (P<0.01, respectively); decreased liver ceramide (22% and 39%, P<0.05 and P<0.01, respectively) and sphingosine levels (22% and 31%, P<0.05 and P<0.01, respectively);	SEN:10019622	16216550
BEL:20032866	cat(p(MGI:St3gal5)) decreases bp(GOBP:"insulin receptor signaling pathway")	GM3 ganglioside has been described as a negative regulator of insulin receptor signaling. Mutant cells that express GM3 ganglioside display impaired insulin-dependent growth relative to parental cells expressing only lactosylceramide (8).	SEN:10019626	12629211
BEL:20032888	cat(p(MGI:Tert)) decreases path(MESHD:Hypertension)	Mice lacking telomerase activity develop hypertension in the first and third generations as a result of an increased plasma endothelin-1 level due to the overexpression of endothelin-converting enzyme (99).	SEN:10019634	17981770
BEL:20032890	cat(p(MGI:Tert)) decreases p(MGI:Ece1)	Mice lacking telomerase activity develop hypertension in the first and third generations as a result of an increased plasma endothelin-1 level due to the overexpression of endothelin-converting enzyme (99).	SEN:10019634	17981770
BEL:20032892	cat(p(MGI:Tert)) decreases p(MGI:Edn1)	Mice lacking telomerase activity develop hypertension in the first and third generations as a result of an increased plasma endothelin-1 level due to the overexpression of endothelin-converting enzyme (99).	SEN:10019634	17981770
BEL:20032894	cat(p(MGI:Tgfb1)) increases kin(p(MGI:Tgfbr1))	Moreover, inhibition of the TGFbeta1 converting enzyme, furin, resulted in increased PHD2 expression, and decreased basal HIF-1alpha and VEGF levels, suggesting that endogenous production of bioactive TGFbeta1 efficiently regulates HIF-1-targeted genes.	SEN:10019116	16815840
BEL:20032896	cat(p(MGI:Tgfb1)) increases kin(p(MGI:Tgfbr2))	Moreover, inhibition of the TGFbeta1 converting enzyme, furin, resulted in increased PHD2 expression, and decreased basal HIF-1alpha and VEGF levels, suggesting that endogenous production of bioactive TGFbeta1 efficiently regulates HIF-1-targeted genes.	SEN:10019116	16815840
BEL:20032898	cat(p(MGI:Tgfbr2)) increases r(MGI:Foxa1)	Foxa1 upregulation in the absence of HNF-6 results from increased TGF-beta signaling via increased expression of the TGF-beta receptor II.	SEN:10005150	15562441
BEL:20032902	cat(p(MGI:Thra)) increases r(MGI:Atp2a1)	Protein analysis of TRalpha1-/-beta-/- soleus muscles showed a marked increase in expression of the slow isoform of the sarcoplasmic reticulum Ca2+ pump (SERCa2), whilst expression of the fast type (SERCa1) was decreased	SEN:10019636	12562961
BEL:20032904	cat(p(MGI:Thra)) decreases r(MGI:Atp2a2)	Protein analysis of TRalpha1-/-beta-/- soleus muscles showed a marked increase in expression of the slow isoform of the sarcoplasmic reticulum Ca2+ pump (SERCa2), whilst expression of the fast type (SERCa1) was decreased	SEN:10019636	12562961
BEL:20032906	cat(p(MGI:Thrb)) increases r(MGI:Atp2a1)	Protein analysis of TRalpha1-/-beta-/- soleus muscles showed a marked increase in expression of the slow isoform of the sarcoplasmic reticulum Ca2+ pump (SERCa2), whilst expression of the fast type (SERCa1) was decreased	SEN:10019636	12562961
BEL:20032908	cat(p(MGI:Thrb)) decreases r(MGI:Atp2a2)	Protein analysis of TRalpha1-/-beta-/- soleus muscles showed a marked increase in expression of the slow isoform of the sarcoplasmic reticulum Ca2+ pump (SERCa2), whilst expression of the fast type (SERCa1) was decreased	SEN:10019636	12562961
BEL:20032910	cat(p(MGI:Ticam1)) increases bp(GOBP:autophagy)	These results indicate that LPS induces autophagy through a TRIF-dependent TLR4 signaling pathway.	SEN:10019638	17658277
BEL:20032912	cat(p(MGI:Ticam1)) increases kin(p(MGI:Ripk1))	We reasoned that these same pathways might be involved in downstream signaling of TLR4/TRIF/RIP1 pathway.	SEN:10019640	17658277
BEL:20032914	cat(p(MGI:Ticam1)) increases p(MGI:Tnf)	In the absence of functional TRIF, the production of TNF-alpha protein was severely impaired, whereas TNF-alpha mRNA levels and stability, as well as transcriptional activity of the Tnfa gene, were not affected.	SEN:10005154	20375303
BEL:20032916	cat(p(MGI:Ticam1)) increases p(MGI:Tnf)	We provide evidence that, in LPS-stimulated murine dendritic cells, TRIF stimulates TNF-alpha biosynthesis selectively at the posttranscriptional level by promoting mRNA translation.	SEN:10015896	20375303
BEL:20032918	cat(p(MGI:Ticam1)) increases r(MGI:Tnf)	In peritoneal macrophages, however, TRIF was also required for normal induction of TNF-alpha mRNA, suggesting cell type-related functions of TRIF.	SEN:10019642	20375303
BEL:20032920	cat(p(MGI:Timp3)) decreases bp(GOBP:"inflammatory response")	Timp3-/- mice showed a dramatic increase in the initial inflammatory response to intra-articular antigen injection	SEN:10005156	15920158
BEL:20032924	cat(p(MGI:Tkt)) increases bp(GOBP:"cell growth")	We show here by gene targeting that TKT-null mouse embryos are not viable and that disruption of one TKT allele can cause growth retardation	SEN:10005158	12167708
BEL:20032926	cat(p(MGI:Tkt)) increases path(MESHD:Obesity)	Our data suggest that TKT deficiency may have clinical significance in humans and raise the possibility that obesity may be treated by partial inhibition of TKT in adipose tissue	SEN:10005160	12167708
BEL:20032928	cat(p(MGI:Tlr1)) increases cat(p(MGI:Myd88))	Interestingly, signaling through TLR1 or TLR3 induced similar responses, despite their use of different adaptor proteins, MydD88 for TLR1 and Trif for TLR3.	SEN:10019646	18772134
BEL:20032932	cat(p(MGI:Tlr2)) decreases bp(GOBP:"insulin receptor signaling pathway")	RNA interference-mediated inhibition of TLR2 and MyD88 expression in C2C12 muscle cells resulted in a near complete inhibition of palmitate-induced insulin resistance and IL-6 production.	SEN:10004954	16798732
BEL:20032934	cat(p(MGI:Tlr2)) increases path(MESHD:"Insulin Resistance")	RNA interference-mediated inhibition of TLR2 and MyD88 expression in C2C12 muscle cells resulted in a near complete inhibition of palmitate-induced insulin resistance and IL-6 production.	SEN:10004954	16798732
BEL:20032936	cat(p(MGI:Tlr2)) increases cat(p(MGI:Nlrp3))	Furthermore, activation of TLRs 2, 3 and 7 also induced priming of the NLRP3 inflammasome and macrophages lacking TLRs for the respective stimuli failed to activate caspase-1 after activation via ATP (Fig. 2B).	SEN:10019648	19570822
BEL:20032942	cat(p(MGI:Tlr2)) increases p(MGI:Il6)	Figure 1. Activation of toll-like receptor (TLR) 2 signaling induces interleukin (IL) 6 production and kinase phosphorylation in VSMCs.	SEN:10019650	22995520
BEL:20032950	cat(p(MGI:Tlr2)) increases r(MGI:Il6)	When compared with an equimolar concentration of palmitate, fibroblast-stimulating lipopeptide-1, a known TLR2 ligand, was a slightly more potent activator of signal transduction and interleukin (IL)-6 production.	SEN:10019654	16798732
BEL:20032952	cat(p(MGI:Tlr2)) decreases r(MGI:Pparg)	Similar findings were observed with other agonists of TLR2 including the synthetic lipoprotein FSL-1 and lipoteichoic acid (LTA) (data not shown). The TLR5 agonist flagellin reduced PPARgamma mRNA abundance to a lesser extent	SEN:10019656	18422969
BEL:20032954	cat(p(MGI:Tlr2)) increases r(MGI:Scd1)	In normal mice, transcription of Scd1-a gene with numerous NF-kappaB elements in its promoter--is strongly and specifically induced by TLR2 signaling.	SEN:10005164	16040962
BEL:20032962	cat(p(MGI:Tlr3)) increases cat(p(MGI:Nlrp3))	Furthermore, activation of TLRs 2, 3 and 7 also induced priming of the NLRP3 inflammasome and macrophages lacking TLRs for the respective stimuli failed to activate caspase-1 after activation via ATP (Fig. 2B).	SEN:10019648	19570822
BEL:20032964	cat(p(MGI:Tlr3)) increases cat(p(MGI:Ticam1))	Interestingly, signaling through TLR1 or TLR3 induced similar responses, despite their use of different adaptor proteins, MydD88 for TLR1 and Trif for TLR3.	SEN:10019646	18772134
BEL:20032966	cat(p(MGI:Tlr3)) increases complex(p(MGI:Ticam1),p(MGI:Becn1))	exposure to the TLR4 ligand LPS triggered both MyD88 and Trif to recruit Beclin 1, whereas exposure to the TLR3 ligand poly(I:C) led to an increased association between Trif and Beclin 1 (Fig. 4A).	SEN:10019662	18772134
BEL:20032974	cat(p(MGI:Tlr3)) decreases r(MGI:Ddit3)	Furthermore, pre-treatment of macrophages with the TLR3 ligand poly(I:C), which only uses TRIF signaling11, markedly suppressed tunicamycin-induced CHOP expression (Fig. 2d).	SEN:10019660	19855386
BEL:20032980	cat(p(MGI:Tlr3)) increases r(MGI:Tlr3)	The TLR3 ligand poly(I)poly(C) triggered up-regulation of its own receptor in NOR and pre-diabetic NOD, but TLR3 was already highly expressed in diabetic NOD mice.	SEN:10000670	16728431
BEL:20032982	cat(p(MGI:Tlr3)) increases sec(p(MGI:Ccl2))	The TLR3 agonist poly (I:C) significantly increased bidirectional secretion of CCL2, IL6, TNFA and CSF2 and basolateral secretion of CSF3.	SEN:10019670	16510838
BEL:20032984	cat(p(MGI:Tlr3)) increases sec(p(MGI:Csf2))	The TLR3 agonist poly (I:C) significantly increased bidirectional secretion of CCL2, IL6, TNFA and CSF2 and basolateral secretion of CSF3.	SEN:10019670	16510838
BEL:20032986	cat(p(MGI:Tlr3)) increases sec(p(MGI:Il6))	The TLR3 agonist poly (I:C) significantly increased bidirectional secretion of CCL2, IL6, TNFA and CSF2 and basolateral secretion of CSF3.	SEN:10019670	16510838
BEL:20032988	cat(p(MGI:Tlr3)) increases sec(p(MGI:Tnf))	The TLR3 agonist poly (I:C) significantly increased bidirectional secretion of CCL2, IL6, TNFA and CSF2 and basolateral secretion of CSF3.	SEN:10019670	16510838
BEL:20032998	cat(p(MGI:Tlr4)) increases bp(GOBP:autophagy)	LPS-induced autophagy was markedly inhibited in cells transfected with TLR4 dominant-negative compared to cells transfected with vector only (Figure 3A and Supplementary Figure 2A).	SEN:10019680	17658277
BEL:20033000	cat(p(MGI:Tlr4)) decreases bp(GOBP:glycolysis)	Similarly, insulin-stimulated glycolysis appeared to be suppressed to a lesser extent in TLR4-/- mice after lipid infusion as compared with WT mice	SEN:10019682	17053832
BEL:20033002	cat(p(MGI:Tlr4)) decreases bp(GOBP:"insulin receptor signaling pathway")	Moreover, mice lacking TLR4 are substantially protected from the ability of systemic lipid infusion to (a) suppress insulin signaling in muscle and (b) reduce insulin-mediated changes in systemic glucose metabolism.	SEN:10019684	17053832
BEL:20033004	cat(p(MGI:Tlr4)) increases bp(GOBP:"macrophage activation")	To obtain direct evidence of TLR activation upon THP engagement, we isolated bone marrow–derived macrophages from MyD88 and TLR2, TLR4, and TLR9 KO mice as well as from WT mice. While THP potently stimulated TNF-? production in APCs obtained from WT, TLR2–/–, and TLR9–/– mice, cells from TLR4–/– and MyD88–/– mice were completely resistant to THP or LPS stimulation (Figure ?(Figure6A).6A)	SEN:10019686	15650774
BEL:20033006	cat(p(MGI:Tlr4)) increases bp(GOBP:"myeloid dendritic cell activation")	THP activates myeloid DCs via Toll-like receptor-4 (TLR4) to acquire a fully mature DC phenotype...To investigate a role of TLR4 in THP-induced immune cell activation, human DCs were preincubated with the anti-TLR4 Ab, mAb HTA-125, and a significant impairment of cytokine production was observed (Figure ?(Figure5C).5C). These results indicate a critical role of TLR4 in THP-mediated immunostimulatory effects on DCs.	SEN:10019688	15650774
BEL:20033008	cat(p(MGI:Tlr4)) increases bp(GOBP:"myeloid dendritic cell activation")	Also in lung tissue, the CS-induced expression of MHCII on DCs was significantly lower in Tlr4 defective animals than in Tlr4 WT animals (MHCII-positive DCs: 36.3 8 1.5% vs. 41.1 8 1.4% for CS-exposed Tlr4 defective vs. CS-exposed Tlr4 WT , p ! 0.05, n = 8 per group).	SEN:10017650	16940747
BEL:20033014	cat(p(MGI:Tlr4)) increases bp(GOBP:"T cell activation")	The authors demonstrate that HMGB1 binds to TLR4 and that HMGB1, which is released by chemotherapy-induced cell death, can activate TLR4 and induce anti-tumour T-cell immunity79.	SEN:10019692	19052556
BEL:20033016	cat(p(MGI:Tlr4)) increases path(MESHD:"Insulin Resistance")	Moreover, mice lacking TLR4 are substantially protected from the ability of systemic lipid infusion to (a) suppress insulin signaling in muscle and (b) reduce insulin-mediated changes in systemic glucose metabolism.	SEN:10019684	17053832
BEL:20033028	cat(p(MGI:Tlr4)) decreases cat(p(MGI:Irs1))	Figure 6 and p 3018: lipid infusion markedly inhibited insulin-stimulated insulin receptor substrate-1 (IRS-1) phosphorylation in skeletal muscle of WT mice...This was substantially attenuated in TLR4 -/- mice.	SEN:10017306	17053832
BEL:20033030	cat(p(MGI:Tlr4)) increases cat(p(MGI:Myd88))	An impaired IRAK4 activation was observed with TLR4 mutant PMN, in which the HMGB1-induced IRAK4 activity was attenuated by 64% compared with that in TLR4 WT PMN (Fig. 5B).	SEN:10019700	17475888
BEL:20033032	cat(p(MGI:Tlr4)) increases cat(p(MGI:Myd88))	TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4).	SEN:10019702	18772134
BEL:20033034	cat(p(MGI:Tlr4)) increases cat(p(MGI:Ticam1))	These results indicate that LPS induces autophagy through a TRIF-dependent TLR4 signaling pathway.	SEN:10019638	17658277
BEL:20033036	cat(p(MGI:Tlr4)) increases cat(p(MGI:Ticam1))	TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4).	SEN:10019702	18772134
BEL:20033038	cat(p(MGI:Tlr4)) increases complex(p(MGI:Myd88),p(MGI:Becn1))	exposure to the TLR4 ligand LPS triggered both MyD88 and Trif to recruit Beclin 1, whereas exposure to the TLR3 ligand poly(I:C) led to an increased association between Trif and Beclin 1 (Fig. 4A).	SEN:10019662	18772134
BEL:20033044	cat(p(MGI:Tlr4)) increases complex(p(MGI:Myd88),p(MGI:Ticam1),p(MGI:Irak4),p(MGI:Becn1))	These data strongly suggest that ligand activated TLR4 assembles signaling complexes that contained MyD88, Trif, Irak4, and Beclin 1.	SEN:10019706	18772134
BEL:20033046	cat(p(MGI:Tlr4)) increases complex(p(MGI:Ticam1),p(MGI:Becn1))	exposure to the TLR4 ligand LPS triggered both MyD88 and Trif to recruit Beclin 1, whereas exposure to the TLR3 ligand poly(I:C) led to an increased association between Trif and Beclin 1 (Fig. 4A).	SEN:10019662	18772134
BEL:20033050	cat(p(MGI:Tlr4)) increases kin(p(MGI:Jak2))	We used a murine macrophage-like cell line, RAW264.7, to demonstrate that Janus kinase (JAK)2 is tyrosine phosphorylated immediately after LPS stimulation. Anti-Toll-like receptor (TLR)4 neutralization antibody inhibits the phosphorylation of JAK2 and the c-Jun NH2-terminal protein kinase (JNK).	SEN:10015962	12686512
BEL:20033062	cat(p(MGI:Tlr4)) decreases p(MGI:Bambi)	LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappaB-dependent pathway	SEN:10000458	17952090
BEL:20033068	cat(p(MGI:Tlr4)) increases p(MGI:Ccl2)	Studies using TLR-4 -/- mice have demonstrated that induction of MCP-1 in BAL fluid upon exposure of mice to subacute (exposed for a period of 5 weeks) levels of CS depends on the presence of wild-type TLR-4, whereas TLR-4 plays a minor role in MCP-1 induction in the presence of chronic smoke exposure (26 weeks) [45].	SEN:10019720	19842832
BEL:20033070	cat(p(MGI:Tlr4)) increases p(MGI:Cxcl2)	freezing or disruption of the matrix by subcutaneous sterile bead injection, induce the release of fragments of HA that in turn stimulates a TLR4-dependent increase in CXCL2 chemokines	SEN:10015746	19258328
BEL:20033076	cat(p(MGI:Tlr4)) increases p(MGI:Irs1,pmod(P,S))	Lipid infusion markedly induced serine (Ser307) phosphorylation of IRS-1 in WT mice while this stimulation was greatly attenuated in TLR4-/- mice.	SEN:10017308	17053832
BEL:20033078	cat(p(MGI:Tlr4)) decreases p(MGI:Irs1,pmod(P,Y))	Figure 6 and p 3018: lipid infusion markedly inhibited insulin-stimulated insulin receptor substrate-1 (IRS-1) phosphorylation in skeletal muscle of WT mice...This was substantially attenuated in TLR4 -/- mice.	SEN:10017306	17053832
BEL:20033080	cat(p(MGI:Tlr4)) increases p(MGI:Jak2,pmod(P,Y))	We used a murine macrophage-like cell line, RAW264.7, to demonstrate that Janus kinase (JAK)2 is tyrosine phosphorylated immediately after LPS stimulation. Anti-Toll-like receptor (TLR)4 neutralization antibody inhibits the phosphorylation of JAK2 and the c-Jun NH2-terminal protein kinase (JNK).	SEN:10015962	12686512
BEL:20033082	cat(p(MGI:Tlr4)) increases p(MGI:Tgfb1)	LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappaB-dependent pathway	SEN:10000458	17952090
BEL:20033090	cat(p(MGI:Tlr4)) decreases r(MGI:Ddit3)	from full ext - The marked suppression of CHOP by LPS in wild-type macrophage was almost completely absent in Tlr4?/? and Trif?/? macrophages, but not in Myd88?/? macrophages (Fig. 2a?c).	SEN:10019676	19855386
BEL:20033096	cat(p(MGI:Tlr4)) increases r(MGI:Nqo1)	Treatment of control cells with LPS substantially increased the mRNA of p62 along with that of NAD(P)H:quinone oxidoreductase (NQO1) and peroxiredoxin 1 (Prdx1), known Nrf2 target genes (Fig. 4F and Fig. S4G) (25, 26), demonstrating activation of Nrf2 in LPSstimulated cells.	SEN:10019722	21220332
BEL:20033098	cat(p(MGI:Tlr4)) decreases r(MGI:Pparg)	these data demonstrate that the effect of LPS on PPARgamma expression is specifically mediated through TLR4	SEN:10019724	18422969
BEL:20033100	cat(p(MGI:Tlr4)) increases r(MGI:Prdx1)	Treatment of control cells with LPS substantially increased the mRNA of p62 along with that of NAD(P)H:quinone oxidoreductase (NQO1) and peroxiredoxin 1 (Prdx1), known Nrf2 target genes (Fig. 4F and Fig. S4G) (25, 26), demonstrating activation of Nrf2 in LPSstimulated cells.	SEN:10019722	21220332
BEL:20033106	cat(p(MGI:Tlr4)) increases r(MGI:Sqstm1)	Treatment of control cells with LPS substantially increased the mRNA of p62 along with that of NAD(P)H:quinone oxidoreductase (NQO1) and peroxiredoxin 1 (Prdx1), known Nrf2 target genes (Fig. 4F and Fig. S4G) (25, 26), demonstrating activation of Nrf2 in LPSstimulated cells.	SEN:10019722	21220332
BEL:20033116	cat(p(MGI:Tlr5)) decreases r(MGI:Pparg)	Similar findings were observed with other agonists of TLR2 including the synthetic lipoprotein FSL-1 and lipoteichoic acid (LTA) (data not shown). The TLR5 agonist flagellin reduced PPARgamma mRNA abundance to a lesser extent	SEN:10019656	18422969
BEL:20033118	cat(p(MGI:Tlr7)) increases bp(GOBP:phagocytosis)	TLR7 siRNA-transfected cells showed a weaker phagocytic response to treatment with HSP70 as compared with either cells transfected with the empty vector (P 0.05) or the parental cells themselves (P 0.05), indicating that HSP70- induced phagocytosis is mediated via TLR7.	SEN:10019732	16979664
BEL:20033120	cat(p(MGI:Tlr7)) increases cat(p(MGI:Nlrp3))	Furthermore, activation of TLRs 2, 3 and 7 also induced priming of the NLRP3 inflammasome and macrophages lacking TLRs for the respective stimuli failed to activate caspase-1 after activation via ATP (Fig. 2B).	SEN:10019648	19570822
BEL:20033124	cat(p(MGI:Tlr7)) increases sec(p(MGI:Tnf))	A cytokine release assay using antibodies to Tumor Necrosis Factor-alfa (TNF) was performed (Fig. 3D). TNF- release in response to HSP70 and (to a lesser extent) following ssPolyU treatment was blunted in SiRNA-TLR7 transfected RAW264.7 cells versus the parental cells or mocktransfected cells	SEN:10019736	16979664
BEL:20033126	cat(p(MGI:Tlr9)) increases cat(p(MGI:Myd88))	TLR9 primarily induces ISRE gene expression through IRF7...TLR9, which exclusively couples to the MyD88-dependent pathway	SEN:10019378	16143103
BEL:20033132	cat(p(MGI:Tlr9)) increases p(MGI:Olr1)	TLR9 activation of Raw264.7 cells or mouse primary peritoneal macrophages by CpG ODN treatment enhanced Lox-1 gene and protein expression.	SEN:10000600	18817866
BEL:20033136	cat(p(MGI:Tlr9)) increases r(MGI:Olr1)	TLR9 activation of Raw264.7 cells or mouse primary peritoneal macrophages by CpG ODN treatment enhanced Lox-1 gene and protein expression.	SEN:10000600	18817866
BEL:20033140	cat(p(MGI:Tlr9)) increases tscript(p(MGI:Irf7))	TLR9 primarily induces ISRE gene expression through IRF7...TLR9, which exclusively couples to the MyD88-dependent pathway	SEN:10019378	16143103
BEL:20033148	cat(p(MGI:Tnfrsf10b)) decreases bp(GOBP:"inflammatory response")	Herein we show that TNF-related apoptosis-inducing ligand receptor (TRAIL-R), the only proapoptotic death-signaling receptor for TRAIL in the mouse, suppresses inflammation and tumorigenesis.	SEN:10019742	18079962
BEL:20033150	cat(p(MGI:Tnfrsf10b)) increases bp(GOBP:"apoptotic process")	Herein we show that TNF-related apoptosis-inducing ligand receptor (TRAIL-R), the only proapoptotic death-signaling receptor for TRAIL in the mouse, suppresses inflammation and tumorigenesis.	SEN:10019742	18079962
BEL:20033152	cat(p(MGI:Tnfrsf10b)) decreases path(MESHD:Neoplasms)	Herein we show that TNF-related apoptosis-inducing ligand receptor (TRAIL-R), the only proapoptotic death-signaling receptor for TRAIL in the mouse, suppresses inflammation and tumorigenesis.	SEN:10019742	18079962
BEL:20033170	cat(p(MGI:Tnfrsf17)) increases kin(p(MGI:Mapk8))	This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation.	SEN:10019750	9743536
BEL:20033192	cat(p(MGI:Tnfrsf1b)) decreases cat(p(MGI:Mmp2))	These responses to TNFalpha were absent in TNFR2-/- and TNFR1/2-/- myofibroblasts, whereas TNFR1-/- cells showed similar responses to WT.	SEN:10019760	16141211
BEL:20033194	cat(p(MGI:Tnfrsf1b)) increases kin(p(MGI:Src))	We therefore conclude that TNFR2 activates a novel Src-regulated pathway involving FAK tyrosine phosphorylation that enhances migration of intestinal epithelial cells	SEN:10001170	12466150
BEL:20033200	cat(p(MGI:Tnfrsf1b)) increases p(MGI:Mapk1,pmod(P))	These responses to TNFalpha were absent in TNFR2-/- and TNFR1/2-/- myofibroblasts, whereas TNFR1-/- cells showed similar responses to WT.	SEN:10019760	16141211
BEL:20033202	cat(p(MGI:Tnfrsf1b)) increases p(MGI:Src,pmod(P,Y,416))	TNF (1ng/ml, 15min) stimulated SRC phosphorylation (Tyr 416) and activation through TNFR2 in Young adult mouse colon cells (YAMC) and Mouse colon epithelial (MCER1-/-) cells (lacking TNFR1). Src specific inhibitors PD-161430, PP1 or PP2 blocked TNF induced cell migration. Loss of TNFR2 (MCER2-/- cells) inhibited SRC activation.	SEN:10019764	12466150
BEL:20033206	cat(p(MGI:Tnfrsf1b)) increases r(MGI:Timp1)	These responses to TNFalpha were absent in TNFR2-/- and TNFR1/2-/- myofibroblasts, whereas TNFR1-/- cells showed similar responses to WT.	SEN:10019760	16141211
BEL:20033210	cat(p(MGI:Tnfrsf4)) increases r(MGI:Birc5)	Survivin was expressed after triggering OX40, and this was not dependent on cell division, as significant expression was retained in the presence of hydroxyurea, aphidicolin, and nocodazole (Figure 3B).	SEN:10019768	15894279
BEL:20033214	cat(p(MGI:Tnfrsf4)) decreases r(MGI:Foxp3)	Here we show that OX40 (CD134) signaling inhibits TGF-beta-driven Foxp3 mRNA and suppresses the conversion of naive Ag-specific transgenic CD4 T cells into CD25(+)Foxp3(+) T cells.	SEN:10019772	17641007
BEL:20033216	cat(p(MGI:Tnfrsf4)) decreases r(MGI:Il10)	As demonstrated in Fig. 3A, blockade of the OX40/OX40L interaction significantly reduced the Th1-specific transcription factor T-bet to 30.8% compared with controls (p=0.007). On the other hand, expression of IL-10, a cytokine that was shown to be protective in chronic DSS-induced colitis [29], increased 3.6-fold (p=0.008).	SEN:10019774	14635034
BEL:20033218	cat(p(MGI:Tnfrsf4)) increases r(MGI:Tbx21)	As demonstrated in Fig. 3A, blockade of the OX40/OX40L interaction significantly reduced the Th1-specific transcription factor T-bet to 30.8% compared with controls (p=0.007). On the other hand, expression of IL-10, a cytokine that was shown to be protective in chronic DSS-induced colitis [29], increased 3.6-fold (p=0.008).	SEN:10019774	14635034
BEL:20033220	cat(p(MGI:Tnfrsf4)) decreases sec(p(MGI:Il10))	IL- 10 secretion increased 20-fold (p X 0.0001). This was accompanied by a significant, 18-fold, increase of IL-5 secretion. IFNG levels were not altered, but IL-6 secretion was reduced to 60% compared with controls.	SEN:10019776	14635034
BEL:20033222	cat(p(MGI:Tnfrsf4)) decreases sec(p(MGI:Il5))	IL- 10 secretion increased 20-fold (p X 0.0001). This was accompanied by a significant, 18-fold, increase of IL-5 secretion. IFNG levels were not altered, but IL-6 secretion was reduced to 60% compared with controls.	SEN:10019776	14635034
BEL:20033224	cat(p(MGI:Tnfrsf4)) increases sec(p(MGI:Il6))	IL- 10 secretion increased 20-fold (p X 0.0001). This was accompanied by a significant, 18-fold, increase of IL-5 secretion. IFNG levels were not altered, but IL-6 secretion was reduced to 60% compared with controls.	SEN:10019776	14635034
BEL:20033244	cat(p(MGI:Tradd)) increases cat(p(MGI:Traf2))	The TNFR1-containing fibroblasts had significantly higher levels of JNK activation than the TNFR2-containing fibroblasts ( Figure 5A), substantiating TRADD as the more effective initiator of TRAF2 signaling.	SEN:10019786	10892748
BEL:20033264	cat(p(MGI:Trpv1)) increases bp(GOBP:"response to endoplasmic reticulum stress")	endogenous TRPV1 agonists produced during inflammation activate TRPV1 in lung cells, cause ER stress and GADD153 expression, and promote lung injury.	SEN:10019796	21949157
BEL:20033280	cat(p(MGI:Unc5b)) decreases bp(GOBP:angiogenesis)	Stimulation of UNC5B-expressing neovessels with an agonist (Netrin-1) inhibits sprouting angiogenesis. Genetic loss of function of unc5b reduces Netrin-1-mediated angiogenesis inhibition.	SEN:10019804	17908930
BEL:20033282	cat(p(MGI:Unc5b)) decreases bp(GOBP:"patterning of blood vessels")	Stimulation of UNC5B-expressing neovessels with an agonist (Netrin-1) inhibits sprouting angiogenesis. Genetic loss of function of unc5b reduces Netrin-1-mediated angiogenesis inhibition.	SEN:10019804	17908930
BEL:20033284	cat(p(MGI:Unc5b)) directlyIncreases complex(p(MGI:Dapk1),p(MGI:Unc5b))	Thus, the pair netrin-1/UNC5H2 may regulate cell fate by controlling the proapoptotic kinase activity of DAP-kinase.	SEN:10019806	15729359
BEL:20033286	cat(p(MGI:Vcl)) decreases bp(GOBP:"cell migration")	Considering that vinculin stabilizes FAs and thereby decreases cell migration (Ziegler et al., 2006), the contribution of this protein to both increased FA content and lower migration of T-FGM and MEF AhR-/- fibroblast (Mulero-Navarro et al., 2005; Gomez- Duran et al., 2009) deserves further consideration.	SEN:10019808	19158396
BEL:20033296	cat(p(MGI:Vipr2)) increases bp(GOBP:"inflammatory response")	T cell VPAC(2)Rs mediate changes in cytokine generation, which potently increase the Th2/Th1 ratio and consequently shift the effector responses toward allergy and inflammation.	SEN:10000356	15187104
BEL:20033302	cat(p(MGI:Vipr2)) decreases r(MGI:Fasl)	The protective effect is mediated through the specific type 2 VIP receptor, and the cAMP/protein kinase A pathway.	SEN:10005200	11145682
BEL:20033310	cat(p(MGI:Vipr2)) decreases tscript(p(MGI:Nfatc2))	The inhibition in NF-ATp binding results from a calcineurin-independent reduction in NF-ATp nuclear translocation.	SEN:10005202	11145682
BEL:20033312	cat(p(MGI:Wwp2)) directlyIncreases deg(p(MGI:Polr2a))	We found that Wwp2 specifically interacted with mouse Rpb1 and targeted it for ubiquitination both in vitro and in vivo	SEN:10005204	17526739
BEL:20033314	cat(p(MGI:Wwp2)) directlyIncreases deg(p(MGI:Pou5f1))	We describe here a novel murine ubiquitin ligase, Wwp2, that specifically interacts with Oct-4 and promotes its ubiquitination both in vivo and in vitro.	SEN:10000346	15047715
BEL:20033320	cat(p(MGI:Xdh)) increases a(CHEBI:"uric acid")	Finally, uric acid, which is the by-product of xanthine oxidase-dependent xanthine metabolism, has also been reported to mediate autocrine growth (257). Exposure of VSMC to uric acid stimulated accumulation of PDGF-A mRNA and secretion of PDGF-like material in conditioned medium (>10-fold at 24 h). Thus uric acid stimulates VSMC growth via an autocrine mechanism involving PDGF-A	SEN:10016376	11427690
BEL:20033324	cat(p(MGI:Xiap)) increases r(MGI:Ifng)	To determine if XIAP enhanced proinflammatory gene expression in vivo, we performed qRT-PCR analysis on splenic RNA from WT and XIAP knockout mice. RNA was isolated from splenocytes harvested from uninfected animals or animals infected with L. monocytogenes for 48 h (Figure 6) {to activate XIAP}. The expression of il6 and ifng mRNAs were significantly enhanced in the presence of XIAP during infection.	SEN:10019816	18769721
BEL:20033326	cat(p(MGI:Xiap)) increases r(MGI:Il6)	To determine if XIAP enhanced proinflammatory gene expression in vivo, we performed qRT-PCR analysis on splenic RNA from WT and XIAP knockout mice. RNA was isolated from splenocytes harvested from uninfected animals or animals infected with L. monocytogenes for 48 h (Figure 6) {to activate XIAP}. The expression of il6 and ifng mRNAs were significantly enhanced in the presence of XIAP during infection.	SEN:10019816	18769721
BEL:20033332	cat(p(MGI:Zfp36)) decreases r(MGI:Csf2)	Tristetraprolin (TTP) is an mRNA-destabilizing protein that negatively regulates the expression of proinflammatory mediators such as tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor, and cyclooxygenase 2	SEN:10019822	15187092
BEL:20033334	cat(p(MGI:Zfp36)) decreases r(MGI:Ptgs2)	Tristetraprolin (TTP) is an mRNA-destabilizing protein that negatively regulates the expression of proinflammatory mediators such as tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor, and cyclooxygenase 2	SEN:10019822	15187092
BEL:20033336	cat(p(MGI:Zfp36)) decreases r(MGI:Tnf)	Tristetraprolin (TTP) is an mRNA-destabilizing protein that negatively regulates the expression of proinflammatory mediators such as tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor, and cyclooxygenase 2	SEN:10019822	15187092
BEL:20033390	chap(p(HGNC:HSPA5)) increases p(HGNC:IGH)	Transport of this heteromeric complex is dependent on the correct assembly of the component parts, which is controlled, in part, by the association of incompletely assembled Ig heavy chains with the endoplasmic reticulum (ER) chaperone, BiP	SEN:10019838	10397760
BEL:20033392	chap(p(HGNC:HSPD1)) increases cat(complex(p(HGNC:BCKDHA),p(HGNC:BCKDK),p(HGNC:BCKDHB)))	distinct functional sequences in a large polypeptide exhibit different folding characteristics on the same GroEL scaffold productive folding of a large multidomain polypeptide can only occur in the GroEL cavity that is not sequestered by GroES	SEN:10019840	10187830
BEL:20033396	chap(p(MGI:Clgn)) increases complex(p(MGI:Adam1a),p(MGI:Adam2))	Calmegin is a putative testis-specific molecular chaperone required for the heterodimerization of fertilin alpha/beta and the appearance of fertilin beta on the sperm surface.	SEN:10005220	12376108
BEL:20033406	chap(p(MGI:Hsp90aa1)) increases p(MGI:Hif1a)	The mechanism by which YC-1 reduces HIF-1a levels has not been established. HIF-1a interacts with the chaperone HSP90, and the HSP90 inhibitor 17-allyl-aminogeldanamycin (17-AAG) induces HIF-1a degradation in a VHL-independent manner 84 86, indicating that HSP90 is required for HIF-1a stability.	SEN:10019846	13130303
BEL:20033420	complex(a(CHEBI:estradiol),p(HGNC:ESR1)) increases complex(p(HGNC:NCOA1),p(HGNC:ESR1))	oestrogenic conditions SRC-1 preferentially binds to the ER which effectively sequesters it thereby reducing enhancer activity	SEN:10019852	10698518
BEL:20033426	complex(a(CHEBI:estradiol),p(HGNC:GPER1)) increases kin(p(HGNC:MAPK1))	Estrogen rapidly activates the mitogen-activated protein kinases, Erk-1 and Erk-2, via an as yet unknown mechanism. requires the expression of the G protein-coupled receptor homolog, GPR30. We show that 17beta-estradiol activates Erk-1/-2 not only in MCF-7 cells, which express both estrogen receptor alpha (ER alpha) and ER beta, but	SEN:10019856	11043579
BEL:20033428	complex(a(CHEBI:estradiol),p(HGNC:GPER1)) increases kin(p(HGNC:MAPK3))	Estrogen rapidly activates the mitogen-activated protein kinases, Erk-1 and Erk-2, via an as yet unknown mechanism. requires the expression of the G protein-coupled receptor homolog, GPR30. We show that 17beta-estradiol activates Erk-1/-2 not only in MCF-7 cells, which express both estrogen receptor alpha (ER alpha) and ER beta, but	SEN:10019856	11043579
BEL:20033432	complex(a(CHEBI:estradiol),p(HGNC:GPER1)) increases sec(p(HGNC:HBEGF))	Reinforcing this idea, estradiol signaling to Erk-1/-2 was dependent upon trans-activation of the epidermal growth factor (EGF) receptor via release of heparan-bound EGF (HB-EGF).	SEN:10005228	11043579
BEL:20033438	complex(a(CHEBI:heparin),p(HGNC:CMA1)) directlyIncreases cat(p(HGNC:CMA1))	The tight binding of chymase to heparin PG results in increased activity of the protease toward certain substrates, e.g., thrombin and MeO-Suc-Arg-Pro-Tyr-pNA (S-2586).	SEN:10003404	10508424
BEL:20033444	complex(a(CHEBI:"hyaluronic acid"),p(HGNC:CD44)) increases bp(GOBP:"cell migration")	The CD44 glycoprotein is expressed in multiple isoforms on a variety of cell types where it functions as a receptor for hyaluronan-mediated motility.	SEN:10005234	10713114
BEL:20033446	complex(a(CHEBI:"hyaluronic acid"),p(HGNC:CD44)) increases gtp(p(HGNC:RAC1))	Here, we show that the small guanine nucleotide (GTP)-binding protein, Rac1, can be activated upon HA binding to CD44.	SEN:10019860	10725329
BEL:20033528	complex(p(HGNC:INS),p(HGNC:INSR)) increases tloc(p(HGNC:INSR),GOCCID:0005886,GOCCID:0005768)	Interestingly, this NPXY sequence is also a receptor internalization motif found in many members of the tyrosine kinase receptor family, the low-density lipoprotein receptor (11-13), and the transferrin receptor (14), all of which are internalized in a ligand-dependent fashion.	SEN:10019902	10194465
BEL:20033540	complex(p(HGNC:ABL1),p(HGNC:RB1)) decreases kin(p(HGNC:ABL1))	<A8> c-Abl tyrosine kinase activity is blocked by pRb, which binds to the c-Abl kinase domain (Welch and Wang, 1995).	SEN:10019908	10436023
BEL:20033542	complex(p(HGNC:ABL1),p(HGNC:TP53)) directlyDecreases deg(p(HGNC:TP53))	<A4> c-Abl binds to p53 in response to 1-b-d-arabinofuransylcytosine or methylmethanesulfonate (Yuan et al., 1996); this interaction does not require c-Abl kinase activity. Moreover, c-Abl kinase activity does not require p53. Binding of c-Abl to p53 inhibits the Mdm2-mediated degradation of p53 (Sionov et al., 1999).	SEN:10017968	10436023
BEL:20033558	complex(p(HGNC:ANK1),p(HGNC:TIAM1)) increases bp(GOBP:"cell migration")	Most importantly, ankyrin binding to Tiam1 activates GDP/GTP exchange on Rho GTPases (e.g., Rac1) Transfection of SP-1 cell with Tiam1 cDNAs stimulates all of the following: (1) Tiam1-ankyrin association in the membrane projection; (2) Rac1 activation; and (3) breast tumor cell invasion and migration.	SEN:10019914	10893266
BEL:20033562	complex(p(HGNC:ANXA6),p(HGNC:SPTBN1)) decreases p(HGNC:SPTBN1)	The decline in spectrin depends on the ability of annexin VI to bind spectrin and activate a calpain-like protease.	SEN:10019918	10585476
BEL:20033570	complex(p(HGNC:APPL1),p(HGNC:AKT2),p(HGNC:PIK3CA)) directlyIncreases kin(p(HGNC:AKT2))	These data suggest that APPL is an adaptor that may tether inactive AKT2 to p110alpha in the cytoplasm and thereby may expedite recruitment of AKT2 and p110alpha to the cell membrane upon mitogenic stimulation.	SEN:10005260	10490823
BEL:20033576	complex(p(HGNC:AXIN1),p(HGNC:GSK3B)) directlyIncreases kin(p(HGNC:GSK3B))	beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex.	SEN:10019924	10228155
BEL:20033588	complex(p(HGNC:BCAP29),p(HGNC:BCAP31)) decreases r(HGNC:CFTR)	The putative BAP31/BAP29 heterodimer was also able to inhibit expression of CFTR Cl - conductance, as shown in Fig. 7 .	SEN:10019932	11274174
BEL:20033596	complex(p(HGNC:BCL2),p(HGNC:BCL2L11)) directlyDecreases cat(p(HGNC:BCL2))	This freed Bim to translocate together with LC8 to Bcl-2 and to neutralize its antiapoptotic activity.	SEN:10018408	10198631
BEL:20033602	complex(p(HGNC:BTG2),p(HGNC:HOXB9)) directlyIncreases tscript(p(HGNC:HOXB9))	We further show that Btg1 and Btg2 enhance Hoxb9-mediated transcription in transfected cells, and we report the formation of a Hoxb9.Btg2 complex on a Hoxb9-responsive target, and the fact that this interaction facilitates the binding of Hoxb9 to DNA.	SEN:10019936	10617598
BEL:20033604	complex(p(HGNC:BTRC),p(HGNC:CTNNB1)) directlyIncreases deg(p(HGNC:CTNNB1))	FWD1 facilitated ubiquitination and promoted degradation of beta-catenin, resulting in reduced cytoplasmic beta-catenin levels.	SEN:10005268	10228155
BEL:20033606	complex(p(HGNC:C1QBP),p(EGID:6426)) decreases cat(p(EGID:6426))	We further show that p32 inhibits ASF/SF2 function as both a splicing enhancer and splicing repressor protein by preventing stable ASF/SF2 interaction with RNA, but p32 does not block SRp30c function.	SEN:10005270	10022843
BEL:20033628	complex(p(HGNC:CCNA2),p(HGNC:CDK1)) increases p(HGNC:RPA2,pmod(P,S,29))	<s10> Cyclin A:Cdk2 and Cyclin A:Cdc2 phosphorylate RPA2; the major site for Cdc2 has been mapped to Ser29 (Niu et al.,1997).	SEN:10019942	10436023
BEL:20033634	complex(p(HGNC:CCND3),p(HGNC:PCNA)) decreases bp(GOBP:"DNA replication")	<r11> Cyclin D binds PCNA directly and inhibits PCNA-dependent replication (Matsuoka et al., 1994; Pagano et al., 1994).	SEN:10019946	10436023
BEL:20033638	complex(p(HGNC:CCNE1),p(HGNC:CDK2)) directlyDecreases deg(p(HGNC:CCNE1))	<C13> Cyclin E has a half-life of ~30 min. It is degraded by way of the ubiquitin?proteasome pathway subsequent to phosphorylation (possibly autophosphorylation) at threonine-380 (Clurman et al., 1996; Won and Reed, 1996). However, it can be stabilized by binding to Cdk2.	SEN:10019950	10436023
BEL:20033640	complex(p(HGNC:CCNE1),p(HGNC:CDK2)) increases p(HGNC:POLD3,pmod(P))	<r2> DPase a-primase may be regulated by phosphorylation of its p68 subunit by Cyclin A:Cdk2, which reduces and Cyclin E:Cdk2 which increases its DNA initiation activity (Voitenleitner et al., 1999).	SEN:10019948	10436023
BEL:20033646	complex(p(HGNC:CD40LG),p(HGNC:CD40)) increases complex(p(HGNC:CD40),p(HGNC:TRAF2))	While the binding of CD154 to CD40 induces the assembly of a CD40-TRAF receptor complex, IKK is not recruited to this complex	SEN:10005282	10229103
BEL:20033650	complex(p(HGNC:CD44),p(HGNC:FGF2)) increases kin(p(HGNC:FGFR1))	Furthermore, we show these isoforms are preferentially modified with heparan rather than chondroitin sulfate, bind the macrophage-derived growth factors FGF-2, vascular endothelial growth factor, and heparin-binding epidermal growth factor with varying affinities (K(d) 25-330 nM) and in the case of FGF-2, can stimulate productive binding to the high affinity tyrosine kinase FGF receptor 1 (FGFR1).	SEN:10005284	10713114
BEL:20033652	complex(p(HGNC:CDC25C),p(HGNC:SFN)) decreases p(HGNC:CDC25C,pmod(P))	<C40> Ser216-phosphorylated Cdc25C is recognized and bound by 14-3-3 protein family members (Peng et al., 1997, 1998). Ser216 phosphorylation and 14-3-3 binding probably sequester Cdc25C and thus prevent it from interacting with Cdk1 in vivo (Peng et al., 1997). 14-3-3s is localized to the cytoplasm and may be the means by which Cdc25C is sequestered outside of the nucleus (Hermeking et al., 1997).	SEN:10019952	10436023
BEL:20033658	complex(p(HGNC:CDK10),p(HGNC:ETS2)) decreases tscript(p(HGNC:ETS2))	We find that Cdk10 binds full length Ets2 in vitro and in vivo and inhibits Ets2 transactivation in mammalian cells.	SEN:10005286	11313931
BEL:20033660	complex(p(HGNC:CDK1),p(HGNC:CCNB1)) increases bp(GOBP:"cell cycle")	Gadd45 was also able to physically interact with Cdc2, but not Cyclin B1. Addition of Gadd45 to immunoprecipitated Cdc2/Cyclin B1 in vitro led to a dissociation of this complex, and thus may represent a new checkpoint mechanism whereby Cdc2/Cyclin B1 can be inhibited.	SEN:10005288	10362260
BEL:20033662	complex(p(HGNC:CDK1),p(HGNC:CCNB1)) increases p(HGNC:CDC25C,pmod(P))	<C36> Cdc25C is activated by hyperphosphorylation of the Nterminal domain (Gabrielli et al., 1997), which can be phosphorylated by Cyclin B:Cdk1 (Hoffman et al., 1993).	SEN:10019958	10436023
BEL:20033666	complex(p(HGNC:CDK2),p(HGNC:CCNA2)) increases p(HGNC:POLD3,pmod(P))	<r2> DPase a-primase may be regulated by phosphorylation of its p68 subunit by Cyclin A:Cdk2, which reduces and Cyclin E:Cdk2 which increases its DNA initiation activity (Voitenleitner et al., 1999).	SEN:10019948	10436023
BEL:20033668	complex(p(HGNC:CDK2),p(HGNC:CCNA2)) increases p(HGNC:RPA2,pmod(P))	<s10> Cyclin A:Cdk2 and Cyclin A:Cdc2 phosphorylate RPA2; the major site for Cdc2 has been mapped to Ser29 (Niu et al.,1997).	SEN:10019942	10436023
BEL:20033680	complex(p(HGNC:CHRM3),p(HGNC:CSNK1A1)) decreases r(HGNC:CSNK1A1)	a peptide corresponding to the third intracellular loop of the m3-muscarinic receptor (Ser(345)-Leu(463)) is an inhibitor of CK1alpha due to its ability to both act as a pseudo-substrate for CK1alpha and form a high affinity complex with CK1alpha	SEN:10019964	10777483
BEL:20033694	complex(p(HGNC:CSK),p(HGNC:IRS1)) decreases p(HGNC:PTK2,pmod(P,Y))	Csk has been reported to associate with IRS-1 through its SH2 domain and promote dephosphorylation of the focal adhesion kinase (FAK) in an insulin-dependent manner (56).	SEN:10019968	10194465
BEL:20033712	complex(p(HGNC:DAPK3),p(HGNC:AATF)) decreases bp(GOBP:"apoptotic process")	Dlk can induce apoptosis. In search for interaction partners that might serve as regulators or targets of this kinase we identified apoptosis antagonizing transcription factor (AATF) Interestingly, AATF interfered with Dlk-induced apoptosis.	SEN:10019976	10580117
BEL:20033716	complex(p(HGNC:DAPK3),p(HGNC:PAWR)) directlyIncreases tloc(p(HGNC:DAPK3),GOCCID:0005634,GOCCID:0005737)	Strikingly, coexpression of Dlk and Par-4 lead to relocation of Dlk from the nucleus to the cytoplasm, particularly to actin filaments. These interactions provoked a dramatic reorganization of the cytoskeleton and morphological symptoms of apoptosis, thus suggesting a functional relationship between Dlk and Par-4 in the control of apoptosis.	SEN:10005296	10602480
BEL:20033720	complex(p(HGNC:DCC),p(HGNC:APPL1)) directlyIncreases cat(p(HGNC:CASP9))	Moreover, we demonstrate that DCC interacts with both caspase-3 and caspase-9 and drives the activation of caspase-3 through caspase-9 without a requirement for cytochrome c or Apaf-1.	SEN:10000182	11248093
BEL:20033732	complex(p(HGNC:EGF),p(HGNC:EGFR)) directlyIncreases kin(p(HGNC:EGFR))	This is consistent with our finding that EGF, an upstream activator of MAPK, enhances the effect of SRC-1 on PR-dependent gene transcription (50).	SEN:10019986	11073973
BEL:20033736	complex(p(HGNC:EIF4EBP1),p(HGNC:EIF4E)) decreases cat(p(HGNC:EIF4E))	4E-BP1 is a translation inhibitor that is phosphorylated and inactivated in response to a growth signal. Phosphorylated 4E-BP1 dissociates from eIF4E, the translation initiation factor that binds the cap structure (m7G(5')ppp(5')N) present at the 5' termini of mRNAs, thereby allowing cap-dependent translation.	SEN:10019990	11057898
BEL:20033752	complex(p(HGNC:ESR1),p(HGNC:BRCA1)) directlyDecreases tscript(p(HGNC:ESR1))	The BRCA1 protein was found to associate with ER-alpha in vivo and to bind to ER-alpha in vitro, by an estrogen-independent interaction that mapped to the amino-terminal region of BRCA1 (ca. amino acid 1-300) and the conserved carboxyl-terminal activation function [AF-2] domain of ER-alpha	SEN:10019996	11244506
BEL:20033762	complex(p(HGNC:FOS),p(HGNC:JUN)) increases r(HGNC:F3)	LPS-induced monocyte TF expression is regulated through a 56-bp promoter region (2227 through 2172 bp) containing 2 activator protein-1 (AP-1) binding sites and a nuclear factor (NF)-kB binding site, elements that bind c-fos/c-jun and c-Rel/p65 heterodimers, respectively.8,9 LPS-induced TF expression in cells of the monocyte lineage requires functional interaction between these transcription factors.10	SEN:10019998	11208679
BEL:20033764	complex(p(HGNC:FOS),p(HGNC:JUN)) increases r(HGNC:IL6)	Cotransfection of c-Jun and c-Fos also strongly activated the wild-type human IL-6 promoter (Fig. 3B).	SEN:10020000	10542237
BEL:20033778	complex(p(HGNC:HCK),p(HGNC:AP2B1)) increases kin(p(HGNC:HCK))	Interleukin 8 (IL-8) activation of the chemokine receptor CXCRI was found to stimulate rapid formation of beta-arrestin complexes with Hck or c-Fgr. Formation of beta-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions.	SEN:10004236	10973280
BEL:20033780	complex(p(HGNC:HDAC1),p(HGNC:NOLC1)) directlyIncreases tscript(p(HGNC:NOLC1))	<E14> The interaction with HDAC1 enhances transcriptional repression by pocket proteins (Brehm et al., 1998; Ferreira et al., 1998; Luo et al., 1998). HDAC1:RB1^taof(RB1) HDAC1:NOLC1^taof(RB1) HDAC1:RBL1^taof(RB1)	SEN:10020010	10436023
BEL:20033782	complex(p(HGNC:HDAC1),p(HGNC:RB1)) directlyIncreases tscript(p(HGNC:RB1))	<E14> The interaction with HDAC1 enhances transcriptional repression by pocket proteins (Brehm et al., 1998; Ferreira et al., 1998; Luo et al., 1998). HDAC1:RB1^taof(RB1) HDAC1:NOLC1^taof(RB1) HDAC1:RBL1^taof(RB1)	SEN:10020010	10436023
BEL:20033784	complex(p(HGNC:HDAC1),p(HGNC:RBL1)) directlyIncreases tscript(p(HGNC:RBL1))	<E14> The interaction with HDAC1 enhances transcriptional repression by pocket proteins (Brehm et al., 1998; Ferreira et al., 1998; Luo et al., 1998). HDAC1:RB1^taof(RB1) HDAC1:NOLC1^taof(RB1) HDAC1:RBL1^taof(RB1)	SEN:10020010	10436023
BEL:20033796	complex(p(HGNC:HMGB1),p(HGNC:PRKDC)) directlyIncreases kin(p(HGNC:PRKDC))	<B10> HMG1 or 2 competes with Ku for binding to DNA-PK and stimulates DNA-dependent kinase activity in vitro in the absence of Ku (Yumoto et al., 1998).	SEN:10020014	10436023
BEL:20033798	complex(p(HGNC:HMGB2),p(HGNC:PRKDC)) directlyIncreases kin(p(HGNC:PRKDC))	<B10> HMG1 or 2 competes with Ku for binding to DNA-PK and stimulates DNA-dependent kinase activity in vitro in the absence of Ku (Yumoto et al., 1998).	SEN:10020014	10436023
BEL:20033802	complex(p(HGNC:ICAM3),p(HGNC:ITGAL),p(HGNC:ITGB2)) increases sec(p(HGNC:TNF))	In contrast, ICAM-2 and ICAM-3 induced a much stronger secretion of the Th1 cytokine TNF-alpha compared to LFA-1/ICAM-1 induced co-stimulation, despite the lower proliferation rate.	SEN:10005306	10427988
BEL:20033804	complex(p(HGNC:IGF1),p(HGNC:IGF1R)) increases p(HGNC:JAK1,pmod(P))	We found that STAT3, but not STAT5, was activated in response to IGF-I in 293T cells cotransfected with IGF-IR and STAT expression vectors. Moreover, tyrosine phosphorylation of STAT3, JAK1, and JAK2 was increased upon IGF-I stimulation of endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK expression vector.	SEN:10020016	10747872
BEL:20033806	complex(p(HGNC:IGF1),p(HGNC:IGF1R)) increases p(HGNC:JAK2,pmod(P))	We found that STAT3, but not STAT5, was activated in response to IGF-I in 293T cells cotransfected with IGF-IR and STAT expression vectors. Moreover, tyrosine phosphorylation of STAT3, JAK1, and JAK2 was increased upon IGF-I stimulation of endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK expression vector.	SEN:10020016	10747872
BEL:20033808	complex(p(HGNC:IGF1),p(HGNC:IGF1R)) increases p(HGNC:STAT3,pmod(P))	We found that STAT3, but not STAT5, was activated in response to IGF-I in 293T cells cotransfected with IGF-IR and STAT expression vectors. Moreover, tyrosine phosphorylation of STAT3, JAK1, and JAK2 was increased upon IGF-I stimulation of endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK expression vector.	SEN:10020016	10747872
BEL:20033810	complex(p(HGNC:IGF2),p(HGNC:IGF1R)) increases kin(p(HGNC:IGF1R))	The IGF-II gene is overexpressed in malignant adrenocortical tumors and its proliferative effects are mediated by the type-1 IGF receptor (IGF1R).	SEN:10005308	11182753
BEL:20033812	complex(p(HGNC:IGF2R),p(HGNC:IGF2)) increases deg(p(HGNC:IGF2))	The mannose 6-phosphate/IGF2 receptor (M6P/IGF2R) plays a key role in regulating cell growth, by ensuring the clearance and inactivation of IGF-II and facilitating activation of the growth inhibitor, transforming growth factor beta (TGFbeta1).	SEN:10018568	11182753
BEL:20033814	complex(p(HGNC:IGF2R),p(HGNC:IGF2)) decreases p(HGNC:IGF2)	The mannose 6-phosphate/IGF2 receptor (M6P/IGF2R) plays a key role in regulating cell growth, by ensuring the clearance and inactivation of IGF-II and facilitating activation of the growth inhibitor, transforming growth factor beta (TGFbeta1).	SEN:10018568	11182753
BEL:20033818	complex(p(HGNC:IL12A),p(HGNC:IL12B)) increases p(HGNC:IFNG)	Consistent with these observations, IL-12, a known inducer of IFN-gamma, augmented IL-1beta-induced IFN-gamma but suppressed IL-1beta-induced PGE(2) by 75%.	SEN:10020020	10681439
BEL:20033830	complex(p(HGNC:IRF8),p(HGNC:IRF1)) decreases tscript(p(HGNC:IRF1))	The phosphorylated residue is essential for efficient association with IRF-1 and thus for the repressor activity of ICSBP exerted on IRF-1.	SEN:10020028	10991940
BEL:20033834	complex(p(HGNC:ITGA5),p(HGNC:ITGB1)) directlyIncreases kin(p(HGNC:EGFR))	These results suggest that integrin alpha5/beta1 mediates fibronectin-induced epithelial cell proliferation through activation of the EGFR.	SEN:10020032	10888683
BEL:20033836	complex(p(HGNC:ITGAL),p(HGNC:ITGB2),p(HGNC:ICAM1)) increases sec(p(HGNC:IL10))	Interestingly, we observed that LFA-1/ICAM-1 co-stimulation of T cells resulted in high production of the Th2 cytokine IL-10 compared to ICAM-2 or ICAM-3 co-stimulation.	SEN:10020034	10427988
BEL:20033838	complex(p(HGNC:ITGAL),p(HGNC:ITGB2),p(HGNC:ICAM2)) increases sec(p(HGNC:TNF))	In contrast, ICAM-2 and ICAM-3 induced a much stronger secretion of the Th1 cytokine TNF-alpha compared to LFA-1/ICAM-1 induced co-stimulation, despite the lower proliferation rate.	SEN:10005306	10427988
BEL:20033858	complex(p(HGNC:JAK2),p(HGNC:SIRPA)) increases complex(p(HGNC:SIRPA),p(HGNC:JAK2),p(HGNC:PTPN11))	SIRP is a transmembrane protein that is now known to bind to integrin-associated protein. It appears to bind directly to JAK2 by a process that does not require tyrosyl phosphorylation, although is itself highly phosphorylated on tyrosines in response to GH. The phosphorylated SIRP recruits one or more molecules of the tyrosine phosphatase SHP2 that, in turn, de-phosphorylates SIRP and most likely JAK2.	SEN:10020042	11036942
BEL:20033860	complex(p(HGNC:KDR),p(HGNC:ITGAV),p(HGNC:ITGB3)) directlyIncreases kin(p(HGNC:KDR))	This hypothesis is strongly supported by the result that VEGFA165- stimulated, tyrosine phosphorylated VEGFR-2 was associated with b3 integrin. The specificity of the model was restricted to avb3 integrin.	SEN:10020044	10022831
BEL:20033862	complex(p(HGNC:KITLG),p(HGNC:KIT)) increases r(HGNC:SOCS1)	We show that the expression of Socs1 mRNA is rapidly increased in primary bone marrow-derived mast cells following exposure to Steel factor	SEN:10020046	10022833
BEL:20033864	complex(p(HGNC:KIT),p(HGNC:KIT)) directlyIncreases kin(p(HGNC:KIT))	% In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail.	SEN:10020048	10377264
BEL:20033866	complex(p(HGNC:KLF1),p(HGNC:HDAC1)) decreases tscript(p(HGNC:KLF1))	When linked to a GAL4 DNA binding domain, full-length EKLF or its zinc finger domain alone can repress transcription in vivo. This repressive activity can be relieved by the HDAC inhibitor trichostatin A.	SEN:10020050	11287616
BEL:20033872	complex(p(HGNC:LGALS1),p(HGNC:CD7)) increases bp(GOBP:"cell death")	We show that CD7 is required for galectin-1-mediated death. This demonstrates a novel function for CD7 as a death trigger and identifies galectin-1/CD7 as a new biologic death signaling pair.	SEN:10005314	10946254
BEL:20033874	complex(p(HGNC:LGALS1),p(HGNC:CD7)) directlyIncreases cat(p(HGNC:CD7))	We show that CD7 is required for galectin-1-mediated death. This demonstrates a novel function for CD7 as a death trigger and identifies galectin-1/CD7 as a new biologic death signaling pair.	SEN:10005314	10946254
BEL:20033876	complex(p(HGNC:LGALS1),p(HGNC:CD7)) increases cat(p(HGNC:CD7))	We show that CD7 is required for galectin-1-mediated death. This demonstrates a novel function for CD7 as a death trigger and identifies galectin-1/CD7 as a new biologic death signaling pair.	SEN:10005314	10946254
BEL:20033882	complex(p(HGNC:MAF),p(HGNC:MYB)) decreases tscript(p(HGNC:MYB))	We have shown that the c-Maf and c-Myb transcription factors physically interact in myeloid cells to form inhibitory complexes that hinder transactivation of c-Myb target genes through direct binding to Myb consensus sites.	SEN:10020058	10477683
BEL:20033890	complex(p(HGNC:MEF2A),p(HGNC:HDAC4)) decreases tscript(p(HGNC:MEF2A))	Because Cabin-1 also associates with mSin3a and histone deacetylases 1 and 2 (HDAC1/2), its dissociation from MEF2 may replace a repressing complex with an activating complex (51). In a like manner, MEF2 binds and is repressed by HDAC4 but is released by Ca2+/CaM binding to HDAC4 (52).	SEN:10000142	11096122
BEL:20033894	complex(p(HGNC:MMP2),p(HGNC:MMP14),p(HGNC:TIMP2)) decreases cat(p(HGNC:MMP2))	It has been demonstrated that MMP2 activation is dependent on the complex (membrane type 1 [MT1]-MMP/tissue inhibitor of MMP2 [TIMP2]) receptor and MMP2.	SEN:10005322	11049985
BEL:20033896	complex(p(HGNC:MTOR),p(HGNC:GPHN)) directlyIncreases kin(p(HGNC:MTOR))	In mammalian cells RAFT1 interacted with gephyrin, a widely expressed protein necessary for the clustering of glycine receptors at the cell membrane of neurons.	SEN:10005324	10325225
BEL:20033900	complex(p(HGNC:MYLIP),p(HGNC:MYL5)) increases bp(GOBP:"cell migration")	In the yeast two-hybrid system and in transfected COS cells, MIR interacts with myosin regulatory light chain B, which in turn regulates the activity of the actomyosin complex.	SEN:10020064	10593918
BEL:20033902	complex(p(HGNC:MYLIP),p(HGNC:MYL9)) increases bp(GOBP:"cell migration")	In the yeast two-hybrid system and in transfected COS cells, MIR interacts with myosin regulatory light chain B, which in turn regulates the activity of the actomyosin complex.	SEN:10020064	10593918
BEL:20033904	complex(p(HGNC:NCK1),p(HGNC:IRS1)) increases complex(p(HGNC:HRAS),p(HGNC:SOS1))	Nck associates with IRS-1 (45), many different tyrosine kinases, several serine/threonine kinases through its SH2 domain, as well as Sos through its SH3 domains	SEN:10020066	10194465
BEL:20033908	complex(p(HGNC:NCOA1),p(HGNC:ESR1)) decreases r(HGNC:ERBB2)	oestrogenic conditions SRC-1 preferentially binds to the ER which effectively sequesters it thereby reducing enhancer activity	SEN:10019852	10698518
BEL:20033924	complex(p(HGNC:NFE2L2),p(HGNC:ATF4)) directlyIncreases tscript(p(HGNC:NFE2L2))	Furthermore, Nrf2.ATF4 dimers bound to an StRE sequence from the ho-1 gene. CdCl(2), a potent inducer of HO-1, increased expression of ATF4 in mouse hepatoma cells, and detectable induction of ATF4 protein preceded that of HO-1	SEN:10020072	11274184
BEL:20033932	complex(p(HGNC:NR0B2),p(HGNC:HNF4A)) decreases tscript(p(HGNC:HNF4A))	The minimal SHP sequences previously found to be required for interaction with other receptors are sufficient for interaction with HNF-4,	SEN:10005330	10594021
BEL:20033938	complex(p(HGNC:PARK2),p(HGNC:UBE2L6)) directlyIncreases cat(p(HGNC:PARK2))	Here, we show that Parkin binds to the E2 ubiquitin-conjugating human enzyme 8 (UbcH8) through its C-terminal ring-finger. Parkin has ubiquitin-protein ligase activity in the presence of UbcH8.	SEN:10005332	11078524
BEL:20033948	complex(p(HGNC:PDGFA),p(HGNC:PDGFB)) increases p(HGNC:KDR)	However, in specific organs, the effect of PDGF on angiogenesis may be significant. Thus stimulation of PDGF-AB production in cardiac microvascular cells leads to induction of both von Willebrand factor and VEGF and VEGF receptor-2, suggesting an important role of PDGF in cardiac angiogenesis (110).	SEN:10020088	10508235
BEL:20033950	complex(p(HGNC:PDGFA),p(HGNC:PDGFB)) increases p(HGNC:VEGFA)	However, in specific organs, the effect of PDGF on angiogenesis may be significant. Thus stimulation of PDGF-AB production in cardiac microvascular cells leads to induction of both von Willebrand factor and VEGF and VEGF receptor-2, suggesting an important role of PDGF in cardiac angiogenesis (110).	SEN:10020088	10508235
BEL:20033952	complex(p(HGNC:PDGFA),p(HGNC:PDGFB)) increases p(HGNC:VWF)	However, in specific organs, the effect of PDGF on angiogenesis may be significant. Thus stimulation of PDGF-AB production in cardiac microvascular cells leads to induction of both von Willebrand factor and VEGF and VEGF receptor-2, suggesting an important role of PDGF in cardiac angiogenesis (110).	SEN:10020088	10508235
BEL:20033958	complex(p(HGNC:PDGFB),p(HGNC:PDGFB)) increases bp(GOBP:"DNA replication")	K. Control of PDGF Signaling Moreover, angiotensin II has been shown to delay PDGF-BB-induced DNA synthesis in vascular smooth muscle cells; the mechanism behind the effect remains to be elucidated (88).	SEN:10015426	10508235
BEL:20033962	complex(p(HGNC:PDGFB),p(HGNC:PDGFB)) increases complex(p(HGNC:ITGA2),p(HGNC:ITGB1))	On the other hand, PDGF simulates the synthesis of the collagen binding integrin alpha 2beta 1 (5, 246).	SEN:10020090	10508235
BEL:20033970	complex(p(HGNC:PDGFB),p(HGNC:PDGFB)) increases p(HGNC:VEGFA)	VEGF endogenous production may be upregulated in vascular smooth muscle cells by hypoxia, growth factors (bFGF and PDGF-BB), and cytokines	SEN:10018124	11350732
BEL:20033974	complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA)) increases bp(GOBP:chemotaxis)	Moreover, activation of the beta -receptor stimulates chemotaxis; in contrast, activation of the alpha -receptors inhibits chemotaxis of certain cell types including fibroblasts and smooth muscle cells (255, 429, 513), whereas chemotaxis of certain other cell types is stimulated (201, 334, 428, 515).	SEN:10020096	10508235
BEL:20033976	complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA)) decreases bp(GOBP:chemotaxis)	Moreover, activation of the beta -receptor stimulates chemotaxis; in contrast, activation of the alpha -receptors inhibits chemotaxis of certain cell types including fibroblasts and smooth muscle cells (255, 429, 513), whereas chemotaxis of certain other cell types is stimulated (201, 334, 428, 515).	SEN:10020096	10508235
BEL:20033982	complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA),p(HGNC:CRK)) increases complex(p(HGNC:CRK),p(HGNC:RAPGEF1),p(HGNC:BCAR1))	Crk, which is the only SH2 protein known that binds with significantly higher affinity to the alpha -receptor than to the beta -receptor (511), forms a complex with the docking protein Cas and the nucleotide exchange protein C3G, which has been linked to the activation of JNK/SAPK (462).	SEN:10020100	10508235
BEL:20033986	complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA),p(HGNC:CRK)) directlyIncreases p(HGNC:CRK)	Crk, which is the only SH2 protein known that binds with significantly higher affinity to the alpha -receptor than to the beta -receptor (511), forms a complex with the docking protein Cas and the nucleotide exchange protein C3G, which has been linked to the activation of JNK/SAPK (462).	SEN:10020100	10508235
BEL:20033996	complex(p(HGNC:PDGFRB),p(HGNC:PDGFRB)) increases bp(GOBP:chemotaxis)	Moreover, activation of the beta -receptor stimulates chemotaxis; in contrast, activation of the alpha -receptors inhibits chemotaxis of certain cell types including fibroblasts and smooth muscle cells (255, 429, 513), whereas chemotaxis of certain other cell types is stimulated (201, 334, 428, 515).	SEN:10020096	10508235
BEL:20034006	complex(p(HGNC:PGF),p(HGNC:KDR)) directlyIncreases kin(p(HGNC:KDR))	VEGF/PIGF heterodimers do, however, have biological activity in vivo and exhibit high-affinity binding to VEGFR2	SEN:10020106	11350732
BEL:20034008	complex(p(HGNC:PGF),p(HGNC:VEGFA)) increases kin(p(HGNC:FLT1))	VEGFR1 does appear to mediate VEGF- and PIGF-induced tissue factor expression and chemotaxis in monocytes, a cell type that expresses only VEGFR1	SEN:10020108	11350732
BEL:20034016	complex(p(HGNC:PLAU),p(HGNC:PLAUR)) directlyIncreases cat(p(HGNC:PLAUR))	The interaction of uPA with its receptor concentrates the enzyme activity to the so-called \"focal attachment sites\" on the cell surface and stimulates signal transduction through the uPAR, leading to induction of cell migration and invasion (19).	SEN:10000170	11172729
BEL:20034024	complex(p(HGNC:PRKDC),a(CHEBI:"double-stranded DNA")) directlyIncreases kin(p(HGNC:PRKDC))	<B10> HMG1 or 2 competes with Ku for binding to DNA-PK and stimulates DNA-dependent kinase activity in vitro in the absence of Ku (Yumoto et al., 1998).	SEN:10020014	10436023
BEL:20034026	complex(p(HGNC:PRKDC),a(CHEBI:"double-stranded DNA")) directlyIncreases kin(p(HGNC:PRKDC))	<B4> The kinase activity of DNA-PK is stimulated by binding to dsDNA ends; however, the stimulation is greater in the complex with Ku (Yaneva et al., 1997; West et al., 1998).	SEN:10020114	10436023
BEL:20034028	complex(p(HGNC:PSEN1),p(HGNC:CTNNB1)) directlyIncreases deg(p(HGNC:CTNNB1))	Inducible overexpression of PS1 led to increased association of beta-catenin with glycogen synthase kinase-3beta (GSK-3beta), a negative regulator of beta-catenin, and accelerated the turnover of endogenous beta-catenin.	SEN:10001352	10341227
BEL:20034044	complex(p(HGNC:RAD51),p(HGNC:ABL1)) decreases complex(p(HGNC:RAD51),a(CHEBI:"single-stranded DNA"))	<N12> Rad51 binds to c-Abl directly (Yuan et al., 1998). c-Abl phosphorylates Rad51 Tyr54, as a consequence of which the binding of Rad51 to ssDNA is inhibited (Yuan et al., 1998). IR induces c-Abl-dependent phosphorylation of Rad51 (Yuan et al., 1998).	SEN:10018178	10436023
BEL:20034046	complex(p(HGNC:RAF1),p(HGNC:BAG1)) directlyIncreases kin(p(HGNC:RAF1))	Bag1, a co-chaperone for heat-shock protein 70 (Hsp70), coordinates signals for cell growth in response to cell stress, by downregulating the activity of Raf-1 kinase. Raf-1 and Hsp70 compete for binding to Bag1, such that Bag1 binds to and activates Raf-1, subsequently activating the downstream extracellular signal-related kinases	SEN:10020122	11231577
BEL:20034062	complex(p(HGNC:REL),p(HGNC:RELA)) increases r(HGNC:F3)	LPS-induced monocyte TF expression is regulated through a 56-bp promoter region (2227 through 2172 bp) containing 2 activator protein-1 (AP-1) binding sites and a nuclear factor (NF)-kB binding site, elements that bind c-fos/c-jun and c-Rel/p65 heterodimers, respectively.8,9 LPS-induced TF expression in cells of the monocyte lineage requires functional interaction between these transcription factors.10	SEN:10019998	11208679
BEL:20034066	complex(p(HGNC:RPA1),p(HGNC:TP53)) decreases complex(p(HGNC:RPA2),p(HGNC:RPA3),p(HGNC:RPA1),a(CHEBI:"single-stranded DNA"))	<s7> The binding of RPA to p53 inhibits the binding of RPA to ssDNA (Dutta et al., 1993) and the binding of p53 to its promoter sites (Miller et al., 1997).	SEN:10020132	10436023
BEL:20034068	complex(p(HGNC:RPA1),p(HGNC:TP53)) decreases tscript(p(HGNC:TP53))	<s7> The binding of RPA to p53 inhibits the binding of RPA to ssDNA (Dutta et al., 1993) and the binding of p53 to its promoter sites (Miller et al., 1997).	SEN:10020132	10436023
BEL:20034080	complex(p(HGNC:SHC1),p(HGNC:GRB2)) increases gtp(p(HGNC:HRAS))	Phosphorylation of Shc produces its binding to the adaptor protein Grb2, causing activation of the protooncogene ras, which is also upstream of the MAP kinase pathway.	SEN:10020136	11239409
BEL:20034088	complex(p(HGNC:SIRPA),p(HGNC:JAK2),p(HGNC:PTPN11)) decreases p(HGNC:JAK2,pmod(P))	SIRP is a transmembrane protein that is now known to bind to integrin-associated protein. It appears to bind directly to JAK2 by a process that does not require tyrosyl phosphorylation, although is itself highly phosphorylated on tyrosines in response to GH. The phosphorylated SIRP recruits one or more molecules of the tyrosine phosphatase SHP2 that, in turn, de-phosphorylates SIRP and most likely JAK2.	SEN:10020042	11036942
BEL:20034090	complex(p(HGNC:SIRPA),p(HGNC:JAK2),p(HGNC:PTPN11)) decreases p(HGNC:SIRPA,pmod(P))	SIRP is a transmembrane protein that is now known to bind to integrin-associated protein. It appears to bind directly to JAK2 by a process that does not require tyrosyl phosphorylation, although is itself highly phosphorylated on tyrosines in response to GH. The phosphorylated SIRP recruits one or more molecules of the tyrosine phosphatase SHP2 that, in turn, de-phosphorylates SIRP and most likely JAK2.	SEN:10020042	11036942
BEL:20034092	complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:FBXO5),p(HGNC:BTRC)) directlyIncreases complex(p(HGNC:BTRC),p(HGNC:CTNNB1))	Mutations at the signal-induced phosphorylation site of beta-catenin inhibited its association with FWD1.	SEN:10020138	10228155
BEL:20034094	complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:FBXW11),p(HGNC:RBX1)) increases deg(p(HGNC:NFKBIA))	Consistent with this, these reagents also eliminate the ability of the Skp1-CUL1-HOS-ROC1 E3 ligase complex to support the ubiquitination of IkappaBalpha.	SEN:10020140	10748083
BEL:20034096	complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:FBXW11),p(HGNC:RBX1)) increases p(HGNC:NFKBIA,pmod(U))	Consistent with this, these reagents also eliminate the ability of the Skp1-CUL1-HOS-ROC1 E3 ligase complex to support the ubiquitination of IkappaBalpha.	SEN:10020140	10748083
BEL:20034106	complex(p(HGNC:SMAD2),p(HGNC:SMAD3),p(HGNC:SMAD4),p(HGNC:SP1)) directlyIncreases r(HGNC:CDKN2B)	p15(Ink4B) induction was mediated by a TGF-beta-induced complex of Smad2, Smad3, Smad4 and Sp1. Smad3 interacted indirectly with Sp1 through its association with Smad2 and/or Smad4, and bound directly to the p15(Ink4B) promoter.	SEN:10020146	11013220
BEL:20034116	complex(p(HGNC:SP1),p(HGNC:NOLC1)) decreases tscript(p(HGNC:SP1))	<E27> p107 inhibits Sp1-dependent transcription. Binding of p107 to Sp1 seems to inhibit the binding of Sp1 to DNA (Datta et al., 1995).	SEN:10020152	10436023
BEL:20034118	complex(p(HGNC:SP1),p(HGNC:SMAD2)) directlyIncreases tscript(p(HGNC:SP1))	In the nucleoprotein complex, Smad2 interacted through its C-domain with Sp1 and enhanced the DNA binding and transcriptional activity of Sp1	SEN:10005360	11013220
BEL:20034128	complex(p(HGNC:STAT5A),p(HGNC:STAT5A)) increases tscript(p(HGNC:STAT5A))	Introduction of an additional mutation (Y694F) to STAT5A-N642H, which disrupted critical tyrosine 694 required for dimerization of STAT5, abolished all the activities manifested by the mutant STAT5A-N642H, which indicates that dimerization is required for the activity of STAT5A-N642H as was the case for the wild-type STAT5A. T	SEN:10005366	10823841
BEL:20034130	complex(p(HGNC:TCF3),p(HGNC:HLF)) increases r(HGNC:SNAI2)	In a search for E2A-HLF-responsive genes, we identified a zinc finger transcription factor, SLUG, whose product belongs to the Snail family of developmental regulatory proteins.	SEN:10005368	10518215
BEL:20034136	complex(p(HGNC:TNF),p(HGNC:TNFRSF1A)) directlyIncreases cat(p(HGNC:TNFRSF1A))	In contrast, the expression of cyclin D and E and the phosphorylation of Rb protein were not affected by ectopic expression of the drs gene, suggesting that an Rb-independent downregulation of cyclin A is involved in the suppression of anchorage-independent growth by means of the drs gene.	SEN:10005370	10490811
BEL:20034138	complex(p(HGNC:TNFSF10),p(HGNC:TNFRSF10B)) directlyIncreases cat(p(HGNC:TNFRSF10B))	Both sensitive and resistant cell lines expressed TRAIL death receptor (DR5), adapter protein Fas-associated death domain (FADD), and caspase-8; but resistant cell lines expressed 2-fold higher levels of the apoptosis inhibitor phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes-15 kDa (PED/PEA-15).	SEN:10020158	11221847
BEL:20034146	complex(p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53)) increases tscript(p(HGNC:TP53))	<p17> Ser392 phosphorylation of P53 increases 10-fold the association constant for tetramerization, but this effect is reversed by Ser315 phosphorylation. The tetramerization activates P53 for specific DNA binding and transcription	SEN:10020166	10436023
BEL:20034154	complex(p(HGNC:VEGFA),p(HGNC:FLT1)) directlyIncreases kin(p(HGNC:FLT1))	VEGFR1 does appear to mediate VEGF- and PIGF-induced tissue factor expression and chemotaxis in monocytes, a cell type that expresses only VEGFR1	SEN:10020108	11350732
BEL:20034156	complex(p(HGNC:VEGFA),p(HGNC:FLT1),p(HGNC:KDR)) decreases kin(p(HGNC:KDR))	VEGFR1 functions as a negative regulator of VEGFR2 a soluble form of the extracellular VEGFR1 domain occurs naturally, and overexpression of this form, but not of an artificial soluble VEGFR2, inhibits VEGF-induced migration and proliferation of HUVECs by forming an inactive complex with VEGF and the full-length VEGFR2	SEN:10020170	11350732
BEL:20034160	complex(p(HGNC:VTN),p(HGNC:ITGAV),p(HGNC:ITGB3)) increases kin(p(HGNC:KDR))	VEGFR2 associates selectively with alphaVbeta3 integrin and VEGF mitogenicity and receptor activity were enhanced by endothelial adhesion to the alphaVbeta3 ligand vitronectin	SEN:10020172	11350732
BEL:20034162	complex(p(HGNC:XRCC1),p(HGNC:LIG3)) directlyIncreases cat(p(HGNC:LIG3))	POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates.	SEN:10018604	10583946
BEL:20034172	complex(p(HGNC:YWHAB),p(HGNC:HDAC4)) decreases cat(p(HGNC:HDAC4))	These results indicate that 14-3-3 proteins negatively regulate HDAC4 by preventing its nuclear localization and thereby uncover a novel regulatory mechanism for HDACs.	SEN:10005378	10958686
BEL:20034186	complex(p(MGI:Apob),a(CHEBI:lipid)) directlyIncreases sec(p(MGI:Apob))	apoB has a prolonged interaction with translocon-associated proteins and completion of translation may be delayed until a lipid-associated signal for secretion occurs provides a potential mechanism for regulation of translocation by lipid availability	SEN:10020184	12006608
BEL:20034188	complex(p(MGI:Apob),a(CHEBI:lipid)) increases tloc(p(MGI:Apob),GOCCID:0005737,GOCCID:0005788)	regulation at the level of elongation a profound decrease in apoB synthesis with no change in apoB mRNA abundance decreased synthesis could be explained by a prolonged elongation rate for apoB the elongation of apoB mRNA in HepG2 cells slows when translocation of nascent apoB across the endoplasmic reticulum is inhibited by preventing Mttp-associated transfer of lipids to the nascent polypeptide	SEN:10020186	12006608
BEL:20034192	complex(p(MGI:Arrb2),p(MGI:Ldlr)) directlyIncreases cat(p(MGI:Ldlr))	We conclude that beta-arrestin2 can bind to and enhance endocytosis of the LDLR, both in vitro and in vivo, and may thereby influence lipoprotein metabolism	SEN:10005380	12944399
BEL:20034194	complex(p(MGI:Asxl1),p(MGI:Rara)) decreases bp(GOBP:"cell proliferation")	stable expression of ASXL1 increased the expression of endogenous RA-regulated genes and enhanced the antiproliferative potential of RA. Overall, these results suggest that ASXL1 is a novel coactivator of RAR that cooperates with SRC-1 and implicates it as a potential antitumor target of RA in RA-resistant cancer cells.	SEN:10005382	16606617
BEL:20034196	complex(p(MGI:Asxl1),p(MGI:Rara)) directlyIncreases cat(p(MGI:Rara))	Systematic binding assays showed that the C-terminal nuclear receptor box (LVMQLL) of ASXL1 and the activation function-2 activation domain (AF-2 AD) core of the RAR are critical for ligand-dependent interaction	SEN:10005384	16606617
BEL:20034198	complex(p(MGI:Atf1),p(MGI:Creb1)) increases r(MGI:Hspa5)	ER stress induces CREB1 phosphorylation and ATF1/CREB1 binding to the Grp78 promoter. Through the use of adenoviral vector expression systems, we provide evidence that when ATF4 function is suppressed and its binding partners are not able to compensate for its function, Grp78 induction by Tg and Tu is partially inhibited.	SEN:10018096	12871976
BEL:20034214	complex(p(MGI:Bcl2),p(MGI:Bid)) directlyIncreases cat(p(MGI:Bid))	Another subset characterized by the BH3 peptides from BAD and BIK cannot directly activate BAX, BAK but instead binds antiapoptotic BCL-2, resulting in the displacement of BID-like BH3 domains that initiate mitochondrial dysfunction.	SEN:10020198	12242151
BEL:20034234	complex(p(MGI:Ccna1),p(MGI:Cdk2)) directlyIncreases kin(p(MGI:Cdk2))	CDK2-cyclin A1/E1 and CDK1-cyclin B1 phosphorylate BARD1 on its NH(2) terminus in vivo and in vitro.	SEN:10005396	15665273
BEL:20034236	complex(p(MGI:Ccnb1),p(MGI:Cdk2)) increases kin(p(MGI:Cdk2))	CDK2-cyclin A1/E1 and CDK1-cyclin B1 phosphorylate BARD1 on its NH(2) terminus in vivo and in vitro.	SEN:10005396	15665273
BEL:20034238	complex(p(MGI:Ccnd1),p(MGI:Cdk6)) decreases bp(GOBP:"Wnt receptor signaling pathway")	hus, the CCND1-CDK6 complex is like to negatively regulate Wnt signaling by mediating beta-catenin phosphorylation and its subsequent degradation in Wnt-stimulated cells.	SEN:10005398	17208333
BEL:20034242	complex(p(MGI:Ccne1),p(MGI:Cdk2)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	We further show that cyclin E-CDK2-dependent phosphorylation of p27 results in elimination of p27 from the cell, allowing cells to transit from G1 to S phase.	SEN:10020208	9192873
BEL:20034244	complex(p(MGI:Ccne1),p(MGI:Cdk2)) directlyIncreases kin(p(MGI:Cdk2))	TGF-beta inhibits Cdk2-cyclin E kinase activity by promoting the binding of cell cycle inhibitor Kip1 protein to the kinase complexes.	SEN:10020210	14676846
BEL:20034246	complex(p(MGI:Ccne1),p(MGI:Cdk2)) directlyIncreases kin(p(MGI:Cdk2))	CDK2-cyclin A1/E1 and CDK1-cyclin B1 phosphorylate BARD1 on its NH(2) terminus in vivo and in vitro.	SEN:10005396	15665273
BEL:20034250	complex(p(MGI:Ccng1),p(MGI:Mdm2)) increases deg(p(MGI:Trp53))	These results suggest that cyclin G1 stabilizes and promotes the degradation of p53 protein by associating, respectively, with MDM2 complexes containing ARF and PP2A.	SEN:10005402	12167164
BEL:20034256	complex(p(MGI:Cd244),p(MGI:Cd48)) increases bp(GOBP:"cell proliferation")	Furthermore, 2B4/CD48 interactions between NK cells also enhanced proliferation of NK cells in response to IL-2	SEN:10020214	15210772
BEL:20034272	complex(p(MGI:Cd40lg),p(MGI:Cd40)) increases complex(p(MGI:Il12a),p(MGI:Il12b))	Furthermore, blocking CD40/CD40L interactions with blocking Ab decreased BAL production of Th1-mediators (IL-12 and TNF-alpha).	SEN:10005410	11207316
BEL:20034274	complex(p(MGI:Cd40lg),p(MGI:Cd40)) increases p(MGI:Tnf)	Furthermore, blocking CD40/CD40L interactions with blocking Ab decreased BAL production of Th1-mediators (IL-12 and TNF-alpha).	SEN:10005410	11207316
BEL:20034276	complex(p(MGI:Cd74),p(MGI:Mif)) increases p(MGI:Rb1,pmod(P))	After receptor binding, the intracellular signalling cascade is activated via the ERK-MAP kinase pathway, resulting in increased cell proliferation via cyclin D1 transcription and subsequent phosphorylation of the Rb gene [16] .	SEN:10020222	18791328
BEL:20034278	complex(p(MGI:Cd74),p(MGI:Mif)) increases r(MGI:Ccnd1)	After receptor binding, the intracellular signalling cascade is activated via the ERK-MAP kinase pathway, resulting in increased cell proliferation via cyclin D1 transcription and subsequent phosphorylation of the Rb gene [16] .	SEN:10020222	18791328
BEL:20034296	complex(p(MGI:Cdkn1b),p(MGI:Ccne1),p(MGI:Cdk2)) decreases kin(p(MGI:Cdk2))	We show that p27 interacts with cyclin E-CDK2 in at least two distinct ways: one resulting in p27 phosphorylation and release, the other in tight binding and cyclin E-CDK2 inhibition.	SEN:10020230	9192873
BEL:20034300	complex(p(MGI:Cebpa),p(MGI:Cdk2)) decreases bp(GOBP:"cell proliferation")	Cyclin D3-cdk4/cdk6 specifically phosphorylate C/EBPalpha at Ser193 in vitro and in the liver and support growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.	SEN:10005400	16537903
BEL:20034302	complex(p(MGI:Cebpa),p(MGI:Smarca2)) decreases bp(GOBP:"cell proliferation")	Cyclin D3-cdk4/cdk6 specifically phosphorylate C/EBPalpha at Ser193 in vitro and in the liver and support growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.	SEN:10005400	16537903
BEL:20034304	complex(p(MGI:Cebpb),p(MGI:Casp1)) decreases cat(p(MGI:Casp1))	C/EBPbeta-PThr(217) and the phosphorylation mimic C/EBPbeta-Glu(217), but not C/EBPbeta-Ala(217), were associated with procaspases 1 and 8 in vivo and in vitro and inhibited their activation.	SEN:10020234	11684016
BEL:20034306	complex(p(MGI:Cebpb),p(MGI:Casp8)) decreases cat(p(MGI:Casp8))	C/EBPbeta-PThr(217) and the phosphorylation mimic C/EBPbeta-Glu(217), but not C/EBPbeta-Ala(217), were associated with procaspases 1 and 8 in vivo and in vitro and inhibited their activation.	SEN:10020234	11684016
BEL:20034308	complex(p(MGI:Cebpb),p(MGI:Nfe2l1)) directlyDecreases r(MGI:Dspp)	Nrf1 has also been reported to function as a repressor of transcription. The dentin sialophosphoprotein (DSPP) gene encodes DSP and DPP, which are expressed in terminally differentiated odontoblast. In undifferentiated odontoblast, Nrf1 interacts with C/EBP-? to repress DSPP expression.	SEN:10020236	19665035
BEL:20034312	complex(p(MGI:Chat),p(MGI:Bcar1)) increases cat(p(MGI:Rap1a))	proposed a novel role for the Chat-Cas complex in controlling cell adhesion via the activation of Rap1	SEN:10019522	12432078
BEL:20034320	complex(p(MGI:Clock),p(MGI:Arntl)) increases r(MGI:Wee1)	from full text - Three E-box elements were found within 1.2 kb of the mouse wee1 gene 5-upstream region (Fig. 3B). CLOCK and BMAL1 together, but neither of them alone, produced a major increase in transcriptional activity through this fragment in transfected NIH3T3 cells	SEN:10020242	12934012
BEL:20034328	complex(p(MGI:Cnot7),p(MGI:Btg1)) decreases bp(GOBP:"cell proliferation")	formation of the hCAF-1/BTG1 complex is driven by phosphorylation at BTG1 (Ser-159) and implicates this complex in the signalling events of cell division that lead to changes in cellular proliferation associated with cell-cell contact.	SEN:10005420	9820826
BEL:20034334	complex(p(MGI:Crebbp),p(MGI:Mitf)) directlyIncreases tscript(p(MGI:Mitf))	E1A acting to partition CBP p300 from Mitf and thereby reduce its ability to activate transcription.	SEN:10020244	10898786
BEL:20034336	complex(p(MGI:Cry1),p(MGI:Per1)) decreases tscript(complex(p(MGI:Clock),p(MGI:Arntl)))	when CRY and PER proteins accumulate to a critical threshold, they act as transcriptional repressors of their own genes by attenuating activity of clock and bmal1	SEN:10020246	14551421
BEL:20034338	complex(p(MGI:Cry2),p(MGI:Per2)) decreases tscript(complex(p(MGI:Clock),p(MGI:Arntl)))	when CRY and PER proteins accumulate to a critical threshold, they act as transcriptional repressors of their own genes by attenuating activity of clock and bmal1	SEN:10020246	14551421
BEL:20034342	complex(p(MGI:Ctnnb1),p(MGI:Cdh1)) increases bp(GOBP:"cell adhesion")	Activated KRAS is known to induce tyrosine phosphorylation of beta-catenin, leading to its release from E-cadherin at the adherens junction	SEN:10005428	17030180
BEL:20034348	complex(p(MGI:Ctnnb1),p(MGI:Cdh5)) decreases bp(GOBP:"regulation of vascular permeability")	Disruption of the -catenin/VE-cadherin complex increased monolayer permeability, as shown in Fig. 5B.	SEN:10020250	17317723
BEL:20034356	complex(p(MGI:Dapk1),p(MGI:Unc5b)) directlyIncreases kin(p(MGI:Dapk1))	Thus, the pair netrin-1/UNC5H2 may regulate cell fate by controlling the proapoptotic kinase activity of DAP-kinase.	SEN:10019806	15729359
BEL:20034368	complex(p(MGI:Egf),p(MGI:Egfr)) directlyIncreases kin(p(MGI:Egfr))	EGF strongly inhibited the expression of WDNM1 and SGP-2 genes. Our recent results are reviewed and discussed.	SEN:10005438	9854140
BEL:20034370	complex(p(MGI:Egf),p(MGI:Egfr)) increases r(MGI:Mmp14)	The delayed lung maturation characterized by abnormal branching and poor alveolization in EGFR(-/-) is accompanied by aberrant expression of MMP's. Inhibition of MMP's in developing lungs in vivo or in vitro severely retarded morphogenesis.	SEN:10020254	11865039
BEL:20034374	complex(p(MGI:Egln1),p(MGI:Hif1a)) directlyIncreases deg(p(MGI:Hif1a))	As a consequence, the degradation of HIF-1alpha was inhibited as determined by impaired degradation of a reporter protein containing the HIF-1alpha oxygen-dependent degradation domain encompassing the PHD-targeted prolines.	SEN:10005442	16815840
BEL:20034382	complex(p(MGI:Ep300),p(MGI:Mitf)) directlyIncreases tscript(p(MGI:Mitf))	E1A acting to partition CBP p300 from Mitf and thereby reduce its ability to activate transcription.	SEN:10020244	10898786
BEL:20034384	complex(p(MGI:Ep300),p(MGI:Myod1)) directlyIncreases tscript(p(MGI:Myod1))	PCAF and p300 have also been demonstrated to function as critical coactivators for the muscle-specific basic helix-loop-helix (bHLH) protein MyoD during myogenic commitment.	SEN:10005448	10817756
BEL:20034398	complex(p(MGI:Fcer1a),p(MGI:Fcer1g)) increases a(CHEBI:"sphingosine 1-phosphate")	As discussed earlier, S1P is rapidly generated and secreted by mast cells following FcepsilonRI aggregation81,100.	SEN:10020258	16470226
BEL:20034402	complex(p(MGI:Fcer1a),p(MGI:Fcer1g)) increases sec(a(CHEBI:"sphingosine 1-phosphate"))	As discussed earlier, S1P is rapidly generated and secreted by mast cells following FcepsilonRI aggregation81,100.	SEN:10020258	16470226
BEL:20034410	complex(p(MGI:Gipc1),p(MGI:Myo6),p(MGI:Ntrk2)) directlyIncreases kin(p(MGI:Ntrk2))	Moreover, BDNF-mediated enhancement of glutamate release from presynaptic terminals depended not only upon TrkB but also upon Myo6 and GIPC1.	SEN:10005462	16819522
BEL:20034420	complex(p(MGI:"H2-T23"),p(MGI:Ins2)) increases bp(GOBP:"inflammatory response")	Specific binding of Ins II to Qa-1b was confirmed by a CTL peptide-blocking assay. Demonstration of IFN-gamma-regulated Qa-1 expression in beta cells and identification of a Qa-1-binding peptide in the preproinsulin leader sequence invoke further consideration of possible roles of Qa-1 in the progression of islet inflammation.	SEN:10020268	9708188
BEL:20034424	complex(p(MGI:Hdac4),p(MGI:Mef2d)) decreases tscript(p(MGI:Mef2d))	HDAC4 interacts with the SUMO E2 conjugating enzyme Ubc9 and is itself sumoylated HDAC4 stimulates MEF2 sumoylation in a reconstituted system in vitro	SEN:10020270	16166628
BEL:20034436	complex(p(MGI:Hspb8),p(MGI:Pgm1)) directlyIncreases cat(p(MGI:Pgm1))	To test the biochemical relevance of this interaction, PGM activity was measured in the heart from wild type and transgenic mice, showing a 20% increase of Vmax in the transgenic group, without change in KM.	SEN:10005468	15543936
BEL:20034444	complex(p(MGI:Igf1),p(MGI:Igf1r)) increases kin(p(MGI:Igf1r))	Thus, IGFBP-4.7A results in greater growth inhibition than equivalent levels of native IGFBP-4 in vivo, demonstrating a role for IGFBP-4 proteolysis in the regulation of IGF-I action.	SEN:10005472	11923290
BEL:20034448	complex(p(MGI:Igf2r),p(MGI:Igf2)) increases cat(p(MGI:Igf2r))	IGF2R/IGF-II-deficient mice have elevated levels of circulating IGF binding protein (IGFBP)-3 and show a strong IGFBP-6 immunoreactivity in all pancreatic islet cells	SEN:10019226	10226807
BEL:20034452	complex(p(MGI:Igf2r),p(MGI:Igf2)) directlyIncreases tport(p(MGI:Igf2r))	Igf2r can titrate extracellular levels of Igf2, and so regulate the growth-promoting function of Igf2.	SEN:10020284	11311167
BEL:20034456	complex(p(MGI:Ikbkg),p(MGI:Irs1)) directlyIncreases tloc(p(MGI:Ikbkg),GOCCID:0005737,GOCCID:0005634)	In this study, we report nuclear factor kappaB essential modulator (NEMO)/IKK-gamma subunit accumulation in membrane ruffles followed by an interaction with IRS-1.	SEN:10005476	16754954
BEL:20034458	complex(p(MGI:Il10),p(MGI:Il10ra)) directlyIncreases cat(p(MGI:Il10ra))	Here we show that IL-10 directly affects progenitor myeloid cells by protecting them from death following the removal of growth factors.	SEN:10019228	11591769
BEL:20034460	complex(p(MGI:Il12a),p(MGI:Il12b)) increases a(CHEBI:hydroxyproline)	the IL-12 recipient mice had significantly less (p? 0.05) hydroxyproline deposition in the lung compared with the WT recipient mice.	SEN:10020286	11207316
BEL:20034464	complex(p(MGI:Il12a),p(MGI:Il12b)) increases bp(GOBP:"inflammatory response")	The anti-IL-12 antibody treatment decreased the number of apoptotic cells and the degree of inflammation and fibrosis in lung tissue	SEN:10000214	11350791
BEL:20034466	complex(p(MGI:Il12a),p(MGI:Il12b)) increases bp(GOBP:"T-helper 1 type immune response")	CyCAP is a widely expressed secreted glycoprotein that modulates the host response to endotoxin gene-targeted CyCAP-deficient mice are more sensitive to the lethal effects of endotoxin in response to endotoxin, CyCAP-deficient mice overproduce interleukin 12 and interferon-gamma systemically and tumor necrosis factor alpha locally, these are proinflammatory molecules that also promote T helper 1 responses	SEN:10020288	10077627
BEL:20034468	complex(p(MGI:Il12a),p(MGI:Il12b)) increases bp(GOBP:"apoptotic process")	The anti-IL-12 antibody treatment decreased the number of apoptotic cells and the degree of inflammation and fibrosis in lung tissue	SEN:10000214	11350791
BEL:20034472	complex(p(MGI:Il12a),p(MGI:Il12b)) increases kin(p(MGI:Map2k3))	To determine whether activation of p38 MAPK by IL-12 occurred via characterized MAPK kinases, we analyzed the ability of IL-12 to induce phosphorylation of MAPK kinases known to phosphorylate p38 MAPK, including MKK3, MKK6, and MKK4 (24, 25, 26, 27). Using an Ab that detects phosphorylation of MKK3 and MKK6, activation of MKK3/6 was detected following IL-12 stimulation (Fig. 5).	SEN:10020292	10903740
BEL:20034474	complex(p(MGI:Il12a),p(MGI:Il12b)) increases kin(p(MGI:Map2k6))	To determine whether activation of p38 MAPK by IL-12 occurred via characterized MAPK kinases, we analyzed the ability of IL-12 to induce phosphorylation of MAPK kinases known to phosphorylate p38 MAPK, including MKK3, MKK6, and MKK4 (24, 25, 26, 27). Using an Ab that detects phosphorylation of MKK3 and MKK6, activation of MKK3/6 was detected following IL-12 stimulation (Fig. 5).	SEN:10020292	10903740
BEL:20034476	complex(p(MGI:Il12a),p(MGI:Il12b)) increases kin(p(MGI:Mapk14))	In this report we demonstrate that IL-12 activates mitogen-activated protein kinase kinase 3/6 (MKK) and p38 mitogen-activated protein kinase (MAPK), but not p44/42 (ERK) or stress-activated protein kinase/c-Jun N-terminal kinase MAPK. The activation of p38 MAPK is required for normal induction of IFN-gamma mRNA and IFN-gamma secretion by IL-12 in activated T cells and Th1 cells.	SEN:10020294	10903740
BEL:20034478	complex(p(MGI:Il12a),p(MGI:Il12b)) increases path(MESHD:Atherosclerosis)	the injection of IFNG, or the IFNG-releasing factors IL12 and -18 enhances the extent of the disease in apoE-/- mice (36, 39, 40)	SEN:10020296	16293001
BEL:20034484	complex(p(MGI:Il12a),p(MGI:Il12b)) increases p(MGI:Atf2,pmod(P,T,71))	Fig. 8 demonstrates that there was a 4-fold increase in ATF-2 phosphorylation following IL-12 stimulation, but no corresponding increase in ATF-1 or CREB phosphorylation.	SEN:10020300	10903740
BEL:20034490	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Ctss)	Mice treated with i.p. injection of recombinant murine IL-18 or IL-12 expressed significantly higher pulmonary mRNA levels of the matrix degrading enzymes metalloproteinase (MMP) 12 and cathepsin S	SEN:10005482	22908875
BEL:20034492	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Fasl)	The upregulation of FasL, IL-12Rbeta2, and tumor necrosis factor-alpha mRNA expression in lung tissue was suppressed by anti-IL-12 antibody treatment	SEN:10005484	11350791
BEL:20034494	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Gzmg)	IL-12 drives high expression of IL-12Rß2, but little IL-23R, consistent with the ability of these cells to respond to IL-12 (Fig. 4 A).IFN-{gamma} and granzyme G expression was also significantly increased.	SEN:10020304	15657292
BEL:20034496	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Ifng)	IL-12 drives high expression of IL-12Rß2, but little IL-23R, consistent with the ability of these cells to respond to IL-12 (Fig. 4 A).IFN-{gamma} and granzyme G expression was also significantly increased.	SEN:10020304	15657292
BEL:20034498	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Il12rb2)	The upregulation of FasL, IL-12Rbeta2, and tumor necrosis factor-alpha mRNA expression in lung tissue was suppressed by anti-IL-12 antibody treatment	SEN:10005484	11350791
BEL:20034500	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Il12rb2)	IL-12 drives high expression of IL-12Rß2, but little IL-23R, consistent with the ability of these cells to respond to IL-12 (Fig. 4 A).IFN-{gamma} and granzyme G expression was also significantly increased.	SEN:10020304	15657292
BEL:20034502	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Mmp12)	Mice treated with i.p. injection of recombinant murine IL-18 or IL-12 expressed significantly higher pulmonary mRNA levels of the matrix degrading enzymes metalloproteinase (MMP) 12 and cathepsin S	SEN:10005482	22908875
BEL:20034506	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Tnf)	The upregulation of FasL, IL-12Rbeta2, and tumor necrosis factor-alpha mRNA expression in lung tissue was suppressed by anti-IL-12 antibody treatment	SEN:10005484	11350791
BEL:20034508	complex(p(MGI:Il12a),p(MGI:Il12b)) increases r(MGI:Twist1)	Upon restimulation of Th1 cells, cells cultured in the absence of IL-12 showed a 12-fold increase in the expression of twist1, as compared with a 16-fold increase in the presence of IL-12 (Fig. 2 E).	SEN:10020306	18663125
BEL:20034522	complex(p(MGI:Il12b),p(MGI:Il23a)) increases p(MGI:Il17a)	IL-17 and IL-17F were found to be derived mainly from lung CD4+ T cells, and were increased upon IL-23 stimulation in vitro....In vivo blocking of IL-23p19 alone or in combination with IL-23/IL-12p40 resulted in a significant reduction of Mp-induced IL-17 protein and IL-17/IL-17F mRNA expression,	SEN:10005494	17198762
BEL:20034530	complex(p(MGI:Il12b),p(MGI:Il23a)) increases p(MGI:Il17f)	IL-17 and IL-17F were found to be derived mainly from lung CD4+ T cells, and were increased upon IL-23 stimulation in vitro....In vivo blocking of IL-23p19 alone or in combination with IL-23/IL-12p40 resulted in a significant reduction of Mp-induced IL-17 protein and IL-17/IL-17F mRNA expression,	SEN:10005494	17198762
BEL:20034538	complex(p(MGI:Il12b),p(MGI:Il23a)) decreases r(MGI:Foxp3)	However, in CD4+ T cells from naive mice, IL-23 significantly increased the TGFbeta1/IL-6-induced Th17 polarization, including elevated levels of IL-17A and IL-17F and decreased expression of T-bet and FoxP3. Of note, the IL-23-induced increase in IL-17A and IL-17F levels was prevented in T-bet-deficient mice.	SEN:10020312	20131264
BEL:20034540	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Il17a)	IL-17 and IL-17F were found to be derived mainly from lung CD4+ T cells, and were increased upon IL-23 stimulation in vitro....In vivo blocking of IL-23p19 alone or in combination with IL-23/IL-12p40 resulted in a significant reduction of Mp-induced IL-17 protein and IL-17/IL-17F mRNA expression,	SEN:10005494	17198762
BEL:20034542	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Il17a)	However, in CD4+ T cells from naive mice, IL-23 significantly increased the TGFbeta1/IL-6-induced Th17 polarization, including elevated levels of IL-17A and IL-17F and decreased expression of T-bet and FoxP3. Of note, the IL-23-induced increase in IL-17A and IL-17F levels was prevented in T-bet-deficient mice.	SEN:10020312	20131264
BEL:20034544	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Il17f)	IL-17 and IL-17F were found to be derived mainly from lung CD4+ T cells, and were increased upon IL-23 stimulation in vitro....In vivo blocking of IL-23p19 alone or in combination with IL-23/IL-12p40 resulted in a significant reduction of Mp-induced IL-17 protein and IL-17/IL-17F mRNA expression,	SEN:10005494	17198762
BEL:20034546	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Il17f)	However, in CD4+ T cells from naive mice, IL-23 significantly increased the TGFbeta1/IL-6-induced Th17 polarization, including elevated levels of IL-17A and IL-17F and decreased expression of T-bet and FoxP3. Of note, the IL-23-induced increase in IL-17A and IL-17F levels was prevented in T-bet-deficient mice.	SEN:10020312	20131264
BEL:20034548	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Il22)	CD4(+) T cells were the main source of IL-22 in the small intestinal lamina propria. Thus, IL-23 regulates small intestinal inflammation via IL-22 but independent of IL-17	SEN:10020314	19995958
BEL:20034550	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Il22)	In contrast to TGFbeta1/IL-6, IL-23 was critical for the induction of IL-22 in CD4+ T cells from both naive and CII-immunized DBA/1 mice.	SEN:10005500	20131264
BEL:20034552	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Il23r)	Conversely, IL-23 drives high mRNA expression of IL-23R, but little IL-12Rß2, consistent with the ability of these cells to respond to IL-23 (Fig. 4 A).	SEN:10020316	15657292
BEL:20034554	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Itga3)	Integrin-{alpha}3, which enhances cellular migration within the target organ during inflammation (18), was also up-regulated in the IL-23?driven cells	SEN:10020318	15657292
BEL:20034556	complex(p(MGI:Il12b),p(MGI:Il23a)) increases r(MGI:Mmp2)	We report interleukin (IL)-23-mediated gelatinase A (matrixmetalloproteinase [MMP]-2) up-regulation in the ileum of infected mice.	SEN:10020320	19995958
BEL:20034560	complex(p(MGI:Il1r1),p(MGI:Irak1)) increases tloc(p(MGI:Irak1),GOCCID:0005886,GOCCID:0005634)	Upon stimulation of cells with interleukin-1 (IL-1) the IL-1 receptor type I (IL-1RI) associated kinase-1 (IRAK-1) transiently associates to and dissociates from the IL-1RI and thereafter translocates into the nucleus.	SEN:10005502	15896328
BEL:20034562	complex(p(MGI:Il1rl1),p(MGI:Myd88)) directlyDecreases complex(p(MGI:Myd88),p(MGI:Tlr4))	ST2 has been shown to sequester MyD88 (an adaptor molecule necessary for PAMP activation of cells) away from TLR4 thereby blunting LPS-induced activation of mouse macrophages [23].	SEN:10020322	20958987
BEL:20034564	complex(p(MGI:Il23a),p(MGI:Il1b)) decreases r(MGI:Tbx21)	: In CD4+ T cells from naive DBA/1 mice, IL-23 alone hardly induced retinoic acid-related orphan receptor gammat (RORgammat), Th17 polarization, and Th17 cytokines, but it inhibited T-bet expression.	SEN:10005504	20131264
BEL:20034566	complex(p(MGI:Il2),p(MGI:Il2ra)) directlyIncreases complex(p(MGI:Il2rb),p(MGI:Il2rb))	IL-2-mediated hetero-dimerization of its receptor triggers a rapid increase in the recruitment of Jak3 and activation of both Jak1 and Jak3	SEN:10019244	10851055
BEL:20034568	complex(p(MGI:Il2),p(MGI:Il2rb)) increases p(MGI:Bcl2)	Interleukin 2 (IL-2)- and IL-4-mediated stimulation of survival and growth, reflected by the induction of bcl2 and c-myc, respectively, depends on the integrity of the membrane-proximal region (S-region) in the IL-2 receptor beta-chain (IL-2R beta) and the haematopoietin homology box1-containing region of the IL-4 receptor alpha-chain (IL-4R alpha).	SEN:10020324	9619370
BEL:20034570	complex(p(MGI:Il2),p(MGI:Il2rb)) increases r(MGI:Fos)	IL-2 induces the expression of c-fos and c-jun family genes, mediated by the acidic region (A-region) within the cytoplasmic domain of IL-2R beta.	SEN:10020326	9619370
BEL:20034572	complex(p(MGI:Il2),p(MGI:Il2rb)) increases r(MGI:Jun)	IL-2 induces the expression of c-fos and c-jun family genes, mediated by the acidic region (A-region) within the cytoplasmic domain of IL-2R beta.	SEN:10020326	9619370
BEL:20034574	complex(p(MGI:Il2rb),p(MGI:Il2rb)) directlyIncreases cat(p(MGI:Il2rb))	IL-2-mediated hetero-dimerization of its receptor triggers a rapid increase in the recruitment of Jak3 and activation of both Jak1 and Jak3	SEN:10019244	10851055
BEL:20034580	complex(p(MGI:Il4),p(MGI:Il4ra)) increases p(MGI:Myc)	Interleukin 2 (IL-2)- and IL-4-mediated stimulation of survival and growth, reflected by the induction of bcl2 and c-myc, respectively, depends on the integrity of the membrane-proximal region (S-region) in the IL-2 receptor beta-chain (IL-2R beta) and the haematopoietin homology box1-containing region of the IL-4 receptor alpha-chain (IL-4R alpha).	SEN:10020324	9619370
BEL:20034588	complex(p(MGI:Il6),p(MGI:Il6ra)) increases bp(GOBP:"osteoclast differentiation")	when Il6 and Il6R were combined, significant stimulation of both mineral and matrix release from bone explants was noted	SEN:10020330	12218157
BEL:20034596	complex(p(MGI:Il6),p(MGI:Il6ra)) decreases r(MGI:Tnfrsf11a)	Il6 plus Il6R enhanced the expression of RANKL and OPG in calvarial bones, but decreased RANK expression	SEN:10020336	12218157
BEL:20034598	complex(p(MGI:Il6),p(MGI:Il6ra)) increases r(MGI:Tnfrsf11b)	Il6 plus Il6R enhanced the expression of RANKL and OPG in calvarial bones, but decreased RANK expression	SEN:10020336	12218157
BEL:20034600	complex(p(MGI:Il6),p(MGI:Il6ra)) increases r(MGI:Tnfsf11)	Il6 plus Il6R enhanced the expression of RANKL and OPG in calvarial bones, but decreased RANK expression	SEN:10020336	12218157
BEL:20034602	complex(p(MGI:Il6),p(MGI:Il6ra)) increases tscript(p(MGI:Stat3))	It hasrecently been reported that a cytosolic isoform of PTPepsilon (PTPepsilonC) whenover-expressed in murine M1 myeloid cells inhibits interleukin-6 (IL-6)- and leukemia inhibitory factor-induced activation of Janus kinases (JAKs), thereby suppressing STAT3 tyrosine phosphorylation and STAT3 signaling.	SEN:10020332	11698287
BEL:20034604	complex(p(MGI:Il6st),p(MGI:Hck)) increases bp(GOBP:"cell proliferation")	identification of an acidic domain of gp130 as a binding region for Hck, which mediates proliferative signaling the deletion of this region of gp130 resulted in a significant reduction of Hck kinase activity and cell proliferation upon stimulation of gp130 compared to wild-type gp130	SEN:10019254	11689697
BEL:20034608	complex(p(MGI:Il6st),p(MGI:Socs3)) decreases p(MGI:Ptpn11,pmod(P,Y))	in Il6 signal cascade, the SHP2 interaction site of gp130 has also been shown to be a Socs3 contact site so that Socs3 may compete for the SHP2-gp130 interaction site	SEN:10020340	12110143
BEL:20034610	complex(p(MGI:Inhba),p(MGI:Inhba)) increases r(MGI:Fshb)	Expression of the FSHbeta subunit and GnRH receptor (GnRHR) genes in gonadotropes is stimulated by activin.	SEN:10005512	10098536
BEL:20034612	complex(p(MGI:Inhba),p(MGI:Inhba)) increases r(MGI:Gnrhr)	Expression of the FSHbeta subunit and GnRH receptor (GnRHR) genes in gonadotropes is stimulated by activin.	SEN:10005512	10098536
BEL:20034614	complex(p(MGI:Ins1),p(MGI:Insr)) directlyIncreases kin(p(MGI:Insr))	Direct addition of GM3 ganglioside to 3T3-L1 adipocytes was shown to suppress insulin-stimulated phosphorylation of the insulin receptor (6).	SEN:10019628	12629211
BEL:20034622	complex(p(MGI:Irs3),p(MGI:Ptpn11)) increases bp(GOBP:"MAPK cascade")	Others are themselves enzymes, including the phosphotyrosine phosphatase SHP2 and the cytoplasmic tyrosine kinase Fyn.	SEN:10020342	11742412
BEL:20034624	complex(p(MGI:Irs3),p(MGI:Ptpn11)) directlyIncreases phos(p(MGI:Ptpn11))	Others are themselves enzymes, including the phosphotyrosine phosphatase SHP2 and the cytoplasmic tyrosine kinase Fyn.	SEN:10020342	11742412
BEL:20034628	complex(p(MGI:Itga5),p(MGI:Itgb1)) increases kin(p(MGI:Ptk2))	Stimulation with protein I/II resulted in an increasing amount of phosphorylated FAK (Fig. 1A), which was detectable within 5 min and remained elevated for at least 30 min.	SEN:10020346	15905587
BEL:20034634	complex(p(MGI:Itgb6),p(MGI:Tgfb1)) directlyIncreases p(MGI:Tgfb1)	We have shown previously that the epithelial-restricted integrin alpha(v)beta6 has another critical function; that is, it binds and activates latent transforming growth factor-beta (TGF-beta).	SEN:10020350	12634787
BEL:20034638	complex(p(MGI:Jun),p(MGI:Mitf)) increases tscript(p(MGI:Jun))	The binding of +-MITF to c-Jun enhanced the transactivation of MMCP-7 gene, and that of mi-MITF suppressed the transactivation.	SEN:10005520	11157480
BEL:20034640	complex(p(MGI:Jun),p(MGI:Mitf)) directlyIncreases tscript(p(MGI:Mitf))	The binding of +-MITF to c-Jun enhanced the transactivation of MMCP-7 gene, and that of mi-MITF suppressed the transactivation.	SEN:10005520	11157480
BEL:20034642	complex(p(MGI:Kat2b),p(MGI:Myod1)) directlyIncreases tscript(p(MGI:Myod1))	PCAF and p300 have also been demonstrated to function as critical coactivators for the muscle-specific basic helix-loop-helix (bHLH) protein MyoD during myogenic commitment.	SEN:10005448	10817756
BEL:20034660	complex(p(MGI:Lpl),p(MGI:Apoc2)) directlyIncreases cat(p(MGI:Lpl))	LPL, which acts as a homodimeric enzyme requires apoCII as a cofactor and is produced in a large number of tissues.	SEN:10020356	11852057
BEL:20034662	complex(p(MGI:Lpl),p(MGI:Lpl)) directlyIncreases cat(p(MGI:Lpl))	LPL, which acts as a homodimeric enzyme requires apoCII as a cofactor and is produced in a large number of tissues.	SEN:10020356	11852057
BEL:20034664	complex(p(MGI:Lrp1),p(MGI:Mmp9),p(MGI:Timp1)) decreases cat(p(MGI:Mmp9))	In vitro assays reveal that the MMP-9.TIMP-1 complex binds to LRP with high affinity and that the binding determinant for LRP appears to reside on MMP-9.	SEN:10020358	11279011
BEL:20034666	complex(p(MGI:Lrp1),p(MGI:Mmp9),p(MGI:Timp1)) decreases p(MGI:Mmp9)	In vitro assays reveal that the MMP-9.TIMP-1 complex binds to LRP with high affinity and that the binding determinant for LRP appears to reside on MMP-9.	SEN:10020358	11279011
BEL:20034672	complex(p(MGI:Map2k5),p(MGI:Mapk7)) increases complex(p(MGI:Map3k2),p(MGI:Map2k5))	mutations in the ERK5 docking site that prevent Map2k5/ERK5 interaction also abrogate the ability of Map3k2 to bind and activate Map2k5.	SEN:10020362	16260599
BEL:20034674	complex(p(MGI:Map2k5),p(MGI:Mapk7)) increases kin(p(MGI:Map2k5))	mutations in the ERK5 docking site that prevent Map2k5/ERK5 interaction also abrogate the ability of Map3k2 to bind and activate Map2k5.	SEN:10020362	16260599
BEL:20034676	complex(p(MGI:Map2k5),p(MGI:Mapk7)) increases tscript(p(MGI:Mef2a))	The formation of the Map2k5/extracellular signal-regulated kinase 5 (ERK5) complex is critical for Map2k5 to activate ERK5, to increase transcription via MEF2, and to enhance cellular survival in response to osmotic stress.	SEN:10020360	16260599
BEL:20034680	complex(p(MGI:Mdm2),p(MGI:Trp53)) increases deg(p(MGI:Trp53))	Regulation of the stability of p53 is key to its tumor-suppressing activities. mdm2 directly binds to the amino-terminal region of p53 and targets it for degradation through the ubiquitin-proteasome pathway.	SEN:10005532	11278372
BEL:20034682	complex(p(MGI:Med23),p(MGI:Elk1)) increases tscript(p(MGI:Elk1))	We show here that for the mouse Egr1 gene, controlled largely by MAP kinase phosphorylation of the ELK1 transcription factor, the MED23 Mediator subunit that interacts with phospho-ELK1 is also required to stimulate Pol II initiation at a step subsequent to preinitiation complex assembly.	SEN:10020364	15749018
BEL:20034710	complex(p(MGI:Mttp),p(MGI:Pdia2)) increases sec(p(MGI:Apob))	Mttp activity is required for apoB lipoprotein assembly and secretion Mttp is a heterodimer consisting of protein-disulfide isomerase and a large subunit that transfers neutral lipids between membranes	SEN:10020378	12006608
BEL:20034726	complex(p(MGI:Myom1),p(MGI:Itgb1)) increases bp(GOBP:"cell adhesion")	title := \"Identification of an interaction between the m-band protein skelemin and beta-integrin subunits. Colocalization of a skelemin-like protein with beta1- and beta3-integrins in non-muscle cells.\"	SEN:10020386	9857037
BEL:20034728	complex(p(MGI:Myom1),p(MGI:Itgb3)) increases bp(GOBP:"cell adhesion")	title := \"Identification of an interaction between the m-band protein skelemin and beta-integrin subunits. Colocalization of a skelemin-like protein with beta1- and beta3-integrins in non-muscle cells.\"	SEN:10020386	9857037
BEL:20034736	complex(p(MGI:Nfe2l1),p(MGI:Mafg)) increases r(MGI:"Hba-a1")	Human MafG heterodimerizes with p45 NF-E2 and binds DNA with specificity identical to that of purified NF-E2 DNA binding activity. A tethered heterodimer of p45 and MafG is fully functional in supporting expression of alpha- and beta-globin, and in promoting erythroid differentiation in CB3, a p45-deficient mouse erythroleukemia cell line	SEN:10005544	9166829
BEL:20034738	complex(p(MGI:Nfe2l1),p(MGI:Mafg)) increases r(MGI:"Hbb-b1")	Human MafG heterodimerizes with p45 NF-E2 and binds DNA with specificity identical to that of purified NF-E2 DNA binding activity. A tethered heterodimer of p45 and MafG is fully functional in supporting expression of alpha- and beta-globin, and in promoting erythroid differentiation in CB3, a p45-deficient mouse erythroleukemia cell line	SEN:10005544	9166829
BEL:20034748	complex(p(MGI:Nfkb1),p(MGI:Rxra)) decreases tscript(p(MGI:Nfkb1))	In this study, we found that retinoids inhibit this LPS-stimulated production of IL-12 in a dose-dependent manner. The NFkappaB components p50 and p65 bound retinoid X receptor (RXR) in a ligand-independent manner in vitro, and the interaction interfaces involved the p50 residues 1-245, the p65 residues 194-441, and the N-terminal A/B/C domains of RXR.	SEN:10020396	10075655
BEL:20034750	complex(p(MGI:Nfkb1),p(MGI:Rxrb)) decreases tscript(p(MGI:Nfkb1))	In this study, we found that retinoids inhibit this LPS-stimulated production of IL-12 in a dose-dependent manner. The NFkappaB components p50 and p65 bound retinoid X receptor (RXR) in a ligand-independent manner in vitro, and the interaction interfaces involved the p50 residues 1-245, the p65 residues 194-441, and the N-terminal A/B/C domains of RXR.	SEN:10020396	10075655
BEL:20034752	complex(p(MGI:Nfkb2),p(MGI:Rxra)) decreases tscript(p(MGI:Nfkb2))	In this study, we found that retinoids inhibit this LPS-stimulated production of IL-12 in a dose-dependent manner. The NFkappaB components p50 and p65 bound retinoid X receptor (RXR) in a ligand-independent manner in vitro, and the interaction interfaces involved the p50 residues 1-245, the p65 residues 194-441, and the N-terminal A/B/C domains of RXR.	SEN:10020396	10075655
BEL:20034754	complex(p(MGI:Nfkb2),p(MGI:Rxrb)) decreases tscript(p(MGI:Nfkb2))	In this study, we found that retinoids inhibit this LPS-stimulated production of IL-12 in a dose-dependent manner. The NFkappaB components p50 and p65 bound retinoid X receptor (RXR) in a ligand-independent manner in vitro, and the interaction interfaces involved the p50 residues 1-245, the p65 residues 194-441, and the N-terminal A/B/C domains of RXR.	SEN:10020396	10075655
BEL:20034758	complex(p(MGI:Npnt),p(MGI:Itga8),p(MGI:Itgb1)) increases bp(GOBP:"cell adhesion")	These results suggest that POEM is a novel ligand for alpha(8)beta(1) integrin and that POEM may be involved in the development and function of various tissues, such as kidney, bone, muscles, and endocrine organs.	SEN:10004212	11546798
BEL:20034762	complex(p(MGI:Nppa),p(MGI:Npr3)) decreases p(MGI:Nppa)	Mesangial cells from nonobese diabetic (NOD) mice (D-NOD) that develop diabetes at 2-4 mo express an increased density of atrial natriuretic peptide (ANP) clearance receptors [natriuretic peptide C receptor (NPR-C)] and produce less GMP in response to ANP than their nondiabetic counterparts (ND-NOD).	SEN:10005548	11457715
BEL:20034768	complex(p(MGI:Nr1h4),p(MGI:Rxra)) increases r(MGI:Apoc2)	recombinant Fxr and Rxr bind to 2 Fxr response elements that are contained within 2 important distal enhancer elements that are upstream of the transcription start site of the apoC2 gene	SEN:10020398	11579204
BEL:20034770	complex(p(MGI:Nr1h4),p(MGI:Rxrb)) increases r(MGI:Apoc2)	recombinant Fxr and Rxr bind to 2 Fxr response elements that are contained within 2 important distal enhancer elements that are upstream of the transcription start site of the apoC2 gene	SEN:10020398	11579204
BEL:20034772	complex(p(MGI:Nr1h4),p(MGI:Rxrg)) increases r(MGI:Apoc2)	recombinant Fxr and Rxr bind to 2 Fxr response elements that are contained within 2 important distal enhancer elements that are upstream of the transcription start site of the apoC2 gene	SEN:10020398	11579204
BEL:20034778	complex(p(MGI:Nr3c1),p(MGI:Ncoa2)) increases tscript(p(MGI:Nr3c1))	In contrast, activated glucocorticoid receptor (GR) preferentially associated with SRC-2 (TIF-2/GRIP-1), which subsequently recruited pCAF and led to specific modification of histone H3, suggesting that specific coactivators recruit distinct histone acetyltransferases to modulate the transcription of steroid-responsive genes.	SEN:10020402	12748280
BEL:20034780	complex(p(MGI:Nr3c1),p(MGI:Rela)) decreases complex(p(MGI:Irf3),p(MGI:Rela))	The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation	SEN:10005552	16143103
BEL:20034782	complex(p(MGI:Nr3c1),p(MGI:Rela)) decreases complex(p(MGI:Irf7),p(MGI:Rela))	The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation	SEN:10005552	16143103
BEL:20034784	complex(p(MGI:Nr4a2),p(MGI:Pias4)) decreases p(MGI:Th)	Co-expression of PIASgamma with Nurr1 results in a potent repression of Nurr1-dependent transcriptional activation of an artificial NGFI-B response element (NBRE) reporter as well as of a reporter driven by the native tyrosine hydroxylase promoter.	SEN:10005554	14559918
BEL:20034786	complex(p(MGI:Nr4a2),p(MGI:Pias4)) decreases tscript(p(MGI:Nr4a2))	Co-expression of PIASgamma with Nurr1 results in a potent repression of Nurr1-dependent transcriptional activation of an artificial NGFI-B response element (NBRE) reporter as well as of a reporter driven by the native tyrosine hydroxylase promoter.	SEN:10005554	14559918
BEL:20034796	complex(p(MGI:Odc1),p(MGI:Odc1)) directlyIncreases cat(p(MGI:Odc1))	From introduction Az1 binds the ODC monomer, dissociating the enzymatically active ODC homodimer and thereby inhibiting its activity	SEN:10020406	12562772
BEL:20034806	complex(p(MGI:Pgr),p(MGI:Src)) increases p(MGI:Crebbp)	Upon ligand treatment, progesterone receptor (PR) interacted preferentially with SRC-1, which recruited CBP and significantly enhanced acetylation at K5 of histone H4.	SEN:10020414	12748280
BEL:20034808	complex(p(MGI:Pgr),p(MGI:Src)) increases p(MGI:Hist4h4,pmod(A,K,5))	Upon ligand treatment, progesterone receptor (PR) interacted preferentially with SRC-1, which recruited CBP and significantly enhanced acetylation at K5 of histone H4.	SEN:10020414	12748280
BEL:20034816	complex(p(MGI:Polr2a),p(MGI:Wwp2)) directlyIncreases deg(p(MGI:Polr2a))	We found that Wwp2 specifically interacted with mouse Rpb1 and targeted it for ubiquitination both in vitro and in vivo	SEN:10005204	17526739
BEL:20034818	complex(p(MGI:Pou2af1),p(MGI:Pou2f1)) directlyIncreases tscript(p(MGI:Pou2f1))	We have identified genes both induced and repressed by BOB.1/OBF.1. Using different genetic systems, we demonstrate regulation of a selection of these genes. Identified targets included genes encoding Ahd2-like, AKR1C13, Rbp1, Sdh, Idh2, protocadherin gamma, alpha-catenin, Ptprs, Id3, and Creg.	SEN:10005564	12947107
BEL:20034820	complex(p(MGI:Pou2f2),p(MGI:Pou2af1)) increases tscript(p(MGI:Pou2f2))	We have identified genes both induced and repressed by BOB.1/OBF.1. Using different genetic systems, we demonstrate regulation of a selection of these genes. Identified targets included genes encoding Ahd2-like, AKR1C13, Rbp1, Sdh, Idh2, protocadherin gamma, alpha-catenin, Ptprs, Id3, and Creg.	SEN:10005564	12947107
BEL:20034824	complex(p(MGI:Ppara),p(MGI:Lpl)) increases r(MGI:Lpl)	Incubation of murine J774 macrophages with high glucose concentrations increased the expression of PPARalpha at the mRNA and protein levels and enhanced nuclear protein binding to the peroxisome proliferator responsive element of the LPL promoter...Lpl is upregulated by glucose	SEN:10017312	10634806
BEL:20034832	complex(p(MGI:Ppargc1a),p(MGI:Foxo1)) increases bp(GOBP:gluconeogenesis)	FoxO1 interacts with the co-activator PGC-1 (peroxisome proliferative activated receptor-g co-activator) and this interaction is important for the expression of gluconeogenic genes in liver cells (Puigserver et al., 2003).	SEN:10020420	18391970
BEL:20034834	complex(p(MGI:Pparg),p(MGI:Rxra)) increases r(MGI:Aqp7)	The gel mobility shift assay showed the direct binding of PPARgamma-retinoid Xreceptor alpha complex to the PPRE.	SEN:10020422	11679588
BEL:20034840	complex(p(MGI:Ppp1r13b),p(MGI:Socs6)) directlyDecreases deg(p(MGI:Socs6))	In contrast, SOCS-6-associated p85 was not degraded and could be recruited to the newly synthesized SOCS-6 molecules in the presence of insulin, suggesting that SOCS-6 expression and its interaction with p85, but not the degradation, is regulated by insulin.	SEN:10003438	15123678
BEL:20034842	complex(p(MGI:Prdx1),p(MGI:Abl1)) directlyDecreases kin(p(MGI:Abl1))	Pag, also known as MSP23 and peroxiredoxin-1 Pag, a member of the peroxiredoxin family, has been reported previously to bind to and inhibit the cytostatic properties of the c-Abl oncoprotein.	SEN:10019474	12196529
BEL:20034848	complex(p(MGI:Prkcz),p(MGI:Pawr)) decreases kin(p(MGI:Prkcz))	We have reported that ceramide mediates binding of atypical protein kinase C (PKC) zeta to its inhibitor protein, PAR-4 (prostate apoptosis response-4), thereby inducing apoptosis in differentiating embryonic stem cells.	SEN:10003320	15901738
BEL:20034858	complex(p(MGI:Ptpn11),p(MGI:Tek)) decreases bp(GOBP:"cell migration")	Angiopoietin-1 stimulates association of SHP-2 to the phosphorylated Tie-2 receptor (47), which in turn inhibits PI3 kinase-dependent signaling pathways leading to EC migration.	SEN:10020428	17511588
BEL:20034862	complex(p(MGI:Rab4a),p(MGI:Kif3a)) directlyIncreases cat(p(MGI:Kif3a))	(i) insulin signaling stimulates Rab4 activity, the association of Rab4 with kinesin, and the interaction of KIF3 with microtubules and (ii) this process is mediated by insulin-induced PI3-kinase-dependent PKC-lambda activation and participates in GLUT4 exocytosis in 3T3-L1 adipocytes.	SEN:10003440	12832475
BEL:20034870	complex(p(MGI:Rara),p(MGI:Klf5)) increases r(MGI:Pdgfa)	we determined that KLF5 interacted with the retinoic-acid receptor (RAR), that synthetic RAR ligands modulated KLF5 transcriptional activity,	SEN:10020432	12101409
BEL:20034900	complex(p(MGI:Rxrb),p(MGI:Vdr)) increases tscript(p(MGI:Vdr))	The repressive effect of Hr is observed on both synthetic and naturally-occurring VDR-responsive promoters, and also when VDR-mediated transactivation is augmented by overexpression of its heterodimeric partner, retinoid X	SEN:10000308	12847098
BEL:20034916	complex(p(MGI:Serpinb1a),p(MGI:Ctsg)) decreases cat(p(MGI:Ctsg))	Upon incubation with serine proteases, EIA formed inhibitory covalent complexes with pancreatic and neutrophil elastases, cathepsin G, proteinase-3, and chymotrypsin, as previously shown for MNEI, whereas EIB was only able to do so with cathepsin G.	SEN:10020458	12189154
BEL:20034918	complex(p(MGI:Serpinb1a),p(MGI:Prtn3)) decreases cat(p(MGI:Prtn3))	Upon incubation with serine proteases, EIA formed inhibitory covalent complexes with pancreatic and neutrophil elastases, cathepsin G, proteinase-3, and chymotrypsin, as previously shown for MNEI, whereas EIB was only able to do so with cathepsin G.	SEN:10020458	12189154
BEL:20034920	complex(p(MGI:Serpinb1b),p(MGI:Ctsg)) decreases cat(p(MGI:Ctsg))	Upon incubation with serine proteases, EIA formed inhibitory covalent complexes with pancreatic and neutrophil elastases, cathepsin G, proteinase-3, and chymotrypsin, as previously shown for MNEI, whereas EIB was only able to do so with cathepsin G.	SEN:10020458	12189154
BEL:20034934	complex(p(MGI:Sort1),p(MGI:Lpl)) directlyIncreases deg(p(MGI:Lpl))	The results demonstrate that sortilin is a multifunctional receptor that binds lipoprotein lipase and, when expressed on the cell surface, mediates its endocytosis and degradation.	SEN:10005588	10085125
BEL:20034958	complex(p(MGI:Taf9),p(MGI:Trp53)) directlyDecreases deg(p(MGI:Trp53))	The coactivator protein TAF(II)31 binds to p53 at the amino-terminal region that is also required for interaction with mdm2. In this report, we demonstrate that expression of TAF(II)31 inhibits mdm2-mediated ubiquitination of p53 and increases p53 levels.	SEN:10005602	11278372
BEL:20034960	complex(p(MGI:Taf9),p(MGI:Trp53)) directlyIncreases tscript(p(MGI:Trp53))	TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts.	SEN:10020470	11278372
BEL:20034962	complex(p(MGI:Tfdp1),p(MGI:Cdkn2a)) decreases complex(p(MGI:Tfdp1),p(MGI:E2f1))	Interestingly, binding of ARF to DP1 results in an inhibition of the interaction between DP1 and E2F1.	SEN:10020472	16135794
BEL:20034964	complex(p(MGI:Tfdp1),p(MGI:Cdkn2a)) decreases tscript(complex(p(MGI:Tfdp1),p(MGI:E2f1)))	Moreover, we provide evidence that ARF inhibits the E2F-activated genes independently of p53 and Mdm2.	SEN:10005604	16135794
BEL:20034968	complex(p(MGI:Tgfb1),p(MGI:Tgfbr1)) increases complex(p(MGI:Tgfb1),p(MGI:Tgfbr1),p(MGI:Tgfbr2))	Further work revealed that TGF-R signaling (Massague and Wotton, 2000) was required for EMT, invasion in vitro, and metastasis in vivo,	SEN:10020476	11790801
BEL:20034970	complex(p(MGI:Tgfb1),p(MGI:Tgfbr1)) increases p(MGI:Elk3)	Moreover, TGF-beta 1 significantly increased endogenous Elk-3 mRNA levels that had been down-regulated by LPS in macrophages. This increase in Elk-3 correlated with a TGF-beta 1-induced down-regulation of NOS2.	SEN:10005606	12896968
BEL:20034972	complex(p(MGI:Tgfb1),p(MGI:Tgfbr1)) decreases p(MGI:Nos2)	Moreover, TGF-beta 1 significantly increased endogenous Elk-3 mRNA levels that had been down-regulated by LPS in macrophages. This increase in Elk-3 correlated with a TGF-beta 1-induced down-regulation of NOS2.	SEN:10005606	12896968
BEL:20034974	complex(p(MGI:Tgfb1),p(MGI:Tgfbr1),p(MGI:Tgfbr2)) directlyIncreases kin(p(MGI:Tgfbr1))	Further work revealed that TGF-R signaling (Massague and Wotton, 2000) was required for EMT, invasion in vitro, and metastasis in vivo,	SEN:10020476	11790801
BEL:20034976	complex(p(MGI:Tgfb1),p(MGI:Tgfbr2)) increases cat(p(MGI:Tgfbr2))	We also found that TGF-beta can stimulate the expression of Foxa1 in Hnf6(+/+) cells and that inhibition of TGF-beta signaling in Hnf6(-/-) cells down-regulates the expression of Foxa1.	SEN:10020478	15562441
BEL:20034980	complex(p(MGI:Tlk2),p(MGI:Ywhaz)) decreases tloc(p(MGI:Tlk2),GOCCID:0005737,GOCCID:0005634)	PKUalpha has been found by coimmunoprecipitation to bind to 14-3-3zeta in vivo. Transfection of cells with a dominant negative form of 14-3-3eta promotes the nuclear localization of PKUalpha.	SEN:10000058	10455159
BEL:20034984	complex(p(MGI:Tnf),p(MGI:Tnfrsf1b)) directlyIncreases cat(p(MGI:Tnfrsf1b))	TNF (1ng/ml, 15min) stimulated SRC phosphorylation (Tyr 416) and activation through TNFR2 in Young adult mouse colon cells (YAMC) and Mouse colon epithelial (MCER1-/-) cells (lacking TNFR1). Src specific inhibitors PD-161430, PP1 or PP2 blocked TNF induced cell migration. Loss of TNFR2 (MCER2-/- cells) inhibited SRC activation.	SEN:10019764	12466150
BEL:20034988	complex(p(MGI:Tnfrsf1a),p(MGI:Ern1)) directlyIncreases cat(p(MGI:Tnfrsf1a))	We also found that TNFR1 functions downstream of IRE1 and that IRE1 is present in the same complex with TNFR1 under ER stress condition. Therefore, our study shows a novel role of TNFR1 in mediating ER stress-induced JNK activation.	SEN:10004132	16680093
BEL:20034990	complex(p(MGI:Tnfsf13),p(MGI:Fas)) increases bp(GOBP:"apoptotic process")	this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM.	SEN:10020480	9743536
BEL:20034992	complex(p(MGI:Tnfsf13),p(MGI:Tnfrsf14)) increases bp(GOBP:"apoptotic process")	this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM.	SEN:10020480	9743536
BEL:20035018	complex(p(MGI:Ttr),p(MGI:Rbp4)) directlyIncreases p(MGI:Rbp4)	To circumvent the possibility of developmental or compensatory effects of RBP4 overexpression in transgenic mice, we purified recombinant human RBP4 and injected it into normal, adult FVB mice. RBP4 is a 21-kDa protein that is easily filtered through the renal glomerular membrane. In the circulation, RBP4 binds transthyretin (TTR) to form an 80-kDa protein complex that prevents renal clearance of RBP4 (ref. 20).	SEN:10020488	16034410
BEL:20035034	complex(p(MGI:Vdr),p(MGI:Rxra)) directlyIncreases tscript(p(MGI:Vdr))	The repressive effect of Hr is observed on both synthetic and naturally-occurring VDR-responsive promoters, and also when VDR-mediated transactivation is augmented by overexpression of its heterodimeric partner, retinoid X	SEN:10000308	12847098
BEL:20035038	complex(p(MGI:Vhl),p(MGI:Polr2a)) increases deg(p(MGI:Polr2a))	we show biochemical evidence that pVHL specifically binds the hyperphosphorylated Rpb1 in a proline-hydroxylation-dependent manner, targeting it for ubiquitination. This interaction is regulated by UV radiation.	SEN:10020498	12604794
BEL:20035050	complex(p(MGI:Wwp2),p(MGI:Pou5f1)) directlyIncreases deg(p(MGI:Pou5f1))	We describe here a novel murine ubiquitin ligase, Wwp2, that specifically interacts with Oct-4 and promotes its ubiquitination both in vivo and in vitro.	SEN:10000346	15047715
BEL:20035052	complex(p(MGI:Yy1),p(MGI:Rb1)) decreases tscript(p(MGI:Yy1))	These observations suggest that the interaction of YY1 with hypophosphorylated Rb in resting B cells prevents interaction of YY1 with DNA. After stimulation with class-switching activators, such as LPS, Rb becomes hyperphosphorylated and YY1 is released and can then bind to the hs3 enhancer and E mu.	SEN:10005624	12759432
BEL:20035056	complex(p(MGI:Zfp346),p(MGI:Trp53)) directlyIncreases tscript(p(MGI:Trp53))	JAZ associates with p53 to stimulate its transcriptional activity in p53-expressing cells, but not in p53-null cells unless complemented with p53. JAZ functions to mediate G1 cell-cycle arrest followed by apoptosis in a p53-dependent mechanism	SEN:10020506	16931621
BEL:20035680	deg(p(HGNC:CDKN1A)) decreases p(HGNC:CDKN1A)	TNF-alpha-induced apoptosis in LNCaP cells was accompanied by caspase-dependent proteolysis of p21/WAF1 and Rb, which was significantly attenuated in LN-56.	SEN:10001308	10773886
BEL:20035684	deg(p(HGNC:IGFBP3)) increases p(HGNC:IGF1)	ADAM 12-S has IGFBP-3 protease activity, and it may contribute to the IGFBP-3 protease activity present in pregnancy serum.	SEN:10004242	10849447
BEL:20035690	deg(p(HGNC:RB1)) decreases p(HGNC:RB1)	TNF-alpha-induced apoptosis in LNCaP cells was accompanied by caspase-dependent proteolysis of p21/WAF1 and Rb, which was significantly attenuated in LN-56.	SEN:10001308	10773886
BEL:20035692	deg(p(HGNC:SMAD2)) directlyDecreases tscript(p(HGNC:SMAD2))	Lo and Massagué1 found that the ubiquitination of Smad2 was achieved by certain E2 enzymes, including UbcH5b or UbcH5c and, to a lesser extent, Ubc3, but not by others, such as E2-20K.	SEN:10018716	10587654
BEL:20035696	deg(p(MGI:Ctnnb1)) decreases path(MESHD:Neoplasms)	As shown, GSK3b exists in a large complex with Axin, APC, and other components. Wild-type APC and Axin trigger beta-catenin degradation through recruitment of GSK3b to the Axin-APC scaffold, which provides for potent activation of GSK3b.	SEN:10020826	15225871
BEL:20035698	deg(p(MGI:Ctnnb1)) decreases tloc(p(MGI:Ctnnb1),GOCCID:0005737,GOCCID:0005634)	DeltaNp63alpha also associates with and blocks activation of the adenomatous polyposis coli (APC) destruction complex that targets free cytoplasmic beta-catenin for degradation.	SEN:10005730	14647429
BEL:20035702	deg(p(MGI:Igfbp4)) increases p(MGI:Igf1)	Thus, IGFBP-4.7A results in greater growth inhibition than equivalent levels of native IGFBP-4 in vivo, demonstrating a role for IGFBP-4 proteolysis in the regulation of IGF-I action.	SEN:10005472	11923290
BEL:20035704	deg(p(MGI:Il6)) decreases p(MGI:Il6)	The increase in IL-6 in septic DPPI(-/-) mice, which appears to protect these mice from death, may be related to reduced DPPI-mediated activation of mast cell tryptase and other peptidases, which we show cleave IL-6 in vitro.	SEN:10018984	14966572
BEL:20035706	deg(p(MGI:Pfkfb3)) decreases p(MGI:Pfkfb3)	the expression of the pfkfb3 gene in C2C12 cells and its downregulation during myogenic cell differentiation. We also show that the decrease of ubiquitous 6-phosphofructo-2-kinase isozyme levels, product of pfkfb3 gene, is due to its enhanced degradation through the ubiquitin-proteasome proteolytic pathway.	SEN:10005732	12935880
BEL:20035718	gtp(p(HGNC:ARF6)) increases sec(p(HGNC:CFD))	In contrast, the secretion of adipsin, a serine protease specifically expressed in adipocytes, was increased by the expression of wild-type ARF6 and was inhibited by the expression of D125N. These results indicate a requirement for ARF6 in basal and insulin-regulated adipsin secretion but not in glucose transport.	SEN:10020830	10464254
BEL:20035728	gtp(p(HGNC:CDC42)) increases cat(p(HGNC:WAS))	The activity of N-WASp is enhanced by the binding of effectors like Cdc42-guanosine 5'-3-O-(thio)triphosphate, phosphatidylinositol bisphosphate, or the Shigella IcsA protein. Here we show that the SH3-SH2-SH3 adaptor Grb2 is another activator of N-WASp that stimulates actin polymerization by increasing the amount of N-WASp. Arp2/3 complex.	SEN:10005738	10781580
BEL:20035730	gtp(p(HGNC:CDC42)) directlyIncreases complex(p(HGNC:CDC42),p(HGNC:WASL))	The activity of N-WASp is enhanced by the binding of effectors like Cdc42-guanosine 5'-3-O-(thio)triphosphate, phosphatidylinositol bisphosphate,	SEN:10019954	10781580
BEL:20035734	gtp(p(HGNC:CDC42)) increases kin(p(HGNC:AKT1))	We show that in Jurkat cells, activated forms of Rac1 or Cdc42, but not Rho, stimulate an increase in Akt/PKB activity.	SEN:10005740	10891487
BEL:20035744	gtp(p(HGNC:GNAQ)) decreases tloc(p(HGNC:RGS2),GOCCID:0005737,GOCCID:0005634)	Expression of activated G(q) increased RGS2 association with the plasma membrane and decreased accumulation in the nucleus, suggesting that signal-induced redistribution may regulate RGS2 function	SEN:10005742	11278586
BEL:20035746	gtp(p(HGNC:GNAQ)) increases tloc(p(HGNC:RGS2),GOCCID:0005737,GOCCID:0005886)	Expression of activated G(q) increased RGS2 association with the plasma membrane and decreased accumulation in the nucleus, suggesting that signal-induced redistribution may regulate RGS2 function	SEN:10005742	11278586
BEL:20035750	gtp(p(HGNC:HRAS)) decreases bp(GOBP:"apoptotic process")	In situ end-labeling detection showed that apoptotic cell death was significantly increased in cells with 5-day treatment of antisense H-ras oligodeoxynucleotide (34.0 +/- 4.5%) in comparing with cells without treatment (2.5 +/- 1.2%, t = 13.434, P < 0.01) or treated with non-specific antisense oligodeoxynucleotide (4.8 +/- 1.4%, t = 12.453, P < 0.01) at the corresponding time.	SEN:10020850	10791191
BEL:20035760	gtp(p(HGNC:HRAS)) increases r(HGNC:CCND1)	We found that TPO stimulation or Ha-Ras G12V expression led to up-regulation of cyclin D1, cyclin D2, and cyclin D3 expression.	SEN:10005746	10681535
BEL:20035762	gtp(p(HGNC:HRAS)) increases r(HGNC:CCND2)	We found that TPO stimulation or Ha-Ras G12V expression led to up-regulation of cyclin D1, cyclin D2, and cyclin D3 expression.	SEN:10005746	10681535
BEL:20035764	gtp(p(HGNC:HRAS)) increases r(HGNC:CCND3)	We found that TPO stimulation or Ha-Ras G12V expression led to up-regulation of cyclin D1, cyclin D2, and cyclin D3 expression.	SEN:10005746	10681535
BEL:20035770	gtp(p(HGNC:HRAS)) increases r(HGNC:MGAT5)	GnT-V transcription was stimulated by several oncogenes including src , her -2/ neu , H- ras , and v- sis (9 , 10 , 11) , and this overexpression was regulated through the ras-raf-ets pathways.	SEN:10020858	11029459
BEL:20035782	gtp(p(HGNC:KRAS)) increases r(HGNC:PTGS2)	K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1.	SEN:10005754	11289146
BEL:20035784	gtp(p(HGNC:KRAS)) decreases r(HGNC:SRPX)	We have previously reported that the drs gene, whose mRNA expression is downregulated by retroviral oncogenes such as v-src and v-K-ras, has the ability to suppress transformation by v-src in a rat cell line F2408.	SEN:10020862	10490811
BEL:20035804	gtp(p(HGNC:RAC1)) increases bp(GOBP:"cell adhesion")	Rac promotes cell cycle progression, an effect that correlates with its ability to organize the cytoskeleton and promote spreading, rather than with its ability to activate MAP kinases (63).	SEN:10020870	10446041
BEL:20035806	gtp(p(HGNC:RAC1)) increases bp(GOBP:"cell cycle")	Rac promotes cell cycle progression, an effect that correlates with its ability to organize the cytoskeleton and promote spreading, rather than with its ability to activate MAP kinases (63).	SEN:10020870	10446041
BEL:20035810	gtp(p(HGNC:RAC1)) increases bp(GOBP:"cell migration")	When applied locally to a passive cell edge, HA promoted the formation of lamellipodial protrusions in the direction of the stimulus. This process was inhibited by the prior injection of cells with dominant-negative N17Rac recombinant protein or by pretreatment of cells with monoclonal anti-CD44 antibodies, interfering with HA binding, implying the direct involvement of CD44 in signaling to Rac1.	SEN:10019862	10725329
BEL:20035814	gtp(p(HGNC:RAC1)) increases bp(GOBP:phagocytosis)	Furthermore, Iba1 colocalized with a small GTPase Rac in the membrane ruffles and the phagocytic cups. The Iba1 mutants also suppressed membrane ruffling induced by dominant active Rac1V12	SEN:10019910	10934045
BEL:20035824	gtp(p(HGNC:RAC1)) increases kin(p(HGNC:AKT1))	We show that in Jurkat cells, activated forms of Rac1 or Cdc42, but not Rho, stimulate an increase in Akt/PKB activity.	SEN:10005740	10891487
BEL:20035826	gtp(p(HGNC:RAC1)) increases kin(p(HGNC:MAP2K1))	Correspondingly, in vitro kinase assays showed that N17Rac1 inhibited the kinase activities of MEK1/2 and ERK1/2 stimulated by target signals (Fig. 4b).	SEN:10020878	11062502
BEL:20035828	gtp(p(HGNC:RAC1)) increases kin(p(HGNC:MAP2K2))	Correspondingly, in vitro kinase assays showed that N17Rac1 inhibited the kinase activities of MEK1/2 and ERK1/2 stimulated by target signals (Fig. 4b).	SEN:10020878	11062502
BEL:20035830	gtp(p(HGNC:RAC1)) increases kin(p(HGNC:MAPK1))	Correspondingly, in vitro kinase assays showed that N17Rac1 inhibited the kinase activities of MEK1/2 and ERK1/2 stimulated by target signals (Fig. 4b).	SEN:10020878	11062502
BEL:20035832	gtp(p(HGNC:RAC1)) increases kin(p(HGNC:MAPK3))	Correspondingly, in vitro kinase assays showed that N17Rac1 inhibited the kinase activities of MEK1/2 and ERK1/2 stimulated by target signals (Fig. 4b).	SEN:10020878	11062502
BEL:20035836	gtp(p(HGNC:RAC1)) increases kin(p(HGNC:PAK1))	Introduction of N17Rac1 into NK92 cells totally blocked PAK1 activation triggered by target ligation, whereas introduction of V12Rac1 strongly stimulated PAK1 activity even in the absence of target cells (Fig. 7d).	SEN:10020880	11062502
BEL:20035844	gtp(p(HGNC:RAC3)) increases bp(GOBP:"cell proliferation")	Rac3V12 expression significantly increased the incorporation of BrdUrd into nascent DNA (Fig. 3), emphasizing that transfection of active Rac3 drives epithelial cell proliferation.	SEN:10020884	10618392
BEL:20035846	gtp(p(HGNC:RAC3)) increases bp(GOBP:"DNA replication")	Rac3V12 expression significantly increased the incorporation of BrdUrd into nascent DNA (Fig. 3), emphasizing that transfection of active Rac3 drives epithelial cell proliferation.	SEN:10020884	10618392
BEL:20035848	gtp(p(HGNC:RAC3)) increases kin(p(HGNC:MAPK8))	Expression of either dominant-negative Rac3N17 or PBD F107 almost completely blocked Pak and JNK activities, demonstrating that Rac3 is upstream of these proteins (Fig. 4B).	SEN:10020886	10618392
BEL:20035850	gtp(p(HGNC:RAC3)) increases kin(p(HGNC:MAPK9))	Expression of either dominant-negative Rac3N17 or PBD F107 almost completely blocked Pak and JNK activities, demonstrating that Rac3 is upstream of these proteins (Fig. 4B).	SEN:10020886	10618392
BEL:20035852	gtp(p(HGNC:RAC3)) increases kin(p(HGNC:PAK1))	Expression of either dominant-negative Rac3N17 or PBD F107 almost completely blocked Pak and JNK activities, demonstrating that Rac3 is upstream of these proteins (Fig. 4B).	SEN:10020886	10618392
BEL:20035854	gtp(p(HGNC:RAC3)) increases kin(p(HGNC:PAK2))	Expression of either dominant-negative Rac3N17 or PBD F107 almost completely blocked Pak and JNK activities, demonstrating that Rac3 is upstream of these proteins (Fig. 4B).	SEN:10020886	10618392
BEL:20035856	gtp(p(HGNC:RAC3)) increases kin(p(HGNC:PAK2))	Pak activity was increased 4- to 6-fold in the three cell lines containing active Rac3 (Fig. 4A). This increased kinase activity was mainly associated with the Pak2 isoform, which can phosphorylate and positively regulate Raf-1 activity, another key component in cell proliferation (38-40)	SEN:10020888	10618392
BEL:20035866	gtp(p(HGNC:RHOA)) directlyIncreases kin(p(HGNC:ROCK1))	p160ROCK, a serine/threonine protein kinase, is a direct RhoA target mediating RhoA-induced assembly of focal adhesions and stress fibers.	SEN:10001530	10845663
BEL:20035886	gtp(p(MGI:Cdc42)) directlyIncreases kin(p(MGI:Prkcz))	Cdc42-mediated regulation of beta-catenin turnover was completely dependent on PKCzeta, which associated with Cdc42, Par6, and Par3.	SEN:10005768	16510873
BEL:20035902	gtp(p(MGI:Hras)) increases a(CHEBI:"reactive oxygen species")	In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS.	SEN:10020900	15369676
BEL:20035906	gtp(p(MGI:Hras)) increases bp(GOBP:"MAPK cascade")	Although inhibitors of PKC had no effect on this suppression, MAPK inhibitors completely prevented the TPA effect. RasGRP1 activates the MAPK pathway through activation of the small G protein H-Ras.	SEN:10004108	18077438
BEL:20035910	gtp(p(MGI:Hras)) increases cat(p(MGI:St6gal1))	The accumulation of the ST6Gal I transcript in response to activated Ras was accompanied by an increase of alpha2,6-sialyltransferase activity and of Neu5Acalpha2,6Gal at the cell surface.	SEN:10005770	15355339
BEL:20035916	gtp(p(MGI:Hras)) increases p(MGI:Mapk1,pmod(P,T))	Following depletion of both serum and Epo for 2 hours, p44/42 ERK (Phospho ERK1 (Thr202/Tyr204); phospho-ERK2 (Thr185/Tyr187)) remained active in H-ras.V12-transduced cells but not in the control cells. No difference was seen in the expression of total p44/42 ERK in the 2 populations of cells	SEN:10020904	15166036
BEL:20035918	gtp(p(MGI:Hras)) increases p(MGI:Mapk1,pmod(P,Y))	Following depletion of both serum and Epo for 2 hours, p44/42 ERK (Phospho ERK1 (Thr202/Tyr204); phospho-ERK2 (Thr185/Tyr187)) remained active in H-ras.V12-transduced cells but not in the control cells. No difference was seen in the expression of total p44/42 ERK in the 2 populations of cells	SEN:10020904	15166036
BEL:20035920	gtp(p(MGI:Hras)) increases p(MGI:Mapk3,pmod(P,T))	Following depletion of both serum and Epo for 2 hours, p44/42 ERK (Phospho ERK1 (Thr202/Tyr204); phospho-ERK2 (Thr185/Tyr187)) remained active in H-ras.V12-transduced cells but not in the control cells. No difference was seen in the expression of total p44/42 ERK in the 2 populations of cells	SEN:10020904	15166036
BEL:20035922	gtp(p(MGI:Hras)) increases p(MGI:Mapk3,pmod(P,Y))	Following depletion of both serum and Epo for 2 hours, p44/42 ERK (Phospho ERK1 (Thr202/Tyr204); phospho-ERK2 (Thr185/Tyr187)) remained active in H-ras.V12-transduced cells but not in the control cells. No difference was seen in the expression of total p44/42 ERK in the 2 populations of cells	SEN:10020904	15166036
BEL:20035924	gtp(p(MGI:Hras)) decreases p(MGI:Pawr)	Of potential functional relevance, the expression of Par-4 allows TNFalpha to induce apoptosis in NIH-3T3 cells. In addition, the down-regulation of Par-4 levels by oncogenic Ras sensitizes cells to TNFalpha-induced NF-kappaB activation.	SEN:10005774	10391896
BEL:20035932	gtp(p(MGI:Hras)) increases p(MGI:Spry2)	We compared human fibroblasts malignantly transformed by overexpression of H-Ras(V12) oncogene to their nontransformed parental cells and found that the malignant cells express a high level of Spry2.	SEN:10020908	18048363
BEL:20035936	gtp(p(MGI:Hras)) decreases r(MGI:Nfix)	Stable transfection of activated Ha-ras into a number of murine cells correlated with a down-regulation of the expression of the NF1 genes NF1/CTF and NF1/X.	SEN:10005778	8125955
BEL:20035938	gtp(p(MGI:Hras)) increases r(MGI:Plau)	Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.	SEN:10020912	10347197
BEL:20035940	gtp(p(MGI:Hras)) increases r(MGI:St6gal1)	Transformation by human K-Ras or H-Ras (S12 and V12 point mutations, respectively) results in a 10-fold increase in ST6Gal I mRNA, but no alteration in the expression of related sialyltransferases.	SEN:10020914	15355339
BEL:20035942	gtp(p(MGI:Hras)) decreases surf(p(MGI:Thy1))	When c-H-ras expression was induced with heavy metal ions there was a marked reduction in the expression of two glycosylphosphatidylinositol (GPI) anchored proteins, TAP/Ly-6A.2 and Thy-1, on the plasma membrane of the transformed cells.	SEN:10020916	1679532
BEL:20035946	gtp(p(MGI:Hras)) increases tscript(p(MGI:Rela))	e show here that oncogenic forms of Ha-Ras activate NF-kappaB, not through induced nuclear translocation, but rather through the activation of the transcriptional function of the NF-kappaB RelA/p65 subunit.	SEN:10005780	9305854
BEL:20035950	gtp(p(MGI:Kras)) increases cat(p(MGI:Ptgs2))	COX-2 protein and activity measured as prostaglandin E(2) level were up-regulated in cells expressing mutant K-ras(V12);	SEN:10001506	15284181
BEL:20035952	gtp(p(MGI:Kras)) increases cat(p(MGI:St6gal1))	The accumulation of the ST6Gal I transcript in response to activated Ras was accompanied by an increase of alpha2,6-sialyltransferase activity and of Neu5Acalpha2,6Gal at the cell surface.	SEN:10005770	15355339
BEL:20035954	gtp(p(MGI:Kras)) increases path(MESHD:Neoplasms)	Inactivation of Icmt inhibited cell growth and K-Ras-induced oncogenic transformation, both in soft agar assays and in a nude mice model.	SEN:10000336	14966563
BEL:20035970	gtp(p(MGI:Kras)) increases r(MGI:St6gal1)	Transformation by human K-Ras or H-Ras (S12 and V12 point mutations, respectively) results in a 10-fold increase in ST6Gal I mRNA, but no alteration in the expression of related sialyltransferases.	SEN:10020914	15355339
BEL:20035992	gtp(p(MGI:Rac1)) decreases bp(GOBP:"fat cell differentiation")	Constitutively active but not dominant-negative Rac inhibits differentiation when overexpressed in preadipocytes,	SEN:10005786	16154099
BEL:20035994	gtp(p(MGI:Rac1)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	We observed in primary mouse embryonic fibroblasts that deletion of rac1 by gene targeting, as well as expression of the constitutively active Rac1 mutant L61Rac1, led to decreased cell growth that was associated with altered cell cycle progression at both G(1)/S and G(2)/M phases, increased apoptosis, and premature senescence.	SEN:10020942	17032649
BEL:20036000	gtp(p(MGI:Rac1)) decreases bp(GOBP:"apoptotic process")	We observed in primary mouse embryonic fibroblasts that deletion of rac1 by gene targeting, as well as expression of the constitutively active Rac1 mutant L61Rac1, led to decreased cell growth that was associated with altered cell cycle progression at both G(1)/S and G(2)/M phases, increased apoptosis, and premature senescence.	SEN:10020942	17032649
BEL:20036006	gtp(p(MGI:Rac1)) decreases gtp(p(MGI:Rhoa))	it has been reported that Rac1 inhibits RhoA activity in a number of cell systems (Rottner et al., 1999; Sander et al., 1999)	SEN:10020946	19158396
BEL:20036018	gtp(p(MGI:Rac2)) increases a(CHEBI:"reactive oxygen species")	Rac GTPases regulate cytoskeletal structure, gene expression, and reactive oxygen species (ROS) production. Rac2-deficient neutrophils cannot chemotax, produce ROS, or degranulate upon G protein-coupled receptor (GPCR) activation.	SEN:10020950	16243035
BEL:20036020	gtp(p(MGI:Rac2)) increases bp(GOBP:chemotaxis)	Rac GTPases regulate cytoskeletal structure, gene expression, and reactive oxygen species (ROS) production. Rac2-deficient neutrophils cannot chemotax, produce ROS, or degranulate upon G protein-coupled receptor (GPCR) activation.	SEN:10020950	16243035
BEL:20036022	gtp(p(MGI:Rac2)) increases bp(GOBP:"neutrophil chemotaxis")	Rac GTPases regulate cytoskeletal structure, gene expression, and reactive oxygen species (ROS) production. Rac2-deficient neutrophils cannot chemotax, produce ROS, or degranulate upon G protein-coupled receptor (GPCR) activation.	SEN:10020950	16243035
BEL:20036026	gtp(p(MGI:Rac2)) increases kin(p(MGI:Mapk1))	hyperactivation of the extracellular signal-regulated kinase (ERK) via the hematopoietic-specific Rho GTPase, Rac2, directly contributes to the hyperproliferation of Nf1-deficient mast cells in vitro and in vivo	SEN:10001762	11435472
BEL:20036038	gtp(p(MGI:Ran)) increases bp(GOBP:"cell cycle")	Our results indicate that Ran has a cell cycle-dependent localization and may have regulatory roles in cell cycle progression and microtubule organization in mouse oocytes, fertilized eggs and early embryos.	SEN:10020956	16183861
BEL:20036050	gtp(p(MGI:Rap1a)) increases cat(p(MGI:Plce1))	Overall, these data indicate Rap activity is required for betaAR-mediated activation of PLCepsilon and places the Epac-Rap- PLCepsilon pathway downstream of betaAR stimulation.	SEN:10020962	17178726
BEL:20036052	gtp(p(MGI:Rap1a)) increases cat(p(MGI:Plce1))	The data in Figs. 1 and 2 provide strong evidence that the Epac/Rap/PLCepsilon pathway contributes to betaAR signaling in the heart.	SEN:10019526	17178726
BEL:20036058	gtp(p(MGI:Rhoa)) increases kin(p(MGI:Limk2))	Consequently, dominant-negative RhoA and RhoB mutants blocked TGF-beta1-induced actin reorganization. Because Rho GTPases are known to regulate the activity of LIM-kinases (LIMK), we found that TGF-beta1 induced LIMK2 phosphorylation with similar kinetics to Rho activation.	SEN:10020966	15647284
BEL:20036068	gtp(p(MGI:Rhoa)) increases p(MGI:Myl2,pmod(P))	Western blotting of WT cells expressing constitutively active RhoA mutants showed a significant increase in phospho-myosin light chain 2 compared with WT cells expressing only EGFP (Fig. 6B). However, STAT3-/- cells were unresponsive to L63RhoA in myosin light chain phosphorylation, similar to the MCLK inhibitor ML-7-treated WT cells (Fig. 6B).	SEN:10020974	15705584
BEL:20036072	gtp(p(MGI:Rhoa)) increases r(MGI:Myocd)	inactivation of RhoA with C3-exoenzyme or treatment with ROK inhibitors strongly inhibited myocardin mRNA expression in retinoic acid-treated A404 cells	SEN:10003998	16397143
BEL:20036092	gtp(p(MGI:Rhob)) increases kin(p(MGI:Limk2))	Consequently, dominant-negative RhoA and RhoB mutants blocked TGF-beta1-induced actin reorganization. Because Rho GTPases are known to regulate the activity of LIM-kinases (LIMK), we found that TGF-beta1 induced LIMK2 phosphorylation with similar kinetics to Rho activation.	SEN:10020966	15647284
BEL:20036168	kin(complex(p(HGNC:CCNH),p(HGNC:CDK7),p(HGNC:MNAT1))) directlyIncreases p(HGNC:TP53,pmod(P,S,378))	<p10> PKC phosphorylates P53 at Serine378 <p11> The Cdk7:CycH:p36 (CAK) component of TFIIH phosphorylates p53 at sites which may include 372,376, 378, 392 [serine residues]	SEN:10021014	10436023
BEL:20036170	kin(complex(p(HGNC:CCNH),p(HGNC:CDK7),p(HGNC:MNAT1))) directlyIncreases p(HGNC:TP53,pmod(P,S,392))	<p10> PKC phosphorylates P53 at Serine378 <p11> The Cdk7:CycH:p36 (CAK) component of TFIIH phosphorylates p53 at sites which may include 372,376, 378, 392 [serine residues]	SEN:10021014	10436023
BEL:20036172	kin(complex(p(HGNC:CDK1),p(HGNC:CCNB1))) directlyIncreases p(HGNC:CDC25C,pmod(P))	<C40> Ser216-phosphorylated Cdc25C is recognized and bound by 14-3-3 protein family members (Peng et al., 1997, 1998). Ser216 phosphorylation and 14-3-3 binding probably sequester Cdc25C and thus prevent it from interacting with Cdk1 in vivo (Peng et al., 1997). 14-3-3s is localized to the cytoplasm and may be the means by which Cdc25C is sequestered outside of the nucleus (Hermeking et al., 1997).	SEN:10019952	10436023
BEL:20036176	kin(complex(p(HGNC:EGFR),p(HGNC:ERBB2))) increases kin(p(HGNC:PIK3C2A))	Stimulation of quiescent cultures with EGF resulted in the rapid recruitment of both enzymes to a phosphotyrosine signaling complex that contained the EGF receptor and Erb-B2.	SEN:10021016	10805725
BEL:20036178	kin(complex(p(HGNC:EGFR),p(HGNC:ERBB2))) increases kin(p(HGNC:PIK3C2B))	Stimulation of quiescent cultures with EGF resulted in the rapid recruitment of both enzymes to a phosphotyrosine signaling complex that contained the EGF receptor and Erb-B2.	SEN:10021016	10805725
BEL:20036180	kin(complex(p(HGNC:IKBKG),p(HGNC:CHUK),p(HGNC:IKBKB))) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,32))	A third component of the large IkBalpha kinase complex has also been cloned and is referred to as NEMO (NF-kB essential modulator) ( [47]), IKKgamma ( [39]), IKKAP ( [31]), or FIP-3 ( [27]).	SEN:10021018	10882136
BEL:20036182	kin(complex(p(HGNC:IKBKG),p(HGNC:CHUK),p(HGNC:IKBKB))) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,36))	A third component of the large IkBalpha kinase complex has also been cloned and is referred to as NEMO (NF-kB essential modulator) ( [47]), IKKgamma ( [39]), IKKAP ( [31]), or FIP-3 ( [27]).	SEN:10021018	10882136
BEL:20036184	kin(complex(p(MGI:Ccnd1),p(MGI:Cdk4))) directlyIncreases p(MGI:Rb1,pmod(P,S,773))	Phosphorylation of Ser780 in pRb protein is mediated by the cyclin D1/cdk4 complex (30). A significant increase in endogenous Rb phosphorylation at Ser780 was observed in islets from caAktTg mice, suggesting that cdk4 activity is augmented (Fig. 4B) (P 0.05).	SEN:10021020	16443763
BEL:20036186	kin(complex(p(MGI:Ccnd1),p(MGI:Cdk6))) decreases bp(GOBP:"Wnt receptor signaling pathway")	hus, the CCND1-CDK6 complex is like to negatively regulate Wnt signaling by mediating beta-catenin phosphorylation and its subsequent degradation in Wnt-stimulated cells.	SEN:10005398	17208333
BEL:20036188	kin(complex(p(MGI:Pdpk1),p(MGI:Pdpk1))) directlyIncreases p(MGI:Pdpk1,pmod(P,T,516))	Here we show that mouse PDK-1 (mPDK-1) undergoes autophosphorylation in vitro on both serine and threonine residues. In addition, we have identified Ser(399) and Thr(516) as the major mPDK-1 autophosphorylation sites in vitro	SEN:10021022	11877406
BEL:20036336	kin(p(EGID:1018)) directlyIncreases p(MGI:Jun,pmod(P,S,63))	Results indicated that c-Jun phosphorylation at Ser63 and Ser73 was induced by co-transfection of pHA-Cdk3 (Fig. 2B, lane1), but not by Cdk3-DN (Fig. 2B, lane 2); and the mutant His-c-Jun M63/73 could not be phosphorylated by pHA-Cdk3 (Fig. 2B, lane 4).	SEN:10021090	19118012
BEL:20036338	kin(p(EGID:1018)) directlyIncreases p(MGI:Jun,pmod(P,S,73))	Results indicated that c-Jun phosphorylation at Ser63 and Ser73 was induced by co-transfection of pHA-Cdk3 (Fig. 2B, lane1), but not by Cdk3-DN (Fig. 2B, lane 2); and the mutant His-c-Jun M63/73 could not be phosphorylated by pHA-Cdk3 (Fig. 2B, lane 4).	SEN:10021090	19118012
BEL:20036342	kin(p(EGID:12534)) directlyIncreases p(MGI:Mycn,pmod(P,S,54))	We report that phosphorylation-induced turnover of endogenous N-myc protein in CGNPs increases during mitosis, due to increased priming phosphorylation of N-myc for GSK-3beta. The priming phosphorylation requires the Cdk1 complex, whose cyclin subunits are indirect Sonic hedgehog targets	SEN:10021092	16139224
BEL:20036346	kin(p(EGID:279561)) directlyDecreases cat(p(MGI:Slc12a4))	We previously demonstrated that WNK3, a paralog of serine-threonine kinases mutated in hereditary hypertension, is coexpressed with several cation/Cl- cotransporters and regulates their activity. Here, we show that WNK3 completely prevents the cell swelling-induced activation of KCC1-KCC4 in Xenopus oocytes.	SEN:10021096	16446421
BEL:20036354	kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:PRKCD,pmod(P,Y))	The present studies demonstrate that treatment of cells with hydrogen peroxide (H(2)O(2)) induces binding of the PKCdelta isoform and the c-Abl protein-tyrosine kinase. The results show that c-Abl phosphorylates PKCdelta in the H(2)O(2) response. We also show that PKCdelta phosphorylates and activates c-Abl in vitro.	SEN:10015764	10713049
BEL:20036356	kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:PRKDC,pmod(P,Y))	<B8> c-Abl phosphorylates DNA-PK in the C-terminal region (amino acids 3414?3850) (Jin et al., 1997). c-Abl-dependent phosphorylation of DNA-PK is stimulated by IR (Kharbanda et al., 1997). c-Abl does not phosphorylate Ku (Kharbanda et al., 1997).	SEN:10018176	10436023
BEL:20036358	kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:PXN,pmod(P,Y))	<A7> c-Abl binds and tyrosine phosphorylates paxillin in an adhesion-dependent manner (Lewis and Schwartz, 1998).	SEN:10021100	10436023
BEL:20036360	kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD51,pmod(P,Y))	<N12> Rad51 binds to c-Abl directly (Yuan et al., 1998). c-Abl phosphorylates Rad51 Tyr54, as a consequence of which the binding of Rad51 to ssDNA is inhibited (Yuan et al., 1998). IR induces c-Abl-dependent phosphorylation of Rad51 (Yuan et al., 1998).	SEN:10018178	10436023
BEL:20036372	kin(p(HGNC:AKT1)) decreases kin(p(HGNC:MAP3K5))	Akt decreased ASK1 kinase activity stimulated by both oxidative stress and overexpression in 293 cells by phosphorylating a consensus Akt site at serine 83 of ASK1.	SEN:10021104	11154276
BEL:20036378	kin(p(HGNC:AKT1)) increases p(HGNC:FOXO1,pmod(P,S,319))	the mutation S256A greatly reduced the rate of phosphorylation of Thr-24 and Ser-319 by PKB in ?itro,	SEN:10021108	11237865
BEL:20036380	kin(p(HGNC:AKT1)) increases p(HGNC:FOXO1,pmod(P,T,24))	the mutation S256A greatly reduced the rate of phosphorylation of Thr-24 and Ser-319 by PKB in ?itro,	SEN:10021108	11237865
BEL:20036384	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:MAP3K5,pmod(P,S,83))	Akt decreased ASK1 kinase activity stimulated by both oxidative stress and overexpression in 293 cells by phosphorylating a consensus Akt site at serine 83 of ASK1.	SEN:10021104	11154276
BEL:20036392	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:RAC1,pmod(P,S,71))	It was shown that the Rac1 peptide and the recombinant protein were phosphorylated by the activated recombinant Akt kinase and the lysate of SK-MEL28 cells, a human melanoma cell line.	SEN:10021116	10617634
BEL:20036394	kin(p(HGNC:AKT1)) increases r(HGNC:IGF1R)	The downstream targets of Src that lead to the up-regulation of IGF-IR expression were previously unknown. We demonstrate here that AKT regulates IGF-IR expression in PANC-1	SEN:10021118	11212254
BEL:20036398	kin(p(HGNC:AKT1)) decreases tscript(p(HGNC:FOXO1))	Insulin disrupts IRS-dependent transactivation by FKHR, and phosphorylation of Ser-256 by PKB is necessary and sufficient to mediate this effect.	SEN:10002368	10358076
BEL:20036406	kin(p(HGNC:AKT2)) increases r(HGNC:IGF1R)	The downstream targets of Src that lead to the up-regulation of IGF-IR expression were previously unknown. We demonstrate here that AKT regulates IGF-IR expression in PANC-1	SEN:10021118	11212254
BEL:20036408	kin(p(HGNC:ATM)) increases kin(p(HGNC:CHEK2))	However, no such activation was found in A-T cells indicating that caffeine inhibited the ATM-dependent Chk2/Cds1 activation (Fig. 3A, lanes 6 and 8).	SEN:10015500	10744722
BEL:20036410	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ABL1,pmod(P,S,465))	<A2> ATM phosphorylates c-Abl on Ser465 and thereby activates the kinase (Baskaran et al., 1997b). <A3> Phosphorylation by ATM activates c-Abl (Baskaran et al., 1997b). c-Abl tyrosine kinase activity is stimulated in response to ionizing radiation (IR), 1-b-d-arabinofuransylcytosine, camptothecin, or etoposide (Yuan et al., 1996, 1998).	SEN:10021124	10436023
BEL:20036414	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))	Substitution of threonine 68 by alanine in the full-length kinase-dead Chk2 dramatically reduced but did not abolish the ATM phosphorylation of Chk2/Cds1 in vitro (Fig. 4B; threonine 68 accounts for approximately 70% of the total phosphorylation).	SEN:10021126	10744722
BEL:20036426	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))	Serine 15 in the N terminus of p53 has been shown to be the preferred ATM phosphorylation site (27, 29, 30). As shown in Fig. 7A, ATM immunoprecipitated from irradiated cells was more active than that from control cells, and both ATM activities were inhibited by caffeine with IC50 at around 200 M.	SEN:10021132	10744722
BEL:20036428	kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))	In this study, we show that BRCA1 phosphorylation is only partially ATM dependent in response to IR and ATM independent in response to treatment with UV light, or the DNA replication inhibitors hydroxyurea (HU) and aphidicolin (APH) We provide evidence that the kinase responsible for this phosphorylation is the ATM-related kinase, ATR. ATR phosphorylates BRCA1 on six Ser/Thr residues, including Ser 1423, in vitro.	SEN:10021134	11114888
BEL:20036430	kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))	ATR phosphorylates Chk2 on Thr68 in vitro, and phosphorylation of Thr68 in response to IR occurs later in cells lacking ATM (data not shown).	SEN:10021136	10973490
BEL:20036444	kin(p(HGNC:BMX)) increases tscript(p(HGNC:STAT3))	Furthermore, the Etk-PTPD1 interaction stimulated the kinase activity of Etk, resulting in an increased phosphotyrosine content in both factors. The Etk-PTPD1 interaction also increased Stat3 activation. In addition, Tec (but not Btk) kinase can also be activated by PTPD1.	SEN:10021146	11013262
BEL:20036452	kin(p(HGNC:CAMK4)) directlyIncreases p(HGNC:CAMK4,pmod(P,S,12))	A second autoinhibitory mechanism unique to CaMKIV is relaxed by the autophosphorylation of Ser-12 and Ser-13 (4).	SEN:10021148	11096122
BEL:20036454	kin(p(HGNC:CAMK4)) directlyIncreases p(HGNC:CAMK4,pmod(P,S,13))	A second autoinhibitory mechanism unique to CaMKIV is relaxed by the autophosphorylation of Ser-12 and Ser-13 (4).	SEN:10021148	11096122
BEL:20036456	kin(p(HGNC:CDC7)) directlyIncreases p(HGNC:MCM2,pmod(P))	Two-dimensional tryptic phosphopeptide-mapping analysis of in vivo (32)P-labeled MCM2 from HeLa cells reveals that several major tryptic phosphopeptides of MCM2 comigrate with those of MCM2 phosphorylated by HsCdc7-HsDbf4 in vitro, suggesting that MCM2 is a physiological HsCdc7-HsDbf4 substrate.	SEN:10021150	10523313
BEL:20036480	kin(p(HGNC:CDK2)) directlyIncreases p(HGNC:PPP1CA,pmod(P,T,320))	In this study, we examined the cell cycle-dependent phosphorylation of PP1alpha in vivo using three different antibodies. PP1alpha was phosphorylated at Thr-320 during M-phase and again in late G(1)- through early S-phase. Inhibition of Cdk2 led to a small increase in PP1 activity and also prevented PP1alpha phosphorylation. In vitro, PP1alpha was a substrate for Cdk2 but not Cdk4.	SEN:10021162	10506210
BEL:20036482	kin(p(HGNC:CDK2)) increases p(HGNC:PPP1CA,pmod(P,T,320))	In this study, we examined the cell cycle-dependent phosphorylation of PP1alpha in vivo using three different antibodies. PP1alpha was phosphorylated at Thr-320 during M-phase and again in late G(1)- through early S-phase. Inhibition of Cdk2 led to a small increase in PP1 activity and also prevented PP1alpha phosphorylation. In vitro, PP1alpha was a substrate for Cdk2 but not Cdk4.	SEN:10021162	10506210
BEL:20036484	kin(p(HGNC:CDK2)) increases phos(p(HGNC:PPP1CA))	In this study, we examined the cell cycle-dependent phosphorylation of PP1alpha in vivo using three different antibodies. PP1alpha was phosphorylated at Thr-320 during M-phase and again in late G(1)- through early S-phase. Inhibition of Cdk2 led to a small increase in PP1 activity and also prevented PP1alpha phosphorylation. In vitro, PP1alpha was a substrate for Cdk2 but not Cdk4.	SEN:10021162	10506210
BEL:20036486	kin(p(HGNC:CDK2)) increases r(HGNC:TKT)	treatment of young HDFs during the late G1 transition with a specific inhibitor of CDK2, roscovitine, blocked the induction of TK RNA expression.	SEN:10003876	11287748
BEL:20036488	kin(p(HGNC:CDK5)) directlyIncreases p(HGNC:PPP1R1B,pmod(P,T,75))	In resting neostriatal slices, cyclin-dependent kinase 5 (Cdk5) phosphorylates DARPP-32 at Thr-75, thereby reducing the efficacy of dopaminergic signaling.	SEN:10021164	11050161
BEL:20036498	kin(p(HGNC:CHEK1)) directlyIncreases p(HGNC:CDC25C,pmod(P,S,216))	Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (18–21).	SEN:10021168	10744722
BEL:20036502	kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:CDC25C,pmod(P,S,216))	As shown in the Western blot (Fig. 1A, lane 3), the phospho-S216 antibody recognized Cdc25C that was incubated with a wild type Chk2 in the in vitro kinase assay but failed to recognize unphosphorylated Cdc25C, incubated with a kinase-dead mutant (D347A) (Fig. 1A, lane 2).	SEN:10021170	10744722
BEL:20036504	kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:CDC25C,pmod(P,S,216))	Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (18–21).	SEN:10021168	10744722
BEL:20036506	kin(p(HGNC:CHUK)) directlyIncreases kin(p(HGNC:IKBKB))	Moreover, IKKalpha either directly or indirectly enhances IKKbeta kinase activity for IkappaBalpha.	SEN:10005866	10779355
BEL:20036508	kin(p(HGNC:CHUK)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S))	Two related kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta, phosphorylate the IkappaB proteins, leading to their degradation and the subsequent activation of gene expression by NF-kappaB	SEN:10021172	10779355
BEL:20036510	kin(p(HGNC:CHUK)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,32))	Characterization of purified recombinant IKKalpha and IKKbeta revealed that both kinases directly phosphorylate S32 and S36 in IkBalpha ( [22 and 49]).	SEN:10021174	10882136
BEL:20036512	kin(p(HGNC:CHUK)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,36))	Characterization of purified recombinant IKKalpha and IKKbeta revealed that both kinases directly phosphorylate S32 and S36 in IkBalpha ( [22 and 49]).	SEN:10021174	10882136
BEL:20036520	kin(p(HGNC:CLK1)) increases p(EGID:6426,pmod(P))	We interpret these results to indicate that Clk/Sty phosphorylates a residue(s) that directly affects p32:ASF/SF2 interaction, whereas SRPK1-induced RS domain phosphorylation affects p32 interaction indirectly through ASF/SF2 protein conformation.	SEN:10021176	10022843
BEL:20036526	kin(p(HGNC:CLK4)) directlyIncreases p(HGNC:MBP,pmod(P))	When fused to glutathione S-transferase, the catalytically active human CLK4 is able to autophosphorylate and to phosphorylate myelin basic protein, but not histone H2B as a substrate. I	SEN:10021180	11170754
BEL:20036534	kin(p(HGNC:CSK)) decreases p(HGNC:PTK2,pmod(P))	Csk has been reported to associate with IRS-1 through its SH2 domain and promote dephosphorylation of the focal adhesion kinase (FAK) in an insulin-dependent manner (56).	SEN:10019968	10194465
BEL:20036538	kin(p(HGNC:CSNK1A1)) directlyIncreases p(HGNC:CHRM3,pmod(P,Y))	a peptide corresponding to the third intracellular loop of the m3-muscarinic receptor (Ser(345)-Leu(463)) is an inhibitor of CK1alpha due to its ability to both act as a pseudo-substrate for CK1alpha and form a high affinity complex with CK1alpha	SEN:10019964	10777483
BEL:20036548	kin(p(HGNC:DAPK3)) increases bp(GOBP:"apoptotic process")	Dlk can induce apoptosis. In search for interaction partners that might serve as regulators or targets of this kinase we identified apoptosis antagonizing transcription factor (AATF) Interestingly, AATF interfered with Dlk-induced apoptosis.	SEN:10019976	10580117
BEL:20036558	kin(p(HGNC:EGFR)) directlyIncreases complex(p(HGNC:GAB1),p(HGNC:SYP))	Recently, we identified a similar cohort of tyrosine phosphorylation sites for the epidermal growth factor receptor (EGFR) with a predominant phosphorylation of tyrosine residue Y657 and binding of Syp [Lehr, S. et al. (1999) Biochemistry 38, 151-159].	SEN:10005880	10978177
BEL:20036562	kin(p(HGNC:EGFR)) increases kin(p(HGNC:PIK3C2A))	In this study, we demonstrate that PI3K-C2alpha and PI3K-C2beta represent two downstream targets of the activated epidermal growth factor (EGF) receptor in human carcinoma-derived A431 cells.	SEN:10021182	10805725
BEL:20036564	kin(p(HGNC:EGFR)) increases kin(p(HGNC:PIK3C2B))	In this study, we demonstrate that PI3K-C2alpha and PI3K-C2beta represent two downstream targets of the activated epidermal growth factor (EGF) receptor in human carcinoma-derived A431 cells.	SEN:10021182	10805725
BEL:20036566	kin(p(HGNC:EGFR)) increases p(HGNC:CTNND1,pmod(P,Y))	p120(ctn) forms a complex with E-cadherin at the adherens junction and is phosphorylated by ligands such as epidermal growth factor receptor as well as pp60 src	SEN:10021184	10547572
BEL:20036570	kin(p(HGNC:EGFR)) increases p(HGNC:EGFR,pmod(U,K))	Indeed, when a wild-type receptor and a kinase-defective mutant were each transiently expressed in HEK-293 human cells and their ubiquitination tested in vitro, we found that only the wild-type form underwent ubiquitination ( Figure 4B).	SEN:10021188	10635327
BEL:20036574	kin(p(HGNC:EGFR)) directlyIncreases p(HGNC:EZR,pmod(P,Y,145))	In ezrin, two tyrosine residues, corresponding to amino acids 145 and 353, are phosphorylated by the epidermal growth factor receptor	SEN:10021190	10377409
BEL:20036576	kin(p(HGNC:EGFR)) directlyIncreases p(HGNC:EZR,pmod(P,Y,353))	In ezrin, two tyrosine residues, corresponding to amino acids 145 and 353, are phosphorylated by the epidermal growth factor receptor	SEN:10021190	10377409
BEL:20036578	kin(p(HGNC:EGFR)) directlyIncreases p(HGNC:GAB1,pmod(P,Y))	Gab-1 is heavily phosphorylated by the epidermal growth factor receptor, but poorly by the insulin receptor	SEN:10021192	10194465
BEL:20036586	kin(p(HGNC:EGFR)) increases p(HGNC:IL8)	EGF-R activation was significantly blocked by therapy with PKI166 and was associated with significant reduction in tumor cell production of VEGF and IL-8, which in turn correlated with a significant decrease in microvessel density and an increase in apoptotic endothelial cells.	SEN:10021196	10850439
BEL:20036588	kin(p(HGNC:EGFR)) increases p(HGNC:VEGFA)	EGF-R activation was significantly blocked by therapy with PKI166 and was associated with significant reduction in tumor cell production of VEGF and IL-8, which in turn correlated with a significant decrease in microvessel density and an increase in apoptotic endothelial cells.	SEN:10021196	10850439
BEL:20036590	kin(p(HGNC:EGFR)) increases r(HGNC:HNRNPK)	Both EGF and heregulin-beta1 induced expression of hnRNP K mRNA and protein in human breast cancer cells. This growth factor-mediated hnRNP K expression was effectively blocked by pretreatment of cultures with humanized anti-EGF receptor (EGFR) antibody C225, or anti-human epidermal growth factor receptor-2 (HER2) antibody.	SEN:10005884	11121407
BEL:20036596	kin(p(HGNC:EPHA2)) decreases bp(GOBP:"integrin-mediated signaling pathway")	Here we show that activation of endogenous EphA2 kinase induces an inactive conformation of integrins and inhibits cell spreading, migration and integrin-mediated adhesion.	SEN:10021198	10655584
BEL:20036602	kin(p(HGNC:EPHA4)) directlyIncreases p(HGNC:EPHA4,pmod(P,Y,596))	N-terminal to the kinase domain, in the juxtamembrane region, lie two invariant tyrosine residues (tyrosines 596 and 602 of EphA4; tyrosines 604 and 610 of EphB2) which are embedded in a characteristic and highly conserved ;10-aminoacid sequence motif. These tyrosine residues are major sites for autophosphorylation (9, 15, 27, 54)	SEN:10021200	10848605
BEL:20036604	kin(p(HGNC:EPHA4)) directlyIncreases p(HGNC:EPHA4,pmod(P,Y,602))	N-terminal to the kinase domain, in the juxtamembrane region, lie two invariant tyrosine residues (tyrosines 596 and 602 of EphA4; tyrosines 604 and 610 of EphB2) which are embedded in a characteristic and highly conserved ;10-aminoacid sequence motif. These tyrosine residues are major sites for autophosphorylation (9, 15, 27, 54)	SEN:10021200	10848605
BEL:20036618	kin(p(HGNC:EPHB2)) increases p(HGNC:DOK1,pmod(P,Y))	We have previously found that the scaffolding protein p62dok becomes prominently tyrosine phosphorylated in NG-EphB2WT cells upon EphB2 activation (23).	SEN:10021208	10848605
BEL:20036620	kin(p(HGNC:EPHB2)) directlyIncreases p(HGNC:EPHB2,pmod(P,Y,604))	N-terminal to the kinase domain, in the juxtamembrane region, lie two invariant tyrosine residues (tyrosines 596 and 602 of EphA4; tyrosines 604 and 610 of EphB2) which are embedded in a characteristic and highly conserved ;10-aminoacid sequence motif. These tyrosine residues are major sites for autophosphorylation (9, 15, 27, 54)	SEN:10021200	10848605
BEL:20036622	kin(p(HGNC:EPHB2)) directlyIncreases p(HGNC:EPHB2,pmod(P,Y,610))	N-terminal to the kinase domain, in the juxtamembrane region, lie two invariant tyrosine residues (tyrosines 596 and 602 of EphA4; tyrosines 604 and 610 of EphB2) which are embedded in a characteristic and highly conserved ;10-aminoacid sequence motif. These tyrosine residues are major sites for autophosphorylation (9, 15, 27, 54)	SEN:10021200	10848605
BEL:20036628	kin(p(HGNC:ERBB2)) increases r(HGNC:HNRNPK)	Both EGF and heregulin-beta1 induced expression of hnRNP K mRNA and protein in human breast cancer cells. This growth factor-mediated hnRNP K expression was effectively blocked by pretreatment of cultures with humanized anti-EGF receptor (EGFR) antibody C225, or anti-human epidermal growth factor receptor-2 (HER2) antibody.	SEN:10005884	11121407
BEL:20036630	kin(p(HGNC:ERN1)) increases complex(p(HGNC:ERN1),p(HGNC:TRAF2))	Endogenous IRE1alpha was recovered in the TRAF2 immunoprecipitates only when the cells were treated with an agent that causes ER stress (Fig. 3B). These results suggest that ER stress-induced activation of IRE1 kinase activity is important for TRAF2 recruitment, whereas endonuclease activity of IRE1 is dispensable.	SEN:10016328	10650002
BEL:20036632	kin(p(HGNC:ERN1)) increases kin(p(HGNC:MAPK8))	Mutant forms of IRE 1 that lack kinase activity and are impaired in induction of the unfolded protein response (13, 14, 16, 17) caused little or no activation of SAPK1beta even though they were expressed at much higher amounts than were the wild-type proteins (Fig. 1B).	SEN:10021212	10650002
BEL:20036638	kin(p(HGNC:FER)) directlyIncreases tscript(p(HGNC:STAT3))	When combined with immunoprecipitation analysis, this assay showed that p94(fer) can lead to the tyrosine phosphorylation and activation of Stat3 but not of Stat1 or Stat2.	SEN:10005894	10878010
BEL:20036646	kin(p(HGNC:FGFR3)) increases p(HGNC:PTPN11,pmod(P,Y))	Addition of a single tyrosine residue, Y724, restored its [Fgfr3] ability to stimulate cellular transformation, phosphatidylinositol 3-kinase activation, and phosphorylation of Shp2, MAPK, Stat1, and Stat3.	SEN:10021214	11294897
BEL:20036648	kin(p(HGNC:FGFR3)) increases p(HGNC:STAT3,pmod(P))	B9 clones expressing either wild-type FGFR3 at high levels or mutant FGFR3 displayed increased phosphorylation of STAT3 and higher levels of bcl-x(L) expression than did parental B9 cells after cytokine withdrawal.	SEN:10021218	10648414
BEL:20036650	kin(p(HGNC:FGFR3)) increases r(HGNC:BCL2L1)	B9 clones expressing either wild-type FGFR3 at high levels or mutant FGFR3 displayed increased phosphorylation of STAT3 and higher levels of bcl-x(L) expression than did parental B9 cells after cytokine withdrawal.	SEN:10021218	10648414
BEL:20036652	kin(p(HGNC:FGFR3)) increases tscript(p(HGNC:STAT1))	Addition of a single tyrosine residue, Y724, restored its [Fgfr3] ability to stimulate cellular transformation, phosphatidylinositol 3-kinase activation, and phosphorylation of Shp2, MAPK, Stat1, and Stat3.	SEN:10021214	11294897
BEL:20036654	kin(p(HGNC:FGFR3)) increases tscript(p(HGNC:STAT3))	B9 clones expressing either wild-type FGFR3 at high levels or mutant FGFR3 displayed increased phosphorylation of STAT3 and higher levels of bcl-x(L) expression than did parental B9 cells after cytokine withdrawal.	SEN:10021218	10648414
BEL:20036656	kin(p(HGNC:FGFR3)) increases tscript(p(HGNC:STAT3))	Addition of a single tyrosine residue, Y724, restored its [Fgfr3] ability to stimulate cellular transformation, phosphatidylinositol 3-kinase activation, and phosphorylation of Shp2, MAPK, Stat1, and Stat3.	SEN:10021214	11294897
BEL:20036658	kin(p(HGNC:FLT1)) increases bp(GOBP:chemotaxis)	VEGFR1 does appear to mediate VEGF- and PIGF-induced tissue factor expression and chemotaxis in monocytes, a cell type that expresses only VEGFR1	SEN:10020108	11350732
BEL:20036660	kin(p(HGNC:FLT1)) increases r(HGNC:F3)	VEGFR1 does appear to mediate VEGF- and PIGF-induced tissue factor expression and chemotaxis in monocytes, a cell type that expresses only VEGFR1	SEN:10020108	11350732
BEL:20036662	kin(p(HGNC:FLT1)) increases r(HGNC:PLAU)	VEGFR1 is also implicated in VEGF stimulation of urokinase and plasminogen activator inhibitor 1 and of metalloproteinase expression in SMCs	SEN:10021220	11350732
BEL:20036664	kin(p(HGNC:FLT1)) increases r(HGNC:SERPINE1)	VEGFR1 is also implicated in VEGF stimulation of urokinase and plasminogen activator inhibitor 1 and of metalloproteinase expression in SMCs	SEN:10021220	11350732
BEL:20036670	kin(p(HGNC:FLT4)) increases bp(GOBP:angiogenesis)	VEGFE binds with high affinity to VEGFR2 VEGFR3, a specific role of this receptor in lymph angiogenesis	SEN:10021222	11350732
BEL:20036678	kin(p(HGNC:FYN)) directlyIncreases p(HGNC:CAV1,pmod(P,Y))	Recently, it was shown that Fyn is one of the kinases responsible for the phosphorylation of caveolin	SEN:10021226	10194465
BEL:20036680	kin(p(HGNC:FYN)) directlyIncreases p(HGNC:CAV2,pmod(P,Y))	Recently, it was shown that Fyn is one of the kinases responsible for the phosphorylation of caveolin	SEN:10021226	10194465
BEL:20036692	kin(p(HGNC:GSK3B)) increases deg(p(HGNC:CTNNB1))	Axin, a Wnt signal negative regulator, enhances glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of beta-catenin and stimulates the degradation of beta-catenin.	SEN:10001338	10488109
BEL:20036694	kin(p(HGNC:GSK3B)) increases deg(p(HGNC:JUP))	These results suggest that Axin regulates the stability of plakoglobin by enhancing its phosphorylation by GSK-3beta and that Axin may act on beta-catenin and plakoglobin in similar manners.	SEN:10021230	10488109
BEL:20036696	kin(p(HGNC:GSK3B)) directlyIncreases p(HGNC:CTNNB1,pmod(P,S))	beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex.	SEN:10019924	10228155
BEL:20036710	kin(p(HGNC:IGF1R)) increases bp(GOBP:"cell proliferation")	The IGF-II gene is overexpressed in malignant adrenocortical tumors and its proliferative effects are mediated by the type-1 IGF receptor (IGF1R).	SEN:10005308	11182753
BEL:20036712	kin(p(HGNC:IGF1R)) increases kin(p(HGNC:JAK1))	tyrosine phosphorylation of STAT3, JAK1, and JAK2 was increased upon IGF-I stimulation of endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK expression vector.	SEN:10021236	10747872
BEL:20036714	kin(p(HGNC:IGF1R)) increases kin(p(HGNC:JAK2))	tyrosine phosphorylation of STAT3, JAK1, and JAK2 was increased upon IGF-I stimulation of endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK expression vector.	SEN:10021236	10747872
BEL:20036718	kin(p(HGNC:IGF1R)) increases tscript(p(HGNC:STAT3))	STAT3, but not STAT5, was activated in response to IGF-I in 293T cells cotransfected with IGF-IR and STAT expression vectors.	SEN:10021238	10747872
BEL:20036720	kin(p(HGNC:IKBKB)) decreases bp(GOBP:"apoptotic process")	Na+-salicylate and cyclopentenone PGs, direct inhibitors of IKK beta, interfered in the activation of the Bcl-xL promoter and induced apoptosis in CD28-costimulated CD4+ T cells.	SEN:10003950	10925251
BEL:20036726	kin(p(HGNC:IKBKB)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S))	Two related kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta, phosphorylate the IkappaB proteins, leading to their degradation and the subsequent activation of gene expression by NF-kappaB	SEN:10021172	10779355
BEL:20036728	kin(p(HGNC:IKBKB)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,32))	Characterization of purified recombinant IKKalpha and IKKbeta revealed that both kinases directly phosphorylate S32 and S36 in IkBalpha ( [22 and 49]).	SEN:10021174	10882136
BEL:20036730	kin(p(HGNC:IKBKB)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,36))	Characterization of purified recombinant IKKalpha and IKKbeta revealed that both kinases directly phosphorylate S32 and S36 in IkBalpha ( [22 and 49]).	SEN:10021174	10882136
BEL:20036736	kin(p(HGNC:IKBKB)) increases r(HGNC:BCL2L1)	Na+-salicylate and cyclopentenone PGs, direct inhibitors of IKK beta, interfered in the activation of the Bcl-xL promoter and induced apoptosis in CD28-costimulated CD4+ T cells.	SEN:10003950	10925251
BEL:20036742	kin(p(HGNC:IKBKE)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,32))	Phosphorylation of full-length IkBalpha by IKK epsilon was also examined using the recombinant kinase. The wild-type IkBalpha was efficiently phosphorylated by IKK epsilon, while substitution of serines 32 and 36 with alanine decreased the level of phosphorylation 5-fold (Figure 2C).	SEN:10021248	10882136
BEL:20036746	kin(p(HGNC:IKBKE)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,36))	Phosphorylation of full-length IkBalpha by IKK epsilon was also examined using the recombinant kinase. The wild-type IkBalpha was efficiently phosphorylated by IKK epsilon, while substitution of serines 32 and 36 with alanine decreased the level of phosphorylation 5-fold (Figure 2C).	SEN:10021248	10882136
BEL:20036748	kin(p(HGNC:IKBKE)) increases p(HGNC:NFKBIA,pmod(P,S,36))	recombinant IKKepsilon expressed in HeLa cells specifically phosphorylates only serine 36 of IkBalpha	SEN:10021250	10882136
BEL:20036752	kin(p(HGNC:ILK)) increases p(HGNC:CCND1)	We show here that ILK overexpression elevates cyclin D1 protein levels and directly induces the cyclin D1 gene in mammary epithelial cells. I	SEN:10021252	10915780
BEL:20036754	kin(p(HGNC:ILK)) increases r(HGNC:CCND1)	We show here that ILK overexpression elevates cyclin D1 protein levels and directly induces the cyclin D1 gene in mammary epithelial cells. I	SEN:10021252	10915780
BEL:20036756	kin(p(HGNC:INSR)) increases complex(p(HGNC:GAB1),p(HGNC:PIK3R1))	Accordingly, pull down assays with human HepG2 cell lysates showed that IR-specific phosphorylation of wild-type hGab-1 strongly enhanced PI-3 kinase binding.	SEN:10005906	10978177
BEL:20036762	kin(p(HGNC:INSR)) directlyIncreases p(HGNC:GAB1,pmod(P,Y))	Gab-1 is heavily phosphorylated by the epidermal growth factor receptor, but poorly by the insulin receptor	SEN:10021192	10194465
BEL:20036766	kin(p(HGNC:INSR)) directlyIncreases p(HGNC:GRB10,pmod(P,Y))	It also contains an additional binding site located in the phosphorylated kinase activation loop of the insulin receptor but is only very slightly phosphorylated by insulin receptor.	SEN:10021256	10194465
BEL:20036768	kin(p(HGNC:INSR)) directlyIncreases p(HGNC:SHC1,pmod(P,Y))	insulin receptor phosphorylates a number of intracellular substrates on tyrosine including members of the insulin receptor substrate family (IRS1/2/3/4), the Shc adaptor...	SEN:10021258	11239409
BEL:20036772	kin(p(HGNC:IRAK1)) increases kin(p(HGNC:MAPK1))	Fibroblasts electroinjected with a mouse monoclonal anti-IRAK antibody to block the recruitment of IRAK into FACs failed to activate ERK after IL-1 treatment, indicating that FAC-associated IRAK is required for the activation of ERK.	SEN:10005910	10823834
BEL:20036784	kin(p(HGNC:JAK1)) increases tscript(p(HGNC:STAT3))	Dominant-negative JAK1 or JAK2 was able to block the IGF-IR-mediated tyrosine phosphorylation of STAT3 in 293T cells.	SEN:10021262	10747872
BEL:20036790	kin(p(HGNC:JAK2)) directlyIncreases p(HGNC:ERBB2,pmod(P,Y))	Our results indicate that autocrine secretion of PRL stimulates tyrosine phosphorylation of ErbB-2 by Jak2, provides docking sites for Grb2 and stimulates Ras-MAP kinase cascade, thereby causing unrestricted cellular proliferation.	SEN:10021268	10938266
BEL:20036798	kin(p(HGNC:JAK2)) decreases tscript(p(HGNC:STAT3))	Using these methods, we found that JAK2 was essential for signal transduction but that loss of TYK2 made no appreciable difference in tyrosine phosphorylation of downstream molecules, including Mpl, STAT3, and Shc (33).....In fact, tyrosine phosphorylation of STATs and DNA binding assays seem to be almost interchangeable measures of transcriptional activity.	SEN:10021272	10080909
BEL:20036800	kin(p(HGNC:JAK2)) increases tscript(p(HGNC:STAT3))	Dominant-negative JAK1 or JAK2 was able to block the IGF-IR-mediated tyrosine phosphorylation of STAT3 in 293T cells.	SEN:10021262	10747872
BEL:20036806	kin(p(HGNC:KDR)) increases cat(complex(p(HGNC:ITGA2),p(HGNC:ITGB1)))	Sixth, based upon the activity of different forms of VEGF ligands, VEGFR2 but not VEGFR1 ligation was capable of activating integrins, and this conclusion was confirmed by overexpression of VEGFR2 in cells.	SEN:10021276	11090623
BEL:20036808	kin(p(HGNC:KDR)) increases cat(complex(p(HGNC:ITGA5),p(HGNC:ITGB1)))	Sixth, based upon the activity of different forms of VEGF ligands, VEGFR2 but not VEGFR1 ligation was capable of activating integrins, and this conclusion was confirmed by overexpression of VEGFR2 in cells.	SEN:10021276	11090623
BEL:20036810	kin(p(HGNC:KDR)) increases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	Sixth, based upon the activity of different forms of VEGF ligands, VEGFR2 but not VEGFR1 ligation was capable of activating integrins, and this conclusion was confirmed by overexpression of VEGFR2 in cells.	SEN:10021276	11090623
BEL:20036812	kin(p(HGNC:KDR)) increases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB5)))	Sixth, based upon the activity of different forms of VEGF ligands, VEGFR2 but not VEGFR1 ligation was capable of activating integrins, and this conclusion was confirmed by overexpression of VEGFR2 in cells.	SEN:10021276	11090623
BEL:20036820	kin(p(HGNC:KIT)) increases bp(GOBP:"cell differentiation")	Stem cell factor (SCF) or c-Kit ligand is a cytokine associated with the differentiation, survival, and activation of mast cells.	SEN:10002636	11159541
BEL:20036822	kin(p(HGNC:KIT)) increases bp(GOBP:"mast cell activation")	Stem cell factor (SCF) or c-Kit ligand is a cytokine associated with the differentiation, survival, and activation of mast cells.	SEN:10002636	11159541
BEL:20036824	kin(p(HGNC:KIT)) increases p(HGNC:KIT,pmod(P,Y,703))	% In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail.	SEN:10020048	10377264
BEL:20036828	kin(p(HGNC:KIT)) increases p(HGNC:KIT,pmod(P,Y,936))	% In this paper we demonstrate the presence of two novel in vivo autophosphorylation sites in the c-Kit/stem cell factor receptor (c-Kit/SCFR): Tyr-703 in the kinase insert and Tyr-936 in the C-terminal tail.	SEN:10020048	10377264
BEL:20036838	kin(p(HGNC:KSR1)) directlyIncreases kin(p(HGNC:RAF1))	Using purified wild-type and mutant c-Raf-1 proteins, we demonstrate that Thr(269) is the major c-Raf-1 site phosphorylated by KSR in vitro and that phosphorylation of this site is essential for c-Raf-1 activation by KSR.	SEN:10021280	11134016
BEL:20036840	kin(p(HGNC:KSR1)) directlyIncreases p(HGNC:RAF1,pmod(P,T,269))	Using purified wild-type and mutant c-Raf-1 proteins, we demonstrate that Thr(269) is the major c-Raf-1 site phosphorylated by KSR in vitro and that phosphorylation of this site is essential for c-Raf-1 activation by KSR.	SEN:10021280	11134016
BEL:20036842	kin(p(HGNC:LCK)) increases complex(p(HGNC:FYN),p(HGNC:SHC1))	Yes and Lck are known to be enriched in rafts and may mediate the activation of Shc when Fyn is not expressed.	SEN:10021282	10446041
BEL:20036848	kin(p(HGNC:LCK)) directlyIncreases p(HGNC:SHC1,pmod(P,Y,317))	Yes and Lck are known to be enriched in rafts and may mediate the activation of Shc when Fyn is not expressed.	SEN:10021282	10446041
BEL:20036852	kin(p(HGNC:LIMK1)) directlyIncreases p(HGNC:CFL1,pmod(P,S))	Y-27632, a specific inhibitor of ROCK, inhibited LIM-kinase-induced cofilin phosphorylation but did not affect fibronectin-induced or TESK1-induced cofilin phosphorylation in HeLa cells.	SEN:10021288	11294912
BEL:20036856	kin(p(HGNC:LIMK1)) directlyIncreases p(HGNC:DSTN,pmod(P,S,3))	We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3	SEN:10021290	11171090
BEL:20036858	kin(p(HGNC:LIMK2)) directlyIncreases p(HGNC:CFL1,pmod(P,S,3))	We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3	SEN:10021290	11171090
BEL:20036860	kin(p(HGNC:LIMK2)) directlyIncreases p(HGNC:DSTN,pmod(P,S,3))	We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3	SEN:10021290	11171090
BEL:20036862	kin(p(HGNC:LYN)) increases kin(p(HGNC:MAP2K7))	FIG. 7. Lyn induces SAPK activation by an MKK7- and MEKK1-dependent, SEK1-independent mechanism.	SEN:10021292	10891478
BEL:20036864	kin(p(HGNC:LYN)) increases kin(p(HGNC:MAP3K1))	FIG. 7. Lyn induces SAPK activation by an MKK7- and MEKK1-dependent, SEK1-independent mechanism.	SEN:10021292	10891478
BEL:20036870	kin(p(HGNC:LYN)) increases p(HGNC:PTPN6,pmod(P,Y,564))	The results show that Lyn phosphorylates SHPTP1 at the C-terminal Tyr-564 site. Lyn-mediated phosphorylation of SHPTP1 stimulates SHPTP1 tyrosine phosphatase activity.	SEN:10021296	10574931
BEL:20036872	kin(p(HGNC:LYN)) increases phos(p(HGNC:PTPN6))	The results show that Lyn phosphorylates SHPTP1 at the C-terminal Tyr-564 site. Lyn-mediated phosphorylation of SHPTP1 stimulates SHPTP1 tyrosine phosphatase activity.	SEN:10021296	10574931
BEL:20036878	kin(p(HGNC:MAP2K1)) increases p(HGNC:EEF2)	Inhibition of MEK1 also led to reduced expression of alpha-enolase, phosphoglycerate kinase, elongation factor 2 and heterogeneous nuclear ribonucleoprotein A3, the latter two being detected as truncated proteins.	SEN:10005928	10228560
BEL:20036880	kin(p(HGNC:MAP2K1)) increases p(HGNC:HNRNPA3)	Inhibition of MEK1 also led to reduced expression of alpha-enolase, phosphoglycerate kinase, elongation factor 2 and heterogeneous nuclear ribonucleoprotein A3, the latter two being detected as truncated proteins.	SEN:10005928	10228560
BEL:20036882	kin(p(HGNC:MAP2K1)) increases r(HGNC:MMP1)	constitutively active kinases within the ERK1/2 pathway (MEKK1, MEK1) or the p38 pathway (ASK1, MEKK1, MKK3) are potent activators of the MMP-1 promoter	SEN:10005930	10912795
BEL:20036890	kin(p(HGNC:MAP2K3)) increases r(HGNC:MMP1)	constitutively active kinases within the ERK1/2 pathway (MEKK1, MEK1) or the p38 pathway (ASK1, MEKK1, MKK3) are potent activators of the MMP-1 promoter	SEN:10005930	10912795
BEL:20036896	kin(p(HGNC:MAP2K6)) increases kin(p(HGNC:MAPK14))	Ectopic expression of PP2Cbeta-1 inhibited the TAK1-mediated mitogen-activated protein kinase kinase 4-c-Jun amino-terminal kinase and mitogen-activated protein kinase kinase 6-p38 signaling pathways.	SEN:10005934	11104763
BEL:20036904	kin(p(HGNC:MAP2K7)) decreases p(HGNC:STAT3,pmod(P,Y,705))	We further demonstrate that JNK1, activated by its upstream kinase MKK7, negatively regulated the tyrosine phosphorylation and DNA binding and transcriptional activities of Stat3 stimulated by EGF.	SEN:10021304	10521505
BEL:20036906	kin(p(HGNC:MAP2K7)) decreases tscript(p(HGNC:STAT3))	We further demonstrate that JNK1, activated by its upstream kinase MKK7, negatively regulated the tyrosine phosphorylation and DNA binding and transcriptional activities of Stat3 stimulated by EGF.	SEN:10021304	10521505
BEL:20036920	kin(p(HGNC:MAP3K1)) increases bp(GOBP:"apoptotic process")	Our findings demonstrate that expression of constitutively active MEKK1 induces apoptosis in androgen receptor-positive but not in androgen receptor-negative prostate cancer cells.	SEN:10021310	10373563
BEL:20036922	kin(p(HGNC:MAP3K1)) increases kin(p(HGNC:MAPK9))	Activation of SAPK by forced expression of DeltaMEKK1 increased overall ATF2 ubiquitination, presumably because of the enhanced dimerization of ATF2.	SEN:10005940	10777545
BEL:20036924	kin(p(HGNC:MAP3K1)) increases r(HGNC:MMP1)	constitutively active kinases within the ERK1/2 pathway (MEKK1, MEK1) or the p38 pathway (ASK1, MEKK1, MKK3) are potent activators of the MMP-1 promoter	SEN:10005930	10912795
BEL:20036936	kin(p(HGNC:MAP3K5)) increases r(HGNC:MMP1)	constitutively active kinases within the ERK1/2 pathway (MEKK1, MEK1) or the p38 pathway (ASK1, MEKK1, MKK3) are potent activators of the MMP-1 promoter	SEN:10005930	10912795
BEL:20036940	kin(p(HGNC:MAP3K7)) increases kin(p(HGNC:MAP2K4))	Ectopic expression of PP2Cbeta-1 inhibited the TAK1-mediated mitogen-activated protein kinase kinase 4-c-Jun amino-terminal kinase and mitogen-activated protein kinase kinase 6-p38 signaling pathways.	SEN:10005934	11104763
BEL:20036960	kin(p(HGNC:MAPK14)) increases p(HGNC:RB1,pmod(P))	These results suggest that Fas-mediated inactivation of Rb is mediated via the p38 kinase, independent of cdks	SEN:10021320	10075927
BEL:20036964	kin(p(HGNC:MAPK14)) increases r(HGNC:CCND1)	Optimal induction of cyclin D1 by pp60(v-src) involved the extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase members of the mitogen-activated protein kinase family.	SEN:10005948	10066798
BEL:20036966	kin(p(HGNC:MAPK14)) increases r(HGNC:EPO)	inhibition of MAPK14 activity also interfered with stabilization of EPO mRNA in human hepatoma cells undergoing hypoxic stress	SEN:10021324	10943842
BEL:20036968	kin(p(HGNC:MAPK14)) decreases r(HGNC:FAS)	ASK1/p38 silences the Fas promoter by inhibition of IkappaBalpha phosphorylation - thereby limiting NF-kappaB activity.	SEN:10005950	10871852
BEL:20036978	kin(p(HGNC:MAPK14)) decreases tscript(p(HGNC:RB1))	These results suggest that Fas-mediated inactivation of Rb is mediated via the p38 kinase, independent of cdks	SEN:10021320	10075927
BEL:20036988	kin(p(HGNC:MAPK1)) increases kin(p(HGNC:RPS6KA3))	Its (RSK2) activation requires phosphorylation of the linker region at Ser(369), catalyzed by extracellular signal-regulated kinase (ERK)	SEN:10021330	10480933
BEL:20036996	kin(p(HGNC:MAPK1)) increases p(HGNC:NCOA1,pmod(P,S,1179))	Furthermore, Erk-2 phosphorylated threonine 1179 and serine 1185 (and to a lesser extent, serine 395) in vitro, suggesting the importance of this pathway for SRC-1 regulation.	SEN:10021334	10660621
BEL:20036998	kin(p(HGNC:MAPK1)) increases p(HGNC:NCOA1,pmod(P,S,1185))	Furthermore, Erk-2 phosphorylated threonine 1179 and serine 1185 (and to a lesser extent, serine 395) in vitro, suggesting the importance of this pathway for SRC-1 regulation.	SEN:10021334	10660621
BEL:20037000	kin(p(HGNC:MAPK1)) increases p(HGNC:NCOA1,pmod(P,S,395))	Furthermore, Erk-2 phosphorylated threonine 1179 and serine 1185 (and to a lesser extent, serine 395) in vitro, suggesting the importance of this pathway for SRC-1 regulation.	SEN:10021334	10660621
BEL:20037002	kin(p(HGNC:MAPK1)) directlyIncreases p(HGNC:"NKX2-1",pmod(P,S))	Indeed, ERK directly phosphorylates TTF-1 at three serine residues, and concomitant mutation of these serines to alanines completely abolishes ERK-mediated phosphorylation both in vitro and in vivo.	SEN:10021336	10733581
BEL:20037010	kin(p(HGNC:MAPK1)) increases p(HGNC:RPS6KA3,pmod(P,S))	Its (RSK2) activation requires phosphorylation of the linker region at Ser(369), catalyzed by extracellular signal-regulated kinase (ERK)	SEN:10021330	10480933
BEL:20037016	kin(p(HGNC:MAPK1)) increases r(HGNC:CCND1)	Integrin signaling may be needed for the transcription of cyclin D1, because the cyclin D1 promoter is coordinately regulated by JNK and ERK (37) (Fig. 4).	SEN:10021342	10446041
BEL:20037030	kin(p(HGNC:MAPK1)) increases tscript(p(HGNC:EPAS1))	We further show that p42/p44 MAPK is critical for the hypoxia-induced transactivation of endothelial PAS-domain protein 1 (EPAS1),	SEN:10018164	11207433
BEL:20037048	kin(p(HGNC:MAPK3)) increases r(HGNC:CCND1)	Integrin signaling may be needed for the transcription of cyclin D1, because the cyclin D1 promoter is coordinately regulated by JNK and ERK (37) (Fig. 4).	SEN:10021342	10446041
BEL:20037056	kin(p(HGNC:MAPK3)) increases tscript(p(HGNC:EPAS1))	We further show that p42/p44 MAPK is critical for the hypoxia-induced transactivation of endothelial PAS-domain protein 1 (EPAS1),	SEN:10018164	11207433
BEL:20037072	kin(p(HGNC:MAPK8)) increases p(HGNC:E2F1,pmod(P))	JNK1 phosphorylates E2F1 in vitro, and co-transfection of JNK1 reduces the DNA binding activity of E2F1;	SEN:10021360	10075927
BEL:20037074	kin(p(HGNC:MAPK8)) directlyIncreases p(HGNC:JUN,pmod(P,S,73))	Phosphorylated GST-c-Jun-(1–89) was detected by immunoblot analysis with antibodies specific for c-Jun phosphorylated on Ser73. Exposure of cells to CdCl2 induced a biphasic increase in JNK activity in nuclear fraction of MRC5CV1 and AT5BIVA cells (Fig. 2B).	SEN:10016638	11278277
BEL:20037076	kin(p(HGNC:MAPK8)) increases p(HGNC:STAT3,pmod(P,S,727))	Here, we report that Ser-727 phosphorylation of Stat3 can also be induced by JNK and activated either by stress or by its upstream kinase and that various stress treatments induce serine phosphorylation of Stat3 in the absence of tyrosine phosphorylation	SEN:10021362	10521505
BEL:20037078	kin(p(HGNC:MAPK8)) decreases p(HGNC:STAT3,pmod(P,Y,705))	We further demonstrate that JNK1, activated by its upstream kinase MKK7, negatively regulated the tyrosine phosphorylation and DNA binding and transcriptional activities of Stat3 stimulated by EGF.	SEN:10021304	10521505
BEL:20037080	kin(p(HGNC:MAPK8)) increases r(HGNC:CCND1)	Optimal induction of cyclin D1 by pp60(v-src) involved the extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase members of the mitogen-activated protein kinase family.	SEN:10005948	10066798
BEL:20037082	kin(p(HGNC:MAPK8)) increases r(HGNC:CCND1)	Integrin signaling may be needed for the transcription of cyclin D1, because the cyclin D1 promoter is coordinately regulated by JNK and ERK (37) (Fig. 4).	SEN:10021342	10446041
BEL:20037088	kin(p(HGNC:MAPK8)) decreases tscript(p(HGNC:E2F1))	JNK1 phosphorylates E2F1 in vitro, and co-transfection of JNK1 reduces the DNA binding activity of E2F1;	SEN:10021360	10075927
BEL:20037090	kin(p(HGNC:MAPK8)) increases tscript(p(HGNC:JUN))	Activated JNK enters the nucleus and phosphorylates the transcription factor c-Jun, which combines with c-Fos to form the AP-1 transcription factor complex.	SEN:10021364	10446041
BEL:20037092	kin(p(HGNC:MAPK8)) decreases tscript(p(HGNC:STAT3))	Here, we report that Ser-727 phosphorylation of Stat3 can also be induced by JNK and activated either by stress or by its upstream kinase and that various stress treatments induce serine phosphorylation of Stat3 in the absence of tyrosine phosphorylation	SEN:10021362	10521505
BEL:20037094	kin(p(HGNC:MAPK8)) directlyIncreases tscript(p(HGNC:TP53))	Forced expression of MKP5, a JNK phosphatase, in JNK kinase-expressing cells decreased T81 phosphorylation while reducing p53 transcriptional activity and p53-mediated apoptosis.	SEN:10005962	11283254
BEL:20037098	kin(p(HGNC:MAPK9)) increases r(HGNC:CCND1)	Optimal induction of cyclin D1 by pp60(v-src) involved the extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase members of the mitogen-activated protein kinase family.	SEN:10005948	10066798
BEL:20037102	kin(p(HGNC:MAPKAPK2)) increases cat(p(HGNC:ALOX5))	At least two p38-dependent 5-LO kinase activities were found. Based on migration properties in in-gel kinase assays and immunoreactivity, one of these was identified as mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP kinase 2). The other appeared to be MAPKAP kinase 3	SEN:10021366	10779545
BEL:20037106	kin(p(HGNC:MAPKAPK3)) increases cat(p(HGNC:ALOX5))	At least two p38-dependent 5-LO kinase activities were found. Based on migration properties in in-gel kinase assays and immunoreactivity, one of these was identified as mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP kinase 2). The other appeared to be MAPKAP kinase 3	SEN:10021366	10779545
BEL:20037112	kin(p(HGNC:MARK2)) increases p(HGNC:MAP2,pmod(P,S))	We have shown that MAP/microtubule affinity regulating kinases (MARK) can phosphorylate the microtubule-associated-proteins MAP4, MAP2c, and tau on their microtubule-binding domain in vitro. This leads to their detachment from microtubules (MT) and an increased dynamic instability of MT. In CHO cells expressing MARK1 or MARK2 under control of an inducible promoter, MARK2 phosphorylates an endogenous MAP4-related protein.	SEN:10021370	10542369
BEL:20037114	kin(p(HGNC:MARK2)) increases p(HGNC:MAP4,pmod(P,S))	We have shown that MAP/microtubule affinity regulating kinases (MARK) can phosphorylate the microtubule-associated-proteins MAP4, MAP2c, and tau on their microtubule-binding domain in vitro. This leads to their detachment from microtubules (MT) and an increased dynamic instability of MT. In CHO cells expressing MARK1 or MARK2 under control of an inducible promoter, MARK2 phosphorylates an endogenous MAP4-related protein.	SEN:10021370	10542369
BEL:20037116	kin(p(HGNC:MARK2)) increases p(HGNC:MAPT,pmod(P,S))	We have shown that MAP/microtubule affinity regulating kinases (MARK) can phosphorylate the microtubule-associated-proteins MAP4, MAP2c, and tau on their microtubule-binding domain in vitro. This leads to their detachment from microtubules (MT) and an increased dynamic instability of MT. In CHO cells expressing MARK1 or MARK2 under control of an inducible promoter, MARK2 phosphorylates an endogenous MAP4-related protein.	SEN:10021370	10542369
BEL:20037118	kin(p(HGNC:MARK3)) directlyIncreases p(HGNC:CDC25C,pmod(P,S,216))	<C39> Cdc25C Ser216 also binds and is phosphorylated by CTAK1 (Peng et al., 1998). Cdc25C Ser216 is phosphorylated throughout interphase but not in mitosis (Peng et al., 1997).	SEN:10021372	10436023
BEL:20037128	kin(p(HGNC:MET)) increases kin(p(HGNC:MAPK1))	We also show that both Cbl and Gab1 enhance Met-induced activation of another MAP kinase cascade, the ERK pathway, in a Crk-independent manner. Taken together, our studies demonstrate a previously unidentified functional role for Cbl in Met signaling and suggest that Met utilizes at least two docking proteins, Gab1 and Cbl, to activate downstream signaling pathways.	SEN:10005966	10962563
BEL:20037138	kin(p(HGNC:MTOR)) increases cat(p(HGNC:EIF4E))	Rapamycin blocks both 4E-BP1 phosphorylation and cap-dependent translation ( [6]), and mTOR has been demonstrated to phosphorylate 4E-BP1 directly (discussed in further detail below) ( [14]).	SEN:10021374	11057898
BEL:20037140	kin(p(HGNC:MTOR)) increases p(HGNC:EIF4EBP1,pmod(P))	Rapamycin blocks both 4E-BP1 phosphorylation and cap-dependent translation ( [6]), and mTOR has been demonstrated to phosphorylate 4E-BP1 directly (discussed in further detail below) ( [14]).	SEN:10021374	11057898
BEL:20037148	kin(p(HGNC:MTOR)) directlyIncreases p(HGNC:STAT3,pmod(P,S,727))	A STAT3 peptide was efficiently phosphorylated on Ser727 in a CNTF-dependent manner by mTOR, but not by a kinase-inactive mTOR mutant or by p70 S6 kinase.	SEN:10021376	10660304
BEL:20037164	kin(p(HGNC:NTRK1)) directlyIncreases p(HGNC:IRS1,pmod(P,Y))	Here, we show that IRS-1 and IRS-2 are phosphorylated on tyrosine in presence of both TRK-T1 and the activated TrkA receptor.	SEN:10021380	11147812
BEL:20037166	kin(p(HGNC:NTRK1)) directlyIncreases p(HGNC:IRS2,pmod(P,Y))	Here, we show that IRS-1 and IRS-2 are phosphorylated on tyrosine in presence of both TRK-T1 and the activated TrkA receptor.	SEN:10021380	11147812
BEL:20037176	kin(p(HGNC:PAK1)) increases kin(p(HGNC:MAP2K1))	Consistent with the earlier results, p42/44 MAPK and its upstream kinase MEK1/2 were activated in a time-dependent manner by the induction of Pak1 (Fig. 3C).	SEN:10021384	10945974
BEL:20037178	kin(p(HGNC:PAK1)) increases kin(p(HGNC:MAP2K2))	Consistent with the earlier results, p42/44 MAPK and its upstream kinase MEK1/2 were activated in a time-dependent manner by the induction of Pak1 (Fig. 3C).	SEN:10021384	10945974
BEL:20037180	kin(p(HGNC:PAK1)) increases kin(p(HGNC:MAPK1))	Consistent with the earlier results, p42/44 MAPK and its upstream kinase MEK1/2 were activated in a time-dependent manner by the induction of Pak1 (Fig. 3C).	SEN:10021384	10945974
BEL:20037182	kin(p(HGNC:PAK1)) increases kin(p(HGNC:MAPK1))	Examination of whole cell lysates from the same NK92 cells showed that kinase-deficient (KD) PAK1, unlike control CD56, also effectively suppressed MEK and ERK activation by target ligation (Fig. 7b). Thus, PAK1 is upstream of both MEK and ERK in the NK lytic process.	SEN:10021386	11062502
BEL:20037184	kin(p(HGNC:PAK1)) increases kin(p(HGNC:MAPK3))	Consistent with the earlier results, p42/44 MAPK and its upstream kinase MEK1/2 were activated in a time-dependent manner by the induction of Pak1 (Fig. 3C).	SEN:10021384	10945974
BEL:20037186	kin(p(HGNC:PAK1)) increases kin(p(HGNC:MAPK3))	Examination of whole cell lysates from the same NK92 cells showed that kinase-deficient (KD) PAK1, unlike control CD56, also effectively suppressed MEK and ERK activation by target ligation (Fig. 7b). Thus, PAK1 is upstream of both MEK and ERK in the NK lytic process.	SEN:10021386	11062502
BEL:20037198	kin(p(HGNC:PAK4)) increases p(HGNC:BAD,pmod(P))	consistent with an antiapoptotic function, expression of PAK4 leads to an increase in phosphorylation of the proapoptotic protein Bad and an inhibition of caspase activation.	SEN:10021392	11278822
BEL:20037208	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:PKN1))	These include PRK1 and PRK2, whose interaction with Rho-GTP through their N-terminal Rho-binding domains results in a conformational change that enables PDK1 to interact with these kinases and phosphorylate their T-loop #[JL] PRK1 and 2 are PKN1 and 2	SEN:10021012	10698680
BEL:20037210	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:PKN2))	These include PRK1 and PRK2, whose interaction with Rho-GTP through their N-terminal Rho-binding domains results in a conformational change that enables PDK1 to interact with these kinases and phosphorylate their T-loop #[JL] PRK1 and 2 are PKN1 and 2	SEN:10021012	10698680
BEL:20037216	kin(p(HGNC:PDPK1)) increases kin(p(HGNC:RPS6KA1))	Similarly, two other members of the RSK family, RSK1 and RSK3, were partially activated by PDK1 in COS7 cells	SEN:10005988	10480933
BEL:20037218	kin(p(HGNC:PDPK1)) increases kin(p(HGNC:RPS6KA2))	Similarly, two other members of the RSK family, RSK1 and RSK3, were partially activated by PDK1 in COS7 cells	SEN:10005988	10480933
BEL:20037220	kin(p(HGNC:PDPK1)) increases kin(p(HGNC:RPS6KA3))	Here, we show that the isolated N-terminal kinase of RSK2 (amino acids 1-360) is phosphorylated at Ser(227) by PDK1, a constitutively active kinase, leading to 100-fold stimulation of kinase activity	SEN:10021398	10480933
BEL:20037222	kin(p(HGNC:PDPK1)) increases kin(p(HGNC:RPS6KA3))	The N-terminal kinase is activated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) through phosphorylation of Ser227, and phosphorylates the substrates of RSK.	SEN:10021400	10856237
BEL:20037224	kin(p(HGNC:PDPK1)) increases kin(p(HGNC:RPS6KB1))	Our study extend recent findings which implicate PDK1 in the activation of protein kinases B and C and p70(S6K)	SEN:10005990	10480933
BEL:20037226	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:RPS6KB1))	PDK1 has now been shown to play a central role in activating many of the AGC subfamily members (reviewed in [150,151]). Apart from phosphorylating PKB on Thr308, PDK1 phosphorylates the equivalent residues on PKC isoforms [48,152,153], p70-S6K [32,154], the three isoforms of SGK [27,28,155] and PKA [156] (Figure 6).	SEN:10021402	10698680
BEL:20037230	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:SGK1))	PDK1 has now been shown to play a central role in activating many of the AGC subfamily members (reviewed in [150,151]). Apart from phosphorylating PKB on Thr308, PDK1 phosphorylates the equivalent residues on PKC isoforms [48,152,153], p70-S6K [32,154], the three isoforms of SGK [27,28,155] and PKA [156] (Figure 6).	SEN:10021402	10698680
BEL:20037242	kin(p(HGNC:PDPK1)) increases p(HGNC:AKT1,pmod(P,S,473))	As purified or recombinant PDK1 only phosphorylated Thr308 of PKBa and not Ser473, it was assumed that the phosphorylation of Ser473 would be catalysed by a distinct protein kinase, tentatively termed PDK2 [29]. Recent evidence (discussed below) suggests that PDK1 itself, rather than a distinct kinase, may phosphorylate PKB on Ser473 in vivo.	SEN:10021404	10698680
BEL:20037244	kin(p(HGNC:PDPK1)) directlyIncreases p(HGNC:AKT1,pmod(P,T,308))	PDK1 was first identified by its ability to phosphorylate Thr308 of PKBa in vitro [17,29,30]. As this activity was absolutely dependent on the inclusion of PtdIns(3,4)P2 or PtdIns(3,4,5)P3 in the reaction mixture	SEN:10017202	10698680
BEL:20037250	kin(p(HGNC:PDPK1)) increases p(HGNC:RPS6KA3,pmod(P,S))	Here, we show that the isolated N-terminal kinase of RSK2 (amino acids 1-360) is phosphorylated at Ser(227) by PDK1, a constitutively active kinase, leading to 100-fold stimulation of kinase activity	SEN:10021398	10480933
BEL:20037252	kin(p(HGNC:PDPK1)) increases p(HGNC:RPS6KA3,pmod(P,S,227))	The N-terminal kinase is activated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) through phosphorylation of Ser227, and phosphorylates the substrates of RSK.	SEN:10021400	10856237
BEL:20037256	kin(p(HGNC:PIK3C2A)) directlyIncreases a(CHEBI:"1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate")	Both enzymes are characterized by the presence of a C2 domain at the carboxy terminus and, in vitro, preferentially utilize phosphatidylinositol and phosphatidylinositol 4-monophosphate as lipid substrates.	SEN:10021406	10805725
BEL:20037258	kin(p(HGNC:PIK3C2A)) directlyIncreases a(CHEBI:"phosphatidylinositol 3-phosphate")	Both enzymes are characterized by the presence of a C2 domain at the carboxy terminus and, in vitro, preferentially utilize phosphatidylinositol and phosphatidylinositol 4-monophosphate as lipid substrates.	SEN:10021406	10805725
BEL:20037260	kin(p(HGNC:PIK3C2B)) directlyIncreases a(CHEBI:"1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate")	Both enzymes are characterized by the presence of a C2 domain at the carboxy terminus and, in vitro, preferentially utilize phosphatidylinositol and phosphatidylinositol 4-monophosphate as lipid substrates.	SEN:10021406	10805725
BEL:20037262	kin(p(HGNC:PIK3C2B)) directlyIncreases a(CHEBI:"phosphatidylinositol 3-phosphate")	Both enzymes are characterized by the presence of a C2 domain at the carboxy terminus and, in vitro, preferentially utilize phosphatidylinositol and phosphatidylinositol 4-monophosphate as lipid substrates.	SEN:10021406	10805725
BEL:20037266	kin(p(HGNC:PIK3CG)) increases kin(p(HGNC:AKT1))	The serine/threonine kinase Akt (also known as protein kinase B) (Akt/PKB) is activated upon T-cell antigen receptor (TCR) engagement or upon expression of an active form of phosphatidylinositide (PI) 3-kinase in T lymphocytes.	SEN:10018324	10891487
BEL:20037274	kin(p(HGNC:PLK1)) directlyIncreases p(HGNC:CCNB1,pmod(P))	<C41> Cyclin B is degraded late in mitosis through the ubiquitin-protein ligase (E3) activity of the anaphase-promoting complex, which is probably activated by phosphorylation by Plk1 (Glover et al., 1998).	SEN:10021412	10436023
BEL:20037276	kin(p(HGNC:PLK1)) directlyIncreases p(HGNC:CDC25C,pmod(P))	<C37> The Cdc25C N-terminal domain can also be phosphorylated by Plk1 (Hamanaka et al., 1994). During mitosis, Plk1, by way of its polo boxes, localizes progressively to the centromeres, spindle poles, centrosomes, and spindle midzone or midbody (Glover et al., 1998; Lee et al., 1998c).	SEN:10021414	10436023
BEL:20037280	kin(p(HGNC:PRKCA)) directlyDecreases complex(p(HGNC:STX4),p(HGNC:SNAP23))	In vitro, PKC directly phosphorylated platelet syntaxin 4 and recombinant syntaxin 4. PKC phosphorylation in vitro inhibited (71 +/- 8%) the binding of syntaxin 4 to SNAP-23.	SEN:10021418	10856305
BEL:20037286	kin(p(HGNC:PRKCA)) directlyIncreases p(HGNC:GSK3A,pmod(P,S,21))	Consistent with this in vivo activity, PKAc enzyme efficiently phosphorylated GSK-3a and -b at serine 21 and 9 in vitro (Fig. 4B), which was blocked by addition of the PKA peptide inhibitor (PKI) (26).	SEN:10021422	11035810
BEL:20037288	kin(p(HGNC:PRKCA)) directlyIncreases p(HGNC:GSK3B,pmod(P,S,9))	Consistent with this in vivo activity, PKAc enzyme efficiently phosphorylated GSK-3a and -b at serine 21 and 9 in vitro (Fig. 4B), which was blocked by addition of the PKA peptide inhibitor (PKI) (26).	SEN:10021422	11035810
BEL:20037292	kin(p(HGNC:PRKCA)) directlyIncreases p(HGNC:INSR,pmod(P))	inhibition of PKCalpha expression caused an increase in IRS phosphorylation by the insulin receptor this effect was independent of insulin	SEN:10021424	10497232
BEL:20037296	kin(p(HGNC:PRKCA)) decreases p(HGNC:PDGFRA)	Protein kinase C (PKC) seems to be involved in negative regulation of the alpha -receptor, since overexpression of PKC-alpha suppressed the expression of the alpha -receptor but not the beta -receptor (125).	SEN:10021428	10508235
BEL:20037298	kin(p(HGNC:PRKCA)) directlyIncreases p(HGNC:STX4,pmod(P))	In vitro, PKC directly phosphorylated platelet syntaxin 4 and recombinant syntaxin 4. PKC phosphorylation in vitro inhibited (71 +/- 8%) the binding of syntaxin 4 to SNAP-23.	SEN:10021418	10856305
BEL:20037302	kin(p(HGNC:PRKCA)) decreases r(HGNC:PDGFRA)	Protein kinase C (PKC) seems to be involved in negative regulation of the alpha -receptor, since overexpression of PKC-alpha suppressed the expression of the alpha -receptor but not the beta -receptor (125).	SEN:10021428	10508235
BEL:20037304	kin(p(HGNC:PRKCA)) increases tloc(complex(p(HGNC:S100A8),p(HGNC:S100A9)),GOCCID:0005737,GOCCID:0005856)	Upon the activation of protein kinase C S100A8/A9 heterodimers are released from human monocytes by a novel secretion pathway that is energy-consuming and depends on an intact microtubule network	SEN:10021430	10551823
BEL:20037310	kin(p(HGNC:PRKCD)) directlyIncreases kin(p(HGNC:ABL1))	The present studies demonstrate that treatment of cells with hydrogen peroxide (H(2)O(2)) induces binding of the PKCdelta isoform and the c-Abl protein-tyrosine kinase. The results show that c-Abl phosphorylates PKCdelta in the H(2)O(2) response. We also show that PKCdelta phosphorylates and activates c-Abl in vitro.	SEN:10015764	10713049
BEL:20037312	kin(p(HGNC:PRKCD)) increases p(HGNC:ABL1,pmod(P))	The present studies demonstrate that treatment of cells with hydrogen peroxide (H(2)O(2)) induces binding of the PKCdelta isoform and the c-Abl protein-tyrosine kinase. The results show that c-Abl phosphorylates PKCdelta in the H(2)O(2) response. We also show that PKCdelta phosphorylates and activates c-Abl in vitro.	SEN:10015764	10713049
BEL:20037322	kin(p(HGNC:PRKCD)) decreases tscript(p(HGNC:STAT3))	Finally, we showed that the phosphorylation of Stat3 by PKC delta led to a negative regulation of Stat3 DNA binding and transcriptional activity.	SEN:10005998	10446219
BEL:20037324	kin(p(HGNC:PRKCE)) directlyIncreases p(HGNC:INSR,pmod(P,S))	PKC, a serine kinase, can phosphorylate and inhibit tyrosine kinase activity of the insulin receptor as well as tyrosine phosphorylation of insulin receptor substrate (IRS)-1	SEN:10021436	10905472
BEL:20037332	kin(p(HGNC:PRKCQ)) directlyIncreases p(HGNC:INSR,pmod(P,S))	PKC, a serine kinase, can phosphorylate and inhibit tyrosine kinase activity of the insulin receptor as well as tyrosine phosphorylation of insulin receptor substrate (IRS)-1	SEN:10021436	10905472
BEL:20037340	kin(p(HGNC:PRKCZ)) increases tscript(p(HGNC:SP1))	It has been shown through electrophoretic mobility shift assay that Ras promoted the PKCzeta-induced binding of Sp1 to the VPF/VEGF promoter.	SEN:10006004	11060301
BEL:20037348	kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P))	<B5> DNA-PK phosphorylates itself, thereby blocking its interaction with Ku:DNA complex and inhibiting its kinase activity; it also phosphorylates Ku70 . Ku80, but without effect (Chan and Lees-Miller, 1996).	SEN:10021440	10436023
BEL:20037354	kin(p(HGNC:PRKDC)) decreases r(HGNC:TOMM7)	Therefore, this result suggests that DNA-PK may negatively regulate the transcriptional level of thisgene in M059K cells upon UV damage (50 J/m2), associated with celltoxicity.	SEN:10018246	10647823
BEL:20037360	kin(p(HGNC:PTK2B)) increases kin(p(HGNC:SYK))	Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation.	SEN:10002144	10747947
BEL:20037362	kin(p(HGNC:PTK2)) increases bp(GOBP:"myoblast differentiation")	The degree of FAK activation during myogenesis by b1A-integrin signaling can regulate myoblast progression through proliferation and differentiation (52).	SEN:10018588	10642399
BEL:20037366	kin(p(HGNC:PTK2B)) directlyIncreases p(HGNC:PTK2B,pmod(P,Y,402))	First, we generated site-specific CADTK mutants. Mutation of Tyr402 eliminated autophosphorylation and significantly decreased kinase activity.	SEN:10021442	10085136
BEL:20037370	kin(p(HGNC:PTK2)) increases cat(p(HGNC:PXN))	A downstream target of FAK is paxillin, a phosphoprotein that also can localize to focal adhesion complexes (9).	SEN:10021444	10642399
BEL:20037372	kin(p(HGNC:PTK2)) increases p(HGNC:PXN,pmod(P,Y))	A downstream target of FAK is paxillin, a phosphoprotein that also can localize to focal adhesion complexes (9).	SEN:10021444	10642399
BEL:20037380	kin(p(HGNC:RAF1)) decreases tscript(p(HGNC:"NKX2-1"))	Expression of an activated form of Raf (Raf-BXB) also inhibits TTF-1 function to a similar extent,	SEN:10021452	10733581
BEL:20037382	kin(p(HGNC:RIPK2)) increases bp(GOBP:"apoptotic process")	RIP2 is a serine-threonine kinase associated with the tumor necrosis factor (TNF) receptor complex and is implicated in the activation of NF-kappaB and cell death in mammalian cells.	SEN:10021454	10559258
BEL:20037384	kin(p(HGNC:RIPK2)) increases kin(p(HGNC:MAPK1))	Here we show that RIP2 activates the extracellular signal-regulated kinase (ERK) pathway and that the kinase activity of RIP2 appears to be important in this process.	SEN:10006012	10559258
BEL:20037386	kin(p(HGNC:RIPK2)) increases kin(p(HGNC:MAPK3))	Here we show that RIP2 activates the extracellular signal-regulated kinase (ERK) pathway and that the kinase activity of RIP2 appears to be important in this process.	SEN:10006012	10559258
BEL:20037394	kin(p(HGNC:RIPK2)) directlyIncreases tscript(p(HGNC:ELK1))	RIP2 activates AP-1 and serum response element regulated expression by inducing the activation of the Elk1 transcription factor.	SEN:10006014	10559258
BEL:20037420	kin(p(HGNC:RPS6KA1)) decreases bp(GOBP:"apoptotic process")	Rsk1 directly phosphorylated the pro-apoptotic protein Bad at the serine %residues that, when phosphorylated, abrogate Bad's pro-apoptotic function.	SEN:10000878	10679322
BEL:20037424	kin(p(HGNC:RPS6KA1)) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,32))	Previous studies have suggested a role for the Rsk1 kinase in the PMA induction of NF-kB; however, Rsk1 phosphorylates only S32 of IkBalpha.	SEN:10021460	10882136
BEL:20037432	kin(p(HGNC:RPS6KA3)) increases kin(p(HGNC:PDPK1))	Here, we identify Ser386 in the hydrophobic motif of RSK2 as a phosphorylation-dependent docking site and activator of PDK1	SEN:10021466	10856237
BEL:20037438	kin(p(HGNC:RPS6KA3)) increases p(HGNC:HSF1,pmod(P))	we showed that HSF 1 is phosphorylated by the protein kinase RSK2 in vitro we demonstrate that RSK2 slightly represses activation of HSF1 in vivo	SEN:10021468	11189448
BEL:20037444	kin(p(HGNC:RPS6KA3)) decreases tscript(p(HGNC:HSF1))	we showed that HSF 1 is phosphorylated by the protein kinase RSK2 in vitro we demonstrate that RSK2 slightly represses activation of HSF1 in vivo	SEN:10021468	11189448
BEL:20037450	kin(p(HGNC:SRC)) increases complex(p(HGNC:ACP1),p(HGNC:GRB2))	Tyr131 phosphorylation is followed by a strong (about 25-fold) increase of the enzyme specific activity, whereas phosphorylation at Tyr132 leads to Grb2 recruitment. These differing effects are discussed on the light of the enzyme structure.	SEN:10006032	10452533
BEL:20037462	kin(p(HGNC:SRC)) increases kin(p(HGNC:AKT1))	The downstream targets of Src that lead to the up-regulation of IGF-IR expression were previously unknown. We demonstrate here that AKT regulates IGF-IR expression in PANC-1	SEN:10021118	11212254
BEL:20037464	kin(p(HGNC:SRC)) increases kin(p(HGNC:AKT2))	The downstream targets of Src that lead to the up-regulation of IGF-IR expression were previously unknown. We demonstrate here that AKT regulates IGF-IR expression in PANC-1	SEN:10021118	11212254
BEL:20037466	kin(p(HGNC:SRC)) increases kin(p(HGNC:BMX))	Coexpression of v-Src and Etk led to a transphosphorylation on tyrosine 566 of Etk and subsequent autophosphorylation. These events correlated with a substantial increase in the kinase activity of Etk.	SEN:10006036	10688651
BEL:20037484	kin(p(HGNC:SRC)) increases r(HGNC:IGF1R)	AKT (1 or 2)regulates IGF-IR expression in PANC-1 IGF-IR expression was reported to be up-regulated in the human pancreatic cancer cell line PANC-1 when cells were stably transfected with active Src	SEN:10021478	11212254
BEL:20037486	kin(p(HGNC:SRC)) increases r(HGNC:MMP2)	Inhibiting Src tyrosine kinases with herbimycin A reduced MMP-2 and MMP-9 production with no effect on cell attachment.	SEN:10021480	10515879
BEL:20037488	kin(p(HGNC:SRC)) increases r(HGNC:MMP9)	Inhibiting Src tyrosine kinases with herbimycin A reduced MMP-2 and MMP-9 production with no effect on cell attachment.	SEN:10021480	10515879
BEL:20037490	kin(p(HGNC:SRC)) increases r(HGNC:PLAUR)	A dominant negative inhibitor of c-Src effectively inhibited RalA-dependent uPAR transcription identifying it as a downstream effector in the RalA signalling pathway.	SEN:10021482	11313929
BEL:20037492	kin(p(HGNC:SRC)) decreases r(HGNC:SRPX)	We have previously reported that the drs gene, whose mRNA expression is downregulated by retroviral oncogenes such as v-src and v-K-ras, has the ability to suppress transformation by v-src in a rat cell line F2408.	SEN:10020862	10490811
BEL:20037498	kin(p(HGNC:STK33)) increases cat(p(HGNC:F2R))	treatment of platelets with thromboxane A1 analog, STA2, led to an activation of this protein kinase and phosphorylation of PAR1	SEN:10016480	10780327
BEL:20037500	kin(p(HGNC:STK33)) increases p(HGNC:F2R,pmod(P))	treatment of platelets with thromboxane A1 analog, STA2, led to an activation of this protein kinase and phosphorylation of PAR1	SEN:10016480	10780327
BEL:20037504	kin(p(HGNC:SYK)) increases cat(p(HGNC:FCGR2B))	Inhibition of p72(Syk) by piceatannol resulted in partial or total inhibition of FcgammaRII phosphorylation, after immunological activation or addition of thrombin, respectively, suggesting that p72(Syk) participates in FcgammaRII phosphorylation.	SEN:10006044	10704823
BEL:20037506	kin(p(HGNC:SYK)) increases cat(p(HGNC:SHC1))	More recent studies have suggested that tyrosine kinase (syk)-mediated phosphorylation of shc is responsible for the ras-ERK cascade via the formation of shc-Grb2-Sos2 following stimulation with anti-IgE antibody, but not FMLP, in human basophils	SEN:10006046	10979966
BEL:20037508	kin(p(HGNC:SYK)) increases cat(p(HGNC:VAV1))	Inhibition of Syk activity by piceatannol prevents both in vitro and in vivo Vav tyrosine phosphorylation, its association with the regulatory subunit of phosphoinositide 3-kinase, and the nuclear modifications typically observed during granulocytic differentiation of this cell line.	SEN:10006048	11331248
BEL:20037528	kin(p(HGNC:TGFBR1)) increases complex(p(HGNC:KAT2B),p(HGNC:SMAD3))	Moreover, Smad2 and Smad3 interacted with P/CAF upon TGF-beta type I receptor activation in cultured mammalian cells.	SEN:10021484	11058129
BEL:20037530	kin(p(HGNC:TGFBR1)) increases complex(p(HGNC:SMAD2),p(HGNC:KAT2B))	Moreover, Smad2 and Smad3 interacted with P/CAF upon TGF-beta type I receptor activation in cultured mammalian cells.	SEN:10021484	11058129
BEL:20037538	kin(p(HGNC:TGFBR3)) decreases p(HGNC:CDKN1A)	Each of three Ki-ras(G12V) transfectants responded to TGF-beta1 by an increase in proliferation and by decreasing the abundance of the Cdk inhibitor p21 and the tumor suppressor PTEN, whereas each of three wild-type Ki-ras transfectants remained unresponsive to TGF-beta1.	SEN:10021486	11029459
BEL:20037540	kin(p(HGNC:TGFBR3)) decreases p(HGNC:PTEN)	Each of three Ki-ras(G12V) transfectants responded to TGF-beta1 by an increase in proliferation and by decreasing the abundance of the Cdk inhibitor p21 and the tumor suppressor PTEN, whereas each of three wild-type Ki-ras transfectants remained unresponsive to TGF-beta1.	SEN:10021486	11029459
BEL:20037544	kin(p(HGNC:TNK2)) increases cat(p(HGNC:RASGRF1))	We show here that activated ACK1, a nonreceptor tyrosine kinase that belongs to the focal adhesion kinase family, causes tyrosine phosphorylation of Ras-GRF1.	SEN:10021490	10882715
BEL:20037546	kin(p(HGNC:TNK2)) increases p(HGNC:RASGRF1,pmod(P,Y))	We show here that activated ACK1, a nonreceptor tyrosine kinase that belongs to the focal adhesion kinase family, causes tyrosine phosphorylation of Ras-GRF1.	SEN:10021490	10882715
BEL:20037560	kin(p(HGNC:WEE1)) directlyIncreases p(HGNC:CDK2,pmod(P,Y))	<C27> p45Skp2 inhibits Cdk2 kinase activity and blocks phosphorylation of Cdk2 by Wee1 or CAK (Yam et al., 1999). Similarly to p21Cip1, two molecules of p45Skp2 seem to be required to inhibit Cdk2. Binding to p45Skp2 is mutually exclusive with p21cip1.	SEN:10021494	10436023
BEL:20037562	kin(p(HGNC:YES1)) increases complex(p(HGNC:FYN),p(HGNC:SHC1))	Yes and Lck are known to be enriched in rafts and may mediate the activation of Shc when Fyn is not expressed.	SEN:10021282	10446041
BEL:20037564	kin(p(HGNC:YES1)) directlyIncreases p(HGNC:SHC1,pmod(P,Y,317))	Yes and Lck are known to be enriched in rafts and may mediate the activation of Shc when Fyn is not expressed.	SEN:10021282	10446041
BEL:20037570	kin(p(MGI:Abl1)) increases bp(GOBP:"cell proliferation")	Inactivation of cytoplasmic c-Abl by the kinase-inactive Abl-PP-K(-) (AblP242E/P249E/K290M) or by microinjection of Abl neutralizing antibodies inhibited mitogenesis.	SEN:10021498	11847100
BEL:20037572	kin(p(MGI:Abl1)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	The kinase-inactive SrcK295M induced a G(1) block that was overcome by the constitutively active Abl-PP (AblP242E/P249E). Conversely, the inhibitory effect of Abl-PP-K(-) was not compensated by Src.	SEN:10006056	11847100
BEL:20037582	kin(p(MGI:Abl1)) increases p(MGI:Cdkn1b)	we identify two previously unknown targets of v-Abl signaling: (1) cyclin D1 and D2 mRNAs are induced upon v-Abl activation; and (2) the CDK inhibitor p27 is decreased upon v-Abl activation.	SEN:10006060	10698498
BEL:20037586	kin(p(MGI:Abl1)) increases r(MGI:Ccnd1)	we identify two previously unknown targets of v-Abl signaling: (1) cyclin D1 and D2 mRNAs are induced upon v-Abl activation; and (2) the CDK inhibitor p27 is decreased upon v-Abl activation.	SEN:10006060	10698498
BEL:20037588	kin(p(MGI:Abl1)) increases r(MGI:Ccnd2)	we identify two previously unknown targets of v-Abl signaling: (1) cyclin D1 and D2 mRNAs are induced upon v-Abl activation; and (2) the CDK inhibitor p27 is decreased upon v-Abl activation.	SEN:10006060	10698498
BEL:20037592	kin(p(MGI:Acvrl1)) decreases bp(GOBP:"patterning of blood vessels")	Combined blockade of Alk1 and Notch signaling further exacerbates hypervascularization, whereas activation of Alk1 by its high-affinity ligand BMP9 rescues hypersprouting induced by Notch inhibition	SEN:10021504	22421041
BEL:20037594	kin(p(MGI:Acvrl1)) increases r(MGI:Id1)	BMP9 also activates the Id1 promoter-derived BMP response element (BRE) in a dose-dependent manner (EC50 = 45 +/-; 27 pg/ml) and this activation is abolished by silencing ALK1 expression	SEN:10021506	17068149
BEL:20037598	kin(p(MGI:Adrbk1)) directlyIncreases p(MGI:Scnn1b,pmod(P,S,633))	We identified this kinase to be the G protein-coupled receptor kinase 2 (Grk2), and we showed that it acts on S633 in the C terminus of ?-ENaC. The kinase increases the activity of the channels and renders them insensitive to the ubiquitin protein ligase Nedd4-2.	SEN:10021508	15284439
BEL:20037600	kin(p(MGI:Adrbk1)) increases tport(p(MGI:Scnn1b))	We identified this kinase to be the G protein-coupled receptor kinase 2 (Grk2), and we showed that it acts on S633 in the C terminus of ?-ENaC. The kinase increases the activity of the channels and renders them insensitive to the ubiquitin protein ligase Nedd4-2.	SEN:10021508	15284439
BEL:20037602	kin(p(MGI:Adrbk2)) decreases cat(p(MGI:Oprk1))	The result suggests that tolerance to kappa agonists includes phosphorylation of serine 369 within KOR by GRK3	SEN:10006062	14597630
BEL:20037610	kin(p(MGI:Ak1)) decreases bp(GOBP:glycolysis)	genetic disruption of AK1-catalyzed ss-phosphoryl transfer in mice decreases the potential of myofibers to sustain nucleotide ratios despite up-regulation of high-energy phosphoryl flux through glycolytic, guanylate and creatine kinase phosphotransfer pathways	SEN:10006064	11101510
BEL:20037612	kin(p(MGI:Ak1)) decreases kin(p(MGI:Ckm))	genetic disruption of AK1-catalyzed ss-phosphoryl transfer in mice decreases the potential of myofibers to sustain nucleotide ratios despite up-regulation of high-energy phosphoryl flux through glycolytic, guanylate and creatine kinase phosphotransfer pathways	SEN:10006064	11101510
BEL:20037616	kin(p(MGI:Akt1)) increases a(CHEBI:"nitric oxide")	Mechanistically, the loss of Akt1 reduces the basal phosphorylation of several Akt substrates, the migration of fibroblasts and ECs, and NO release.	SEN:10006066	16075056
BEL:20037618	kin(p(MGI:Akt1)) increases a(CHEBI:"reactive oxygen species")	ROS production with ischemia was significantly reduced in lungs with knockout of Akt1 while the response of Akt2 null lungs to ischemia was similar to wild type (Fig. 4A and B). Thus, Akt1 is required for activation of endothelial ROS production with ischemia.	SEN:10021512	22003059
BEL:20037620	kin(p(MGI:Akt1)) increases bp(GOBP:angiogenesis)	Here we show that the genetic loss of Akt1, but not Akt2, in mice results in defective ischemia and VEGF-induced angiogenesis	SEN:10006068	16075056
BEL:20037622	kin(p(MGI:Akt1)) increases bp(GOBP:"cell migration")	Mechanistically, the loss of Akt1 reduces the basal phosphorylation of several Akt substrates, the migration of fibroblasts and ECs, and NO release.	SEN:10006066	16075056
BEL:20037628	kin(p(MGI:Akt1)) increases kin(p(MGI:Nfkbib))	PI3K activation, however, results in the recruitment of the serine/threonine kinase PDK1 (3-phosphoinositidedependent protein kinase 1) to the plasma membrane, where PDK1 subsequently phosphorylates and activates another serine/threonine kinase, AKT 86. AKT positively regulates the function of the transcription factor NF-kB by phosphorylating inhibitor of NF-kB (IkB), which is a key regulator of NF-kB 87.	SEN:10021054	16470226
BEL:20037632	kin(p(MGI:Akt1)) increases p(MGI:Ccnd1)	Cyclins D1 and D2 but not D3 protein levels were markedly increased in caAktTg/cdk4/ mice (4.1 1 and 1.9 0.1, respectively, P 0.05) (Fig. 1C–E).	SEN:10021518	16443763
BEL:20037634	kin(p(MGI:Akt1)) increases p(MGI:Ccnd2)	Cyclins D1 and D2 but not D3 protein levels were markedly increased in caAktTg/cdk4/ mice (4.1 1 and 1.9 0.1, respectively, P 0.05) (Fig. 1C–E).	SEN:10021518	16443763
BEL:20037636	kin(p(MGI:Akt1)) increases p(MGI:Cdkn1a)	Levels of p21 were significantly increased in caAktTg mice when compared with those of nontransgenic cdk4/ (Fig. 2C). Analysis of p57 expression showed decreased levels in caAktTg mice (Fig. 2C).	SEN:10021520	16443763
BEL:20037638	kin(p(MGI:Akt1)) decreases p(MGI:Cdkn1c)	Levels of p21 were significantly increased in caAktTg mice when compared with those of nontransgenic cdk4/ (Fig. 2C). Analysis of p57 expression showed decreased levels in caAktTg mice (Fig. 2C).	SEN:10021520	16443763
BEL:20037640	kin(p(MGI:Akt1)) increases p(MGI:Foxo1,pmod(P,S,256))	As shown in Fig. 2A, a significant increase in Foxo1 phosphorylation at Ser256 specifically seen in slower migrating bands was obtained in islet lysates from caAktTg/cdk4/ mice.	SEN:10021522	16443763
BEL:20037644	kin(p(MGI:Akt1)) increases p(MGI:Gsk3b,pmod(P,S,9))	Mice overexpressing constitutively active Akt1 in -cells (caAktTg) are in C57/B6 background and have been described previously (13). Low levels of phospho-Ser9 GSK3 staining were observed in nontransgenic cdk4/ mice (Fig. 1A). In contrast, islets from caAktTg mice exhibited striking immunostaining for phospho- Ser9 GSK3 (Fig. 1A).	SEN:10021526	16443763
BEL:20037648	kin(p(MGI:Akt1)) increases p(MGI:Hes1)	We first investigated whether hyperactive mTOR could cause abnormal Notch signaling by monitoring the levels of Hes1, a direct target of Notch. We found that Hes1 protein expression was dramatically elevated in cells with constitutively active mTOR caused by loss of the Tsc2 or Pten tumor suppressor gene or oncogenic myristoylation of AKT1 (myrAKT1) (34) (Figure 2A).	SEN:10021528	20038814
BEL:20037652	kin(p(MGI:Akt1)) increases p(MGI:Mdm2,pmod(P))	The reduced level of p53 protein in myr-Akt1 salivary glands corresponds with an increase in MDM2 phosphorylation in vivo, suggesting that the Akt/MDM2/p53 pathway is responsible for suppression of apoptosis. Dominant-negative Akt blocked phosphorylation of MDM2 in salivary acinar cells from myr-Akt1 transgenic mice.	SEN:10021532	16982679
BEL:20037654	kin(p(MGI:Akt1)) decreases p(MGI:Msr1)	Insr(-/-) macrophages showed diminished Akt phosphorylation and an augmented ER stress response, leading to induction of scavenger receptor A and increased apoptosis when challenged with cholesterol loading or nutrient deprivation.	SEN:10004134	16581003
BEL:20037656	kin(p(MGI:Akt1)) directlyIncreases p(MGI:Nos3,pmod(P,S,1176))	Akt, a serine/threonine kinase that is a major target of phosphatidylinositol 3-kiniase (PI3K), phosphorylates eNOS at Ser1177, and this phosphorylation enhances eNOS activity and increases NO production in vascular endothelial cells.	SEN:10019394	17000928
BEL:20037658	kin(p(MGI:Akt1)) increases p(MGI:Rb1,pmod(P,S,773))	Phosphorylation of Ser780 in pRb protein is mediated by the cyclin D1/cdk4 complex (30). A significant increase in endogenous Rb phosphorylation at Ser780 was observed in islets from caAktTg mice, suggesting that cdk4 activity is augmented (Fig. 4B) (P 0.05).	SEN:10021020	16443763
BEL:20037662	kin(p(MGI:Akt1)) increases p(MGI:Trp63)	Both TA-p63 and deltaN-p63 were overexpressed in cells with mTOR activation because of either a lack of Tsc2 or Pten or expression of AKT1-E17K, and were repressed by rapamycin	SEN:10021534	20038814
BEL:20037668	kin(p(MGI:Akt1)) decreases r(MGI:Ckm)	Heterologous expression of Akt1/PKB(alpha) potently suppressed MCK gene transcription without affecting myogenin gene transcription, whereas heterologous expression of Akt2 increased myogenin and MCK gene transcription.	SEN:10021536	11861503
BEL:20037670	kin(p(MGI:Akt1)) increases r(MGI:Jag1)	upregulation of Jagged1 by mTOR was due, at least in part, to higher levels of Jagged1 mRNA in the Tsc2-null and mutant AKT-expressing cell lines (Figure 3B) and appeared to be directly responsible for Notch activation and Hes1 expression, as these were blocked by decreased Jagged1 expression using siRNA (Figure 3C).	SEN:10021538	20038814
BEL:20037684	kin(p(MGI:Akt1)) decreases tscript(p(MGI:Foxo3))	we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.	SEN:10021546	15109499
BEL:20037690	kin(p(MGI:Akt2)) increases r(MGI:Ckm)	Heterologous expression of Akt1/PKB(alpha) potently suppressed MCK gene transcription without affecting myogenin gene transcription, whereas heterologous expression of Akt2 increased myogenin and MCK gene transcription.	SEN:10021536	11861503
BEL:20037692	kin(p(MGI:Akt2)) increases r(MGI:Myog)	Heterologous expression of Akt1/PKB(alpha) potently suppressed MCK gene transcription without affecting myogenin gene transcription, whereas heterologous expression of Akt2 increased myogenin and MCK gene transcription.	SEN:10021536	11861503
BEL:20037712	kin(p(MGI:Atm)) increases p(MGI:Rad51)	Furthermore, inhibition of ATM/ATR kinases abolishes both induction of Rad51 and phosphorylation of p53 and reduced the level of apoptosis induced by coexpression of oncogenes and ARF (Pauklin et al., 2005).	SEN:10021552	18955973
BEL:20037714	kin(p(MGI:Atm)) increases p(MGI:Trp53,pmod(P))	Furthermore, inhibition of ATM/ATR kinases abolishes both induction of Rad51 and phosphorylation of p53 and reduced the level of apoptosis induced by coexpression of oncogenes and ARF (Pauklin et al., 2005).	SEN:10021552	18955973
BEL:20037718	kin(p(MGI:Aurka)) directlyIncreases p(MGI:Brca1,pmod(P,S,308))	We propose that BRCA1 phosphorylation by Aurora-A plays a role in G(2) to M transition of cell cycle.	SEN:10021560	14990569
BEL:20037722	kin(p(MGI:Bcr)) directlyIncreases p(MGI:Pparg,pmod(P,S,82))	Point-mutation and in vitro kinase analyses showed that PPARgamma was phosphorylated by Bcr at serine 82.	SEN:10021562	19023129
BEL:20037726	kin(p(MGI:Bcr)) directlyDecreases tscript(p(MGI:Pparg))	Overexpression of Bcr significantly inhibited PPARgamma activity. In contrast, knockdown of Bcr using Bcr small interfering RNA and a dominant-negative form of Bcr (DN-Bcr) reversed Ang II-mediated inhibition of PPARgamma activity significantly, suggesting the critical role of Bcr in Ang II-mediated inhibition of PPARgamma activity.	SEN:10006080	19023129
BEL:20037728	kin(p(MGI:Bcr)) directlyDecreases tscript(p(MGI:Pparg))	Overexpression of wild-type Bcr kinase did not inhibit ligand-mediated PPARgamma1 S82A mutant transcriptional activity, indicating that Bcr regulates PPARgamma activity via S82 phosphorylation.	SEN:10021564	19023129
BEL:20037738	kin(p(MGI:Braf)) increases kin(p(MGI:Map2k1))	Similar observation that immunoprecipitated B-Raf from EGF-stimulated Swiss3T3 cells could activate both MEK1 and MEK2 was also obtained (data not shown).	SEN:10021570	8621729
BEL:20037740	kin(p(MGI:Braf)) increases kin(p(MGI:Map2k2))	Similar observation that immunoprecipitated B-Raf from EGF-stimulated Swiss3T3 cells could activate both MEK1 and MEK2 was also obtained (data not shown).	SEN:10021570	8621729
BEL:20037742	kin(p(MGI:Braf)) increases path(MESHD:Neoplasms)	The effect of inactivating Icmt was not limited to the inhibition of K-Ras-induced transformation: inactivation of Icmt blocked transformation by an oncogenic form of B-Raf	SEN:10000338	14966563
BEL:20037746	kin(p(MGI:Braf)) increases tscript(p(MGI:Elk1))	calcium-independent pathways are accounted for in part by MAPK activation (Rap1/B-Raf/MAPK-ERK kinase/ERK1/2) AtT-20 corticotrophs express B-Raf, as do other cells in which cAMP stimulates MAPK. CRH/cAMP stimulated ERK2 (Mapk1) activity and increased transcriptional activity of a Gal4-Elk1 protein, which was blocked by overexpression of dominant negative mutants and kinase inhibitors and stimulated by expression of B-Raf.	SEN:10019824	12089357
BEL:20037750	kin(p(MGI:Btk)) increases kin(p(MGI:Prkcb))	We also examined the effect of terreic acid, a specific inhibitor of Btk (35), on PKCs in mast cells. Terreic acid inhibited the autophosphorylating activity of PKCbI ... Furthermore, the Fc«RI-induced activation of PKCbI was enhanced in btk2 mast cells by transfecting with wt btk cDNA, but not empty vector or kinase-dead (K430R) btk cDNA (8) (Fig. 1E).	SEN:10021574	10852954
BEL:20037758	kin(p(MGI:Camk4)) increases cat(p(MGI:Cpt1b))	Calcineurin Directly Induces Transcription of the PPARA Target Gene, M-CPT I. muscle-type carnitine palmitoyltransferase I or M-CPT I, which catalyzes the rate-limiting step of fatty acid oxidation, was activated by both Cn and CaMK.	SEN:10021576	15262994
BEL:20037762	kin(p(MGI:Camk4)) increases p(MGI:Ppargc1a)	calcium/calmodulin-dependent protein kinase IV induces the expression of PGC-1 in transgenic mice that selectively express a constitutively active form of the kinase in skeletal muscle. PGC-1 binds to various transcription factors to maximize transcriptional activity, and leads to up-regulation of mitochondrial enzymes involved in fatty acid metabolism and electron transport, as well as mitochondrial DNA replication	SEN:10021580	16568236
BEL:20037764	kin(p(MGI:Camk4)) increases r(MGI:Ppargc1a)	Specifically, Cn and CaMK have been shown to activate PGC-1a gene transcription through myocyte enhancer factor 2 (MEF2) and cAMP response element binding protein (12). in transgenic mice skeletal muscle specific overexpression of Cn* or CaMK* results in increased expression of PGC-1a (7,13).	SEN:10021582	15262994
BEL:20037766	kin(p(MGI:Camk4)) increases tscript(p(MGI:Creb1))	CaMKIV activates PGC-1alpha largely through the binding of cAMP response element-binding protein to the PGC-1alpha promoter.	SEN:10006084	12764228
BEL:20037774	kin(p(MGI:Cdk2)) increases deg(p(MGI:Cdkn1b))	We further show that cyclin E-CDK2-dependent phosphorylation of p27 results in elimination of p27 from the cell, allowing cells to transit from G1 to S phase.	SEN:10020208	9192873
BEL:20037780	kin(p(MGI:Cdk2)) directlyIncreases p(MGI:Cdkn1b,pmod(P,T,187))	We show that expression of cyclin E-CDK2 in murine fibroblasts causes phosphorylation of the CDK inhibitor p27Kip1 on T187, and that cyclin E-CDK2 can directly phosphorylate p27 T187 in vitro.	SEN:10021588	9192873
BEL:20037788	kin(p(MGI:Cdk2)) decreases r(MGI:Ckm)	In contrast, ectopic expression of cyclin A or cyclin E inhibits MCK expression only when they are co-expressed with their catalytic partner cyclin-dependent kinase 2 (Cdk2).	SEN:10021594	8995365
BEL:20037808	kin(p(MGI:Cdk5)) increases path(MESHD:"Insulin Resistance")	All these findings strongly suggest that Cdk5-mediated phosphorylation of PPARgamma may be involved in the pathogenesis of insulin-resistance	SEN:10006090	20651683
BEL:20037810	kin(p(MGI:Cdk5)) directlyIncreases kin(p(EGID:18555))	Pctaire1 can be phosphorylated by the Cdk5/p25 complex, and serine 95 is the major phosphorylation site. In brain and muscle of Cdk5 null mice, Pctaire1 activity is significantly reduced Pctaire1 interacts with p35, both in vitro and in vivo, and that phosphorylation of Pctaire1 by Cdk5 enhances its kinase activity.	SEN:10021608	12084709
BEL:20037812	kin(p(MGI:Cdk5)) directlyIncreases p(EGID:18555,pmod(P,S,95))	Pctaire1 can be phosphorylated by the Cdk5/p25 complex, and serine 95 is the major phosphorylation site. In brain and muscle of Cdk5 null mice, Pctaire1 activity is significantly reduced Pctaire1 interacts with p35, both in vitro and in vivo, and that phosphorylation of Pctaire1 by Cdk5 enhances its kinase activity.	SEN:10021608	12084709
BEL:20037820	kin(p(MGI:Cdk6)) decreases bp(GOBP:"Wnt receptor signaling pathway")	hus, the CCND1-CDK6 complex is like to negatively regulate Wnt signaling by mediating beta-catenin phosphorylation and its subsequent degradation in Wnt-stimulated cells.	SEN:10005398	17208333
BEL:20037822	kin(p(MGI:Chek1)) decreases path(MESHD:Neoplasms)	CHK1 heterozygosity modestly enhances the tumorigenesis phenotype of WNT-1 transgenic mice. Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression	SEN:10021610	10859164
BEL:20037832	kin(p(MGI:Chuk)) increases deg(p(MGI:Nfkbia))	This finding agrees with previous studies that showed that IkBa is a better substrate for the IKKs than IkBb (17). The kinetics of IkBa and IkBb phosphorylation were coincident with the degradation of endogenous IkBa as well as the appearance of DNA-binding NF-kB complexes in the nucleus at approximately 15–30 min (Fig. 1B, bottom three panels).	SEN:10021614	10553070
BEL:20037834	kin(p(MGI:Chuk)) increases deg(p(MGI:Nfkbia))	The IkappaB kinases, IKK1 and IKK2, have been implicated in both IkappaB degradation and subsequent modifications of NFkappaB.	SEN:10006102	14585967
BEL:20037836	kin(p(MGI:Chuk)) increases deg(p(MGI:Nfkbib))	This finding agrees with previous studies that showed that IkBa is a better substrate for the IKKs than IkBb (17). The kinetics of IkBa and IkBb phosphorylation were coincident with the degradation of endogenous IkBa as well as the appearance of DNA-binding NF-kB complexes in the nucleus at approximately 15–30 min (Fig. 1B, bottom three panels).	SEN:10021614	10553070
BEL:20037838	kin(p(MGI:Chuk)) directlyDecreases p(MGI:Nfkbia)	This finding agrees with previous studies that showed that IkBa is a better substrate for the IKKs than IkBb (17). The kinetics of IkBa and IkBb phosphorylation were coincident with the degradation of endogenous IkBa as well as the appearance of DNA-binding NF-kB complexes in the nucleus at approximately 15–30 min (Fig. 1B, bottom three panels).	SEN:10021614	10553070
BEL:20037850	kin(p(MGI:Csf1r)) directlyIncreases p(MGI:Ctnnd1,pmod(P,Y))	A novel protein tyrosine kinase (PTK) substrate, p120, has been previously implicated in ligand-induced signaling through the epidermal growth factor, platelet-derived growth factor and colony-stimulating factor 1 receptors	SEN:10021620	1334250
BEL:20037854	kin(p(MGI:Csk)) decreases p(MGI:Bcar1,pmod(P,Y))	The Cas-associated tyrosine kinase activity was remarkably elevated in Csk-/- cells, which resulted in hyperphosphorylation of cellular Cas.	SEN:10021622	9136985
BEL:20037858	kin(p(MGI:Csnk1a1)) directlyIncreases p(MGI:Cdh1,pmod(P))	CK1 phosphorylation of E-cadherin increased the binding affinity to beta-catenin from approximately 230 to 4 nM.	SEN:10021624	16945320
BEL:20037866	kin(p(MGI:Csnk2a1)) increases tscript(p(MGI:Myf6))	we demonstrate that overexpression of CKII increases the transcriptional activities of MRF4 and MyoD in vivo.	SEN:10006112	8657135
BEL:20037868	kin(p(MGI:Csnk2a1)) increases tscript(p(MGI:Myod1))	we demonstrate that overexpression of CKII increases the transcriptional activities of MRF4 and MyoD in vivo.	SEN:10006112	8657135
BEL:20037870	kin(p(MGI:Csnk2a1)) increases tscript(p(MGI:Nfe2l1))	In a gel shift analysis, this bacterially expressed splice variant binds to the TNFalpha promoter site after in vitro phosphorylation by casein kinase II (CKII). In addition, cotransfection studies demonstrate that this splice variant mediates induced transcription at the TNFalpha promoter after stimulation/activation in a heterologous system.	SEN:10006114	9580677
BEL:20037874	kin(p(MGI:Csnk2a2)) directlyIncreases p(MGI:Cdh1,pmod(P))	A similar increase in affinity, from 260 to 4 nM, was obtained with CK2 phosphorylation of E-cadherin.	SEN:10021628	16945320
BEL:20037876	kin(p(MGI:Csnk2a2)) directlyIncreases p(MGI:Rplp0,pmod(P))	These studies demonstrate that exogenous CK II and a ribosome-bound, CK II-like enzyme phosphorylate the ribosomal P proteins in vitro and localize the target site for phosphorylation to the COOH terminus.	SEN:10021630	1856214
BEL:20037888	kin(p(MGI:Egfr)) increases bp(GOBP:"cell differentiation")	observations that inhibition of PI3K or EGF-R is sufficient to prevent terminal differentiation in keratinocytes in suspension (Rodeck et al., 1997; Nikolopoulos et al., 2005), and that function disrupting antibodies to E-cadherin abrogate Akt phosphorylation inducing growth arrest and terminal differentiation in conventional submerged mouse keratinocyte cultures at confluency (Calautti et al., 2005).	SEN:10021638	18268536
BEL:20037894	kin(p(MGI:Egfr)) increases kin(p(MGI:Fyn))	EGF-R causes disassembly of hemidesmosomes by activating Fyn, which in turn phosphorylates the beta4 cytoplasmic domain. Neoplastic cells expressing dominant negative Fyn display increased hemidesmosomes and migrate poorly in vitro in response to EGF.	SEN:10021644	11684709
BEL:20037898	kin(p(MGI:Egfr)) increases kin(p(MGI:Src))	The stimulatory EGFR signal is insensitive to inhibition of JAKs and appears to involve Src kinases and STAT proteins as shown by inhibition through overexpression of C-terminal Src kinase (Csk) and transdominant negative STAT3, respectively	SEN:10001634	10462375
BEL:20037902	kin(p(MGI:Egfr)) directlyIncreases p(MGI:Eps8,pmod(P,Y))	Eps8 protein, which contains an SH3 domain, is coupled functionally and physically to the EGFR and is tyrosine phosphorylated by this receptor	SEN:10021650	9365239
BEL:20037904	kin(p(MGI:Egfr)) decreases p(MGI:Npr3)	The EGF effect depended on activation of its receptor tyrosine kinase but not on that of protein kinase C, mitogen-activated protein kinases, or phosphoinositide-3 kinase.	SEN:10021652	11457715
BEL:20037912	kin(p(MGI:Egfr)) increases r(MGI:Alox5)	As shown in Figs. 6B and C, acrolein induced 5-LO expression was inhibited in a dose-dependent manner by pretreatment with AG1478...These results indicate that acrolein increased 5-LO expression through activation of the EGFR pathway.	SEN:10021654	20153347
BEL:20037914	kin(p(MGI:Egfr)) decreases r(MGI:Clu)	EGF strongly inhibited the expression of WDNM1 and SGP-2 genes. Our recent results are reviewed and discussed.	SEN:10005438	9854140
BEL:20037916	kin(p(MGI:Egfr)) decreases r(MGI:Wfdc18)	EGF strongly inhibited the expression of WDNM1 and SGP-2 genes. Our recent results are reviewed and discussed.	SEN:10005438	9854140
BEL:20037918	kin(p(MGI:Egfr)) decreases r(MGI:Npr3)	The EGF effect depended on activation of its receptor tyrosine kinase but not on that of protein kinase C, mitogen-activated protein kinases, or phosphoinositide-3 kinase.	SEN:10021652	11457715
BEL:20037924	kin(p(MGI:Egfr)) increases tloc(p(MGI:Rasa2),GOCCID:0005737,GOCCID:0005886)	Here, using rat pheochromocytoma PC12 cells transiently transfected with a plasmid expressing a chimera of green fluorescent protein fused to GAP1(m) (GFP-GAP1(m)), we show that epidermal growth factor (EGF) induces a rapid (less than 60 seconds) recruitment of GFP-GAP1(m) from the cytosol to the plasma membrane.	SEN:10017208	10074452
BEL:20037928	kin(p(MGI:Egfr)) increases tscript(p(MGI:Stat3))	The stimulatory EGFR signal is insensitive to inhibition of JAKs and appears to involve Src kinases and STAT proteins as shown by inhibition through overexpression of C-terminal Src kinase (Csk) and transdominant negative STAT3, respectively	SEN:10001634	10462375
BEL:20037930	kin(p(MGI:Egfr)) increases tscript(p(MGI:Stat3))	Experiments in primary mammary epithelial cells and transfected COS-7 cells revealed a p44/42 MAPK and EGFR-dependent Stat3 activation.	SEN:10021658	15292206
BEL:20037932	kin(p(MGI:Egfr)) increases tscript(p(MGI:Stat3))	In vivo, b4-integrin amplifies proproliferative signals in basal epidermal keratinocytes (Nikolopoulos et al., 2005), where STAT3 is expressed and can be activated by EGF/EGF-R (Nishio et al., 2001; Chan et al., 2004; Li et al., 2007)	SEN:10021660	18268536
BEL:20037934	kin(p(MGI:Eif2ak2)) increases kin(p(MGI:Mapk1))	since in PKR-null MEFs there is a marked defect in Erk1 and Erk2 activation by PDGF (Figure1D), it appears that PKR is involved in serine phosphorylation of Stat3 through the activation of Erks.	SEN:10021662	11350938
BEL:20037936	kin(p(MGI:Eif2ak2)) increases kin(p(MGI:Mapk3))	since in PKR-null MEFs there is a marked defect in Erk1 and Erk2 activation by PDGF (Figure1D), it appears that PKR is involved in serine phosphorylation of Stat3 through the activation of Erks.	SEN:10021662	11350938
BEL:20037938	kin(p(MGI:Eif2ak2)) increases p(MGI:Stat3,pmod(P,S,727))	Whereas PKR+/+ cells exhibited a clear induction in phospho-Ser727 Stat3, PKR-null cells were defective in this process (Figure1B)	SEN:10021664	11350938
BEL:20037940	kin(p(MGI:Eif2ak2)) increases r(MGI:Bax)	Our studies demonstrated that activation of PKR induces the expression of members of the tumor necrosis factor receptor (TNFR) family, including Fas (CD95/Apo-1) and pro-apopotic Bax	SEN:10006122	9843495
BEL:20037942	kin(p(MGI:Eif2ak2)) increases r(MGI:Fas)	Our studies demonstrated that activation of PKR induces the expression of members of the tumor necrosis factor receptor (TNFR) family, including Fas (CD95/Apo-1) and pro-apopotic Bax	SEN:10006122	9843495
BEL:20037944	kin(p(MGI:Eif2ak2)) increases tscript(p(MGI:Stat3))	Accordingly, nuclear extracts prepared from PDGF-treated PKR- null cells were severely deficient in Stat3 containing DNA-binding complexes compared with wild-type MEFs (data not shown). Taken together, we conclude that PDGF-induced activation of Stat3 DNA binding is PKR dependent.	SEN:10021666	11350938
BEL:20037946	kin(p(MGI:Eif2ak3)) decreases bp(GOBP:"cell death")	The extensive beta-cell death in PERK-/- islets appears to be caused by the accumulation of unfolded proteins in the ER, as suggested by abnormal ER morphology in PERK-/- cells (10).	SEN:10021668	12588811
BEL:20037948	kin(p(MGI:Eif2ak3)) directlyDecreases complex(p(MGI:Keap1),p(MGI:Nfe2l2))	PERK-dependent phosphorylation triggers dissociation of Nrf2/Keap1 complexes and inhibits reassociation of Nrf2/Keap1 complexes in vitro.	SEN:10006124	14517290
BEL:20037956	kin(p(MGI:Eif2ak3)) increases p(MGI:Eif2s1,pmod(P))	Inactivation of PERK resulted in a dramatic decrease in the phosphorylated form of eIF-2alpha in the pancreas (13).	SEN:10021674	12588811
BEL:20037962	kin(p(MGI:Eif2ak3)) increases r(MGI:Atf4)	Phosphorylation of eIF2alpha results in inhibition of general protein synthesis ( ) and selective activation of ATF4 transcription that up-regulates CHOP gene expression, which in turn causes islet beta-cell apoptosis.	SEN:10021676	12588811
BEL:20037964	kin(p(MGI:Eif2ak3)) increases r(MGI:Egr1)	We also observe an approximately 2 fold PERK-dependent increase in egr-1 mRNA levels in response to CPA at 1 h;	SEN:10021678	16124869
BEL:20037966	kin(p(MGI:Eif2ak3)) increases r(MGI:Hspa5)	Mammalian cells respond to endoplasmic reticulum (ER) stress by attenuation of protein translation The disruption of PERK function or the blocking of eIF2alpha Ser51 phosphorylation fails to attenuate translation after ER stress and also results in substantial impairment of Grp78/BiP induction by ER stress.	SEN:10021680	12871976
BEL:20037968	kin(p(MGI:Eif2ak3)) increases r(MGI:Myc)	In cells treated with DTT, the level of c-myc mRNA was not increased until 2 h after treatment in wild-type cells (Figure 2B). By contrast, no significant change in c-myc mRNA levels was observed in Perk-/- MEFs upon DTT treatment (Figure 2B), indicating that the induction of c-myc expression by DTT is PERK-dependent.	SEN:10016832	16124869
BEL:20037988	kin(p(MGI:Erbb2)) increases p(MGI:Errfi1)	The ErbB-2 interacting protein receptor-associated late transducer (RALT) was previously identified as a feedback inhibitor of ErbB-2 mitogenic signals.	SEN:10021688	12833145
BEL:20037994	kin(p(MGI:Ern1)) increases cat(p(MGI:Tnfrsf1a))	We also found that TNFR1 functions downstream of IRE1 and that IRE1 is present in the same complex with TNFR1 under ER stress condition. Therefore, our study shows a novel role of TNFR1 in mediating ER stress-induced JNK activation.	SEN:10004132	16680093
BEL:20037996	kin(p(MGI:Ern1)) increases kin(p(MGI:Mapk8))	ER stress led to a twofold increase in JNK activity in wild-type fibroblasts, whereas in the IRE1alpha-^sup 1^- fibroblasts JNK activity was decreased by ER stress (Fig. 2B).	SEN:10016334	10650002
BEL:20038008	kin(p(MGI:Fgfr1)) increases r(MGI:Ctsk)	FGF-2 (>/=10(-12) m) also increased cathepsin K and MMP-9 mRNA levels in mouse and rabbit osteoclasts. Among FGF receptors (FGFR1 to 4) only FGFR1 was detected on isolated mouse osteoclasts, whereas all FGFRs were identified on mouse osteoblasts.	SEN:10021692	10896947
BEL:20038010	kin(p(MGI:Fgfr1)) increases r(MGI:Mmp9)	FGF-2 (>/=10(-12) m) also increased cathepsin K and MMP-9 mRNA levels in mouse and rabbit osteoclasts. Among FGF receptors (FGFR1 to 4) only FGFR1 was detected on isolated mouse osteoclasts, whereas all FGFRs were identified on mouse osteoblasts.	SEN:10021692	10896947
BEL:20038016	kin(p(MGI:Fgfr2)) increases bp(GOBP:"MAPK cascade")	FGFs activate the endogenous FGFRs leading to the formation of a Grb2/FRS2/Shp2 complex and activation of MAP kinase.	SEN:10006144	10851026
BEL:20038018	kin(p(MGI:Fgfr2)) increases complex(p(MGI:Frs2),p(MGI:Grb2),p(MGI:Ptpn11))	FGFs activate the endogenous FGFRs leading to the formation of a Grb2/FRS2/Shp2 complex and activation of MAP kinase.	SEN:10006144	10851026
BEL:20038020	kin(p(MGI:Fgfr2)) increases r(MGI:Dach1)	Immunolocalization of FGFR2 and FGFR3 revealed overlap with Dach1 expression during skeletal patterning and chondrocyte maturation. We conclude that Dach1 is a target gene of FGF signaling during limb skeletal development, and Dach1 may function as an intermediary in the FGF signaling pathway regulating cell proliferation or differentiation.	SEN:10021696	12203718
BEL:20038022	kin(p(MGI:Fgfr2)) increases r(MGI:Frs2)	On the other hand, FRS2 expression seemed to be up-regulated slightly in the FGF8-stimulated cells	SEN:10021698	15897591
BEL:20038026	kin(p(MGI:Fgfr3)) increases r(MGI:Dach1)	Immunolocalization of FGFR2 and FGFR3 revealed overlap with Dach1 expression during skeletal patterning and chondrocyte maturation. We conclude that Dach1 is a target gene of FGF signaling during limb skeletal development, and Dach1 may function as an intermediary in the FGF signaling pathway regulating cell proliferation or differentiation.	SEN:10021696	12203718
BEL:20038028	kin(p(MGI:Fgfr3)) increases r(MGI:Frs2)	On the other hand, FRS2 expression seemed to be up-regulated slightly in the FGF8-stimulated cells	SEN:10021698	15897591
BEL:20038030	kin(p(MGI:Fgfr4)) increases r(MGI:Frs2)	On the other hand, FRS2 expression seemed to be up-regulated slightly in the FGF8-stimulated cells	SEN:10021698	15897591
BEL:20038032	kin(p(MGI:Flt1)) increases bp(GOBP:"macrophage activation")	moreover, migration of macrophages was suppressed in VEGFR1 kinase domain-deifient mice, suggesting that signaling through this receptor may play a role in regulation of monocyte/macrophage functions in vivo	SEN:10021702	11350732
BEL:20038072	kin(p(MGI:Fyn)) directlyIncreases cat(p(MGI:Gab2))	Both Fyn and Hck phosphorylate the adaptor protein Gab2 to activate PI3K signaling and promote microtubule formation that is important for granule translocation to the plasma membrane (9, 11).	SEN:10019124	20944008
BEL:20038074	kin(p(MGI:Fyn)) decreases deg(p(MGI:Agap2))	Employing fyn-deficient mouse embryonic fibroblast cells and tissues, we demonstrate that fyn is essential for phosphorylating PIKE-A and protects it from apoptotic cleavage. Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues.	SEN:10006152	16841086
BEL:20038082	kin(p(MGI:Fyn)) increases kin(p(MGI:Skap2))	Transient expression of mSKAP55R in COS cells demonstrated that tyrosine 260 was the predominant site of phosphorylation by FYN kinase. Furthermore, this phosphotyrosine was essential for coimmunoprecipitation of FYN with mSKAP55R	SEN:10006154	11063873
BEL:20038088	kin(p(MGI:Fyn)) directlyIncreases p(MGI:Agap2,pmod(P,Y,682))	Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues.	SEN:10021720	16841086
BEL:20038090	kin(p(MGI:Fyn)) directlyIncreases p(MGI:Agap2,pmod(P,Y,774))	Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues.	SEN:10021720	16841086
BEL:20038098	kin(p(MGI:Fyn)) directlyIncreases p(MGI:Itgb4,pmod(P,Y))	EGF-R causes disassembly of hemidesmosomes by activating Fyn, which in turn phosphorylates the beta4 cytoplasmic domain. Neoplastic cells expressing dominant negative Fyn display increased hemidesmosomes and migrate poorly in vitro in response to EGF.	SEN:10021644	11684709
BEL:20038104	kin(p(MGI:Fyn)) directlyIncreases p(MGI:Prkcd,pmod(P,Y))	However, purified EGFR did not phosphorylate recombinant PKC delta in vitro, whereas members of the Src family (c-Src, c-Fyn) and membrane preparations from keratinocytes did.	SEN:10021722	8621384
BEL:20038120	kin(p(MGI:Gck)) increases bp(GOBP:glycolysis)	Hepatic glucokinase (GK)1 catalyzes the phosphorylation of glucose to glucose 6-phosphate (G6P), a key step of glycolysis, glycogen synthesis, and pentose phosphate pathway (1).	SEN:10021724	14985368
BEL:20038124	kin(p(MGI:Gck)) increases r(MGI:Acaca)	acute stimulation by glucose of l-pyruvate kinase (l-PK), fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and Spot 14 genes requires GK expression.	SEN:10006158	14985368
BEL:20038126	kin(p(MGI:Gck)) increases r(MGI:Fasn)	acute stimulation by glucose of l-pyruvate kinase (l-PK), fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and Spot 14 genes requires GK expression.	SEN:10006158	14985368
BEL:20038128	kin(p(MGI:Gck)) increases r(MGI:Mlxipl)	Our studies also reveal that the loss of glucose effect observed in hGK-KO hepatocytes is associated with a decreased in the carbohydrate responsive element-binding protein (ChREBP) gene expression	SEN:10006160	14985368
BEL:20038130	kin(p(MGI:Gck)) increases r(MGI:Pklr)	acute stimulation by glucose of l-pyruvate kinase (l-PK), fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and Spot 14 genes requires GK expression.	SEN:10006158	14985368
BEL:20038132	kin(p(MGI:Gck)) increases r(MGI:Thrsp)	acute stimulation by glucose of l-pyruvate kinase (l-PK), fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and Spot 14 genes requires GK expression.	SEN:10006158	14985368
BEL:20038142	kin(p(MGI:Gsk3b)) decreases bp(GOBP:"cell growth")	Inhibition of glycogen synthase kinase-3beta by a dominant negative mutant (Rommel et al. 2001) or by LiCl (Vyas et al. 2002) is associated with an enlargement of C2C12 myotubes in culture.	SEN:10016982	12205177
BEL:20038144	kin(p(MGI:Gsk3b)) increases bp(GOBP:"apoptotic process")	we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3beta inhibitors lithium chloride and SB216763, and by GSK-3beta knockdown using short interfering RNA.	SEN:10018856	17666435
BEL:20038146	kin(p(MGI:Gsk3b)) increases cat(p(MGI:Casp2))	we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3beta inhibitors lithium chloride and SB216763, and by GSK-3beta knockdown using short interfering RNA.	SEN:10018856	17666435
BEL:20038148	kin(p(MGI:Gsk3b)) increases deg(p(MGI:Ctnnb1))	The accumulation of beta-catenin results from the inhibition of the GSK3b kinase, which normally would phosphorylate beta-catenin as a degradation signal.	SEN:10018280	15225871
BEL:20038156	kin(p(MGI:Gsk3b)) decreases p(MGI:Ctnnb1)	The accumulation of beta-catenin results from the inhibition of the GSK3b kinase, which normally would phosphorylate beta-catenin as a degradation signal.	SEN:10018280	15225871
BEL:20038160	kin(p(MGI:Gsk3b)) directlyIncreases p(MGI:Mycn,pmod(P,T,50))	We report that phosphorylation-induced turnover of endogenous N-myc protein in CGNPs increases during mitosis, due to increased priming phosphorylation of N-myc for GSK-3beta. The priming phosphorylation requires the Cdk1 complex, whose cyclin subunits are indirect Sonic hedgehog targets	SEN:10021092	16139224
BEL:20038174	kin(p(MGI:Hck)) directlyIncreases cat(p(MGI:Gab2))	Both Fyn and Hck phosphorylate the adaptor protein Gab2 to activate PI3K signaling and promote microtubule formation that is important for granule translocation to the plasma membrane (9, 11).	SEN:10019124	20944008
BEL:20038180	kin(p(MGI:Hck)) increases p(MGI:Stat5b,pmod(P,Y,699))	We show here that the BCR/ABL SH3 and SH2 domains interact with hematopoietic cell kinase (Hck), leading to the stimulation of Hck catalytic activity. Active Hck phosphorylated STAT5B on Tyr699, which represents an essential step in STAT5B stimulation.	SEN:10021734	12411494
BEL:20038184	kin(p(MGI:Hk2)) increases a(CHEBI:"lactic acid")	Increased HK activity was also associated with increased glucose (Glc) utilization and lactate accumulation	SEN:10006170	12110510
BEL:20038198	kin(p(MGI:Igf1r)) increases kin(p(MGI:Pik3ca))	Cardiac hypertrophy induced by over-expression of IGF1R was completely blocked by a dominant negative PI3K(p110alpha) mutant, suggesting IGF1R promotes compensated cardiac hypertrophy in a PI3K(p110alpha) dependent manner.	SEN:10021742	14597618
BEL:20038208	kin(p(MGI:Igf1r)) increases r(MGI:Socs3)	SOCS-3 gene expression is induced, at least in part, by activation of the IGF-I receptor during myoblast differentiation.	SEN:10006172	15653674
BEL:20038226	kin(p(MGI:Ikbkb)) increases path(MESHD:"Insulin Resistance")	Insulin resistance was improved by systemic neutralization of IL-6 or salicylate inhibition of IKK-beta.	SEN:10006180	15685173
BEL:20038228	kin(p(MGI:Ikbkb)) increases path(MESHD:"Insulin Resistance")	Genetic disruption of these pathways improves insulin resistance (86,87). Heterozygous IKKbeta+/- mice, fed with a high-fat diet or crossed with obese ob/ob mice, showed a significant decrease in blood glucose levels and improved insulin resistance (87).	SEN:10021750	15793228
BEL:20038230	kin(p(MGI:Ikbkb)) increases deg(p(MGI:Nfkbia))	The IkappaB kinases, IKK1 and IKK2, have been implicated in both IkappaB degradation and subsequent modifications of NFkappaB.	SEN:10006102	14585967
BEL:20038242	kin(p(MGI:Ikbkb)) increases r(MGI:Il2)	While kinase-inactive IKKa had a minor effect, kinase-inactive IKKb was a potent (76% decrease) inhibitor of IL-2 Luc activity (Fig. 5). The effect of kinase-inactive IKKb was comparable to the effect of kinase-inactive MEKK1, which acts as a MAP3K in the JNK cascade (Fig. 5).	SEN:10021758	10553070
BEL:20038252	kin(p(MGI:Ikbke)) increases r(MGI:Adar)	By contrast, array (Affymetrix, Santa Clara, CA) analysis of RNA from pooled primary lung samples revealed a subset of ISGs, including Ifit3, Ifi203, and the double-stranded RNA (dsRNA)-activated adenosine deaminase gene (Adar1), that were poorly induced in the absence of IKKe as corroborated by RT-PCR analyses (Fig. 2B and fig. S4B).	SEN:10021760	17332413
BEL:20038254	kin(p(MGI:Ikbke)) increases r(MGI:Adar)	RT-PCR analyses from the WT and Ikbke-/- samples showed comparable induction of IFNb but revealed a decrease in the expression of a subset of ISGs (Fig. 2E).	SEN:10021762	17332413
BEL:20038256	kin(p(MGI:Ikbke)) increases r(MGI:Ifi203)	By contrast, array (Affymetrix, Santa Clara, CA) analysis of RNA from pooled primary lung samples revealed a subset of ISGs, including Ifit3, Ifi203, and the double-stranded RNA (dsRNA)-activated adenosine deaminase gene (Adar1), that were poorly induced in the absence of IKKe as corroborated by RT-PCR analyses (Fig. 2B and fig. S4B).	SEN:10021760	17332413
BEL:20038258	kin(p(MGI:Ikbke)) increases r(MGI:Ifi203)	RT-PCR analyses from the WT and Ikbke-/- samples showed comparable induction of IFNb but revealed a decrease in the expression of a subset of ISGs (Fig. 2E).	SEN:10021762	17332413
BEL:20038260	kin(p(MGI:Ikbke)) increases r(MGI:Ifit3)	By contrast, array (Affymetrix, Santa Clara, CA) analysis of RNA from pooled primary lung samples revealed a subset of ISGs, including Ifit3, Ifi203, and the double-stranded RNA (dsRNA)-activated adenosine deaminase gene (Adar1), that were poorly induced in the absence of IKKe as corroborated by RT-PCR analyses (Fig. 2B and fig. S4B).	SEN:10021760	17332413
BEL:20038270	kin(p(MGI:Insr)) decreases kin(p(MGI:Gsk3b))	GSK3-beta is also phosphorylated in response to hormonal stimuli not involving mechanical stress, such as insulin28; this pathway, however, was unaffected in the melusin-null background.	SEN:10018008	12496958
BEL:20038278	kin(p(MGI:Insr)) directlyIncreases p(MGI:Cbl,pmod(P,Y))	This pathway begins with the phosphorylation of the adaptor protein Cbl by the insulin receptor, and results in the activation of a small GTP binding protein, TC10	SEN:10021766	12436329
BEL:20038282	kin(p(MGI:Insr)) directlyIncreases p(MGI:Insr,pmod(P,Y))	Direct addition of GM3 ganglioside to 3T3-L1 adipocytes was shown to suppress insulin-stimulated phosphorylation of the insulin receptor (6).	SEN:10019628	12629211
BEL:20038294	kin(p(MGI:Insr)) decreases r(MGI:Ppargc1a)	These data suggest that PGC-1 expression, like gluconeogensis itself, is suppressed by the action of the insulin receptor.	SEN:10021772	11557972
BEL:20038300	kin(p(MGI:Irak1)) increases kin(p(MGI:Mapk8))	The role of IRAK in IL-18-induced responses was studied in IRAK-deficient mice. Significant defects in JNK induction and partial impairment in NF-kappaB activation were found in IRAK-deficient Th1 cells, resulting in a dramatic decrease in interferon (IFN)-gamma mRNA expression.	SEN:10001666	10190904
BEL:20038308	kin(p(MGI:Irak1)) increases p(MGI:Stat3,pmod(P,S,727))	IRAK1 can directly use Stat3 as a substrate and cause Stat3 serine 727 phosphorylation. Splenocytes from IRAK1-deficient mice fail to exhibit LPS-induced Stat3 serine phosphorylation and IL-10 gene expression	SEN:10021774	15465816
BEL:20038312	kin(p(MGI:Irak1)) increases r(MGI:Ifng)	The role of IRAK in IL-18-induced responses was studied in IRAK-deficient mice. Significant defects in JNK induction and partial impairment in NF-kappaB activation were found in IRAK-deficient Th1 cells, resulting in a dramatic decrease in interferon (IFN)-gamma mRNA expression.	SEN:10001666	10190904
BEL:20038314	kin(p(MGI:Irak1)) increases r(MGI:Il10)	IRAK1 can directly use Stat3 as a substrate and cause Stat3 serine 727 phosphorylation. Splenocytes from IRAK1-deficient mice fail to exhibit LPS-induced Stat3 serine phosphorylation and IL-10 gene expression	SEN:10021774	15465816
BEL:20038316	kin(p(MGI:Irak1)) increases tloc(p(MGI:Irak1),GOCCID:0005886,GOCCID:0005634)	Here we show that nuclear translocation of IRAK-1 depends on its kinase activity since translocation was not observed in EL-4 cells overexpressing a kinase negative IRAK-1 mutant (EL-4(IRAK-1-K239S)).	SEN:10021776	15896328
BEL:20038324	kin(p(MGI:Irak1)) increases tscript(p(MGI:Stat3))	IRAK1 can directly use Stat3 as a substrate and cause Stat3 serine 727 phosphorylation. Splenocytes from IRAK1-deficient mice fail to exhibit LPS-induced Stat3 serine phosphorylation and IL-10 gene expression	SEN:10021774	15465816
BEL:20038332	kin(p(MGI:Irak4)) increases p(MGI:Nfkbia,pmod(P,S))	acLDL-induced IkapaBaplha (Ser32/36) phosphorylation was greatly reduced in bone marrow-derived macrophages from IRAK4 kinase-inactive knock-in	SEN:10021780	21278342
BEL:20038334	kin(p(MGI:Irak4)) increases r(MGI:Il23r)	Furthermore, the absence of IRAK4 kinase activity blocked induction of IL-23R expression, STAT3 activation by IL-23	SEN:10006204	19542468
BEL:20038340	kin(p(MGI:Irak4)) increases tscript(p(MGI:Stat3))	Furthermore, the absence of IRAK4 kinase activity blocked induction of IL-23R expression, STAT3 activation by IL-23	SEN:10006204	19542468
BEL:20038350	kin(p(MGI:Jak1)) increases p(MGI:Irs1,pmod(P,Y))	Following ligand binding to the IL-10R, Jak1 and Tyk2, which are constitutively associated with IL-10R1 and IL-10R2, respectively (3, 14), are phosphorylated on tyrosine The phosphorylated IL-10R/Jak1/Tyk2 complex serves as a docking site for the transcription factors Stat-1 and Stat-3 Jak1, which is required for the biological activity of IL-10 (20), also tyrosine phosphorylates the insulin receptor substrate-1 (IRS-1)	SEN:10021788	11591769
BEL:20038362	kin(p(MGI:Jak2)) increases surf(p(MGI:Mpl))	Tyk2, along with JAK2, does appear to regulate TPO receptor localization at the plasma membrane by stimulating recycling and enhancing the stability of the receptor in Ba/F3 cells	SEN:10021794	17127443
BEL:20038364	kin(p(MGI:Jak2)) increases tscript(p(MGI:Stat3))	In contrast, enhanced thrombopoietin signaling, conferred by enforced expression of constitutively active JAK2 or c-MPL, induced phosphorylation of STAT3 and STAT5, but not STAT1, and failed to rescue megakaryocyte maturation.	SEN:10001688	18060035
BEL:20038370	kin(p(MGI:Jak3)) increases bp(GOBP:"cell migration")	when we analyzed the migration of Jak3(-/-) and Jak3(+/+) mature DCs in response to CCL19 and CCL21 chemokines, we found that the absence of Jak3 results in impaired chemotactic responses both in vitro and in vivo.	SEN:10021796	19759904
BEL:20038372	kin(p(MGI:Jak3)) increases cat(p(MGI:Alox5))	(WHI-P97) is a rationally designed potent inhibitor of Janus kinase (JAK)-3. Treatment of mast cells with WHI-P97 inhibited the translocation of 5-lipoxygenase (5-LO) from the nucleoplasm to the nuclear membrane and consequently 5-LO-dependent leukotriene (LT) synthesis	SEN:10021798	11082424
BEL:20038376	kin(p(MGI:Jak3)) increases tloc(p(MGI:Alox5),GOCCID:0005737,GOCCID:0005634)	(WHI-P97) is a rationally designed potent inhibitor of Janus kinase (JAK)-3. Treatment of mast cells with WHI-P97 inhibited the translocation of 5-lipoxygenase (5-LO) from the nucleoplasm to the nuclear membrane and consequently 5-LO-dependent leukotriene (LT) synthesis	SEN:10021798	11082424
BEL:20038390	kin(p(MGI:Kdr)) increases p(MGI:Il6)	Pharmacological intervention with a VEGFR-2-neutralizing Ab (anti-Flk1 mAb) abolished the production of IL-6 (but not IL-12p70) and the subsequent development of allergen-specific Th17 cell response.	SEN:10003016	20921519
BEL:20038408	kin(p(MGI:Kit)) increases kin(p(MGI:Fyn))	PTP? is required for SCF-induced c-Kit and Fyn activation, and in this way regulates a Fyn-based c-Kit signaling axis (Fyn/Gab2/Shp2/Vav/PAK/Rac/JNK) that mediates mast cell migration.	SEN:10019126	20944008
BEL:20038418	kin(p(MGI:Lck)) decreases r(MGI:Cd48)	Interestingly, lck (null) CD8+ T cells expressed higher levels of CD48 when compared with wt T cells	SEN:10021816	15210772
BEL:20038422	kin(p(MGI:Limk2)) increases p(MGI:Cfl1,pmod(P))	Cofilin and LIMK2 co-precipitated and cofilin became phosphorylated in response to TGF-beta1, whereas RNA interference against LIMK2 blocked formation of new stress fibers by TGF-beta1.	SEN:10021818	15647284
BEL:20038438	kin(p(MGI:Lyn)) directlyIncreases kin(p(MGI:Syk))	Subsequent to its association with Fc?RI, Syk is phosphorylated and activated by Lyn. Syk phosphorylates the adaptor proteins LAT and NTAL/LAB/LAT2	SEN:10021828	9000133
BEL:20038454	kin(p(MGI:Lyn)) increases tscript(p(MGI:Gata1))	In this study, we show that J2E erythroid cells lacking Lyn have impaired signaling and reduced levels of transcription factors STAT5a, EKLF and GATA-1.	SEN:10006216	15516974
BEL:20038456	kin(p(MGI:Lyn)) increases tscript(p(MGI:Klf1))	In this study, we show that J2E erythroid cells lacking Lyn have impaired signaling and reduced levels of transcription factors STAT5a, EKLF and GATA-1.	SEN:10006216	15516974
BEL:20038460	kin(p(MGI:Lyn)) increases tscript(p(MGI:Stat5a))	In this study, we show that J2E erythroid cells lacking Lyn have impaired signaling and reduced levels of transcription factors STAT5a, EKLF and GATA-1.	SEN:10006216	15516974
BEL:20038478	kin(p(MGI:Map2k1)) increases r(MGI:Plau)	Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.	SEN:10020912	10347197
BEL:20038484	kin(p(MGI:Map2k1)) increases tscript(p(MGI:Elk1))	activated MEK1 increased Elk-1- and c-Jun-dependent gene expression but not ATF2-dependent gene expression (Fig. 4).	SEN:10021840	8622669
BEL:20038486	kin(p(MGI:Map2k1)) increases tscript(p(MGI:Jun))	activated MEK1 increased Elk-1- and c-Jun-dependent gene expression but not ATF2-dependent gene expression (Fig. 4).	SEN:10021840	8622669
BEL:20038490	kin(p(MGI:Map2k3)) decreases bp(GOBP:"cell proliferation")	A loss of both MKK6 and MKK3 resulted in cells with increased proliferation and susceptibility to tumorigenic conversion (Brancho et al., 2003).	SEN:10021842	15225871
BEL:20038498	kin(p(MGI:Map2k3)) increases kin(p(MGI:Mapk14))	TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation.	SEN:10021846	12374793
BEL:20038504	kin(p(MGI:Map2k3)) increases r(MGI:Slc2a1)	Constitutively active MKK6/3 mutants up-regulated GLUT1 expression and down-regulated GLUT4 expression, thereby significantly increasing basal glucose transport but diminishing transport induced by insulin.	SEN:10021850	11279172
BEL:20038506	kin(p(MGI:Map2k3)) decreases r(MGI:Slc2a4)	Constitutively active MKK6/3 mutants up-regulated GLUT1 expression and down-regulated GLUT4 expression, thereby significantly increasing basal glucose transport but diminishing transport induced by insulin.	SEN:10021850	11279172
BEL:20038508	kin(p(MGI:Map2k3)) increases tscript(p(MGI:Atf2))	MKK3(Glu) increased ATF2- and Elk-1-dependent reporter gene expression but caused only a small increase in Jun-dependent gene expression (Fig. 4).	SEN:10021852	8622669
BEL:20038510	kin(p(MGI:Map2k3)) increases tscript(p(MGI:Elk1))	MKK3(Glu) increased ATF2- and Elk-1-dependent reporter gene expression but caused only a small increase in Jun-dependent gene expression (Fig. 4).	SEN:10021852	8622669
BEL:20038512	kin(p(MGI:Map2k4)) increases r(MGI:Dusp1)	we show in NIH3T3 fibroblasts that activation of the stress-activated protein kinase (SAPK) pathway by either specific extracellular stress stimuli or via induction of MEKK, an upstream kinase of SAPK, results in MKP-1 gene expression.	SEN:10021854	8557667
BEL:20038514	kin(p(MGI:Map2k6)) decreases bp(GOBP:"cell proliferation")	A loss of both MKK6 and MKK3 resulted in cells with increased proliferation and susceptibility to tumorigenic conversion (Brancho et al., 2003).	SEN:10021842	15225871
BEL:20038518	kin(p(MGI:Map2k6)) decreases path(MESHD:Ischemia)	I/R injury is reduced in the hearts of transgenic mice that over-express the p38 MAPK activator, MAPK kinase 6 (MKK6)	SEN:10021856	16766635
BEL:20038522	kin(p(MGI:Map2k6)) increases p(MGI:Atf2,pmod(P,T,51))	In contrast, the effect of MKK6(Glu) was markedly reduced in experiments using phosphorylation-defective (Ala-69, Ala-71) ATF2.	SEN:10021858	8622669
BEL:20038524	kin(p(MGI:Map2k6)) increases p(MGI:Atf2,pmod(P,T,53))	In contrast, the effect of MKK6(Glu) was markedly reduced in experiments using phosphorylation-defective (Ala-69, Ala-71) ATF2.	SEN:10021858	8622669
BEL:20038526	kin(p(MGI:Map2k6)) increases r(MGI:Slc2a1)	Constitutively active MKK6/3 mutants up-regulated GLUT1 expression and down-regulated GLUT4 expression, thereby significantly increasing basal glucose transport but diminishing transport induced by insulin.	SEN:10021850	11279172
BEL:20038528	kin(p(MGI:Map2k6)) decreases r(MGI:Slc2a4)	Constitutively active MKK6/3 mutants up-regulated GLUT1 expression and down-regulated GLUT4 expression, thereby significantly increasing basal glucose transport but diminishing transport induced by insulin.	SEN:10021850	11279172
BEL:20038530	kin(p(MGI:Map2k6)) increases tscript(p(MGI:Atf2))	Increased ATF2-dependent gene expression was observed in cells transfected with MKK6(Glu). In contrast, MKK3(Glu) did not increase ATF2-dependent gene expression in the absence of overexpression of p38 MAP kinase (Fig. 8A).	SEN:10021860	8622669
BEL:20038536	kin(p(MGI:Map3k11)) increases kin(p(MGI:Mapk8))	This kinase (Map3k11) preferentially activates MAPK8/JNK kinase, and functions as a positive regulator of JNK signaling pathway.	SEN:10021866	9553058
BEL:20038538	kin(p(MGI:Map3k11)) increases kin(p(MGI:Mapk9))	This kinase (Map3k11) preferentially activates MAPK8/JNK kinase, and functions as a positive regulator of JNK signaling pathway.	SEN:10021866	9553058
BEL:20038542	kin(p(MGI:Map3k11)) increases tscript(p(MGI:Cebpb))	MLK3 appears to activate C/EBP-beta in response to IFN-gamma by a mechanism involving decreased phosphorylation of a specific phosphoacceptor residue, Ser(64), within the transactivation domain.	SEN:10006232	15878863
BEL:20038544	kin(p(MGI:Map3k11)) increases tscript(p(MGI:Gabpa))	In T cells, overexpression of SPRK/MLK3, an activator of JNK/SAPK, strongly induces DSE-dependent transcription and dominant negative kinases of SEK and SAPK impair TPA/ionomycin-induced DSE activity.	SEN:10006234	9553058
BEL:20038546	kin(p(MGI:Map3k11)) increases tscript(p(MGI:Gabpb1))	In T cells, overexpression of SPRK/MLK3, an activator of JNK/SAPK, strongly induces DSE-dependent transcription and dominant negative kinases of SEK and SAPK impair TPA/ionomycin-induced DSE activity.	SEN:10006234	9553058
BEL:20038554	kin(p(MGI:Map3k1)) increases bp(GOBP:"wound healing")	Reconstituting MEKK1 expression in the Mekk1?KD/?KD wounds with adenovirus-mediated MEKK1(WT) expression significantly accelerated wound closure; conversely, infecting wild-type mice wounds with Ad MEKK1 interfering RNA (iRNA) and Ad MEKK1(KM), expressing a kinase-inactive MEKK1, delayed the closure in comparison with uninfected, control Ad ?-Gal-, or Ad GFP-infected wounds (Figure 1D).	SEN:10021868	16760432
BEL:20038558	kin(p(MGI:Map3k1)) increases r(MGI:Il2)	While kinase-inactive IKKa had a minor effect, kinase-inactive IKKb was a potent (76% decrease) inhibitor of IL-2 Luc activity (Fig. 5). The effect of kinase-inactive IKKb was comparable to the effect of kinase-inactive MEKK1, which acts as a MAP3K in the JNK cascade (Fig. 5).	SEN:10021758	10553070
BEL:20038562	kin(p(MGI:Map3k1)) increases r(MGI:Serpine1)	PAI-1 induction was completely blocked by MEKK1 ablation, but it was restored by the expression of MEKK1(WT) using adenoviral-mediated gene delivery to the wounds (Figure 4C).	SEN:10021872	16760432
BEL:20038586	kin(p(MGI:Map3k8)) increases p(MGI:Ptgs2)	Thus, LPS-stimulated Tpl2(-/-) macrophages express low levels of COX-2 and PGE2, compared with wild-type Tpl2(+/+) cells. {Tpl2 Official Gene Symbol: MAP3K8}	SEN:10015914	12234923
BEL:20038592	kin(p(MGI:Mapk14)) increases a(CHEBI:"reactive oxygen species")	Among the three MAPK inhibitors, SB203580 (the p38 MAPK inhibitor) had the strongest effects on Lox-1 and Nox1 expression (Fig. 7B–D). Furthermore, the production of ROS induced by CpG ODN was attenuated by the inhibition of p38 MAPK activity (data not shown).	SEN:10021890	18817866
BEL:20038600	kin(p(MGI:Mapk14)) decreases bp(GOBP:"cell cycle")	In our work, the inhibition of the p38 MAPK pathway by expressing a dominant-negative mutant MKK 3 promotes cell cycle progression in a liver regeneration cycle (in preparation).	SEN:10021892	15225871
BEL:20038602	kin(p(MGI:Mapk14)) decreases bp(GOBP:"cell cycle")	The association between HBP1 and p38 MAPK was initially defined by a two-hybrid interaction. Like the p21 results, the apparent mechanism was that p38 MAPK-mediated phosphorylation of the HBP1 led to increased protein stability and a G1 arrest.	SEN:10021894	15225871
BEL:20038604	kin(p(MGI:Mapk14)) increases bp(GOBP:"cell differentiation")	We found that p38alpha positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation.	SEN:10001754	17468755
BEL:20038606	kin(p(MGI:Mapk14)) decreases bp(GOBP:"cell proliferation")	deletion of p38alpha mitogen-activated protein (MAP) kinase in adult mice results in increased proliferation	SEN:10001748	17468755
BEL:20038608	kin(p(MGI:Mapk14)) decreases bp(GOBP:"fat cell differentiation")	In agreement with an inhibitory role of p38MAPK in this process, we found that in vitro inhibition of p38MAPK, with the specific inhibitor PD169316, increased the expression of adipocyte markers in several cellular models, from embryonic to adult stages.	SEN:10006244	16443758
BEL:20038626	kin(p(MGI:Mapk14)) decreases deg(p(MGI:Hbp1))	The association between HBP1 and p38 MAPK was initially defined by a two-hybrid interaction. Like the p21 results, the apparent mechanism was that p38 MAPK-mediated phosphorylation of the HBP1 led to increased protein stability and a G1 arrest.	SEN:10021894	15225871
BEL:20038630	kin(p(MGI:Mapk14)) increases kin(p(MGI:Akt2))	cross-talk and activation between the PI 3-kinase/Akt and p38 MAPK pathways that is essential for efficient myoblast differentiation. During myoblast differentiation, Akt kinase activity correlated with S473 but not T308 phosphorylation and occurred 24 h after p38 activation Akt2 promoter activity and protein levels were regulated by p38 activation, thus providing a mechanism for communication.	SEN:10021904	15082758
BEL:20038632	kin(p(MGI:Mapk14)) decreases kin(p(MGI:Egfr))	In addition, p38alpha controls self-renewal of the lung stem and progenitor cell population by inhibiting proliferation-inducing signals, most notably epidermal growth factor receptor	SEN:10001750	17468755
BEL:20038646	kin(p(MGI:Mapk14)) increases p(MGI:Akt2)	cross-talk and activation between the PI 3-kinase/Akt and p38 MAPK pathways that is essential for efficient myoblast differentiation. During myoblast differentiation, Akt kinase activity correlated with S473 but not T308 phosphorylation and occurred 24 h after p38 activation Akt2 promoter activity and protein levels were regulated by p38 activation, thus providing a mechanism for communication.	SEN:10021904	15082758
BEL:20038648	kin(p(MGI:Mapk14)) increases p(MGI:Akt2,pmod(P,S,474))	cross-talk and activation between the PI 3-kinase/Akt and p38 MAPK pathways that is essential for efficient myoblast differentiation. During myoblast differentiation, Akt kinase activity correlated with S473 but not T308 phosphorylation and occurred 24 h after p38 activation Akt2 promoter activity and protein levels were regulated by p38 activation, thus providing a mechanism for communication.	SEN:10021904	15082758
BEL:20038658	kin(p(MGI:Mapk14)) directlyIncreases p(MGI:Creb1,pmod(P))	Insulin treatment increased the phosphorylation of both p38 MAPK and its downstream target CREB...	SEN:10017366	12864733
BEL:20038662	kin(p(MGI:Mapk14)) increases p(MGI:Elk4,pmod(P))	a part of the phosphorylation of Sap-1a upon stimulation with H2O2 is due to p38 MAPK, while the rest can most likely be attributed to JNKs that are also inducible by H2O2.	SEN:10015776	9130707
BEL:20038668	kin(p(MGI:Mapk14)) increases p(MGI:Hbp1)	A specific p38 MAPK-docking site (aa 81 125) and a p38 MAPK phosphorylation site (serine 401) were identified in the HBP1 protein. No other MAPK appeared to specifically bind and phosphorylate HBP1. In defining the role of p38 MAPK regulation, the inhibition of p38 MAPK activity was shown to decrease HBP1 protein levels by triggering protein instability that is manifested by a decrease in protein half-life.	SEN:10021918	15225871
BEL:20038670	kin(p(MGI:Mapk14)) increases p(MGI:Hbp1,pmod(P,S,401))	A specific p38 MAPK-docking site (aa 81 125) and a p38 MAPK phosphorylation site (serine 401) were identified in the HBP1 protein. No other MAPK appeared to specifically bind and phosphorylate HBP1. In defining the role of p38 MAPK regulation, the inhibition of p38 MAPK activity was shown to decrease HBP1 protein levels by triggering protein instability that is manifested by a decrease in protein half-life.	SEN:10021918	15225871
BEL:20038678	kin(p(MGI:Mapk14)) directlyIncreases p(MGI:Slc2a4,pmod(P,S,488))	The literature reports that S488 within the C-terminus is the only site of phosphorylation for GLUT4 in the basal state.	SEN:10021922	12864733
BEL:20038692	kin(p(MGI:Mapk14)) increases r(MGI:Ifng)	In this report we demonstrate that IL-12 activates mitogen-activated protein kinase kinase 3/6 (MKK) and p38 mitogen-activated protein kinase (MAPK), but not p44/42 (ERK) or stress-activated protein kinase/c-Jun N-terminal kinase MAPK. The activation of p38 MAPK is required for normal induction of IFN-gamma mRNA and IFN-gamma secretion by IL-12 in activated T cells and Th1 cells.	SEN:10020294	10903740
BEL:20038694	kin(p(MGI:Mapk14)) increases r(MGI:Myod1)	Inhibition of p38 MAPK by SB203580 in differentiating C2C12 myoblasts blocks MyoD expression, SHPS-1 tyrosyl phosphorylation and the association of SHPS-1 with SHP-2.	SEN:10006262	11493654
BEL:20038696	kin(p(MGI:Mapk14)) increases r(MGI:Nox1)	Among the three MAPK inhibitors, SB203580 (the p38 MAPK inhibitor) had the strongest effects on Lox-1 and Nox1 expression (Fig. 7B–D). Furthermore, the production of ROS induced by CpG ODN was attenuated by the inhibition of p38 MAPK activity (data not shown).	SEN:10021890	18817866
BEL:20038698	kin(p(MGI:Mapk14)) decreases r(MGI:Rxrb)	TNF-alpha represses the promoter activity of the 250-bp region, and the repression is mediated by p38 MAP kinase independent of NF-kappaB	SEN:10006264	9607817
BEL:20038700	kin(p(MGI:Mapk14)) increases r(MGI:Slc2a1)	SB203580, a specific p38 MAPK inhibitor, attenuated these effects, further confirming that both MMK6 and MMK3 act via p38 MAPK, whereas they had no effect on the increase in glucose transport induced by a constitutively active MAPK kinase 1 (MEK1) mutant or by myristoylated Akt.	SEN:10006266	11279172
BEL:20038702	kin(p(MGI:Mapk14)) decreases r(MGI:Slc2a4)	SB203580, a specific p38 MAPK inhibitor, attenuated these effects, further confirming that both MMK6 and MMK3 act via p38 MAPK, whereas they had no effect on the increase in glucose transport induced by a constitutively active MAPK kinase 1 (MEK1) mutant or by myristoylated Akt.	SEN:10006266	11279172
BEL:20038704	kin(p(MGI:Mapk14)) decreases r(MGI:Slc39a7)	TNF-alpha represses the promoter activity of the 250-bp region, and the repression is mediated by p38 MAP kinase independent of NF-kappaB	SEN:10006264	9607817
BEL:20038706	kin(p(MGI:Mapk14)) increases r(MGI:Ucp1)	cAMP- and protein kinase A-dependent activation of p38 mitogen-activated protein kinase (MAPK) in brown adipocytes is an indispensable step in the transcription of the UCP1 gene in mice.	SEN:10021928	15024092
BEL:20038708	kin(p(MGI:Mapk14)) increases r(MGI:Ucp1)	Here we demonstrate that cAMP- and protein kinase A-dependent activation of p38 mitogen-activated protein kinase (MAPK) in brown adipocytes is an indispensable step in the transcription of the UCP1 gene in mice.	SEN:10003734	15024092
BEL:20038710	kin(p(MGI:Mapk14)) increases r(MGI:Zfp36)	We show that TTP mRNA is expressed in a biphasic manner following stimulation of cells with lipopolysaccharide and that the second phase of expression, like the first, is dependent on mitogen-activated protein kinase (MAPK) p38	SEN:10021930	15187092
BEL:20038712	kin(p(MGI:Mapk14)) increases tport(p(MGI:Slc2a4))	...insulin increases glucose uptake not only through the recruitment of transporters to the plasma membrane but also by increasing the activity of these transporters. This activation step is prevented by inhibitors of p38 MAPK. ...GLUT4 is activated via this p38 MAPK-mediated pathway.	SEN:10017340	12864733
BEL:20038720	kin(p(MGI:Mapk14)) directlyIncreases tscript(p(MGI:Cebpb))	The reduction in C/EBPa could be accounted for by lower levels of phospho-C/EBPb (Fig. 3a), a known target for p38a (refs. 12,20), which in turn regulates the expression of C/EBPa (ref. 21).	SEN:10021936	17468755
BEL:20038752	kin(p(MGI:Mapk1)) increases bp(GOBP:"cell proliferation")	Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways	SEN:10001760	11408560
BEL:20038754	kin(p(MGI:Mapk1)) increases bp(GOBP:"cell proliferation")	hyperactivation of the extracellular signal-regulated kinase (ERK) via the hematopoietic-specific Rho GTPase, Rac2, directly contributes to the hyperproliferation of Nf1-deficient mast cells in vitro and in vivo	SEN:10001762	11435472
BEL:20038756	kin(p(MGI:Mapk1)) increases bp(GOBP:"cell proliferation")	We conclude that TNFalpha and IGF-I may additively contribute to fibrosis during intestinal inflammation. TNFR2 is a primary mediator of fibrogenic actions of TNFalpha acting through ERK1/2 to stimulate proliferation and through STAT3 to stimulate TIMP-1 and inhibit collagen degradation.	SEN:10001764	16141211
BEL:20038768	kin(p(MGI:Mapk1)) increases kin(p(MGI:Sgk1))	By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.	SEN:10021950	15383658
BEL:20038770	kin(p(MGI:Mapk1)) directlyIncreases p(MGI:Bcl2,pmod(P,S,70))	p44MAPK/extracellular signal-regulated kinase 1 (ERK1) and p42 MAPK/ERK2 are activated by IL-3, colocalize with mitochondrial Bcl2, and can directly phosphorylate Bcl2 on Ser-70 in a stauro-resistant manner both in vitro and in vivo	SEN:10021952	10677502
BEL:20038790	kin(p(MGI:Mapk1)) increases r(MGI:Plau)	Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.	SEN:10020912	10347197
BEL:20038796	kin(p(MGI:Mapk1)) increases tscript(p(MGI:Creb1))	These results suggest that ERK2 has a regulatory role in activating CREB in vivo in lung neutrophils after hemorrhage or endotoxemia.	SEN:10021962	11123332
BEL:20038800	kin(p(MGI:Mapk1)) increases tscript(p(MGI:Nr4a1))	The MAPK kinase inhibitors did not affect Nur77 and Nurr1 mRNA induction but blocked CRH or cAMP-stimulated Nur transcriptional activity.	SEN:10006280	12089357
BEL:20038802	kin(p(MGI:Mapk1)) increases tscript(p(MGI:Nr4a2))	The MAPK kinase inhibitors did not affect Nur77 and Nurr1 mRNA induction but blocked CRH or cAMP-stimulated Nur transcriptional activity.	SEN:10006280	12089357
BEL:20038806	kin(p(MGI:Mapk1)) increases tscript(p(MGI:Ppargc1a))	p38 MAPK has been reported to activate PPAR-a through increased phosphorylation of PPAR-a and increased co-activation specifically by PGC-1 (refs 22, 23), thereby stimulating fatty-acid oxidation.	SEN:10021968	12802337
BEL:20038812	kin(p(MGI:Mapk3)) increases bp(GOBP:"cell proliferation")	Both early passage and immortalized MEF cells from GSTpi(-/-) animals expressed significantly elevated activity of extracellular signal-regulated kinases ERK1/ERK2, kinases linked to cell proliferation pathways	SEN:10001760	11408560
BEL:20038822	kin(p(MGI:Mapk3)) increases kin(p(MGI:Sgk1))	By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.	SEN:10021950	15383658
BEL:20038824	kin(p(MGI:Mapk3)) increases path(MESHD:Mesothelioma)	In asbestos-associated transformation of rodent mesothelial cells, the use of dominant negative ERK1 or Fra-1 constructs reverses the phenotype of mesothelioma cells to that of normal mesothelial cells (12). Moreover, Fra-1 expression is increased in human mesotheliomas and in other tumor types.	SEN:10021972	16484683
BEL:20038826	kin(p(MGI:Mapk3)) directlyIncreases p(MGI:Bcl2,pmod(P,S,70))	p44MAPK/extracellular signal-regulated kinase 1 (ERK1) and p42 MAPK/ERK2 are activated by IL-3, colocalize with mitochondrial Bcl2, and can directly phosphorylate Bcl2 on Ser-70 in a stauro-resistant manner both in vitro and in vivo	SEN:10021952	10677502
BEL:20038828	kin(p(MGI:Mapk3)) increases p(MGI:Nfe2l2,pmod(P,S))	Collectively, these results indicate that ERK-1 regulates hyperoxia-stimulated Nrf2 phosphorylation and the subsequent ARE-driven transcriptional response.	SEN:10000380	15292179
BEL:20038832	kin(p(MGI:Mapk3)) increases r(MGI:Fosl1)	TNF-a strongly stimulated FRA-1 promoter activity in WT MEFs as compared with the erk1-/- MEFs (Fig. 9B).	SEN:10021974	17082637
BEL:20038842	kin(p(MGI:Mapk3)) increases tscript(p(MGI:Jun))	the recruitment of c-Jun was strongly enhanced following TNF-a treatment (Fig. 10B, lanes 3 and 4). In contrast, the binding of c-Jun to the fra-1 promoter was significantly diminished in MEFS lacking the erk1-/- signaling (cf lanes 7 and 8 with lanes 3 and 4).	SEN:10021978	17082637
BEL:20038844	kin(p(MGI:Mapk8)) increases path(MESHD:"Insulin Resistance")	JNK1 knockout mice gain less weight and are protected against diet-induced insulin resistance or insulin resistance associated with a genetic model of obesity (ob/ob) (86).	SEN:10021980	15793228
BEL:20038846	kin(p(MGI:Mapk8)) increases complex(p(MGI:Srf),p(MGI:Elk1))	Figure 3b shows that activated SAPKs isolated from cells stimulate the formation of a ternary complex by Elk-1 (Fig. 3b, lanes 8 and 10).	SEN:10021982	8548291
BEL:20038854	kin(p(MGI:Mapk8)) decreases p(MGI:Adipoq)	Ablation of jnk1 led to an increase in serum adiponectin but had no effect on serum levels of tumor necrosis factor-alpha.	SEN:10006286	16374858
BEL:20038856	kin(p(MGI:Mapk8)) increases p(MGI:Elk1,pmod(P))	Elk-1 is phosphorylated by both kinases (MAPK8 and MAPK9) , each of which is strongly stimulated by pre-treatment of cells with ultraviolet light.	SEN:10018250	8548291
BEL:20038858	kin(p(MGI:Mapk8)) directlyIncreases p(MGI:Elk1,pmod(P))	The two SAPK isoforms are 46 and 54 kDa. A 46 kDa kinase activity was induced in response to anisomycin but not in response to TPA.	SEN:10016558	8548291
BEL:20038860	kin(p(MGI:Mapk8)) increases p(MGI:Foxo4,pmod(P,T,447))	JNK (c-Jun kinase), another stress-activated protein kinase, phosphorylates FoxO4 at Thr447 and Thr451 and triggers the relocalization of FoxO family members from the cytoplasm to the nucleus (Essers et al., 2004; Oh et al., 2005) (Figure 2).	SEN:10021984	18391970
BEL:20038862	kin(p(MGI:Mapk8)) increases p(MGI:Foxo4,pmod(P,T,451))	JNK (c-Jun kinase), another stress-activated protein kinase, phosphorylates FoxO4 at Thr447 and Thr451 and triggers the relocalization of FoxO family members from the cytoplasm to the nucleus (Essers et al., 2004; Oh et al., 2005) (Figure 2).	SEN:10021984	18391970
BEL:20038870	kin(p(MGI:Mapk8)) increases p(MGI:Jun,pmod(P))	PDGF or serum treatment both activate c-Jun N-terminal kinase (JNK), the mitogen-activated protein kinase responsible for phosphorylation and activation of c-Jun.	SEN:10021990	8940199
BEL:20038878	kin(p(MGI:Mapk8)) increases p(MGI:Ywhaq,pmod(P))	JNK also phosphorylates 14-3-3, which helps release FoxO factors from their 14-3-3 anchors (Sunayama et al., 2005).	SEN:10021994	18391970
BEL:20038886	kin(p(MGI:Mapk8)) directlyIncreases tscript(p(MGI:Elk1))	As shown in Figure 6e, expression of MEKK1 fails to activate either ERK1 or ERK2, whereas both p46 SAPK and p54SAPK are activated at expression levels that result in reporter gene expression.	SEN:10022000	8548291
BEL:20038888	kin(p(MGI:Mapk8)) increases tscript(p(MGI:Jun))	PDGF or serum treatment both activate c-Jun N-terminal kinase (JNK), the mitogen-activated protein kinase responsible for phosphorylation and activation of c-Jun.	SEN:10021990	8940199
BEL:20038892	kin(p(MGI:Mapk9)) increases cat(p(MGI:Msr1))	JNK2-dependent phosphorylation of SR-A promotes uptake of lipids in macrophages, thereby regulating foam cell formation, a critical step in atherogenesis	SEN:10006292	15567863
BEL:20038894	kin(p(MGI:Mapk9)) increases complex(p(MGI:Srf),p(MGI:Elk1))	Figure 3b shows that activated SAPKs isolated from cells stimulate the formation of a ternary complex by Elk-1 (Fig. 3b, lanes 8 and 10).	SEN:10021982	8548291
BEL:20038898	kin(p(MGI:Mapk9)) increases p(MGI:Elk1,pmod(P))	Elk-1 is phosphorylated by both kinases (MAPK8 and MAPK9) , each of which is strongly stimulated by pre-treatment of cells with ultraviolet light.	SEN:10018250	8548291
BEL:20038906	kin(p(MGI:Mapk9)) directlyIncreases tscript(p(MGI:Elk1))	As shown in Figure 6e, expression of MEKK1 fails to activate either ERK1 or ERK2, whereas both p46 SAPK and p54SAPK are activated at expression levels that result in reporter gene expression.	SEN:10022000	8548291
BEL:20038922	kin(p(MGI:Met)) increases r(MGI:Mtch2)	Using differential display polymerase chain reaction, we cloned a novel gene, designated mimp (Met-Induced Mitochondrial Protein), which is upregulated in NIH-3T3 cells cotransfected with both HGF/SF and Met (HMH cells).	SEN:10006300	12407445
BEL:20038926	kin(p(MGI:Mknk1)) increases p(MGI:Ccl2)	Studies using bone marrow-derived macrophages (BMDM) isolated from a spontaneous mouse model of Crohn's disease-like ileitis (SAMP1/YitFc strain) revealed significant inhibition by CGP57380 of the proinflammatory cytokines TNF, IL-6, and monocyte chemoattractant protein-1 at 4 and 24 h after LPS stimulation	SEN:10006302	18032482
BEL:20038928	kin(p(MGI:Mknk1)) increases p(MGI:Il6)	Studies using bone marrow-derived macrophages (BMDM) isolated from a spontaneous mouse model of Crohn's disease-like ileitis (SAMP1/YitFc strain) revealed significant inhibition by CGP57380 of the proinflammatory cytokines TNF, IL-6, and monocyte chemoattractant protein-1 at 4 and 24 h after LPS stimulation	SEN:10006302	18032482
BEL:20038930	kin(p(MGI:Mknk1)) directlyIncreases p(MGI:Spry2)	Mnk1 was also activated at lower levels in Mapk14-null mice (Fig. 3b). This p38a-activated protein kinase phosphorylates and stabilizes Sprouty2 (ref. 26), which in turn can negatively regulate tyrosine kinase receptor signaling in lung cells27.	SEN:10022008	17468755
BEL:20038932	kin(p(MGI:Mknk1)) increases p(MGI:Tnf)	Studies using bone marrow-derived macrophages (BMDM) isolated from a spontaneous mouse model of Crohn's disease-like ileitis (SAMP1/YitFc strain) revealed significant inhibition by CGP57380 of the proinflammatory cytokines TNF, IL-6, and monocyte chemoattractant protein-1 at 4 and 24 h after LPS stimulation	SEN:10006302	18032482
BEL:20038934	kin(p(MGI:Mst1r)) increases bp(GOBP:"macrophage activation")	These results suggest that Mst1r signaling may be involved in the regulation of macrophage and T-lymphocyte activation	SEN:10006304	16166746
BEL:20038936	kin(p(MGI:Mtor)) increases bp(GOBP:"cell proliferation")	We indeed found that suppression of the Notch pathway by the Notch inhibitor N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) compromised the proliferation of both MEFs and human cancer cells with activated mTOR signaling	SEN:10022010	20038814
BEL:20038938	kin(p(MGI:Mtor)) increases bp(GOBP:"fat cell differentiation")	Adipocyte differentiation is impaired in fld/fld mice and inhibiting mTOR with rapamycin blocks fat cell differentiation in vivo	SEN:10022012	11792863
BEL:20038942	kin(p(MGI:Mtor)) increases kin(p(MGI:Rps6kb1))	Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways.	SEN:10022014	16640565
BEL:20038944	kin(p(MGI:Mtor)) increases kin(p(MGI:Rps6kb2))	Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways.	SEN:10022014	16640565
BEL:20038950	kin(p(MGI:Myc)) decreases r(MGI:Cflar)	MYC has been shown to transactivate the CD95L gene (Amanullah et al., 2002; Brunner et al., 2000; Kasibhatla et al., 2000), as well as to downregulate FLIP (Ricci et al., 2004).	SEN:10022018	18955973
BEL:20038952	kin(p(MGI:Myc)) increases r(MGI:Fasl)	MYC has been shown to transactivate the CD95L gene (Amanullah et al., 2002; Brunner et al., 2000; Kasibhatla et al., 2000), as well as to downregulate FLIP (Ricci et al., 2004).	SEN:10022018	18955973
BEL:20038960	kin(p(MGI:Nek9)) decreases p(MGI:Lgals1)	The proteins galectin-1, sorcin and vimentin were found to be induced 9-, 9- and 25-fold, respectively, in the PKD proteome	SEN:10022022	15872312
BEL:20038962	kin(p(MGI:Nek9)) decreases p(MGI:Mup1)	a series of protein isoforms observed only in the ARPKD kidney was identified as the major urinary protein (MUP).	SEN:10006310	15872312
BEL:20038964	kin(p(MGI:Nek9)) decreases p(MGI:Mup2)	a series of protein isoforms observed only in the ARPKD kidney was identified as the major urinary protein (MUP).	SEN:10006310	15872312
BEL:20038966	kin(p(MGI:Nek9)) decreases p(MGI:Sri)	The proteins galectin-1, sorcin and vimentin were found to be induced 9-, 9- and 25-fold, respectively, in the PKD proteome	SEN:10022022	15872312
BEL:20038968	kin(p(MGI:Nek9)) decreases p(MGI:Vim)	The proteins galectin-1, sorcin and vimentin were found to be induced 9-, 9- and 25-fold, respectively, in the PKD proteome	SEN:10022022	15872312
BEL:20038984	kin(p(MGI:Ntrk1)) increases p(MGI:Tnf)	To examine the role of TrkA in NGF's effects, we used K252a, which inhibits the tyrosine kinase activity of this receptor. Pretreatment of the cells with K252a (50 ng/mL) inhibited the production of TNF-a by NGF	SEN:10022028	11404390
BEL:20038988	kin(p(MGI:Ntrk2)) increases sec(a(CHEBI:"L-glutamic acid"))	Moreover, BDNF-mediated enhancement of glutamate release from presynaptic terminals depended not only upon TrkB but also upon Myo6 and GIPC1.	SEN:10005462	16819522
BEL:20038990	kin(p(MGI:Nucks1)) directlyIncreases p(MGI:Rplp0,pmod(P))	These studies demonstrate that exogenous CK II and a ribosome-bound, CK II-like enzyme phosphorylate the ribosomal P proteins in vitro and localize the target site for phosphorylation to the COOH terminus.	SEN:10021630	1856214
BEL:20039004	kin(p(MGI:Pdgfra)) increases cat(p(MGI:Nos2))	PDGF stimulates nitric oxide synthase activity in NIH3T3 cells, but not in the superoxide dismutase-expressing clones.	SEN:10019390	7574691
BEL:20039006	kin(p(MGI:Pdgfra)) increases cat(p(MGI:Ptgs1))	The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.	SEN:10001800	7574691
BEL:20039008	kin(p(MGI:Pdgfra)) increases cat(p(MGI:Ptgs2))	The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.	SEN:10001800	7574691
BEL:20039016	kin(p(MGI:Pdgfra)) increases kin(p(MGI:Rps6kb1))	the platelet-derived growth factor receptor-alpha (PDGFRalpha)-p70S6K signal transduction pathway in mesenchymal cells, which is required for functional angiogenesis induced by fibroblast growth factor-2	SEN:10022036	15059936
BEL:20039024	kin(p(MGI:Pdgfrb)) increases cat(p(MGI:Nos2))	PDGF stimulates nitric oxide synthase activity in NIH3T3 cells, but not in the superoxide dismutase-expressing clones.	SEN:10019390	7574691
BEL:20039026	kin(p(MGI:Pdgfrb)) increases cat(p(MGI:Ptgs1))	The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.	SEN:10001800	7574691
BEL:20039028	kin(p(MGI:Pdgfrb)) increases cat(p(MGI:Ptgs2))	The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.	SEN:10001800	7574691
BEL:20039030	kin(p(MGI:Pdgfrb)) increases kin(p(MGI:Mapk1))	Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].	SEN:10022040	19742316
BEL:20039032	kin(p(MGI:Pdgfrb)) increases kin(p(MGI:Mapk3))	Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].	SEN:10022040	19742316
BEL:20039042	kin(p(MGI:Pdk1)) increases kin(p(MGI:Akt1))	PI3K activation, however, results in the recruitment of the serine/threonine kinase PDK1 (3-phosphoinositidedependent protein kinase 1) to the plasma membrane, where PDK1 subsequently phosphorylates and activates another serine/threonine kinase, AKT 86. AKT positively regulates the function of the transcription factor NF-kB by phosphorylating inhibitor of NF-kB (IkB), which is a key regulator of NF-kB 87.	SEN:10021054	16470226
BEL:20039048	kin(p(MGI:Pdpk1)) directlyIncreases kin(p(MGI:Rps6kb1))	Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways.	SEN:10022014	16640565
BEL:20039050	kin(p(MGI:Pdpk1)) directlyIncreases kin(p(MGI:Rps6kb2))	Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways.	SEN:10022014	16640565
BEL:20039054	kin(p(MGI:Pdpk1)) increases p(MGI:Mmp14)	PDK1 mediates its effect in part by MT1-MMP induction, which in turn activates MMP-2 and modulates the ECM proteins decorin and collagen	SEN:10004928	16551362
BEL:20039056	kin(p(MGI:Pdpk1)) directlyIncreases p(MGI:Pdpk1,pmod(P,S,399))	Here we show that mouse PDK-1 (mPDK-1) undergoes autophosphorylation in vitro on both serine and threonine residues. In addition, we have identified Ser(399) and Thr(516) as the major mPDK-1 autophosphorylation sites in vitro	SEN:10021022	11877406
BEL:20039076	kin(p(MGI:Pik3cg)) increases gtp(p(MGI:Rac2))	P-Rex1, a guanine-nucleotide exchange factor (GEF) for Rac, is believed to link GPCRs and PI3Kgamma to Rac-dependent neutrophil responses.	SEN:10022060	16243035
BEL:20039080	kin(p(MGI:Pim1)) increases kin(p(MGI:Mtor))	Based on our observations, it is possible that PIM protein kinases overexpressed in human tumors, i.e., leukemia and prostate cancer, could play a role in stimulating mTORC1 activity by PRAS40 phosphorylation.	SEN:10022062	19276681
BEL:20039084	kin(p(MGI:Pkn2)) increases kin(p(MGI:Fyn))	Increased PRK2 expression induces catenin tyrosine phosphorylation and Fyn activation Tyrosine phosphorylation of beta and gamma catenin and p120ctn was also induced by PRK2 overexpression	SEN:10022066	11777936
BEL:20039086	kin(p(MGI:Pkn2)) increases p(MGI:Ctnnb1,pmod(P,Y))	Increased PRK2 expression induces catenin tyrosine phosphorylation and Fyn activation Tyrosine phosphorylation of beta and gamma catenin and p120ctn was also induced by PRK2 overexpression	SEN:10022066	11777936
BEL:20039088	kin(p(MGI:Pkn2)) increases p(MGI:Ctnnd1,pmod(P,Y))	Increased PRK2 expression induces catenin tyrosine phosphorylation and Fyn activation Tyrosine phosphorylation of beta and gamma catenin and p120ctn was also induced by PRK2 overexpression	SEN:10022066	11777936
BEL:20039090	kin(p(MGI:Pkn2)) increases p(MGI:Jup,pmod(P,Y))	Increased PRK2 expression induces catenin tyrosine phosphorylation and Fyn activation Tyrosine phosphorylation of beta and gamma catenin and p120ctn was also induced by PRK2 overexpression	SEN:10022066	11777936
BEL:20039098	kin(p(MGI:Prkaa2)) increases r(MGI:Slc2a4)	AMPK transmits a portion of the signal by which muscle contraction increases glucose uptake, but other AMPK-independent pathways also contribute to the response.	SEN:10004144	11389854
BEL:20039104	kin(p(MGI:Prkaca)) directlyIncreases p(MGI:Maz,pmod(P))	We further show that SAF-1 is phosphorylated in vitro by PKA-Calpha and that addition of cAMP markedly induces in vivo phosphorylation of SAF-1 and transcription of SAF-regulated reporter genes.	SEN:10022070	11490023
BEL:20039112	kin(p(MGI:Prkca)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	We demonstrated that suppression of both PKC {alpha} and {theta}, using the antisense oligonucleotides, arrests cells in the G1 phase of the cell cycle.	SEN:10022072	12896972
BEL:20039118	kin(p(MGI:Prkca)) increases kin(p(MGI:Ptk2))	Suppression of the PAF effects by calphostin C, a PKC inhibitor, suggests that PKC is an upstream activator of FAK	SEN:10022074	10729607
BEL:20039120	kin(p(MGI:Prkca)) decreases r(MGI:Cdkn1a)	These results indicate that cell cycle arrest mediated by PKC {alpha} and {theta} antisense oligonucleotides is probably through eliciting p21WAF1/CIP1 expression/function.	SEN:10022076	12896972
BEL:20039124	kin(p(MGI:Prkcb)) increases p(MGI:Shc1,pmod(P,S,36))	More recent work suggests that PKC phosphorylation of p66Shc on Ser36 could cause its translocation to mitochondria [65].	SEN:10022080	19307700
BEL:20039126	kin(p(MGI:Prkcb)) increases r(MGI:Ptgs2)	In murine colon cancer models, elevated expression of PKCBII elevates cyclooxygenase-2 expression and represses TBRII expression to increase susceptibility to colon cancer.130	SEN:10022082	15774796
BEL:20039128	kin(p(MGI:Prkcb)) decreases r(MGI:Tgfbr2)	In murine colon cancer models, elevated expression of PKCBII elevates cyclooxygenase-2 expression and represses TBRII expression to increase susceptibility to colon cancer.130	SEN:10022082	15774796
BEL:20039130	kin(p(MGI:Prkcb)) increases sec(p(MGI:Il2))	Consistent with the ability of PKCbI to activate the JNK pathway, production of TNF-a and IL-2 in Fc«RI-stimulated mast cells was sensitive not only to a general PKC inhibitor, RO31-8425, and a cPKC-selective inhibitor, Go 6976, but also to a PKCb-selective inhibitor, LY379196 (Fig. 4A).	SEN:10022084	10852954
BEL:20039132	kin(p(MGI:Prkcb)) increases sec(p(MGI:Tnf))	Consistent with the ability of PKCbI to activate the JNK pathway, production of TNF-a and IL-2 in Fc«RI-stimulated mast cells was sensitive not only to a general PKC inhibitor, RO31-8425, and a cPKC-selective inhibitor, Go 6976, but also to a PKCb-selective inhibitor, LY379196 (Fig. 4A).	SEN:10022084	10852954
BEL:20039136	kin(p(MGI:Prkcd)) directlyIncreases p(MGI:Eef1a1,pmod(P,T,431))	p37, identified as annexin I, is preferentially phosphorylated by cPKC, whereas p50, identified as elongation factor eEF-1 alpha, is phosphorylated with much greater efficacy by PKC delta than by cPKC. PKC delta phosphorylates eEF-1 alpha at Thr-431 (based on the murine amino acid sequence).	SEN:10022088	7890750
BEL:20039138	kin(p(MGI:Prkcd)) increases p(MGI:Hif1a)	Instead, a novel protein kinase C, PKCdelta, was activated by AsIII to induce VEGF and stabilize HIF-1alpha.	SEN:10006338	15089098
BEL:20039140	kin(p(MGI:Prkcd)) increases p(MGI:Vcam1)	Intraperitoneal administration of rottlerin or SB-203580 at least 1 h before TNF-? clearly diminished the level of VCAM-1 expression in lung tissue, suggesting that PKC? and p38 kinase do indeed play a role in the TNF-? signaling to VCAM-1 expression in vivo	SEN:10022090	15489375
BEL:20039142	kin(p(MGI:Prkcd)) increases p(MGI:Vegfa)	Instead, a novel protein kinase C, PKCdelta, was activated by AsIII to induce VEGF and stabilize HIF-1alpha.	SEN:10006338	15089098
BEL:20039152	kin(p(MGI:Prkce)) increases kin(p(MGI:Ptk2))	Suppression of the PAF effects by calphostin C, a PKC inhibitor, suggests that PKC is an upstream activator of FAK	SEN:10022074	10729607
BEL:20039166	kin(p(MGI:Prkcq)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	We demonstrated that suppression of both PKC {alpha} and {theta}, using the antisense oligonucleotides, arrests cells in the G1 phase of the cell cycle.	SEN:10022072	12896972
BEL:20039168	kin(p(MGI:Prkcq)) decreases r(MGI:Cdkn1a)	These results indicate that cell cycle arrest mediated by PKC {alpha} and {theta} antisense oligonucleotides is probably through eliciting p21WAF1/CIP1 expression/function.	SEN:10022076	12896972
BEL:20039172	kin(p(MGI:Prkcz)) decreases bp(GOBP:"apoptotic process")	Elevated expression and activation of PKCzeta increased cell survival, whereas expression of PAR-4 promoted apoptosis.	SEN:10006344	15901738
BEL:20039186	kin(p(MGI:Prkg1)) directlyIncreases complex(p(MGI:Gkap1),p(MGI:Prkg1))	Although both cGK-Ialpha and -Ibeta, but not cAMP-dependent protein kinase, phosphorylated GKAP42 in vitro, GKAP42 was a good substrate only for cGK-Ialpha in intact cells	SEN:10022102	10671526
BEL:20039188	kin(p(MGI:Prkg1)) directlyIncreases p(MGI:Gkap1,pmod(P))	Although both cGK-Ialpha and -Ibeta, but not cAMP-dependent protein kinase, phosphorylated GKAP42 in vitro, GKAP42 was a good substrate only for cGK-Ialpha in intact cells	SEN:10022102	10671526
BEL:20039202	kin(p(MGI:Ptk2)) increases r(MGI:Tnc)	These results appear to be relevant in vivo because Prx1 and TN-C expression levels were reduced in FAK-null embryos.	SEN:10022108	12741393
BEL:20039204	kin(p(MGI:Ptk6)) decreases cat(p(MGI:Khdrbs2))	The phosphorylation of SLM-1 and SLM-2 has functional relevance and leads to inhibition of their RNA-binding abilities	SEN:10006354	15471878
BEL:20039206	kin(p(MGI:Ptk6)) decreases cat(p(MGI:Khdrbs3))	The phosphorylation of SLM-1 and SLM-2 has functional relevance and leads to inhibition of their RNA-binding abilities	SEN:10006354	15471878
BEL:20039216	kin(p(MGI:Raf1)) decreases bp(GOBP:"apoptotic process")	Focus formation was consistently observed with both mutants. However, C-RAF mutant proteins caused the formation of much smaller cell aggregates (Fig. 5A) as compared with v-Raf.	SEN:10022112	16585161
BEL:20039222	kin(p(MGI:Raf1)) increases kin(p(MGI:Mapk8))	We show that JNK- but not p38-activating pathways regulate the DSE activity. Furthermore, the JNK/SAPK signaling pathway cooperates with the Raf-MEK-ERK cascade in TPA/ionomycin-induced DSE activity.	SEN:10020998	9553058
BEL:20039224	kin(p(MGI:Raf1)) increases kin(p(MGI:Mapk9))	We show that JNK- but not p38-activating pathways regulate the DSE activity. Furthermore, the JNK/SAPK signaling pathway cooperates with the Raf-MEK-ERK cascade in TPA/ionomycin-induced DSE activity.	SEN:10020998	9553058
BEL:20039238	kin(p(MGI:Raf1)) increases p(MGI:Errfi1)	NIH3T3 cells expressing either Raf :ER-DD or Raf : ER-YY synthesized RALT upon stimulation with Tamoxifen for 4 ± 8 h in serum-deprived medium (Figure 4b). The effect of tamoxifen was as strong as serum stimulation and was reverted by the administra- tion of U0126 (Figure 4b)	SEN:10017890	12226756
BEL:20039246	kin(p(MGI:Raf1)) increases r(MGI:Plau)	Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.	SEN:10020912	10347197
BEL:20039260	kin(p(MGI:Ret)) increases tscript(p(MGI:Stat3))	Overexpression of both MEN2A-RET and STAT3 strongly enhanced reporter activation, indicating that MEN2A-RET induces cyclin-D1 gene expression via STAT3 (Figure 4a).	SEN:10022124	11536047
BEL:20039262	kin(p(MGI:Ret)) increases tscript(p(MGI:Stat3))	These data indicate that MEN2A-RET enhances proliferation via STAT3, and that a full length STAT3 is required to mediate the MEN2A-RET induced proliferation.	SEN:10022126	11536047
BEL:20039266	kin(p(MGI:Ripk1)) increases bp(GOBP:"necrotic cell death")	Moreover, it has been reported that H2O2-induced necrosis is also reduced in RIP1-deficient mouse embryonic fibroblasts (MEF).21	SEN:10022130	20010783
BEL:20039268	kin(p(MGI:Ripk1)) increases kin(p(MGI:Mapk8))	As shown in Fig 1C, ER stressinduced JNK activation was recovered in RIP-reconstituted RIP-/- cells, even though the protein level of RIP was much lower in RIP-reconstituted cells than in WT cells (Fig 1B). These results indicate that RIP, like TRAF2, is essential for JNK activation in response to ER stress.	SEN:10018100	16680093
BEL:20039276	kin(p(MGI:Ripk3)) increases bp(GOBP:"necrotic cell death")	We identified the protein kinase receptor-interacting protein 3 (RIP3) as a molecular switch between TNF-induced apoptosis and necrosis in NIH 3T3 cells and found that RIP3 was required for necrosis in other cells	SEN:10001852	19498109
BEL:20039278	kin(p(MGI:Ripk3)) increases bp(GOBP:"necrotic cell death")	Moreover, overexpression of catalytically active RIP3 can trigger necroptosis irrespective of the presence of RIP1 (Ref. 12)	SEN:10022134	20823910
BEL:20039282	kin(p(MGI:Ripk3)) directlyIncreases cat(p(MGI:Glud1))	Zhang et al. identify seven metabolic enzymes in the RIP3 complex immunoprecipitated from N-type NIH 3T3 cells that are treated with TNF/zVAD. Of these enzymes, RIP3 directly interacts with glycogen phosphorylase (PYGL), glutamate ammonia ligase (GLUL), and glutamate dehydrogenase 1 (GLUD1). RIP kinase activity is required to enhance the activities of all three enzymes both in vivo and in vitro.	SEN:10022138	19632174
BEL:20039284	kin(p(MGI:Ripk3)) directlyIncreases cat(p(MGI:Glul))	Zhang et al. identify seven metabolic enzymes in the RIP3 complex immunoprecipitated from N-type NIH 3T3 cells that are treated with TNF/zVAD. Of these enzymes, RIP3 directly interacts with glycogen phosphorylase (PYGL), glutamate ammonia ligase (GLUL), and glutamate dehydrogenase 1 (GLUD1). RIP kinase activity is required to enhance the activities of all three enzymes both in vivo and in vitro.	SEN:10022138	19632174
BEL:20039286	kin(p(MGI:Ripk3)) increases cat(p(MGI:Glul))	Wild-type, but not kinase-dead, RIP3 enhances the activity of PYGL, GLUL, and GLUD1 in vitro and in cells (55), which suggests that these metabolic enzymes could be direct substrates of RIP3.	SEN:10022140	20354226
BEL:20039288	kin(p(MGI:Ripk3)) directlyIncreases cat(p(MGI:Pygl))	To determine whether PYGL is involved in necrosis, we used siRNAs to deplete PYGL in N cells and found that reduction of PYGL partially inhibited TNF+zVAD–induced cell death (Fig. 3F). Thus, PYGL activation by RIP3 appears to contribute to necrosis.	SEN:10022142	19498109
BEL:20039290	kin(p(MGI:Ripk3)) directlyIncreases cat(p(MGI:Pygl))	Zhang et al. identify seven metabolic enzymes in the RIP3 complex immunoprecipitated from N-type NIH 3T3 cells that are treated with TNF/zVAD. Of these enzymes, RIP3 directly interacts with glycogen phosphorylase (PYGL), glutamate ammonia ligase (GLUL), and glutamate dehydrogenase 1 (GLUD1). RIP kinase activity is required to enhance the activities of all three enzymes both in vivo and in vitro.	SEN:10022138	19632174
BEL:20039292	kin(p(MGI:Ripk3)) increases cat(p(MGI:Pygl))	Wild-type, but not kinase-dead, RIP3 enhances the activity of PYGL, GLUL, and GLUD1 in vitro and in cells (55), which suggests that these metabolic enzymes could be direct substrates of RIP3.	SEN:10022140	20354226
BEL:20039304	kin(p(MGI:Rock1)) increases bp(GOBP:"apoptotic process")	In contrast, inhibition of ROCK activity using the small-molecule inhibitor Y-27632 (ref. 19) resulted in a marked reduction in formation of membrane blebs (Fig. 1a)	SEN:10022148	11283606
BEL:20039310	kin(p(MGI:Rock1)) decreases cat(p(MGI:Ctsb))	ROCK1, known in part for its role in the inhibition of the non-amyloidogenic alpha-secretase processing of the amyloid precursor protein	SEN:10006366	16751189
BEL:20039324	kin(p(MGI:Rock2)) decreases bp(GOBP:"cell migration")	Cyclin D1 promotes cellular motility through inhibiting ROCK signaling and repressing the metastasis suppressor TSP-1	SEN:10006372	16705174
BEL:20039330	kin(p(MGI:Rock2)) increases surf(p(MGI:Cd44))	In this work we show the Rho effector, Rho kinase (ROK-alpha), to be a potent activator of CD44 surface expression.	SEN:10006376	12730217
BEL:20039336	kin(p(MGI:Rps6ka1)) increases p(MGI:Stk11,pmod(P,S,431))	We present pharmacological and genetic evidence that p90(RSK) mediated this phosphorylation in response to agonists that activate ERK1/2 and that cAMP-dependent protein kinase mediated this phosphorylation in response to agonists that activate adenylate cyclase	SEN:10022158	11297520
BEL:20039358	kin(p(MGI:Rps6kb1)) increases p(HGNC:INS)	S6K1-deficient mice develop hyperglycemia in response to glucose challenge because of impaired insulin secretion and decreased insulin content in the beta-cells	SEN:10022162	12588811
BEL:20039364	kin(p(MGI:Rps6kb1)) increases bp(GOBP:"insulin secretion")	S6K1-deficient mice develop hyperglycemia in response to glucose challenge because of impaired insulin secretion and decreased insulin content in the beta-cells	SEN:10022162	12588811
BEL:20039368	kin(p(MGI:Rps6kb1)) decreases cat(p(MGI:Irs1))	Harrington et al. (2004) showed in the same study that a downstream target of mTORC1, S6K1 was able to phosphorylate and inhibit IRS-1 in Ser302.	SEN:10022166	18794886
BEL:20039372	kin(p(MGI:Rps6kb1)) directlyIncreases p(MGI:Irs1,pmod(P,S,302))	Harrington et al. (2004) showed in the same study that a downstream target of mTORC1, S6K1 was able to phosphorylate and inhibit IRS-1 in Ser302.	SEN:10022166	18794886
BEL:20039382	kin(p(MGI:Sik1)) directlyDecreases tscript(p(MGI:Creb1))	Salt-inducible kinase (SIK), a serine/threonine protein kinase expressed at an early stage of adrenocorticotropic hormone (ACTH) stimulation in Y1 mouse adrenocortical tumor cells, repressed the cAMP-responsive element (CRE)-dependent gene transcription by acting on the basic leucine zipper domain of the CRE-binding protein	SEN:10006384	12200423
BEL:20039388	kin(p(MGI:Sphk1)) decreases bp(GOBP:"apoptotic process")	bC also downregulated the expression of the pro-apoptotic gene Fan, and induced expression of the anti-apoptotic Sphk1a.	SEN:10022168	17707332
BEL:20039390	kin(p(MGI:Src)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	The kinase-inactive SrcK295M induced a G(1) block that was overcome by the constitutively active Abl-PP (AblP242E/P249E). Conversely, the inhibitory effect of Abl-PP-K(-) was not compensated by Src.	SEN:10006056	11847100
BEL:20039392	kin(p(MGI:Src)) decreases bp(GOBP:"apoptotic process")	Mutant src(-/-) mice have osteopetrosis resulting from defective osteoclasts (increased apoptosis). Expression of a truncated Src mutant lacking the kinase domain induced osteopetrosis in wildtype and Src +/- mice and worsened osteopetrosis in Src -/- mice by increased osteoclast apoptosis.	SEN:10022170	11157779
BEL:20039398	kin(p(MGI:Src)) decreases path(MESHD:Osteopetrosis)	Mutant src(-/-) mice have osteopetrosis resulting from defective osteoclasts (increased apoptosis). Expression of a truncated Src mutant lacking the kinase domain induced osteopetrosis in wildtype and Src +/- mice and worsened osteopetrosis in Src -/- mice by increased osteoclast apoptosis.	SEN:10022170	11157779
BEL:20039406	kin(p(MGI:Src)) increases p(MGI:Cav1,pmod(P,Y,14))	site-directed mutagenesis directly show that tyrosine 14 is the principal substrate for Src kinase. Only alpha-caveolin underwent tyrosine phosphorylation in v-Src transformed NIH 3T3 cells, although beta-caveolin is well expressed in these cells.	SEN:10022174	8632005
BEL:20039410	kin(p(MGI:Src)) increases p(MGI:Ctnna1,pmod(P,Y))	Src-family kinases then phosphorylate the plaque proteins b-catenin, plakoglobin, p120cnt, and acatenin, which is required for their association with the E-cadherin tail (Calautti et al., 1998, 2005).	SEN:10022176	18268536
BEL:20039412	kin(p(MGI:Src)) increases p(MGI:Ctnnb1,pmod(P,Y))	Src-family kinases then phosphorylate the plaque proteins b-catenin, plakoglobin, p120cnt, and acatenin, which is required for their association with the E-cadherin tail (Calautti et al., 1998, 2005).	SEN:10022176	18268536
BEL:20039414	kin(p(MGI:Src)) increases p(MGI:Ctnnd1,pmod(P,Y))	Src-family kinases then phosphorylate the plaque proteins b-catenin, plakoglobin, p120cnt, and acatenin, which is required for their association with the E-cadherin tail (Calautti et al., 1998, 2005).	SEN:10022176	18268536
BEL:20039420	kin(p(MGI:Src)) increases p(MGI:Egfr,pmod(P,Y,920))	JNK2 might potentially be activated via Src kinasemediated phosphorylation of EGF-R on Tyr920 (Calautti et al., 2005),	SEN:10022182	18268536
BEL:20039428	kin(p(MGI:Src)) increases p(MGI:Itgb1,pmod(P,Y))	b1-integrin phosphorylation by Src results in EGF-R activation (Miranti and Brugge, 2002), and b1-integrin expression is required for the initiation of mouse mammary tumors expressing the polyoma virus middle T antigen (White et al., 2004).	SEN:10022186	18268536
BEL:20039430	kin(p(MGI:Src)) increases p(MGI:Jup,pmod(P,Y))	Src-family kinases then phosphorylate the plaque proteins b-catenin, plakoglobin, p120cnt, and acatenin, which is required for their association with the E-cadherin tail (Calautti et al., 1998, 2005).	SEN:10022176	18268536
BEL:20039432	kin(p(MGI:Src)) directlyIncreases p(MGI:Prkcd,pmod(P,Y))	However, purified EGFR did not phosphorylate recombinant PKC delta in vitro, whereas members of the Src family (c-Src, c-Fyn) and membrane preparations from keratinocytes did.	SEN:10021722	8621384
BEL:20039434	kin(p(MGI:Src)) directlyIncreases p(MGI:Rps6kb1,pmod(P,Y))	Using PDGFR mutants, we have shown that the phosphorylation is exerted via a PDGFR-src pathway. Furthermore, src kinase phosphorylates and coimmunoprecipitates with S6K in vivo.	SEN:10022188	16640565
BEL:20039436	kin(p(MGI:Src)) directlyIncreases p(MGI:Rps6kb1,pmod(P,Y,39))	In addition, we mapped the sites of tyrosine phosphorylation in S6K1 and S6K2 to Y39 and Y45, respectively.	SEN:10022190	16640565
BEL:20039438	kin(p(MGI:Src)) directlyIncreases p(MGI:Rps6kb2,pmod(P,Y))	Using PDGFR mutants, we have shown that the phosphorylation is exerted via a PDGFR-src pathway. Furthermore, src kinase phosphorylates and coimmunoprecipitates with S6K in vivo.	SEN:10022188	16640565
BEL:20039440	kin(p(MGI:Src)) directlyIncreases p(MGI:Rps6kb2,pmod(P,Y,45))	In addition, we mapped the sites of tyrosine phosphorylation in S6K1 and S6K2 to Y39 and Y45, respectively.	SEN:10022190	16640565
BEL:20039446	kin(p(MGI:Src)) decreases r(EGID:665646)	9 cDNAs whose abundance in NIH3T3 fibroblasts is decreased 3-15-fold following transformation by the activated oncogene, v-src. The remaining 6 cDNAs are indentical or highly similar to rat helix-destabilizing protein gene (hnRNP A1), mouse CTLA-2 alpha cysteine protease, rat cytochrome c oxidase (COX) VIc subunit, mouse Type I collagen, human gravin	SEN:10022194	7832805
BEL:20039448	kin(p(MGI:Src)) decreases r(MGI:Akap12)	9 cDNAs whose abundance in NIH3T3 fibroblasts is decreased 3-15-fold following transformation by the activated oncogene, v-src. The remaining 6 cDNAs are indentical or highly similar to rat helix-destabilizing protein gene (hnRNP A1), mouse CTLA-2 alpha cysteine protease, rat cytochrome c oxidase (COX) VIc subunit, mouse Type I collagen, human gravin	SEN:10022194	7832805
BEL:20039450	kin(p(MGI:Src)) decreases r(MGI:Cox6c)	9 cDNAs whose abundance in NIH3T3 fibroblasts is decreased 3-15-fold following transformation by the activated oncogene, v-src. The remaining 6 cDNAs are indentical or highly similar to rat helix-destabilizing protein gene (hnRNP A1), mouse CTLA-2 alpha cysteine protease, rat cytochrome c oxidase (COX) VIc subunit, mouse Type I collagen, human gravin	SEN:10022194	7832805
BEL:20039452	kin(p(MGI:Src)) increases r(MGI:Eps8)	Eps8 is expressed at low levels in resting fibroblasts, but its expression is strongly induced during activation by serum, phorbol esters and the v-src oncogene	SEN:10022196	9365239
BEL:20039456	kin(p(MGI:Src)) increases r(MGI:Ptgs2)	A consensus cyclic AMP response element (CRE) in the murine prostaglandin synthase-2 (PGS2) promoter is essential for pgs2 gene expression induced by pp60v-src, the v-src oncogene product	SEN:10006394	7499226
BEL:20039458	kin(p(MGI:Src)) increases tscript(p(MGI:Klf2))	In addition, KLF2(-/-) MEFs exhibit a significant growth defect, indicating that KLF2 is required to maintain the viability of MEF cells. The PDGF signal is mediated through the Src signaling pathway, and a downstream target of KLF2 is sphingosine 1-phosphate receptor 1.	SEN:10022198	18063572
BEL:20039468	kin(p(MGI:Stk11)) decreases bp(GOBP:"cell proliferation")	The reintroduction of wild-type LKB1 into a cancer cell line that lacks LKB1 suppressed growth, but mutants of LKB1 in which Ser(431) was mutated to Ala to prevent phosphorylation of LKB1 were ineffective in inhibiting growth.	SEN:10006398	11297520
BEL:20039476	kin(p(MGI:Stk11)) decreases kin(p(MGI:Akt1))	MLKB1KO mice had increased insulin-stimulated Akt phosphorylation and a 80% decrease in muscle expression of TRB3, a recently identified Akt inhibitor	SEN:10022204	16966378
BEL:20039478	kin(p(MGI:Stk11)) decreases kin(p(MGI:Mtor))	LKB1-deficient tumors are shown here to exhibit elevated levels of S6K1 activity and phospho-4EBP1, indicative of hyperactivation of mTOR signaling	SEN:10022206	15261145
BEL:20039480	kin(p(MGI:Stk11)) increases kin(p(MGI:Prkaa1))	We show that LKB1 directly phosphorylates Thr-172 of AMPKalpha in vitro and activates its kinase activity.	SEN:10022208	14985505
BEL:20039482	kin(p(MGI:Stk11)) decreases kin(p(MGI:Rps6kb1))	LKB1-deficient tumors are shown here to exhibit elevated levels of S6K1 activity and phospho-4EBP1, indicative of hyperactivation of mTOR signaling	SEN:10022206	15261145
BEL:20039490	kin(p(MGI:Stk11)) decreases p(MGI:Eif4ebp1)	LKB1-deficient tumors are shown here to exhibit elevated levels of S6K1 activity and phospho-4EBP1, indicative of hyperactivation of mTOR signaling	SEN:10022206	15261145
BEL:20039494	kin(p(MGI:Stk11)) directlyIncreases p(MGI:Prkaa1,pmod(P,S,172))	We show that LKB1 directly phosphorylates Thr-172 of AMPKalpha in vitro and activates its kinase activity.	SEN:10022208	14985505
BEL:20039496	kin(p(MGI:Stk11)) directlyIncreases p(MGI:Prkaa2,pmod(P,T,172))	We show that LKB1 directly phosphorylates Thr-172 of AMPKalpha in vitro and activates its kinase activity.	SEN:10022208	14985505
BEL:20039502	kin(p(MGI:Stk11)) increases r(MGI:Trib3)	MLKB1KO mice had increased insulin-stimulated Akt phosphorylation and a 80% decrease in muscle expression of TRB3, a recently identified Akt inhibitor	SEN:10022204	16966378
BEL:20039508	kin(p(MGI:Stk39)) decreases cat(p(MGI:Slc12a5))	We also have shown that the transport function of K+-Cl- cotransporter type 2 (KCC2), a neuron-specific KCl cotransporter, was diminished by the expression of both kinases under both isosmotic and hyposmotic conditions.	SEN:10022226	15930150
BEL:20039512	kin(p(MGI:Syk)) directlyIncreases cat(p(MGI:Lat2))	Subsequent to its association with Fc?RI, Syk is phosphorylated and activated by Lyn. Syk phosphorylates the adaptor proteins LAT and NTAL/LAB/LAT2	SEN:10021828	9000133
BEL:20039514	kin(p(MGI:Syk)) directlyIncreases cat(p(MGI:Lat))	Subsequent to its association with Fc?RI, Syk is phosphorylated and activated by Lyn. Syk phosphorylates the adaptor proteins LAT and NTAL/LAB/LAT2	SEN:10021828	9000133
BEL:20039526	kin(p(MGI:Syk)) increases r(MGI:Tnf)	As expected from Btk regulation by Syk, two Syk-selective inhibitors, piceatannol and ER-27319, suppressed Fc epsilon RI-induced transcriptional activation of the TNF-a gene promoter and cytokine secretion (Fig. 4C).	SEN:10022232	10852954
BEL:20039528	kin(p(MGI:Syk)) increases sec(p(MGI:Il2))	As expected from Btk regulation by Syk, two Syk-selective inhibitors, piceatannol and ER-27319, suppressed Fc epsilon RI-induced transcriptional activation of the TNF-a gene promoter and cytokine secretion (Fig. 4C).	SEN:10022232	10852954
BEL:20039534	kin(p(MGI:Tek)) increases bp(GOBP:"cell migration")	Furthermore, exposure of aortic rings from p47(phox-/-) mice to Ang-1 demonstrated fewer vessel sprouts than WT mice. Inhibition of the Tie-2 receptor inhibited Ang-1-induced endothelial migration and vessel sprouting	SEN:10022236	16679392
BEL:20039536	kin(p(MGI:Tek)) increases bp(GOBP:"patterning of blood vessels")	Furthermore, exposure of aortic rings from p47(phox-/-) mice to Ang-1 demonstrated fewer vessel sprouts than WT mice. Inhibition of the Tie-2 receptor inhibited Ang-1-induced endothelial migration and vessel sprouting	SEN:10022236	16679392
BEL:20039538	kin(p(MGI:Tgfbr1)) decreases bp(GOBP:"cell adhesion")	In agreement with this possibility, we observed that TGFbeta1 inhibited cell adhesion, and transfection of TbetaRI further enhanced this inhibition (Figure 8C, D).	SEN:10022238	17203972
BEL:20039540	kin(p(MGI:Tgfbr1)) increases bp(GOBP:"cell migration")	We found that TGFbeta1 enhanced Mv1Lu cell migration, which was strongly increased upon expression of TâRI (Figure 8A, B). Coexpression of Epac1 with TbetaRI significantly decreased cell migration, as compared to cells transfected with TbetaRI only.	SEN:10019528	17203972
BEL:20039542	kin(p(MGI:Tgfbr1)) increases bp(GOBP:"epithelial to mesenchymal transition")	Further work revealed that TGF-R signaling (Massague and Wotton, 2000) was required for EMT, invasion in vitro, and metastasis in vivo,	SEN:10020476	11790801
BEL:20039544	kin(p(MGI:Tgfbr1)) decreases bp(GOBP:"myoblast differentiation")	TGF-beta inhibited myogenic differentiation by 98% and stimulated mac25/IGFBP-7 mRNA expression 2-fold.	SEN:10006402	9417882
BEL:20039546	kin(p(MGI:Tgfbr1)) increases deg(p(MGI:Skp2))	Using a pulse-chase analysis, we demonstrated that the stability of Skp2 decreases in the presence of TGF-beta.	SEN:10006404	14676846
BEL:20039548	kin(p(MGI:Tgfbr1)) decreases kin(p(MGI:Cdk2))	TGF-beta inhibits Cdk2-cyclin E kinase activity by promoting the binding of cell cycle inhibitor Kip1 protein to the kinase complexes.	SEN:10020210	14676846
BEL:20039550	kin(p(MGI:Tgfbr1)) increases p(MGI:Hif1a)	we demonstrate that TGFbeta acts on HIF-1alpha accumulation and activity by increasing HIF-1alpha protein stability	SEN:10006406	16815840
BEL:20039554	kin(p(MGI:Tgfbr1)) increases r(MGI:Igfbp7)	TGF-beta inhibited myogenic differentiation by 98% and stimulated mac25/IGFBP-7 mRNA expression 2-fold.	SEN:10006402	9417882
BEL:20039556	kin(p(MGI:Tgfbr1)) increases tscript(p(MGI:Smad2))	We observed that transfection of Epac1 in the Mv1Lu cells inhibited TGFbeta/TbetaRI-dependent phosphorylation of Smad2 (Figure 6A).	SEN:10019530	17203972
BEL:20039558	kin(p(MGI:Tgfbr1)) increases tscript(p(MGI:Smad3))	We used a luciferase reporter construct that contains CAGA elements which are sites of direct DNA binding for activated Smad3 (CAGA(12)-luc).35 We observed that Epac1 strongly inhibited TGFbeta/TbetaRI-dependent activation of CAGA(12)-luc in Mv1Lu cells, as compared to cells transfected with TbetaRI alone (Figure 7A, B).	SEN:10019532	17203972
BEL:20039564	kin(p(MGI:Tgfbr2)) increases p(MGI:Hif1a)	we demonstrate that TGFbeta acts on HIF-1alpha accumulation and activity by increasing HIF-1alpha protein stability	SEN:10006406	16815840
BEL:20039580	kin(p(MGI:Tyk2)) increases surf(p(MGI:Mpl))	Tyk2, along with JAK2, does appear to regulate TPO receptor localization at the plasma membrane by stimulating recycling and enhancing the stability of the receptor in Ba/F3 cells	SEN:10021794	17127443
BEL:20039594	kin(p(MGI:Wee1)) increases p(EGID:12534,pmod(P,Y,15))	from full text - The wee1 gene product phosphorylates Cdc2 on Tyr-15 [p-Cdc2(Tyr 15)] and keeps it in an inactive form	SEN:10022244	12934012
BEL:20039990	path(MESHD:Acidosis) increases p(MGI:Edn1)	In conclusion, metabolic acidosis increases ET-1 expression, which increases NHE3 activity via the ET(B) receptor.	SEN:10000218	11413164
BEL:20039996	path(MESHD:Hyperoxia) increases cat(p(MGI:Casp3))	In hyperoxic lungs, there was a significant increase in the amount of cleaved caspase-3 (17 kD) and cleaved PARP-1 (85 kD) in WT mice, whereas in NOX1-deficient mice only small increases were observed (Figures 6A26C).	SEN:10022398	19661248
BEL:20039998	path(MESHD:Hyperoxia) increases cat(p(MGI:Parp1))	In hyperoxic lungs, there was a significant increase in the amount of cleaved caspase-3 (17 kD) and cleaved PARP-1 (85 kD) in WT mice, whereas in NOX1-deficient mice only small increases were observed (Figures 6A26C).	SEN:10022398	19661248
BEL:20040000	path(MESHD:Hyperoxia) increases complex(p(MGI:Cav1),p(MGI:Hmox1))	To investigate the relationship between cav-1 and HO-1 in hyperoxia, we evaluated the physical interaction between cav-1 and HO-1 in fibroblasts by co-immunoprecipitation. Interestingly, hyperoxia induced the formation of a complex between cav-1 and HO-1 as illustrated in Figure 4D.	SEN:10022400	18323531
BEL:20040002	path(MESHD:Hyperoxia) increases kin(p(MGI:Mapk1))	hyperoxia stimulated ERK-1 and ERK-2 phosphorylation {SE: Canonical ERK phosphorylation leading directly to activation}	SEN:10022402	15292179
BEL:20040004	path(MESHD:Hyperoxia) increases kin(p(MGI:Mapk3))	Collectively, these results indicate that ERK-1 regulates hyperoxia-stimulated Nrf2 phosphorylation and the subsequent ARE-driven transcriptional response.	SEN:10000380	15292179
BEL:20040006	path(MESHD:Hyperoxia) increases kin(p(MGI:Mapk3))	hyperoxia stimulated ERK-1 and ERK-2 phosphorylation {SE: Canonical ERK phosphorylation leading directly to activation}	SEN:10022402	15292179
BEL:20040008	path(MESHD:Hyperoxia) increases p(MGI:Bcl2)	Lung Bcl-2 mRNA and protein increased in the neonatal but not in the adult lungs (Figure 6, A and B).	SEN:10022404	15343385
BEL:20040010	path(MESHD:Hyperoxia) increases p(MGI:Btrc)	dditionally, after 72 hours of hyperoxia, neonates showed an increased level of beta-TrCP, a protein that targets pI-kappaBalpha for degradation, whereas adults showed no detectable levels of this protein (Figure 3E).	SEN:10022406	15343385
BEL:20040012	path(MESHD:Hyperoxia) increases p(MGI:Chuk)	Hyperoxia was associated with increased lung IKK-alpha and IKK-beta but not increased IKK-gamma, whereas adults showed no increase in IKK-alpha, loss of IKK-gamma, and a modest increase in IKK-beta (Figure 4).	SEN:10022408	15343385
BEL:20040014	path(MESHD:Hyperoxia) increases p(MGI:Hmox1)	Again, significantly higher levels of HO-1 induced by hyperoxia were found in cav-1-/- fibroblasts relative to wildtype fibroblasts (Figure 4C), indicating that hyperoxia induced the time-dependent elevation of HO-1 protein in vitro.	SEN:10022410	18323531
BEL:20040016	path(MESHD:Hyperoxia) increases p(MGI:Hmox1)	Interestingly, basal and hyperoxia-inducible HO-1 levels were dramatically higher in cav-1-/- mice than in corresponding wild-type mice (Figure 4A).	SEN:10022412	18323531
BEL:20040018	path(MESHD:Hyperoxia) increases p(MGI:Ikbkb)	Hyperoxia was associated with increased lung IKK-alpha and IKK-beta but not increased IKK-gamma, whereas adults showed no increase in IKK-alpha, loss of IKK-gamma, and a modest increase in IKK-beta (Figure 4).	SEN:10022408	15343385
BEL:20040020	path(MESHD:Hyperoxia) decreases p(MGI:Ikbkg)	Hyperoxia was associated with increased lung IKK-alpha and IKK-beta but not increased IKK-gamma, whereas adults showed no increase in IKK-alpha, loss of IKK-gamma, and a modest increase in IKK-beta (Figure 4).	SEN:10022408	15343385
BEL:20040022	path(MESHD:Hyperoxia) increases p(MGI:Nfe2l2,pmod(P,S))	As was seen for wild-type MEFs, hyperoxia enhanced the phosphorylation of endogenous Nrf2 (lane 6) when compared with room air-exposed controls (lane 5).	SEN:10000382	15292179
BEL:20040024	path(MESHD:Hyperoxia) increases p(MGI:Nfe2l2,pmod(P,S))	In ERK-1+/+ MEFs, hyperoxia stimulated phosphorylation of Nrf2 (lane 4), when compared with room air-exposed controls (lane 3).	SEN:10000384	15292179
BEL:20040026	path(MESHD:Hyperoxia) increases p(MGI:Nfkbia)	eonatal lung showed an increase in pI-kappaBalpha protein levels after only 30 minutes of hyperoxia and a decrease in total I-kappaBalpha by 4 hours of hyperoxic exposure (Figure 3). In contrast, adults had barely detectable pI-kappaBalpha and had increased total lung I-kappaBalpha protein levels at all time points after hyperoxic exposure (Figure 3).	SEN:10022414	15343385
BEL:20040028	path(MESHD:Hyperoxia) decreases p(MGI:Nfkbia)	eonatal lung showed an increase in pI-kappaBalpha protein levels after only 30 minutes of hyperoxia and a decrease in total I-kappaBalpha by 4 hours of hyperoxic exposure (Figure 3). In contrast, adults had barely detectable pI-kappaBalpha and had increased total lung I-kappaBalpha protein levels at all time points after hyperoxic exposure (Figure 3).	SEN:10022414	15343385
BEL:20040030	path(MESHD:Hyperoxia) increases p(MGI:Nfkbia,pmod(P,S,32))	eonatal lung showed an increase in pI-kappaBalpha protein levels after only 30 minutes of hyperoxia and a decrease in total I-kappaBalpha by 4 hours of hyperoxic exposure (Figure 3). In contrast, adults had barely detectable pI-kappaBalpha and had increased total lung I-kappaBalpha protein levels at all time points after hyperoxic exposure (Figure 3).	SEN:10022414	15343385
BEL:20040034	path(MESHD:Hyperoxia) increases tloc(p(MGI:Nfe2l2),GOCCID:0005737,GOCCID:0005634)	However, a high proportion of Nrf2 accumulated in the nucleus of both cell types following the exposure of cells to hyperoxia (Fig. 1A, right panels).	SEN:10000386	15292179
BEL:20040036	path(MESHD:Hyperoxia) increases tloc(p(MGI:Nfe2l2),GOCCID:0005737,GOCCID:0005634)	hyperoxia caused the translocation of Nrf2 from the cytoplasm to the nucleus within 30-60 min of exposure	SEN:10000388	15292179
BEL:20040038	path(MESHD:Hyperoxia) increases tscript(p(MGI:Nfe2l2))	hyperoxia caused the translocation of Nrf2 from the cytoplasm to the nucleus within 30-60 min of exposure	SEN:10000388	15292179
BEL:20040044	path(MESHD:Hypoglycemia) increases tscript(p(MGI:Hif1a))	As shown in Figure 4d, Ero1-La was also strongly induced by hypoglycemia under normoxic conditions. Furthermore, this response was abrogated in the absence of a functional HIF-1.	SEN:10022422	15592500
BEL:20040052	path(MESHD:Ischemia) increases p(MGI:Alox12)	Brain endothelial cells were protected against hypoxia and H(2)O(2) by the lipoxygenase inhibitor baicalein. After focal ischemia, 12/15-LOX was increased in neurons and endothelial cells. The vascular tight junction protein claudin-5 underwent extensive degradation in the peri-infarct area, which was partially prevented by the lipoxygenase inhibitor baicalein.	SEN:10003288	18635843
BEL:20040054	path(MESHD:Ischemia) increases p(MGI:Clu)	In the brain, it accumulates in dying neurons following seizures and hypoxic-ischemic (H-I) injury.	SEN:10006488	11231633
BEL:20040058	path(MESHD:Ischemia) increases p(MGI:Nfatc2)	Ischemia also activated the expression and binding of p53 to an adjacent enhancer site (RE-1) and increased expression and binding of nuclear factor of activated T-cells-c2 to consensus sequences within the first intron. Deletion of either the 5' AP-1/RE-1 region of the promoter or substitution of the first intron abolished ischemia-induced MMP-2 transcription in vivo.	SEN:10022426	16258061
BEL:20040066	path(MESHD:Sepsis) increases sec(p(MGI:Il6))	The increase in IL-6 in septic DPPI(-/-) mice, which appears to protect these mice from death, may be related to reduced DPPI-mediated activation of mast cell tryptase and other peptidases, which we show cleave IL-6 in vitro.	SEN:10018984	14966572
BEL:20040238	p(MGI:Il1a) increases complex(p(MGI:Il1r1),p(MGI:Irak1))	Upon stimulation of cells with interleukin-1 (IL-1) the IL-1 receptor type I (IL-1RI) associated kinase-1 (IRAK-1) transiently associates to and dissociates from the IL-1RI and thereafter translocates into the nucleus.	SEN:10005502	15896328
BEL:20040240	p(MGI:Il1a) increases p(MGI:Il1rn)	interleukin 1 receptor antagonist (IL-1ra) is induced in mouse liver after lipopolysaccharide (LPS) or recombinant interleukin 1 (IL-1	SEN:10015950	9112333
BEL:20040242	p(MGI:Il1a) increases tscript(p(MGI:Cebpb))	In contrast, IL-1, which activates only the \"NF-IL6\" pathway, synergizes with heat shock to produce strong activation of hsp90.	SEN:10022508	9461509
BEL:20040244	p(MGI:Il1a) increases tscript(p(MGI:Maz))	Serum amyloid A-activating factor-1 (SAF-1) is a zinc finger transcription factor that is activated by many mediators of inflammation including IL-1, IL-6, and bacterial LPS.	SEN:10003486	11490023
BEL:20040254	p(MGI:Ifna1) increases tscript(p(MGI:Stat1))	IL-10 inhibits IFN-alpha-activated STAT1 in the liver, at least in part, by inducing SOCS2, SOCS3, and CIS expression	SEN:10022516	11034314
BEL:20040256	p(MGI:Ifna1) increases tscript(p(MGI:Stat1))	These findings suggest that IL-10 inhibits IFN-alpha-activated STAT1 in the liver, at least in part, by inducing SOCS2, SOCS3, and CIS expression	SEN:10006528	11034314
BEL:20040258	p(EGID:122953) decreases p(MGI:Ccnd1)	. A similar analysis was performed for cyclin D1; however, whereas control-C2 cells expressed high levels of cyclin D1 protein when grown in GM, JDP2-C2 cells expressed significantly reduced levels of cyclin D1	SEN:10022518	12171923
BEL:20040264	p(EGID:12765) increases p(MGI:Cxcl10)	ELISA analysis of whole lung levels of IP-10/CXCL10 and MIG/CXCL9 in both groups of mice revealed that both non-ELR CXC chemokines were significantly elevated in CXCR2-/- mice compared with those in CXCR2+/+ mice (Fig. 8Go).	SEN:10022524	11801688
BEL:20040266	p(EGID:12765) increases p(MGI:Cxcl9)	ELISA analysis of whole lung levels of IP-10/CXCL10 and MIG/CXCL9 in both groups of mice revealed that both non-ELR CXC chemokines were significantly elevated in CXCR2-/- mice compared with those in CXCR2+/+ mice (Fig. 8Go).	SEN:10022524	11801688
BEL:20040274	p(EGID:12806) decreases tscript(p(MGI:Irf8))	CO abrogates the synergistic effect of interferon (IFN)-gamma on lipopolysaccharide-induced IL-12 p40 in murine macrophages and alters IFN-gamma signaling by inhibiting a member of the IFN regulatory factor (IRF) family of transcription factors, IRF-8.	SEN:10022532	16365149
BEL:20040282	p(EGID:19368) increases cat(p(MGI:Casp3))	Assessments of bioactivity of the apoptotic markers active caspase 3 (Casp3) and Casp3/7 revealed that the apoptosis signals in the lungs of Raet1a Tg mice were increased (Figure 3, A and B).	SEN:10022538	19197141
BEL:20040284	p(EGID:19368) increases cat(p(MGI:Casp7))	Assessments of bioactivity of the apoptotic markers active caspase 3 (Casp3) and Casp3/7 revealed that the apoptosis signals in the lungs of Raet1a Tg mice were increased (Figure 3, A and B).	SEN:10022538	19197141
BEL:20040286	p(EGID:19368) increases p(MGI:Gzmb)	we observed increased granzyme B protein levels in Raet1a Tg lungs both before and during the development of alveolar destruction (Figure 3C).	SEN:10022540	19197141
BEL:20040298	p(EGID:5424,pmod(P,T,14)) directlyDecreases kin(p(HGNC:CDK1))	<C17> Phosphorylation of Thr14 or Tyr15 in Cdk1 reduces kinase activity 10-fold; phosphorylation of both sites reduces activity 100-fold (Liu et al., 1997).	SEN:10022542	10436023
BEL:20040300	p(EGID:5424,pmod(P,Y,15)) directlyDecreases kin(p(HGNC:CDK1))	<C17> Phosphorylation of Thr14 or Tyr15 in Cdk1 reduces kinase activity 10-fold; phosphorylation of both sites reduces activity 100-fold (Liu et al., 1997).	SEN:10022542	10436023
BEL:20040310	p(HGNC:ABCB1) decreases bp(GOBP:"apoptotic process")	In combination with cell proliferative activities of c-myc and cyclin D1, MDR1 may initiate colorectal tumorigenesis by suppressing cell death pathways programmed in intestinal epithelial cells.	SEN:10002158	10987283
BEL:20040314	p(HGNC:ABL1,pmod(P,S,465)) directlyIncreases kin(p(HGNC:ABL1))	<A2> ATM phosphorylates c-Abl on Ser465 and thereby activates the kinase (Baskaran et al., 1997b). <A3> Phosphorylation by ATM activates c-Abl (Baskaran et al., 1997b). c-Abl tyrosine kinase activity is stimulated in response to ionizing radiation (IR), 1-b-d-arabinofuransylcytosine, camptothecin, or etoposide (Yuan et al., 1996, 1998).	SEN:10021124	10436023
BEL:20040324	p(HGNC:ACSL4) decreases a(CHEBI:"arachidonic acid")	the cellular level of unesterified arachidonic acid is a general mechanism by which apoptosis is regulated and that COX-2 and FACL4 promote carcinogenesis by lowering this level.	SEN:10006544	11005842
BEL:20040328	p(HGNC:ACTN2) increases cat(p(HGNC:KCNA5))	both proteins. The ion channels and alpha-actinin-2 co-localize at the membrane in HEK cells, where disruption of the actin cytoskeleton and antisense constructs to alpha-actinin-2 modulate the ion and gating current density.	SEN:10022546	10812072
BEL:20040330	p(HGNC:ACTN2) decreases cat(p(HGNC:KCNA5))	both proteins. The ion channels and alpha-actinin-2 co-localize at the membrane in HEK cells, where disruption of the actin cytoskeleton and antisense constructs to alpha-actinin-2 modulate the ion and gating current density.	SEN:10022546	10812072
BEL:20040360	p(HGNC:AIF1) increases bp(GOBP:phagocytosis)	Expression of mutant Iba1 carrying either N- or C-terminal deletions or carrying a substitution in the calcium binding domain, suppressed the membrane ruffling and the phagocytosis.	SEN:10006558	10934045
BEL:20040370	p(HGNC:ALDOA) decreases complex(p(HGNC:ALDOA),p(HGNC:EIF4G2))	We demonstrate that the binding between AldA-NRE and p97 decreases during differentiation of human Caco-2 cells and is inversely correlated with L-type mRNA expression.	SEN:10004056	10413096
BEL:20040372	p(HGNC:ALDOB) increases r(HGNC:HNF1A)	HNF1alpha regulates aldolase B mRNA in a similar manner but the underlying mechanism remains to be established.	SEN:10022562	10944108
BEL:20040378	p(HGNC:ANGPT2) increases bp(GOBP:"patterning of blood vessels")	In contrast, costimulation with VEGF and Ang-2 induced sprouting angiogenesis originating from coculture spheroids consistent with a model of Ang-2-mediated vessel destabilization resulting in VEGF responsiveness. Ang-2 on its own was able to stimulate endothelial cells in the absence of Ang-1 producing SMC, inducing lateral sheet migration as well as in gel sprouting angiogenesis.	SEN:10022566	11156960
BEL:20040392	p(HGNC:APC) decreases p(HGNC:CTNNB1)	Most colorectal cancers have loss of function mutations in the adenomatosis polyposis coli (APC) tumor suppressor gene. This leads to accumulation of beta-catenin, which together with the DNA binding protein TCF-4 functions as a transcriptional activator.	SEN:10006570	10514384
BEL:20040398	p(HGNC:API5) increases r(HGNC:CTNNB1)	In cervical cancer cells transfected with AAC-11, the expression of beta-catenin was up-regulated.	SEN:10022574	10780674
BEL:20040400	p(HGNC:API5) increases r(HGNC:MMP2)	Northern blot analysis showed that matrix metalloproteinase (MMP)-2 and membrane type 1 MMP (MT1-MMP) genes were found to be expressed in high levels in AAC-11-transfected cancer cells.	SEN:10022576	10780674
BEL:20040402	p(HGNC:API5) decreases r(HGNC:TIMP2)	On the contrary, tissue inhibitor of MMP (TIMP-2) expression was detectable in cells transfected with vector alone or wild-type cells, respectively. Its expression was undetectable in AAC-11 transfected cells.	SEN:10006574	10780674
BEL:20040404	p(HGNC:APLN) decreases r(HGNC:APLNR)	Because apelin is an endogenous ligand for the APJ receptor, we examined the inhibitory effects of apelin peptides on HIV infection, and found that the apelin peptides inhibit the entry of some HIV-1 and HIV-2 into the NP-2/CD4 cells expressing APJ.	SEN:10006576	10802050
BEL:20040422	p(HGNC:APP) decreases r(EGID:6431)	(ii) the SRp55 gene encoding a splicing factor involved in constitutive pre-mRNA splicing and alternative splice site selection.	SEN:10022584	10448433
BEL:20040424	p(HGNC:APP) decreases r(HGNC:CD59)	By the use of a ribonuclease protection technique, amyloid beta-peptide was found to downregulate CD59 expression at the mRNA level, suggesting a partial explanation of CD59 deficits in the AD brain.	SEN:10006580	11027207
BEL:20040426	p(HGNC:APP) increases r(HGNC:CYR61)	(iii) a new growth factor-inducible immediate-early gene, CYR61, the product of which functions as an extracellular matrix signaling molecule;	SEN:10006582	10448433
BEL:20040428	p(HGNC:APP) increases r(HGNC:DLD)	(vi) a gene encoding a constituent of the mitochondrial pyruvate dehydrogenase complex, the dihydrolipoamide dehydrogenase-binding protein (E3-BP); and	SEN:10006584	10448433
BEL:20040434	p(HGNC:APP) increases r(HGNC:MAP2K1)	(ii) a stress-signaling kinase gene encoding the mitogen-activated protein kinase/Erk kinase kinase-1 (MEKK1);	SEN:10022588	10448433
BEL:20040436	p(HGNC:APP) decreases r(HGNC:UQCRC2)	A beta not only activates but also respresses genes: (i) the gene encoding \"hinge\" protein, a subunit of the mitochondrial cytochrome-c reductase and	SEN:10022590	10448433
BEL:20040438	p(HGNC:APP) decreases r(HGNC:UQCRH)	A beta not only activates but also respresses genes: (i) the gene encoding \"hinge\" protein, a subunit of the mitochondrial cytochrome-c reductase and	SEN:10022590	10448433
BEL:20040464	p(HGNC:ATF2) increases r(HGNC:PPARG)	ATF-2 regulated gene transcription of PPARgamma, which was synergistically enhanced by p38beta kinase and C/EBPbeta proteins expression.	SEN:10006598	11243868
BEL:20040470	p(HGNC:ATM) increases p(HGNC:BRCA1,pmod(P))	The ataxia-telangiectasia-mutated (ATM) gene product controls overall BRCA1 phosphorylation in response to gamma-irradiation (IR)	SEN:10022598	11114888
BEL:20040472	p(HGNC:ATM) increases p(HGNC:JUN,pmod(P,S,73))	However, pretreatment of AT5BIVA/pMAT1 cells with CdCl2, which induces ATM expression in these cells, resulted in a substantial induction of c-Jun phosphorylation that was further increased by exposure to ionizing radiation;	SEN:10022600	11278277
BEL:20040474	p(HGNC:ATOH7) increases r(HGNC:POU3F2)	Transient transfection of a Math5 (Atoh7) expression plasmid with the reporter construct in 293T and ND7 cells, respectively, resulted in a 10- and 8-fold increase in luciferase activity, indicating a direct regulation of Brn3b by Math5	SEN:10022602	11172005
BEL:20040480	p(HGNC:AXIN1) decreases complex(p(HGNC:DVL1),p(HGNC:CXXC4))	Immunocytochemical analyses showed that Idax was localized to the same place as Dvl in cells and that expression of Axin inhibited the colocalization of Dvl and Idax.	SEN:10006602	11113207
BEL:20040482	p(HGNC:B2M) increases r(HGNC:TNF)	The addition of exogenous TGF-beta1 (0.1 to 10 ng/mL) decreased AGE-beta2m-induced TNF-alpha production and increased IL-1Ra production in a dose-dependent fashion.	SEN:10006604	10652049
BEL:20040510	p(HGNC:BCAP31) decreases r(HGNC:CFTR)	Antisense inhibition of BAP31 in various cell types increased expression of both wild-type CFTR and [DeltaPhe(508)]CFTR and enabled cAMP-activated Cl(-) currents in [DeltaPhe(508)]CFTR-expressing CHO cells.	SEN:10006608	11274174
BEL:20040512	p(HGNC:BCAR1) increases bp(GOBP:"cell adhesion")	Hef1, p130Cas, and Efs define a family of multidomain docking proteins which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion	SEN:10022612	10502414
BEL:20040522	p(HGNC:BCAR1,pmod(P,Y)) directlyIncreases complex(p(HGNC:BCAR1),p(HGNC:CRK))	Crk has been reported to associate with tyrosine-phosphorylated proteins, such as p130Cas and paxillin (42, 43), involved in the rearrangement of cytoskeletal components, through its SH2 domain.	SEN:10022614	10194465
BEL:20040524	p(HGNC:BCAR1,pmod(P,Y)) increases p(HGNC:BCAR1)	The over-expression of LAR in tissue culture cells specifically decreased the steady state protein level of p130Cas, a multifunctional signal assembly protein in signal transduction, by reducing the tyrosine phosphorylation and protein stability of p130Cas.	SEN:10022616	10320483
BEL:20040526	p(HGNC:BCCIP) decreases bp(GOBP:"cell proliferation")	Furthermore, expression of BCCIPalpha inhibits breast and brain cancer cell growth, but fails to inhibit HT1080 cells and a non-transformed human skin fibroblast.	SEN:10006614	11313963
BEL:20040530	p(HGNC:BCL2A1) decreases cat(p(HGNC:CASP3))	The restoration of A1 in NF-kappaB null cells diminished TNF-induced apoptosis by inhibiting the release of cytochrome c and by blocking caspase 3 activation.	SEN:10022618	10454539
BEL:20040534	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	Finally, apoptotic events elicited by TIEG overexpression can be effectively prevented by ectopic co-expression of Bcl-2	SEN:10002092	10471833
BEL:20040536	p(HGNC:BCL2L11) increases bp(GOBP:"apoptotic process")	In healthy cells, most Bim molecules were bound to LC8 cytoplasmic dynein light chain and thereby sequestered to the microtubule-associated dynein motor complex. Certain apoptotic stimuli disrupted the interaction between LC8 and the dynein motor complex.	SEN:10002102	10198631
BEL:20040538	p(HGNC:BCL2L1) decreases bp(GOBP:"apoptotic process")	Transduction of proliferating CD4+ T cells with a tetracycline-regulated retrovirus encoding for a dominant-interfering, degradation-resistant I-kappaBalpha (inhibitor of kappa B alpha factor) mutant induced apoptosis. Bcl-xL features as a prominent anti-apoptotic member among a number of early CD28-inducible genes.	SEN:10022620	10925251
BEL:20040552	p(HGNC:BCL2) decreases r(HGNC:CD38)	Second, germinal center B cells within the mesenteric LNs of bcl -2transgenic mice reduced CD38 expression to the same extent as control mice ( Fig 1 B), indicating that CD38 expression is regulated appropriately in these mice.	SEN:10022624	10662793
BEL:20040558	p(HGNC:BECN1) increases bp(GOBP:autophagy)	Unlike wild-type Beclin 1, the nuclear export mutant of Beclin 1 fails to promote nutrient deprivation-induced autophagy and fails to inhibit in vitro clonigenicity and in vivo tumorigenicity of MCF7 cells.	SEN:10022628	11309306
BEL:20040562	p(HGNC:BIN1) increases bp(GOBP:"cell death")	In this study, we show that Bin1 engages a caspase-independent cell death process similar to type II apoptosis,	SEN:10022630	11032017
BEL:20040564	p(HGNC:BIN1) increases bp(GOBP:"apoptotic process")	In this study, we show that Bin1 engages a caspase-independent cell death process similar to type II apoptosis,	SEN:10022630	11032017
BEL:20040570	p(HGNC:BMP2) decreases bp(GOBP:"cell cycle")	We showed that BMP-2 caused cell-cycle arrest in the G1 phase and the subsequent apoptosis of myeloma cells.	SEN:10006624	10979940
BEL:20040576	p(HGNC:BMP2) increases bp(GOBP:"apoptotic process")	We showed that BMP-2 caused cell-cycle arrest in the G1 phase and the subsequent apoptosis of myeloma cells.	SEN:10006624	10979940
BEL:20040580	p(HGNC:BMP2) decreases p(HGNC:RB1,pmod(P))	BMP-2 up-regulated the expression of cyclin-dependent kinase inhibitors (p21(CIP1/WAF1) and p27(KIP1)) and caused hypophosphorylation of retinoblastoma (Rb) protein.	SEN:10022636	10979940
BEL:20040582	p(HGNC:BMP2) decreases r(HGNC:BCL2L1)	A high level of Bcl-x L , an antiapoptotic member of the Bcl-2 family, was detected in the control U266 cells, and BMP-2 down-regulated the expression of Bcl-x L (Figure 6 ).	SEN:10022638	10979940
BEL:20040584	p(HGNC:BMP2) decreases r(HGNC:BCL2L1)	In studies of apoptosis-associated proteins, BMP-2 was seen to down-regulate the expression of Bcl-x(L); however, BMP-2 had no effects on the expression of Bcl-2, Bax, or Bad.	SEN:10006628	10979940
BEL:20040586	p(HGNC:BMP2) increases r(HGNC:CDKN1A)	BMP-2 up-regulated the expression of cyclin-dependent kinase inhibitors (p21(CIP1/WAF1) and p27(KIP1)) and caused hypophosphorylation of retinoblastoma (Rb) protein.	SEN:10022636	10979940
BEL:20040588	p(HGNC:BMP2) increases r(HGNC:CDKN1B)	BMP-2 up-regulated the expression of cyclin-dependent kinase inhibitors (p21(CIP1/WAF1) and p27(KIP1)) and caused hypophosphorylation of retinoblastoma (Rb) protein.	SEN:10022636	10979940
BEL:20040598	p(HGNC:BMP2) increases r(HGNC:KLF10)	However, TGF-beta remained the most potent of these cytokines, inducing TIEG mRNA steady-state levels at 0.1 ng/ml, with a maximum induction of 24-fold at 2.0 ng/ml. The BMP-2 (16-fold), BMP-4 (4-fold), and activin (1-3-fold) also induced TIEG mRNA levels	SEN:10022646	10861837
BEL:20040604	p(HGNC:BMP2) decreases r(HGNC:PTH1R)	In cultured chondrocytes, BMP-2 down-regulates the expression of PTHrP and PTH/ PTHrP receptor ( 32 , 33 ).	SEN:10022650	11145607
BEL:20040612	p(HGNC:BMP2) decreases tscript(p(HGNC:STAT3))	Further analysis showed that the signal transducer and activator of transcription 3 (STAT3) was inactivated immediately after BMP-2 treatment.	SEN:10006634	10979940
BEL:20040614	p(HGNC:BMP4) increases r(HGNC:CCNG1)	Moreover, we have discovered that cyclin G expression is rapidly induced in P19 cells after exposure to Bone Morphogenic Protein-4 (BMP-4), suggesting that cyclin G may mediate apoptotic signals generated by BMP-4.	SEN:10022656	10467405
BEL:20040616	p(HGNC:BMP4) increases r(HGNC:KLF10)	However, TGF-beta remained the most potent of these cytokines, inducing TIEG mRNA steady-state levels at 0.1 ng/ml, with a maximum induction of 24-fold at 2.0 ng/ml. The BMP-2 (16-fold), BMP-4 (4-fold), and activin (1-3-fold) also induced TIEG mRNA levels	SEN:10022646	10861837
BEL:20040622	p(HGNC:BMP7) increases r(HGNC:CD44)	OP-1 stimulated the expression of HAS-2, CD44, and aggrecan mRNA in a time-dependent manner, resulting in increased expression of HA, CD44, and aggrecan.	SEN:10022658	10643717
BEL:20040626	p(HGNC:BMP7) increases r(HGNC:IGF1)	In osteoblasts, BMP-2 and osteogenic protein-1 stimulate the expression of insulin-like growth factors I and II ( 37 , 38 ).	SEN:10022660	11145607
BEL:20040652	p(HGNC:BRCA1) increases r(HGNC:CDKN1A)	In this study, we show that the BRCA1 tumor suppressor acts in concert with STAT1 to differentially activate transcription of a subset of IFN-gamma target genes and mediates growth inhibition by this cytokine After IFN-gamma treatment, induction of the cyclin-dependent kinase inhibitor, p21WAF1, was synergistically activated by BRCA1	SEN:10022666	10792030
BEL:20040658	p(HGNC:BRCA1) decreases r(HGNC:IGF1R)	Cotransfection of Saos-2, MCF7, and CHO cells with IGF-I-R promoter constructs driving luciferase reporter genes, and with a BRCA1 expression vector, suppressed promoter activity in a dose-dependent manner.	SEN:10006648	10720440
BEL:20040660	p(HGNC:BRCA1) decreases r(HGNC:IGF1R)	These results suggest that BRCA1 is capable of suppressing the IGF-I-R promoter in a number of cell lines, thus resulting in low levels of receptor mRNA and protein.	SEN:10006650	10720440
BEL:20040670	p(HGNC:BRCA1) directlyDecreases tscript(p(HGNC:ESR1))	The BRCA1 protein was found to associate with ER-alpha in vivo and to bind to ER-alpha in vitro, by an estrogen-independent interaction that mapped to the amino-terminal region of BRCA1 (ca. amino acid 1-300) and the conserved carboxyl-terminal activation function [AF-2] domain of ER-alpha	SEN:10019996	11244506
BEL:20040692	p(HGNC:BTG1) directlyIncreases tscript(p(HGNC:HOXB9))	We further show that Btg1 and Btg2 enhance Hoxb9-mediated transcription in transfected cells, and we report the formation of a Hoxb9.Btg2 complex on a Hoxb9-responsive target, and the fact that this interaction facilitates the binding of Hoxb9 to DNA.	SEN:10019936	10617598
BEL:20040694	p(HGNC:BTG2) directlyIncreases tscript(p(HGNC:HOXB9))	We further show that Btg1 and Btg2 enhance Hoxb9-mediated transcription in transfected cells, and we report the formation of a Hoxb9.Btg2 complex on a Hoxb9-responsive target, and the fact that this interaction facilitates the binding of Hoxb9 to DNA.	SEN:10019936	10617598
BEL:20040698	p(HGNC:BTRC) increases deg(p(HGNC:CTNNB1))	FWD1 facilitated ubiquitination and promoted degradation of beta-catenin, resulting in reduced cytoplasmic beta-catenin levels.	SEN:10005268	10228155
BEL:20040702	p(HGNC:CALCR) increases p(HGNC:NEDD9,pmod(P,Y))	found that NEDD9, but not p130Cas, is tyrosine-phosphorylated following stimulation of the C1a calcitonin receptor stably expressed in cells	SEN:10022684	10455189
BEL:20040704	p(HGNC:CAMK1,pmod(P,T)) directlyIncreases kin(p(HGNC:CAMK1))	In addition to deinhibition, CaMKI and CaMIV are activated 10-50-fold by trans phosphorylation on a single Thr residue in the activation loop. Once activated, CaMKIV acquires Ca2+/CaM independence, whereas CaMKI remains Ca2+/CaM-dependent (5).	SEN:10022686	11096122
BEL:20040706	p(HGNC:CAMK4,pmod(P,S,12)) directlyIncreases kin(p(HGNC:CAMK4))	A second autoinhibitory mechanism unique to CaMKIV is relaxed by the autophosphorylation of Ser-12 and Ser-13 (4).	SEN:10021148	11096122
BEL:20040708	p(HGNC:CAMK4,pmod(P,S,13)) directlyIncreases kin(p(HGNC:CAMK4))	A second autoinhibitory mechanism unique to CaMKIV is relaxed by the autophosphorylation of Ser-12 and Ser-13 (4).	SEN:10021148	11096122
BEL:20040710	p(HGNC:CAMK4,pmod(P,T)) directlyIncreases kin(p(HGNC:CAMK4))	In addition to deinhibition, CaMKI and CaMIV are activated 10-50-fold by trans phosphorylation on a single Thr residue in the activation loop. Once activated, CaMKIV acquires Ca2+/CaM independence, whereas CaMKI remains Ca2+/CaM-dependent (5).	SEN:10022686	11096122
BEL:20040716	p(HGNC:CARTPT) increases r(HGNC:UCP1)	CART induced gene expression of uncoupling protein 1 (UCP1), UCP2, and UCP3 in brown and white adipose tissue and biceps femoris muscle respectively.	SEN:10006662	11043558
BEL:20040718	p(HGNC:CARTPT) increases r(HGNC:UCP2)	CART induced gene expression of uncoupling protein 1 (UCP1), UCP2, and UCP3 in brown and white adipose tissue and biceps femoris muscle respectively.	SEN:10006662	11043558
BEL:20040720	p(HGNC:CARTPT) increases r(HGNC:UCP3)	CART induced gene expression of uncoupling protein 1 (UCP1), UCP2, and UCP3 in brown and white adipose tissue and biceps femoris muscle respectively.	SEN:10006662	11043558
BEL:20040730	p(HGNC:CASP9,pmod(P,S,196)) directlyDecreases cat(p(HGNC:CASP9))	Akt phosphorylates caspase 9 at Ser-196 (Cardone et al. 1998). This phosphorylation event has functional consequences, as extracts from cell lines overexpressing Akt block cytochrome C-mediated caspase 9 activation in vitro (Cardone et al. 1998). In 293 cells Akt can suppress caspase 9-induced cell death in a manner that is partially dependent on the phopshorylation of Ser-196.	SEN:10022254	10579998
BEL:20040744	p(HGNC:CAV1) increases bp(GOBP:"integrin-mediated signaling pathway")	Several integrins have been found to associate laterally with the oligomeric membrane protein caveolin-1, at least in primary cells (4, 5). Although the biochemical nature of this interaction is not known, inhibiting caveolin expression suppresses the formation of focal adhesions and integrin signaling (4, 5).	SEN:10022694	10446041
BEL:20040756	p(HGNC:CAV1) decreases r(HGNC:JUN)	Interestingly, we found that caveolin-1 also inhibited the activity of the c- jun promoter, a gene that is also activated by eta-catenin/TCF signaling and that contains a TCF site in its promoter ( 62 ).	SEN:10022700	10747899
BEL:20040760	p(HGNC:CAV1) increases tscript(p(HGNC:AR))	Conversely, down-regulation of caveolin-1 expression by a caveolin-1 antisense expression construct can down-regulate ligand-dependent AR activation	SEN:10006668	11278309
BEL:20040762	p(HGNC:CAV1) increases tscript(p(HGNC:AR))	we investigate the potential interactions between AR signaling and caveolin-1 and demonstrate that overexpression of caveolin-1 potentiates ligand-dependent AR activation.	SEN:10006670	11278309
BEL:20040772	p(HGNC:CBL,pmod(P,Y,371)) directlyIncreases cat(p(HGNC:CBL))	However, a mutant at site 371 completely lost the ability to enhance receptor ubiquitination and degradation in living cells ( Figure 6D).	SEN:10022704	10635327
BEL:20040774	p(HGNC:CBL,pmod(P,Y,371)) increases deg(p(HGNC:EGFR))	However, a mutant at site 371 completely lost the ability to enhance receptor ubiquitination and degradation in living cells ( Figure 6D).	SEN:10022704	10635327
BEL:20040776	p(HGNC:CBL,pmod(P,Y,371)) increases p(HGNC:EGFR,pmod(U,K))	However, a mutant at site 371 completely lost the ability to enhance receptor ubiquitination and degradation in living cells ( Figure 6D).	SEN:10022704	10635327
BEL:20040780	p(HGNC:CBL,pmod(P,Y)) directlyIncreases complex(p(HGNC:FYN),p(HGNC:CBL))	c-Cbl is tyrosine-phosphorylated, binds to Fyn upon insulin stimulation, and is translocated to small invaginations of the plasma membrane, called caveolae, after insulin stimulation	SEN:10017324	10194465
BEL:20040782	p(HGNC:CBL,pmod(P,Y)) directlyIncreases complex(p(HGNC:SORBS1),p(HGNC:CBL),p(HGNC:INSR))	c-Cbl associated protein (CAP) that has three sequential SH3 domains is specifically expressed in insulin-responsive cell types and associates with both c- Cbl and the insulin receptor	SEN:10022706	10194465
BEL:20040796	p(HGNC:CCL2) increases kin(p(HGNC:PIK3CA))	we found that MCP-1 triggered monocyte adhesion and activation of the PI3Kalpha isoform, but not PI3Kgamma in purified human monocytes. PI3K activation correlated temporally with our functional studies. Furthermore, PI3K was necessary for the chemokine-triggered conversion of monocyte rolling to firm adhesion and sufficient to enhance monocyte arrest under physiological flow conditions.	SEN:10021408	11278864
BEL:20040798	p(HGNC:CCL2) increases p(HGNC:ICAM1)	MCP-1, a CC-chemokine, enhances tissue factor production by macrophages and increases ICAM-1 expression on endothelial cells.	SEN:10022714	10412150
BEL:20040800	p(HGNC:CCL2) increases r(HGNC:F3)	MCP-1, a CC-chemokine, enhances tissue factor production by macrophages and increases ICAM-1 expression on endothelial cells.	SEN:10022714	10412150
BEL:20040804	p(HGNC:CCL2) increases r(HGNC:ITGAM)	Furthermore, IL-8, MCP-1, and GRO-1 are known to promote expression of CD11b/CD18 (CR3) on the surface of neutrophils and monocytes ( 32 , 33 ).	SEN:10022718	11087813
BEL:20040806	p(HGNC:CCL3) increases bp(GOBP:"cell migration")	The chemokine macrophage inflammatory protein-1 alpha (MIP-1alpha) stimulates migration of B cells	SEN:10006680	11152622
BEL:20040808	p(HGNC:CCL3) increases bp(GOBP:chemotaxis)	The chemokine macrophage inflammatory protein-1 alpha (MIP-1alpha) stimulates migration of B cells	SEN:10006680	11152622
BEL:20040810	p(HGNC:CCL3) increases deg(p(HGNC:NFKBIA))	MIP-1alpha treatment stimulated the degradation of IkappaBalpha, a cytoplasmic inhibitor of NF-kappaB	SEN:10001426	11152622
BEL:20040814	p(HGNC:CCL4) increases cat(p(HGNC:CCR5))	Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation.	SEN:10002144	10747947
BEL:20040822	p(HGNC:CCNA2) increases p(HGNC:CDKN1B,pmod(P))	<C21> p27Kip1 can be phosphorylated by Cyclin E- or Cyclin A-dependent kinases and thereby may be targeted for degradation (Sheaff et al., 1997).	SEN:10022720	10436023
BEL:20040826	p(HGNC:CCNB1,pmod(P)) directlyIncreases deg(p(HGNC:CCNB1))	<C41> Cyclin B is degraded late in mitosis through the ubiquitin-protein ligase (E3) activity of the anaphase-promoting complex, which is probably activated by phosphorylation by Plk1 (Glover et al., 1998).	SEN:10021412	10436023
BEL:20040832	p(HGNC:CCND1) increases bp(GOBP:"cell proliferation")	In combination with cell proliferative activities of c-myc and cyclin D1, MDR1 may initiate colorectal tumorigenesis by suppressing cell death pathways programmed in intestinal epithelial cells.	SEN:10002158	10987283
BEL:20040834	p(HGNC:CCND1,pmod(P,T,286)) directlyIncreases deg(p(HGNC:CCND1))	<C9> Cyclin D1 has a short half-life (,30 min), regardless of whether free or Cdk4-bound. Rapid degradation of Cyclin D1 requires phosphorylation at threonine-286 (kinase unknown, but not Cdk2 or Cdk4); degradation is by way of the ubiquitin-proteasome pathway (Diehl et al., 1997).	SEN:10022724	10436023
BEL:20040838	p(HGNC:CCND1) increases r(HGNC:CDKN1A)	Ectopic expression of cyclin D1 has been shown to induce p21 expression through activation of E2F (26) .	SEN:10022728	11034077
BEL:20040846	p(HGNC:CCNDBP1) decreases p(HGNC:RB1,pmod(P))	GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity.	SEN:10022732	11118353
BEL:20040848	p(HGNC:CCNDBP1) decreases tscript(p(HGNC:E2F1))	GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity.	SEN:10022732	11118353
BEL:20040850	p(HGNC:CCNDBP1) decreases tscript(p(HGNC:RB1))	GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity.	SEN:10022732	11118353
BEL:20040852	p(HGNC:CCNE1) directlyIncreases kin(p(HGNC:CDK2))	total p27KiP1 levels and cyclin E-associated p27Kip1 increased as cells arrested and the amount of the CAK activated cdk2 bound to cyclin E decreased	SEN:10002162	10698512
BEL:20040854	p(HGNC:CCNE1) increases p(HGNC:CDKN1B,pmod(P))	<C21> p27Kip1 can be phosphorylated by Cyclin E- or Cyclin A-dependent kinases and thereby may be targeted for degradation (Sheaff et al., 1997).	SEN:10022720	10436023
BEL:20040856	p(HGNC:CCNE1,pmod(P,T,380)) directlyIncreases deg(p(HGNC:CCNE1))	<C13> Cyclin E has a half-life of ~30 min. It is degraded by way of the ubiquitin?proteasome pathway subsequent to phosphorylation (possibly autophosphorylation) at threonine-380 (Clurman et al., 1996; Won and Reed, 1996). However, it can be stabilized by binding to Cdk2.	SEN:10019950	10436023
BEL:20040870	p(HGNC:CD14) increases p(HGNC:TNF)	These findings suggest that the CD14 antisense ODN is distributed in the liver and efficiently suppresses LPS-induced TNF-alpha production by reducing CD14 expression on Kupffer cells.	SEN:10006694	11332197
BEL:20040872	p(HGNC:CD14) increases r(HGNC:CEACAM1)	Our results indicate that neisserial infection of primary endothelial cells induces CEACAM1 expression via a pathway that is triggered by the LPS-specific CD14 and TLR-4-dependent activation of NF-kappaB (Fig. 11 ).	SEN:10022740	11306560
BEL:20040874	p(HGNC:CD164) increases bp(GOBP:"cell adhesion")	Functional analyses have indicated that the human CD164 sialomucin may play a key role in hematopoiesis by facilitating the adhesion of human CD34(+) cells to the stroma and by negatively regulating CD34(+)CD38(lo/-) cell proliferation.	SEN:10006696	11027692
BEL:20040878	p(HGNC:CD28) decreases p(HGNC:CFL1)	Following co-stimulation through accessory receptors (e.g. CD2 or CD28) - however, not following TCR/CD3 stimulation alone - cofilin undergoes dephosphorylation the dephosphorylated form of cofilin associates with the actin cytoskeleton and possesses the capability to translocate into the nucleus.	SEN:10022742	11093160
BEL:20040880	p(HGNC:CD28) decreases p(HGNC:CFL1,pmod(P,S,3))	Following co-stimulation through accessory receptors (e.g. CD2 or CD28) - however, not following TCR/CD3 stimulation alone - cofilin undergoes dephosphorylation the dephosphorylated form of cofilin associates with the actin cytoskeleton and possesses the capability to translocate into the nucleus.	SEN:10022742	11093160
BEL:20040882	p(HGNC:CD28) increases r(HGNC:BCL2L1)	Transduction of proliferating CD4+ T cells with a tetracycline-regulated retrovirus encoding for a dominant-interfering, degradation-resistant I-kappaBalpha (inhibitor of kappa B alpha factor) mutant induced apoptosis. Bcl-xL features as a prominent anti-apoptotic member among a number of early CD28-inducible genes.	SEN:10022620	10925251
BEL:20040886	p(HGNC:CD2) decreases p(HGNC:CFL1)	Following co-stimulation through accessory receptors (e.g. CD2 or CD28) - however, not following TCR/CD3 stimulation alone - cofilin undergoes dephosphorylation the dephosphorylated form of cofilin associates with the actin cytoskeleton and possesses the capability to translocate into the nucleus.	SEN:10022742	11093160
BEL:20040888	p(HGNC:CD2) decreases p(HGNC:CFL1,pmod(P,S,3))	Following co-stimulation through accessory receptors (e.g. CD2 or CD28) - however, not following TCR/CD3 stimulation alone - cofilin undergoes dephosphorylation the dephosphorylated form of cofilin associates with the actin cytoskeleton and possesses the capability to translocate into the nucleus.	SEN:10022742	11093160
BEL:20040898	p(HGNC:CD38) increases sec(p(HGNC:IL6))	Furthermore, the anti-CD38 agonist antibody expectedly inhibited bone resorption in the pit assay and elevated interleukin-6 (IL-6) secretion. IL-6, in turn, enhanced CD38 mRNA expression	SEN:10022748	10477767
BEL:20040904	p(HGNC:CD40LG) increases bp(GOBP:"T cell activation")	The results reported in Figure 1 demonstrated that although they were activated, as shown by the expression of the IL-2R a-chain and CD40L (data not shown), peripheral T lymphocytes did not express IL-3.	SEN:10022752	11157721
BEL:20040906	p(HGNC:CD40LG) increases cat(p(HGNC:CD40))	This study demonstrates that the engagement of CD40 results in the activation of the recently described IkappaB kinase (IKK) in a human B cell line	SEN:10018456	10229103
BEL:20040926	p(HGNC:CD40) increases p(HGNC:IL1B)	the data demonstrate that CD40-mediated induction of IL-1beta and tumor necrosis factor-alpha synthesis is dependent on a MEK/ERK pathway which is obstructed by signals generated through the action of IL-4 and IL-10	SEN:10006700	10026206
BEL:20040928	p(HGNC:CD40) increases r(HGNC:IL12B)	SB203580 strongly blocked CD40-induced IL-12 p40 production in DCs at both mRNA and protein levels, while having minimal effect on CD40-induced expression of the chemokine RANTES.	SEN:10004310	10570261
BEL:20040944	p(HGNC:CDC25C,pmod(P)) directlyIncreases phos(p(HGNC:CDC25C))	<C36> Cdc25C is activated by hyperphosphorylation of the Nterminal domain (Gabrielli et al., 1997), which can be phosphorylated by Cyclin B:Cdk1 (Hoffman et al., 1993).	SEN:10019958	10436023
BEL:20040948	p(HGNC:CDC25C,pmod(P,S,216)) directlyIncreases complex(p(HGNC:CDC25C),p(HGNC:SFN))	<C40> Ser216-phosphorylated Cdc25C is recognized and bound by 14-3-3 protein family members (Peng et al., 1997, 1998). Ser216 phosphorylation and 14-3-3 binding probably sequester Cdc25C and thus prevent it from interacting with Cdk1 in vivo (Peng et al., 1997). 14-3-3s is localized to the cytoplasm and may be the means by which Cdc25C is sequestered outside of the nucleus (Hermeking et al., 1997).	SEN:10019952	10436023
BEL:20040956	p(HGNC:CDH1) decreases r(HGNC:MMP2)	Furthermore, important parameters for cellular invasiveness, including random and stimulated in vitro invasive ability and MMP-2 expression, were suppressed by E-cadherin expression.	SEN:10022770	10446959
BEL:20040962	p(HGNC:CDH5) decreases bp(GOBP:"apoptotic process")	Recently, knockout studies in mice demonstrated that a deficiency or truncation of VE-cadherin induces endothelial apoptosis and inhibits transmission of the endothelial survival signal by VEGF, leading to lethality at 9.5 days of gestation (36).	SEN:10022772	11172729
BEL:20040966	p(HGNC:CDK10) decreases tscript(p(HGNC:ETS2))	We find that Cdk10 binds full length Ets2 in vitro and in vivo and inhibits Ets2 transactivation in mammalian cells.	SEN:10005286	11313931
BEL:20040972	p(HGNC:CDKN1A) increases bp(GOBP:"cell differentiation")	Several genes including the cyclin-dependent kinase inhibitor p21(waf1/cip1) and the homeobox gene transcription factor HOXA10 are induced at the onset of differentiation. Ectopic expression of either gene results in U937 differentiation.	SEN:10006714	11040212
BEL:20040974	p(HGNC:CDKN1A) increases bp(GOBP:"cell differentiation")	Thus, our results indicate that p21(WAF1/CIP1) mediates TPA-induced growth arrest and differentiation of TSU-Pr1 cells.	SEN:10000206	11313866
BEL:20040976	p(HGNC:CDKN1A) decreases bp(GOBP:"cell growth")	Thus, our results indicate that p21(WAF1/CIP1) mediates TPA-induced growth arrest and differentiation of TSU-Pr1 cells.	SEN:10000206	11313866
BEL:20040980	p(HGNC:CDKN1A) directlyDecreases kin(p(HGNC:CDK2))	Titration of unbound p27Kip1 and p21Cip1 molecules into higher order complexes with assembling cyclin D-dependent kinases relieves cyclin E-CDK2 from Cip/Kip constraint, thereby facilitating cyclin E-CDK2 activation later in G1 phase.	SEN:10019944	10385618
BEL:20040982	p(HGNC:CDKN1A) decreases kin(p(HGNC:CDK2))	Furthermore, the results of three different types of experiments showed that TOK-1alpha enhanced the inhibitory activity of p21 toward histone H1 kinase activity of CDK2. TOK-1alpha is thus thought to be a new type of CDK2 modulator.	SEN:10006616	10878006
BEL:20040992	p(HGNC:CDKN1A) increases r(HGNC:SFN)	Effect of p53 Overexpression on p21/waf1 and 14-3-3 Proteins p53 can transactivate the promoter of the 14-3-3sigma gene (Hermeking et al. , 1997 ).	SEN:10022780	10564259
BEL:20041000	p(HGNC:CDKN1B) directlyDecreases kin(p(HGNC:CDK2))	Titration of unbound p27Kip1 and p21Cip1 molecules into higher order complexes with assembling cyclin D-dependent kinases relieves cyclin E-CDK2 from Cip/Kip constraint, thereby facilitating cyclin E-CDK2 activation later in G1 phase.	SEN:10019944	10385618
BEL:20041002	p(HGNC:CDKN1B) decreases kin(p(HGNC:CDK2))	total p27KiP1 levels and cyclin E-associated p27Kip1 increased as cells arrested and the amount of the CAK activated cdk2 bound to cyclin E decreased	SEN:10002162	10698512
BEL:20041004	p(HGNC:CDKN1B,pmod(P)) directlyIncreases deg(p(HGNC:CDKN1B))	<C21> p27Kip1 can be phosphorylated by Cyclin E- or Cyclin A-dependent kinases and thereby may be targeted for degradation (Sheaff et al., 1997).	SEN:10022720	10436023
BEL:20041014	p(HGNC:CDKN2A) decreases kin(p(HGNC:CDK2))	Whereas cdk4/cdk6 inhibition and Rb dephosphorylation are expected on p16Ink4a expression, we have also observed indirect cdk2 inhibition.	SEN:10002192	11063124
BEL:20041016	p(HGNC:CDKN2A) directlyDecreases kin(p(HGNC:CDK4))	Whereas cdk4/cdk6 inhibition and Rb dephosphorylation are expected on p16Ink4a expression, we have also observed indirect cdk2 inhibition.	SEN:10002192	11063124
BEL:20041018	p(HGNC:CDKN2A) directlyDecreases kin(p(HGNC:CDK6))	Whereas cdk4/cdk6 inhibition and Rb dephosphorylation are expected on p16Ink4a expression, we have also observed indirect cdk2 inhibition.	SEN:10002192	11063124
BEL:20041030	p(HGNC:CDKN2B) decreases kin(p(HGNC:CDK4))	Assembly and activity of the proto-oncogenic cyclin D/CDK4(6) complexes, the major driving force of G1 phase progression, is negatively regulated by a family of INK4 CDK inhibitors p16INK4a, p15INK4b, p18INK4c, and p19INK4d.	SEN:10022788	10851091
BEL:20041034	p(HGNC:CDKN2C) decreases kin(p(HGNC:CDK4))	Assembly and activity of the proto-oncogenic cyclin D/CDK4(6) complexes, the major driving force of G1 phase progression, is negatively regulated by a family of INK4 CDK inhibitors p16INK4a, p15INK4b, p18INK4c, and p19INK4d.	SEN:10022788	10851091
BEL:20041036	p(HGNC:CDKN2D) decreases kin(p(HGNC:CDK4))	Assembly and activity of the proto-oncogenic cyclin D/CDK4(6) complexes, the major driving force of G1 phase progression, is negatively regulated by a family of INK4 CDK inhibitors p16INK4a, p15INK4b, p18INK4c, and p19INK4d.	SEN:10022788	10851091
BEL:20041040	p(HGNC:CEBPB) increases r(HGNC:LDLR)	cotransfection of a human C/EBPbeta expression vector (pEF-NFIL6) with the LDLR promoter construct pLDLR234 increases LDLR promoter activity;	SEN:10006728	10671569
BEL:20041046	p(HGNC:CEBPD) increases r(HGNC:PLA2G10)	The increase of C/EBPdelta mRNA levels after 2 h is consistent with the delayed increase of the sPLA2 mRNA levels, which we previously measured in rabbit primary culture chondrocytes ( 9 ).	SEN:10022796	10791956
BEL:20041086	p(HGNC:CLU) increases r(HGNC:HNF1A)	Finally, cotransfection of HNF-1eta, another transcription factor that contains a homeodomain, failed to activate transcription of the clusterin promoter.	SEN:10022814	11123208
BEL:20041092	p(HGNC:CNTF) increases r(HGNC:GFAP)	Activation of the GFAP gene promoter by IL-11 and related cytokines Previous studies have shown that stimulation of gp130 molecules on neuroepithelial cells by LIF, CNTF, or the IL-6/sIL-6R complex induces activation of the GFAP gene promoter (Bonni et al., 1997 ; Nakashima et al., 1999 b ).	SEN:10022816	10737606
BEL:20041118	p(HGNC:CREBBP) increases r(HGNC:SFTPB)	TTF-1 protein synergistically stimulated the hSP-B promoter with RARalpha, CBP, and nuclear receptor coactivators in H441 cells.	SEN:10006760	10617585
BEL:20041122	p(HGNC:CREBBP) increases tscript(p(HGNC:NCOA1))	Although phosphorylation at Thr-1179 and Ser-1185 did not directly regulate physical interaction between SRC-1 and CBP, it was required for functional cooperation.	SEN:10022824	11073973
BEL:20041142	p(HGNC:CSF1) increases p(HGNC:FYN,pmod(P,Y))	The Src tyrosine kinases c-Src, c-Yes, c-Fyn, and c-Hck were tyrosine phosphorylated in the M1/WT cells in response to CSF-1 and bound to the WT CSF-1R through their SH2 domains.	SEN:10022832	10356364
BEL:20041144	p(HGNC:CSF1) increases p(HGNC:GAB2,pmod(P,Y))	The docking protein Gab2 may link SFK to PI3-kinase. CSF-1 induced Gab2 tyrosyl phosphorylation and association with PI3-kinase in cells expressing WT or DeltaKI receptors.	SEN:10022834	10958675
BEL:20041146	p(HGNC:CSF1) increases p(HGNC:HCK,pmod(P,Y))	The Src tyrosine kinases c-Src, c-Yes, c-Fyn, and c-Hck were tyrosine phosphorylated in the M1/WT cells in response to CSF-1 and bound to the WT CSF-1R through their SH2 domains.	SEN:10022832	10356364
BEL:20041148	p(HGNC:CSF1) increases p(HGNC:SRC,pmod(P,Y))	The Src tyrosine kinases c-Src, c-Yes, c-Fyn, and c-Hck were tyrosine phosphorylated in the M1/WT cells in response to CSF-1 and bound to the WT CSF-1R through their SH2 domains.	SEN:10022832	10356364
BEL:20041150	p(HGNC:CSF1) increases p(HGNC:YES1,pmod(P,Y))	The Src tyrosine kinases c-Src, c-Yes, c-Fyn, and c-Hck were tyrosine phosphorylated in the M1/WT cells in response to CSF-1 and bound to the WT CSF-1R through their SH2 domains.	SEN:10022832	10356364
BEL:20041152	p(HGNC:CSF1) increases r(HGNC:BCL2L1)	We show that CSF-1 stimulation of BAC1.2F5 macrophages results in the upregulation of expression of ets2 and bcl-xL with similar kinetics of induction.	SEN:10022836	10082528
BEL:20041156	p(HGNC:CSF1) increases r(HGNC:CCR5)	We found that macrophage colony-stimulating factor caused the greatest up-regulation of both CCR5 and CXCR4 on macrophage maturation	SEN:10006762	10220446
BEL:20041162	p(HGNC:CSF1) increases r(HGNC:CD4)	M-CSF acts via a paracrine mechanism ( c ) to enhance the susceptibility of the infiltrating cells via differentiation and increased expression of CD4 and CCR5.	SEN:10022840	10779806
BEL:20041166	p(HGNC:CSF1) increases r(HGNC:CXCR4)	We found that macrophage colony-stimulating factor caused the greatest up-regulation of both CCR5 and CXCR4 on macrophage maturation	SEN:10006762	10220446
BEL:20041168	p(HGNC:CSF1) increases r(HGNC:ETS2)	We show that CSF-1 stimulation of BAC1.2F5 macrophages results in the upregulation of expression of ets2 and bcl-xL with similar kinetics of induction.	SEN:10022836	10082528
BEL:20041180	p(HGNC:CSF2) increases r(HGNC:CCR5)	whereas granulocyte-macrophage colony-stimulating factor caused a marked decrease of CXCR4 (from approximately 5,000 ABS to <500) while up-regulating CCR5 expression	SEN:10022850	10220446
BEL:20041188	p(HGNC:CSF2) decreases r(HGNC:CXCR4)	whereas granulocyte-macrophage colony-stimulating factor caused a marked decrease of CXCR4 (from approximately 5,000 ABS to <500) while up-regulating CCR5 expression	SEN:10022850	10220446
BEL:20041194	p(HGNC:CSF2) increases r(HGNC:GADD45G)	ResnetDB sentence: Gadd45gamma expression is induced by several cytokines, including IL-3, IL-6, and GM-CSF (20).	SEN:10022858	11287618
BEL:20041200	p(HGNC:CSF2) increases r(HGNC:PLA2G4A)	GM- CSF also increased cPLA 2 expression (day 4: 343.8% .. 86.1% of day 1, P = .02 n = 8; day 8: 138.9% .. 45.6% of day 1).	SEN:10022860	10572106
BEL:20041222	p(HGNC:CSF3) decreases r(HGNC:CD44)	At day 3 to day 5 following the onset of G-CSF administration, a strong decrease of CD44 and CD31 expression was observed on mobilized CD34(+) cells compared to controls: the relative fluorescence intensity of CD44 and CD31 was, respectively, 50%-70% and 40%-90% lower than that of controls.	SEN:10006782	10924094
BEL:20041224	p(HGNC:CSF3) increases r(HGNC:EGR1)	We showed that G-CSF rapidly and transiently induces expression of egr-1 in the NFS60 myeloid cell line.	SEN:10022868	10806199
BEL:20041228	p(HGNC:CSF3) decreases r(HGNC:PECAM1)	At day 3 to day 5 following the onset of G-CSF administration, a strong decrease of CD44 and CD31 expression was observed on mobilized CD34(+) cells compared to controls: the relative fluorescence intensity of CD44 and CD31 was, respectively, 50%-70% and 40%-90% lower than that of controls.	SEN:10006782	10924094
BEL:20041244	p(HGNC:CTNNB1,pmod(P,S)) increases complex(p(HGNC:BTRC),p(HGNC:CTNNB1))	Mutations at the signal-induced phosphorylation site of beta-catenin inhibited its association with FWD1.	SEN:10020138	10228155
BEL:20041246	p(HGNC:CTNNB1,pmod(P,S)) directlyIncreases deg(p(HGNC:CTNNB1))	beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex.	SEN:10019924	10228155
BEL:20041270	p(HGNC:CXCL12) increases kin(p(HGNC:MAPK1))	resulted in an elevation in intracellular Ca(2+) concentration and activation of the mitogen-activated protein kinase cascade, specifically, extracellular signal-regulated kinase 2 (ERK2) mitogen-activated protein kinase.	SEN:10022880	11160334
BEL:20041274	p(HGNC:CXCL12) increases p(HGNC:CCL2)	SDF-1alpha treatment induced expression of the chemokines monocyte chemoattractant protein-1, IL-8, and IFN-gamma-inducible protein-10.	SEN:10006798	11160334
BEL:20041276	p(HGNC:CXCL12) increases p(HGNC:CXCL10)	SDF-1alpha treatment induced expression of the chemokines monocyte chemoattractant protein-1, IL-8, and IFN-gamma-inducible protein-10.	SEN:10006798	11160334
BEL:20041278	p(HGNC:CXCL12) increases p(HGNC:CXCR4)	Stimulation of cells with the ligand for CXCR4, stromal cell-derived factor-1alpha (SDF-1alpha), resulted in an elevation in intracellular Ca(2+) concentration	SEN:10022876	11160334
BEL:20041280	p(HGNC:CXCL12) increases p(HGNC:IL8)	SDF-1alpha treatment induced expression of the chemokines monocyte chemoattractant protein-1, IL-8, and IFN-gamma-inducible protein-10.	SEN:10006798	11160334
BEL:20041288	p(HGNC:CXCL1) increases surf(p(HGNC:ITGAM))	Furthermore, IL-8, MCP-1, and GRO-1 are known to promote expression of CD11b/CD18 (CR3) on the surface of neutrophils and monocytes ( 32 , 33 ).	SEN:10022718	11087813
BEL:20041302	p(HGNC:CYP7A1) increases r(HGNC:HNF1B)	Hepatocyte nuclear factor 4 (HNF4) and chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) synergistically activate transcription of the CYP7A1 promoter.	SEN:10022888	10627496
BEL:20041314	p(HGNC:DBF4) directlyIncreases kin(p(HGNC:CDC7))	We show that HsDbf4 binds to HsCdc7 and activates HsCdc7 kinase activity when HsDbf4 and HsCdc7 are coexpressed in insect and mammalian cells.	SEN:10006810	10523313
BEL:20041328	p(HGNC:DEFA1) increases r(HGNC:PPARG)	Since PPARgamma levels increase during adipogenesis, this result could imply that DEF-1 promotes PPARgamma expression or that augmented PPARgamma levels are the result of DEF-1-induced fibroblastic differentiation ( 60 ).	SEN:10022902	10022919
BEL:20041342	p(HGNC:DMTF1) decreases bp(GOBP:"cell cycle")	<C11b> DMTF1 activates transcription from the p19ARF promoter and induces cell cycle arrest and p21Cip1 accumulation in a p19ARF- and p53-dependent manner (Inoue et al., 1999). Another DMTF1-regulated gene is CD13/aminopeptidase N, which is activated cooperatively by DMTF1 and c-Myb; its activation by DMTF1 is inhibited by cyclin D independent of Cdk4/6.	SEN:10022908	10436023
BEL:20041348	p(HGNC:DNAJC27) increases r(HGNC:RAP1A)	Western blotting of total lysates with anti-Rap1 (Fig. 2 A, lower panel) shows that an increase in pulled-down Rap1-GTP occurred in the absence of an increase in Rap1 expression.	SEN:10022912	11283246
BEL:20041358	p(HGNC:DOK1,pmod(P,Y)) directlyIncreases complex(p(HGNC:DOK1),p(HGNC:RASA1))	Recently, phosphorylated p62dok was demonstrated to associate with the GTPase-activating protein (GAP) for Ras.	SEN:10022914	10194465
BEL:20041372	p(HGNC:DTNA) increases cat(p(HGNC:NOS1))	Structural components of the DGC are retained in the absence of alpha-dystrobrevin, but a DGC-associated signalling protein, nitric oxide synthase, is displaced from the membrane and nitric-oxide-mediated signalling is impaired.	SEN:10006824	10559919
BEL:20041388	p(HGNC:E2F2) increases r(HGNC:BAX)	Expression of either E2F1 or E2F2 was sufficient to induce the transcription of cyclins (A2, B1, and E), as well as p53 and Bax in the lens fibercells.	SEN:10022928	11095619
BEL:20041392	p(HGNC:E2F2) increases r(HGNC:TP53)	Expression of either E2F1 or E2F2 was sufficient to induce the transcription of cyclins (A2, B1, and E), as well as p53 and Bax in the lens fibercells.	SEN:10022928	11095619
BEL:20041398	p(HGNC:EDF1,pmod(P)) directlyDecreases complex(p(HGNC:CALM1),p(HGNC:EDF1))	(ii) EDF-1 is phosphorylated in vitro and in vivo by protein kinase C;...In addition, 12-O-tetradecanoylphorbol-13-acetate treatment of human umbilical vein endothelial cell stimulates the nuclear translocation of EDF-1. and (iii) EDF-1-CaM interaction is modulated by the concentrations of Ca(2+) and by the phosphorylation of EDF-1 by protein kinase C both in vitro and in vivo.	SEN:10022368	10816571
BEL:20041400	p(HGNC:EDF1,pmod(P)) directlyIncreases tscript(p(HGNC:EDF1))	(ii) EDF-1 is phosphorylated in vitro and in vivo by protein kinase C;...In addition, 12-O-tetradecanoylphorbol-13-acetate treatment of human umbilical vein endothelial cell stimulates the nuclear translocation of EDF-1. and (iii) EDF-1-CaM interaction is modulated by the concentrations of Ca(2+) and by the phosphorylation of EDF-1 by protein kinase C both in vitro and in vivo.	SEN:10022368	10816571
BEL:20041406	p(HGNC:EDN1) increases kin(p(HGNC:ROCK1))	p160ROCK is a mediator of endothelin-1 (ET-1) induction of the brain natriuretic peptide promoter by RhoA in hypertrophying cardiac myocytes (40)	SEN:10022930	10642399
BEL:20041414	p(HGNC:EDN1) decreases r(HGNC:MMP14)	In addition, ET-1 was found to be able to suppress the expression of membrane type-1 MMP (MT1-MMP) and promote the conversion of tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) from cell associated form to secreted form.	SEN:10006836	11249854
BEL:20041420	p(HGNC:EFS) increases bp(GOBP:"cell adhesion")	Hef1, p130Cas, and Efs define a family of multidomain docking proteins which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion	SEN:10022612	10502414
BEL:20041438	p(HGNC:EGF) directlyIncreases complex(p(HGNC:EGFR),p(HGNC:ERBB2))	Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt.	SEN:10019988	11297548
BEL:20041444	p(HGNC:EGF) increases complex(p(HGNC:PRKCI),p(HGNC:MAP2K5))	The results of these experiments clearly show that EGF triggers the association of endogenous lambda /iota PKC with endogenous MEK5 in HeLa (Fig. 3C) and PC12 (results not shown) cells.	SEN:10022942	11158308
BEL:20041448	p(HGNC:EGF) decreases complex(p(HGNC:SORBS3),p(HGNC:SOS1))	Stimulation of NIH/3T3 cells with serum, epidermal growth factor (EGF), or platelet-derived growth factor (PDGF) decreased the electrophoretic mobility of Sos and concomitantly inhibited formation of the vinexin-Sos complex.	SEN:10022946	10585480
BEL:20041450	p(HGNC:EGF) increases deg(p(HGNC:EGFR))	In vivo and in vitro experiments revealed that c-Cbl and UbcH7 synergistically promote the ligand-induced ubiquitination of the epidermal growth factor receptor (EGFR).	SEN:10018718	10531381
BEL:20041452	p(HGNC:EGF) decreases deg(p(HGNC:TGIF1))	epidermal growth factor (EGF) signaling via the Ras-Mek pathway causes the phosphorylation of TGIF at two Erk MAP kinase sites, leading to TGIF stabilization	SEN:10006844	11226163
BEL:20041458	p(HGNC:EGF) increases kin(p(HGNC:KSR1))	In vivo, low physiologic doses of EGF (0.001-0.1 ng/ml) stimulated KSR activation and induced Thr(269) phosphorylation and activation of c-Raf-1.	SEN:10022950	11134016
BEL:20041476	p(HGNC:EGF) increases p(HGNC:BCAR1,pmod(P,Y))	In contrast, LAR selectively inhibited the epidermal growth factor (EGF)-induced phosphorylation of p130CAS and the formation of the complex between p130CAS and GRB2 but this effect did not influence the activation of MAPK by EGF.	SEN:10022954	10822386
BEL:20041486	p(HGNC:EGF) increases p(HGNC:TGIF1)	epidermal growth factor (EGF) signaling via the Ras-Mek pathway causes the phosphorylation of TGIF at two Erk MAP kinase sites, leading to TGIF stabilization	SEN:10006844	11226163
BEL:20041508	p(HGNC:EGF) decreases r(HGNC:HNF1B)	Also at the mRNA level, TGF-beta1 counteracted at one point or another the decrease in C/EBPalpha, C/EBPbeta, HNF1beta, and HNF4 expression	SEN:10006858	10425225
BEL:20041510	p(HGNC:EGF) increases r(HGNC:HNRNPK)	Both EGF and heregulin-beta1 induced expression of hnRNP K mRNA and protein in human breast cancer cells. This growth factor-mediated hnRNP K expression was effectively blocked by pretreatment of cultures with humanized anti-EGF receptor (EGFR) antibody C225, or anti-human epidermal growth factor receptor-2 (HER2) antibody.	SEN:10005884	11121407
BEL:20041514	p(HGNC:EGF) decreases r(HGNC:IL18)	By contrast, epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha), respectively, strongly decreased IL-18 mRNA expression in HaCaT keratinocytes in the absence of IL-18 protein release from the cells.	SEN:10022968	11125306
BEL:20041534	p(HGNC:EGFR,pmod(P,Y,1016)) directlyIncreases complex(p(HGNC:EGFR),p(HGNC:PIK3C2B))	These findings identify (p)Y992 as an important binding site on the EGFR, while (p)Y1068 and (p)Y1173 also contribute to its interaction with PI3K-C2beta . Sequence alignment of these three sites revealed the putative consensus binding site for PI3K-C2beta to be E(p)YL/I.	SEN:10022978	10805725
BEL:20041536	p(HGNC:EGFR,pmod(P,Y,1045)) directlyIncreases complex(p(HGNC:CBL),p(HGNC:EGFR))	In conclusion, c-Cbl interacts with EGFR in an inducible manner primarily through an autophosphorylated tyrosine 1045 of the receptor.	SEN:10022980	10635327
BEL:20041538	p(HGNC:EGFR,pmod(P,Y,1045)) increases p(HGNC:EGFR,pmod(U,K))	This assay revealed that one of the mutants, a receptor whose tyrosine 1045 was changed into a phenylalanine, lost the ability to undergo ubiquitination ( Figure 4B)	SEN:10022982	10635327
BEL:20041540	p(HGNC:EGFR,pmod(P,Y,1092)) directlyIncreases complex(p(HGNC:PIK3CB),p(HGNC:EGFR))	These findings identify (p)Y992 as an important binding site on the EGFR, while (p)Y1068 and (p)Y1173 also contribute to its interaction with PI3K-C2beta . Sequence alignment of these three sites revealed the putative consensus binding site for PI3K-C2beta to be E(p)YL/I.	SEN:10022978	10805725
BEL:20041542	p(HGNC:EGFR,pmod(P,Y,1197)) directlyIncreases complex(p(HGNC:EGFR),p(HGNC:PIK3C2B))	These findings identify (p)Y992 as an important binding site on the EGFR, while (p)Y1068 and (p)Y1173 also contribute to its interaction with PI3K-C2beta . Sequence alignment of these three sites revealed the putative consensus binding site for PI3K-C2beta to be E(p)YL/I.	SEN:10022978	10805725
BEL:20041550	p(HGNC:EGF) increases tscript(p(HGNC:NCOA1))	Treatment of cells expressing SRC-1 with epidermal growth factor enhanced the ligand-dependent, progesterone receptor-mediated activation of a target reporter gene. These results identify phosphorylation as a regulatory modification of SRC-1 and provide a basis upon which to identify signaling pathways that regulate SRC-1 function and, consequently, modify steroid/nuclear receptor action.	SEN:10006864	10660621
BEL:20041552	p(HGNC:EGR1) increases bp(GOBP:"cell cycle")	In contrast, the expression of Egr-1 increased entry into S/G2 phase of the cell cycle with little apoptosis via a mechanism involving elevated FAK and low caspase activities.	SEN:10022986	10380885
BEL:20041554	p(HGNC:EGR1) decreases r(HGNC:BCL2)	Bcl2, a survival gene product, was repressed in Egr-1 expressing cells, as described earlier (Huang et al., 1998b), a feature that would decrease survival rather than increase it	SEN:10022988	10380885
BEL:20041558	p(HGNC:EGR1) increases r(HGNC:CST6)	Guanylate cyclase b1 subunit (3.3) Proteases/protease inhibitors ----------------------------------------- Cystatin M/CST6 (216)	SEN:10022992	10984481
BEL:20041562	p(HGNC:EGR1) increases r(HGNC:EMP2)	Membrane-associated proteins ----------------------------------------- Epithelial membrane protein 2/XMP (16.9)	SEN:10022996	10984481
BEL:20041574	p(HGNC:EIF4EBP1,pmod(P)) decreases complex(p(HGNC:EIF4EBP1),p(HGNC:EIF4E))	4E-BP1 is a translation inhibitor that is phosphorylated and inactivated in response to a growth signal. Phosphorylated 4E-BP1 dissociates from eIF4E, the translation initiation factor that binds the cap structure (m7G(5')ppp(5')N) present at the 5' termini of mRNAs, thereby allowing cap-dependent translation.	SEN:10019990	11057898
BEL:20041580	p(HGNC:EIF5A) increases bp(GOBP:"T cell activation")	Furthermore, an inhibitor of the hypusine modification, GC7 (N(1)-guanyl-1, 7-diaminoheptane), prevents CD83 surface expression by apparently interfering with nucleocytoplasmic translocation of the CD83 mRNA and, importantly, significantly inhibits DC-mediated T lymphocyte activation.	SEN:10006870	10790432
BEL:20041582	p(HGNC:EIF5A) increases surf(p(HGNC:CD83))	Furthermore, an inhibitor of the hypusine modification, GC7 (N(1)-guanyl-1, 7-diaminoheptane), prevents CD83 surface expression by apparently interfering with nucleocytoplasmic translocation of the CD83 mRNA and, importantly, significantly inhibits DC-mediated T lymphocyte activation.	SEN:10006870	10790432
BEL:20041588	p(HGNC:ELANE) decreases deg(p(HGNC:MUC5AC))	Nuclear runoff studies revealed that NE treatment did not stimulate new transcription of 32P-labeled MUC5AC mRNA (Fig. 6). However, RNA stability assays demonstrated an NEinduced increase in MUC5AC mRNA half-life from 4.5 h in resting cells to 14.75 h (Fig. 7A).	SEN:10023008	10330040
BEL:20041590	p(HGNC:ELANE) increases p(HGNC:MUC5AC)	NE (22 h) increased MUC5AC protein and glycoprotein levels in A549 cell lysates compared with control cell lysates (Fig. 8, lanes 1 and 2).	SEN:10023010	10330040
BEL:20041592	p(HGNC:ELANE) increases p(HGNC:MUC5AC,pmod(G))	NE (22 h) increased MUC5AC protein and glycoprotein levels in A549 cell lysates compared with control cell lysates (Fig. 8, lanes 1 and 2).	SEN:10023010	10330040
BEL:20041594	p(HGNC:ELANE) increases r(HGNC:MUC5AC)	Densitometry of Northern analyses showed that 500 nM NE (1 h) upregulated MUC5AC mRNA levels approximately two- to fourfold in NHBE cells (Fig. 3A).	SEN:10023012	10330040
BEL:20041596	p(HGNC:ELANE) increases r(HGNC:MUC5AC)	NE (75 nM, 24 h) increased MUC5AC mRNA levels in A549 cells approximately sixfold compared with vehicle alone (Fig. 1A).	SEN:10023014	10330040
BEL:20041598	p(HGNC:ELANE) decreases sec(p(HGNC:MUC5AC))	MUC5AC glycoprotein was barely detectable in NE-treated medium, whereas MUC5AC glycoprotein was present in control vehicle-treated A549 cellconditioned medium as shown by Western analysis (Fig. 9).	SEN:10023016	10330040
BEL:20041600	p(HGNC:ELAVL1) increases r(HGNC:CCNA1)	Our results indicate that HuR may play a critical role in cell proliferation, at least in part by mediating cell cycle-dependent stabilization of mRNAs encoding cyclins A and B1.	SEN:10023018	10811625
BEL:20041602	p(HGNC:ELAVL1) increases r(HGNC:CCNB1)	Our results indicate that HuR may play a critical role in cell proliferation, at least in part by mediating cell cycle-dependent stabilization of mRNAs encoding cyclins A and B1.	SEN:10023018	10811625
BEL:20041630	p(HGNC:EMILIN1) increases bp(GOBP:"cell adhesion")	The gC1q domain of EMILIN-1 can form relatively stable and compact homotrimers and this association is then followed by a multimeric assembly of disulfide-bonded protomers. Recombinant EMILIN-1 purified from the supernatant of 293 cells represents a very efficient ligand for cell adhesion of several cell types.	SEN:10006880	10963989
BEL:20041632	p(HGNC:EMILIN2) increases bp(GOBP:"cell adhesion")	The gC1q domain of EMILIN-1 can form relatively stable and compact homotrimers and this association is then followed by a multimeric assembly of disulfide-bonded protomers. Recombinant EMILIN-1 purified from the supernatant of 293 cells represents a very efficient ligand for cell adhesion of several cell types.	SEN:10006880	10963989
BEL:20041638	p(HGNC:EP300) increases r(HGNC:MGMT)	This possibility is supported by the observation that ectopic expression of the transcriptional coactivator CBP/p300 enhanced MGMT promoter activity (Fig. 4 , A and B ).	SEN:10023026	10942771
BEL:20041642	p(HGNC:EP300) increases tscript(p(HGNC:E2F1))	<h5> p300 binds to the transactivation domain of E2F1 (Lee et al., 1998a). E2F1 and p53 may be reciprocally regulated by their mutual dependence on coactivation by limiting amounts of p300 (Lee et al., 1998a).	SEN:10023028	10436023
BEL:20041646	p(HGNC:EP300) increases tscript(p(HGNC:MYOD1))	The process also involves the subsequent recruitment of p300/CBP and PCAF to a complex that synergistically regulates transcription and remodels the chromatin. PCAF and p300 have also been demonstrated to function as critical coactivators for the muscle-specific basic helix-loop-helix (bHLH) protein MyoD during myogenic commitment.	SEN:10006884	10817756
BEL:20041648	p(HGNC:EP300) directlyIncreases tscript(p(HGNC:TP53))	<p24> P300 coactivates P53-activated promotors, including p21, Bax, and Mdm2. <p25> P300 binds the transactivation domain in the Nterminal region of p53 - this interaction is involved in the coactivation of p53 by p300	SEN:10023030	10436023
BEL:20041656	p(HGNC:EPO) increases complex(p(HGNC:INPP5D),p(HGNC:IRS2))	In the case of insulin, it is unclear whether SHIP associates with IRS proteins or the insulin receptor, although a recent report has demonstrated SHIP association with IRS-2 in response to erythropoietin	SEN:10023034	10194465
BEL:20041660	p(HGNC:EPO) increases r(HGNC:ALAS2)	The mechanism by which transcription of the gene for ALAS2 is increased by erythropoietin late in erythropoiesis remains an interesting issue.	SEN:10006888	10582344
BEL:20041668	p(HGNC:ERBB2IP) increases p(HGNC:ERBB2)	Expression of Erbin increases the amount of ErbB2 labeled by biotin in transfected cells, suggesting that Erbin is able to increase ErbB2 surface expression.	SEN:10006890	11279080
BEL:20041670	p(HGNC:ERBB2IP) increases surf(p(HGNC:ERBB2))	Expression of Erbin increases the amount of ErbB2 labeled by biotin in transfected cells, suggesting that Erbin is able to increase ErbB2 surface expression.	SEN:10006890	11279080
BEL:20041694	p(HGNC:ERN1) increases kin(p(HGNC:MAPK8))	IRE1 activates chaperone genes in response to stress in the endoplasmic reticulum and also activates JNK	SEN:10018222	10650002
BEL:20041706	p(HGNC:EZR,pmod(P,Y,353)) directlyIncreases complex(p(HGNC:EZR),p(HGNC:PIK3R1))	While investigating the mechanism responsible for this apoptosis, we found that ezrin interacts with p85, the regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase). Two distinct sites of ezrin are involved in this interaction, the amino-terminal domain containing the first 309 aa and the phosphorylated Tyr-353 residue, which binds to the carboxyl-terminal SH2 domain of p85.	SEN:10023048	10377409
BEL:20041726	p(HGNC:F2) increases p(HGNC:PLA2G4A,pmod(P,S,505))	We have previously reported that in thrombin-stimulated human platelets, cytosolic phospholipase A(2) (cPLA2) is phosphorylated on Ser-505 by p38 protein kinase and on Ser-727 by an unknown kinase.	SEN:10023054	10978317
BEL:20041728	p(HGNC:F2) increases p(HGNC:PLA2G4A,pmod(P,S,727))	We have previously reported that in thrombin-stimulated human platelets, cytosolic phospholipase A(2) (cPLA2) is phosphorylated on Ser-505 by p38 protein kinase and on Ser-727 by an unknown kinase.	SEN:10023054	10978317
BEL:20041732	p(HGNC:F2) increases p(HGNC:STX4,pmod(P))	We found that syntaxin 4 was phosphorylated in human platelets treated with a physiologic agent that induces secretion (thrombin) but not when they were treated with an agent that prevents secretion (prostacyclin).	SEN:10016878	10856305
BEL:20041736	p(HGNC:F2R,pmod(P)) directlyIncreases cat(p(HGNC:F2R))	Stimulation of human platelets with thrombin or thrombin receptor agonist peptide (TRAP/ Ser-Phe-Leu-Leu-Arg-Asn) resulted in phosphorylation of the protease-activated receptor 1 (PAR1)	SEN:10000096	10780327
BEL:20041740	p(HGNC:F2) increases sec(p(HGNC:CSF3))	The levels of IL6 and of G-CSF mRNAs showed a time dependent increase during two to eight hours after thrombin stimulation....Cytokines were measured by enzyme linked immunosorbent assay (ELISA) in the supernatants of cultured rheumatoid synovial fibroblasts stimulated by thrombin	SEN:10023056	10343541
BEL:20041742	p(HGNC:F2) increases sec(p(HGNC:IL6))	The levels of IL6 and of G-CSF mRNAs showed a time dependent increase during two to eight hours after thrombin stimulation....Cytokines were measured by enzyme linked immunosorbent assay (ELISA) in the supernatants of cultured rheumatoid synovial fibroblasts stimulated by thrombin	SEN:10023056	10343541
BEL:20041754	p(HGNC:FAS) increases bp(GOBP:"apoptotic process")	Treatment of control cells transfected with the vector alone (MCF-7PC) with IgMFAS induced morphological changes typical of apoptosis with rounding up, membrane blebbing, and lifting off from the plate (Figure 1b).	SEN:10023064	10442631
BEL:20041756	p(HGNC:FAS) increases bp(GOBP:"apoptotic process")	Treatment of the tumor cell lines MCF-7 and MDA-MB231 with IFN-gamma significantly facilitated apoptosis induced by CD95 receptor ligation at the plasma membrane, independently of p53 status.	SEN:10006906	11059759
BEL:20041762	p(HGNC:FAS) increases cat(p(HGNC:CASP8))	Following FAS stimulation, caspase-8 activates caspase-3, which in turn activates the caspase-activated DNAse (CAD) by proteolysis of its inhibitor (ICAD)	SEN:10004290	11004695
BEL:20041770	p(HGNC:FBXL2) decreases r(HGNC:MED1)	The human FBL2 gene was found to be a highly interrupted gene of at least 126.6 kb located on chromosome 17 in close proximity to the TRAP220 gene in a head-to-tail orientation.	SEN:10006908	10508920
BEL:20041774	p(HGNC:FBXW11) increases deg(p(HGNC:CTNNB1))	We identified a human F-box/WD40 repeats protein (HOS), which is homologous to Slimb/h betaTrCP. Being a part of SCF complex with Skp1 and Cullin1, HOS specifically interacted with the phosphorylated IkappaB and beta-catenin, targeting these proteins for proteasome-dependent degradation in vivo.	SEN:10001364	10321728
BEL:20041784	p(HGNC:FGF1) increases bp(GOBP:"cell differentiation")	Acidic fibroblast growth factor (FGF-1), a prototype member of the heparin-binding growth factor family, influences proliferation, differentiation, and protein synthesis in different cell types	SEN:10000040	10226073
BEL:20041786	p(HGNC:FGF1) increases bp(GOBP:"cell proliferation")	Acidic fibroblast growth factor (FGF-1), a prototype member of the heparin-binding growth factor family, influences proliferation, differentiation, and protein synthesis in different cell types	SEN:10000040	10226073
BEL:20041788	p(HGNC:FGF1) increases bp(GOBP:"protein metabolic process")	Acidic fibroblast growth factor (FGF-1), a prototype member of the heparin-binding growth factor family, influences proliferation, differentiation, and protein synthesis in different cell types	SEN:10000040	10226073
BEL:20041794	p(HGNC:FGF1) decreases r(HGNC:COL1A1)	Our results show that FGF-1 induced collagenase mRNA expression, which was strongly enhanced when FGF-1 was used with heparin. Likewise, both FGF-1 and FGF-1 plus heparin reduced by 70 to 80% the expression of type I collagen transcript, in part through effect on pro-alpha1(I) collagen mRNA stability. A downregulation of HSP47 gene expression was also observed	SEN:10015734	10226073
BEL:20041798	p(HGNC:FGF1) increases r(HGNC:MMP1)	Our results show that FGF-1 induced collagenase mRNA expression, which was strongly enhanced when FGF-1 was used with heparin. Likewise, both FGF-1 and FGF-1 plus heparin reduced by 70 to 80% the expression of type I collagen transcript, in part through effect on pro-alpha1(I) collagen mRNA stability. A downregulation of HSP47 gene expression was also observed	SEN:10015734	10226073
BEL:20041800	p(HGNC:FGF1) decreases r(HGNC:SERPINH1)	Our results show that FGF-1 induced collagenase mRNA expression, which was strongly enhanced when FGF-1 was used with heparin. Likewise, both FGF-1 and FGF-1 plus heparin reduced by 70 to 80% the expression of type I collagen transcript, in part through effect on pro-alpha1(I) collagen mRNA stability. A downregulation of HSP47 gene expression was also observed	SEN:10015734	10226073
BEL:20041806	p(HGNC:FGF2) increases bp(GOBP:"blood vessel development")	Both low and high MW FGF-2 isoforms show angiogenic activity in vivo and induce cell proliferation, chemotaxis, and uPA production in cultured endothelial cells (188). Also, FGF-2 was found to induce tube formation in collagen gels and to modulate integrin expression, gap junction intercellular communication and VEGF, Flk-1 and uPAR upregulation in vitro (31, 100).	SEN:10023082	11172729
BEL:20041808	p(HGNC:FGF2) increases bp(GOBP:"cell proliferation")	PTK, but not PKC, was involved in the activation of the proliferative response of basic fibroblast growth factor in the same experimental conditions.	SEN:10005912	10801075
BEL:20041810	p(HGNC:FGF2) increases bp(GOBP:"cell proliferation")	insulin-like growth factor-1 and basic fibroblast growth factor (bFGF) activate MAPK/Erk, and both growth factors promote myoblast proliferation	SEN:10023084	11279003
BEL:20041812	p(HGNC:FGF2) increases bp(GOBP:"MAPK cascade")	insulin-like growth factor-1 and basic fibroblast growth factor (bFGF) activate MAPK/Erk, and both growth factors promote myoblast proliferation	SEN:10023084	11279003
BEL:20041824	p(HGNC:FGF2) increases p(HGNC:KDR)	Both low and high MW FGF-2 isoforms show angiogenic activity in vivo and induce cell proliferation, chemotaxis, and uPA production in cultured endothelial cells (188). Also, FGF-2 was found to induce tube formation in collagen gels and to modulate integrin expression, gap junction intercellular communication and VEGF, Flk-1 and uPAR upregulation in vitro (31, 100).	SEN:10023082	11172729
BEL:20041828	p(HGNC:FGF2) increases p(HGNC:PLAU)	Both low and high MW FGF-2 isoforms show angiogenic activity in vivo and induce cell proliferation, chemotaxis, and uPA production in cultured endothelial cells (188). Also, FGF-2 was found to induce tube formation in collagen gels and to modulate integrin expression, gap junction intercellular communication and VEGF, Flk-1 and uPAR upregulation in vitro (31, 100).	SEN:10023082	11172729
BEL:20041832	p(HGNC:FGF2) increases p(HGNC:VEGFA)	VEGF endogenous production may be upregulated in vascular smooth muscle cells by hypoxia, growth factors (bFGF and PDGF-BB), and cytokines	SEN:10018124	11350732
BEL:20041836	p(HGNC:FGF2) increases r(HGNC:ANGPT2)	Vascular endothelial growth factor and basic fibroblast growth factor, which were overexpressed in involved psoriasis skin, enhanced angiopoietin 2 and Tie2 expression in dermal microvascular endothelial cell cultures.	SEN:10006916	11348459
BEL:20041846	p(HGNC:FGF2) increases r(HGNC:CCND1)	On the other hand, bFGF (.. PD)-treated cells express cyclin D1 through 30 h during which time the cells are proliferating (see Fig. 4 ) and then its expression drops to basal levels at 48 h.	SEN:10023096	11279003
BEL:20041858	p(HGNC:FGF2) decreases r(HGNC:ELN)	Previous studies demonstrated that basic fibroblast growth factor (bFGF) decreases elastin gene transcription in pulmonary fibroblasts.	SEN:10006924	10559225
BEL:20041874	p(HGNC:FGF2) decreases r(HGNC:MYOD1)	insulin-like growth factor-1 enhances muscle cell differentiation, whereas bFGF inhibits the expression of the muscle-specific transcription factors MyoD and myogenin.	SEN:10023112	11279003
BEL:20041876	p(HGNC:FGF2) decreases r(HGNC:MYOG)	insulin-like growth factor-1 enhances muscle cell differentiation, whereas bFGF inhibits the expression of the muscle-specific transcription factors MyoD and myogenin.	SEN:10023112	11279003
BEL:20041880	p(HGNC:FGF2) increases r(HGNC:PDGFRA)	On the other hand, stimulation with basic fibroblast growth factor (bFGF) selectively increases the expression of the alpha -receptor, but not the beta -receptor, in vascular smooth muscular cells (416) and in bronchial smooth muscle cells (56), and lipopolysaccharide upregulates the alpha -receptor but not the beta -receptor in rat lung myofibroblasts (83).	SEN:10023116	10508235
BEL:20041886	p(HGNC:FGF2) increases r(HGNC:SFTPC)	In contrast to MAPK, FGF-2-induced SP-C expression was partially inhibited by PI 3-kinase inhibitor wortmannin.	SEN:10006932	10353697
BEL:20041890	p(HGNC:FGF2) increases r(HGNC:TEK)	Vascular endothelial growth factor and basic fibroblast growth factor, which were overexpressed in involved psoriasis skin, enhanced angiopoietin 2 and Tie2 expression in dermal microvascular endothelial cell cultures.	SEN:10006916	11348459
BEL:20041910	p(HGNC:FGFR3,pmod(P,Y,770)) directlyDecreases p(HGNC:FGFR3)	We also found that Y770 may function as a negative regulatory site for FGFR3-stimulated transformation and PI 3-kinase activation.	SEN:10023128	11294897
BEL:20041912	p(HGNC:FIGF) increases bp(GOBP:"cell migration")	VEGF-D enhancedHUVEC migration at concentration,,, In contrast, PlGF induced minimal stimulation HUVEC migration at concentrations, which stimulated proliferative response.	SEN:10023130	11090623
BEL:20041914	p(HGNC:FIGF) increases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	VEGF-D enhancedHUVEC migration at concentration,,, In contrast, PlGF induced minimal stimulation HUVEC migration at concentrations, which stimulated proliferative response.	SEN:10023130	11090623
BEL:20041916	p(HGNC:FIGF) increases kin(p(HGNC:KDR))	VEGF-D enhancedHUVEC migration at concentration,,, In contrast, PlGF induced minimal stimulation HUVEC migration at concentrations, which stimulated proliferative response.	SEN:10023130	11090623
BEL:20041928	p(HGNC:FN1) directlyIncreases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	avb3 is a receptor for a number of proteins with an exposed Arg-Gly-Asp (RGD) sequence, including fibronectin, vitronectin, laminin, von Willebrand factor (vWF), fibrinogen and denatured collagen.	SEN:10020538	11172729
BEL:20041934	p(HGNC:FN1) increases r(HGNC:MMP2)	we show that transient adherence to fibronectin induces the production of activated forms of matrix metalloproteinase-2 (MMP-2) and MMP-9, as well as downregulation of tissue inhibitor of metalloproteinase-2 (TIMP-2) by T-cell lines.	SEN:10023136	10515879
BEL:20041936	p(HGNC:FN1) increases r(HGNC:MMP9)	we show that transient adherence to fibronectin induces the production of activated forms of matrix metalloproteinase-2 (MMP-2) and MMP-9, as well as downregulation of tissue inhibitor of metalloproteinase-2 (TIMP-2) by T-cell lines.	SEN:10023136	10515879
BEL:20041938	p(HGNC:FN1) decreases r(HGNC:TIMP2)	we show that transient adherence to fibronectin induces the production of activated forms of matrix metalloproteinase-2 (MMP-2) and MMP-9, as well as downregulation of tissue inhibitor of metalloproteinase-2 (TIMP-2) by T-cell lines.	SEN:10023136	10515879
BEL:20041940	p(HGNC:FOSB) decreases r(HGNC:TIMP1)	Overexpression of c-Jun, JunB, Fra2, or FosB in activated HSCs repressed TIMP-1 promoter activity, whereas c-Fos and Fra1 had little effect.	SEN:10023138	11337499
BEL:20041942	p(HGNC:FOSL2) decreases r(HGNC:TIMP1)	Overexpression of c-Jun, JunB, Fra2, or FosB in activated HSCs repressed TIMP-1 promoter activity, whereas c-Fos and Fra1 had little effect.	SEN:10023138	11337499
BEL:20041950	p(HGNC:FOS) increases r(HGNC:IL6)	Cotransfection of c-Jun and c-Fos also strongly activated the wild-type human IL-6 promoter (Fig. 3 B ).	SEN:10023142	10542237
BEL:20041952	p(HGNC:FOS) increases r(HGNC:SERPINE1)	Moreover, this D dimer- induced c-fos expression was found to increase PAI-1 transcriptional activation through this same element.	SEN:10023144	11158248
BEL:20041954	p(HGNC:FOXA1) increases r(HGNC:COL18A1)	Cotransfection experiments showed that the Col18a1 promoter 2 was transactivated by Sp1 and HNF3alpha.	SEN:10006952	11093745
BEL:20041962	p(HGNC:FOXO1,sub(S,256,A)) decreases p(HGNC:FOXO1,pmod(P,S,319))	the mutation S256A completely prevented phosphorylation at Thr- 24 and Ser-319 (Figure 1A, lanes 7 and 8, numbering from the left)	SEN:10023146	11237865
BEL:20041964	p(HGNC:FOXO1,sub(S,256,A)) decreases p(HGNC:FOXO1,pmod(P,T,24))	the mutation S256A completely prevented phosphorylation at Thr- 24 and Ser-319 (Figure 1A, lanes 7 and 8, numbering from the left)	SEN:10023146	11237865
BEL:20042002	p(HGNC:GAB1,pmod(P,Y)) directlyIncreases complex(p(HGNC:GAB1),p(HGNC:PTPN11))	Insulin stimulates the tyrosine kinase activity of its receptor, leading to the phosphorylation of a number of cellular substrates, including Gab1, Shc, IRS 1 - 4, and Cbl. Gab1 appears to interact with the SH2 containing tyrosine phosphatase SHP2, leading to the activation of the MAP kinase pathway.	SEN:10023154	11239409
BEL:20042008	p(HGNC:GABPA) increases r(HGNC:UTRN)	Using this region of the utrophin promoter for DNA affinity purification, immunoblots, in vitro kinase assays, electrophoretic mobility shift assays, and in vitro expression in cultured muscle cells, we demonstrate that ets-related GA-binding protein alpha/beta transcription factors are activators of the utrophin promoter.	SEN:10006962	10359616
BEL:20042010	p(HGNC:GADD45A) decreases complex(p(HGNC:CDK1),p(HGNC:CCNB1))	Gadd45 was also able to physically interact with Cdc2, but not Cyclin B1. Addition of Gadd45 to immunoprecipitated Cdc2/Cyclin B1 in vitro led to a dissociation of this complex, and thus may represent a new checkpoint mechanism whereby Cdc2/Cyclin B1 can be inhibited.	SEN:10005288	10362260
BEL:20042012	p(HGNC:GADD45A) directlyDecreases kin(p(HGNC:CDK1))	Gadd45 was also able to physically interact with Cdc2, but not Cyclin B1. Addition of Gadd45 to immunoprecipitated Cdc2/Cyclin B1 in vitro led to a dissociation of this complex, and thus may represent a new checkpoint mechanism whereby Cdc2/Cyclin B1 can be inhibited.	SEN:10005288	10362260
BEL:20042014	p(HGNC:GADD45B) increases kin(p(HGNC:MAP3K4))	GADD45 beta, which activates mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase kinase 4 (MEKK4), was induced by IL-18 and augmented by IL-12.	SEN:10023158	11175814
BEL:20042022	p(HGNC:GATA5) increases r(HGNC:EDN1)	GATA-4/5 Are Sequence-specific Activators of the ET-1 Promoter-- Among the six members of the GATA transcription factor family, only GATA-4, -5, and -6 are expressed in the heart ( 19-22 ).	SEN:10023166	10788492
BEL:20042028	p(HGNC:GCG) decreases r(HGNC:NOS2)	Glucagon and forskolin also decreased iNOS expression in RIN5F cells, and rat and human islets, as shown by Western blotting.	SEN:10023172	10433805
BEL:20042032	p(HGNC:GCG) increases r(HGNC:PDX1)	Glucagon-like peptide-1 also increased the expression of PDX-1, glucose transporter 2, glucokinase and insulin mRNAs.	SEN:10006964	10440129
BEL:20042034	p(HGNC:GCK) increases bp(GOBP:"insulin secretion")	MODY2 is caused by mutations in the glucokinase gene (Bell et al., 1996). Glucokinase plays an essential role in the glucose-sensing mechanism of b cells, and muta- tions in this gene lead to a partial deficiency of insulin secretion.	SEN:10023176	10199397
BEL:20042052	p(HGNC:GH1) increases r(HGNC:PRLR)	Expression of the prolactin receptor (PRLR) gene is increased in pancreatic islets during pregnancy and in vitro in insulin-producing cells by growth hormone (GH) and prolactin (PRL).	SEN:10006974	10373481
BEL:20042074	p(HGNC:GNB5) decreases r(HGNC:SFTPA1)	Mutagenesis of the GBS inhibited TTF-1-dependent activation of the SP-A promoter, and the activity of the GBS was influenced by mutations in any of three distinct TTF-1 regulatory elements located within the 5'-flanking region of the SP-A gene.	SEN:10023186	10625644
BEL:20042080	p(HGNC:GNRH1) increases r(HGNC:FOS)	We have found GnRH receptors on a subset of GH, FSH, and LH cells ( 8 ), but GnRH stimulates c- fos expression by only GH or ACTH cells ( 16 ).	SEN:10023192	11159858
BEL:20042092	p(HGNC:GRB2) increases cat(p(HGNC:WAS))	The activity of N-WASp is enhanced by the binding of effectors like Cdc42-guanosine 5'-3-O-(thio)triphosphate, phosphatidylinositol bisphosphate, or the Shigella IcsA protein. Here we show that the SH3-SH2-SH3 adaptor Grb2 is another activator of N-WASp that stimulates actin polymerization by increasing the amount of N-WASp. Arp2/3 complex.	SEN:10005738	10781580
BEL:20042098	p(HGNC:GRB2,pmod(P,Y)) directlyIncreases complex(p(HGNC:IRS1),p(HGNC:GRB2))	The SH2 domain of the adaptor protein Grb- 2 and the SH2 domain of the phosphotyrosine phosphatase SHP-2 bind other sequences, including pYVNI, pYIDL, and pYASI sequences (1).	SEN:10023202	10194465
BEL:20042112	p(HGNC:GSK3B) increases deg(p(HGNC:CTNNB1))	Inducible overexpression of PS1 led to increased association of beta-catenin with glycogen synthase kinase-3beta (GSK-3beta), a negative regulator of beta-catenin, and accelerated the turnover of endogenous beta-catenin.	SEN:10001352	10341227
BEL:20042124	p(HGNC:HCRT) increases r(HGNC:APOC1)	HCR-1 appears to have a dominant effect on apoE and apoCI and HCR-2 has a dominant effect on apoCIV and apoCII gene expressio	SEN:10006988	11229886
BEL:20042126	p(HGNC:HCRT) increases r(HGNC:APOC2)	HCR-1 appears to have a dominant effect on apoE and apoCI and HCR-2 has a dominant effect on apoCIV and apoCII gene expressio	SEN:10006988	11229886
BEL:20042128	p(HGNC:HCRT) increases r(HGNC:APOC4)	HCR-1 appears to have a dominant effect on apoE and apoCI and HCR-2 has a dominant effect on apoCIV and apoCII gene expressio	SEN:10006988	11229886
BEL:20042130	p(HGNC:HCRT) increases r(HGNC:APOE)	HCR-1 appears to have a dominant effect on apoE and apoCI and HCR-2 has a dominant effect on apoCIV and apoCII gene expressio	SEN:10006988	11229886
BEL:20042148	p(HGNC:HGF) increases bp(GOBP:"MAPK cascade")	SF/HGF activated mitogen-activated protein kinase (MAPK) and inhibition of either Ras or MAPK-kinase completely inhibited SF/HGF-mediated c-met induction.	SEN:10021000	11238734
BEL:20042162	p(HGNC:HGF) increases r(HGNC:BAX)	During the first 24 h after HGF treatment, enhanced expression of the pro-apoptotic genes bax and c-Myc was observed at level of mRNA and protein.	SEN:10006992	11169978
BEL:20042164	p(HGNC:HGF) increases r(HGNC:FLT1)	Moreover, HGF/SF also stimulates the expression of VEGF receptor in vascular endothelial cells (48) .	SEN:10023230	11085539
BEL:20042168	p(HGNC:HGF) decreases r(HGNC:HNF1B)	Also at the mRNA level, TGF-beta1 counteracted at one point or another the decrease in C/EBPalpha, C/EBPbeta, HNF1beta, and HNF4 expression	SEN:10006858	10425225
BEL:20042174	p(HGNC:HGF) increases r(HGNC:JUN)	SF/HGF induced the expression of c-fos and c-jun mRNA and increased the levels of AP-1 transcription factor in both cells lines as determined by AP-1-luciferase reporter expression. Transfection of either cell line with TAM-67, a dominant negative for the jun transactivation domain, completely inhibited AP-1 and c-met induction by SF/HGF.	SEN:10023234	11238734
BEL:20042176	p(HGNC:HGF) increases r(HGNC:MET)	In the present study SF/HGF is shown to induce the expression of c-met in two human glioblastoma cell lines, U-373 MG and T98G	SEN:10023236	11238734
BEL:20042180	p(HGNC:HGF) increases r(HGNC:MYC)	During the first 24 h after HGF treatment, enhanced expression of the pro-apoptotic genes bax and c-Myc was observed at level of mRNA and protein.	SEN:10006992	11169978
BEL:20042184	p(HGNC:HGF) increases r(HGNC:SERPINE1)	in human keratinocytes HGF/SF but not the related cytokine macrophage stimulating protein (MSP) significantly increases expression of VEGF and plasminogen activator inhibitor-1 (PAI-1) on the level of protein and mRNA.	SEN:10007000	10211995
BEL:20042188	p(HGNC:HGF) increases r(HGNC:VEGFA)	in human keratinocytes HGF/SF but not the related cytokine macrophage stimulating protein (MSP) significantly increases expression of VEGF and plasminogen activator inhibitor-1 (PAI-1) on the level of protein and mRNA.	SEN:10007000	10211995
BEL:20042204	p(HGNC:HMGB1) directlyIncreases tscript(p(HGNC:TP53))	<p52> HMG1 binds p53 and enhances p53 binding to DNA, asl well as p53-mediated transcriptional activation	SEN:10023244	10436023
BEL:20042208	p(HGNC:HNF1A) decreases r(HGNC:CPT1A)	It is also unlikely that a defect in mitochondrial fatty acid import, mediated by L -CPT1, resulted in the differences between peroxisomal and mitochondrial eta-oxidation, because the expression of the gene for L -CPT1 was unaffected by HNF1alpha gene inactivation.	SEN:10023248	10852923
BEL:20042210	p(HGNC:HNF1A) increases r(HGNC:CYP1A2)	Similarly HNF1 stimulates the expression of CYP1A2 (Chung and Bresnick, 1995 ), UGT1A1 (Bernard et al., 1999 ), UGT1A7 ( Metz et al., 2000 ), and UGT2B1 (Hansen et al., 1997 ), whereas C/EBP regulates UGT2B1 (Hansen et al., 1998 ) and GST Ya (Pimental et al., 1993 ; Chen and Ramos, 2000 ).	SEN:10023250	11302926
BEL:20042214	p(HGNC:HNF1A) increases r(HGNC:NPM1)	The normal actions of HNF-1 include enhancing the transcription of apo B 23 24 25 and suppressing the transcription of apo AI. 27 Thus, in subjects with type 2 diabetes, the lower plasma total and LDL cholesterol and apo B levels would also be consistent with transactivational loss of function of the HNF1A S319 product.	SEN:10023254	10634821
BEL:20042218	p(HGNC:HNF1A) increases r(HGNC:SLC35A2)	Similarly HNF1 stimulates the expression of CYP1A2 (Chung and Bresnick, 1995 ), UGT1A1 (Bernard et al., 1999 ), UGT1A7 ( Metz et al., 2000 ), and UGT2B1 (Hansen et al., 1997 ), whereas C/EBP regulates UGT2B1 (Hansen et al., 1998 ) and GST Ya (Pimental et al., 1993 ; Chen and Ramos, 2000 ).	SEN:10023250	11302926
BEL:20042220	p(HGNC:HNF1A) increases r(HGNC:UCP2)	However, a recent in vitro study showed that expressing a dominant negative form of Hnf-1 , HNF1 -P291fsinsC, in insulinoma INS-1 cells affects mitochondrial function by reducing the expression of Ogdh and increasing the expression of Ucp2 ( 31 ).	SEN:10023258	10944108
BEL:20042222	p(HGNC:HNF1A) increases r(HGNC:UGT1A1)	Similarly HNF1 stimulates the expression of CYP1A2 (Chung and Bresnick, 1995 ), UGT1A1 (Bernard et al., 1999 ), UGT1A7 ( Metz et al., 2000 ), and UGT2B1 (Hansen et al., 1997 ), whereas C/EBP regulates UGT2B1 (Hansen et al., 1998 ) and GST Ya (Pimental et al., 1993 ; Chen and Ramos, 2000 ).	SEN:10023250	11302926
BEL:20042224	p(HGNC:HNF1A) increases r(HGNC:UGT1A7)	Similarly HNF1 stimulates the expression of CYP1A2 (Chung and Bresnick, 1995 ), UGT1A1 (Bernard et al., 1999 ), UGT1A7 ( Metz et al., 2000 ), and UGT2B1 (Hansen et al., 1997 ), whereas C/EBP regulates UGT2B1 (Hansen et al., 1998 ) and GST Ya (Pimental et al., 1993 ; Chen and Ramos, 2000 ).	SEN:10023250	11302926
BEL:20042226	p(HGNC:HNF1A) increases r(HGNC:UGT2B7)	UGT2B7 promoter activity with the HNF1/AT-rich element was stimulated by cotransfection with HNF1alpha.	SEN:10007006	10779377
BEL:20042238	p(HGNC:HNRNPC) decreases r(HGNC:TIA1)	The smaller effect of phnRNP C1 transfection could be explained if the transfection-induced increase in hnRNP C1 levels is lower than that in TIA-1 levels.	SEN:10023262	10938105
BEL:20042240	p(HGNC:HNRNPK) increases bp(GOBP:"cell proliferation")	Finally, overexpression of hnRNP K in breast cancer cells significantly increased target c-myc promoter activity and c-Myc protein, hnRNP K protein levels, and enhanced breast cancer cell proliferation and growth in an anchorage-independent manner.	SEN:10000148	11121407
BEL:20042242	p(HGNC:HNRNPK) increases r(HGNC:MYC)	Finally, overexpression of hnRNP K in breast cancer cells significantly increased target c-myc promoter activity and c-Myc protein, hnRNP K protein levels, and enhanced breast cancer cell proliferation and growth in an anchorage-independent manner.	SEN:10000148	11121407
BEL:20042244	p(HGNC:HOXA10) increases bp(GOBP:"cell differentiation")	Several genes including the cyclin-dependent kinase inhibitor p21(waf1/cip1) and the homeobox gene transcription factor HOXA10 are induced at the onset of differentiation. Ectopic expression of either gene results in U937 differentiation.	SEN:10006714	11040212
BEL:20042266	p(HGNC:HRAS) increases kin(p(HGNC:PRKCZ))	The present study investigates a novel pathway whereby Ras promotes the transcription of VPF/VEGF by activating protein kinase Czeta (PKCzeta). The Ras-mediated overexpression of VPF/VEGF was also found to be inhibited by using the antisense or the dominant-negative mutant of PKCzeta.	SEN:10007020	11060301
BEL:20042268	p(HGNC:HRAS) increases p(HGNC:CCND1)	though V12Ras was able to stimulate ERK phosphorylation and induce cyclin D1 expression in the absence of androgen	SEN:10023270	10939590
BEL:20042270	p(HGNC:HRAS) increases p(HGNC:MAPK1,pmod(P))	though V12Ras was able to stimulate ERK phosphorylation and induce cyclin D1 expression in the absence of androgen	SEN:10023270	10939590
BEL:20042274	p(HGNC:HRAS) increases r(HGNC:TP53)	From full text: RAS stimulates expression of p53 level when LNCaP cells were transfected with V12RAS	SEN:10023274	10939590
BEL:20042276	p(HGNC:HRAS) increases r(HGNC:VEGFA)	The up-regulation of VPF/VEGF expression by Ras has been found to be through both transcription and mRNA stability.	SEN:10023276	11060301
BEL:20042282	p(HGNC:HSF1,pmod(P)) directlyDecreases tscript(p(HGNC:HSF1))	we showed that HSF 1 is phosphorylated by the protein kinase RSK2 in vitro we demonstrate that RSK2 slightly represses activation of HSF1 in vivo	SEN:10021468	11189448
BEL:20042284	p(HGNC:HSP90AA1) increases r(HGNC:MYOD1)	Such a mechanism has been previously reported, where the activity of MyoD1 is enhanced in the presence of heat shock protein 90 ( 40 ).	SEN:10023278	10082537
BEL:20042298	p(HGNC:HSPA4) decreases r(HGNC:FOS)	HSP70 repressed Ras-induced c-fos transcription only in the presence of functional heat shock factor1 (HSF1).	SEN:10007026	11189444
BEL:20042312	p(HGNC:IAPP) increases r(HGNC:TNF)	Whereas treatment of THP-1 cells with human amylin for 30 min resulted in the expected increase in the level of TNF-alpha mRNA, nonfibrillar rat amylin had no effect on the mRNA for this cytokine ( Fig. 7 ).	SEN:10023288	10693932
BEL:20042314	p(HGNC:ICAM1) increases bp(GOBP:"cell adhesion")	These EC adhesion molecules include vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin, and P-selectin.6,7	SEN:10023290	10377075
BEL:20042320	p(HGNC:IFNA1) increases p(HGNC:ISG15)	IFN-alpha induces the expression of ubiquitin cross-reactive protein (ISG15) and two ubiquitin-conjugating enzymes, UbcH5 and UbcH8.	SEN:10023296	10866800
BEL:20042322	p(HGNC:IFNA1) increases p(HGNC:UBE2D1)	IFN-alpha induces the expression of ubiquitin cross-reactive protein (ISG15) and two ubiquitin-conjugating enzymes, UbcH5 and UbcH8.	SEN:10023296	10866800
BEL:20042324	p(HGNC:IFNA1) increases p(HGNC:UBE2L6)	IFN-alpha induces the expression of ubiquitin cross-reactive protein (ISG15) and two ubiquitin-conjugating enzymes, UbcH5 and UbcH8.	SEN:10023296	10866800
BEL:20042336	p(HGNC:IFNA1) decreases r(HGNC:FGF2)	IFN alpha and beta treatment leads to a down-regulation of bFGF expression independent of their antiproliferative effects, suggesting that IFN treatment might result in a reduction of angiogenesis in HNSCC.	SEN:10007032	10679908
BEL:20042348	p(HGNC:IFNA1) increases r(HGNC:SPP1)	Recently, Takahashi and colleagues ( 22 ) also demonstrated that OPN mRNA expression is increased by IFN-LPS-induced NO production in RAW 264.7 cells.	SEN:10023310	11145688
BEL:20042352	p(HGNC:IFNA1) increases r(HGNC:UBE2D1)	Northern-blot analysis showed that IFN-alpha rapidly enhances mRNA expression of UbcH5, UbcH6 and UbcH8 in T cells.	SEN:10023314	10866800
BEL:20042354	p(HGNC:IFNA1) increases r(HGNC:UBE2E1)	Northern-blot analysis showed that IFN-alpha rapidly enhances mRNA expression of UbcH5, UbcH6 and UbcH8 in T cells.	SEN:10023314	10866800
BEL:20042356	p(HGNC:IFNA1) increases r(HGNC:UBE2L6)	Northern-blot analysis showed that IFN-alpha rapidly enhances mRNA expression of UbcH5, UbcH6 and UbcH8 in T cells.	SEN:10023314	10866800
BEL:20042358	p(HGNC:IFNA1) increases tscript(p(HGNC:STAT4))	in contrast to the direct recruitment of Stat4 by the IL-12 receptor, Stat4 activation by the human IFN-alpha receptor occurs through indirect recruitment by intermediates involving Stat2	SEN:10023316	10644731
BEL:20042374	p(HGNC:IFNG) increases a(CHEBI:"nitric oxide")	Endogenously produced NO, by IFN-gamma pretreatment or exogenous nitrodonors, resulted in the upregulation of Fas receptor mRNA	SEN:10007036	10329044
BEL:20042380	p(HGNC:IFNG) increases cat(p(HGNC:NOS2))	These findings demonstrate that sensitization of human ovarian carcinoma cell lines to Fas-mediated apoptosis by IFN-gamma can be due, in part, to the induction of iNOS and the subsequent upregulation of Fas gene expression by reactive nitrogen intermediates	SEN:10018632	10329044
BEL:20042386	p(HGNC:IFNG) increases gtp(p(HGNC:RAP1A))	This results in the IFN-gamma-dependent activation of Rap1, a protein known to exhibit tumor suppressor activity and mediate growth inhibitory responses.	SEN:10007040	10657627
BEL:20042398	p(HGNC:IFNG) increases p(HGNC:CXCL10)	Western blot analysis for IP-10, Mig, and I-TAC extended Northern blot results to detection of all 3 proteins after IFN-g stimulation in ECs (Figure 7b).	SEN:10023324	10525042
BEL:20042400	p(HGNC:IFNG) increases p(HGNC:CXCL11)	Western blot analysis for IP-10, Mig, and I-TAC extended Northern blot results to detection of all 3 proteins after IFN-g stimulation in ECs (Figure 7b).	SEN:10023324	10525042
BEL:20042402	p(HGNC:IFNG) increases p(HGNC:CXCL9)	Western blot analysis for IP-10, Mig, and I-TAC extended Northern blot results to detection of all 3 proteins after IFN-g stimulation in ECs (Figure 7b).	SEN:10023324	10525042
BEL:20042418	p(HGNC:IFNG) decreases r(HGNC:CCL23)	In contrast, CD40 ligation and interferon-gamma treatment, while stimulating the production of the other chemokines, caused a pronounced reduction of MPIF-1 transcript and protein release	SEN:10023330	10380905
BEL:20042436	p(HGNC:IFNG) decreases r(HGNC:CDH1)	In contrast, IFN-gamma was found to suppress the E-cadherin expression and to be a strong antagonist of IL-4 by inhibiting the production of CD1a(+) cells.	SEN:10023334	10629465
BEL:20042438	p(HGNC:IFNG) increases r(HGNC:CDKN1A)	In this study, we show that the BRCA1 tumor suppressor acts in concert with STAT1 to differentially activate transcription of a subset of IFN-gamma target genes and mediates growth inhibition by this cytokine After IFN-gamma treatment, induction of the cyclin-dependent kinase inhibitor, p21WAF1, was synergistically activated by BRCA1	SEN:10022666	10792030
BEL:20042444	p(HGNC:IFNG) increases r(HGNC:CX3CL1)	We have found the enhanced expression of fractalkine in human umbilical vein endothelial cells stimulated with interferon-gamma (IFN-gamma).	SEN:10023340	11211312
BEL:20042446	p(HGNC:IFNG) increases r(HGNC:CX3CL1)	We found that tumor-necrosis factor alpha (TNF-alpha) and interferon-gamma (IFN-gamma) synergistically enhance the expression of fractalkine.	SEN:10007056	11311510
BEL:20042448	p(HGNC:IFNG) increases r(HGNC:CXCL10)	IFN-g (1,000 U/mL for 18 hours) induced IP-10 mRNA accumulation in ECs and MØ and, to a lesser extent, in SMCs.	SEN:10023342	10525042
BEL:20042454	p(HGNC:IFNG) decreases r(HGNC:ENPP2)	Recently, we described the decreased expression of ATX mRNA in cultured fibroblast-like synoviocytes (SFC) of patients with RA by interferon-gamma.	SEN:10007062	11168012
BEL:20042456	p(HGNC:IFNG) increases r(HGNC:EPCAM)	The cytokines IFN-alpha or IFN-gamma combined with MoAb 17-1A enhanced further slightly the expression of EpCAM	SEN:10007064	11167991
BEL:20042458	p(HGNC:IFNG) increases r(HGNC:FAS)	Fas is constitutively expressed by primary murine microglia at a low level and significantly up-regulated by TNF-alpha or IFN-gamma stimulation	SEN:10007066	10640741
BEL:20042460	p(HGNC:IFNG) increases r(HGNC:FAS)	IFN-gamma induced Fas expression of the cells without the activation of caspase8 or caspase3 during 16 hours of incubation, while deprivation of EPO induced expression of Fas and the activation of both caspase8 and caspase3	SEN:10004342	10845905
BEL:20042464	p(HGNC:IFNG) decreases r(HGNC:FCGR2B)	Fc gamma RIIb2, is expressed on circulating human monocytes, and when co-cross-linked with stimulatory Fc gamma R it down-regulates effector function. Fc gamma RIIb2 expression is increased by IL-4 and decreased by IFN-gamma	SEN:10023344	11123333
BEL:20042468	p(HGNC:IFNG) increases r(HGNC:GTPBP1)	The expression of GTPBP1 is enhanced by IFN-gamma in THP-1 cells, accompanying the expression of genes related to functions of macrophages, and this molecule is abundantly expressed in peritoneal macrophages elicited by stimulation with thioglycollate.	SEN:10023348	10938096
BEL:20042488	p(HGNC:IFNG) decreases r(HGNC:MSR1)	In contrast, gamma-IFN inhibits SR-A expression in mature macrophages as well as after prolonged gamma-IFN incubation of THP-1 monocyte	SEN:10007074	11348881
BEL:20042490	p(HGNC:IFNG) increases r(HGNC:MSR1)	we demonstrate gamma-interferon (gamma-IFN)-inducible scavenger receptor A (SR-A) mRNA expression during the early stages of THP-1 and blood monocyte differentiation	SEN:10007076	11348881
BEL:20042504	p(HGNC:IFNG) decreases r(HGNC:PLA2G7)	Additionally, IFN-gamma and LPS decreased the human PAF acetylhydrolase promoter activity by 35% and 50% respectively in monocyte-derived macrophages and various established macrophage cell lines ( 11 ).	SEN:10023360	10748027
BEL:20042510	p(HGNC:IFNG) increases r(HGNC:RARB)	STAT-1, IRF-1, and RAR-beta expression were enhanced by IFN-gamma and ATRA in combination, and to a greater degree in BALM-3 cells than in BALM-1 cells, suggesting that these IFN-gamma related genes were involved in the induction of apoptosis.	SEN:10023364	10863413
BEL:20042530	p(HGNC:IFNG) decreases r(HGNC:TNF)	However, IL-4 still induced significant inhibition of the production of TNF-alpha and IL-12 from STAT6 null macrophages that were stimulated with the more physiologically relevant combination of LPS and IFN-gamma.	SEN:10007088	10227996
BEL:20042534	p(HGNC:IFNG) increases r(HGNC:UBE2E2)	In contrast with IFN-alpha stimulation, IFN-gamma induced UbcH5 and UbcH8 mRNA expression with delayed kinetics (Fig. 6 ).	SEN:10023378	10866800
BEL:20042540	p(HGNC:IGF1) increases bp(GOBP:"cell differentiation")	insulin-like growth factor-1 enhances muscle cell differentiation, whereas bFGF inhibits the expression of the muscle-specific transcription factors MyoD and myogenin.	SEN:10023112	11279003
BEL:20042542	p(HGNC:IGF1) increases bp(GOBP:"cell migration")	The neurotrophin, nerve growth factor (NGF), and insulin-like growth factor 1 induce the migration but not the proliferation of smooth muscle cells, whereas PDGF-BB stimulates both responses.	SEN:10007092	10195934
BEL:20042544	p(HGNC:IGF1) increases bp(GOBP:"cell proliferation")	insulin-like growth factor-1 and basic fibroblast growth factor (bFGF) activate MAPK/Erk, and both growth factors promote myoblast proliferation	SEN:10023084	11279003
BEL:20042550	p(HGNC:IGF1) increases bp(GOBP:"MAPK cascade")	insulin-like growth factor-1 and basic fibroblast growth factor (bFGF) activate MAPK/Erk, and both growth factors promote myoblast proliferation	SEN:10023084	11279003
BEL:20042552	p(HGNC:IGF1) decreases bp(GOBP:"apoptotic process")	Since an inhibitor against SERCA induces apoptosis in some cell lines (76), the IRS/SERCA complex might be involved in an insulin and IGF-1-dependent antiapoptotic effect.	SEN:10023382	10194465
BEL:20042556	p(HGNC:IGF1) decreases cat(p(HGNC:HSD11B1))	Insulin-like growth factor I (IGF-I) caused a dose-dependent inhibition of 11betaHSD1 activity in sc [49.7 +/- 15.0% (IGF-I, 100 ng/ml]; P < 0.05 vs. control (100%)] and omental [71.6 +/- 7.5 (IGF-I, 100 ng/ml); P < 0.01 vs. control (100%)] stromal cells, but not in human hepatocytes [101.8 +/- 15.7% (IGF-I, 100 ng/ml); P = NS vs. control (100%)].	SEN:10023384	11316764
BEL:20042564	p(HGNC:IGF1) increases kin(p(HGNC:IGF1R))	ADAM 12-S has IGFBP-3 protease activity, and it may contribute to the IGFBP-3 protease activity present in pregnancy serum.	SEN:10004242	10849447
BEL:20042570	p(HGNC:IGF1) increases p(HGNC:AMBN)	Our results showed that after 6-days in culture; treatment with insulin, IGF-I and IGF-II increased the synthesis of amelogenin and ameloblastin.	SEN:10007098	11063034
BEL:20042572	p(HGNC:IGF1) increases p(HGNC:FOXO1,pmod(P,S,256))	there was little phosphorylation of wild-type GST±FKHR in unstimulated cells and, as expected, all three sites became maximally phosphorylated in 15±30 min when transfected cells were stimulated with IGF-1 (Figure 1A). at Thr-24, Ser-256 and Ser-319	SEN:10023388	11237865
BEL:20042574	p(HGNC:IGF1) increases p(HGNC:FOXO1,pmod(P,S,319))	there was little phosphorylation of wild-type GST±FKHR in unstimulated cells and, as expected, all three sites became maximally phosphorylated in 15±30 min when transfected cells were stimulated with IGF-1 (Figure 1A). at Thr-24, Ser-256 and Ser-319	SEN:10023388	11237865
BEL:20042576	p(HGNC:IGF1) increases p(HGNC:FOXO1,pmod(P,T,24))	there was little phosphorylation of wild-type GST±FKHR in unstimulated cells and, as expected, all three sites became maximally phosphorylated in 15±30 min when transfected cells were stimulated with IGF-1 (Figure 1A). at Thr-24, Ser-256 and Ser-319	SEN:10023388	11237865
BEL:20042578	p(HGNC:IGF1) increases p(HGNC:IRS1,pmod(P,Y))	In smooth muscle cells, blocking ligand occupancy of aVb3 integrin reduces IGF-1-induced IRS-1 phosphorylation	SEN:10020030	10194465
BEL:20042580	p(HGNC:IGF1) increases p(HGNC:IRS1,pmod(P,Y))	Insulin and IGF-1 stimulation also promote association between IRS-1 and aVb3 integrin (vitronectin receptor)	SEN:10017346	10194465
BEL:20042592	p(HGNC:IGF1) increases r(HGNC:BGLAP)	We have found that forskolin, cAMP, and PTH, as well as insulin-like growth factor I (IGF-I) and basic fibroblast growth factor, all were effective in activating the osteocalcin promoter.	SEN:10023396	10625638
BEL:20042610	p(HGNC:IGF1) increases r(HGNC:IL6)	Our previous study indicated that IGF-1 could significantly increase IL-6 mRNA expression and protein production in PHA- activated cord blood MNC ( 12 ).	SEN:10023408	10903734
BEL:20042620	p(HGNC:IGF1) increases r(HGNC:MYCN)	These results demonstrate that IGF-I promotion of both IGF-I-induced N-Myc expression and cell cycle progression occurs via the IGF-IR.	SEN:10023414	10646854
BEL:20042624	p(HGNC:IGF1) decreases r(HGNC:MYOG)	In the first 24 h, we find that IGF-I inhibits myogenin gene transcription by >80% but has no effect on myogenin mRNA stability.	SEN:10023418	10861859
BEL:20042638	p(HGNC:IGF1) decreases tscript(p(HGNC:FOXO1))	IGF-1 treatment decreased GST±FKHR-stimulated transcription by 60%and, in agreement with our previous results in HepG2 cells [18], this effect was blocked by an inhibitor of PI 3-kinase (LY 294002),	SEN:10016998	11237865
BEL:20042646	p(HGNC:IGF2) increases r(HGNC:EGR1)	Furthermore, we found that IGF-II injection into the mouse mammary gland induced Egr-1 protein expression in vivo ( Fig. 4 D ).	SEN:10023428	10606246
BEL:20042664	p(HGNC:IKBKB,pmod(P,S,177)) directlyIncreases kin(p(HGNC:IKBKB))	Phosphorylation of two closely spaced serine residues in this domain, at positions 176 and 180 in IKK? and positions 177 and 181 in IKK?, has been shown to be important for IKK kinase activity (22).	SEN:10023438	10779355
BEL:20042668	p(HGNC:IKBKB,pmod(P,S,181)) directlyIncreases kin(p(HGNC:IKBKB))	Phosphorylation of two closely spaced serine residues in this domain, at positions 176 and 180 in IKK? and positions 177 and 181 in IKK?, has been shown to be important for IKK kinase activity (22).	SEN:10023438	10779355
BEL:20042674	p(HGNC:IKBKG) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,32))	A third component of the large IkBalpha kinase complex has also been cloned and is referred to as NEMO (NF-kB essential modulator) ( [47]), IKKgamma ( [39]), IKKAP ( [31]), or FIP-3 ( [27]).	SEN:10021018	10882136
BEL:20042676	p(HGNC:IKBKG) directlyIncreases p(HGNC:NFKBIA,pmod(P,S,36))	A third component of the large IkBalpha kinase complex has also been cloned and is referred to as NEMO (NF-kB essential modulator) ( [47]), IKKgamma ( [39]), IKKAP ( [31]), or FIP-3 ( [27]).	SEN:10021018	10882136
BEL:20042680	p(HGNC:IL10) decreases bp(GOBP:"macrophage activation")	Interleukin (IL)-10 suppresses macrophage activation and down-regulates proinflammatory cytokine production	SEN:10007126	10806208
BEL:20042682	p(HGNC:IL10) increases complex(p(HGNC:FST),p(HGNC:INHBA),p(HGNC:INHBA))	IL-10 induction of FS secretion (and FS binding of activin A) restores the normal growth capabilities of HGPIN cultures	SEN:10007128	10339677
BEL:20042686	p(HGNC:IL10) decreases p(HGNC:CCL5)	Thus, RANTES produced by human airway muscle cells is stimulated by TNF-a plus IFN-g but inhibited by IL-4, IL-10, and IL-13 (12).	SEN:10020616	10072486
BEL:20042688	p(HGNC:IL10) decreases p(HGNC:CD80)	IL-10 also reduces the expression of major histocompatibility complex class II, B7.1/B7.2 antigens and clonal designator (CD)23 by these cells, thereby decreasing their accessory cell function (30). In contrast, IL-10 upregulates the release of another antiinflammatory cytokine, IL-1 receptor antagonist (30).	SEN:10023444	11029344
BEL:20042690	p(HGNC:IL10) decreases p(HGNC:CD86)	IL-10 also reduces the expression of major histocompatibility complex class II, B7.1/B7.2 antigens and clonal designator (CD)23 by these cells, thereby decreasing their accessory cell function (30). In contrast, IL-10 upregulates the release of another antiinflammatory cytokine, IL-1 receptor antagonist (30).	SEN:10023444	11029344
BEL:20042692	p(HGNC:IL10) decreases p(HGNC:FCER2)	IL-10 also reduces the expression of major histocompatibility complex class II, B7.1/B7.2 antigens and clonal designator (CD)23 by these cells, thereby decreasing their accessory cell function (30). In contrast, IL-10 upregulates the release of another antiinflammatory cytokine, IL-1 receptor antagonist (30).	SEN:10023444	11029344
BEL:20042694	p(HGNC:IL10) increases p(HGNC:IL1RN)	IL-10 also reduces the expression of major histocompatibility complex class II, B7.1/B7.2 antigens and clonal designator (CD)23 by these cells, thereby decreasing their accessory cell function (30). In contrast, IL-10 upregulates the release of another antiinflammatory cytokine, IL-1 receptor antagonist (30).	SEN:10023444	11029344
BEL:20042702	p(HGNC:IL10) increases r(HGNC:SOCS3)	IL-10 and LPS both induce expression of SOCS3 but not SOCS1, SOCS2 or CIS mRNA in monocytes and macrophages, respectively	SEN:10023450	10910765
BEL:20042706	p(HGNC:IL10) increases sec(p(HGNC:FST))	IL-10 induction of FS secretion (and FS binding of activin A) restores the normal growth capabilities of HGPIN cultures	SEN:10007128	10339677
BEL:20042708	p(HGNC:IL10) increases sec(p(HGNC:TIMP1))	IL-10 induced a dose-dependent increase in the level of TIMP-1 released by AM without affecting the release of MMP-9 by these cells (Figure 5). This cytokine also significantly reduced the production of TNF-alpha in a dose-dependent manner (Figure 5).	SEN:10023454	11029344
BEL:20042710	p(HGNC:IL10) decreases sec(p(HGNC:TNF))	IL-10 induced a dose-dependent increase in the level of TIMP-1 released by AM without affecting the release of MMP-9 by these cells (Figure 5). This cytokine also significantly reduced the production of TNF-alpha in a dose-dependent manner (Figure 5).	SEN:10023454	11029344
BEL:20042712	p(HGNC:IL10) decreases sec(p(HGNC:TNF))	Regulation of the macrophage protease/antiprotease balance by IL-10 is likely to be a complex phenomenon resulting from both direct and indirect effects, since we and others (30) demonstrated that this cytokine also decreases the release of proinflammatory mediators such as TNF-alpha	SEN:10023456	11029344
BEL:20042720	p(HGNC:IL11) increases r(HGNC:GFAP)	We have further identified, in the GFAP promoter region, a STAT3 site at which nucleotide substitutions almost completely abolished the IL-11-induced GFAP promoter activation.	SEN:10007132	10737606
BEL:20042724	p(HGNC:IL12RB1) increases tscript(p(HGNC:STAT4))	in contrast to the direct recruitment of Stat4 by the IL-12 receptor, Stat4 activation by the human IFN-alpha receptor occurs through indirect recruitment by intermediates involving Stat2	SEN:10023316	10644731
BEL:20042728	p(HGNC:IL13) decreases p(HGNC:CCL5)	Thus, RANTES produced by human airway muscle cells is stimulated by TNF-a plus IFN-g but inhibited by IL-4, IL-10, and IL-13 (12).	SEN:10020616	10072486
BEL:20042736	p(HGNC:IL13) increases p(HGNC:JAK1,pmod(P,Y))	Tyrosine phosphorylation of JAK1 was detected at a very low concentration of IL-4 (1 ng/ml), while IL-13 induced phosphorylation only at concentrations of 50 ng/ml and above, both in normal (Figure 2a,b, upper blots) and tumor lung myo®broblasts (Figure 2c,d, upper blots).	SEN:10023468	11127821
BEL:20042740	p(HGNC:IL13) increases p(HGNC:STAT3,pmod(P,Y))	the constitutive phosphorylation of STAT3 was observed repeatedly in tumor myo®bro- blasts (Figure 6f), but only occasionally in normal ®broblasts (Figure 6e). In the latter cells, IL-4 and IL- 13 induced (Figure 6d) or increased (Figure 6e) the tyrosine phosphorylation of STAT3, whereas in tumor myo®broblasts the two cytokines only caused an increase in the phosphorylation of STAT3 (Figure 6f).	SEN:10023470	11127821
BEL:20042742	p(HGNC:IL13) increases p(HGNC:STAT6,pmod(P,Y))	In normal lung ®broblasts and in tumor myo®broblasts, STAT6 was indeed phosphorylated on tyrosine residues in response to IL-4 and IL-13 (Figure 4a,b, upper blots).	SEN:10023472	11127821
BEL:20042744	p(HGNC:IL13) increases p(HGNC:TYK2,pmod(P,Y))	Finally, Tyk2, the fourth member of the JAK family, was found to be constitutively tyrosine-phosphorylated in these cells. However, IL-4 and IL-13 increased its phosphorylation level in lung myo®broblasts (Figure 2j), but not in normal cells, where both cytokines appear to slightly decrease its extent of phosphoryla- tion (Figure 2i).	SEN:10023474	11127821
BEL:20042756	p(HGNC:IL13) increases tloc(p(HGNC:STAT6),GOCCID:0005737,GOCCID:0005634)	IL-4 and IL-13 induced tyrosine phosphorylation of STAT6 (green cytoplasmic staining) but probably also nuclear translocation of some phosphorylated STAT6 mole- cules, accounting for the yellow signal detected. Similar results were obtained with normal lung ®broblasts.	SEN:10023486	11127821
BEL:20042762	p(HGNC:IL15) increases r(HGNC:BCL2)	These results indicate that IL-7 and IL-15 may increase bcl-2 expression in CTCL cells by the activation of c-myb and STAT factors.	SEN:10023492	11133738
BEL:20042776	p(HGNC:IL16) increases cat(p(HGNC:CD4))	Interleukin-16 (IL-16), a natural ligand for the CD4 receptor, has been found to modulate T-lymphocyte function and to inhibit human immunodeficiency virus type 1 (HIV-1) replication.	SEN:10023502	10447738
BEL:20042778	p(HGNC:IL16) decreases sec(p(HGNC:IFNG))	Therapy for 14 days with recombinant human IL-16 significantly inhibited the production of IFN-gamma, IL-1beta, and TNF-alpha in the synovium.	SEN:10023504	10201961
BEL:20042780	p(HGNC:IL16) decreases sec(p(HGNC:IL1B))	Therapy for 14 days with recombinant human IL-16 significantly inhibited the production of IFN-gamma, IL-1beta, and TNF-alpha in the synovium.	SEN:10023504	10201961
BEL:20042782	p(HGNC:IL16) decreases sec(p(HGNC:TNF))	Therapy for 14 days with recombinant human IL-16 significantly inhibited the production of IFN-gamma, IL-1beta, and TNF-alpha in the synovium.	SEN:10023504	10201961
BEL:20042784	p(HGNC:IL16) decreases surf(p(HGNC:CD4))	Recombinant IL-16 was found to up-regulate CD25 and CD80 but to down-regulate CD4 and CD86 surface expression in MDM cultures.	SEN:10007142	10447738
BEL:20042786	p(HGNC:IL16) increases surf(p(HGNC:CD80))	Recombinant IL-16 was found to up-regulate CD25 and CD80 but to down-regulate CD4 and CD86 surface expression in MDM cultures.	SEN:10007142	10447738
BEL:20042788	p(HGNC:IL16) increases surf(p(HGNC:IL2RA))	Recombinant IL-16 was found to up-regulate CD25 and CD80 but to down-regulate CD4 and CD86 surface expression in MDM cultures.	SEN:10007142	10447738
BEL:20042790	p(HGNC:IL17A) increases kin(p(HGNC:JAK1))	interleukin-17 induces time-dependent stimulation of tyrosine phosphorylation of JAK 1, 2 and 3, Tyk 2 and STAT 1, 2, 3 and 4 within 0.5 to 30 min	SEN:10023506	10448060
BEL:20042792	p(HGNC:IL17A) increases kin(p(HGNC:JAK2))	interleukin-17 induces time-dependent stimulation of tyrosine phosphorylation of JAK 1, 2 and 3, Tyk 2 and STAT 1, 2, 3 and 4 within 0.5 to 30 min	SEN:10023506	10448060
BEL:20042794	p(HGNC:IL17A) increases kin(p(HGNC:JAK3))	interleukin-17 induces time-dependent stimulation of tyrosine phosphorylation of JAK 1, 2 and 3, Tyk 2 and STAT 1, 2, 3 and 4 within 0.5 to 30 min	SEN:10023506	10448060
BEL:20042806	p(HGNC:IL17A) increases surf(p(HGNC:KITLG))	IL-17 induces G-CSF release and enhances cell surface SCF expression on murine BM stroma cells in vitro.	SEN:10023510	10779785
BEL:20042812	p(HGNC:IL18) increases kin(p(HGNC:MAPK1))	Stimulation by IL-18 strongly enhanced tyrosine phosphorylation of STAT3 and of the mitogen-activated protein kinases (MAPK) p44erk-1and p42erk-2.	SEN:10002472	10903731
BEL:20042814	p(HGNC:IL18) increases kin(p(HGNC:MAPK3))	Stimulation by IL-18 strongly enhanced tyrosine phosphorylation of STAT3 and of the mitogen-activated protein kinases (MAPK) p44erk-1and p42erk-2.	SEN:10002472	10903731
BEL:20042816	p(HGNC:IL18) increases kin(p(HGNC:MAPK8))	Interleukin (IL)-18 is functionally similar to IL-12 in mediating T helper cell type 1 (Th1) response and natural killer (NK) cell activity but is related to IL-1 in protein structure and signaling, including recruitment of IL-1 receptor-associated kinase (IRAK) to the receptor and activation of c-Jun NH2-terminal kinase (JNK) and nuclear factor (NF)-kappaB.	SEN:10007150	10190904
BEL:20042822	p(HGNC:IL18) increases p(HGNC:IFNG)	The suppressive effect of IL-18 on PGE(2) production was mediated by interferon (IFN)-gamma because anti-human IFN-gamma-antibody prevented IL-18-induced reduction in PGE(2).	SEN:10018572	10681439
BEL:20042826	p(HGNC:IL18) increases r(HGNC:GADD45B)	GADD45 beta, which activates mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase kinase 4 (MEKK4), was induced by IL-18 and augmented by IL-12.	SEN:10023158	11175814
BEL:20042828	p(HGNC:IL18) increases r(HGNC:IFNG)	Interleukin-12 (IL-12) and IL-18 induce synergistic transcription of interferon gamma (IFN-gamma) that is T cell receptor (TCR)-independent, not inhibited by cyclosporin A and requires new protein synthesis.	SEN:10023512	11175814
BEL:20042832	p(HGNC:IL18) increases r(HGNC:VCAM1)	Exogenous IL-18 added to HSE also increased the number of adhering melanoma cells; however, this was not affected by IL-1 receptor blockade or TNF neutralization but rather by anti-VCAM-1. The IL-18 cytokine increases expression of VCAM-1 and the adherence of melanoma cells.	SEN:10023514	10639148
BEL:20042836	p(HGNC:IL18) increases tscript(p(HGNC:STAT3))	Stimulation by IL-18 strongly enhanced tyrosine phosphorylation of STAT3 and of the mitogen-activated protein kinases (MAPK) p44erk-1and p42erk-2.	SEN:10002472	10903731
BEL:20042842	p(HGNC:IL1A) increases complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA))	Moreover, interleukin (IL)-1alpha and tumor necrosis factor (TNF)-alpha induce the alpha -receptor in osteoblast cultures from fetal rat bone (75, 468).	SEN:10023518	10508235
BEL:20042844	p(HGNC:IL1A) increases kin(p(HGNC:MAP3K5))	Apoptosis signal-regulating kinase 1 (ASK 1) is a mitogen-activated protein (MAP) kinase kinase kinase (MAPKKK) that is activated by TNF and IL-1	SEN:10023520	10921242
BEL:20042846	p(HGNC:IL1A) increases kin(p(HGNC:MAP3K7))	In this study, we determined the role of PP2Cbeta-1, a major isoform of mammalian PP2C, in the TAK1 signaling pathway, a stress-activated protein kinase cascade that is activated by interleukin-1, transforming growth factor-beta, or stress.	SEN:10018224	11104763
BEL:20042848	p(HGNC:IL1A) increases p(HGNC:CX3CL1)	It was first identified as a membrane protein in endothelial cells activated with IL-1 or TNF-alpha.	SEN:10007158	11211312
BEL:20042850	p(HGNC:IL1A) decreases r(HGNC:APOC3)	Pro-inflammatory cytokines such as TNF-alpha and IL-1 repress, and TGF-beta stimulates the apoCIII promoter activity	SEN:10023522	11229886
BEL:20042854	p(HGNC:IL1A) increases r(HGNC:CD44)	Furthermore, IL-1alpha increased expression of a reporter gene under the control of the CD44 promoter (up to -1.75 kb).	SEN:10023524	10202038
BEL:20042862	p(HGNC:IL1A) increases r(HGNC:IL1RN)	To study the transcriptional regulation of icIL-1Ra expression induced by IL-1alpha, we functionally characterized 4.5 kb of the 5'-flanking region of the human icIL-1Ra gene.	SEN:10023528	11342635
BEL:20042866	p(HGNC:IL1A) increases r(HGNC:MMP14)	Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA (Figs. 1–4).	SEN:10023530	10207013
BEL:20042868	p(HGNC:IL1A) increases r(HGNC:MMP14)	Tumor necrosis factor-alpha (TNF-alpha ), interleukin-1alpha, or interleukin-1beta caused a time-dependent increase in the steady-state MT1-MMP mRNA levels within 4 h of exposure, peaking about 4-fold by 6 h, and remaining elevated for 12 h.	SEN:10007166	10207013
BEL:20042872	p(HGNC:IL1A) increases surf(p(HGNC:CD44))	Here we show primary human monocytes rather than lymphocytes express CD44 HSPGs, but only following in vitro differentiation to macrophages or activation with the proinflammatory cytokine interleukin-1alpha or bacterial lipopolysaccharide.	SEN:10007170	10713114
BEL:20042882	p(HGNC:IL1B) increases cat(p(HGNC:HSD11B1))	Treatment with interleukin-1beta induced 11betaHSD1 activity and expression in sc and omental ASC in a time- and dose-dependent manner.	SEN:10007174	11316764
BEL:20042890	p(HGNC:IL1B) increases cat(p(HGNC:MMP9))	IL-1beta significantly increased the release of MMP-9 but did not affect TIMP-1 in smokers (Figure 2), and did not significantly alter the levels of these two products in nonsmokers.	SEN:10023534	11029344
BEL:20042892	p(HGNC:IL1B) increases kin(p(HGNC:MAP3K7))	In this study, we determined the role of PP2Cbeta-1, a major isoform of mammalian PP2C, in the TAK1 signaling pathway, a stress-activated protein kinase cascade that is activated by interleukin-1, transforming growth factor-beta, or stress.	SEN:10018224	11104763
BEL:20042896	p(HGNC:IL1B) increases p(HGNC:CSF2)	GM-CSF was detectable in the supernatant only 6 h after stimulation and accumulated over the subsequent time points (Figure 2A); intracellular levels reached a maximum 2 to 6 h after stimulation (Figure 2B)	SEN:10023536	10783130
BEL:20042898	p(HGNC:IL1B) increases p(HGNC:CXCL5)	Progesterone, lipopolysaccharide, tumour necrosis factor-alpha, and interleukin-1beta significantly stimulated the expression of ENA-78 by ESC. ....The expression of ENA-78 was also detected in cyclic endometrium by immunohistochemistry.	SEN:10015920	11331668
BEL:20042900	p(HGNC:IL1B) increases p(HGNC:CXCR4)	CXCR4 protein expression was also enhanced upon treatment with TNF-alpha and IL-1beta (2- to 3-fold).	SEN:10007176	11160334
BEL:20042902	p(HGNC:IL1B) increases p(HGNC:F3)	Tissue factor (TF) can be induced in monocytes by external signals such as growth factors, inflammatory cytokines (interleukin [IL]-1b and tumor necrosis factor [TNF]-a), oxidized LDLs, and endotoxin. 2	SEN:10016854	11208678
BEL:20042912	p(HGNC:IL1B) increases p(HGNC:PTGS2)	Airway epithelial cells respond to proinflammatory cytokines, such as IL-1b, by induction of COX-2 and release of PGE2 (6).	SEN:10023538	10946303
BEL:20042914	p(HGNC:IL1B) increases p(HGNC:VEGFA)	VEGF production induced by IL-1beta, TNF-alpha, and TGF-beta was further increased when CD40L+ L cells were coincubated, by factors of 5.9, 5.5, and 9.6, respectively, which indicated that these cytokines had an additive effect on VEGF production driven by CD40L.	SEN:10023540	10799861
BEL:20042916	p(HGNC:IL1B) increases r(HGNC:ADAM15)	The mRNA levels for ADAM-15 were elevated in human monolayer chondrocytes exposed to IL-1 or retinoic acid, while transcripts levels for TNF-alpha converting enzyme were increased in response to retinoic acid.	SEN:10023542	10429942
BEL:20042918	p(HGNC:IL1B) decreases r(HGNC:ADAM9)	In contrast, ADAM-9 mRNA levels were decreased in human monolayer chondrocytes exposed to IL-1 or retinoic acid.	SEN:10007180	10429942
BEL:20042926	p(HGNC:IL1B) increases r(HGNC:CEBPD)	Interleukin-1beta increased the levels of C/EBPdelta mRNA as soon as 2 h and up to 24 h without affecting those of C/EBPbeta. Higher amounts of C/EBPdelta proteins correlate with the stimulation of C/EBPdelta mRNA.	SEN:10007186	10791956
BEL:20042928	p(HGNC:IL1B) increases r(HGNC:CEBPD)	We have previously shown that IL-1beta stimulates expression of the C/EBPdelta gene without affecting that of the C/EBPeta gene [ 25 ].	SEN:10023546	10791956
BEL:20042938	p(HGNC:IL1B) increases r(HGNC:CSF2)	IL-4 was shown to interfere with the transcriptional upregulation of IL-2 (19) as well as the IL-1 b–induced transcriptional upregulation of macrophage (CSF) from primary human monocytes (20).	SEN:10023554	10783130
BEL:20042940	p(HGNC:IL1B) increases r(HGNC:CSF2)	IL-1?–stimulated GM-CSF mRNA was expressed at higher levels in smokers than in nonsmokers and was enhanced following combined IL-1?/TSA treatment in the nonsmokers but not smokers.	SEN:10016364	11292684
BEL:20042944	p(HGNC:IL1B) increases r(HGNC:CXCL1)	In the whole ovarian dispersate culture, FSH, hCG, IL-1beta, and TNFalpha stimulated the production of CINC/gro protein in a dose-dependent manner.	SEN:10007192	10859250
BEL:20042946	p(HGNC:IL1B) increases r(HGNC:CXCR4)	Enhancement of CXC chemokine receptor 4 (CXCR4) mRNA expression was observed upon treatment with the cytokines TNF-alpha and IL-1beta.	SEN:10007194	11160334
BEL:20042948	p(HGNC:IL1B) increases r(HGNC:CXCR4)	IL-1beta stimulation also enhanced CXCR4 expression (28.8% for CRT-J and 41.6% for U87-MG cells).	SEN:10023556	11160334
BEL:20042954	p(HGNC:IL1B) decreases r(HGNC:ENPP2)	Both the ATX mRNA amount and the 5'-nucleotide phosphodiesterase (PDE) activity of SFC lysate were reduced after treatment of SFC with the cytokines IL-1beta or IL-4.	SEN:10007196	11168012
BEL:20042958	p(HGNC:IL1B) increases r(HGNC:F3)	Incubation of monocytes with LPS or IL-1b resulted in a 10- and 5-fold increase of TF activity, respectively.	SEN:10023564	11208678
BEL:20042964	p(HGNC:IL1B) decreases r(HGNC:HPGD)	IL-1beta increased PGHS-2 mRNA and PGE2 output from villous and chorion trophoblasts and decreased PGDH mRNA	SEN:10007198	10599732
BEL:20042974	p(HGNC:IL1B) increases r(HGNC:IL8)	Using a naturally occurring compound found in the colon of vertebrates, butyrate, we provide evidence in an intestinal cell line that alteration of IkappaB-beta expression can modulate the transcriptional activation of the interleukin-8 (IL-8) gene by preventing the nuclear translocation of NF-kappaB proteins......Expression of IkB-b in Caco-2 cells inhibits transcriptional activation of the IL-8 promoter by IL-1b	SEN:10023574	10614789
BEL:20042982	p(HGNC:IL1B) increases r(HGNC:MMP14)	Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA (Figs. 1–4).	SEN:10023530	10207013
BEL:20042984	p(HGNC:IL1B) increases r(HGNC:MMP14)	Tumor necrosis factor-alpha (TNF-alpha ), interleukin-1alpha, or interleukin-1beta caused a time-dependent increase in the steady-state MT1-MMP mRNA levels within 4 h of exposure, peaking about 4-fold by 6 h, and remaining elevated for 12 h.	SEN:10007166	10207013
BEL:20042986	p(HGNC:IL1B) increases r(HGNC:MMP3)	For the MMPs, IL-1 treatment resulted in an approximately two to threefold increase in human and porcine MMP-3 and MMP-13 mRNAs, while retinoic acid treatment caused a statistically significant increase in human MMP-3 mRNA levels, but no significant change in transcript levels for porcine MMP-3 nor human or porcine MMP-13.	SEN:10023580	10429942
BEL:20042992	p(HGNC:IL1B) decreases r(HGNC:OXTR)	Contrary to the hypothesis, both IL-1beta and IL-6 treatment resulted in a significant decrease in OT receptor messenger RNA measured by ribonuclease protection analysis.	SEN:10023582	11250916
BEL:20042996	p(HGNC:IL1B) increases r(HGNC:PLA2G10)	In arterial smooth muscle cells, IL-1beta- induced type II-sPLA 2 gene expression can therefore be expected to involve either the ceramide pathway or the NFkappaB pathway.	SEN:10023584	10438477
BEL:20042998	p(HGNC:IL1B) increases r(HGNC:PLA2G2A)	Transfection experiments showed that interleukin-1beta stimulates the phospholipase A(2) [-1614; +20] promoter activity by 6-7-fold and that the [-210; -176]	SEN:10023586	10791956
BEL:20043006	p(HGNC:IL1B) increases r(HGNC:PTGS2)	IL-1beta increased PGHS-2 mRNA and PGE2 output from villous and chorion trophoblasts and decreased PGDH mRNA	SEN:10007198	10599732
BEL:20043026	p(HGNC:IL1B) increases r(HGNC:VCAM1)	Proinflammatory cytokines, including IL-1beta and tumor necrosis factor-alpha (TNF-alpha), promote cancer cell adhesion and liver metastases by up-regulating the expression of vascular cell adhesion molecule-1 (VCAM-1)	SEN:10007214	10639148
BEL:20043030	p(HGNC:IL1B) increases sec(p(HGNC:C3))	The addition of interleukin (IL)-1beta or tumor necrosis factor (TNF)-alpha induced a dose- and time-dependent increase in C3 and factor B secretion.	SEN:10007216	10719060
BEL:20043032	p(HGNC:IL1B) increases sec(p(HGNC:CFB))	The addition of interleukin (IL)-1beta or tumor necrosis factor (TNF)-alpha induced a dose- and time-dependent increase in C3 and factor B secretion.	SEN:10007216	10719060
BEL:20043034	p(HGNC:IL1B) increases sec(p(HGNC:CSF2))	IL-1b stimulation of A549 cells released GM-CSF, whereas levels were undetectable without stimulation. Coincubation with the transcriptional blocker actinomycin D and the translational blocker cycloheximide totally inhibited GM-CSF production after IL-1b stimulation (Figure 1A),	SEN:10015584	10783130
BEL:20043036	p(HGNC:IL1B) increases sec(p(HGNC:CSF2))	we examined the effect of oxidant stress (100 ?M H2O2) on GMCSF release and inhibition by dexamethasone in A549 cells (Fig. 6a). IL-1? caused a significant increase in GM-CSF (23.0 ± 4.4 versus 714 ± 93.6 pg/ml) that was inhibited 96% by dexamethasone (1 ?M) (Fig. 6a).	SEN:10015618	11292684
BEL:20043038	p(HGNC:IL1B) increases sec(p(HGNC:TNF))	In smokers and in controls, LPS increased the release of both TNF-alpha and IL-10 (Figure 4), with the increase in TNF-alpha being greater than the increase in IL-10. IL-1beta had no effect on TNF-alpha and IL-10 levels in smokers, whereas in nonsmokers this cytokine increased the production of TNF-alpha but not that of IL-10, although TNF-alpha levels remained very low.	SEN:10016016	11029344
BEL:20043050	p(HGNC:IL1R1) decreases r(HGNC:CD44)	In addition, basal CD44 standard expression was also reduced in the presence of IL-1Ra (Fig. 1 B , lane 2 compared with lane 1 ), indicating that constitutive expression was likely to be due to endogenous expression of IL-1.	SEN:10023606	10202038
BEL:20043062	p(HGNC:IL22) increases r(HGNC:HP)	IL-TIF stimulation of HepG2 human hepatoma cells up-regulated the production of acute phase reactants such as serum amyloid A, alpha1-antichymotrypsin, and haptoglobin.	SEN:10023610	10954742
BEL:20043066	p(HGNC:IL2) increases bp(GOBP:"natural killer cell activation")	The mechanism of antitumor efficacy of IL-2 is closely related to its ability to expand and activate cytotoxic lymphocytes of the natural killer (NK)- and thymic (T)-cell subsets that express IL-2 receptors (IL-2R).	SEN:10007224	10768598
BEL:20043068	p(HGNC:IL2) increases cat(p(HGNC:IL2RB))	the association of lyn with IL-2Rbeta was markedly elevated by IL-2 stimulation. Furthermore the activity of lyn kinase, evaluated by an in vitro kinase assay with enolase as a substrate, increased following IL-2 stimulation.	SEN:10001026	11131153
BEL:20043076	p(HGNC:IL2RA) increases bp(GOBP:"T cell activation")	The results reported in Figure 1 demonstrated that although they were activated, as shown by the expression of the IL-2R a-chain and CD40L (data not shown), peripheral T lymphocytes did not express IL-3.	SEN:10022752	11157721
BEL:20043082	p(HGNC:IL2) increases r(HGNC:CCR3)	We have observed a novel phenomenon that IL-2 and IL-4 induce the expression of CCR3 on T lymphocytes	SEN:10007226	10201960
BEL:20043084	p(HGNC:IL2) increases r(HGNC:CCR3)	We have observed a novel phenomenon that IL-2 and IL-4 induce the expression of CCR3 on T lymphocytes.	SEN:10007228	10201960
BEL:20043094	p(HGNC:IL2) increases r(HGNC:GADD45G)	Gadd45gamma, a family member of the growth arrest and DNA damage-inducible gene family 45 (Gadd45), is strongly induced by interleukin-2 (IL-2) in peripheral T cells.	SEN:10023626	11287618
BEL:20043112	p(HGNC:IL3) increases bp(GOBP:chemotaxis)	As shown in Figure 5A, IL-3 induced chemotaxis of primary SMCs, and preincubation with an anti-IL-3 antiserum almost completely abolished this effect.	SEN:10023632	11157721
BEL:20043124	p(HGNC:IL3) increases r(HGNC:CISH)	Furthermore, the induction of CIS mRNA in response to IL-3 is inhibited in cell lines expressing a dominant negative version of STAT5 (Mui et al., 1996) and CIS expression in mouse ovary is eliminated in mice lacking both STAT5a and STAT5b	SEN:10023634	10910765
BEL:20043126	p(HGNC:IL3) increases r(HGNC:GADD45G)	ResnetDB sentence: Gadd45gamma expression is induced by several cytokines, including IL-3, IL-6, and GM-CSF (20).	SEN:10022858	11287618
BEL:20043128	p(HGNC:IL3) increases r(HGNC:VEGFA)	Finally, IL-3 was found to stimulate vascular endothelial growth factor (VEGF) gene transcription.	SEN:10007242	11157721
BEL:20043130	p(HGNC:IL3) increases tscript(p(HGNC:IL3RA))	Moreover, in experiments that are not presented, we found that 24 hours of treatment with IL-3 (20 ng/mL) was able to upregulate '60% of the level of the receptor transcript in SMCs.	SEN:10023636	11157721
BEL:20043138	p(HGNC:IL4) increases p(HGNC:CCL11)	Eotaxin expression by human dermal fibroblasts (13) and lung epithelial cells (14) was stimulated by IFN-g in the presence of IL-1 and TNF-a, while eotaxin produced by human fibroblasts was induced by IL-4 (15).	SEN:10020614	10072486
BEL:20043140	p(HGNC:IL4) decreases p(HGNC:CCL5)	Thus, RANTES produced by human airway muscle cells is stimulated by TNF-a plus IFN-g but inhibited by IL-4, IL-10, and IL-13 (12).	SEN:10020616	10072486
BEL:20043146	p(HGNC:IL4) increases p(HGNC:JAK1,pmod(P,Y))	Tyrosine phosphorylation of JAK1 was detected at a very low concentration of IL-4 (1 ng/ml), while IL-13 induced phosphorylation only at concentrations of 50 ng/ml and above, both in normal (Figure 2a,b, upper blots) and tumor lung myo®broblasts (Figure 2c,d, upper blots).	SEN:10023468	11127821
BEL:20043148	p(HGNC:IL4) increases p(HGNC:STAT3,pmod(P,Y))	the constitutive phosphorylation of STAT3 was observed repeatedly in tumor myo®bro- blasts (Figure 6f), but only occasionally in normal ®broblasts (Figure 6e). In the latter cells, IL-4 and IL- 13 induced (Figure 6d) or increased (Figure 6e) the tyrosine phosphorylation of STAT3, whereas in tumor myo®broblasts the two cytokines only caused an increase in the phosphorylation of STAT3 (Figure 6f).	SEN:10023470	11127821
BEL:20043150	p(HGNC:IL4) increases p(HGNC:STAT6,pmod(P,Y))	In normal lung ®broblasts and in tumor myo®broblasts, STAT6 was indeed phosphorylated on tyrosine residues in response to IL-4 and IL-13 (Figure 4a,b, upper blots).	SEN:10023472	11127821
BEL:20043152	p(HGNC:IL4) increases p(HGNC:TYK2,pmod(P,Y))	Finally, Tyk2, the fourth member of the JAK family, was found to be constitutively tyrosine-phosphorylated in these cells. However, IL-4 and IL-13 increased its phosphorylation level in lung myo®broblasts (Figure 2j), but not in normal cells, where both cytokines appear to slightly decrease its extent of phosphoryla- tion (Figure 2i).	SEN:10023474	11127821
BEL:20043156	p(HGNC:IL4) increases r(HGNC:ALOX12)	Interleukin (IL)-4 specifically induces 12/15-lipoxygenase messenger RNA, protein, and enzymatic activity in primary cultures of human monocytes and airway epithelial cells	SEN:10007244	10657944
BEL:20043158	p(HGNC:IL4) increases r(HGNC:ALOX15)	Interleukin (IL)-4 specifically induces 12/15-lipoxygenase messenger RNA, protein, and enzymatic activity in primary cultures of human monocytes and airway epithelial cells	SEN:10007244	10657944
BEL:20043170	p(HGNC:IL4) decreases r(HGNC:CCL2)	IL-4 inhibited the BCG-mediated MIP-1alpha and MCP-1 expression in a concentration-dependent manner.	SEN:10023644	10228140
BEL:20043172	p(HGNC:IL4) decreases r(HGNC:CCL3)	IL-4 inhibited the BCG-mediated MIP-1alpha and MCP-1 expression in a concentration-dependent manner.	SEN:10023644	10228140
BEL:20043174	p(HGNC:IL4) increases r(HGNC:CCR3)	We have observed a novel phenomenon that IL-2 and IL-4 induce the expression of CCR3 on T lymphocytes	SEN:10007226	10201960
BEL:20043176	p(HGNC:IL4) increases r(HGNC:CCR3)	We have observed a novel phenomenon that IL-2 and IL-4 induce the expression of CCR3 on T lymphocytes.	SEN:10007228	10201960
BEL:20043178	p(HGNC:IL4) decreases r(HGNC:CD14)	In vivo exposure to GM-CSF and IL-4 down-regulates the expression of CD14 and up-regulates the expression of HLA-DR and CD11c in a dose-responsive manner.	SEN:10023646	10766183
BEL:20043182	p(HGNC:IL4) decreases r(HGNC:CD40)	IL-4 suppresses IFN-gamma-induced CD40 gene expression in both macrophages and microglia, and such inhibition is dependent on the activation of STAT-6.	SEN:10007250	11086058
BEL:20043184	p(HGNC:IL4) increases r(HGNC:CD86)	IL-4 also up-regulates expression of class II, CD40, B7.1, and B7.2 (42) , all of which promote an enhanced capacity for antigen presentation to T cells.	SEN:10023648	11289140
BEL:20043186	p(HGNC:IL4) increases r(HGNC:CDH1)	IL-4 strongly enhanced the generation of CD1a(+) LC/DC and also up-regulated the expression of the skin-homing structures E-cadherin and cutaneous lymphocyte antigen.	SEN:10007252	10629465
BEL:20043192	p(HGNC:IL4) decreases r(HGNC:DPT)	Transforming growth factor-beta1 increased dermatopontin mRNA and protein levels, while interleukin-4 reduced dermatopontin expression.	SEN:10023652	10233760
BEL:20043194	p(HGNC:IL4) decreases r(HGNC:ENPP2)	Both the ATX mRNA amount and the 5'-nucleotide phosphodiesterase (PDE) activity of SFC lysate were reduced after treatment of SFC with the cytokines IL-1beta or IL-4.	SEN:10007196	11168012
BEL:20043196	p(HGNC:IL4) decreases r(HGNC:EPCAM)	We found that only IFN-alpha increased significantly whereas IL-4 decreased both EpCAM and LewisY expression. IFN-gamma significantly increased LewisY expression only	SEN:10023654	11167991
BEL:20043200	p(HGNC:IL4) increases r(HGNC:FCGR2B)	Fc gamma RIIb2, is expressed on circulating human monocytes, and when co-cross-linked with stimulatory Fc gamma R it down-regulates effector function. Fc gamma RIIb2 expression is increased by IL-4 and decreased by IFN-gamma	SEN:10023344	11123333
BEL:20043202	p(HGNC:IL4) increases r(HGNC:"HLA-DOA")	IL-4 strongly enhanced the generation of CD1a(+) LC/DC and also up-regulated the expression of the skin-homing structures E-cadherin and cutaneous lymphocyte antigen.	SEN:10007252	10629465
BEL:20043210	p(HGNC:IL4) increases r(HGNC:ITGAX)	In vivo exposure to GM-CSF and IL-4 down-regulates the expression of CD14 and up-regulates the expression of HLA-DR and CD11c in a dose-responsive manner.	SEN:10023646	10766183
BEL:20043216	p(HGNC:IL4) increases r(HGNC:PPARG)	Similarly, in murine monocytes IL-4 induces expression of the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma) and a homologous 12/15-lipoxygenase.	SEN:10023660	10657944
BEL:20043230	p(HGNC:IL4) increases sec(p(HGNC:CCL23))	## from full text ## However, monocyte-derived DC constitutively release the chemokine. Addition of IL-4 to the monocyte cultures is essential for MPIF-1 production.	SEN:10023664	10380905
BEL:20043232	p(HGNC:IL4) increases tloc(p(HGNC:STAT6),GOCCID:0005737,GOCCID:0005634)	IL-4 and IL-13 induced tyrosine phosphorylation of STAT6 (green cytoplasmic staining) but probably also nuclear translocation of some phosphorylated STAT6 mole- cules, accounting for the yellow signal detected. Similar results were obtained with normal lung ®broblasts.	SEN:10023486	11127821
BEL:20043238	p(HGNC:IL5) increases r(HGNC:CD69)	Because HES eosinophils contain abundant cytosolic phospholipase A2 (cPLA2) and 5-lipoxygenase (5-LO), we examined the roles of several enzymes involved in the metabolism of arachidonic acid in the PAF- or IL-5-induced CD69 expression on eosinophils.	SEN:10007266	11200053
BEL:20043252	p(HGNC:IL6) increases bp(GOBP:"cell migration")	The IL-6-type cytokines, IL-6 and oncostatin M, simultaneously inhibited cell proliferation and increased cell migration	SEN:10023672	11196191
BEL:20043254	p(HGNC:IL6) increases bp(GOBP:"cell proliferation")	Overexpression of mutant FGFR3 resulted in IL-6 independence, decreased apoptosis, and an enhanced proliferative response to IL-6.	SEN:10021216	10648414
BEL:20043256	p(HGNC:IL6) decreases bp(GOBP:"cell proliferation")	The IL-6-type cytokines, IL-6 and oncostatin M, simultaneously inhibited cell proliferation and increased cell migration	SEN:10023672	11196191
BEL:20043268	p(HGNC:IL6) increases complex(p(HGNC:PRKCD),p(HGNC:STAT3))	Here, we report that Stat3 was specifically associated with PKC delta in vivo in an IL-6-dependent manner in several cell types.	SEN:10007272	10446219
BEL:20043270	p(HGNC:IL6) increases complex(p(HGNC:PTK2B),p(HGNC:PTPN11))	We show that IL-6 triggers selective activation of SHP2 and its association with RAFTK in Dex-treated MM cells.	SEN:10007274	10880513
BEL:20043272	p(HGNC:IL6) increases complex(p(HGNC:STAT3),p(HGNC:PDIA3))	In-gel tryptic fragmentation and mass spectroscopy identified the major IL-6-dependent STAT3-co-shifted p60 protein as the chaperone GRP58/ER-60/ERp57.	SEN:10023680	10464281
BEL:20043276	p(HGNC:IL6) increases kin(p(HGNC:JAK1))	In T47D cells, IL-6 stimulated the activation of Janus-activated kinase 1 tyrosine kinase and signal transducers and activators of transcription (STAT) 1 and STAT3 transcription factors. Expression of dominant negative STAT3 in the cells strongly reduced IL-6-mediated growth inhibition but did not prevent IL-6-induced cell migration.	SEN:10002576	11196191
BEL:20043280	p(HGNC:IL6) increases p(HGNC:MMP2)	Moreover, in human lymphoid cell lines of B- and T-cell origin (Raji, Jurkat, and NC-37), IL-6 stimulated production of MMP-9 and MMP-2 but not TIMP-1. In the Matrigel invasion assay IL-6 significantly upregulated transmigration of Raji and Jurkat cells, which in turn was inhibited by recombinant human TIMP-1 and anti-MMP-9 and MMP-2 antibodies.	SEN:10007276	10477738
BEL:20043282	p(HGNC:IL6) increases p(HGNC:MMP9)	Moreover, in human lymphoid cell lines of B- and T-cell origin (Raji, Jurkat, and NC-37), IL-6 stimulated production of MMP-9 and MMP-2 but not TIMP-1. In the Matrigel invasion assay IL-6 significantly upregulated transmigration of Raji and Jurkat cells, which in turn was inhibited by recombinant human TIMP-1 and anti-MMP-9 and MMP-2 antibodies.	SEN:10007276	10477738
BEL:20043288	p(HGNC:IL6) increases phos(p(HGNC:PTPN11))	We and others have shown that IL-6 induces growth in MM cells via the MAPK pathway, which includes activation of protein-tyrosine phosphatase SHP2 (16, 28)	SEN:10023686	10880513
BEL:20043298	p(HGNC:IL6) increases r(HGNC:CD38)	Furthermore, the anti-CD38 agonist antibody expectedly inhibited bone resorption in the pit assay and elevated interleukin-6 (IL-6) secretion. IL-6, in turn, enhanced CD38 mRNA expression	SEN:10022748	10477767
BEL:20043310	p(HGNC:IL6) increases r(HGNC:ENO1)	Northern blot analysis documented that two transcription factor genes chosen for further study, c-myc promoter-binding protein (MBP-1) and X-box binding protein 1 (XBP-1), were up-regulated in U266 cells about 3-fold relative to the cell cycle-dependent beta-actin gene 12 h after IL-6 treatment.	SEN:10023694	10375612
BEL:20043318	p(HGNC:IL6) increases r(HGNC:GADD45G)	ResnetDB sentence: Gadd45gamma expression is induced by several cytokines, including IL-3, IL-6, and GM-CSF (20).	SEN:10022858	11287618
BEL:20043320	p(HGNC:IL6) increases r(HGNC:GFAP)	Activation of the GFAP gene promoter by IL-11 and related cytokines Previous studies have shown that stimulation of gp130 molecules on neuroepithelial cells by LIF, CNTF, or the IL-6/sIL-6R complex induces activation of the GFAP gene promoter (Bonni et al., 1997 ; Nakashima et al., 1999 b ).	SEN:10022816	10737606
BEL:20043324	p(HGNC:IL6) increases r(HGNC:HMOX1)	Endothelial cells treated with heme (10 microM) and IL-6 (25 ng/ml), increased HO-1 mRNA 15- and 60-fold, respectively.	SEN:10007290	10564544
BEL:20043330	p(HGNC:IL6) increases r(HGNC:IGFBP4)	In conclusion , our results show that IL-6 stimulates hepatic IGFBP-4 gene expression and production in vitro and in vivo , thereby suggesting another mechanism by which cytokines could control IGF-I action.	SEN:10007292	11145587
BEL:20043350	p(HGNC:IL6) increases r(HGNC:XBP1)	Northern blot analysis documented that two transcription factor genes chosen for further study, c-myc promoter-binding protein (MBP-1) and X-box binding protein 1 (XBP-1), were up-regulated in U266 cells about 3-fold relative to the cell cycle-dependent beta-actin gene 12 h after IL-6 treatment.	SEN:10023694	10375612
BEL:20043352	p(HGNC:IL6R) increases kin(p(HGNC:MAPK1))	Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.	SEN:10018580	10409724
BEL:20043360	p(HGNC:IL6ST) increases tscript(p(HGNC:STAT3))	The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. #[JL] IL6ST is gp130	SEN:10023710	10626893
BEL:20043370	p(HGNC:IL6) increases tscript(p(HGNC:STAT1))	In T47D cells, IL-6 stimulated the activation of Janus-activated kinase 1 tyrosine kinase and signal transducers and activators of transcription (STAT) 1 and STAT3 transcription factors. Expression of dominant negative STAT3 in the cells strongly reduced IL-6-mediated growth inhibition but did not prevent IL-6-induced cell migration.	SEN:10002576	11196191
BEL:20043372	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	In T47D cells, IL-6 stimulated the activation of Janus-activated kinase 1 tyrosine kinase and signal transducers and activators of transcription (STAT) 1 and STAT3 transcription factors. Expression of dominant negative STAT3 in the cells strongly reduced IL-6-mediated growth inhibition but did not prevent IL-6-induced cell migration.	SEN:10002576	11196191
BEL:20043390	p(HGNC:IL8) increases bp(GOBP:angiogenesis)	EGF-R activation was significantly blocked by therapy with PKI166 and was associated with significant reduction in tumor cell production of VEGF and IL-8, which in turn correlated with a significant decrease in microvessel density and an increase in apoptotic endothelial cells.	SEN:10021196	10850439
BEL:20043396	p(HGNC:IL8) increases cat(p(EGID:3577))	Interleukin 8 (IL-8) activation of the chemokine receptor CXCRI was found to stimulate rapid formation of beta-arrestin complexes with Hck or c-Fgr. Formation of beta-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions.	SEN:10004236	10973280
BEL:20043400	p(HGNC:IL8) decreases r(HGNC:CDH1)	IL-8 increases the expression of EGF receptor, VEGF and IL-8 itself by tumor cells themselves, whereas IL-8 decreases expression of E-Cadherin, associated with increase in expression and activity of MMP-9 by tumor cells.	SEN:10023718	11217448
BEL:20043406	p(HGNC:IL9) increases r(HGNC:CISH)	In BW5147 T-cell lymphoma, IL-9 induced the rapid expression of CIS, SOCS-2 and SOCS-3 with a peak after 2 h of stimulation	SEN:10007310	11115404
BEL:20043408	p(HGNC:IL9) increases r(HGNC:MUC2)	In vitro, our studies showed that IL-9 also induces expression of MUC2 and MUC5AC in human primary lung cultures and in the human muccoepidermoid NCI-H292 cell line, indicating a direct effect of IL-9 on inducing mucin expression in these cells.	SEN:10007312	10837360
BEL:20043410	p(HGNC:IL9) increases r(HGNC:MUC5AC)	In vitro, our studies showed that IL-9 also induces expression of MUC2 and MUC5AC in human primary lung cultures and in the human muccoepidermoid NCI-H292 cell line, indicating a direct effect of IL-9 on inducing mucin expression in these cells.	SEN:10007312	10837360
BEL:20043412	p(HGNC:IL9) increases r(HGNC:SOCS2)	In BW5147 T-cell lymphoma, IL-9 induced the rapid expression of CIS, SOCS-2 and SOCS-3 with a peak after 2 h of stimulation	SEN:10007310	11115404
BEL:20043414	p(HGNC:IL9) increases r(HGNC:SOCS3)	In BW5147 T-cell lymphoma, IL-9 induced the rapid expression of CIS, SOCS-2 and SOCS-3 with a peak after 2 h of stimulation	SEN:10007310	11115404
BEL:20043422	p(HGNC:ILK) decreases kin(p(HGNC:GSK3B))	ILK overexpression can also inhibit GSK-3 activity (Delcommenne et al., 1998; Troussard et al., 1999) and also results in nuclear accumulation of beta-catenin (Novak et al., 1998).	SEN:10023724	11244511
BEL:20043424	p(HGNC:ILK) increases r(HGNC:CCND1)	GSK-3eta inhibited ILK-induced cyclin D1 promoter activity and CREB binding to the cyclin D1 CRE.	SEN:10023726	10915780
BEL:20043430	p(HGNC:ILK) directlyIncreases r(HGNC:SNAI1)	As shown in Figure 4c, snail promoter activity is stimulated in these ILK overexpressing clones compared to parental IEC-18 cells and anti-sense ILK expressing control cells.	SEN:10023728	11244511
BEL:20043432	p(HGNC:ILK) increases tloc(p(HGNC:CTNNB1),GOCCID:0005737,GOCCID:0005634)	ILK overexpression can also inhibit GSK-3 activity (Delcommenne et al., 1998; Troussard et al., 1999) and also results in nuclear accumulation of beta-catenin (Novak et al., 1998).	SEN:10023724	11244511
BEL:20043438	p(HGNC:INPP5D,pmod(P,Y)) directlyIncreases complex(p(HGNC:INPP5D),p(HGNC:IRS2))	In the case of insulin, it is unclear whether SHIP associates with IRS proteins or the insulin receptor, although a recent report has demonstrated SHIP association with IRS-2 in response to erythropoietin	SEN:10023034	10194465
BEL:20043444	p(HGNC:INS) decreases p(HGNC:SELE)	Alternatively, insulin, an activator of PI 3'-kinase, decreased basal and VEGF-induced ICAM-1 , VCAM-1 , and E-selectin expression.	SEN:10023734	11108718
BEL:20043448	p(HGNC:INS) increases p(HGNC:TUBA4A,pmod(P,Y))	The insulin receptor beta-subunits and alpha-tubulin were tyrosine-phosphorylated upon the addition of insulin. The phosphorylation of alpha-tubulin afforded conditions unfavorable for microtubule assembly that is responsible for phosphodiesterase inhibition.	SEN:10023738	11104824
BEL:20043450	p(HGNC:INSR) decreases bp(GOBP:"insulin secretion")	However, Kulkarni et al. (1999) identified an important difference in phenotypes between bIRKO mice and human patients. Whereas insulin secretion is impaired in bIRKO mice, humans with mutations in the insulin receptor gene (e.g., patients with leprechaunism) exhibit striking hyperplasia of pancreatic islets and hypers ecretion of insulin (Elders et al., 1982).	SEN:10023740	10199397
BEL:20043460	p(HGNC:INS) decreases r(HGNC:GOT1)	Expression of the rat cytosolic aspartate aminotransferase gene is stimulated by glucocorticoids and repressed by insulin in the liver.	SEN:10007324	10527950
BEL:20043462	p(HGNC:INS) increases r(HGNC:HK2)	Insulin (+/-1,000 pmol/l) induced a two- to threefold increase (P hexokinase II, p85alphaPI3K, and SREBP-1c mRNA levels in muscle and in adipose tissue in control subjects, in insulin-resistant nondiabetic obese patients, and in hyperglycemic type 1 diabetic subjects.	SEN:10023744	11334418
BEL:20043466	p(HGNC:INS) increases r(HGNC:PIK3R1)	Insulin (+/-1,000 pmol/l) induced a two- to threefold increase (P hexokinase II, p85alphaPI3K, and SREBP-1c mRNA levels in muscle and in adipose tissue in control subjects, in insulin-resistant nondiabetic obese patients, and in hyperglycemic type 1 diabetic subjects.	SEN:10023744	11334418
BEL:20043468	p(HGNC:INS) increases r(HGNC:SREBF1)	Insulin (+/-1,000 pmol/l) induced a two- to threefold increase (P hexokinase II, p85alphaPI3K, and SREBP-1c mRNA levels in muscle and in adipose tissue in control subjects, in insulin-resistant nondiabetic obese patients, and in hyperglycemic type 1 diabetic subjects.	SEN:10023744	11334418
BEL:20043474	p(HGNC:INSR,pmod(P,S)) directlyDecreases kin(p(HGNC:INSR))	PKC, a serine kinase, can phosphorylate and inhibit tyrosine kinase activity of the insulin receptor as well as tyrosine phosphorylation of insulin receptor substrate (IRS)-1	SEN:10021436	10905472
BEL:20043480	p(HGNC:INSR,pmod(P,Y,960)) directlyIncreases complex(p(HGNC:INSR),p(HGNC:STAT5B))	this negative regulation likely results from competition between SOCS3 and Stat5B binding to the same insulin receptor motif SOCS3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds	SEN:10023748	10821852
BEL:20043482	p(HGNC:INSR,pmod(P,Y,960)) directlyIncreases complex(p(HGNC:SOCS3),p(HGNC:INSR))	First, using a yeast two-hybrid system, we show that SOCS-3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds.	SEN:10020150	10821852
BEL:20043484	p(HGNC:INSR,pmod(P,Y,960)) directlyIncreases complex(p(HGNC:SOCS3),p(HGNC:INSR))	this negative regulation likely results from competition between SOCS3 and Stat5B binding to the same insulin receptor motif SOCS3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds	SEN:10023748	10821852
BEL:20043486	p(HGNC:INSR,pmod(P,Y,960)) directlyIncreases tloc(p(HGNC:SOCS3),GOCCID:0005737,GOCCID:0005886)	insulin induces translocation of SOCS3 from an intracellular compartment to the cell membrane, leading to colocalization of SOCS3 with the insulin receptor this colocalization is dependent upon phosphorylation of insulin receptor tyrosine 960	SEN:10023750	10821852
BEL:20043488	p(HGNC:INSR,pmod(P,Y)) directlyIncreases complex(p(HGNC:GRB10),p(HGNC:INSR))	Grb-IR is a recently discovered SH2 domain protein that may translocate from the cytosol to the plasma membrane and bind directly to the tyrosine-phosphorylated insulin receptor	SEN:10023752	10194465
BEL:20043492	p(HGNC:INSR,pmod(P,Y)) directlyIncreases kin(p(HGNC:INSR))	PKC, a serine kinase, can phosphorylate and inhibit tyrosine kinase activity of the insulin receptor as well as tyrosine phosphorylation of insulin receptor substrate (IRS)-1	SEN:10021436	10905472
BEL:20043496	p(HGNC:INS) increases sec(p(HGNC:CFD))	In contrast, the secretion of adipsin, a serine protease specifically expressed in adipocytes, was increased by the expression of wild-type ARF6 and was inhibited by the expression of D125N. These results indicate a requirement for ARF6 in basal and insulin-regulated adipsin secretion but not in glucose transport.	SEN:10020830	10464254
BEL:20043504	p(HGNC:IRF1) increases r(HGNC:IFNB1)	IFN-beta expression can be activated by interferon regulatory factor-1 (IRF-1) and interferon-stimulated gene factor 3gamma (ISGF3gamma).	SEN:10007332	10363677
BEL:20043514	p(HGNC:IRF7,pmod(P,S,477)) directlyIncreases tscript(p(HGNC:IRF7))	Substitution of Ser-477 and Ser-479 with the phosphomimetic Asp resulted in a form of IRF-7 that activated the IFNA promoter up to 200-fold (Fig. 2 B).	SEN:10023758	10893229
BEL:20043516	p(HGNC:IRF7,pmod(P,S,479)) directlyIncreases tscript(p(HGNC:IRF7))	Substitution of Ser-477 and Ser-479 with the phosphomimetic Asp resulted in a form of IRF-7 that activated the IFNA promoter up to 200-fold (Fig. 2 B).	SEN:10023758	10893229
BEL:20043518	p(HGNC:IRF8,pmod(P,S)) directlyIncreases complex(p(HGNC:IRF8),p(HGNC:IRF1))	The phosphorylated residue is essential for efficient association with IRF-1 and thus for the repressor activity of ICSBP exerted on IRF-1.	SEN:10020028	10991940
BEL:20043522	p(HGNC:IRF8) directlyDecreases tscript(p(HGNC:IRF1))	The phosphorylated residue is essential for efficient association with IRF-1 and thus for the repressor activity of ICSBP exerted on IRF-1.	SEN:10020028	10991940
BEL:20043524	p(HGNC:IRF9) increases r(HGNC:IFNB1)	IFN-beta expression can be activated by interferon regulatory factor-1 (IRF-1) and interferon-stimulated gene factor 3gamma (ISGF3gamma).	SEN:10007332	10363677
BEL:20043534	p(HGNC:IRS1,pmod(G,S)) directlyDecreases cat(p(HGNC:IRS1))	We also demonstrated that glucosamine % infusion results in O-linked N-acetylglucosamine modification of IRS-1 and % IRS-2.	SEN:10015718	10426374
BEL:20043536	p(HGNC:IRS1,pmod(P,S)) directlyIncreases complex(p(HGNC:YWHAB),p(HGNC:IRS1))	The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.	SEN:10023766	10194465
BEL:20043538	p(HGNC:IRS1,pmod(P,S)) directlyIncreases complex(p(HGNC:YWHAE),p(HGNC:IRS1))	The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.	SEN:10023766	10194465
BEL:20043540	p(HGNC:IRS1,pmod(P,S)) directlyIncreases complex(p(HGNC:YWHAZ),p(HGNC:IRS1))	The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.	SEN:10023766	10194465
BEL:20043542	p(HGNC:IRS1,pmod(P,S)) decreases kin(p(HGNC:INSR))	TNF-a appears to impair insulin signaling by increasing serine phosphorylation of IRS-1. Serine-phosphorylated IRS-1 inhibits insulin receptor tyrosine kinase activity, which leads to impaired downstream signaling	SEN:10023768	10194465
BEL:20043544	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:CRK),p(HGNC:IRS1))	other SH2 proteins, such as Crk (adaptor), Nck (adaptor), Fyn (tyrosine kinase), and Csk (tyrosine kinase), bind to tyrosine residues on IRS proteins through their specific SH2 domains.	SEN:10023770	10194465
BEL:20043546	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:CSK),p(HGNC:IRS1))	Csk has been reported to associate with IRS-1 through its SH2 domain and promote dephosphorylation of the focal adhesion kinase (FAK) in an insulin-dependent manner (56).	SEN:10019968	10194465
BEL:20043548	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:CSK),p(HGNC:IRS1))	other SH2 proteins, such as Crk (adaptor), Nck (adaptor), Fyn (tyrosine kinase), and Csk (tyrosine kinase), bind to tyrosine residues on IRS proteins through their specific SH2 domains.	SEN:10023770	10194465
BEL:20043550	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:FYN),p(HGNC:CBL),p(HGNC:IRS1))	Fyn is not activated directly by the insulin receptor, but rather by interaction with IRS-1 (49) and another insulin receptor substrate, c-Cbl (50).	SEN:10023772	10194465
BEL:20043552	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:FYN),p(HGNC:IRS1))	other SH2 proteins, such as Crk (adaptor), Nck (adaptor), Fyn (tyrosine kinase), and Csk (tyrosine kinase), bind to tyrosine residues on IRS proteins through their specific SH2 domains.	SEN:10023770	10194465
BEL:20043554	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:IRS1),p(HGNC:ITGAV))	In smooth muscle cells, blocking ligand occupancy of aVb3 integrin reduces IGF-1-induced IRS-1 phosphorylation	SEN:10020030	10194465
BEL:20043556	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:IRS1),p(HGNC:ITGAV))	Insulin and IGF-1 stimulation also promote association between IRS-1 and aVb3 integrin (vitronectin receptor)	SEN:10017346	10194465
BEL:20043560	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:NCK1),p(HGNC:IRS1))	Nck associates with IRS-1 (45), many different tyrosine kinases, several serine/threonine kinases through its SH2 domain, as well as Sos through its SH3 domains	SEN:10020066	10194465
BEL:20043562	p(HGNC:IRS1,pmod(P,Y)) directlyIncreases complex(p(HGNC:NCK1),p(HGNC:IRS1))	other SH2 proteins, such as Crk (adaptor), Nck (adaptor), Fyn (tyrosine kinase), and Csk (tyrosine kinase), bind to tyrosine residues on IRS proteins through their specific SH2 domains.	SEN:10023770	10194465
BEL:20043564	p(HGNC:IRS2,pmod(P,Y)) directlyIncreases complex(p(HGNC:INPP5D),p(HGNC:IRS2))	In the case of insulin, it is unclear whether SHIP associates with IRS proteins or the insulin receptor, although a recent report has demonstrated SHIP association with IRS-2 in response to erythropoietin	SEN:10023034	10194465
BEL:20043570	p(HGNC:ITGA4) increases r(HGNC:MMP2)	Blocking monoclonal antibodies against alpha4, alpha5, and alphav integrins strongly reduced MMP-2 and MMP-9 production induced by fibronectin.	SEN:10007340	10515879
BEL:20043572	p(HGNC:ITGA4) increases r(HGNC:MMP9)	Blocking monoclonal antibodies against alpha4, alpha5, and alphav integrins strongly reduced MMP-2 and MMP-9 production induced by fibronectin.	SEN:10007340	10515879
BEL:20043576	p(HGNC:ITGA5) increases r(HGNC:MMP2)	Blocking monoclonal antibodies against alpha4, alpha5, and alphav integrins strongly reduced MMP-2 and MMP-9 production induced by fibronectin.	SEN:10007340	10515879
BEL:20043578	p(HGNC:ITGA5) increases r(HGNC:MMP9)	Blocking monoclonal antibodies against alpha4, alpha5, and alphav integrins strongly reduced MMP-2 and MMP-9 production induced by fibronectin.	SEN:10007340	10515879
BEL:20043580	p(HGNC:ITGAM) increases r(HGNC:CCL3)	We found that incubation of monocytes with anti-CD11b or anti-CD11c mAbs led rapidly to a marked induction of MIP-1alpha, MIP-1beta, and IL-8 mRNAs.	SEN:10023782	11342414
BEL:20043582	p(HGNC:ITGAM) increases r(HGNC:CCL4)	We found that incubation of monocytes with anti-CD11b or anti-CD11c mAbs led rapidly to a marked induction of MIP-1alpha, MIP-1beta, and IL-8 mRNAs.	SEN:10023782	11342414
BEL:20043586	p(HGNC:ITGAM) increases r(HGNC:IL8)	We found that incubation of monocytes with anti-CD11b or anti-CD11c mAbs led rapidly to a marked induction of MIP-1alpha, MIP-1beta, and IL-8 mRNAs.	SEN:10023782	11342414
BEL:20043588	p(HGNC:ITGB1) increases complex(p(HGNC:PDGFRB),p(HGNC:PDGFRB))	Moreover, engagement of beta 1-integrins by plating of fibroblasts on collagen or fibronectin caused a transient tyrosine phosphorylation of PDGF receptors in the absence of PDGF (459).	SEN:10023786	10508235
BEL:20043590	p(HGNC:ITGB1) increases p(HGNC:IRS1,pmod(P,Y))	Recently, b1 integrins have also been reported to enhance IRS-1 phosphorylation and interaction, but not glucose transport, with downstream molecules such as PI3-kinase and Akt (74). These results suggest that integrins and insulin/IGF-1 receptor signaling pathways converge at an early point in the signaling cascade around the IRS proteins.	SEN:10023788	10194465
BEL:20043618	p(HGNC:JUNB) decreases r(HGNC:TIMP1)	Overexpression of c-Jun, JunB, Fra2, or FosB in activated HSCs repressed TIMP-1 promoter activity, whereas c-Fos and Fra1 had little effect.	SEN:10023138	11337499
BEL:20043620	p(HGNC:JUND) increases r(HGNC:TIMP1)	As JunD/ eb1 homodimers are strong stimulators of TIMP-1 gene transcription, the most likely explanation for the inhibitory effects of exogenously added Fra2 and FosB is that they form heterodimers with endogenous JunD that are less active than JunD homodimers.	SEN:10023796	11337499
BEL:20043624	p(HGNC:JUN) increases r(HGNC:ITGA2)	We present a model in which activation of the MAPK cascade signals via c-fos/c-jun family members to activate alpha 2 integrin gene expression.	SEN:10023800	10029589
BEL:20043628	p(HGNC:KAT2B) increases tscript(p(HGNC:MYOD1))	The process also involves the subsequent recruitment of p300/CBP and PCAF to a complex that synergistically regulates transcription and remodels the chromatin. PCAF and p300 have also been demonstrated to function as critical coactivators for the muscle-specific basic helix-loop-helix (bHLH) protein MyoD during myogenic commitment.	SEN:10006884	10817756
BEL:20043636	p(HGNC:KDR,pmod(P,Y)) directlyIncreases complex(p(HGNC:KDR),p(HGNC:ITGAV),p(HGNC:ITGB3))	This hypothesis is strongly supported by the result that VEGFA165- stimulated, tyrosine phosphorylated VEGFR-2 was associated with b3 integrin. The specificity of the model was restricted to avb3 integrin.	SEN:10020044	10022831
BEL:20043638	p(HGNC:KIT) increases bp(GOBP:"cell proliferation")	Socs1 suppresses the mitogenic potential of Kit while maintaining Steel factor-dependent cell survival signals.	SEN:10023806	10022833
BEL:20043640	p(HGNC:KITLG) decreases bp(GOBP:"cell death")	Socs1 suppresses the mitogenic potential of Kit while maintaining Steel factor-dependent cell survival signals.	SEN:10023806	10022833
BEL:20043642	p(HGNC:KITLG) increases bp(GOBP:"mast cell activation")	Keratinocyte-derived SCF plays a role, in part, in the increased number of mast cells in the papillary dermis of psoriasis	SEN:10004090	11084298
BEL:20043648	p(HGNC:KITLG) directlyIncreases kin(p(HGNC:KIT))	Stem cell factor (SCF) or c-Kit ligand is a cytokine associated with the differentiation, survival, and activation of mast cells.	SEN:10002636	11159541
BEL:20043654	p(HGNC:KITLG) increases p(HGNC:RB1)	In cells stimulated towards neutrophilic differentiation with G-CSF plus SCF, a slight increase in the level of pRb was detected on days 3 and 5.	SEN:10023814	10477726
BEL:20043658	p(HGNC:KITLG) increases r(HGNC:IL2RG)	SCF was shown to act synergistically with IL-2 in inducing IEL proliferation, IFNgamma production, non-MHC-restricted cytotoxic activity, and upregulation of the expression of the gammac.	SEN:10007348	11078608
BEL:20043668	p(HGNC:KLC1) increases r(HGNC:KIF5A)	This difference presumably arises because KIF5B is expressed in nonneural cells where KLC1 is ordinarily less abundant, whereas KIF5A is expressed primarily in neural cells in which KLC1 expression is enhanced.	SEN:10023820	10491391
BEL:20043680	p(HGNC:KRAS) increases r(HGNC:PTGS2)	Thus, Akt/PKB activity is involved in K-Ras-induced expression of COX-2 and stabilization of COX-2 mRNA largely depends on the activation of Akt/PKB.	SEN:10007350	11289146
BEL:20043686	p(HGNC:KRT10) increases bp(GOBP:"cell cycle")	ii) K10-mediated cell growth arrest is rescued by the coexpression of specific cyclins, cyclin-dependent kinases (CDKs), or cyclin-CDK complexes;	SEN:10023832	10082575
BEL:20043688	p(HGNC:KRT10) decreases bp(GOBP:"cell proliferation")	Specifically, we demonstrate that the ectopic expression of K10 inhibits the proliferation of human keratinocytes in culture while K16 expression appears to promote the proliferation of these cells	SEN:10023834	10082575
BEL:20043690	p(HGNC:KRT10) increases tscript(p(HGNC:RB1))	K10-induced inhibition is hampered by cotransfection with viral oncoproteins which interfere with pRb but not with p53;	SEN:10023836	10082575
BEL:20043692	p(HGNC:KRT16) increases bp(GOBP:"cell proliferation")	Specifically, we demonstrate that the ectopic expression of K10 inhibits the proliferation of human keratinocytes in culture while K16 expression appears to promote the proliferation of these cells	SEN:10023834	10082575
BEL:20043700	p(HGNC:LCK) increases p(HGNC:STAT5A,pmod(P,Y,694))	Indeed, STAT5a phosphorylation on tyrosine 694 was detected upon transfection of STAT5a/Lck genes into the vector-only (Vo) control cells (Fig. 6A, upper panel).	SEN:10023838	11254359
BEL:20043708	p(HGNC:LEF1) increases r(HGNC:MMP7)	It was somewhat surprising to find that LEF-1 alone was capable of cooperating with PEA3 to transactivate the matrilysin promoter in HEK293 cells.	SEN:10023842	11158321
BEL:20043710	p(HGNC:LEP) increases cat(p(HGNC:HSD11B1))	Leptin treatment did not alter 11betaHSD1 activity in human hepatocytes, but increased activity in omental ASC [135.8 +/- 14.1% (leptin, 100 ng/ml); P = 0.08 vs. control (100%)]. Treatment with interleukin-1beta induced 11betaHSD1 activity and expression in sc and omental ASC in a time- and dose-dependent manner.	SEN:10007352	11316764
BEL:20043730	p(HGNC:LFNG) increases r(HGNC:RBPJ)	Further analysis indicated that Dll1 , Notch1 , and RBP-Jkappa are required for proper lfng expression in the mouse, suggesting that the Notch pathway is required for at least some readouts of the clock (del Barco Barrantes et al. 1999 ).	SEN:10023856	10887161
BEL:20043746	p(HGNC:LIF) increases r(HGNC:CEBPD)	LIF stimulates expression of adipogenic transcription factor C/EBPeta and C/EBPdelta and acts in a synergistic manner with PPARgamma ligand to induce adipocyte differentiation of Ob1771 preadipose cells.	SEN:10023864	10455174
BEL:20043748	p(HGNC:LIF) increases r(HGNC:GFAP)	Activation of the GFAP gene promoter by IL-11 and related cytokines Previous studies have shown that stimulation of gp130 molecules on neuroepithelial cells by LIF, CNTF, or the IL-6/sIL-6R complex induces activation of the GFAP gene promoter (Bonni et al., 1997 ; Nakashima et al., 1999 b ).	SEN:10022816	10737606
BEL:20043752	p(HGNC:LIF) increases r(HGNC:NTF3)	LIF can increase neurotrophic factor expression and promote the growth of a specific class of injured axons in the CNS.	SEN:10023868	10212315
BEL:20043758	p(HGNC:LIG1) increases bp(GOBP:"DNA replication")	<r8> PCNA binds DNA ligase I; the complex may function to join Okazaki fragments during DNA replication (Levin et al.,1997).	SEN:10023872	10436023
BEL:20043776	p(HGNC:LTB) increases bp(GOBP:"inflammatory response")	Th1 cells produce interleukin (IL)-2, interferon-gamma (IFN-gamma) and lymphotoxin-beta, which mediate pro-inflammatory functions critical for the development of cell-mediated immune responses	SEN:10023882	11057672
BEL:20043780	p(HGNC:MAF) decreases tscript(p(HGNC:MYB))	We have shown that the c-Maf and c-Myb transcription factors physically interact in myeloid cells to form inhibitory complexes that hinder transactivation of c-Myb target genes through direct binding to Myb consensus sites.	SEN:10020058	10477683
BEL:20043786	p(HGNC:MAP2K1,pmod(P,S,218)) directlyIncreases kin(p(HGNC:MAP2K1))	Activation of MEK1 and MEK2 involves phosphorylation upon conserved serine residues (Ser-218 and Ser-222 on MEK1, Ser-222 and Ser-226 on MEK2	SEN:10023884	10085062
BEL:20043788	p(HGNC:MAP2K1,pmod(P,S,222)) directlyIncreases kin(p(HGNC:MAP2K1))	Activation of MEK1 and MEK2 involves phosphorylation upon conserved serine residues (Ser-218 and Ser-222 on MEK1, Ser-222 and Ser-226 on MEK2	SEN:10023884	10085062
BEL:20043794	p(HGNC:MAP2K1) increases r(HGNC:ITGA2B)	In addition, constitutive activation of the pathway via expression of the constitutively active mutants of MAPKK1 or MAPKK2 induced the expression of the platelet/megakaryocytic-specific genes alpha IIb and eta 3 .	SEN:10023888	10029589
BEL:20043796	p(HGNC:MAP2K2,pmod(P,S,222)) directlyIncreases kin(p(HGNC:MAP2K2))	Activation of MEK1 and MEK2 involves phosphorylation upon conserved serine residues (Ser-218 and Ser-222 on MEK1, Ser-222 and Ser-226 on MEK2	SEN:10023884	10085062
BEL:20043798	p(HGNC:MAP2K2,pmod(P,S,226)) directlyIncreases kin(p(HGNC:MAP2K2))	Activation of MEK1 and MEK2 involves phosphorylation upon conserved serine residues (Ser-218 and Ser-222 on MEK1, Ser-222 and Ser-226 on MEK2	SEN:10023884	10085062
BEL:20043800	p(HGNC:MAP2K2) increases r(HGNC:ITGA2B)	In addition, constitutive activation of the pathway via expression of the constitutively active mutants of MAPKK1 or MAPKK2 induced the expression of the platelet/megakaryocytic-specific genes alpha IIb and eta 3 .	SEN:10023888	10029589
BEL:20043802	p(HGNC:MAP2K4) increases kin(p(HGNC:MAPK9))	Using a coupled assay, we were able to show that MLK3-mediated phosphorylation of SEK1 resulted in activation because GST-SEK1 is able to phosphorylate recombinant SAPK? (Fig. 5D)	SEN:10023890	10232608
BEL:20043808	p(HGNC:MAP2K7) increases r(HGNC:KAT5)	Expression of constitutively active JNK constructs, obtained by expressing fusion proteins of JNK fused to MKK7 increased cPLA 2 promoter activity.	SEN:10023892	11042196
BEL:20043810	p(HGNC:MAP3K11) increases kin(p(HGNC:MAP2K1))	Wild type, but not KD, MLK3 was able to phosphorylate His-MEK1 (Fig. 5A) ? and GST-SEK1 (Fig. 5B) ? in vitro.	SEN:10023894	10232608
BEL:20043812	p(HGNC:MAP3K11) increases kin(p(HGNC:MAP2K4))	Wild type, but not KD, MLK3 was able to phosphorylate His-MEK1 (Fig. 5A) ? and GST-SEK1 (Fig. 5B) ? in vitro.	SEN:10023894	10232608
BEL:20043814	p(HGNC:MAP3K11) increases kin(p(HGNC:MAPK9))	expression of MLK3 strongly activated SAPK? to the same extent seen with the established JNK/SAPK activator arsenite (45)	SEN:10016572	10232608
BEL:20043818	p(HGNC:MAP3K14) increases kin(p(HGNC:CHUK))	PKC-theta activation of NF-kappaB is mediated through the selective induction of IKKbeta, while the Cot- and NIK-dependent pathway involves induction of both IKKalpha and IKKbeta.	SEN:10007374	10733597
BEL:20043820	p(HGNC:MAP3K14) increases kin(p(HGNC:IKBKB))	PKC-theta activation of NF-kappaB is mediated through the selective induction of IKKbeta, while the Cot- and NIK-dependent pathway involves induction of both IKKalpha and IKKbeta.	SEN:10007374	10733597
BEL:20043822	p(HGNC:MAP3K1) increases r(HGNC:KAT5)	Expression of constitutively active MEKK1 also markedly increased cPLA 2 promoter activity (Fig. 6 ).	SEN:10023896	11042196
BEL:20043824	p(HGNC:MAP3K1) increases tscript(p(HGNC:AR))	MEKK1 also stimulates the transcriptional activity of the androgen receptor in the presence or absence of ligand, whereas a dominant negative mutant of MEKK1 impairs activation of the androgen receptor by androgen.	SEN:10007376	10373563
BEL:20043828	p(HGNC:MAP3K5) decreases complex(p(HGNC:MAP3K7),p(HGNC:TRAF6))	Here we report that ASK 1 binds to TAK 1 and dissociates TAK 1 from TNF receptor-associated factor 6 (TRAF 6), and inhibits TAK 1- and TRAF 6-, but not NF-kappa B-inducing kinase (NIK)-induced NF-kappa B activation	SEN:10005320	10921242
BEL:20043830	p(HGNC:MAP3K5,pmod(P,S,83)) directlyDecreases kin(p(HGNC:MAP3K5))	Akt decreased ASK1 kinase activity stimulated by both oxidative stress and overexpression in 293 cells by phosphorylating a consensus Akt site at serine 83 of ASK1.	SEN:10021104	11154276
BEL:20043832	p(HGNC:MAP3K8) increases kin(p(HGNC:CHUK))	PKC-theta activation of NF-kappaB is mediated through the selective induction of IKKbeta, while the Cot- and NIK-dependent pathway involves induction of both IKKalpha and IKKbeta.	SEN:10007374	10733597
BEL:20043834	p(HGNC:MAP3K8) increases kin(p(HGNC:IKBKB))	PKC-theta activation of NF-kappaB is mediated through the selective induction of IKKbeta, while the Cot- and NIK-dependent pathway involves induction of both IKKalpha and IKKbeta.	SEN:10007374	10733597
BEL:20043856	p(HGNC:MAX) decreases r(HGNC:CDH1)	Max blocks transcriptional activation from the E-cadherin promoter by c-Myc, presumably because it blocks the binding between c-Myc and AP2.	SEN:10023902	10436023
BEL:20043866	p(HGNC:MCAM) increases kin(p(HGNC:FYN))	CD146 engagement initiates an outside-in signaling pathway involving the protein tyrosine kinases FYN and FAK as well as paxillin.	SEN:10007382	11036077
BEL:20043868	p(HGNC:MCAM) increases kin(p(HGNC:PTK2))	CD146 engagement initiates an outside-in signaling pathway involving the protein tyrosine kinases FYN and FAK as well as paxillin.	SEN:10007382	11036077
BEL:20043870	p(HGNC:MCAM) increases p(HGNC:PTK2B,pmod(P,Y))	In addition, biochemical and pharmacological analysis revealed that CD146 engagement initiates the tyrosine phosphorylation of phospholipase C-gamma, Pyk2, and p130(Cas).	SEN:10023908	11036077
BEL:20043876	p(HGNC:MDM2) increases deg(p(HGNC:TP53))	<p30> p53 is rapidly degraded by the process of ubiquitiation and proteasome. <p31> mdm2 stimulates p53 degradation	SEN:10018610	10436023
BEL:20043884	p(HGNC:MDM2) directlyDecreases tscript(p(HGNC:TP53))	<p29> mdm2 inhibits p53-mediated transactivation; it inhibits the expression of p53 dependent genes	SEN:10023914	10436023
BEL:20043888	p(HGNC:MDM4) decreases tscript(p(HGNC:SMAD1))	MDMX can inhibit the transcriptional activity of ectopically expressed SMAD1, SMAD2, SMAD3, and SMAD4	SEN:10007386	10537276
BEL:20043890	p(HGNC:MDM4) decreases tscript(p(HGNC:SMAD3))	MDMX can inhibit the transcriptional activity of ectopically expressed SMAD1, SMAD2, SMAD3, and SMAD4	SEN:10007386	10537276
BEL:20043892	p(HGNC:MDM4) decreases tscript(p(HGNC:SMAD4))	MDMX can inhibit the transcriptional activity of ectopically expressed SMAD1, SMAD2, SMAD3, and SMAD4	SEN:10007386	10537276
BEL:20043920	p(HGNC:MSGN1) increases r(HGNC:NOTCH1)	Thus pMesogenin1 is absolutely required for expression of Notch1 , Notch2 , Dll-3 , Hes1 , and Lunatic fringe in the trunk and tail PSM, whereas Dll-1 appeared slightly reduced in RNA expression in the absence of pMesogenin1 (Fig. 3 ).	SEN:10023928	11124811
BEL:20043932	p(HGNC:MYBL2) increases r(HGNC:CCNA2)	Accordingly, B-MYB function parallels endogenous levels of cyclin A in different cell types ( 8 , 10 ).	SEN:10023936	10770937
BEL:20043934	p(HGNC:MYBL2) increases r(HGNC:CLU)	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES In this report, we provide evidence that B-MYB, the ubiquitous member of the Myb family, positively regulates expression of the anti-apoptotic gene ApoJ/Clusterin, conferring on B- MYB -expressing cells resistance to death induced by the chemotherapeutic drug doxorubicin.	SEN:10023938	10770937
BEL:20043938	p(HGNC:MYC) increases bp(GOBP:"cell proliferation")	In combination with cell proliferative activities of c-myc and cyclin D1, MDR1 may initiate colorectal tumorigenesis by suppressing cell death pathways programmed in intestinal epithelial cells.	SEN:10002158	10987283
BEL:20043948	p(HGNC:MYC,pmod(P,S,62)) increases p(HGNC:MYC,pmod(P,T,58))	phosphorylation sites in Myc, Thr 58 and Ser 62 Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc	SEN:10023942	11018017
BEL:20043950	p(HGNC:MYC,pmod(P,T,58)) directlyIncreases deg(p(HGNC:MYC))	phosphorylation sites in Myc, Thr 58 and Ser 62 Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc	SEN:10023942	11018017
BEL:20043958	p(HGNC:MYD88) increases kin(p(HGNC:IKBKB))	The pathway from TLR2 to apoptosis also requires the intracellular TIR domain of the receptor and MyD88 (Figure 1B). However, dominant-negative versions of TRAF6, NIK and IKKbeta do not inhibit cell death.	SEN:10018700	10880445
BEL:20043960	p(HGNC:MYD88) increases p(HGNC:TRAF6)	MyD88 initiates a signaling pathway which sequentially involves IL-1R-associated kinase 1 (IRAK1), tumor necrosis factor-{alpha} receptor (TNFR)-associated factor 6 (TRAF6) and nuclear factor (NF)-{kappa}B-inducing kinase (NIK) (Medzhitov et al., 1998; Muzio et al., 1998a; O'Neill and Greene, 1998; Kopp and Medzhitov, 1999; Yang et al., 1999; Zhang et al., 1999).	SEN:10018620	10880445
BEL:20043966	p(HGNC:MYOG) increases r(HGNC:CRYAB)	In vitro studies have demonstrated that both MyoD and myogenin can bind to the E-box element in the alphaB- crystallin promotor and fully transactivate alphaB-crystallin expression in a muscle specific manner ( 25 ).	SEN:10023948	10625651
BEL:20043974	p(HGNC:NCOA1) increases r(HGNC:SFTPB)	RAR coactivators ACTR, SRC-1, and transcriptional intermediary factor 2 (TIF2) stimulated human (h) SP-B promoter activity in a dose-dependent fashion in pulmonary adenocarcinoma H441 cells.	SEN:10023952	10617585
BEL:20043976	p(HGNC:NCOA1) increases tscript(p(HGNC:CREBBP))	Although phosphorylation at Thr-1179 and Ser-1185 did not directly regulate physical interaction between SRC-1 and CBP, it was required for functional cooperation.	SEN:10022824	11073973
BEL:20043978	p(HGNC:NCOA2) increases bp(GOBP:"myoblast differentiation")	title := \"The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.\"	SEN:10023954	10817756
BEL:20043980	p(HGNC:NCOA2) increases r(HGNC:SFTPB)	RAR coactivators ACTR, SRC-1, and transcriptional intermediary factor 2 (TIF2) stimulated human (h) SP-B promoter activity in a dose-dependent fashion in pulmonary adenocarcinoma H441 cells.	SEN:10023952	10617585
BEL:20043982	p(HGNC:NCOA2) increases tscript(p(HGNC:MEF2C))	title := \"The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.\"	SEN:10023954	10817756
BEL:20043986	p(HGNC:NCOA3) increases r(HGNC:SFTPB)	RAR coactivators ACTR, SRC-1, and transcriptional intermediary factor 2 (TIF2) stimulated human (h) SP-B promoter activity in a dose-dependent fashion in pulmonary adenocarcinoma H441 cells.	SEN:10023952	10617585
BEL:20044012	p(HGNC:NEDD8) increases deg(p(HGNC:CDKN1B))	Here we show that the p27 ubiquitination activity in cell extracts depends on the presence of the ubiquitin-like protein Nedd8 and enzymes that catalyze Nedd8 conjugation to proteins. Moreover, we show that reconstitution of the p27 ubiquitination activity of recombinant SCF(Skp2) also requires Nedd8 conjugation pathway components.	SEN:10018688	10781063
BEL:20044024	p(HGNC:NEUROG1) increases r(HGNC:NEUROG2)	Thus, regulatory interactions between the Ngns exist in the forebrain, such that Ngn2 mutant progenitors in the dorsal/medial cortex fail to express both Ngn1 and Ngn2 , and Ngn1 mutant progenitors express reduced levels of Ngn2 throughout the dorsal telencephalon.	SEN:10023970	10640277
BEL:20044030	p(HGNC:NFIX) decreases r(HGNC:HGF)	We found that the NF1/X and NF1/Red1 isoforms strongly suppressed HGF promoter activity while the NF1/L variant had no obvious effects.	SEN:10023974	10851080
BEL:20044032	p(HGNC:NFKBIA) decreases a(CHEBI:"nitric oxide")	Furthermore, nitric oxide production was prevented and, more importantly, Fas-triggered apoptosis was inhibited following IkappaBalpha gene transfer	SEN:10007410	10967112
BEL:20044040	p(HGNC:NFKBIA,pmod(P,S)) directlyIncreases deg(p(HGNC:NFKBIA))	Two related kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta, phosphorylate the IkappaB proteins, leading to their degradation and the subsequent activation of gene expression by NF-kappaB	SEN:10021172	10779355
BEL:20044044	p(HGNC:NFKBIA) decreases r(HGNC:IFNB1)	Inhibition of IFN-beta expression directly correlated with a reduction in the binding of NF-kappaB (p50-RelA) complex to PRDII after Sendai virus infection in IkappaBalpha-expressing cells, whereas IFN-beta expression and NF-kappaB binding were only slightly reduced in IkappaBbeta-expressing cells.	SEN:10023976	10074115
BEL:20044048	p(HGNC:NFKBIA) decreases tscript(p(HGNC:NFKB1))	MIP-1alpha treatment stimulated the degradation of IkappaBalpha, a cytoplasmic inhibitor of NF-kappaB	SEN:10001426	11152622
BEL:20044052	p(HGNC:NFKBIB) decreases r(HGNC:IFNB1)	Inhibition of IFN-beta expression directly correlated with a reduction in the binding of NF-kappaB (p50-RelA) complex to PRDII after Sendai virus infection in IkappaBalpha-expressing cells, whereas IFN-beta expression and NF-kappaB binding were only slightly reduced in IkappaBbeta-expressing cells.	SEN:10023976	10074115
BEL:20044054	p(HGNC:NFKBIB) decreases r(HGNC:IL8)	Using a naturally occurring compound found in the colon of vertebrates, butyrate, we provide evidence in an intestinal cell line that alteration of IkappaB-beta expression can modulate the transcriptional activation of the interleukin-8 (IL-8) gene by preventing the nuclear translocation of NF-kappaB proteins......Expression of IkB-b in Caco-2 cells inhibits transcriptional activation of the IL-8 promoter by IL-1b	SEN:10023574	10614789
BEL:20044058	p(HGNC:NGF) increases bp(GOBP:"cell migration")	The neurotrophin, nerve growth factor (NGF), and insulin-like growth factor 1 induce the migration but not the proliferation of smooth muscle cells, whereas PDGF-BB stimulates both responses.	SEN:10007092	10195934
BEL:20044060	p(HGNC:NGF) increases bp(GOBP:"MAPK cascade")	NGF induces prolonged activation of the Shc/MAP kinase pathway and phospholipase Cgamma compared with PDGF-BB.	SEN:10023978	10195934
BEL:20044066	p(HGNC:NGF) increases cat(p(HGNC:PLCG1))	NGF induces prolonged activation of the Shc/MAP kinase pathway and phospholipase Cgamma compared with PDGF-BB.	SEN:10023978	10195934
BEL:20044074	p(HGNC:NGF) decreases p(HGNC:BAX)	NGF withdrawal resulted in abrupt down-regulation of bcl-xl and up-regulation of bax, favoring apoptosis.	SEN:10007414	10349838
BEL:20044076	p(HGNC:NGF) increases p(HGNC:NFKBIA,pmod(P,Y,42))	NGF failed to phosphorylate IkappaBalpha at serine residue 32, but instead caused significant tyrosine phosphorylation. Overexpression of a Y42F mutant of IkappaBalpha potently suppressed NFG-, but not TNF-alpha-induced NFkappaB activation.	SEN:10023982	11266466
BEL:20044084	p(HGNC:NGF) increases r(HGNC:BAG1)	Both bak and bag-1 were expressed in undifferentiated PC12 cells, and their levels increased slightly with NGF treatment (data not shown).	SEN:10023988	10349838
BEL:20044086	p(HGNC:NGF) increases r(HGNC:BAK1)	Both bak and bag-1 were expressed in undifferentiated PC12 cells, and their levels increased slightly with NGF treatment (data not shown).	SEN:10023988	10349838
BEL:20044088	p(HGNC:NGF) increases r(HGNC:BCL2L1)	Treatment of rat pheochromocytoma PC12 cells, human neuroblastoma SH-SY5Y cells, or primary rat hippocampal neurons with NGF (0.1-10 ng/ml) increased the expression of bcl-xL mRNA and protein	SEN:10007416	11266466
BEL:20044092	p(HGNC:NGF) increases r(HGNC:CCL5)	NGF significantly increased RANTES production by the keratinocytes (p < 0.001, 2-tailed Student's t-test).	SEN:10023990	11028855
BEL:20044104	p(HGNC:NGF) increases r(HGNC:HIST1H2BO)	Note that both panels are reprobes of the same blot. d, In vitro Akt activation using histone H2B as a substrate in lysates of sympathetic neurons treated for 15 min with increasing concentrations of NGF (ng/ml) or KCl (mM).	SEN:10024000	10477751
BEL:20044112	p(HGNC:NGF) increases r(HGNC:NRG1)	In PC12 cells, nerve growth factor induces neuronal differentiation and repressed expression of nrg-1.	SEN:10007420	10532805
BEL:20044114	p(HGNC:NGF) decreases r(HGNC:NRG1)	In PC12 cells, nerve growth factor induces neuronal differentiation and repressed expression of nrg-1.	SEN:10007420	10532805
BEL:20044120	p(HGNC:NGF) increases r(HGNC:PTGS2)	Similarly, NGF increased the expression of the NF B target gene COX-2 in the presence of the proteasome inhibitor lactacystin ( Fig 7 b).	SEN:10024012	11266466
BEL:20044122	p(HGNC:NGF) increases r(HGNC:RAB40A)	These results suggest that the RAR..2 gene could be in a basal repressed state and NGF could increase RAR..2 transcription by inducing the release of some inhibitory factors from the INR.	SEN:10024014	11158236
BEL:20044124	p(HGNC:NGF) increases r(HGNC:RARB)	These results suggest that the RARbeta2 gene could be in a basal repressed state and NGF could increase RARbeta2 transcription by inducing the release of some inhibitory factors from the INR.	SEN:10007422	11158236
BEL:20044126	p(HGNC:NGF) increases r(HGNC:SLC18A3)	In the present study, nerve growth factor (NGF; 100 ng/ml) was shown to enhance expression of VAChT and ChAT mRNA in primary cultured rat embryonic septal cells.	SEN:10007424	10412029
BEL:20044132	p(HGNC:"NKX2-1") increases r(HGNC:SFTPA1)	Mutagenesis of the GBS inhibited TTF-1-dependent activation of the SP-A promoter, and the activity of the GBS was influenced by mutations in any of three distinct TTF-1 regulatory elements located within the 5'-flanking region of the SP-A gene.	SEN:10023186	10625644
BEL:20044134	p(HGNC:"NKX2-1") increases r(HGNC:SFTPB)	TTF-1 protein synergistically stimulated the hSP-B promoter with RARalpha, CBP, and nuclear receptor coactivators in H441 cells.	SEN:10006760	10617585
BEL:20044158	p(HGNC:NOTCH1) increases r(HGNC:HEY2)	In the present study, we show that the intracellular domain of the Notch1 receptor (Notch1 IC), which is constitutively active, up-regulates HRT2 expression in 10T(1/2) fibroblasts.	SEN:10024028	11095750
BEL:20044160	p(HGNC:NOTCH1) increases r(HGNC:LIPA)	LIN-12/NOTCH up-regulates lip-1 transcription in P5.p and P7.p where LIP-1 inactivates the MAP kinase to inhibit primary fate specification.	SEN:10024030	11161219
BEL:20044168	p(HGNC:NPPA) decreases r(HGNC:IL1B)	ANP significantly attenuated production of TNF-alpha and IL-1beta without affecting production of IL-10 and IL-1ra.	SEN:10007432	10861050
BEL:20044170	p(HGNC:NPPA) decreases r(HGNC:IL1R1)	ANP significantly attenuated production of TNF-alpha and IL-1beta without affecting production of IL-10 and IL-1ra.	SEN:10007432	10861050
BEL:20044184	p(HGNC:NR2F1) increases r(HGNC:CYP7A1)	The E/F region of COUP-TF1 is required for transactivation from the DR4 element of the CYP7A gene promoter.	SEN:10024044	10652338
BEL:20044196	p(HGNC:NR4A1) increases bp(GOBP:"apoptotic process")	Nur77 (NGFI-B) is an orphan nuclear receptor that has been implicated in activation-induced T-cell apoptosis.	SEN:10007436	10772826
BEL:20044202	p(HGNC:NRG1) directlyIncreases complex(p(HGNC:ERBB3),p(HGNC:ERBB2))	Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt.	SEN:10019988	11297548
BEL:20044204	p(HGNC:NRG1) directlyIncreases complex(p(HGNC:ERBB3),p(HGNC:ERBB2))	In MDA-MB-453 cells, NRG1beta acting through an ErbB2/ErbB3 heterodimer stimulated prolonged signaling of all pathways examined relative to NRG2beta acting through the same heterodimeric receptor species. Surprisingly, NRG1beta and NRG2beta also regulated partially overlapping but distinct sets of genes in these cells.	SEN:10024054	11297548
BEL:20044206	p(HGNC:NRG1) increases complex(p(HGNC:GRB2),p(HGNC:ERBB3))	As expected, EGF preferentially stimulated the recruitment of the adaptor protein Grb2 to EGF receptor whereas NRG1beta preferentially stimulated the recruitment of this protein to ErbB3. NRG1beta also preferentially stimulated the association of p85, the 85-kDa subunit of PI3K, with ErbB3, as demonstrated previously (40).	SEN:10024056	11297548
BEL:20044208	p(HGNC:NRG1) increases complex(p(HGNC:GRB2),p(HGNC:PIK3R1))	As expected, EGF preferentially stimulated the recruitment of the adaptor protein Grb2 to EGF receptor whereas NRG1beta preferentially stimulated the recruitment of this protein to ErbB3. NRG1beta also preferentially stimulated the association of p85, the 85-kDa subunit of PI3K, with ErbB3, as demonstrated previously (40).	SEN:10024056	11297548
BEL:20044210	p(HGNC:NRG1) increases kin(p(HGNC:ERBB4))	Activation of ERBB4 was observed upon treatment of cells with NDF. BTC was more efficient than NDF at phosphorylating ErbB4. However, SKBR3-ErbB4 was not growth inhibited by BTC. Instead, the presence of ErbB4 appeared to increase the growth effect of BTC. Interestingly, the growth of SKBR3-ErbB1 was inhibited by BTC (61.7% of controls).	SEN:10024058	10376522
BEL:20044218	p(HGNC:NRG1) increases p(HGNC:ERBB3,pmod(P,Y))	NDF and Betacellulin (BTC) induced increase in tyrosine phosphorylation of ErbB3. NDF induced the strongest increase in the ErbB3 phosphotyrosine.	SEN:10024064	10376522
BEL:20044228	p(HGNC:NRG1) increases r(HGNC:HMGA1)	HMG-I(Y) expression is reduced in MDA-MB-231 cells on antisense-HRG transfection and MMP-9 inhibitor treatment.	SEN:10024070	10582687
BEL:20044230	p(HGNC:NRG1) increases r(HGNC:HNRNPK)	Both EGF and heregulin-beta1 induced expression of hnRNP K mRNA and protein in human breast cancer cells.	SEN:10024072	11121407
BEL:20044240	p(HGNC:NRG2) directlyIncreases complex(p(HGNC:ERBB3),p(HGNC:ERBB2))	In MDA-MB-453 cells, NRG1beta acting through an ErbB2/ErbB3 heterodimer stimulated prolonged signaling of all pathways examined relative to NRG2beta acting through the same heterodimeric receptor species. Surprisingly, NRG1beta and NRG2beta also regulated partially overlapping but distinct sets of genes in these cells.	SEN:10024054	11297548
BEL:20044242	p(HGNC:NRP1) increases kin(p(HGNC:KDR))	At least for the interaction between VEGF-A165 and VEGFR-2, it has been demonstrated that neuropilin-1 acts as a co-receptor which enhances the affinity of the receptor for the ligand (Soker et al., 1998).	SEN:10024076	10022831
BEL:20044252	p(HGNC:NTF3) increases r(HGNC:GAP43)	NT-3 Enhances Expression of the Neuronal Differentiation Marker Genes GAP-43 and NPY in SH-SY5Y/ trkC Cells.	SEN:10024080	11205744
BEL:20044254	p(HGNC:NTF3) increases r(HGNC:NPY)	NT-3 Enhances Expression of the Neuronal Differentiation Marker Genes GAP-43 and NPY in SH-SY5Y/ trkC Cells.	SEN:10024080	11205744
BEL:20044256	p(HGNC:NTF3) increases r(HGNC:NTRK1)	During this phase, NT-3 serves as a trophic and survival factor, resulting in growth arrest, trkA expression, and NGF dependency (23 , 24 , 25 , 26) .	SEN:10024082	11205744
BEL:20044262	p(HGNC:NTRK1) increases r(HGNC:FOS)	As demonstrated in Fig. 8 A ,c- fos expression was strongly induced by 100 ng/ml NGF in SH-SY5Y/ trkA cells, whereas p145 trkC activation induced a barely detectable increase in c- fos expression.In particular, c-fos was not induced in the SH-SY5Y/trkC cells	SEN:10024086	11205744
BEL:20044264	p(HGNC:NTS) increases cat(p(HGNC:SORT1))	The identification of gp95sortilin, a sorting protein, as being the 100 kDa neurotensin (NT) receptor	SEN:10007446	11257441
BEL:20044266	p(HGNC:OSM) increases bp(GOBP:"cell migration")	The IL-6-type cytokines, IL-6 and oncostatin M, simultaneously inhibited cell proliferation and increased cell migration	SEN:10023672	11196191
BEL:20044268	p(HGNC:OSM) decreases bp(GOBP:"cell proliferation")	The IL-6-type cytokines, IL-6 and oncostatin M, simultaneously inhibited cell proliferation and increased cell migration	SEN:10023672	11196191
BEL:20044274	p(HGNC:OSM) decreases r(HGNC:CSF1)	As shown in Fig. 4 C and D , OSM inhibited expression of M-CSF and macrophage chemoattractant protein 1 mRNA in hepatic cells (Fig. 4 C ), and chemotactic activity produced in culture media also was decreased by OSM (Fig. 4 D ).	SEN:10024088	10377403
BEL:20044276	p(HGNC:OSM) increases r(HGNC:F3)	Inhibition of MEK activity by U0126 prevented OSM-induced TF expression by suppressing NF-kappaB DNA binding activity as determined by gel-shift analysis.	SEN:10024090	11157486
BEL:20044278	p(HGNC:OSM) increases r(HGNC:LDLR)	The cytokine oncostatin M (OM) activates human low density lipoprotein receptor (LDLR) gene transcription through a sterol-independent mechanism.	SEN:10007452	10671569
BEL:20044304	p(HGNC:PCNA) directlyIncreases cat(p(HGNC:LIG1))	<r8> PCNA binds DNA ligase I; the complex may function to join Okazaki fragments during DNA replication (Levin et al.,1997).	SEN:10023872	10436023
BEL:20044306	p(HGNC:PDAP1) increases complex(p(HGNC:PDGFA),p(HGNC:PDGFA))	Another PDGF binding protein was isolated from a rat neural retina cell line and called PDGF-associated protein (PAP) (124). PAP binds PDGF with low affinity and was found to enhance the activity of PDGF-AA but depress the activity of PDGF-BB.	SEN:10024098	10508235
BEL:20044308	p(HGNC:PDAP1) decreases complex(p(HGNC:PDGFB),p(HGNC:PDGFB))	Another PDGF binding protein was isolated from a rat neural retina cell line and called PDGF-associated protein (PAP) (124). PAP binds PDGF with low affinity and was found to enhance the activity of PDGF-AA but depress the activity of PDGF-BB.	SEN:10024098	10508235
BEL:20044310	p(HGNC:PDE3B,pmod(P)) directlyIncreases cat(p(HGNC:PDE3B))	Moreover, the phosphorylation and activation of PDE3B correlates with the inactivation of PKA and the dephosphorylation of HSL	SEN:10018648	10976911
BEL:20044316	p(HGNC:PDGFA) increases r(HGNC:CCND2)	The withdrawal of the mitogen platelet-derived growth factor (PDGF), but not TH or RA treatment, causes a rapid decrease in c-fos, NGFI-A/Krox-24, and cyclin D2 mRNA	SEN:10007464	10479451
BEL:20044318	p(HGNC:PDGFA) decreases r(HGNC:CCND3)	PDGF withdrawal and TH treatment, but not RA treatment, induce an increase in cyclin D3 mRNA within 4 h	SEN:10007466	10479451
BEL:20044320	p(HGNC:PDGFA) increases r(HGNC:EGR1)	The withdrawal of the mitogen platelet-derived growth factor (PDGF), but not TH or RA treatment, causes a rapid decrease in c-fos, NGFI-A/Krox-24, and cyclin D2 mRNA	SEN:10007464	10479451
BEL:20044322	p(HGNC:PDGFA) increases r(HGNC:FOS)	The withdrawal of the mitogen platelet-derived growth factor (PDGF), but not TH or RA treatment, causes a rapid decrease in c-fos, NGFI-A/Krox-24, and cyclin D2 mRNA	SEN:10007464	10479451
BEL:20044324	p(HGNC:PDGFB) increases bp(GOBP:"cell migration")	The neurotrophin, nerve growth factor (NGF), and insulin-like growth factor 1 induce the migration but not the proliferation of smooth muscle cells, whereas PDGF-BB stimulates both responses.	SEN:10007092	10195934
BEL:20044326	p(HGNC:PDGFB) increases bp(GOBP:"cell proliferation")	The neurotrophin, nerve growth factor (NGF), and insulin-like growth factor 1 induce the migration but not the proliferation of smooth muscle cells, whereas PDGF-BB stimulates both responses.	SEN:10007092	10195934
BEL:20044332	p(HGNC:PDGFB) increases p(HGNC:VEGFA)	VEGF endogenous production may be upregulated in vascular smooth muscle cells by hypoxia, growth factors (bFGF and PDGF-BB), and cytokines	SEN:10018124	11350732
BEL:20044342	p(HGNC:PEA15) decreases complex(p(HGNC:FADD),p(HGNC:CASP8))	As shown in Figure 7b (top), PED cDNA transfection induced a fourfold overexpression of this protein by the cells but also reduced FADD co-precipitation with FLICE by threefold (Figure 7a). The levels of FADD and FLICE were identical in PED overexpressing and in control cells (Figure 7b, middle and bottom panels), indicating that PED displaces FADD interaction with FLICE.	SEN:10024106	10442631
BEL:20044370	p(HGNC:PHOX2B) increases r(HGNC:CREB1)	Furthermore, we found that NBPhox can also enhance second messenger-mediated activation of the c-fos promoter and several enhancers, including cyclic AMP-response element, the binding site for activator protein 1, and serum-response element.	SEN:10007474	10395798
BEL:20044372	p(HGNC:PHOX2B) increases r(HGNC:DBH)	However, NBPhox substantially enhances second messenger-mediated activation of the DBH promoter by forskolin and/or phorbol ester.	SEN:10024122	10395798
BEL:20044374	p(HGNC:PHOX2B) increases r(HGNC:FOS)	Furthermore, we found that NBPhox can also enhance second messenger-mediated activation of the c-fos promoter and several enhancers, including cyclic AMP-response element, the binding site for activator protein 1, and serum-response element.	SEN:10007474	10395798
BEL:20044376	p(HGNC:PHOX2B) increases r(HGNC:SRF)	Furthermore, we found that NBPhox can also enhance second messenger-mediated activation of the c-fos promoter and several enhancers, including cyclic AMP-response element, the binding site for activator protein 1, and serum-response element.	SEN:10007474	10395798
BEL:20044378	p(HGNC:PIAS1) increases tscript(p(HGNC:AR))	In transient cotransfection assays using CV1 cells with full-length human AR and a mouse mammary tumor virus luciferase reporter vector, there was an androgen-dependent 3- to 5-fold greater increase in luciferase activity with PIAS1 over that obtained with an equal amount of control antisense cDNA or mutant PIAS1	SEN:10024124	10628744
BEL:20044380	p(HGNC:PIAS1) decreases tscript(p(HGNC:STAT1))	Methyl-thioadenosine, a methyl-transferase inhibitor that accumulates in many transformed cells, inhibits STAT1-mediated IFN responses. This inhibition arises from impaired STAT1-DNA binding due to an increased association of the STAT inhibitor PIAS1 with phosphorylated STAT1 dimers in the absence of arginine methylation.	SEN:10024126	11257227
BEL:20044382	p(HGNC:PIGF) increases kin(p(HGNC:FLT1))	VEGF-D is a ligand specific for VEGFR2, whereas plaaVb3- cental growth factor (PlGF) interacts selectively with VEGFR1 (Ferrara, 1999).	SEN:10024128	11090623
BEL:20044392	p(HGNC:PLA2G4A,pmod(P,S,505)) directlyIncreases cat(p(HGNC:PLA2G4A))	we show that phosphorylation of cPLA2 at both Ser-505 and Ser-727 and elevation of Ca(2+) leads to its activation in agonist-stimulated cells.	SEN:10024134	10978317
BEL:20044394	p(HGNC:PLA2G4A,pmod(P,S,727)) directlyIncreases cat(p(HGNC:PLA2G4A))	we show that phosphorylation of cPLA2 at both Ser-505 and Ser-727 and elevation of Ca(2+) leads to its activation in agonist-stimulated cells.	SEN:10024134	10978317
BEL:20044396	p(HGNC:PLA2G4A) increases r(HGNC:PTGIS)	Furthermore, the PGI2 synthesis was strongly inhibited by the cytosolic phospholipase A2 inhibitor, MAFP and totally suppressed by the combination of the calcium chelators, BAPTA and EGTA.	SEN:10007476	11129656
BEL:20044406	p(HGNC:POMC) increases r(HGNC:PPT1)	Indeed, ACTH and PRL induced the expression of PPT-I and NK-1 in human bone marrow stroma with no effect on NK-2.	SEN:10007482	11108948
BEL:20044416	p(HGNC:POU4F2) increases r(HGNC:NGF)	In these experiments, no statistically significant alteration in survival was observed in the cells overexpressing BRN-3B compared with the vector controls in cultures maintained in the presence of NGF (Fig. 11 A ).	SEN:10024146	11053412
BEL:20044442	p(HGNC:PPARA) decreases p(HGNC:IL6)	In human aortic smooth muscle cells, fibrates inhibit the IL-1b?induced expression of cyclooxygenase (COX)-2 and IL-6 by inhibiting the NF-kB and AP-1 signaling pathway.9,10	SEN:10024148	11208678
BEL:20044444	p(HGNC:PPARA) decreases p(HGNC:JUN)	In human aortic smooth muscle cells, fibrates inhibit the IL-1b?induced expression of cyclooxygenase (COX)-2 and IL-6 by inhibiting the NF-kB and AP-1 signaling pathway.9,10	SEN:10024148	11208678
BEL:20044446	p(HGNC:PPARA) decreases p(HGNC:JUN)	In human vascular endothelial cells, PPARa inhibits the thrombin-mediated activation of endothelin-1 via negative interference with the AP-1 signaling pathway.13	SEN:10024166	11208678
BEL:20044448	p(HGNC:PPARA) decreases p(HGNC:PTGS2)	In human aortic smooth muscle cells, fibrates inhibit the IL-1b?induced expression of cyclooxygenase (COX)-2 and IL-6 by inhibiting the NF-kB and AP-1 signaling pathway.9,10	SEN:10024148	11208678
BEL:20044452	p(HGNC:PPARA) decreases p(HGNC:VCAM1)	PPARa activators prevent TNF-a?induced VCAM-1 expression in human saphenous vein endothelial cells, partly via inhibition of the NF-kB pathway.14	SEN:10024150	11208678
BEL:20044454	p(HGNC:PPARA) decreases r(HGNC:F3)	Incubation of THP-1 cells with PPARa activators 1 hour before LPS stimulation for 2 hours resulted in a decreased level of TF mRNA compared with cells incubated with only LPS (Figure 2A).	SEN:10024170	11208678
BEL:20044470	p(HGNC:PPP1CA,pmod(P,T,320)) directlyIncreases complex(p(HGNC:PPP1CA),p(HGNC:RB1))	Consistent with this result, PP1alpha phosphorylated at Thr-320 co-precipitated with pRB during G(1)/S but was found in extracts immunodepleted of pRB in M-phase.	SEN:10024184	10506210
BEL:20044478	p(HGNC:PPP1R1B,pmod(P,T,75)) directlyDecreases cat(p(HGNC:PPP1R1B))	In resting neostriatal slices, cyclin-dependent kinase 5 (Cdk5) phosphorylates DARPP-32 at Thr-75, thereby reducing the efficacy of dopaminergic signaling.	SEN:10021164	11050161
BEL:20044480	p(HGNC:PRDM1) decreases r(HGNC:FCER2)	Cotransfection of Blimp1 blocked the ability of IRF-4 to drive CD23b promoter activity and to augment the IL-4 inducibility of this reporter construct.	SEN:10024186	11342629
BEL:20044482	p(HGNC:PRDX6) decreases a(CHEBI:"reactive oxygen species")	Additionally, several studies have shown that antioxidant enzymes and mimics also block NF-kB activation by various stimuli. For example, overexpression of peroxiredoxin [247] or thioredoxin [111] blocks NF-kB activation by H2O2.	SEN:10024188	10699758
BEL:20044484	p(HGNC:PRDX6) decreases bp(GOBP:"response to oxidative stress")	Additionally, several studies have shown that antioxidant enzymes and mimics also block NF-kB activation by various stimuli. For example, overexpression of peroxiredoxin [247] or thioredoxin [111] blocks NF-kB activation by H2O2.	SEN:10024188	10699758
BEL:20044490	p(HGNC:PRKACA) increases p(HGNC:GSK3A,pmod(P,S,21))	Transfection of PKAc, but not empty vector, enhanced phosphorylation of cotransfected GSK-3a and -b at serine 21 and 9 in HEK293 cells (Fig. 4A).	SEN:10024192	11035810
BEL:20044492	p(HGNC:PRKACA) increases p(HGNC:GSK3B,pmod(P,S,9))	Transfection of PKAc, but not empty vector, enhanced phosphorylation of cotransfected GSK-3a and -b at serine 21 and 9 in HEK293 cells (Fig. 4A).	SEN:10024192	11035810
BEL:20044498	p(HGNC:PRKCA) decreases p(HGNC:PDGFRA)	Protein kinase C (PKC) seems to be involved in negative regulation of the alpha -receptor, since overexpression of PKC-alpha suppressed the expression of the alpha -receptor but not the beta -receptor (125).	SEN:10021428	10508235
BEL:20044500	p(HGNC:PRKCA) decreases r(HGNC:PDGFRA)	Protein kinase C (PKC) seems to be involved in negative regulation of the alpha -receptor, since overexpression of PKC-alpha suppressed the expression of the alpha -receptor but not the beta -receptor (125).	SEN:10021428	10508235
BEL:20044516	p(HGNC:PRKCI) directlyIncreases kin(p(HGNC:MAP2K5))	Here we demonstrate that the aPKCs interact in an EGF-inducible manner with MEK5 and that this interaction is required and sufficient for the activation of MEK5 in response to EGF.	SEN:10024196	11158308
BEL:20044524	p(HGNC:PRKCZ) increases deg(p(HGNC:NFKBIA))	overexpressing PKC-zeta results in lower steady-state protein levels of free IkappaBalpha, which is dependent on S293.	SEN:10001436	10764587
BEL:20044526	p(HGNC:PRKCZ) directlyIncreases kin(p(HGNC:MAP2K5))	Here we demonstrate that the aPKCs interact in an EGF-inducible manner with MEK5 and that this interaction is required and sufficient for the activation of MEK5 in response to EGF.	SEN:10024196	11158308
BEL:20044532	p(HGNC:PRL) increases p(HGNC:ERBB2,pmod(P,Y))	Our results indicate that autocrine secretion of PRL stimulates tyrosine phosphorylation of ErbB-2 by Jak2, provides docking sites for Grb2 and stimulates Ras-MAP kinase cascade, thereby causing unrestricted cellular proliferation.	SEN:10021268	10938266
BEL:20044536	p(HGNC:PRL) increases r(HGNC:CISH)	SOCS-3 and SOCS-1 genes were transiently expressed in response to PRL, both in vivo and in vitro, whereas the expression of SOCS-2 and CIS genes was still elevated 24 h after hormonal stimulation	SEN:10007488	10455112
BEL:20044544	p(HGNC:PRL) increases r(HGNC:PRLR)	Expression of the prolactin receptor (PRLR) gene is increased in pancreatic islets during pregnancy and in vitro in insulin-producing cells by growth hormone (GH) and prolactin (PRL).	SEN:10006974	10373481
BEL:20044546	p(HGNC:PRL) increases r(HGNC:SOCS2)	SOCS-3 and SOCS-1 genes were transiently expressed in response to PRL, both in vivo and in vitro, whereas the expression of SOCS-2 and CIS genes was still elevated 24 h after hormonal stimulation	SEN:10007488	10455112
BEL:20044548	p(HGNC:PRL) increases tloc(p(HGNC:STAT5A),GOCCID:0005737,GOCCID:0005634)	Following prolactin activation, both STAT5A and STAT5B were rapidly translocated into the nucleus and displayed a detergent-resistant, punctate nuclear staining pattern.	SEN:10007490	10428824
BEL:20044550	p(HGNC:PRL) increases tloc(p(HGNC:STAT5B),GOCCID:0005737,GOCCID:0005634)	Following prolactin activation, both STAT5A and STAT5B were rapidly translocated into the nucleus and displayed a detergent-resistant, punctate nuclear staining pattern.	SEN:10007490	10428824
BEL:20044560	p(HGNC:PROS1) directlyIncreases cat(p(HGNC:MMP2))	APC activation of gelatinase A occurred in the absence of cells, indicating that it acts directly. APC may contribute to the physiological/pathological mechanism of gelatinase A activation, especially during angiogenesis.	SEN:10007494	10734039
BEL:20044564	p(HGNC:PRPH) decreases r(HGNC:VIM)	The absence of peripherin resulted in 50% increase of vimentin levels in spinal cord extracts and in 60% increase of -internexin levels in the snDRGs ( Fig. 1d ).	SEN:10024208	10693932
BEL:20044566	p(HGNC:PRSS1) increases r(HGNC:MUC5AC)	pancreatic trypsin, a serine protease, stimulated a significant increase in MUC5AC transcript levels in A549 cells (Fig. 5A)	SEN:10024210	10330040
BEL:20044568	p(HGNC:PRTN3) increases r(HGNC:CCL2)	Incubation of HUVEC in the presence of increasing concentrations of PR3 resulted in a dose-dependent increase of MCP-1 production.	SEN:10024212	11316851
BEL:20044570	p(HGNC:PRTN3) increases r(HGNC:ICAM1)	Incubation of the cells in the presence of PR3 (10 mg/ml) resulted in a 2.9-fold increase in fluorescence intensity (MFI of 1074), indicating enhanced ICAM-1 expression. PR3 enhanced the expression of ICAM-1 in six of six primary HUVEC cultures.	SEN:10024214	11316851
BEL:20044574	p(HGNC:PSEN1) increases complex(p(HGNC:CTNNB1),p(HGNC:GSK3B))	Inducible overexpression of PS1 led to increased association of beta-catenin with glycogen synthase kinase-3beta (GSK-3beta), a negative regulator of beta-catenin, and accelerated the turnover of endogenous beta-catenin.	SEN:10001352	10341227
BEL:20044576	p(HGNC:PSEN1) increases deg(p(HGNC:CTNNB1))	Inducible overexpression of PS1 led to increased association of beta-catenin with glycogen synthase kinase-3beta (GSK-3beta), a negative regulator of beta-catenin, and accelerated the turnover of endogenous beta-catenin.	SEN:10001352	10341227
BEL:20044578	p(HGNC:PSEN1) increases deg(p(HGNC:CTNNB1))	In support of this finding, the beta-catenin half-life was dramatically longer in fibroblasts deficient in PS1, and this phenotype was completely rescued by replacement of PS1, demonstrating that PS1 normally stimulates the degradation of beta-catenin.	SEN:10024216	10341227
BEL:20044580	p(HGNC:PSEN1) decreases p(HGNC:CTNNB1)	In support of this finding, the beta-catenin half-life was dramatically longer in fibroblasts deficient in PS1, and this phenotype was completely rescued by replacement of PS1, demonstrating that PS1 normally stimulates the degradation of beta-catenin.	SEN:10024216	10341227
BEL:20044590	p(HGNC:PTAFR) increases p(HGNC:PLA2G7)	In addition, we demonstrated that the PAF receptor participates in the signaling pathway, which results in the induction of PAF acetylhydrolase expression in response to endotoxin.	SEN:10024222	10748027
BEL:20044618	p(HGNC:PTGER1) increases bp(GOBP:"wound healing")	To determine which receptors were stimulated by PGE2 to promote wound closure, wounded monolayers of 16HBE14o2 cells were treated with agonists and antagonists of EP1, EP3, and EP4 receptors. Figure 5 shows that both the EP1 receptor antagonist AH-6809 and the EP4 receptor antagonist AH-23848B significantly inhibited wound repair compared with that in untreated control monolayers.	SEN:10024232	11159024
BEL:20044620	p(HGNC:PTGER4) increases bp(GOBP:"wound healing")	To determine which receptors were stimulated by PGE2 to promote wound closure, wounded monolayers of 16HBE14o2 cells were treated with agonists and antagonists of EP1, EP3, and EP4 receptors. Figure 5 shows that both the EP1 receptor antagonist AH-6809 and the EP4 receptor antagonist AH-23848B significantly inhibited wound repair compared with that in untreated control monolayers.	SEN:10024232	11159024
BEL:20044624	p(HGNC:PTGS1) increases bp(GOBP:"wound healing")	we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin. Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells	SEN:10015812	11159024
BEL:20044626	p(HGNC:PTGS2) decreases a(CHEBI:"arachidonic acid")	the cellular level of unesterified arachidonic acid is a general mechanism by which apoptosis is regulated and that COX-2 and FACL4 promote carcinogenesis by lowering this level.	SEN:10006544	11005842
BEL:20044628	p(HGNC:PTGS2) increases bp(GOBP:"wound healing")	we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin. Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells	SEN:10015812	11159024
BEL:20044636	p(HGNC:PTHLH) decreases r(HGNC:CDKN1A)	Furthermore, PTHrP up-regulated the cell proliferation and down-regulated the expression of the p21 messengers in SW-1353 chondrosarcoma cells.	SEN:10007502	11136536
BEL:20044638	p(HGNC:PTHLH) decreases r(HGNC:IBSP)	Results demonstrated that PTHrP repressed gene expression and protein synthesis of bone sialoprotein (BSP) and abolished cementoblast-mediated biomineralization in vitro. The BSP gene inhibition required protein synthesis.	SEN:10024238	11108282
BEL:20044640	p(HGNC:PTH) increases r(HGNC:IGF1)	Both parathyroid hormone and prostaglandin E 2 (PGE 2 ) stimulate IGF-I synthesis in cultured osteoblasts by enhancing IGF-I gene expression ( 11 , 12 ) through mechanisms that are secondary to hormonal induction of cAMP accumulation ( 5 , 7 , 11 ).	SEN:10024240	10187857
BEL:20044642	p(HGNC:PTH) decreases r(HGNC:PTH1R)	PTHR1 mRNA was expressed predominantly by osteoblasts, but also by resorbing osteoclasts, suggesting that these cells may be stimulated directly by PTH.	SEN:10007504	10633457
BEL:20044646	p(HGNC:PTK2B,pmod(P,Y,402)) directlyIncreases kin(p(HGNC:PTK2B))	First, we generated site-specific CADTK mutants. Mutation of Tyr402 eliminated autophosphorylation and significantly decreased kinase activity.	SEN:10021442	10085136
BEL:20044650	p(HGNC:PTK2,pmod(P,S)) decreases complex(p(HGNC:PTK2),p(HGNC:GRB2),p(HGNC:SOS1))	Whereas FAK is phosphorylated on tyrosine upon assembly of focal adhesions, it becomes phosphorylated on serine and disassociates from Src and p130CAS during mitosis (14). These events may loosen cell-substrate contacts and allow cells to divide and move apart.	SEN:10018060	10446041
BEL:20044652	p(HGNC:PTK2,pmod(P,S)) directlyDecreases kin(p(HGNC:PTK2))	Whereas FAK is phosphorylated on tyrosine upon assembly of focal adhesions, it becomes phosphorylated on serine and disassociates from Src and p130CAS during mitosis (14). These events may loosen cell-substrate contacts and allow cells to divide and move apart.	SEN:10018060	10446041
BEL:20044654	p(HGNC:PTK2,pmod(P,Y)) decreases bp(GOBP:"apoptotic process")	FAK is critical for maintaining survival signals in several adherent cell types, and in endothelial cells FAK tyrosine dephosphorylation and caspase-mediated proteolytic cleavage are early responses to apoptogenic stimuli	SEN:10024244	11350732
BEL:20044656	p(HGNC:PTK2,pmod(P,Y)) directlyIncreases kin(p(HGNC:PTK2))	Downstream Signaling Mediator: FAK FAK is recruited to focal adhesion complexes. The clustering of integrins and formation of the focal adhesion complex can induce tyrosine phosphorylation of FAK, as can other stimuli (32, 54).	SEN:10018592	10642399
BEL:20044660	p(HGNC:PTN) decreases phos(p(HGNC:PTPRB))	Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta	SEN:10007508	10706604
BEL:20044662	p(HGNC:PTN) decreases phos(p(HGNC:PTPRZ1))	Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta	SEN:10007508	10706604
BEL:20044666	p(HGNC:PTPN11,pmod(P,Y)) increases bp(GOBP:"MAPK cascade")	This study shows that in hepatoma cells, the recruitment and tyrosine phosphorylation of SHP-2, but not SHC, is the primary signaling event associated with the activation of MAP kinases (ERK1/2) by gp130.	SEN:10023704	10409724
BEL:20044668	p(HGNC:PTPN11,pmod(P,Y)) directlyIncreases complex(p(HGNC:PTPN11),p(HGNC:IRS1))	The SH2 domain of the adaptor protein Grb- 2 and the SH2 domain of the phosphotyrosine phosphatase SHP-2 bind other sequences, including pYVNI, pYIDL, and pYASI sequences (1).	SEN:10023202	10194465
BEL:20044672	p(HGNC:PTPN3) decreases bp(GOBP:"cell growth")	Ectopic expression of wild type PTPH1 dramatically inhibited cell growth, whereas a catalytically impaired mutant showed no effect.	SEN:10024248	10364224
BEL:20044674	p(HGNC:PTPN6,pmod(P,Y,564)) directlyIncreases phos(p(HGNC:PTPN6))	The results show that Lyn phosphorylates SHPTP1 at the C-terminal Tyr-564 site. Lyn-mediated phosphorylation of SHPTP1 stimulates SHPTP1 tyrosine phosphatase activity.	SEN:10021296	10574931
BEL:20044678	p(HGNC:PTTG1) increases bp(GOBP:"apoptotic process")	In MCF-7 breast cancer cells that express wild type p53, PTTG overexpression caused apoptosis. p53 was translocated to the nuclei in cells expressing PTTG .	SEN:10007514	11013229
BEL:20044680	p(HGNC:PTTG1) increases tloc(p(HGNC:TP53),GOCCID:0005737,GOCCID:0005634)	In MCF-7 breast cancer cells that express wild type p53, PTTG overexpression caused apoptosis. p53 was translocated to the nuclei in cells expressing PTTG .	SEN:10007514	11013229
BEL:20044684	p(HGNC:PXN) increases bp(GOBP:"cell cycle")	Certain integrins may regulate proliferation by additional mechanisms. For example, the a6b1 integrin may in part promote exit from the cell cycle in myoblasts, because the cytoplasmic domain of a6 inhibits paxillin signaling (44).	SEN:10018334	10446041
BEL:20044686	p(HGNC:PXN,pmod(P,Y)) directlyIncreases cat(p(HGNC:PXN))	A downstream target of FAK is paxillin, a phosphoprotein that also can localize to focal adhesion complexes (9).	SEN:10021444	10642399
BEL:20044688	p(HGNC:PXN,pmod(P,Y)) directlyIncreases complex(p(HGNC:PXN),p(HGNC:CRK))	Crk has been reported to associate with tyrosine-phosphorylated proteins, such as p130Cas and paxillin (42, 43), involved in the rearrangement of cytoskeletal components, through its SH2 domain.	SEN:10022614	10194465
BEL:20044704	p(HGNC:RAC1,pmod(P,S,71)) directlyDecreases gtp(p(HGNC:RAC1))	The phosphorylation of Rac1 inhibited its GTP-binding activity without any significant change in GTPase activity.	SEN:10022248	10617634
BEL:20044714	p(HGNC:RAF1,pmod(P,T,269)) directlyIncreases kin(p(HGNC:RAF1))	Using purified wild-type and mutant c-Raf-1 proteins, we demonstrate that Thr(269) is the major c-Raf-1 site phosphorylated by KSR in vitro and that phosphorylation of this site is essential for c-Raf-1 activation by KSR.	SEN:10021280	11134016
BEL:20044716	p(HGNC:RALA) increases r(HGNC:PLAUR)	A dominant negative inhibitor of c-Src effectively inhibited RalA-dependent uPAR transcription identifying it as a downstream effector in the RalA signalling pathway.	SEN:10021482	11313929
BEL:20044730	p(HGNC:RARA) increases r(HGNC:SFTPB)	TTF-1 protein synergistically stimulated the hSP-B promoter with RARalpha, CBP, and nuclear receptor coactivators in H441 cells.	SEN:10006760	10617585
BEL:20044736	p(HGNC:RASGRF1,pmod(P,Y)) directlyIncreases cat(p(HGNC:RASGRF1))	We show here that activated ACK1, a nonreceptor tyrosine kinase that belongs to the focal adhesion kinase family, causes tyrosine phosphorylation of Ras-GRF1.	SEN:10021490	10882715
BEL:20044742	p(HGNC:RB1) decreases p(HGNC:BRCA1)	inactivation of pRb increased BRCA1 expression and abolished the ability of TGF-beta1 to inhibit BRCA1 expression.	SEN:10024260	11027532
BEL:20044744	p(HGNC:RB1,pmod(P)) decreases complex(p(HGNC:ABL1),p(HGNC:RB1))	<A9> Phosphorylation of pRb disrupts the c-Abl:pRb complex and releases active c-Abl (Welch and Wang, 1995).	SEN:10024262	10436023
BEL:20044746	p(HGNC:RB1,pmod(P,S,780)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	PD 0183812 causes a sustained cytostatic block in MDA-MB-453 cell proliferation, which is correlated with the loss of pRb phosphorylation, which block is reversible and accompanied by a return of phosphorylation on pRb serine 780	SEN:10024264	11278443
BEL:20044750	p(HGNC:RB1,pmod(P)) directlyDecreases tscript(p(HGNC:RB1))	GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity.	SEN:10022732	11118353
BEL:20044754	p(HGNC:RB1) decreases r(HGNC:RBL1)	<E21> The p107 promoter contains E2F recognition elements and can be repressed by pRb or p107 (Zhu et al., 1995).	SEN:10024268	10436023
BEL:20044756	p(HGNC:RBL1) decreases r(HGNC:RBL1)	<E21> The p107 promoter contains E2F recognition elements and can be repressed by pRb or p107 (Zhu et al., 1995).	SEN:10024268	10436023
BEL:20044760	p(HGNC:RBMS1) increases bp(GOBP:"DNA replication")	MSSP possesses versatile functions, including stimulation of DNA replication, transcriptional regulation, apoptosis induction, and cell transformation coordinated by c-Myc.	SEN:10007526	10869558
BEL:20044762	p(HGNC:RBMS1) increases bp(GOBP:"apoptotic process")	MSSP possesses versatile functions, including stimulation of DNA replication, transcriptional regulation, apoptosis induction, and cell transformation coordinated by c-Myc.	SEN:10007526	10869558
BEL:20044764	p(HGNC:RBMS1) increases cat(p(HGNC:MYC))	MSSP possesses versatile functions, including stimulation of DNA replication, transcriptional regulation, apoptosis induction, and cell transformation coordinated by c-Myc.	SEN:10007526	10869558
BEL:20044766	p(HGNC:RBMS1) increases cat(p(HGNC:POLA1))	interacts with a catalytic subunit of DNA polymerase alpha and stimulates its polymerase activity... MSSP stimulated DNA polymerase activity in vitro.	SEN:10024272	10869558
BEL:20044772	p(HGNC:RBPJ) decreases r(HGNC:MYOD1)	VP16-RBP-J, inhibited muscle differentiation of C2C12 cells by blocking the expression of MyoD protein.	SEN:10007530	10066785
BEL:20044792	p(HGNC:RELA) increases r(HGNC:IL6)	Cotransfection of the p65 NF-kB subunit resulted in a strong activation of wild-type IL-6 promoter activity (11-fold) (Fig. 3A).	SEN:10024282	10542237
BEL:20044806	p(HGNC:REL) increases r(HGNC:LYZ)	These factors and c-rel are responsible for the upregulation of the lysozyme promoter during LPS-induced macrophage activation (Goethe and Phi van 1994 ; Phi van 1996 ).	SEN:10024290	10950873
BEL:20044818	p(HGNC:RFC1) directlyIncreases complex(p(HGNC:PCNA),p(HGNC:PCNA),p(HGNC:PCNA),a(CHEBI:"double-stranded DNA"))	<r4> Clamp-loader RF-C loads PCNA onto the DNA (Kelman, 1997). RF-C interacts with the C-terminal side of PCNA (Mossi et al., 1997).	SEN:10024294	10436023
BEL:20044828	p(HGNC:ROCK1) increases kin(p(HGNC:LIMK1))	Y-27632, a specific inhibitor of ROCK, inhibited LIM-kinase-induced cofilin phosphorylation but did not affect fibronectin-induced or TESK1-induced cofilin phosphorylation in HeLa cells.	SEN:10021288	11294912
BEL:20044830	p(HGNC:ROCK1) decreases p(HGNC:CFL1,pmod(P,S))	Y-27632, a specific inhibitor of ROCK, inhibited LIM-kinase-induced cofilin phosphorylation but did not affect fibronectin-induced or TESK1-induced cofilin phosphorylation in HeLa cells.	SEN:10021288	11294912
BEL:20044832	p(HGNC:RPA2,pmod(P,S,33)) decreases complex(p(HGNC:RPA2),p(HGNC:RPA3),p(HGNC:RPA1),p(HGNC:PRKDC))	<s16> DNA-PK can bind to RPA (Shao et al., 1999). <s17> Phosphorylation of RPA2 by DNA-PK impairs the binding of RPA to DNA-PK (Shao et al., 1999).	SEN:10024302	10436023
BEL:20044834	p(HGNC:RPA2,pmod(P,T,21)) decreases complex(p(HGNC:RPA2),p(HGNC:RPA3),p(HGNC:RPA1),p(HGNC:PRKDC))	<s16> DNA-PK can bind to RPA (Shao et al., 1999). <s17> Phosphorylation of RPA2 by DNA-PK impairs the binding of RPA to DNA-PK (Shao et al., 1999).	SEN:10024302	10436023
BEL:20044836	p(HGNC:RPS6KA3,pmod(P,S,227)) directlyIncreases kin(p(HGNC:RPS6KA3))	The N-terminal kinase is activated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) through phosphorylation of Ser227, and phosphorylates the substrates of RSK.	SEN:10021400	10856237
BEL:20044838	p(HGNC:RPS6KA3,pmod(P,S,386)) directlyIncreases complex(p(HGNC:RPS6KA3),p(HGNC:PDPK1))	Here, we identify Ser386 in the hydrophobic motif of RSK2 as a phosphorylation-dependent docking site and activator of PDK1.	SEN:10024304	10856237
BEL:20044840	p(HGNC:RPS6KA3,pmod(P,S,386)) increases kin(p(HGNC:PDPK1))	Here, we identify Ser386 in the hydrophobic motif of RSK2 as a phosphorylation-dependent docking site and activator of PDK1.	SEN:10024304	10856237
BEL:20044842	p(HGNC:RPS6KA3,pmod(P,S,386)) directlyIncreases kin(p(HGNC:RPS6KA3))	Here, we identify Ser386 in the hydrophobic motif of RSK2 as a phosphorylation-dependent docking site and activator of PDK1.	SEN:10024304	10856237
BEL:20044844	p(HGNC:RPS6KA3,pmod(P,S)) directlyIncreases kin(p(HGNC:RPS6KA3))	Its (RSK2) activation requires phosphorylation of the linker region at Ser(369), catalyzed by extracellular signal-regulated kinase (ERK)	SEN:10021330	10480933
BEL:20044850	p(HGNC:RRAD) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	Melanoma cells transfected with wild-type Rad, but not the S105N-Rad, showed enhanced DNA synthesis in response to serum; this effect was lost with coexpression of nm23.	SEN:10007428	10611312
BEL:20044864	p(HGNC:S100A9) increases bp(GOBP:"cell adhesion")	Recently, Newton and Hogg showed that S100A9 stimulates neutrophil adhesion, and S100A8 reversed the stimulatory effect probably by the formation of the heterodimer.	SEN:10024308	10551823
BEL:20044870	p(HGNC:SCN2A) increases r(HGNC:CD4)	Administration of NAC i.v. stimulates the production of CD4 + T cells in the spleens of mice immunized with allogeneic splenocytes.	SEN:10024310	10667587
BEL:20044874	p(HGNC:SELE) increases bp(GOBP:"cell adhesion")	These EC adhesion molecules include vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin, and P-selectin.6,7	SEN:10023290	10377075
BEL:20044876	p(HGNC:SELE) increases p(HGNC:HCK,pmod(P))	Human peripheral blood monocytes stimulated with sE-selectin showed a time-dependent increase in the tyrosine phosphorylation of a broad range of cellular proteins, predominantly in the molecular size range of Src family kinases (50-60 kDa) and mitogen-activated protein kinases (MAPKs). Western blot analysis of Src family kinases showed a time-dependent increase in Src, Hck, and Lyn phosphorylation.	SEN:10024312	11274196
BEL:20044878	p(HGNC:SELE) increases p(HGNC:LYN,pmod(P))	Human peripheral blood monocytes stimulated with sE-selectin showed a time-dependent increase in the tyrosine phosphorylation of a broad range of cellular proteins, predominantly in the molecular size range of Src family kinases (50-60 kDa) and mitogen-activated protein kinases (MAPKs). Western blot analysis of Src family kinases showed a time-dependent increase in Src, Hck, and Lyn phosphorylation.	SEN:10024312	11274196
BEL:20044880	p(HGNC:SELE) increases p(HGNC:SRC,pmod(P))	Human peripheral blood monocytes stimulated with sE-selectin showed a time-dependent increase in the tyrosine phosphorylation of a broad range of cellular proteins, predominantly in the molecular size range of Src family kinases (50-60 kDa) and mitogen-activated protein kinases (MAPKs). Western blot analysis of Src family kinases showed a time-dependent increase in Src, Hck, and Lyn phosphorylation.	SEN:10024312	11274196
BEL:20044882	p(HGNC:SELP) increases bp(GOBP:"cell adhesion")	These EC adhesion molecules include vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin, and P-selectin.6,7	SEN:10023290	10377075
BEL:20044886	p(HGNC:SERINC3) decreases bp(GOBP:"cell proliferation")	Inducible expression of TMS1 inhibited cellular proliferation and induced DNA fragmentation in a time-dependent manner.	SEN:10024316	11103777
BEL:20044888	p(HGNC:SERINC3) increases bp(GOBP:"apoptotic process")	Ectopic expression of TMS1 induced apoptosis in 293 cells and inhibited the survival of human breast cancer cells.	SEN:10024318	11103776
BEL:20044912	p(HGNC:SFN) decreases bp(GOBP:"cell cycle")	Overexpression of 14-3-3 sigma obstructs cell cycle entry by inhibiting cyclin -CDK activity in many breast cancer cell lines.	SEN:10024322	10767298
BEL:20044914	p(HGNC:SFN) decreases bp(GOBP:"cell proliferation")	Overexpression of 14-3-3 sigma can also inhibit cell proliferation and prevent anchorage-independent growth of these cell lines.	SEN:10007564	10767298
BEL:20044916	p(HGNC:SFN) decreases kin(p(HGNC:CDK4))	Overexpression of 14-3-3 sigma obstructs cell cycle entry by inhibiting cyclin -CDK activity in many breast cancer cell lines.	SEN:10024322	10767298
BEL:20044932	p(HGNC:SFTPA1) decreases r(HGNC:EN1)	Transfection of a construct expressing GATA-6- engrailed fusion protein inhibited basal expression of the SP-A/chloramphenicol acetyltransferase construct in MLE-15 cells.	SEN:10007570	10625644
BEL:20044938	p(HGNC:SFTPA1) decreases r(HGNC:TNF)	SP-A can inhibit smooth LPS-induced tumor necrosis factor alpha expression by alveolar macrophages.	SEN:10024330	10801802
BEL:20044948	p(HGNC:SHC1,pmod(P,Y)) directlyIncreases complex(p(HGNC:SHC1),p(HGNC:GRB2))	Phosphorylation of Shc produces its binding to the adaptor protein Grb2, causing activation of the protooncogene ras, which is also upstream of the MAP kinase pathway.	SEN:10020136	11239409
BEL:20044956	p(HGNC:SKP1) increases deg(p(HGNC:CCNA2))	<C29> p19Skp1, through its F-box motif, may link Cyclin A to the ubiquitin?proteasome protein degradation device (Bai et al., 1996).	SEN:10024340	10436023
BEL:20044958	p(HGNC:SKP2) decreases kin(p(HGNC:CDK2))	<C27> p45Skp2 inhibits Cdk2 kinase activity and blocks phosphorylation of Cdk2 by Wee1 or CAK (Yam et al., 1999). Similarly to p21Cip1, two molecules of p45Skp2 seem to be required to inhibit Cdk2. Binding to p45Skp2 is mutually exclusive with p21cip1.	SEN:10021494	10436023
BEL:20044986	p(HGNC:SMAD2) decreases bp(GOBP:"cell proliferation")	These findings explain the tumor suppressor roles of Smad2 and Smad4 in growth arrest signaling by TGF-beta.	SEN:10024346	11013220
BEL:20044988	p(HGNC:SMAD2) decreases path(MESHD:Carcinoma)	These findings explain the tumor suppressor roles of Smad2 and Smad4 in growth arrest signaling by TGF-beta.	SEN:10024346	11013220
BEL:20044990	p(HGNC:SMAD2,pmod(U,K)) directlyIncreases deg(p(HGNC:SMAD2))	Lo and Massagué1 found that the ubiquitination of Smad2 was achieved by certain E2 enzymes, including UbcH5b or UbcH5c and, to a lesser extent, Ubc3, but not by others, such as E2-20K.	SEN:10018716	10587654
BEL:20044992	p(HGNC:SMAD2) increases tscript(p(HGNC:SP1))	In the nucleoprotein complex, Smad2 interacted through its C-domain with Sp1 and enhanced the DNA binding and transcriptional activity of Sp1	SEN:10005360	11013220
BEL:20045004	p(HGNC:SNAI2) decreases bp(GOBP:"apoptotic process")	SLUG is an evolutionarily conserved transcriptional repressor whose activation by E2A-HLF promotes the aberrant survival and eventual malignant transformation of mammalian pro-B cells otherwise slated for apoptotic death.	SEN:10007582	10518215
BEL:20045010	p(HGNC:SNRNP70) increases r(HGNC:IL1A)	Supernatants of monocytes stimulated with the F(ab')2 preparation of anti-U1-RNP antibodies enhanced the amounts of both Il-1 alpha and IL-6 associated with HPAECs almost as effectively as those stimulated with intact autoantibody molecules.	SEN:10024352	10609069
BEL:20045012	p(HGNC:SNRNP70) increases r(HGNC:IL6)	Supernatants of monocytes stimulated with the F(ab')2 preparation of anti-U1-RNP antibodies enhanced the amounts of both Il-1 alpha and IL-6 associated with HPAECs almost as effectively as those stimulated with intact autoantibody molecules.	SEN:10024352	10609069
BEL:20045032	p(HGNC:SOCS1) decreases r(HGNC:CSN2)	Unlike SOCS-2, both SOCS-1 and SOCS-3 abolished the ability of the PRLR to induce beta-casein gene promoter activation.	SEN:10007590	10630404
BEL:20045034	p(HGNC:SOCS1) decreases r(HGNC:SERPINA3)	Furthermore, SOCS-1 and SOCS-3 were shown to inhibit GH stimulated transcription of the GH-responsive serine protease inhibitor 2.1 gene promoter.	SEN:10024358	10433229
BEL:20045036	p(HGNC:SOCS1) decreases r(HGNC:STAT1)	We demonstrated that SOCS-1 suppressed cytokine-induced STAT-1 phosphorylation and increased cellular accumulation.	SEN:10007592	11342558
BEL:20045046	p(HGNC:SOCS3) decreases complex(p(HGNC:INSR),p(HGNC:STAT5B))	this negative regulation likely results from competition between SOCS3 and Stat5B binding to the same insulin receptor motif SOCS3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds	SEN:10023748	10821852
BEL:20045056	p(HGNC:SOCS3) decreases r(HGNC:CSN2)	Unlike SOCS-2, both SOCS-1 and SOCS-3 abolished the ability of the PRLR to induce beta-casein gene promoter activation.	SEN:10007590	10630404
BEL:20045058	p(HGNC:SOCS3) decreases r(HGNC:SERPINA3)	Furthermore, SOCS-1 and SOCS-3 were shown to inhibit GH stimulated transcription of the GH-responsive serine protease inhibitor 2.1 gene promoter.	SEN:10024358	10433229
BEL:20045060	p(HGNC:SOD1) decreases p(HGNC:IL6)	SOD (250 U/ml) significantly suppressed the IL-6 production and IL-6 mRNA expression induced by XO, whereas catalase (500 U/ml) did not modulate the IL-6 response to XO (Fig. 4).	SEN:10024360	10362713
BEL:20045066	p(HGNC:SOD1) decreases r(HGNC:IL6)	SOD (250 U/ml) significantly suppressed the IL-6 production and IL-6 mRNA expression induced by XO, whereas catalase (500 U/ml) did not modulate the IL-6 response to XO (Fig. 4).	SEN:10024360	10362713
BEL:20045068	p(HGNC:SOD1) increases r(HGNC:MT2A)	Compared to wild-type littermates, transgenic mice carrying the G93A SOD1 mutation demonstrate markedly increased expression of MT-I and MT-II within astrocytes in both white and gray matter as weakness develops.	SEN:10007598	10716886
BEL:20045070	p(HGNC:SOD2) increases a(CHEBI:"hydrogen peroxide")	Thus, a 15-fold increase in Sod2 levels, which is well within the range of activity observed in response to cytokines and growth factors, can enhance MMP-1 expression in an H2O2-dependent fashion.	SEN:10024362	11297530
BEL:20045072	p(HGNC:SOD2) increases cat(p(HGNC:MMP2))	In support of this hypothesis, the gelatinolytic activity of MMP-2 and the mRNA levels of MMP-3 and MMP-7 were increased in the Sod2 overexpressors compared with control cell lines (Fig. 5C, left panel).	SEN:10024364	11297530
BEL:20045074	p(HGNC:SOD2) decreases cat(p(HGNC:MMP9))	The observed decline in MMP-9 activity in the HT15 cell line may represent a negative regulatory aspect of Sod2 in MMP expression.	SEN:10024366	11297530
BEL:20045076	p(HGNC:SOD2) increases kin(p(HGNC:MAPK1))	Immunoblot analysis of extracts from control and HT15 cells showed an increase in the activated forms of ERK1/2 in the Sod2-overexpressing cells that was reversed upon coexpression of catalase (Fig. 5A).	SEN:10022688	11297530
BEL:20045078	p(HGNC:SOD2) increases kin(p(HGNC:MAPK3))	Immunoblot analysis of extracts from control and HT15 cells showed an increase in the activated forms of ERK1/2 in the Sod2-overexpressing cells that was reversed upon coexpression of catalase (Fig. 5A).	SEN:10022688	11297530
BEL:20045082	p(HGNC:SOD2) increases p(HGNC:IL1A)	Analysis of IL-1a levels in Sod2-overexpressing cells showed a 3-fold increase in basal IL-1a levels that was reversed when catalase was coexpressed in these cell lines (Fig. 2A).	SEN:10022690	11297530
BEL:20045084	p(HGNC:SOD2) increases r(HGNC:MMP3)	In support of this hypothesis, the gelatinolytic activity of MMP-2 and the mRNA levels of MMP-3 and MMP-7 were increased in the Sod2 overexpressors compared with control cell lines (Fig. 5C, left panel).	SEN:10024364	11297530
BEL:20045086	p(HGNC:SOD2) increases r(HGNC:MMP7)	In support of this hypothesis, the gelatinolytic activity of MMP-2 and the mRNA levels of MMP-3 and MMP-7 were increased in the Sod2 overexpressors compared with control cell lines (Fig. 5C, left panel).	SEN:10024364	11297530
BEL:20045098	p(HGNC:SP1) increases r(HGNC:GATA1)	Most of these proteins, including FOG (Tsang et al. 1997 ), CREB-binding protein (CBP; Blobel et al. 1998 ), EKLF, and Sp1 stimulate GATA-1 transcriptional activation.	SEN:10024368	10364157
BEL:20045102	p(HGNC:SPARC) decreases bp(GOBP:"cell adhesion")	SPARC is a glycoprotein of the extracellular matrix that exhibits a number of biological functions such as disruption of cell adhesion	SEN:10007604	11255229
BEL:20045136	p(HGNC:SRPX) decreases bp(GOBP:"cell proliferation")	We have previously reported that the drs gene, whose mRNA expression is downregulated by retroviral oncogenes such as v-src and v-K-ras, has the ability to suppress transformation by v-src in a rat cell line F2408.	SEN:10020862	10490811
BEL:20045138	p(HGNC:SRPX) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	We also found that the G1-S progression of the cell cycle and expression of cyclin A mRNA were significantly suppressed in T24 cells expressing the drs gene under non-adhesion culture conditions.	SEN:10024384	10490811
BEL:20045142	p(HGNC:SRPX) decreases r(HGNC:CCNA1)	We also found that the G1-S progression of the cell cycle and expression of cyclin A mRNA were significantly suppressed in T24 cells expressing the drs gene under non-adhesion culture conditions.	SEN:10024384	10490811
BEL:20045146	p(HGNC:STAM2) increases r(HGNC:MYC)	Finally, overexpression of wild type STAM2 led to an increase in IL-2-mediated induction of c-Myc promoter activation indicating that it potentiates cytokine receptor signaling.	SEN:10007612	10993906
BEL:20045164	p(HGNC:STAT3,pmod(P)) directlyIncreases tscript(p(HGNC:STAT3))	B9 clones expressing either wild-type FGFR3 at high levels or mutant FGFR3 displayed increased phosphorylation of STAT3 and higher levels of bcl-x(L) expression than did parental B9 cells after cytokine withdrawal.	SEN:10021218	10648414
BEL:20045174	p(HGNC:STAT5A,pmod(P,Y,694)) directlyIncreases complex(p(HGNC:STAT5A),p(HGNC:STAT5A))	Tyrosine phosphorylation is essential for Stat dimerization, nuclear translocation, DNA binding, and transcriptional activation.	SEN:10024394	10744710
BEL:20045178	p(HGNC:STAT5A,pmod(P,Y,694)) increases tloc(p(HGNC:STAT5A),GOCCID:0005737,GOCCID:0005634)	Tyrosine phosphorylation is essential for Stat dimerization, nuclear translocation, DNA binding, and transcriptional activation.	SEN:10024394	10744710
BEL:20045180	p(HGNC:STAT5A,pmod(P,Y,694)) directlyIncreases tscript(p(HGNC:STAT5A))	Tyrosine phosphorylation is essential for Stat dimerization, nuclear translocation, DNA binding, and transcriptional activation.	SEN:10024394	10744710
BEL:20045186	p(HGNC:STAT5A) increases r(HGNC:IL2RA)	Stat5 activated by IL-2 enhances IL-2Ralpha gene expression and cell cycle progression ( 42 , 61 ).	SEN:10024398	11290598
BEL:20045188	p(HGNC:STAT5B) decreases complex(p(HGNC:SOCS3),p(HGNC:INSR))	this negative regulation likely results from competition between SOCS3 and Stat5B binding to the same insulin receptor motif SOCS3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds	SEN:10023748	10821852
BEL:20045198	p(HGNC:STX4,pmod(P)) directlyDecreases complex(p(HGNC:STX4),p(HGNC:SNAP23))	In vitro, PKC directly phosphorylated platelet syntaxin 4 and recombinant syntaxin 4. PKC phosphorylation in vitro inhibited (71 +/- 8%) the binding of syntaxin 4 to SNAP-23.	SEN:10021418	10856305
BEL:20045200	p(HGNC:SUMO1) increases cat(p(HGNC:MDM2))	In vitro sumoylation of Mdm2 abrogates its self-ubiquitination and increases its ubiquitin ligase activity toward p53	SEN:10001474	10892746
BEL:20045202	p(HGNC:SUMO1) decreases deg(p(HGNC:MDM2))	In vitro sumoylation of Mdm2 abrogates its self-ubiquitination and increases its ubiquitin ligase activity toward p53	SEN:10001474	10892746
BEL:20045204	p(HGNC:SUMO1) decreases deg(p(HGNC:NFKBIA))	SUMO-1 modification was found to antagonize IkappaBalpha ubiquitination and protect it from degradation	SEN:10001446	10788439
BEL:20045206	p(HGNC:SUMO1) increases deg(p(HGNC:TP53))	In vitro sumoylation of Mdm2 abrogates its self-ubiquitination and increases its ubiquitin ligase activity toward p53	SEN:10001474	10892746
BEL:20045222	p(HGNC:TCF4) directlyIncreases r(HGNC:ABCB1)	The promoter of the MDR1 gene contains multiple TCF4-binding sequences, concluding that MDR1 is a direct target gene of the TCF4/?-catenin transcriptional complex.	SEN:10024408	10987283
BEL:20045238	p(HGNC:TFAP2A) decreases r(HGNC:AFP)	Finally, stable expression of AP-2 in hepatoma cells significantly reduced the expression of endogenous SAA, albumin, and alpha-fetoprotein genes.	SEN:10007628	11278660
BEL:20045240	p(HGNC:TFAP2A) decreases r(HGNC:ALB)	Finally, stable expression of AP-2 in hepatoma cells significantly reduced the expression of endogenous SAA, albumin, and alpha-fetoprotein genes.	SEN:10007628	11278660
BEL:20045252	p(HGNC:TFPI) decreases p(HGNC:F3)	TF activity of circulating monocytes appears controlled locally by its intrinsic inhibitor, TF pathway inhibitor (TFPI).7	SEN:10024424	11208679
BEL:20045258	p(HGNC:TF) increases r(HGNC:GPX4)	Results indicated that the addition of Se to cells cultured in medium containing either 10% FBS or insulin and transferrin also increased the level of endogenous PHGPx mRNA: the higher the level of Se, the higher the level of PHGPx mRNA (Figure 7 ).	SEN:10024426	11294903
BEL:20045272	p(HGNC:TGFA) increases r(HGNC:FGF7)	Transforming growth factor alpha stimulates both kit ligand/stem cell factor and keratinocyte growth factor production by OSE.	SEN:10007634	10952922
BEL:20045276	p(HGNC:TGFA) decreases r(HGNC:IL18)	By contrast, epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha), respectively, strongly decreased IL-18 mRNA expression in HaCaT keratinocytes in the absence of IL-18 protein release from the cells.	SEN:10022968	11125306
BEL:20045280	p(HGNC:TGFB1) increases a(CHEBI:"hydrogen peroxide")	TGF-b1 also stimulates H2O2 production in bovine pulmonary artery endothelial cells (22), vascular endothelial cells (23), mouse osteoblastic cells (24), and human lung fibroblast (HLF) cells (25, 26).	SEN:10024430	10925306
BEL:20045282	p(HGNC:TGFB1) increases a(CHEBI:"reactive oxygen species")	TGF-b1 (1 ng/ml)-induced intracellular ROS levels in HLF cells were measured with DCFH-DA and laser-scanning confocal microscopy...As shown in Fig. 1, A and B, DCF fluorescence displayed a rapid increase with maximal intensity at 5 min after treatment and was followed by a decline in fluorescence to the basal level by 20 min.	SEN:10024432	10925306
BEL:20045286	p(HGNC:TGFB1) increases bp(GOBP:"cell adhesion")	TGF-beta increased cell adhesion to vitronectin and up-regulated the surface level of alpha(v)beta(5) via increasing beta(5) protein synthesis by a transcriptional mechanism.	SEN:10024436	10964912
BEL:20045300	p(HGNC:TGFB1) increases complex(p(HGNC:ITGAV),p(HGNC:ITGB5),p(HGNC:VTN))	TGF-beta increased cell adhesion to vitronectin and up-regulated the surface level of alpha(v)beta(5) via increasing beta(5) protein synthesis by a transcriptional mechanism.	SEN:10024436	10964912
BEL:20045302	p(HGNC:TGFB1) decreases complex(p(HGNC:ZBTB17),p(HGNC:MYC))	Endogenous Miz-1 is present in HaCaT cells as two species of relative molecular mass 85,000 (Mr 85K) and 100K, respectively, the latter species forming a complex with Myc (Fig. 2a). TGFbeta had no effect on levels of Miz-1 but caused a rapid reduction in levels of Myc. This was accompanied by a marked reduction in levels of the Myc–Miz-1 complex (Fig. 2a).	SEN:10024442	11283614
BEL:20045306	p(HGNC:TGFB1) increases kin(p(HGNC:MAP3K7))	In this study, we determined the role of PP2Cbeta-1, a major isoform of mammalian PP2C, in the TAK1 signaling pathway, a stress-activated protein kinase cascade that is activated by interleukin-1, transforming growth factor-beta, or stress.	SEN:10018224	11104763
BEL:20045308	p(HGNC:TGFB1) increases kin(p(HGNC:TGFBR3))	The wild-type Ki-ras transfectants lack functional TGF-beta receptors, whereas all three Ki-ras(G12V) transfectants expressed functional TGF-beta receptors that bound (125)I-TGF-beta1.	SEN:10007644	11029459
BEL:20045316	p(HGNC:TGFB1) increases p(HGNC:DPT)	Transforming growth factor-beta1 increased dermatopontin mRNA and protein levels, while interleukin-4 reduced dermatopontin expression.	SEN:10023652	10233760
BEL:20045330	p(HGNC:TGFB1) increases p(HGNC:IL6)	Also, stimulation with TGF-b1 (1 ng/ml) caused a time-dependent increase in IL-6 protein accumulation in the culture supernatants (Fig. 2C).	SEN:10024450	10925306
BEL:20045334	p(HGNC:TGFB1) decreases p(HGNC:MYC)	Endogenous Miz-1 is present in HaCaT cells as two species of relative molecular mass 85,000 (Mr 85K) and 100K, respectively, the latter species forming a complex with Myc (Fig. 2a). TGFbeta had no effect on levels of Miz-1 but caused a rapid reduction in levels of Myc. This was accompanied by a marked reduction in levels of the Myc–Miz-1 complex (Fig. 2a).	SEN:10024442	11283614
BEL:20045338	p(HGNC:TGFB1) increases p(HGNC:VEGFA)	VEGF production induced by IL-1beta, TNF-alpha, and TGF-beta was further increased when CD40L+ L cells were coincubated, by factors of 5.9, 5.5, and 9.6, respectively, which indicated that these cytokines had an additive effect on VEGF production driven by CD40L.	SEN:10023540	10799861
BEL:20045342	p(HGNC:TGFB1) increases r(HGNC:APOC3)	Pro-inflammatory cytokines such as TNF-alpha and IL-1 repress, and TGF-beta stimulates the apoCIII promoter activity	SEN:10023522	11229886
BEL:20045344	p(HGNC:TGFB1) decreases r(HGNC:BCL2L1)	TGF-beta 1 down-regulates expression of Bcl-xL and poly(ADP-ribosyl)polymerase (PARP), promotes cytochrome c release, up-regulates expression of latent caspase-3, and activates caspases 3 and 9.	SEN:10007650	11320089
BEL:20045346	p(HGNC:TGFB1) increases r(HGNC:BMP2)	The upregulation of bone morphogenetic protein-2 mRNA expression was also enhanced by exogenously added transforming growth factor-beta1 in the presence of fetal calf serum.	SEN:10007652	10632460
BEL:20045356	p(HGNC:TGFB1) increases r(HGNC:CDKN2B)	Transforming growth factor-beta (TGF-beta) arrests growth of epithelial cells by inducing the transcription of p15(Ink4B)	SEN:10024456	11013220
BEL:20045364	p(HGNC:TGFB1) increases r(HGNC:CTGF)	TNFalpha was found to suppress the TGF-beta-induced expression of CTGF protein in cultured normal fibroblasts.	SEN:10007656	10809757
BEL:20045366	p(HGNC:TGFB1) increases r(HGNC:DPT)	Transforming growth factor-beta1 increased dermatopontin mRNA and protein levels, while interleukin-4 reduced dermatopontin expression.	SEN:10023652	10233760
BEL:20045378	p(HGNC:TGFB1) increases r(HGNC:IL10)	TGF-beta1 induced IL-10 production, slightly decreased TNF-alpha production and decreased IFN-gamma production.	SEN:10024460	10880840
BEL:20045382	p(HGNC:TGFB1) increases r(HGNC:IL6)	The amount of 1 ng/ml TGF-b1 was sufficient to induce the IL-6 mRNA (Fig. 2A). TGF-b1 (1 ng/ml) treatment produced a progressive increase in IL-6 mRNA concentrations, beginning as early as 30 min, peaking at 12 h, and decreasing after 24 h (Fig. 2B).	SEN:10024464	10925306
BEL:20045388	p(HGNC:TGFB1) increases r(HGNC:ITGB5)	TGF-beta increased cell adhesion to vitronectin and up-regulated the surface level of alpha(v)beta(5) via increasing beta(5) protein synthesis by a transcriptional mechanism.	SEN:10024436	10964912
BEL:20045394	p(HGNC:TGFB1) increases r(HGNC:MMP13)	Adenovirus-mediated expression of dominant negative p38alpha and dominant negative c-Jun potently inhibited induction of MMP-13 expression in gingival fibroblasts by TGF-beta1.	SEN:10021322	10601295
BEL:20045398	p(HGNC:TGFB1) increases r(HGNC:MYOC)	Treatment with TGF-beta1 for 24 hours had no effect; however, after 3 and 12 days of treatment a 3.8- and 4-fold increase in myocilin/TIGR mRNA expression was observed.	SEN:10007664	10509652
BEL:20045402	p(HGNC:TGFB1) decreases r(HGNC:PDGFRA)	Also, TGF-beta stimulation of fibroblasts or mesothelial cells leads to a decrease in the expression of the alpha -receptor (57, 154, 262, 349).	SEN:10024470	10508235
BEL:20045408	p(HGNC:TGFB1) increases r(HGNC:SERPINE1)	TSP-1 and TGF-beta1 promoted a dose-dependent upregulation of ASPC-1 and COLO-357 PAI-1 expression.	SEN:10007666	10482694
BEL:20045422	p(HGNC:TGFB1) increases surf(complex(p(HGNC:ITGAV),p(HGNC:ITGB5),p(HGNC:VTN)))	TGF-beta increased cell adhesion to vitronectin and up-regulated the surface level of alpha(v)beta(5) via increasing beta(5) protein synthesis by a transcriptional mechanism.	SEN:10024436	10964912
BEL:20045424	p(HGNC:TGFB1) decreases tloc(p(HGNC:PTPN14),GOCCID:0005737,GOCCID:0005634)	TGFbeta, which inhibits cell proliferation but not migration, inhibited the translocation of Pez to the nucleus in the cells at the 'wound' edge, further strengthening the argument that Pez plays a role in the nucleus during cell proliferation.	SEN:10007670	10934049
BEL:20045436	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	Furthermore, expression of dominant negative Smad3 or Smad4 in cells decreased or abolished the stimulation of beta(5) promoter activity by TGF-beta. Smad4 mutant also inhibited the up-regulation of surface beta(5) level by TGF-beta. Thus, TGF-beta increases expression of the integrin beta(5) gene by mechanisms involving Sp1/Sp3 and Smad transcription factors.	SEN:10024480	10964912
BEL:20045438	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD4))	Furthermore, expression of dominant negative Smad3 or Smad4 in cells decreased or abolished the stimulation of beta(5) promoter activity by TGF-beta. Smad4 mutant also inhibited the up-regulation of surface beta(5) level by TGF-beta. Thus, TGF-beta increases expression of the integrin beta(5) gene by mechanisms involving Sp1/Sp3 and Smad transcription factors.	SEN:10024480	10964912
BEL:20045460	p(HGNC:THBS1) increases cat(p(HGNC:ITGB3))	IAP, an immunoglobulin superfamily transmembrane protein, cooperates with b3 integrins in binding thrombospondin to cells, and it also activates an inhibitory trimeric guanine nucleotide- binding protein (29).	SEN:10024492	10446041
BEL:20045464	p(HGNC:THBS1) increases kin(p(HGNC:PTK2))	These results suggest that activation of PI 3-K is an early signal induced by TSP-1 and is critical for chemotaxis. Activation of this kinase precedes and may occur upstream from FAK phosphorylation, although the nature of the interaction between these 2 enzymes remains obscure.	SEN:10024494	10479655
BEL:20045468	p(HGNC:THBS1) increases r(HGNC:SERPINE1)	TSP-1 and TGF-beta1 promoted a dose-dependent upregulation of ASPC-1 and COLO-357 PAI-1 expression.	SEN:10007666	10482694
BEL:20045470	p(HGNC:THPO) increases r(HGNC:CCND1)	By using a refined model of megakaryocytic differentiation, we found that either TPO stimulation or Ha-Ras G12V expression could up-regulate the expression of cyclin D1 and cyclin D2 in addition to cyclin D3, and that, when cdc2 activity was suppressed, each of cyclin D1, cyclin D2, and cyclin D3 expression was able to induce megakaryocytic differentiation with a similar efficiency.	SEN:10024496	10681535
BEL:20045472	p(HGNC:THPO) increases r(HGNC:CCND2)	By using a refined model of megakaryocytic differentiation, we found that either TPO stimulation or Ha-Ras G12V expression could up-regulate the expression of cyclin D1 and cyclin D2 in addition to cyclin D3, and that, when cdc2 activity was suppressed, each of cyclin D1, cyclin D2, and cyclin D3 expression was able to induce megakaryocytic differentiation with a similar efficiency.	SEN:10024496	10681535
BEL:20045474	p(HGNC:THPO) increases r(HGNC:CCND3)	We found that TPO stimulation or Ha-Ras G12V expression led to up-regulation of cyclin D1, cyclin D2, and cyclin D3 expression.	SEN:10005746	10681535
BEL:20045478	p(HGNC:TIMP1) directlyDecreases cat(p(HGNC:MMP9))	The TIMPs bind with high affinity in a 1:1 molar ratio to the catalytic site of active MMPs resulting in loss of proteolytic activity. Moreover, TIMP-1 and TIMP-2 can form a specific complex with the zymogens of MMP-9 and MMP-2, respectively.	SEN:10024498	10881049
BEL:20045480	p(HGNC:TIMP2) directlyDecreases cat(p(HGNC:MMP2))	The TIMPs bind with high affinity in a 1:1 molar ratio to the catalytic site of active MMPs resulting in loss of proteolytic activity. Moreover, TIMP-1 and TIMP-2 can form a specific complex with the zymogens of MMP-9 and MMP-2, respectively.	SEN:10024498	10881049
BEL:20045482	p(HGNC:TIMP2) decreases cat(p(HGNC:MMP2))	Flow cytometry analysis showed that MT1-MMP, MMP2, and TIMP2 expressions were enhanced at the activated platelet surface. MMP inhibitors, recombinant TIMP2, and synthetic BB94 inhibited collagen-induced platelet aggregation in a concentration-dependent manner, indicating the role of activated MT1-MMP in the modulation of platelet function.	SEN:10024500	11049985
BEL:20045488	p(HGNC:TNC) increases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	Alternatively, this integrin complex can interact with tenascin-C, thus favoring the clustering of EGF receptors and EGF-dependent growth (Jones et al., 1997).	SEN:10018346	10022831
BEL:20045492	p(HGNC:TNF) decreases a(CHEBI:glutathione)	Treatment with TNF-a significantly decreased the intracellular GSH content of HS-24 cells. Pretreatment of this culture with DMSO recovered the TNF-a-induced decrease in GSH (Table 1).	SEN:10015636	10362713
BEL:20045496	p(HGNC:TNFAIP3) decreases r(HGNC:NOS2)	In our study, iNOS transcriptional activation occurred despite the induction of TNFAIP3 expression; in some cells, TNFAIP3 blocks transcription of iNOS ( 14 ).	SEN:10024506	11087813
BEL:20045502	p(HGNC:TNF) decreases bp(GOBP:"fat cell differentiation")	Tumor necrosis factor-alpha (TNF) inhibits fat cell differentiation and may also mediate insulin resistance in adipocytes	SEN:10024510	10875261
BEL:20045504	p(HGNC:TNF) increases bp(GOBP:"apoptotic process")	Figure 2. Flow-cytometric quantitation of IgMFas- and TNFalpha-induced apoptosis in PED overexpressing MCF-7 cells.	SEN:10024110	10442631
BEL:20045506	p(HGNC:TNF) increases bp(GOBP:"apoptotic process")	The restoration of A1 in NF-kappaB null cells diminished TNF-induced apoptosis by inhibiting the release of cytochrome c and by blocking caspase 3 activation.	SEN:10022618	10454539
BEL:20045508	p(HGNC:TNF) increases bp(GOBP:"apoptotic process")	TNF-sensitive cells, when exposed to 4-10 microg/ml concentrations of TIP-B1 prior to the addition of TNF, are completely protected from TNF-induced lysis. Furthermore, TIP-B1 protects cells from apoptotic lysis induced by TNF.	SEN:10018684	10554026
BEL:20045510	p(HGNC:TNF) increases bp(GOBP:"apoptotic process")	P53 inactivation in LN-56 was associated with an increased resistance to apoptosis induced by TNF-alpha.	SEN:10024512	10773886
BEL:20045514	p(HGNC:TNF) increases bp(GOBP:"apoptotic process")	Expression of wild-type or constitutively active PAK4 delays the onset of apoptosis in response to tumor necrosis factor alpha stimulation, UV irradiation, and serum starvation	SEN:10007456	11278822
BEL:20045516	p(HGNC:TNF) increases path(MESHD:"Insulin Resistance")	Tumor necrosis factor-alpha (TNF) inhibits fat cell differentiation and may also mediate insulin resistance in adipocytes	SEN:10024510	10875261
BEL:20045518	p(HGNC:TNF) increases cat(p(HGNC:CASP7))	TNF caused a rapid activation of caspase-8 and -7 in cells transfected with a vector. The activation of these caspases was potentiated by the PKC inhibitor bisindolylmaleimide (BIM) which downregulates PKC eta and sensitizes cells to TNF.	SEN:10007486	11112424
BEL:20045520	p(HGNC:TNF) increases cat(p(HGNC:CASP8))	TNF caused a rapid activation of caspase-8 and -7 in cells transfected with a vector. The activation of these caspases was potentiated by the PKC inhibitor bisindolylmaleimide (BIM) which downregulates PKC eta and sensitizes cells to TNF.	SEN:10007486	11112424
BEL:20045524	p(HGNC:TNF) increases cat(p(HGNC:HSD11B1))	Treatment with tumor necrosis factor-alpha (TNFalpha) caused a dose-dependent increase in 11betaHSD1 activity in primary cultures of both sc [1743.1 +/- 1015.4% (TNFalpha, 10 ng/ml); P < 0.05 vs. control (100%)] and omental [375.8 +/- 57.0% (TNFalpha, 10 ng/ml); P < 0.01 vs. control (100%)] ASC, but had no effect on activity in human hepatocytes [90.2 +/- 2.8% (TNFalpha, 10 ng/ml); P = NS vs. control (100%)].	SEN:10024514	11316764
BEL:20045530	p(HGNC:TNF) increases cat(p(HGNC:TNFRSF1A))	c-Raf-1 kinase was identified as an intracellular target of a signal transduction cascade initiated by binding of TNF-alpha to TNFR-I.	SEN:10024516	10359574
BEL:20045532	p(HGNC:TNF) increases complex(p(HGNC:PDGFRA),p(HGNC:PDGFRA))	Moreover, interleukin (IL)-1alpha and tumor necrosis factor (TNF)-alpha induce the alpha -receptor in osteoblast cultures from fetal rat bone (75, 468).	SEN:10023518	10508235
BEL:20045542	p(HGNC:TNF) increases kin(complex(p(HGNC:CHUK),p(HGNC:IKBKB)))	Mercurio et al. have recently shown that HeLa cells contain two distinct IKK complexes, one consisting of IKKa/IKKb heterodimers, and the other containing IKKb homodimers (23). Moreover, both complex types could be activated by TNF-a, with heterodimeric complexes showing more abundant IKK activity than homodimeric complexes (23).	SEN:10024520	10553070
BEL:20045544	p(HGNC:TNF) increases kin(complex(p(HGNC:IKBKB),p(HGNC:IKBKB)))	Mercurio et al. have recently shown that HeLa cells contain two distinct IKK complexes, one consisting of IKKa/IKKb heterodimers, and the other containing IKKb homodimers (23). Moreover, both complex types could be activated by TNF-a, with heterodimeric complexes showing more abundant IKK activity than homodimeric complexes (23).	SEN:10024520	10553070
BEL:20045546	p(HGNC:TNF) increases kin(p(HGNC:AKT1))	Exposure of human umbilical vein endothelial cells (HUVECs) to TNF-alpha elicited the rapid phosphorylation of Akt/PKB.	SEN:10024522	11027549
BEL:20045548	p(HGNC:TNF) increases kin(p(HGNC:MAP3K5))	Apoptosis signal-regulating kinase 1 (ASK 1) is a mitogen-activated protein (MAP) kinase kinase kinase (MAPKKK) that is activated by TNF and IL-1	SEN:10023520	10921242
BEL:20045550	p(HGNC:TNF) increases kin(p(HGNC:MAPK1))	Kinase-defective point and deletion variants of RIP2 also significantly blocked the activation of ERK2 by TNFalpha but not epidermal growth factor.	SEN:10021456	10559258
BEL:20045552	p(HGNC:TNF) increases kin(p(HGNC:MAPK1))	TNF-a induced minimal activation of MAPKerk after brief periods of exposure (5–15 min); however, phosphoactivation of MAPKerk was observed by 60 min.	SEN:10024524	10903772
BEL:20045556	p(HGNC:TNF) increases kin(p(HGNC:MAPK3))	TNF-a induced minimal activation of MAPKerk after brief periods of exposure (5–15 min); however, phosphoactivation of MAPKerk was observed by 60 min.	SEN:10024524	10903772
BEL:20045558	p(HGNC:TNF) increases kin(p(HGNC:RIPK2))	RIP2 is a serine-threonine kinase associated with the tumor necrosis factor (TNF) receptor complex and is implicated in the activation of NF-kappaB and cell death in mammalian cells.	SEN:10021454	10559258
BEL:20045568	p(HGNC:TNF) increases p(HGNC:AKT1,pmod(P))	Exposure of human umbilical vein endothelial cells (HUVECs) to TNF-alpha elicited the rapid phosphorylation of Akt/PKB.	SEN:10024522	11027549
BEL:20045572	p(HGNC:TNF) increases p(HGNC:CSF2)	As shown in Fig. 1a, stimulation of HBECs with TNF-a elicited a dose-dependent increase in GM-CSF production	SEN:10024532	10903772
BEL:20045574	p(HGNC:TNF) increases p(HGNC:CSF2)	Exposure of BEAS-2B to either TNF-a (0.3 mM) or IL-1 (0.6 mM) resulted in a roughly 2-fold increase in GM-CSF above the unstimulated control value (223 6 11 and 148 6 20% above unstimulated control, respectively; n 5 3; p , 0.05).	SEN:10024534	10903772
BEL:20045576	p(HGNC:TNF) increases p(HGNC:CX3CL1)	It was first identified as a membrane protein in endothelial cells activated with IL-1 or TNF-alpha.	SEN:10007158	11211312
BEL:20045578	p(HGNC:TNF) increases p(HGNC:CX3CL1)	We found that tumor-necrosis factor alpha (TNF-alpha) and interferon-gamma (IFN-gamma) synergistically enhance the expression of fractalkine.	SEN:10007056	11311510
BEL:20045580	p(HGNC:TNF) increases p(HGNC:CXCL5)	Progesterone, lipopolysaccharide, tumour necrosis factor-alpha, and interleukin-1beta significantly stimulated the expression of ENA-78 by ESC. ....The expression of ENA-78 was also detected in cyclic endometrium by immunohistochemistry.	SEN:10015920	11331668
BEL:20045582	p(HGNC:TNF) increases p(HGNC:CXCR4)	CXCR4 protein expression was also enhanced upon treatment with TNF-alpha and IL-1beta (2- to 3-fold).	SEN:10007176	11160334
BEL:20045586	p(HGNC:TNF) increases p(HGNC:F3)	Tissue factor (TF) can be induced in monocytes by external signals such as growth factors, inflammatory cytokines (interleukin [IL]-1b and tumor necrosis factor [TNF]-a), oxidized LDLs, and endotoxin. 2	SEN:10016854	11208678
BEL:20045600	p(HGNC:TNF) increases p(HGNC:IL6)	TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts	SEN:10024536	10362713
BEL:20045602	p(HGNC:TNF) increases p(HGNC:IL6)	TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).	SEN:10024538	10362713
BEL:20045606	p(HGNC:TNF) increases p(HGNC:IRS1,pmod(P,S))	TNF-a appears to impair insulin signaling by increasing serine phosphorylation of IRS-1. Serine-phosphorylated IRS-1 inhibits insulin receptor tyrosine kinase activity, which leads to impaired downstream signaling	SEN:10023768	10194465
BEL:20045610	p(HGNC:TNF) increases p(HGNC:MAPK1,pmod(P,T,185))	TNF-a induced minimal activation of MAPKerk after brief periods of exposure (5–15 min); however, phosphoactivation of MAPKerk was observed by 60 min.	SEN:10024524	10903772
BEL:20045612	p(HGNC:TNF) increases p(HGNC:MAPK3,pmod(P,T,202))	TNF-a induced minimal activation of MAPKerk after brief periods of exposure (5–15 min); however, phosphoactivation of MAPKerk was observed by 60 min.	SEN:10024524	10903772
BEL:20045614	p(HGNC:TNF) increases p(HGNC:MMP14)	TNF-a-mediated increase in MT1-MMP mRNA correlated with a 2.5-fold increase in MT1-MMP protein levels in EC membranes (Fig. 6A).	SEN:10024542	10207013
BEL:20045618	p(HGNC:TNF) increases p(HGNC:PTGS2)	TNF-a induced COX-2 expression in NCI-H292 cells. When the cells were exposed to 10 ng/ml of IL-1b, TNF-a, or IFN-g, 1 mg/ml of LPS, or 1 mM TPA, only TNF-a and TPA stimulated COX-2 expression (data not shown).	SEN:10017810	10946303
BEL:20045632	p(HGNC:TNF) increases p(HGNC:VCAM1)	As expected, cell surface EIAs of human ECs revealed a marked increase of VCAM-1 expression in response to stimulation with TNF-a 10 mg/L.	SEN:10024544	10377075
BEL:20045638	p(HGNC:TNF) increases r(HGNC:AKR1B1)	AR protein expression increased severalfold in human liver cells after 1 day of exposure to 100 units/ml TNF-alpha	SEN:10007690	10075698
BEL:20045642	p(HGNC:TNF) decreases r(HGNC:APOC3)	Pro-inflammatory cytokines such as TNF-alpha and IL-1 repress, and TGF-beta stimulates the apoCIII promoter activity	SEN:10023522	11229886
BEL:20045646	p(HGNC:TNF) increases r(HGNC:BTG1)	Comparable to the gene encoding RB6K, GSPT1 and RGS5 , two genes involved in cell cycle initiation, were found to be repressed, whereas the antiproliverative BTG1 gene was upregulated by tumor necrosis factor alpha ( 11 ).	SEN:10024550	11283271
BEL:20045658	p(HGNC:TNF) decreases r(HGNC:CCR2)	Treatment of monocytes with TNF-a caused a time-dependent reduction in CCR2 surface protein (Fig. 2B) and mRNA expression (Fig. 2C) by up to 50%.	SEN:10024554	10428302
BEL:20045672	p(HGNC:TNF) increases r(HGNC:CSF2)	As shown in the representative Northern blot in Fig. 1c, steady-state GM-CSF mRNA was barely detectable in unstimulated HBECs. Consistent with the ability of PMA to stimulate a larger GM-CSF release than TNF-a, the amount of message observed was greater in PMA-treated cells than in TNF-a-treated cells.	SEN:10024560	10903772
BEL:20045676	p(HGNC:TNF) increases r(HGNC:CXCR4)	Enhancement of CXC chemokine receptor 4 (CXCR4) mRNA expression was observed upon treatment with the cytokines TNF-alpha and IL-1beta.	SEN:10007194	11160334
BEL:20045682	p(HGNC:TNF) increases r(HGNC:FADD)	The transcript level of Caspase-8, Fas, FADD, DR3, TNFR1 and FRDD were increased by the TNF-alpha signaling pathway.	SEN:10024564	10784420
BEL:20045684	p(HGNC:TNF) increases r(HGNC:FAS)	Following TNF alpha up-regulation, there was increased expression of Fas (CD95) and Fas-ligand (Fas-L)	SEN:10007700	10608299
BEL:20045686	p(HGNC:TNF) increases r(HGNC:FAS)	Fas is constitutively expressed by primary murine microglia at a low level and significantly up-regulated by TNF-alpha or IFN-gamma stimulation	SEN:10007066	10640741
BEL:20045688	p(HGNC:TNF) increases r(HGNC:FAS)	The transcript level of Caspase-8, Fas, FADD, DR3, TNFR1 and FRDD were increased by the TNF-alpha signaling pathway.	SEN:10024564	10784420
BEL:20045690	p(HGNC:TNF) increases r(HGNC:FASLG)	Following TNF alpha up-regulation, there was increased expression of Fas (CD95) and Fas-ligand (Fas-L)	SEN:10007700	10608299
BEL:20045700	p(HGNC:TNF) decreases r(HGNC:IL18)	Tumor necrosis factor-alpha (TNF-alpha) mediated a large decrease in IL-18 mRNA levels in the human keratinocyte cell line HaCaT, which was accompanied by a subsequent accumulation of IL-18 protein in the cell culture supernatants, which was shown to be biologically active.	SEN:10024572	11125306
BEL:20045702	p(HGNC:TNF) increases r(HGNC:IL6)	TNF-a (200 U/ml) significantly increased the levels of IL-6 mRNA in HS-24 cells and DMSO (1.0%) markedly reduced those induced with the cytokine (Fig. 5E).	SEN:10015640	10362713
BEL:20045704	p(HGNC:TNF) increases r(HGNC:IL6)	TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts	SEN:10024536	10362713
BEL:20045712	p(HGNC:TNF) decreases r(HGNC:LEP)	48-h exposure of in vitro differentiated human adipocytes to TNF-alpha led to a significant decrease in leptin mRNA levels to 70 +/- 8% and 49 +/- 13% of controls respectively.	SEN:10024578	10526261
BEL:20045716	p(HGNC:TNF) increases r(HGNC:MMP14)	Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA (Figs. 1–4).	SEN:10023530	10207013
BEL:20045718	p(HGNC:TNF) increases r(HGNC:MMP14)	Tumor necrosis factor-alpha (TNF-alpha ), interleukin-1alpha, or interleukin-1beta caused a time-dependent increase in the steady-state MT1-MMP mRNA levels within 4 h of exposure, peaking about 4-fold by 6 h, and remaining elevated for 12 h.	SEN:10007166	10207013
BEL:20045720	p(HGNC:TNF) decreases r(HGNC:MSR1)	We previously reported tumor necrosis factor-alpha (TNF) modulates transcriptional and post-transcriptional down-regulation of macrophage scavenger receptor (MSR)	SEN:10007704	10969071
BEL:20045728	p(HGNC:TNF) increases r(HGNC:PLAUR)	Selected mediators, including TGF-beta, TNF-alpha, LPS and PMA, uniformly enhanced uPAR expression in each of the tumor cell lines.	SEN:10007708	10544967
BEL:20045732	p(HGNC:TNF) increases r(HGNC:PTGS2)	Treatment with 30 ng/ml TNF-a or 1 mM TPA led to a 3.2- or 5.2-fold increase, respectively, in COX-2 promoter activity, these effects being inhibited by 64% or 54%, respectively, by 100 mM PDTC (Fig. 12A).	SEN:10017240	10946303
BEL:20045748	p(HGNC:TNF) increases r(HGNC:TNFRSF1A)	The transcript level of Caspase-8, Fas, FADD, DR3, TNFR1 and FRDD were increased by the TNF-alpha signaling pathway.	SEN:10024564	10784420
BEL:20045750	p(HGNC:TNF) increases r(HGNC:TNFRSF25)	The transcript level of Caspase-8, Fas, FADD, DR3, TNFR1 and FRDD were increased by the TNF-alpha signaling pathway.	SEN:10024564	10784420
BEL:20045756	p(HGNC:TNF) increases r(HGNC:VCAM1)	Northern blot analysis revealed increased VCAM-1 mRNA levels after 3 hours of stimulation of human ECs with TNF-a 10 mg/L, which could be inhibited in a concentration-dependent manner by pretreatment with the PPARa activators fenofibrate or WY14643 (Figure 4A).	SEN:10024164	10377075
BEL:20045758	p(HGNC:TNF) increases r(HGNC:VCAM1)	Proinflammatory cytokines, including IL-1beta and tumor necrosis factor-alpha (TNF-alpha), promote cancer cell adhesion and liver metastases by up-regulating the expression of vascular cell adhesion molecule-1 (VCAM-1)	SEN:10007214	10639148
BEL:20045764	p(HGNC:TNF) increases r(HGNC:ZFP36)	TTP expression is induced by TNF-alpha, and evidence indicates that TTP can bind and destabilize the TNF-alpha mRNA.	SEN:10024586	10763822
BEL:20045772	p(HGNC:TNFRSF1A) decreases bp(GOBP:"fat cell differentiation")	Adipocyte precursor cells exposed to the 60-kDa TNF receptor (p60-TNFR)-specific TNF(R32W-S86T) showed a marked decrease in the percentage of differentiating cells in response to adipogenic factors as well as a reduction in peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) messenger RNA (mRNA) and glycerophosphate dehydrogenase (GPDH) activity, but increased endogenous TNF mRNA expression	SEN:10018706	10875261
BEL:20045774	p(HGNC:TNFRSF1A) decreases cat(p(HGNC:GPD1))	Adipocyte precursor cells exposed to the 60-kDa TNF receptor (p60-TNFR)-specific TNF(R32W-S86T) showed a marked decrease in the percentage of differentiating cells in response to adipogenic factors as well as a reduction in peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) messenger RNA (mRNA) and glycerophosphate dehydrogenase (GPDH) activity, but increased endogenous TNF mRNA expression	SEN:10018706	10875261
BEL:20045776	p(HGNC:TNFRSF1A) increases kin(p(HGNC:RAF1))	c-Raf-1 kinase was identified as an intracellular target of a signal transduction cascade initiated by binding of TNF-alpha to TNFR-I.	SEN:10024516	10359574
BEL:20045780	p(HGNC:TNFRSF1A) decreases r(HGNC:SLC2A4)	p60-TNFR-mediated inhibition increased continuously during 6 h of treatment and was associated with a down-regulation of glucose transporter-4 (GLUT4) mRNA and GLUT4 protein, whereas the p80-TNFR-specific mutein caused a transient increase in GLUT4 mRNA, but did not alter GLUT4 protein expression after a 24-h incubation	SEN:10007726	10875261
BEL:20045782	p(HGNC:TNFRSF1A) increases r(HGNC:TNF)	Adipocyte precursor cells exposed to the 60-kDa TNF receptor (p60-TNFR)-specific TNF(R32W-S86T) showed a marked decrease in the percentage of differentiating cells in response to adipogenic factors as well as a reduction in peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) messenger RNA (mRNA) and glycerophosphate dehydrogenase (GPDH) activity, but increased endogenous TNF mRNA expression	SEN:10018706	10875261
BEL:20045784	p(HGNC:TNFRSF1B) increases bp(GOBP:"fat cell differentiation")	When cells were incubated with the p80-TNFR-specific TNF(D143N-A145R), adipogenesis and PPARgamma2 mRNA expression were stimulated, GPDH activity was unchanged, and TNF mRNA was completely suppressed	SEN:10004522	10875261
BEL:20045786	p(HGNC:TNFRSF1B) increases r(HGNC:SLC2A4)	p60-TNFR-mediated inhibition increased continuously during 6 h of treatment and was associated with a down-regulation of glucose transporter-4 (GLUT4) mRNA and GLUT4 protein, whereas the p80-TNFR-specific mutein caused a transient increase in GLUT4 mRNA, but did not alter GLUT4 protein expression after a 24-h incubation	SEN:10007726	10875261
BEL:20045788	p(HGNC:TNFRSF1B) decreases r(HGNC:TNF)	When cells were incubated with the p80-TNFR-specific TNF(D143N-A145R), adipogenesis and PPARgamma2 mRNA expression were stimulated, GPDH activity was unchanged, and TNF mRNA was completely suppressed	SEN:10004522	10875261
BEL:20045792	p(HGNC:TNF) increases sec(p(HGNC:C3))	The addition of interleukin (IL)-1beta or tumor necrosis factor (TNF)-alpha induced a dose- and time-dependent increase in C3 and factor B secretion.	SEN:10007216	10719060
BEL:20045796	p(HGNC:TNF) increases sec(p(HGNC:CFB))	The addition of interleukin (IL)-1beta or tumor necrosis factor (TNF)-alpha induced a dose- and time-dependent increase in C3 and factor B secretion.	SEN:10007216	10719060
BEL:20045800	p(HGNC:TNF) increases sec(p(HGNC:IL18))	Tumor necrosis factor-alpha (TNF-alpha) mediated a large decrease in IL-18 mRNA levels in the human keratinocyte cell line HaCaT, which was accompanied by a subsequent accumulation of IL-18 protein in the cell culture supernatants, which was shown to be biologically active.	SEN:10024572	11125306
BEL:20045802	p(HGNC:TNF) increases sec(p(HGNC:IL6))	TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).	SEN:10024538	10362713
BEL:20045806	p(HGNC:TNF) increases sec(p(HGNC:VEGFA))	VEGF production induced by IL-1beta, TNF-alpha, and TGF-beta was further increased when CD40L+ L cells were coincubated, by factors of 5.9, 5.5, and 9.6, respectively, which indicated that these cytokines had an additive effect on VEGF production driven by CD40L.	SEN:10023540	10799861
BEL:20045808	p(HGNC:TNFSF10) increases bp(GOBP:"apoptotic process")	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) preferentially triggers apoptosis in tumor cells versus normal cells	SEN:10007728	11221847
BEL:20045828	p(HGNC:TNF) increases surf(p(HGNC:MMP14))	Stimulation of EC with TNF-a and/or Ox-LDL for 24 h increased the number of MT1-MMP-bearing cells to about 1.8-fold (Ox-LDL), 1.7-fold (TNF-a), or 2.5-fold (TNF-a and Ox-LDL together) as compared with unstimulated cells (Fig. 6B - flow cytometric analysis of HSVEC using purified mouse monoclonal antibody to human MT1- MMP.)	SEN:10017094	10207013
BEL:20045830	p(HGNC:TNF) increases tloc(p(HGNC:RELA),GOCCID:0005737,GOCCID:0005634)	As shown in Fig. 10C, p65 was rapidly (10 min) translocated from the cytosol to the nuclear compartment in (TNF) stimulated cells.	SEN:10024604	10946303
BEL:20045850	p(HGNC:TP53) increases cat(p(HGNC:CASP3))	HPV-16 E6 expression suppresses CD437-induced CPP32 activation (A), PARP cleavage (B), and cytochrome c (C) in H460 cells.	SEN:10024610	10383141
BEL:20045868	p(HGNC:TP53,pmod(P,S,392)) directlyIncreases complex(p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53),p(HGNC:TP53))	<p17> Ser392 phosphorylation of P53 increases 10-fold the association constant for tetramerization, but this effect is reversed by Ser315 phosphorylation. The tetramerization activates P53 for specific DNA binding and transcription	SEN:10020166	10436023
BEL:20045870	p(HGNC:TP53,pmod(P,S,392)) directlyIncreases tscript(p(HGNC:TP53))	<p17> Ser392 phosphorylation of P53 increases 10-fold the association constant for tetramerization, but this effect is reversed by Ser315 phosphorylation. The tetramerization activates P53 for specific DNA binding and transcription	SEN:10020166	10436023
BEL:20045874	p(HGNC:TP53,pmod(P,T,18)) decreases complex(p(HGNC:MDM2),p(HGNC:TP53))	<p4> Unknown Phosphatase dephosphorylates P53 at Thr18 <p5> Phosphorylation of Ser18 (note discrepancy with Thr18 above) prevents stable binding of p53 to Mdm2 - other sites may be involved in this process	SEN:10024616	10436023
BEL:20045884	p(HGNC:TPO) increases tscript(p(HGNC:STAT3))	It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)	SEN:10024618	10080909
BEL:20045886	p(HGNC:TPO) increases tscript(p(HGNC:STAT5A))	It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)	SEN:10024618	10080909
BEL:20045888	p(HGNC:TPO) increases tscript(p(HGNC:STAT5B))	It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)	SEN:10024618	10080909
BEL:20045900	p(HGNC:TRAF2) increases r(HGNC:FASN)	Nonetheless, a functional link between TRAF2 and IKK activity in B cells is demonstrated by the fact that overexpression of TRAF2 constitutively induces IKK activity, NF-kappaB luciferase and Fas expression	SEN:10024620	10229103
BEL:20045920	p(HGNC:TSHB) increases bp(GOBP:"DNA replication")	activation supports synergistic stimulation of DNA synthesis by insulin (INS) and thyroid stimulating hormone (TSHB)	SEN:10024632	11112439
BEL:20045928	p(HGNC:TWIST1) decreases bp(GOBP:"cell proliferation")	Cells that overexpressed TWIST exhibited a spindle shaped morphology, reduced levels of alkaline phosphatase, a reduced proliferation rate, and failed to respond to basic fibroblast growth factor (bFGF).	SEN:10024636	10572240
BEL:20045930	p(HGNC:TWIST1) decreases p(HGNC:ALPL)	Cells that overexpressed TWIST exhibited a spindle shaped morphology, reduced levels of alkaline phosphatase, a reduced proliferation rate, and failed to respond to basic fibroblast growth factor (bFGF).	SEN:10024636	10572240
BEL:20045932	p(HGNC:TWIST1) decreases r(HGNC:ALPL)	TWIST antisense cells exhibited increased levels of alkaline phosphatase and type I collagen mRNA, initiated osteopontin mRNA expression, and had a reduced proliferation rate.	SEN:10024638	10572240
BEL:20045934	p(HGNC:TWIST1) decreases r(HGNC:COL1A1)	TWIST antisense cells exhibited increased levels of alkaline phosphatase and type I collagen mRNA, initiated osteopontin mRNA expression, and had a reduced proliferation rate.	SEN:10024638	10572240
BEL:20045936	p(HGNC:TWIST1) decreases r(HGNC:SPP1)	TWIST antisense cells exhibited increased levels of alkaline phosphatase and type I collagen mRNA, initiated osteopontin mRNA expression, and had a reduced proliferation rate.	SEN:10024638	10572240
BEL:20045942	p(HGNC:TXN) decreases a(CHEBI:"reactive oxygen species")	Additionally, several studies have shown that antioxidant enzymes and mimics also block NF-kB activation by various stimuli. For example, overexpression of peroxiredoxin [247] or thioredoxin [111] blocks NF-kB activation by H2O2.	SEN:10024188	10699758
BEL:20045944	p(HGNC:TXN) decreases bp(GOBP:"response to oxidative stress")	Additionally, several studies have shown that antioxidant enzymes and mimics also block NF-kB activation by various stimuli. For example, overexpression of peroxiredoxin [247] or thioredoxin [111] blocks NF-kB activation by H2O2.	SEN:10024188	10699758
BEL:20045956	p(HGNC:TYMP) increases r(HGNC:DPYD)	Downregulation of DPD gene expression may enhance the negative prognostic effect of high TP gene expression in patients with epithelial ovarian cancer.	SEN:10007744	11099324
BEL:20045972	p(HGNC:UGT1A7) increases r(HGNC:HNF1A)	These data provide evidence for an important stimulatory role of HNF1 in promoting UGT1A7 gene expression in rat liver.	SEN:10024648	10908299
BEL:20045978	p(HGNC:USF2) increases r(HGNC:ATP5E)	We have previously determined that the transcription factor, upstream stimulatory factor 2 (USF2), can activate the ATPA gene through an initiator element in the core promoter.	SEN:10007750	10434034
BEL:20045994	p(HGNC:VCAM1) increases bp(GOBP:angiogenesis)	Furthermore, VCAM-1 can induce chemotaxis in endothelial cells in vitro and angiogenesis in vivo (134).	SEN:10024654	11172729
BEL:20045996	p(HGNC:VCAM1) increases bp(GOBP:"cell adhesion")	These EC adhesion molecules include vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin, and P-selectin.6,7	SEN:10023290	10377075
BEL:20045998	p(HGNC:VCAM1) increases bp(GOBP:"cell adhesion")	Proinflammatory cytokines, including IL-1beta and tumor necrosis factor-alpha (TNF-alpha), promote cancer cell adhesion and liver metastases by up-regulating the expression of vascular cell adhesion molecule-1 (VCAM-1)	SEN:10007214	10639148
BEL:20046000	p(HGNC:VCAM1) increases bp(GOBP:"cell migration")	Furthermore, VCAM-1 can induce chemotaxis in endothelial cells in vitro and angiogenesis in vivo (134).	SEN:10024654	11172729
BEL:20046008	p(HGNC:VCP,pmod(P,Y)) directlyIncreases cat(p(HGNC:VCP))	Moreover, induction of wild type PTPH1 resulted in specific dephosphorylation of VCP without changing the overall phosphotyrosine profile of the cells.	SEN:10024658	10364224
BEL:20046010	p(HGNC:VEGFA) increases a(CHEBI:"nitric oxide")	VEGF-dependent cell survival and VEGF-induced synthesis of nitric oxide and prostacyclin are likely to be key mediators of a vascular protective effect.	SEN:10007760	11350732
BEL:20046018	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	EGF-R activation was significantly blocked by therapy with PKI166 and was associated with significant reduction in tumor cell production of VEGF and IL-8, which in turn correlated with a significant decrease in microvessel density and an increase in apoptotic endothelial cells.	SEN:10021196	10850439
BEL:20046020	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	Vascular endothelial growth factor (VEGF) is essential for angiogenesis in health and pathophysiology	SEN:10003040	11350732
BEL:20046026	p(HGNC:VEGFA) decreases bp(GOBP:"cell proliferation")	VEGF-induced enhancement of endothelial functions that mediate the inhibition of vascular smooth muscle cell proliferation, enhanced endothelial cell survival, suppression of thrombosis, and anti-inflammatory effects	SEN:10007762	11350732
BEL:20046028	p(HGNC:VEGFA) decreases bp(GOBP:"inflammatory response")	VEGF-induced enhancement of endothelial functions that mediate the inhibition of vascular smooth muscle cell proliferation, enhanced endothelial cell survival, suppression of thrombosis, and anti-inflammatory effects	SEN:10007762	11350732
BEL:20046032	p(HGNC:VEGFA) increases bp(GOBP:"patterning of blood vessels")	In contrast, costimulation with VEGF and Ang-2 induced sprouting angiogenesis originating from coculture spheroids consistent with a model of Ang-2-mediated vessel destabilization resulting in VEGF responsiveness. Ang-2 on its own was able to stimulate endothelial cells in the absence of Ang-1 producing SMC, inducing lateral sheet migration as well as in gel sprouting angiogenesis.	SEN:10022566	11156960
BEL:20046036	p(HGNC:VEGFA) decreases bp(GOBP:"apoptotic process")	Recently, knockout studies in mice demonstrated that a deficiency or truncation of VE-cadherin induces endothelial apoptosis and inhibits transmission of the endothelial survival signal by VEGF, leading to lethality at 9.5 days of gestation (36).	SEN:10022772	11172729
BEL:20046038	p(HGNC:VEGFA) decreases bp(GOBP:"apoptotic process")	VEGF-induced enhancement of endothelial functions that mediate the inhibition of vascular smooth muscle cell proliferation, enhanced endothelial cell survival, suppression of thrombosis, and anti-inflammatory effects	SEN:10007762	11350732
BEL:20046046	p(HGNC:VEGFA) increases kin(p(HGNC:KDR))	At least for the interaction between VEGF-A165 and VEGFR-2, it has been demonstrated that neuropilin-1 acts as a co-receptor which enhances the affinity of the receptor for the ligand (Soker et al., 1998).	SEN:10024076	10022831
BEL:20046056	p(HGNC:VEGFA) increases p(HGNC:ICAM1)	VEGF may also cause an impairment of leukocyte interactions with the endothelium via the ability of endogenous NO synthesis to inhibit leukocyte rolling and adhesion and upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1	SEN:10024660	11350732
BEL:20046058	p(HGNC:VEGFA) increases p(HGNC:VCAM1)	VEGF may also cause an impairment of leukocyte interactions with the endothelium via the ability of endogenous NO synthesis to inhibit leukocyte rolling and adhesion and upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1	SEN:10024660	11350732
BEL:20046060	p(HGNC:VEGFA) increases r(HGNC:ACE)	VEGF (0.07-1.2 x 10(-6) mmol/l) caused a dose-dependent increase in ACE measured in intact endothelial cells and increased the expression of ACE mRNA.	SEN:10024668	11158990
BEL:20046068	p(HGNC:VEGFA) increases r(HGNC:ICAM1)	VEGF increased VCAM-1 and ICAM-1 protein levels and increased leukocyte adhesiveness in a NF-kappaB-dependent manner. These results suggest that VEGF-stimulated expression of ICAM-1, VCAM-1, and E-selectin mRNAs was mainly through NF-kappaB activation	SEN:10007770	11108718
BEL:20046070	p(HGNC:VEGFA) increases r(HGNC:SELE)	VEGF increased VCAM-1 and ICAM-1 protein levels and increased leukocyte adhesiveness in a NF-kappaB-dependent manner. These results suggest that VEGF-stimulated expression of ICAM-1, VCAM-1, and E-selectin mRNAs was mainly through NF-kappaB activation	SEN:10007770	11108718
BEL:20046072	p(HGNC:VEGFA) increases r(HGNC:TEK)	Vascular endothelial growth factor and basic fibroblast growth factor, which were overexpressed in involved psoriasis skin, enhanced angiopoietin 2 and Tie2 expression in dermal microvascular endothelial cell cultures.	SEN:10006916	11348459
BEL:20046074	p(HGNC:VEGFA) increases r(HGNC:VCAM1)	VEGF increased VCAM-1 and ICAM-1 protein levels and increased leukocyte adhesiveness in a NF-kappaB-dependent manner. These results suggest that VEGF-stimulated expression of ICAM-1, VCAM-1, and E-selectin mRNAs was mainly through NF-kappaB activation	SEN:10007770	11108718
BEL:20046078	p(HGNC:VEGFA) increases tscript(p(HGNC:RELA))	Incubation of HUVECs with 20 ng/ml VEGF-165 for 4 hours resulted in the sphingosine kinase-mediated increase in p65 subunit of NFKB activity. VEGF-induced p65 activation was found to be inhibited by 5 microM sphigosine kinase-inhibitor, DMS.	SEN:10024674	11108718
BEL:20046100	p(HGNC:VTN) increases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	For example, avb3 associates with the PDGF receptor, and fibroblasts show greater proliferation in response to PDGFb when adhering to the avb3 ligand vitronectin than when they adhere to the b1 integrin ligand collagen (26).	SEN:10018348	10446041
BEL:20046102	p(HGNC:VWF) directlyIncreases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	avb3 is a receptor for a number of proteins with an exposed Arg-Gly-Asp (RGD) sequence, including fibronectin, vitronectin, laminin, von Willebrand factor (vWF), fibrinogen and denatured collagen.	SEN:10020538	11172729
BEL:20046106	p(HGNC:WASL) increases complex(p(HGNC:ACTG1),p(HGNC:ACTG1))	The ubiquitous homolog of WASp, N-WASp, is a multidomain protein that interacts with the Arp2/3 complex and G-actin via its C-terminal WA domain to stimulate actin polymerization.	SEN:10018362	10781580
BEL:20046108	p(HGNC:WASL) directlyIncreases complex(p(HGNC:ACTR2),p(HGNC:ACTR3))	The ubiquitous homolog of WASp, N-WASp, is a multidomain protein that interacts with the Arp2/3 complex and G-actin via its C-terminal WA domain to stimulate actin polymerization.	SEN:10018362	10781580
BEL:20046110	p(HGNC:WNT1) increases r(HGNC:CCND1)	Wnt-1 overexpression in mammary epithelial cells induced cyclin D1 mRNA and targeted overexpression of Wnt-1 in the mammary gland of transgenic mice increased both ILK activity and cyclin D1 levels.	SEN:10007774	10915780
BEL:20046112	p(HGNC:WNT1) increases r(HGNC:PTGS2)	Expression of Wnt-1 in these cells caused transcriptional up-regulation of the cyclooxygenase-2 gene, resulting in increased levels of cyclooxygenase-2 mRNA and protein.	SEN:10007776	10197631
BEL:20046122	p(HGNC:WT1) decreases bp(GOBP:"apoptotic process")	These data suggest that in certain cellular contexts, WT1 exhibits oncogenic potential through the transcriptional upregulation of anti-apoptotic genes such as bcl-2.	SEN:10007778	10406804
BEL:20046126	p(HGNC:WT1) directlyIncreases r(HGNC:BCL2)	overexpressing WT1, we show that WT1 activates the endogenous bcl-2 gene through a transcriptional mechanism. Transient transfections and electromobility shift assays demonstrate that WT1 positively stimulates the bcl-2 promoter through a direct interaction.	SEN:10007782	10406804
BEL:20046132	p(HGNC:WT1) decreases r(HGNC:CTGF)	To clarify the mechanism by which WT1 represses the CTGF promoter, we were interested in identifying sequences within the promoter that are recognized by WT1.	SEN:10024684	10973960
BEL:20046136	p(HGNC:WT1) increases r(HGNC:SRY)	Our hypothesis is that because mutation of both genes causes sex reversal in humans and WT1 is expressed before SRY in the gonadal ridge, WT1 may regulate the expression of SRY.	SEN:10024688	11278460
BEL:20046138	p(HGNC:XDH) increases p(HGNC:IL6)	As shown in Fig. 3A, stimulation with XO resulted in a significant increase in the levels of IL-6 at 12 and 24 h compared with those with 0.7 mM X alone (P , 0.0001). Consistent with these protein data, stimulation of HS-24 cells with XO caused the maximum elevation in IL-6 mRNAlevels at 6 h, whereas XO did not modulate control GAPDH transcript levels (Fig. 3B).	SEN:10024690	10362713
BEL:20046140	p(HGNC:XDH) increases r(HGNC:IL6)	As shown in Fig. 3A, stimulation with XO resulted in a significant increase in the levels of IL-6 at 12 and 24 h compared with those with 0.7 mM X alone (P , 0.0001). Consistent with these protein data, stimulation of HS-24 cells with XO caused the maximum elevation in IL-6 mRNAlevels at 6 h, whereas XO did not modulate control GAPDH transcript levels (Fig. 3B).	SEN:10024690	10362713
BEL:20046150	p(HGNC:XRCC5) increases kin(p(HGNC:PRKDC))	<s18> KARP1 stimulates DNA-PK activity and may function in complex with DNA-PK and Ku (Mysung et al., 1997; Myung et al., 1998) (also see P50).	SEN:10024698	10436023
BEL:20046154	p(HGNC:YWHAB) decreases cat(p(HGNC:HDAC4))	These results indicate that 14-3-3 proteins negatively regulate HDAC4 by preventing its nuclear localization and thereby uncover a novel regulatory mechanism for HDACs.	SEN:10005378	10958686
BEL:20046160	p(HGNC:YY1) decreases r(HGNC:SAA1)	In nonstimulated hepatic cells such as HepG2, YY1 functions as a constitutively expressed transcription repressor that occupies its site in the CRU and accounts for the low basal expression of SAA1 .	SEN:10024700	11278660
BEL:20046164	p(HGNC:ZFP36) increases bp(GOBP:"apoptotic process")	Supporting this idea, continuous expression of each TTP/TIS11 protein at physiological levels causes apoptotic cell death.	SEN:10024702	10763822
BEL:20046206	phos(p(HGNC:CDC25C)) directlyIncreases kin(p(HGNC:CDK1))	In the case of Cdk1, these inhibitory phosphorylations are removed by dual-action phosphatase Cdc25C, which is in turn activated by phosphorylations (C18) introduced by mammalian polo-like kinase 1 (Plk1) (C37) and/or Cdk1 (C36). Cdc25C can be phosphorylated at Ser216 by Chk1 (C38) or C-TAK1 (C39). Ser216 phosphorylation generates a binding site for 14-3-3, and this binding inhibits the phosphatase (C40).	SEN:10024712	10436023
BEL:20046212	phos(p(HGNC:CDC25C)) directlyDecreases p(EGID:5424,pmod(P,T,14))	<C18> Dephosphorylation of Cdk1 Thr14 and Tyr15 sites is carried out by Cdc25C, which must itself be activated by phosphorylation in its N-terminal domain (Jackman and Pines, 1997). Cdc25C activity is high in mitosis during mitosis and low during interphase.	SEN:10024714	10436023
BEL:20046216	phos(p(HGNC:CDC25C)) directlyDecreases p(EGID:5424,pmod(P,Y,15))	<C18> Dephosphorylation of Cdk1 Thr14 and Tyr15 sites is carried out by Cdc25C, which must itself be activated by phosphorylation in its N-terminal domain (Jackman and Pines, 1997). Cdc25C activity is high in mitosis during mitosis and low during interphase.	SEN:10024714	10436023
BEL:20046218	phos(p(HGNC:DUSP10)) decreases kin(p(HGNC:MAPK8))	Forced expression of MKP5, a JNK phosphatase, in JNK kinase-expressing cells decreased T81 phosphorylation while reducing p53 transcriptional activity and p53-mediated apoptosis.	SEN:10005962	11283254
BEL:20046240	phos(p(HGNC:ENPP1)) decreases kin(p(HGNC:INSR))	PC-1 is a membrane glycoprotein with ectonucleotide pyrophosphatase activity that seems to act as an intrinsic inhibitor of insulin receptor tyrosine kinase activity	SEN:10024722	10194465
BEL:20046242	phos(p(HGNC:ENPP1)) directlyDecreases p(HGNC:INSR,pmod(P,Y))	It has been reported that PC-1 overexpression in skeletal muscle of obese subjects explains downregulation of insulin receptor tyrosine phosphorylation	SEN:10024724	10194465
BEL:20046252	phos(p(HGNC:PPM1A)) decreases kin(p(HGNC:CDK2))	Moreover, purified recombinant PP2C alpha and PP2C beta 2 proteins efficiently dephosphorylated monomeric Cdk2/Cdk6 in vitro.	SEN:10007806	10934208
BEL:20046268	phos(p(HGNC:PTEN)) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	We have shown previously that PTEN negatively controls the G1/S cell cycle transition and regulates the levels of p27(KIP1), a CDK inhibitor	SEN:10007816	11250155
BEL:20046270	phos(p(HGNC:PTEN)) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	We have shown previously that PTEN negatively controls the G1/S cell cycle transition and regulates the levels of p27(KIP1), a CDK inhibitor [3, 4].	SEN:10007818	11250155
BEL:20046278	phos(p(HGNC:PTEN)) decreases complex(p(HGNC:IRS1),p(HGNC:GRB2))	The latter was accompanied by a decrease in the phosphorylation of insulin receptor substrate 1 (IRS-1) and the association of IRS-1 with Grb2/Sos	SEN:10007824	11230180
BEL:20046284	phos(p(HGNC:PTEN)) decreases kin(p(HGNC:BTK))	This is consistent with the reports that several Btk kinases are activated by PI3-kinase (August et al., 1997; Li et al., 1997a; Qiu et al., 1998b) and that Btk becomes membrane localized when PTEN a lipid phosphatase which counteracts PI3K is defective (Satterthwaite et al., 2000; Shan et al., 2000).	SEN:10021050	11114746
BEL:20046286	phos(p(HGNC:PTEN)) increases p(HGNC:CDKN1B)	Here we report that PTEN and the PI 3-kinase pathway regulate p27 protein stability. PTEN-deficiency in mouse embryonic stem (ES) cells causes a decrease of p27 levels with concomitant increase of SKP2, a key component of the SCF(SKP2) complex. Conversely, in human glioblastoma cells, ectopic PTEN expression leads to p27 accumulation, which is accompanied by a reduction of SKP2.	SEN:10007810	11250155
BEL:20046288	phos(p(HGNC:PTEN)) increases p(HGNC:CDKN1B)	We have shown previously that PTEN negatively controls the G1/S cell cycle transition and regulates the levels of p27(KIP1), a CDK inhibitor	SEN:10007816	11250155
BEL:20046296	phos(p(HGNC:PTEN)) decreases p(HGNC:SKP2)	Here we report that PTEN and the PI 3-kinase pathway regulate p27 protein stability. PTEN-deficiency in mouse embryonic stem (ES) cells causes a decrease of p27 levels with concomitant increase of SKP2, a key component of the SCF(SKP2) complex. Conversely, in human glioblastoma cells, ectopic PTEN expression leads to p27 accumulation, which is accompanied by a reduction of SKP2.	SEN:10007810	11250155
BEL:20046298	phos(p(HGNC:PTEN)) increases tscript(p(HGNC:FOXO1))	Here we show that Forkhead transcription factors FKHRL1 and FKHR, substrates of the Akt kinase, are aberrantly localized to the cytoplasm and cannot activate transcription in PTEN-deficient cells. Restoration of PTEN function restores FKHR to the nucleus and restores transcriptional activation.	SEN:10007826	11073996
BEL:20046300	phos(p(HGNC:PTEN)) increases tscript(p(HGNC:FOXO3))	Here we show that Forkhead transcription factors FKHRL1 and FKHR, substrates of the Akt kinase, are aberrantly localized to the cytoplasm and cannot activate transcription in PTEN-deficient cells. Restoration of PTEN function restores FKHR to the nucleus and restores transcriptional activation.	SEN:10007826	11073996
BEL:20046304	phos(p(HGNC:PTPN11)) directlyIncreases kin(p(HGNC:FYN))	The FAK and Shc pathways are regulated both positively and negatively by tyrosine phosphatases. Integrin-mediated activation of ERK is suppressed in cells that lack the re- ceptor-type protein tyrosine phosphatase a or the cytosolic phosphatase SHP-2 (19). These enzymes dephosphorylate the negative regulatory site in Src-family kinases and thus, presumably, amplify both FAK and Shc signaling.	SEN:10024730	10446041
BEL:20046306	phos(p(HGNC:PTPN11)) directlyIncreases kin(p(HGNC:LCK))	The FAK and Shc pathways are regulated both positively and negatively by tyrosine phosphatases. Integrin-mediated activation of ERK is suppressed in cells that lack the re- ceptor-type protein tyrosine phosphatase a or the cytosolic phosphatase SHP-2 (19). These enzymes dephosphorylate the negative regulatory site in Src-family kinases and thus, presumably, amplify both FAK and Shc signaling.	SEN:10024730	10446041
BEL:20046310	phos(p(HGNC:PTPN11)) directlyIncreases kin(p(HGNC:YES1))	The FAK and Shc pathways are regulated both positively and negatively by tyrosine phosphatases. Integrin-mediated activation of ERK is suppressed in cells that lack the re- ceptor-type protein tyrosine phosphatase a or the cytosolic phosphatase SHP-2 (19). These enzymes dephosphorylate the negative regulatory site in Src-family kinases and thus, presumably, amplify both FAK and Shc signaling.	SEN:10024730	10446041
BEL:20046326	phos(p(HGNC:PTPN11)) decreases r(HGNC:SOCS3)	Inhibition of SHP2 activation leads to increased SOCS3-mRNA levels, whereas increased expression of SOCS3 results in a reduction of SHP2 phosphorylation after activation of the interleukin-6 signal transduction pathway.	SEN:10007596	10777583
BEL:20046340	phos(p(HGNC:PTPN21)) increases kin(p(HGNC:BMX))	Furthermore, the Etk-PTPD1 interaction stimulated the kinase activity of Etk, resulting in an increased phosphotyrosine content in both factors. The Etk-PTPD1 interaction also increased Stat3 activation. In addition, Tec (but not Btk) kinase can also be activated by PTPD1.	SEN:10021146	11013262
BEL:20046342	phos(p(HGNC:PTPN21)) increases kin(p(HGNC:TEC))	Furthermore, the Etk-PTPD1 interaction stimulated the kinase activity of Etk, resulting in an increased phosphotyrosine content in both factors. The Etk-PTPD1 interaction also increased Stat3 activation. In addition, Tec (but not Btk) kinase can also be activated by PTPD1.	SEN:10021146	11013262
BEL:20046344	phos(p(HGNC:PTPN21)) increases tscript(p(HGNC:STAT3))	Furthermore, the Etk-PTPD1 interaction stimulated the kinase activity of Etk, resulting in an increased phosphotyrosine content in both factors. The Etk-PTPD1 interaction also increased Stat3 activation. In addition, Tec (but not Btk) kinase can also be activated by PTPD1.	SEN:10021146	11013262
BEL:20046346	phos(p(HGNC:PTPN3)) decreases cat(p(HGNC:VCP))	Moreover, induction of wild type PTPH1 resulted in specific dephosphorylation of VCP without changing the overall phosphotyrosine profile of the cells.	SEN:10024658	10364224
BEL:20046348	phos(p(HGNC:PTPN3)) decreases p(HGNC:VCP,pmod(P,Y))	Moreover, induction of wild type PTPH1 resulted in specific dephosphorylation of VCP without changing the overall phosphotyrosine profile of the cells.	SEN:10024658	10364224
BEL:20046358	phos(p(HGNC:PTPN7)) decreases kin(p(HGNC:MAP2K1))	The haematopoietic protein tyrosine phosphatase (HePTP) is a negative regulator of the MAP kinases Erk1, Erk2 and p38.	SEN:10007830	10559944
BEL:20046360	phos(p(HGNC:PTPN7)) decreases kin(p(HGNC:MAPK1))	The haematopoietic protein tyrosine phosphatase (HePTP) is a negative regulator of the MAP kinases Erk1, Erk2 and p38.	SEN:10007830	10559944
BEL:20046362	phos(p(HGNC:PTPN7)) decreases kin(p(HGNC:MAPK3))	The haematopoietic protein tyrosine phosphatase (HePTP) is a negative regulator of the MAP kinases Erk1, Erk2 and p38.	SEN:10007830	10559944
BEL:20046366	phos(p(HGNC:PTPRB)) decreases p(HGNC:CTNNB1,pmod(P,Y))	We also have found that an active site-containing domain of RPTP beta zeta both binds beta-catenin and functionally reduces its levels of tyrosine phosphorylation Finally, in parallel to its ability to inactivate endogenous RPTP beta zeta, PTN sharply increases tyrosine phosphorylation of beta-catenin in PTN-treated cells	SEN:10018674	10706604
BEL:20046368	phos(p(HGNC:PTPRC)) decreases kin(p(HGNC:LYN))	CD45 selectively dephosphorylates the Src-family protein tyrosine kinase Lyn and inhibits its kinase activity.	SEN:10007368	10415030
BEL:20046370	phos(p(HGNC:PTPRC)) decreases kin(p(HGNC:MAPK1))	reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKCdelta activation.	SEN:10007832	11124968
BEL:20046372	phos(p(HGNC:PTPRC)) decreases kin(p(HGNC:MAPK3))	reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKCdelta activation.	SEN:10007832	11124968
BEL:20046374	phos(p(HGNC:PTPRC)) decreases kin(p(HGNC:PRKCD))	reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKCdelta activation.	SEN:10007832	11124968
BEL:20046384	phos(p(HGNC:PTPRF)) decreases bp(GOBP:"MAPK cascade")	We found that although both EGF and FGF induce activation of mitogen-activated protein kinase (MAPK), LAR only inhibits FGF-induced MAPK activation.	SEN:10007834	10822386
BEL:20046386	phos(p(HGNC:PTPRF)) increases bp(GOBP:"apoptotic process")	The over-expression of LAR in mammalian tissue culture cells does not affect cell adhesion but induces caspase-dependent apoptosis.	SEN:10007836	10320483
BEL:20046388	phos(p(HGNC:PTPRF)) decreases complex(p(HGNC:BCAR1),p(HGNC:GRB2))	In contrast, LAR selectively inhibited the epidermal growth factor (EGF)-induced phosphorylation of p130CAS and the formation of the complex between p130CAS and GRB2 but this effect did not influence the activation of MAPK by EGF.	SEN:10022954	10822386
BEL:20046390	phos(p(HGNC:PTPRF)) decreases complex(p(HGNC:FRS2),p(HGNC:GRB2))	The specific effect of LAR on FGF-induced MAPK activation appeared to be mediated by specific inhibition of the phosphorylation of two signal transducers that act downstream of the FGF receptor, FRS2 and a 180 kDa protein, and by prevention of their interaction with the adaptor protein GRB2.	SEN:10007838	10822386
BEL:20046392	phos(p(HGNC:PTPRF)) decreases kin(p(HGNC:INSR))	Overexpression of these enzymes [LAR and PTP1B] in cultured cells prevents insulin receptor kinase activation.	SEN:10024744	11239409
BEL:20046394	phos(p(HGNC:PTPRF)) decreases p(HGNC:BCAR1)	The over-expression of LAR in tissue culture cells specifically decreased the steady state protein level of p130Cas, a multifunctional signal assembly protein in signal transduction, by reducing the tyrosine phosphorylation and protein stability of p130Cas.	SEN:10022616	10320483
BEL:20046396	phos(p(HGNC:PTPRF)) decreases p(HGNC:BCAR1,pmod(P,Y))	The over-expression of LAR in tissue culture cells specifically decreased the steady state protein level of p130Cas, a multifunctional signal assembly protein in signal transduction, by reducing the tyrosine phosphorylation and protein stability of p130Cas.	SEN:10022616	10320483
BEL:20046422	phos(p(MGI:Dusp22)) decreases tscript(p(MGI:Stat3))	In contrast, small-interfering RNA-mediated reduction of LMW-DSP2 expression enhanced IL-6-induced STAT3-dependent transcription.	SEN:10024748	16636663
BEL:20046424	phos(p(MGI:Dusp22)) decreases tscript(p(MGI:Stat3))	LMW-DSP2 overexpression in 293T cells suppressed IL-6-induced phosphorylation and activation of STAT3.	SEN:10007850	16636663
BEL:20046430	phos(p(MGI:Dusp8)) decreases kin(p(MGI:Mapk1))	M3/6 is the first phosphatase of this family to display highly specific inactivation of JNK/SAPK and p38 MAP kinases.	SEN:10007852	8910287
BEL:20046432	phos(p(MGI:Dusp8)) decreases kin(p(MGI:Mapk1))	stress-induced activation of p54 SAPKbeta, p46 SAPKgamma (JNK1) or p38 MAP kinases is abolished upon co-transfection with increasing amounts of M3/6	SEN:10024752	8910287
BEL:20046434	phos(p(MGI:Dusp8)) decreases kin(p(MGI:Mapk9))	stress-induced activation of p54 SAPKbeta, p46 SAPKgamma (JNK1) or p38 MAP kinases is abolished upon co-transfection with increasing amounts of M3/6	SEN:10024752	8910287
BEL:20046442	phos(p(MGI:Inppl1)) decreases kin(p(MGI:Akt2))	in 3T3-L1 adipocytes Insulin-induced phosphorylation of Akt, one of the molecules downstream of PI3-kinase, was inhibited by xpression of wild-type SHIP2 expression of SHIP2 appeared to affect the myr-p110-induced phosphorylation, and not the translocation, of Akt2.	SEN:10024756	14744864
BEL:20046444	phos(p(MGI:Inppl1)) decreases p(MGI:Akt2,pmod(P))	in 3T3-L1 adipocytes Insulin-induced phosphorylation of Akt, one of the molecules downstream of PI3-kinase, was inhibited by xpression of wild-type SHIP2 expression of SHIP2 appeared to affect the myr-p110-induced phosphorylation, and not the translocation, of Akt2.	SEN:10024756	14744864
BEL:20046448	phos(p(MGI:Ppm1b)) directlyDecreases p(MGI:Bad,pmod(P,S,155))	PP1 and PP2A were most effective in the dephosphorylation of BAD after phosphorylation with PKA. This was confirmed by a Western blot using the antiserum directed against P-Ser155 on BAD (Fig. 2B, upper panel). Autoradiogram and Western blot clearly showed dephosphorylation of BAD by PP2C at P-Ser155 (Fig. 2). The rate of dephosphorylation by PP2C was as good as for PP1 and PP2A.	SEN:10024760	12590938
BEL:20046454	phos(p(MGI:Ppp1cb)) increases cat(p(MGI:Slc12a4))	This activation is completely abolished by calyculin A and cyclosporine A, inhibitors of protein phosphatase 1 and 2B, respectively.	SEN:10003706	16446421
BEL:20046462	phos(p(MGI:Ppp1r15a)) decreases p(MGI:Eif2s1,pmod(P,S,52))	Recently, Novoa et al. (29, 31) demonstrated that GADD34, also known as Myd116 in mouse, promotes the dephosphorylation of eIF-2alpha and is induced by both ER stress and amino acid deprivation.	SEN:10018102	12840028
BEL:20046470	phos(p(MGI:Ppp3cb)) increases cat(p(MGI:Slc12a4))	This activation is completely abolished by calyculin A and cyclosporine A, inhibitors of protein phosphatase 1 and 2B, respectively.	SEN:10003706	16446421
BEL:20046472	phos(p(MGI:Pten)) increases bp(GOBP:angiogenesis)	the accelerated tumor growth in Tie2CrePtenflox/+ mice results from enhanced angiogenesis driven by increased endothelial cell proliferation/migration and not from defects in macrophages or tumor immunosurveillance	SEN:10024766	16107612
BEL:20046474	phos(p(MGI:Pten)) decreases bp(GOBP:"insulin receptor signaling pathway")	Our results demonstrate that in vivo PTEN is a potent negative regulator of insulin signaling and insulin sensitivity in adipose tissue.	SEN:10007858	15743841
BEL:20046482	phos(p(MGI:Ptpn11)) decreases p(MGI:Jak1,pmod(P))	Jak1 phosphorylation was reduced in wildtype indivduals after Il13 treatement, implying that SHP-2 is responsible for this effect.	SEN:10024772	12204103
BEL:20046492	phos(p(MGI:Ptpn13)) directlyDecreases p(MGI:Efnb1,pmod(P,Y))	Moreover, wild-type PTP-BL tyrosine phosphatase domain, but not the Cys?Ser inactive mu-tant, led to the complete dephosphorylation of ephrinB immunoprecipitated from mouse embryo lysates, sug-gesting its specificity for ephrinB’s in vivo phosphoryla-tion sites (Figure 5E).	SEN:10024776	11983165
BEL:20046504	phos(p(MGI:Ptpn2)) directlyDecreases kin(p(MGI:Jak1))	Cotransfection of JAK1 or JAK3 with TCPTP-WT resulted in substantial dephosphorylation of the kinases	SEN:10024784	11909529
BEL:20046506	phos(p(MGI:Ptpn2)) directlyDecreases kin(p(MGI:Jak3))	Cotransfection of JAK1 or JAK3 with TCPTP-WT resulted in substantial dephosphorylation of the kinases	SEN:10024784	11909529
BEL:20046508	phos(p(MGI:Ptpn2)) directlyDecreases p(MGI:Jak1,pmod(P,Y))	Cotransfection of JAK1 or JAK3 with TCPTP-WT resulted in substantial dephosphorylation of the kinases	SEN:10024784	11909529
BEL:20046510	phos(p(MGI:Ptpn2)) directlyDecreases p(MGI:Jak3,pmod(P,Y))	Cotransfection of JAK1 or JAK3 with TCPTP-WT resulted in substantial dephosphorylation of the kinases	SEN:10024784	11909529
BEL:20046514	phos(p(MGI:Ptpn6)) directlyDecreases p(MGI:Jak1,pmod(P,Y))	In addition, SHP-1 and its mutants showed similar association and dephosphorylation of the other Jak family members (JAK1, Tyk2, and JAK3) but not c-fes when coexpressed in Cos-7 cells (data not shown).	SEN:10024786	8943354
BEL:20046516	phos(p(MGI:Ptpn6)) directlyDecreases p(MGI:Jak3,pmod(P,Y))	In addition, SHP-1 and its mutants showed similar association and dephosphorylation of the other Jak family members (JAK1, Tyk2, and JAK3) but not c-fes when coexpressed in Cos-7 cells (data not shown).	SEN:10024786	8943354
BEL:20046518	phos(p(MGI:Ptpn6)) directlyDecreases p(MGI:Tyk2,pmod(P,Y))	In addition, SHP-1 and its mutants showed similar association and dephosphorylation of the other Jak family members (JAK1, Tyk2, and JAK3) but not c-fes when coexpressed in Cos-7 cells (data not shown).	SEN:10024786	8943354
BEL:20046522	phos(p(MGI:Ptpra)) increases kin(p(MGI:Src))	Protein tyrosine phosphatase alpha (PTPalpha) is believed to dephosphorylate physiologically the Src proto-oncogene at phosphotyrosine (pTyr)527, a critical negative-regulatory residue. It thereby activates Src	SEN:10007866	10698938
BEL:20046524	phos(p(MGI:Ptpra)) increases p(MGI:Grin2a)	Tyrosine phosphorylation of the NMDAR NR2A and NR2B subunits was reduced upon PTPalpha ablation, indicating a positive effect of this phosphatase on NMDAR phosphorylation via intermediate molecules.	SEN:10024788	16899073
BEL:20046526	phos(p(MGI:Ptpra)) increases p(MGI:Grin2b)	Tyrosine phosphorylation of the NMDAR NR2A and NR2B subunits was reduced upon PTPalpha ablation, indicating a positive effect of this phosphatase on NMDAR phosphorylation via intermediate molecules.	SEN:10024788	16899073
BEL:20046530	phos(p(MGI:Ptprc)) increases kin(p(MGI:Lck))	Defects in TCR-mediated signals underlying these abnormalities have now been investigated using CD45-null T cells. No T cell proliferation was detected in response to a CD3 mAb. In thymocytes the p56(lck) and p59(fyn) tyrosine kinases were hyperphosphorylated, and p56(lck) was in its inactive conformation.	SEN:10024790	9190928
BEL:20046532	phos(p(MGI:Ptprc)) decreases p(MGI:Fyn,pmod(P,Y))	Defects in TCR-mediated signals underlying these abnormalities have now been investigated using CD45-null T cells. No T cell proliferation was detected in response to a CD3 mAb. In thymocytes the p56(lck) and p59(fyn) tyrosine kinases were hyperphosphorylated, and p56(lck) was in its inactive conformation.	SEN:10024790	9190928
BEL:20046538	phos(p(MGI:Ptprc)) decreases p(MGI:Lck,pmod(P,Y))	Defects in TCR-mediated signals underlying these abnormalities have now been investigated using CD45-null T cells. No T cell proliferation was detected in response to a CD3 mAb. In thymocytes the p56(lck) and p59(fyn) tyrosine kinases were hyperphosphorylated, and p56(lck) was in its inactive conformation.	SEN:10024790	9190928
BEL:20046544	phos(p(MGI:Ptpre)) increases kin(p(MGI:Src))	Lack of RPTPepsilon reduced Src activity and altered Src phosphorylation in tumor cells; RPTPepsilon dephosphorylated and activated Src; and Src bound a substrate-trapping mutant of RPTPepsilon.	SEN:10024794	12598528
BEL:20046596	p(MGI:Aatk) increases bp(GOBP:"apoptotic process")	Overexpression of wild-type AATYK, but not its kinase-deficient mutant, stimulates apoptosis in LK.	SEN:10007888	16100393
BEL:20046598	p(MGI:Abca1) increases a(CHEBI:cholesterol)	Inactivation of the ABCA1 gene in ABCA1-knockout mice resulted in a decrease in plasma cholesterol and phospholipids and the virtual absence of plasma HDL.16,19,20	SEN:10024812	12679197
BEL:20046602	p(MGI:Abca1) increases a(CHEBI:phospholipid)	Inactivation of the ABCA1 gene in ABCA1-knockout mice resulted in a decrease in plasma cholesterol and phospholipids and the virtual absence of plasma HDL.16,19,20	SEN:10024812	12679197
BEL:20046608	p(MGI:Abca1) decreases path(MESHD:Atherosclerosis)	Aortic atherosclerosis in hABCA1-tg mice after 15 weeks on the atherogenic diet was significantly reduced by 65%, which established that overexpression of ABCA1 had decreased diet-induced atherosclerosis (Figure 4).22	SEN:10000294	12679197
BEL:20046630	p(MGI:Abcb1a) increases r(MGI:Ctnnb1)	biological involvement of Abcb1a in intestinal tumorigenesis aberrant induction of the Abcb1a gene product, p-glycoprotein, associated with nuclear accumulation of the beta-catenin protein, was observed	SEN:10024828	12615699
BEL:20046636	p(MGI:Abcg1) decreases a(CHEBI:cholesterol)	Abcg1/ macrophages accumulate sterols, notably 7-ketocholesterol and desmosterol after feeding of a high-cholesterol diet (Table) as well as 27-OH cholesterol (0.260.04 versus 0.440.04 ng/mg protein in macrophages from WT and Abcg1/ mice fed a chow diet, respectively; P0.05).	SEN:10024834	18852364
BEL:20046638	p(MGI:Abcg1) decreases a(CHEBI:desmosterol)	Abcg1/ macrophages accumulate sterols, notably 7-ketocholesterol and desmosterol after feeding of a high-cholesterol diet (Table) as well as 27-OH cholesterol (0.260.04 versus 0.440.04 ng/mg protein in macrophages from WT and Abcg1/ mice fed a chow diet, respectively; P0.05).	SEN:10024834	18852364
BEL:20046640	p(MGI:Abcg1) decreases a(CHEBI:lipid)	Mice that are deficient in ABCG1 have lipid accumulation in macrophages within multiple tissues when they are fed a high-fat, high-cholesterol diet (7).	SEN:10024836	19064999
BEL:20046650	p(MGI:Abcg1) decreases r(MGI:Mmp12)	Consistent with the altered histology and increased cytokine expression, we found elevated expression of Mmp-8 and Mmp-12 mRNAs in the lungs of Abcg1-/- mice, compared with wild-type controls (Fig. 5)... We also noted a small but significant increase in Timp-1, but not Timp-2 and Timp-3, mRNA levels in the lungs of Abcg1-/- mice (Fig. 5). p? 0.01	SEN:10024842	18292583
BEL:20046652	p(MGI:Abcg1) decreases r(MGI:Mmp8)	Consistent with the altered histology and increased cytokine expression, we found elevated expression of Mmp-8 and Mmp-12 mRNAs in the lungs of Abcg1-/- mice, compared with wild-type controls (Fig. 5)... We also noted a small but significant increase in Timp-1, but not Timp-2 and Timp-3, mRNA levels in the lungs of Abcg1-/- mice (Fig. 5). p? 0.01	SEN:10024842	18292583
BEL:20046654	p(MGI:Abcg1) decreases r(MGI:Timp1)	Consistent with the altered histology and increased cytokine expression, we found elevated expression of Mmp-8 and Mmp-12 mRNAs in the lungs of Abcg1-/- mice, compared with wild-type controls (Fig. 5)... We also noted a small but significant increase in Timp-1, but not Timp-2 and Timp-3, mRNA levels in the lungs of Abcg1-/- mice (Fig. 5). p? 0.01	SEN:10024842	18292583
BEL:20046656	p(MGI:Abcg1) decreases surf(p(MGI:Tlr4))	Although overall expression levels of TLR4 mRNA and protein were unaltered (Figure IIA in the online-only Data Supplement and data not shown), fluorescence-activated cell sorter analysis showed an increased cell surface expression of TLR4 in Abcg1/ and Abca1/Abcg1/ macrophages, both under basal conditions and after treatment with lipopolysaccharide (Figure 4A and 4C).	SEN:10020638	18852364
BEL:20046658	p(MGI:Abcg5) decreases a(CHEBI:sitosterol)	mutations in the Abca1 gene have little or no plasma HDL mutations in Abcg5 or Abcg8 result in elevated levels of cholesterol and plant sterols, especially sitosterol, in both blood and tissues, and show evidence of premature coronary atherosclerosis	SEN:10024844	11792716
BEL:20046662	p(MGI:Abcg8) decreases a(CHEBI:sitosterol)	mutations in the Abca1 gene have little or no plasma HDL mutations in Abcg5 or Abcg8 result in elevated levels of cholesterol and plant sterols, especially sitosterol, in both blood and tissues, and show evidence of premature coronary atherosclerosis	SEN:10024844	11792716
BEL:20046666	p(MGI:Abl1) increases bp(GOBP:"cell proliferation")	c-Abl function was dispensable in cells deficient in active p53 and inhibition of c-Abl reduced mitogen-induced c-myc expression. These data identify a novel function of cytoplasmic c-Abl in the signalling pathways regulating growth factor-induced c-myc expression and we propose the existence of a tyrosine kinase signalling cascade (PDGFR/c-Src/c-Abl) important for mitogenesis.	SEN:10007892	11847100
BEL:20046668	p(MGI:Abl1) increases kin(p(MGI:Hck))	We show here that the BCR/ABL SH3 and SH2 domains interact with hematopoietic cell kinase (Hck), leading to the stimulation of Hck catalytic activity. Active Hck phosphorylated STAT5B on Tyr699, which represents an essential step in STAT5B stimulation.	SEN:10021734	12411494
BEL:20046672	p(MGI:Abl1,pmod(P,Y,245)) directlyIncreases kin(p(MGI:Abl1))	These results support a model where c-Abl is inhibited in part through an intramolecular Src homology 3-linker interaction and stimulated to full catalytic activity by sequential phosphorylation at Tyr-412 and Tyr-245.	SEN:10024846	10964922
BEL:20046674	p(MGI:Abl1,pmod(P,Y,412)) directlyIncreases kin(p(MGI:Abl1))	These results support a model where c-Abl is inhibited in part through an intramolecular Src homology 3-linker interaction and stimulated to full catalytic activity by sequential phosphorylation at Tyr-412 and Tyr-245.	SEN:10024846	10964922
BEL:20046678	p(MGI:Abl1) increases r(MGI:Myc)	c-Abl function was dispensable in cells deficient in active p53 and inhibition of c-Abl reduced mitogen-induced c-myc expression. These data identify a novel function of cytoplasmic c-Abl in the signalling pathways regulating growth factor-induced c-myc expression and we propose the existence of a tyrosine kinase signalling cascade (PDGFR/c-Src/c-Abl) important for mitogenesis.	SEN:10007892	11847100
BEL:20046688	p(MGI:Acadvl) decreases a(CHEBI:carnitine)	Acylcarnitines in SkM predominantly accumulated during exercise with a concomitant decrease of free carnitine.	SEN:10007896	15774826
BEL:20046690	p(MGI:Acadvl) decreases a(CHEBI:carnitine)	Fasting combined with a cold challenge for 8 h significantly induced liver long-chain acylcarnitine and free carnitine production.	SEN:10007898	15774826
BEL:20046694	p(MGI:Acadvl) increases a(CHEBI:"O-acylcarnitine")	Acylcarnitines in SkM predominantly accumulated during exercise with a concomitant decrease of free carnitine.	SEN:10007896	15774826
BEL:20046696	p(MGI:Acadvl) decreases a(CHEBI:"O-acylcarnitine")	Fasting combined with a cold challenge for 8 h significantly induced liver long-chain acylcarnitine and free carnitine production.	SEN:10007898	15774826
BEL:20046714	p(MGI:Ace) increases a(CHEBI:hydroxyproline)	N-KO, but not C-KO mice, have a marked resistance to bleomycin lung injury as assessed by lung histology and hydroxyproline content.	SEN:10024856	20651228
BEL:20046718	p(MGI:Ace) increases path(MESHD:Fibrosis)	N-KO, but not C-KO mice, have a marked resistance to bleomycin lung injury as assessed by lung histology and hydroxyproline content.	SEN:10024856	20651228
BEL:20046728	p(MGI:Acss1,pmod(A,K,635)) directlyDecreases cat(p(MGI:Acss1))	specifically deacetylated by mitochondrial SIRT3 AceCS2 was completely inactivated upon acetylation and was rapidly reactivated by SIRT3 deacetylation	SEN:10019600	16790548
BEL:20046736	p(MGI:Actn2) increases p(MGI:Grip1)	We further demonstrated that mACTN2 could enhance two transactivation activities of GRIP1, which in turn could enhance the homodimerization of mACTN2.	SEN:10024868	15072553
BEL:20046746	p(MGI:Adam10) increases sec(p(MGI:Btc))	In addition, ADAM10 can release soluble EGFR ligands that also occur in tumours, such as ?-cellulin and EGF32,47.	SEN:10024878	19005493
BEL:20046748	p(MGI:Adam10) increases sec(p(MGI:Cd44))	ADAM10 mediates the shedding of the adhesion molecule CD44 in response to Ca2+ influx. It is proposed that Ca2+ dissociates the inhibitory interaction between ADAM10 and calmodulin66, which could potentially be important in CD44-mediated cell migration during tumorigenesis	SEN:10016682	19005493
BEL:20046750	p(MGI:Adam10) increases sec(p(MGI:Egf))	In addition, ADAM10 can release soluble EGFR ligands that also occur in tumours, such as ?-cellulin and EGF32,47.	SEN:10024878	19005493
BEL:20046752	p(MGI:Adam10) increases sec(p(MGI:Met))	Suppression of ADAM10 in vitro prevents shedding of the hepatocyte growth factor (HGF) receptor (HGFR, encoded by the proto-oncogene MET) and it was found that increased stromal expression of TIMP1 promotes liver metastasis in two independent tumour models	SEN:10024880	19005493
BEL:20046760	p(MGI:Adam17) increases bp(GOBP:"cell proliferation")	This complemented other data showing that overexpression of ADAM17 in MCF-7 breast cancer cells increased invasion and proliferation in vitro, whereas the same was true when ADAM17 expression was downregulated in MDA-Mb-435 cells26	SEN:10024886	19005493
BEL:20046762	p(MGI:Adam17) decreases bp(GOBP:"cell proliferation")	This complemented other data showing that overexpression of ADAM17 in MCF-7 breast cancer cells increased invasion and proliferation in vitro, whereas the same was true when ADAM17 expression was downregulated in MDA-Mb-435 cells26	SEN:10024886	19005493
BEL:20046770	p(MGI:Adam17) increases kin(p(MGI:Egfr))	The resulting mice called ADAM17(ex/ex) were viable, showed compromised shedding of ADAM17 substrates from the cell surface, and developed eye, heart, and skin defects as a consequence of impaired EGF-R signaling caused by failure of shedding of EGF-R ligands.	SEN:10007910	20603312
BEL:20046774	p(MGI:Adam17) increases p(MGI:Tnf)	Besides regulating the systemic availability of the proinflammatory cytokine TNF, our results demonstrate that ADAM17 is needed for vital regenerative activities during the immune response	SEN:10002032	20603312
BEL:20046780	p(MGI:Adam17) increases sec(p(MGI:Egfr))	Studies of mice in which the catalytic domain of ADAM17 has been ablated indicate similarities to an Egfr–/– phenotype and the analysis of isolated Adam17–/– embryonic fibroblasts have shown that ADAM17 is a major regulator of EGFR signalling32	SEN:10024890	19005493
BEL:20046782	p(MGI:Adam17) increases sec(p(MGI:Il6))	Cytokine determination within BAL fluid revealed that LPS challenged Tie2-adam17 -/- mice showed reduced release of IL-6 (Fig 7A, 3.9-fold) and TNF-a (Fig 7B, 1.6-fold), whereas no effect was observed in PBS-challenged mice.	SEN:10024892	22367719
BEL:20046784	p(MGI:Adam17) increases sec(p(MGI:Tnf))	ADAM17, also known as the TnF?-converting enzyme (TACE), releases membrane-bound proTnF?, which permits TnF? paracrine signalling.	SEN:10024894	19005493
BEL:20046786	p(MGI:Adam17) increases sec(p(MGI:Tnf))	Cytokine determination within BAL fluid revealed that LPS challenged Tie2-adam17 -/- mice showed reduced release of IL-6 (Fig 7A, 3.9-fold) and TNF-a (Fig 7B, 1.6-fold), whereas no effect was observed in PBS-challenged mice.	SEN:10024892	22367719
BEL:20046788	p(MGI:Adam19) increases sec(p(MGI:Nrg1))	Similarly, cleavage by ADAM19 of its substrate proneuregulin occurs in an intracellular compartment74.	SEN:10024896	19005493
BEL:20046790	p(MGI:Adam9) increases sec(p(MGI:Egf))	overexpression of ADAM9 causes shedding of EGF and fibroblast growth factor receptor, FGFR2iiib (a murine splice variant of FGFR2), both of which have pivotal functions in the pathogenesis of this disease.	SEN:10024898	19005493
BEL:20046792	p(MGI:Adam9) increases sec(p(MGI:Fgfr2))	overexpression of ADAM9 causes shedding of EGF and fibroblast growth factor receptor, FGFR2iiib (a murine splice variant of FGFR2), both of which have pivotal functions in the pathogenesis of this disease.	SEN:10024898	19005493
BEL:20046800	p(MGI:Ada) decreases p(MGI:Ccl7)	Similar results were seen with immunohistochemical evaluations that demonstrated that MCP-3 is readily appreciated in epithelial cells from IL-13 Tg mice and that the levels of MCP-3 protein decreased significantly after ADA therapy (Figure 12d).	SEN:10024902	12897202
BEL:20046802	p(MGI:Ada) decreases r(MGI:Adora1)	Four adenosine receptors have been identified: A1R, A2AR, A2BR, and A3R (20, 28)....As previously noted (10), there were increases in transcript levels for all of the adenosine receptors except the A2AR in the lungs of ADA-/-A2AR+/+ mice.	SEN:10024904	17601796
BEL:20046804	p(MGI:Ada) decreases r(MGI:Adora2a)	Four adenosine receptors have been identified: A1R, A2AR, A2BR, and A3R (20, 28)....As previously noted (10), there were increases in transcript levels for all of the adenosine receptors except the A2AR in the lungs of ADA-/-A2AR+/+ mice.	SEN:10024904	17601796
BEL:20046806	p(MGI:Ada) decreases r(MGI:Adora2b)	Four adenosine receptors have been identified: A1R, A2AR, A2BR, and A3R (20, 28)....As previously noted (10), there were increases in transcript levels for all of the adenosine receptors except the A2AR in the lungs of ADA-/-A2AR+/+ mice.	SEN:10024904	17601796
BEL:20046808	p(MGI:Ada) decreases r(MGI:Adora3)	Four adenosine receptors have been identified: A1R, A2AR, A2BR, and A3R (20, 28)....As previously noted (10), there were increases in transcript levels for all of the adenosine receptors except the A2AR in the lungs of ADA-/-A2AR+/+ mice.	SEN:10024904	17601796
BEL:20046810	p(MGI:Ada) decreases r(MGI:Ccl7)	MCP-3 was elevated in the lungs of ADA-/-A2AR+/+ mice but was not altered following the removal of the A2AR (data not shown).	SEN:10024906	17601796
BEL:20046812	p(MGI:Ada) decreases r(MGI:Il13)	In contrast, the levels of IL-13 mRNA were impressively elevated in the lungs of ADA-deficient mice	SEN:10024908	12897202
BEL:20046814	p(MGI:Ada) decreases r(MGI:Il13)	Other cytokines that were elevated in the lungs of ADA-/-A2AR+/+ mice but were not altered following the removal of the A2AR included IL-4, IL-5, IL-13, and IL-9 (data not shown).	SEN:10024910	17601796
BEL:20046816	p(MGI:Ada) decreases r(MGI:Il19)	Other cytokines that were elevated in the lungs of ADA-/-A2AR+/+ mice but were not altered following the removal of the A2AR included IL-4, IL-5, IL-13, and IL-9 (data not shown).	SEN:10024910	17601796
BEL:20046818	p(MGI:Ada) decreases r(MGI:Il4)	Other cytokines that were elevated in the lungs of ADA-/-A2AR+/+ mice but were not altered following the removal of the A2AR included IL-4, IL-5, IL-13, and IL-9 (data not shown).	SEN:10024910	17601796
BEL:20046820	p(MGI:Ada) decreases r(MGI:Il5)	Other cytokines that were elevated in the lungs of ADA-/-A2AR+/+ mice but were not altered following the removal of the A2AR included IL-4, IL-5, IL-13, and IL-9 (data not shown).	SEN:10024910	17601796
BEL:20046822	p(MGI:Ada) decreases sec(p(MGI:Muc5ac))	PEG-ADA therapy did, however, cause a modest decrease in mucin secretion into BAL fluid as assessed by immunoblot analysis (Figure 10).	SEN:10024912	12897202
BEL:20046824	p(MGI:Adcyap1) decreases bp(GOBP:"apoptotic process")	We reported previously that VIP/PACAP protect T cells from activation-induced cell death through down-regulation of Fas ligand (FasL).	SEN:10007916	11145682
BEL:20046826	p(MGI:Adcyap1) decreases r(MGI:Fasl)	We reported previously that VIP/PACAP protect T cells from activation-induced cell death through down-regulation of Fas ligand (FasL).	SEN:10007916	11145682
BEL:20046832	p(MGI:Add2) increases r(MGI:Add1)	In this work we show that deficiency of beta-adducin produces an 80% decrease of alpha-adducin and a fourfold up-regulation of gamma-adducin in erythrocytes.	SEN:10007922	10845937
BEL:20046834	p(MGI:Add2) decreases r(MGI:Add3)	In this work we show that deficiency of beta-adducin produces an 80% decrease of alpha-adducin and a fourfold up-regulation of gamma-adducin in erythrocytes.	SEN:10007922	10845937
BEL:20046838	p(MGI:Adipoq) increases bp(GOBP:"fatty acid oxidation")	One of the mechanisms through which adiponectin exerts such effects involves an increase in fatty acid oxidation in muscle and liver.	SEN:10024916	16936205
BEL:20046852	p(MGI:Adipoq) increases kin(p(MGI:Map2k1))	gAd induced the phosphorylation of MEK1/2 and ERK1/2 in RAW264 cells. In addition, the gAd-induced phosphorylation of MEK1/2 and ERK1/2 was dramatically reduced by PD98059 and U0126, respectively.	SEN:10024926	18555587
BEL:20046854	p(MGI:Adipoq) increases kin(p(MGI:Map2k2))	gAd induced the phosphorylation of MEK1/2 and ERK1/2 in RAW264 cells. In addition, the gAd-induced phosphorylation of MEK1/2 and ERK1/2 was dramatically reduced by PD98059 and U0126, respectively.	SEN:10024926	18555587
BEL:20046856	p(MGI:Adipoq) increases kin(p(MGI:Mapk1))	gAd induced the phosphorylation of MEK1/2 and ERK1/2 in RAW264 cells. In addition, the gAd-induced phosphorylation of MEK1/2 and ERK1/2 was dramatically reduced by PD98059 and U0126, respectively.	SEN:10024926	18555587
BEL:20046858	p(MGI:Adipoq) increases kin(p(MGI:Mapk3))	gAd induced the phosphorylation of MEK1/2 and ERK1/2 in RAW264 cells. In addition, the gAd-induced phosphorylation of MEK1/2 and ERK1/2 was dramatically reduced by PD98059 and U0126, respectively.	SEN:10024926	18555587
BEL:20046866	p(MGI:Adipoq) increases p(MGI:Kdr)	expressions of vascular endothelial growth factor receptor-2 and platelet endothelial cell adhesion molecule-1 on endothelial cells were decreased in the adiponectin-knockout mice.	SEN:10007926	21239691
BEL:20046868	p(MGI:Adipoq) increases p(MGI:Kdr)	the APN KO lung showed enhanced endothelial dysfunction, reflected as an increase in endothelial apoptosis, which resulted from a decrease in VEGFR-2 and PECAM-1 expression	SEN:10024928	21239691
BEL:20046872	p(MGI:Adipoq) increases p(MGI:Pecam1)	expressions of vascular endothelial growth factor receptor-2 and platelet endothelial cell adhesion molecule-1 on endothelial cells were decreased in the adiponectin-knockout mice.	SEN:10007926	21239691
BEL:20046874	p(MGI:Adipoq) increases p(MGI:Pecam1)	the APN KO lung showed enhanced endothelial dysfunction, reflected as an increase in endothelial apoptosis, which resulted from a decrease in VEGFR-2 and PECAM-1 expression	SEN:10024928	21239691
BEL:20046882	p(MGI:Adipoq) increases r(MGI:Csf3)	We investigated whether globular adiponectin (gAd) affects the expression of inflammation-related genes in murine macrophages (RAW264 cells). DNA microarray analysis indicated that granulocyte colony-stimulating factor (G-CSF) showed the largest increase in expression in gAd-stimulated RAW264 cells. The gAd-induced secretion of G-CSF increased in a time- and dose-dependent manner.	SEN:10007928	18555587
BEL:20046888	p(MGI:Adipoq) increases sec(p(MGI:Csf3))	We investigated whether globular adiponectin (gAd) affects the expression of inflammation-related genes in murine macrophages (RAW264 cells). DNA microarray analysis indicated that granulocyte colony-stimulating factor (G-CSF) showed the largest increase in expression in gAd-stimulated RAW264 cells. The gAd-induced secretion of G-CSF increased in a time- and dose-dependent manner.	SEN:10007928	18555587
BEL:20046890	p(MGI:Adipoq) increases tscript(p(MGI:Ppara))	In muscle and liver, adiponectin activated AMP kinase and PPARalpha pathways thereby increasing beta-oxidation of lipids, leading to decreased TG content, which ameliorated insulin resistance under a high-fat diet.	SEN:10024924	14683455
BEL:20046896	p(MGI:Adm) increases bp(GOBP:"cell growth")	ADM, in addition to regulating blood pressure and water and electrolyte balance, also exerts a major growth promoting action in several normal and neoplastic cells	SEN:10007930	12684703
BEL:20046900	p(MGI:Adm) increases bp(GOBP:"cell proliferation")	L1-R is the main subtype of ADM receptor in both keratinocytes and fibroblasts ADM concentration-dependently raised the proliferation rate and lowered the apoptotic rate of both keratinocytes and fibroblasts	SEN:10024934	12684703
BEL:20046902	p(MGI:Adm) decreases bp(GOBP:"apoptotic process")	L1-R is the main subtype of ADM receptor in both keratinocytes and fibroblasts ADM concentration-dependently raised the proliferation rate and lowered the apoptotic rate of both keratinocytes and fibroblasts	SEN:10024934	12684703
BEL:20046904	p(MGI:Adora1) increases path(MESHD:Bradycardia)	hree distinct Ado receptors (AAR), namely, the A1, A2, and A3AR are expressed in heart tissue (346). Transgenic mice overexpressing A1ARs have significant bradycardia and constitutive slowing of atrioventricular conduction (242).	SEN:10024936	18626064
BEL:20046906	p(MGI:Adora2a) decreases bp(GOBP:"apoptotic process")	Thus, we can conclude that A2AR antagonists reduce tumor growth at least in part due to the induction of apoptosis in NSCLC tumor cells	SEN:10024938	23917542
BEL:20046924	p(MGI:Ager) decreases bp(GOBP:"bone mineralization")	Ager-/- mice, although being resistant to septic shock, exhibit osteosclerotic-like phenotypes with increased bone mass and bone mineral density, and decreased bone resorptive activity (18,64).	SEN:10024952	19273137
BEL:20046944	p(MGI:Agtr1a) increases a(CHEBI:hydroxyproline)	When the susceptibility of the same mice to BLEO-induced fibrosis was measured, heterozygous AT1a-null mice did not exhibit a statistically significant increase in lung hydroxyproline at 14 days after intratracheal BLEO (Figure 7A) [triangle] , in contrast to wild-type mice.	SEN:10024962	14633624
BEL:20046946	p(MGI:Agtr1a) increases bp(GOBP:"wound healing")	In comparison to wild-type (WT) mice, wound healing and wound-induced angiogenesis were significantly suppressed in AT1a(-/-) mice, and these mice exhibited reduced expression of CD31 in wound granulation tissues.	SEN:10024964	19464844
BEL:20046950	p(MGI:Agtr1a) increases p(MGI:Casp3)	In Figure 6 [triangle] , the deletion of one allele of the AT1a gene (+/?) reduced BLEO-induced ISEL by 89% (Figure 6A) [triangle] and inhibited BLEO-induced caspase 3 IHC by 85% (Figure 6B) [triangle] , both relative to the response in wild-type mice (**, P < 0.01).	SEN:10024968	14633624
BEL:20046952	p(MGI:Agtr1a) increases p(MGI:Pecam1)	In comparison to wild-type (WT) mice, wound healing and wound-induced angiogenesis were significantly suppressed in AT1a(-/-) mice, and these mice exhibited reduced expression of CD31 in wound granulation tissues.	SEN:10024964	19464844
BEL:20046954	p(MGI:Agtr1a) increases p(MGI:Vegfa)	In comparison to vehicle-treated mice, wound healing was delayed significantly in mice treated with an AT1-R antagonist and this delay was accompanied by the reduced expression of vascular endothelial growth factor in wound granulation tissues.	SEN:10007932	19464844
BEL:20046960	p(MGI:Agt) decreases tscript(p(MGI:Pparg))	Among transcription factors that might regulate Ang II-mediated inflammatory responses we found that ligand-mediated peroxisome proliferator-activated receptor (PPAR)gamma transcriptional activity was significantly decreased by Ang II.	SEN:10024972	19023129
BEL:20046968	p(MGI:Ahr) decreases a(CHEBI:catecholamine)	We detected two-fold higher catecholamine plasma levels in Ahr-/- mice than in wild type animals (Fig. 3A,B). These levels were, however, significantly lower than those found in the plasma of Vav3-deficient mice (Fig. 3A,B).	SEN:10024976	21115475
BEL:20046984	p(MGI:Ahr) decreases bp(GOBP:"cell adhesion")	As shown in Figure 6A, the kinetic of EGTA-dependent detachment was much slower in T-FGM AhR-/- cells than in their wild-type counterparts. Similar results were obtained when AhR-/- and AhR-/- MEFs were compared, although, similarly to the cell spreading experiments, the differences with respect to wild-type cells were less pronounced than in the case of the immortalized T-FGM cell line (Figure 6B).	SEN:10024984	19158396
BEL:20046988	p(MGI:Ahr) increases bp(GOBP:"cell migration")	We have shown previously that immortalized mouse fibroblasts lacking AhR expression (T-FGM AhR-/- cells) had impaired migration rates (Mulero-Navarro et al., 2005).	SEN:10024988	19158396
BEL:20046990	p(MGI:Ahr) decreases bp(GOBP:"cell migration")	Using wild-type (Ahr+/+) and AhR-null (Ahr-/-) mouse primary keratinocyte cultures and tissue explants, we show that lack of AhR increases keratinocyte migration and accelerates skin re-epithelialization without affecting cell proliferation or recruitment of inflammatory cells.	SEN:10007938	19435800
BEL:20046992	p(MGI:Ahr) decreases bp(GOBP:"wound healing")	Using wild-type (Ahr+/+) and AhR-null (Ahr-/-) mouse primary keratinocyte cultures and tissue explants, we show that lack of AhR increases keratinocyte migration and accelerates skin re-epithelialization without affecting cell proliferation or recruitment of inflammatory cells.	SEN:10007938	19435800
BEL:20046998	p(MGI:Ahr) increases gtp(p(MGI:Rac1))	However, pull-down assays using a PAK-CRIB-GST fusion protein revealed that T-FGM AhR-/- cells had reduced levels of activated GTP-Rac1 compared with wildtype T-FGM fibroblasts (Figure 7A, left).	SEN:10024992	19158396
BEL:20047000	p(MGI:Ahr) decreases gtp(p(MGI:Rhoa))	These experiments showed that T-FGM AhR-/- did have higher levels of GTP-bound RhoA than the wild-type cells (Figure 7A, right), indicating that the former cell line has higher levels of RhoA activity than the latter one.	SEN:10024994	19158396
BEL:20047002	p(MGI:Ahr) decreases path(MESHD:Tachycardia)	In agreement with our hypothesis, we observed that Ahr–/– animals displayed tachypnea, showing inspiratory/expiratory cycles very similar to those observed in Vav3-deficient mice (Fig. 1A,B). Likewise, as in the case of the latter mouse strain (38,40), we detected high blood pressure (Fig. 1C,E) and tachycardia (Fig. 1D,F) in Ahr–/– animals both under sentient (Fig. 1C,D) and unconscious (Fig. 1E,F) conditions.	SEN:10024996	21115475
BEL:20047020	p(MGI:Ahr) decreases p(MGI:Tgfb1)	Protein expression in whole cell extracts from basal skin showed that Ahr-/- mice expressed higher levels of total TGFbeta than did Ahr+/+ mice.	SEN:10025004	19435800
BEL:20047022	p(MGI:Ahr) increases p(MGI:Th)	Immunohistochemical analyses of serial sections also revealed that, similar to what happens in Vav3-/- animals (40), neurons located in the RVLM of Ahr-/- mice contained higher levels of tyrosine hydroxylase than those present in the RVLM of wild type mice (Fig. 5C,D).	SEN:10025006	21115475
BEL:20047026	p(MGI:Ahr) decreases p(MGI:Vcl)	vinculin levels seemed moderately elevated in T-FGM and MEF AhR-/- fibroblasts (Supplemental Figure S3).	SEN:10025010	19158396
BEL:20047032	p(MGI:Ahr) increases r(MGI:Vav3)	Consistent with the microarray results, we observed that the vav3 transcript was remarkably decreased in AhR-/- T-FGM and MEFs cells, as determined by quantitative, real-time PCR analysis (Figure 8B, left and middle).	SEN:10025016	19158396
BEL:20047036	p(MGI:Ahr) decreases sec(p(MGI:Tgfb1))	Ahr-/- dermal fibroblasts secreted higher levels of active TGFbeta (measured as the active:total cytokine ratio) than did wild-type cells (Fig. 6B, CM-DF).	SEN:10025020	19435800
BEL:20047050	p(MGI:Aif1) increases bp(GOBP:chemotaxis)	we introduced Iba1 into Swiss 3T3 fibroblasts and demonstrated the enhancement of platelet-derived growth factor (PDGF)-induced membrane ruffling and chemotaxis	SEN:10007946	11916959
BEL:20047052	p(MGI:Aif1) increases bp(GOBP:phagocytosis)	Iba1 is a macrophage/microglia-specific calcium-binding protein that is involved in RacGTPase-dependent membrane ruffling and phagocytosis.	SEN:10007948	11916959
BEL:20047058	p(MGI:Aif1) increases r(MGI:Il10)	the transfectants that overexpressed AIF-1 showed marked morphological changes and produced significantly large amounts of interleukin (IL)-6, IL-10 and IL-12p40	SEN:10007950	11722645
BEL:20047060	p(MGI:Aif1) increases r(MGI:Il12b)	the transfectants that overexpressed AIF-1 showed marked morphological changes and produced significantly large amounts of interleukin (IL)-6, IL-10 and IL-12p40	SEN:10007950	11722645
BEL:20047062	p(MGI:Aif1) increases r(MGI:Il6)	the transfectants that overexpressed AIF-1 showed marked morphological changes and produced significantly large amounts of interleukin (IL)-6, IL-10 and IL-12p40	SEN:10007950	11722645
BEL:20047064	p(MGI:Aifm1) decreases a(CHEBI:"reactive oxygen species")	Harlequin (Hq) mutant mice have progressive degeneration of terminally differentiated cerebellar and retinal neurons. We have identified the Hq mutation as a proviral insertion in the apoptosis-inducing factor (Aif) gene, causing about an 80% reduction in AIF expression. Mutant cerebellar granule cells are susceptible to exogenous and endogenous peroxide-mediated apoptosis, but can be rescued by AIF expression.	SEN:10025030	12353028
BEL:20047066	p(MGI:Aifm1) increases bp(GOBP:"cell death")	Overexpression of a mutant AIF protein in which the MLS has been deleted (AIF Delta 1-100) results in the primary cytosolic accumulation of AIF. AIF Delta 1-100-induced cell death is suppressed by neither Z-VAD.fmk or by Bcl-2. Thus, extramitochondrially targeted AIF is a dominant cell death inducer.	SEN:10025032	11259394
BEL:20047078	p(MGI:Aifm1) decreases bp(GOBP:"response to oxidative stress")	AIF is a mitochondrial oxidoreductase that translocates to the nucleus leading to nuclear condensation and apoptosis18. In addition to its role in inducing apoptosis, AIF has a potent redox function in vitro, which is separable from its apoptogenic activity20. Many oxidoreductases have been shown to have important roles in maintaining intracellular free radical homeostasis	SEN:10025036	12353028
BEL:20047104	p(MGI:Ak1) decreases r(MGI:Acadl)	AK1 knockouts we observed lower mRNA levels for long chain acyl-CoA dehydrogenase and glutamate dehydrogenase (35 and 54% reduction),	SEN:10025042	12562761
BEL:20047106	p(MGI:Ak1) decreases r(MGI:Eno3)	there was a significant increase in the steady-state level of the beta enolase mRNA in the gastrocnemius knockout muscle	SEN:10025044	12562761
BEL:20047108	p(MGI:Ak1) decreases r(MGI:Gapdh)	Similarly, the levels of mRNAs for PK-M, GAPDH, and GPDH were ~1.5-fold increased in mutant gastrocnemius compared with wild type	SEN:10025046	12562761
BEL:20047110	p(MGI:Ak1) decreases r(MGI:Glud1)	AK1 knockouts we observed lower mRNA levels for long chain acyl-CoA dehydrogenase and glutamate dehydrogenase (35 and 54% reduction),	SEN:10025042	12562761
BEL:20047112	p(MGI:Ak1) decreases r(MGI:Gpd1)	Similarly, the levels of mRNAs for PK-M, GAPDH, and GPDH were ~1.5-fold increased in mutant gastrocnemius compared with wild type	SEN:10025046	12562761
BEL:20047114	p(MGI:Ak1) decreases r(MGI:Ldha)	AK1 ko produced an 80% increase in the steady-state level of enolase mRNA and down-regulated LDH-A mRNA levels with no changes in PK-M, GAPDH, and GPDH mRNAs levels	SEN:10025048	12562761
BEL:20047116	p(MGI:Ak1) increases r(MGI:Ldha)	Conversely, there was a 23% decrease in the level of the mRNA for the tetrameric glycolytic enzyme lactate dehydrogenase (LDH), LDH-A,	SEN:10025050	12562761
BEL:20047118	p(MGI:Ak1) decreases r(MGI:Myf5)	Expression levels of MyoD and Myf5 strongly correlate with the fast muscle phenotype (35, 36), while myogenin has been shown to be associated with the slow muscle phenotype (37). In fast-twitch gastrocnemius muscles lacking AK1 the MYF5 transcript level was increased by more than 200%	SEN:10025052	12562761
BEL:20047120	p(MGI:Ak1) decreases r(MGI:Myod1)	Whereas signals of myogenin transcripts could not be reliably detected, the MyoD mRNA level tended to be up-regulated (73% with low significance p < 0.09; n = 4).	SEN:10025054	12562761
BEL:20047122	p(MGI:Ak1) decreases r(MGI:Pkm)	Similarly, the levels of mRNAs for PK-M, GAPDH, and GPDH were ~1.5-fold increased in mutant gastrocnemius compared with wild type	SEN:10025046	12562761
BEL:20047128	p(MGI:Akt1) increases bp(GOBP:angiogenesis)	Fig. 1 Absence of Akt1, but not Akt2, in mice results in decreased blood vessel area in wounded skin.	SEN:10025060	18415691
BEL:20047130	p(MGI:Akt1) increases p(MGI:Vegfa)	Western analysis of 4-day-old wound lysates showed that the expression of VEGF in Akt1-/- wounds were reduced by approximately 40% compared to WT (Fig. 5a, b).	SEN:10025062	18415691
BEL:20047132	p(MGI:Akt1,pmod(P,S,473)) increases kin(p(MGI:Akt1))	Furthermore, the loss of MnSOD dramatically altered several markers involved in cell proliferation and growth, including decreased growth stimulatory function of mTOR signaling and enhanced growth inhibitory function of GSK-3B signaling... We first detected significantly reduced phosphorylation of Akt (Ser473) in Sod2-/- MEFs.	SEN:10025064	20638473
BEL:20047142	p(MGI:Akt1,sub(E,17,K)) increases p(MGI:Trp63)	Both TA-p63 and deltaN-p63 were overexpressed in cells with mTOR activation because of either a lack of Tsc2 or Pten or expression of AKT1-E17K, and were repressed by rapamycin	SEN:10021534	20038814
BEL:20047148	p(MGI:Akt2) increases path(MESHD:"Insulin Resistance")	Blockade of the pathway with dominant negative mutants or pharmacological inhibitors prevents the stimulation of cell growth by insulin, but has no effect on the metabolic actions of the hormone deletion of Akt2 produces hepatic insulin resistance in mice	SEN:10025070	11742412
BEL:20047158	p(MGI:Alb) increases sec(p(MGI:Mmp12))	Figure 2. Effects of albumin. (A) Alveolar macrophage supernatant TNF- and (B) MMP-12 after in vitro exposure to smoke-conditioned medium and A1AT or albumin (Alb).	SEN:10025076	17395890
BEL:20047160	p(MGI:Alb) increases sec(p(MGI:Tnf))	Figure 2. Effects of albumin. (A) Alveolar macrophage supernatant TNF- and (B) MMP-12 after in vitro exposure to smoke-conditioned medium and A1AT or albumin (Alb).	SEN:10025076	17395890
BEL:20047168	p(MGI:Alkbh2) increases bp(GOBP:"double-strand break repair")	Similar to AlkB, ABH2 and ABH3 have the ability to repair 1meA and 3meC residues. However, whereas ABH2 prefers double-stranded DNA, ABH3 and AlkB favour single-stranded DNA and RNA (Aas et al, 2003; Falnes et al, 2004).	SEN:10025080	18285820
BEL:20047170	p(MGI:Alkbh3) increases bp(GOBP:"single strand break repair")	Similar to AlkB, ABH2 and ABH3 have the ability to repair 1meA and 3meC residues. However, whereas ABH2 prefers double-stranded DNA, ABH3 and AlkB favour single-stranded DNA and RNA (Aas et al, 2003; Falnes et al, 2004).	SEN:10025080	18285820
BEL:20047178	p(MGI:Alox5) increases a(CHEBI:"leukotriene B4")	Cys-LT production was reduced by zileuton 15 min after challenge with Ova, and at 6 h, all the LT were reduced (Fig. 2B, other time points not shown).	SEN:10025088	12794006
BEL:20047180	p(MGI:Alox5) increases a(CHEBI:"leukotriene C4")	Cys-LT production was reduced by zileuton 15 min after challenge with Ova, and at 6 h, all the LT were reduced (Fig. 2B, other time points not shown).	SEN:10025088	12794006
BEL:20047182	p(MGI:Alox5) increases a(CHEBI:"leukotriene D4")	Cys-LT production was reduced by zileuton 15 min after challenge with Ova, and at 6 h, all the LT were reduced (Fig. 2B, other time points not shown).	SEN:10025088	12794006
BEL:20047184	p(MGI:Alox5) increases a(CHEBI:"leukotriene E4")	Cys-LT production was reduced by zileuton 15 min after challenge with Ova, and at 6 h, all the LT were reduced (Fig. 2B, other time points not shown).	SEN:10025088	12794006
BEL:20047186	p(MGI:Alox5ap) increases r(MGI:Ltb)	We demonstrate that IL-10 suppresses the production of LTB(4) from DC by inhibiting FLAP protein expression without any effect on 5-LO and cytosolic phospholipase A(2).	SEN:10025090	12496393
BEL:20047208	p(MGI:Alox5) increases p(MGI:Muc5ac)	Zileuton dose dependently inhibited mucus accumulation in the lungs after Ova challenge and completely so at 50 mg/kg three times a day for 3 days (39, 47), as evaluated by RT-PCR for MUC5AC mRNAs (Fig. 6A), by ELISA for MUC5AC proteins (Fig. 6B)	SEN:10025102	12794006
BEL:20047210	p(MGI:Alox5) increases r(MGI:Muc5ac)	Zileuton dose dependently inhibited mucus accumulation in the lungs after Ova challenge and completely so at 50 mg/kg three times a day for 3 days (39, 47), as evaluated by RT-PCR for MUC5AC mRNAs (Fig. 6A), by ELISA for MUC5AC proteins (Fig. 6B)	SEN:10025102	12794006
BEL:20047222	p(MGI:Alx4) decreases r(MGI:Mmp2)	MMP3 is similarly expressed while a 40% increase in MMP2 and a 50% decrease in MMP9 message levels in Alx4-deficient mice relative to their wild-type littermates is observed.	SEN:10007970	16916507
BEL:20047224	p(MGI:Alx4) increases r(MGI:Mmp9)	MMP3 is similarly expressed while a 40% increase in MMP2 and a 50% decrease in MMP9 message levels in Alx4-deficient mice relative to their wild-type littermates is observed.	SEN:10007970	16916507
BEL:20047238	p(MGI:Angpt1) increases bp(GOBP:"patterning of blood vessels")	Furthermore, exposure of aortic rings from p47(phox-/-) mice to Ang-1 demonstrated fewer vessel sprouts than WT mice. Inhibition of the Tie-2 receptor inhibited Ang-1-induced endothelial migration and vessel sprouting	SEN:10022236	16679392
BEL:20047240	p(MGI:Angpt1) increases complex(p(MGI:Ptpn11),p(MGI:Tek))	Angiopoietin-1 stimulates association of SHP-2 to the phosphorylated Tie-2 receptor (47), which in turn inhibits PI3 kinase-dependent signaling pathways leading to EC migration.	SEN:10020428	17511588
BEL:20047246	p(MGI:Angpt2) increases bp(GOBP:angiogenesis)	These data support the hypothesis that Ang2 plays a critical role in physiologic and pathologic angiogenesis	SEN:10007976	12115724
BEL:20047248	p(MGI:Angpt2) increases path(MESHD:"Retinal Neovascularization")	Mice deficient in Ang2 showed delayed and incomplete development of the superficial vascular bed of the retina, which develops primarily by vasculogenesis,	SEN:10000270	12115724
BEL:20047266	p(MGI:Anxa1) decreases sec(p(MGI:Tnf))	Exogenous ANXA1 but not ANXA5, administered to IL-6 KO mice before LPS challenge inhibited TNF-alpha release.	SEN:10007986	11583971
BEL:20047300	p(MGI:Anxa7) increases tport(p(MGI:Itpr1))	Mice heterozygous for the annexin A7 (Anx7) gene have a profound reduction in IP3 receptor function in pancreatic islets along with defective insulin secretion.	SEN:10004904	15590065
BEL:20047304	p(MGI:Apbb1) directlyIncreases tscript(p(MGI:Kat5))	the LrpICD is translocated to the nucleus, where it co-localizes in the nucleus with a transcription modulator, Tip60, which is known to interact with Fe65 and with the APP-derived intracellular domain, AICD LrpICD has a close interaction with Tip60 in the nucleus	SEN:10018798	12888553
BEL:20047306	p(MGI:Apc) decreases a(CHEBI:aldosterone)	Plasma corticosterone and aldosterone concentrations were significantly enhanced in apc(Min/+) mice.	SEN:10007998	19494170
BEL:20047308	p(MGI:Apc) decreases a(CHEBI:corticosterone)	Plasma corticosterone and aldosterone concentrations were significantly enhanced in apc(Min/+) mice.	SEN:10007998	19494170
BEL:20047310	p(MGI:Apc) increases bp(GOBP:"wound healing")	Compared with (PBS) control-treated wounds, APC significantly reduced wound size at each time point over the course of the healing process (Figure 1A).	SEN:10025136	21907694
BEL:20047312	p(MGI:Apc) decreases path(MESHD:Adenoma)	In this study, we investigated the efficacy of several plant-derived phenolics... These animals bear a germline mutation in the Apc gene and spontaneously develop numerous intestinal adenomas by 15 weeks of age. At a dietary level of 0.15%, CAPE decreased tumor formation in Min/+ mice by 63%. Curcumin induced a similar tumor inhibition	SEN:10025138	10783313
BEL:20047316	p(MGI:Apc) increases r(MGI:Dbp)	Daily Dbp mean expression levels are also reduced (mesor, wild type = 63.4+- 7.3 vs. ApcMin/+ = 25.3+-3.4, P < 0.001, Fig 4E).	SEN:10025142	19106159
BEL:20047318	p(MGI:Apc) decreases r(MGI:Dtna)	Although PAR2 was upregulated in cytokine-stimulated endothelial cells, APC signaling remained PAR1-dependent. Large-scale gene expression profiling documented marked differences in both up- and downregulated genes between APC and thrombin signaling in cytokine-stimulated cells. APC downregulated IIa upregulated	SEN:10025144	15769747
BEL:20047320	p(MGI:Apc) increases r(MGI:Wee1)	Wee1 RNA rhythm is, however, much damped (amplitude, wild type = 5.4+-0.8 vs. ApcMin/+ = 1.6+-0.4) and overall levels (mesor, wild type = 5.7+-0.3 vs. ApcMin/+ = 1.8+-0.1) are also diminished nearly 3-fold, throughout the day, in intestinal epithelial from ApcMin/+ mice (Fig 4F).	SEN:10025146	19106159
BEL:20047324	p(MGI:Apcs) decreases p(MGI:Col1a1)	human SAP also significantly reduced the histopathological extent of bleomycin-induced collagen deposition (Fig. 3 A) and the generation of collagen at the protein (Fig. 3 B) and gene level (Fig. 3 C).	SEN:10025150	20300636
BEL:20047326	p(MGI:Apcs) increases p(MGI:Cxcl10)	Moreover, SAP treatment increased the level of the M1 macrophage-associated chemokine IP10/CXCL10, in the circulation of mice treated with SAP, in comparison to control treated bleomycin-challenged animals (Fig. 3 G).	SEN:10025152	20300636
BEL:20047328	p(MGI:Apcs) decreases r(MGI:Ccl2)	Analysis of a wider panel of M2-associated genes using branched DNA technology in the lungs of bleomycin challenged mice treated with SAP indicated that SAP also reduced the expression of the M2-associated proteins MARCO (Fig. 3 E), ST2 and FIZZ- 1 (Fig. 3 F); as well as attenuating the bleomycin-induced profibrotic mediators CCL2 (MCP1/JE) [14], and oncostatin M (OSM) (OSM) [15] (Fig. 3 E).	SEN:10025154	20300636
BEL:20047330	p(MGI:Apcs) decreases r(MGI:Col1a1)	human SAP also significantly reduced the histopathological extent of bleomycin-induced collagen deposition (Fig. 3 A) and the generation of collagen at the protein (Fig. 3 B) and gene level (Fig. 3 C).	SEN:10025150	20300636
BEL:20047332	p(MGI:Apcs) decreases r(MGI:Marco)	Analysis of a wider panel of M2-associated genes using branched DNA technology in the lungs of bleomycin challenged mice treated with SAP indicated that SAP also reduced the expression of the M2-associated proteins MARCO (Fig. 3 E), ST2 and FIZZ- 1 (Fig. 3 F); as well as attenuating the bleomycin-induced profibrotic mediators CCL2 (MCP1/JE) [14], and oncostatin M (OSM) (OSM) [15] (Fig. 3 E).	SEN:10025154	20300636
BEL:20047334	p(MGI:Apcs) decreases r(MGI:Osm)	Analysis of a wider panel of M2-associated genes using branched DNA technology in the lungs of bleomycin challenged mice treated with SAP indicated that SAP also reduced the expression of the M2-associated proteins MARCO (Fig. 3 E), ST2 and FIZZ- 1 (Fig. 3 F); as well as attenuating the bleomycin-induced profibrotic mediators CCL2 (MCP1/JE) [14], and oncostatin M (OSM) (OSM) [15] (Fig. 3 E).	SEN:10025154	20300636
BEL:20047336	p(MGI:Apcs) decreases r(MGI:Retnlb)	Analysis of a wider panel of M2-associated genes using branched DNA technology in the lungs of bleomycin challenged mice treated with SAP indicated that SAP also reduced the expression of the M2-associated proteins MARCO (Fig. 3 E), ST2 and FIZZ- 1 (Fig. 3 F); as well as attenuating the bleomycin-induced profibrotic mediators CCL2 (MCP1/JE) [14], and oncostatin M (OSM) (OSM) [15] (Fig. 3 E).	SEN:10025154	20300636
BEL:20047360	p(MGI:Apoc3) decreases cat(p(MGI:Lpl))	Lpl...can hydrolyse mildly oxidized LDL forms like LDL(-), although this may be limited as suggested by LDL(-)'s higher content of both triglycerides and the LDL inhibitor Apo CIII	SEN:10025166	12878589
BEL:20047406	p(MGI:Apoe) decreases path(MESHD:Atherosclerosis)	Studies crossing PPAR-–deficient mice with apolipoprotein E atherosclerosis-prone mice and placing them on high-fat diets found less atherosclerosis, despite the PPAR- null mice having higher atherogenic lipids.101	SEN:10025184	12957325
BEL:20047408	p(MGI:Apoe) decreases path(MESHD:Atherosclerosis)	When administered to ob/ob mice, adiponectin prevents diabetes, and in APOE/ mice it attenuates atherosclerosis.74,75	SEN:10000328	14732733
BEL:20047432	p(MGI:Apoe) decreases r(MGI:F3)	In diabetic apolipoprotein E (apo E) deficient mice, RAGE signaling mediates prolonged vascular inflammation, and enhances the expression of vascular cell adhesion molecule (VCAM)-1 and tissue factor, leading to an exacerbation of the inflammatory state (82).	SEN:10025198	19273137
BEL:20047442	p(MGI:Apoe) increases r(MGI:Mir143)	qRT-PCR revealed that the aorta of ApoE KO mice had markedly decreased constitutive levels of miR-143 and miR-145, and that expression was further reduced (to less than 75% of WT levels) when fed on a high-fat diet (HFD) (Figure 2b).	SEN:10025204	19816508
BEL:20047444	p(MGI:Apoe) increases r(MGI:Mir145)	qRT-PCR revealed that the aorta of ApoE KO mice had markedly decreased constitutive levels of miR-143 and miR-145, and that expression was further reduced (to less than 75% of WT levels) when fed on a high-fat diet (HFD) (Figure 2b).	SEN:10025204	19816508
BEL:20047446	p(MGI:Apoe) decreases r(MGI:Olr1)	Gene expression of LOX-1 (Fig. 1A) was significantly up-regulated in apoE¡/¡ mice at baseline (3.1-fold, p < 0.01) and throughout the experiment compared to wild-type mice.	SEN:10025206	18930708
BEL:20047450	p(MGI:Apoe) decreases r(MGI:Tlr2)	level of both TLR-2 and TLR-4 mRNA is increased with time in arterial tissue obtained from Apo E-deficient mice, and TLR-2 and TLR-4 expression on circulating monocytes is increased at 40 weeks in Apo E-deficient mice compared with controls [96].	SEN:10025208	19309349
BEL:20047452	p(MGI:Apoe) decreases r(MGI:Tlr4)	level of both TLR-2 and TLR-4 mRNA is increased with time in arterial tissue obtained from Apo E-deficient mice, and TLR-2 and TLR-4 expression on circulating monocytes is increased at 40 weeks in Apo E-deficient mice compared with controls [96].	SEN:10025208	19309349
BEL:20047454	p(MGI:Apoe) decreases r(MGI:Vcam1)	The gene expression of VCAM-1 (Fig. 1B) in apoE¡/¡ mice was significantly up-regulated at baseline (2.6-fold, p < 0.001) compared to wild-type mice.	SEN:10025210	18930708
BEL:20047456	p(MGI:Apoe) decreases r(MGI:Vcam1)	In diabetic apolipoprotein E (apo E) deficient mice, RAGE signaling mediates prolonged vascular inflammation, and enhances the expression of vascular cell adhesion molecule (VCAM)-1 and tissue factor, leading to an exacerbation of the inflammatory state (82).	SEN:10025198	19273137
BEL:20047470	p(MGI:Areg) decreases r(MGI:Cbs)	We also observed that the hepatic mRNA levels of cistathionine {beta}-synthase and the modifier subunit of {gamma}-glutamylcysteine synthetase, two enzymes that are induced under oxidative stress, were up-regulated in AR null mice.	SEN:10025214	15753092
BEL:20047472	p(MGI:Areg) decreases r(MGI:Gclm)	We also observed that the hepatic mRNA levels of cistathionine {beta}-synthase and the modifier subunit of {gamma}-glutamylcysteine synthetase, two enzymes that are induced under oxidative stress, were up-regulated in AR null mice.	SEN:10025214	15753092
BEL:20047488	p(MGI:Arnt) increases bp(GOBP:"wound healing")	floxed ARNT mice were bred with lysozyme M-Cre recombinase animals to generate lysozyme M-ARNT (LAR) mice with reduced ARNT expression. Myeloid cells of LAR mice had altered mRNA expression and delayed wound healing.	SEN:10008028	24990649
BEL:20047490	p(MGI:Arnt) increases r(MGI:Ero1l)	As shown in Figure 4a and b, HIF-1anull cells totally failed to upregulate Ero1-La under hypoxia. Likewise, HIF-1b-null cells were incapable of inducing Ero1-La under hypoxia.	SEN:10025216	15592500
BEL:20047492	p(MGI:Arnt) increases surf(complex(p(MGI:Itgav),p(MGI:Itgb3)))	Furthermore, this defect is associated with decreased cell surface expression of integrin alphavbeta3 and significantly decreased expression of this integrin in focal adhesions.	SEN:10025218	15689487
BEL:20047498	p(MGI:Arrb1) decreases cat(p(MGI:Adrb2))	Both beta arr1-KO and beta arr2-KO cells showed similar impairment in agonist-stimulated beta(2)-AR and AT(1A)-R desensitization, when compared with their WT control cells	SEN:10025224	11171997
BEL:20047500	p(MGI:Arrb1) decreases cat(p(MGI:Agtr1a))	Both beta arr1-KO and beta arr2-KO cells showed similar impairment in agonist-stimulated beta(2)-AR and AT(1A)-R desensitization, when compared with their WT control cells	SEN:10025224	11171997
BEL:20047514	p(MGI:Arrb2) decreases cat(p(MGI:Adrb2))	Both beta arr1-KO and beta arr2-KO cells showed similar impairment in agonist-stimulated beta(2)-AR and AT(1A)-R desensitization, when compared with their WT control cells	SEN:10025224	11171997
BEL:20047516	p(MGI:Arrb2) decreases cat(p(MGI:Agtr1a))	Both beta arr1-KO and beta arr2-KO cells showed similar impairment in agonist-stimulated beta(2)-AR and AT(1A)-R desensitization, when compared with their WT control cells	SEN:10025224	11171997
BEL:20047518	p(MGI:Arrb2) increases cat(p(MGI:Ldlr))	We conclude that beta-arrestin2 can bind to and enhance endocytosis of the LDLR, both in vitro and in vivo, and may thereby influence lipoprotein metabolism	SEN:10005380	12944399
BEL:20047540	p(MGI:Arrb2) decreases p(MGI:Mmp9)	Isoprenaline inhibited OA-mediated MMP-9 expression in NIH3T3, in a beta-arrestin 2- and PP2A-dependent manner.	SEN:10025234	21718298
BEL:20047550	p(MGI:Arx) increases r(MGI:Myl1)	The apparent increase in the differentiation of the cells overexpressing hARX was accompanied by increased levels of MLC1/3F and Myogenin, as determined by PCR and western blot (Figure 4l and m)	SEN:10025242	17932502
BEL:20047552	p(MGI:Arx) increases r(MGI:Myog)	The apparent increase in the differentiation of the cells overexpressing hARX was accompanied by increased levels of MLC1/3F and Myogenin, as determined by PCR and western blot (Figure 4l and m)	SEN:10025242	17932502
BEL:20047558	p(MGI:Asxl1) directlyIncreases cat(p(MGI:Rara))	Systematic binding assays showed that the C-terminal nuclear receptor box (LVMQLL) of ASXL1 and the activation function-2 activation domain (AF-2 AD) core of the RAR are critical for ligand-dependent interaction	SEN:10005384	16606617
BEL:20047560	p(MGI:Atf2) increases p(MGI:Il23a)	ATF-2 or SMAD-3, but not IRF-3, short-hairpin RNA reduced p19 promoter activity and protein expression in RAW264.7 cells responding to TMEV.	SEN:10025246	18802055
BEL:20047564	p(MGI:Atf2,pmod(P,T,51)) directlyIncreases tscript(p(MGI:Atf2))	In contrast, the effect of MKK6(Glu) was markedly reduced in experiments using phosphorylation-defective (Ala-69, Ala-71) ATF2.	SEN:10021858	8622669
BEL:20047566	p(MGI:Atf2,pmod(P,T,53)) directlyIncreases tscript(p(MGI:Atf2))	In contrast, the effect of MKK6(Glu) was markedly reduced in experiments using phosphorylation-defective (Ala-69, Ala-71) ATF2.	SEN:10021858	8622669
BEL:20047568	p(MGI:Atf2) increases r(MGI:Csrp2)	To evaluate the functional role of CREB and ATF2 in the induction of CRP2, we cotransfected ?795Csrp2-luc construct with expression plasmids in transient transfection assays. CREB did not increase Csrp2 promoter activity (Fig. 8A). In contrast, ATF2 expression increased Csrp2 promoter activity by ?3-fold (Fig. 8A), and TGF? further enhanced the transcriptional activation by ATF2 7-fold (Fig. 8A).	SEN:10025250	18387947
BEL:20047570	p(MGI:Atf2) increases r(MGI:Il23a)	ATF-2 or SMAD-3, but not IRF-3, short-hairpin RNA reduced p19 promoter activity and protein expression in RAW264.7 cells responding to TMEV.	SEN:10025246	18802055
BEL:20047592	p(MGI:Atf3) decreases r(MGI:Myl7)	Whereas c-Jun resulted in a twofold activation of the MLC2a promoter, both ATF3 and JDP2 expression resulted in a marked suppression of the MLC2a-dependent luciferase activity (Fig. 4B).	SEN:10025264	16631626
BEL:20047608	p(MGI:Atf4) increases p(MGI:Hspa5)	Although the rates of BiP synthesis before ER stress were comparable in the two MEFs, BiP protein induction during the course of ER stress was almost completely abolished in cells lacking ATF4 expression (Fig. 3D).	SEN:10016350	12840028
BEL:20047658	p(MGI:Atg7) decreases p(MGI:Il1b)	Macrophages from Atg7-deficient mice also show enhanced production of IL-1b, indicating the importance of Atg in the regulation of the inflammatory response.	SEN:10025304	20548099
BEL:20047660	p(MGI:Atg9a) increases bp(GOBP:autophagy)	Mice lacking Atg9a cannot survive neonatal starvation periods, and cells lacking Atg9a are deficient in the generation of autophagosomes under both nutrient-rich and nutrientstarved conditions, indicating that Atg9a is an essential component of autophagy (Saitoh et al., 2009).	SEN:10025306	20548099
BEL:20047662	p(MGI:Atm) decreases bp(GOBP:"cell proliferation")	To study this issue, we generated Atm-/- p53-/- and Atm-/- p21-/- mice and derived MEFs from them. The cellular proliferative defects observed in Atm-/- MEFs are absent in Atm-/- p21-/- and Atm-/- p53-/- MEFs.	SEN:10025308	9632822
BEL:20047664	p(MGI:Atm) decreases bp(GOBP:"DNA replication")	Furthermore, primary cells derived from the Atm-/- mice displayed cellular defects characteristic of A-T, including hypersensitivity to ?-irradiation and defective cell cycle G1/S and S-phase checkpoint control following ?-irradiation (3, 33).	SEN:10025310	9632822
BEL:20047666	p(MGI:Atm) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	Furthermore, primary cells derived from the Atm-/- mice displayed cellular defects characteristic of A-T, including hypersensitivity to ?-irradiation and defective cell cycle G1/S and S-phase checkpoint control following ?-irradiation (3, 33).	SEN:10025310	9632822
BEL:20047670	p(MGI:Atm) increases bp(GOBP:"apoptotic process")	it has been recently shown that ATM is critical for p53 activation and the induction of apoptosis in response to c-MYC, suggesting that, in at least some cases, the ARF and ATM pathways cooperate with c-MYC to activate p53 and promote apoptosis (Figure 1a; Pusapati et al., 2006).	SEN:10020654	18955973
BEL:20047672	p(MGI:Atm) decreases p(MGI:Cdkn1a)	Atm-/- cells show an impaired p53 upregulation in response to gamma-irradiation and an increased level of p21, either or both of which could be responsible for their cellular defects and increased tumorigenesis.	SEN:10025312	9632822
BEL:20047676	p(MGI:Atm) increases p(MGI:Trp53)	Atm-/- cells show an impaired p53 upregulation in response to gamma-irradiation and an increased level of p21, either or both of which could be responsible for their cellular defects and increased tumorigenesis.	SEN:10025312	9632822
BEL:20047680	p(MGI:Atm) increases tscript(p(MGI:Trp53))	it has been recently shown that ATM is critical for p53 activation and the induction of apoptosis in response to c-MYC, suggesting that, in at least some cases, the ARF and ATM pathways cooperate with c-MYC to activate p53 and promote apoptosis (Figure 1a; Pusapati et al., 2006).	SEN:10020654	18955973
BEL:20047738	p(MGI:Bace1) increases deg(p(MGI:App))	Interestingly, recombinant overexpression of caveolin-3 in cultured cells stimulated beta-secretase-mediated processing of APP	SEN:10008062	10414982
BEL:20047742	p(MGI:Bach1) increases bp(GOBP:"cell proliferation")	Bach1-/- MEFs showed a markedly reduced proliferation rate when compared with control wild-type cells (Fig. 1a).	SEN:10025334	19011633
BEL:20047744	p(MGI:Bach1) increases bp(GOBP:"DNA replication")	Whereas 12.8% of control cells were positive for BrdU, indicating replication, only 6.7% of Bach1-/- MEFs incorporated BrdU (Fig. 1b and Supplementary Fig. 2).	SEN:10025336	19011633
BEL:20047746	p(MGI:Bach1) decreases bp(GOBP:"stress-induced premature senescence")	Unexpectedly, Bach1-/- MEFs showed a senescence-like phenotype more rapidly than control cells, as judged by enlarged cell morphology (data not shown) and expression of senescence-associated beta-galactosidase (SA beta-Gal) activity18 (Fig. 2a,b).	SEN:10025338	19011633
BEL:20047760	p(MGI:Bach1) decreases p(MGI:Hmox1)	HO-1 protein was upregulated in the aorta of Bach1 KO mice and DKO mice even before starting the diet, indicating that Bach1 disruption caused the elevation of basal HO-1 expression.	SEN:10025348	18633191
BEL:20047762	p(MGI:Bach1) decreases p(MGI:Hmox1)	As shown in Fig. 1A, the HO-1 level in Bach1-/- mouse lungs was significantly higher than that of WT mice even before hyperoxic exposure, and the time-dependent increase in HO-1 expression in Bach1-/- mouse lungs was much greater than that ofWT mice during hyperoxic exposure.	SEN:10025342	19439223
BEL:20047764	p(MGI:Bad,pmod(P,S,112)) directlyDecreases cat(p(MGI:Bad))	Protein phosphatase 2A (PP2A) is the major pSer112 phosphatase. PP2A dephosphorylation of pSer112 is the key initiating event regulating the activation of BAD during interleukin-3 withdrawal-induced apoptosis.	SEN:10025350	12944463
BEL:20047782	p(MGI:Bax) increases bp(GOBP:"apoptotic process")	Further support for the importance of Bax, but not Bak, inMYC-mediated apoptosis was obtained using a switchable mouse model of MYC-induced apoptosis in pancreatic beta cells, where it was shown that c-MYC induces apoptosis in vivo exclusively through Bax (Dansen et al., 2006).	SEN:10025356	18955973
BEL:20047798	p(MGI:Bbc3) increases cat(p(MGI:Bak1))	Reversibly, overexpression of NOXA or PUMA induces apoptosis as evidenced by the activation of BAK and caspase-7.	SEN:10008070	16407291
BEL:20047800	p(MGI:Bbc3) increases cat(p(MGI:Casp7))	Reversibly, overexpression of NOXA or PUMA induces apoptosis as evidenced by the activation of BAK and caspase-7.	SEN:10008070	16407291
BEL:20047806	p(MGI:Bcar1) increases p(MGI:Crk)	it is likely that Chat-induced Rap1 activation was mediated by upregulation of the Cas-Crk-C3G signaling pathway rather than direct guanine nucleotide exchange factor activity of Chat	SEN:10025366	12432078
BEL:20047808	p(MGI:Bcar3) increases kin(p(MGI:Pak1))	And34 overexpression augments both autophosphorylation and kinase activity of the Cdc42/Rac-responsive serine/threonine kinase PAK1	SEN:10025368	12517963
BEL:20047810	p(MGI:Bcar3) increases kin(p(MGI:Pak1))	AND-34 overexpression augments both autophosphorylation and kinase activity of the Cdc42/Rac-responsive serine/threonine kinase PAK1	SEN:10025370	12517963
BEL:20047812	p(MGI:Bcar3) increases p(MGI:Pak1,pmod(P))	And34 overexpression augments both autophosphorylation and kinase activity of the Cdc42/Rac-responsive serine/threonine kinase PAK1	SEN:10025368	12517963
BEL:20047814	p(MGI:Bcl2) increases a(CHEBI:glutathione)	Astrocytes overexpressing bcl-2 had elevated glutathione levels (130-200%), increased superoxide dismutase (170%) and glutathione peroxidase (140%) activities	SEN:10008074	9749779
BEL:20047822	p(MGI:Bcl2) decreases bp(GOBP:"apoptotic process")	Bcl-2 inhibits MYC-mediated apoptosis in some but not all cell systems, although having no effect on the proliferative function of c-MYC (Hoffman and Liebermann, 1998; Nilsson and Cleveland, 2003).	SEN:10025372	18955973
BEL:20047824	p(MGI:Bcl2) decreases bp(GOBP:"apoptotic process")	c-MYC overexpression accelerated apoptosis when these cells were deprived of IL-3 (Eischen et al., 2001b). Furthermore, c-MYC overexpression suppresses Bcl-2 protein and RNA levels, and restoration of Bcl-2 protein blocks this accelerated apoptosis.	SEN:10025374	18955973
BEL:20047826	p(MGI:Bcl2) increases cat(p(MGI:Gpx1))	Astrocytes overexpressing bcl-2 had elevated glutathione levels (130-200%), increased superoxide dismutase (170%) and glutathione peroxidase (140%) activities	SEN:10008074	9749779
BEL:20047828	p(MGI:Bcl2) increases cat(p(MGI:Sod1))	Astrocytes overexpressing bcl-2 had elevated glutathione levels (130-200%), increased superoxide dismutase (170%) and glutathione peroxidase (140%) activities	SEN:10008074	9749779
BEL:20047842	p(MGI:Bcl2) increases path(MESHD:Hypertrophy)	BCL-2 overexpression reduced neuronal loss during the NOCD period, which led to hypertrophy of the nervous system.	SEN:10025384	7946326
BEL:20047858	p(MGI:Bcl2) increases r(MGI:Ptpn11)	Cystic kidneys from postnatal day 20 bcl-2 -/- mice demonstrate a reduced expression, sixfold decrease in activity, and altered distribution of SHP-2 and PTP 1B	SEN:10008082	11832424
BEL:20047860	p(MGI:Bcl2) increases r(MGI:Ptpn1)	Cystic kidneys from postnatal day 20 bcl-2 -/- mice demonstrate a reduced expression, sixfold decrease in activity, and altered distribution of SHP-2 and PTP 1B.	SEN:10008084	11832424
BEL:20047862	p(MGI:Bcl2) increases r(MGI:Sirpa)	Cystic kidneys from postnatal day 20 bcl-2 -/- mice demonstrate a reduced expression, sixfold decrease in activity, and altered distribution of SHP-2 and PTP 1B	SEN:10008082	11832424
BEL:20047872	p(MGI:Bcl6) decreases r(MGI:Ccnd2)	We found that in primary mouse B cells, BCL-6 repressed expression of the Blimp-1, p27kip1, and cyclin D2 target genes.	SEN:10008088	14737119
BEL:20047874	p(MGI:Bcl6) decreases r(MGI:Cdkn1b)	We found that in primary mouse B cells, BCL-6 repressed expression of the Blimp-1, p27kip1, and cyclin D2 target genes.	SEN:10008088	14737119
BEL:20047876	p(MGI:Bcr) increases p(MGI:Btk,pmod(P,Y))	Control Ramos B cells and cells infected with a vaccinia virus expression vector for Lyn were treated with anti-IgM to activate the BCR for 0–30 min. A marked increase in BCRmediated tyrosine phosphorylation of Btk is found in the presence of an increased dosage of Lyn.	SEN:10025392	9326643
BEL:20047878	p(MGI:Bdkrb2) increases r(MGI:Ren1)	renal renin mRNA levels are 50 percent lower in newborn bradykinin B2 knockout mice than wild-type mice bradykinin stimulates renin gene expression	SEN:10025394	11592936
BEL:20047884	p(MGI:Bdnf) directlyIncreases kin(p(MGI:Ntrk2))	BDNF modulates synaptic transmission and plasticity primarily through the TrkB receptor, but the molecules involved in BDNF-mediated synaptic modulation are largely unknown.	SEN:10006316	16819522
BEL:20047886	p(MGI:Bdnf) increases p(MGI:Calb1)	Thus, BDNF stimulates calbindin expression in cultured hippocampal and cortical neurons (Ip et al., 1993 ; Widmer and Hefti, 1994 ).	SEN:10025398	10800929
BEL:20047890	p(MGI:Bdnf) increases r(MGI:Calb1)	Thus, BDNF stimulates calbindin expression in cultured hippocampal and cortical neurons (Ip et al., 1993 ; Widmer and Hefti, 1994 ).	SEN:10025398	10800929
BEL:20047892	p(MGI:Bdnf) increases r(MGI:Chn1)	alpha chimaerin which has 91% homology to human alpha2 chimaerin, was also up-regulated following exposure to BDNF figure shows NGF also induces	SEN:10025402	15447672
BEL:20047894	p(MGI:Bdnf) increases r(MGI:Chn2)	An increase in the expression of beta chimaerin mRNA by the BDNF treatment was found during the observation period, Expression of beta chimaerin mRNA is induced transiently by NGF as well as BDNF	SEN:10025404	15447672
BEL:20047912	p(MGI:Becn1) increases bp(GOBP:autophagy)	A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy.	SEN:10025412	21179212
BEL:20047916	p(MGI:Becn1) decreases cat(p(MGI:Casp1))	Becn1+/- macrophages displayed greater caspase-1 activation and cleaved IL-1b after LPS and ATP treatment (Fig. 1a).	SEN:10025416	21151103
BEL:20047924	p(MGI:Becn1) decreases sec(p(MGI:Il18))	IL-1b and IL-18 secretion into the medium was also increased in Map1lc3b-/- and Becn1+/- macrophages compared to corresponding wild-type macrophages (Fig. 1b).	SEN:10025420	21151103
BEL:20047926	p(MGI:Becn1) decreases sec(p(MGI:Il1b))	Becn1+/- macrophages displayed greater caspase-1 activation and cleaved IL-1b after LPS and ATP treatment (Fig. 1a).	SEN:10025416	21151103
BEL:20047928	p(MGI:Bgn) increases bp(GOBP:"cell migration")	the combination of biglycan overexpression and Ang II infusion resulted in marked increases in vascular smooth muscle cell proliferation and migration in the coronary arteries, as well as increases in fibrosis surrounding the vessels. In vitro, biglycan caused an increase in thymidine incorporation and migration of vascular smooth muscle cells, whereas these parameters were unchanged or reduced in endothelial cells.	SEN:10008094	15031262
BEL:20047930	p(MGI:Bgn) increases bp(GOBP:"DNA replication")	the combination of biglycan overexpression and Ang II infusion resulted in marked increases in vascular smooth muscle cell proliferation and migration in the coronary arteries, as well as increases in fibrosis surrounding the vessels. In vitro, biglycan caused an increase in thymidine incorporation and migration of vascular smooth muscle cells, whereas these parameters were unchanged or reduced in endothelial cells.	SEN:10008094	15031262
BEL:20047932	p(MGI:Bgn) increases p(MGI:Casp1)	Biglycan deficiency resulted in a reduction of pro-Il1B (Figure7A) and Nlrp3 (Figure7B) mRNA expression as well as in decreased levels of active caspase-1 (Figure 7, C and E) and mature IL-1B (Figure7F) over the whole experimental period.	SEN:10025422	21084753
BEL:20047934	p(MGI:Bgn) increases p(MGI:Cdk2)	addition of biglycan resulted in an increase in cdk2 expression and decrease in p27 levels in the vascular smooth muscle cells.	SEN:10008096	15031262
BEL:20047936	p(MGI:Bgn) decreases p(MGI:Cdkn1b)	addition of biglycan resulted in an increase in cdk2 expression and decrease in p27 levels in the vascular smooth muscle cells.	SEN:10008096	15031262
BEL:20047940	p(MGI:Bgn) increases r(EGID:12096)	mRNA levels of several osteoblast-specific marker genes were tested to determine the effect of Bgn on MC3T3-E1 differentiation. ocn transcript levels markedly increased in Bgn-treated cells. Higher levels of runx2 and bmp2 mRNA were also observed in Bgn-treated cells.	SEN:10025424	21048317
BEL:20047942	p(MGI:Bgn) increases r(MGI:Bmp2)	mRNA levels of several osteoblast-specific marker genes were tested to determine the effect of Bgn on MC3T3-E1 differentiation. ocn transcript levels markedly increased in Bgn-treated cells. Higher levels of runx2 and bmp2 mRNA were also observed in Bgn-treated cells.	SEN:10025424	21048317
BEL:20047946	p(MGI:Bgn) increases r(MGI:Cxcl13)	Biglycan deficiency resulted in a reduction of Cxcl13 mRNA expression over the whole experimental period (Figure8A).	SEN:10025428	21084753
BEL:20047954	p(MGI:Bgn) increases r(MGI:Il1b)	Biglycan deficiency resulted in a reduction of pro-Il1B (Figure7A) and Nlrp3 (Figure7B) mRNA expression as well as in decreased levels of active caspase-1 (Figure 7, C and E) and mature IL-1B (Figure7F) over the whole experimental period.	SEN:10025422	21084753
BEL:20047958	p(MGI:Bgn) increases r(MGI:Nlrp3)	Biglycan deficiency resulted in a reduction of pro-Il1B (Figure7A) and Nlrp3 (Figure7B) mRNA expression as well as in decreased levels of active caspase-1 (Figure 7, C and E) and mature IL-1B (Figure7F) over the whole experimental period.	SEN:10025422	21084753
BEL:20047962	p(MGI:Bgn) increases r(MGI:Runx2)	mRNA levels of several osteoblast-specific marker genes were tested to determine the effect of Bgn on MC3T3-E1 differentiation. ocn transcript levels markedly increased in Bgn-treated cells. Higher levels of runx2 and bmp2 mRNA were also observed in Bgn-treated cells.	SEN:10025424	21048317
BEL:20047970	p(MGI:Bhlhe41) directlyIncreases complex(p(MGI:Cebpb),p(MGI:Hdac1))	Protein interaction studies confirm that SHARP1 interacts with and inhibits the transcriptional activity of both C/EBPbeta and C/EBPalpha, and enhances the association of C/EBPbeta with histone deacetylase 1 (HDAC1).	SEN:10025442	19029947
BEL:20047974	p(MGI:Bhlhe41) directlyDecreases tscript(p(MGI:Cebpa))	Protein interaction studies confirm that SHARP1 interacts with and inhibits the transcriptional activity of both C/EBPbeta and C/EBPalpha, and enhances the association of C/EBPbeta with histone deacetylase 1 (HDAC1).	SEN:10025442	19029947
BEL:20047976	p(MGI:Bhlhe41) directlyDecreases tscript(p(MGI:Cebpb))	Protein interaction studies confirm that SHARP1 interacts with and inhibits the transcriptional activity of both C/EBPbeta and C/EBPalpha, and enhances the association of C/EBPbeta with histone deacetylase 1 (HDAC1).	SEN:10025442	19029947
BEL:20047992	p(MGI:Birc3) decreases p(MGI:Nfkbia)	As might be predicted, ectopic expression of human cIAP2 rescued TNFa-mediated IkBa degradation, whereas ectopic expression of XIAP did not (Fig. 3C). These data demonstrate that cIAP2 is required for proper TNFa-induced NF-kB signal transduction in MEFs	SEN:10025452	18697935
BEL:20047996	p(MGI:Birc5) increases bp(GOBP:"cell proliferation")	Survivin disruption by DN T34A Survivin blocked CA-Ras-induced IL-3-independent cell survival and proliferation; however, it did not affect CA-Ras-mediated enhancement of S-phase, indicating that the anti-apoptotic activity of CA-Ras is Survivin dependent while its S-phase enhancing effect is not.	SEN:10008104	15369798
BEL:20048006	p(MGI:Blmh) decreases path(MESHD:"Cystic Fibrosis")	with controls, Blmh null mice were more sensitive to acute BLM lethality and developed pulmonary fibrosis more readily following BLM treatment.	SEN:10000038	10200322
BEL:20048008	p(MGI:Blnk) increases bp(GOBP:"cell proliferation")	Here we identified BLNK as a direct target of the transcription factor Pax5 (BSAP). Restoration of BLNK expression in Ig(mu) transgenic Pax5(--) pro-B cells resulted in constitutive pre-BCR signaling and increased cell proliferation without inducing progression to the pre-B cell stage.....Pax5 Activates BLNK by Binding to the Transcription Initiation Region	SEN:10025456	12387741
BEL:20048010	p(MGI:Blnk) increases p(MGI:Plcg2,pmod(P,Y,1217))	By contrast, phospholipase C-gamma2 (PLC-gamma2) phosphorylation and an increase in intracellular Ca(2+) level mediated by pre-BCR cross-linking were observed only in the BLNK-expressing cells, indicating that BLNK is essential for PLC-gamma2-induced Ca(2+) influx.	SEN:10025458	15270728
BEL:20048018	p(MGI:Bmi1) decreases bp(GOBP:"cell aging")	Indeed, mouse embryonic fibroblasts deficient for the polycomb group protein BMI1 underwent premature cellular senescence, due to the derepression of both the INK4A and ARF genes (Jacobs et al., 1999).	SEN:10025462	21383691
BEL:20048020	p(MGI:Bmi1) increases bp(GOBP:"cell proliferation")	Bmi1- deficient BASCs in culture exhibited a defect in proliferation....Bmi1 influences BASC proliferation in culture in a dose-dependent manner.	SEN:10025464	18697930
BEL:20048036	p(MGI:Bmi1) decreases r(MGI:Cdkn2a)	However, once the BASCs were cultured, we observed an increase in the levels of both p16 and p19ARF transcripts (Fig. 4D).	SEN:10025478	18697930
BEL:20048038	p(MGI:Bmi1) decreases r(MGI:Cdkn2a)	we examined the level of p16 and p19ARF mRNA in total lung from both Bmi1+/+ and Bmi1-/- animals at ~7 weeks of age. Levels of p19ARF were 19 +/- 5-fold greater in Bmi1-/- lungs compared with WT lungs (P<0.001). Levels of p16 were not significantly greater (P=0.2)	SEN:10025480	18697930
BEL:20048040	p(MGI:Bmi1) decreases r(MGI:Cdkn2a)	Indeed, mouse embryonic fibroblasts deficient for the polycomb group protein BMI1 underwent premature cellular senescence, due to the derepression of both the INK4A and ARF genes (Jacobs et al., 1999).	SEN:10025462	21383691
BEL:20048046	p(MGI:Bmp1) increases p(MGI:Col1a1)	Bone morphogenetic protein 1 (BMP-1) and mammalian Tolloid (mTLD), two proteinases encoded by Bmp1, provide procollagen C-proteinase (pCP) activity that converts procollagens I to III into the major fibrous components of mammalian extracellular matrix (ECM)	SEN:10008114	12808086
BEL:20048048	p(MGI:Bmp1) increases p(MGI:Col1a2)	Bone morphogenetic protein 1 (BMP-1) and mammalian Tolloid (mTLD), two proteinases encoded by Bmp1, provide procollagen C-proteinase (pCP) activity that converts procollagens I to III into the major fibrous components of mammalian extracellular matrix (ECM)	SEN:10008114	12808086
BEL:20048050	p(MGI:Bmp1) increases p(MGI:Col2a1)	Bone morphogenetic protein 1 (BMP-1) and mammalian Tolloid (mTLD), two proteinases encoded by Bmp1, provide procollagen C-proteinase (pCP) activity that converts procollagens I to III into the major fibrous components of mammalian extracellular matrix (ECM)	SEN:10008114	12808086
BEL:20048052	p(MGI:Bmp1) increases p(MGI:Col3a1)	Bone morphogenetic protein 1 (BMP-1) and mammalian Tolloid (mTLD), two proteinases encoded by Bmp1, provide procollagen C-proteinase (pCP) activity that converts procollagens I to III into the major fibrous components of mammalian extracellular matrix (ECM)	SEN:10008114	12808086
BEL:20048070	p(MGI:Bmp2) increases phos(p(MGI:Alpl))	Following confluence, BMP-2was added tomedium at 200 ng/mL for 2-3 weeks, causing a 6-fold induction of ALP activity in wild-type MEFs. In RB/ MEFs, we observed a reduction in both basal and BMP-2-induced ALP activity as compared to that in wild-type MEFs, although BMP-2 still stimulated activity 3-fold in these cells (Figure 2A).	SEN:10025486	11545733
BEL:20048072	p(MGI:Bmp2) increases p(MGI:Acta2)	Cells cultured in the presence of BMP4, -7 or ?2 showed increased expression of alpha-SMA in AECs by immunofluorescence and Western blotting	SEN:10025488	23509993
BEL:20048078	p(MGI:Bmp2) increases r(EGID:12096)	Consistent with a requirement for pRb in osteocalcin expression, weobserved using RT-PCR that osteocalcin mRNA was induced by BMP-2 in wild-type but not RB/ MEFs (Figure 2C, inset).	SEN:10025492	11545733
BEL:20048080	p(MGI:Bmp2) decreases r(EGID:12096)	Moreover, the knockdown of Sam68 using short hairpin RNA in the embryonic mesenchymal multipotential progenitor C3H10T1/2 cells resulted in more pronounced expression of the mature osteoblast marker osteocalcin when differentiation was induced with bone morphogenetic protein-2.	SEN:10025494	16362077
BEL:20048082	p(MGI:Bmp2) increases r(MGI:Alpl)	BMP-2 induces expression of molecular markers characteristic of pre- and hypertrophic chondrocytes, such as Indian hedgehog, parathyroid hormone/parathyroid hormone-related peptide receptor, type X collagen, and alkaline phosphatase	SEN:10008120	12082094
BEL:20048084	p(MGI:Bmp2) increases r(MGI:Bglap2)	Consistent with a requirement for pRb in osteocalcin expression, weobserved using RT-PCR that osteocalcin mRNA was induced by BMP-2 in wild-type but not RB/ MEFs (Figure 2C, inset).	SEN:10025492	11545733
BEL:20048086	p(MGI:Bmp2) decreases r(MGI:Bglap2)	Moreover, the knockdown of Sam68 using short hairpin RNA in the embryonic mesenchymal multipotential progenitor C3H10T1/2 cells resulted in more pronounced expression of the mature osteoblast marker osteocalcin when differentiation was induced with bone morphogenetic protein-2.	SEN:10025494	16362077
BEL:20048092	p(MGI:Bmp2) increases r(MGI:Bmpr1a)	After BMP-2 implantation into the back muscles of 198 mice, expression of BMPR-1A, -2, and Noggin was increased during the early phase of the reaction	SEN:10008122	14584896
BEL:20048096	p(MGI:Bmp2) increases r(MGI:Bmpr2)	After BMP-2 implantation into the back muscles of 198 mice, expression of BMPR-1A, -2, and Noggin was increased during the early phase of the reaction	SEN:10008122	14584896
BEL:20048098	p(MGI:Bmp2) increases r(MGI:Col10a1)	BMP-2 induces expression of molecular markers characteristic of pre- and hypertrophic chondrocytes, such as Indian hedgehog, parathyroid hormone/parathyroid hormone-related peptide receptor, type X collagen, and alkaline phosphatase	SEN:10008120	12082094
BEL:20048104	p(MGI:Bmp2) increases r(MGI:Hes5)	BMP2 stimulation, in addition to the introduction of the intracellular domain of Notch (NIC), resulted in enhanced activation of the Hes-5 gene promoter.	SEN:10025498	14500836
BEL:20048106	p(MGI:Bmp2) increases r(MGI:Hey1)	In this paper, we show that BMP2 enhances Notch-induced transcriptional activation of Hes-5 and Hesr-1 in mouse neuroepithelial cells.	SEN:10025500	14500836
BEL:20048110	p(MGI:Bmp2) increases r(MGI:Hhex)	We find that Hex expression in avian anterior lateral endoderm is regulated by autocrine BMP signaling.	SEN:10008128	12270938
BEL:20048112	p(MGI:Bmp2) increases r(MGI:Ihh)	BMP-2 induces expression of molecular markers characteristic of pre- and hypertrophic chondrocytes, such as Indian hedgehog, parathyroid hormone/parathyroid hormone-related peptide receptor, type X collagen, and alkaline phosphatase	SEN:10008120	12082094
BEL:20048114	p(MGI:Bmp2) increases r(MGI:Mapk1)	increased Erk2 protein level under BMP2 inducement comes from BMP2-up-regulated Erk2 mRNA expression.	SEN:10025504	12220517
BEL:20048116	p(MGI:Bmp2) increases r(MGI:Nog)	After BMP-2 implantation into the back muscles of 198 mice, expression of BMPR-1A, -2, and Noggin was increased during the early phase of the reaction	SEN:10008122	14584896
BEL:20048122	p(MGI:Bmp2) increases r(MGI:Pth1r)	BMP-2 induces expression of molecular markers characteristic of pre- and hypertrophic chondrocytes, such as Indian hedgehog, parathyroid hormone/parathyroid hormone-related peptide receptor, type X collagen, and alkaline phosphatase	SEN:10008120	12082094
BEL:20048124	p(MGI:Bmp2) increases r(MGI:Runx2)	Loss of either p107 or p130 resulted in a consistently greater increase in ALP due to BMP-2 than was observed in wild-type cells. Furthermore, CBFA1 mRNA levels were increased by BMP-2 treatment in both wild-type and RB/ MEFs	SEN:10025508	11545733
BEL:20048126	p(MGI:Bmp2) increases r(MGI:Runx2)	Using reverse transcriptase-real time PCR to measure mRNA expression we found that ZNF450, Runx2/Cbfa-1, and Sp7/osterix were induced by BMP-2 after 4 h in C2C12 myoblast cells.	SEN:10025510	15526281
BEL:20048128	p(MGI:Bmp2) increases r(MGI:Sp7)	Using reverse transcriptase-real time PCR to measure mRNA expression we found that ZNF450, Runx2/Cbfa-1, and Sp7/osterix were induced by BMP-2 after 4 h in C2C12 myoblast cells.	SEN:10025510	15526281
BEL:20048132	p(MGI:Bmp2) increases r(MGI:Zbtb24)	Using reverse transcriptase-real time PCR to measure mRNA expression we found that ZNF450, Runx2/Cbfa-1, and Sp7/osterix were induced by BMP-2 after 4 h in C2C12 myoblast cells.	SEN:10025510	15526281
BEL:20048134	p(MGI:Bmp2) increases sec(p(EGID:12096))	blastic differentiation induced by BMP-2. In contrast, secretion of the late marker osteocalcin was undetect( able in RB/ MEFs, while clearly induced in wild-type MEFs as well as in p107/ and p130/ MEFs (Figure 2C).	SEN:10025514	11545733
BEL:20048136	p(MGI:Bmp2) increases sec(p(MGI:Bglap2))	blastic differentiation induced by BMP-2. In contrast, secretion of the late marker osteocalcin was undetect( able in RB/ MEFs, while clearly induced in wild-type MEFs as well as in p107/ and p130/ MEFs (Figure 2C).	SEN:10025514	11545733
BEL:20048138	p(MGI:Bmp2) increases tscript(p(MGI:Rbpj))	RBP-Jkappa binding to its target sequence is important not only for Notch signaling, but also for BMP2 signaling, to activate the Hes-5 gene promoter	SEN:10008132	14500836
BEL:20048140	p(MGI:Bmp2) increases tscript(p(MGI:Smad1))	Smad1, a Smad species that is activated by BMP2, barely interacted with NIC, but did form a complex with NIC in the simultaneous presence of the coactivators P/CAF and p300.	SEN:10005586	14500836
BEL:20048142	p(MGI:Bmp2) increases tscript(p(MGI:Sp1))	Sp1-mediated transcription is one of the mechanisms, which is responsible for BMP2-induced up-regulation of Erk2 expression.	SEN:10008134	12220517
BEL:20048156	p(MGI:Bmp4) increases p(MGI:Acta2)	Cells cultured in the presence of BMP4, -7 or ?2 showed increased expression of alpha-SMA in AECs by immunofluorescence and Western blotting	SEN:10025488	23509993
BEL:20048160	p(MGI:Bmp4) increases r(MGI:Barx2)	We also found that two members of the BMP family that are crucial for chondrogenesis, GDF5 and BMP4, regulate the pattern of Barx2 expression	SEN:10008138	15800003
BEL:20048170	p(MGI:Bmp4) decreases r(MGI:Pitx1)	Bead implantation experiments demonstrate that ectopic expression of Fgf8 can induce/maintain the expression of both Pitx1 and Pitx2 at E9.5. In contrast, Bmp4-expressing tissues and BMP4-soaked beads were able to repress Pitx1 expression in mandibular mesenchyme and Pitx2 expression	SEN:10025520	10625557
BEL:20048172	p(MGI:Bmp4) decreases r(MGI:Pitx2)	Bead implantation experiments demonstrate that ectopic expression of Fgf8 can induce/maintain the expression of both Pitx1 and Pitx2 at E9.5. In contrast, Bmp4-expressing tissues and BMP4-soaked beads were able to repress Pitx1 expression in mandibular mesenchyme and Pitx2 expression	SEN:10025520	10625557
BEL:20048180	p(MGI:Bmp6) decreases bp(GOBP:"wound healing")	we analyzed the wound response of transgenic mice overexpressing BMP-6 in the epidermis. In these mice, reepitheliazation of skin wounds was significantly delayed.	SEN:10025524	9856831
BEL:20048182	p(MGI:Bmp7) decreases cat(p(MGI:Serpine1))	TGF-beta reduces the activity of MMPs through increasing plasminogen activator inhibitor (PAI)-1, we tested whether BMP7 interferes with this TGF-beta effect. BMP7 reduces, by about two-thirds, the activation of a PAI-1	SEN:10025526	12676736
BEL:20048186	p(MGI:Bmp7) increases p(MGI:Acta2)	Cells cultured in the presence of BMP4, -7 or ?2 showed increased expression of alpha-SMA in AECs by immunofluorescence and Western blotting	SEN:10025488	23509993
BEL:20048190	p(MGI:Bmp7) decreases r(MGI:Col1a2)	BMP-7 suppressed the expression of mRNAs for COL1A2 and tissue inhibitor of metalloproteinase-2 while increasing those of inhibitors of differentiation (Id) 2 and 3.	SEN:10008144	16126788
BEL:20048192	p(MGI:Bmp7) increases r(MGI:Id2)	BMP-7 suppressed the expression of mRNAs for COL1A2 and tissue inhibitor of metalloproteinase-2 while increasing those of inhibitors of differentiation (Id) 2 and 3.	SEN:10008144	16126788
BEL:20048194	p(MGI:Bmp7) increases r(MGI:Id3)	BMP-7 suppressed the expression of mRNAs for COL1A2 and tissue inhibitor of metalloproteinase-2 while increasing those of inhibitors of differentiation (Id) 2 and 3.	SEN:10008144	16126788
BEL:20048200	p(MGI:Bmp7) decreases r(MGI:Timp2)	BMP-7 suppressed the expression of mRNAs for COL1A2 and tissue inhibitor of metalloproteinase-2 while increasing those of inhibitors of differentiation (Id) 2 and 3.	SEN:10008144	16126788
BEL:20048214	p(MGI:Bnip3) increases bp(GOBP:autophagy)	A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy.	SEN:10025412	21179212
BEL:20048226	p(MGI:Braf,sub(V,600,E)) increases path(MESHD:Adenoma)	Papillary adenomas (1.2.1.2.2) were detected 6–8 wk after BRafVE expression and appeared to increase in number and size. These lesions were bronchiolocentric, but did not appear to involve the terminal bronchioles. Rather, the lesions appeared to arise in alveolar ducts and expand outward and around bronchioles (Fig. 4B).	SEN:10025542	17299132
BEL:20048228	p(MGI:Braf,sub(V,600,E)) increases path(MESHD:Hyperplasia)	At early times after induced BRafVE expression, we detected evidence of epithelial hyperplasia (classified as 1.1.1.1) arising within the terminal bronchioles and within the central lung parenchyma.	SEN:10025544	17299132
BEL:20048232	p(MGI:Braf,sub(V,600,E)) increases p(MGI:Sftpc)	the majority of cells within BRafVE-induced tumors expressed SP-C, suggesting that they have properties of ATII pneumocytes (Fig. 2K,L).	SEN:10025548	17299132
BEL:20048238	p(MGI:Brca1) decreases bp(GOBP:"apoptotic process")	A targeted Brca1-null mutation to the T-cell lineage resulted in increased genomic instability, apoptosis, cell-cycle arrest, and a drastic depletion of the T-cell lineage (Mak et al, 2000).	SEN:10025550	18285820
BEL:20048240	p(MGI:Brca1) decreases r(MGI:Man1a)	Table 6 Selected genes whose expression is decreased in Brca1 delta ex11 delta ex (versus Brca1 +/+) mouse embryo fibroblasts (Brca1 deficient)	SEN:10025552	15520196
BEL:20048244	p(MGI:Brca2,pmod(P,S,3291)) decreases complex(p(MGI:Brca2),p(MGI:Rad51))	BRCA2 functions in the loading of the HR protein RAD51 during filament formation. It directly binds to RAD51 and its phosphorylation on Ser3291 inhibits this binding (Esashi et al, 2005).	SEN:10025556	18285820
BEL:20048246	p(MGI:Brca2) decreases tscript(p(MGI:Trp53))	null mutations for Brca2 result in early mouse embryonic lethality and impaired HR (Ludwig et al, 1997; Suzuki et al, 1997; Moynahan et al, 2001). Furthermore, loss of Brca2 in murine cells resulted in increased genomic instability and activation of p53.	SEN:10025554	18285820
BEL:20048258	p(MGI:Btg1) decreases bp(GOBP:"cell proliferation")	The human BTG1 protein is thought to be a potential tumour suppressor because its overexpression inhibits NIH 3T3 cell proliferation.	SEN:10008154	9820826
BEL:20048272	p(MGI:Btk) decreases p(MGI:Ifng)	Consistent with the increases in inflammatory cells in the BAL fluids from btk-/- mice, BAL fluids from these mice contained increased levels of IL-4, IL-5, and IL-13 (Fig. 7C). Interestingly, btk -/- BAL fluids also had higher levels of IFN-G, in line with the increased IgG2a levels in these mice (Fig. 7A).	SEN:10025570	16371463
BEL:20048274	p(MGI:Btk) decreases p(MGI:Ifng)	Production of both Th1 (IFN-G) and Th2 (IL-4, IL-5, and IL-13) cytokines was antigen-dependent and more abundant in cultures with btk -/- DCs than in those with WT DCs (Fig. 4B ).	SEN:10025572	16371463
BEL:20048276	p(MGI:Btk) decreases p(MGI:Il13)	Consistent with the increases in inflammatory cells in the BAL fluids from btk-/- mice, BAL fluids from these mice contained increased levels of IL-4, IL-5, and IL-13 (Fig. 7C). Interestingly, btk -/- BAL fluids also had higher levels of IFN-G, in line with the increased IgG2a levels in these mice (Fig. 7A).	SEN:10025570	16371463
BEL:20048278	p(MGI:Btk) decreases p(MGI:Il13)	Production of both Th1 (IFN-G) and Th2 (IL-4, IL-5, and IL-13) cytokines was antigen-dependent and more abundant in cultures with btk -/- DCs than in those with WT DCs (Fig. 4B ).	SEN:10025572	16371463
BEL:20048280	p(MGI:Btk) decreases p(MGI:Il4)	Consistent with the increases in inflammatory cells in the BAL fluids from btk-/- mice, BAL fluids from these mice contained increased levels of IL-4, IL-5, and IL-13 (Fig. 7C). Interestingly, btk -/- BAL fluids also had higher levels of IFN-G, in line with the increased IgG2a levels in these mice (Fig. 7A).	SEN:10025570	16371463
BEL:20048282	p(MGI:Btk) decreases p(MGI:Il4)	Production of both Th1 (IFN-G) and Th2 (IL-4, IL-5, and IL-13) cytokines was antigen-dependent and more abundant in cultures with btk -/- DCs than in those with WT DCs (Fig. 4B ).	SEN:10025572	16371463
BEL:20048284	p(MGI:Btk) decreases p(MGI:Il5)	Consistent with the increases in inflammatory cells in the BAL fluids from btk-/- mice, BAL fluids from these mice contained increased levels of IL-4, IL-5, and IL-13 (Fig. 7C). Interestingly, btk -/- BAL fluids also had higher levels of IFN-G, in line with the increased IgG2a levels in these mice (Fig. 7A).	SEN:10025570	16371463
BEL:20048286	p(MGI:Btk) decreases p(MGI:Il5)	Production of both Th1 (IFN-G) and Th2 (IL-4, IL-5, and IL-13) cytokines was antigen-dependent and more abundant in cultures with btk -/- DCs than in those with WT DCs (Fig. 4B ).	SEN:10025572	16371463
BEL:20048288	p(MGI:C1qa) increases bp(GOBP:"apoptotic process")	Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls.	SEN:10025574	9590289
BEL:20048292	p(MGI:C1qa) decreases path(MESHD:Glomerulonephritis)	Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls.	SEN:10025574	9590289
BEL:20048302	p(MGI:C3) increases p(MGI:Icam1)	In WT mice CH induced an approximate 2-fold increase in IL-6 mRNA at three weeks that was abrogated in C3 -/- mice... We observed increases in lung intracellular adhesion molecule 1 (ICAM-1)...the increase in ICAM-1 was abrogated in C3 -/- mice (Fig. 7).	SEN:10025580	22194859
BEL:20048310	p(MGI:C3) increases r(MGI:Il6)	In WT mice CH induced an approximate 2-fold increase in IL-6 mRNA at three weeks that was abrogated in C3 -/- mice... We observed increases in lung intracellular adhesion molecule 1 (ICAM-1)...the increase in ICAM-1 was abrogated in C3 -/- mice (Fig. 7).	SEN:10025580	22194859
BEL:20048318	p(MGI:Cacna1d) decreases path(MESHD:Bradycardia)	The unexpected observation that mice lacking L-type Cav1.3 channels had pronounced bradycardia and SAN arrhythmia was the first genetic indication of the importance of these channels in pacemaker activity (393).	SEN:10025586	18626064
BEL:20048334	p(MGI:Calb1) decreases bp(GOBP:"apoptotic process")	Because the calcium-binding protein calbindin-D(28k) has anti-apoptotic properties in neuronal cells and lymphocytes, we searched for the presence of this protein in osteoblastic cells and investigated whether it can modify their response to proapoptotic signals.	SEN:10008164	10835428
BEL:20048336	p(MGI:Calb1) decreases cat(p(MGI:Casp3))	cell extracts from MC3T3-E1 cells expressing high levels of calbindin-D(28k) decreased caspase-3 activity, compared with extracts from vector-transfected cells.	SEN:10025596	10835428
BEL:20048356	p(MGI:Camk2a) decreases p(MGI:Cdkn1a)	The in vivo administration of KN-93 to mice xenografted with human osteosarcoma cells significantly decreased intratibial and subcutaneous tumor growth. Mechanistically, KN-93 and alpha-CaMKII siRNA increased p21((CIP/KIP)) gene expression, protein levels, and decreased the phosphorylation of retinoblastoma protein and E2F transactivation	SEN:10008168	17632540
BEL:20048358	p(MGI:Camk2a) decreases r(MGI:Cdkn1a)	The in vivo administration of KN-93 to mice xenografted with human osteosarcoma cells significantly decreased intratibial and subcutaneous tumor growth. Mechanistically, KN-93 and alpha-CaMKII siRNA increased p21((CIP/KIP)) gene expression, protein levels, and decreased the phosphorylation of retinoblastoma protein and E2F transactivation	SEN:10008168	17632540
BEL:20048370	p(MGI:Capn1) increases bp(GOBP:"cell migration")	The absence of both mu- and m-calpain activity, caused by disruption of the capn4 gene in mice, retarded migration, and disrupted the cytoskeleton, both in primary capn4(-/-) embryonic fibroblasts (mEF) and in capn4(-/-) mEF immortalized with SV40 large T-antigen (TAg).	SEN:10008172	12237117
BEL:20048374	p(MGI:Capn2) increases bp(GOBP:"cell migration")	The absence of both mu- and m-calpain activity, caused by disruption of the capn4 gene in mice, retarded migration, and disrupted the cytoskeleton, both in primary capn4(-/-) embryonic fibroblasts (mEF) and in capn4(-/-) mEF immortalized with SV40 large T-antigen (TAg).	SEN:10008172	12237117
BEL:20048376	p(MGI:Capn3) increases r(MGI:Ctsl)	mRNA levels for cathepsin L, the 14-kDa ubiquitin-conjugating enzyme E2, and the C2 subunit of the 20S proteasome decreased by approximately 47% (P<0.005) in the gastrocnemius muscle from calpain-3 deficient mice.	SEN:10025606	12672459
BEL:20048378	p(MGI:Capn3) increases r(MGI:Psma1)	mRNA levels for cathepsin L, the 14-kDa ubiquitin-conjugating enzyme E2, and the C2 subunit of the 20S proteasome decreased by approximately 47% (P<0.005) in the gastrocnemius muscle from calpain-3 deficient mice.	SEN:10025606	12672459
BEL:20048382	p(MGI:Capns1) increases bp(GOBP:"cell migration")	The absence of both mu- and m-calpain activity, caused by disruption of the capn4 gene in mice, retarded migration, and disrupted the cytoskeleton, both in primary capn4(-/-) embryonic fibroblasts (mEF) and in capn4(-/-) mEF immortalized with SV40 large T-antigen (TAg).	SEN:10008172	12237117
BEL:20048406	p(MGI:Casp3) increases bp(GOBP:"apoptotic process")	Importantly, apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema.	SEN:10008182	15944319
BEL:20048408	p(MGI:Casp3) increases path(MESHD:Emphysema)	Importantly, apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema.	SEN:10008182	15944319
BEL:20048422	p(MGI:Casp3) decreases p(MGI:Runx2)	Figure 5 Runx2/Cbfa1 expression in preosteoblasts by Western blot analysis. Caspase-3–deficient (Casp3–/– and Casp3+/–) preosteoblasts showed decreased Runx2/Cbfa1 expression and altered expression pattern of Runx2/Cbfa1 in response to TGF-? treatment when compared with WT preosteoblasts. (Western Blot)	SEN:10025620	15599395
BEL:20048424	p(MGI:Casp4) increases p(MGI:Il1b)	Caspase-11, which is needed for the activation of procaspase-1 and pro-IL-1, was induced by LPS treatment in the lung and primary cultured macrophages. The induction of caspase-11 by LPS was suppressed in Chop knockout mice.	SEN:10025622	16670335
BEL:20048434	p(MGI:Casp8) increases r(MGI:Il6)	the induction of Tnfa and Il-6 was severely impaired after 2 h of poly(I:C) stimulation and reduced after 6 h of stimulation in caspase-8-deficient cells (Fig. 4B).	SEN:10025628	16585540
BEL:20048436	p(MGI:Casp8) increases r(MGI:Tnf)	the induction of Tnfa and Il-6 was severely impaired after 2 h of poly(I:C) stimulation and reduced after 6 h of stimulation in caspase-8-deficient cells (Fig. 4B).	SEN:10025628	16585540
BEL:20048438	p(MGI:Casp8) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	nuclear translocation of p65, a component of NF-{kappa}B, was reduced in caspase-8-deficient cells (Fig. 4C)	SEN:10025630	16585540
BEL:20048448	p(MGI:Casq1) decreases r(MGI:Atp2a2)	Several genes are downregulated at 13 weeks, including SR Ca2+-ATPase (SERCA2) and adenine nucleotide translocase 1 (Ant1) genes.	SEN:10025638	12127059
BEL:20048450	p(MGI:Casq1) increases r(MGI:Dcn)	Cardiac ankyrin repeat protein (CARP), glutathione peroxidase (Gpx1), and genes which participate in the formation of extracellular matrix including decorin, TSC-36, Magp2, Osf2, and SPARC are upregulated in CSQ mouse hearts at 7 and 13 weeks of age compared to those of non-transgenic littermates.	SEN:10025640	12127059
BEL:20048452	p(MGI:Casq1) increases r(MGI:Fstl1)	Cardiac ankyrin repeat protein (CARP), glutathione peroxidase (Gpx1), and genes which participate in the formation of extracellular matrix including decorin, TSC-36, Magp2, Osf2, and SPARC are upregulated in CSQ mouse hearts at 7 and 13 weeks of age compared to those of non-transgenic littermates.	SEN:10025640	12127059
BEL:20048456	p(MGI:Casq1) increases r(MGI:Mfap5)	Cardiac ankyrin repeat protein (CARP), glutathione peroxidase (Gpx1), and genes which participate in the formation of extracellular matrix including decorin, TSC-36, Magp2, Osf2, and SPARC are upregulated in CSQ mouse hearts at 7 and 13 weeks of age compared to those of non-transgenic littermates.	SEN:10025640	12127059
BEL:20048458	p(MGI:Casq1) decreases r(MGI:Slc25a4)	Several genes are downregulated at 13 weeks, including SR Ca2+-ATPase (SERCA2) and adenine nucleotide translocase 1 (Ant1) genes.	SEN:10025638	12127059
BEL:20048460	p(MGI:Casq1) increases r(MGI:Sparc)	Cardiac ankyrin repeat protein (CARP), glutathione peroxidase (Gpx1), and genes which participate in the formation of extracellular matrix including decorin, TSC-36, Magp2, Osf2, and SPARC are upregulated in CSQ mouse hearts at 7 and 13 weeks of age compared to those of non-transgenic littermates.	SEN:10025640	12127059
BEL:20048498	p(MGI:Cav1) increases path(MESHD:Obesity)	A more thorough analysis of Cav-1 null mice revealed that, whereas a caveolin-1 deficiency did not lead to an overt diabetic phenotype, it did result in abnormalities in lipid homeostasis, characterized by resistance to diet induced obesity, ablation of the hypodermal fat layer, progressive white adipose tissue atrophy, and hypertrophy of brown adipose tissue (58).	SEN:10025660	14607781
BEL:20048512	p(MGI:Cav1) increases p(MGI:Atm,pmod(P,S,1981))	Interestingly, caveolin-1 expression was required for the activation ofATMafter hydrogen peroxide treatment, as shown by a dramatically reduced expression of phospho-Ser-1981 ATM in caveolin-1 null MEFs, as compared with wild type MEFs (Fig. 1C).	SEN:10025648	19103597
BEL:20048514	p(MGI:Cav1) decreases p(MGI:Hmox1)	Interestingly, basal and hyperoxia-inducible HO-1 levels were dramatically higher in cav-1-/- mice than in corresponding wild-type mice (Figure 4A).	SEN:10022412	18323531
BEL:20048516	p(MGI:Cav1) decreases p(MGI:Mapk11)	Increased p38b expression was observed in cav-1-/- cells and tissue (Figure 6C and data not shown).	SEN:10025670	18323531
BEL:20048518	p(MGI:Cav1,pmod(P,Y,14)) directlyIncreases cat(p(MGI:Cav1))	site-directed mutagenesis directly show that tyrosine 14 is the principal substrate for Src kinase. Only alpha-caveolin underwent tyrosine phosphorylation in v-Src transformed NIH 3T3 cells, although beta-caveolin is well expressed in these cells.	SEN:10022174	8632005
BEL:20048532	p(MGI:Cav2,pmod(P,Y,19)) directlyIncreases complex(p(MGI:Cav2),p(MGI:Nck1))	In support of this notion, we identify several SH2 domain containing proteins, namely c-Src, NCK, and Ras-GAP, that interact with caveolin-2 in a phosphorylation-dependent manner.	SEN:10025678	12091389
BEL:20048536	p(MGI:Cav2,pmod(P,Y,19)) directlyIncreases complex(p(MGI:Cav2),p(MGI:Src))	In support of this notion, we identify several SH2 domain containing proteins, namely c-Src, NCK, and Ras-GAP, that interact with caveolin-2 in a phosphorylation-dependent manner.	SEN:10025678	12091389
BEL:20048538	p(MGI:Cav2,pmod(P,Y,19)) directlyIncreases complex(p(MGI:Cav2),p(MGI:Syngap1))	In support of this notion, we identify several SH2 domain containing proteins, namely c-Src, NCK, and Ras-GAP, that interact with caveolin-2 in a phosphorylation-dependent manner.	SEN:10025678	12091389
BEL:20048540	p(MGI:Cav3) increases complex(p(MGI:Psen1),p(MGI:App))	Because the presenilins also form a physical complex with caveolin-3, caveolin-3 may provide a common platform for APP and the presenilins to associate in astrocytes	SEN:10008196	10414982
BEL:20048542	p(MGI:Cav3) increases complex(p(MGI:Psen2),p(MGI:App))	Because the presenilins also form a physical complex with caveolin-3, caveolin-3 may provide a common platform for APP and the presenilins to associate in astrocytes	SEN:10008196	10414982
BEL:20048546	p(MGI:Cav3) increases p(MGI:Psen1)	Immunoreactivities of APP and presenilins were concomitantly increased in caveolin-3-positive astrocytes	SEN:10008198	10414982
BEL:20048548	p(MGI:Cav3) increases p(MGI:Psen2)	Immunoreactivities of APP and presenilins were concomitantly increased in caveolin-3-positive astrocytes	SEN:10008198	10414982
BEL:20048550	p(MGI:Cav3) decreases r(MGI:Dag1)	Analysis of skeletal muscle tissue from caveolin-3- overexpressing transgenic mice reveals: (i) a dramatic increase in the number of sarcolemmal muscle cell caveolae; (ii) a preponderance of hypertrophic, necrotic, and immature/regenerating skeletal muscle fibers with characteristic central nuclei; and (iii) down-regulation of dystrophin and beta-dystroglycan protein expression.	SEN:10025680	10931944
BEL:20048552	p(MGI:Cav3) decreases r(MGI:Dmd)	Analysis of skeletal muscle tissue from caveolin-3- overexpressing transgenic mice reveals: (i) a dramatic increase in the number of sarcolemmal muscle cell caveolae; (ii) a preponderance of hypertrophic, necrotic, and immature/regenerating skeletal muscle fibers with characteristic central nuclei; and (iii) down-regulation of dystrophin and beta-dystroglycan protein expression.	SEN:10025680	10931944
BEL:20048562	p(MGI:Cbl,pmod(P,Y)) increases cat(p(MGI:Rhoq))	This pathway begins with the phosphorylation of the adaptor protein Cbl by the insulin receptor, and results in the activation of a small GTP binding protein, TC10	SEN:10021766	12436329
BEL:20048570	p(MGI:Ccl11) increases a(CHEBI:hydroxyproline)	As shown in Figure 3A, lung fibrosis in CCL11?/? mice was abrogated compared to their corresponding wild-type counterparts (CCL11+/+) as estimated by the levels of OH-proline.	SEN:10025684	16314464
BEL:20048572	p(MGI:Ccl11) increases bp(GOBP:"neutrophil activation")	On day 7 after blm treatment, pulmonary eosinophil and neutrophil numbers were significantly increased in rCCL11-administered mice (200 ng) in comparison to the corresponding control group (0.1% of serum) (Table 2).	SEN:10025686	16314464
BEL:20048586	p(MGI:Ccl17) decreases r(MGI:Foxp3)	The expression of Foxp3 mRNA was hardly detectable in aortas of Apoe-/- mice treated with isotype control but significantly elevated in anti-CCL17-treated Apoe-/- mice (Figure 6C), reflecting an increased presence of Treg in the aorta.	SEN:10025696	21633167
BEL:20048594	p(MGI:Ccl19) increases kin(p(MGI:Jak3))	when we analyzed the migration of Jak3(-/-) and Jak3(+/+) mature DCs in response to CCL19 and CCL21 chemokines, we found that the absence of Jak3 results in impaired chemotactic responses both in vitro and in vivo.	SEN:10021796	19759904
BEL:20048604	p(MGI:Ccl19) increases r(MGI:Cd40)	More interestingly, CCL19 and CCL21 have recently been involved in DC maturation, by enhancing the up-regulation of CD86 and CD40 expression markers, whereas CCL19 stimulation also led to increased secretion of IL-12, IL-1? and TNF? from DCs.	SEN:10025704	19759904
BEL:20048606	p(MGI:Ccl19) increases r(MGI:Cd86)	More interestingly, CCL19 and CCL21 have recently been involved in DC maturation, by enhancing the up-regulation of CD86 and CD40 expression markers, whereas CCL19 stimulation also led to increased secretion of IL-12, IL-1? and TNF? from DCs.	SEN:10025704	19759904
BEL:20048612	p(MGI:Ccl21a) increases kin(p(MGI:Jak3))	when we analyzed the migration of Jak3(-/-) and Jak3(+/+) mature DCs in response to CCL19 and CCL21 chemokines, we found that the absence of Jak3 results in impaired chemotactic responses both in vitro and in vivo.	SEN:10021796	19759904
BEL:20048628	p(MGI:Ccl2) increases bp(GOBP:"macrophage chemotaxis")	Peritoneal macrophages pre-attached to Transwell membranes were exposed to media, fMLP, GM-CSF, or MCP-1. After 21 h incubation, the concentration of migrated CD44-deficient macrophages was significantly less than that of migrated C57BL/6 macrophages under all conditions	SEN:10025714	17446529
BEL:20048636	p(MGI:Ccl2) increases path(MESHD:Atherosclerosis)	knockout of MCP1 or its receptor CCR-2 also attenuates atherosclerosis in murine models,40,41 and knockout of macrophage colony-stimulation factor (MCSF), which converts monocytes to macrophages, similarly attenuates atherosclerosis.42	SEN:10000330	14732733
BEL:20048654	p(MGI:Ccl2) increases p(MGI:Ifng)	Development of secondary pulmonary granulomata in response to Schistosoma mansoni eggs was blunted in MCP-1(-/-) mice, as was expression of IL-4, IL-5, and interferon gamma in splenocytes.	SEN:10002132	9463410
BEL:20048656	p(MGI:Ccl2) increases p(MGI:Il4)	Development of secondary pulmonary granulomata in response to Schistosoma mansoni eggs was blunted in MCP-1(-/-) mice, as was expression of IL-4, IL-5, and interferon gamma in splenocytes.	SEN:10002132	9463410
BEL:20048658	p(MGI:Ccl2) increases p(MGI:Il5)	Development of secondary pulmonary granulomata in response to Schistosoma mansoni eggs was blunted in MCP-1(-/-) mice, as was expression of IL-4, IL-5, and interferon gamma in splenocytes.	SEN:10002132	9463410
BEL:20048668	p(MGI:Ccl3) increases bp(GOBP:angiogenesis)	Wounds of mice treated with anti-MIP-1alpha antiserum had significantly fewer macrophages than control (41% decrease, P < 0. 01). This decrease in wound macrophages was paralleled by decreased angiogenic activity and collagen synthesis.	SEN:10025734	9541500
BEL:20048670	p(MGI:Ccl3) increases bp(GOBP:"cell proliferation")	Incubation of neutralizing CCL3 antibody in MLR, profoundly suppressed the CSE-primed cDC-induced proliferation of CD8+T cells in the MLR (Fig. 7).	SEN:10025736	19293939
BEL:20048672	p(MGI:Ccl3) increases bp(GOBP:"macrophage activation")	Wounds of mice treated with anti-MIP-1alpha antiserum had significantly fewer macrophages than control (41% decrease, P < 0. 01). This decrease in wound macrophages was paralleled by decreased angiogenic activity and collagen synthesis.	SEN:10025734	9541500
BEL:20048682	p(MGI:Ccl3) increases path(MESHD:Fibrosis)	Neutralization of MIP-1alpha protein with anti-MIP-1alpha antibodies significantly attenuated both mononuclear phagocyte recruitment and pulmonary fibrosis in bleomycin-challenged CBA/J mice.	SEN:10008224	9766634
BEL:20048702	p(MGI:Ccna1) decreases r(MGI:Ckm)	In contrast, ectopic expression of cyclin A or cyclin E inhibits MCK expression only when they are co-expressed with their catalytic partner cyclin-dependent kinase 2 (Cdk2).	SEN:10021594	8995365
BEL:20048706	p(MGI:Ccna2) decreases r(MGI:Ckm)	In contrast, ectopic expression of cyclin A or cyclin E inhibits MCK expression only when they are co-expressed with their catalytic partner cyclin-dependent kinase 2 (Cdk2).	SEN:10021594	8995365
BEL:20048708	p(MGI:Ccnd1) increases bp(GOBP:"cell migration")	Cyclin D1 promotes cellular motility through inhibiting ROCK signaling and repressing the metastasis suppressor TSP-1	SEN:10006372	16705174
BEL:20048716	p(MGI:Ccnd1) decreases r(MGI:Ckm)	During skeletal myogenesis, cell cycle withdrawal accompanies the expression of the contractile phenotype. Here we show that ectopic expression of each D-type cyclin is sufficient to inhibit the transcriptional activation of the muscle-specific creatine kinase (MCK) gene.	SEN:10008230	8995365
BEL:20048724	p(MGI:Ccnd2) decreases r(MGI:Ckm)	During skeletal myogenesis, cell cycle withdrawal accompanies the expression of the contractile phenotype. Here we show that ectopic expression of each D-type cyclin is sufficient to inhibit the transcriptional activation of the muscle-specific creatine kinase (MCK) gene.	SEN:10008230	8995365
BEL:20048726	p(MGI:Ccnd3) increases p(MGI:Cebpa,pmod(P,S,193))	In these cells, cyclin D3 is increased during differentiation and phosphorylates C/EBPalpha at Ser193, leading to the formation of growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.	SEN:10025750	16537903
BEL:20048728	p(MGI:Ccnd3) decreases r(MGI:Ckm)	During skeletal myogenesis, cell cycle withdrawal accompanies the expression of the contractile phenotype. Here we show that ectopic expression of each D-type cyclin is sufficient to inhibit the transcriptional activation of the muscle-specific creatine kinase (MCK) gene.	SEN:10008230	8995365
BEL:20048730	p(MGI:Ccne1) directlyIncreases kin(p(MGI:Cdk2))	We show that expression of cyclin E-CDK2 in murine fibroblasts causes phosphorylation of the CDK inhibitor p27Kip1 on T187, and that cyclin E-CDK2 can directly phosphorylate p27 T187 in vitro.	SEN:10021588	9192873
BEL:20048732	p(MGI:Ccng1) decreases bp(GOBP:"cell proliferation")	Pharmacological and genetic studies provide evidence that the expression of cyclin G1, not cyclin G2, is regulated by progesterone via its nuclear receptor. Furthermore, the expression of these genes is aberrantly up-regulated in homeo box A-10 mutant uteri, suggesting that cyclin G1 and cyclin G2 genes act as downstream targets of homeobox A-10 and negatively impact uterine cell proliferation.	SEN:10025752	15661853
BEL:20048734	p(MGI:Ccng2) increases bp(GOBP:"cell differentiation")	The results suggest that cyclin G1 is primarily associated with epithelial cell differentiation before implantation and stromal cell proliferation and differentiation during decidualization, whereas cyclin G2 is associated with terminal differentiation and apoptosis of the luminal epithelial and stromal cells at the site of blastocyst after implantation.	SEN:10008234	15661853
BEL:20048736	p(MGI:Ccng2) decreases bp(GOBP:"cell proliferation")	Pharmacological and genetic studies provide evidence that the expression of cyclin G1, not cyclin G2, is regulated by progesterone via its nuclear receptor. Furthermore, the expression of these genes is aberrantly up-regulated in homeo box A-10 mutant uteri, suggesting that cyclin G1 and cyclin G2 genes act as downstream targets of homeobox A-10 and negatively impact uterine cell proliferation.	SEN:10025752	15661853
BEL:20048738	p(MGI:Ccng2) increases bp(GOBP:"apoptotic process")	The results suggest that cyclin G1 is primarily associated with epithelial cell differentiation before implantation and stromal cell proliferation and differentiation during decidualization, whereas cyclin G2 is associated with terminal differentiation and apoptosis of the luminal epithelial and stromal cells at the site of blastocyst after implantation.	SEN:10008234	15661853
BEL:20048740	p(MGI:Ccr2) increases bp(GOBP:"cell proliferation")	Additionally, T cells from CCR2(-/)- immunized mice showed decreased antigen-induced proliferation and production of IFN-gamma compared with wild-type immunized controls, suggesting that CCR2 enhances the T helper cell type 1 immune response in EAE.	SEN:10008236	11015448
BEL:20048746	p(MGI:Ccr2) increases path(MESHD:Atherosclerosis)	knockout of MCP1 or its receptor CCR-2 also attenuates atherosclerosis in murine models,40,41 and knockout of macrophage colony-stimulation factor (MCSF), which converts monocytes to macrophages, similarly attenuates atherosclerosis.42	SEN:10000330	14732733
BEL:20048762	p(MGI:Ccr2) increases p(MGI:Ifng)	Additionally, T cells from CCR2(-/)- immunized mice showed decreased antigen-induced proliferation and production of IFN-gamma compared with wild-type immunized controls, suggesting that CCR2 enhances the T helper cell type 1 immune response in EAE.	SEN:10008236	11015448
BEL:20048764	p(MGI:Ccr2) increases p(MGI:Ifng)	At days 8, 11, 20, 23, and 26 after disease induction, splenocytes from CCR2-deficient mice also proliferated less robustly to Ag and secreted lower levels of IFN-{gamma} and IL-6 than splenocytes from wild-type controls	SEN:10018896	11015448
BEL:20048774	p(MGI:Ccr2) increases p(MGI:Il6)	At days 8, 11, 20, 23, and 26 after disease induction, splenocytes from CCR2-deficient mice also proliferated less robustly to Ag and secreted lower levels of IFN-{gamma} and IL-6 than splenocytes from wild-type controls	SEN:10018896	11015448
BEL:20048776	p(MGI:Ccr2) decreases r(MGI:Timp1)	levels of mRNA encoding ...C were evaluated in lungs from IL-13 transgene and transgene mice...Interestingly, the levels of expression of TIMP-1 and TIMP-4 were increased in CCR2/ animals (Fig. 7B).	SEN:10025764	11884467
BEL:20048778	p(MGI:Ccr2) decreases r(MGI:Timp4)	levels of mRNA encoding ...C were evaluated in lungs from IL-13 transgene and transgene mice...Interestingly, the levels of expression of TIMP-1 and TIMP-4 were increased in CCR2/ animals (Fig. 7B).	SEN:10025764	11884467
BEL:20048780	p(MGI:Ccr2) increases sec(p(MGI:Ifng))	However, those CCR2-deficient mice also showed defects in IL-4 and IL-5 secretion as well as IFN-gamma secretion, similar to our mice.	SEN:10025766	9463410
BEL:20048782	p(MGI:Ccr2) increases sec(p(MGI:Il4))	However, those CCR2-deficient mice also showed defects in IL-4 and IL-5 secretion as well as IFN-gamma secretion, similar to our mice.	SEN:10025766	9463410
BEL:20048784	p(MGI:Ccr2) increases sec(p(MGI:Il5))	However, those CCR2-deficient mice also showed defects in IL-4 and IL-5 secretion as well as IFN-gamma secretion, similar to our mice.	SEN:10025766	9463410
BEL:20048788	p(MGI:Ccr3) increases a(CHEBI:hydroxyproline)	The anti-CCR3 administration was associated with a substantially less severe lung fibrosis than that in the control group (blm + nonimmune IgG) (Figure 7A).	SEN:10025770	16314464
BEL:20048790	p(MGI:Ccr3) increases r(MGI:Tgfb1)	The expression of these profibrotic mediators was significantly (TGF-?1) and weakly (CCL2) decreased after administration of anti-CCR3 Ab (Figure 7, B and C).	SEN:10025772	16314464
BEL:20048802	p(MGI:Ccr5) increases complex(p(MGI:Il12a),p(MGI:Il12b))	. The concentration of IL-6, IL-13 and IL-17 was significantly higher in KO mice relative to wild-type mice, while that of IL-12 was significantly higher in wild-type mice relative to KO mice.	SEN:10025776	22438032
BEL:20048816	p(MGI:Ccr5) decreases p(MGI:Il13)	. The concentration of IL-6, IL-13 and IL-17 was significantly higher in KO mice relative to wild-type mice, while that of IL-12 was significantly higher in wild-type mice relative to KO mice.	SEN:10025776	22438032
BEL:20048818	p(MGI:Ccr5) decreases p(MGI:Il17a)	. The concentration of IL-6, IL-13 and IL-17 was significantly higher in KO mice relative to wild-type mice, while that of IL-12 was significantly higher in wild-type mice relative to KO mice.	SEN:10025776	22438032
BEL:20048820	p(MGI:Ccr5) decreases p(MGI:Il6)	. The concentration of IL-6, IL-13 and IL-17 was significantly higher in KO mice relative to wild-type mice, while that of IL-12 was significantly higher in wild-type mice relative to KO mice.	SEN:10025776	22438032
BEL:20048822	p(MGI:Ccr5) decreases p(MGI:Msln)	the expression of tissue damage-related proteins, TGF-? and mesothelin was more markedly increased in the lungs of KO mice relative to wild-type mice.	SEN:10025784	22438032
BEL:20048824	p(MGI:Ccr5) decreases p(MGI:Tgfb1)	the expression of tissue damage-related proteins, TGF-? and mesothelin was more markedly increased in the lungs of KO mice relative to wild-type mice.	SEN:10025784	22438032
BEL:20048848	p(MGI:Cd244) increases bp(GOBP:"cell proliferation")	Furthermore, 2B4/CD48 interactions between NK cells also enhanced proliferation of NK cells in response to IL-2	SEN:10020214	15210772
BEL:20048850	p(MGI:Cd247) increases r(MGI:Pla2g6)	stimulation with OKT3 resulted in greatly increased quantities of the group VI calcium-independent phospholipase A2	SEN:10008246	11278296
BEL:20048856	p(MGI:Cd276) decreases bp(GOBP:"T cell activation")	Furthermore, Lung cancer and TAM-related B7-H3 was identified as a strong inhibitor of T-cell effect and influenced the outcome of T cell immune response.	SEN:10025798	22999863
BEL:20048858	p(MGI:Cd27) increases tscript(p(MGI:Ctnnb1))	active beta-catenin was preferentially localized in the nucleus in LSCs with intact CD27 signaling, whereas only a minority of normal HSCs or Cd27-/- LSCs expressed beta-catenin in the nucleus (Figure 5C).	SEN:10025800	22232214
BEL:20048860	p(MGI:Cd2ap) decreases bp(GOBP:"apoptotic process")	increased transforming growth factor-beta1 (TGF-beta1) expression and apoptosis were present in podocytes at the onset of albuminuria and were followed by depletion of podocytes associated with progressive focal-segmental glomerulosclerosis in CD2AP-/- mice	SEN:10025802	15213232
BEL:20048862	p(MGI:Cd2ap) decreases p(MGI:Tgfb1)	increased transforming growth factor-beta1 (TGF-beta1) expression and apoptosis were present in podocytes at the onset of albuminuria and were followed by depletion of podocytes associated with progressive focal-segmental glomerulosclerosis in CD2AP-/- mice	SEN:10025802	15213232
BEL:20048876	p(MGI:Cd36) increases kin(p(MGI:Mapk9))	Both foam cell formation and activation of JNK2 in hyperlipidemic mice were diminished in the absence of CD36.	SEN:10025810	16950138
BEL:20048884	p(MGI:Cd36) increases r(MGI:Ccl2)	acLDL-mediated induction of these four inflammatory genes was substantially reduced in CD36-deficient macrophages (MCP-1, TNF-alpha, KC, and IL-1beta)	SEN:10025814	21278342
BEL:20048890	p(MGI:Cd36) increases r(MGI:Cxcl1)	acLDL-mediated induction of these four inflammatory genes was substantially reduced in CD36-deficient macrophages (MCP-1, TNF-alpha, KC, and IL-1beta)	SEN:10025814	21278342
BEL:20048894	p(MGI:Cd36) increases r(MGI:Il1b)	acLDL-mediated induction of these four inflammatory genes was substantially reduced in CD36-deficient macrophages (MCP-1, TNF-alpha, KC, and IL-1beta)	SEN:10025814	21278342
BEL:20048896	p(MGI:Cd36) increases r(MGI:Tnf)	acLDL-mediated induction of these four inflammatory genes was substantially reduced in CD36-deficient macrophages (MCP-1, TNF-alpha, KC, and IL-1beta)	SEN:10025814	21278342
BEL:20048900	p(MGI:Cd38) increases r(MGI:Aurkb)	Analysis of CD28 KO T cells also revealed a strong defect in Survivin expression; however, this was accompanied by many defects, such as reduced levels of cyclin D, cyclin E, CDK2, and Aurora B (see Figure S1 in the Supplemental Data available with this article online).	SEN:10025818	15894279
BEL:20048902	p(MGI:Cd38) increases r(MGI:Birc5)	Analysis of CD28 KO T cells also revealed a strong defect in Survivin expression; however, this was accompanied by many defects, such as reduced levels of cyclin D, cyclin E, CDK2, and Aurora B (see Figure S1 in the Supplemental Data available with this article online).	SEN:10025818	15894279
BEL:20048904	p(MGI:Cd38) increases r(MGI:Cdk2)	Analysis of CD28 KO T cells also revealed a strong defect in Survivin expression; however, this was accompanied by many defects, such as reduced levels of cyclin D, cyclin E, CDK2, and Aurora B (see Figure S1 in the Supplemental Data available with this article online).	SEN:10025818	15894279
BEL:20048906	p(MGI:Cd3d) increases r(MGI:Pla2g6)	stimulation with OKT3 resulted in greatly increased quantities of the group VI calcium-independent phospholipase A2	SEN:10008246	11278296
BEL:20048908	p(MGI:Cd3e) increases r(MGI:Pla2g6)	stimulation with OKT3 resulted in greatly increased quantities of the group VI calcium-independent phospholipase A2	SEN:10008246	11278296
BEL:20048910	p(MGI:Cd3g) increases r(MGI:Pla2g6)	stimulation with OKT3 resulted in greatly increased quantities of the group VI calcium-independent phospholipase A2	SEN:10008246	11278296
BEL:20048914	p(MGI:Cd40lg) increases a(CHEBI:hydroxyproline)	Furthermore, the hydroxyproline content was significantly reduced in the anti-CD154 mAb–treated group compared with the control IgG– treated group (Figure 5c).	SEN:10025820	18975310
BEL:20048918	p(MGI:Cd40lg) increases bp(GOBP:"cell proliferation")	In contrast, the number of BrdU-positive proliferating dermal fibroblasts at 1 week was significantly reduced in the anti-CD154 mAb–treated group compared with the control IgG–treated group	SEN:10025824	18975310
BEL:20048920	p(MGI:Cd40lg) increases bp(GOBP:"integrin-mediated signaling pathway")	recombinant soluble CD40L alone was demonstrated to enhance integrin-mediated platelet aggregation at high shear rates, restoring normall thrombosis in CD40L-/- mice (26)	SEN:10025826	16293001
BEL:20048928	p(MGI:Cd40lg) increases cat(p(MGI:Cd40))	in vivo, an important role for CD40L-CD40 interaction in the progression of atherosclerosis was demonstrated using mice deficient in CD40L and apoE, showing a dramatic decrease in plaque area compared with normal apoE-deficient animals	SEN:10018926	16293001
BEL:20048942	p(MGI:Cd40lg) increases r(MGI:Ccl2)	In addition, the anti-CD154 mAb treatment suppressed the up-regulated expression of COL1A1, RANTES, and MCP-1 mRNA (Figure 5g).	SEN:10025836	18975310
BEL:20048944	p(MGI:Cd40lg) increases r(MGI:Ccl5)	In addition, the anti-CD154 mAb treatment suppressed the up-regulated expression of COL1A1, RANTES, and MCP-1 mRNA (Figure 5g).	SEN:10025836	18975310
BEL:20048946	p(MGI:Cd40lg) increases r(MGI:Col1a1)	In addition, the anti-CD154 mAb treatment suppressed the up-regulated expression of COL1A1, RANTES, and MCP-1 mRNA (Figure 5g).	SEN:10025836	18975310
BEL:20048950	p(MGI:Cd40lg) increases sec(p(MGI:Ccl2))	Exposure of CD40L enhanced the constitutive production of IL-6 and MCP-1 protein (Figure 4A and 4B).	SEN:10025838	17332487
BEL:20048952	p(MGI:Cd40lg) increases sec(p(MGI:Il6))	Exposure of CD40L enhanced the constitutive production of IL-6 and MCP-1 protein (Figure 4A and 4B).	SEN:10025838	17332487
BEL:20048954	p(MGI:Cd40) increases p(MGI:Becn1)	Beclin 1 expression in microglia/macrophages from T. gondii-infected B6 mice was higher than in microglia/macrophages from infected CD40-/- mice (Figure 4B).	SEN:10025840	21217818
BEL:20048958	p(MGI:Cd44) decreases a(CHEBI:"hyaluronic acid")	The hyaluronan content in the BAL of CD44-/- mice was 2-fold higher compared with that of wild-type mice	SEN:10025844	17277154
BEL:20048960	p(MGI:Cd44) decreases a(CHEBI:"hyaluronic acid")	Forty-eight hours after the LPS exposure, C57BL/6CD44-/- mice had a 5-fold increase in HA in the lung lavage when compared with C57BL/6 mice (10.6 ± 2.1 ng/ml versus 2.1 ± 0.4 ng/ml; P < 0.05) at the same time point	SEN:10025846	17446529
BEL:20048980	p(MGI:Cd44) increases bp(GOBP:"cell adhesion")	In the absence of stimulation, CD44-deficient macrophages had significantly attenuated adhesion to endothelial cells (Figure 5). This difference was accentuated in the presence of TNF-alpha stimulation	SEN:10025856	17446529
BEL:20048984	p(MGI:Cd44) decreases bp(GOBP:"macrophage chemotaxis")	Examination of the inflammatory response to intratracheal LPS revealed a significant increase in total inflammatory cell numbers in the BAL fluid from CD44-/- mice...an increase in the cell numbers of macrophage, neutrophils, and lymphocytes	SEN:10025858	17277154
BEL:20048986	p(MGI:Cd44) increases bp(GOBP:"macrophage chemotaxis")	Peritoneal macrophages pre-attached to Transwell membranes were exposed to media, fMLP, GM-CSF, or MCP-1. After 21 h incubation, the concentration of migrated CD44-deficient macrophages was significantly less than that of migrated C57BL/6 macrophages under all conditions	SEN:10025714	17446529
BEL:20048988	p(MGI:Cd44) decreases bp(GOBP:"neutrophil chemotaxis")	Examination of the inflammatory response to intratracheal LPS revealed a significant increase in total inflammatory cell numbers in the BAL fluid from CD44-/- mice...an increase in the cell numbers of macrophage, neutrophils, and lymphocytes	SEN:10025858	17277154
BEL:20048998	p(MGI:Cd44) increases p(MGI:Il1b)	IL-1beta release was inhibited in peritoneal macrophages derived from CD44-deficient mice, in an MH-S macrophage cell line treated with antibodies to CD44, or by inhibitors of lysosome function.	SEN:10025862	19258328
BEL:20049002	p(MGI:Cd44) increases p(MGI:Tnf)	CD44-deficient macrophages produced significantly less TNF- in response to increasing doses of LPS when compared with C57BL/6 wild-type macrophages	SEN:10025848	17446529
BEL:20049008	p(MGI:Cd48) increases bp(GOBP:"cell proliferation")	Furthermore, 2B4/CD48 interactions between NK cells also enhanced proliferation of NK cells in response to IL-2	SEN:10020214	15210772
BEL:20049014	p(MGI:Cd4) increases bp(GOBP:"T cell proliferation")	Anti-CD4 was found to perturb proximal signalling events upon TCR/CD3 ligation, resulting in reduced tyrosine phosphorylation of Zap-70 and LAT (linker for activation of T cells) and reduced association of tyrosine-phosphorylated LAT with lck. This ultimately resulted in severely reduced proliferation of the responding CD4+ T cells	SEN:10025872	12662296
BEL:20049016	p(MGI:Cd4) increases complex(p(MGI:Lat),p(MGI:Lck))	Anti-CD4 was found to perturb proximal signalling events upon TCR/CD3 ligation, resulting in reduced tyrosine phosphorylation of Zap-70 and LAT (linker for activation of T cells) and reduced association of tyrosine-phosphorylated LAT with lck. This ultimately resulted in severely reduced proliferation of the responding CD4+ T cells	SEN:10025872	12662296
BEL:20049018	p(MGI:Cd4) increases p(MGI:Lat,pmod(P,Y))	Anti-CD4 was found to perturb proximal signalling events upon TCR/CD3 ligation, resulting in reduced tyrosine phosphorylation of Zap-70 and LAT (linker for activation of T cells) and reduced association of tyrosine-phosphorylated LAT with lck. This ultimately resulted in severely reduced proliferation of the responding CD4+ T cells	SEN:10025872	12662296
BEL:20049020	p(MGI:Cd4) increases p(MGI:Zap70,pmod(P,Y))	Anti-CD4 was found to perturb proximal signalling events upon TCR/CD3 ligation, resulting in reduced tyrosine phosphorylation of Zap-70 and LAT (linker for activation of T cells) and reduced association of tyrosine-phosphorylated LAT with lck. This ultimately resulted in severely reduced proliferation of the responding CD4+ T cells	SEN:10025872	12662296
BEL:20049022	p(MGI:Cd5l) increases bp(GOBP:"inflammatory response")	Api6 overexpression in lung epithelial cells only caused regional inflammation, not systemic inflammation.	SEN:10025874	21697282
BEL:20049034	p(MGI:Cd5l) increases r(MGI:Il6)	At the gene transcriptional level, Api6 overexpression stimulated mRNA expression of Stat3 and its upstream stimuli IL-6 in whole lung cells, AT II epithelial cells, and alveolar macrophages (Fig. 4A).	SEN:10025878	21697282
BEL:20049036	p(MGI:Cd5l) increases r(MGI:Stat3)	At the gene transcriptional level, Api6 overexpression stimulated mRNA expression of Stat3 and its upstream stimuli IL-6 in whole lung cells, AT II epithelial cells, and alveolar macrophages (Fig. 4A).	SEN:10025878	21697282
BEL:20049046	p(MGI:Cd8a) increases p(MGI:Mmp12)	In WT mice, MMP-12 was induced upon exposure to cigarette smoke, as shown by Western blots on lung homogenates from WT nonsmoke exposed and smoke-exposed mice (Fig. 6A). However, CD8/ mice had minimal baseline expression without induction upon exposure to cigarette smoke (Fig. 6A).	SEN:10017566	17548647
BEL:20049050	p(MGI:Cdc42) increases bp(GOBP:"cell differentiation")	Differentiation of skin stem cells into hair follicles (HFs) requires the inhibition of beta-catenin degradation, which is controlled by a complex containing axin and the protein kinase GSK3beta. Using conditional gene targeting in mice, we show now that the small GTPase Cdc42 is crucial for differentiation of skin progenitor cells into HF lineage and that it regulates the turnover of beta-catenin.	SEN:10008258	16510873
BEL:20049054	p(MGI:Cdc42) decreases deg(p(MGI:Ctnnb1))	In the absence of Cdc42, degradation of beta-catenin was increased corresponding to a decreased phosphorylation of GSK3beta at Ser 9 and an increased phosphorylation of axin, which is known to be required for binding of beta-catenin to the degradation machinery	SEN:10008056	16510873
BEL:20049064	p(MGI:Cdca4) decreases bp(GOBP:"cell proliferation")	Cdca4 (Hepp) was originally identified as a gene expressed specifically in hematopoietic progenitor cells as opposed to hematopoietic stem cells. More recently, it has been shown to stimulate p53 activity and also lead to p53-independent growth inhibition when overexpressed.	SEN:10008262	16546331
BEL:20049068	p(MGI:Cdca4) increases tscript(p(MGI:Trp53))	Cdca4 (Hepp) was originally identified as a gene expressed specifically in hematopoietic progenitor cells as opposed to hematopoietic stem cells. More recently, it has been shown to stimulate p53 activity and also lead to p53-independent growth inhibition when overexpressed.	SEN:10008262	16546331
BEL:20049070	p(MGI:Cdh1) decreases bp(GOBP:"cell proliferation")	E-cadherin gene deletion, which results in some hyperproliferation in the epidermis (Young et al., 2003; Tinkle et al., 2004; Tunggal et al., 2005).	SEN:10025888	18268536
BEL:20049072	p(MGI:Cdh1) decreases bp(GOBP:"cell proliferation")	E-cadherinknockout epidermis displays some hyperproliferation, which however appears to be limited due to compensatory upregulation of P-cadherin (Young et al., 2003; Tinkle et al., 2004; Tunggal et al., 2005)	SEN:10025890	18268536
BEL:20049076	p(MGI:Cdh1) decreases p(MGI:Cdh3)	E-cadherinknockout epidermis displays some hyperproliferation, which however appears to be limited due to compensatory upregulation of P-cadherin (Young et al., 2003; Tinkle et al., 2004; Tunggal et al., 2005)	SEN:10025890	18268536
BEL:20049078	p(MGI:Cdh1) decreases p(MGI:Egfr,pmod(P,Y,845))	Recently reported in A431 cells, this can occur through E-cadherin-mediated inhibition of transphosphorylation on Tyr845EGF-R (Perrais et al., 2007), the site, which catalyzes EGF-induced mitogenesis (Ishizawar and Parsons, 2004).	SEN:10025892	18268536
BEL:20049080	p(MGI:Cdh1,pmod(P)) directlyIncreases complex(p(MGI:Ctnnb1),p(MGI:Cdh1))	A similar increase in affinity, from 260 to 4 nM, was obtained with CK2 phosphorylation of E-cadherin.	SEN:10021628	16945320
BEL:20049082	p(MGI:Cdh1,pmod(P)) directlyIncreases complex(p(MGI:Ctnnb1),p(MGI:Cdh1))	CK1 phosphorylation of E-cadherin increased the binding affinity to beta-catenin from approximately 230 to 4 nM.	SEN:10021624	16945320
BEL:20049086	p(MGI:Cdh1) increases r(MGI:Sdc1)	Furthermore, transfection of E-cadherin cDNA into invasive NM-f-ras-TD cells resulted in the upregulation of syndecan-1 expression in association with decreased invasiveness.	SEN:10025894	8799827
BEL:20049094	p(MGI:Cdk4) decreases bp(GOBP:"cell death")	A majority of CDK4(-/-) mice developed diabetes mellitus by 6 weeks, associated with degeneration of pancreatic islets.	SEN:10008268	10490638
BEL:20049124	p(MGI:Cdkn1a) decreases bp(GOBP:"cell cycle")	When Notch-IC is present, however, it competes with the inhibitory proteins to bind to CSL. Notch1-IC also directly stimulates expression of the cell-cycle regulator Waf1 (also known as Cip1 and p21) in primary mouse keratinocytes25. The increase in Waf1 concentration causes proliferating keratinocytes to withdraw from the cell cycle and helps to initiate terminal differentiation.	SEN:10025912	14570040
BEL:20049126	p(MGI:Cdkn1a) decreases bp(GOBP:"cell differentiation")	When Notch-IC is present, however, it competes with the inhibitory proteins to bind to CSL. Notch1-IC also directly stimulates expression of the cell-cycle regulator Waf1 (also known as Cip1 and p21) in primary mouse keratinocytes25. The increase in Waf1 concentration causes proliferating keratinocytes to withdraw from the cell cycle and helps to initiate terminal differentiation.	SEN:10025912	14570040
BEL:20049128	p(MGI:Cdkn1a) decreases bp(GOBP:"cell proliferation")	When Notch-IC is present, however, it competes with the inhibitory proteins to bind to CSL. Notch1-IC also directly stimulates expression of the cell-cycle regulator Waf1 (also known as Cip1 and p21) in primary mouse keratinocytes25. The increase in Waf1 concentration causes proliferating keratinocytes to withdraw from the cell cycle and helps to initiate terminal differentiation.	SEN:10025912	14570040
BEL:20049130	p(MGI:Cdkn1a) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	Increased levels of the p21 protein are also observed in other contexts of cell cycle arrest, such as differentiation and senescence.	SEN:10025914	15225871
BEL:20049134	p(MGI:Cdkn1a) decreases kin(p(MGI:Cdk2))	Molecular analysis indicated that myostatin down-regulated the protein levels of Cdk2 and up-regulated the levels of its inhibitor p21, thereby rendering Cdk2 inactive.	SEN:10025916	12242286
BEL:20049136	p(MGI:Cdkn1a) decreases kin(p(MGI:Cdk2))	For each of these conditions, myogenic transcriptional inhibition is reversed by the ectopic co-expression of the general Cdk inhibitor p21.	SEN:10025918	8995365
BEL:20049148	p(MGI:Cdkn1a) increases p(MGI:Cxcl2)	peritoneal macrophages from p21-/- mice exhibit a higher phagocytotic capacity and lower expression of cytokines such as IL-1b, macrophage inflammatory protein (MIP)-1, and MIP-2 than do their wild-type (WT) counterparts (24).	SEN:10025926	18239191
BEL:20049150	p(MGI:Cdkn1a) increases p(MGI:Il1b)	peritoneal macrophages from p21-/- mice exhibit a higher phagocytotic capacity and lower expression of cytokines such as IL-1b, macrophage inflammatory protein (MIP)-1, and MIP-2 than do their wild-type (WT) counterparts (24).	SEN:10025926	18239191
BEL:20049156	p(MGI:Cdkn1a) increases r(MGI:Ccl2)	LPC markedly increased mRNA levels of VCAM-1 (2.7-fold) and MCP-1 (3.7-fold) in WT-EC 24 hours after addition of LPC, whereas, interestingly, this effect was blocked by pretreatment with anti-TNFalpha antibody (1 ug/mL in final concentration) or p21Cip1 small interfering RNA (siRNA)	SEN:10025928	21372295
BEL:20049160	p(MGI:Cdkn1a) increases r(MGI:Ckm)	For each of these conditions, myogenic transcriptional inhibition is reversed by the ectopic co-expression of the general Cdk inhibitor p21.	SEN:10025918	8995365
BEL:20049164	p(MGI:Cdkn1a) increases r(MGI:Vcam1)	LPC markedly increased mRNA levels of VCAM-1 (2.7-fold) and MCP-1 (3.7-fold) in WT-EC 24 hours after addition of LPC, whereas, interestingly, this effect was blocked by pretreatment with anti-TNFalpha antibody (1 ug/mL in final concentration) or p21Cip1 small interfering RNA (siRNA)	SEN:10025928	21372295
BEL:20049166	p(MGI:Cdkn1a) increases tscript(p(MGI:Ep300))	Taken together, these data indicate that PYK2-induced p21Cip1 activates p300, which promotes Ets-1 binding to the MCP-1 promoter, leading to enhancement of MCP-1 transcription.	SEN:10025934	21372295
BEL:20049168	p(MGI:Cdkn1a) increases tscript(p(MGI:Ets1))	Furthermore, siRNA knockdown of p21Cip1 (88+/-3% inhibition in p21Cip1 protein levels, n=4, P,0.05) attenuated TNFa-mediated Ets-1 binding to MCP-1 promoter in WT-EC (Figure 5D). Thus, TNFa actually induced the transcription of MCP-1 gene by activating Ets-1 binding to the promoter region.	SEN:10025936	21372295
BEL:20049174	p(MGI:Cdkn1b) directlyDecreases kin(p(MGI:Cdk2))	TGF-beta inhibits Cdk2-cyclin E kinase activity by promoting the binding of cell cycle inhibitor Kip1 protein to the kinase complexes.	SEN:10020210	14676846
BEL:20049176	p(MGI:Cdkn1b) decreases kin(p(MGI:Cdk2))	We show that p27 interacts with cyclin E-CDK2 in at least two distinct ways: one resulting in p27 phosphorylation and release, the other in tight binding and cyclin E-CDK2 inhibition.	SEN:10020230	9192873
BEL:20049182	p(MGI:Cdkn1b,pmod(P,T,187)) directlyIncreases deg(p(MGI:Cdkn1b))	We further show that cyclin E-CDK2-dependent phosphorylation of p27 results in elimination of p27 from the cell, allowing cells to transit from G1 to S phase.	SEN:10020208	9192873
BEL:20049192	p(MGI:Cdkn1c) decreases bp(GOBP:"cell proliferation")	Entrez gene: Cyclin-dependent kinase inhibitor 1C is a tight-binding inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation.	SEN:10025946	15647320
BEL:20049198	p(MGI:Cdkn2a) decreases bp(GOBP:"cell proliferation")	these data show that increased levels of Ink4a/Arf inhibit the proliferation and self-renewal potential of Bmi1- deficient BASCs in vitro.	SEN:10025950	18697930
BEL:20049202	p(MGI:Cdkn2a) increases bp(GOBP:"apoptotic process")	Sustained Myc signaling induces Arf expression, resulting in apoptosis through the inhibition of Mdm2 and stabilization of the p53 tumor suppressor protein (37, 38).	SEN:10025952	18223157
BEL:20049206	p(MGI:Cdkn2a) decreases kin(p(MGI:Cdk4))	There are several ways to achieve de-regulation of the RB network and the activation of E2F. There are clear loss-of-function RB mutations that are deficient in E2F binding, and p16 mutations that are defective in Cyclin D/CDK4 inhibition (Sherr, 2001).	SEN:10025954	15225871
BEL:20049214	p(MGI:Cdkn2a) decreases p(MGI:Mdm2)	Sustained Myc signaling induces Arf expression, resulting in apoptosis through the inhibition of Mdm2 and stabilization of the p53 tumor suppressor protein (37, 38).	SEN:10025952	18223157
BEL:20049220	p(MGI:Cdkn2a) increases tloc(p(MGI:Myc),GOCCID:0005654,GOCCID:0005730)	ARF negatively regulates the transcriptional activity of MYC by associating with and relocating MYC from the nucleoplasm to the nucleolus (Amente et al., 2006; Meyer et al., 2006; Sarker and Fisher, 2006),	SEN:10025964	18955973
BEL:20049222	p(MGI:Cdkn2a) decreases tscript(p(MGI:Myc))	ARF negatively regulates the transcriptional activity of MYC by associating with and relocating MYC from the nucleoplasm to the nucleolus (Amente et al., 2006; Meyer et al., 2006; Sarker and Fisher, 2006),	SEN:10025964	18955973
BEL:20049226	p(MGI:Cdkn2a) directlyDecreases tscript(p(MGI:Tfdp1))	Interestingly, binding of ARF to DP1 results in an inhibition of the interaction between DP1 and E2F1.	SEN:10020472	16135794
BEL:20049238	p(MGI:Cebpa) decreases bp(GOBP:"cell proliferation")	Our results indicated that the p38a-deficient lungs had hyperproliferative alveolar tissue with loss of differentiation markers. A similar but more marked lung phenotype, with hyperproliferation and defective cell maturation, has been described previously in CCAAT/ enhancer-binding protein (C/EBP)a knockout mice, which die shortly after birth because of respiratory failure16–18.	SEN:10025974	17468755
BEL:20049246	p(MGI:Cebpa) decreases p(MGI:Sftpa1)	Fig. 1a?d Immunohistochemical stainings for surfactant proteins SP-A (a, b) and SP-C (c, d) in the lungs of control (a, c) and CCAAT/enhancer-binding protein (C/EBP)-A-deficient (b, d) mice. Note the stronger immunoreactive products of SP-A (b) and SP-C (d) over the alveolar cells in the hyperplastic alveolar wall and over materials in the alveolar spaces	SEN:10025978	11683182
BEL:20049248	p(MGI:Cebpa) decreases p(MGI:Sftpc)	Fig. 1a?d Immunohistochemical stainings for surfactant proteins SP-A (a, b) and SP-C (c, d) in the lungs of control (a, c) and CCAAT/enhancer-binding protein (C/EBP)-A-deficient (b, d) mice. Note the stronger immunoreactive products of SP-A (b) and SP-C (d) over the alveolar cells in the hyperplastic alveolar wall and over materials in the alveolar spaces	SEN:10025978	11683182
BEL:20049250	p(MGI:Cebpa,pmod(P,S,193)) directlyIncreases complex(p(MGI:Cebpa),p(MGI:Cdk2))	In these cells, cyclin D3 is increased during differentiation and phosphorylates C/EBPalpha at Ser193, leading to the formation of growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.	SEN:10025750	16537903
BEL:20049252	p(MGI:Cebpa,pmod(P,S,193)) directlyIncreases complex(p(MGI:Cebpa),p(MGI:Smarca2))	In these cells, cyclin D3 is increased during differentiation and phosphorylates C/EBPalpha at Ser193, leading to the formation of growth-inhibitory C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.	SEN:10025750	16537903
BEL:20049256	p(MGI:Cebpa) increases r(MGI:Nupr1)	Collectively, these results show that C/EBPalpha and C/EBPbeta trans-acting factors can promote transcription of the mouse p8 gene (i) by direct binding to the C/EBP consensus site, and (ii) by enhancing the activity of other trans-acting factors interacting with the p8 promoter.	SEN:10025980	10510303
BEL:20049258	p(MGI:Cebpa) increases r(MGI:Pck1)	Of members of the C/EBP family of transcription factors, C/EBP alpha was the strongest trans-activator of the PEPCK-C gene promoter in the NIH3T3 cell line.	SEN:10025982	12560325
BEL:20049260	p(MGI:Cebpa) decreases r(MGI:Sftpa1)	Accumulation of b-actin mRNA was essentially identical in both wild-type (+/+) and knockout (-/-) lungs. The ratios of the calculated dot areas for SP-A, SP-B, and SP-C mRNAs divided by those for the b-actin mRNAs in the wild-type (+/+) and knockout (-/-) lungs were 0.16±0.04 and 0.24±0.04 (n=4, P<0.05), 0.52±0.12 and 0.79±0.09 (n=4, P<0.05), and 1.98±0.24 and 2.49±0.31 (n=4), respectively (Fig. 5).	SEN:10025984	11683182
BEL:20049262	p(MGI:Cebpa) decreases r(MGI:Sftpb)	Accumulation of b-actin mRNA was essentially identical in both wild-type (+/+) and knockout (-/-) lungs. The ratios of the calculated dot areas for SP-A, SP-B, and SP-C mRNAs divided by those for the b-actin mRNAs in the wild-type (+/+) and knockout (-/-) lungs were 0.16±0.04 and 0.24±0.04 (n=4, P<0.05), 0.52±0.12 and 0.79±0.09 (n=4, P<0.05), and 1.98±0.24 and 2.49±0.31 (n=4), respectively (Fig. 5).	SEN:10025984	11683182
BEL:20049264	p(MGI:Cebpa) decreases r(MGI:Sftpc)	Accumulation of b-actin mRNA was essentially identical in both wild-type (+/+) and knockout (-/-) lungs. The ratios of the calculated dot areas for SP-A, SP-B, and SP-C mRNAs divided by those for the b-actin mRNAs in the wild-type (+/+) and knockout (-/-) lungs were 0.16±0.04 and 0.24±0.04 (n=4, P<0.05), 0.52±0.12 and 0.79±0.09 (n=4, P<0.05), and 1.98±0.24 and 2.49±0.31 (n=4), respectively (Fig. 5).	SEN:10025984	11683182
BEL:20049266	p(MGI:Cebpa) decreases r(MGI:Tgfb1)	the amount of Tgfb1 (TGFb) mRNA was higher in p38a-deficient lungs compared with Mapk14D/+ lungs (Fig. 3e). TGFb has been found to be overexpressed in C/EBPa knockout lungs17, so the reduced C/EBPa levels in the Mapk14-null lungs could account for the higher TGFb expression.	SEN:10025986	17468755
BEL:20049270	p(MGI:Cebpb) increases bp(GOBP:"fat cell differentiation")	To further confirm the effect of C/EBPbeta on Xbp1 induction, we generated 3T3-L1 cells stably expressing C/EBP? shRNA with over 80% knockdown efficacy (Figures 2F?2G). Loss of C/EBP? significantly blocked differentiation as expected (Figure S2C). Indeed, Xbp1 mRNA levels were reduced by nearly 60% in differentiating C/EBP?i 3T3-L1 cells compared with CONi cells at 8 hr postinduction (Figure 2G).	SEN:10025988	19490910
BEL:20049272	p(MGI:Cebpb) increases bp(GOBP:"macrophage differentiation")	Cebpb expression is therefore required in infiltrating macrophages for upregulation of M2-specific genes	SEN:10008276	19805133
BEL:20049284	p(MGI:Cebpb,pmod(P,T,217)) directlyIncreases complex(p(MGI:Cebpb),p(MGI:Casp1))	C/EBPbeta-PThr(217) and the phosphorylation mimic C/EBPbeta-Glu(217), but not C/EBPbeta-Ala(217), were associated with procaspases 1 and 8 in vivo and in vitro and inhibited their activation.	SEN:10020234	11684016
BEL:20049286	p(MGI:Cebpb,pmod(P,T,217)) directlyIncreases complex(p(MGI:Cebpb),p(MGI:Casp8))	C/EBPbeta-PThr(217) and the phosphorylation mimic C/EBPbeta-Glu(217), but not C/EBPbeta-Ala(217), were associated with procaspases 1 and 8 in vivo and in vitro and inhibited their activation.	SEN:10020234	11684016
BEL:20049290	p(MGI:Cebpb,pmod(P,T)) directlyIncreases tscript(p(MGI:Cebpb))	Phosphorylation of C/EBPbeta, which enhances its transcriptional activity, is increased after p38MAPK inhibition.	SEN:10021914	16443758
BEL:20049292	p(MGI:Cebpb) increases r(MGI:Arg1)	deletion of two CREB-binding sites from the Cebpb promoter abrogates Cebpb induction upon macrophage activation. This blocks the downstream induction of M2-specific Msr1, Il10, II13ra, and Arg-1 genes, whereas the inflammatory (M1) genes Il1, Il6, Tnfa, and Il12 are not affected	SEN:10025992	19805133
BEL:20049294	p(MGI:Cebpb) decreases r(MGI:Egr2)	C/EBPbeta knockdown increases levels of KLF4 and Krox20, suggesting that C/EBPbeta normally suppresses Krox20 and KLF4 expression via a tightly controlled negative feedback loop	SEN:10008280	18396140
BEL:20049296	p(MGI:Cebpb) increases r(MGI:Il10)	deletion of two CREB-binding sites from the Cebpb promoter abrogates Cebpb induction upon macrophage activation. This blocks the downstream induction of M2-specific Msr1, Il10, II13ra, and Arg-1 genes, whereas the inflammatory (M1) genes Il1, Il6, Tnfa, and Il12 are not affected	SEN:10025992	19805133
BEL:20049298	p(MGI:Cebpb) increases r(MGI:Il13ra1)	deletion of two CREB-binding sites from the Cebpb promoter abrogates Cebpb induction upon macrophage activation. This blocks the downstream induction of M2-specific Msr1, Il10, II13ra, and Arg-1 genes, whereas the inflammatory (M1) genes Il1, Il6, Tnfa, and Il12 are not affected	SEN:10025992	19805133
BEL:20049300	p(MGI:Cebpb) decreases r(MGI:Klf4)	C/EBPbeta knockdown increases levels of KLF4 and Krox20, suggesting that C/EBPbeta normally suppresses Krox20 and KLF4 expression via a tightly controlled negative feedback loop	SEN:10008280	18396140
BEL:20049302	p(MGI:Cebpb) increases r(MGI:Msr1)	deletion of two CREB-binding sites from the Cebpb promoter abrogates Cebpb induction upon macrophage activation. This blocks the downstream induction of M2-specific Msr1, Il10, II13ra, and Arg-1 genes, whereas the inflammatory (M1) genes Il1, Il6, Tnfa, and Il12 are not affected	SEN:10025992	19805133
BEL:20049304	p(MGI:Cebpb) increases r(MGI:Nupr1)	Collectively, these results show that C/EBPalpha and C/EBPbeta trans-acting factors can promote transcription of the mouse p8 gene (i) by direct binding to the C/EBP consensus site, and (ii) by enhancing the activity of other trans-acting factors interacting with the p8 promoter.	SEN:10025980	10510303
BEL:20049306	p(MGI:Cebpb) increases r(MGI:Xbp1)	In addition, overexpression of C/EBPbeta in HEK293T cells activated a Xbp1 promoter (?689 to +37 bp)-luciferase reporter (Figure 2E). This activation was significantly attenuated over 50% by deleting the putative binding element (Figures S2B and 2E).	SEN:10025994	19490910
BEL:20049308	p(MGI:Cebpb) increases r(MGI:Xbp1)	To further confirm the effect of C/EBPbeta on Xbp1 induction, we generated 3T3-L1 cells stably expressing C/EBP? shRNA with over 80% knockdown efficacy (Figures 2F?2G). Loss of C/EBP? significantly blocked differentiation as expected (Figure S2C). Indeed, Xbp1 mRNA levels were reduced by nearly 60% in differentiating C/EBP?i 3T3-L1 cells compared with CONi cells at 8 hr postinduction (Figure 2G).	SEN:10025988	19490910
BEL:20049314	p(MGI:Cela1) increases bp(GOBP:"apoptotic process")	Elastase treatment resulted in increases in TUNEL-positive cells in the lungs of wild-type, PPE-treated mice (Fig. 4).Brown staining was detected in cells in the alveolar wall but was predominantly found in the cytoplasm of macrophages.	SEN:10025998	11796828
BEL:20049316	p(MGI:Cela1) increases path(MESHD:Emphysema)	We examined the time course of development of emphysema after porcine pancreatic elastase (PPE) treatment in wild-type mice (Fig. 1).	SEN:10026000	11796828
BEL:20049318	p(MGI:Cela1) increases p(MGI:Cxcl1)	Male Balb/c mice showed MUC5AC mRNA and protein expression, and goblet cell metaplasia after 8 days of intratracheal instillation of pancreatic elastase. These changes were mediated by elastase proteolytic activity and subsequent initiation of an inflammatory process documented by increases in Gro-{alpha}/KC and IL-5 (338).	SEN:10026002	17615396
BEL:20049320	p(MGI:Cela1) increases p(MGI:Il5)	Male Balb/c mice showed MUC5AC mRNA and protein expression, and goblet cell metaplasia after 8 days of intratracheal instillation of pancreatic elastase. These changes were mediated by elastase proteolytic activity and subsequent initiation of an inflammatory process documented by increases in Gro-{alpha}/KC and IL-5 (338).	SEN:10026002	17615396
BEL:20049322	p(MGI:Cela1) increases p(MGI:Muc5ac)	Male Balb/c mice showed MUC5AC mRNA and protein expression, and goblet cell metaplasia after 8 days of intratracheal instillation of pancreatic elastase. These changes were mediated by elastase proteolytic activity and subsequent initiation of an inflammatory process documented by increases in Gro-{alpha}/KC and IL-5 (338).	SEN:10026002	17615396
BEL:20049324	p(MGI:Cela1) increases r(MGI:Eln)	we isolated total RNA from these mice at 20 days after an intratracheal instillation of either saline or PPE and analyzed by Northern blot (Fig. 1)....Fibulin-5 mRNA is induced 3.8 0.4-fold over baseline (P 0.009, n 3) in the elastase-treated lung at day 20. Elastin mRNA is elevated only 2.4 0.5-fold (P 0.23, n 3) over baseline.	SEN:10026004	12909585
BEL:20049326	p(MGI:Cela1) increases r(MGI:Eln)	We reported that elastin mRNA expression, as assessed by in situ hybridization, was upregulated in lung tissue, including interstitial cells, in a rodent model of (ELA1) elastase-induced emphysema (9).	SEN:10026006	12909585
BEL:20049328	p(MGI:Cela1) increases r(MGI:Fbln5)	we isolated total RNA from these mice at 20 days after an intratracheal instillation of either saline or PPE and analyzed by Northern blot (Fig. 1)....Fibulin-5 mRNA is induced 3.8 0.4-fold over baseline (P 0.009, n 3) in the elastase-treated lung at day 20. Elastin mRNA is elevated only 2.4 0.5-fold (P 0.23, n 3) over baseline.	SEN:10026004	12909585
BEL:20049330	p(MGI:Cela1) decreases surf(p(MGI:Fbln5))	To examine whether mature fibulin-5 remained cell associated, we performed an elastase hydrolysis experiment (Fig. 4). A 67-kDa signal for mature fibulin-5 protein was detected in the cell layers that were washed solely with PBS. This signal was absent from those cells treated briefly with elastase (5 min).	SEN:10026008	12909585
BEL:20049344	p(MGI:Cflar) decreases bp(GOBP:"apoptotic process")	Silencing FLIP expression significantly increased human sarcoma cells to both FasL-induced and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, and ectopic expression of IRF8 also significantly increased the sensitivity of these human sarcoma cells to FasL- and TRAIL-induced apoptosis.	SEN:10002200	19155307
BEL:20049360	p(MGI:Cftr) decreases p(MGI:Nfkbia)	This was accompanied by reduced lung caspase-3 activity and defective degradation of NF-kappaB inhibitor IkappaB-alpha.	SEN:10002202	18372427
BEL:20049408	p(MGI:Cgn) decreases p(MGI:Cldn2)	immunoblotting analysis shows a twofold increase in the levels of claudin-2 protein in the duodenum and the kidney of CGN(-/-) mice, compared to CGN(+/+) littermates	SEN:10026024	22946046
BEL:20049410	p(MGI:Chat) increases bp(GOBP:"cell proliferation")	Myr-Chat expression induced cell periphery spreading and cell shape branching and that this activity also depended on the Cas-Crk-C3G pathway and Rap1 activity	SEN:10008328	12432078
BEL:20049412	p(MGI:Chat) increases p(MGI:Bcar1)	it is likely that Chat-induced Rap1 activation was mediated by upregulation of the Cas-Crk-C3G signaling pathway rather than direct guanine nucleotide exchange factor activity of Chat	SEN:10025366	12432078
BEL:20049416	p(MGI:Chek1) decreases bp(GOBP:"cell death")	By gene disruption, we show that CHK1 deficiency results in a severe proliferation defect and death in embryonic stem (ES) cells, and peri-implantation embryonic lethality in mice.	SEN:10000110	10859164
BEL:20049418	p(MGI:Chek1) increases bp(GOBP:"cell proliferation")	These results suggested that CHK1-/- blastocysts have a proliferation defect and that Chk1 may be required for proliferation or survival of early embryonic cells.	SEN:10000112	10859164
BEL:20049422	p(MGI:Chek1) decreases bp(GOBP:"apoptotic process")	Indeed, many cells in CHK1-/- embryos had condensed and fragmented nuclei that is characteristic of apoptosis (Fig. 2E).	SEN:10026030	10859164
BEL:20049424	p(MGI:Chek2) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	Tissues from Chk2(-/-) mice, including those from the thymus, central nervous system, fibroblasts, epidermis, and hair follicles, show significant defects in IR-induced apoptosis or impaired G(1)/S arrest.	SEN:10026032	12192050
BEL:20049434	p(MGI:Chrd) decreases cat(p(EGID:109899))	Osteocalcin (OCN) mRNA levels decrease following both Tsg and Chd treatment. Tsg and Chd also inhibit alkaline phosphatase (ALP) activity in a dose-dependent manner	SEN:10026036	15780974
BEL:20049438	p(MGI:Chrd) decreases r(MGI:Bglap2)	Osteocalcin (OCN) mRNA levels decrease following both Tsg and Chd treatment. Tsg and Chd also inhibit alkaline phosphatase (ALP) activity in a dose-dependent manner	SEN:10026036	15780974
BEL:20049440	p(MGI:Chrna7) decreases bp(GOBP:"inflammatory response")	Furthermore, {alpha}7nAChR-deficient mice produced greater amounts of proinflammatory cytokines than wild-type mice when treated with lipopolysaccharide (LPS), consistent with an anti-inflammatory role of nicotine/{alpha}7nAChR signaling (342).	SEN:10026038	17615396
BEL:20049446	p(MGI:Cidea) decreases cat(p(MGI:Ucp1))	provide evidence that the role of Cidea in regulating thermogenesis, lipolysis and obesity may be mediated in part through its direct suppression of Ucp1 activity.	SEN:10008330	12910269
BEL:20049464	p(MGI:Clca3) decreases r(MGI:Bax)	In contrast, Bax expression was up-regulated in asthmatic mice and antibody intervention mice, and the highest level of Bax was observed after mCLCA3 antibody treatment.	SEN:10026048	24349268
BEL:20049466	p(MGI:Clca3) increases r(MGI:Bcl2)	As shown in Figure 5C, down-regulation of the anti-apoptosis gene Bcl-2 was observed in asthmatic mice and antibody intervention mice, whereas the lowest level of Bcl-2 was detected in mCLCA3 antibody intervention mice.	SEN:10026050	24349268
BEL:20049472	p(MGI:Clcn2) decreases path(MESHD:"Heart Block")	b). Preliminary telemetry electrocardiograph studies in conscious ClC-2 knockout (Clcn2?/?) mice revealed an increased incidence of atrial-ventricular block and a decreased chronotropic response to acute exercise stress when compared to their age-matched Clcn2+/+ and Clcn2+/? littermates.	SEN:10026054	19171656
BEL:20049480	p(MGI:Clcn3) decreases kin(p(MGI:Mapk14))	In ClC-3- deficient PMNs there was enhanced phosphorylation in ~27% of cells (Fig. 9B and D), but phosphorylation was diminished as compared with wild-type PMNs (Fig. 9C).	SEN:10026060	17908687
BEL:20049482	p(MGI:Clcn3) decreases p(MGI:Itgam)	Clcn3-/- PMNs also demonstrated an increase in CD11b after LOS; however, it was significantly reduced from that seen in the wildtype PMNs (Fig. 6, B and C).	SEN:10026062	17908687
BEL:20049484	p(MGI:Clec5a) directlyIncreases cat(p(MGI:Tyrobp))	Crosslinking of MDL-1/DAP12 complexes in J774 mouse macrophage cells resulted in calcium mobilization. These findings suggest that signaling via MDL-1/DAP12 complexes may constitute a significant activation pathway in myeloid cells	SEN:10008338	10449773
BEL:20049486	p(MGI:Clec5a) increases r(MGI:Ccl22)	from full text - Fig. 6. Signal through MDL-1 up-regulated RANTES, IP-10, and MDC mRNA expression in G-CSF-pretreated 32Dcl3 cells	SEN:10026064	19074552
BEL:20049488	p(MGI:Clec5a) increases r(MGI:Ccl5)	from full text - Fig. 6. Signal through MDL-1 up-regulated RANTES, IP-10, and MDC mRNA expression in G-CSF-pretreated 32Dcl3 cells	SEN:10026064	19074552
BEL:20049490	p(MGI:Clec5a) increases r(MGI:Cxcl10)	from full text - Fig. 6. Signal through MDL-1 up-regulated RANTES, IP-10, and MDC mRNA expression in G-CSF-pretreated 32Dcl3 cells	SEN:10026064	19074552
BEL:20049492	p(MGI:Clec5a) increases r(MGI:Itgam)	from full text - The signal through MDL-1 revealed an up-regulation of CD11b in 32Dcl3 cells with MDL-1 stimulation (Fig. 7D).	SEN:10026066	19074552
BEL:20049506	p(MGI:Clgn) increases chap(p(MGI:Clgn))	Calmegin is a putative testis-specific molecular chaperone required for the heterodimerization of fertilin alpha/beta and the appearance of fertilin beta on the sperm surface.	SEN:10005220	12376108
BEL:20049538	p(MGI:Cntf) increases cat(p(MGI:Il6st))	ciliary neurotrophic factor, CNTF, activation of gp130 in NSCs rapidly increased Notch1 expression	SEN:10008352	12629177
BEL:20049548	p(MGI:Cntf) increases r(MGI:Notch1)	infusion of EGF and CNTF into adult forebrain lateral ventricles increased periventricular NOTCH1 compared with EGF alone	SEN:10026086	12629177
BEL:20049550	p(MGI:Cntf) increases r(MGI:Socs3)	However, the expression of WSB mRNA is induced by sonic hedgehog (Shh) in explant cultures of somitic mesoderm and in the chick limb bud GH induces the expression of CIS, SOCS2 and SOCS3 mRNAs in murine liver, but only CIS and SOCS2 mRNAs are induced in mammary gland either leptin or ciliary neurotrophic factor (CNTF) induces the expression of SOCS3 but not SOCS1, SOCS2 or CIS mRNA in the mouse hypothalamus	SEN:10026088	10910765
BEL:20049566	p(MGI:Cops2) decreases p(MGI:Ccne1)	In addition, lack of Csn2 disrupted the CSN complex and resulted in a drastic increase in cyclin E, supporting a role for CSN in cooperating with the SCF-ubiquitin-proteasome system to regulate protein turnover.	SEN:10008360	12972599
BEL:20049568	p(MGI:Cops2) decreases p(MGI:Cdkn1a)	Furthermore, Csn2(-/-) embryos contained elevated levels of p53 and p21, which may contribute to premature cell cycle arrest of the mutant.	SEN:10026094	12972599
BEL:20049570	p(MGI:Cops2) decreases p(MGI:Trp53)	Furthermore, Csn2(-/-) embryos contained elevated levels of p53 and p21, which may contribute to premature cell cycle arrest of the mutant.	SEN:10026094	12972599
BEL:20049574	p(MGI:Cops2) increases tloc(p(MGI:Nif3l1),GOCCID:0005737,GOCCID:0005634)	This interaction was confirmed by a pull-down assay and an epitope-tagged coimmunoprecipitation. Although Nif3l1 was mainly detected in the cytoplasm, the translocation of Nif3l1 into the nuclei was observed in retinoic acid-primed neural differentiation of P19 cells and enhanced by the enforced expression of Trip15/CSN2.	SEN:10008362	12522100
BEL:20049584	p(MGI:Cpt1c) increases bp(GOBP:"fatty acid oxidation")	These effects correlated with decreased hepatic and intramuscular fatty acid oxidation and expression of oxidative genes as well as with elevated triacylglycerol content in these tissues.	SEN:10026098	19224198
BEL:20049586	p(MGI:Cpt1c) decreases bp(GOBP:gluconeogenesis)	Impaired glucose tolerance in Cpt1c KO mice was attributable to elevated hepatic gluconeogenesis and decreased glucose uptake in skeletal muscle.	SEN:10008366	19224198
BEL:20049588	p(MGI:Cpt1c) decreases path(MESHD:"Insulin Resistance")	After 8 weeks of HFD feeding, Cpt1c KO mice developed a phenotype of more severe insulin resistance than that in wild-type controls.	SEN:10008368	19224198
BEL:20049590	p(MGI:Cpt1c) decreases cat(p(MGI:Cpt1a))	Interestingly, Cpt1c deletion caused a specific elevation of hypothalamic CPT1a and CPT1b isoform expression and activity.	SEN:10008370	19224198
BEL:20049592	p(MGI:Cpt1c) decreases cat(p(MGI:Cpt1b))	Interestingly, Cpt1c deletion caused a specific elevation of hypothalamic CPT1a and CPT1b isoform expression and activity.	SEN:10008370	19224198
BEL:20049596	p(MGI:Cpt1c) decreases p(MGI:Cpt1a)	Interestingly, Cpt1c deletion caused a specific elevation of hypothalamic CPT1a and CPT1b isoform expression and activity.	SEN:10008370	19224198
BEL:20049598	p(MGI:Cpt1c) decreases p(MGI:Cpt1b)	Interestingly, Cpt1c deletion caused a specific elevation of hypothalamic CPT1a and CPT1b isoform expression and activity.	SEN:10008370	19224198
BEL:20049600	p(MGI:Cpt1c) decreases r(MGI:G6pc)	mRNA levels of hepatic glucoregulatory genes G6pc and Pck1 were significantly increased in WT mice on HFD and to an even greater degree in Cpt1c KO mice (Fig. 3b).	SEN:10026102	19224198
BEL:20049602	p(MGI:Cpt1c) decreases r(MGI:Pck1)	mRNA levels of hepatic glucoregulatory genes G6pc and Pck1 were significantly increased in WT mice on HFD and to an even greater degree in Cpt1c KO mice (Fig. 3b).	SEN:10026102	19224198
BEL:20049608	p(MGI:Cr2) increases cat(p(MGI:Sh3bp2))	This suggests the presence of an intermediate molecule between activated CR2 and tyrosine-phosphorylated p95, which may be 3BP2. these data clearly demonstrated that CR2 activation triggered in vivo PI 3-kinase activation through a pathway distinct from that triggered through CD19 activation.	SEN:10026104	9886379
BEL:20049610	p(MGI:Cr2) increases p(MGI:Grb2,pmod(P))	CR2 activation induced, within a brief span of 2 min, tyrosine phosphorylation of nucleolin and its interaction with Src homology 2 domains of the p85 subunit of PI 3 kinase and of 3BP2 and Grb2	SEN:10026106	11207269
BEL:20049612	p(MGI:Cr2) increases p(MGI:Ncl,pmod(P))	CR2 activation induced, within a brief span of 2 min, tyrosine phosphorylation of nucleolin and its interaction with Src homology 2 domains of the p85 subunit of PI 3 kinase and of 3BP2 and Grb2	SEN:10026106	11207269
BEL:20049614	p(MGI:Cr2) increases p(MGI:Sh3bp2,pmod(P))	CR2 activation induced, within a brief span of 2 min, tyrosine phosphorylation of nucleolin and its interaction with Src homology 2 domains of the p85 subunit of PI 3 kinase and of 3BP2 and Grb2	SEN:10026106	11207269
BEL:20049626	p(MGI:Creb1,pmod(P)) increases r(MGI:Crem)	apigenin, a selective casein kinase 2 (CK2) inhibitor, was found to inhibit response% IFN-gamma stimulated CK2 activity and the level of phosphorylated cAMP response element-binding protein, which is known to induce ICER gene transcription, and this response was inhibited in the presence of apigenin.	SEN:10015452	12609974
BEL:20049634	p(MGI:Crebbp) increases bp(GOBP:"fat cell differentiation")	both CBP and p300 are indispensable for the full activation of PPARgamma and adipocyte differentiation and that CBP and p300 do not mutually complement in the process.	SEN:10008380	11884404
BEL:20049638	p(MGI:Crebbp) increases tscript(p(MGI:Pparg))	both CBP and p300 are indispensable for the full activation of PPARgamma and adipocyte differentiation and that CBP and p300 do not mutually complement in the process.	SEN:10008380	11884404
BEL:20049640	p(MGI:Crebbp) increases tscript(p(MGI:Trp53))	Since p53 activation requires recruitment of CREB binding protein (CBP) as a coactivator, we also examined the effect of CBP on TNFalpha-induced attenuation of p53 promoter activation. Overexpression of CBP induced p53 transcriptional activity and recovery of TNFalpha-induced inhibition.	SEN:10008382	12165799
BEL:20049654	p(MGI:Crh) increases r(MGI:Nr4a1)	CRH and cAMP induce Nur77 and Nurr1 expression and transcription at the NurRE site by protein kinase A (PKA) and calcium-dependent and -independent mechanisms.	SEN:10026116	12089357
BEL:20049656	p(MGI:Crh) increases r(MGI:Nr4a2)	CRH and cAMP induce Nur77 and Nurr1 expression and transcription at the NurRE site by protein kinase A (PKA) and calcium-dependent and -independent mechanisms.	SEN:10026116	12089357
BEL:20049658	p(MGI:Crh) increases sec(a(CHEBI:corticosterone))	These data indicate that ICER is required for DMI to reduce stress-induced corticosterone release through regulation of hypothalamic CRF expression, revealing a novel role for ICER in antidepressant regulation of the hypothalamic-pituitary adrenal axis.	SEN:10026118	14985439
BEL:20049662	p(MGI:Crkl) increases bp(GOBP:"cell adhesion")	Upon examining these Crkl-overexpressing cell cultures, we noted a pronounced increase in the attachment of these normally nonadherent cells to the bottom of the tissue culture dish.	SEN:10026120	9710592
BEL:20049664	p(MGI:Crk) increases p(MGI:Rapgef1)	it is likely that Chat-induced Rap1 activation was mediated by upregulation of the Cas-Crk-C3G signaling pathway rather than direct guanine nucleotide exchange factor activity of Chat	SEN:10025366	12432078
BEL:20049684	p(MGI:Cry1) increases bp(GOBP:"cell cycle")	from full text - Furthermore, Cdc2 kinase activity was reduced (Figs. 2B and 1C). Therefore, the cell cycle progression from S to M phase was impaired during liver regeneration in Cry-deficient mice	SEN:10026132	12934012
BEL:20049686	p(MGI:Cry1) increases kin(p(EGID:12534))	from full text - Furthermore, Cdc2 kinase activity was reduced (Figs. 2B and 1C). Therefore, the cell cycle progression from S to M phase was impaired during liver regeneration in Cry-deficient mice	SEN:10026132	12934012
BEL:20049690	p(MGI:Cry1) increases r(MGI:Ccnd1)	from full text - The expression profiles of cyclin D1 and wee1 transcripts were markedly different between Cry-deficient and wildtype mice throughout the liver regeneration process: cyclin D1 expression decreased up to 86% and wee1 expression increased up to 4.6-fold	SEN:10026134	12934012
BEL:20049696	p(MGI:Cry1) decreases r(MGI:Wee1)	from full text - The expression profiles of cyclin D1 and wee1 transcripts were markedly different between Cry-deficient and wildtype mice throughout the liver regeneration process: cyclin D1 expression decreased up to 86% and wee1 expression increased up to 4.6-fold	SEN:10026134	12934012
BEL:20049704	p(MGI:Csf1) increases path(MESHD:Atherosclerosis)	knockout of MCP1 or its receptor CCR-2 also attenuates atherosclerosis in murine models,40,41 and knockout of macrophage colony-stimulation factor (MCSF), which converts monocytes to macrophages, similarly attenuates atherosclerosis.42	SEN:10000330	14732733
BEL:20049706	p(MGI:Csf1) increases path(MESHD:Fibrosis)	As shown in Figure 1, M-CSF-/- mice were protected from bleomycin-induced pulmonary fibrosis when compared with M-CSF+/+ littermates.	SEN:10026138	17431224
BEL:20049712	p(MGI:Csf1) increases p(MGI:Ctgf)	As shown in Figures 2D and 2E, lungs from M-CSF-/- mice had reduced CTGF expression compared with lungs from M-CSF+/+ mice treated with bleomycin, as shown by mRNAand protein analysis.	SEN:10026144	17431224
BEL:20049714	p(MGI:Csf1) increases p(MGI:Lhb)	The CSF-1-deficient males also have reduced serum LH and disruption of the normal testosterone negative feedback response of the hypothalamus, as demonstrated by the failure to increase LH secretion in castrated males and their lack of response to exogenous testosterone.	SEN:10026146	9328346
BEL:20049716	p(MGI:Csf1) increases r(EGID:111785)	In addition, the Leydig cells from csfm(op)/ csfm(op) males have diminished amounts of the steroidogenic enzyme proteins P450 side chain cleavage, 3beta-hydroxysteroid dehydrogenase, and P450 17alpha-hydroxylase-lyase, with associated reductions in the activity of all these steroidogenic enzymes, as well as in 17beta-hydroxysteroid dehydrogenase.	SEN:10008400	9328346
BEL:20049718	p(MGI:Csf1) increases r(MGI:Bcl2)	We show that CSF-1 stimulation of BAC1.2F5 macrophages results in the upregulation of expression of ets2 and bcl-xL with similar kinetics of induction.	SEN:10022836	10082528
BEL:20049720	p(MGI:Csf1) decreases r(MGI:Car2)	Exposure to exogenous MCSF (3500 U/ml) days 2-4 dose-dependently inhibited tartrate resistant acid phosphatase positive multinuclear cell (TRAP+ MNC) formation counted at the end of day 7, by 64.3 +/- 4.1%. This inhibition of TRAP+ MNC formation was preceded by a 92 +/- 9% decrease in the expression of carbonic anhydrase II mRNA measurable at 4 days.	SEN:10026148	9286754
BEL:20049722	p(MGI:Csf1) increases r(MGI:Ctgf)	As shown in Figures 2D and 2E, lungs from M-CSF-/- mice had reduced CTGF expression compared with lungs from M-CSF+/+ mice treated with bleomycin, as shown by mRNAand protein analysis.	SEN:10026144	17431224
BEL:20049724	p(MGI:Csf1) increases r(MGI:Cyp11a1)	In addition, the Leydig cells from csfm(op)/ csfm(op) males have diminished amounts of the steroidogenic enzyme proteins P450 side chain cleavage, 3beta-hydroxysteroid dehydrogenase, and P450 17alpha-hydroxylase-lyase, with associated reductions in the activity of all these steroidogenic enzymes, as well as in 17beta-hydroxysteroid dehydrogenase.	SEN:10008400	9328346
BEL:20049726	p(MGI:Csf1) increases r(MGI:Cyp17a1)	In addition, the Leydig cells from csfm(op)/ csfm(op) males have diminished amounts of the steroidogenic enzyme proteins P450 side chain cleavage, 3beta-hydroxysteroid dehydrogenase, and P450 17alpha-hydroxylase-lyase, with associated reductions in the activity of all these steroidogenic enzymes, as well as in 17beta-hydroxysteroid dehydrogenase.	SEN:10008400	9328346
BEL:20049730	p(MGI:Csf1) increases r(MGI:Ets2)	We show that CSF-1 stimulation of BAC1.2F5 macrophages results in the upregulation of expression of ets2 and bcl-xL with similar kinetics of induction.	SEN:10022836	10082528
BEL:20049738	p(MGI:Csf1) increases r(MGI:Pparg)	Insight into the regulatoin of Pparg expression in activated macrophages has recently been provided by Ricote et al, who demonstrated an induction of Pparg expression in these cells by colony-stimulating factor, granulocyte/macrophage colony stumulating factor, and oxidized LDL.	SEN:10026152	10634806
BEL:20049750	p(MGI:Csf2) decreases bp(GOBP:"cell differentiation")	In contrast, when cells are stimulated with granulocyte macrophage colony-stimulating factor (GM-CSF), intracellular notch2 is not phosphorylated at these residues and differentiation is inhibited.	SEN:10026156	11577080
BEL:20049762	p(MGI:Csf2) increases bp(GOBP:"macrophage chemotaxis")	Peritoneal macrophages pre-attached to Transwell membranes were exposed to media, fMLP, GM-CSF, or MCP-1. After 21 h incubation, the concentration of migrated CD44-deficient macrophages was significantly less than that of migrated C57BL/6 macrophages under all conditions	SEN:10025714	17446529
BEL:20049766	p(MGI:Csf2) increases bp(GOBP:"myeloid dendritic cell activation")	Transgenic expression of GM-CSF in the lung promoted the differentiation and activation of a myeloid DC population, from which the majority was localized in the airway epithelium and peribronchial / perivascular areas. 134	SEN:10026158	19262504
BEL:20049768	p(MGI:Csf2) increases cat(complex(p(MGI:Csf2ra),p(MGI:Csf2rb)))	AEC grown on Matrigel:collagen matrix, thereby maintained in the \"classical\" type II phenotype until Day 3 of culture ... similarly expressed and released GM-CSF on LPS stimulation in the coculture and responded to GM-CSF stimulation with enhanced proliferation (Figure E2), further supporting the concept that the proliferative response to GM-CSF is related to the type II AEC phenotype.	SEN:10015932	19590023
BEL:20049770	p(MGI:Csf2) increases deg(p(MGI:Nfkbia))	In addition, western blot assays revealed that exposure of FSDC to GM-CSF induces the phosphorylation and degradation of the inhibitor of NF-kappaB (IkB), with subsequent translocation of the p50, p52 and RelB subunits of the transcription nuclear factor kappa B (NF-kappaB) from the cytosol to the nucleus.	SEN:10008416	11903618
BEL:20049772	p(MGI:Csf2) increases kin(p(MGI:Nfkbia))	In addition, western blot assays revealed that exposure of FSDC to GM-CSF induces the phosphorylation and degradation of the inhibitor of NF-kappaB (IkB), with subsequent translocation of the p50, p52 and RelB subunits of the transcription nuclear factor kappa B (NF-kappaB) from the cytosol to the nucleus.	SEN:10008416	11903618
BEL:20049780	p(MGI:Csf2) increases p(MGI:Ccl2)	In addition, we also observed increased levels of chemokines MIP-1a and MCP-1 in the BAL in the AdGM-CSF group, particularly at early time points (data not shown).	SEN:10026168	10733504
BEL:20049782	p(MGI:Csf2) increases p(MGI:Ccl3)	In addition, we also observed increased levels of chemokines MIP-1a and MCP-1 in the BAL in the AdGM-CSF group, particularly at early time points (data not shown).	SEN:10026168	10733504
BEL:20049784	p(MGI:Csf2) increases p(MGI:Ifng)	In sharp contrast, there was a significant induction of IFNg in the lung of the GM-CSF group, which peaked at day 7 and remained high at day 12 and markedly declined by day 19 (Figure 8).	SEN:10026170	10733504
BEL:20049786	p(MGI:Csf2) increases p(MGI:Nos2)	In this study, we found that GM-CSF stimulates the expression of the inducible isoform of nitric oxide synthase (iNOS) in a fetal-skin-derived dendritic cell line (FSDC) and, consequently, increases the nitrite production from 11.9 +/- 3.2 micromol/L (basal level) to 26.9 +/- 4.2 micromol/L.	SEN:10026154	11903618
BEL:20049806	p(MGI:Csf2) increases r(MGI:Ccnd1)	Stimulation of AEC at Day 1 of culture with recombinant murine GM-CSF induced rapid and transient phosphorylation of Stat5 and increased expression of Cyclin D1 mRNA	SEN:10026174	19590023
BEL:20049814	p(MGI:Csf2) increases r(MGI:Pparg)	Insight into the regulatoin of Pparg expression in activated macrophages has recently been provided by Ricote et al, who demonstrated an induction of Pparg expression in these cells by colony-stimulating factor, granulocyte/macrophage colony stumulating factor, and oxidized LDL.	SEN:10026152	10634806
BEL:20049822	p(MGI:Csf2) increases sec(p(MGI:Tnf))	LPS stimulated pulmonary neutrophil recruitment, NF-kB promoter activity, and TNF-a secretion are found to be severely impaired in GM-CSF-/- mice.	SEN:10026184	19842832
BEL:20049828	p(MGI:Csf2) increases surf(p(MGI:Cd80))	In terms of absolute cell number, GM-CSF induced an approximately 14-fold and 7-fold increase in the number of DCs expressing bright MHC class II and B7.1, respectively, compared with control groups (Figure 2B).	SEN:10026186	10733504
BEL:20049830	p(MGI:Csf2) increases surf(p(MGI:Cd80))	Similar to the effect on lung residential CD11blow/CD11cbright DCs, GM-CSF induced about 9-fold and 7-fold increases in the number of macrophages expressing bright MHC class II and B7.1, respectively, compared with control groups (Figure 4B).	SEN:10026188	10733504
BEL:20049836	p(MGI:Csf3) increases bp(GOBP:angiogenesis)	G-CSF accelerated tumor growth and intratumoral vessel density, while it did not accelerate proliferation of LLCs, KLN205 cells or human umbilical vein endothelial cells in vitro.	SEN:10008420	16352631
BEL:20049838	p(MGI:Csf3) increases bp(GOBP:"cell differentiation")	However, when these cells are transferred to medium containing G-CSF, the cell number increases 4-5-fold and after 12 days the entire population is differentiated into granulocytes followed by apoptotic death.	SEN:10008422	9444961
BEL:20049840	p(MGI:Csf3) increases bp(GOBP:"cell migration")	Here we show that implantation of tumour cells in mice resulted in upregulation of Bv8 (PROK2) in CD11b1Gr11 myeloid cells. We identified granulocyte colony-stimulating factor as a major positive regulator of Bv8 (mRNA) expression. Anti-Bv8 antibodies reduced CD11b1Gr11 cell mobilization elicited by granulocyte colony-stimulating factor.	SEN:10026192	18064003
BEL:20049844	p(MGI:Csf3) increases bp(GOBP:"cell proliferation")	However, when these cells are transferred to medium containing G-CSF, the cell number increases 4-5-fold and after 12 days the entire population is differentiated into granulocytes followed by apoptotic death.	SEN:10008422	9444961
BEL:20049848	p(MGI:Csf3) increases bp(GOBP:"inflammatory response")	In conclusion, 67LR up-regulation in G-CSF-mobilized HSCs correlates with their successful mobilization and reflects its increase in marrow HSCs, which contributes to the egress from bone marrow by mediating laminin-dependent cell adhesion and transendothelial migration.	SEN:10002224	16788104
BEL:20049852	p(MGI:Csf3) decreases deg(p(MGI:Fli1))	Finally, we showed that the half-life of Fli-1 is prolonged in G-CSF-treated cells compared with control-treated cells.	SEN:10008426	15557108
BEL:20049858	p(MGI:Csf3) increases p(MGI:Fli1)	Our results demonstrated that levels of Fli-1 protein, but not RNA, were higher in extracts from cells treated with G-CSF.	SEN:10026196	15557108
BEL:20049860	p(MGI:Csf3) increases r(MGI:Aatk)	In our search for genes that are induced during apoptosis and/or terminal differentiation of 32Dcl3 cells, we identified a novel gene termed AATYK (Apoptosis Associated Tyrosine Kinase), whose expression is dramatically upregulated during IL-3 deprivation as well as G-CSF-induced terminal differentiation.	SEN:10008428	9444961
BEL:20049864	p(MGI:Csf3) increases r(MGI:Prok2)	Here we show that implantation of tumour cells in mice resulted in upregulation of Bv8 (PROK2) in CD11b1Gr11 myeloid cells. We identified granulocyte colony-stimulating factor as a major positive regulator of Bv8 (mRNA) expression. Anti-Bv8 antibodies reduced CD11b1Gr11 cell mobilization elicited by granulocyte colony-stimulating factor.	SEN:10026192	18064003
BEL:20049866	p(MGI:Csf3) decreases sec(p(MGI:Il18))	G-CSF decrease of IL-18 production may be a major mechanism explaining the effects of G-CSF on the production of IFN-gamma.	SEN:10008430	14698138
BEL:20049868	p(MGI:Csf3) increases surf(p(MGI:Rpsa))	During G-CSF-induced HSC mobilization, the expression of laminin receptors switched from alpha6 integrins, which mediated laminin-dependent adhesion of steady-state human marrow HSCs, to 67LR, responsible for G-CSF-mobilized HSC adhesion and migration toward laminin.	SEN:10008432	16788104
BEL:20049870	p(MGI:Csnk1a1) increases p(MGI:Ctnnb1,pmod(P))	cytoplasmic ??catenin is recruited into a destruction complex, in which it interacts with APC and the axins, and is N?terminally phosphorylated by casein kinase 1? (CK1a) and GSK3?84?88	SEN:10026200	18432252
BEL:20049872	p(MGI:Csnk1a1) increases p(MGI:Lrp5,pmod(P))	In the presence of canonical Wnt ligands (FIG. 1b), LRP5–LRP6 is phosphorylated by CK1? and GSK3?96,97 (and possibly other protein kinases yet to be identified), and Dishevelled is recruited to the plasma membrane, where it interacts with Frizzled receptors and polymerizes with other Dishevelled molecules98,99	SEN:10026202	18432252
BEL:20049874	p(MGI:Csnk1a1) increases p(MGI:Lrp6,pmod(P))	In the presence of canonical Wnt ligands (FIG. 1b), LRP5–LRP6 is phosphorylated by CK1? and GSK3?96,97 (and possibly other protein kinases yet to be identified), and Dishevelled is recruited to the plasma membrane, where it interacts with Frizzled receptors and polymerizes with other Dishevelled molecules98,99	SEN:10026202	18432252
BEL:20049876	p(MGI:Csrp2) decreases bp(GOBP:"cell migration")	Interestingly, compared with untreated controls, TGFbeta treatment reduced wild type VSMC migration by ?50%, whereas Csrp2-/- VSMC migration was not affected (Fig. 1C), indicating that up-regulation of CRP2 correlated with a blunted VSMC motility	SEN:10026204	18387947
BEL:20049880	p(MGI:Csrp3) increases bp(GOBP:"myoblast differentiation")	Over-expression of MLP in C2 myoblasts potentiates myogenic differentiation and reduces its sensitivity to TGF beta	SEN:10026206	7954791
BEL:20049886	p(MGI:Ctgf) increases a(CHEBI:hydroxyproline)	In bleomycin-injured animals, a similar trend towards a (human anti-CTGF antibody) FG-3019 treatment effect was observed (38% reduction in the total lung Hyp, p<0.056).	SEN:10026210	21284856
BEL:20049888	p(MGI:Ctgf) increases bp(GOBP:angiogenesis)	These results demonstrate that Fisp12 is a novel angiogenic inducer and suggest a direct role for Fisp12 in the adhesion, migration, and survival of endothelial cells during blood vessel growth.	SEN:10026212	10082563
BEL:20049890	p(MGI:Ctgf) increases bp(GOBP:"cell adhesion")	In this study, we show that purified Fisp12 (mCTGF) protein promotes the adhesion of microvascular endothelial cells through the integrin receptor alphavbeta3.	SEN:10018356	10082563
BEL:20049892	p(MGI:Ctgf) increases bp(GOBP:"cell migration")	Furthermore, Fisp12 stimulates the migration of microvascular endothelial cells in culture, also through an integrin-alphavbeta3-dependent mechanism.	SEN:10004218	10082563
BEL:20049894	p(MGI:Ctgf) increases cat(complex(p(MGI:Itgav),p(MGI:Itgb3)))	In this study, we show that purified Fisp12 (mCTGF) protein promotes the adhesion of microvascular endothelial cells through the integrin receptor alphavbeta3.	SEN:10018356	10082563
BEL:20049896	p(MGI:Ctgf) increases path(MESHD:Fibrosis)	These data indicate that epithelial overexpression of CTGF results in excessive pulmonary vascular remodeling.	SEN:10026214	21239535
BEL:20049910	p(MGI:Ctla4) directlyIncreases cat(p(MGI:Cd80))	TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.	SEN:10002836	16517699
BEL:20049916	p(MGI:Ctla4) decreases r(MGI:Foxp3)	Administration of anti-CTLA4 Ab decreased LPS-induced bronchoalveolar lavage albumin and IL-17A, while increasing CD4(+)Foxp3(+) cell number and Foxp3 expression in CD4(+)Foxp3(+) cells.	SEN:10026222	20385880
BEL:20049922	p(MGI:Ctla4) decreases r(MGI:Il4ra)	We found, indeed, that CTLA-4 engagement inhibits STAT6 activation leaving unaffected the STAT6 protein level. Moreover, CTLA-4 engagement drastically inhibits IL-4Ralpha mRNA and protein up-regulation under Th2-polarizing conditions.	SEN:10008442	16476055
BEL:20049924	p(MGI:Ctla4) decreases tscript(p(MGI:Stat6))	We found, indeed, that CTLA-4 engagement inhibits STAT6 activation leaving unaffected the STAT6 protein level. Moreover, CTLA-4 engagement drastically inhibits IL-4Ralpha mRNA and protein up-regulation under Th2-polarizing conditions.	SEN:10008442	16476055
BEL:20049928	p(MGI:Ctnnb1) increases bp(GOBP:"cell proliferation")	Hepatocyte growth factor (HGF) and beta-catenin both play a crucial role in stimulating hepatocyte proliferation,	SEN:10026226	17006939
BEL:20049930	p(MGI:Ctnnb1) increases cat(p(MGI:Ptgs2))	COX-2 protein and activity clearly decreased in cells transfected with -catenin after treatment compared to cells transfected with non-specific siRNA (Fig. 4A, B).	SEN:10026228	17317723
BEL:20049936	p(MGI:Ctnnb1) increases p(MGI:Ptgs2)	COX-2 protein and activity clearly decreased in cells transfected with -catenin after treatment compared to cells transfected with non-specific siRNA (Fig. 4A, B).	SEN:10026228	17317723
BEL:20049938	p(MGI:Ctnnb1,pmod(P)) increases deg(p(MGI:Ctnnb1))	Following phosphorylation, ??catenin is targeted for proteasome-dependent degradation involving interaction with ??TrCP (?-transducin repeat-containing protein), a component of the E3 ubiquitin ligase complex89–92	SEN:10026232	18432252
BEL:20049962	p(MGI:Ctnnd1,pmod(P,Y)) directlyIncreases complex(p(MGI:Cdh1),p(MGI:Ctnnd1))	The localization of p120ctn to the cell membrane is dependent on its association with cadherins (Thoreson et al., 2000), which is in turn positively regulated by p120ctn tyrosine phosphorylation	SEN:10026242	11777936
BEL:20049964	p(MGI:Ctnnd1,pmod(P,Y)) increases complex(p(MGI:Ctnnd1),p(MGI:Pik3r1))	In mouse keratinocytes, Src kinase-mediated phosphorylation was found to generate a docking site for PI3K (p85) on plakoglobin in an EGF-R-dependent manner, to a minor extent on p120cnt, but not on b-catenin, which apparently lacks a PI3K (p85)-docking motive (Calautti et al., 2005).	SEN:10026244	18268536
BEL:20049986	p(MGI:Ctss) increases bp(GOBP:"cellular response to DNA damage stimulus")	a targeted null mutation or chemical inhibition of Cat S ameliorates IFN--induced DNA injury, apoptosis, and emphysema.	SEN:10026254	15944319
BEL:20049988	p(MGI:Ctss) increases bp(GOBP:"apoptotic process")	a targeted null mutation or chemical inhibition of Cat S ameliorates IFN--induced DNA injury, apoptosis, and emphysema.	SEN:10026254	15944319
BEL:20049990	p(MGI:Ctss) increases path(MESHD:Emphysema)	a targeted null mutation or chemical inhibition of Cat S ameliorates IFN--induced DNA injury, apoptosis, and emphysema.	SEN:10026254	15944319
BEL:20049996	p(MGI:Cul5) decreases bp(GOBP:"cell proliferation")	Cellular proliferation of VACM-1-expressing cell lines was significantly lower compared with that of the vector-transfected cells,	SEN:10008452	12917106
BEL:20050000	p(MGI:Cul5) decreases kin(p(MGI:Mapk1))	Furthermore, expression of VACM-1 but not S730AVACM-1 protein retarded cytokinesis and prevented MAPK phosphorylation.	SEN:10026260	12917106
BEL:20050002	p(MGI:Cul5) decreases kin(p(MGI:Mapk3))	Furthermore, expression of VACM-1 but not S730AVACM-1 protein retarded cytokinesis and prevented MAPK phosphorylation.	SEN:10026260	12917106
BEL:20050030	p(MGI:Cxcl10) increases bp(GOBP:"T cell proliferation")	IFN-gamma-inducible protein 10/CXCL10 and IFN-inducible T cell alpha chemoattractant/CXCL11 had similar effects on T lymphocyte proliferation,	SEN:10026274	15187119
BEL:20050044	p(MGI:Cxcl11) increases bp(GOBP:"T cell proliferation")	IFN-gamma-inducible protein 10/CXCL10 and IFN-inducible T cell alpha chemoattractant/CXCL11 had similar effects on T lymphocyte proliferation,	SEN:10026274	15187119
BEL:20050046	p(MGI:Cxcl11) decreases r(MGI:Col1a1)	Systemic administration of CXCL11 attenuates collagen deposition and procollagen I gene expression in the lungs of mice exposed to bleomycin in a CXCR3-dependent manner.	SEN:10026284	15502109
BEL:20050048	p(MGI:Cxcl12) increases bp(GOBP:"cell migration")	CXCL12 stimulation of membrane GTPase activity was unaffected in splenocytes derived from GRK5-deficient mice but was increased in splenocytes from the beta-arrestin2- and GRK6-deficient animals	SEN:10021728	12032308
BEL:20050052	p(MGI:Cxcl12) increases cat(p(MGI:Cxcr4))	Moreover, muscle satellite cells, which are pivotal for regeneration of muscle, highly expressed on their surface CXCR4, a G-protein-coupled receptor that binds SDF-1.	SEN:10026286	12705474
BEL:20050064	p(MGI:Cxcl12) increases kin(p(MGI:Mapk1))	It has been shown that chemokines, for example, SDF-1?, can induce the activation of two downstream effectors of Ras, i.e., ERK and PI3-K [34, 46].	SEN:10026290	12545245
BEL:20050066	p(MGI:Cxcl12) increases kin(p(MGI:Mapk3))	we stimulated murine satellite cells (the C2C12 cell line) with SDF-1 and demonstrated the phosphorylation of p42/44 MAPK and AKT serine-threonine kinase in these cells.	SEN:10002248	12705474
BEL:20050088	p(MGI:Cxcl16) decreases path(MESHD:Atherosclerosis)	Consistent with this, genetic inactivation of cxcl16 in hyperlipidemic low density lipoprotein (LDL) receptor knockout mice (ldlr/) results in accelerated atherosclerosis due to enhanced M recruitment to the aortic arch (8).	SEN:10026298	19494317
BEL:20050094	p(MGI:Cxcl1) increases bp(GOBP:angiogenesis)	Gro I is a member of the C–X–C chemokine family and is associated with inflammation, angiogenesis, chemotaxis, and growth or survival of tumor cells	SEN:10026304	17707332
BEL:20050096	p(MGI:Cxcl1) increases bp(GOBP:"cell proliferation")	Treatment with KC results in stimulation of mIMCD-3 cell proliferation but has no effect on basal rates of cell migration or branching morphogenesis.	SEN:10026306	14600031
BEL:20050098	p(MGI:Cxcl1) increases bp(GOBP:chemotaxis)	Gro I is a member of the C–X–C chemokine family and is associated with inflammation, angiogenesis, chemotaxis, and growth or survival of tumor cells	SEN:10026304	17707332
BEL:20050104	p(MGI:Cxcl1) increases cat(p(EGID:12765))	they do express the GROa homologue KC, and the GROb,g homologue MIP-2, which are known to bind and activate mIL-8RH (43, 44).	SEN:10026308	9435307
BEL:20050116	p(MGI:Cxcl2) increases bp(GOBP:"neutrophil chemotaxis")	MIP-2 mRNA expression was observed in lung tissue after CLP and numerous neutrophils were accumulated in the lung under those conditions. Anti-MIP-2 antibody contributed to the inhibition of the CD11b expression and chemotaxis of pulmonary neutrophils, lung edema, and thus the reduction in peritonitis-related mortality.	SEN:10002252	11855919
BEL:20050120	p(MGI:Cxcl2) increases cat(p(EGID:12765))	We confirmed the ability of CXCL2 to induce neutrophil chemotaxis through CXCR2, using antibodies to CXCR2 and the CXCR2 antagonist RPX (Fig. 4B). The decreased surface expression of CXCR2 by LTA was accompanied by reduced F-actin polymerization in response to CXCL2 (Fig. 4D).	SEN:10026312	19234125
BEL:20050124	p(MGI:Cxcl2) increases cat(p(EGID:12765))	they do express the GROa homologue KC, and the GROb,g homologue MIP-2, which are known to bind and activate mIL-8RH (43, 44).	SEN:10026308	9435307
BEL:20050214	p(MGI:Cyp7a1) increases a(CHEBI:"bile salt")	the hepatic enzyme cholesterol 7alpha-hydroxylase catalyzes the rate limiting reaction in the conversion of cholesterol to bile acids in the classic pathway, and consequently plays a critical role in cholesterol and bile acid homeostasis, enzyme encoded by Cyp7a1	SEN:10026358	11792716
BEL:20050216	p(MGI:Cyp7a1) increases a(CHEBI:chenodeoxycholate)	bile acids function as end product inhibitors and repress the synthesis of both chenodeoxycholic acid and cholic acid as a result of the decreased expression of Cyp7a1 and Cyp8b1, respectively	SEN:10026360	11792716
BEL:20050218	p(MGI:Cyp7a1) decreases a(CHEBI:cholesterol)	the hepatic enzyme cholesterol 7alpha-hydroxylase catalyzes the rate limiting reaction in the conversion of cholesterol to bile acids in the classic pathway, and consequently plays a critical role in cholesterol and bile acid homeostasis, enzyme encoded by Cyp7a1	SEN:10026358	11792716
BEL:20050222	p(MGI:Cyp7a1) increases p(MGI:Abcg5)	Hepatic Abcg5/g8 protein levels were higher in Cyp7a1-tg mice than their wild-type littermates, whereas intestine Abcg5/g8 protein expression showed no difference (Fig. 4A).	SEN:10026364	21319191
BEL:20050224	p(MGI:Cyp7a1) increases p(MGI:Abcg8)	Hepatic Abcg5/g8 protein levels were higher in Cyp7a1-tg mice than their wild-type littermates, whereas intestine Abcg5/g8 protein expression showed no difference (Fig. 4A).	SEN:10026364	21319191
BEL:20050226	p(MGI:Cyp7a1) increases r(MGI:Abcb11)	Expression of bile salt export pump (Bsep or Abcb11), a major biliary bile acid efflux transporter was significantly increased (1.7-fold) in Cyp7a1-tg mice (Table 1).	SEN:10026366	21319191
BEL:20050228	p(MGI:Cyp7a1) increases r(MGI:Abcg5)	Cyp7a1-tg mice had significantly higher Abcg5 (2.7-fold) and Abcg8 (1.7-fold) mRNA expression in the liver, but not in the intestine (Table 1)	SEN:10026368	21319191
BEL:20050230	p(MGI:Cyp7a1) increases r(MGI:Abcg8)	Cyp7a1-tg mice had significantly higher Abcg5 (2.7-fold) and Abcg8 (1.7-fold) mRNA expression in the liver, but not in the intestine (Table 1)	SEN:10026368	21319191
BEL:20050232	p(MGI:Cyp7a1) increases r(MGI:Nr0b2)	Expression levels of the FXR-induced fibroblast growth factor 15 (Fgf15) and Shp were drastically induced in Cyp7a1-tg mice, as a result of increased intestinal bile acids (Table 1).	SEN:10026370	21319191
BEL:20050234	p(MGI:Cyp7a1) increases r(MGI:Scarb1)	expression of Sr-b1 mRNA increased 1.9-fold in Cyp7a1-tg mouse livers, but not in the intestine (Table 1).	SEN:10026372	21319191
BEL:20050236	p(MGI:Cyp7b1) increases a(CHEBI:"bile salt")	an alternative pathway has been described that involves the hydroxylation of oxysterols by oxysterol 7alpha-hydroxylase [Cyp7b] prior to their conversion to primary bile acids	SEN:10026374	11792716
BEL:20050238	p(MGI:Cyp7b1) decreases a(CHEBI:oxysterol)	an alternative pathway has been described that involves the hydroxylation of oxysterols by oxysterol 7alpha-hydroxylase [Cyp7b] prior to their conversion to primary bile acids	SEN:10026374	11792716
BEL:20050240	p(MGI:Cyp8b1) increases a(CHEBI:"cholic acid")	bile acids function as end product inhibitors and repress the synthesis of both chenodeoxycholic acid and cholic acid as a result of the decreased expression of Cyp7a1 and Cyp8b1, respectively	SEN:10026360	11792716
BEL:20050244	p(MGI:Dab2) decreases bp(GOBP:"Wnt receptor signaling pathway")	Ectopic expression of Dab2 in NIH-3T3 mouse fibroblasts attenuates canonical Wnt/beta-catenin-mediated signaling, including accumulation of beta-catenin, activation of beta-catenin/T-cell-specific factor/lymphoid enhancer-binding factor 1-dependent reporter constructs, and endogenous cyclin D1 induction.	SEN:10008470	12805222
BEL:20050246	p(MGI:Dab2) decreases bp(GOBP:"Wnt receptor signaling pathway")	Mouse embryo fibroblasts which lack Dab2 exhibit constitutive Wnt signaling as evidenced by increased levels of nuclear beta-catenin and cyclin D1 protein levels.	SEN:10008472	12805222
BEL:20050248	p(MGI:Dab2) decreases complex(p(MGI:Axin1),p(MGI:Dvl3))	Wnt stimulation leads to a time-dependent dissociation of endogenous Dab2-Dvl-3 and Dvl-3-axin interactions in NIH-3T3 cells, while Dab2 overexpression leads to maintenance of Dab2-Dvl-3 association and subsequent loss of Dvl-3-axin interactions.	SEN:10026378	12805222
BEL:20050252	p(MGI:Dab2) increases r(MGI:Ccnd1)	Ectopic expression of Dab2 in NIH-3T3 mouse fibroblasts attenuates canonical Wnt/beta-catenin-mediated signaling, including accumulation of beta-catenin, activation of beta-catenin/T-cell-specific factor/lymphoid enhancer-binding factor 1-dependent reporter constructs, and endogenous cyclin D1 induction.	SEN:10008470	12805222
BEL:20050254	p(MGI:Dag1) increases bp(GOBP:"cell cycle")	Cells in which DG expression was suppressed were growth inhibited, accumulated in the S-phase of the cell cycle, failed to undergo lactogenic differentiation, and displayed an increase in the percentage of apoptotic cells.	SEN:10026380	16447256
BEL:20050256	p(MGI:Dag1) increases bp(GOBP:"cell differentiation")	Cells in which DG expression was suppressed were growth inhibited, accumulated in the S-phase of the cell cycle, failed to undergo lactogenic differentiation, and displayed an increase in the percentage of apoptotic cells.	SEN:10026380	16447256
BEL:20050258	p(MGI:Dag1) decreases bp(GOBP:"apoptotic process")	Cells in which DG expression was suppressed were growth inhibited, accumulated in the S-phase of the cell cycle, failed to undergo lactogenic differentiation, and displayed an increase in the percentage of apoptotic cells.	SEN:10026380	16447256
BEL:20050262	p(MGI:Daxx) increases kin(p(MGI:Map3k5))	The protein Daxx promotes Fas-mediated cell death through activation of apoptosis signal-regulating kinase 1, leading to the activation of the MAPKs JNK and p38.	SEN:10002340	17082815
BEL:20050278	p(MGI:Dcn) decreases r(MGI:Acta2)	Furthermore, forced expression of decorin was accompanied by a suppression of alpha-SMA expression, whereas knocking down of decorin expression by RNA interference increased the expression of alpha-SMA.	SEN:10008480	17952560
BEL:20050296	p(MGI:Ddit3) increases bp(GOBP:"apoptotic process")	Phosphorylation of eIF2alpha results in inhibition of general protein synthesis ( ) and selective activation of ATF4 transcription that up-regulates CHOP gene expression, which in turn causes islet beta-cell apoptosis.	SEN:10021676	12588811
BEL:20050304	p(MGI:Ddit3) increases cat(p(MGI:Il1b))	The LPS-induced inflammation in lung, including the IL-1beta activity in bronchoalveolar lavage fluid, was attenuated in the Chop knockout mice.	SEN:10008484	16670335
BEL:20050314	p(MGI:Ddit3) increases p(MGI:Bax)	To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.	SEN:10026404	19109422
BEL:20050316	p(MGI:Ddit3) increases p(MGI:Bbc3)	To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.	SEN:10026404	19109422
BEL:20050318	p(MGI:Ddit3) increases p(MGI:Bcl2l11)	To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.	SEN:10026404	19109422
BEL:20050320	p(MGI:Ddit3) increases p(MGI:Ero1l)	In Chop-/- macrophages, the increase in Ero1a mRNA and both basal and ER stress–induced ERO1-alpha protein were diminished.	SEN:10026392	19752026
BEL:20050322	p(MGI:Ddit3) increases r(MGI:Bcl2l11)	Bim regulation by Chop occurred at least in part by modulation of Bim mRNA levels, as shRNAi inhibition of Chop completely prevented the increase in Bim mRNA after IL3 withdrawal (Figure 9E).	SEN:10026406	19109422
BEL:20050324	p(MGI:Ddit3) increases r(MGI:Ero1l)	In Chop-/- macrophages, the increase in Ero1a mRNA and both basal and ER stress–induced ERO1-alpha protein were diminished.	SEN:10026392	19752026
BEL:20050326	p(MGI:Ddit3) increases r(MGI:Ero1l)	In ER-stressed cells, ERO1-alpha is induced by CHOP, and small interfering RNA (siRNA) knockdown of ERO1-alpha suppresses apoptosis. IP3-induced calcium release (IICR) is increased during ER stress, and this response is blocked by siRNA-mediated silencing of ERO1-alpha or IP3R1 and by loss-of-function mutations in Ero1a or Chop. Reconstitution of ERO1-alpha in Chop(-/-) macrophages	SEN:10008486	19752026
BEL:20050330	p(MGI:Ddit4) increases cat(complex(p(MGI:Tsc1),p(MGI:Tsc2)))	In contrast to energy depletion, mTOR inhibition by hypoxia does not require AMPK or LKB1. Down-regulation of mTOR activity by hypoxia requires de novo mRNA synthesis and correlates with increased expression of the hypoxia-inducible REDD1 gene.	SEN:10026408	15545625
BEL:20050338	p(MGI:Ddit4) decreases kin(p(MGI:Mtor))	In contrast to energy depletion, mTOR inhibition by hypoxia does not require AMPK or LKB1. Down-regulation of mTOR activity by hypoxia requires de novo mRNA synthesis and correlates with increased expression of the hypoxia-inducible REDD1 gene.	SEN:10026408	15545625
BEL:20050340	p(MGI:Ddit4) decreases kin(p(MGI:Mtor))	We observed that two stress-induced proteins, RTP801/Redd1 and RTP801L/Redd2, potently inhibit signaling through mTOR.	SEN:10002264	15632201
BEL:20050342	p(MGI:Ddit4l) decreases kin(p(MGI:Mtor))	We observed that two stress-induced proteins, RTP801/Redd1 and RTP801L/Redd2, potently inhibit signaling through mTOR.	SEN:10002264	15632201
BEL:20050356	p(MGI:Defb4) directlyIncreases cat(p(MGI:Tlr4))	We demonstrate that murine beta-defensin 2 (mDF2beta) acts directly on immature dendritic cells as an endogenous ligand for Toll-like receptor 4 (TLR-4), inducing up-regulation of costimulatory molecules and dendritic cell maturation.	SEN:10026418	12411706
BEL:20050366	p(MGI:Dgat1) increases a(CHEBI:cholesterol)	This inhibitor also significantly reduced plasma and/or hepatic cholesterol levels in KKA(y) mice in a high-fat feeding condition.	SEN:10026422	20478303
BEL:20050378	p(MGI:Dgat1) decreases kin(p(MGI:Prkce))	Similarly, lower activity levels of PKCepsilon (P = 0.04) and PKCtheta (P = 0.08) were also observed in the muscles of HFD-fed Dgat1 mice compared with those of HFD-fed WT mice (Supplemental Figure 3).	SEN:10026428	17510710
BEL:20050388	p(MGI:Dgat1) decreases p(MGI:Pyy)	In contrast, the increases in plasma GLP-1 and PYY in both KO mouse strains were comparable to Wt mice 30 min after triglyceride loading, however, they remained elevated in DGAT1KO mice even 2h after triglyceride loading.	SEN:10026424	19732742
BEL:20050396	p(MGI:Dicer1) increases bp(GOBP:"cell differentiation")	Specific deletion of dcr-1 in the T cell lineage resulted in impaired T cell development and aberrant T helper cell differentiation and cytokine production.	SEN:10026434	16009718
BEL:20050398	p(MGI:Dicer1) increases bp(GOBP:"cell proliferation")	A severe block in peripheral CD8(+) T cell development was observed upon dcr-1 deletion in the thymus. These cells were defective in microRNA processing, and upon stimulation they proliferated poorly and underwent increased apoptosis.	SEN:10026436	16009718
BEL:20050400	p(MGI:Dicer1) increases bp(GOBP:"cell proliferation")	MEFs lacking Dicer proliferate far slower than control-infected MEFs or MEFs retaining Dicer ( Fig. 2 B ).	SEN:10026438	18591425
BEL:20050402	p(MGI:Dicer1) decreases bp(GOBP:"apoptotic process")	A severe block in peripheral CD8(+) T cell development was observed upon dcr-1 deletion in the thymus. These cells were defective in microRNA processing, and upon stimulation they proliferated poorly and underwent increased apoptosis.	SEN:10026436	16009718
BEL:20050412	p(MGI:Dicer1) decreases p(MGI:Cdkn1a)	Similarly, p21 protein levels are higher in Dicer-ablated MEFs, suggesting that premature senescence in Dicer-ablated MEFs may be due to induction of p19 Arf -p53-p21 signaling.	SEN:10026448	18591425
BEL:20050414	p(MGI:Dicer1) decreases p(MGI:Cdkn2a)	The data reveal an increase in p19 Arf levels over time, with higher levels of p19 Arf consistently found in cells lacking Dicer.	SEN:10026450	18591425
BEL:20050416	p(MGI:Dicer1) decreases p(MGI:Nfat5)	in cells transfected with any of the three siRNAs, Dicer-depletion caused great up-regulations in OREBP protein under both the isotonic and hypertonic conditions (e.g. 2.6-folds for hypertonic condition, P<0.001) (Figure 2D), indicating that OREBP expression could be tightly regulated by miRNAs	SEN:10026452	20852262
BEL:20050418	p(MGI:Dicer1) decreases p(MGI:Trp53,pmod(P,S,18))	In addition, activation of p53 could also be detected in Dicerablated MEFs as judged by p53-serine18 phosphorylation ( Webley et al., 2000 ).	SEN:10026454	18591425
BEL:20050420	p(MGI:Dicer1) decreases r(MGI:Ccnd2)	Furthermore, Dicer loss resulted in increased expression of p53 target genes associated with p53-mediated cell senescence, including p21 , PAI-1 , PAl-2 , and CylinD2 ( Fig. 3 E ).	SEN:10026456	18591425
BEL:20050422	p(MGI:Dicer1) decreases r(MGI:Cdkn1a)	Furthermore, Dicer loss resulted in increased expression of p53 target genes associated with p53-mediated cell senescence, including p21 , PAI-1 , PAl-2 , and CylinD2 ( Fig. 3 E ).	SEN:10026456	18591425
BEL:20050426	p(MGI:Dicer1) decreases r(MGI:Ifng)	Independent of their proliferation defect, Dicer-deficient helper T cells preferentially expressed interferon-gamma, the hallmark effector cytokine of the Th1 lineage.	SEN:10008496	16009718
BEL:20050428	p(MGI:Dicer1) decreases r(MGI:Serpinb2)	Furthermore, Dicer loss resulted in increased expression of p53 target genes associated with p53-mediated cell senescence, including p21 , PAI-1 , PAl-2 , and CylinD2 ( Fig. 3 E ).	SEN:10026456	18591425
BEL:20050430	p(MGI:Dicer1) decreases r(MGI:Serpine1)	Furthermore, Dicer loss resulted in increased expression of p53 target genes associated with p53-mediated cell senescence, including p21 , PAI-1 , PAl-2 , and CylinD2 ( Fig. 3 E ).	SEN:10026456	18591425
BEL:20050432	p(MGI:Dkk1) decreases a(CHEBI:hydroxyproline)	Overexpression of Dkk-1 prevented the profibrotic effects of Wnt-10b on dermal thickening and normalized both hydroxyproline content and myofibroblast counts at 12 weeks to the levels of wild-type control mice	SEN:10026460	22415826
BEL:20050434	p(MGI:Dkk1) decreases bp(GOBP:"Wnt receptor signaling pathway")	we generated retroviruses that express either Dkk1, a secreted antagonist that prevents Wnt ligands from binding to the LRP5/6 co-receptor (Mao et al., 2001aGo), or a dominant-negative form of Tcf4	SEN:10026462	15576404
BEL:20050436	p(MGI:Dkk1) decreases bp(GOBP:"Wnt receptor signaling pathway")	DKK1 antagonizes Wnt signalling during head formation in mice77. An additional DKK-receptor, Kremen, was shown to inhibit the Wnt signalling pathway by internalization of LRP78.	SEN:10026464	18432252
BEL:20050438	p(MGI:Dkk1) decreases bp(GOBP:"Wnt receptor signaling pathway")	In recent years, other mechanisms of activation of the canonical Wnt pathway in tumours have been discovered; for example, silencing of the genes that encode the inhibitory Wnt ligands SFRPs and DKKs by hypermethylation, or by overexpression of Wnt proteins (WNT2B for example), Frizzleds (FZD10 for example) or Dishevelled142–149	SEN:10026466	18432252
BEL:20050440	p(MGI:Dkk1) decreases cat(p(MGI:Lrp5))	we generated retroviruses that express either Dkk1, a secreted antagonist that prevents Wnt ligands from binding to the LRP5/6 co-receptor (Mao et al., 2001aGo), or a dominant-negative form of Tcf4	SEN:10026462	15576404
BEL:20050442	p(MGI:Dkk1) decreases cat(p(MGI:Lrp6))	we generated retroviruses that express either Dkk1, a secreted antagonist that prevents Wnt ligands from binding to the LRP5/6 co-receptor (Mao et al., 2001aGo), or a dominant-negative form of Tcf4	SEN:10026462	15576404
BEL:20050468	p(MGI:Dlc1) decreases path(MESHD:Neoplasms)	restoration of DLC-1 expression in HCC cells resulted in caspase-3-mediated apoptosis, inhibition of cell growth and invasiveness in vitro as well as in reduction of the ability of the cells to form tumors in athymic nude mice.	SEN:10008500	14647417
BEL:20050472	p(MGI:Dlk1) decreases bp(GOBP:angiogenesis)	DLK1 overexpression strongly inhibited angiotube formation, whereas lung endothelial cells from Dlk1-null mice were highly angiogenic. In vivo studies demonstrated DLK1-mediated inhibition of neovessel formation and revealed an altered pattern of angiogenesis in the retinas of Dlk1-null mice.	SEN:10008502	22068159
BEL:20050474	p(MGI:Dlk1) decreases bp(GOBP:"blood vessel development")	DLK1 overexpression strongly inhibited angiotube formation, whereas lung endothelial cells from Dlk1-null mice were highly angiogenic. In vivo studies demonstrated DLK1-mediated inhibition of neovessel formation and revealed an altered pattern of angiogenesis in the retinas of Dlk1-null mice.	SEN:10008502	22068159
BEL:20050482	p(MGI:Dll4) decreases bp(GOBP:angiogenesis)	In a model of ischemic retinopathy, Dll4 blockade also enhanced angiogenic sprouting and regrowth of lost retinal vessels while suppressing ectopic pathological neovascularization	SEN:10008506	17296940
BEL:20050486	p(MGI:Dll4) decreases bp(GOBP:"patterning of blood vessels")	In a model of ischemic retinopathy, Dll4 blockade also enhanced angiogenic sprouting and regrowth of lost retinal vessels while suppressing ectopic pathological neovascularization	SEN:10008506	17296940
BEL:20050488	p(MGI:Dll4) decreases bp(GOBP:"patterning of blood vessels")	these data reveal Dll4 as a negative regulator of vascular sprouting and vessel branching that is required for normal vascular network formation during development	SEN:10008508	17296941
BEL:20050492	p(MGI:Dlx3) increases r(EGID:109899)	Here we show that BMP2 induces DLX3, a homeodomain protein that activates Runx2 gene transcription. Small interfering RNA knockdown studies in osteoblasts validate that DLX3 is a potent regulator of Runx2.Furthermore in Runx2 null cells, DLX3 forced expression suffices to induce transcription of Runx2, osteocalcin, and alkaline phosphatase genes, thus defining DLX3 as an osteogenic regulator independent of RUNX2.	SEN:10008512	17060321
BEL:20050494	p(MGI:Dlx3) increases r(MGI:Bglap2)	Here we show that BMP2 induces DLX3, a homeodomain protein that activates Runx2 gene transcription. Small interfering RNA knockdown studies in osteoblasts validate that DLX3 is a potent regulator of Runx2.Furthermore in Runx2 null cells, DLX3 forced expression suffices to induce transcription of Runx2, osteocalcin, and alkaline phosphatase genes, thus defining DLX3 as an osteogenic regulator independent of RUNX2.	SEN:10008512	17060321
BEL:20050496	p(MGI:Dlx3) increases r(MGI:Esx1)	However, by day 10.5 of development, expression of the paired-like homeodomain gene Esx1 was strongly down-regulated in affected placenta tissue, suggesting that Dlx3 is required for the maintenance of Esx1 expression, normal placental morphogenesis, and embryonic survival.	SEN:10008514	9874789
BEL:20050498	p(MGI:Dlx3) increases r(MGI:Runx2)	Here we show that BMP2 induces DLX3, a homeodomain protein that activates Runx2 gene transcription. Small interfering RNA knockdown studies in osteoblasts validate that DLX3 is a potent regulator of Runx2.Furthermore in Runx2 null cells, DLX3 forced expression suffices to induce transcription of Runx2, osteocalcin, and alkaline phosphatase genes, thus defining DLX3 as an osteogenic regulator independent of RUNX2.	SEN:10008512	17060321
BEL:20050514	p(MGI:Dmp1) increases bp(GOBP:"bone mineralization")	Dentin matrix protein 1 (DMP1) is an acidic noncollagenous protein localized specifically in the mineralized matrix of bone and dentin.	SEN:10008524	15308641
BEL:20050530	p(MGI:Dnaja1) decreases r(EGID:18617)	In Sertoli cells of DjA1(-/-) mice, the androgen receptor markedly accumulated with enhanced transcription of several androgen-responsive genes, including Pem and testin	SEN:10026490	15660130
BEL:20050532	p(MGI:Dnaja1) decreases r(EGID:21753)	In Sertoli cells of DjA1(-/-) mice, the androgen receptor markedly accumulated with enhanced transcription of several androgen-responsive genes, including Pem and testin	SEN:10026490	15660130
BEL:20050534	p(MGI:Dnaja1) decreases r(MGI:Ar)	In Sertoli cells of DjA1(-/-) mice, the androgen receptor markedly accumulated with enhanced transcription of several androgen-responsive genes, including Pem and testin	SEN:10026490	15660130
BEL:20050536	p(MGI:Dnaja1) increases tscript(p(MGI:Ar))	% Experiments with DjA1(-/-) fibroblasts and primary Sertoli cells indicated aberrant androgen receptor signaling.	SEN:10026492	15660130
BEL:20050582	p(MGI:Dpp4) decreases p(MGI:Il13)	IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group. po0.05, po0.01 as determined by unpaired, two-tailed Student’s t-test. Results shown are representative of three independent experiments.	SEN:10026504	22101691
BEL:20050584	p(MGI:Dpp4) decreases p(MGI:Il4)	IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group. po0.05, po0.01 as determined by unpaired, two-tailed Student’s t-test. Results shown are representative of three independent experiments.	SEN:10026504	22101691
BEL:20050586	p(MGI:Dpp4) decreases p(MGI:Il5)	IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group. po0.05, po0.01 as determined by unpaired, two-tailed Student’s t-test. Results shown are representative of three independent experiments.	SEN:10026504	22101691
BEL:20050608	p(MGI:Dusp4) decreases cat(p(MGI:Arg1))	Furthermore, we find that basal arginase 1 expression and associated arginase activity is markedly increased in MKP-2 deletion mice, a response which would also mediate a reduction in NO formation, this is again different to the findings in MKP-1?/? macrophages .	SEN:10026518	21085614
BEL:20050610	p(MGI:Dusp4) decreases r(MGI:Arg1)	Furthermore, we find that basal arginase 1 expression and associated arginase activity is markedly increased in MKP-2 deletion mice, a response which would also mediate a reduction in NO formation, this is again different to the findings in MKP-1?/? macrophages .	SEN:10026518	21085614
BEL:20050612	p(MGI:Dusp4) increases r(MGI:Il10)	MKP-2 negatively regulated IL-12, IL-6 and TNF-a expression and positively regulates IL-10 confirming this hypothesis.	SEN:10026520	21085614
BEL:20050614	p(MGI:Dusp4) decreases r(MGI:Il12a)	MKP-2 negatively regulated IL-12, IL-6 and TNF-a expression and positively regulates IL-10 confirming this hypothesis.	SEN:10026520	21085614
BEL:20050616	p(MGI:Dusp4) decreases r(MGI:Il6)	MKP-2 negatively regulated IL-12, IL-6 and TNF-a expression and positively regulates IL-10 confirming this hypothesis.	SEN:10026520	21085614
BEL:20050618	p(MGI:Dusp4) decreases r(MGI:Tnf)	MKP-2 negatively regulated IL-12, IL-6 and TNF-a expression and positively regulates IL-10 confirming this hypothesis.	SEN:10026520	21085614
BEL:20050620	p(MGI:Dvl1) increases bp(GOBP:"Wnt receptor signaling pathway")	In recent years, other mechanisms of activation of the canonical Wnt pathway in tumours have been discovered; for example, silencing of the genes that encode the inhibitory Wnt ligands SFRPs and DKKs by hypermethylation, or by overexpression of Wnt proteins (WNT2B for example), Frizzleds (FZD10 for example) or Dishevelled142–149	SEN:10026466	18432252
BEL:20050626	p(MGI:Dvl2) increases bp(GOBP:"Wnt receptor signaling pathway")	Dvl binds to the intracellular domain of the frizzled transmembrane receptors, and also to axin to block its activity, which results in the activation of beta-catenin and, consequently, in a transcriptional switch.	SEN:10008544	17606995
BEL:20050632	p(MGI:Dvl2) increases tscript(p(MGI:Ctnnb1))	Dvl binds to the intracellular domain of the frizzled transmembrane receptors, and also to axin to block its activity, which results in the activation of beta-catenin and, consequently, in a transcriptional switch.	SEN:10008544	17606995
BEL:20050640	p(MGI:E2f1) increases bp(GOBP:"apoptotic process")	overexpression of either E2F1 or E2F2 in lens fiber cells was sufficient to cause cell cycle entry and subsequent apoptosis	SEN:10026524	11095619
BEL:20050648	p(MGI:E2f2) increases bp(GOBP:"apoptotic process")	overexpression of either E2F1 or E2F2 in lens fiber cells was sufficient to cause cell cycle entry and subsequent apoptosis	SEN:10026524	11095619
BEL:20050654	p(MGI:E2f4) increases bp(GOBP:"cell cycle")	We show that loss of E2f4 results in an impaired expansion of the fetal erythroid compartment in vivo that is associated with impaired cell cycle progression and decreased erythroid proliferation.	SEN:10026528	16861343
BEL:20050668	p(MGI:Ebi3) increases p(MGI:Il4)	A sustained decrease in IL-4 production was also observed in EBI3-/- mice after alphaGalCer stimulation in vivo	SEN:10008552	12482940
BEL:20050670	p(MGI:Ebna1bp2) increases bp(GOBP:"cell proliferation")	NoBP overexpression conferred a proliferating effect onto NIH 3T3 cells and can counteract the inhibitory effect of nuclear FGF3, suggesting a role of NoBP in controlling proliferation in cells. We propose that NoBP is the functional target of nuclear FGF3 action.	SEN:10008554	11438656
BEL:20050672	p(MGI:Edn1) increases a(CHEBI:"nitric oxide")	in isolated thick ascending limbs from wild-type mice, 1 nmol/liter endothelin-1 increased fluorescence (measure NO) by 3.81 ± 0.46 fluorescence units/min.	SEN:10026534	19033447
BEL:20050678	p(MGI:Edn1) increases cat(p(MGI:Nos3))	endothelin-1 failed to stimulate NO production by tubules from NOS3–/– mice (?= 0.38 ± 0.22 fluorescence units/min; p < 0.001 versus wild-type mice; n = 4) (Fig. 1A).	SEN:10019396	19033447
BEL:20050684	p(MGI:Edn1) increases kin(p(MGI:Mapk1))	Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B.	SEN:10026540	23343326
BEL:20050686	p(MGI:Edn1) increases kin(p(MGI:Mapk3))	Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B.	SEN:10026540	23343326
BEL:20050690	p(MGI:Edn1) decreases r(MGI:Dkk1)	ET-1 decreased the transcript for the Wnt signaling pathway inhibitor, dickkopf homolog 1 (Dkk1).	SEN:10026544	17068196
BEL:20050712	p(MGI:Efna5) directlyIncreases kin(p(MGI:Ephb2))	Exposure of EphB2-expressing cells to ephrin-A5 leads to receptor clustering, autophosphorylation and initiation of downstream signaling.	SEN:10008566	15107857
BEL:20050720	p(MGI:Egf) increases bp(GOBP:"cell cycle")	Upon stimulation with EGF (0.3 ng/ml) or bFGF (0.3 ng/ml) about 20% of uninjected EGFR/ErbB-2 cells entered S phase (data not shown). We observed a similar rate of entrance into S phase when counting cells microinjected with a control antiserum (RAM, Figure 1e). Cells micro- injected with anti-RALT antibodies and stimulated with EGF progressed to S phase at a frequency which was 2.8-fold higher than control cells.	SEN:10026554	12226756
BEL:20050734	p(MGI:Egf) decreases complex(p(MGI:Nppa),p(MGI:Npr3))	Epidermal growth factor (EGF) and heparin-binding (HB)-EGF, but not platelet-derived growth factor or insulin-like growth factor I, inhibited (125)I-ANP binding to ND-NOD and D-NOD mesangial cells, particularly in the latter.	SEN:10026560	11457715
BEL:20050736	p(MGI:Egf) increases kin(p(MGI:Braf))	Similar observation that immunoprecipitated B-Raf from EGF-stimulated Swiss3T3 cells could activate both MEK1 and MEK2 was also obtained (data not shown).	SEN:10021570	8621729
BEL:20050738	p(MGI:Egf) increases kin(p(MGI:Csk))	Further analyses revealed that c-src kinase activity was dramatically elevated in cultured mouse keratinocytes exposed to EGF.	SEN:10008570	9136987
BEL:20050740	p(MGI:Egf) increases kin(p(MGI:Egfr))	The EGF effect depended on activation of its receptor tyrosine kinase but not on that of protein kinase C, mitogen-activated protein kinases, or phosphoinositide-3 kinase.	SEN:10021652	11457715
BEL:20050750	p(MGI:Egf) increases p(MGI:Cav1,pmod(P,Y))	Furthermore, the Src family kinase inhibitor, PP1, does not affect autophosphorylation of the receptor, but it does inhibit the EGF-induced mobility shift and phosphorylation of caveolin-1.	SEN:10026570	10713051
BEL:20050754	p(MGI:Egf) increases p(MGI:Elk1,pmod(P))	Upon EGF treatment, the phosphorylation state of Elk-1 was increased in only wild-type and JNK2-deficient cells.	SEN:10026574	17074809
BEL:20050756	p(MGI:Egf) increases p(MGI:Elk1,pmod(P,S,383))	Treatment of the cells with EGF or serum induces the rapid phosphorylation of an -60 kDa protein that is not detected in untransfected or quiescent cells.....Elk- I phosphopeptides can be detected that are also phosphorylated by purified ERKI in .vitro. Most of the radioactivity is contained in the set of partially overlapping peptides encompassing serines 383 and 389 (peptides 1- 4, 8 and 9).	SEN:10026576	7889942
BEL:20050758	p(MGI:Egf) increases p(MGI:Elk1,pmod(P,S,389))	Treatment of the cells with EGF or serum induces the rapid phosphorylation of an -60 kDa protein that is not detected in untransfected or quiescent cells.....Elk- I phosphopeptides can be detected that are also phosphorylated by purified ERKI in .vitro. Most of the radioactivity is contained in the set of partially overlapping peptides encompassing serines 383 and 389 (peptides 1- 4, 8 and 9).	SEN:10026576	7889942
BEL:20050760	p(MGI:Egf) increases p(MGI:Gja1,pmod(P))	As shown in Fig. 2a, EGF (100 ng/mL) increased the level of Cx43 phosphorylation from 5 min, to reach a maximum at 60 min.	SEN:10026578	18823499
BEL:20050768	p(MGI:Egf) increases p(MGI:Nppa)	The cGMP response to physiological concentrations of ANP was greater in EGF-treated D-NOD cells. These studies suggest that EGF potentiates the ANP glomerular effects in diabetes by inhibition of its degradation by mesangial NPR-C via a mechanism involving AP-1.	SEN:10008574	11457715
BEL:20050770	p(MGI:Egf) decreases p(MGI:Npr3)	NPR-C density decreased with no change in the apparent dissociation constant, and there was also a decrease in NPR-C mRNA expression.	SEN:10026580	11457715
BEL:20050772	p(MGI:Egf) increases p(MGI:Spry2,pmod(P,Y))	Using an antibody against Spry2, we showed that endogenous Spry2 becomes phosphorylated on tyrosine in response to EGF or FGF stimulation in C2C12 cells (Fig. 4b, left) and in COS7 cells (Fig. 4b, right).	SEN:10026582	12402043
BEL:20050774	p(MGI:Egf) increases p(MGI:Spry2,pmod(P,Y,55))	In addition, neither xSpry1Y53F nor mSpry2Y55F was tyrosine phosphorylated in cells stimulated with EGF (data not shown).	SEN:10026584	12402043
BEL:20050790	p(MGI:Egf) decreases r(EGID:104191)	Results demonstrate that EGF inhibits expression of WDNM1 and SGP-2 genes in mammary epithelial cells.	SEN:10008578	9367891
BEL:20050796	p(MGI:Egf) increases r(MGI:Errfi1)	Ablation of RALT expression by MEK- 1 inhibitors is caused by suppression of RALT transcription, as indicated by the Northern blot analysis presented in Figure 3.	SEN:10017894	12226756
BEL:20050798	p(MGI:Egf) increases r(MGI:Fos)	In NIH3T3HERc cells treated with EGF, activation of the corresponding reporter construct (el2CAT) - reporter containing c-fos SRE - is dependent on co-transfection of Gal-Elk.	SEN:10026590	7889942
BEL:20050802	p(MGI:Egf) decreases r(MGI:Wfdc18)	Results demonstrate that EGF inhibits expression of WDNM1 and SGP-2 genes in mammary epithelial cells.	SEN:10008578	9367891
BEL:20050804	p(MGI:Egf) increases r(MGI:Notch1)	infusion of EGF and CNTF into adult forebrain lateral ventricles increased periventricular NOTCH1 compared with EGF alone	SEN:10026086	12629177
BEL:20050806	p(MGI:Egf) decreases r(MGI:Npr3)	NPR-C density decreased with no change in the apparent dissociation constant, and there was also a decrease in NPR-C mRNA expression.	SEN:10026580	11457715
BEL:20050814	p(MGI:Egf) increases r(MGI:Tbp)	EGF enhanced TBP mRNA levels in wildtype and Jnk2-/- cells, while no significant increase in TBP mRNA was observed upon EGF treatment of Jnk1-/- cells (Fig. 1B).	SEN:10026594	17074809
BEL:20050828	p(MGI:Egfr) increases r(MGI:Hif1a)	In egfr (-/-) MEF cells, UV radiation did not induce HIF-1alpha and VEGF expression, in contrast, in egfr (+/+) MEF cells, UV radiation strongly induced HIF-1alpha and VEGF expression.	SEN:10026600	16964427
BEL:20050830	p(MGI:Egfr) increases r(MGI:Vegfa)	In egfr (-/-) MEF cells, UV radiation did not induce HIF-1alpha and VEGF expression, in contrast, in egfr (+/+) MEF cells, UV radiation strongly induced HIF-1alpha and VEGF expression.	SEN:10026600	16964427
BEL:20050832	p(MGI:Egf) increases tloc(complex(p(MGI:Grb2),p(MGI:Spry2)),GOCCID:0005737,GOCCID:0005886)	When Myc-tagged mSpry2 and haemagluttinin A (HA)- tagged Grb2 were expressed in cultured cells, both molecules translocated to the ruffling membrane region in response to stimulation with FGF or EGF and colocalized there (Fig. 1c).	SEN:10026602	12402043
BEL:20050834	p(MGI:Egf) increases tloc(p(MGI:Rasa2),GOCCID:0005737,GOCCID:0005886)	Here, using rat pheochromocytoma PC12 cells transiently transfected with a plasmid expressing a chimera of green fluorescent protein fused to GAP1(m) (GFP-GAP1(m)), we show that epidermal growth factor (EGF) induces a rapid (less than 60 seconds) recruitment of GFP-GAP1(m) from the cytosol to the plasma membrane.	SEN:10017208	10074452
BEL:20050836	p(MGI:Egf) increases tscript(p(MGI:Elk1))	In NIH3T3HERc cells treated with EGF, activation of the corresponding reporter construct (el2CAT) - reporter containing c-fos SRE - is dependent on co-transfection of Gal-Elk.	SEN:10026590	7889942
BEL:20050838	p(MGI:Egf) increases tscript(p(MGI:Stat3))	In vivo, b4-integrin amplifies proproliferative signals in basal epidermal keratinocytes (Nikolopoulos et al., 2005), where STAT3 is expressed and can be activated by EGF/EGF-R (Nishio et al., 2001; Chan et al., 2004; Li et al., 2007)	SEN:10021660	18268536
BEL:20050840	p(MGI:Egln1) decreases tscript(p(MGI:Hif1a))	As a consequence, the degradation of HIF-1alpha was inhibited as determined by impaired degradation of a reporter protein containing the HIF-1alpha oxygen-dependent degradation domain encompassing the PHD-targeted prolines.	SEN:10005442	16815840
BEL:20050848	p(MGI:Egr1) increases bp(GOBP:"cell proliferation")	as long as Egr1 expression was inhibited, the proliferation rate of C2 cells was markedly reduced and then resumed as soon as Egr1 expression recovered	SEN:10026606	12556466
BEL:20050850	p(MGI:Egr1) increases bp(GOBP:"inflammatory response")	Egr-1 appeared to play an important role in these responses because tissue (Fig. 2A) and BAL inflammation were all significantly diminished in Tg (+) mice with null mutant Egr-1 loci (Fig. 2B).	SEN:10026608	16439363
BEL:20050856	p(MGI:Egr1) decreases bp(GOBP:"apoptotic process")	Furthermore we also showed that Egr1 is responsible for cyclin D2overexpression in tumorigenic DU145 human prostate cells. The regulation ofthese genes by Egr1 was demonstrated using Egr1 antisense oligonucleotides thatfurther implicated Egr1 in resistance to apoptotic signals	SEN:10026614	12556466
BEL:20050868	p(MGI:Egr1) increases p(MGI:Il1b)	Reynolds et al. (137) investigated the expression of Egr-1 (early growth response gene 1) in NZW and AKR mice. Egr-1 gene induces IL-1b and TNFa, cytokines that contribute to the recruitment of inflammatory cells after smoke exposure.	SEN:10026622	18223159
BEL:20050870	p(MGI:Egr1) increases p(MGI:Tgfb1)	Egr-1 did, however, play a critical role in the activation of TGF-B1 because the ability of IL-13 to activate TGF-B1 was markedly diminished in comparisons of BAL fluids from Tg (+) mice with wild type and null mutant Egr-1 loci (Fig. 8B).	SEN:10026624	16439363
BEL:20050872	p(MGI:Egr1) increases p(MGI:Tnf)	Reynolds et al. (137) investigated the expression of Egr-1 (early growth response gene 1) in NZW and AKR mice. Egr-1 gene induces IL-1b and TNFa, cytokines that contribute to the recruitment of inflammatory cells after smoke exposure.	SEN:10026622	18223159
BEL:20050874	p(MGI:Egr1) increases r(EGID:319520)	Egr-1/MGRE binding was induced by GnRH in an ERK-dependent manner. Transcriptional activity of Egr-1 protein was enhanced by GnRH treatment.	SEN:10016976	11591707
BEL:20050876	p(MGI:Egr1) increases r(MGI:Dusp4)	Egr-1/MGRE binding was induced by GnRH in an ERK-dependent manner. Transcriptional activity of Egr-1 protein was enhanced by GnRH treatment.	SEN:10016976	11591707
BEL:20050878	p(MGI:Egr1) increases r(MGI:F3)	EGR target genes include bFGF, TGFbeta1, tissue factor, several Hox genes, platelet-derived growth factor A and B, Fas ligand and LHbeta	SEN:10026626	10734128
BEL:20050880	p(MGI:Egr1) increases r(MGI:Il13)	To examine if Egr-1 is required for SCF-induced IL-13 expression, Egr-1-deficient BMMC were used. Levels of SCF-induced IL-13 mRNA and protein were reduced in Egr-1 deficient BMMC when compared with wild-type BMMC	SEN:10008590	18569387
BEL:20050882	p(MGI:Egr1) directlyIncreases r(MGI:Lhb)	Erg1 transcription factor directly activates the luteinizing hormone beta LHbeta subuit promoter, and female mice lacking Egr1 are infertile due to LHbeta deficiency	SEN:10026618	10734128
BEL:20050898	p(MGI:Egr3) increases r(MGI:Fasl)	EGR target genes include bFGF, TGFbeta1, tissue factor, several Hox genes, platelet-derived growth factor A and B, Fas ligand and LHbeta	SEN:10026626	10734128
BEL:20050900	p(MGI:Egr4) increases bp(GOBP:spermatogenesis)	loss of EGR4 results in male infertility due to increased germ cell apoptosis and defective spermiogenesis	SEN:10026636	10734128
BEL:20050902	p(MGI:Egr4) decreases bp(GOBP:"apoptotic process")	loss of EGR4 results in male infertility due to increased germ cell apoptosis and defective spermiogenesis	SEN:10026636	10734128
BEL:20050910	p(MGI:Eif2ak2) increases bp(GOBP:"apoptotic process")	To investigate this issue, the two pathways were dissected following the induction of the expression of PKRwt in NIH3T3 PKRwt cells. These inducible cells undergo apoptosis upon PKR expression without the requirement for dsRNA (Donze´ et al, 1999).	SEN:10026642	14749731
BEL:20050916	p(MGI:Eif2ak2) decreases p(MGI:Nfkbib)	To confirm the EMSA data, we ascertained byWestern blot analysis that IkBb levels are reduced at early times following PKR induction (Supplementary Figure 1) (Zamanian-Daryoush et al, 2000)	SEN:10026646	14749731
BEL:20050930	p(MGI:Eif2ak2) increases r(MGI:Fos)	The results (Figure4A and B) showed a 16-fold induction in PKR wild-type cells in contrast to a 0.8-fold induction in c-fos message in PKR-null cells at 15 min of PDGF treatment	SEN:10026650	11350938
BEL:20050952	p(MGI:Eif2ak3) decreases r(MGI:Bax)	The promoter activity of a p53 downstream gene, Bax, was also upregulated more in MEFGCN2-/- andMEFPERK-/-cells than in MEF WT and MEF A/A cells (Figure 3D).	SEN:10026658	20072654
BEL:20050954	p(MGI:Eif2ak3) increases r(MGI:Ddit3)	The expression of CHOP, previously shown to be positively regulated by PERK in response to thapsigargin [20,39], was significantly reduced in Perk-/- MEFs by both microarray and RT-PCR analysis (results not shown).	SEN:10026660	16124869
BEL:20050956	p(MGI:Eif2ak3) decreases tscript(p(MGI:Trp53))	Our data showed that p53 transcriptional activity was up to 4.0 ± 0.5- and 4.4 ± 0.8-folds in MEF PERK-/- and MEF GCN2-/- cells, whereas the activity was only up to 1.4 ± 0.1- and 1.7 ± 0.1-folds in MEF WT and MEFA/A cells, respectively, in hypoxia (Figure 3C).	SEN:10026662	20072654
BEL:20050966	p(MGI:Eif2ak4) decreases r(MGI:Bax)	The promoter activity of a p53 downstream gene, Bax, was also upregulated more in MEFGCN2-/- andMEFPERK-/-cells than in MEF WT and MEF A/A cells (Figure 3D).	SEN:10026658	20072654
BEL:20050978	p(MGI:Eif2ak4) decreases tscript(p(MGI:Trp53))	Our data showed that p53 transcriptional activity was up to 4.0 ± 0.5- and 4.4 ± 0.8-folds in MEF PERK-/- and MEF GCN2-/- cells, whereas the activity was only up to 1.4 ± 0.1- and 1.7 ± 0.1-folds in MEF WT and MEFA/A cells, respectively, in hypoxia (Figure 3C).	SEN:10026662	20072654
BEL:20050986	p(MGI:Eif2s1,pmod(P)) increases kin(p(MGI:Pck1))	In accordance with the hypoglycemia in S51A mutant mice, the activity of PEPCK enzyme is significantly reduced (11).	SEN:10026670	12588811
BEL:20050988	p(MGI:Eif2s1,pmod(P)) increases r(MGI:Atf4)	Phosphorylation of eIF2alpha by PERK leads to the inhibition of general protein synthesis but, remarkably, results in selective increase of mRNA translation of activating transcription factor 4 (ATF4)	SEN:10026672	12588811
BEL:20050992	p(MGI:Eif2s1,pmod(P)) increases r(MGI:Hspa5)	Mammalian cells respond to endoplasmic reticulum (ER) stress by attenuation of protein translation The disruption of PERK function or the blocking of eIF2alpha Ser51 phosphorylation fails to attenuate translation after ER stress and also results in substantial impairment of Grp78/BiP induction by ER stress.	SEN:10021680	12871976
BEL:20050994	p(MGI:Eif2s1,pmod(P,S,51)) increases r(MGI:Hspa5)	Mammalian cells respond to endoplasmic reticulum (ER) stress by attenuation of protein translation The disruption of PERK function or the blocking of eIF2alpha Ser51 phosphorylation fails to attenuate translation after ER stress and also results in substantial impairment of Grp78/BiP induction by ER stress.	SEN:10021680	12871976
BEL:20050998	p(MGI:Eif2s1,pmod(P,S,52)) increases bp(GOBP:"apoptotic process")	FIGURE 1. Induction of apoptosis by severe hypertonic stress is dependent on eIF2A phosphorylation.	SEN:10026674	20338999
BEL:20051002	p(MGI:Eif2s1,pmod(P,S,52)) decreases r(MGI:Bcl2l1)	FIGURE 3. eIF2a phosphorylation during hypertonic stress induces translational inhibition of Bcl-xL mRNA.	SEN:10026676	20338999
BEL:20051012	p(MGI:Eif4ebp1,pmod(P,T,37)) increases bp(GOBP:"protein metabolic process")	Transfection with the Thr37,46-->Ala37,46 mutant of 4E-BP1 showed that phosphorylation of Thr37,46 residues was required for IGF-I induction of protein synthesis in MCT cells	SEN:10019222	12388420
BEL:20051016	p(MGI:Eif4ebp1,pmod(P,T,46)) increases bp(GOBP:"protein metabolic process")	Transfection with the Thr37,46-->Ala37,46 mutant of 4E-BP1 showed that phosphorylation of Thr37,46 residues was required for IGF-I induction of protein synthesis in MCT cells	SEN:10019222	12388420
BEL:20051038	p(MGI:Elk1,pmod(P,S,383)) directlyIncreases tscript(p(MGI:Elk1))	In NIH3T3 cells, co-transfection of an expression vector for Gal-Elk mediates expression from a transfected GAL-CAT reporter gene, which, as shown in Figure 6a,b, is potentiated upon treatment of serum-starved cells with anisomycin. Replacement of the major SAPK phosphorylation site in Gal-Elk, Ser383, with alanine (Gal-Elks 383 A) abrogates induction of reporter gene expression.	SEN:10016560	8548291
BEL:20051042	p(MGI:Elk3) decreases p(MGI:Nos2)	LPS administration to macrophages led to a dose-dependent decrease in endogenous Elk-3 mRNA levels, and this decrease in Elk-3 preceded the induction of NOS2 mRNA.	SEN:10015940	12896968
BEL:20051066	p(MGI:Ep300) increases bp(GOBP:"fat cell differentiation")	both CBP and p300 are indispensable for the full activation of PPARgamma and adipocyte differentiation and that CBP and p300 do not mutually complement in the process.	SEN:10008380	11884404
BEL:20051072	p(MGI:Ep300) increases tscript(p(MGI:Jun))	In this paper, we demonstrate a regulatory mechanism by which JunB transcriptionally controls the expression of DMP1 during osteoblast differentiation. The cooperative interaction of JunB with p300 has been shown to dramatically modulate the DMP1 promoter activity during mineralization.	SEN:10008608	15308641
BEL:20051074	p(MGI:Ep300) increases tscript(p(MGI:Pparg))	both CBP and p300 are indispensable for the full activation of PPARgamma and adipocyte differentiation and that CBP and p300 do not mutually complement in the process.	SEN:10008380	11884404
BEL:20051078	p(MGI:Epas1,pmod(H,N,851)) directlyDecreases complex(p(MGI:Epas1),p(MGI:Ep300))	To identify the modified residue, the relevant tryptic peptides from each sample were further analyzed by tandem mass spectrometry. Comparison of the fragment patterns revealed that Asn 851 contained the additional oxygen atom (Fig. 4B). Together these data show that FIH-1 is an asparaginyl hydroxylase that inhibits HIF transcriptional activity by preventing CAD association with the coactivator p300.	SEN:10026706	12080085
BEL:20051080	p(MGI:Epas1,pmod(H,N,851)) directlyDecreases tscript(p(MGI:Epas1))	To identify the modified residue, the relevant tryptic peptides from each sample were further analyzed by tandem mass spectrometry. Comparison of the fragment patterns revealed that Asn 851 contained the additional oxygen atom (Fig. 4B). Together these data show that FIH-1 is an asparaginyl hydroxylase that inhibits HIF transcriptional activity by preventing CAD association with the coactivator p300.	SEN:10026706	12080085
BEL:20051090	p(MGI:Ephb1) increases bp(GOBP:angiogenesis)	EphB1/Fc induced endothelial ephrin-B1 tyrosine phosphorylation, migration and integrin-mediated (alpha(v)beta(3) and alpha(5)beta(1)) attachment and promoted neovascularization, in vivo, in a mouse corneal micropocket assay.	SEN:10026710	12118063
BEL:20051092	p(MGI:Ephb1) increases bp(GOBP:"cell migration")	EphB1/Fc induced endothelial ephrin-B1 tyrosine phosphorylation, migration and integrin-mediated (alpha(v)beta(3) and alpha(5)beta(1)) attachment and promoted neovascularization, in vivo, in a mouse corneal micropocket assay.	SEN:10026710	12118063
BEL:20051096	p(MGI:Ephb1) increases p(MGI:Efnb1,pmod(P,Y))	EphB1/Fc induced endothelial ephrin-B1 tyrosine phosphorylation, migration and integrin-mediated (alpha(v)beta(3) and alpha(5)beta(1)) attachment and promoted neovascularization, in vivo, in a mouse corneal micropocket assay.	SEN:10026710	12118063
BEL:20051100	p(MGI:Ephb2,pmod(P,Y,604)) increases p(MGI:Dok1,pmod(P,Y))	Ephrin-B1-induced tyrosine phosphorylation of both EphB2 and p62dok was abrogated in cells expressing the double juxtamembrane mutant or EphB2KDIIM (23) (data not shown).	SEN:10026714	10848605
BEL:20051104	p(MGI:Ephb2,pmod(P,Y,610)) increases p(MGI:Dok1,pmod(P,Y))	Ephrin-B1-induced tyrosine phosphorylation of both EphB2 and p62dok was abrogated in cells expressing the double juxtamembrane mutant or EphB2KDIIM (23) (data not shown).	SEN:10026714	10848605
BEL:20051134	p(MGI:Eps15,pmod(P)) decreases complex(p(MGI:Eps15),p(MGI:Ap2a2))	We demonstrate that Eps15 is constitutively associated with both alpha-adaptin and clathrin. Upon EGF stimulation, Eps15 and alpha-adaptin are recruited to the EGF receptor.	SEN:10026720	9049247
BEL:20051136	p(MGI:Eps15,pmod(P)) increases complex(p(MGI:Eps15),p(MGI:Egfr))	We demonstrate that Eps15 is constitutively associated with both alpha-adaptin and clathrin. Upon EGF stimulation, Eps15 and alpha-adaptin are recruited to the EGF receptor.	SEN:10026720	9049247
BEL:20051152	p(MGI:Erbb4) decreases bp(GOBP:"apoptotic process")	ErbB4 expression and signaling are key elements for TNF responses in vivo and in cell culture, protecting intestinal epithelial cells from apoptosis	SEN:10008630	18973758
BEL:20051172	p(MGI:Ereg) decreases r(MGI:Il18)	Figure 3. (C and D) Down-regulation of IL-18 mRNA expression by IL-1{alpha} (C) and EP (D) in primary keratinocytes.	SEN:10026734	15365177
BEL:20051174	p(MGI:Ereg) decreases r(MGI:Il18)	rmEP reduced IL-18 expression in WT- and EP –/–-derived keratinocytes at 8 h after stimulation, and there was no obvious difference between WT and EP –/– (Fig. 3D).	SEN:10026736	16182244
BEL:20051176	p(MGI:Erf,pmod(P)) increases tloc(p(MGI:Erf),GOCCID:0005634,GOCCID:0005737)	We have shown previously that ERF is phosphorylated in vitro and in vivo by Erks at multiple sites. This phosphorylation determines its cytoplasmic localization and inactivation.....ERF nuclear export is dependent on extensive phosphorylation and is a CRM1-dependent process.	SEN:10026738	14729966
BEL:20051180	p(MGI:Ern1) increases bp(GOBP:"apoptotic process")	overexpression of IRE1 has been shown to induce apoptosis mediated partly by activation of the Janus kinase pathway (33, 34).	SEN:10026742	12588811
BEL:20051182	p(MGI:Ern1) increases kin(p(MGI:Mapk8))	As shown in Fig 4A, overexpression of IRE1a activates JNK in WT fibroblast cells, but not in TNFR1-/- cells.	SEN:10026744	16680093
BEL:20051188	p(MGI:Ern1) increases tscript(p(MGI:Xbp1))	Here we demonstrate that the IRE1alpha-XBP1 pathway, the most conserved branch of the unfolded protein response (UPR), is indispensable for adipogenesis. Indeed, XBP1-deficient mouse embryonic fibroblasts and 3T3-L1 cells with XBP1 or IRE1alpha knockdown exhibit profound defects in adipogenesis	SEN:10018230	19490910
BEL:20051200	p(MGI:Ero1l) increases bp(GOBP:"cell proliferation")	The reduction in Ero1-La caused a significant inhibition of cell proliferation, evidenced by a two-fold decrease in cells in the S phase and in the G2 phase.	SEN:10026754	15592500
BEL:20051202	p(MGI:Ero1l) increases bp(GOBP:"apoptotic process")	Cholesterol induced apoptosis was partially suppressed in Chop-/- macrophages transduced with control adeno-LacZ, which is consistent with our previous data (Feng et al., 2003; Kim et al., 2008), but apoptosis was not suppressed in cholesterol-loaded Chop-/- macrophages transduced with Ero1a.	SEN:10026756	19752026
BEL:20051204	p(MGI:Ero1l) increases sec(p(MGI:Adipoq))	The reduction in Ero1-L{alpha} expression had no significant effect on synthesis of adiponectin or actin or secretion of adipsin, but it did significantly reduce the amount of adiponectin secreted from the cells (Fig. 7, compare lanes 1 to 3 with lane 4).	SEN:10026758	17452443
BEL:20051206	p(MGI:Ero1l) increases sec(p(MGI:Vegfa))	This reduction in Ero1-La led to a significant reduction in the constitutive amount of VEGF secreted to the medium (Figure 6b).	SEN:10026760	15592500
BEL:20051208	p(MGI:Errfi1) decreases bp(GOBP:"cell cycle")	Upon stimulation with EGF (0.3 ng/ml) or bFGF (0.3 ng/ml) about 20% of uninjected EGFR/ErbB-2 cells entered S phase (data not shown). We observed a similar rate of entrance into S phase when counting cells microinjected with a control antiserum (RAM, Figure 1e). Cells micro- injected with anti-RALT antibodies and stimulated with EGF progressed to S phase at a frequency which was 2.8-fold higher than control cells.	SEN:10026554	12226756
BEL:20051212	p(MGI:Errfi1) decreases complex(p(MGI:Erbb3),p(MGI:Erbb2))	We now report that RALT binds to ligand-activated epidermal growth factor receptor (EGFR), ErbB-4 and ErbB-2.ErbB-3 dimers. When ectopically expressed in 32D cells reconstituted with the above ErbB receptor tyrosine kinases (RTKs) RALT behaved as a pan-ErbB inhibitor.	SEN:10008634	12833145
BEL:20051216	p(MGI:Errfi1) decreases kin(p(MGI:Egfr))	We now report that RALT binds to ligand-activated epidermal growth factor receptor (EGFR), ErbB-4 and ErbB-2.ErbB-3 dimers. When ectopically expressed in 32D cells reconstituted with the above ErbB receptor tyrosine kinases (RTKs) RALT behaved as a pan-ErbB inhibitor.	SEN:10008634	12833145
BEL:20051220	p(MGI:Errfi1) decreases kin(p(MGI:Erbb2))	The ErbB-2 interacting protein receptor-associated late transducer (RALT) was previously identified as a feedback inhibitor of ErbB-2 mitogenic signals.	SEN:10021688	12833145
BEL:20051222	p(MGI:Errfi1) decreases kin(p(MGI:Erbb4))	We now report that RALT binds to ligand-activated epidermal growth factor receptor (EGFR), ErbB-4 and ErbB-2.ErbB-3 dimers. When ectopically expressed in 32D cells reconstituted with the above ErbB receptor tyrosine kinases (RTKs) RALT behaved as a pan-ErbB inhibitor.	SEN:10008634	12833145
BEL:20051230	p(MGI:Errfi1) decreases p(MGI:Erbb2)	We conclude that endogenous RALT protein behaves as a bonafide feedback inhibitor of the ErbB-2 kinase.	SEN:10026768	12226756
BEL:20051238	p(MGI:Esr1) increases r(MGI:F5)	\"Estrogen increases coagulation factor V mRNA levels via both estrogen receptor-alpha and -beta in murine bone marrow/bone.\"	SEN:10026772	15296482
BEL:20051248	p(MGI:Esr2) increases r(MGI:F5)	\"Estrogen increases coagulation factor V mRNA levels via both estrogen receptor-alpha and -beta in murine bone marrow/bone.\"	SEN:10026772	15296482
BEL:20051250	p(MGI:Ets1) increases bp(GOBP:"inflammatory response")	Figure 3 Reduction in the recruitment of inflammatory cells in Ets1–/– mice in response to Ang II.	SEN:10026778	16138193
BEL:20051252	p(MGI:Ets1) increases path(MESHD:Fibrosis)	Arterial wall thickening, perivascular fibrosis, and cardiac hypertrophy are significantly diminished in Ets1-/- mice compared with control mice in response to Ang II.	SEN:10008640	16138193
BEL:20051254	p(MGI:Ets1) increases path(MESHD:Hypertrophy)	Arterial wall thickening, perivascular fibrosis, and cardiac hypertrophy are significantly diminished in Ets1-/- mice compared with control mice in response to Ang II.	SEN:10008640	16138193
BEL:20051258	p(MGI:Ets1) increases r(MGI:Ccl2)	Knockdown of Ets-1 in WT-EC (70+/-3% reduction at Ets-1 protein level, n=4, P<0.05) abolished LPC- and TNFa-mediated VCAM-1 and MCP-1 mRNA expression (Figure 5B), suggesting that Ets-1 plays an important role in LPC/TNFa-mediated synthesis of VCAM-1 and MCP-1 downstream of PYK2.	SEN:10026782	21372295
BEL:20051260	p(MGI:Ets1) increases r(MGI:Nr1h3)	The Zta, Ets, and Hes1 transcription factors were all shown to mediate alterations in reporter gene activity driven by LXRalpha promoter deletion constructs	SEN:10008642	14680824
BEL:20051262	p(MGI:Ets1) increases r(MGI:Vcam1)	Knockdown of Ets-1 in WT-EC (70+/-3% reduction at Ets-1 protein level, n=4, P<0.05) abolished LPC- and TNFa-mediated VCAM-1 and MCP-1 mRNA expression (Figure 5B), suggesting that Ets-1 plays an important role in LPC/TNFa-mediated synthesis of VCAM-1 and MCP-1 downstream of PYK2.	SEN:10026782	21372295
BEL:20051264	p(MGI:Ets2) increases bp(GOBP:angiogenesis)	Consistent with these results, Ets2 ablation in TAMs led to decreased angiogenesis and decreased growth of tumors.	SEN:10008644	20145133
BEL:20051268	p(MGI:Ets2) increases bp(GOBP:"apoptotic process")	As shown in Fig. 7A, most cells undergoing Ets2 overexpression induced apoptosis (as judged from the condensed and fragmented appearance of the nuclei (Fig. 7B)) display activation of caspase-3.	SEN:10026784	14678752
BEL:20051270	p(MGI:Ets2) increases cat(p(MGI:Casp3))	As shown in Fig. 7A, most cells undergoing Ets2 overexpression induced apoptosis (as judged from the condensed and fragmented appearance of the nuclei (Fig. 7B)) display activation of caspase-3.	SEN:10026784	14678752
BEL:20051288	p(MGI:Ext1) decreases path(MESHD:Neoplasms)	Furthermore, the re-introduction of EXT1 into cancer cell lines displaying methylation-dependent silencing of EXT1 induces tumor-suppressor-like features,	SEN:10008652	15385438
BEL:20051322	p(MGI:F2) increases bp(GOBP:"neutrophil chemotaxis")	Concentrations of tumour necrosis factor-alpha (TNF-alpha) were elevated in BAL fluid from thrombin-treated mice, and a TNF-alpha-neutralising antibody inhibited the influx of neutrophils in response to thrombin.	SEN:10026804	15302675
BEL:20051332	p(MGI:F2rl1) increases path(MESHD:Fibrosis)	In PAR-2-/- mice, both the extent and severity of fibrotic lesions are reduced, whereas myofibroblast differentiation is diminished and collagen expression is decreased.	SEN:10026808	20971733
BEL:20051334	p(MGI:F2) increases r(MGI:Col1a1)	However, when bleomycin-treated animals concurrently received a continuous infusion of a direct thrombin inhibitor at an anticoagulant dose, lung collagen accumulation in response to bleomycin was attenuated by up to 40%. Furthermore, alpha(1)(I) procollagen and CTGF mRNA levels were also significantly reduced in these animals.	SEN:10008662	12023853
BEL:20051336	p(MGI:F2) increases r(MGI:Ctgf)	However, when bleomycin-treated animals concurrently received a continuous infusion of a direct thrombin inhibitor at an anticoagulant dose, lung collagen accumulation in response to bleomycin was attenuated by up to 40%. Furthermore, alpha(1)(I) procollagen and CTGF mRNA levels were also significantly reduced in these animals.	SEN:10008662	12023853
BEL:20051338	p(MGI:F2) increases r(MGI:Dtna)	Although PAR2 was upregulated in cytokine-stimulated endothelial cells, APC signaling remained PAR1-dependent. Large-scale gene expression profiling documented marked differences in both up- and downregulated genes between APC and thrombin signaling in cytokine-stimulated cells. APC downregulated IIa upregulated	SEN:10025144	15769747
BEL:20051342	p(MGI:F3) increases bp(GOBP:angiogenesis)	mice embryos deficient in tissue factor have an impaired pattern of extraembryonic angiogenesis and VWF increases endothelial cell activation	SEN:10026812	11350732
BEL:20051346	p(MGI:Fabp3) increases a(CHEBI:"arachidonic acid")	In brains from H-FABP gene-ablated mice, the incorporation coefficient for [1-(14)C]20:4n-6 was reduced 24%	SEN:10008664	15835924
BEL:20051350	p(MGI:Fabp3) increases a(CHEBI:phospholipid)	The brain total phospholipid mass was reduced 17% by gene ablation, ascribed to a 27% and 32% reduction in the masses of ChoGpl and sphingomyelin	SEN:10008666	15835924
BEL:20051352	p(MGI:Fabp3) increases a(CHEBI:sphingomyelin)	The brain total phospholipid mass was reduced 17% by gene ablation, ascribed to a 27% and 32% reduction in the masses of ChoGpl and sphingomyelin	SEN:10008666	15835924
BEL:20051378	p(MGI:Fabp4) increases kin(p(MGI:Ikbkb))	It has also been demonstrated that A-FABP deficiency results in reduction in the activity of the inhibitor of kappa kinase (IKK)-nuclear factor-kappaB (NF-kappaB) pathway	SEN:10026824	18511927
BEL:20051382	p(MGI:Fabp4) decreases r(MGI:Abca1)	PPAR-gamma activity was elevated in A-FABP-/- macrophages with stimulation of downstream targets including LXR-alpha and ABCA1, resulting in enhanced efflux of cholesterol	SEN:10026820	18511927
BEL:20051388	p(MGI:Fabp4) decreases r(MGI:Nr1h3)	PPAR-gamma activity was elevated in A-FABP-/- macrophages with stimulation of downstream targets including LXR-alpha and ABCA1, resulting in enhanced efflux of cholesterol	SEN:10026820	18511927
BEL:20051392	p(MGI:Fabp4) decreases tscript(p(MGI:Pparg))	PPAR-gamma activity was elevated in A-FABP-/- macrophages with stimulation of downstream targets including LXR-alpha and ABCA1, resulting in enhanced efflux of cholesterol	SEN:10026820	18511927
BEL:20051416	p(MGI:Fadd) increases bp(GOBP:"necrotic cell death")	However, TNF-induced necrosis is inhibited in Fadd-deficient mouse embryonic fibroblasts (MEFs) (49).	SEN:10026836	20354226
BEL:20051422	p(MGI:Fadd) increases r(MGI:Ifna2)	FADD-/- fibroblasts are defective in type I IFN induction that is independent of IFN signaling [57].	SEN:10026840	16474425
BEL:20051424	p(MGI:Fadd) increases r(MGI:Ifna4)	FADD-/- fibroblasts are defective in type I IFN induction that is independent of IFN signaling [57].	SEN:10026840	16474425
BEL:20051426	p(MGI:Fadd) increases r(MGI:Ifna5)	FADD-/- fibroblasts are defective in type I IFN induction that is independent of IFN signaling [57].	SEN:10026840	16474425
BEL:20051428	p(MGI:Fadd) increases r(MGI:Irf7)	FADD-/- fibroblasts are defective in type I IFN induction that is independent of IFN signaling [57].	SEN:10026840	16474425
BEL:20051442	p(MGI:Fap) increases p(MGI:Ptk2,pmod(P,Y,397))	Indeed, we found that tumors from Fap-null mice compared with those from Fap wild-type mice and tumors from mice treated with PT630 but not with LAF237 compared with those from vehicle control–treated mice showed an increase in phospho-FAK Tyr397 and phospho-ERK (p44/42)	SEN:10026846	19920354
BEL:20051444	p(MGI:Fas) increases bp(GOBP:"apoptotic process")	Finally, reconstitution of Stat6-deficient splenic B cells with Bcl-xL was able to protect those cells from Fas-induced cell death. These results suggest that the anti-apoptotic activity of IL-4 in B cells is mediated through the activation of Stat6 and subsequent transcription of Bcl-xL.	SEN:10026848	12023955
BEL:20051446	p(MGI:Fas) increases kin(p(MGI:Mapk8))	Peroxynitrite-mediated JNK activation has been associated with apoptotic cell death in murine alveolar C10 cells, in which JNK was activated upon the oxidation of the death receptor Fas.	SEN:10016160	19273391
BEL:20051448	p(MGI:Fasl) increases bp(GOBP:"inflammatory response")	Fas ligand-deficient generalized lymphoproliferative disease mutant (gld) mice did not develop silicosis. The gld mice had markedly reduced neutrophil extravasation into bronchoalveolar space, and did not show increased TNF-alpha production, nor pulmonary inflammation	SEN:10026850	11457890
BEL:20051450	p(MGI:Fasl) increases bp(GOBP:"neutrophil extravasation")	Fas ligand-deficient generalized lymphoproliferative disease mutant (gld) mice did not develop silicosis. The gld mice had markedly reduced neutrophil extravasation into bronchoalveolar space, and did not show increased TNF-alpha production, nor pulmonary inflammation	SEN:10026850	11457890
BEL:20051454	p(MGI:Fasl) directlyIncreases cat(p(MGI:Fas))	The protein Daxx promotes Fas-mediated cell death through activation of apoptosis signal-regulating kinase 1, leading to the activation of the MAPKs JNK and p38.	SEN:10002340	17082815
BEL:20051464	p(MGI:Fasl) increases sec(p(MGI:Tnf))	Fas ligand-deficient generalized lymphoproliferative disease mutant (gld) mice did not develop silicosis. The gld mice had markedly reduced neutrophil extravasation into bronchoalveolar space, and did not show increased TNF-alpha production, nor pulmonary inflammation	SEN:10026850	11457890
BEL:20051484	p(MGI:Fbxo32) increases cat(p(MGI:Fbxo32))	we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.	SEN:10021546	15109499
BEL:20051502	p(MGI:Fdft1) increases a(CHEBI:dolichol)	it was found that a 6-fold increase in Fdft1 activity compared with that of the wild-type did not cause significant changes in HmgCoA reductase activity, while the amounts of synthesized dolichols and ergosterols increased by 80 and 32 percent respectively Fdft1 is the enzyme that regulates the flow rate of synthesized mevalonic acid pathway products independent of HmgCoA reductase	SEN:10000074	10623644
BEL:20051504	p(MGI:Fdft1) increases a(CHEBI:ergosterol)	it was found that a 6-fold increase in Fdft1 activity compared with that of the wild-type did not cause significant changes in HmgCoA reductase activity, while the amounts of synthesized dolichols and ergosterols increased by 80 and 32 percent respectively Fdft1 is the enzyme that regulates the flow rate of synthesized mevalonic acid pathway products independent of HmgCoA reductase	SEN:10000074	10623644
BEL:20051508	p(MGI:Fgb) increases p(MGI:Plg)	Fibrinogen (Fgb), the tissue activator of plasminogen (t-PA) and its inhibitor (PAI-1) are described as so-called cardiovascular risk factors.	SEN:10008684	8681360
BEL:20051510	p(MGI:Fgf10) increases r(MGI:Ctsh)	In a global screen for transcriptional targets of Fgf10, we identified Ctsh (cathepsin H), a gene encoding a lysosomal cysteine protease of the papain family, highly up-regulated in the developing lung epithelium.	SEN:10008686	17500053
BEL:20051518	p(MGI:Fgf1) increases bp(GOBP:"epithelial to mesenchymal transition")	In addition to oncogenic Ras (Oft et al., 1996), hepatocyte growth factor (HGF)/scatter factor (SF), fibroblast growth factor (FGF), and TGF alone induce mesenchymal features in diverse epithelial cell systems (Brinkmann et al., 1995; Piek et al., 1999; Thiery and Chopin, 1999).	SEN:10026880	11790801
BEL:20051522	p(MGI:Fgf1) increases bp(GOBP:"apoptotic process")	However, immature osteoblasts respond to FGF treatment with increased proliferation, whereas in differentiating cells FGF does not induce DNA synthesis but causes apoptosis.	SEN:10008692	10851026
BEL:20051524	p(MGI:Fgf1) increases kin(p(MGI:Fgfr2))	FGFs activate the endogenous FGFRs leading to the formation of a Grb2/FRS2/Shp2 complex and activation of MAP kinase.	SEN:10006144	10851026
BEL:20051532	p(MGI:Fgf1) decreases r(MGI:Alpl)	When either primary or OB1 osteoblasts are induced to differentiate, FGF signaling inhibits expression of alkaline phosphatase, and blocks mineralization.	SEN:10008694	10851026
BEL:20051538	p(MGI:Fgf1) increases r(MGI:Atp2a2)	The level of FAS and SERCA2 mRNA expression is increased rapidly after FGF-1 addition; in contrast, PFK mRNA is induced with kinetics more typical of delayed-early genes. These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation	SEN:10008698	7506544
BEL:20051540	p(MGI:Fgf1) increases r(MGI:Atp2a2)	These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation.	SEN:10008700	7506544
BEL:20051544	p(MGI:Fgf1) increases r(MGI:Fasn)	The level of FAS and SERCA2 mRNA expression is increased rapidly after FGF-1 addition; in contrast, PFK mRNA is induced with kinetics more typical of delayed-early genes. These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation	SEN:10008698	7506544
BEL:20051546	p(MGI:Fgf1) increases r(MGI:Fasn)	These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation.	SEN:10008700	7506544
BEL:20051552	p(MGI:Fgf1) increases r(MGI:Pfkl)	The level of FAS and SERCA2 mRNA expression is increased rapidly after FGF-1 addition; in contrast, PFK mRNA is induced with kinetics more typical of delayed-early genes. These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation	SEN:10008698	7506544
BEL:20051554	p(MGI:Fgf1) increases r(MGI:Pfkl)	These results indicate that enhanced expression of the PFK, FAS and SERCA2 proteins may be important for FGF-1-stimulated cell proliferation.	SEN:10008700	7506544
BEL:20051566	p(MGI:Fgf2) increases bp(GOBP:angiogenesis)	These data demonstrate that the heparin-binding specificities of intact TSP1 and peptides from the type 1 repeats overlap with that of basic fibroblast growth factor (FGF2) and are consistent with the ability of these TSP1-derived molecules to inhibit FGF2-stimulated angiogenesis.	SEN:10026888	10640391
BEL:20051568	p(MGI:Fgf2) increases bp(GOBP:angiogenesis)	the platelet-derived growth factor receptor-alpha (PDGFRalpha)-p70S6K signal transduction pathway in mesenchymal cells, which is required for functional angiogenesis induced by fibroblast growth factor-2	SEN:10022036	15059936
BEL:20051570	p(MGI:Fgf2) increases bp(GOBP:"cell cycle")	Here we provide evidence that both the mitogenic effect of bFGF and the differentiation-promoting effect of NT3 are linked with modifications of cell cycle kinetics in mouse cortical precursor cells	SEN:10000274	12151540
BEL:20051572	p(MGI:Fgf2) increases bp(GOBP:"cell proliferation")	IL-18 is a novel inhibitor of angiogenesis, sufficiently potent to supress tumor growth by directly inhibiting fibroblast growth factor 2 induced endothelial cell proliferation	SEN:10026890	12857959
BEL:20051578	p(MGI:Fgf2) increases bp(GOBP:mitosis)	Both the mitogenic potential and the nuclear localization of bFGF were markedly inhibited in the Swiss 3T3 cells upon its oxidation by LO.	SEN:10000284	12461785
BEL:20051588	p(MGI:Fgf2) increases bp(GOBP:"apoptotic process")	However, immature osteoblasts respond to FGF treatment with increased proliferation, whereas in differentiating cells FGF does not induce DNA synthesis but causes apoptosis.	SEN:10008692	10851026
BEL:20051590	p(MGI:Fgf2) decreases cat(p(MGI:Cdkn1b))	bFGF downregulates p27(kip1) and upregulates cyclin D2 expression. This contrasts with NT3, which upregulates p27(kip1) and downregulates cyclin D2 expression	SEN:10008708	12151540
BEL:20051592	p(MGI:Fgf2) increases cat(p(MGI:Sdc4))	recent studies showed that syndecan-4, a non-tyrosine kinase transmembrane protein also funcrions as an FGF receptor	SEN:10026896	16940428
BEL:20051596	p(MGI:Fgf2) directlyIncreases kin(p(MGI:Fgfr1))	FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.	SEN:10026898	10896947
BEL:20051598	p(MGI:Fgf2) increases kin(p(MGI:Fgfr1))	These data indicate that adenovirus-mediated expression of mSef reduced FGF-induced tyrosine phosphorylation of FGFR without affecting the overall level of FGFR expression (Fig.4 A).	SEN:10026900	12604616
BEL:20051600	p(MGI:Fgf2) increases kin(p(MGI:Fgfr2))	FGFs activate the endogenous FGFRs leading to the formation of a Grb2/FRS2/Shp2 complex and activation of MAP kinase.	SEN:10006144	10851026
BEL:20051602	p(MGI:Fgf2) increases kin(p(MGI:Mapk1))	FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.	SEN:10026898	10896947
BEL:20051604	p(MGI:Fgf2) increases kin(p(MGI:Mapk3))	FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.	SEN:10026898	10896947
BEL:20051608	p(MGI:Fgf2) increases p(MGI:Fgfr1,pmod(P,Y))	These data indicate that adenovirus-mediated expression of mSef reduced FGF-induced tyrosine phosphorylation of FGFR without affecting the overall level of FGFR expression (Fig.4 A).	SEN:10026900	12604616
BEL:20051612	p(MGI:Fgf2) decreases r(MGI:Alpl)	When either primary or OB1 osteoblasts are induced to differentiate, FGF signaling inhibits expression of alkaline phosphatase, and blocks mineralization.	SEN:10008694	10851026
BEL:20051614	p(MGI:Fgf2) increases r(MGI:Ccnd2)	bFGF downregulates p27(kip1) and upregulates cyclin D2 expression. This contrasts with NT3, which upregulates p27(kip1) and downregulates cyclin D2 expression	SEN:10008708	12151540
BEL:20051616	p(MGI:Fgf2) increases r(MGI:Cdkn1a)	We show here that fibroblast growth factor-2 (FGF-2), platelet-derived growth factor (PDGF), and transforming growth factor-beta1 (TGF-beta1) all induce p21 expression in mouse fibroblasts, but with markedly different kinetics.	SEN:10026904	10511312
BEL:20051622	p(MGI:Fgf2) decreases r(MGI:Lox)	Function blocking anti-fibroblast growth factor-2 (FGF-2) antibody enhanced lysyl oxidase expression in the absence of suramin.	SEN:10008714	12788924
BEL:20051628	p(MGI:Fgf2) increases r(MGI:Plau)	We have previously shown in NIH 3T3 fibroblasts that treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA) or fibroblast growth factor-2 (FGF-2) activates the Ras/Erk signaling pathway in NIH 3T3 fibroblasts, leading to the induction of the urokinase-type plasminogen activator (uPA) gene.	SEN:10008710	9409785
BEL:20051630	p(MGI:Fgf2) decreases r(MGI:Pparg)	We observed that certain cytokine and growth factors [such as TNF alpha, basic fibroblast growth factor, transforming growth factor beta, and protein kinase C-activating agents plus calcium ionophore], when added to differentiated adipocytes, cause rapid down-regulation of PPARgamma mRNA expression	SEN:10008716	9202217
BEL:20051636	p(MGI:Fgf7) increases bp(GOBP:"cell proliferation")	The vaginae cultured with 5 microg/ml E2 or 5 microg/ml KGF had a cornified thick epithelium, while the epithelium of the vehicle-treated controls stayed thin. The E2 effect was blocked by concurrent treatment with anti-KGF antibody or KGFR inhibitory peptide.	SEN:10003376	15480797
BEL:20051644	p(MGI:Fgf8) decreases bp(GOBP:"cell death")	Thus, unlike other FGF family members, which regulate growth and branching morphogenesis of the collecting duct system, Fgf8 encodes a factor essential for gene regulation and cell survival at distinct steps in nephrogenesis.	SEN:10008720	16049112
BEL:20051646	p(MGI:Fgf8) increases r(MGI:Frs2)	On the other hand, FRS2 expression seemed to be up-regulated slightly in the FGF8-stimulated cells	SEN:10021698	15897591
BEL:20051650	p(MGI:Fgf8) increases r(MGI:Lhx1)	In the absence of FGF8 signaling, nephron formation is initiated, but the nascent nephrons do not express Wnt4 or Lim1, and nephrogenesis does not progress to the S-shaped body stage.	SEN:10008722	16049112
BEL:20051654	p(MGI:Fgf8) increases r(MGI:Pitx1)	Bead implantation experiments demonstrate that ectopic expression of Fgf8 can induce/maintain the expression of both Pitx1 and Pitx2 at E9.5. In contrast, Bmp4-expressing tissues and BMP4-soaked beads were able to repress Pitx1 expression in mandibular mesenchyme and Pitx2 expression	SEN:10025520	10625557
BEL:20051656	p(MGI:Fgf8) increases r(MGI:Pitx2)	Bead implantation experiments demonstrate that ectopic expression of Fgf8 can induce/maintain the expression of both Pitx1 and Pitx2 at E9.5. In contrast, Bmp4-expressing tissues and BMP4-soaked beads were able to repress Pitx1 expression in mandibular mesenchyme and Pitx2 expression	SEN:10025520	10625557
BEL:20051660	p(MGI:Fgf8) increases r(MGI:Wnt4)	In the absence of FGF8 signaling, nephron formation is initiated, but the nascent nephrons do not express Wnt4 or Lim1, and nephrogenesis does not progress to the S-shaped body stage.	SEN:10008722	16049112
BEL:20051662	p(MGI:Fgfbp1) increases p(MGI:Fgf1)	FGF-BP1 is an extracellular matrix bound protein that enhances fibroblast growth factor (FGF) signaling.	SEN:10026914	16690027
BEL:20051670	p(MGI:Fhit) decreases kin(p(MGI:Atr))	We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.	SEN:10026918	16204026
BEL:20051672	p(MGI:Fhit) decreases kin(p(MGI:Chek1))	We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.	SEN:10026918	16204026
BEL:20051704	p(MGI:Fkbp1a) decreases r(MGI:Mmp9)	We further confirmed FKBP mediated up-regulation of Sdc1 mRNA levels (Table 2) and down-regulation of MMP9 by stably overexpressing Fkbp1a or Fkbp8 in B16-F10 cells	SEN:10026928	14612567
BEL:20051706	p(MGI:Fkbp1a) decreases r(MGI:Mmp9)	We then used gene expression profiling to identify syndecan 1 (Sdc1) and matrix metalloproteinase 9 (MMP9) as genes directly regulated by Fkbp1a and Fkbp8.	SEN:10008738	14612567
BEL:20051708	p(MGI:Fkbp1a) increases r(MGI:Sdc1)	Syndecan 1 (Sdc1) mRNA was consistently up-regulated 4-5 fold in B16-F10 cells by either Fkbp8 or Fkbp1a gene expression,	SEN:10026930	14612567
BEL:20051710	p(MGI:Fkbp1a) increases r(MGI:Sdc1)	We then used gene expression profiling to identify syndecan 1 (Sdc1) and matrix metalloproteinase 9 (MMP9) as genes directly regulated by Fkbp1a and Fkbp8.	SEN:10008738	14612567
BEL:20051714	p(MGI:Fkbp8) decreases r(MGI:Mmp9)	We further confirmed FKBP mediated up-regulation of Sdc1 mRNA levels (Table 2) and down-regulation of MMP9 by stably overexpressing Fkbp1a or Fkbp8 in B16-F10 cells	SEN:10026928	14612567
BEL:20051716	p(MGI:Fkbp8) increases r(MGI:Sdc1)	Syndecan 1 (Sdc1) mRNA was consistently up-regulated 4-5 fold in B16-F10 cells by either Fkbp8 or Fkbp1a gene expression,	SEN:10026930	14612567
BEL:20051724	p(MGI:Fli1) increases tscript(p(MGI:Gata1))	Unexpectedly, FLI-1 enhances the stimulating activity of GATA-1 on a GATA-1-responsive promoter but represses that of EKLF on beta-globin and an EKLF-responsive artificial promoters.	SEN:10026936	12556498
BEL:20051726	p(MGI:Fli1) decreases tscript(p(MGI:Klf1))	Unexpectedly, FLI-1 enhances the stimulating activity of GATA-1 on a GATA-1-responsive promoter but represses that of EKLF on beta-globin and an EKLF-responsive artificial promoters.	SEN:10026936	12556498
BEL:20051750	p(MGI:Flt3l) increases tscript(p(MGI:Stat3))	Consistent with this model, studies of conditional Stat3 KO mice show that Stat3 is activated by Flt3L in lineage negative bone marrow progenitor cells and Stat3 is required for the development of pDC and CD8alpha+ DC [13].	SEN:10026944	16474425
BEL:20051754	p(MGI:Fn1) increases complex(p(MGI:Itga5),p(MGI:Itgb1))	The matrix glycoprotein fibronectin stimulates the proliferation of non-small cell lung carcinoma (NSCLC) in vitro through alpha5beta1 integrin receptor-mediated signals.	SEN:10026948	20081050
BEL:20051772	p(MGI:Fosl1) increases r(MGI:Cd44)	We have used siRNA approaches to show that Fra-1 expression is critical to the expression of genes, such as cd44 and c-met, that are critical to migration and autocrine growth factor production in transformation and invasion of mesotheliomas (13).	SEN:10026962	16484683
BEL:20051774	p(MGI:Fosl1) increases r(MGI:Met)	We have used siRNA approaches to show that Fra-1 expression is critical to the expression of genes, such as cd44 and c-met, that are critical to migration and autocrine growth factor production in transformation and invasion of mesotheliomas (13).	SEN:10026962	16484683
BEL:20051784	p(MGI:Foxa2) decreases bp(GOBP:"response to endoplasmic reticulum stress")	Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress.	SEN:10008748	18660816
BEL:20051788	p(MGI:Foxa2) increases p(MGI:Abcc2)	Both mRNA and protein levels of Mrp2 and Mrp4 were decreased in the livers of Foxa2-mutant mice on both standard chow and cholic acid–enriched feed (Fig. 3a,b).	SEN:10026970	18660816
BEL:20051790	p(MGI:Foxa2) increases p(MGI:Abcc3)	Furthermore, the induction of Mrp3 normally seen in livers of mice fed a cholic acid–supplemented diet was blunted in the absence of Foxa2 (Fig. 3a,b).	SEN:10026972	18660816
BEL:20051792	p(MGI:Foxa2) increases p(MGI:Abcc4)	Both mRNA and protein levels of Mrp2 and Mrp4 were decreased in the livers of Foxa2-mutant mice on both standard chow and cholic acid–enriched feed (Fig. 3a,b).	SEN:10026970	18660816
BEL:20051794	p(MGI:Foxa2) decreases r(MGI:Abcb1b)	mRNA levels of two isoforms of Mdr1, an alternative bile acid transporter23, were increased in Foxa2 mutants (significantly (P < 0.02)	SEN:10026974	18660816
BEL:20051796	p(MGI:Foxa2) increases r(MGI:Abcc2)	Both mRNA and protein levels of Mrp2 and Mrp4 were decreased in the livers of Foxa2-mutant mice on both standard chow and cholic acid–enriched feed (Fig. 3a,b).	SEN:10026970	18660816
BEL:20051798	p(MGI:Foxa2) increases r(MGI:Abcc3)	Furthermore, the induction of Mrp3 normally seen in livers of mice fed a cholic acid–supplemented diet was blunted in the absence of Foxa2 (Fig. 3a,b).	SEN:10026972	18660816
BEL:20051800	p(MGI:Foxa2) increases r(MGI:Abcc4)	Both mRNA and protein levels of Mrp2 and Mrp4 were decreased in the livers of Foxa2-mutant mice on both standard chow and cholic acid–enriched feed (Fig. 3a,b).	SEN:10026970	18660816
BEL:20051802	p(MGI:Foxa2) decreases r(MGI:Nr0b2)	Strikingly, maximal activation of Shp transcription also occurs in Foxa2-deficient mice on standard chow (Fig. 1c).	SEN:10026976	18660816
BEL:20051826	p(MGI:Foxc2) increases bp(GOBP:angiogenesis)	Finally, ex vivo aortic ring assay to test the sprouting and microvessel formation revealed enhanced microvessel outgrowth by Foxc2 overexpression	SEN:10008752	18579532
BEL:20051828	p(MGI:Foxc2) increases bp(GOBP:"patterning of blood vessels")	Finally, ex vivo aortic ring assay to test the sprouting and microvessel formation revealed enhanced microvessel outgrowth by Foxc2 overexpression	SEN:10008752	18579532
BEL:20051850	p(MGI:Foxf1) increases r(MGI:Tbx2)	By cDNA expression array analysis and RNase protection assay, the Tbx family of transcription factors such as Tbx2, 3, 4, and 5 which, like Foxf1, are expressed in the lung mesenchyme (Chapman et al., 1996) were found to be diminished in Foxf1+/- mutant background (Kalinichenko et al., 2001b), implicating the potential role of Foxf1 in the transcriptional regulation of Tbx genes.	SEN:10027000	15136151
BEL:20051852	p(MGI:Foxf1) increases r(MGI:Tbx3)	By cDNA expression array analysis and RNase protection assay, the Tbx family of transcription factors such as Tbx2, 3, 4, and 5 which, like Foxf1, are expressed in the lung mesenchyme (Chapman et al., 1996) were found to be diminished in Foxf1+/- mutant background (Kalinichenko et al., 2001b), implicating the potential role of Foxf1 in the transcriptional regulation of Tbx genes.	SEN:10027000	15136151
BEL:20051854	p(MGI:Foxf1) increases r(MGI:Tbx4)	By cDNA expression array analysis and RNase protection assay, the Tbx family of transcription factors such as Tbx2, 3, 4, and 5 which, like Foxf1, are expressed in the lung mesenchyme (Chapman et al., 1996) were found to be diminished in Foxf1+/- mutant background (Kalinichenko et al., 2001b), implicating the potential role of Foxf1 in the transcriptional regulation of Tbx genes.	SEN:10027000	15136151
BEL:20051856	p(MGI:Foxf1) increases r(MGI:Tbx5)	By cDNA expression array analysis and RNase protection assay, the Tbx family of transcription factors such as Tbx2, 3, 4, and 5 which, like Foxf1, are expressed in the lung mesenchyme (Chapman et al., 1996) were found to be diminished in Foxf1+/- mutant background (Kalinichenko et al., 2001b), implicating the potential role of Foxf1 in the transcriptional regulation of Tbx genes.	SEN:10027000	15136151
BEL:20051880	p(MGI:Foxl1) increases r(MGI:Il7r)	This alteration is shown to be due to the delayed formation of Peyer's patches organizing centers as revealed by the expressions of VCAM1 and IL-7 receptor alpha-chain at 17.5 days postcoitus.	SEN:10008758	12648490
BEL:20051884	p(MGI:Foxl1) increases r(MGI:Vcam1)	This alteration is shown to be due to the delayed formation of Peyer's patches organizing centers as revealed by the expressions of VCAM1 and IL-7 receptor alpha-chain at 17.5 days postcoitus.	SEN:10008758	12648490
BEL:20051910	p(MGI:Foxm1) increases r(MGI:Aqp5)	Consistent with diminished numbers of squamous type I cells in epFoxm1-/- lungs, mRNA levels of T1-alpha and aquaporin 5 were significantly decreased as demonstrated by quantitative real-time (RT-PCR) (qRT-PCR) analysis (Fig. 3B).	SEN:10027030	19033457
BEL:20051912	p(MGI:Foxm1) increases r(MGI:Ccnb1)	Western and Northern analyses reveals that elevated FoxM1 levels lead to stimulation of cyclin B1 but not cyclin D1 expression. Transient reporter assays in the dox-inducible lines and upon co-transfection with a constitutive FoxM1 expression plasmid suggest that FoxM1 can activate the cyclin B1 promoter.	SEN:10008762	11682060
BEL:20051920	p(MGI:Foxm1) increases r(MGI:Cdc25b)	Significantly decreased mRNA levels of M-phase-promoting Cdc25B phosphatase (Fig. 3B), a known transcriptional target of Foxm1 (15), were observed in the lungs of epFoxm1-/- mice.	SEN:10027038	19033457
BEL:20051922	p(MGI:Foxm1) increases r(MGI:Pdpn)	Consistent with diminished numbers of squamous type I cells in epFoxm1-/- lungs, mRNA levels of T1-alpha and aquaporin 5 were significantly decreased as demonstrated by quantitative real-time (RT-PCR) (qRT-PCR) analysis (Fig. 3B).	SEN:10027030	19033457
BEL:20051934	p(MGI:Foxo1) decreases bp(GOBP:"cell migration")	Partial knockout of Foxo1 in Foxo1(+/-) mice throughout the body led to accelerated skin wound healing with enhanced keratinocyte migration	SEN:10008766	25010393
BEL:20051944	p(MGI:Foxo1) decreases bp(GOBP:"wound healing")	Partial knockout of Foxo1 in Foxo1(+/-) mice throughout the body led to accelerated skin wound healing with enhanced keratinocyte migration	SEN:10008766	25010393
BEL:20051950	p(MGI:Foxo1) increases p(MGI:Kcnj8)	In electrophoretic mobility-shift assays, FoxO1 binds to the FoxO concensus site of the KATP channel subunit KIR6.1 promoter. In primary atrial culture, targeting FoxO1 and FoxO3 with siRNA specifically reduces mRNA expression of FoxO1 and -O3 and KIR6.1.	SEN:10008774	18202312
BEL:20051958	p(MGI:Foxo1) decreases r(MGI:Adipoq)	Fibroblast growth factor 2, adiponectin, and notch1 genes were significantly increased at wound sites in Foxo1+/? mice	SEN:10008780	25010393
BEL:20051960	p(MGI:Foxo1) decreases r(MGI:Fgf2)	Fibroblast growth factor 2, adiponectin, and notch1 genes were significantly increased at wound sites in Foxo1+/? mice	SEN:10008780	25010393
BEL:20051962	p(MGI:Foxo1) decreases r(MGI:Notch1)	Fibroblast growth factor 2, adiponectin, and notch1 genes were significantly increased at wound sites in Foxo1+/? mice	SEN:10008780	25010393
BEL:20051966	p(MGI:Foxo3) increases bp(GOBP:"apoptotic process")	Both cytokine withdrawal and FKHR-L1 activity induced apoptosis within a similar time frame. (Annexin V staining)	SEN:10027044	11815629
BEL:20051968	p(MGI:Foxo3) increases cat(p(MGI:Casp3))	Using antibodies specific for cleaved caspase-3 and -7, their activation was analyzed after cytokine withdrawal (and FKHR-L1 activation). Caspase-3 (Fig. 4 A, top) and -7 (Fig. 4 A, middle) were both cleaved after cytokine withdrawal.	SEN:10027046	11815629
BEL:20051970	p(MGI:Foxo3) increases cat(p(MGI:Casp7))	Using antibodies specific for cleaved caspase-3 and -7, their activation was analyzed after cytokine withdrawal (and FKHR-L1 activation). Caspase-3 (Fig. 4 A, top) and -7 (Fig. 4 A, middle) were both cleaved after cytokine withdrawal.	SEN:10027046	11815629
BEL:20051972	p(MGI:Foxo3) increases cat(p(MGI:Parp1))	Both IL-3 withdrawal (Fig. 4 C, left) and forkhead activity (Fig. 4 C, right) resulted in PARP cleavage with kinetics similar to caspase activation. (Western Blot)	SEN:10027048	11815629
BEL:20051976	p(MGI:Foxo3) increases p(MGI:Bcl2l11)	Both cytokine withdrawal and FKHR-L1 activation resulted in an upregulation of p27KIP1 and Bim. (Western Blot).	SEN:10027052	11815629
BEL:20051980	p(MGI:Foxo3) increases p(MGI:Cdkn1b)	Both cytokine withdrawal and FKHR-L1 activation resulted in an upregulation of p27KIP1 and Bim. (Western Blot).	SEN:10027052	11815629
BEL:20051984	p(MGI:Foxo3) increases tloc(p(MGI:Cycs),GOCCID:0005739,GOCCID:0005737)	Again, in control cells, cytochrome c was localized in the mitochondria, whereas in the presence of LY294002 (PI3K inhibitor), cytochrome c was released into the cytosol. Similarly, treatment with 4-OHT strongly induced cytochrome c release into the cytosol in FKHR-L1(A3):ER* Ba/F3 cells.	SEN:10017004	11815629
BEL:20051986	p(MGI:Foxo4,pmod(P,T,447)) increases tloc(p(MGI:Foxo4),GOCCID:0005737,GOCCID:0005634)	JNK (c-Jun kinase), another stress-activated protein kinase, phosphorylates FoxO4 at Thr447 and Thr451 and triggers the relocalization of FoxO family members from the cytoplasm to the nucleus (Essers et al., 2004; Oh et al., 2005) (Figure 2).	SEN:10021984	18391970
BEL:20051988	p(MGI:Foxo4,pmod(P,T,451)) increases tloc(p(MGI:Foxo4),GOCCID:0005737,GOCCID:0005634)	JNK (c-Jun kinase), another stress-activated protein kinase, phosphorylates FoxO4 at Thr447 and Thr451 and triggers the relocalization of FoxO family members from the cytoplasm to the nucleus (Essers et al., 2004; Oh et al., 2005) (Figure 2).	SEN:10021984	18391970
BEL:20052006	p(MGI:Fpr1) increases bp(GOBP:"macrophage chemotaxis")	Compared with wild-type mice, Fpr1 knockout mice displayed marked decreases in the lung migration of neutrophils and macrophages after CS exposure.	SEN:10027068	22461430
BEL:20052008	p(MGI:Fpr1) increases bp(GOBP:"neutrophil chemotaxis")	Compared with wild-type mice, Fpr1 knockout mice displayed marked decreases in the lung migration of neutrophils and macrophages after CS exposure.	SEN:10027068	22461430
BEL:20052010	p(MGI:Frs2,pmod(P,Y,196)) directlyIncreases complex(p(MGI:Frs2),p(MGI:Grb2))	We have previously demonstrated that complex formation between the SH2 domain of Grb2 and FRS2a is mediated via Y196-, Y306-, Y349-, and Y392-designated Grb2 binding sites (4, 5).	SEN:10027070	11447289
BEL:20052012	p(MGI:Frs2,pmod(P,Y,306)) directlyIncreases complex(p(MGI:Frs2),p(MGI:Grb2))	We have previously demonstrated that complex formation between the SH2 domain of Grb2 and FRS2a is mediated via Y196-, Y306-, Y349-, and Y392-designated Grb2 binding sites (4, 5).	SEN:10027070	11447289
BEL:20052014	p(MGI:Frs2,pmod(P,Y,349)) directlyIncreases complex(p(MGI:Frs2),p(MGI:Grb2))	We have previously demonstrated that complex formation between the SH2 domain of Grb2 and FRS2a is mediated via Y196-, Y306-, Y349-, and Y392-designated Grb2 binding sites (4, 5).	SEN:10027070	11447289
BEL:20052016	p(MGI:Frs2,pmod(P,Y,392)) directlyIncreases complex(p(MGI:Frs2),p(MGI:Grb2))	We have previously demonstrated that complex formation between the SH2 domain of Grb2 and FRS2a is mediated via Y196-, Y306-, Y349-, and Y392-designated Grb2 binding sites (4, 5).	SEN:10027070	11447289
BEL:20052018	p(MGI:Frs2,pmod(P,Y,436)) directlyIncreases complex(p(MGI:Frs2),p(MGI:Ptpn11))	In addition, FRS2a recruits Grb2 indirectly by means of two binding sites for the SH2 domains of the protein tyrosine phosphatase Shp2 at Y436- and Y471-designated Shp2 binding sites (5).	SEN:10027072	11447289
BEL:20052020	p(MGI:Frs2,pmod(P,Y,471)) directlyIncreases complex(p(MGI:Frs2),p(MGI:Ptpn11))	In addition, FRS2a recruits Grb2 indirectly by means of two binding sites for the SH2 domains of the protein tyrosine phosphatase Shp2 at Y436- and Y471-designated Shp2 binding sites (5).	SEN:10027072	11447289
BEL:20052036	p(MGI:Fst) directlyDecreases r(MGI:Gnrhr)	Since alphaT3-1 cells, like gonadotropes, secrete activin, we examined the ability of follistatin, an activin binding protein, to block the activin response. Increasing concentrations of follistatin from 0 to 100 ng/ml resulted in a dose dependent decrease in activity of the -600 promoter.	SEN:10008782	10098536
BEL:20052038	p(MGI:Furin) increases cat(p(MGI:Adam17))	It is thought that ADAM17 maturation (activation by the cleavage of the propeptide by proprotein convertases, such as furin and PC7) occurs during transit or on arrival at the cell surface (FIG. 4a), and this may be similar for other ADAMs.	SEN:10027084	19005493
BEL:20052042	p(MGI:Fzd10) increases bp(GOBP:"Wnt receptor signaling pathway")	In recent years, other mechanisms of activation of the canonical Wnt pathway in tumours have been discovered; for example, silencing of the genes that encode the inhibitory Wnt ligands SFRPs and DKKs by hypermethylation, or by overexpression of Wnt proteins (WNT2B for example), Frizzleds (FZD10 for example) or Dishevelled142–149	SEN:10026466	18432252
BEL:20052044	p(MGI:Fzd2) increases p(MGI:Sftpc)	By contrast, reexpression of Fzd2 in Gata6 flox/flox:Sftpc-cre mutant lungs by electroporation of a Fzd2 expression plasmid led to a substantial increase in SP-C expression (Fig. 5m).	SEN:10027088	18536717
BEL:20052048	p(MGI:Fzd4) increases bp(GOBP:angiogenesis)	Administration of 1.99.25 inhibited physiological and pathologic sprouting angiogenesis within the retina	SEN:10027092	21743011
BEL:20052050	p(MGI:Fzd4) increases bp(GOBP:"patterning of blood vessels")	Administration of 1.99.25 inhibited physiological and pathologic sprouting angiogenesis within the retina	SEN:10027092	21743011
BEL:20052058	p(MGI:Fzr1) decreases deg(p(MGI:Skp2))	The deficiency of Cks1 in TGF-beta-treated cells likely contributes to the stabilization of Kip1 protein and destabilization of Skp2, because in the absence of Cks1, SCFSkp2 cannot ubiquitinate Kip1 protein; instead, self-ubiquitination of Skp2 occurs.	SEN:10027096	14676846
BEL:20052060	p(MGI:Fzr1) decreases p(MGI:Cdkn1b)	The deficiency of Cks1 in TGF-beta-treated cells likely contributes to the stabilization of Kip1 protein and destabilization of Skp2, because in the absence of Cks1, SCFSkp2 cannot ubiquitinate Kip1 protein; instead, self-ubiquitination of Skp2 occurs.	SEN:10027096	14676846
BEL:20052062	p(MGI:Fzr1) increases p(MGI:Skp2)	The deficiency of Cks1 in TGF-beta-treated cells likely contributes to the stabilization of Kip1 protein and destabilization of Skp2, because in the absence of Cks1, SCFSkp2 cannot ubiquitinate Kip1 protein; instead, self-ubiquitination of Skp2 occurs.	SEN:10027096	14676846
BEL:20052070	p(MGI:G6pdx) decreases a(CHEBI:"reactive oxygen species")	Inhibition of G6PD with siRNA led to increased ROS and apoptosis, decreased proliferation, and impaired insulin secretion.	SEN:10027098	20032314
BEL:20052072	p(MGI:G6pdx) increases bp(GOBP:"cell proliferation")	Inhibition of G6PD with siRNA led to increased ROS and apoptosis, decreased proliferation, and impaired insulin secretion.	SEN:10027098	20032314
BEL:20052074	p(MGI:G6pdx) increases bp(GOBP:"insulin secretion")	Inhibition of G6PD with siRNA led to increased ROS and apoptosis, decreased proliferation, and impaired insulin secretion.	SEN:10027098	20032314
BEL:20052084	p(MGI:Gabarap) increases bp(GOBP:autophagy)	A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy.	SEN:10025412	21179212
BEL:20052100	p(MGI:Gadd45a) directlyDecreases kin(p(MGI:Aurka))	Furthermore Gadd45a was demonstrated to strongly inhibit Aurora-A kinase activity and to antagonize Aurora-A-induced centrosome amplification.	SEN:10027106	16772293
BEL:20052102	p(MGI:Gadd45a) directlyIncreases kin(p(MGI:Gsk3b))	We show that Gadd45a not only directly associates with two components of the APC complex, namely protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta) but also promotes GSK3beta dephosphorylation at Ser9, which is essential for GSK3beta activation, and resultant activation of the APC destruction complex.	SEN:10008794	14647429
BEL:20052122	p(MGI:Gadd45a) decreases tscript(p(MGI:Ctnnb1))	While most beta-catenin protein is localized to the cell membrane and is involved in cell-cell adhesion, accumulation of free cytoplasmic beta-catenin will translocate into the nucleus where it functions in a bipartite transcription factor complex, whose targets include invasion and metastasis promoting endopeptidases, matrix metalloproteinases (MMP).	SEN:10027112	14647429
BEL:20052152	p(MGI:Gata1) increases r(MGI:Jak2)	Other notable genes downregulated with GATA-1 knockdown are the p45 subunit of nuclear factor erythroid-derived 2 (NF- E2), JAK2, and beta1-tubulin.	SEN:10027130	17127443
BEL:20052154	p(MGI:Gata1) increases r(MGI:Nfe2)	Other notable genes downregulated with GATA-1 knockdown are the p45 subunit of nuclear factor erythroid-derived 2 (NF- E2), JAK2, and beta1-tubulin.	SEN:10027130	17127443
BEL:20052156	p(MGI:Gata1) increases r(MGI:Nfe2)	Figure 5. Synergistic Activation of Transcription by FOG and GATA-1 from p45 NF-E2 Regulatory Sequences	SEN:10027132	9230307
BEL:20052160	p(MGI:Gata1) increases r(MGI:Tubb1)	Other notable genes downregulated with GATA-1 knockdown are the p45 subunit of nuclear factor erythroid-derived 2 (NF- E2), JAK2, and beta1-tubulin.	SEN:10027130	17127443
BEL:20052170	p(MGI:Gata3) increases bp(GOBP:"T-helper 2 cell differentiation")	early studies have indicated that Stat6 (8, 9, 10), a cytosolic latent transcription factor that is rapidly activated after cellular exposure to IL-4 and IL-13, is essential for Th2 cell differentiation through the induction of GATA3 (5, 6, 7),	SEN:10027138	15749913
BEL:20052180	p(MGI:Gata3) increases r(MGI:Gfi1b)	Gfi1b mRNA was decreased approximately 3-fold 48 hours after infection of lymphomas with Gata3siRNA virus (Figure 7A). To further test the ability of Gata3 to promote Gfi1b mRNA expression we used a Gata3-producing retrovirus to ectopically express Gata3 protein (Figure 7C). Gata3 induced Gfi1b mRNA by 12- or 6-fold over control virus-infected cells in 1.F9 or 0531 lymphomas, respectively (Figure 7D).	SEN:10027144	17272506
BEL:20052184	p(MGI:Gata4) increases r(MGI:Hnf1b)	In contrast to Sox7, exogenous expression of Gata-4 or Gata-6 induced the expression of laminin alpha1 and Hnf1b in undifferentiated F9 and F9H1Sox7 cells without RA/Bt2cAMP treatment (Fig. 5 and 6 ).	SEN:10027148	15542856
BEL:20052188	p(MGI:Gata4) increases tscript(p(MGI:"Nkx2-5"))	Within the proximal A1AR promoter, putative binding sites for cardiac transcription factors GATA and Nkx2.5 were identified. Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression	SEN:10027152	10318839
BEL:20052190	p(MGI:Gata6) decreases bp(GOBP:"cell proliferation")	In wild-type lungs, cellular proliferation is normally very low in bronchiolar epithelium (Fig. 3 and ref. 6). By contrast, cellular proliferation was substantially increased in bronchiolar epithelium of Gata6 flox/flox:Sftpc-cre mutants (Fig. 3a–g).	SEN:10027154	18536717
BEL:20052192	p(MGI:Gata6) decreases p(MGI:Ctnnb1)	Increased expression of activated b-catenin protein was readily observed in Gata6 flox/flox:Sftpc-cre mutants at E18.5 (Fig. 5a,b).	SEN:10027156	18536717
BEL:20052202	p(MGI:Gata6) decreases r(MGI:Bmp4)	Previously described targets of canonical Wnt signaling such as Fgfr2, Mycn (N-myc) and Bmp4 were also upregulated in Gata6 flox/flox:Sftpc-cre mutants (Supplementary Fig. 2 online).	SEN:10027160	18536717
BEL:20052204	p(MGI:Gata6) decreases r(MGI:Fgfr2)	Previously described targets of canonical Wnt signaling such as Fgfr2, Mycn (N-myc) and Bmp4 were also upregulated in Gata6 flox/flox:Sftpc-cre mutants (Supplementary Fig. 2 online).	SEN:10027160	18536717
BEL:20052206	p(MGI:Gata6) increases r(MGI:Fzd2)	Fzd2 expression was specifically downregulated in airway epithelium of Gata6 flox/flox:Sftpc-cre mutants, as determined by RT-PCR and in situ hybridization analyses (Fig. 4b–f).	SEN:10027162	18536717
BEL:20052208	p(MGI:Gata6) increases r(MGI:Hnf1b)	In contrast to Sox7, exogenous expression of Gata-4 or Gata-6 induced the expression of laminin alpha1 and Hnf1b in undifferentiated F9 and F9H1Sox7 cells without RA/Bt2cAMP treatment (Fig. 5 and 6 ).	SEN:10027148	15542856
BEL:20052210	p(MGI:Gata6) increases r(MGI:Lama1)	The laminin alpha1 expression levels were significantly reduced in cells silenced for Sox7, Gata-6, or Gata-4/6 compared to those in control cells, indicating that either Sox7 or Gata-6 is indispensable for the induction of laminin alpha1 expression in F9 cells treated with RA/Bt2cAMP (Fig. 2 ).	SEN:10027164	15542856
BEL:20052212	p(MGI:Gata6) decreases r(MGI:Mycn)	Previously described targets of canonical Wnt signaling such as Fgfr2, Mycn (N-myc) and Bmp4 were also upregulated in Gata6 flox/flox:Sftpc-cre mutants (Supplementary Fig. 2 online).	SEN:10027160	18536717
BEL:20052240	p(MGI:Gdf11) decreases bp(GOBP:"cell proliferation")	TSA up-regulates the expression of the gene encoding growth-differentiation factor 11 (Gdf11), a transforming growth factor beta family member that inhibits cell proliferation.	SEN:10008802	15169878
BEL:20052248	p(MGI:Gdf2) increases kin(p(MGI:Acvrl1))	BMP9 also activates the Id1 promoter-derived BMP response element (BRE) in a dose-dependent manner (EC50 = 45 +/-; 27 pg/ml) and this activation is abolished by silencing ALK1 expression	SEN:10021506	17068149
BEL:20052250	p(MGI:Gdf2) directlyIncreases kin(p(MGI:Acvrl1))	Combined blockade of Alk1 and Notch signaling further exacerbates hypervascularization, whereas activation of Alk1 by its high-affinity ligand BMP9 rescues hypersprouting induced by Notch inhibition	SEN:10021504	22421041
BEL:20052252	p(MGI:Gdf2) increases p(MGI:Acvrl1)	BMP9 also induced expression of the inhibitory SMAD6 2 hr after growth factor addition (Figure 3A). SMAD1,5,8 and ERK activation was ALK1 dependent, as shown by siRNA-mediated knockdown of ALK1, which abolished BMP9-mediated SMAD phosphorylation and decreased phospho-ERK levels (Figure 3B).	SEN:10027178	22421041
BEL:20052254	p(MGI:Gdf2) increases r(MGI:Id1)	BMP9 also activates the Id1 promoter-derived BMP response element (BRE) in a dose-dependent manner (EC50 = 45 +/-; 27 pg/ml) and this activation is abolished by silencing ALK1 expression	SEN:10021506	17068149
BEL:20052258	p(MGI:Gdf5) increases r(MGI:Barx2)	We also found that two members of the BMP family that are crucial for chondrogenesis, GDF5 and BMP4, regulate the pattern of Barx2 expression	SEN:10008138	15800003
BEL:20052272	p(MGI:Gfap) decreases bp(GOBP:"cell proliferation")	We find that mutant GFAP, as well as excess wild type GFAP, promotes formation of cytoplasmic inclusions, disrupts the cytoskeleton, decreases cell proliferation, increases cell death, reduces proteasomal function, and compromises astrocyte resistance to stress.	SEN:10008810	19146851
BEL:20052274	p(MGI:Gfap) increases bp(GOBP:"apoptotic process")	We find that mutant GFAP, as well as excess wild type GFAP, promotes formation of cytoplasmic inclusions, disrupts the cytoskeleton, decreases cell proliferation, increases cell death, reduces proteasomal function, and compromises astrocyte resistance to stress.	SEN:10008810	19146851
BEL:20052280	p(MGI:Gfpt1) increases path(MESHD:"Insulin Resistance")	For example, insulin resistance results when the rate-limiting enzyme for hexosamine synthesis, glutamine:fructose-6-phosphate amidotransferase (GFA), is overexpressed in muscle and adipose tissue of transgenic mice	SEN:10008812	10067838
BEL:20052306	p(MGI:Gh) increases p(MGI:Ckm)	At 36 weeks of age, significant increases in AST, CK, and LDH values were observed in the transgenic mice c	SEN:10027196	16026778
BEL:20052308	p(MGI:Gh) increases p(MGI:Fabp3)	Minute histological changes along with focal and slight degeneration of cardiomyocytes were observed in the transgenic hearts at 12 weeks of age, but the only chemical value to change was that of H-FABP, which increased significantly	SEN:10008826	16026778
BEL:20052310	p(MGI:Gh) increases p(MGI:Got1)	At 36 weeks of age, significant increases in AST, CK, and LDH values were observed in the transgenic mice c	SEN:10027196	16026778
BEL:20052314	p(MGI:Gh) increases p(MGI:Jak2)	The isoform SH2-Bbeta modulates JAK2 activity by binding to the phosphorylated enzyme, further increasing its activity. in an animal model of GH excess in which JAK2 is not phosphorylated, although it is increased in the membrane-fraction, both the level of SH2-Bbeta, and especially its association to membranes, are augmented.	SEN:10027198	15845922
BEL:20052318	p(MGI:Gh) increases p(MGI:Sh2b1)	The isoform SH2-Bbeta modulates JAK2 activity by binding to the phosphorylated enzyme, further increasing its activity. in an animal model of GH excess in which JAK2 is not phosphorylated, although it is increased in the membrane-fraction, both the level of SH2-Bbeta, and especially its association to membranes, are augmented.	SEN:10027198	15845922
BEL:20052330	p(MGI:Gh) increases r(MGI:Cebpd)	Concomitant with the translationally activated increase in C/EBP beta, a GH-dependent increase was observed in C/EBP delta transcription.	SEN:10008834	7760844
BEL:20052332	p(MGI:Gh) decreases r(MGI:Fabp3)	Administration of IGF-I or GH to Ghrhrlit/Ghrhrlit mice suppressed MDGI mRNA levels in a dose-dependent manner.	SEN:10008836	9683796
BEL:20052334	p(MGI:Gh) decreases r(MGI:Fasn)	In this study, we demonstrate that GH and PRL decrease the mRNA and protein levels of FAS in 3T3-L1 adipocytes.	SEN:10027204	15983196
BEL:20052336	p(MGI:Gh) increases r(MGI:Fos)	In 3T3-F442A fibroblasts stably expressing the c-fos promoter mutated at the C/EBP binding site upstream of luciferase, c-fos promoter activity is stimulated by GH 6-7-fold; wild type c-fos promoter shows only a 2-fold induction by GH.	SEN:10008838	10531366
BEL:20052348	p(MGI:Gh) increases r(MGI:Pik3r1)	We found that p85alpha expression 1) is decreased in WAT from mice with isolated GH deficiency, 2) is increased in WAT from mice with chronic GH excess, 3) is acutely upregulated in WAT from GH-deficient and -sufficient mice after GH administration,	SEN:10027208	17363744
BEL:20052350	p(MGI:Gh) decreases r(MGI:Ppara)	Previous in vitro studies have shown that growth hormone (GH) can inhibit PPARalpha-dependent gene expression by down-regulation of PPARalpha expression and by a novel inhibitory cross-talk involving the GH-activated transcription factor STAT5b. ...A corresponding increase in mRNA, was observed in the STAT5b-deficient mice, suggesting a transcriptional mechanism for the observed increases.	SEN:10027210	12127257
BEL:20052352	p(MGI:Gh) increases r(MGI:Serpina3k)	GAGA box of the rat serine protease inhibitor 2 (spi 2) genes not only acts as a basal promoter element, but also mediates transcriptional activation by growth hormone and interleukin-6.	SEN:10008844	11154060
BEL:20052354	p(MGI:Gh) increases r(MGI:Serpine1)	Interestingly, 500 ng/ml GH and 30 ng/ml IL-6 increased PAI-1 secretion five-fold and 3.6-fold, respectively. Furthermore, GH and IL-6 induced PAI-1 mRNA by up to 7.3-fold, and 3.6-fold, respectively, in a time-dependent fashion with significant stimulation seen at concentrations as low as 5 ng/ml GH and 10 ng/ml IL-6.	SEN:10008846	16713670
BEL:20052358	p(MGI:Gh) increases sec(p(MGI:Serpine1))	Interestingly, 500 ng/ml GH and 30 ng/ml IL-6 increased PAI-1 secretion five-fold and 3.6-fold, respectively. Furthermore, GH and IL-6 induced PAI-1 mRNA by up to 7.3-fold, and 3.6-fold, respectively, in a time-dependent fashion with significant stimulation seen at concentrations as low as 5 ng/ml GH and 10 ng/ml IL-6.	SEN:10008846	16713670
BEL:20052360	p(MGI:Gh) increases tscript(p(MGI:Stat5b))	Previous in vitro studies have shown that growth hormone (GH) can inhibit PPARalpha-dependent gene expression by down-regulation of PPARalpha expression and by a novel inhibitory cross-talk involving the GH-activated transcription factor STAT5b. ...A corresponding increase in mRNA, was observed in the STAT5b-deficient mice, suggesting a transcriptional mechanism for the observed increases.	SEN:10027210	12127257
BEL:20052366	p(MGI:Gja1) decreases bp(GOBP:"fat cell differentiation")	Remarkably, retroviral expression of either Gja1 or Tll1 in 3T3-L1 preadipocytes also inhibited adipocyte differentiation	SEN:10008850	18945812
BEL:20052374	p(MGI:Gja1) decreases kin(p(MGI:Src))	In addition, NECA- or Cx43-specific siRNA also stimulated Src phosphorylation as shown in Figure 3B.	SEN:10027218	20232318
BEL:20052386	p(MGI:Gkap1,pmod(P)) directlyIncreases complex(p(MGI:Gkap1),p(MGI:Prkg1))	Although both cGK-Ialpha and -Ibeta, but not cAMP-dependent protein kinase, phosphorylated GKAP42 in vitro, GKAP42 was a good substrate only for cGK-Ialpha in intact cells	SEN:10022102	10671526
BEL:20052392	p(MGI:Gli1) increases bp(GOBP:"apoptotic process")	Figure 4. Forced Gli1 expression in NSCs results in increased cell death and accumulation of cells in G2/M phase of the cell cycle.	SEN:10027224	18276799
BEL:20052404	p(MGI:Gli3) decreases p(MGI:Kdr)	Interestingly, we found that the level of endothelial cell differentiation in the E15.5 Shh-/- lung mesenchyme is reduced, based on PECAM-1 and Flk-1 staining, while Shh-/-;Gli3-/- lung mesenchyme displays a relatively increased distribution of PECAM-1- and Flk-1-positive cells (Figs. 6A-b–c,h–i).	SEN:10027230	15136151
BEL:20052406	p(MGI:Gli3) decreases p(MGI:Pecam1)	Interestingly, we found that the level of endothelial cell differentiation in the E15.5 Shh-/- lung mesenchyme is reduced, based on PECAM-1 and Flk-1 staining, while Shh-/-;Gli3-/- lung mesenchyme displays a relatively increased distribution of PECAM-1- and Flk-1-positive cells (Figs. 6A-b–c,h–i).	SEN:10027230	15136151
BEL:20052408	p(MGI:Gli3) decreases r(MGI:Foxf1)	Foxf1 is derepressed in Shh-/- lung in the absence of Gli3, although not to the levels expressed in age-matched wild-type lung (Fig. 5A-l, E12.5 and Fig. 5Bc, E15.5).	SEN:10027232	15136151
BEL:20052412	p(MGI:Gli3) decreases r(MGI:Tbx2)	In contrast, Tbx2 and Tbx3 expressions are significantly repressed in Shh-/- and enhanced in Shh-/-;Gli3-/- lungs (Figs. 5B-e,h,f,i).	SEN:10027236	15136151
BEL:20052414	p(MGI:Gli3) decreases r(MGI:Tbx3)	In contrast, Tbx2 and Tbx3 expressions are significantly repressed in Shh-/- and enhanced in Shh-/-;Gli3-/- lungs (Figs. 5B-e,h,f,i).	SEN:10027236	15136151
BEL:20052416	p(MGI:Glp1r) increases bp(GOBP:"cell proliferation")	In contrast, Glp1r-/- thymocytes exhibited a hypoproliferative response, whilst peripheral Glp1r-/- lymphocytes were hyperproliferative in response to mitogenic stimulation	SEN:10008860	20225396
BEL:20052418	p(MGI:Glp1r) decreases bp(GOBP:"cell proliferation")	In contrast, Glp1r-/- thymocytes exhibited a hypoproliferative response, whilst peripheral Glp1r-/- lymphocytes were hyperproliferative in response to mitogenic stimulation	SEN:10008860	20225396
BEL:20052422	p(MGI:Glrx) increases p(MGI:Ccl3)	In the Grx1 KO, the cigarette smoke-induced upregulation of these cytokines was significantly impaired, compared to the wild type controls. Moreover, the baseline levels of IL12(p40), GCSF, RANTES, MIP-1a, TNFa (data not shown) and IFNg (data not shown) were found to be lower in the BAL fluid of Grx1 KO mice compared to wild type mice	SEN:10027240	22723915
BEL:20052424	p(MGI:Glrx) increases p(MGI:Ccl5)	In the Grx1 KO, the cigarette smoke-induced upregulation of these cytokines was significantly impaired, compared to the wild type controls. Moreover, the baseline levels of IL12(p40), GCSF, RANTES, MIP-1a, TNFa (data not shown) and IFNg (data not shown) were found to be lower in the BAL fluid of Grx1 KO mice compared to wild type mice	SEN:10027240	22723915
BEL:20052426	p(MGI:Glrx) increases p(MGI:Csf3)	In the Grx1 KO, the cigarette smoke-induced upregulation of these cytokines was significantly impaired, compared to the wild type controls. Moreover, the baseline levels of IL12(p40), GCSF, RANTES, MIP-1a, TNFa (data not shown) and IFNg (data not shown) were found to be lower in the BAL fluid of Grx1 KO mice compared to wild type mice	SEN:10027240	22723915
BEL:20052428	p(MGI:Glrx) increases p(MGI:Il12b)	In the Grx1 KO, the cigarette smoke-induced upregulation of these cytokines was significantly impaired, compared to the wild type controls. Moreover, the baseline levels of IL12(p40), GCSF, RANTES, MIP-1a, TNFa (data not shown) and IFNg (data not shown) were found to be lower in the BAL fluid of Grx1 KO mice compared to wild type mice	SEN:10027240	22723915
BEL:20052432	p(MGI:Glul) increases a(CHEBI:"reactive oxygen species")	Knockdown of PYGL, GLUL, or GLUD1 partially reduced the degree of TNF- and zVAD-fmk–mediated ROS production and necrosis.	SEN:10027244	20354226
BEL:20052434	p(MGI:Gmfb,pmod(P)) directlyIncreases kin(p(MGI:Mapk14))	intracellular interaction of PKA, GMF, and p38 is supported by the phosphorylation of GMF upon cellular stimulation by forskolin (blocked by PKA inhibitor) and by the co-immunoprecipitation of p38 with GMF from cell lysates. Withdrawal of nerve growth factor from PC12 leads to increased GMF phosphorylation with a time course similar to that reported for p38 activation.	SEN:10016716	8798479
BEL:20052442	p(MGI:Gmnn) directlyDecreases cat(p(MGI:Cdt1))	Geminin binds tightly to Cdt1, an essential component of the replication licensing system, and prevents the inappropriate reinitiation of replication on an already fired origin.	SEN:10027246	15286659
BEL:20052448	p(MGI:Gnai2) decreases phos(p(MGI:Ptpn1))	The expression and activity of the protein-tyrosine phosphatase 1B (PTP1B), but not protein-tyrosine phosphatases SHP-1, SHP-2, and LAR, were constitutively decreased in tissues expressing the Q205L Galpha(i2).	SEN:10008864	11500506
BEL:20052450	p(MGI:Gnai2) decreases r(MGI:Ptpn1)	The expression and activity of the protein-tyrosine phosphatase 1B (PTP1B), but not protein-tyrosine phosphatases SHP-1, SHP-2, and LAR, were constitutively decreased in tissues expressing the Q205L Galpha(i2).	SEN:10008864	11500506
BEL:20052452	p(MGI:Gnaq) increases tport(p(MGI:Slc2a4))	As shown in Fig. 1B, single-cell microinjection of Galpha q/11 antibody or RGS2 protein into 3T3-L1 adipocytes markedly inhibited (70 and 81%, respectively) insulin induced-GLUT4 translocation.	SEN:10027248	10490615
BEL:20052458	p(MGI:Gopc) decreases p(MGI:Cftr)	when overexpressed, GOPC, which is thought to influence traffic in the endocytic/secretory pathway, causes a large reduction in the amounts of both channels, probably by leading them to the degradative end of this pathway.	SEN:10008866	12471024
BEL:20052460	p(MGI:Gopc) decreases p(MGI:Clcn3)	when overexpressed, GOPC, which is thought to influence traffic in the endocytic/secretory pathway, causes a large reduction in the amounts of both channels, probably by leading them to the degradative end of this pathway.	SEN:10008866	12471024
BEL:20052464	p(MGI:Gpi1) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	Ectopic overexpression of PGI results in the acquisition of a transformed phenotype associated with an acceleration of G1 to S cell cycle transition.	SEN:10008868	12783864
BEL:20052470	p(MGI:Gpi1) increases p(MGI:Ccnd1)	These were manifested by up-regulation of cyclin D1 expression and cyclin-dependent kinase activity and down-regulation of the cyclin-dependent kinase inhibitor p27Kip1.	SEN:10008870	12783864
BEL:20052472	p(MGI:Gpi1) decreases p(MGI:Cdkn1b)	The reduced p27Kip1 protein expression level in PGI-overexpressing cells could be restored to control levels by treatment with proteasome inhibitor.	SEN:10018322	12783864
BEL:20052474	p(MGI:Gpi1) decreases p(MGI:Cdkn1b)	These were manifested by up-regulation of cyclin D1 expression and cyclin-dependent kinase activity and down-regulation of the cyclin-dependent kinase inhibitor p27Kip1.	SEN:10008870	12783864
BEL:20052478	p(MGI:Gpi1) increases p(MGI:Skp2)	PGI-overexpressing cells also exhibited elevated expression of Skp2 involved in p27Kip1 ubiquitination and elevation in the levels of retinoblastoma protein hyperphosphorylation.	SEN:10008872	12783864
BEL:20052484	p(MGI:Gpm6a) increases p(MGI:Dcx)	Moreover, our results show a decrease in both the number of neuronal markers and the number of differentiating neuronal cells (cholinergic, catecholaminergic, and GABAergic neurons) from NSC in D3m-shM6A cells (tubb3, MAP2, DCX, nestin)	SEN:10027252	18522499
BEL:20052486	p(MGI:Gpm6a) increases p(MGI:Tubb3)	Moreover, our results show a decrease in both the number of neuronal markers and the number of differentiating neuronal cells (cholinergic, catecholaminergic, and GABAergic neurons) from NSC in D3m-shM6A cells (tubb3, MAP2, DCX, nestin)	SEN:10027252	18522499
BEL:20052552	p(MGI:Grb2) increases path(MESHD:Fibrosis)	Mice with haploinsufficiency of the Grb2 gene (Grb2(+/-) mice) appear normal at birth but have defective T cell signaling. In response to pressure overload, cardiac p38 MAPK and JNK activation was inhibited and cardiac hypertrophy and fibrosis was blocked in Grb2(+/-) mice.	SEN:10027278	12639989
BEL:20052554	p(MGI:Grb2) increases path(MESHD:Hypertrophy)	Mice with haploinsufficiency of the Grb2 gene (Grb2(+/-) mice) appear normal at birth but have defective T cell signaling. In response to pressure overload, cardiac p38 MAPK and JNK activation was inhibited and cardiac hypertrophy and fibrosis was blocked in Grb2(+/-) mice.	SEN:10027278	12639989
BEL:20052556	p(MGI:Grb2) increases r(MGI:Plau)	Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.	SEN:10008888	10347197
BEL:20052560	p(MGI:Grip1) increases complex(p(MGI:Actn2),p(MGI:Actn2))	We further demonstrated that mACTN2 could enhance two transactivation activities of GRIP1, which in turn could enhance the homodimerization of mACTN2.	SEN:10024868	15072553
BEL:20052564	p(MGI:Grn) increases bp(GOBP:"neutrophil extravasation")	When applied to a cutaneous wound, progranulin increased the accumulation of neutrophils, macrophages, blood vessels and fibroblasts in the wound.	SEN:10008890	12524533
BEL:20052578	p(MGI:Gsk3b) increases p(MGI:Ctnnb1,pmod(P))	cytoplasmic ??catenin is recruited into a destruction complex, in which it interacts with APC and the axins, and is N?terminally phosphorylated by casein kinase 1? (CK1a) and GSK3?84?88	SEN:10026200	18432252
BEL:20052582	p(MGI:Gsn) decreases bp(GOBP:"apoptotic process")	Thus, our data on Jo2-induced hepatic failure suggest that gelsolin exerts an overall anti-apoptotic effect in vivo.	SEN:10008898	16507893
BEL:20052584	p(MGI:Gsn) decreases r(MGI:Il1b)	Significant reductions in brain levels of early cytokines, including IL-1beta and IL-6 mRNA expression, and late cytokine high mobility group box-1 protein (HMGB1), were found in the gelsolin-treated group compared to the placebo group at all time points (Figure 4).	SEN:10027282	21936896
BEL:20052586	p(MGI:Gsn) decreases r(MGI:Il6)	Significant reductions in brain levels of early cytokines, including IL-1beta and IL-6 mRNA expression, and late cytokine high mobility group box-1 protein (HMGB1), were found in the gelsolin-treated group compared to the placebo group at all time points (Figure 4).	SEN:10027282	21936896
BEL:20052616	p(MGI:"H2-T23") increases bp(GOBP:"T cell activation")	the non-classical MHC class IB molecule Qa-1, encoded by H2-T23, is capable of presenting antigens to alpha beta and gamma delta T cells	SEN:10008902	9708188
BEL:20052618	p(MGI:H6pd) decreases bp(GOBP:"response to endoplasmic reticulum stress")	We propose that the absence of H6PD induces a progressive myopathy by altering the SR redox state, thereby impairing protein folding and activating the unfolded protein response pathway. These studies thus define a novel metabolic pathway that links ER stress to skeletal muscle integrity and function.	SEN:10027304	18222920
BEL:20052630	p(MGI:Hbegf) decreases complex(p(MGI:Nppa),p(MGI:Npr3))	Epidermal growth factor (EGF) and heparin-binding (HB)-EGF, but not platelet-derived growth factor or insulin-like growth factor I, inhibited (125)I-ANP binding to ND-NOD and D-NOD mesangial cells, particularly in the latter.	SEN:10026560	11457715
BEL:20052632	p(MGI:Hbegf) decreases p(MGI:Npr3)	NPR-C density decreased with no change in the apparent dissociation constant, and there was also a decrease in NPR-C mRNA expression.	SEN:10026580	11457715
BEL:20052638	p(MGI:Hbegf) decreases r(MGI:Npr3)	NPR-C density decreased with no change in the apparent dissociation constant, and there was also a decrease in NPR-C mRNA expression.	SEN:10026580	11457715
BEL:20052640	p(MGI:Hbp1) decreases bp(GOBP:"cell cycle")	As depicted in Fig. 1, several observations indicated that HBP1 could be part of proliferation barriers with shared functional similarity to RB in differentiation and in G1 control. HBP1 is consistently up regulated in differentiation and under conditions of cell cycle arrest in muscle, adipocyte, erythroid, and other cell types.	SEN:10027312	15225871
BEL:20052642	p(MGI:Hbp1) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	In each of the differentiation models, the cells exit the cell cycle and trigger differentiation-specific genes (reviewed in Yee et al., 1998). In one system, the proper ratio of HBP1 and RB was necessary for orderly progression of the differentiation process (Shih et al., 1998). Consistent with these results, we showed that overexpression of HBP1 in cells inhibited G1 and S-phase progression (Tevosian et al., 1997).	SEN:10027314	15225871
BEL:20052650	p(MGI:Hbp1,pmod(P,S,401)) directlyDecreases deg(p(MGI:Hbp1))	A specific p38 MAPK-docking site (aa 81 125) and a p38 MAPK phosphorylation site (serine 401) were identified in the HBP1 protein. No other MAPK appeared to specifically bind and phosphorylate HBP1. In defining the role of p38 MAPK regulation, the inhibition of p38 MAPK activity was shown to decrease HBP1 protein levels by triggering protein instability that is manifested by a decrease in protein half-life.	SEN:10021918	15225871
BEL:20052662	p(MGI:Hck) increases bp(GOBP:"cell proliferation")	identification of an acidic domain of gp130 as a binding region for Hck, which mediates proliferative signaling the deletion of this region of gp130 resulted in a significant reduction of Hck kinase activity and cell proliferation upon stimulation of gp130 compared to wild-type gp130	SEN:10019254	11689697
BEL:20052686	p(MGI:Hcn4) decreases path(MESHD:Bradycardia)	Younger embryos lacking HCN4 channels have slow heart rate and show almost complete suppression of If.	SEN:10027340	18626064
BEL:20052690	p(MGI:Hdac1) increases bp(GOBP:"apoptotic process")	overexpression of HDAC1 enhanced TGF-B1-induced apoptosis, and the rescue of HDAC1 expression in HDAC1 RNAi cells restored the apoptotic response of cells to TGF-B1. These data indicate that HDAC1 functions as a proapoptotic factor in TGF-B1-induced apoptosis	SEN:10027342	21364650
BEL:20052696	p(MGI:Hdac2) decreases bp(GOBP:"apoptotic process")	In contrast, downregulation of HDAC2 by RNAi increased spontaneous apoptosis and markedly enhanced TGF-B1-induced apoptosis, suggesting that HDAC2 has a reciprocal role in controlling cell survival.	SEN:10027348	21364650
BEL:20052718	p(MGI:Hdac7) decreases tscript(p(MGI:Mef2c))	Furthermore, we demonstrate that DNA-bound MEF2C is capable of recruiting HDAC7, demonstrating that the HDAC7-dependent repression of transcription is not due to the inhibition of the MEF2 DNA binding activity.	SEN:10008918	11585834
BEL:20052722	p(MGI:Hes1) decreases complex(p(MGI:Ascl1),p(MGI:Tcf3))	n addition, Hes6 suppresses Hes1 from inhibiting Mash1-E47 heterodimer and thereby enables Mash1 and E47 to upregulate transcription in the presence of Hes1.	SEN:10027352	10851137
BEL:20052724	p(MGI:Hes1) increases complex(p(MGI:Jak2),p(MGI:Stat3))	Importantly, expression of Myc–Hes1 greatly increased the amount of endogenous JAK2 coprecipitated with endogenous STAT3 (Fig. 4e), suggesting that Hes1 facilitates the interaction between JAK2 and its substrate STAT3	SEN:10027354	15156153
BEL:20052732	p(MGI:Hes1) increases r(MGI:Nr1h3)	The Zta, Ets, and Hes1 transcription factors were all shown to mediate alterations in reporter gene activity driven by LXRalpha promoter deletion constructs	SEN:10008642	14680824
BEL:20052734	p(MGI:Hes1) increases tscript(p(MGI:Stat3))	Expression of either Hes1 or Hes5 significantly activated the STAT reporter gene construct in both E13 neuroepithelial cells and MNS-70 cells,	SEN:10027358	15156153
BEL:20052748	p(MGI:Hes5) increases tscript(p(MGI:Stat3))	Expression of either Hes1 or Hes5 significantly activated the STAT reporter gene construct in both E13 neuroepithelial cells and MNS-70 cells,	SEN:10027358	15156153
BEL:20052754	p(MGI:Hes6) decreases r(MGI:Msc)	Constitutive expression of HES6 in myoblasts inhibited expression of MyoR, a repressor of myogenesis, and induced differentiation, as evidenced by fusion into myotubes and expression of the muscle marker myosin heavy chain.	SEN:10008926	11551980
BEL:20052756	p(MGI:Hes6) increases tscript(p(MGI:Ascl1))	n addition, Hes6 suppresses Hes1 from inhibiting Mash1-E47 heterodimer and thereby enables Mash1 and E47 to upregulate transcription in the presence of Hes1.	SEN:10027352	10851137
BEL:20052758	p(MGI:Hes6) increases tscript(p(MGI:Tcf3))	n addition, Hes6 suppresses Hes1 from inhibiting Mash1-E47 heterodimer and thereby enables Mash1 and E47 to upregulate transcription in the presence of Hes1.	SEN:10027352	10851137
BEL:20052764	p(MGI:Hey1) decreases bp(GOBP:"patterning of blood vessels")	siRNA-mediated knockdown of HEY1 and HEY2 (Figure S4E) suppressed BMP9-mediated inhibition of tube formation and effects on downstream gene expression (Figures 4A, 4D, 4E, and 4G)	SEN:10027362	22421041
BEL:20052766	p(MGI:Hey1) decreases bp(GOBP:"skeletal muscle tissue development")	Our data indicate that CHF2 functions as a transcriptional repressor of myogenesis by formation of an inactive heterodimeric complex with MyoD and likely plays an important role in muscle development.	SEN:10027364	11279181
BEL:20052778	p(MGI:Hey2) decreases bp(GOBP:"patterning of blood vessels")	siRNA-mediated knockdown of HEY1 and HEY2 (Figure S4E) suppressed BMP9-mediated inhibition of tube formation and effects on downstream gene expression (Figures 4A, 4D, 4E, and 4G)	SEN:10027362	22421041
BEL:20052788	p(MGI:Hfe2) decreases r(MGI:Cybrd1)	In 129SvJ mice with targeted disruption of the hemojuvelin (Hfe2) gene, which display very low expression of liver hepcidin, Cybrd1 mRNA content increased to 1040 %, Dmt1 mRNA content to 200 % and Fpn1 mRNA to 150 % when compared to wild-type mice	SEN:10008934	17007103
BEL:20052790	p(MGI:Hfe2) decreases r(MGI:Slc11a2)	In 129SvJ mice with targeted disruption of the hemojuvelin (Hfe2) gene, which display very low expression of liver hepcidin, Cybrd1 mRNA content increased to 1040 %, Dmt1 mRNA content to 200 % and Fpn1 mRNA to 150 % when compared to wild-type mice	SEN:10008934	17007103
BEL:20052792	p(MGI:Hfe2) decreases r(MGI:Slc40a1)	In 129SvJ mice with targeted disruption of the hemojuvelin (Hfe2) gene, which display very low expression of liver hepcidin, Cybrd1 mRNA content increased to 1040 %, Dmt1 mRNA content to 200 % and Fpn1 mRNA to 150 % when compared to wild-type mice	SEN:10008934	17007103
BEL:20052796	p(MGI:Hfe) decreases r(MGI:Cybrd1)	We found unexpected alterations in the expression of Slc39a1 (mouse ortholog of SLC11A3) and Cybrd1, which encode key iron transport proteins, and Hamp (hepcidin antimicrobial peptide), a hepatic regulator of iron transport.	SEN:10027370	12704390
BEL:20052798	p(MGI:Hfe) increases r(MGI:Hamp)	We found unexpected alterations in the expression of Slc39a1 (mouse ortholog of SLC11A3) and Cybrd1, which encode key iron transport proteins, and Hamp (hepcidin antimicrobial peptide), a hepatic regulator of iron transport.	SEN:10027370	12704390
BEL:20052804	p(MGI:Hfe) increases r(MGI:Slc40a1)	We found unexpected alterations in the expression of Slc39a1 (mouse ortholog of SLC11A3) and Cybrd1, which encode key iron transport proteins, and Hamp (hepcidin antimicrobial peptide), a hepatic regulator of iron transport.	SEN:10027370	12704390
BEL:20052808	p(MGI:Hgf) increases bp(GOBP:"cell proliferation")	Hepatocyte growth factor (HGF) and beta-catenin both play a crucial role in stimulating hepatocyte proliferation,	SEN:10026226	17006939
BEL:20052810	p(MGI:Hgf) increases bp(GOBP:"epithelial to mesenchymal transition")	In addition to oncogenic Ras (Oft et al., 1996), hepatocyte growth factor (HGF)/scatter factor (SF), fibroblast growth factor (FGF), and TGF alone induce mesenchymal features in diverse epithelial cell systems (Brinkmann et al., 1995; Piek et al., 1999; Thiery and Chopin, 1999).	SEN:10026880	11790801
BEL:20052812	p(MGI:Hgf) increases bp(GOBP:glycolysis)	We have recently demonstrated that HGF/SF also alters the metabolic activity of cells by enhancing both the glycolytic and oxidative phosphorylation pathways of energy production.	SEN:10027374	12407445
BEL:20052824	p(MGI:Hgf) increases complex(p(MGI:Ctnnb1),p(MGI:Cdh1))	In both studies there was an associated increase in the E-cadherin-beta-catenin association at the membrane.	SEN:10027376	17006939
BEL:20052826	p(MGI:Hgf) directlyDecreases complex(p(MGI:Met),p(MGI:Ctnnb1))	We have previously reported that beta-catenin forms a complex with c-Met (HGF receptor) that undergoes dissociation because of beta-catenin tyrosine phosphorylation on stimulation by HGF.	SEN:10008448	17006939
BEL:20052840	p(MGI:Hgf) increases r(MGI:Cxcl1)	Microarray analysis after HGF stimulation of these cells revealed upregulation of the chemokine KC.	SEN:10008946	14600031
BEL:20052844	p(MGI:Hgf) increases r(MGI:Junb)	Additionally, HGF induced increased transcription of c-fos, c-jun, junB, junD, and c-myc early response genes in both cell lines.	SEN:10008950	7549943
BEL:20052846	p(MGI:Hgf) increases r(MGI:Mtch2)	Using differential display polymerase chain reaction, we cloned a novel gene, designated mimp (Met-Induced Mitochondrial Protein), which is upregulated in NIH-3T3 cells cotransfected with both HGF/SF and Met (HMH cells).	SEN:10006300	12407445
BEL:20052848	p(MGI:Hgf) increases r(MGI:Myc)	Additionally, HGF induced increased transcription of c-fos, c-jun, junB, junD, and c-myc early response genes in both cell lines.	SEN:10008950	7549943
BEL:20052852	p(MGI:Hgf) increases r(MGI:Plau)	Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.	SEN:10008888	10347197
BEL:20052856	p(MGI:Hgf) increases tloc(p(MGI:Ctnnb1),GOCCID:0005737,GOCCID:0005634)	Here we report that delivery of the human HGF gene delivery in mice led to hepatomegaly via beta-catenin activation in the liver in 1- and 4-week studies. The mechanisms of beta-catenin activation in the 1-week study included loss of c-Met-beta-catenin association as well as canonical beta-catenin activation, leading to its nuclear translocation.	SEN:10027382	17006939
BEL:20052884	p(MGI:Hif1a) increases p(MGI:Epas1)	Surprisingly, the increased Cre recombinase and subsequent loss of HIF1alpha expression also led to a drastic decline in HIF2alpha levels in the lung (Fig. 7, C and F).	SEN:10027394	18801745
BEL:20052886	p(MGI:Hif1a) increases p(MGI:Sftpa1)	All four surfactants displayed a substantial reduction in protein levels in the HIF1alpha -/- mice as compared with control pups (Fig. 5B).	SEN:10027396	18801745
BEL:20052888	p(MGI:Hif1a) increases p(MGI:Sftpb)	All four surfactants displayed a substantial reduction in protein levels in the HIF1alpha -/- mice as compared with control pups (Fig. 5B).	SEN:10027396	18801745
BEL:20052890	p(MGI:Hif1a) increases p(MGI:Sftpc)	All four surfactants displayed a substantial reduction in protein levels in the HIF1alpha -/- mice as compared with control pups (Fig. 5B).	SEN:10027396	18801745
BEL:20052892	p(MGI:Hif1a) increases p(MGI:Sftpd)	All four surfactants displayed a substantial reduction in protein levels in the HIF1alpha -/- mice as compared with control pups (Fig. 5B).	SEN:10027396	18801745
BEL:20052896	p(MGI:Hif1a) increases r(MGI:Bnip3)	These experiments document that BNip3 and NIX expression is HIF1alpha-dependent, and cobalt induces their expression in a time and dose dependent manner.	SEN:10027398	15375294
BEL:20052898	p(MGI:Hif1a) increases r(MGI:Bnip3l)	These experiments document that BNip3 and NIX expression is HIF1alpha-dependent, and cobalt induces their expression in a time and dose dependent manner.	SEN:10027398	15375294
BEL:20052900	p(MGI:Hif1a) increases r(MGI:Ctnnb1)	However, lower levels of beta-catenin, CCSP, HIMF, VEGF, and HIF2alpha mRNA in neonatal HIF1alpha-/- pups compared with control littermates suggest that HIF1alpha plays a role in controlling their expression during maturation of the lung (7, 15).	SEN:10027400	18801745
BEL:20052902	p(MGI:Hif1a) increases r(MGI:Epas1)	However, lower levels of beta-catenin, CCSP, HIMF, VEGF, and HIF2alpha mRNA in neonatal HIF1alpha-/- pups compared with control littermates suggest that HIF1alpha plays a role in controlling their expression during maturation of the lung (7, 15).	SEN:10027400	18801745
BEL:20052904	p(MGI:Hif1a) increases r(MGI:Ero1l)	As shown in Figure 4a and b, HIF-1anull cells totally failed to upregulate Ero1-La under hypoxia. Likewise, HIF-1b-null cells were incapable of inducing Ero1-La under hypoxia.	SEN:10025216	15592500
BEL:20052908	p(MGI:Hif1a) increases r(MGI:Retnla)	However, lower levels of beta-catenin, CCSP, HIMF, VEGF, and HIF2alpha mRNA in neonatal HIF1alpha-/- pups compared with control littermates suggest that HIF1alpha plays a role in controlling their expression during maturation of the lung (7, 15).	SEN:10027400	18801745
BEL:20052910	p(MGI:Hif1a) increases r(MGI:Scgb1a1)	However, lower levels of beta-catenin, CCSP, HIMF, VEGF, and HIF2alpha mRNA in neonatal HIF1alpha-/- pups compared with control littermates suggest that HIF1alpha plays a role in controlling their expression during maturation of the lung (7, 15).	SEN:10027400	18801745
BEL:20052912	p(MGI:Hif1a) increases r(MGI:Sftpa1)	qRT-PCR analysis of the genes for surfactant proteins show a decreased expression of SP-A, SP-B, and SP-C in the HIF1alpha-/- mice compared with control pups (Fig. 5A).	SEN:10027404	18801745
BEL:20052914	p(MGI:Hif1a) increases r(MGI:Sftpb)	qRT-PCR analysis of the genes for surfactant proteins show a decreased expression of SP-A, SP-B, and SP-C in the HIF1alpha-/- mice compared with control pups (Fig. 5A).	SEN:10027404	18801745
BEL:20052916	p(MGI:Hif1a) increases r(MGI:Sftpc)	qRT-PCR analysis of the genes for surfactant proteins show a decreased expression of SP-A, SP-B, and SP-C in the HIF1alpha-/- mice compared with control pups (Fig. 5A).	SEN:10027404	18801745
BEL:20052918	p(MGI:Hif3a) decreases r(MGI:Edn1)	The expression of endothelin 1 and platelet-derived growth factor beta was increased in the lung endothelial cells of NEPAS/HIF-3alpha-null mice.	SEN:10027406	18070924
BEL:20052920	p(MGI:Hif3a) decreases r(MGI:Pdgfb)	The expression of endothelin 1 and platelet-derived growth factor beta was increased in the lung endothelial cells of NEPAS/HIF-3alpha-null mice.	SEN:10027406	18070924
BEL:20052922	p(MGI:Hif3a) decreases tscript(p(MGI:Epas1))	NEPAS mRNA is derived from the HIF-3alpha gene by alternative splicing, replacing the first exon of HIF-3alpha with that of inhibitory PAS. NEPAS can dimerize with Arnt and exhibits only low levels of transcriptional activity, similar to that of HIF-3alpha. NEPAS suppressed reporter gene expression driven by HIF-1alpha and HIF-2alpha	SEN:10008960	18070924
BEL:20052924	p(MGI:Hif3a) decreases tscript(p(MGI:Hif1a))	NEPAS mRNA is derived from the HIF-3alpha gene by alternative splicing, replacing the first exon of HIF-3alpha with that of inhibitory PAS. NEPAS can dimerize with Arnt and exhibits only low levels of transcriptional activity, similar to that of HIF-3alpha. NEPAS suppressed reporter gene expression driven by HIF-1alpha and HIF-2alpha	SEN:10008960	18070924
BEL:20052942	p(MGI:Hivep2) decreases r(MGI:Bcl2l11)	Increased expression of FasL was observed in most of the Shn-2–/– cultured cells tested. Increased expression of Fas and Bim was observed only in Shn-2–/– effector Th2 cells.	SEN:10027416	17404274
BEL:20052946	p(MGI:Hivep2) decreases r(MGI:Fas)	Increased expression of FasL was observed in most of the Shn-2–/– cultured cells tested. Increased expression of Fas and Bim was observed only in Shn-2–/– effector Th2 cells.	SEN:10027416	17404274
BEL:20052948	p(MGI:Hivep2) decreases r(MGI:Fasl)	Increased expression of FasL was observed in most of the Shn-2–/– cultured cells tested. Increased expression of Fas and Bim was observed only in Shn-2–/– effector Th2 cells.	SEN:10027416	17404274
BEL:20052958	p(MGI:Hmgb1) increases bp(GOBP:"neutrophil activation")	administration of HMGB1 induces rapid neutrophil recruitment to the endothelium in an ICAM-1 or fibrinogen-dependent manner (17).	SEN:10027424	19273137
BEL:20052962	p(MGI:Hmgb1) increases cat(p(MGI:Tlr4))	The authors demonstrate that HMGB1 binds to TLR4 and that HMGB1, which is released by chemotherapy-induced cell death, can activate TLR4 and induce anti-tumour T-cell immunity79.	SEN:10019692	19052556
BEL:20052970	p(MGI:Hmgb1) increases kin(p(MGI:Akt1))	We detected Akt and p38 MAPK activation in PMN in response to HMGB1 using kinase assays. As shown in Fig. 6, A and B, HMGB1 induced activation of both Akt and p38 MAPK in TLR4 WT PMN as early as 15 min, detected as the phosphorylation of GSK-3 and ATF-2, respectively	SEN:10027432	17475888
BEL:20052972	p(MGI:Hmgb1) increases kin(p(MGI:Irak4))	Next, the role of IRAK4 in MyD88 signaling was examined by evaluating IRAK4 activity in the PMN. We found that HMGB1 induced a 6-fold increase in IRAK4 activity in TLR4 WT PMN compared with the non-HMGB1-treated WT PMN (p < 0.01; Fig. 5B)....Pretreatment with MyD88 inhibitor decreased IRAK4 activity by 91% in WT PMN (Fig. 5B).	SEN:10019374	17475888
BEL:20052998	p(MGI:Hmgcr) decreases kin(p(MGI:Akt1))	HMG-CoA reductase inhibition results in the activation of protein kinase Akt and the posttranslational phosphorylation of the eNOS protein.82,83	SEN:10027444	14656742
BEL:20053000	p(MGI:Hmgcr) decreases p(MGI:Nos3,pmod(P))	HMG-CoA reductase inhibition results in the activation of protein kinase Akt and the posttranslational phosphorylation of the eNOS protein.82,83	SEN:10027444	14656742
BEL:20053006	p(MGI:Hmgn3) increases p(MGI:Slc2a2)	Q-RT-PCR (Fig.4F) and Western blot analyses (Fig.4G) revealed that loss of HMGN3 leads to an 80% reduction in the amount of Glut2 transcripts and a 50% reduction in the amount of GLUT2 protein.	SEN:10027446	19651901
BEL:20053008	p(MGI:Hmgn3) increases r(MGI:Slc2a2)	Q-RT-PCR (Fig.4F) and Western blot analyses (Fig.4G) revealed that loss of HMGN3 leads to an 80% reduction in the amount of Glut2 transcripts and a 50% reduction in the amount of GLUT2 protein.	SEN:10027446	19651901
BEL:20053014	p(MGI:Hmox1) decreases bp(GOBP:"inflammatory response")	HO-1 gene–deficient mice display reduced stress defense, a pro-inflammatory tendency (10), and susceptibility to atherosclerotic lesion formation (11).	SEN:10027452	18633191
BEL:20053018	p(MGI:Hmox1) increases r(MGI:Sod2)	Heme oxygenase-1 (HO-1) has been identified as an inducer of manganese superoxide dismutase (MnSOD), playing a cytoprotective role under the condition of nitrosative stress.	SEN:10008972	15993853
BEL:20053020	p(MGI:Hnf1a) decreases a(CHEBI:"bile salt")	looking at the molecular basis for hypercholesterolemia, mice lacking Tcf1 have a defect in bile acid transport, increased bile acid and liver cholesterol synthesis, and impaired HDL metabolism	SEN:10027454	11279518
BEL:20053032	p(MGI:Hnf1a) increases cat(p(MGI:Lcat))	this is most likely due to reduced activity of HDL-cholsterol esterifying enzyme lecithin:cholesterol acyl transferase, Lcat	SEN:10027460	11279518
BEL:20053034	p(MGI:Hnf1a) decreases path(MESHD:Hypercholesterolemia)	mice lacking Tcf1 have type 2 diabetes, dwarfism, renal Fanconi syndrome, hepatic dysfunction and hypercholesterolemia	SEN:10027458	11279518
BEL:20053038	p(MGI:Hnf1a) increases p(MGI:Il13)	Loss of TCF-1 expression impaired the capacity of these ILC subsets to produce IL-5, IL-13, and IL-22 and resulted in crippled responses to intestinal infection with Citrobacter rodentium.	SEN:10027462	24038093
BEL:20053040	p(MGI:Hnf1a) increases p(MGI:Il22)	Loss of TCF-1 expression impaired the capacity of these ILC subsets to produce IL-5, IL-13, and IL-22 and resulted in crippled responses to intestinal infection with Citrobacter rodentium.	SEN:10027462	24038093
BEL:20053042	p(MGI:Hnf1a) increases p(MGI:Il5)	Loss of TCF-1 expression impaired the capacity of these ILC subsets to produce IL-5, IL-13, and IL-22 and resulted in crippled responses to intestinal infection with Citrobacter rodentium.	SEN:10027462	24038093
BEL:20053044	p(MGI:Hnf1a) increases r(MGI:Cyp7a1)	the Tcf1 protein [aka Hnf-1lapha] also regulates transcription of the gene Nr1h4 encoding Fxr, thereby leading to reduced expression of small heterodimer partner-1 [Shp-1] and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway	SEN:10026362	11279518
BEL:20053046	p(MGI:Hnf1a) increases r(MGI:Nr0b2)	the Tcf1 protein [aka Hnf-1lapha] also regulates transcription of the gene Nr1h4 encoding Fxr, thereby leading to reduced expression of small heterodimer partner-1 [Shp-1] and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway	SEN:10026362	11279518
BEL:20053048	p(MGI:Hnf1a) increases r(MGI:Nr1h4)	the Tcf1 protein [aka Hnf-1lapha] also regulates transcription of the gene Nr1h4 encoding Fxr, thereby leading to reduced expression of small heterodimer partner-1 [Shp-1] and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway	SEN:10026362	11279518
BEL:20053050	p(MGI:Hnf1a) increases r(MGI:Slc10a2)	in intestine and kidneys, Tcf1 lacking mice lack expression of the ileal bile acid transporter, Slc10a2, resulting in increased fecal and urinary bile acid excretion	SEN:10027464	11279518
BEL:20053070	p(MGI:Hnf4a) increases tscript(p(MGI:Pparg))	Furthermore, hepatocyte nuclear factor 4alpha (HNF4alpha) was found to enhance PPARgamma-mediated SR-BI transcription	SEN:10027474	12763030
BEL:20053072	p(MGI:Hnrnpa1) increases p(MGI:Ccnd1)	Here we identify hnRNP A1 as an IRES trans-acting factor that regulates cyclin D1 and c-myc IRES activity, depending on the Akt status of the cell. hnRNP A1 binds both IRESs in vitro and in intact cells and enhances in vitro IRES-dependent reporter expression.	SEN:10008976	18562319
BEL:20053074	p(MGI:Hnrnpa1) increases p(MGI:Myc)	Here we identify hnRNP A1 as an IRES trans-acting factor that regulates cyclin D1 and c-myc IRES activity, depending on the Akt status of the cell. hnRNP A1 binds both IRESs in vitro and in intact cells and enhances in vitro IRES-dependent reporter expression.	SEN:10008976	18562319
BEL:20053080	p(MGI:Hnrnpab) increases p(MGI:Ptgs2)	Functional pathway analysis showed that HNRPAB augments mRNA and protein levels of COX-2 and subsequent prostaglandin E(2) (PGE(2)) production by suppressing degradation of COX-2 mRNA	SEN:10008978	19837676
BEL:20053082	p(MGI:Hnrnpab) increases r(MGI:Ptgs2)	Functional pathway analysis showed that HNRPAB augments mRNA and protein levels of COX-2 and subsequent prostaglandin E(2) (PGE(2)) production by suppressing degradation of COX-2 mRNA	SEN:10008978	19837676
BEL:20053094	p(MGI:Hopx) increases cat(p(MGI:Hdac2))	Here we show that Hop can inhibit SRF-dependent transcriptional activation by recruiting histone deacetylase (HDAC) activity and can form a complex that includes HDAC2.	SEN:10008986	12975471
BEL:20053100	p(MGI:Hopx) decreases r(MGI:Ddx3y)	Microarray analysis of Hop transgenic hearts, however, indicates repression of c-fos, a classic SRF transcriptional target (41), consistent with previous data indicating that Hop can repress SRF-dependent transcription (19, 20). Interestingly, we also identified an RNA helicase, Dby, that is consistently downregulated in Hop transgenic hearts.	SEN:10027478	12975471
BEL:20053102	p(MGI:Hopx) decreases r(MGI:Fos)	Microarray analysis of Hop transgenic hearts, however, indicates repression of c-fos, a classic SRF transcriptional target (41), consistent with previous data indicating that Hop can repress SRF-dependent transcription (19, 20). Interestingly, we also identified an RNA helicase, Dby, that is consistently downregulated in Hop transgenic hearts.	SEN:10027478	12975471
BEL:20053106	p(MGI:Hoxa13) decreases r(MGI:Igfbp3)	TABLE 2. Loss of HOXA13 function causes increased sinusoidal and lymphatic endothelial gene expression.	SEN:10027482	18483557
BEL:20053108	p(MGI:Hoxa13) decreases r(MGI:Lyve1)	TABLE 2. Loss of HOXA13 function causes increased sinusoidal and lymphatic endothelial gene expression.	SEN:10027482	18483557
BEL:20053110	p(MGI:Hoxa13) decreases r(MGI:Selenbp1)	TABLE 2. Loss of HOXA13 function causes increased sinusoidal and lymphatic endothelial gene expression.	SEN:10027482	18483557
BEL:20053122	p(MGI:Hoxa5) decreases bp(GOBP:angiogenesis)	Whereas HoxA5 is downregulated in active angiogenic endothelial cells (EC), sustained expression of HoxA5 induces TSP-2 and blocks angiogenesis	SEN:10008992	19262140
BEL:20053130	p(MGI:Hoxa5) increases kin(p(MGI:Akt1))	Finally we show that HoxA5 increases Akt1 mRNA, protein expression and further enhances Akt activity via a coordinate down regulation of PTEN....Figure 7...HoxA5 induces Akt mRNA and protein expression and increases Akt activity in endothelial cells.	SEN:10027492	19262140
BEL:20053132	p(MGI:Hoxa5) increases p(MGI:Akt1)	Finally we show that HoxA5 increases Akt1 mRNA, protein expression and further enhances Akt activity via a coordinate down regulation of PTEN....Figure 7...HoxA5 induces Akt mRNA and protein expression and increases Akt activity in endothelial cells.	SEN:10027492	19262140
BEL:20053136	p(MGI:Hoxa5) increases r(MGI:Akt1)	Finally we show that HoxA5 increases Akt1 mRNA, protein expression and further enhances Akt activity via a coordinate down regulation of PTEN....Figure 7...HoxA5 induces Akt mRNA and protein expression and increases Akt activity in endothelial cells.	SEN:10027492	19262140
BEL:20053138	p(MGI:Hoxa9) increases bp(GOBP:"cell proliferation")	Retroviral transduction with a Hoxa-9 expression vector dramatically enhanced the cytokine-driven proliferation and in vivo engraftment of Hoxa-9-/- marrow cells.	SEN:10002414	16091451
BEL:20053158	p(MGI:Hoxb7) increases r(MGI:Cnn1)	sults showed that overexpression of HOXB7 increased proliferation 3.5-fold, and induced an SMC-like cell morphology. In addition, expression of the early SMC markers calponin and SM22 increased 4-fold and 3-fold respectively by semi-quantitative RT-PCR.	SEN:10027504	10842316
BEL:20053160	p(MGI:Hoxb7) increases r(MGI:Tagln)	sults showed that overexpression of HOXB7 increased proliferation 3.5-fold, and induced an SMC-like cell morphology. In addition, expression of the early SMC markers calponin and SM22 increased 4-fold and 3-fold respectively by semi-quantitative RT-PCR.	SEN:10027504	10842316
BEL:20053164	p(MGI:Hoxc4) increases r(MGI:Aicda)	The cytidine deaminase AID is critical for immunoglobulin class-switch recombination (CSR) and somatic hypermutation (SHM). HoxC4 deficiency also resulted in impaired CSR and SHM because of lower AID expression and not some other putative HoxC4-dependent activity.	SEN:10025026	19363484
BEL:20053182	p(MGI:Hp) decreases a(CHEBI:"reactive oxygen species")	These data suggest that Hp plays a pivotal role in reducing renal oxidative damage during haemolysis	SEN:10008996	11865980
BEL:20053186	p(MGI:Hp) decreases bp(GOBP:"response to oxidative stress")	These data suggest that Hp plays a pivotal role in reducing renal oxidative damage during haemolysis	SEN:10008996	11865980
BEL:20053188	p(MGI:Hpgd) decreases cat(p(MGI:Ptgs2))	TGF? can also suppress gastrointestinal inflammatory activity by stimulating the expression of the prostaglandin-degrading enzyme 15-PGDH, which antagonizes the proinflammatory action of COX2 (Yan et al., 2004).	SEN:10027510	18662538
BEL:20053206	p(MGI:Hp) decreases sec(p(MGI:Orm1))	Hp-/- mice suffered greater tissue damage, as evidenced by the induction of a hepatic acute phase response, resulting in increased plasma alpha1-acidic glycoprotein (AGP) levels	SEN:10009000	11865980
BEL:20053210	p(MGI:Hras) increases bp(GOBP:"cell proliferation")	Survivin disruption by DN T34A Survivin blocked CA-Ras-induced IL-3-independent cell survival and proliferation; however, it did not affect CA-Ras-mediated enhancement of S-phase, indicating that the anti-apoptotic activity of CA-Ras is Survivin dependent while its S-phase enhancing effect is not.	SEN:10008104	15369798
BEL:20053212	p(MGI:Hras) increases bp(GOBP:"epithelial to mesenchymal transition")	Ha-Ras cooperates with transforming growth factor beta (TGFbeta) to cause epithelial mesenchymal transition (EMT) characterized by spindle-like cell morphology, loss of epithelial markers, and induction of mesenchymal markers.	SEN:10027514	11790801
BEL:20053214	p(MGI:Hras) decreases bp(GOBP:"apoptotic process")	Over-expression of constitutively activated H-Ras (CA-Ras) in Ba/F3 cells blocked down-modulation of Survivin expression, G0/G1 arrest, and apoptosis induced by IL-3 withdrawal, while dominant-negative (DN) H-Ras down-regulated Survivin.	SEN:10027516	15369798
BEL:20053220	p(MGI:Hras) increases p(MGI:Birc5)	Over-expression of constitutively activated H-Ras (CA-Ras) in Ba/F3 cells blocked down-modulation of Survivin expression, G0/G1 arrest, and apoptosis induced by IL-3 withdrawal, while dominant-negative (DN) H-Ras down-regulated Survivin.	SEN:10027516	15369798
BEL:20053226	p(MGI:Hras) decreases r(MGI:Nf1)	Stable transfection of activated Ha-ras into a number of murine cells correlated with a down-regulation of the expression of the NF1 genes NF1/CTF and NF1/X.	SEN:10005778	8125955
BEL:20053242	p(MGI:Hras) decreases tscript(p(MGI:Nfix))	The level of the DNA binding activity of the NF1 proteins was also reduced in Ha-v-ras-transformed cells, and the expression of a gene that depends on this family of transcription factors was specifically repressed.	SEN:10009008	8125955
BEL:20053244	p(MGI:Hrg) decreases bp(GOBP:angiogenesis)	Histidine-rich glycoprotein (HRGP) is an abundant heparin-binding plasma protein that efficiently arrests growth and vascularization of mouse tumor models.	SEN:10009010	16489009
BEL:20053246	p(MGI:Hrg) decreases bp(GOBP:"cell proliferation")	Histidine-rich glycoprotein (HRGP) is an abundant heparin-binding plasma protein that efficiently arrests growth and vascularization of mouse tumor models.	SEN:10009010	16489009
BEL:20053256	p(MGI:Hrh1) increases r(MGI:Il10)	In contrast, OVA-exposed H1R-/- tissues consistently displayed only modest increases in gene expression with statistically significant reductions in transcripts for IL-5, IL-13, and IL-10 compared with WT levels (P < 0.005, P < 0.005, and P < 0.05 respectively).	SEN:10027524	16680192
BEL:20053258	p(MGI:Hrh1) increases r(MGI:Il13)	In contrast, OVA-exposed H1R-/- tissues consistently displayed only modest increases in gene expression with statistically significant reductions in transcripts for IL-5, IL-13, and IL-10 compared with WT levels (P < 0.005, P < 0.005, and P < 0.05 respectively).	SEN:10027524	16680192
BEL:20053260	p(MGI:Hrh1) increases r(MGI:Il5)	In contrast, OVA-exposed H1R-/- tissues consistently displayed only modest increases in gene expression with statistically significant reductions in transcripts for IL-5, IL-13, and IL-10 compared with WT levels (P < 0.005, P < 0.005, and P < 0.05 respectively).	SEN:10027524	16680192
BEL:20053276	p(MGI:Hsd11b1) decreases r(MGI:Apoa1)	11beta-HSD-1(-/-) mice also have increased HDL cholesterol, with elevated liver mRNA and serum levels of apolipoprotein AI. % Conversely, liver Aalpha-fibrinogen mRNA levels are decreased.	SEN:10009014	11546766
BEL:20053278	p(MGI:Hsd11b1) increases r(MGI:Fga)	11beta-HSD-1(-/-) mice also have increased HDL cholesterol, with elevated liver mRNA and serum levels of apolipoprotein AI. % Conversely, liver Aalpha-fibrinogen mRNA levels are decreased.	SEN:10009014	11546766
BEL:20053280	p(MGI:Hsd17b10) decreases bp(GOBP:"apoptotic process")	Cells derived from conditional Hsd17b10(-/-) mice demonstrate that a property of HSD10 independent of its enzymatic activity is essential for structural and functional integrity of mitochondria. Impairment of this function in neural cells causes apoptotic cell death	SEN:10027530	20077426
BEL:20053284	p(MGI:Hsf1) decreases a(CHEBI:"reactive oxygen species")	Here we report that, in mice, HSF1 deficiency reduces cardiac expression of Hsp25, alphaB-crystallin and Hsp70, Con sequently, superoxide was generated at a higher rate, and several mitochondrial proteins, including adenine nucleotide translocase 1 (ANT1), were more oxidized by HSF1 deficiency in vivo.	SEN:10009018	12356732
BEL:20053288	p(MGI:Hsf1) increases p(MGI:Cxcl12)	Taken together with the increased expression of Tgf-b and Sdf1 in WT MEFs compared to Hsf1 null MEFs (Figure 4A), these results suggest that TGF-b and SDF1 are produced and secreted by fibroblasts in an HSF1-dependent manner.	SEN:10027534	25083868
BEL:20053290	p(MGI:Hsf1) increases p(MGI:Tgfb1)	Taken together with the increased expression of Tgf-b and Sdf1 in WT MEFs compared to Hsf1 null MEFs (Figure 4A), these results suggest that TGF-b and SDF1 are produced and secreted by fibroblasts in an HSF1-dependent manner.	SEN:10027534	25083868
BEL:20053292	p(MGI:Hsf1) increases r(MGI:Cryab)	Here we report that, in mice, HSF1 deficiency reduces cardiac expression of Hsp25, alphaB-crystallin and Hsp70	SEN:10009022	12356732
BEL:20053294	p(MGI:Hsf1) increases r(MGI:Cxcl12)	This confirmed that expression levels of Sdf1, Tgf-b1, and Tgf-b2 were significantly lower in Hsf1 null MEFs than in WT MEFs, even without coculture with cancer cells (Figures 4A and S4A).	SEN:10027536	25083868
BEL:20053296	p(MGI:Hsf1) increases r(MGI:Hspb1)	Here we report that, in mice, HSF1 deficiency reduces cardiac expression of Hsp25, alphaB-crystallin and Hsp70	SEN:10009022	12356732
BEL:20053298	p(MGI:Hsf1) increases r(MGI:Tgfb1)	This confirmed that expression levels of Sdf1, Tgf-b1, and Tgf-b2 were significantly lower in Hsf1 null MEFs than in WT MEFs, even without coculture with cancer cells (Figures 4A and S4A).	SEN:10027536	25083868
BEL:20053300	p(MGI:Hsf1) increases r(MGI:Tgfb2)	This confirmed that expression levels of Sdf1, Tgf-b1, and Tgf-b2 were significantly lower in Hsf1 null MEFs than in WT MEFs, even without coculture with cancer cells (Figures 4A and S4A).	SEN:10027536	25083868
BEL:20053310	p(MGI:Hsp90b1) increases bp(GOBP:"myeloid dendritic cell activation")	Immunization of mice with the heat shock protein (HSP) gp96 but not control proteins leads to 5- to 7-fold enlargement of draining lymph nodes (LNs) resulting from accumulation of large numbers of mature CD11c(+) cells, but not T or B lymphocytes in them.	SEN:10027544	11086034
BEL:20053316	p(MGI:Hsp90b1) increases cat(p(MGI:Tlr4))	These responses arise through interactions of gp96 with Toll-like (APC activation) and endocytic (cross-presentation) receptors of APC.	SEN:10027546	14609958
BEL:20053326	p(MGI:Hspa1a) decreases path(MESHD:Hypertrophy)	These alterations can be attributed to the absence of Hsp70 because viral expression of Hsp70 in KO cultured cardiomyocytes restored these parameters	SEN:10009030	16735677
BEL:20053334	p(MGI:Hspa1b) increases bp(GOBP:"wound healing")	Further, we tested the direct application of HSP-treatment in vivo by treating mice with full thickness wounds with either HSP70 or controls and observed that HSP-treated wounds showed a faster rate of healing [2].	SEN:10027550	16979664
BEL:20053344	p(MGI:Hspa1b) decreases path(MESHD:Hypertrophy)	These alterations can be attributed to the absence of Hsp70 because viral expression of Hsp70 in KO cultured cardiomyocytes restored these parameters	SEN:10009030	16735677
BEL:20053348	p(MGI:Hspa1b) increases p(MGI:Mapk14)	the presence of phosphorylated-p38 by using either total p38 polyclonal antibody or phospho-p38 monoclonal antibody (Cell Signaling Technology). As seen in Fig. 5B, treatment of RAW264.7 cells with HSP70 resulted in significant up-regulation of p38 (up to 60 min) as compared with cells treated with medium alone. Further, there was no concurrent up-regulation of the controls	SEN:10027554	16979664
BEL:20053352	p(MGI:Hspa1b) increases sec(p(MGI:Tnf))	A cytokine release assay using antibodies to Tumor Necrosis Factor-alfa (TNF) was performed (Fig. 3D). TNF- release in response to HSP70 and (to a lesser extent) following ssPolyU treatment was blunted in SiRNA-TLR7 transfected RAW264.7 cells versus the parental cells or mocktransfected cells	SEN:10019736	16979664
BEL:20053370	p(MGI:Hspb8) increases a(CHEBI:glycogen)	Glycogen content was increased proportionately to the expression of the transgene, reaching a 40% increase in high-expression transgenic mice	SEN:10019454	15543936
BEL:20053372	p(MGI:Hspb8) increases cat(p(MGI:Pgm1))	To test the biochemical relevance of this interaction, PGM activity was measured in the heart from wild type and transgenic mice, showing a 20% increase of Vmax in the transgenic group, without change in KM.	SEN:10005468	15543936
BEL:20053380	p(MGI:Htt) increases r(EGID:15127)	Gene expression profiles of Htt KO mice and Flx-treated mice in six regions of the brain and their regulator candidates. Fold changes detected with RT-PCR in the two experimental conditions (Htt KO/WT and treated with Flx/Sal for 3 days) are calculated in the 30 genes listed in the Table 1	SEN:10027568	18211820
BEL:20053384	p(MGI:Htt) decreases r(MGI:Pid1)	Gene expression profiles of Htt KO mice and Flx-treated mice in six regions of the brain and their regulator candidates. Fold changes detected with RT-PCR in the two experimental conditions (Htt KO/WT and treated with Flx/Sal for 3 days) are calculated in the 30 genes listed in the Table 1	SEN:10027568	18211820
BEL:20053386	p(MGI:Htt) increases r(MGI:Pitpna)	Gene expression profiles of Htt KO mice and Flx-treated mice in six regions of the brain and their regulator candidates. Fold changes detected with RT-PCR in the two experimental conditions (Htt KO/WT and treated with Flx/Sal for 3 days) are calculated in the 30 genes listed in the Table 1	SEN:10027568	18211820
BEL:20053388	p(MGI:Htt) decreases r(MGI:Tuba1a)	Gene expression profiles of Htt KO mice and Flx-treated mice in six regions of the brain and their regulator candidates. Fold changes detected with RT-PCR in the two experimental conditions (Htt KO/WT and treated with Flx/Sal for 3 days) are calculated in the 30 genes listed in the Table 1	SEN:10027568	18211820
BEL:20053400	p(MGI:Icam1) increases bp(GOBP:"cell migration")	We found that liver from ICAM-1-deficient mice exhibited impaired regeneration after partial hepatectomy. This finding is associated with dramatic decrease in leukocyte recruitment and tissue TNF-alpha and IL-6 levels.	SEN:10009036	12612908
BEL:20053418	p(MGI:Id1) decreases bp(GOBP:"cell differentiation")	TGF? also modulates differentiation through the regulation of Id proteins (Inhibitor of Differentiation/DNA binding) that negatively regulate cell differentiation by interfering with prodifferentiation bHLH transcription factors (Ruzinova and Benezra, 2003).	SEN:10027582	18662538
BEL:20053420	p(MGI:Id1) decreases r(MGI:Cdkn2a)	Furthermore, mouse embryonic fibroblasts derived from Id1-deficient mice express high levels of INK4A (Lyden et al., 1999; Alani et al., 2001)	SEN:10027584	21383691
BEL:20053432	p(MGI:Id1) decreases tscript(p(MGI:Myod1))	Transfection experiments indicate that over-expression of Id inhibits the trans-activation of the muscle creatine kinase enhancer by MyoD.	SEN:10006530	2156629
BEL:20053436	p(MGI:Id2) decreases bp(GOBP:"cell proliferation")	Further, when evaluated in vitro loss of Id2 results in decreased proliferation of neural progenitors and decreased expression of the Hes1 and Ascl1 (Mash1) transcription factors, known mediators of neuronal differentiation.	SEN:10009042	19109490
BEL:20053440	p(MGI:Id2) decreases r(MGI:Ascl1)	Further, when evaluated in vitro loss of Id2 results in decreased proliferation of neural progenitors and decreased expression of the Hes1 and Ascl1 (Mash1) transcription factors, known mediators of neuronal differentiation.	SEN:10009042	19109490
BEL:20053444	p(MGI:Id2) increases r(MGI:Epor)	We found that overexpression of Id2 in EML cells induced the expression of GATA-1 target genes including GATA-1, ELKF, EpoR, and alpha-globin (Figure 6F).	SEN:10027590	18523151
BEL:20053446	p(MGI:Id2) increases r(MGI:Gata1)	We found that overexpression of Id2 in EML cells induced the expression of GATA-1 target genes including GATA-1, ELKF, EpoR, and alpha-globin (Figure 6F).	SEN:10027590	18523151
BEL:20053448	p(MGI:Id2) increases r(MGI:"Hba-a1")	We found that overexpression of Id2 in EML cells induced the expression of GATA-1 target genes including GATA-1, ELKF, EpoR, and alpha-globin (Figure 6F).	SEN:10027590	18523151
BEL:20053450	p(MGI:Id2) decreases r(MGI:Hes1)	Further, when evaluated in vitro loss of Id2 results in decreased proliferation of neural progenitors and decreased expression of the Hes1 and Ascl1 (Mash1) transcription factors, known mediators of neuronal differentiation.	SEN:10009042	19109490
BEL:20053452	p(MGI:Id2) increases r(MGI:Klf1)	We found that overexpression of Id2 in EML cells induced the expression of GATA-1 target genes including GATA-1, ELKF, EpoR, and alpha-globin (Figure 6F).	SEN:10027590	18523151
BEL:20053458	p(MGI:Id2) decreases tscript(p(MGI:Spi1))	Rb promotes differentiation of macrophages by opposing the inhibitory functions of Id2 on the transcription factor PU.1, a master regulator of macrophage differentiation	SEN:10009046	15616565
BEL:20053464	p(MGI:Id3) decreases p(MGI:Smarcc1)	FIG. 1. Retroviral transduction of Id3 down-modulates the SRG3 protein expression.FIG. 2. Id3 transcriptionally represses SRG3 gene expression	SEN:10027594	15016815
BEL:20053466	p(MGI:Id3) decreases r(MGI:Smarcc1)	FIG. 1. Retroviral transduction of Id3 down-modulates the SRG3 protein expression.FIG. 2. Id3 transcriptionally represses SRG3 gene expression	SEN:10027594	15016815
BEL:20053480	p(MGI:Ier3) increases bp(GOBP:"cell proliferation")	Human keratinocytes and mouse fibroblasts transfected with an expression plasmid for IEX-1 grow at a faster rate than keratinocytes transfected with a similar plasmid that does not contain the IEX-1 sequence.	SEN:10009050	9878538
BEL:20053486	p(MGI:Ifna1) increases r(MGI:"H2-Ab1")	FIGURE 1. MHC II expression on macrophages.These observations suggest that Stat2 normally serves to suppress the IFN-I-dependent MHC II expression in WT macrophages.	SEN:10027604	17579067
BEL:20053502	p(MGI:Ifnar1) increases p(MGI:Ifna1)	as evidenced by the abolition of IFN induction in DC derived from IFNAR KO and IRF-9 KO mice [39, 45].	SEN:10027610	16474425
BEL:20053504	p(MGI:Ifnar1) increases r(MGI:Ifnb1)	as evidenced by the abolition of IFN induction in DC derived from IFNAR KO and IRF-9 KO mice [39, 45].	SEN:10027610	16474425
BEL:20053508	p(MGI:Ifnb1) increases bp(GOBP:"wound healing")	Like pDC-depleted mice, IFN-alpha/beta receptor-deficient mice showed a significant delay in wound reepithelization (Fig. 5 E) and displayed a profound deficiency in IL-6, IL-17, and IL-22 expression levels in injured skin, without affecting the expression of IFN-gamma (Fig. 5 F).	SEN:10027614	21115688
BEL:20053510	p(MGI:Ifnb1) increases kin(p(MGI:Ikbke))	We demonstrate that IKKepsilon is activated by IFNbeta and that IKKepsilon directly phosphorylates signal transducer and activator of transcription 1 (STAT1), a component of ISGF3.	SEN:10006186	17332413
BEL:20053512	p(MGI:Ifnb1) decreases path(MESHD:Fibrosis)	Bleomycin induced pulmonary fibrosis predominantly in the subpleural area of ICR mouse lung. MuIFN- markedly attenuated bleomycin-induced pulmonary fibrosis at 28 d.	SEN:10027616	15557019
BEL:20053516	p(MGI:Ifnb1) increases p(MGI:Il22)	Like pDC-depleted mice, IFN-alpha/beta receptor-deficient mice showed a significant delay in wound reepithelization (Fig. 5 E) and displayed a profound deficiency in IL-6, IL-17, and IL-22 expression levels in injured skin, without affecting the expression of IFN-gamma (Fig. 5 F).	SEN:10027614	21115688
BEL:20053518	p(MGI:Ifnb1) increases p(MGI:Il6)	Like pDC-depleted mice, IFN-alpha/beta receptor-deficient mice showed a significant delay in wound reepithelization (Fig. 5 E) and displayed a profound deficiency in IL-6, IL-17, and IL-22 expression levels in injured skin, without affecting the expression of IFN-gamma (Fig. 5 F).	SEN:10027614	21115688
BEL:20053520	p(MGI:Ifnb1) decreases p(MGI:Tgfb1)	The bleomycin- alone group exhibited prominent expression of TGF-1 in alveolar epithelial cells and ECM in pulmonary tissue (Figure 3c, Table 1). However, this expression was decreased to basal level by treatment with IFN-B (Figure 3d, Table 1).	SEN:10027618	15557019
BEL:20053522	p(MGI:Ifnb1) increases r(MGI:C1qb)	Both exogenous IFN-alpha and IFN-beta effectively substituted for IFN-gamma in stimulating M phi C1q mRNA expression in a dose-dependent fashion by northern blot analysis.	SEN:10027620	8697143
BEL:20053536	p(MGI:Ifnb1) increases tscript(p(MGI:Irf1))	In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12.	SEN:10019900	8920893
BEL:20053538	p(MGI:Ifng) increases a(CHEBI:calcitriol)	It has been demonstrated that macrophages can produce 1alpha,25(OH)2D3 on activation with interferon gamma (IFN-gamma)	SEN:10002434	16118315
BEL:20053554	p(MGI:Ifng) increases bp(GOBP:"inflammatory response")	When compared with WT mice on normal or dox water, transgenic IFN- caused a significant increase in BAL total cell, neutrophil, lymphocyte, and macrophage recovery and a patchy mononuclear tissue inflammatory response.	SEN:10027640	15944319
BEL:20053556	p(MGI:Ifng) increases bp(GOBP:"inflammatory response")	As previously reported (19), transgenic IFN-? caused significant increases in bronchoalveolar lavage (BAL) total cell, macrophage, and neutrophil recovery and induced a patchy macrophage-rich tissue inflammatory response (Figure 3 and data not shown).	SEN:10027642	16284650
BEL:20053560	p(MGI:Ifng) increases bp(GOBP:"macrophage differentiation")	IFN-gamma inhibited colony formation, while promoting macrophage maturation in ICSBP(+/+) cells. In contrast, the effects of IFN-gamma were completely absent in ICSBP(-/-) progenitors.	SEN:10009062	12133947
BEL:20053562	p(MGI:Ifng) decreases bp(GOBP:"T cell proliferation")	the proliferative effects of MIG/CXCL9 were mediated via an IL-2-independent pathway and were controlled by IFN-gamma	SEN:10009064	15187119
BEL:20053564	p(MGI:Ifng) increases bp(GOBP:"T-helper 1 type immune response")	CyCAP is a widely expressed secreted glycoprotein that modulates the host response to endotoxin gene-targeted CyCAP-deficient mice are more sensitive to the lethal effects of endotoxin in response to endotoxin, CyCAP-deficient mice overproduce interleukin 12 and interferon-gamma systemically and tumor necrosis factor alpha locally, these are proinflammatory molecules that also promote T helper 1 responses	SEN:10020288	10077627
BEL:20053566	p(MGI:Ifng) increases bp(GOBP:"apoptotic process")	PKR is required for poly IC- and poly IC plus interferon gamma (IFNg)-induced islet cell apoptosis, implicating a role of PKR in the etiology of type 1 diabetes (43).	SEN:10026644	12588811
BEL:20053568	p(MGI:Ifng) increases bp(GOBP:"apoptotic process")	In contrast, IFN- induction in transgenic mice caused a remarkable increase in the number of TUNEL nuclei (Fig. 1A)....Their lungs were then removed and TUNEL staining was evaluated.	SEN:10027646	15944319
BEL:20053570	p(MGI:Ifng) increases bp(GOBP:"apoptotic process")	The majority of these cells were airway epithelial cells and type I and type II alveolar epithelial cells on light microscopic evaluations (Fig. 1, B and C)....In accord with these observations, double staining with TUNEL and anti-SP-C Abs revealed a large number of alveolar type II epithelial cells that were TUNEL positive and SP-C positive (Fig. 1, D).	SEN:10027648	15944319
BEL:20053572	p(MGI:Ifng) increases bp(GOBP:"apoptotic process")	dox induction of IFN-? caused a significant increase in TUNEL staining in lungs from Tg+ mice (Figure 8, A and B).	SEN:10027650	16284650
BEL:20053574	p(MGI:Ifng) increases bp(GOBP:"apoptotic process")	The same group demonstrated just recently that mast cells actively participate in the formation of aortic aneurysms by release of IL-6 and IFN?, which induced apoptosis of smooth muscle cells and protease expression [111].	SEN:10027652	19238385
BEL:20053576	p(MGI:Ifng) increases cat(p(MGI:Bid))	IFN-? also activated caspase-3, -8, and -9 and Bid, causing readily detectable increases in caspase bioactivities and truncated Bid (tBid) accumulation (Figure 9, F and G).	SEN:10027654	16284650
BEL:20053578	p(MGI:Ifng) increases cat(p(MGI:Casp3))	IFN-? also activated caspase-3, -8, and -9 and Bid, causing readily detectable increases in caspase bioactivities and truncated Bid (tBid) accumulation (Figure 9, F and G).	SEN:10027654	16284650
BEL:20053580	p(MGI:Ifng) increases cat(p(MGI:Casp8))	IFN-? also activated caspase-3, -8, and -9 and Bid, causing readily detectable increases in caspase bioactivities and truncated Bid (tBid) accumulation (Figure 9, F and G).	SEN:10027654	16284650
BEL:20053582	p(MGI:Ifng) increases cat(p(MGI:Casp8))	Caspase-8, an activator caspase that interacts with the death domain of the TNF receptor and CD95 (Fas) receptor, was activated in experimental emphysema caused by lung overexpression of either IFN-{gamma} (370) or IL-13 (196).	SEN:10027656	17615396
BEL:20053584	p(MGI:Ifng) increases cat(p(MGI:Casp9))	IFN-? also activated caspase-3, -8, and -9 and Bid, causing readily detectable increases in caspase bioactivities and truncated Bid (tBid) accumulation (Figure 9, F and G).	SEN:10027654	16284650
BEL:20053586	p(MGI:Ifng) increases cat(p(MGI:Csnk2a2))	apigenin, a selective casein kinase 2 (CK2) inhibitor, was found to inhibit response% IFN-gamma stimulated CK2 activity and the level of phosphorylated cAMP response element-binding protein, which is known to induce ICER gene transcription, and this response was inhibited in the presence of apigenin.	SEN:10015452	12609974
BEL:20053588	p(MGI:Ifng) increases cat(p(MGI:Irs1))	We and others have shown that activation of IL-4 (23) and IFN-{alpha} receptors stimulates tyrosyl phosphorylation of IRS docking proteins, which depends upon Jak,	SEN:10027658	11591769
BEL:20053590	p(MGI:Ifng) increases cat(p(MGI:Mmp12))	Zymography also demonstrated IFN-g induced BAL moieties that comigrated with the unprocessed and/or fully processed forms of MMP-12 (Fig. 11).	SEN:10027660	11104801
BEL:20053592	p(MGI:Ifng) increases cat(p(MGI:Nos2))	Because IFN-g is known to induce NOS2, an important mediator of inflammation and host defense, we also analyzed effects of acrolein exposure on LPS-mediated induction of NOS2 (28) and observed a strong trend toward reduced NOS2 expression after acrolein exposure	SEN:10015386	18566440
BEL:20053600	p(MGI:Ifng) increases kin(p(MGI:Jak1))	As expected, we found that IFN-gamma led to a rapid rise in both JAK1 and JAK2 phosphorylation band density above baseline levels, and this IFN-gamma-induced JAK activation was not altered by adenosine treatment at any time point (data not shown).	SEN:10027666	19846878
BEL:20053604	p(MGI:Ifng) increases kin(p(MGI:Jak2))	As expected, we found that IFN-gamma led to a rapid rise in both JAK1 and JAK2 phosphorylation band density above baseline levels, and this IFN-gamma-induced JAK activation was not altered by adenosine treatment at any time point (data not shown).	SEN:10027666	19846878
BEL:20053606	p(MGI:Ifng) increases kin(p(MGI:Map3k11))	MLK3 appears to activate C/EBP-beta in response to IFN-gamma by a mechanism involving decreased phosphorylation of a specific phosphoacceptor residue, Ser(64), within the transactivation domain.	SEN:10006232	15878863
BEL:20053614	p(MGI:Ifng) increases path(MESHD:Atherosclerosis)	the injection of IFNG, or the IFNG-releasing factors IL12 and -18 enhances the extent of the disease in apoE-/- mice (36, 39, 40)	SEN:10020296	16293001
BEL:20053616	p(MGI:Ifng) increases path(MESHD:Emphysema)	Here we demonstrate that interferon gamma (IFN-gamma), a prominent product of CD8(+) cells, causes emphysema	SEN:10009066	11104801
BEL:20053624	p(MGI:Ifng) decreases p(MGI:Ighg2b)	rIFN-gamma strikingly enhances the secretion of IgG2a by murine splenic B cells stimulated with bacterial LPS in vitro and concomitantly suppresses the production of IgG3, IgG1, IgG2b, and IgE while sparing IgM secretion.	SEN:10027670	3127461
BEL:20053626	p(MGI:Ifng) decreases p(EGID:16020)	rIFN-gamma strikingly enhances the secretion of IgG2a by murine splenic B cells stimulated with bacterial LPS in vitro and concomitantly suppresses the production of IgG3, IgG1, IgG2b, and IgE while sparing IgM secretion.	SEN:10027670	3127461
BEL:20053628	p(MGI:Ifng) increases p(EGID:380793)	rIFN-gamma strikingly enhances the secretion of IgG2a by murine splenic B cells stimulated with bacterial LPS in vitro and concomitantly suppresses the production of IgG3, IgG1, IgG2b, and IgE while sparing IgM secretion.	SEN:10027670	3127461
BEL:20053632	p(MGI:Ifng) increases p(MGI:C2)	Recombinant IFN-gamma increased the synthesis of C2 and factor B in primary cultures of human mononuclear phagocytes and in murine fibroblasts transfected with cosmid DNA bearing the human C2 and factor B genes.	SEN:10027674	2866182
BEL:20053636	p(MGI:Ifng) increases p(MGI:Ccr5)	the levels of CCR5 mRNA and protein were markedly increased in dox-treated IFN-?– transgenic animals (Figure 2, A and B).	SEN:10027678	16284650
BEL:20053638	p(MGI:Ifng) increases p(MGI:Cebpb,pmod(P))	In response to IFN-gamma, C/EBP-beta undergoes phosphorylation at a critical ERK1/2 phosphorylation motif.	SEN:10018042	15879117
BEL:20053640	p(MGI:Ifng) increases p(MGI:Cfb)	Recombinant IFN-gamma increased the synthesis of C2 and factor B in primary cultures of human mononuclear phagocytes and in murine fibroblasts transfected with cosmid DNA bearing the human C2 and factor B genes.	SEN:10027674	2866182
BEL:20053642	p(MGI:Ifng) increases p(MGI:Ctss)	In contrast, Cat S protein was readily appreciated in macrophages and alveolar epithelial cells in lungs from transgenic mice on dox water (Fig. 4B).	SEN:10027680	15944319
BEL:20053648	p(MGI:Ifng) increases p(MGI:Icam1)	highly sensitive to IFN-g but poorly responsive to TNF-a (references 4, 5, 7, 9, 10, and 12 and unpublished observations). For these experiments, we first verified that this profile of cytokine responsiveness for ICAM-1 gene expression was similar in isolated mTE cells (Fig. 1 A).	SEN:10027682	11157054
BEL:20053650	p(MGI:Ifng) increases p(MGI:Icam1)	treatment with both IFN-g and TNF-a resulted in equivalent ICAM-1 induction by immunostaining (Fig. 1, B and C)	SEN:10027684	11157054
BEL:20053652	p(MGI:Ifng) decreases p(MGI:Ighg1)	rIFN-gamma strikingly enhances the secretion of IgG2a by murine splenic B cells stimulated with bacterial LPS in vitro and concomitantly suppresses the production of IgG3, IgG1, IgG2b, and IgE while sparing IgM secretion.	SEN:10027670	3127461
BEL:20053664	p(MGI:Ifng) increases p(MGI:Itgal)	Specifically, macrophage-activating factor (MAF), interferon-gamma (IFN-gamma), or picogram amounts of endotoxin (LPS) induced LFA-1 on TG-elicited macrophages following overnight incubation.	SEN:10009070	3923098
BEL:20053670	p(MGI:Ifng) increases p(MGI:Stat1,pmod(P))	IFN-gamma treatment induced phosphorylation of STAT1 and IFN-gamma-induced GKLF mRNA expression was attenuated by tyrosine protein kinase inhibitors, suggesting that phosphorylation of STAT1 played an essential role in this process IFN-gamma treatment increased GKLF promoter activity by 3.5-fold.	SEN:10027692	12441126
BEL:20053672	p(MGI:Ifng) increases r(EGID:15033)	Type I (alpha/beta) and type II (gamma) IFN enhance MHC class I gene expression through an IFN-responsive element (IRE) present in the 5' flanking region of the class I-a genes. We have found that cell surface expression of thymus leukemia Ag (TL) was up-regulated by IFN-gamma	SEN:10027694	8360484
BEL:20053680	p(MGI:Ifng) increases r(MGI:Bnip3)	Expression of BNIP3 was also induced in macrophages by LPS/IFN-gamma, and the induction was blocked by a NOS2 inhibitor, S-methyl-isothiourea	SEN:10004968	15358175
BEL:20053686	p(MGI:Ifng) increases r(MGI:Ccl2)	we treated cells with IFN-g, resulting in a several-fold increase in monocyte chemotactic protein-1 (MCP-1) expression. Nicotinic acid strongly inhibited this effect in macrophages from WT but not from GPR109A-deficient mice (Figure 6A).	SEN:10017040	21317532
BEL:20053688	p(MGI:Ifng) increases r(MGI:Ccr5)	the levels of CCR5 mRNA and protein were markedly increased in dox-treated IFN-?– transgenic animals (Figure 2, A and B).	SEN:10027678	16284650
BEL:20053692	p(MGI:Ifng) increases r(MGI:Cd40)	In this report, we describe the molecular mechanisms by which IL-4 inhibits IFN-gamma-induced CD40 expression.	SEN:10027700	11086058
BEL:20053696	p(MGI:Ifng) increases r(MGI:Clec4e)	Mincle mRNA expression was strongly induced in response to several inflammatory stimuli, such as LPS, TNF-alpha, IL-6, and IFN-gamma in wild-type macrophages.	SEN:10009080	10528209
BEL:20053698	p(MGI:Ifng) increases r(MGI:Crem)	IFN-gamma leads to a dramatic induction in the expression of the inducible cAMP early repressor (ICER), a potent inhibitor of gene transcription. addition, a synergistic action of IFN-gamma and calcium in the activation of ICER expression was identified.	SEN:10016690	12609974
BEL:20053700	p(MGI:Ifng) increases r(MGI:Ctsb)	RT-PCR and Northern blot evaluations demonstrated that IFN-g increased the levels of mRNA encoding cathepsins D, H, S, and B.	SEN:10027704	11104801
BEL:20053702	p(MGI:Ifng) increases r(MGI:Ctsd)	RT-PCR and Northern blot evaluations demonstrated that IFN-g increased the levels of mRNA encoding cathepsins D, H, S, and B.	SEN:10027704	11104801
BEL:20053704	p(MGI:Ifng) increases r(MGI:Ctsh)	RT-PCR and Northern blot evaluations demonstrated that IFN-g increased the levels of mRNA encoding cathepsins D, H, S, and B.	SEN:10027704	11104801
BEL:20053706	p(MGI:Ifng) increases r(MGI:Ctss)	RT-PCR and Northern blot evaluations demonstrated that IFN-g increased the levels of mRNA encoding cathepsins D, H, S, and B.	SEN:10027704	11104801
BEL:20053708	p(MGI:Ifng) increases r(MGI:Egr1)	The levels of EGR1, ZBP-1, GADD45-b, C/EBP-d, and GAPDH expression in control and IFN-c-treated RAW 264.7 macrophage cells were determined by real-time PCR analysis.	SEN:10027706	16516165
BEL:20053714	p(MGI:Ifng) increases r(MGI:Gadd45b)	The levels of EGR1, ZBP-1, GADD45-b, C/EBP-d, and GAPDH expression in control and IFN-c-treated RAW 264.7 macrophage cells were determined by real-time PCR analysis.	SEN:10027706	16516165
BEL:20053716	p(MGI:Ifng) increases r(MGI:Gapdh)	The levels of EGR1, ZBP-1, GADD45-b, C/EBP-d, and GAPDH expression in control and IFN-c-treated RAW 264.7 macrophage cells were determined by real-time PCR analysis.	SEN:10027706	16516165
BEL:20053718	p(MGI:Ifng) increases r(MGI:Gbp2)	In addition to the well-known GBP-2 and IRG- 47, we confirmed two novel members of this group—the ATP-dependent interferon-responsive gene (ADIR), and interferon-induced helicase (Ifih, Helicard, and mda-5), that are induced by IFN-c in RAW 264.7 cells (Fig. 2).	SEN:10027710	16516165
BEL:20053726	p(MGI:Ifng) increases r(MGI:"H2-Eb2")	it has been shown that the retinoblastoma tumor suppressor protein, Rb, is also required for IFN-gamma-inducible MHC class II gene expression	SEN:10027714	11533238
BEL:20053728	p(MGI:Ifng) increases r(MGI:"H2-T23")	Specific binding of Ins II to Qa-1b was confirmed by a CTL peptide-blocking assay. Demonstration of IFN-gamma-regulated Qa-1 expression in beta cells and identification of a Qa-1-binding peptide in the preproinsulin leader sequence invoke further consideration of possible roles of Qa-1 in the progression of islet inflammation.	SEN:10020268	9708188
BEL:20053730	p(MGI:Ifng) increases r(MGI:Icam1)	highly sensitive to IFN-g but poorly responsive to TNF-a (references 4, 5, 7, 9, 10, and 12 and unpublished observations). For these experiments, we first verified that this profile of cytokine responsiveness for ICAM-1 gene expression was similar in isolated mTE cells (Fig. 1 A).	SEN:10027682	11157054
BEL:20053732	p(MGI:Ifng) increases r(MGI:Ifi47)	In addition to the well-known GBP-2 and IRG- 47, we confirmed two novel members of this group—the ATP-dependent interferon-responsive gene (ADIR), and interferon-induced helicase (Ifih, Helicard, and mda-5), that are induced by IFN-c in RAW 264.7 cells (Fig. 2).	SEN:10027710	16516165
BEL:20053734	p(MGI:Ifng) increases r(MGI:Ifih1)	In addition to the well-known GBP-2 and IRG- 47, we confirmed two novel members of this group—the ATP-dependent interferon-responsive gene (ADIR), and interferon-induced helicase (Ifih, Helicard, and mda-5), that are induced by IFN-c in RAW 264.7 cells (Fig. 2).	SEN:10027710	16516165
BEL:20053736	p(MGI:Ifng) increases r(MGI:Il12a)	STE significantly elevated background and IFNg- induced activity of both the p35 and p40 promoters (Fig. 2)	SEN:10017840	12757742
BEL:20053738	p(MGI:Ifng) increases r(MGI:Il12b)	STE significantly elevated background and IFNg- induced activity of both the p35 and p40 promoters (Fig. 2)	SEN:10017840	12757742
BEL:20053740	p(MGI:Ifng) increases r(MGI:Irf1)	IFN-gamma increased GKLF and interferon regulatory factor-1 mRNA levels in a parallel fashion and these effects were abolished in STAT1 knockout mouse STAT1 mediated IFN-gamma-stimulated GKLF gene expression.	SEN:10027716	12441126
BEL:20053744	p(MGI:Ifng) increases r(MGI:Klf4)	IFN-gamma increased GKLF and interferon regulatory factor-1 mRNA levels in a parallel fashion and these effects were abolished in STAT1 knockout mouse STAT1 mediated IFN-gamma-stimulated GKLF gene expression.	SEN:10027716	12441126
BEL:20053748	p(MGI:Ifng) increases r(MGI:Lgals9)	Galectin-9 expression can be induced by IFN-gamma or IL-1beta in various tissues such as endothelial cells, fibroblasts and astrocytes26, 27, 28.	SEN:10027722	16286920
BEL:20053752	p(MGI:Ifng) increases r(MGI:Mmp12)	These studies demonstrated that IFN-g is a potent stimulator of MMP-12 mRNA accumulation (Fig. 10).	SEN:10027724	11104801
BEL:20053782	p(MGI:Ifng) decreases r(MGI:Slpi)	However, IFN-g did significantly inhibit the expression of secretory leukocyte proteinase inhibitor (SLPI; Fig. 14, and data not shown).	SEN:10027734	11104801
BEL:20053790	p(MGI:Ifng) increases r(MGI:Tlr2)	Using RT-PCR, the enhanced TLR2 and TLR4 mRNA expression was shown to be completely dependent on the action of IFN-gamma and TNF-alpha.	SEN:10009092	11801667
BEL:20053794	p(MGI:Ifng) increases r(MGI:Tnfsf13b)	IFN-gamma caused phosphorylation of CREB, and overexpression of CREB increased IFN-gamma-induced BAFF promoter activity.	SEN:10009096	18334541
BEL:20053796	p(MGI:Ifng) increases r(MGI:Tor3a)	In addition to the well-known GBP-2 and IRG- 47, we confirmed two novel members of this group—the ATP-dependent interferon-responsive gene (ADIR), and interferon-induced helicase (Ifih, Helicard, and mda-5), that are induced by IFN-c in RAW 264.7 cells (Fig. 2).	SEN:10027710	16516165
BEL:20053798	p(MGI:Ifng) increases r(MGI:Vdr)	Quantification of Vdr mRNA levels showed that treatment of BMDMs with 1?,25(OH)2D3 but also the activation of macrophages with IFN-G led to an induction of Vdr expression, which was 135-fold and 27-fold, respectively (Figure 4A).	SEN:10027742	16118315
BEL:20053800	p(MGI:Ifng) increases r(MGI:Zbp1)	The levels of EGR1, ZBP-1, GADD45-b, C/EBP-d, and GAPDH expression in control and IFN-c-treated RAW 264.7 macrophage cells were determined by real-time PCR analysis.	SEN:10027706	16516165
BEL:20053802	p(MGI:Ifng) increases sec(p(MGI:Lrp1))	In this study, we show that LPS and IFN-G induce shedding of LRP1 from RAW 264.7 cells and BMMs in vitro.	SEN:10016022	20610799
BEL:20053804	p(MGI:Ifng) increases sec(p(MGI:Mif))	Since macrophages activated by lipopolysaccharide, tumor necrosis factor (TNF)-?, and interferon-? have been shown to secret substantial amounts of preformed MIF [17], it is reasonable to assume that macrophage-derived MIF could be involved in atherogenesis.	SEN:10016024	18385967
BEL:20053806	p(MGI:Ifng) increases surf(p(EGID:15033))	Type I (alpha/beta) and type II (gamma) IFN enhance MHC class I gene expression through an IFN-responsive element (IRE) present in the 5' flanking region of the class I-a genes. We have found that cell surface expression of thymus leukemia Ag (TL) was up-regulated by IFN-gamma	SEN:10027694	8360484
BEL:20053810	p(MGI:Ifng) increases surf(p(MGI:"H2-D1"))	Type I (alpha/beta) and type II (gamma) IFN enhance MHC class I gene expression through an IFN-responsive element (IRE) present in the 5' flanking region of the class I-a genes. We have found that cell surface expression of thymus leukemia Ag (TL) was up-regulated by IFN-gamma	SEN:10027694	8360484
BEL:20053812	p(MGI:Ifng) increases surf(p(MGI:"H2-K1"))	Type I (alpha/beta) and type II (gamma) IFN enhance MHC class I gene expression through an IFN-responsive element (IRE) present in the 5' flanking region of the class I-a genes. We have found that cell surface expression of thymus leukemia Ag (TL) was up-regulated by IFN-gamma	SEN:10027694	8360484
BEL:20053814	p(MGI:Ifng) increases tloc(p(MGI:Nfkb1),GOCCID:0005737,GOCCID:0005634)	Similarly, IFN-g induced a significant nuclear localization of p50 and a larger nuclear localization of p65	SEN:10027744	12757742
BEL:20053816	p(MGI:Ifng) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	Similarly, IFN-g induced a significant nuclear localization of p50 and a larger nuclear localization of p65	SEN:10027744	12757742
BEL:20053826	p(MGI:Ifng) increases tscript(p(MGI:Cebpb))	We have reported earlier that C/EBP-beta induces gene transcription through a novel interferon (IFN)-response element called gamma-IFN-activated transcriptional element	SEN:10009098	15878863
BEL:20053828	p(MGI:Ifng) increases tscript(p(MGI:Creb1))	IFN-gamma caused phosphorylation of CREB, and overexpression of CREB increased IFN-gamma-induced BAFF promoter activity.	SEN:10009096	18334541
BEL:20053834	p(MGI:Ifng) increases tscript(p(MGI:Stat1))	IFN-gamma-induced inhibition of STAT6 phosphorylation and eotaxin production were mediated by SOCS-1 induced in STAT1-dependent manner.	SEN:10002780	14733929
BEL:20053838	p(MGI:Ifng) increases tscript(p(MGI:Stat1))	Including adenosine with IFN-gamma treatment delayed any measureable increase in STAT1 activation by >60 min, and led to significantly reduced STAT1 activity at 60, 120, and 240 min post-stimulation compared with cells treated with IFN-gamma alone ( p < 0.05; Fig. 4).	SEN:10015410	19846878
BEL:20053848	p(MGI:Ifrd1) decreases r(MGI:Myc)	TIS7 homologous deletion in mouse embryonic fibroblasts increased not only the TOPflash reporter gene transcriptional activity but also the expression of c-Myc and OPN	SEN:10027752	16204248
BEL:20053854	p(MGI:Ifrd1) decreases r(MGI:Spp1)	Here we show that TIS7 has the capacity to inhibit OPN expression also through Lef-1, the second identified OPN regulatory element.	SEN:10027754	16204248
BEL:20053858	p(MGI:Ifrd1) decreases tscript(p(MGI:Sp1))	The inhibitory effect of TIS7 on C/EBPalpha-Sp1-mediated transcription was confirmed by reporter assays. the TIS7 effect was mediated through specific interference with Sp1 transcriptional activity.	SEN:10009104	15095974
BEL:20053874	p(MGI:Igf1) increases bp(GOBP:glycolysis)	Here we show that stable expression of a gene encoding insulin-like growth factor 1 (IGF-1) in C2C12 skeletal muscle cells, or treatment of these cells with recombinant IGF-1 or with insulin and dexamethasone, results in hypertrophy of differentiated myotubes and a switch to glycolytic metabolism.	SEN:10027764	10448861
BEL:20053876	p(MGI:Igf1) increases bp(GOBP:"inflammatory response")	We conclude that TNFalpha and IGF-I may additively contribute to fibrosis during intestinal inflammation. TNFR2 is a primary mediator of fibrogenic actions of TNFalpha acting through ERK1/2 to stimulate proliferation and through STAT3 to stimulate TIMP-1 and inhibit collagen degradation.	SEN:10001764	16141211
BEL:20053878	p(MGI:Igf1) increases bp(GOBP:"MAPK cascade")	IRS-3 expression in WT cells also caused an increase in IGF-1-induced mitogen-activated protein kinase phosphorylation and egr-1 expression	SEN:10009112	11113178
BEL:20053880	p(MGI:Igf1) increases bp(GOBP:mitosis)	However, increased IRS-2 expression augmented glucose/IGF-1 induced beta-cell growth mitogenesis and decreased apoptosis due to glucose-deprivation	SEN:10009114	12850284
BEL:20053892	p(MGI:Igf1) increases deg(p(MGI:Arrb1))	from full text - Similarly, we find that both b-arrestin1 and 2 are ubiquitinated in IGF-1-stimulated WT MEF cells.	SEN:10027774	17303558
BEL:20053894	p(MGI:Igf1) increases deg(p(MGI:Arrb2))	from full text - Similarly, we find that both b-arrestin1 and 2 are ubiquitinated in IGF-1-stimulated WT MEF cells.	SEN:10027774	17303558
BEL:20053902	p(MGI:Igf1) increases kin(p(MGI:Mapk1))	from full text - As shown in Fig. 1A, ERK1/2 in wild-type MEFs is phosphorylated after IGF-1 stimulation with a peak at 5–10 min, after which pERK declined substantially. In b-arrestin1 KO MEFs, on the other hand, ERK1/2 remained essentially inactivated upon IGF-1 stimulation (Fig. 1A).	SEN:10025228	17303558
BEL:20053904	p(MGI:Igf1) increases kin(p(MGI:Mapk3))	from full text - As shown in Fig. 1A, ERK1/2 in wild-type MEFs is phosphorylated after IGF-1 stimulation with a peak at 5–10 min, after which pERK declined substantially. In b-arrestin1 KO MEFs, on the other hand, ERK1/2 remained essentially inactivated upon IGF-1 stimulation (Fig. 1A).	SEN:10025228	17303558
BEL:20053922	p(MGI:Igf1) increases p(MGI:Arrb1,pmod(U,K))	from full text - Similarly, we find that both b-arrestin1 and 2 are ubiquitinated in IGF-1-stimulated WT MEF cells.	SEN:10027774	17303558
BEL:20053924	p(MGI:Igf1) increases p(MGI:Arrb2,pmod(U,K))	from full text - Similarly, we find that both b-arrestin1 and 2 are ubiquitinated in IGF-1-stimulated WT MEF cells.	SEN:10027774	17303558
BEL:20053928	p(MGI:Igf1) increases p(MGI:Ddit3)	At the doses tested, IGF-I restored CHOP induction by amino acid deprivation, but EGF did not (Fig. 2B), indicating that IGF-I can substitute for the serum requirement.	SEN:10027782	11145585
BEL:20053946	p(MGI:Igf1) increases r(MGI:Amelx)	Our results showed that after 6-days in culture; treatment with insulin, IGF-I and IGF-II increased the synthesis of amelogenin and ameloblastin.	SEN:10007098	11063034
BEL:20053950	p(MGI:Igf1) decreases r(MGI:Fabp3)	Administration of IGF-I or GH to Ghrhrlit/Ghrhrlit mice suppressed MDGI mRNA levels in a dose-dependent manner.	SEN:10008836	9683796
BEL:20053958	p(MGI:Igf1) decreases r(MGI:Lcn2)	We found that IGF-1 blocked the transcriptional activation of 24p3 that normally occurs after IL-3 withdrawal (Fig. 6C, lane 2 versus 3). These results strongly suggest that IGF-1 promotes survival after IL-3 withdrawal by inhibiting 24p3 transcriptional activation. Direct addition of 24p3 bypasses this transcriptional block, and therefore IGF-1 has no effect	SEN:10027792	11486081
BEL:20053960	p(MGI:Igf1) increases r(MGI:Mbp)	We found that myelin staining, MBP and PLP expression, and the percentage of oligodendrocytes and their precursors are significantly reduced in all brain regions of developing IGF-I KO mice but are similar to controls in adult IGF-I KO mice.	SEN:10027794	12122065
BEL:20053962	p(MGI:Igf1) increases r(MGI:Plp1)	We found that myelin staining, MBP and PLP expression, and the percentage of oligodendrocytes and their precursors are significantly reduced in all brain regions of developing IGF-I KO mice but are similar to controls in adult IGF-I KO mice.	SEN:10027794	12122065
BEL:20053964	p(MGI:Igf1) increases r(MGI:Qdpr)	Transgenic overexpression of IGF-1 resulted in marked increases in skeletal muscle DHPR alpha(1S) and RyR1 mRNA in young and old mice and in enhance	SEN:10009130	11240160
BEL:20053966	p(MGI:Igf1) decreases r(MGI:Rbm39)	Table 2 The temporal pattern of genes down-regulated with IGF-1 treatment: Genes down-regulated at 1 & 4 hrs	SEN:10027796	19014463
BEL:20053968	p(MGI:Igf1) increases r(MGI:Ryr1)	Transgenic overexpression of IGF-1 resulted in marked increases in skeletal muscle DHPR alpha(1S) and RyR1 mRNA in young and old mice and in enhance	SEN:10009130	11240160
BEL:20053970	p(MGI:Igf1) increases r(MGI:Sertad3)	Table 1 The temporal pattern of genes up-regulated with IGF-1 treatment: Genes up-regulated at 1 & 4 hrs	SEN:10027798	19014463
BEL:20053972	p(MGI:Igf1) decreases r(MGI:Txnip)	Table 2 The temporal pattern of genes down-regulated with IGF-1 treatment: Genes down-regulated at 1 & 4 hrs	SEN:10027796	19014463
BEL:20053974	p(MGI:Igf1) increases tloc(p(MGI:Trp53),GOCCID:0005634,GOCCID:0005737)	We showed that after 4-nitroquinoline 1-oxide-induced DNA damage, IGF-I induced exclusion of the p53 protein from the nucleus and led to its degradation in the cytoplasm, whereas p53 mRNA was unaffected.	SEN:10027800	11877395
BEL:20053978	p(MGI:Igf2) increases bp(GOBP:"cell growth")	Igf2r encodes a trans-membrane receptor that transports mannose-6-phosphate tagged proteins and insulin-like growth factor 2 to lysosomes. Inactivating mutations of Igf2r in mice lead to increased systemic Igf2 levels that cause embryonic overgrowth and perinatal lethality	SEN:10027802	11311167
BEL:20053984	p(MGI:Igf2r) increases cat(p(MGI:Ctsd))	Fibroblasts derived from double mutant mice missort the lysosomal protease cathepsin D, and are able to degrade endocytosed (125I)IGFBP-3 intracellularly,	SEN:10027804	10226807
BEL:20053986	p(MGI:Igf2r) decreases p(MGI:Igf2)	The Type-2 insulin-like growth factor receptor (IGF2R) mediates the transport of lysosomal hydrolases to lysosomes and the clearance of insulin-like growth factor II (IGF-II).	SEN:10009136	10226807
BEL:20053988	p(MGI:Igf2r) decreases p(MGI:Igf2)	Igf2r encodes a trans-membrane receptor that transports mannose-6-phosphate tagged proteins and insulin-like growth factor 2 to lysosomes. Inactivating mutations of Igf2r in mice lead to increased systemic Igf2 levels that cause embryonic overgrowth and perinatal lethality	SEN:10027802	11311167
BEL:20053996	p(MGI:Igfbp4) decreases p(MGI:Igf1)	Thus, IGFBP-4.7A results in greater growth inhibition than equivalent levels of native IGFBP-4 in vivo, demonstrating a role for IGFBP-4 proteolysis in the regulation of IGF-I action.	SEN:10005472	11923290
BEL:20054000	p(MGI:Igfbp5) increases bp(GOBP:"apoptotic process")	The concentration of the proapoptotic molecule caspase-3 was increased during lactation in ATF4-transgenic animal. Mammary glands from ATF4-transgenic mice also showed significant nuclear translocation of activated STAT3 and up-regulation of one of its target genes, insulin-like growth factor-binding protein-5, which is thought to facilitate apoptosis by sequestering insulin-like growth factor	SEN:10009142	12611881
BEL:20054006	p(MGI:Igfbp7) decreases bp(GOBP:"myoblast differentiation")	TGF-beta inhibited myogenic differentiation by 98% and stimulated mac25/IGFBP-7 mRNA expression 2-fold.	SEN:10006402	9417882
BEL:20054008	p(MGI:Igfbp7) increases bp(GOBP:"replicative cell aging")	IGFBP-7, Mac25/IGFBP-7 is hypothesized to have growth-suppressing activity, since mac25/IGFBP-7 mRNA is down-regulated in several tumor cell lines and is highly expressed in senescent mammary epithelial cells.	SEN:10009144	9417882
BEL:20054024	p(MGI:Ihh) increases r(MGI:Dkk1)	In the Ihh-- littermate, however, no expression was detected in the perichondrium for either Tcf1 or Dkk1	SEN:10027816	15576404
BEL:20054032	p(MGI:Ihh) increases r(MGI:Hnf1a)	In the Ihh-- littermate, however, no expression was detected in the perichondrium for either Tcf1 or Dkk1	SEN:10027816	15576404
BEL:20054034	p(MGI:Ihh) increases r(MGI:Lef1)	In the Ihh-- littermate, whereas Tcf3 and Tcf4 remained expressed in the chondrocytes (Fig. 5D',E', `C'), Lef1 was no longer detectable	SEN:10027820	15576404
BEL:20054048	p(MGI:Ihh) increases r(MGI:Wnt7b)	Wnt7b was strictly expressed by perichondrial cells flanking the prehypertrophic chondrocytes (Fig. 8G, arrow), but the expression was abolished in the Ihh-- mutant	SEN:10027822	15576404
BEL:20054052	p(MGI:Ikbkb) increases path(MESHD:"Insulin Resistance")	Insulin resistance was improved by systemic neutralization of IL-6 or salicylate inhibition of IKK-beta.	SEN:10006180	15685173
BEL:20054062	p(MGI:Ikbkb) decreases r(MGI:Cyp1b1)	Expression profiling experiments revealed an increased expression of p450 family CYP1B1 mRNA in Ikkbeta(-/-) cells compared with wild-type cells.	SEN:10027828	14633691
BEL:20054064	p(MGI:Ikbkg) decreases bp(GOBP:"glucose import")	NEMO expression also enhanced TNF-alpha-induced Ser307-IRS-1 phosphorylation and inhibited glucose uptake.	SEN:10009152	16754954
BEL:20054080	p(MGI:Il10) decreases a(CHEBI:cholesterol)	Intramuscular injection of AAV5-mIL10 into ApoE-deficient, atherosclerosis-susceptible mice inhibit atherogenesis through both antiinflammatory and cholesterol-lowering effects [85, 86].	SEN:10027836	19601851
BEL:20054082	p(MGI:Il10) increases a(CHEBI:lipid)	IL-10-deficient mice fed an atherogenic diet exhibit a significant increase in lipid accumulation and demonstrate increased lesions compared with wild-type mice [78, 79].	SEN:10027838	19601851
BEL:20054100	p(MGI:Il10) decreases bp(GOBP:"inflammatory response")	Intramuscular injection of AAV5-mIL10 into ApoE-deficient, atherosclerosis-susceptible mice inhibit atherogenesis through both antiinflammatory and cholesterol-lowering effects [85, 86].	SEN:10027836	19601851
BEL:20054102	p(MGI:Il10) decreases bp(GOBP:"T-helper 1 cell differentiation")	Thus, while IL-10 can reduce Th2 recall immune responses, its major effect evident during the primary response is to inhibit the development of Th1 responses, thereby favoring Th2 development.	SEN:10027850	16940042
BEL:20054104	p(MGI:Il10) increases bp(GOBP:"T-helper 2 cell differentiation")	Thus, while IL-10 can reduce Th2 recall immune responses, its major effect evident during the primary response is to inhibit the development of Th1 responses, thereby favoring Th2 development.	SEN:10027850	16940042
BEL:20054110	p(MGI:Il10) increases bp(GOBP:"apoptotic process")	IL-10 can directly promote the death of inflammatory cells, including activated macrophages (4), neutrophils (5), and T cells	SEN:10027854	11591769
BEL:20054112	p(MGI:Il10) decreases cat(p(MGI:Casp3))	Pinderski and colleagues have recently reported that a reduction in macrophage caspase3 activity in LDL-receptor null mice overexpressing IL10 most likely accounts for the decreased formation of necrotic cores within the atherosclerotic lesions of these animals, suggesting antiapoptotic and plaque-stabilizing effects of IL10 (114)	SEN:10027856	16293001
BEL:20054122	p(MGI:Il10) decreases path(MESHD:Fibrosis)	Although some studies suggest that IL-10 (alone or in combination with IFN-g) also functions as a repressor of the fibrotic process (97), the role of IL-10 in SSc remains to be clarified.	SEN:10027864	17332883
BEL:20054142	p(MGI:Il10) decreases p(MGI:Alox5ap)	We demonstrate that IL-10 suppresses the production of LTB4 from DC by inhibiting FLAP protein expression without any effect on 5-LO and cytosolic phospholipase A2.	SEN:10018790	12496393
BEL:20054144	p(MGI:Il10) increases p(MGI:Cd276)	In support, IL-10 released from TAM could stimulate cancer cell expression of membrane bound B7-H3.	SEN:10009158	22999863
BEL:20054146	p(MGI:Il10) decreases p(MGI:Elk1,pmod(P,S,383))	Pretreatment of the cells with IL-10 resulted in a marked reduction of Elk-1 phosphorylation (Figure 6A).	SEN:10027874	16037570
BEL:20054148	p(MGI:Il10) decreases p(MGI:Ifng)	from full text - An inactivation of IL-10 in mice results in an increased production of IL-12 and IFN-gamma [42,43]. Inflamed tissues and granulomas of CD show low IL-10[44]. Melgar et al[45] reported a highly significant increase in IL-10 mRNA levels in T lymphocytes and in IL-10-positive cells in the colons of UC patients.	SEN:10027860	18666314
BEL:20054150	p(MGI:Il10) increases p(MGI:Socs3)	In monocytes, IL-10 induction of SOCS-3, or over expression of SOCS3 inhibits NF-??B activity [60].	SEN:10019616	19601851
BEL:20054152	p(MGI:Il10) increases p(MGI:Tgfb1)	In accord with these findings, IL-10 caused a significant increase in TGF-b1 mRNA and latent TGF-b1 protein accumulation in lungs from transgene () mice (Fig. 6).	SEN:10027876	12107190
BEL:20054154	p(MGI:Il10) increases p(MGI:Tsc22d3)	Overall, these results show that, in mice, GC treatment and IL-10 overproduction both stimulate GILZ production in vivo	SEN:10027878	12393603
BEL:20054156	p(MGI:Il10) decreases r(MGI:Alox5ap)	We demonstrate that IL-10 suppresses the production of LTB4 from DC by inhibiting FLAP protein expression without any effect on 5-LO and cytosolic phospholipase A2.	SEN:10018790	12496393
BEL:20054158	p(MGI:Il10) increases r(MGI:Bcl2)	In contrast, IL-10 increases the survival of some types of human cancer cells, such as Burkitt lymphoma (7). Non-Hodgkin s lymphoma cells secrete IL-10, and inhibition of this autocrine IL-10 has recently been shown to promote cell death and reduce expression of the anti-apoptotic protein Bcl-2	SEN:10027880	11591769
BEL:20054160	p(MGI:Il10) increases r(MGI:Bcl2l1)	Similarly, IL-10 increases the expression of Bcl-xL in thyrocytes from patients with Graves disease	SEN:10027882	11591769
BEL:20054162	p(MGI:Il10) increases r(MGI:Bcl3)	We compared CLPMphi gene expression profiles of wild-type mice with IL-10-deficient mice, and identified genes that are selectively expressed in wild-type CLPMphi. These genes included nuclear IkappaB proteins such as Bcl-3 and IkappaBNS.	SEN:10027884	15749903
BEL:20054164	p(MGI:Il10) decreases r(MGI:Ccl2)	Expression of all proinflammatory/profibrotic mediators as assessed by reverse transcriptase-PCR and densitometry was less in Lenti-IL-10-injected wounds compared with Lenti-GFP-injected wounds, with the difference in the expression of IL-6, MCP-1, and HSP47 reaching statistical significance (Figure 5).	SEN:10027886	18200061
BEL:20054172	p(MGI:Il10) increases r(MGI:Il13)	Th2 cytokines were not detected in total lung RNA from transgene () animals. They were, however, readily apparent in lungs from antigen-sensitized and -challenged WT animals (Fig. 5). As shown in Fig. 5, increased levels of mRNA encoding IL-13 were detected in RNA from IL-10 transgenic mice.	SEN:10027888	12107190
BEL:20054174	p(MGI:Il10) decreases r(MGI:Il6)	Expression of all proinflammatory/profibrotic mediators as assessed by reverse transcriptase-PCR and densitometry was less in Lenti-IL-10-injected wounds compared with Lenti-GFP-injected wounds, with the difference in the expression of IL-6, MCP-1, and HSP47 reaching statistical significance (Figure 5).	SEN:10027886	18200061
BEL:20054176	p(MGI:Il10) decreases r(MGI:Ltb)	We demonstrate that IL-10 suppresses the production of LTB(4) from DC by inhibiting FLAP protein expression without any effect on 5-LO and cytosolic phospholipase A(2).	SEN:10025090	12496393
BEL:20054178	p(MGI:Il10) increases r(MGI:Nfkbid)	We compared CLPMphi gene expression profiles of wild-type mice with IL-10-deficient mice, and identified genes that are selectively expressed in wild-type CLPMphi. These genes included nuclear IkappaB proteins such as Bcl-3 and IkappaBNS.	SEN:10027884	15749903
BEL:20054180	p(MGI:Il10) decreases r(MGI:Serpinh1)	Expression of all proinflammatory/profibrotic mediators as assessed by reverse transcriptase-PCR and densitometry was less in Lenti-IL-10-injected wounds compared with Lenti-GFP-injected wounds, with the difference in the expression of IL-6, MCP-1, and HSP47 reaching statistical significance (Figure 5).	SEN:10027886	18200061
BEL:20054182	p(MGI:Il10) decreases r(MGI:Slc6a4)	Serotonin reuptake transporter expression was significantly increased in the inflamed colons of IL-10(-/-) mice	SEN:10009166	20219086
BEL:20054184	p(MGI:Il10) increases r(MGI:Socs3)	Treatment of RAW cells with IL-10 resulted in induction of SOCS-3 expression. (Figure 7A); whereas no significant induction in SOCS-1 expression could be observed (data not shown).	SEN:10027890	16037570
BEL:20054186	p(MGI:Il10) increases r(MGI:Tgfb1)	In accord with these findings, IL-10 caused a significant increase in TGF-b1 mRNA and latent TGF-b1 protein accumulation in lungs from transgene () mice (Fig. 6).	SEN:10027876	12107190
BEL:20054190	p(MGI:Il10) increases sec(p(MGI:Il4))	In the case of Th2-type cytokines, enhanced production of IL-4 and IL-6 was reduced by treatment with anti-TGF-/3 or anti-IL- IO (Fig. 5B).	SEN:10027892	8598496
BEL:20054192	p(MGI:Il10) increases sec(p(MGI:Il6))	In the case of Th2-type cytokines, enhanced production of IL-4 and IL-6 was reduced by treatment with anti-TGF-/3 or anti-IL- IO (Fig. 5B).	SEN:10027892	8598496
BEL:20054196	p(MGI:Il10) decreases tscript(p(MGI:Elk1))	Pretreatment of the cells with IL-10 resulted in a marked reduction of Elk-1 phosphorylation (Figure 6A).	SEN:10027874	16037570
BEL:20054198	p(MGI:Il10) decreases tscript(p(MGI:Stat1))	IL-10 inhibits IFN-alpha-activated STAT1 in the liver, at least in part, by inducing SOCS2, SOCS3, and CIS expression	SEN:10022516	11034314
BEL:20054204	p(MGI:Il11) increases kin(p(MGI:Src))	Immune-complex kinase reactions using the artificial substrate enolase showed that upon stimulation with IL-11, p62yes and p60src were activated, but p59fyn did not appear to be activated. These results correlate with antiphosphotyrosine (APT) immunoblots.	SEN:10027896	8641341
BEL:20054206	p(MGI:Il11) increases kin(p(MGI:Yes1))	Immune-complex kinase reactions using the artificial substrate enolase showed that upon stimulation with IL-11, p62yes and p60src were activated, but p59fyn did not appear to be activated. These results correlate with antiphosphotyrosine (APT) immunoblots.	SEN:10027896	8641341
BEL:20054208	p(MGI:Il11) increases p(MGI:Il6st,pmod(P))	tryosine phosphorylation of gp130 was observed in fibroblasts after stimulation with all the cytokines	SEN:10027898	11820727
BEL:20054210	p(MGI:Il11) increases p(MGI:Src,pmod(P,Y))	Immune-complex kinase reactions using the artificial substrate enolase showed that upon stimulation with IL-11, p62yes and p60src were activated, but p59fyn did not appear to be activated. These results correlate with antiphosphotyrosine (APT) immunoblots.	SEN:10027896	8641341
BEL:20054212	p(MGI:Il11) increases p(MGI:Yes1,pmod(P,Y))	Immune-complex kinase reactions using the artificial substrate enolase showed that upon stimulation with IL-11, p62yes and p60src were activated, but p59fyn did not appear to be activated. These results correlate with antiphosphotyrosine (APT) immunoblots.	SEN:10027896	8641341
BEL:20054230	p(MGI:Il13) increases a(CHEBI:adenosine)	By 3 months of age, adenosine concentrations in lungs from IL-13 Tg mice had increased to levels tenfold greater than those measured in wild-type lungs.	SEN:10027910	12897202
BEL:20054232	p(MGI:Il13) increases a(CHEBI:"hyaluronic acid")	IL-13 caused an impressive increase in lung collagen (measured by hydroxyproline content assay) and BAL HA content that could be easily appreciated with the histochemical and biochemical measurement techniques (Fig. 5 and data not shown).	SEN:10027912	11884467
BEL:20054236	p(MGI:Il13) increases a(CHEBI:hydroxyproline)	IL-13 caused an impressive increase in lung collagen (measured by hydroxyproline content assay) and BAL HA content that could be easily appreciated with the histochemical and biochemical measurement techniques (Fig. 5 and data not shown).	SEN:10027912	11884467
BEL:20054242	p(MGI:Il13) increases bp(GOBP:"inflammatory response")	In the CC10-IL-13 mice, progressive lung pathology is noted. At 1 mo of age, these animals manifest peribronchial inflammation, mucus metaplasia, alveolar enlargement, and subepithelial fibrosis (10).	SEN:10027916	11884467
BEL:20054246	p(MGI:Il13) increases bp(GOBP:"inflammatory response")	In contrast, 5-LO ablation significantly decreased BAL total cell and eosinophil recovery and the tissue inflammation in lungs from Tg IL-13 animals (Fig. 3, A–C).	SEN:10025094	16849505
BEL:20054250	p(MGI:Il13) decreases cat(p(MGI:Ada))	In contrast, there was a significant decrease in ADA parameters in lungs from 3-month-old IL-13 Tg animals.This decrease was readily apparent in assays for ADA enzymatic activity on lung extracts. Decreases were visualized using zymogram gel analysis (Figure 2b)	SEN:10027918	12897202
BEL:20054252	p(MGI:Il13) increases cat(p(MGI:Casp8))	Caspase-8, an activator caspase that interacts with the death domain of the TNF receptor and CD95 (Fas) receptor, was activated in experimental emphysema caused by lung overexpression of either IFN-{gamma} (370) or IL-13 (196).	SEN:10027656	17615396
BEL:20054254	p(MGI:Il13) increases cat(p(MGI:Mmp12))	Zymography also demonstrated IL-13–induced BAL moieties that comigrated with the unprocessed and/or fully processed forms of MMP-9, -12, and -2 (Figure 8, a and b).	SEN:10027920	11067861
BEL:20054256	p(MGI:Il13) increases cat(p(MGI:Mmp2))	Zymography also demonstrated IL-13–induced BAL moieties that comigrated with the unprocessed and/or fully processed forms of MMP-9, -12, and -2 (Figure 8, a and b).	SEN:10027920	11067861
BEL:20054258	p(MGI:Il13) increases cat(p(MGI:Mmp9))	Zymography also demonstrated IL-13–induced BAL moieties that comigrated with the unprocessed and/or fully processed forms of MMP-9, -12, and -2 (Figure 8, a and b).	SEN:10027920	11067861
BEL:20054260	p(MGI:Il13) increases cat(p(MGI:Tgfb1))	As previously reported by our laboratory (36), the BAL fluids from IL-13-producing mice had significant levels of TGF-1 bioactivity	SEN:10027922	11884467
BEL:20054262	p(MGI:Il13) increases cat(p(MGI:Tgfb1))	In contrast, significant amounts of total and activated TGF-1 were seen in BAL from Tg mice (Fig. 7, A and B).	SEN:10027924	16849505
BEL:20054264	p(MGI:Il13) increases path(MESHD:Asthma)	In animal models of allergic asthma, blockade of IL-13 markedly inhibits allergen-induced AHR, mucus production and eosinophilia. Furthermore, IL-13 delivery to the airway causes all of these effects. IL-13 is thus both necessary and sufficient for experimental models of asthma.	SEN:10027926	12091879
BEL:20054268	p(MGI:Il13) increases path(MESHD:Fibrosis)	In the CC10-IL-13 mice, progressive lung pathology is noted. At 1 mo of age, these animals manifest peribronchial inflammation, mucus metaplasia, alveolar enlargement, and subepithelial fibrosis (10).	SEN:10027916	11884467
BEL:20054270	p(MGI:Il13) increases path(MESHD:Fibrosis)	As expected, we found that tg-IL-13+Stat6+/- mice had substantial fibrosis as demonstrated by elevated levels of lung hydroxyproline, a constituent of collagen (Fig. 3b). This increase was dependent on STAT6 expression, but expression of hSTAT6 in epithelial cells did not result in reconstitution of the fibrotic response.	SEN:10027930	12091879
BEL:20054272	p(MGI:Il13) increases path(MESHD:Fibrosis)	As previously reported (11), Tg IL-13 was a potent stimulator of fibrosis in Tg mice with (/) 5-LO loci (Fig. 6, A and B).	SEN:10027932	16849505
BEL:20054278	p(MGI:Il13) increases p(MGI:Adam17)	(from text) Similar to EGFR, our studies demonstrated that ADAM17 surface expression on lung epithelial cells was up-regulated in IL-13 transgenic mice (Fig. 3, f and g) and OVA-sensitized and challenged mice (Fig. 3f).	SEN:10017060	18824549
BEL:20054280	p(MGI:Il13) increases p(MGI:Adora3)	The A3 adenosine receptor was expressed diffusely in the lungs of wild-type mice (Figure 6a). In lungs from IL-13 Tg mice this receptor was expressed diffusely in the interstitium (data not shown) and in patches of inflammatory cells that encompassed eosinophils and macrophages near sites of remodeling (Figure 6b).	SEN:10027936	12897202
BEL:20054282	p(MGI:Il13) increases p(MGI:Ccl11)	Among the Th2 cytokines tested, IL-13 was by far the most effective cytokine inducing eotaxin in the lung, up-regulating both the eotaxin mRNA expression and protein production (Fig. 2, A–C).	SEN:10027938	10072486
BEL:20054284	p(MGI:Il13) increases p(MGI:Ccl11)	naive BALB/c mice were treated with different concentrations of IL-4 and IL-13, and eotaxin in lung tissues or in BAL were measured by ELISA...Compared with IL-13, IL-4 induced much lower levels of eotaxin even at higher doses (Fig. 4).	SEN:10027940	10072486
BEL:20054286	p(MGI:Il13) increases p(MGI:Ccl11)	MCP-3, macrophage-derived chemokine (MDC), and C10 have also been demonstrated to be induced in an IL-13-dependent fashion in vivo, and IL-13 stimulates MCP-1, MDC, and eotaxin production in vitro (14, 26, 27).	SEN:10027942	11884467
BEL:20054288	p(MGI:Il13) increases p(MGI:Ccl11)	Previous studies from our laboratory demonstrated that IL-13 is a potent stimulator of eotaxin production in vivo (10).	SEN:10027944	11884467
BEL:20054290	p(MGI:Il13) increases p(MGI:Ccl11)	This was done by quantitating the levels of selected chemokines (MCP-1, MIP-1, eotaxin) in BAL...fluids from CC10-rtTA-IL-13 mice at intervals after dox administration. Rapid inductive patterns and delayed inductive patterns were noted.	SEN:10027946	11884467
BEL:20054292	p(MGI:Il13) increases p(MGI:Ccl2)	MCP-3, macrophage-derived chemokine (MDC), and C10 have also been demonstrated to be induced in an IL-13-dependent fashion in vivo, and IL-13 stimulates MCP-1, MDC, and eotaxin production in vitro (14, 26, 27).	SEN:10027942	11884467
BEL:20054294	p(MGI:Il13) increases p(MGI:Ccl2)	This was done by quantitating the levels of selected chemokines (MCP-1, MIP-1, eotaxin) in BAL...fluids from CC10-rtTA-IL-13 mice at intervals after dox administration. Rapid inductive patterns and delayed inductive patterns were noted.	SEN:10027946	11884467
BEL:20054296	p(MGI:Il13) increases p(MGI:Ccl22)	MCP-3, macrophage-derived chemokine (MDC), and C10 have also been demonstrated to be induced in an IL-13-dependent fashion in vivo, and IL-13 stimulates MCP-1, MDC, and eotaxin production in vitro (14, 26, 27).	SEN:10027942	11884467
BEL:20054298	p(MGI:Il13) increases p(MGI:Ccl3)	This was done by quantitating the levels of selected chemokines (MCP-1, MIP-1, eotaxin) in BAL...fluids from CC10-rtTA-IL-13 mice at intervals after dox administration. Rapid inductive patterns and delayed inductive patterns were noted.	SEN:10027946	11884467
BEL:20054300	p(MGI:Il13) increases p(MGI:Ccl7)	MCP-3, macrophage-derived chemokine (MDC), and C10 have also been demonstrated to be induced in an IL-13-dependent fashion in vivo, and IL-13 stimulates MCP-1, MDC, and eotaxin production in vitro (14, 26, 27).	SEN:10027942	11884467
BEL:20054302	p(MGI:Il13) increases p(MGI:Chia1)	(from text) Using this method, we successfully compared the levels of intracellular AMCase in lung epithelial cells from control mice, mice sensitized and challenged with OVA, and IL-13-overexpressing transgenic animals. These studies demonstrated a significant increase in intracellular AMCase in both of the modeling systems (Fig. 2, a–d).	SEN:10017062	18824549
BEL:20054304	p(MGI:Il13) increases p(MGI:Egfr)	(from text) The increase in intracellular AMCase in these Th2 inflammation/asthma models was paralleled by an increase of total EGFR in lung lysates (Fig. 3a) as well as specific EGFR surface expression on lung epithelial cells as analyzed by immunohistochemistry (Fig. 3b) and flow cytometry (Fig. 3, c and d).	SEN:10017064	18824549
BEL:20054306	p(MGI:Il13) increases p(MGI:Egr1)	IL-13 increased Egr-1 mRNA levels in a biphasic manner in Stat6/ fibroblasts; early induction of Egr-1 mRNA was observed 30 min following exposure to IL-13 and declined after 3–6 h (Fig. 6A). Egr-1 protein was increased in Stat6/ fibroblasts as compared with Stat6/ fibroblasts from 30 min to 3 h after IL-13 treatment (Fig. 6, B and C).	SEN:10027948	16951379
BEL:20054308	p(MGI:Il13) increases p(MGI:Irs2,pmod(P,Y))	as for Jak1, the phosphoryaltions of Tyk2 and IRS-2 were reduced after IL13 stimulaiton in wildtype cells.	SEN:10027950	12204103
BEL:20054310	p(MGI:Il13) increases p(MGI:Mapk1,pmod(P,T,183))	After 24 hours of IL-13 induction, phosphorylation of ERK1 (p44) and ERK2 (p42) but not JNK1/2 or p38 MAPK was observed (Figure 1).	SEN:10027952	16374521
BEL:20054312	p(MGI:Il13) increases p(MGI:Mapk3,pmod(P,T,203))	After 24 hours of IL-13 induction, phosphorylation of ERK1 (p44) and ERK2 (p42) but not JNK1/2 or p38 MAPK was observed (Figure 1).	SEN:10027952	16374521
BEL:20054314	p(MGI:Il13) increases p(MGI:Pdgfa)	PDGF-AA immunostaining was strongly expressed in the lungs of IL-13 transgene-positive mice and localized to the airway epithelium, airway smooth muscle, and interstitial cells (Fig. 1, B–E).	SEN:10027954	16951379
BEL:20054316	p(MGI:Il13) increases p(MGI:Pdgfc)	PDGF-CC immunostaining was strongly expressed in the lungs of IL-13 transgene-positive mice and localized to airway epithelium, type II pneumocytes, alveolar macrophages, and fibroblasts (Fig. 1G).	SEN:10027956	16951379
BEL:20054318	p(MGI:Il13) increases p(MGI:Pik3r1,pmod(P))	Results In cytoplasmic extracts, phosphoryalation of the p85alpha subunit of PI3-kinase was markedly increased after stimulation with Il13 in both groups of probands.	SEN:10027958	12204103
BEL:20054320	p(MGI:Il13) decreases p(MGI:Serpina1a)	Our previous studies demonstrated that IL-13 causes MMP- and cathepsin-dependent lung remodeling and inhibits the expression of a1–AT (4).	SEN:10027960	16374521
BEL:20054322	p(MGI:Il13) increases p(MGI:Spdef)	Likewise, intratracheal IL-13 treatment caused goblet cell hyperplasia in association with increased SPDEF staining in control but not in Stat-6-/- mice (Figure 11, A and B).	SEN:10027962	17347682
BEL:20054324	p(MGI:Il13) increases p(MGI:Stat1,pmod(P,Y))	we observed that IL-13 caused tyrosine phosphorylation of Stat1 in Stat6/ and Stat6/ fibroblasts (Fig. 3, A and C).	SEN:10027964	16951379
BEL:20054326	p(MGI:Il13) increases p(MGI:Stat6,pmod(P,Y))	Next, we observed that Stat6 was tyrosine phosphorylated in Stat1/ and Stat1/ fibroblasts (Fig. 3, B and D).	SEN:10027966	16951379
BEL:20054328	p(MGI:Il13) increases p(MGI:Stat6,pmod(P,Y,651))	IL-13 Tg can be inducibly expressed in the adult murine lung by the administration of doxycycline-containing (dox-containing) water. As expected, increased levels of phospho-STAT6 were readily detected by Western blot analysis after Tg activation (Figure 1).	SEN:10027968	16374521
BEL:20054330	p(MGI:Il13) increases p(MGI:Tgfb1)	Egr-1 did, however, play a critical role in the activation of TGF-B1 because the ability of IL-13 to activate TGF-B1 was markedly diminished in comparisons of BAL fluids from Tg (+) mice with wild type and null mutant Egr-1 loci (Fig. 8B).	SEN:10026624	16439363
BEL:20054332	p(MGI:Il13) increases p(MGI:Tgfb1)	In contrast, significant amounts of total and activated TGF-1 were seen in BAL from Tg mice (Fig. 7, A and B).	SEN:10027924	16849505
BEL:20054334	p(MGI:Il13) increases p(MGI:Tyk2,pmod(P,Y))	as for Jak1, the phosphoryaltions of Tyk2 and IRS-2 were reduced after IL13 stimulaiton in wildtype cells.	SEN:10027950	12204103
BEL:20054336	p(MGI:Il13) increases r(EGID:20755)	4 of these 7 genes (SPRR1a, SPRR2a, SPRR2b, and Ca2T6) were again induced at least 4-fold more by IL-13 than by IL-4	SEN:10027970	15814686
BEL:20054338	p(MGI:Il13) increases r(EGID:20755)	SPRR1a, SPRR2a, SPRR2b, and Ca2T6...these genes were expressed at a higher level in the lungs of the IL-13 transgenic mice than in the matched wild-type mice	SEN:10027972	15814686
BEL:20054340	p(MGI:Il13) decreases r(MGI:Ada)	Pretranslational mechanisms also appeared to be involved in this alteration because the levels of mRNA encoding ADA were decreased in lungs from 3-month-old IL-13 Tg mice (Figure 2d).	SEN:10027974	12897202
BEL:20054342	p(MGI:Il13) increases r(MGI:Adora1)	transcripts for the the A2A adenosine receptor were decreased in the lungs of 3-month-old IL-13 Tg mice, whereas transcripts for the A1, A2B, and A3 adenosine receptors were elevated (Figure 3a).	SEN:10027976	12897202
BEL:20054344	p(MGI:Il13) decreases r(MGI:Adora2a)	transcripts for the the A2A adenosine receptor were decreased in the lungs of 3-month-old IL-13 Tg mice, whereas transcripts for the A1, A2B, and A3 adenosine receptors were elevated (Figure 3a).	SEN:10027976	12897202
BEL:20054346	p(MGI:Il13) decreases r(MGI:Adora2b)	In the IL-13 Tg mice A2B transcripts were found in inflammatory cells, likely macrophages, located within the enlarged alveolar alveolar spaces and in bronchial epithelium and walls of pulmonary blood vessels (Figures 5, b and c).	SEN:10027978	12897202
BEL:20054348	p(MGI:Il13) increases r(MGI:Adora2b)	transcripts for the the A2A adenosine receptor were decreased in the lungs of 3-month-old IL-13 Tg mice, whereas transcripts for the A1, A2B, and A3 adenosine receptors were elevated (Figure 3a).	SEN:10027976	12897202
BEL:20054350	p(MGI:Il13) increases r(MGI:Adora3)	transcripts for the the A2A adenosine receptor were decreased in the lungs of 3-month-old IL-13 Tg mice, whereas transcripts for the A1, A2B, and A3 adenosine receptors were elevated (Figure 3a).	SEN:10027976	12897202
BEL:20054352	p(MGI:Il13) increases r(MGI:Alox5ap)	In addition, as shown in Fig. 1, IL-13 caused a significant increase in the amounts of mRNA encoding cytosolic phospholipase A2 (cPLA2) (Fig. 1A) and lesser increases in LTA4 hydrolase (LTA4H) and 5-LO-activating protein (FLAP) (Fig. 1B). (In Tg IL-13 lung specific overexpression mouse model)	SEN:10027980	16849505
BEL:20054354	p(MGI:Il13) increases r(MGI:Ccl11)	Among the Th2 cytokines tested, IL-13 was by far the most effective cytokine inducing eotaxin in the lung, up-regulating both the eotaxin mRNA expression and protein production (Fig. 2, A–C).	SEN:10027938	10072486
BEL:20054356	p(MGI:Il13) increases r(MGI:Ccl12)	we assessed the levels of mRNA encoding CC chemokines that might be expected to contribute to these responses. As shown in Fig. 1A, IL-13 was a potent stimulator of MCP moieties, including MCP-1, MCP-2, MCP-3, and MCP-5 (Fig. 1).	SEN:10027982	11884467
BEL:20054358	p(MGI:Il13) increases r(MGI:Ccl2)	we assessed the levels of mRNA encoding CC chemokines that might be expected to contribute to these responses. As shown in Fig. 1A, IL-13 was a potent stimulator of MCP moieties, including MCP-1, MCP-2, MCP-3, and MCP-5 (Fig. 1).	SEN:10027982	11884467
BEL:20054360	p(MGI:Il13) increases r(MGI:Ccl7)	we assessed the levels of mRNA encoding CC chemokines that might be expected to contribute to these responses. As shown in Fig. 1A, IL-13 was a potent stimulator of MCP moieties, including MCP-1, MCP-2, MCP-3, and MCP-5 (Fig. 1).	SEN:10027982	11884467
BEL:20054362	p(MGI:Il13) increases r(MGI:Ccl8)	we assessed the levels of mRNA encoding CC chemokines that might be expected to contribute to these responses. As shown in Fig. 1A, IL-13 was a potent stimulator of MCP moieties, including MCP-1, MCP-2, MCP-3, and MCP-5 (Fig. 1).	SEN:10027982	11884467
BEL:20054366	p(MGI:Il13) increases r(MGI:Clca3)	As expected (Figure 4), IL-9 induced the expression of mCLCA3, confirming the observation in IL-9 transgenic mice. In addition, IL-4 and IL-13 were also able to induce the expression of mCLCA3 in the lung, whereas no expression was observed in the lungs of mice treated with IFN-gamma (Figure 4).	SEN:10027986	11694454
BEL:20054368	p(MGI:Il13) increases r(MGI:Clca3)	Tg IL-13 caused increases in lung volume, alveolar size, goblet cell number, and Gob-5, Muc-5ac, and Muc-1 gene expression in Tg+ ERK1/2 MAPK-sufficient animals (Figure 8, A–H).	SEN:10027988	16374521
BEL:20054370	p(MGI:Il13) increases r(MGI:Col6a2)	4 of these 7 genes (SPRR1a, SPRR2a, SPRR2b, and Ca2T6) were again induced at least 4-fold more by IL-13 than by IL-4	SEN:10027970	15814686
BEL:20054372	p(MGI:Il13) increases r(MGI:Col6a2)	SPRR1a, SPRR2a, SPRR2b, and Ca2T6...these genes were expressed at a higher level in the lungs of the IL-13 transgenic mice than in the matched wild-type mice	SEN:10027972	15814686
BEL:20054376	p(MGI:Il13) increases r(MGI:Egr1)	A late peak of Egr-1 mRNA occurred 12–24 h after IL-13 treatment but was not accompanied by an increase in Egr-1 protein.	SEN:10027992	16951379
BEL:20054378	p(MGI:Il13) increases r(MGI:Egr1)	IL-13 increased Egr-1 mRNA levels in a biphasic manner in Stat6/ fibroblasts; early induction of Egr-1 mRNA was observed 30 min following exposure to IL-13 and declined after 3–6 h (Fig. 6A). Egr-1 protein was increased in Stat6/ fibroblasts as compared with Stat6/ fibroblasts from 30 min to 3 h after IL-13 treatment (Fig. 6, B and C).	SEN:10027948	16951379
BEL:20054398	p(MGI:Il13) increases r(MGI:Lta4h)	In addition, as shown in Fig. 1, IL-13 caused a significant increase in the amounts of mRNA encoding cytosolic phospholipase A2 (cPLA2) (Fig. 1A) and lesser increases in LTA4 hydrolase (LTA4H) and 5-LO-activating protein (FLAP) (Fig. 1B). (In Tg IL-13 lung specific overexpression mouse model)	SEN:10027980	16849505
BEL:20054400	p(MGI:Il13) increases r(MGI:Mmp12)	As previously described by our laboratory, the levels of MMP-9 and 12 mRNA were increased in lungs from Tg IL-13 mice (10, 36).	SEN:10027998	16849505
BEL:20054404	p(MGI:Il13) increases r(MGI:Mmp9)	As previously described by our laboratory, the levels of MMP-9 and 12 mRNA were increased in lungs from Tg IL-13 mice (10, 36).	SEN:10027998	16849505
BEL:20054406	p(MGI:Il13) increases r(MGI:Muc1)	Tg IL-13 caused increases in lung volume, alveolar size, goblet cell number, and Gob-5, Muc-5ac, and Muc-1 gene expression in Tg+ ERK1/2 MAPK-sufficient animals (Figure 8, A–H).	SEN:10027988	16374521
BEL:20054408	p(MGI:Il13) increases r(MGI:Muc5ac)	Tg IL-13 caused increases in lung volume, alveolar size, goblet cell number, and Gob-5, Muc-5ac, and Muc-1 gene expression in Tg+ ERK1/2 MAPK-sufficient animals (Figure 8, A–H).	SEN:10027988	16374521
BEL:20054410	p(MGI:Il13) increases r(MGI:Ormdl3)	These studies demonstrated that in vivo administration of either IL-4 or IL-13 intranasally could induce significant expression of ORMDL3 mRNA in WT bronchial epithelium as assessed by qPCR (Fig. S3A)	SEN:10028000	23011799
BEL:20054412	p(MGI:Il13) increases r(MGI:Pdgfa)	IL-13-induced PDGF-A and PDGF-C mRNA levels were significantly reduced in fibroblasts isolated from the lungs of Stat6/ mice compared with fibroblasts isolated from the lungs of the wild-type Stat6/ mice (Fig. 2, A and B).	SEN:10028002	16951379
BEL:20054414	p(MGI:Il13) increases r(MGI:Pdgfc)	IL-13-induced PDGF-A and PDGF-C mRNA levels were significantly reduced in fibroblasts isolated from the lungs of Stat6/ mice compared with fibroblasts isolated from the lungs of the wild-type Stat6/ mice (Fig. 2, A and B).	SEN:10028002	16951379
BEL:20054416	p(MGI:Il13) increases r(MGI:Pla2g4a)	In addition, as shown in Fig. 1, IL-13 caused a significant increase in the amounts of mRNA encoding cytosolic phospholipase A2 (cPLA2) (Fig. 1A) and lesser increases in LTA4 hydrolase (LTA4H) and 5-LO-activating protein (FLAP) (Fig. 1B). (In Tg IL-13 lung specific overexpression mouse model)	SEN:10027980	16849505
BEL:20054418	p(MGI:Il13) increases r(MGI:Retnlb)	FIZZ2 gene expression was significantly upregulated by IL-4 at 4-h and 8-h time points and by IL-13 at the 4-h time point (p < 0.05).	SEN:10028004	21602491
BEL:20054420	p(MGI:Il13) increases r(MGI:Scgb3a1)	In this study we demonstrate that IL-4 and IL-13 enhance Ugrp2 gene expression in the mouse transformed Clara cell line, mtCC, in a time- and dose-dependent manner.	SEN:10028006	16237061
BEL:20054422	p(MGI:Il13) decreases r(MGI:Serpina1a)	Interestingly, IL-13 did cause an approximately 80% decrease in pulmonary a1-AT expression (Figure 13). It also caused a significant increase in TIMP-1 expression that was seen after as little as 1 day and was readily apparent with longer periods of dox administration (Figure 13, and data not shown) (P < 0.05 for all comparisons).	SEN:10028008	11067861
BEL:20054424	p(MGI:Il13) decreases r(MGI:Serpina1a)	As previously reported (13), IL-13 was a potent inducer of TIMP-1 and had lesser stimulatory effects on TIMP-2 and TIMP-4 while inhibiting 1-AT in wild-type animals (Fig. 7B). (RT-PCR analysis)	SEN:10028010	11884467
BEL:20054426	p(MGI:Il13) increases r(MGI:Sprr1a)	4 of these 7 genes (SPRR1a, SPRR2a, SPRR2b, and Ca2T6) were again induced at least 4-fold more by IL-13 than by IL-4	SEN:10027970	15814686
BEL:20054428	p(MGI:Il13) increases r(MGI:Sprr1a)	SPRR1a, SPRR2a, SPRR2b, and Ca2T6...these genes were expressed at a higher level in the lungs of the IL-13 transgenic mice than in the matched wild-type mice	SEN:10027972	15814686
BEL:20054430	p(MGI:Il13) increases r(MGI:Sprr2b)	4 of these 7 genes (SPRR1a, SPRR2a, SPRR2b, and Ca2T6) were again induced at least 4-fold more by IL-13 than by IL-4	SEN:10027970	15814686
BEL:20054432	p(MGI:Il13) increases r(MGI:Sprr2b)	SPRR1a, SPRR2a, SPRR2b, and Ca2T6...these genes were expressed at a higher level in the lungs of the IL-13 transgenic mice than in the matched wild-type mice	SEN:10027972	15814686
BEL:20054434	p(MGI:Il13) increases r(MGI:Timp1)	Interestingly, IL-13 did cause an approximately 80% decrease in pulmonary a1-AT expression (Figure 13). It also caused a significant increase in TIMP-1 expression that was seen after as little as 1 day and was readily apparent with longer periods of dox administration (Figure 13, and data not shown) (P < 0.05 for all comparisons).	SEN:10028008	11067861
BEL:20054436	p(MGI:Il13) increases r(MGI:Timp1)	As previously reported (13), IL-13 was a potent inducer of TIMP-1 and had lesser stimulatory effects on TIMP-2 and TIMP-4 while inhibiting 1-AT in wild-type animals (Fig. 7B). (RT-PCR analysis)	SEN:10028010	11884467
BEL:20054438	p(MGI:Il13) increases r(MGI:Timp2)	As previously reported (13), IL-13 was a potent inducer of TIMP-1 and had lesser stimulatory effects on TIMP-2 and TIMP-4 while inhibiting 1-AT in wild-type animals (Fig. 7B). (RT-PCR analysis)	SEN:10028010	11884467
BEL:20054440	p(MGI:Il13) increases r(MGI:Timp4)	As previously reported (13), IL-13 was a potent inducer of TIMP-1 and had lesser stimulatory effects on TIMP-2 and TIMP-4 while inhibiting 1-AT in wild-type animals (Fig. 7B). (RT-PCR analysis)	SEN:10028010	11884467
BEL:20054444	p(MGI:Il13) increases surf(p(MGI:Cd86))	Numbers of cells expressing high levels of Ag-presentation molecules were increased in mice given IL-13 and IFN-g relative to all other groups of mice (Fig. 6). These cells were detected using anti-CD11c (a molecule expressed by dendritic cells), MHC class II, and CD86 (B7-2) Abs.	SEN:10028012	11466402
BEL:20054446	p(MGI:Il13) increases surf(p(MGI:Egfr))	(from text) The increase in intracellular AMCase in these Th2 inflammation/asthma models was paralleled by an increase of total EGFR in lung lysates (Fig. 3a) as well as specific EGFR surface expression on lung epithelial cells as analyzed by immunohistochemistry (Fig. 3b) and flow cytometry (Fig. 3, c and d).	SEN:10017064	18824549
BEL:20054448	p(MGI:Il13) increases surf(p(MGI:Itgax))	Numbers of cells expressing high levels of Ag-presentation molecules were increased in mice given IL-13 and IFN-g relative to all other groups of mice (Fig. 6). These cells were detected using anti-CD11c (a molecule expressed by dendritic cells), MHC class II, and CD86 (B7-2) Abs.	SEN:10028012	11466402
BEL:20054498	p(MGI:Il17a) increases cat(p(MGI:Il17ra))	Lung tumor tissues attracted migration of mouse RAW264.7 macrophages and primary peritoneal macrophages through IL-17, which was mediated by IL-17RA and IL-17RC.	SEN:10004890	22534817
BEL:20054500	p(MGI:Il17a) increases cat(p(MGI:Il17rc))	Lung tumor tissues attracted migration of mouse RAW264.7 macrophages and primary peritoneal macrophages through IL-17, which was mediated by IL-17RA and IL-17RC.	SEN:10004890	22534817
BEL:20054516	p(MGI:Il17a) decreases p(MGI:Lep)	Consistently, IL-17A and IL-17F treatment of 3T3-L1 pre-adipocytes inhibited adipogenesis, leading to reduced production of leptin.	SEN:10028044	19731364
BEL:20054526	p(MGI:Il17a) increases r(MGI:Col1a1)	The hepatic mRNA expression of TNF-alpha, TGF-beta1, and collagen 1 alpha 1, which increased in the WT mice, also significantly decreased in the KO mice.	SEN:10028050	23578751
BEL:20054534	p(MGI:Il17a) increases r(MGI:Tgfb1)	The hepatic mRNA expression of TNF-alpha, TGF-beta1, and collagen 1 alpha 1, which increased in the WT mice, also significantly decreased in the KO mice.	SEN:10028050	23578751
BEL:20054536	p(MGI:Il17a) increases r(MGI:Tlr2)	In CIA synoviocytes, IL-17 increased the expression of TLR-2, 4, and 9, and this effect was significantly alleviated by neutralizing antibodies to IL-17, IL-1beta, and IL-6.	SEN:10009182	19228664
BEL:20054538	p(MGI:Il17a) increases r(MGI:Tlr4)	In CIA synoviocytes, IL-17 increased the expression of TLR-2, 4, and 9, and this effect was significantly alleviated by neutralizing antibodies to IL-17, IL-1beta, and IL-6.	SEN:10009182	19228664
BEL:20054540	p(MGI:Il17a) increases r(MGI:Tlr9)	In CIA synoviocytes, IL-17 increased the expression of TLR-2, 4, and 9, and this effect was significantly alleviated by neutralizing antibodies to IL-17, IL-1beta, and IL-6.	SEN:10009182	19228664
BEL:20054542	p(MGI:Il17a) increases r(MGI:Tnf)	The hepatic mRNA expression of TNF-alpha, TGF-beta1, and collagen 1 alpha 1, which increased in the WT mice, also significantly decreased in the KO mice.	SEN:10028050	23578751
BEL:20054548	p(MGI:Il17f) decreases p(MGI:Lep)	Consistently, IL-17A and IL-17F treatment of 3T3-L1 pre-adipocytes inhibited adipogenesis, leading to reduced production of leptin.	SEN:10028044	19731364
BEL:20054556	p(MGI:Il17f) increases r(MGI:Cxcl10)	At day 7 following infection, lung tissue from mice given hIL-17F Ad showed substantial increases in the mRNA for inflammatory cytokines and chemokines, including IL-6, IFN-g, inflammatory protein 10, and monokine induced by IFN-g (Fig. 3).	SEN:10028056	12077275
BEL:20054558	p(MGI:Il17f) increases r(MGI:Cxcl9)	At day 7 following infection, lung tissue from mice given hIL-17F Ad showed substantial increases in the mRNA for inflammatory cytokines and chemokines, including IL-6, IFN-g, inflammatory protein 10, and monokine induced by IFN-g (Fig. 3).	SEN:10028056	12077275
BEL:20054560	p(MGI:Il17f) increases r(MGI:Ifng)	At day 7 following infection, lung tissue from mice given hIL-17F Ad showed substantial increases in the mRNA for inflammatory cytokines and chemokines, including IL-6, IFN-g, inflammatory protein 10, and monokine induced by IFN-g (Fig. 3).	SEN:10028056	12077275
BEL:20054564	p(MGI:Il17f) increases r(MGI:Il6)	At day 7 following infection, lung tissue from mice given hIL-17F Ad showed substantial increases in the mRNA for inflammatory cytokines and chemokines, including IL-6, IFN-g, inflammatory protein 10, and monokine induced by IFN-g (Fig. 3).	SEN:10028056	12077275
BEL:20054570	p(MGI:Il17rd) decreases kin(p(MGI:Mapk1))	Adenovirus-mediated expression of mSef but not GFP resulted in a reduction in the levels of activated ERK1/2, whereas overall levels of ERK1/2 were unaffected (Fig. 2 A).	SEN:10028060	12604616
BEL:20054572	p(MGI:Il17rd) decreases kin(p(MGI:Mapk3))	Adenovirus-mediated expression of mSef but not GFP resulted in a reduction in the levels of activated ERK1/2, whereas overall levels of ERK1/2 were unaffected (Fig. 2 A).	SEN:10028060	12604616
BEL:20054586	p(MGI:Il18) increases a(CHEBI:"leukotriene B4")	Finally, we showed that IL-18-activated human peripheral blood neutrophils produced significant amounts of LTB(4) that were effectively blocked by the MK.	SEN:10009186	12847274
BEL:20054588	p(MGI:Il18) increases bp(GOBP:angiogenesis)	To determine whether IL-18 may be angiogenic in vivo, we implanted IL-18 in Matrigel plugs in mice, and IL-18 at 1 and 10 nM induced angiogenesis (p < 0.05).	SEN:10028062	11466388
BEL:20054590	p(MGI:Il18) decreases bp(GOBP:angiogenesis)	IL-18 is a novel inhibitor of angiogenesis, sufficiently potent to supress tumor growth by directly inhibiting fibroblast growth factor 2 induced endothelial cell proliferation	SEN:10026890	12857959
BEL:20054596	p(MGI:Il18) increases kin(p(MGI:Irak1))	The role of IRAK in IL-18-induced responses was studied in IRAK-deficient mice. Significant defects in JNK induction and partial impairment in NF-kappaB activation were found in IRAK-deficient Th1 cells, resulting in a dramatic decrease in interferon (IFN)-gamma mRNA expression.	SEN:10001666	10190904
BEL:20054600	p(MGI:Il18) increases path(MESHD:Atherosclerosis)	the injection of IFNG, or the IFNG-releasing factors IL12 and -18 enhances the extent of the disease in apoE-/- mice (36, 39, 40)	SEN:10020296	16293001
BEL:20054606	p(MGI:Il18) increases p(MGI:Ifng)	Thus, absence of IL-12 led to the shortest burst of IFN-g synthesis, and IL-12 significantly prolonged this duration, which was increased further by the addition of IL-18, a signal known to interact with IL-12 (27)	SEN:10019894	11397944
BEL:20054616	p(MGI:Il18) increases r(MGI:Ctss)	Mice treated with i.p. injection of recombinant murine IL-18 or IL-12 expressed significantly higher pulmonary mRNA levels of the matrix degrading enzymes metalloproteinase (MMP) 12 and cathepsin S	SEN:10005482	22908875
BEL:20054618	p(MGI:Il18) increases r(MGI:Mmp12)	Mice treated with i.p. injection of recombinant murine IL-18 or IL-12 expressed significantly higher pulmonary mRNA levels of the matrix degrading enzymes metalloproteinase (MMP) 12 and cathepsin S	SEN:10005482	22908875
BEL:20054620	p(MGI:Il18) increases sec(a(CHEBI:"leukotriene B4"))	Finally, we showed that IL-18-activated human peripheral blood neutrophils produced significant amounts of LTB(4) that were effectively blocked by the MK.	SEN:10009186	12847274
BEL:20054622	p(MGI:Il18) increases sec(p(MGI:Il1a))	In addition, IL-18 also upregulates the production of proinflammatory cytokines such as IL-1 and tumor necrosis factor-alpha.	SEN:10028068	12571421
BEL:20054624	p(MGI:Il18) increases sec(p(MGI:Ccl11))	IL-18 was subsequently shown to induce eotaxin production from bronchial epithelial cells and isolated macrophages in in vitro assays	SEN:10009188	10623861
BEL:20054626	p(MGI:Il18) increases sec(p(MGI:Il13))	We cultured sorted mast cells and basophils with IL-25, IL-18, or IL-25 IL-18 and detected both IL-5 and IL-13 from IL-18 cultured cell supernatants	SEN:10028070	12077275
BEL:20054630	p(MGI:Il18) increases sec(p(MGI:Il5))	We cultured sorted mast cells and basophils with IL-25, IL-18, or IL-25 IL-18 and detected both IL-5 and IL-13 from IL-18 cultured cell supernatants	SEN:10028070	12077275
BEL:20054632	p(MGI:Il18) increases sec(p(MGI:Tnf))	In addition, IL-18 also upregulates the production of proinflammatory cytokines such as IL-1 and tumor necrosis factor-alpha.	SEN:10028068	12571421
BEL:20054640	p(MGI:Il19) decreases bp(GOBP:"cell proliferation")	IL-19 is anti-proliferative for cultured human coronary artery VSMC. This may be due to the observation that IL-19 transiently reduces HuR expression, which is known to play a role in VSMC proliferation [71].	SEN:10028076	19601851
BEL:20054644	p(MGI:Il19) decreases p(MGI:Elavl1)	IL-19 is anti-proliferative for cultured human coronary artery VSMC. This may be due to the observation that IL-19 transiently reduces HuR expression, which is known to play a role in VSMC proliferation [71].	SEN:10028076	19601851
BEL:20054646	p(MGI:Il1a) increases a(CHEBI:"reactive oxygen species")	It has also been shown that IL-1a may be implicated in early stages of carcinogenesis, as it induces growth factors and stimulates the production of reactive oxygen species in vitro	SEN:10028080	17707332
BEL:20054650	p(MGI:Il1a) increases bp(GOBP:"neutrophil chemotaxis")	Taken together, these data suggest that IL-1alpha, released from dying cells, initiates sterile inflammation by inducing recruitment of neutrophils,	SEN:10028082	21930960
BEL:20054652	p(MGI:Il1a) increases kin(p(MGI:Irak1))	Importantly, endogenous mPLK/IRAK was activated in response to TNF-alpha or interleukin 1 treatment of primary adipose cells.	SEN:10009192	15849359
BEL:20054654	p(MGI:Il1a) increases path(MESHD:Neoplasms)	It has also been shown that IL-1a may be implicated in early stages of carcinogenesis, as it induces growth factors and stimulates the production of reactive oxygen species in vitro	SEN:10028080	17707332
BEL:20054664	p(MGI:Il1a) increases p(MGI:Il17a)	In the lungs of tumor-bearing mice, we have found that IL-1 induces the expression of IL-17 in gd T cells, which consist of the major IL-17-producing cells	SEN:10028086	21300825
BEL:20054670	p(MGI:Il1a) increases r(MGI:C3)	Besides 1 alpha,25-(OH)2D3, local bone-resorbing agents, such as interleukin-1 alpha, tumor necrosis factor-alpha, and lipopolysaccharides, also stimulated the expression of C3 mRNA, not only in ST2 cells, but also in primary osteoblastic cells.	SEN:10009196	1935807
BEL:20054672	p(MGI:Il1a) increases r(MGI:Ccl3)	RT-PCR analysis was performed to assess the degree of activation of the cytokines IL-1b, MIP-1a, MIP-2, and TNF-a. The results showed a significant increase in the mRNA level for MIP-1 and MIP-2 at 6 h after intratracheal IL-1a administration, with a significant attenuation in the transgenic mice (Figure 4)	SEN:10028090	9490661
BEL:20054674	p(MGI:Il1a) increases r(MGI:Cxcl1)	Anti-IL-1a, but not anti-IL-1b intervention significantly attenuated expression of CXCL-1 RNA transcripts and protein in smoke-exposed mice...Furthermore, CXCL-2 and CXCL-5 gene expression, while increased following smoke-exposure, were attenuated by anti-IL-1a	SEN:10028092	22163019
BEL:20054676	p(MGI:Il1a) increases r(MGI:Cxcl2)	Anti-IL-1a, but not anti-IL-1b intervention significantly attenuated expression of CXCL-1 RNA transcripts and protein in smoke-exposed mice...Furthermore, CXCL-2 and CXCL-5 gene expression, while increased following smoke-exposure, were attenuated by anti-IL-1a	SEN:10028092	22163019
BEL:20054678	p(MGI:Il1a) increases r(MGI:Cxcl2)	RT-PCR analysis was performed to assess the degree of activation of the cytokines IL-1b, MIP-1a, MIP-2, and TNF-a. The results showed a significant increase in the mRNA level for MIP-1 and MIP-2 at 6 h after intratracheal IL-1a administration, with a significant attenuation in the transgenic mice (Figure 4)	SEN:10028090	9490661
BEL:20054680	p(MGI:Il1a) increases r(MGI:Cxcl5)	Anti-IL-1a, but not anti-IL-1b intervention significantly attenuated expression of CXCL-1 RNA transcripts and protein in smoke-exposed mice...Furthermore, CXCL-2 and CXCL-5 gene expression, while increased following smoke-exposure, were attenuated by anti-IL-1a	SEN:10028092	22163019
BEL:20054686	p(MGI:Il1a) decreases r(MGI:Il18)	Figure 3. (C and D) Down-regulation of IL-18 mRNA expression by IL-1{alpha} (C) and EP (D) in primary keratinocytes.	SEN:10026734	15365177
BEL:20054688	p(MGI:Il1a) increases r(MGI:Mmp13)	The induction of MMP-13 by IL-1a and phorbol myristate acetate was severely impaired in the Sod2-/+ fibroblasts compared with the Sod2+/+ fibroblasts (Fig. 3, A and B).	SEN:10028094	11297530
BEL:20054714	p(MGI:Il1b) increases bp(GOBP:"inflammatory response")	Previously, it was shown that proinflammatory cytokines characteristic of the APR (TNF-alpha, IL-1beta, and IFNgamma) induced the expression of the PRL receptor (PRLR) by pulmonary fibroblasts in vitro.	SEN:10009068	15186999
BEL:20054716	p(MGI:Il1b) increases bp(GOBP:"inflammatory response")	7 days of administration IL-1? caused tissue injury with marked tissue destruction, disruption of alveolar architecture, inflammation, and fibrosis (although less pronounced than that obtained after BLM treatment; Figure 7, D and E) that was absent in saline controls (Figure 7C)	SEN:10028110	17992263
BEL:20054724	p(MGI:Il1b) decreases complex(p(MGI:Ctnnb1),p(MGI:Cdh5))	Treatment of MCEC monolayers with TS alone (12.8 puffs/l) or TS/IL-1 markedly decreased the association between -catenin and VEcadherin concomitant with -catenin trafficking from junctions into the cytosol (Fig. 5A).	SEN:10017686	17317723
BEL:20054730	p(MGI:Il1b) increases deg(p(MGI:Ikbkb))	Furthermore, after treatment with IL-1beta for 1 h, cytoplasmic IkappaBalpha degradation occurred simultaneously with translocation of p65 into the nucleus.	SEN:10009208	11278608
BEL:20054732	p(MGI:Il1b) increases path(MESHD:Atherosclerosis)	animal models, with reduced atherosclerosis observed in IL-1b [41] and IL-1 receptor-deficient mice [11], while IL-1ra-deficient mice exhibit increased neointima formation [42]. IL-1Ra administration to Apo E-deficient mice or porcine arterial injury models reduced neointima formation significantly [11,43] as well as reducing vascular remodelling following acute myocardial infarction in the rat [44].	SEN:10028112	19309349
BEL:20054748	p(MGI:Il1b) increases p(MGI:Cxcl1)	IL-1b increased the production of neutrophil chemoattractants such as Gro-alpha (CXCL1) and MIP-2 (CXCL2) in lungs.	SEN:10028124	19842832
BEL:20054752	p(MGI:Il1b) increases p(MGI:Cxcl2)	IL-1b increased the production of neutrophil chemoattractants such as Gro-alpha (CXCL1) and MIP-2 (CXCL2) in lungs.	SEN:10028124	19842832
BEL:20054754	p(MGI:Il1b) decreases p(MGI:Fbln5)	To examine whether fibulin-5 accumulates in the culture media of lung interstitial fibroblasts, ... analyzed by Western blot (Fig. 3). ...a prominent signal was present at 21 kDa. The intensity of this signal increased as larger volumes of media were analyzed and decreased following treatment of the fibroblasts with IL-1.	SEN:10028126	12909585
BEL:20054756	p(MGI:Il1b) increases p(MGI:Il17a)	Elevated levels of IL-17 were found in lung tumors in IL-1Ra KO mice, compared with tumors in WT mice, whereas significantly lower levels of IL-17 were detected in IL-1b KO mice, indicating that these cytokines possibly mutually interact in the lung tumor microenvironment	SEN:10028128	21300825
BEL:20054770	p(MGI:Il1b) increases p(MGI:Nos2)	iNOS protein was undetectable at 1 h but was increased after 2, 4, and 24 h of incubation with IL-6. The iNOS expression induced by a 2-h incubation with 10 ng/ml IL-1beta, a well known inducer of iNOS in cardiac myocytes (38), was used as a positive control in these experiments.	SEN:10028136	12595539
BEL:20054788	p(MGI:Il1b) decreases r(MGI:Fbln5)	we treated quiescent fibroblasts with IL-1 or IFN-, and RNA was harvested and analyzed (Fig. 6). Treatment with IL-1 alone and with IL-1 in combination with IFN- completely abolished fibulin-5 mRNA expression.	SEN:10020696	12909585
BEL:20054796	p(MGI:Il1b) increases r(MGI:Lgals9)	Galectin-9 expression can be induced by IFN-gamma or IL-1beta in various tissues such as endothelial cells, fibroblasts and astrocytes26, 27, 28.	SEN:10027722	16286920
BEL:20054802	p(MGI:Il1b) increases r(MGI:Muc5ac)	IL-1B-induced MUC5AC gene expression was dramatically decreased in the mice infected with the virus expressing wild-type c-Ets1 compared with those infected with the virus expressing sh-c-Ets1 (Figure 4b).	SEN:10028148	22294049
BEL:20054806	p(MGI:Il1b) increases r(MGI:Saa2)	Human SAA2 promoter Early experiments in which a human SAA2 genomic clone was transiently transfected into mouse L cells established that A-SAA expression is enhanced by IL-1beta, TNF-alpha, IL-6 and IFN-gamma [ 146 , 147 ].	SEN:10028150	10504381
BEL:20054814	p(MGI:Il1b) increases r(MGI:Stap2)	Because STAP-2 expression is induced by proinflammatory cytokines such as IL-6 or IL-1beta, STAP-2 may play a role in the regulation of inflammation.	SEN:10028154	12540842
BEL:20054816	p(MGI:Il1b) increases r(MGI:Syvn1)	Real-time RT-PCR revealed that IL-1beta induced SYN expression at the transcriptional level, because the mRNA level of SYN was upregulated by IL-1?. TNF-? had a weaker effect on SYN transcription, whereas IL-6 had no effect	SEN:10028156	17105652
BEL:20054818	p(MGI:Il1b) increases tloc(p(MGI:Ctnnb1),GOCCID:0005737,GOCCID:0005634)	We also observed that IL-1, a major proinflammatory cytokine that increases in smokers and plays a key role in atherosclerosis (1, 2, 23, 24), produced -catenin translocation to the nucleus after 30 min (Fig. 1A, C).	SEN:10028158	17317723
BEL:20054820	p(MGI:Il1b) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	Furthermore, after treatment with IL-1beta for 1 h, cytoplasmic IkappaBalpha degradation occurred simultaneously with translocation of p65 into the nucleus.	SEN:10009208	11278608
BEL:20054844	p(MGI:Il1r1) increases path(MESHD:Atherosclerosis)	animal models, with reduced atherosclerosis observed in IL-1b [41] and IL-1 receptor-deficient mice [11], while IL-1ra-deficient mice exhibit increased neointima formation [42]. IL-1Ra administration to Apo E-deficient mice or porcine arterial injury models reduced neointima formation significantly [11,43] as well as reducing vascular remodelling following acute myocardial infarction in the rat [44].	SEN:10028112	19309349
BEL:20054848	p(MGI:Il1r1) decreases p(MGI:Il17a)	Elevated levels of IL-17 were found in lung tumors in IL-1Ra KO mice, compared with tumors in WT mice, whereas significantly lower levels of IL-17 were detected in IL-1b KO mice, indicating that these cytokines possibly mutually interact in the lung tumor microenvironment	SEN:10028128	21300825
BEL:20054852	p(MGI:Il1r1) increases r(MGI:Csf2)	We also investigated the expression of various genes, including, CXCL-1, GM-CSF, and MMP-12 (Figure 5 E–G, respectively), all of which were significantly attenuated in IL-1R1 deficient animals reconstituted with IL-1R1 deficient bone marrow cells (KO into KO)	SEN:10028174	22163019
BEL:20054854	p(MGI:Il1r1) increases r(MGI:Cxcl1)	We also investigated the expression of various genes, including, CXCL-1, GM-CSF, and MMP-12 (Figure 5 E–G, respectively), all of which were significantly attenuated in IL-1R1 deficient animals reconstituted with IL-1R1 deficient bone marrow cells (KO into KO)	SEN:10028174	22163019
BEL:20054856	p(MGI:Il1r1) increases r(MGI:Mmp12)	We also investigated the expression of various genes, including, CXCL-1, GM-CSF, and MMP-12 (Figure 5 E–G, respectively), all of which were significantly attenuated in IL-1R1 deficient animals reconstituted with IL-1R1 deficient bone marrow cells (KO into KO)	SEN:10028174	22163019
BEL:20054868	p(MGI:Il21) increases r(MGI:Il23r)	Forced expression of wild-type mouse Foxp3 inhibited IL-6/IL-21-induced Il23r expression, whereas Foxp3DeltaEx2 had less inhibitory activity (Fig. 4a)	SEN:10027060	18368049
BEL:20054874	p(MGI:Il22) decreases bp(GOBP:"inflammatory response")	from full text - in a murine model of UC, Sugimoto et al demonstrated a novel protective role for IL-22, in which IL-22 attenuates in the intestine inflammation	SEN:10028188	18666314
BEL:20054878	p(MGI:Il22) increases path(MESHD:Hyperplasia)	IL-22 but not saline induced keratinocyte hyperplasia in mouse ears (Figure ?(Figure6B)6Figure 6B) as well as increased defensin ?1, S100A8, and S100A9 transcripts (data not shown). IL-22 also significantly induced IL-1? gene expression,	SEN:10028190	18202747
BEL:20054888	p(MGI:Il22) increases r(MGI:Defb1)	As demonstrated in Figure ?Figure6A,6Figure 6A, IL-22 but not saline induced a significant increase in S100A8, S100A9, and defensin ?1	SEN:10028196	18202747
BEL:20054890	p(MGI:Il22) increases r(MGI:Il1b)	IL-22 but not saline induced keratinocyte hyperplasia in mouse ears (Figure ?(Figure6B)6Figure 6B) as well as increased defensin ?1, S100A8, and S100A9 transcripts (data not shown). IL-22 also significantly induced IL-1? gene expression,	SEN:10028190	18202747
BEL:20054892	p(MGI:Il22) increases r(MGI:S100a8)	As demonstrated in Figure ?Figure6A,6Figure 6A, IL-22 but not saline induced a significant increase in S100A8, S100A9, and defensin ?1	SEN:10028196	18202747
BEL:20054894	p(MGI:Il22) increases r(MGI:S100a9)	As demonstrated in Figure ?Figure6A,6Figure 6A, IL-22 but not saline induced a significant increase in S100A8, S100A9, and defensin ?1	SEN:10028196	18202747
BEL:20054902	p(MGI:Il23a) increases r(MGI:Mmp2)	The increased enzymatic activity of gelatinases in the ileum of infected WT but not IL-23p19?/? mice was paralleled by increased mRNA and protein levels of either gelatinase at day 8 after infection compared with naive WT mice (Fig. 2, C and D). These results indicate that IL-23 is required for the up-regulation of both MMP-2 and MMP-9 in T. gondii–induced ileitis.	SEN:10028204	19995958
BEL:20054904	p(MGI:Il23a) increases r(MGI:Mmp9)	The increased enzymatic activity of gelatinases in the ileum of infected WT but not IL-23p19?/? mice was paralleled by increased mRNA and protein levels of either gelatinase at day 8 after infection compared with naive WT mice (Fig. 2, C and D). These results indicate that IL-23 is required for the up-regulation of both MMP-2 and MMP-9 in T. gondii–induced ileitis.	SEN:10028204	19995958
BEL:20054920	p(MGI:Il25) increases p(MGI:Ifng)	The levels of IFN-gamma mRNA were significantly upregulated in IL-17E overexpressing transgenic mice.	SEN:10028210	11714825
BEL:20054932	p(MGI:Il25) increases r(MGI:Il13)	As has been reported previously, the intratracheal administration of IL-25 induced a type 2 type inflammatory response, characterized by airway hyperreactivity, eosinophil infiltrates, mucus production, and the upregulation of inflammatory genes including Il25 and Il17rb (see Supplemental Fig. 5).	SEN:10028214	22543263
BEL:20054934	p(MGI:Il25) increases r(MGI:Il17rb)	As has been reported previously, the intratracheal administration of IL-25 induced a type 2 type inflammatory response, characterized by airway hyperreactivity, eosinophil infiltrates, mucus production, and the upregulation of inflammatory genes including Il25 and Il17rb (see Supplemental Fig. 5).	SEN:10028214	22543263
BEL:20054936	p(MGI:Il25) increases r(MGI:Il1b)	The levels of IL-1beta mRNA were significantly upregulated in IL-17E overexpressing transgenic mice.	SEN:10028216	11714825
BEL:20054938	p(MGI:Il25) increases r(MGI:Il25)	As has been reported previously, the intratracheal administration of IL-25 induced a type 2 type inflammatory response, characterized by airway hyperreactivity, eosinophil infiltrates, mucus production, and the upregulation of inflammatory genes including Il25 and Il17rb (see Supplemental Fig. 5).	SEN:10028214	22543263
BEL:20054940	p(MGI:Il25) increases r(MGI:Il5)	As has been reported previously, the intratracheal administration of IL-25 induced a type 2 type inflammatory response, characterized by airway hyperreactivity, eosinophil infiltrates, mucus production, and the upregulation of inflammatory genes including Il25 and Il17rb (see Supplemental Fig. 5).	SEN:10028214	22543263
BEL:20054992	p(MGI:Il2) increases tscript(p(MGI:Irf1))	In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12.	SEN:10019900	8920893
BEL:20054996	p(MGI:Il33) increases bp(GOBP:"wound healing")	administration of IL-33 obviously accelerated wound healing with wounds gaping narrower and exhibiting enhanced reepithelialization	SEN:10009244	23911389
BEL:20055000	p(MGI:Il33) directlyIncreases cat(p(MGI:Il1rl1))	These results indicate that the endogenous IL-33/ST2 signaling pathway enhances the expression of CCR3 on eosinophils.	SEN:10019238	20693421
BEL:20055006	p(MGI:Il33) increases p(MGI:Ccl17)	In vitro, IL-33 amplified IL-13-induced polarization of alveolar- and bone marrow-derived macrophage toward an AAM phenotype by increasing the expression of arginase I, Ym1, as well as the production of CCL24 and CCL17	SEN:10009248	19841166
BEL:20055008	p(MGI:Il33) increases p(MGI:Ccl24)	In vitro, IL-33 amplified IL-13-induced polarization of alveolar- and bone marrow-derived macrophage toward an AAM phenotype by increasing the expression of arginase I, Ym1, as well as the production of CCL24 and CCL17	SEN:10009248	19841166
BEL:20055010	p(MGI:Il33) increases r(MGI:Arg1)	In vitro, IL-33 amplified IL-13-induced polarization of alveolar- and bone marrow-derived macrophage toward an AAM phenotype by increasing the expression of arginase I, Ym1, as well as the production of CCL24 and CCL17	SEN:10009248	19841166
BEL:20055014	p(MGI:Il33) increases r(MGI:Chil3)	In vitro, IL-33 amplified IL-13-induced polarization of alveolar- and bone marrow-derived macrophage toward an AAM phenotype by increasing the expression of arginase I, Ym1, as well as the production of CCL24 and CCL17	SEN:10009248	19841166
BEL:20055016	p(MGI:Il33) increases r(MGI:Col3a1)	IL-33-treated mice exhibited substantially increased expression of related components of the ECM such as fibronectin and collagen IIIa, in comparison with that of untreated mice	SEN:10028234	23911389
BEL:20055018	p(MGI:Il33) increases r(MGI:Csf2)	In bone marrow cultures, IL-33 induced mRNA expression of granulocyte macrophage colony-stimulating factor, IL-4, IL-13, and IL-10;	SEN:10028236	21363931
BEL:20055022	p(MGI:Il33) increases r(MGI:Dmp1)	Sclerostin is produced solely by osteocytes, and sclerostin mRNA was both readily detectable and suppressed by IL-33 treatment in both culture systems...IL-33 transiently enhanced DMP-1 steady-state mRNA levels (Fig. 5E), but there was no significant effect on MEPE steady-state mRNA levels.	SEN:10028238	21363931
BEL:20055024	p(MGI:Il33) increases r(MGI:Fn1)	IL-33-treated mice exhibited substantially increased expression of related components of the ECM such as fibronectin and collagen IIIa, in comparison with that of untreated mice	SEN:10028234	23911389
BEL:20055026	p(MGI:Il33) increases r(MGI:Il10)	In bone marrow cultures, IL-33 induced mRNA expression of granulocyte macrophage colony-stimulating factor, IL-4, IL-13, and IL-10;	SEN:10028236	21363931
BEL:20055028	p(MGI:Il33) increases r(MGI:Il13)	In bone marrow cultures, IL-33 induced mRNA expression of granulocyte macrophage colony-stimulating factor, IL-4, IL-13, and IL-10;	SEN:10028236	21363931
BEL:20055032	p(MGI:Il33) increases r(MGI:Il4)	In bone marrow cultures, IL-33 induced mRNA expression of granulocyte macrophage colony-stimulating factor, IL-4, IL-13, and IL-10;	SEN:10028236	21363931
BEL:20055038	p(MGI:Il33) decreases r(MGI:Sost)	Sclerostin is produced solely by osteocytes, and sclerostin mRNA was both readily detectable and suppressed by IL-33 treatment in both culture systems...IL-33 transiently enhanced DMP-1 steady-state mRNA levels (Fig. 5E), but there was no significant effect on MEPE steady-state mRNA levels.	SEN:10028238	21363931
BEL:20055048	p(MGI:Il3) increases bp(GOBP:"cell growth")	the 32Dcl3 cell line, which is derived from normal mouse bone marrow, is non-tumorigenic and diploid. These cells are strictly dependent on IL-3 for growth and apoptose when deprived of IL-3.	SEN:10009250	9444961
BEL:20055052	p(MGI:Il3) decreases bp(GOBP:"apoptotic process")	Over-expression of constitutively activated H-Ras (CA-Ras) in Ba/F3 cells blocked down-modulation of Survivin expression, G0/G1 arrest, and apoptosis induced by IL-3 withdrawal, while dominant-negative (DN) H-Ras down-regulated Survivin.	SEN:10027516	15369798
BEL:20055054	p(MGI:Il3) decreases bp(GOBP:"apoptotic process")	Following IL-3 withdrawal, c-MYC is downregulated and cells become growth arrested, accumulating in the G0/G1 phase of the cell cycle, and rapidly undergo apoptosis. Enforced c-MYC expression accelerates the apoptotic response in the absence of IL-3 (Askew et al., 1991).	SEN:10028244	18955973
BEL:20055056	p(MGI:Il3) decreases bp(GOBP:"apoptotic process")	the 32Dcl3 cell line, which is derived from normal mouse bone marrow, is non-tumorigenic and diploid. These cells are strictly dependent on IL-3 for growth and apoptose when deprived of IL-3.	SEN:10009250	9444961
BEL:20055060	p(MGI:Il3) increases kin(p(MGI:Mapk1))	p44MAPK/extracellular signal-regulated kinase 1 (ERK1) and p42 MAPK/ERK2 are activated by IL-3, colocalize with mitochondrial Bcl2, and can directly phosphorylate Bcl2 on Ser-70 in a stauro-resistant manner both in vitro and in vivo	SEN:10021952	10677502
BEL:20055062	p(MGI:Il3) increases kin(p(MGI:Mapk3))	p44MAPK/extracellular signal-regulated kinase 1 (ERK1) and p42 MAPK/ERK2 are activated by IL-3, colocalize with mitochondrial Bcl2, and can directly phosphorylate Bcl2 on Ser-70 in a stauro-resistant manner both in vitro and in vivo	SEN:10021952	10677502
BEL:20055068	p(MGI:Il3) increases p(MGI:Myc)	Following IL-3 withdrawal, c-MYC is downregulated and cells become growth arrested, accumulating in the G0/G1 phase of the cell cycle, and rapidly undergo apoptosis. Enforced c-MYC expression accelerates the apoptotic response in the absence of IL-3 (Askew et al., 1991).	SEN:10028244	18955973
BEL:20055072	p(MGI:Il3) decreases r(MGI:Aatk)	In our search for genes that are induced during apoptosis and/or terminal differentiation of 32Dcl3 cells, we identified a novel gene termed AATYK (Apoptosis Associated Tyrosine Kinase), whose expression is dramatically upregulated during IL-3 deprivation as well as G-CSF-induced terminal differentiation.	SEN:10008428	9444961
BEL:20055076	p(MGI:Il3) increases r(MGI:Birc5)	Survivin expression is up-regulated by IL-3 in Ba/F3 and CD34+ cells and inhibited by the Ras inhibitor, farnesylthiosalicylic acid.	SEN:10009254	15369798
BEL:20055078	p(MGI:Il3) decreases r(MGI:Lcn2)	We conclude that IL-3 deprivation activates 24p3 transcription, leading to synthesis and secretion of 24p3, which induces apoptosis through an autocrine pathway.	SEN:10009256	11486081
BEL:20055084	p(MGI:Il3) increases r(MGI:Pim1)	In parental Ba/F3 cells, PIM-1 mRNA expression was strictly dependent on IL-3 stimulation and decreased rapidly after IL-3 depletion.	SEN:10028252	16585210
BEL:20055086	p(MGI:Il3) decreases r(MGI:Zfp346)	Now, we report that the stress of IL-3 growth factor withdrawal up-regulates JAZ expression in hematopoietic cells	SEN:10028254	16931621
BEL:20055090	p(MGI:Il4) decreases a(CHEBI:"nitric oxide")	Further, IL-4 inhibits the synthesis of nitric oxide from a murine macrophage cell line stimulated with interferong by the inhibition of inducible nitric oxide synthase mRNA formation	SEN:10000100	10783130
BEL:20055098	p(MGI:Il4) increases bp(GOBP:"myeloid dendritic cell activation")	studies of mouse bone marrow-derived DCs [34] showed that mTOR inhibition suppressed IL-4-dependent maturation through the post-transcriptional downregulation of the IL-4R complex.	SEN:10017406	19390566
BEL:20055100	p(MGI:Il4) decreases bp(GOBP:"T-helper 1 cell differentiation")	In addition to their positive effects on TH2 and TH1 development, IL-4 (Fig. 1) and IL-12 (7, 30), acting via STAT proteins, potently suppress induction of T-bet and Gata-3, thereby limiting differentiation of TH1 and TH2 subsets, respectively.	SEN:10028258	11397944
BEL:20055102	p(MGI:Il4) increases cat(p(MGI:Irs1))	We and others have shown that activation of IL-4 (23) and IFN-{alpha} receptors stimulates tyrosyl phosphorylation of IRS docking proteins, which depends upon Jak,	SEN:10027658	11591769
BEL:20055104	p(MGI:Il4) increases deg(p(MGI:Il1b))	IL-4 increases mRNA turnover of IL-1 b and TNFa in human monocytes and mouse macrophages, respectively (23, 24).	SEN:10028260	10783130
BEL:20055106	p(MGI:Il4) increases deg(p(MGI:Tnf))	IL-4 increases mRNA turnover of IL-1 b and TNFa in human monocytes and mouse macrophages, respectively (23, 24).	SEN:10028260	10783130
BEL:20055116	p(MGI:Il4) decreases p(MGI:C3ar1)	In addition to its effects on human cells, IL-4 reduced C5a receptors in murine bone marrow-derived DC and impaired recruitment of labeled bone marrow-derived DC in syngeneic BALB/c mice to i.p. injected C5a. Overall, these data suggest that inhibition of a rapid anaphylatoxin-induced mobilization of monocytes and DC to inflamed tissues represents an important anti-inflammatory activity of the Th2 cytokine IL-4.	SEN:10028266	12626590
BEL:20055118	p(MGI:Il4) decreases p(MGI:C5ar1)	In addition to its effects on human cells, IL-4 reduced C5a receptors in murine bone marrow-derived DC and impaired recruitment of labeled bone marrow-derived DC in syngeneic BALB/c mice to i.p. injected C5a. Overall, these data suggest that inhibition of a rapid anaphylatoxin-induced mobilization of monocytes and DC to inflamed tissues represents an important anti-inflammatory activity of the Th2 cytokine IL-4.	SEN:10028266	12626590
BEL:20055120	p(MGI:Il4) increases p(MGI:Ccl11)	naive BALB/c mice were treated with different concentrations of IL-4 and IL-13, and eotaxin in lung tissues or in BAL were measured by ELISA...Compared with IL-13, IL-4 induced much lower levels of eotaxin even at higher doses (Fig. 4).	SEN:10027940	10072486
BEL:20055126	p(MGI:Il4) increases p(MGI:Hoxc4)	HoxC4 was 'preferentially' expressed in germinal center B cells and was upregulated by engagement of CD40 by CD154, as well as by lipopolysaccharide and interleukin 4.	SEN:10003464	19363484
BEL:20055128	p(MGI:Il4) decreases p(MGI:Ifng)	Induction of IFN-g was clearly STAT4-independent, consistent with prior in vitro (10) and in vivo (15) findings, and, as expected (16), emergence of IFN-g expressing cells was markedly limited by IL-4 signaling. Combinations of neutralizing antibodies and cytokines further confirmed the specificity of these pathways (17).	SEN:10028268	11397944
BEL:20055146	p(MGI:Il4) decreases p(MGI:Tbx21)	Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6.	SEN:10028280	11397944
BEL:20055150	p(MGI:Il4ra) increases r(MGI:Chia1)	We found that the induction of AMCase and Clca3 transcripts was markedly reduced in mice with Clara cell-specific disruption of Il4ra (Fig. 8, c and d).	SEN:10028284	16148120
BEL:20055152	p(MGI:Il4ra) increases r(MGI:Clca3)	We found that the induction of AMCase and Clca3 transcripts was markedly reduced in mice with Clara cell-specific disruption of Il4ra (Fig. 8, c and d).	SEN:10028284	16148120
BEL:20055156	p(MGI:Il4ra) increases r(MGI:Muc5ac)	Muc5ac and Muc5b were both highly induced by allergen treatment of control mice, but induction of these transcripts was markedly impaired in mice with Clara cell-specific disruption of Il4ra (Fig. 8, a and b).	SEN:10028288	16148120
BEL:20055158	p(MGI:Il4ra) increases r(MGI:Muc5b)	Muc5ac and Muc5b were both highly induced by allergen treatment of control mice, but induction of these transcripts was markedly impaired in mice with Clara cell-specific disruption of Il4ra (Fig. 8, a and b).	SEN:10028288	16148120
BEL:20055160	p(MGI:Il4) increases r(EGID:20755)	IL-4C inhalation failed to induce Ca2T6 or SPRR1a gene expression at any time point studied, it initially induced SPRR2a and SPRR2b gene expression...In addition, an observation that IL-4, but not IL-13, induced IFN- gene expression (Fig. 4)	SEN:10028290	15814686
BEL:20055162	p(MGI:Il4) increases r(MGI:Bcl3)	Both IL-4 and IL-9 can increase the expression of BCL3, a protein with close homology to I??B, thus contributing to NF-??B inhibition [59].	SEN:10028292	19601851
BEL:20055164	p(MGI:Il4) increases r(MGI:Ccl11)	Twenty-four hour stimulation with 25.0 ng/ml mOSM induced detectable increases in eotaxin-1 expression at the mRNA and protein level in both wt and STAT6-/- MLF (Fig. 5, A and C). Stimulation of wt MLF using 10.0 ng/ml mIL-4 induced eotaxin mRNA expression and protein production that was nondetectable in STAT6-/- MLF (Fig. 5, A and C)	SEN:10028294	16547273
BEL:20055170	p(MGI:Il4) increases r(MGI:Clca3)	As expected (Figure 4), IL-9 induced the expression of mCLCA3, confirming the observation in IL-9 transgenic mice. In addition, IL-4 and IL-13 were also able to induce the expression of mCLCA3 in the lung, whereas no expression was observed in the lungs of mice treated with IFN-gamma (Figure 4).	SEN:10027986	11694454
BEL:20055186	p(MGI:Il4) increases r(MGI:Ifng)	IL-4C inhalation failed to induce Ca2T6 or SPRR1a gene expression at any time point studied, it initially induced SPRR2a and SPRR2b gene expression...In addition, an observation that IL-4, but not IL-13, induced IFN- gene expression (Fig. 4)	SEN:10028290	15814686
BEL:20055188	p(MGI:Il4) decreases r(MGI:Ifng)	from full text - T-cell receptor alpha chain-deficient mice (TCR -/-) treated with anti-IL-4 monoclonal antibody showed a decrease in Th2-type mRNA cytokine production and an increase in expression of IFN-gamma, suggesting that IL-4 plays a major role in inducing Th2-type CD4+ cells in the gut to shift towards a Th1 response[51].	SEN:10028300	18666314
BEL:20055190	p(MGI:Il4) increases r(MGI:Maf)	c-Maf-null macrophages exhibit strongly impaired IL-10 protein production and mRNA expression upon LPS stimulation.	SEN:10009264	15749884
BEL:20055194	p(MGI:Il4) increases r(MGI:Ncoa3)	Among the p160/steroid receptor co-activators, only p/CIP (nuclear co-activator 3) has been shown to be up-regulated by interleukin (IL)-4 in B cells through a STAT-6-dependent mechanism using Gene-Chip analysis.	SEN:10028302	15145939
BEL:20055196	p(MGI:Il4) decreases r(MGI:Nos2)	Further, IL-4 inhibits the synthesis of nitric oxide from a murine macrophage cell line stimulated with interferong by the inhibition of inducible nitric oxide synthase mRNA formation	SEN:10000100	10783130
BEL:20055198	p(MGI:Il4) increases r(MGI:Ormdl3)	These studies demonstrated that in vivo administration of either IL-4 or IL-13 intranasally could induce significant expression of ORMDL3 mRNA in WT bronchial epithelium as assessed by qPCR (Fig. S3A)	SEN:10028000	23011799
BEL:20055200	p(MGI:Il4) increases r(MGI:Retnlb)	FIZZ2 gene expression was significantly upregulated by IL-4 at 4-h and 8-h time points and by IL-13 at the 4-h time point (p < 0.05).	SEN:10028004	21602491
BEL:20055202	p(MGI:Il4) increases r(MGI:Scgb3a1)	In this study we demonstrate that IL-4 and IL-13 enhance Ugrp2 gene expression in the mouse transformed Clara cell line, mtCC, in a time- and dose-dependent manner.	SEN:10028006	16237061
BEL:20055204	p(MGI:Il4) increases r(MGI:Sprr2b)	IL-4C inhalation failed to induce Ca2T6 or SPRR1a gene expression at any time point studied, it initially induced SPRR2a and SPRR2b gene expression...In addition, an observation that IL-4, but not IL-13, induced IFN- gene expression (Fig. 4)	SEN:10028290	15814686
BEL:20055206	p(MGI:Il4) decreases r(MGI:Tbx21)	In addition to their positive effects on TH2 and TH1 development, IL-4 (Fig. 1) and IL-12 (7, 30), acting via STAT proteins, potently suppress induction of T-bet and Gata-3, thereby limiting differentiation of TH1 and TH2 subsets, respectively.	SEN:10028258	11397944
BEL:20055212	p(MGI:Il4) increases r(MGI:Zfp36)	Furthermore, IL-4 induced the expression of tristetraprolin (TTP), an RNA-binding protein that promotes decay of ARE-containing mRNA, in mast cells by a Stat6-dependent mechanism, and the depletion of TTP expression by RNA interference prevented IL-4-induced down-regulation of TNF-alpha production in mast cells.	SEN:10028306	14638848
BEL:20055222	p(MGI:Il4) increases tscript(p(MGI:Stat6))	These results suggest that IL-4 inhibition of IFN-gamma-induced CD40 gene expression is mediated by direct STAT-6 binding to the CD40 promoter.	SEN:10002556	11086058
BEL:20055224	p(MGI:Il4) increases tscript(p(MGI:Stat6))	Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6.	SEN:10028280	11397944
BEL:20055230	p(MGI:Il4) increases tscript(p(MGI:Stat6))	This unconventional interaction of SOCS5 protein with the IL-4R resulted in the inhibition of IL-4-mediated signal transducer and activator of transcription-6 activation.	SEN:10020328	12242343
BEL:20055232	p(MGI:Il4) increases tscript(p(MGI:Stat6))	Fig. 4. IL-4 induces STAT6 binding to a site in the 5' upstream regulatory region of the AID gene.	SEN:10028310	14978013
BEL:20055234	p(MGI:Il4) increases tscript(p(MGI:Stat6))	IL-4 and IL-13 induced phosphorylation of STAT6 in mtCC cells, which binds to the proximal STAT-binding element (SBE) in the Ugrp2 gene promoter, leading to transcriptional activation of this gene.	SEN:10009270	16237061
BEL:20055236	p(MGI:Il4) increases tscript(p(MGI:Stat6))	To verify the absence of the STAT6-signaling cascade in STAT6-/- MLF, we assessed mOSM and mIL-4 induced responses with respect to STAT3 and STAT6 activation. Fig. 6 confirms the absence of STAT6 protein and STAT6 induction in STAT6-/- MLF but equivalent activation of STAT3 in both wt and STAT6-/- MLF.	SEN:10028276	16547273
BEL:20055238	p(MGI:Il5) increases a(CHEBI:hydroxyproline)	Treatment with anti-IL-5 antibodies significantly suppressed the bleomycin-induced increase in lung hydroxyproline content (Fig. 5).	SEN:10028312	9823772
BEL:20055242	p(MGI:Il5) increases bp(GOBP:"inflammatory response")	Furthermore, anti-IL-5 antibody caused significant reduction in lung eosinophilia, cytokine expression, and fibrosis. These findings taken together suggest an important role for IL-5 in pulmonary fibrosis via its ability to regulate eosinophilic inflammation, and thus eosinophil-dependent fibrogenic cytokine production	SEN:10009272	9823772
BEL:20055246	p(MGI:Il5) increases cat(p(MGI:Sox4))	syntenin associates with the cytoplasmic tail of the IL5Ralpha subunit syntenin was found to directly associate with the transcription factor Sox4 association of syntenin with IL5Ralpha was required for IL5-mediated activation of Sox4	SEN:10020450	11498591
BEL:20055248	p(MGI:Il5) increases kin(p(MGI:Syk))	Moreover, no difference in IL-5-induced survival of mature eosinophils between Syk(-/-) and wild-type eosinophils could be demonstrated, suggesting that the antiapoptotic effect of IL-5 does not require Syk despite the activation of this tyrosine kinase upon IL-5 receptor ligation.	SEN:10009274	11001904
BEL:20055250	p(MGI:Il5) decreases path(MESHD:Atherosclerosis)	IL5, a typical Th2 cytokine, was recently demonstrated to attentuate atherosclerosis, in part by stimulating the expansion of atheroprotective natural immunoglobin specific for OxLDL (44)	SEN:10028316	16293001
BEL:20055252	p(MGI:Il5) increases path(MESHD:Fibrosis)	Furthermore, anti-IL-5 antibody caused significant reduction in lung eosinophilia, cytokine expression, and fibrosis. These findings taken together suggest an important role for IL-5 in pulmonary fibrosis via its ability to regulate eosinophilic inflammation, and thus eosinophil-dependent fibrogenic cytokine production	SEN:10009272	9823772
BEL:20055254	p(MGI:Il5) increases p(MGI:Acta2)	Purified lung eosinophils from blm-treated IL-5(TG) mice stimulated alpha-smooth muscle actin and collagen expression in mouse lung fibroblasts	SEN:10009276	14607953
BEL:20055260	p(MGI:Il5) increases p(MGI:Ccl2)	Immunostaining with anti-TGF-b and anti-MCP-1 antibodies revealed similar results. As previously reported [8, 9, 16], there was a substantial increase in the number of cells expressing these cytokines in bleomycin-injured lungs, which was also inhibited by treatment with anti-IL-5 antibody as confirmed by morphometric counting of cytokine-positive cells (Fig. 7, B and C, respectively).	SEN:10028320	9823772
BEL:20055262	p(MGI:Il5) increases p(MGI:Fn1)	Indeed at each time point examined, levels of lung hydroxyproline, soluble collagen, fibronectin, and TGF-? were higher in blm-treated IL-5TG relative to IL-5WT mice (Fig. 2?, A–D).	SEN:10028314	14607953
BEL:20055264	p(MGI:Il5) increases p(MGI:Il13)	TNF-alpha, IL-1beta, and IFN-gamma expression were slightly decreased in cultures from blm-treated IL-5-/- mice relative to cultures from blm-treated IL-5+/+ mice (Table IV?), whereas TGF-beta levels were significantly increased. Anti-CD3-induced expression of IL-4 and IL-13 were dramatically diminished in IL-5?/? T cells in comparison to IL-5+/+ T cells.	SEN:10028322	14607953
BEL:20055266	p(MGI:Il5) increases p(MGI:Il4)	TNF-alpha, IL-1beta, and IFN-gamma expression were slightly decreased in cultures from blm-treated IL-5-/- mice relative to cultures from blm-treated IL-5+/+ mice (Table IV?), whereas TGF-beta levels were significantly increased. Anti-CD3-induced expression of IL-4 and IL-13 were dramatically diminished in IL-5?/? T cells in comparison to IL-5+/+ T cells.	SEN:10028322	14607953
BEL:20055268	p(MGI:Il5) increases p(MGI:Tgfb1)	Indeed at each time point examined, levels of lung hydroxyproline, soluble collagen, fibronectin, and TGF-? were higher in blm-treated IL-5TG relative to IL-5WT mice (Fig. 2?, A–D).	SEN:10028314	14607953
BEL:20055270	p(MGI:Il5) increases p(MGI:Tgfb1)	Immunostaining with anti-TGF-b and anti-MCP-1 antibodies revealed similar results. As previously reported [8, 9, 16], there was a substantial increase in the number of cells expressing these cytokines in bleomycin-injured lungs, which was also inhibited by treatment with anti-IL-5 antibody as confirmed by morphometric counting of cytokine-positive cells (Fig. 7, B and C, respectively).	SEN:10028320	9823772
BEL:20055288	p(MGI:Il6) increases bp(GOBP:"inflammatory response")	Several pro-inflammatory mediators up-regulate SAA transcription, including Il1, Il6, TNFalpha, and Lif.	SEN:10028334	11798191
BEL:20055290	p(MGI:Il6) increases bp(GOBP:"inflammatory response")	Il6 can elicit proinflammatory or anti-inflammatory effects, depending on the in vivo environmental circumstances	SEN:10028336	12687404
BEL:20055292	p(MGI:Il6) increases bp(GOBP:"inflammatory response")	More importantly, persistent activation of IL-6 downstream Stat3 in AT II epithelial cellsdirec tly induced lung inflammation and bronchioalveolar adenocarcinoma (22).	SEN:10028338	19706765
BEL:20055296	p(MGI:Il6) increases bp(GOBP:"MAPK cascade")	The hsp90beta gene promoter contains binding sites for the transcription factors nuclear factor IL-6 (\"NF-IL6\") and signal transducer and activator of transcription 3 (STAT-3), which are activated respectively by the mitogen-activated-protein-kinase and Jak-kinase pathways following IL-6 treatment.	SEN:10018046	9461509
BEL:20055302	p(MGI:Il6) increases bp(GOBP:"osteoclast differentiation")	Il6, leukemia inhibitory factor [LIF}, and oncostatin M [OSM] are Il6-type cytokines that stimulate osteoclast formation and function	SEN:10028344	12218157
BEL:20055304	p(MGI:Il6) decreases bp(GOBP:"response to oxidative stress")	GFAP-IL-6 mice showed faster tissue repair and decreased oxidative stress and apoptosis compared with control litter-mate mice.	SEN:10028346	12673834
BEL:20055306	p(MGI:Il6) decreases bp(GOBP:"apoptotic process")	GFAP-IL-6 mice showed faster tissue repair and decreased oxidative stress and apoptosis compared with control litter-mate mice.	SEN:10028346	12673834
BEL:20055308	p(MGI:Il6) increases bp(GOBP:"apoptotic process")	The same group demonstrated just recently that mast cells actively participate in the formation of aortic aneurysms by release of IL-6 and IFN?, which induced apoptosis of smooth muscle cells and protease expression [111].	SEN:10027652	19238385
BEL:20055310	p(MGI:Il6) increases path(MESHD:"Insulin Resistance")	Insulin resistance was improved by systemic neutralization of IL-6 or salicylate inhibition of IKK-beta.	SEN:10006180	15685173
BEL:20055312	p(MGI:Il6) increases path(MESHD:"Insulin Resistance")	and in mice, IL-6 treatment causes insulin resistance in skeletal muscle and in liver most likely due to defects in IRS-1 (and IRS-2, respectively)-associated PI 3-kinase activity (56).	SEN:10028348	15793228
BEL:20055314	p(MGI:Il6) increases kin(p(MGI:Hck))	Il6 induces the activation of the Src family kinase Hck, which is associated with the Il6 receptor beta-chain, gp130	SEN:10028350	11689697
BEL:20055316	p(MGI:Il6) increases kin(p(MGI:Mapk1))	Fig.3 A shows that an increase in phosphorylation of ERK2 at Tyr204 was detected after 5 min of exposure to 10 ng/ml IL-6; this effect peaked at 30 min and was followed by a decline to basal levels by 2 h.	SEN:10028352	12595539
BEL:20055320	p(MGI:Il6) increases path(MESHD:Adenocarcinoma)	More importantly, persistent activation of IL-6 downstream Stat3 in AT II epithelial cellsdirec tly induced lung inflammation and bronchioalveolar adenocarcinoma (22).	SEN:10028338	19706765
BEL:20055330	p(MGI:Il6) increases p(MGI:A2m)	alpha 2-macroglobulin, alpha 1-antichymotrypsin ( = contrapsin), cysteine protease inhibitor ( = thiostatin), alpha 1-antitrypsin, ceruloplasmin and fibrinogens are predominantly regulated by the keratinocyte-derived HSF-III/-II or IL-6	SEN:10028356	2483767
BEL:20055332	p(MGI:Il6) increases p(MGI:Anxa1)	recombinant IL-6 to IL-6 KO animals before LPS or TNF-alpha challenge, replenished ANXA1 liver synthesis to that of WT animals.	SEN:10009278	11583971
BEL:20055334	p(MGI:Il6) increases p(MGI:Batf)	Immunoblots using antibodies to BATF detected an increase in BATF protein in response to LIF/IL-6 stimulation.	SEN:10028358	12444555
BEL:20055338	p(MGI:Il6) increases p(MGI:Ccl3)	Treatment of bleomycin-challenged mice with soluble TNF receptor (sTNFr) or anti-IL-6 antibodies significantly decreased MIP-1alpha protein expression in the lungs.	SEN:10002564	9766634
BEL:20055340	p(MGI:Il6) increases p(MGI:Cp)	alpha 2-macroglobulin, alpha 1-antichymotrypsin ( = contrapsin), cysteine protease inhibitor ( = thiostatin), alpha 1-antitrypsin, ceruloplasmin and fibrinogens are predominantly regulated by the keratinocyte-derived HSF-III/-II or IL-6	SEN:10028356	2483767
BEL:20055342	p(MGI:Il6) increases p(MGI:Fga)	alpha 2-macroglobulin, alpha 1-antichymotrypsin ( = contrapsin), cysteine protease inhibitor ( = thiostatin), alpha 1-antitrypsin, ceruloplasmin and fibrinogens are predominantly regulated by the keratinocyte-derived HSF-III/-II or IL-6	SEN:10028356	2483767
BEL:20055346	p(MGI:Il6) increases p(MGI:Il6st,pmod(P))	tryosine phosphorylation of gp130 was observed in fibroblasts after stimulation with all the cytokines	SEN:10027898	11820727
BEL:20055348	p(MGI:Il6) increases p(MGI:Kng1)	alpha 2-macroglobulin, alpha 1-antichymotrypsin ( = contrapsin), cysteine protease inhibitor ( = thiostatin), alpha 1-antitrypsin, ceruloplasmin and fibrinogens are predominantly regulated by the keratinocyte-derived HSF-III/-II or IL-6	SEN:10028356	2483767
BEL:20055350	p(MGI:Il6) increases p(MGI:Mapk1,pmod(P,Y,204))	Fig.3 A shows that an increase in phosphorylation of ERK2 at Tyr204 was detected after 5 min of exposure to 10 ng/ml IL-6; this effect peaked at 30 min and was followed by a decline to basal levels by 2 h.	SEN:10028352	12595539
BEL:20055352	p(MGI:Il6) increases p(MGI:Mapk3,pmod(P,Y,205))	IL-6 increased phosphorylation of STAT3 (at Tyr(705)) and ERK1/2 (at Tyr(204)) within 5 min that peaked at 15-30 min and returned to basal levels at 2 h	SEN:10028364	12595539
BEL:20055356	p(MGI:Il6) increases p(MGI:Nos2)	iNOS protein was undetectable at 1 h but was increased after 2, 4, and 24 h of incubation with IL-6. The iNOS expression induced by a 2-h incubation with 10 ng/ml IL-1beta, a well known inducer of iNOS in cardiac myocytes (38), was used as a positive control in these experiments.	SEN:10028136	12595539
BEL:20055360	p(MGI:Il6) increases p(MGI:Stat3,pmod(P,Y,705))	Fig. 1 Ashows that phosphorylation of STAT3 at Tyr705 was detected after 5 min of exposure to 10 ng/ml IL-6, reached a maximum at 15 min, and then declined within 1 h. These results demonstrate that IL-6 activates a STAT3 signaling in adult rat ventricular myocytes.	SEN:10028368	12595539
BEL:20055368	p(MGI:Il6ra) increases kin(p(MGI:Btk))	nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck are activated through the Il6R receptor	SEN:10028372	12110143
BEL:20055370	p(MGI:Il6ra) increases kin(p(MGI:Fes))	nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck are activated through the Il6R receptor	SEN:10028372	12110143
BEL:20055372	p(MGI:Il6ra) increases kin(p(MGI:Hck))	nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck are activated through the Il6R receptor	SEN:10028372	12110143
BEL:20055374	p(MGI:Il6ra) increases kin(p(MGI:Tec))	nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck are activated through the Il6R receptor	SEN:10028372	12110143
BEL:20055376	p(MGI:Il6ra) increases p(MGI:Batf)	Immunoblots using antibodies to BATF detected an increase in BATF protein in response to LIF/IL-6 stimulation.	SEN:10028358	12444555
BEL:20055380	p(MGI:Il6) increases r(MGI:Anxa1)	recombinant IL-6 to IL-6 KO animals before LPS or TNF-alpha challenge, replenished ANXA1 liver synthesis to that of WT animals.	SEN:10009278	11583971
BEL:20055384	p(MGI:Il6) increases r(MGI:Clec4e)	Mincle mRNA expression was strongly induced in response to several inflammatory stimuli, such as LPS, TNF-alpha, IL-6, and IFN-gamma in wild-type macrophages.	SEN:10009080	10528209
BEL:20055388	p(MGI:Il6) decreases r(MGI:Foxp3)	IL-6 reduced the expression levels of Foxp3 at 48–72 h. This is probably a direct effect of IL-6 on the Foxp3 promoter because IL-6 suppressed TGF-?1-mediated Foxp3 promoter activity in primary T cells (data not shown).	SEN:10028378	18434325
BEL:20055398	p(MGI:Il6) increases r(MGI:Ifng)	from full text - anti-IL-6 receptor monoclonal antibody to a murine colitis model and found that the treatment with this antibody reduced IFN-gamma, TNF-alpha, and IL-1beta mRNA, and suppressed expression of several intracellular adhesion molecules in the colonic vascular endothelium.	SEN:10028380	18666314
BEL:20055408	p(MGI:Il6) increases r(MGI:Il1b)	from full text - anti-IL-6 receptor monoclonal antibody to a murine colitis model and found that the treatment with this antibody reduced IFN-gamma, TNF-alpha, and IL-1beta mRNA, and suppressed expression of several intracellular adhesion molecules in the colonic vascular endothelium.	SEN:10028380	18666314
BEL:20055410	p(MGI:Il6) increases r(MGI:Il23r)	Forced expression of wild-type mouse Foxp3 inhibited IL-6/IL-21-induced Il23r expression, whereas Foxp3DeltaEx2 had less inhibitory activity (Fig. 4a)	SEN:10027060	18368049
BEL:20055412	p(MGI:Il6) increases r(MGI:Itih4)	We note a marked and differential increase in Itih-4 labeling in proliferating hepatocytes, compared with bile duct cells in liver explant cultures treated with interleukin-6 (IL-6)	SEN:10009290	11803570
BEL:20055414	p(MGI:Il6) increases r(MGI:Lcn2)	A similar 24P3 induction was observed in other T cell lymphomas (EL4 and TH201) in response to IL-9, as well as in EL4 cells stimulated with IL-6 or IL-1.	SEN:10028384	11282560
BEL:20055416	p(MGI:Il6) decreases r(MGI:Lifr)	we found that IL6 effectively inhibited LIF signalling, repressing transcription of the LIF receptor gp190, and strongly inducing axotrophin/MARCH-7, a novel E3 ubitquitin ligase that we discovered to be active in degradation of gp190 protein.	SEN:10019318	19342884
BEL:20055418	p(MGI:Il6) increases r(MGI:March7)	we found that IL6 effectively inhibited LIF signalling, repressing transcription of the LIF receptor gp190, and strongly inducing axotrophin/MARCH-7, a novel E3 ubitquitin ligase that we discovered to be active in degradation of gp190 protein.	SEN:10019318	19342884
BEL:20055422	p(MGI:Il6) increases r(MGI:Ptgs2)	inflammatory cytokines, notably Tnf-alpha, and Il6, induce the expression of Cox2 and the secretion of Pge2 in human prostate cancer cell lines	SEN:10028386	11779161
BEL:20055424	p(MGI:Il6) increases r(MGI:Ptgs2)	the human COx2 gene contains a putative NF-IL-6 element in the 5'-flanking promoter region which can be activated by Il6	SEN:10028388	11779161
BEL:20055426	p(MGI:Il6) increases r(MGI:Serpina3k)	GAGA box of the rat serine protease inhibitor 2 (spi 2) genes not only acts as a basal promoter element, but also mediates transcriptional activation by growth hormone and interleukin-6.	SEN:10008844	11154060
BEL:20055430	p(MGI:Il6) increases r(MGI:Serpine1)	Interestingly, 500 ng/ml GH and 30 ng/ml IL-6 increased PAI-1 secretion five-fold and 3.6-fold, respectively. Furthermore, GH and IL-6 induced PAI-1 mRNA by up to 7.3-fold, and 3.6-fold, respectively, in a time-dependent fashion with significant stimulation seen at concentrations as low as 5 ng/ml GH and 10 ng/ml IL-6.	SEN:10008846	16713670
BEL:20055432	p(MGI:Il6) increases r(MGI:Skap2)	interleukin-6 (IL-6) or leukemia inhibitory factor (LIF)-induced differentiation of the myeloid cell line M1 was associated with a rapid increase in the level of mRNA encoding the signaling adaptor protein, SKAP55R	SEN:10028390	11753615
BEL:20055436	p(MGI:Il6) increases r(MGI:Stap2)	Because STAP-2 expression is induced by proinflammatory cytokines such as IL-6 or IL-1beta, STAP-2 may play a role in the regulation of inflammation.	SEN:10028154	12540842
BEL:20055438	p(MGI:Il6) increases r(MGI:Stap2)	STAP-2 mRNA was strongly induced in the liver in response to lipopolysaccharide and in isolated hepatocytes in response to interleukin-6.	SEN:10009294	12540842
BEL:20055442	p(MGI:Il6) increases r(MGI:Tnf)	from full text - anti-IL-6 receptor monoclonal antibody to a murine colitis model and found that the treatment with this antibody reduced IFN-gamma, TNF-alpha, and IL-1beta mRNA, and suppressed expression of several intracellular adhesion molecules in the colonic vascular endothelium.	SEN:10028380	18666314
BEL:20055448	p(MGI:Il6) increases sec(p(MGI:Serpine1))	Interestingly, 500 ng/ml GH and 30 ng/ml IL-6 increased PAI-1 secretion five-fold and 3.6-fold, respectively. Furthermore, GH and IL-6 induced PAI-1 mRNA by up to 7.3-fold, and 3.6-fold, respectively, in a time-dependent fashion with significant stimulation seen at concentrations as low as 5 ng/ml GH and 10 ng/ml IL-6.	SEN:10008846	16713670
BEL:20055452	p(MGI:Il6st) increases bp(GOBP:"cell proliferation")	this acidic domain of gp130 is responsible for the activation of Hck, Erk, Pyk2 and signals cell proliferation upon growth factor stimulation	SEN:10028396	11689697
BEL:20055462	p(MGI:Il6st) increases kin(p(MGI:Hck))	this acidic domain of gp130 is responsible for the activation of Hck, Erk, Pyk2 and signals cell proliferation upon growth factor stimulation	SEN:10028396	11689697
BEL:20055464	p(MGI:Il6st) increases kin(p(MGI:Ptk2b))	this acidic domain of gp130 is responsible for the activation of Hck, Erk, Pyk2 and signals cell proliferation upon growth factor stimulation	SEN:10028396	11689697
BEL:20055470	p(MGI:Il6st) increases phos(p(MGI:Ptpn11))	functions of the 2 major signaling pathways, the signal transducers and activators of transcription 1 and 3 [STAT1/3] and the Src-homology tyrosine phosphatase 2 [SHP2]-Ras-ERK [Ptpn11], emanating from the common signal transducer, gp130, in the gastrointestinal tract	SEN:10028406	12219085
BEL:20055472	p(MGI:Il6st) increases p(MGI:Notch1)	NOTCH1 activation, indicated by tumor necrosis factor alpha-converting enzyme, TACE [Adam17], and presenilin-mediated processing, also increased	SEN:10028408	12629177
BEL:20055474	p(MGI:Il6st) increases p(MGI:Ptpn11,pmod(P,Y))	in Il6 signal cascade, the SHP2 interaction site of gp130 has also been shown to be a Socs3 contact site so that Socs3 may compete for the SHP2-gp130 interaction site	SEN:10020340	12110143
BEL:20055476	p(MGI:Il6st) increases p(MGI:Socs3,pmod(P,Y))	in Il6 signal cascade, the SHP2 interaction site of gp130 has also been shown to be a Socs3 contact site so that Socs3 may compete for the SHP2-gp130 interaction site	SEN:10020340	12110143
BEL:20055480	p(MGI:Il6st,pmod(P,Y)) increases p(MGI:Ptpn11,pmod(P,Y))	tyrosine phosphorylation of SHP2, a phosphotyrosine phosphatase, and that of STAT3 depend on the second tyrosine residue Y2 from the membrane in gp130	SEN:10028412	12110143
BEL:20055482	p(MGI:Il6st,pmod(P,Y)) increases p(MGI:Stat3,pmod(P,Y))	tyrosine phosphorylation of SHP2, a phosphotyrosine phosphatase, and that of STAT3 depend on the second tyrosine residue Y2 from the membrane in gp130	SEN:10028412	12110143
BEL:20055484	p(MGI:Il6st) increases r(MGI:Notch1)	ciliary neurotrophic factor, CNTF, activation of gp130 in NSCs rapidly increased Notch1 expression	SEN:10008352	12629177
BEL:20055500	p(MGI:Il6st) increases tscript(p(MGI:Stat1))	functions of the 2 major signaling pathways, the signal transducers and activators of transcription 1 and 3 [STAT1/3] and the Src-homology tyrosine phosphatase 2 [SHP2]-Ras-ERK [Ptpn11], emanating from the common signal transducer, gp130, in the gastrointestinal tract	SEN:10028406	12219085
BEL:20055502	p(MGI:Il6st) increases tscript(p(MGI:Stat1))	gp130-mediated Stat1/3 activation is required to maintain the normal balance of hematopoietic progenitors during fetal and adult hematopoiesis	SEN:10002596	12423677
BEL:20055504	p(MGI:Il6st) increases tscript(p(MGI:Stat3))	gp130-mediated Stat1/3 activation is required to maintain the normal balance of hematopoietic progenitors during fetal and adult hematopoiesis	SEN:10002596	12423677
BEL:20055512	p(MGI:Il6) increases tscript(p(MGI:Maz))	Serum amyloid A-activating factor-1 (SAF-1) is a zinc finger transcription factor that is activated by many mediators of inflammation including IL-1, IL-6, and bacterial LPS.	SEN:10003486	11490023
BEL:20055514	p(MGI:Il6) increases tscript(p(MGI:Stat3))	Although STAT3 is essential for IL-6-induced macrophage differentiation of M1 cells, GATA-1 had little or no effect on tyrosine phosphorylation, DNA binding, and transcriptional activities of STAT3 in Western blot analysis, electropholic mobility shift assay (EMSA), and luciferase assays.	SEN:10028424	10666199
BEL:20055516	p(MGI:Il6) increases tscript(p(MGI:Stat3))	IL-6 induced STAT3 transactivation was reduced from sixfold to 2.5-fold when cells were pre- treated with the JAK2 inhibitor (Figure 2b).	SEN:10016526	11536047
BEL:20055518	p(MGI:Il6) increases tscript(p(MGI:Stat3))	Fig. 1 Ashows that phosphorylation of STAT3 at Tyr705 was detected after 5 min of exposure to 10 ng/ml IL-6, reached a maximum at 15 min, and then declined within 1 h. These results demonstrate that IL-6 activates a STAT3 signaling in adult rat ventricular myocytes.	SEN:10028368	12595539
BEL:20055520	p(MGI:Il6) increases tscript(p(MGI:Stat3))	Stat3 controls cell death and tissue remodeling in the mouse mammary gland during involution, which is partially induced by IL6 and LIF.	SEN:10028426	15292206
BEL:20055522	p(MGI:Il6) increases tscript(p(MGI:Stat3))	results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program.	SEN:10002578	15507530
BEL:20055524	p(MGI:Il6) increases tscript(p(MGI:Stat3))	The mouse tumors mimic molecular hallmarks of their human tumor counterparts, including elevated IL-6/Stat3/Bcl-X(L) signaling. The newly developed mouse strains may provide a good preclinical research tool for the design and testing of new approaches to target IL-6 in treatment and prevention of human PCNs.	SEN:10002588	20018915
BEL:20055542	p(MGI:Il7) decreases r(MGI:Tgfb1)	We have previously reported that recombinant IL-7 decreases the expression of TGF-beta 1 by murine macrophages.	SEN:10028434	7752257
BEL:20055544	p(MGI:Il7) increases sec(p(MGI:Ifng))	Fig. 4. ovx-induced increases in IFN-? production and antigen presentation are blocked by anti-IL-7 Ab.	SEN:10028430	16267136
BEL:20055548	p(MGI:Il9) increases p(MGI:Ccl11)	In airway SMC, IL-9 can induce expression of the Th2 related cytokine CCL11, but yet increased the severity of asthma in IL-9 transgenic mice [111].	SEN:10028438	19601851
BEL:20055550	p(MGI:Il9) decreases p(MGI:Ifng)	Although recognized as a T cell growth factor, IL-9 exerts a Th2 inflammatory response in these cells, and suppresses expression of TNF??, IFN??, with a concurrent up regulation of IL-10 [15].	SEN:10028436	19601851
BEL:20055552	p(MGI:Il9) increases p(MGI:Il10)	Although recognized as a T cell growth factor, IL-9 exerts a Th2 inflammatory response in these cells, and suppresses expression of TNF??, IFN??, with a concurrent up regulation of IL-10 [15].	SEN:10028436	19601851
BEL:20055554	p(MGI:Il9) increases p(MGI:Muc2)	IL-9 induced MUC2 and MUC5AC expression in IL-9 transgenic mice (Tg5) and in IL-9 treated C57BL/6 mice. Protein level of MUC2 and MUC5AC was confirmed by dot blot analysis.	SEN:10028440	10837360
BEL:20055556	p(MGI:Il9) increases p(MGI:Muc5ac)	IL-9 induced MUC2 and MUC5AC expression in IL-9 transgenic mice (Tg5) and in IL-9 treated C57BL/6 mice. Protein level of MUC2 and MUC5AC was confirmed by dot blot analysis.	SEN:10028440	10837360
BEL:20055558	p(MGI:Il9) decreases p(MGI:Tnf)	Although recognized as a T cell growth factor, IL-9 exerts a Th2 inflammatory response in these cells, and suppresses expression of TNF??, IFN??, with a concurrent up regulation of IL-10 [15].	SEN:10028436	19601851
BEL:20055562	p(MGI:Il9) increases r(MGI:Bcl3)	Both IL-4 and IL-9 can increase the expression of BCL3, a protein with close homology to I??B, thus contributing to NF-??B inhibition [59].	SEN:10028292	19601851
BEL:20055564	p(MGI:Il9) increases r(MGI:Clca3)	As expected (Figure 4), IL-9 induced the expression of mCLCA3, confirming the observation in IL-9 transgenic mice. In addition, IL-4 and IL-13 were also able to induce the expression of mCLCA3 in the lung, whereas no expression was observed in the lungs of mice treated with IFN-gamma (Figure 4).	SEN:10027986	11694454
BEL:20055566	p(MGI:Il9) increases r(MGI:Il13)	Transcripts for the Th2 cytokines IL-5, IL-13, and IL-9 could be detected in lung tissue from transgene-positive mice after transgene induction (Fig. 6).	SEN:10028442	11781348
BEL:20055568	p(MGI:Il9) increases r(MGI:Il4)	Specific bands from amplified IL-4 cDNA could be clearly detected using RT-PCR on total lung RNA isolated from transgene-positive mice after 14 days of IL-9 transgene induction	SEN:10028444	11781348
BEL:20055570	p(MGI:Il9) increases r(MGI:Il5)	Transcripts for the Th2 cytokines IL-5, IL-13, and IL-9 could be detected in lung tissue from transgene-positive mice after transgene induction (Fig. 6).	SEN:10028442	11781348
BEL:20055572	p(MGI:Il9) increases r(MGI:Lcn2)	Searching for genes specifically modulated by IL-9, we observed that the 24P3 mRNA is strongly upregulated in BW5147 T lymphoma cells upon IL-9 stimulation.	SEN:10028446	11282560
BEL:20055574	p(MGI:Il9) increases r(MGI:Muc2)	In vivo, the constitutive expression of IL-9 in transgenic mice results in elevated MUC2 and MUC5AC gene expression in airway epithelial cells and periodic acid-Schiff-positive staining (reflecting mucous glycogenates).	SEN:10028448	10837360
BEL:20055576	p(MGI:Il9) increases r(MGI:Muc5ac)	In vivo, the constitutive expression of IL-9 in transgenic mice results in elevated MUC2 and MUC5AC gene expression in airway epithelial cells and periodic acid-Schiff-positive staining (reflecting mucous glycogenates).	SEN:10028448	10837360
BEL:20055596	p(MGI:Ing1) decreases r(MGI:Ccnb1)	overexpression of the antisense ING1 stimulated expression of 14 genes, which included cyclin B1, 12-O-tetradecanoylphorbol-13-acetate-inducible sequence 11, proto-oncogene DEK, and osteopontin,	SEN:10009306	11956069
BEL:20055598	p(MGI:Ing1) decreases r(MGI:Dek)	overexpression of the antisense ING1 stimulated expression of 14 genes, which included cyclin B1, 12-O-tetradecanoylphorbol-13-acetate-inducible sequence 11, proto-oncogene DEK, and osteopontin,	SEN:10009306	11956069
BEL:20055600	p(MGI:Ing1) decreases r(MGI:Spp1)	overexpression of the antisense ING1 stimulated expression of 14 genes, which included cyclin B1, 12-O-tetradecanoylphorbol-13-acetate-inducible sequence 11, proto-oncogene DEK, and osteopontin,	SEN:10009306	11956069
BEL:20055602	p(MGI:Ing1) increases r(MGI:Tpt1)	overexpression of the antisense ING1 stimulated transcriptional repression of 5 genes, including TPT1.	SEN:10028464	11956069
BEL:20055614	p(MGI:Insig1) decreases bp(GOBP:"fat cell differentiation")	INSIG1 expression restricts lipogenesis in mature adipocytes and blocks differentiation in preadipocytes.	SEN:10028472	12869692
BEL:20055616	p(MGI:Insig1) decreases bp(GOBP:"lipid biosynthetic process")	INSIG1 expression restricts lipogenesis in mature adipocytes and blocks differentiation in preadipocytes.	SEN:10028472	12869692
BEL:20055624	p(MGI:Insr) decreases bp(GOBP:"response to endoplasmic reticulum stress")	Insr(-/-) macrophages showed diminished Akt phosphorylation and an augmented ER stress response, leading to induction of scavenger receptor A and increased apoptosis when challenged with cholesterol loading or nutrient deprivation.	SEN:10004134	16581003
BEL:20055626	p(MGI:Insr) increases path(MESHD:"Insulin Resistance")	Skeletal Muscle. Insulin receptor function has been inhibited in two ways: muscle-specific knockout of the insulin receptor (MIRKO; Bruning et al., 1998) and muscle-specific expression of a dominant-negative mutant insulin receptor (IR-A1134T) in transgenic mice (Moller et al., 1996). In both models, skeletal muscle was insulin resistant when studied in vitro.	SEN:10028478	10199397
BEL:20055628	p(MGI:Insr) increases kin(p(MGI:Akt1))	Insr(-/-) macrophages showed diminished Akt phosphorylation and an augmented ER stress response, leading to induction of scavenger receptor A and increased apoptosis when challenged with cholesterol loading or nutrient deprivation.	SEN:10004134	16581003
BEL:20055630	p(MGI:Insr) decreases path(MESHD:Gallstones)	Hepatic insulin resistance also decreases expression of the bile acid synthetic enzymes, particularly Cyp7b1, and produces partial resistance to the farnesoid X receptor, leading to a lithogenic bile salt profile. As a result, after twelve weeks on a lithogenic diet, all of the LIRKO (Liver specific knockout of INSR) mice develop gallstones.	SEN:10028480	18587407
BEL:20055634	p(MGI:Insr,pmod(P,Y)) directlyIncreases kin(p(MGI:Insr))	This pathway begins with the phosphorylation of the adaptor protein Cbl by the insulin receptor, and results in the activation of a small GTP binding protein, TC10	SEN:10021766	12436329
BEL:20055636	p(MGI:Insr,pmod(P,Y)) directlyIncreases kin(p(MGI:Insr))	Direct addition of GM3 ganglioside to 3T3-L1 adipocytes was shown to suppress insulin-stimulated phosphorylation of the insulin receptor (6).	SEN:10019628	12629211
BEL:20055648	p(MGI:Irak1) increases r(MGI:Il10)	In this report, we show that IRAK1 is mainly involved in Stat3 activation and subsequent interleukin-10 (IL-10) gene expression.	SEN:10009312	15465816
BEL:20055650	p(MGI:Irak1) increases tscript(p(MGI:Stat3))	In this report, we show that IRAK1 is mainly involved in Stat3 activation and subsequent interleukin-10 (IL-10) gene expression.	SEN:10009312	15465816
BEL:20055660	p(MGI:Irf1) increases bp(GOBP:"inflammatory response")	Taken together, these data suggest that IRF-1 gene activation by reactive oxygen species is an early signal that promotes inflammation after ischemic renal injury.	SEN:10009314	19443641
BEL:20055662	p(MGI:Irf1) increases bp(GOBP:"megakaryocyte differentiation")	We show that ectopic expression of STAT1 or its downstream transcriptional target IRF-1 promotes features of megakaryocytic differentiation of G1ME cells, a Gata1-null erythromegakaryocytic cell line (25),	SEN:10028492	18060035
BEL:20055686	p(MGI:Irf4) increases p(MGI:Il17a)	In TNBS colitis, no differences were found in interleukin (IL)-18 and tumor necrosis factor (TNF)-alpha expression between IRF4 knockout and wild-type mice. However, significant differences were detected in IL-6 and IL-17 production.	SEN:10009324	19693649
BEL:20055690	p(MGI:Irf4) increases p(MGI:Il6)	In TNBS colitis, no differences were found in interleukin (IL)-18 and tumor necrosis factor (TNF)-alpha expression between IRF4 knockout and wild-type mice. However, significant differences were detected in IL-6 and IL-17 production.	SEN:10009324	19693649
BEL:20055692	p(MGI:Irf4) decreases r(EGID:14980)	In contrast, over- expression of either IRF4 or ICSBP in both macrophages and NIH-3T3 fibroblasts suppressed transcription of the PU.1-independent H-2L d MHC class I promoter.	SEN:10028502	10453013
BEL:20055696	p(MGI:Irf4) increases r(MGI:Il1b)	Furthermore, both IRF4 and ICSBP activated transcription of the IL-1beta promoter in both cell types.	SEN:10009328	10453013
BEL:20055704	p(MGI:Irf5) increases p(MGI:Il6)	However, on stimulation with R848 or CpG DNA, B cells from both young and old Irf5 -/- mice produced lower levels of IL-6 than the B cells from C57BL/6 mice.	SEN:10028510	20176957
BEL:20055706	p(MGI:Irf5) increases p(MGI:Irf4)	There was also a decrease in IRF-4 expression in Irf5 -/- B cells, seen both on RNA and protein levels (Fig. 4 A and B ).	SEN:10028512	20176957
BEL:20055712	p(MGI:Irf5) increases r(MGI:Prdm1)	Analysis of the expression of these factors by semiquantitative RT-PCR shows that purified B cells from both young and old Irf5 -/- mice exhibit significantly lower levels of Blimp-1 mRNA than B cells from the age-matched C57BL/6 mice (Fig. 4A ).	SEN:10028516	20176957
BEL:20055716	p(MGI:Irf7) increases r(MGI:Ifna1)	Indeed, pDC from IRF-7 KO mice are almost completely devoid of IFNalpha and IFNbeta induction in response to viral infection and stimulation by TLR7 and 9 ligands [39].	SEN:10028518	16474425
BEL:20055718	p(MGI:Irf7) increases r(MGI:Ifnb1)	Indeed, pDC from IRF-7 KO mice are almost completely devoid of IFNalpha and IFNbeta induction in response to viral infection and stimulation by TLR7 and 9 ligands [39].	SEN:10028518	16474425
BEL:20055720	p(MGI:Irf8) increases a(CHEBI:"cytochrome c")	FasL treatment dramatically increased the cytochrome C levels in both CMS4 and CMS4.Vector cells. In contrast, no constitutive or FasL-induced cytochrome C release was detected in CMS4.K79E cells (Fig 1A).	SEN:10028520	19155307
BEL:20055722	p(MGI:Irf8) decreases bp(GOBP:"T-helper 17 cell differentiation")	Taken together, these results indicate that IRF8 is induced during T-cell activation, and that TH17-cell differentiation is enhanced in cells deficient in IRF8.	SEN:10018270	21587231
BEL:20055724	p(MGI:Irf8) increases cat(p(MGI:Casp3))	Caspase 9 is activated by FasL in both CMS4 and CMS4.Vector cells but not in CMS4.K79E cells. Consistent with caspase 9 activation, caspase 3 activation and PARP cleavage are also inhibited in CMS4.K79E cells (Fig. 1B).	SEN:10028522	19155307
BEL:20055726	p(MGI:Irf8) increases cat(p(MGI:Casp9))	Caspase 9 is activated by FasL in both CMS4 and CMS4.Vector cells but not in CMS4.K79E cells. Consistent with caspase 9 activation, caspase 3 activation and PARP cleavage are also inhibited in CMS4.K79E cells (Fig. 1B).	SEN:10028522	19155307
BEL:20055730	p(MGI:Irf8) decreases p(MGI:Cdkn1a)	Small interfering RNA-induced repression of IRF8 in a GC-derived B cell line resulted in decreased expression of MDM2 at the protein level but increased expression of p53 and p21.	SEN:10009330	19648273
BEL:20055732	p(MGI:Irf8) decreases p(MGI:Cflar)	Furthermore, primary myeloid cells isolated from IRF8-null mice also exhibited increased FLIP protein level, suggesting that IRF8 might be a general repressor of FLIP.	SEN:10009332	19155307
BEL:20055734	p(MGI:Irf8) decreases p(MGI:Il17a)	In addition, IL-17-producing CD4+ T cells were significantly increased among lamina propria lymphocytes isolated from Irf8-/- mice as compared with WT littermate controls following in vitro activation under TH17 conditions or at the basal levels (Fig. 1c and Supplementary Fig. S2).	SEN:10028526	21587231
BEL:20055736	p(MGI:Irf8) increases p(MGI:Mdm2)	Small interfering RNA-induced repression of IRF8 in a GC-derived B cell line resulted in decreased expression of MDM2 at the protein level but increased expression of p53 and p21.	SEN:10009330	19648273
BEL:20055738	p(MGI:Irf8) decreases p(MGI:Trp53)	Small interfering RNA-induced repression of IRF8 in a GC-derived B cell line resulted in decreased expression of MDM2 at the protein level but increased expression of p53 and p21.	SEN:10009330	19648273
BEL:20055740	p(MGI:Irf8) decreases r(EGID:14980)	In contrast, over- expression of either IRF4 or ICSBP in both macrophages and NIH-3T3 fibroblasts suppressed transcription of the PU.1-independent H-2L d MHC class I promoter.	SEN:10028502	10453013
BEL:20055744	p(MGI:Irf8) increases r(MGI:Il1b)	Furthermore, both IRF4 and ICSBP activated transcription of the IL-1beta promoter in both cell types.	SEN:10009328	10453013
BEL:20055748	p(MGI:Irf8) decreases r(MGI:Pmaip1)	Additionally, transcripts of the p53 target Pmaip1 (Noxa) were significantly increased in IRF8-deficient GC B cells as well as in the IRF8 knockdown B cell line.	SEN:10028530	19648273
BEL:20055750	p(MGI:Irf8) increases r(MGI:Spi1)	Over-expression of ICSBP in these macrophages activated transcription of a PU.1/IRF-dependent promoter, whereas over-expression of IRF4 had no effect on this promoter.	SEN:10009336	10453013
BEL:20055752	p(MGI:Irf9) increases p(MGI:Ifna1)	as evidenced by the abolition of IFN induction in DC derived from IFNAR KO and IRF-9 KO mice [39, 45].	SEN:10027610	16474425
BEL:20055766	p(MGI:Irs1) increases bp(GOBP:"insulin receptor signaling pathway")	Insulin receptor substrates (IRS-1 and IRS-2) are essential for intracellular signaling by insulin and insulin-like growth factor-I (IGF-I), anabolic regulators of bone metabolism	SEN:10009340	12379806
BEL:20055768	p(MGI:Irs1) increases bp(GOBP:"insulin secretion")	These changes were paralleled by a lower number of exocytotic events in the KO beta-cells in response to the same secretagogues, indicating reduced insulin secretion	SEN:10009342	15161756
BEL:20055774	p(MGI:Irs1,pmod(P,S,1101)) directlyDecreases cat(p(MGI:Irs1))	S6K can phosphorylate IRS-1 on a different residue, Ser1101, thus reducing its function and leading to insulin resistance in vivo in skeletal muscle (Tremblay et al., 2007).	SEN:10028538	18794886
BEL:20055776	p(MGI:Irs1,pmod(P,S,302)) directlyDecreases cat(p(MGI:Irs1))	Harrington et al. (2004) showed in the same study that a downstream target of mTORC1, S6K1 was able to phosphorylate and inhibit IRS-1 in Ser302.	SEN:10022166	18794886
BEL:20055780	p(MGI:Irs1,pmod(P,Y)) directlyIncreases cat(p(MGI:Irs1))	Following ligand binding to the IL-10R, Jak1 and Tyk2, which are constitutively associated with IL-10R1 and IL-10R2, respectively (3, 14), are phosphorylated on tyrosine The phosphorylated IL-10R/Jak1/Tyk2 complex serves as a docking site for the transcription factors Stat-1 and Stat-3 Jak1, which is required for the biological activity of IL-10 (20), also tyrosine phosphorylates the insulin receptor substrate-1 (IRS-1)	SEN:10021788	11591769
BEL:20055782	p(MGI:Irs1) increases r(MGI:Atp2a2)	Semiquantitative RT-PCR showed a dramatically reduced islet expression of sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA)-2b and -3 in the mutants. These data provide evidence that IRS-1 modulation of insulin secretion is associated with Ca(2+) signaling and expression of SERCA-2b and -3 genes in pancreatic islets and provides a direct link between insulin resistance and defective insulin secretion.	SEN:10028542	15161756
BEL:20055784	p(MGI:Irs1) increases r(MGI:Atp2a3)	Semiquantitative RT-PCR showed a dramatically reduced islet expression of sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA)-2b and -3 in the mutants. These data provide evidence that IRS-1 modulation of insulin secretion is associated with Ca(2+) signaling and expression of SERCA-2b and -3 genes in pancreatic islets and provides a direct link between insulin resistance and defective insulin secretion.	SEN:10028542	15161756
BEL:20055786	p(MGI:Irs2) increases bp(GOBP:"insulin receptor signaling pathway")	Insulin receptor substrates (IRS-1 and IRS-2) are essential for intracellular signaling by insulin and insulin-like growth factor-I (IGF-I), anabolic regulators of bone metabolism	SEN:10009340	12379806
BEL:20055788	p(MGI:Irs2) decreases bp(GOBP:"osteoclast differentiation")	they showed increased receptor activator of nuclear factor kappaB ligand (RANKL) expression and osteoclastogenesis in the coculture with bone marrow cells	SEN:10009348	12379806
BEL:20055796	p(MGI:Irs2) decreases bp(GOBP:"apoptotic process")	However, increased IRS-2 expression augmented glucose/IGF-1 induced beta-cell growth mitogenesis and decreased apoptosis due to glucose-deprivation	SEN:10009114	12850284
BEL:20055802	p(MGI:Irs2) decreases p(MGI:Tnfsf11)	they showed increased receptor activator of nuclear factor kappaB ligand (RANKL) expression and osteoclastogenesis in the coculture with bone marrow cells	SEN:10009348	12379806
BEL:20055812	p(MGI:Irs3) decreases bp(GOBP:mitosis)	In contrast, increased IRS-3 expression significantly inhibited mitogenesis and increased apoptosis	SEN:10009352	12850284
BEL:20055814	p(MGI:Irs3) increases bp(GOBP:"apoptotic process")	In contrast, increased IRS-3 expression significantly inhibited mitogenesis and increased apoptosis	SEN:10009352	12850284
BEL:20055824	p(MGI:Irs3) increases r(MGI:Egr1)	IRS-3 expression in WT cells also caused an increase in IGF-1-induced mitogen-activated protein kinase phosphorylation and egr-1 expression	SEN:10009112	11113178
BEL:20055826	p(MGI:Irs3) decreases r(MGI:Irs2)	Following transduction of IRS-3 or IRS-4, the cells showed a significant decrease in IRS-2 mRNA and protein levels without any change in the IRS-1 protein level.	SEN:10028550	11113178
BEL:20055836	p(MGI:Irs4) decreases r(MGI:Irs2)	Following transduction of IRS-3 or IRS-4, the cells showed a significant decrease in IRS-2 mRNA and protein levels without any change in the IRS-1 protein level.	SEN:10028550	11113178
BEL:20055842	p(MGI:Itga11) increases r(MGI:Igf2)	Gene expression profiling indicated that IGF2 mRNA expression level was >200 times lower in A549+KO compared with A549+WT tumors.	SEN:10028552	17600088
BEL:20055848	p(MGI:Itga5) increases bp(GOBP:"cell migration")	We found that {ITGA5 sh-RNA} transfected LLC cells showed decreased expression of the alpha5 gene, which was associated with decreased adhesion to fibronectin and reduced cell migration, proliferation and colony formation when compared to control cells and cells stably transfected with alpha2 integrin subunit in vitro.	SEN:10028556	20081050
BEL:20055850	p(MGI:Itga5) increases bp(GOBP:"cell proliferation")	Overexpression of alpha5 in preadipocytes results in enhanced proliferation and attenuated differentiation.	SEN:10009360	16154099
BEL:20055852	p(MGI:Itga5) increases bp(GOBP:"cell proliferation")	We found that {ITGA5 sh-RNA} transfected LLC cells showed decreased expression of the alpha5 gene, which was associated with decreased adhesion to fibronectin and reduced cell migration, proliferation and colony formation when compared to control cells and cells stably transfected with alpha2 integrin subunit in vitro.	SEN:10028556	20081050
BEL:20055854	p(MGI:Itga5) decreases bp(GOBP:"fat cell differentiation")	Overexpression of alpha5 in preadipocytes results in enhanced proliferation and attenuated differentiation.	SEN:10009360	16154099
BEL:20055858	p(MGI:Itga6) increases bp(GOBP:"fat cell differentiation")	These findings demonstrate a role for integrin alpha6 in connecting morphogenesis with signaling processes leading to terminal differentiation.	SEN:10009362	16154099
BEL:20055862	p(MGI:Itga6) increases bp(GOBP:"neutrophil extravasation")	whereas regulation of the expression of alpha6 integrins and NE occur via different adhesive mechanisms, these molecules might act in a cooperative manner in mediating neutrophil migration through venular walls, in particular the perivascular basement membrane.	SEN:10018952	15840647
BEL:20055870	p(MGI:Itgav) increases bp(GOBP:"mast cell activation")	We also present data showing that beta(6)(-/-) mice are seriously compromised in their ability to mount a mucosal mast cell response after infection, and there is a significant reduction in the expression and systemic release of the granule chymase, mouse mast cell protease-1.	SEN:10009370	12213704
BEL:20055874	p(MGI:Itgav) increases r(MGI:Mcpt1)	We also present data showing that beta(6)(-/-) mice are seriously compromised in their ability to mount a mucosal mast cell response after infection, and there is a significant reduction in the expression and systemic release of the granule chymase, mouse mast cell protease-1.	SEN:10009370	12213704
BEL:20055876	p(MGI:Itgav) increases sec(p(MGI:Mcpt1))	We also present data showing that beta(6)(-/-) mice are seriously compromised in their ability to mount a mucosal mast cell response after infection, and there is a significant reduction in the expression and systemic release of the granule chymase, mouse mast cell protease-1.	SEN:10009370	12213704
BEL:20055882	p(MGI:Itgb1) decreases p(MGI:Tcf4)	The expression of Tcf-4, a transcription factor known to be required for intestinal epithelial stem cell proliferation, was increased and mislocalized in the intestinal epithelia of the beta1 integrin-deleted mice	SEN:10009372	17088430
BEL:20055884	p(MGI:Itgb1,pmod(P,Y)) directlyIncreases cat(p(MGI:Itgb1))	We analyzed mice in which we mutated the tyrosines of the beta1 tail and the membrane-proximal aspartic acid required for the salt bridge. Tyrosine-to-alanine substitutions abolished beta1 integrin functions and led to a beta1 integrin-null phenotype in vivo.	SEN:10028564	16954348
BEL:20055886	p(MGI:Itgb1,pmod(P,Y)) increases kin(p(MGI:Egfr))	b1-integrin phosphorylation by Src results in EGF-R activation (Miranti and Brugge, 2002), and b1-integrin expression is required for the initiation of mouse mammary tumors expressing the polyoma virus middle T antigen (White et al., 2004).	SEN:10022186	18268536
BEL:20055890	p(MGI:Itgb1) increases tscript(p(MGI:Foxa2))	beta1 integrins were found to drive the expression of Hedgehogs in intestinal epithelial cells in an HNF-3beta (Foxa2)-dependent fashion.	SEN:10028568	17088430
BEL:20055898	p(MGI:Itgb2) decreases r(MGI:Il1b)	As shown in Fig. 4A and B, at baseline (before Listeria inoculation), CD18-ko mice expressed significantly higher levels of IL-1B mRNA in both livers and spleens than did WT mice.	SEN:10028572	14500519
BEL:20055908	p(MGI:Itgb4) increases bp(GOBP:"cell proliferation")	In vivo, b4-integrin amplifies proproliferative signals in basal epidermal keratinocytes (Nikolopoulos et al., 2005), where STAT3 is expressed and can be activated by EGF/EGF-R (Nishio et al., 2001; Chan et al., 2004; Li et al., 2007)	SEN:10021660	18268536
BEL:20055910	p(MGI:Itgb4) increases bp(GOBP:"cell proliferation")	Transgenic mice (both newborn and adult) expressing the signalingdefective b4-integrin mutant showed a twofold decrease in the epidermal proliferative index, confirming that b4-integrin actually contributes to proliferation (Nikolopoulos et al., 2005).	SEN:10028578	18268536
BEL:20055922	p(MGI:Itgb4) increases p(MGI:Erbb2,pmod(P,Y,877))	b4-integrin mediates the phosphorylation of ErbB2 on Tyr877 by a Src-family kinase....(Ishizawar and Parsons, 2004).	SEN:10028582	18268536
BEL:20055924	p(MGI:Itgb4) increases tloc(p(MGI:Mapk1),GOCCID:0005737,GOCCID:0005634)	In parallel to JNK, two other MAPKs, ERK1 and ERK2, were also found to be targeted to the nucleus in a b4-integrindependent manner in keratinocytes (Nikolopoulos et al., 2005).	SEN:10028586	18268536
BEL:20055926	p(MGI:Itgb4) increases tloc(p(MGI:Mapk3),GOCCID:0005737,GOCCID:0005634)	In parallel to JNK, two other MAPKs, ERK1 and ERK2, were also found to be targeted to the nucleus in a b4-integrindependent manner in keratinocytes (Nikolopoulos et al., 2005).	SEN:10028586	18268536
BEL:20055928	p(MGI:Itgb6) decreases path(MESHD:Disease)	Here we report that Itgb6-null mice develop age-related emphysema that is completely abrogated either by transgenic expression of versions of the beta6 integrin subunit that support TGF-beta activation, or by the loss of Mmp12. Furthermore, we show that the effects of Itgb6 deletion are overcome by simultaneous transgenic expression of active TGF-beta1.	SEN:10028588	12634787
BEL:20055932	p(MGI:Itgb6) directlyIncreases p(MGI:Tgfb1)	We have shown previously that the epithelial-restricted integrin alpha(v)beta6 has another critical function; that is, it binds and activates latent transforming growth factor-beta (TGF-beta).	SEN:10020350	12634787
BEL:20055940	p(MGI:Itgb6) decreases r(MGI:Mmp12)	Through a global analysis of pulmonary gene expression in the lungs of mice lacking this integrin (Itgb6 null mice) we have identified a marked induction of macrophage metalloelastase (Mmp12)--a metalloproteinase that preferentially degrades elastin and has been implicated in the chronic lung disease emphysema.	SEN:10028592	12634787
BEL:20055944	p(MGI:Itgb7) increases p(MGI:Vegfc)	c-Maf-driven expression of integrin ß7 enhances myeloma adhesion to the bone marrow stroma and increases the production of VEGF, which enhances cellular proliferation and adhesion (13).	SEN:10028594	16424013
BEL:20055950	p(MGI:Itih4) decreases bp(GOBP:"apoptotic process")	Inter-alpha-trypsin inhibitor-4 (Itih-4) is a liver-restricted member of the serine protease inhibitor family with diverse functions as an anti-apoptotic and matrix stabilizing molecule that are important throughout development.	SEN:10009376	11803570
BEL:20055952	p(MGI:Itpkb) increases p(MGI:Bcl2l11)	Flow cytometry confirmed that follicular B cells present in Itpkb ?/? and Itpkb ?/? E?-2–22 BCL-2 mice expressed a higher level of Bim protein.	SEN:10028596	17709751
BEL:20055954	p(MGI:Itpkb) decreases p(MGI:Mapk1,pmod(P))	Erk1 and Erk2 were found to be much less phosphorylated in Itpkb ?/? E?-2?22-BCL-2 B cells than in control B cells after BCR activation (Fig. 3 b).	SEN:10028598	17709751
BEL:20055956	p(MGI:Itpkb) decreases p(MGI:Mapk3,pmod(P))	Erk1 and Erk2 were found to be much less phosphorylated in Itpkb ?/? E?-2?22-BCL-2 B cells than in control B cells after BCR activation (Fig. 3 b).	SEN:10028598	17709751
BEL:20055958	p(MGI:Itpkb) increases r(MGI:Bcl2l11)	Quantitative real-time RT-PCR analysis revealed a slight, but very significant, increase in Bim messenger RNA level in splenic resting follicular B cells persisting in Itpkb ?/? mice.	SEN:10028600	17709751
BEL:20055968	p(MGI:Jak1,pmod(P)) directlyIncreases kin(p(MGI:Jak1))	Jak1 phosphorylation was reduced in wildtype indivduals after Il13 treatement, implying that SHP-2 is responsible for this effect.	SEN:10024772	12204103
BEL:20055972	p(MGI:Jak3) increases bp(GOBP:"T cell activation")	Moreover, lymphocyte proliferation and contact hypersensitivity experiments showed that DC-mediated T lymphocyte activation is reduced in the absence of Jak3	SEN:10009380	19759904
BEL:20055984	p(MGI:Jdp2) decreases bp(GOBP:"cell cycle")	Endogenous expression of JDP2 was induced in both C2C12 myoblast and rhabdomyosarcoma (RD) cells programmed to differentiate. Ectopic expression of JDP2 in C2C12 myoblast cells inhibited cell cycle progression and induced spontaneous muscle cell differentiation.	SEN:10028610	12171923
BEL:20055986	p(MGI:Jdp2) increases bp(GOBP:"myoblast differentiation")	Endogenous expression of JDP2 was induced in both C2C12 myoblast and rhabdomyosarcoma (RD) cells programmed to differentiate. Ectopic expression of JDP2 in C2C12 myoblast cells inhibited cell cycle progression and induced spontaneous muscle cell differentiation.	SEN:10028610	12171923
BEL:20055988	p(MGI:Jdp2) increases bp(GOBP:"myoblast differentiation")	Likewise, constitutive expression of JDP2 in RD cells reduced their tumorigenic characteristics and restored their ability to differentiate into myotubes.	SEN:10009384	12171923
BEL:20055992	p(MGI:Jdp2) increases p(MGI:Fosl2)	The mechanism of tumor suppressor action of JDP2 can be partially explained by the generation of inhibitory AP-1 complexes via the increase of JunB, JunD, and Fra2 expression and decrease of c-Jun expression.	SEN:10028612	14627710
BEL:20055994	p(MGI:Jdp2) increases p(MGI:Junb)	The mechanism of tumor suppressor action of JDP2 can be partially explained by the generation of inhibitory AP-1 complexes via the increase of JunB, JunD, and Fra2 expression and decrease of c-Jun expression.	SEN:10028612	14627710
BEL:20055996	p(MGI:Jdp2) increases p(MGI:Jund)	The mechanism of tumor suppressor action of JDP2 can be partially explained by the generation of inhibitory AP-1 complexes via the increase of JunB, JunD, and Fra2 expression and decrease of c-Jun expression.	SEN:10028612	14627710
BEL:20056002	p(MGI:Jdp2) increases r(MGI:Acp5)	Transient transfection experiments revealed that overexpression of JDP2 leads to activation of both tartrate-resistant acid phosphatase (TRAP) and cathepsin K gene promoters in RAW264.7 cells.	SEN:10028618	12707301
BEL:20056010	p(MGI:Jdp2) increases r(MGI:Ctsk)	Transient transfection experiments revealed that overexpression of JDP2 leads to activation of both tartrate-resistant acid phosphatase (TRAP) and cathepsin K gene promoters in RAW264.7 cells.	SEN:10028618	12707301
BEL:20056014	p(MGI:Jdp2) decreases r(MGI:Gja1)	ression analysis showed down-regulation of Cx40 and Cx43, but not Cx45 message in JDP2-transgenics (Fig. 4A). Thus we	SEN:10028622	16631626
BEL:20056016	p(MGI:Jdp2) decreases r(MGI:Gja5)	ression analysis showed down-regulation of Cx40 and Cx43, but not Cx45 message in JDP2-transgenics (Fig. 4A). Thus we	SEN:10028622	16631626
BEL:20056018	p(MGI:Jdp2) decreases r(MGI:Jun)	The mechanism of tumor suppressor action of JDP2 can be partially explained by the generation of inhibitory AP-1 complexes via the increase of JunB, JunD, and Fra2 expression and decrease of c-Jun expression.	SEN:10028612	14627710
BEL:20056020	p(MGI:Jdp2) decreases r(MGI:Myl7)	. In contrast, in the atria, the mRNA of the myosin light chain isoform, MLC2a, was markedly down-regulated (Fig. 4A).	SEN:10028624	16631626
BEL:20056052	p(MGI:Jun) increases bp(GOBP:"cell proliferation")	Importantly, over-expression of c-Jun rescued the defects in proliferation and premature senescence observed in mkk7-/- MEFs (Fig. 7b-d).	SEN:10028646	15039780
BEL:20056054	p(MGI:Jun) increases bp(GOBP:"cell proliferation")	Decreased expression of c-Jun in both the wildtype and Jnk2-/- cells diminished the accumulation rates of these cells.	SEN:10028648	17074809
BEL:20056058	p(MGI:Jun) decreases bp(GOBP:"apoptotic process")	As depicted by our data, c-jun–/– cells exhibited a large degree of apoptosis after treatment with TG, while c-Jun Re cells demonstrated relative resistance to TG-induced apoptosis (Fig. 2A and 2B).	SEN:10028634	18641051
BEL:20056070	p(MGI:Jun) decreases cat(p(MGI:Casp12))	n contrast, caspase-12 activation was significantly attenuated in wild-type fibroblast cells and abrogated in c-Jun Re cells in response to TG treatment (Fig. 1B and 1C).	SEN:10028636	18641051
BEL:20056072	p(MGI:Jun) decreases cat(p(MGI:Casp12))	TG treatment led to the activation of caspase-12, as indicated by the cleavage of procaspase-12, in c-jun–/– cells in a time-dependent manner (Fig. 1B and 1C).	SEN:10028638	18641051
BEL:20056076	p(MGI:Jund) increases path(MESHD:Fibrosis)	Moreover, JunD(-/-) mice were protected from bleomycin-induced fibrosis with reduced dermal thickening, decreased myofibroblast counts and lower collagen content of lesional skin.	SEN:10009396	21515915
BEL:20056088	p(MGI:Jun) decreases p(MGI:Ddit3)	Interestingly, c-Jun Re cells had dramatically lower Grp78 and Gadd153 expression in response to TG treatment compared to c-jun–/– cells (Fig. 2C).	SEN:10028658	18641051
BEL:20056090	p(MGI:Jun) decreases p(MGI:Hspa5)	Interestingly, c-Jun Re cells had dramatically lower Grp78 and Gadd153 expression in response to TG treatment compared to c-jun–/– cells (Fig. 2C).	SEN:10028658	18641051
BEL:20056092	p(MGI:Jun) increases p(MGI:Jun,pmod(P,S,73))	Interestingly, overexpression of exogenous c-Jun in the c-jun?/? cells caused both an autophosphorylation of c-Jun in the target cells (Fig. 7A) and induced up-regulation of Adapt78 expression (Fig. 7B).	SEN:10028660	18641051
BEL:20056096	p(MGI:Jun) increases p(MGI:Rcan1)	Interestingly, overexpression of exogenous c-Jun in the c-jun?/? cells caused both an autophosphorylation of c-Jun in the target cells (Fig. 7A) and induced up-regulation of Adapt78 expression (Fig. 7B).	SEN:10028660	18641051
BEL:20056098	p(MGI:Jun) increases p(MGI:Rcan1)	Intriguingly, Adapt78 expression was up-regulated in response to TG treatment in c-Jun Re cells but not in c-jun–/– cells (Fig. 2C).	SEN:10028662	18641051
BEL:20056104	p(MGI:Jun,pmod(P,S,79)) directlyIncreases complex(p(MGI:Jun),p(MGI:Ep300))	Further, phosphorylation of JunB at Ser-79 was found to be essential for its interaction with p300.	SEN:10028664	15308641
BEL:20056108	p(MGI:Jun,pmod(P)) directlyIncreases tscript(p(MGI:Jun))	PDGF or serum treatment both activate c-Jun N-terminal kinase (JNK), the mitogen-activated protein kinase responsible for phosphorylation and activation of c-Jun.	SEN:10021990	8940199
BEL:20056112	p(MGI:Jun) increases r(MGI:Hgf)	HGF expression was nearly completely absent at the transcript level (>99%) in c-Jun knockout fibroblasts (Figure 1a), thus showing an expression behavior in these cells comparable to GM-CSF (Figure 1b).	SEN:10028668	19020551
BEL:20056114	p(MGI:Jun) increases r(MGI:Myl7)	Whereas c-Jun resulted in a twofold activation of the MLC2a promoter, both ATF3 and JDP2 expression resulted in a marked suppression of the MLC2a-dependent luciferase activity (Fig. 4B).	SEN:10025264	16631626
BEL:20056116	p(MGI:Jup) decreases p(MGI:Myc)	plakoglobin-mediated suppression of the pro-proliferative proto-oncogene c-Myc, which is critical for growth inhibition in these cells (Arnold and Watt, 2001; Waikel et al., 2001; Kolly et al., 2005; Figure 2).	SEN:10028670	18268536
BEL:20056118	p(MGI:Jup,pmod(P,Y)) increases complex(p(MGI:Jup),p(MGI:Pik3r1))	In mouse keratinocytes, Src kinase-mediated phosphorylation was found to generate a docking site for PI3K (p85) on plakoglobin in an EGF-R-dependent manner, to a minor extent on p120cnt, but not on b-catenin, which apparently lacks a PI3K (p85)-docking motive (Calautti et al., 2005).	SEN:10026244	18268536
BEL:20056132	p(MGI:Kcne1) decreases path(MESHD:"Atrial Fibrillation")	On the other hand, mice lacking KCNE1 have susceptibility to spontaneous atrial fibrillation, but do not show alterations in SAN pacemaker activity (478).	SEN:10028674	18626064
BEL:20056140	p(MGI:Kcnip2) decreases path(MESHD:Tachycardia)	Ventricular cells isolated from mice lacking KChiP2 have no Ito and display prolonged action potential duration. Episodes of ventricular tachyarrhythmias are recorded in KChiP2 knockout mice (260).	SEN:10028678	18626064
BEL:20056150	p(MGI:Kctd11) decreases bp(GOBP:"cell proliferation")	Conversely, REN functional knock-down impairs Hedgehog antagonism and differentiation and sustains the proliferation of GCPs.	SEN:10009402	16148242
BEL:20056154	p(MGI:Kctd11) increases bp(GOBP:"apoptotic process")	Finally, REN enhances caspase-3 activation and terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling apoptotic GCP numbers;	SEN:10009404	16148242
BEL:20056156	p(MGI:Kctd11) increases cat(p(MGI:Casp3))	Finally, REN enhances caspase-3 activation and terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling apoptotic GCP numbers;	SEN:10009404	16148242
BEL:20056160	p(MGI:Kctd11) decreases r(MGI:Gli2)	REN also impairs both Gli2-dependent gene transcription and Shh-enhanced expression of the target Gli1 mRNA, thus antagonizing the Shh-induced effects on the proliferation and differentiation of cultured GCPs.	SEN:10009406	16148242
BEL:20056162	p(MGI:Kdr) decreases bp(GOBP:"apoptotic process")	the APN KO lung showed enhanced endothelial dysfunction, reflected as an increase in endothelial apoptosis, which resulted from a decrease in VEGFR-2 and PECAM-1 expression	SEN:10024928	21239691
BEL:20056164	p(MGI:Keap1) decreases a(CHEBI:glutathione)	Keap1?2-3/?2-3;CctCre+ mice had significantly higher glutathione levels compared to Keap1flox/flox mice under normal conditions (P < 0.05) (Figure 5C). After CS exposure both Keap1flox/flox mice and Keap1?2-3/?2-3;CctCre+ mice had a significant decrease in GSH levels of 61% and 67% respectively.	SEN:10028684	19520915
BEL:20056174	p(MGI:Keap1) decreases p(MGI:Nfe2)	Among the enriched gene sets (Excel S6), the Nrf2/Keap1 transcription factors were significantly up-regulated in Keap1-/- esophagi (Nfe2, Nrf2, Srebp1), as well as Nrf2-relevant metabolism GO gene sets (GO_666, GO_1221, GO_1333, GO_1374, GO_1408, GO_1418) and canonical pathway gene sets (CP_29, CP_67, CP_68, CP_71, CP_429, CP_530, CP_625, CP_626).	SEN:10028690	22567161
BEL:20056176	p(MGI:Keap1) decreases p(MGI:Nfe2l2)	Among the enriched gene sets (Excel S6), the Nrf2/Keap1 transcription factors were significantly up-regulated in Keap1-/- esophagi (Nfe2, Nrf2, Srebp1), as well as Nrf2-relevant metabolism GO gene sets (GO_666, GO_1221, GO_1333, GO_1374, GO_1408, GO_1418) and canonical pathway gene sets (CP_29, CP_67, CP_68, CP_71, CP_429, CP_530, CP_625, CP_626).	SEN:10028690	22567161
BEL:20056180	p(MGI:Keap1) decreases p(MGI:Ppard)	Real-time PCR showed that Ppard was up-regulated and Pten down-regulated in Keap1?/? esophagus, while keratinization-associated genes (Calm4 and Sbsn) were up-regulated	SEN:10028692	22567161
BEL:20056182	p(MGI:Keap1) increases p(MGI:Pten)	Real-time PCR showed that Ppard was up-regulated and Pten down-regulated in Keap1?/? esophagus, while keratinization-associated genes (Calm4 and Sbsn) were up-regulated	SEN:10028692	22567161
BEL:20056184	p(MGI:Keap1) increases p(MGI:Sbsn)	Real-time PCR showed that Ppard was up-regulated and Pten down-regulated in Keap1?/? esophagus, while keratinization-associated genes (Calm4 and Sbsn) were up-regulated	SEN:10028692	22567161
BEL:20056186	p(MGI:Keap1) decreases p(MGI:Srebf1)	Among the enriched gene sets (Excel S6), the Nrf2/Keap1 transcription factors were significantly up-regulated in Keap1-/- esophagi (Nfe2, Nrf2, Srebp1), as well as Nrf2-relevant metabolism GO gene sets (GO_666, GO_1221, GO_1333, GO_1374, GO_1408, GO_1418) and canonical pathway gene sets (CP_29, CP_67, CP_68, CP_71, CP_429, CP_530, CP_625, CP_626).	SEN:10028690	22567161
BEL:20056188	p(MGI:Keap1) decreases r(EGID:110309)	In the oesophagus of Keap1-/- mice, the expression of keratin 6 is greatly increased in an NRF2-dependent manner (44).	SEN:10028694	19608619
BEL:20056190	p(MGI:Keap1) decreases r(MGI:Gclm)	Both NQO1 and GCLm were significantly up-regulated compared to control cells transfected with a Page 21 of 52 nontargeting siRNA (SS siRNA), 3.8 and 1.75 fold increase respectively (P < 0.05)	SEN:10028696	19520915
BEL:20056192	p(MGI:Keap1) decreases r(MGI:Gclm)	Expression levels of Nqo1 and Gclm mRNA were significantly up-regulated in the lungs of Keap1?2-3/?2-3;CctCre+ mice compared to Keap1flox/flox mice,	SEN:10028698	19520915
BEL:20056194	p(MGI:Keap1) decreases r(MGI:Nqo1)	Both NQO1 and GCLm were significantly up-regulated compared to control cells transfected with a Page 21 of 52 nontargeting siRNA (SS siRNA), 3.8 and 1.75 fold increase respectively (P < 0.05)	SEN:10028696	19520915
BEL:20056196	p(MGI:Keap1) decreases r(MGI:Nqo1)	Expression levels of Nqo1 and Gclm mRNA were significantly up-regulated in the lungs of Keap1?2-3/?2-3;CctCre+ mice compared to Keap1flox/flox mice,	SEN:10028698	19520915
BEL:20056198	p(MGI:Keap1) decreases tscript(p(MGI:Nfe2l2))	For example, hepatocyte-specific disruption of Keap1 leads to increased expression of Nrf2-regulated genes in the liver	SEN:10028700	19520915
BEL:20056200	p(MGI:Keap1) decreases tscript(p(MGI:Nfe2l2))	role of Keap1 has been ascertained by investigations of Keap1?/? mice in which constitutive transactivation of Nrf2 and overproduction of its target genes lead to esophagus and forestomach hyperkeratosis (Wakabayashi et al., 2003).	SEN:10028702	19646463
BEL:20056202	p(MGI:Khdrbs1) increases bp(GOBP:"fat cell differentiation")	Our findings identify endogenous Sam68 as a positive regulator of adipocyte differentiation and a negative regulator of osteoblast differentiation, which is consistent with Sam68 being a modulator of bone marrow mesenchymal cell differentiation, and hence bone metabolism, in aged mice.	SEN:10009412	16362077
BEL:20056204	p(MGI:Khdrbs1) decreases bp(GOBP:"osteoblast differentiation")	Our findings identify endogenous Sam68 as a positive regulator of adipocyte differentiation and a negative regulator of osteoblast differentiation, which is consistent with Sam68 being a modulator of bone marrow mesenchymal cell differentiation, and hence bone metabolism, in aged mice.	SEN:10009412	16362077
BEL:20056210	p(MGI:Khdrbs1) decreases r(EGID:12096)	Moreover, the knockdown of Sam68 using short hairpin RNA in the embryonic mesenchymal multipotential progenitor C3H10T1/2 cells resulted in more pronounced expression of the mature osteoblast marker osteocalcin when differentiation was induced with bone morphogenetic protein-2.	SEN:10025494	16362077
BEL:20056212	p(MGI:Khdrbs1) decreases r(MGI:Bglap2)	Moreover, the knockdown of Sam68 using short hairpin RNA in the embryonic mesenchymal multipotential progenitor C3H10T1/2 cells resulted in more pronounced expression of the mature osteoblast marker osteocalcin when differentiation was induced with bone morphogenetic protein-2.	SEN:10025494	16362077
BEL:20056246	p(MGI:Klf4) increases bp(GOBP:"fat cell differentiation")	Knockdown of KLF4 inhibits adipogenesis and downregulates C/EBPbeta levels. KLF4 binds directly to the C/EBPbeta (Cebpb) promoter as shown by chromatin immunoprecipitation and gel shift assays and, together with Krox20, cooperatively transactivates a C/EBPbeta reporter.	SEN:10009426	18396140
BEL:20056274	p(MGI:Klk1b4) increases r(MGI:Chn1)	alpha chimaerin which has 91% homology to human alpha2 chimaerin, was also up-regulated following exposure to BDNF figure shows NGF also induces	SEN:10025402	15447672
BEL:20056276	p(MGI:Klk1b4) increases r(MGI:Chn2)	An increase in the expression of beta chimaerin mRNA by the BDNF treatment was found during the observation period, Expression of beta chimaerin mRNA is induced transiently by NGF as well as BDNF	SEN:10025404	15447672
BEL:20056298	p(MGI:Kmt2d) decreases r(MGI:Abca5)	Two genes overexpressed in SP3 cells are those encoding DPT, dermatopontin (accession number NM_001937), and ABCA5	SEN:10028740	17178841
BEL:20056300	p(MGI:Kmt2d) decreases r(MGI:Dpt)	Two genes overexpressed in SP3 cells are those encoding DPT, dermatopontin (accession number NM_001937), and ABCA5	SEN:10028740	17178841
BEL:20056312	p(MGI:Kras,sub(G,12,D)) increases kin(p(MGI:Mapk8))	It is reported that KRasG12D-induced lung tumors do not routinely display elevated pERK1/2 but display stress-activated MAP kinase (SAPK/JNK) activation (Lee et al. 2002)... Interestingly, the major difference appears to be that expression of KRasG12D in the lung leads to more rapid and consistent progression to adenocarcinoma than that elicited by BRafVE.	SEN:10028748	17299132
BEL:20056328	p(MGI:Kras,sub(G,12,D)) increases p(MGI:Ptgs2)	Stable knockdown of mutant KRAS(D12) in murine C26 CRC cells by RNA interference lead to a dramatic reduction of COX-2 synthesis and prostaglandin E2 production.	SEN:10028746	15671526
BEL:20056338	p(MGI:Kras,sub(G,12,V)) increases a(CHEBI:"reactive oxygen species")	Constitutively active mutant K-ras(V12) in E10 cells led to a highly significant (P < 0.001) increased level of peroxides, and a corresponding increase in the amount of DNA strand-break damage, compared with the parental line E10 and the vector control	SEN:10028764	15284181
BEL:20056344	p(MGI:Kras,sub(G,12,V)) decreases p(MGI:Cdh1)	Expression of KrasG12V induced also a loss of epithelial markers (as assessed by E-cadherin staining, which was similar in Mapk14D/+ and Mapk14D/D alveoli; Fig. 6c) and an increase in SP-C+ cells (Fig. 6d).	SEN:10028766	17468755
BEL:20056348	p(MGI:Kras,sub(G,12,V)) increases p(MGI:Sftpc)	Expression of KrasG12V induced also a loss of epithelial markers (as assessed by E-cadherin staining, which was similar in Mapk14D/+ and Mapk14D/D alveoli; Fig. 6c) and an increase in SP-C+ cells (Fig. 6d).	SEN:10028766	17468755
BEL:20056358	p(MGI:Kremen1) decreases bp(GOBP:"Wnt receptor signaling pathway")	DKK1 antagonizes Wnt signalling during head formation in mice77. An additional DKK-receptor, Kremen, was shown to inhibit the Wnt signalling pathway by internalization of LRP78.	SEN:10026464	18432252
BEL:20056394	p(MGI:Lat2) decreases p(MGI:Lat)	However, challenge of Ntal -/- BMMCs with antigen results in increased LAT phosphorylation and LAT-dependent signalling events35,3	SEN:10028788	16470226
BEL:20056402	p(MGI:Lat) increases p(MGI:Plcg1)	FcepsilonRI-dependent phosphorylation of PLCg1 and PLCg2 is almost abolished and the calcium signal is reduced in Lat -/- BMMCs26.	SEN:10028794	16470226
BEL:20056406	p(MGI:Lat) increases p(MGI:Plcg2)	FcepsilonRI-dependent phosphorylation of PLCg1 and PLCg2 is almost abolished and the calcium signal is reduced in Lat -/- BMMCs26.	SEN:10028794	16470226
BEL:20056426	p(MGI:Ldlr) increases path(MESHD:Atherosclerosis)	We chose to study a murine model, in which the bone marrow of mice deficient in the CXCR-2 homologue mIL-8RH were used to repopulate irradiated atherosclerosis-susceptible LDLR 2 / 2 mice.	SEN:10028802	9435307
BEL:20056436	p(MGI:Ldlr) increases tscript(p(MGI:Smad2))	An approximately 2.5-fold increase of Smad2 phosphorylation at Ser 465/467 was also detected in LDLR expressing, LRP1-deficient SMCs (Figure 6B, C).	SEN:10028806	19742316
BEL:20056442	p(MGI:Lep) decreases path(MESHD:Obesity)	Leptin administration to lean and ob/ob mice activates a novel metabolic program that depletes adipose tissue.	SEN:10009440	10783168
BEL:20056446	p(MGI:Lep) increases cat(p(MGI:Cs))	Citrate synthase, localized exclusively to the mitochondrial matrix, catalyzes the conversion of acetyl-CoA to citrate, the initial step in the TCA cycle. The activity in inguinal adipose tissue from db/db mice was significantly lower than that from db/ mice (Fig. 5B). RSG dosedependently increased the activity, reaching a plateau at 3 and 10 mg/kg.	SEN:10016254	17456854
BEL:20056448	p(MGI:Lep) increases kin(p(MGI:Mapk14))	In both dietary and genetically (ob/ob) obese mice, adipose tissues displayed a marked decrease in p38MAPK activity compared with the same tissues from lean mice.	SEN:10009442	16443758
BEL:20056452	p(MGI:Lep) decreases r(MGI:Add1)	Further studies confirmed that leptin decreases the levels of SREBP-1/ADD1 RNA and transcriptionally active SREBP-1/ADD1 protein in white adipose tissue.(Figure7)	SEN:10028814	10783168
BEL:20056458	p(MGI:Lep) increases r(MGI:Col1a1)	Collagen I mRNA expression was increased 10-fold in db-db mice, 4-fold in db-m mice, and was unchanged in ob-ob mice.	SEN:10028816	15256362
BEL:20056460	p(MGI:Lep) decreases r(MGI:Ddit3)	We found that macrophages freshly harvested from ob/ob mice had elevated expression of Chop mRNA and showed a striking elevation of IICR compared with macrophages from WT mice (Fig. 5, b and c).	SEN:10028808	19752026
BEL:20056464	p(MGI:Lep) increases r(MGI:Nr1i2)	Our results indicated that leptin up-regulates hepatic pregnane X receptor mRNA expression after 2 days of leptin injection (2.1-fold), suggesting a regulatory role of pregnane X receptor in the transcriptional activation of cyp3A and possibly other P450 family members.	SEN:10028818	11551957
BEL:20056466	p(MGI:Lep) increases r(MGI:Spp1)	mRNA expressions of OPN, TNF-alpha, TGF-beta, and short-form leptin receptors (Ob-Ra) were significantly increased in db-db mice compared with db-m or ob-ob mice.	SEN:10028820	15256362
BEL:20056468	p(MGI:Lep) decreases r(MGI:Srebf1)	Further studies confirmed that leptin decreases the levels of SREBP-1/ADD1 RNA and transcriptionally active SREBP-1/ADD1 protein in white adipose tissue.(Figure7)	SEN:10028814	10783168
BEL:20056470	p(MGI:Lep) increases r(MGI:Tgfb1)	mRNA expressions of OPN, TNF-alpha, TGF-beta, and short-form leptin receptors (Ob-Ra) were significantly increased in db-db mice compared with db-m or ob-ob mice.	SEN:10028820	15256362
BEL:20056472	p(MGI:Lep) increases r(MGI:Tnf)	mRNA expressions of OPN, TNF-alpha, TGF-beta, and short-form leptin receptors (Ob-Ra) were significantly increased in db-db mice compared with db-m or ob-ob mice.	SEN:10028820	15256362
BEL:20056474	p(MGI:Lep) decreases tscript(p(MGI:Srebf1))	Further studies confirmed that leptin decreases the levels of SREBP-1/ADD1 RNA and transcriptionally active SREBP-1/ADD1 protein in white adipose tissue.(Figure7)	SEN:10028814	10783168
BEL:20056488	p(MGI:Lgals3) increases bp(GOBP:"epithelial to mesenchymal transition")	Primary lung alveolar epithelial cells (AEC) from galectin-3?/? mice show reduced epithelial to mesenchymal transition (EMT) in response to transforming growth factor (TGF)-?1 in vitro compared with wild-type (WT) AECs.	SEN:10028830	22095546
BEL:20056490	p(MGI:Lgals3) increases bp(GOBP:"inflammatory response")	In addition, the preputial gland from Nucling-deficient mice expressed a significant level of galectin-3 and exhibited a high incidence of inflammatory lesions, indicating that Nucling plays a crucial role in the homoeostasis of this gland by interacting with the galectin-3 molecule and regulating the expression level of galectin-3.	SEN:10009452	14961764
BEL:20056496	p(MGI:Lgals3) decreases bp(GOBP:"apoptotic process")	Nucling-deficient cells, in which galectin-3 expression is up-regulated, appeared to be resistant to some forms of pro-apoptotic stress as compared with wild-type cells.	SEN:10009456	14961764
BEL:20056500	p(MGI:Lgals3) increases path(MESHD:Fibrosis)	Galectin-3?/? mice show reduced lung fibrosis after intratracheal adenoviral transforming growth factor (TGF)-?1 compared with wild-type (WT) mice.	SEN:10028834	22095546
BEL:20056504	p(MGI:Lgals3) increases p(MGI:Acta2)	Immunofluorescence staining for ?-smooth muscle actin (?-SMA) (green) and collagen-1 (red) showing reduced ?-SMA and collagen-1 expression in galectin-3?/? fibroblasts after TGF-?1	SEN:10028838	22095546
BEL:20056508	p(MGI:Lgals3) decreases p(MGI:Ifng)	As shown in Figure 6A, IL-4 levels in BAL fluid from gal3-/- mice were significantly lower than those from gal3+/+ mice. In contrast, the opposite results were observed for IFN-g (Figure 6B).	SEN:10028842	15579447
BEL:20056510	p(MGI:Lgals3) decreases p(MGI:Ifng)	In addition, we obtained cells from the lungs and the spleen from the OVA-challenged mice and cultured them in the presence of OVA. We noted that cells from gal3-/- mice produced significantly higher amounts of IFN-g (a Th1 cytokine) and lower amounts of IL-4 (a Th2 cytokine), compared to gal3+/+ mice (data not shown). The results suggest that gal3-/- mice have lower Th2 but higher Th1 responses compared to gal3+/+ mice.	SEN:10028836	15579447
BEL:20056512	p(MGI:Lgals3) increases p(MGI:Il4)	As shown in Figure 6A, IL-4 levels in BAL fluid from gal3-/- mice were significantly lower than those from gal3+/+ mice. In contrast, the opposite results were observed for IFN-g (Figure 6B).	SEN:10028842	15579447
BEL:20056514	p(MGI:Lgals3) increases p(MGI:Il4)	In addition, we obtained cells from the lungs and the spleen from the OVA-challenged mice and cultured them in the presence of OVA. We noted that cells from gal3-/- mice produced significantly higher amounts of IFN-g (a Th1 cytokine) and lower amounts of IL-4 (a Th2 cytokine), compared to gal3+/+ mice (data not shown). The results suggest that gal3-/- mice have lower Th2 but higher Th1 responses compared to gal3+/+ mice.	SEN:10028836	15579447
BEL:20056516	p(MGI:Lgals3) increases p(MGI:Socs3)	As depicted in Figure 3(a), higher SOCS3 protein expression was detected in the lungs of the OVA group of mice. The pEGFP-Gal-3 and SS groups showed low constitutive expression of SOCS3.	SEN:10028844	21547260
BEL:20056522	p(MGI:Lgals8) increases bp(GOBP:"cell adhesion")	galectin-8 as a physiological modulator of cell adhesion when immobilized, it functions as a matrix protein equipotent to fibronectin in promoting cell adhesion by ligation and clustering of cell surface integrin receptors	SEN:10028848	11371555
BEL:20056524	p(MGI:Lgals8) decreases bp(GOBP:"cell adhesion")	when present in excess as a soluble ligand, galectin-8 forms a complex with integrins that negatively regulates cell adhesion	SEN:10028850	11371555
BEL:20056528	p(MGI:Lgals8) increases p(MGI:Ptk2,pmod(P,Y))	cell adhesion to immobilized galectin-8 is mediated by sugar-protein interactions with integrins galectin-8 triggers integrin-mediated signaling cascades including Tyr phosphoylation of focal adhesion kinase and paxillin	SEN:10028854	11371555
BEL:20056530	p(MGI:Lgals8) increases p(MGI:Pxn,pmod(P))	cell adhesion to immobilized galectin-8 is mediated by sugar-protein interactions with integrins galectin-8 triggers integrin-mediated signaling cascades including Tyr phosphoylation of focal adhesion kinase and paxillin	SEN:10028854	11371555
BEL:20056534	p(MGI:Lgals9) increases bp(GOBP:"apoptotic process")	According to our confocal image data, there were apoptotic bodies and necrotic-like cells present during galectin-9-induced cell death, suggesting the possible involvement of apoptotic and necrotic cell death. Similarly, galectin-2 can induce both necrosis and apoptosis23.	SEN:10028858	16286920
BEL:20056536	p(MGI:Lgals9) increases bp(GOBP:"necrotic cell death")	According to our confocal image data, there were apoptotic bodies and necrotic-like cells present during galectin-9-induced cell death, suggesting the possible involvement of apoptotic and necrotic cell death. Similarly, galectin-2 can induce both necrosis and apoptosis23.	SEN:10028858	16286920
BEL:20056538	p(MGI:Lgals9) decreases p(MGI:Ifng)	show that galectin-9 is the Tim-3 ligand. Galectin-9-induced intracellular calcium flux, aggregation and death of T(H)1 cells were Tim-3-dependent in vitro, and administration of galectin-9 in vivo resulted in selective loss of interferon-gamma-producing cells and suppression of T(H)1 autoimmunity.	SEN:10028856	16286920
BEL:20056542	p(MGI:Lif) increases bp(GOBP:"inflammatory response")	Several pro-inflammatory mediators up-regulate SAA transcription, including Il1, Il6, TNFalpha, and Lif.	SEN:10028334	11798191
BEL:20056548	p(MGI:Lif) increases bp(GOBP:"osteoclast differentiation")	Il6, leukemia inhibitory factor [LIF}, and oncostatin M [OSM] are Il6-type cytokines that stimulate osteoclast formation and function	SEN:10028344	12218157
BEL:20056556	p(MGI:Lif) increases p(MGI:Batf)	Immunoblots using antibodies to BATF detected an increase in BATF protein in response to LIF/IL-6 stimulation.	SEN:10028358	12444555
BEL:20056558	p(MGI:Lif) increases p(MGI:Foxp3)	Unlike IL6, LIF supported expression of Foxp3, the Treg lineage transcription factor, and LIF opposed IL6 by suppressing IL-6-induced IL-17A protein release.	SEN:10027058	19342884
BEL:20056562	p(MGI:Lif) increases p(MGI:Il6st,pmod(P))	tryosine phosphorylation of gp130 was observed in fibroblasts after stimulation with all the cytokines	SEN:10027898	11820727
BEL:20056570	p(MGI:Lif) increases r(MGI:Skap2)	interleukin-6 (IL-6) or leukemia inhibitory factor (LIF)-induced differentiation of the myeloid cell line M1 was associated with a rapid increase in the level of mRNA encoding the signaling adaptor protein, SKAP55R	SEN:10028390	11753615
BEL:20056572	p(MGI:Lif) increases r(MGI:Socs1)	The expression of SSI-1, SSI-2, and SSI-3 mRNAs was significantly augmented in TG hearts after LIF stimulation	SEN:10009468	11023666
BEL:20056574	p(MGI:Lif) increases r(MGI:Socs2)	The expression of SSI-1, SSI-2, and SSI-3 mRNAs was significantly augmented in TG hearts after LIF stimulation	SEN:10009468	11023666
BEL:20056578	p(MGI:Lif) increases r(MGI:Socs3)	The expression of SSI-1, SSI-2, and SSI-3 mRNAs was significantly augmented in TG hearts after LIF stimulation	SEN:10009468	11023666
BEL:20056580	p(MGI:Lifr) increases p(MGI:Batf)	Immunoblots using antibodies to BATF detected an increase in BATF protein in response to LIF/IL-6 stimulation.	SEN:10028358	12444555
BEL:20056586	p(MGI:Lif) increases tscript(p(MGI:Stat3))	Stat3 controls cell death and tissue remodeling in the mouse mammary gland during involution, which is partially induced by IL6 and LIF.	SEN:10028426	15292206
BEL:20056588	p(MGI:Lig3) decreases bp(GOBP:"apoptotic process")	The death of mutants such as Xrcc1/, LigIII/ and Polb/ was preceded by elevated levels of apoptosis (Gu et al, 1994; Tebbs et al, 1999; Sugo et al, 2000; Puebla-Osorio et al, 2006).	SEN:10028866	18285820
BEL:20056598	p(MGI:Lipe) increases p(MGI:Pparg)	White adipose tissue of HSL null mice was characterized by reduced mass and reduced protein expression of PPARgamma, a key transcription factor in adipogenesis, and stearoyl-CoA desaturase 1, the expression of which is known to be positively correlated to the differentiation state of the adipocyte.	SEN:10009472	18335062
BEL:20056600	p(MGI:Lipe) increases p(MGI:Scd1)	White adipose tissue of HSL null mice was characterized by reduced mass and reduced protein expression of PPARgamma, a key transcription factor in adipogenesis, and stearoyl-CoA desaturase 1, the expression of which is known to be positively correlated to the differentiation state of the adipocyte.	SEN:10009472	18335062
BEL:20056602	p(MGI:Lipe) decreases p(MGI:Ucp1)	The protein expression of uncoupling protein-1 (UCP-1), the highly specific marker of brown adipocytes, was increased 7-fold in white adipose tissue of HSL null mice compared to wildtype littermates.	SEN:10028872	18335062
BEL:20056604	p(MGI:Lipe) decreases r(MGI:Cpt1b)	The mRNA expression of pRb and RIP140 was decreased in isolated white adipocytes, while the expression of UCP-1 and CPT1 was increased in HSL null mice compared to wildtype littermates.	SEN:10009474	18335062
BEL:20056606	p(MGI:Lipe) increases r(MGI:Nrip1)	The mRNA expression of pRb and RIP140 was decreased in isolated white adipocytes, while the expression of UCP-1 and CPT1 was increased in HSL null mice compared to wildtype littermates.	SEN:10009474	18335062
BEL:20056608	p(MGI:Lipe) increases r(MGI:Rb1)	The mRNA expression of pRb and RIP140 was decreased in isolated white adipocytes, while the expression of UCP-1 and CPT1 was increased in HSL null mice compared to wildtype littermates.	SEN:10009474	18335062
BEL:20056610	p(MGI:Lipe) decreases r(MGI:Ucp1)	The mRNA expression of pRb and RIP140 was decreased in isolated white adipocytes, while the expression of UCP-1 and CPT1 was increased in HSL null mice compared to wildtype littermates.	SEN:10009474	18335062
BEL:20056612	p(MGI:Lipg) increases path(MESHD:Atherosclerosis)	LPL and endothelial lipase (EL) are associated with macrophages in human atherosclerotic lesions, and overexpression of LPL in mouse macrophages is associated with a greater extent of atherosclerosis	SEN:10009476	17093291
BEL:20056616	p(MGI:Lmcd1) decreases tscript(p(MGI:Gata6))	Electrophoretic mobility shift and chromatin immunoprecipitation assays show that LMCD1/dyxin represses GATA6 function by inhibiting GATA6 DNA binding. These data reveal an interaction between GATA6 and LMCD1/dyxin and demonstrate a novel mechanism through which LIM proteins can assert their role as transcriptional cofactors of GATA proteins.	SEN:10028874	16199866
BEL:20056648	p(MGI:Lox) decreases gtp(p(MGI:Kras))	LOX enzyme is known to downregulate p21(ras) protein and play a central role in the maturation of collagen and elastin in the extracellular matrix as well as modulate the cytoskeletal elements.	SEN:10009482	10926554
BEL:20056652	p(MGI:Lox) decreases kin(p(MGI:Akt1))	LO potently downregulated the PI3K and Akt kinases, while partially inhibiting MEK kinase activity.	SEN:10009484	12640111
BEL:20056654	p(MGI:Lox) decreases kin(p(MGI:Chuk))	Consistent with this hypothesis, LO expression decreased both the rate of I kappa B alpha turnover and the activities of IKK alpha and IKK beta. Moreover, the ectopic expression of a constitutively active version of either kinase reversed the negative effects of LO.	SEN:10028888	12640111
BEL:20056656	p(MGI:Lox) decreases kin(p(MGI:Ikbkb))	Consistent with this hypothesis, LO expression decreased both the rate of I kappa B alpha turnover and the activities of IKK alpha and IKK beta. Moreover, the ectopic expression of a constitutively active version of either kinase reversed the negative effects of LO.	SEN:10028888	12640111
BEL:20056658	p(MGI:Lox) decreases kin(p(MGI:Map3k1))	LO potently downregulated the PI3K and Akt kinases, while partially inhibiting MEK kinase activity.	SEN:10009484	12640111
BEL:20056676	p(MGI:Lpin1) increases bp(GOBP:"fat cell differentiation")	Adipocyte differentiation is impaired in fld/fld mice and inhibiting mTOR with rapamycin blocks fat cell differentiation in vivo	SEN:10022012	11792863
BEL:20056678	p(MGI:Lpin1) increases bp(GOBP:"fat cell differentiation")	Lipin-1 deficiency in the mouse causes generalized lipodystrophy, characterized by impaired adipose tissue development and insulin resistance.	SEN:10009490	18362392
BEL:20056680	p(MGI:Lpin1) increases bp(GOBP:"lipid biosynthetic process")	lipin deficiency prevents normal lipid accumulation and induction of key adipogenic genes, including peroxisome proliferator-activated receptor (PPAR)gamma and CCAAT enhancer-binding protein (C/EBP)alpha.	SEN:10009492	15123608
BEL:20056682	p(MGI:Lpin1) decreases path(MESHD:"Insulin Resistance")	The fld mouse resembles human patients with generalized lipodystrophy, having ... acquired insulin resistance	SEN:10028898	15123608
BEL:20056686	p(MGI:Lpin1) decreases path(MESHD:"Insulin Resistance")	Lipin-1 deficiency in the mouse causes generalized lipodystrophy, characterized by impaired adipose tissue development and insulin resistance.	SEN:10009490	18362392
BEL:20056688	p(MGI:Lpin1) increases path(MESHD:Obesity)	In adult fld/fld mice, both white and brown fat pads exhibit an 80% reduction in mass compared with wild-type controls	SEN:10009494	10884287
BEL:20056690	p(MGI:Lpin1) decreases path(MESHD:Atherosclerosis)	As insulin resistance is a important risk factor in vascular disease, we examined susceptibility of fld/fld mice to diet-induced atherosclerosis. Mutant mice fed an atherogenic diet developed 2-fold greater aortic lesions than their wild-type counterparts, despite having a less atherogenic lipoprotein cholesterol profile	SEN:10028902	10884287
BEL:20056692	p(MGI:Lpin1) decreases r(MGI:Apoa1)	Preliminary studies to examine levels of apolipoproteins A-I, A-II, A-IV and E revealed slightly higher apo A-I and apo A-II levels in plasma of fld mice	SEN:10028904	10884287
BEL:20056694	p(MGI:Lpin1) decreases r(MGI:Apoa2)	Preliminary studies to examine levels of apolipoproteins A-I, A-II, A-IV and E revealed slightly higher apo A-I and apo A-II levels in plasma of fld mice	SEN:10028904	10884287
BEL:20056696	p(MGI:Lpin1) increases r(MGI:Cebpa)	fld mice exhibited 2 fold reductions in expression of ... PPARG and CEBPA and in ... aP2. The expression of DGAT was reduced 3 fold in fld tissue	SEN:10028906	15123608
BEL:20056698	p(MGI:Lpin1) increases r(MGI:Cebpa)	lipin deficiency prevents normal lipid accumulation and induction of key adipogenic genes, including peroxisome proliferator-activated receptor (PPAR)gamma and CCAAT enhancer-binding protein (C/EBP)alpha.	SEN:10009492	15123608
BEL:20056700	p(MGI:Lpin1) increases r(MGI:Cfd)	As expected, mRNA levels for LPL were reduced in fld white adipose tissue, as were those of adipsin. We also found that uncoupling protein 1 mRNA in brown adipose tissue from fld mice was reduced.	SEN:10028908	10884287
BEL:20056702	p(MGI:Lpin1) increases r(MGI:Dgat1)	fld mice exhibited 2 fold reductions in expression of ... PPARG and CEBPA and in ... aP2. The expression of DGAT was reduced 3 fold in fld tissue	SEN:10028906	15123608
BEL:20056704	p(MGI:Lpin1) increases r(MGI:Fabp4)	fld mice exhibited 2 fold reductions in expression of ... PPARG and CEBPA and in ... aP2. The expression of DGAT was reduced 3 fold in fld tissue	SEN:10028906	15123608
BEL:20056706	p(MGI:Lpin1) increases r(MGI:Pparg)	fld mice exhibited 2 fold reductions in expression of ... PPARG and CEBPA and in ... aP2. The expression of DGAT was reduced 3 fold in fld tissue	SEN:10028906	15123608
BEL:20056708	p(MGI:Lpin1) increases r(MGI:Pparg)	lipin deficiency prevents normal lipid accumulation and induction of key adipogenic genes, including peroxisome proliferator-activated receptor (PPAR)gamma and CCAAT enhancer-binding protein (C/EBP)alpha.	SEN:10009492	15123608
BEL:20056710	p(MGI:Lpin1) increases r(MGI:Ucp1)	As expected, mRNA levels for LPL were reduced in fld white adipose tissue, as were those of adipsin. We also found that uncoupling protein 1 mRNA in brown adipose tissue from fld mice was reduced.	SEN:10028908	10884287
BEL:20056720	p(MGI:Lpl) increases path(MESHD:Atherosclerosis)	LPL and endothelial lipase (EL) are associated with macrophages in human atherosclerotic lesions, and overexpression of LPL in mouse macrophages is associated with a greater extent of atherosclerosis	SEN:10009476	17093291
BEL:20056722	p(MGI:Lpl) decreases r(MGI:Vcam1)	In contrast, exposing LDL(-) to the key lipolytic enzyme lipoprotein lipase (LPL) reversed these responses, inhibiting VCAM1 below levels seen with TNFalpha alone.	SEN:10009498	12878589
BEL:20056730	p(MGI:Lrp1) decreases bp(GOBP:"cell migration")	In this study, we found disorganized actin in the form of membrane ruffling and enhanced cell migration in LRP1-deficient (LRP1-/-) SMCs.	SEN:10009502	19742316
BEL:20056740	p(MGI:Lrp1) decreases kin(p(MGI:Mapk1))	About a two-fold increase of PDGFRb expression was detected in smLRP1-/- mice regardless of LDLR genotype (Figure 2A, C). Increased Erk1/2 phosphorylation was also observed in these aortas (Figure 2A). These data suggest that the expression and activation of PDGFRb is only regulated by LRP1, not LDLR.	SEN:10028914	19742316
BEL:20056742	p(MGI:Lrp1) decreases kin(p(MGI:Mapk3))	About a two-fold increase of PDGFRb expression was detected in smLRP1-/- mice regardless of LDLR genotype (Figure 2A, C). Increased Erk1/2 phosphorylation was also observed in these aortas (Figure 2A). These data suggest that the expression and activation of PDGFRb is only regulated by LRP1, not LDLR.	SEN:10028914	19742316
BEL:20056746	p(MGI:Lrp1) decreases kin(p(MGI:Pdgfrb))	Studies from our laboratory have shown that LRP1 suppresses PDGF receptor b (PDGFRb) activation and protects against atherosclerosis.	SEN:10028918	19742316
BEL:20056752	p(MGI:Lrp1) decreases path(MESHD:Atherosclerosis)	Studies from our laboratory have shown that LRP1 suppresses PDGF receptor b (PDGFRb) activation and protects against atherosclerosis.	SEN:10028918	19742316
BEL:20056758	p(MGI:Lrp1) increases p(MGI:Ccl2)	sLRP1 induced expression of regulatory cytokines by RAW 264.7 cells, including TNF-a, MCP-1/CCL2, and IL-10.	SEN:10009506	20610799
BEL:20056760	p(MGI:Lrp1) increases p(MGI:Il10)	sLRP1 induced expression of regulatory cytokines by RAW 264.7 cells, including TNF-a, MCP-1/CCL2, and IL-10.	SEN:10009506	20610799
BEL:20056766	p(MGI:Lrp1) decreases p(MGI:Nfkbib)	sLRP1 also induced a transient but substantial decrease in IkB, indicating activation of the IKK-NF-kB pathway [28].	SEN:10028924	20610799
BEL:20056774	p(MGI:Lrp1) increases p(MGI:Tnf)	sLRP1 induced expression of regulatory cytokines by RAW 264.7 cells, including TNF-a, MCP-1/CCL2, and IL-10.	SEN:10009506	20610799
BEL:20056780	p(MGI:Lrp1) decreases r(MGI:Pdgfrb)	About a two-fold increase of PDGFRb expression was detected in smLRP1-/- mice regardless of LDLR genotype (Figure 2A, C). Increased Erk1/2 phosphorylation was also observed in these aortas (Figure 2A). These data suggest that the expression and activation of PDGFRb is only regulated by LRP1, not LDLR.	SEN:10028914	19742316
BEL:20056784	p(MGI:Lrp1) decreases tscript(p(MGI:Smad2))	An approximately 2.5-fold increase of Smad2 phosphorylation at Ser 465/467 was also detected in LDLR expressing, LRP1-deficient SMCs (Figure 6B, C).	SEN:10028806	19742316
BEL:20056810	p(MGI:Lsp1) decreases cat(p(MGI:Fpr1))	fMLP-induced filamentous actin polarization is also increased in the absence of LSP1 when cells were layered on fibrinogen, but not on fibronectin.	SEN:10003792	12077272
BEL:20056818	p(MGI:Ltb4r1) increases r(MGI:Ifng)	The supernatants from cultured LN cells were also collected and the production of various cytokines (TNF-alpha, IFN-gamma, IL-6, and IL-17) was measured (Fig. 3B). The cytokine levels in BLT1-/- cells were significantly lower than those in BLT1+/+ cells	SEN:10028942	20226760
BEL:20056820	p(MGI:Ltb4r1) increases r(MGI:Il17a)	The supernatants from cultured LN cells were also collected and the production of various cytokines (TNF-alpha, IFN-gamma, IL-6, and IL-17) was measured (Fig. 3B). The cytokine levels in BLT1-/- cells were significantly lower than those in BLT1+/+ cells	SEN:10028942	20226760
BEL:20056822	p(MGI:Ltb4r1) increases r(MGI:Il6)	The supernatants from cultured LN cells were also collected and the production of various cytokines (TNF-alpha, IFN-gamma, IL-6, and IL-17) was measured (Fig. 3B). The cytokine levels in BLT1-/- cells were significantly lower than those in BLT1+/+ cells	SEN:10028942	20226760
BEL:20056824	p(MGI:Ltb4r1) increases r(MGI:Tnf)	The supernatants from cultured LN cells were also collected and the production of various cytokines (TNF-alpha, IFN-gamma, IL-6, and IL-17) was measured (Fig. 3B). The cytokine levels in BLT1-/- cells were significantly lower than those in BLT1+/+ cells	SEN:10028942	20226760
BEL:20056826	p(MGI:Ltbp4) decreases p(MGI:Bmp4)	Furthermore, LTBP-4-deficient mice also had evidence of activated bone morphogenic protein-4 (BMP-4) signaling, which might have contributed to the lung phenotype (159)	SEN:10028944	17615396
BEL:20056830	p(MGI:Ltbp4) decreases sec(p(MGI:Tgfb1))	Disruption of latent TGF-beta binding protein (LTBP)-4 expression in the mouse leads to abnormal lung development and colorectal cancer. Lung fibroblasts from these mice produced decreased amounts of active TGF-beta, whereas secretion of latent TGF-beta was significantly increased. Expression and secretion of TGF-beta2 and -beta3 increased considerably.	SEN:10009514	15466481
BEL:20056832	p(MGI:Ltbp4) decreases sec(p(MGI:Tgfb2))	Disruption of latent TGF-beta binding protein (LTBP)-4 expression in the mouse leads to abnormal lung development and colorectal cancer. Lung fibroblasts from these mice produced decreased amounts of active TGF-beta, whereas secretion of latent TGF-beta was significantly increased. Expression and secretion of TGF-beta2 and -beta3 increased considerably.	SEN:10009514	15466481
BEL:20056834	p(MGI:Ltbp4) decreases sec(p(MGI:Tgfb3))	Disruption of latent TGF-beta binding protein (LTBP)-4 expression in the mouse leads to abnormal lung development and colorectal cancer. Lung fibroblasts from these mice produced decreased amounts of active TGF-beta, whereas secretion of latent TGF-beta was significantly increased. Expression and secretion of TGF-beta2 and -beta3 increased considerably.	SEN:10009514	15466481
BEL:20056844	p(MGI:Ltbr) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	alpha-LTbetaR also induced RelA translocation to the nucleus, albeit to a lesser extent, but predominantly induced nuclear translocation of RelB at late time points (Figure 1B, right).	SEN:10028952	20139367
BEL:20056846	p(MGI:Ltbr) increases tloc(p(MGI:Relb),GOCCID:0005737,GOCCID:0005634)	alpha-LTbetaR also induced RelA translocation to the nucleus, albeit to a lesser extent, but predominantly induced nuclear translocation of RelB at late time points (Figure 1B, right).	SEN:10028952	20139367
BEL:20056848	p(MGI:Ltbr) increases tscript(p(MGI:Rela))	Electrophoretic mobility shift assay supershift analysis confirmed TNF-induced RelA but not RelB NF-bB binding within 30 minutes (Figure 1C, left). In contrast, a-LTbR induced both RelA and RelB complexes, although with slower kinetics (Figure 1C, right).	SEN:10028954	20139367
BEL:20056850	p(MGI:Ltbr) increases tscript(p(MGI:Relb))	Electrophoretic mobility shift assay supershift analysis confirmed TNF-induced RelA but not RelB NF-bB binding within 30 minutes (Figure 1C, left). In contrast, a-LTbR induced both RelA and RelB complexes, although with slower kinetics (Figure 1C, right).	SEN:10028954	20139367
BEL:20056862	p(MGI:Ly6a) decreases bp(GOBP:"T cell proliferation")	In this study we report reduced proliferation of CD4+ T cells overexpressing Ly-6A.2 in response to a peptide Ag.	SEN:10028956	11751954
BEL:20056864	p(MGI:Ly6a) increases sec(p(MGI:Il4))	Moreover, the Ly-6A.2-overexpressing CD4+ cells generated elevated levels of IL-4, a key factor that propels the differentiation of naive CD4+ T cells into Th2 subset.	SEN:10009520	11751954
BEL:20056874	p(MGI:Lyl1) decreases r(MGI:Cd4)	Mammalian two-hybrid analysis and luciferase assay suggested that excess LYL1 blocked the dimerization of E2A and thus inhibited the regulatory activity of E2A on the CD4 promoter.	SEN:10028958	17486074
BEL:20056888	p(MGI:Lyn) decreases r(MGI:Il13)	Among the cytokines expressed after 4 h of Ag stimulation in BMMCs, our data show that levels of mRNA and protein for IL-4, IL-6, and for IL-13 are all significantly higher in Lyn-/- than in WT BMMCs.	SEN:10028962	16339523
BEL:20056890	p(MGI:Lyn) decreases r(MGI:Il4)	Among the cytokines expressed after 4 h of Ag stimulation in BMMCs, our data show that levels of mRNA and protein for IL-4, IL-6, and for IL-13 are all significantly higher in Lyn-/- than in WT BMMCs.	SEN:10028962	16339523
BEL:20056892	p(MGI:Lyn) decreases r(MGI:Il6)	Among the cytokines expressed after 4 h of Ag stimulation in BMMCs, our data show that levels of mRNA and protein for IL-4, IL-6, and for IL-13 are all significantly higher in Lyn-/- than in WT BMMCs.	SEN:10028962	16339523
BEL:20056896	p(MGI:Lyn) decreases r(MGI:Nfatc1)	Our data show that mRNA coding for at least one transcription factor, the cytoplasmic NF-AT (NF-ATC, also known as NFATC1 and NFAT2) is induced 3-fold more in Lyn–/– BMMCs than in WT BMMCs (Table II).	SEN:10028966	16339523
BEL:20056898	p(MGI:Lyn) decreases r(MGI:Sphk1)	The 33-fold up-regulation of sphingosine kinase 1 in Ag-stimulated Lyn–/– BMMCs may also contribute to increased chemokine production	SEN:10028968	16339523
BEL:20056902	p(MGI:Mab21l1) decreases bp(GOBP:"apoptotic process")	At the 35-somite stage, there were few TUNEL-positive cells but, significantly, they were observed in the Mab21l1-/- lens placode (Fig. 6I,J). We did not see significant differences at either the 32- or 40-somite stages (data not shown). These results suggest that Mab21l1 is required for lens placode cell proliferation and for protection against apoptosis.	SEN:10028972	12642482
BEL:20056904	p(MGI:Mab21l1) increases r(MGI:Foxe3)	These results suggest that MAB21L1 function is required for the appropriate induction and subsequent maintenance of Foxe3 expression.	SEN:10028974	12642482
BEL:20056918	p(MGI:Mafb) decreases r(MGI:Nfatc1)	Given our observation that overexpression of MafB inhibits RANKL-mediated osteoclast differentiation, we examined the expression levels of NFATc1 and OSCAR, which are known to be important modulators of osteoclastogenesis.11,32 As compared to control, exogenous overexpression of MafB attenuated the expression of NFATc1 as well as OSCAR during RANKL-mediated osteoclastogenesis (Figure 3A).	SEN:10028980	17158225
BEL:20056920	p(MGI:Mafb) decreases r(MGI:Oscar)	Given our observation that overexpression of MafB inhibits RANKL-mediated osteoclast differentiation, we examined the expression levels of NFATc1 and OSCAR, which are known to be important modulators of osteoclastogenesis.11,32 As compared to control, exogenous overexpression of MafB attenuated the expression of NFATc1 as well as OSCAR during RANKL-mediated osteoclastogenesis (Figure 3A).	SEN:10028980	17158225
BEL:20056926	p(MGI:Mafg) increases r(MGI:Bach2)	Furthermore, the expression of Bach 2, which can form a heterodimer with mafG protein, was found to be greatly reduced, while Notch 1 expression was increased in mafG deficient mice.	SEN:10009530	20813153
BEL:20056928	p(MGI:Mafg) decreases r(MGI:Notch1)	Furthermore, the expression of Bach 2, which can form a heterodimer with mafG protein, was found to be greatly reduced, while Notch 1 expression was increased in mafG deficient mice.	SEN:10009530	20813153
BEL:20056932	p(MGI:Maf) increases p(MGI:Itgal)	Specifically, macrophage-activating factor (MAF), interferon-gamma (IFN-gamma), or picogram amounts of endotoxin (LPS) induced LFA-1 on TG-elicited macrophages following overnight incubation.	SEN:10009070	3923098
BEL:20056936	p(MGI:Maoa) increases a(CHEBI:ceramide)	MAO-A can promote apoptosis through ROS-dependent sphingosine kinase inhibition that results in the accumulation of ceramide [64].	SEN:10016226	19307700
BEL:20056938	p(MGI:Maoa) increases a(CHEBI:"reactive oxygen species")	With respect to vasculature, MAO-A-mediated ROS production has been shown to induce mitogenic signaling in smooth muscle cells by a process that may involve the activation of the metalloproteinase MMP-2, which likely contributes to vascular wall remodeling [21].	SEN:10028984	19307700
BEL:20056940	p(MGI:Maoa) increases bp(GOBP:"apoptotic process")	MAO-A can promote apoptosis through ROS-dependent sphingosine kinase inhibition that results in the accumulation of ceramide [64].	SEN:10016226	19307700
BEL:20056942	p(MGI:Maoa) increases cat(p(MGI:Mmp2))	With respect to vasculature, MAO-A-mediated ROS production has been shown to induce mitogenic signaling in smooth muscle cells by a process that may involve the activation of the metalloproteinase MMP-2, which likely contributes to vascular wall remodeling [21].	SEN:10028984	19307700
BEL:20056952	p(MGI:Map1lc3b) increases bp(GOBP:autophagy)	LC3-II was increased in FoxO3MyHC cardiomyocytes after ex vivo transgene activation (Figure 4F; see Supplementary material online, Figure S6C). Treatment with lysosomal inhibitors revealed that LC3-II levels could still be stimulated in FoxO3MyHC cardiomyocytes, indicating an activation of autophagy rather than a disturbance in autophagic flux.	SEN:10028990	21628326
BEL:20056954	p(MGI:Map1lc3b) decreases cat(p(MGI:Casp1))	Compared to wild-type Map1lc3b+/+ macrophages, Map1lc3b-/- macrophages displayed a higher level of the active, cleaved (10 kDa) form of caspase-1 in response to LPS and ATP treatment (Fig. 1a).	SEN:10028992	21151103
BEL:20056960	p(MGI:Map1lc3b) decreases sec(p(MGI:Il18))	IL-1b and IL-18 secretion into the medium was also increased in Map1lc3b-/- and Becn1+/- macrophages compared to corresponding wild-type macrophages (Fig. 1b).	SEN:10025420	21151103
BEL:20056962	p(MGI:Map1lc3b) decreases sec(p(MGI:Il1b))	Additionally, the cleaved form of IL-1b, produced from pro IL-1b by the action of activated caspase-1, was increased in the cell lysates and culture medium of Map1lc3b-/- macrophages (Fig. 1a).	SEN:10018854	21151103
BEL:20056984	p(MGI:Map2k4) increases bp(GOBP:"cell proliferation")	Moreover, genetic inactivation of MKK4 in MEFs resulted in reduced proliferation doubling times and premature senescence, indicating that both MKK4 and MKK7 are essential for these cellular processes (data not shown).	SEN:10029004	15039780
BEL:20056998	p(MGI:Map2k7) increases bp(GOBP:"cell proliferation")	In contrast, proliferation of hepatocytes was markedly impaired in E11.5 mkk7-/- embryos, as determined by BrdU in vivo labelling (data not shown).	SEN:10029010	15039780
BEL:20057000	p(MGI:Map2k7) increases bp(GOBP:"cell proliferation")	Re-expression of wild-type MKK7 (Fig. 2c) restored the reduced proliferation of mkk7- /- MEFs to levels observed in wild-type MEFs.	SEN:10029012	15039780
BEL:20057006	p(MGI:Map2k7) increases kin(complex(p(EGID:12534),p(MGI:Ccnb1)))	Importantly, cyclin B1-associated CDC2 kinase activity was markedly reduced in mkk7-/- MEFs (Fig. 4d), indicating that reduced CDC2 expression correlates with impaired cyclin B1/CDC2 activity.	SEN:10029016	15039780
BEL:20057016	p(MGI:Map2k7) increases r(EGID:12534)	Similarly to mkk7-/- MEFs, cdc2 mRNA expression was downregulated in primary mkk7-/- hepatocytes (Fig. 4g).	SEN:10029022	15039780
BEL:20057018	p(MGI:Map2k7) increases tscript(p(MGI:Jun))	loss of MKK7 expression resulted in impaired JNK activation in MEFs at the basal level and after stimulation with tumour necrosis factor alpha (TNF-alpha) or UV irradiation (Fig. 2a).	SEN:10029014	15039780
BEL:20057020	p(MGI:Map3k11) increases tscript(p(MGI:Gabpa))	In T cells, overexpression of SPRK/MLK3, an activator of JNK/SAPK, strongly induces DSE-dependent transcription and dominant negative kinases of SEK and SAPK impair TPA/ionomycin-induced DSE activity.	SEN:10006234	9553058
BEL:20057022	p(MGI:Map3k11) increases tscript(p(MGI:Gabpb1))	In T cells, overexpression of SPRK/MLK3, an activator of JNK/SAPK, strongly induces DSE-dependent transcription and dominant negative kinases of SEK and SAPK impair TPA/ionomycin-induced DSE activity.	SEN:10006234	9553058
BEL:20057024	p(MGI:Map3k1) increases kin(p(MGI:Mapk8))	As shown in Figure 6e, expression of MEKK1 fails to activate either ERK1 or ERK2, whereas both p46 SAPK and p54SAPK are activated at expression levels that result in reporter gene expression.	SEN:10022000	8548291
BEL:20057026	p(MGI:Map3k1) increases kin(p(MGI:Mapk9))	As shown in Figure 6e, expression of MEKK1 fails to activate either ERK1 or ERK2, whereas both p46 SAPK and p54SAPK are activated at expression levels that result in reporter gene expression.	SEN:10022000	8548291
BEL:20057028	p(MGI:Map3k1) increases tscript(p(MGI:Elk1))	Co-transfection of 1.25 ug MEKK1 expression vector elicited a 24-fold activation of Gal-Elk-dependent reporter expression in serum-starved NIH3T3 cells (Fig. 6c,d).	SEN:10029024	8548291
BEL:20057030	p(MGI:Map3k2) increases p(MGI:Il13)	BMMCs from mice lacking Map3k2 showed reduced production (50-60%) of IL-6, IL-13, and TNF-alpha after stimulation	SEN:10029026	16430878
BEL:20057032	p(MGI:Map3k2) increases p(MGI:Il6)	BMMCs from mice lacking Map3k2 showed reduced production (50-60%) of IL-6, IL-13, and TNF-alpha after stimulation	SEN:10029026	16430878
BEL:20057034	p(MGI:Map3k2) increases p(MGI:Tnf)	BMMCs from mice lacking Map3k2 showed reduced production (50-60%) of IL-6, IL-13, and TNF-alpha after stimulation	SEN:10029026	16430878
BEL:20057072	p(MGI:Map3k7) increases r(MGI:Lox)	Figure 5. Inability of TGFbeta to induce expression of mRNA for various tissue remodeling molecules in tak-/- fibroblasts.	SEN:10029044	19116914
BEL:20057074	p(MGI:Map3k7) increases r(MGI:Thbs1)	Figure 5. Inability of TGFbeta to induce expression of mRNA for various tissue remodeling molecules in tak-/- fibroblasts.	SEN:10029044	19116914
BEL:20057076	p(MGI:Map3k7) increases r(MGI:Timp3)	Figure 5. Inability of TGFbeta to induce expression of mRNA for various tissue remodeling molecules in tak-/- fibroblasts.	SEN:10029044	19116914
BEL:20057078	p(MGI:Map3k7) increases r(MGI:Vcl)	Figure 5. Inability of TGFbeta to induce expression of mRNA for various tissue remodeling molecules in tak-/- fibroblasts.	SEN:10029044	19116914
BEL:20057088	p(MGI:Map3k8) decreases r(MGI:Il12a)	Enhanced IL-12 production in Cot/Tpl2-/- macrophages is, at least partly, regulated at the transcriptional level, and the elevated IL-12 mRNA level in Cot/Tpl2-/- macrophages	SEN:10009546	15372110
BEL:20057100	p(MGI:Map3k8) increases r(MGI:Tlr2)	from full text - Gene expression of TLR2 and TLR4 was upregulated with obesity in WT mice, and this increase was diminished in obese TPL2KO mice (Fig. 2).	SEN:10029050	21346175
BEL:20057102	p(MGI:Map3k8) increases r(MGI:Tlr4)	from full text - Gene expression of TLR2 and TLR4 was upregulated with obesity in WT mice, and this increase was diminished in obese TPL2KO mice (Fig. 2).	SEN:10029050	21346175
BEL:20057118	p(MGI:Mapk14) decreases a(CHEBI:"reactive oxygen species")	p38-/- MEF exhibited a 2-fold increase of intracellular ROS levels in comparison to p38+/+ MEF (Fig. 9, A and B).	SEN:10029058	19454702
BEL:20057120	p(MGI:Mapk14) decreases bp(GOBP:"cell proliferation")	Our results indicated that the p38a-deficient lungs had hyperproliferative alveolar tissue with loss of differentiation markers. A similar but more marked lung phenotype, with hyperproliferation and defective cell maturation, has been described previously in CCAAT/ enhancer-binding protein (C/EBP)a knockout mice, which die shortly after birth because of respiratory failure16–18.	SEN:10025974	17468755
BEL:20057122	p(MGI:Mapk14) decreases bp(GOBP:"cell proliferation")	Furthermore, inactivation of JNK or c-Jun suppressed the increased proliferation of Mapk14-deficient hepatocytes and tumor cells.	SEN:10006426	17468757
BEL:20057126	p(MGI:Mapk14) increases kin(p(MGI:Mknk1))	Mnk1 was also activated at lower levels in Mapk14-null mice (Fig. 3b). This p38a-activated protein kinase phosphorylates and stabilizes Sprouty2 (ref. 26), which in turn can negatively regulate tyrosine kinase receptor signaling in lung cells27.	SEN:10022008	17468755
BEL:20057130	p(MGI:Mapk14) increases p(MGI:Cdh1)	However, the SP-C+ cells were more numerous in the Mapk14-/- lungs (with almost twice as many as in Mapk14-/+ lungs; Fig. 2c). Notably, immunohistological staining showed reduced levels of the epithelial marker E-cadherin in the alveolar cells (Fig. 2c), indicating defective differentiation of these cells.	SEN:10029060	17468755
BEL:20057132	p(MGI:Mapk14) increases p(MGI:Cebpa)	Notably, we found that p38a-deficient lungs contained lower levels of C/EBPa and HNF3b, another transcription factor involved in lung differentiation whose expression is controlled by C/EBPa (ref. 19) (Fig. 3a and Supplementary Fig. 1a online).	SEN:10029062	17468755
BEL:20057136	p(MGI:Mapk14) increases p(MGI:Foxa2)	Notably, we found that p38a-deficient lungs contained lower levels of C/EBPa and HNF3b, another transcription factor involved in lung differentiation whose expression is controlled by C/EBPa (ref. 19) (Fig. 3a and Supplementary Fig. 1a online).	SEN:10029062	17468755
BEL:20057138	p(MGI:Mapk14) decreases p(MGI:Mapk1,pmod(P,T,183))	As demonstrated in Fig. 8A, ERK was strongly phosphorylated in p38–/– MEF, but not in p38+/+ MEF.	SEN:10029064	19454702
BEL:20057140	p(MGI:Mapk14) decreases p(MGI:Mapk1,pmod(P,Y,185))	As demonstrated in Fig. 8A, ERK was strongly phosphorylated in p38–/– MEF, but not in p38+/+ MEF.	SEN:10029064	19454702
BEL:20057142	p(MGI:Mapk14) decreases p(MGI:Mki67)	Furthermore, the higher number of AT2 cells correlated with an almost fivefold increase in Ki67+ cells in Mapk14-/- lungs compared with the number of Ki67+ cells in their heterozygous Mapk14D/+ counterparts (Fig. 2d).	SEN:10029066	17468755
BEL:20057144	p(MGI:Mapk14) decreases p(MGI:Sftpc)	However, the SP-C+ cells were more numerous in the Mapk14-/- lungs (with almost twice as many as in Mapk14-/+ lungs; Fig. 2c). Notably, immunohistological staining showed reduced levels of the epithelial marker E-cadherin in the alveolar cells (Fig. 2c), indicating defective differentiation of these cells.	SEN:10029060	17468755
BEL:20057146	p(MGI:Mapk14) increases p(MGI:Stat3)	We also detected a reduction in STAT3 protein in Mapk14D/D lungs (Fig. 3a) that correlated with the reduction in Il6 mRNA (Fig. 3).	SEN:10029068	17468755
BEL:20057148	p(MGI:Mapk14,pmod(P,T,180)) directlyIncreases kin(p(MGI:Mapk14))	...phosphorylation of both T180 and Y182 within the TGY motif of p38 MAPK is necessary for activation of the enzyme...	SEN:10029070	12864733
BEL:20057150	p(MGI:Mapk14,pmod(P,Y,182)) directlyIncreases kin(p(MGI:Mapk14))	...phosphorylation of both T180 and Y182 within the TGY motif of p38 MAPK is necessary for activation of the enzyme...	SEN:10029070	12864733
BEL:20057152	p(MGI:Mapk14) decreases r(MGI:Egfr)	three times as much Egfr mRNA was present in Mapk14D/D lungs (Fig. 3d) compared with Mapk14D/+ lungs, suggesting that EGFR expression was transcriptionally enhanced in the absence of p38a.	SEN:10029072	17468755
BEL:20057154	p(MGI:Mapk14) decreases r(MGI:Hmox1)	Moreover, basal HO-1 gene expression levels were markedly higher in untreated murine embryonic fibroblasts (MEF) from p38alpha(-/-) mice compared with those from wild-type mice.	SEN:10029074	19454702
BEL:20057156	p(MGI:Mapk14) increases r(MGI:Il6)	We also detected a reduction in STAT3 protein in Mapk14D/D lungs (Fig. 3a) that correlated with the reduction in Il6 mRNA (Fig. 3).	SEN:10029068	17468755
BEL:20057158	p(MGI:Mapk14) decreases r(MGI:Nox1)	Nox1 and Nox4 mRNAs were upregulated in H-RasV12-transformed p38??/? MEFs, suggesting that these two NOX family members may be involved in H-RasV12-induced ROS production in fibroblasts (Figure S5B).	SEN:10029076	17292829
BEL:20057160	p(MGI:Mapk14) decreases r(MGI:Nox4)	Nox1 and Nox4 mRNAs were upregulated in H-RasV12-transformed p38??/? MEFs, suggesting that these two NOX family members may be involved in H-RasV12-induced ROS production in fibroblasts (Figure S5B).	SEN:10029076	17292829
BEL:20057162	p(MGI:Mapk14) decreases r(MGI:Tgfb1)	the amount of Tgfb1 (TGFb) mRNA was higher in p38a-deficient lungs compared with Mapk14D/+ lungs (Fig. 3e). TGFb has been found to be overexpressed in C/EBPa knockout lungs17, so the reduced C/EBPa levels in the Mapk14-null lungs could account for the higher TGFb expression.	SEN:10025986	17468755
BEL:20057164	p(MGI:Mapk14) increases tloc(p(MGI:Bach1),GOCCID:0005737,GOCCID:0005634)	Remarkably, cytosolic and nuclear levels of Bach1 were inverse to those of Nrf2, with higher Bach1 levels in cytoplasmic fractions of p38–/– MEF compared with those in p38+/+ MEF (data not shown).	SEN:10029078	19454702
BEL:20057166	p(MGI:Mapk14) decreases tloc(p(MGI:Nfe2l2),GOCCID:0005737,GOCCID:0005634)	Nrf2 levels were higher in nuclear fractions of p38–/– MEF compared with those in p38+/+ MEF and Nrf2 was hardly detectable in the cytoplasmic fractions (Fig. 5). However, only minor differences were observed for total Nrf2 levels	SEN:10029080	19454702
BEL:20057172	p(MGI:Mapk14) decreases tscript(p(MGI:Jun))	Notably, EGFR transcription is regulated by AP-1 (ref. 28), and we observed higher levels of phospho-c-Jun, one of the AP-1 components, in the p38a-deficient lungs (Fig. 3c), suggesting that p38a downregulation might activate AP-1.	SEN:10029082	17468755
BEL:20057202	p(MGI:Mapk8) increases bp(GOBP:"cell proliferation")	These results are consistent with previous data showing that loss of JNK1/JNK2 in MEFs results in reduced proliferation17 and that inactivation of c-Jun in MEFs results in premature senescence and impaired proliferation19.	SEN:10029098	15039780
BEL:20057204	p(MGI:Mapk8) increases bp(GOBP:"cell proliferation")	the absence of JNK1 resulted in decreased accumulation of the cells, whereas JNK2-deficient cells exhibited an increase in the number of cells as compared to wildtype cells (Fig. 5A, left panel), consistent with previous studies (28, 32).	SEN:10029100	17074809
BEL:20057218	p(MGI:Mapk8) increases p(MGI:Elk1,pmod(P))	The total phosphorylation state of Elk-1 was significantly decreased in JNK1-deficient MEFs but increased in JNK2-deficient MEFs compared to wild-type cells (Fig. 4B).	SEN:10029106	17074809
BEL:20057220	p(MGI:Mapk8) increases p(MGI:Jun)	Jnk1-/- cells express reduced amounts of c-Jun, whereas Jnk2-/- cells express increased amounts of c-Jun, compared to wild-type cells (Fig. 5A, right panel).	SEN:10029108	17074809
BEL:20057222	p(MGI:Mapk8) increases r(MGI:Tbp)	Compared to nonstimulated wild-type cells, TBP mRNA expression was decreased in Jnk1-/- cells, whereas TBP mRNA levels were increased in Jnk2-/- cells (Fig. 1B).	SEN:10029110	17074809
BEL:20057226	p(MGI:Mapk9) increases bp(GOBP:"cell proliferation")	These results are consistent with previous data showing that loss of JNK1/JNK2 in MEFs results in reduced proliferation17 and that inactivation of c-Jun in MEFs results in premature senescence and impaired proliferation19.	SEN:10029098	15039780
BEL:20057228	p(MGI:Mapk9) decreases bp(GOBP:"cell proliferation")	the absence of JNK1 resulted in decreased accumulation of the cells, whereas JNK2-deficient cells exhibited an increase in the number of cells as compared to wildtype cells (Fig. 5A, left panel), consistent with previous studies (28, 32).	SEN:10029100	17074809
BEL:20057230	p(MGI:Mapk9) decreases bp(GOBP:"cell proliferation")	JNK2 was found to be necessary for cell-cycle arrest in keratinocytes, as exemplified by hyperproliferation of JNK2-knockout epidermis (Sabapathy and Wagner, 2004; Weston et al., 2004).	SEN:10029114	18268536
BEL:20057232	p(MGI:Mapk9) increases cat(p(MGI:Msr1))	Macrophages lacking JNK2 displayed suppressed foam cell formation caused by defective uptake and degradation of modified lipoproteins and showed increased amounts of the modified lipoprotein-binding and -internalizing scavenger receptor A (SR-A), whose phosphorylation was markedly decreased	SEN:10029116	15567863
BEL:20057234	p(MGI:Mapk9) decreases p(MGI:Elk1,pmod(P))	The total phosphorylation state of Elk-1 was significantly decreased in JNK1-deficient MEFs but increased in JNK2-deficient MEFs compared to wild-type cells (Fig. 4B).	SEN:10029106	17074809
BEL:20057236	p(MGI:Mapk9) decreases p(MGI:Jun)	Jnk1-/- cells express reduced amounts of c-Jun, whereas Jnk2-/- cells express increased amounts of c-Jun, compared to wild-type cells (Fig. 5A, right panel).	SEN:10029108	17074809
BEL:20057238	p(MGI:Mapk9) increases p(MGI:Msr1,pmod(P))	Macrophages lacking JNK2 displayed suppressed foam cell formation caused by defective uptake and degradation of modified lipoproteins and showed increased amounts of the modified lipoprotein-binding and -internalizing scavenger receptor A (SR-A), whose phosphorylation was markedly decreased	SEN:10029116	15567863
BEL:20057240	p(MGI:Mapk9) decreases r(MGI:Tbp)	Compared to nonstimulated wild-type cells, TBP mRNA expression was decreased in Jnk1-/- cells, whereas TBP mRNA levels were increased in Jnk2-/- cells (Fig. 1B).	SEN:10029110	17074809
BEL:20057260	p(MGI:Mat1a) increases a(CHEBI:glutathione)	to examine the influence of Mat1a on hepatic growth, we studied the effects of targeted disruption of the murine Mat1a gene in the absence of Mat1a, plasma methionine levels were increased hepatic S-adenosylmethionine and glutathione levels were reduced	SEN:10029126	11320206
BEL:20057266	p(MGI:Mat1a) decreases a(CHEBI:methionine)	to examine the influence of Mat1a on hepatic growth, we studied the effects of targeted disruption of the murine Mat1a gene in the absence of Mat1a, plasma methionine levels were increased hepatic S-adenosylmethionine and glutathione levels were reduced	SEN:10029126	11320206
BEL:20057296	p(MGI:Maz,pmod(P)) directlyIncreases tscript(p(MGI:Maz))	We further show that SAF-1 is phosphorylated in vitro by PKA-Calpha and that addition of cAMP markedly induces in vivo phosphorylation of SAF-1 and transcription of SAF-regulated reporter genes.	SEN:10022070	11490023
BEL:20057298	p(MGI:Mbnl1) increases bp(GOBP:"myoblast differentiation")	The RNA-mediated pathogenesis model for the myotonic dystrophies DM1 and DM2 proposes that mutant transcripts from the affected genes sequester a family of double-stranded RNA-binding factors, the muscleblind proteins MBNL1, MBNL2 and MBNL3, in the nucleus. These proteins are homologues of the Drosophila muscleblind proteins that are required for the terminal differentiation of muscle and photoreceptor tissues,	SEN:10009564	12915312
BEL:20057300	p(MGI:Mbnl2) increases bp(GOBP:"myoblast differentiation")	The RNA-mediated pathogenesis model for the myotonic dystrophies DM1 and DM2 proposes that mutant transcripts from the affected genes sequester a family of double-stranded RNA-binding factors, the muscleblind proteins MBNL1, MBNL2 and MBNL3, in the nucleus. These proteins are homologues of the Drosophila muscleblind proteins that are required for the terminal differentiation of muscle and photoreceptor tissues,	SEN:10009564	12915312
BEL:20057302	p(MGI:Mbnl3) increases bp(GOBP:"myoblast differentiation")	The RNA-mediated pathogenesis model for the myotonic dystrophies DM1 and DM2 proposes that mutant transcripts from the affected genes sequester a family of double-stranded RNA-binding factors, the muscleblind proteins MBNL1, MBNL2 and MBNL3, in the nucleus. These proteins are homologues of the Drosophila muscleblind proteins that are required for the terminal differentiation of muscle and photoreceptor tissues,	SEN:10009564	12915312
BEL:20057306	p(MGI:Mdk) increases bp(GOBP:angiogenesis)	These unanticipated results identified endothelial cells as the source of soluble MK in the vascular system during hypoxia and defined MK as a pivotal player of angiogenesis during ischemia in nonmalignant tissue	SEN:10009566	22707563
BEL:20057308	p(MGI:Mdk) increases bp(GOBP:"cell proliferation")	In a hind limb ischemia model, the angiogenic response was almost completely absent in MK-deficient mice, whereas control animals showed a profound angiogenic response measured as proliferating endothelial cells per visual field (45 ± 30 vs. 169 ± 34; P < 0.01)	SEN:10029140	22707563
BEL:20057328	p(MGI:Mdm2,pmod(P)) decreases p(MGI:Trp53)	The reduced level of p53 protein in myr-Akt1 salivary glands corresponds with an increase in MDM2 phosphorylation in vivo, suggesting that the Akt/MDM2/p53 pathway is responsible for suppression of apoptosis. Dominant-negative Akt blocked phosphorylation of MDM2 in salivary acinar cells from myr-Akt1 transgenic mice.	SEN:10021532	16982679
BEL:20057358	p(MGI:Mesp1) increases r(MGI:Pax3)	Mesp1 induced the paraxial mesoderm genes Pax3 and Tcf15 on day 4, but this was not sustained at day 6 (Figures S3A and S3B).	SEN:10029156	18593559
BEL:20057360	p(MGI:Mesp1) increases r(MGI:Snai1)	In the presence of DKK1, Mesp1 induced Snai1 and Twist expression within 24 hr (Figure 2B). Snai1 expression increased progressively from 5-fold induction at 6 hr to 39-fold induction after 24 hr of dox treatment (Figures 2C and 2D).	SEN:10029158	18593559
BEL:20057362	p(MGI:Mesp1) increases r(MGI:Tcf15)	Mesp1 induced the paraxial mesoderm genes Pax3 and Tcf15 on day 4, but this was not sustained at day 6 (Figures S3A and S3B).	SEN:10029156	18593559
BEL:20057372	p(MGI:Mfge8) increases bp(GOBP:phagocytosis)	increased TUNEL detection in lesions of Mfge8-/- mice occurred in the absence of enhanced susceptibility of Mfge8-/- macrophages to apoptosis in vitro (Figure 4A and 4B) and was associated with defective in vivo clearance of apoptotic thymocytes by Mfge8?/? macrophages (Figure 4C)	SEN:10029166	17420351
BEL:20057378	p(MGI:Mfge8) decreases r(MGI:Ifng)	We also detected a 2-fold increase in IFNG mRNA levels in ascending atherosclerotic aortas of mice reconstituted with Mfge8-/- bone marrow compared with controls	SEN:10029172	17420351
BEL:20057398	p(MGI:Mif) increases bp(GOBP:"cell differentiation")	Investigators demonstrated that MIF enhances the differentiation of endothelial cells to blood vessels [54, 55] .	SEN:10029182	18791328
BEL:20057400	p(MGI:Mif) increases bp(GOBP:"cell proliferation")	incubation with the neutralizing MIF antibody inhibited the serum-induced proliferation of SMCs, suggesting a possible autocrine response SMC-derived MIF which contributes to the mitogenic effect of serum stimulation [21].	SEN:10029184	18385967
BEL:20057402	p(MGI:Mif) increases bp(GOBP:"inflammatory response")	Treatment of a strain of mice, which spontaneously develop atherosclerotic lesions (apolipoprotein E-deficient mice) with neutralizing anti-MIF Ab, led to a reduction of a variety of inflammatory mediators typically associated with atherosclerosis (32), implying that MIF may also play an important role in arterial intima inflammation.	SEN:10029186	16272275
BEL:20057404	p(MGI:Mif) increases bp(GOBP:"inflammatory response")	In MIF?/? mice, endotoxin-treated macrophages showed decreased viability, reduced proinflammatory function, and increased apoptosis [37].	SEN:10029188	18385967
BEL:20057408	p(MGI:Mif) decreases bp(GOBP:"apoptotic process")	In MIF?/? mice, endotoxin-treated macrophages showed decreased viability, reduced proinflammatory function, and increased apoptosis [37].	SEN:10029188	18385967
BEL:20057414	p(MGI:Mif) increases path(MESHD:Sepsis)	it has been demonstrated that MIF-neutralizing antibodies protect mice against septic shock [5] . Subsequently, investigators demonstrated that MIF deficiency confers protection against lipopolysaccharide (LPS)-induced shock [6]	SEN:10029178	18791328
BEL:20057428	p(MGI:Mif) decreases p(MGI:Dusp1)	Use of antisense MIF led to decreased MIF concentrations in treated macrophages while higher amounts of mitogen-activated protein kinase phosphatase and lower concentrations of cytokines such as TNF were observed. This study thus demonstrated the proinflammatory potential of MIF and stressed the importance of an autocrine action of MIF to override steroid-induced MKP-1 and to inhibit cytokine production [29] .	SEN:10029204	18791328
BEL:20057442	p(MGI:Mif) increases p(MGI:Tnf)	Use of antisense MIF led to decreased MIF concentrations in treated macrophages while higher amounts of mitogen-activated protein kinase phosphatase and lower concentrations of cytokines such as TNF were observed. This study thus demonstrated the proinflammatory potential of MIF and stressed the importance of an autocrine action of MIF to override steroid-induced MKP-1 and to inhibit cytokine production [29] .	SEN:10029204	18791328
BEL:20057450	p(MGI:Mif) increases tscript(p(MGI:Cebpb))	Possible transcriptional regulators of plaque development and inflammation, such as P-c-jun and CEBP- b, were down-regulated in MIF antibody-treated mice [36]	SEN:10029214	18385967
BEL:20057452	p(MGI:Mif) increases tscript(p(MGI:Jun))	Possible transcriptional regulators of plaque development and inflammation, such as P-c-jun and CEBP- b, were down-regulated in MIF antibody-treated mice [36]	SEN:10029214	18385967
BEL:20057454	p(MGI:Mif) decreases tscript(p(MGI:Trp53))	Fingerle-Rowson et al. [61] used a MIF-knockout mouse model and examined mouse fibroblasts where they found p53-dependent growth alterations and an increase in transcriptional activity of p53	SEN:10029216	18791328
BEL:20057456	p(MGI:Mif) decreases tscript(p(MGI:Trp53))	Initially, the interaction of MIF with p53 was shown by Hudson et al. [60] in 1999. They demonstrated that MIF treatment was able to overcome p53 activity and inhibited its transcriptional activity.	SEN:10029218	18791328
BEL:20057494	p(MGI:Mmp12) increases bp(GOBP:"cell proliferation")	As shown in Fig. 3A, there was a steady increase of BrdUrd pulse-labeled AT II epithelial cells in the doxycycline-treated bitransgenic mice compared with untreated littermates. The increase of MMP12-induced cell proliferation wastime dependent.	SEN:10029240	19706765
BEL:20057496	p(MGI:Mmp12) increases bp(GOBP:"inflammatory response")	MMP12 overexpression in lung epithelial cells, bitransgenic mice were treated with doxycycline for various time lengths. Histopathologic analyses revealed lung abnormalities in bitransgenic mice beginning at 6 weeks of doxycycline treatment. At this stage, marked inflammatory cell infiltration and emphysema were readily detectable (Fig. 2A, +Dox 6W).	SEN:10029242	19706765
BEL:20057500	p(MGI:Mmp12) decreases bp(GOBP:"apoptotic process")	FACS analysis showed a more than 5-fold decrease of Annexin V–labeled AT II epithelial cellsin 9-month doxycyclinetreated bitransgenic mice compared with untreated littermates (21.41% versus 4.91%).	SEN:10029244	19706765
BEL:20057502	p(MGI:Mmp12) increases path(MESHD:Adenocarcinoma)	Bronchioalveolar adenocarcinomas were observed in the lungs of bitransgenic mice after doxycycline treatment asearly as16 weeks (Fig. 2A, +Dox 16W).	SEN:10029246	19706765
BEL:20057504	p(MGI:Mmp12) increases path(MESHD:Hyperplasia)	After 10 to 15 weeksof doxycycline treatment, the bitransgenic mice began to develop adenomatoid hyperplasia in both parenchyma and small conducting airways(F ig. 2A, +Dox 10W), which resembles to the histopathologic feature of dysplasia in clinical lesions.	SEN:10029248	19706765
BEL:20057506	p(MGI:Mmp12) increases p(MGI:Foxa3)	In addition, Stat3-induced downstream developmental gene HNF4a wasup-regulated to 78.6-fold, Foxa3 to 9.3-fold, and SHH to 3.3-fold (Fig. 4D).	SEN:10029250	19706765
BEL:20057508	p(MGI:Mmp12) increases p(MGI:Hnf4a)	In addition, Stat3-induced downstream developmental gene HNF4a wasup-regulated to 78.6-fold, Foxa3 to 9.3-fold, and SHH to 3.3-fold (Fig. 4D).	SEN:10029250	19706765
BEL:20057510	p(MGI:Mmp12) increases p(MGI:Il6)	As shown in Fig. 4A, IL-6 concentration in BALF of doxycycline-treated mice was steadily increased compared with those in untreated bitransgenic mice in a time-dependent fashion,	SEN:10029252	19706765
BEL:20057512	p(MGI:Mmp12) decreases p(MGI:Serpina1a)	In response to cigarette smoke, a1AT protein levels were at least as prominent in serum following cigarette smoke exposure in both wild-type and MMP-12-deficient mice (Figure 5, bottom). In the lung, however, a1AT levels were elevated in MMP-12-/- mice, but reduced by 50% in wild-type mice, following exposure to cigarettes (Figure 5, top).	SEN:10029232	14633606
BEL:20057514	p(MGI:Mmp12) directlyDecreases p(MGI:Serpina1b)	who showed that neutrophil elastase activates pro-MMP-12 and destroys tissue inhibitor of metalloprotease (TIMP)-1; conversely, MMP-12 degrades A1AT.	SEN:10029254	18223159
BEL:20057516	p(MGI:Mmp12) increases p(MGI:Shh)	In addition, Stat3-induced downstream developmental gene HNF4a wasup-regulated to 78.6-fold, Foxa3 to 9.3-fold, and SHH to 3.3-fold (Fig. 4D).	SEN:10029250	19706765
BEL:20057522	p(MGI:Mmp12) decreases r(MGI:Mmp13)	Although the TIMP and Th2 cytokine responses were similar, a marked and highly significant increase in MMP13 was observed in the lungs of mmp12-/- mice after egg challenge (Fig. 4A).	SEN:10029258	20181883
BEL:20057524	p(MGI:Mmp12) increases r(MGI:Mmp2)	increased expression of several other MMPs was also observed in doxycycline-treated bitransgenic mice compared with untreated mice. (Fig 4D)	SEN:10029260	19706765
BEL:20057526	p(MGI:Mmp12) increases r(MGI:Mmp7)	increased expression of several other MMPs was also observed in doxycycline-treated bitransgenic mice compared with untreated mice. (Fig 4D)	SEN:10029260	19706765
BEL:20057528	p(MGI:Mmp12) increases r(MGI:Mmp8)	increased expression of several other MMPs was also observed in doxycycline-treated bitransgenic mice compared with untreated mice. (Fig 4D)	SEN:10029260	19706765
BEL:20057530	p(MGI:Mmp12) increases r(MGI:Mmp9)	increased expression of several other MMPs was also observed in doxycycline-treated bitransgenic mice compared with untreated mice. (Fig 4D)	SEN:10029260	19706765
BEL:20057536	p(MGI:Mmp14) increases cat(p(MGI:Mmp2))	The delayed lung maturation characterized by abnormal branching and poor alveolization in EGFR(-/-) is accompanied by aberrant expression of MMP's. Inhibition of MMP's in developing lungs in vivo or in vitro severely retarded morphogenesis.	SEN:10020254	11865039
BEL:20057548	p(MGI:Mmp7) increases bp(GOBP:"cell migration")	Time-lapse microscopy revealed that the Mmp7-/- epithelium appeared to retain the ability to spread over the wound, as these cells formed extended lamellipodial fronts soon after wounding. However, only WT epithelium continued to migrate and complete the wound healing process.	SEN:10029268	19668337
BEL:20057550	p(MGI:Mmp7) increases deg(p(MGI:Eln))	Mmp7-/- mice have been used to identify or at least highly implicate FasL, syndecan-1 , E-cadherin, RANKL , latent TNF-a , elastin , and notch-1 as substrates of MMP7	SEN:10029270	20135274
BEL:20057552	p(MGI:Mmp7) increases p(MGI:Sdc1)	Moreover, shed syndecan-1 was detected in the medium of injured WT cultures and in bronchoalveolar lavage fluid from naphthalene injured WT mice but not in Mmp7?/? samples (Figure 1C).	SEN:10029272	19668337
BEL:20057554	p(MGI:Mmp7) increases p(MGI:Tnf)	Haro and colleagues (33) recently showed that MMP-7 was required for release of TNF- from peritoneal macrophages	SEN:10029274	12522030
BEL:20057574	p(MGI:Mmp9) increases r(MGI:Col3a1)	As shown in Figure 4C, transcript levels of collagen III (i.e. Col3a1) were significantly reduced in the cardiac muscle of mdx/Mmp9-/- mice compared to mdx/Mmp9+/+ mice.	SEN:10029286	21810612
BEL:20057580	p(MGI:Mmp9) increases r(MGI:Mmp12)	Interestingly, the mRNA levels of MMP-3 and MMP-12 (but not MMP-2, MMP-10, TIMP-2, or TIMP-3) were found to be significantly reduced in heart of mdx/Mmp9-/- mice compared to mdx/Mmp9+/+ mice (Figure 6).	SEN:10029290	21810612
BEL:20057582	p(MGI:Mmp9) increases r(MGI:Mmp3)	Interestingly, the mRNA levels of MMP-3 and MMP-12 (but not MMP-2, MMP-10, TIMP-2, or TIMP-3) were found to be significantly reduced in heart of mdx/Mmp9-/- mice compared to mdx/Mmp9+/+ mice (Figure 6).	SEN:10029290	21810612
BEL:20057592	p(MGI:Mst1r) decreases a(CHEBI:"nitric oxide")	macrophage-stimulating protein (MSP), through activation of its receptor RON, negatively regulates NO production in response to IFN-gamma and LPS by inhibiting the expression of inducible NO synthase (iNOS).	SEN:10000252	11777982
BEL:20057594	p(MGI:Mst1r) decreases r(MGI:Nos2)	macrophage-stimulating protein (MSP), through activation of its receptor RON, negatively regulates NO production in response to IFN-gamma and LPS by inhibiting the expression of inducible NO synthase (iNOS).	SEN:10000252	11777982
BEL:20057596	p(MGI:Mstn) decreases bp(GOBP:"cell cycle")	Myostatin appears to function by controlling myoblast cell cycle progression (35). Recombinant myostatin, when added to actively growing myoblasts, inhibited the progression of G1 myoblasts into S phase.	SEN:10029294	12242286
BEL:20057598	p(MGI:Mstn) decreases bp(GOBP:"cell growth")	Myostatin, a transforming growth factor beta (TGF-beta) family member, is a potent negative regulator of skeletal muscle growth.	SEN:10009598	14517293
BEL:20057600	p(MGI:Mstn) decreases bp(GOBP:"G1/S transition of mitotic cell cycle")	Myostatin appears to function by controlling myoblast cell cycle progression (35). Recombinant myostatin, when added to actively growing myoblasts, inhibited the progression of G1 myoblasts into S phase.	SEN:10029294	12242286
BEL:20057608	p(MGI:Mstn) decreases kin(p(MGI:Cdk2))	Molecular analysis indicated that myostatin down-regulated the protein levels of Cdk2 and up-regulated the levels of its inhibitor p21, thereby rendering Cdk2 inactive.	SEN:10025916	12242286
BEL:20057610	p(MGI:Mstn) decreases path(MESHD:Hyperplasia)	INTRO Myostatin is a newly identified member of the transforming growth factor beta superfamily, and myostatin-null mice have been found to show a two- to threefold increase in skeletal muscle mass due to an increase in the number of muscle fibers (hyperplasia) and the size of the fibers (hypertrophy) (21).	SEN:10029300	12242286
BEL:20057612	p(MGI:Mstn) decreases path(MESHD:Hyperplasia)	the inhibitory effect of MSTN on muscle growth is demonstrated by the hypertrophic and hyperplasic muscle phenotype displayed by MSTN-/- mice	SEN:10029298	14715915
BEL:20057614	p(MGI:Mstn) decreases path(MESHD:Hypertrophy)	INTRO Myostatin is a newly identified member of the transforming growth factor beta superfamily, and myostatin-null mice have been found to show a two- to threefold increase in skeletal muscle mass due to an increase in the number of muscle fibers (hyperplasia) and the size of the fibers (hypertrophy) (21).	SEN:10029300	12242286
BEL:20057618	p(MGI:Mstn) decreases p(MGI:Cdk2)	Molecular analysis indicated that myostatin down-regulated the protein levels of Cdk2 and up-regulated the levels of its inhibitor p21, thereby rendering Cdk2 inactive.	SEN:10025916	12242286
BEL:20057620	p(MGI:Mstn) increases p(MGI:Cdkn1a)	Molecular analysis indicated that myostatin down-regulated the protein levels of Cdk2 and up-regulated the levels of its inhibitor p21, thereby rendering Cdk2 inactive.	SEN:10025916	12242286
BEL:20057628	p(MGI:Mt1) decreases bp(GOBP:"response to oxidative stress")	MT-I overexpression regulated the inflammatory response, decreased oxidative stress and apoptosis significantly, and increased brain tissue repair in comparison with either GFAP-IL-6 or control litter-mate mice.	SEN:10029308	12673834
BEL:20057636	p(MGI:Mt1) increases r(MGI:Serpina3k)	The sequences of the other cDNA fragments were identical to those of contrapsin, transketolase, and vanin-3. The latter two were up-regulated, whereas contrapsin was down-regulated in neonatal MT-null mice.	SEN:10009602	10753647
BEL:20057638	p(MGI:Mt1) decreases r(MGI:Tkt)	The sequences of the other cDNA fragments were identical to those of contrapsin, transketolase, and vanin-3. The latter two were up-regulated, whereas contrapsin was down-regulated in neonatal MT-null mice.	SEN:10009602	10753647
BEL:20057640	p(MGI:Mt1) decreases r(MGI:Vnn3)	The sequences of the other cDNA fragments were identical to those of contrapsin, transketolase, and vanin-3. The latter two were up-regulated, whereas contrapsin was down-regulated in neonatal MT-null mice.	SEN:10009602	10753647
BEL:20057642	p(MGI:Mta3) decreases sec(p(MGI:Wnt4))	Here we show that expression of MTA3 inhibits ductal branching in virgin and pregnant murine transgenic mammary glands. MTA3 also suppresses the Wnt4 pathway and, thus, these findings parallel phenotypic changes in Wnt4-null mice. MTA3 represses Wnt4 transcription and Wnt4 secretion, inhibiting Wnt-target genes in mammary epithelial cells	SEN:10009604	17050676
BEL:20057652	p(MGI:Mtor) increases p(MGI:Hes1)	While the reduction of mTOR markedly abolished STAT3, p63, and Notch signaling (Figure 9A), decreased expression of rictor did not affect the STAT3/p63/Notch signaling cascade (Figure 9B).	SEN:10029316	20038814
BEL:20057654	p(MGI:Mtor) increases p(MGI:Notch1)	While the reduction of mTOR markedly abolished STAT3, p63, and Notch signaling (Figure 9A), decreased expression of rictor did not affect the STAT3/p63/Notch signaling cascade (Figure 9B).	SEN:10029316	20038814
BEL:20057656	p(MGI:Mtor) increases p(MGI:Stat3,pmod(P,S,705))	While the reduction of mTOR markedly abolished STAT3, p63, and Notch signaling (Figure 9A), decreased expression of rictor did not affect the STAT3/p63/Notch signaling cascade (Figure 9B).	SEN:10029316	20038814
BEL:20057658	p(MGI:Mtor) increases p(MGI:Trp63)	While the reduction of mTOR markedly abolished STAT3, p63, and Notch signaling (Figure 9A), decreased expression of rictor did not affect the STAT3/p63/Notch signaling cascade (Figure 9B).	SEN:10029316	20038814
BEL:20057660	p(MGI:Mtor) increases sec(p(MGI:Il2))	Furthermore, the inactivation of mTOR decreases IL-2 secretion upon stimulation of DCs through the C-type lectin receptor Dectin [138], indicating that cytokine production through C-type lectin receptor activation involves mTOR.	SEN:10029318	19390566
BEL:20057676	p(MGI:Mttp) directlyIncreases sec(p(MGI:Apob))	the beta-sheet domain makes apoB secretion responsive to the presence of oleic acid in the medium and dependent on Mttp activity from Vance Ch.19 p513- when the fatty acid oleate is added to HepG2 cells the synthesis of TG and phospholipids is stimulated and the amounts of apoB and TG secreted are increased	SEN:10016510	12006608
BEL:20057678	p(MGI:Mttp) directlyIncreases tloc(p(MGI:Apob),GOCCID:0005737,GOCCID:0005788)	regulation at the level of elongation a profound decrease in apoB synthesis with no change in apoB mRNA abundance decreased synthesis could be explained by a prolonged elongation rate for apoB the elongation of apoB mRNA in HepG2 cells slows when translocation of nascent apoB across the endoplasmic reticulum is inhibited by preventing Mttp-associated transfer of lipids to the nascent polypeptide	SEN:10020186	12006608
BEL:20057686	p(MGI:Muc4) increases bp(GOBP:"cell growth")	NIH3T3/ MUC4 cells showed an enhanced growth rate as compared to the empty vector-transfected (NIH3T3/pSecTag) cells.	SEN:10029332	19010895
BEL:20057688	p(MGI:Muc4) increases kin(p(MGI:Mapk1))	NIH3T3/MUC4 cells also showed an increased phosphorylation of ERKs (p42/44 MAPK) as compared to the control NIH3T3/ pSecTag cells.	SEN:10029334	19010895
BEL:20057690	p(MGI:Muc4) increases kin(p(MGI:Mapk3))	NIH3T3/MUC4 cells also showed an increased phosphorylation of ERKs (p42/44 MAPK) as compared to the control NIH3T3/ pSecTag cells.	SEN:10029334	19010895
BEL:20057694	p(MGI:Muc4) increases p(MGI:Erbb2)	Our results clearly show that NIH3T3/ MUC4 cells have increased levels of total and phosphorylated ErbB2 protein as compared to the control NIH3T3/pSecTag cells (Figure 4).	SEN:10029338	19010895
BEL:20057696	p(MGI:Muc4) increases p(MGI:Erbb2,pmod(P,Y,1249))	Our results clearly show that NIH3T3/ MUC4 cells have increased levels of total and phosphorylated ErbB2 protein as compared to the control NIH3T3/pSecTag cells (Figure 4).	SEN:10029338	19010895
BEL:20057698	p(MGI:Mus81) decreases path(MESHD:Lymphoma)	(McPherson et al, 2004a). Heterozygous and homozygous Mus81 mutants show cancer predisposition, particularly to T- and B-cell lymphomas.	SEN:10029340	18285820
BEL:20057702	p(MGI:Mxd1) decreases bp(GOBP:"apoptotic process")	Mad1 can also inhibit apoptosis and reverse the differentiation blocking effect of c-MYC in erythroleukemia cells. These findings are consistent with the notion that Mad and Mxi1 suppress c-MYC function (Amati and Land, 1994; Luscher, 2001).	SEN:10029344	18955973
BEL:20057712	p(MGI:Myc) decreases bp(GOBP:"cell differentiation")	Wild-type c-MYC expression in myeloid cells blocks differentiation and promotes an incompletely penetrant apoptotic response	SEN:10029348	18955973
BEL:20057714	p(MGI:Myc) increases bp(GOBP:"cell proliferation")	The c-Myc oncoprotein functions as a transcription factor that can transform normal cells into tumor cells, as well as playing a direct role in normal cell proliferation.	SEN:10002686	11839798
BEL:20057718	p(MGI:Myc) increases bp(GOBP:"cell proliferation")	BrdU incorporation showed that although there was increased proliferation in c-MYC overexpressing cells compared with control cells	SEN:10029352	18955973
BEL:20057720	p(MGI:Myc) increases bp(GOBP:"apoptotic process")	c-MYC overexpression accelerated apoptosis when these cells were deprived of IL-3 (Eischen et al., 2001b). Furthermore, c-MYC overexpression suppresses Bcl-2 protein and RNA levels, and restoration of Bcl-2 protein blocks this accelerated apoptosis.	SEN:10025374	18955973
BEL:20057722	p(MGI:Myc) increases bp(GOBP:"apoptotic process")	Further support for the importance of Bax, but not Bak, inMYC-mediated apoptosis was obtained using a switchable mouse model of MYC-induced apoptosis in pancreatic beta cells, where it was shown that c-MYC induces apoptosis in vivo exclusively through Bax (Dansen et al., 2006).	SEN:10025356	18955973
BEL:20057726	p(MGI:Mycn,pmod(P,S,54)) directlyDecreases deg(p(MGI:Mycn))	We report that phosphorylation-induced turnover of endogenous N-myc protein in CGNPs increases during mitosis, due to increased priming phosphorylation of N-myc for GSK-3beta. The priming phosphorylation requires the Cdk1 complex, whose cyclin subunits are indirect Sonic hedgehog targets	SEN:10021092	16139224
BEL:20057728	p(MGI:Mycn,pmod(P,T,50)) directlyIncreases deg(p(MGI:Mycn))	We report that phosphorylation-induced turnover of endogenous N-myc protein in CGNPs increases during mitosis, due to increased priming phosphorylation of N-myc for GSK-3beta. The priming phosphorylation requires the Cdk1 complex, whose cyclin subunits are indirect Sonic hedgehog targets	SEN:10021092	16139224
BEL:20057738	p(MGI:Myc) increases p(MGI:Bax)	Further support for the importance of Bax, but not Bak, inMYC-mediated apoptosis was obtained using a switchable mouse model of MYC-induced apoptosis in pancreatic beta cells, where it was shown that c-MYC induces apoptosis in vivo exclusively through Bax (Dansen et al., 2006).	SEN:10025356	18955973
BEL:20057740	p(MGI:Myc) decreases p(MGI:Bcl2)	c-MYC overexpression accelerated apoptosis when these cells were deprived of IL-3 (Eischen et al., 2001b). Furthermore, c-MYC overexpression suppresses Bcl-2 protein and RNA levels, and restoration of Bcl-2 protein blocks this accelerated apoptosis.	SEN:10025374	18955973
BEL:20057752	p(MGI:Myc) decreases r(MGI:Bcl2)	c-MYC overexpression accelerated apoptosis when these cells were deprived of IL-3 (Eischen et al., 2001b). Furthermore, c-MYC overexpression suppresses Bcl-2 protein and RNA levels, and restoration of Bcl-2 protein blocks this accelerated apoptosis.	SEN:10025374	18955973
BEL:20057758	p(MGI:Myc) decreases tscript(p(MGI:Cebpa))	We also found that c-Myc antagonized C/EBP alpha-mediated transactivation of gadd45. Analysis of systematically altered forms of C/EBP alpha revealed that c-Myc antagonism targeted the antimitotic, transcriptional activation domain of C/EBP alpha.	SEN:10029364	10025511
BEL:20057778	p(MGI:Myd88) increases bp(GOBP:"cell migration")	Myd88(-/-) and Tlr4(-/-)Tlr2(-/-) mice showed impaired transepithelial migration of inflammatory cells but decreased survival and enhanced epithelial cell apoptosis after lung injury	SEN:10029372	16244651
BEL:20057782	p(MGI:Myd88) decreases bp(GOBP:"apoptotic process")	Myd88(-/-) and Tlr4(-/-)Tlr2(-/-) mice showed impaired transepithelial migration of inflammatory cells but decreased survival and enhanced epithelial cell apoptosis after lung injury	SEN:10029372	16244651
BEL:20057788	p(MGI:Myd88) increases cat(p(MGI:Nlrp3))	We made use of the fact that heterologous overexpression of MyD88 activates downstream signaling and therefore expressed the Nlrp3 promoter luciferase construct alone or together with MyD88. Indeed, co-expression of the Nlrp3 promoter-luciferase construct with MyD88 led to a ~10-fold induction of luciferase activity indicating that MyD88-mediated signaling can activate the promoter of Nlrp3.	SEN:10020744	19570822
BEL:20057800	p(MGI:Myd88) increases p(MGI:Ccl2)	This was the first direct evidence of an atheroprotective effect of TLR deficiency. These mice had a reduction in plasma monocyte chemotactic protein-1 (MCP-1), an important mediator of tissue macrophage infiltration, as well as a reduction in plaque lipid content and macrophage infiltration. The same changes were found in MyD88–/–apoE–/– mice, in accordance with Bjorkbacka et al. (42).	SEN:10029382	16891671
BEL:20057802	p(MGI:Myd88) increases p(MGI:Ccl3)	By using neutralizing antibody against TLR4, the releases of CCL3 and CXCL2 was decreased (Fig. 3A and B). MyD88 is a critical adapter molecule for the transduction of TLRs signals. Therefore, cDCs lacking MyD88 were investigated. CSE did not induce the release of CCL3 and CXCL2 from cDCs obtained from MyD88 knockout mice (Fig. 3C and D).	SEN:10029384	19293939
BEL:20057804	p(MGI:Myd88) increases p(MGI:Cxcl2)	By using neutralizing antibody against TLR4, the releases of CCL3 and CXCL2 was decreased (Fig. 3A and B). MyD88 is a critical adapter molecule for the transduction of TLRs signals. Therefore, cDCs lacking MyD88 were investigated. CSE did not induce the release of CCL3 and CXCL2 from cDCs obtained from MyD88 knockout mice (Fig. 3C and D).	SEN:10029384	19293939
BEL:20057810	p(MGI:Myd88) increases p(MGI:Il6)	In response to hepatocyte cell death, MyD88 signalling was responsible for the activation of NF-?B and for the production of factors such as IL-6 (ReF. 122).	SEN:10029386	19052556
BEL:20057816	p(MGI:Myd88) increases r(MGI:Ccl3)	Deficiency of MyD88, a downstream signaling molecule of TLR4, also abolished the lipopolysaccharide response in WT and Abcg1-deficient macrophages (Figure IA and IB in the online-only Data Supplement).	SEN:10029392	18852364
BEL:20057818	p(MGI:Myd88) increases r(MGI:Cxcl2)	Deficiency of MyD88, a downstream signaling molecule of TLR4, also abolished the lipopolysaccharide response in WT and Abcg1-deficient macrophages (Figure IA and IB in the online-only Data Supplement).	SEN:10029392	18852364
BEL:20057820	p(MGI:Myd88) increases r(MGI:Il1b)	Deficiency of MyD88, a downstream signaling molecule of TLR4, also abolished the lipopolysaccharide response in WT and Abcg1-deficient macrophages (Figure IA and IB in the online-only Data Supplement).	SEN:10029392	18852364
BEL:20057822	p(MGI:Myd88) increases r(MGI:Tnf)	Deficiency of MyD88, a downstream signaling molecule of TLR4, also abolished the lipopolysaccharide response in WT and Abcg1-deficient macrophages (Figure IA and IB in the online-only Data Supplement).	SEN:10029392	18852364
BEL:20057826	p(MGI:Myf5) increases bp(GOBP:"skeletal muscle tissue development")	Thus, the hyperplasia condition observed in the absence of myostatin could be due to increased proliferation of myoblasts because of a deregulated G1/S checkpoint (35). MyoD and Myf5 are expressed in myoblasts and myotubes and have been shown to be required for myogenesis.	SEN:10029394	12242286
BEL:20057834	p(MGI:Myo1c) increases complex(p(MGI:Ikbkg),p(MGI:Irs1))	In contrast, dominant inhibitory Myo1c cargo domain expression diminished this interaction and inhibited IRS-1 phosphorylation.	SEN:10029398	16754954
BEL:20057836	p(MGI:Myo1c) increases complex(p(MGI:Ikbkg),p(MGI:Irs1))	Increased Myo1c expression enhanced the NEMO-IRS-1 interaction, which is essential for TNF-alpha- induced phosphorylation of Ser307-IRS-1.	SEN:10005474	16754954
BEL:20057838	p(MGI:Myo1c) increases p(MGI:Irs1,pmod(P,S,307))	In contrast, dominant inhibitory Myo1c cargo domain expression diminished this interaction and inhibited IRS-1 phosphorylation.	SEN:10029398	16754954
BEL:20057842	p(MGI:Myod1) increases bp(GOBP:"skeletal muscle tissue development")	Thus, the hyperplasia condition observed in the absence of myostatin could be due to increased proliferation of myoblasts because of a deregulated G1/S checkpoint (35). MyoD and Myf5 are expressed in myoblasts and myotubes and have been shown to be required for myogenesis.	SEN:10029394	12242286
BEL:20057844	p(MGI:Myod1) increases bp(GOBP:"skeletal muscle tissue development")	Both HES-1 and the intracellular domain of murine Notch (mNotch) are able to block MyoD-induced myogenesis.	SEN:10008922	7566092
BEL:20057866	p(MGI:Myt1) increases r(MGI:Neurog3)	These results demonstrate that Myt1b and Ngn3 positively regulate each other's expression to promote endocrine differentiation.	SEN:10009622	18394599
BEL:20057870	p(MGI:Nampt) increases a(CHEBI:"hydrogen peroxide")	Figure 2 shows a significant increase of 1.9-fold in production of superoxide ions (Fig. 2a) and 1.7-fold increase in the generation of hydrogen peroxide (Fig. 2b) following treatment with visfatin compared to control.	SEN:10029416	19898975
BEL:20057872	p(MGI:Nampt) increases a(CHEBI:"reactive oxygen species")	Figure 1 shows that the addition of 100 ng/ml mouse recombinant visfatin for 18 h generates ROS in myotubes, which were partially inhibited by the antioxidant NAC (reduced by approximately 40%).	SEN:10015378	19898975
BEL:20057878	p(MGI:Nampt) increases bp(GOBP:"response to oxidative stress")	In order to assess the effects of increased visfatin on oxidative stress responses in muscle, differentiated C2C12 myocytes were incubated with recombinant mouse visfatin. Dose response (0–200 ng/ml) and time course (0–48 h) studies indicated that a working concentration of 100 ng/ml for 18 h generated highest levels of oxidative stress with low levels of toxicity (data not shown).	SEN:10029418	19898975
BEL:20057882	p(MGI:Nampt) increases p(MGI:Rela,pmod(P,S,536))	Figure 5b shows a twofold increase in the phosphorylated p65 subunit of NFkB following visfatin treatment.	SEN:10029420	19898975
BEL:20057900	p(MGI:Ncf1) increases bp(GOBP:"patterning of blood vessels")	Furthermore, exposure of aortic rings from p47(phox-/-) mice to Ang-1 demonstrated fewer vessel sprouts than WT mice. Inhibition of the Tie-2 receptor inhibited Ang-1-induced endothelial migration and vessel sprouting	SEN:10022236	16679392
BEL:20057926	p(MGI:Ncl,pmod(P)) directlyIncreases complex(p(MGI:Ncl),p(MGI:Pik3cb))	CR2 activation induced, within a brief span of 2 min, tyrosine phosphorylation of nucleolin and its interaction with Src homology 2 domains of the p85 subunit of PI 3 kinase and of 3BP2 and Grb2	SEN:10026106	11207269
BEL:20057930	p(MGI:Ncoa2) increases r(MGI:Cdkn1a)	Exogenous/ectopic expression studies with GRIP-1 sense and antisense vectors in myogenic C2C12 cells demonstrated that this SRC is necessary for (1) induction/activation of myogenin, MEF-2, and the crucial cell cycle regulator, p21, and (2)contractile protein expression and myotube formation	SEN:10009634	10817756
BEL:20057932	p(MGI:Ncoa2) increases r(MGI:Myog)	Exogenous/ectopic expression studies with GRIP-1 sense and antisense vectors in myogenic C2C12 cells demonstrated that this SRC is necessary for (1) induction/activation of myogenin, MEF-2, and the crucial cell cycle regulator, p21, and (2)contractile protein expression and myotube formation	SEN:10009634	10817756
BEL:20057942	p(MGI:Ncor2) decreases r(EGID:216850)	Our data reveal that SMRT represses expression of the jumonji-domain containing gene JMJD3, a direct retinoic-acid-receptor target that functions as a histone H3 trimethyl K27 demethylase and which is capable of activating specific components of the neurogenic program.	SEN:10009638	17928865
BEL:20057944	p(MGI:Ncor2) decreases tscript(p(MGI:Ppard))	We show that the corepressors NCoR and SMRT are capable of fully repressing PPARd-mediated transactivation induced by either by ligands or by cAMO-regulated signaliing pathways.	SEN:10029442	11903058
BEL:20057948	p(MGI:Ndn) decreases bp(GOBP:"cell cycle")	These results suggest that necdin is a nuclear factor that governs the permanent arrest of cell growth of postmitotic neurons during development of the nervous systems of vertebrates.	SEN:10009640	7639751
BEL:20057952	p(MGI:Ndn) decreases bp(GOBP:"cell growth")	These results suggest that necdin is a nuclear factor that governs the permanent arrest of cell growth of postmitotic neurons during development of the nervous systems of vertebrates.	SEN:10009640	7639751
BEL:20057954	p(MGI:Ndn) decreases bp(GOBP:"apoptotic process")	These results are in agreement with Necdin proposed role on cell cycle arrest, inhibition of apoptosis and facilitation of neuronal differentiation in vitro, and with hypothalamic cellular deficiencies reported in mice with abrogation of the Necdin gene.	SEN:10029446	14643685
BEL:20057960	p(MGI:Ndufaf1) increases bp(GOBP:"necrotic cell death")	Knockdown of cPLA2 or a chaperone involved in the assembly of mitochondrial complex I, the NADH dehydrogenase (ubiquinone) 1-? subcomplex assembly factor 1 (NDUFAF1), resulted in a similar inhibition of TNF-induced necroptosis (Supplementary Figure 5c and d),	SEN:10029450	20010783
BEL:20057976	p(MGI:Neurod2) increases r(MGI:Gap43)	Transfection of vectors expressing neuroD and neuroD2 into P19 cells shows that both can activate expression through simple E-box-driven reporter constructs and can activate a reporter driven by the neuroD2 promoter region, but the GAP-43 promoter is preferentially activated by neuroD2.	SEN:10009650	8816493
BEL:20057980	p(MGI:Neurod2) increases r(MGI:Scrt1)	Transient co-transfection in P19 cells with either Mash1 or NeuroD2 plus E12 also induced Scrt gene expression.	SEN:10009652	11687288
BEL:20057982	p(MGI:Neurod4) increases r(MGI:Neurod1)	Math3 similarly had little effect on the NeuroD promoter in the dorsal telencephalon (1 µg/µl, 6.28 ± 0.73; n = 8) but efficiently induced NeuroD promoter activity in ventral domains (1 µg/µl, 3.84 ± 0.39; n = 10; P = 0.0002 versus pCIG2 ventral) (Fig. 7E).	SEN:10029456	18160702
BEL:20057986	p(MGI:Neurog1) increases r(MGI:Gap43)	Transfection of vectors expressing neuroD and neuroD2 into P19 cells shows that both can activate expression through simple E-box-driven reporter constructs and can activate a reporter driven by the neuroD2 promoter region, but the GAP-43 promoter is preferentially activated by neuroD2.	SEN:10009650	8816493
BEL:20057994	p(MGI:Neurog3) increases r(MGI:Myt1)	These results demonstrate that Myt1b and Ngn3 positively regulate each other's expression to promote endocrine differentiation.	SEN:10009622	18394599
BEL:20058022	p(MGI:Nfe2l1) decreases a(CHEBI:"reactive oxygen species")	Thus, Nrf1 has a protective function against oxidative stress and, potentially, a function in lipid homeostasis in the liver. Hepatocytes Lacking Nrf1 show elevated ROS and oxidative damage.	SEN:10029472	15738389
BEL:20058024	p(MGI:Nfe2l1) increases r(MGI:Gclm)	Fibroblasts derived from Nrf1 null embryos showed reduced expression of GCLM and GSS, and Nrf1 has been shown to bind and activate the GCLM promoter	SEN:10029474	19665035
BEL:20058026	p(MGI:Nfe2l1) increases r(MGI:Gss)	Fibroblasts derived from Nrf1 null embryos showed reduced expression of GCLM and GSS, and Nrf1 has been shown to bind and activate the GCLM promoter	SEN:10029474	19665035
BEL:20058064	p(MGI:Nfe2l2) decreases bp(GOBP:"inflammatory response")	In an experimental sepsis model, Nrf2 deficiency increased the inflammation and mortality of mice against bacterial endotoxin (LPS)- and cecal ligation and puncture-induced septic shock (Thimmulappa et al., 2006a).	SEN:10029478	19646463
BEL:20058100	p(MGI:Nfe2l2) decreases p(MGI:Ccl17)	Nrf2(-/-) mice exposed to low-dose DEP showed significantly increased airway hyperresponsiveness and counts of lymphocytes and eosinophils, together with increased concentrations of IL-12 and IL-13, and thymus and activation-regulated chemokine (TARC), in BAL fluid than wild-type mice. In contrast, expression of antioxidant enzyme genes was significantly higher in wild-type mice than in Nrf2(-/-) mice.	SEN:10000634	18614404
BEL:20058104	p(MGI:Nfe2l2) increases p(MGI:Hmox1)	To confirm the requirement of Nrf2 for eckol-induced HO-1 expression, cells were transfected with siNrf2 for 24 h prior to eckol treatment. As shown in Fig. 2F, the both constitutive and eckol-induced expression ofHO-1wasmarkedly inhibited by siRNA knock down of Nrf2 gene.	SEN:10029484	19931411
BEL:20058106	p(MGI:Nfe2l2) decreases p(MGI:Il13)	Nrf2(-/-) mice exposed to low-dose DEP showed significantly increased airway hyperresponsiveness and counts of lymphocytes and eosinophils, together with increased concentrations of IL-12 and IL-13, and thymus and activation-regulated chemokine (TARC), in BAL fluid than wild-type mice. In contrast, expression of antioxidant enzyme genes was significantly higher in wild-type mice than in Nrf2(-/-) mice.	SEN:10000634	18614404
BEL:20058112	p(MGI:Nfe2l2,pmod(P,S)) directlyIncreases tscript(p(MGI:Nfe2l2))	Collectively, these results indicate that ERK-1 regulates hyperoxia-stimulated Nrf2 phosphorylation and the subsequent ARE-driven transcriptional response.	SEN:10000380	15292179
BEL:20058116	p(MGI:Nfe2l2,pmod(P,Y,576)) directlyIncreases complex(p(MGI:Nfe2l2),p(MGI:Xpo1))	FIGURE 3. Phosphorylation of Nrf2Y568 is essential for interaction with Crm1 and nuclear export of Nrf2	SEN:10029518	16513647
BEL:20058120	p(MGI:Nfe2l2,pmod(P,Y,576)) directlyIncreases tloc(p(MGI:Nfe2l2),GOCCID:0005634,GOCCID:0005737)	FIGURE 3. Phosphorylation of Nrf2Y568 is essential for interaction with Crm1 and nuclear export of Nrf2	SEN:10029518	16513647
BEL:20058128	p(MGI:Nfe2l2) increases r(MGI:Col1a1)	The levels of collagen alpha1 (I), alpha1 (III), and fibronectin mRNAs were reduced in 1-day wounds of Nrf2 knockout mice compared to control littermates.	SEN:10029522	12101242
BEL:20058130	p(MGI:Nfe2l2) increases r(MGI:Fn1)	The levels of collagen alpha1 (I), alpha1 (III), and fibronectin mRNAs were reduced in 1-day wounds of Nrf2 knockout mice compared to control littermates.	SEN:10029522	12101242
BEL:20058136	p(MGI:Nfe2l2) increases r(MGI:Il1b)	Interestingly, the normally observed induction of IL-1beta and TNF-alpha expression (22) was delayed in the knockout mice. The levels of IL-1beta mRNA were 50% lower in the 1-day wounds of Nrf2-/- mice than for control littermates.	SEN:10029526	12101242
BEL:20058138	p(MGI:Nfe2l2) increases r(MGI:Il6)	Expression of IL-6 was also lower in 1-day wounds of Nrf2 null mice, but in contrast to IL-1beta the mRNA of this cytokine was no longer detectable at later stages of repair.	SEN:10029528	12101242
BEL:20058146	p(MGI:Nfe2l2) increases r(MGI:Tgfb1)	Indeed, TGF-beta1 mRNA was present at lower levels in unwounded back skin and in 1-day wounds of Nrf2-/- mice (Fig.7).	SEN:10029532	12101242
BEL:20058148	p(MGI:Nfe2l2) increases r(MGI:Tnf)	Interestingly, the normally observed induction of IL-1beta and TNF-alpha expression (22) was delayed in the knockout mice. The levels of IL-1beta mRNA were 50% lower in the 1-day wounds of Nrf2-/- mice than for control littermates.	SEN:10029526	12101242
BEL:20058150	p(MGI:Nfe2l2) increases r(MGI:Vegfa)	Expression of VEGF, a major regulator of angiogenesis, was also reduced in nonwounded skin and in 1-day wounds of Nrf2 null mice (Fig.7).	SEN:10029534	12101242
BEL:20058152	p(MGI:Nfe2) increases p(MGI:Hsd3b1)	There are two isoforms of 3beta- HSD expressed in wild-type megakaryocytes (I and VI), but neither are expressed in NF-E2 null megakaryocytes.	SEN:10029536	17127443
BEL:20058154	p(MGI:Nfe2) increases p(MGI:Hsd3b6)	There are two isoforms of 3beta- HSD expressed in wild-type megakaryocytes (I and VI), but neither are expressed in NF-E2 null megakaryocytes.	SEN:10029536	17127443
BEL:20058158	p(MGI:Nfil3) decreases bp(GOBP:"apoptotic process")	E4bp4 and homologues in other species have been implicated in a diverse range of processes including commitment to cell survival versus apoptosis, the anti-inflammatory response and in the mammalian circadian oscillatory mechanism	SEN:10029538	12386933
BEL:20058170	p(MGI:Nfkb1) directlyDecreases kin(p(MGI:Map3k8))	Upon stimulation with TLR ligands, p105 is phosphorylated by I kappa B kinase (IKK) complex and partially degraded, which releases TPL2. The free TPL2 is active and stimulates the ERK pathway via MEK1/2.	SEN:10005814	17507094
BEL:20058196	p(MGI:Nfya) increases r(MGI:Hoxb4)	NF-Ya overexpression induced the expression of HOXB4 in HSCs-enriched Lin–Sca-1+ population in vivo (Fig. 1A ). In parallel, NF-Ya overexpression increased the expression of the HOX4 paralogs HOXC4 and HOXD4, and to a lesser extent HOXA4 (Fig. 1A ).	SEN:10029558	16081537
BEL:20058198	p(MGI:Nfya) increases r(MGI:Hoxc4)	NF-Ya overexpression induced the expression of HOXB4 in HSCs-enriched Lin–Sca-1+ population in vivo (Fig. 1A ). In parallel, NF-Ya overexpression increased the expression of the HOX4 paralogs HOXC4 and HOXD4, and to a lesser extent HOXA4 (Fig. 1A ).	SEN:10029558	16081537
BEL:20058200	p(MGI:Nfya) increases r(MGI:Hoxd4)	NF-Ya overexpression induced the expression of HOXB4 in HSCs-enriched Lin–Sca-1+ population in vivo (Fig. 1A ). In parallel, NF-Ya overexpression increased the expression of the HOX4 paralogs HOXC4 and HOXD4, and to a lesser extent HOXA4 (Fig. 1A ).	SEN:10029558	16081537
BEL:20058202	p(MGI:Ngef) decreases cat(p(MGI:Cdc42))	Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes.	SEN:10008564	11336673
BEL:20058204	p(MGI:Ngef) decreases gtp(p(MGI:Rac1))	Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes.	SEN:10008564	11336673
BEL:20058206	p(MGI:Ngef) increases gtp(p(MGI:Rhoa))	Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes.	SEN:10008564	11336673
BEL:20058208	p(MGI:Ngf) increases bp(GOBP:"cell differentiation")	NAB2 overexpression blocked NGF-dependent differentiation and prevented NGF induction of TGF-beta1, MMP3 and p21waf1	SEN:10029560	10734128
BEL:20058214	p(MGI:Ngf) increases kin(p(MGI:Mapk1))	NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells... NGF also induced phosphorylation of JNK	SEN:10029562	11404390
BEL:20058216	p(MGI:Ngf) increases kin(p(MGI:Mapk3))	NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells... NGF also induced phosphorylation of JNK	SEN:10029562	11404390
BEL:20058218	p(MGI:Ngf) increases kin(p(MGI:Mapk8))	NGF activates Erk1/Erk2 and JNK but not p38MAPK in J774 cells... NGF also induced phosphorylation of JNK	SEN:10029562	11404390
BEL:20058220	p(MGI:Ngf) increases kin(p(MGI:Ntrk1))	To examine the role of TrkA in NGF's effects, we used K252a, which inhibits the tyrosine kinase activity of this receptor. Pretreatment of the cells with K252a (50 ng/mL) inhibited the production of TNF-a by NGF	SEN:10022028	11404390
BEL:20058222	p(MGI:Ngf) decreases p(MGI:Gmfb,pmod(P))	intracellular interaction of PKA, GMF, and p38 is supported by the phosphorylation of GMF upon cellular stimulation by forskolin (blocked by PKA inhibitor) and by the co-immunoprecipitation of p38 with GMF from cell lysates. Withdrawal of nerve growth factor from PC12 leads to increased GMF phosphorylation with a time course similar to that reported for p38 activation.	SEN:10016716	8798479
BEL:20058228	p(MGI:Ngf) increases p(MGI:Tnf)	The MAP kinase-Erk kinase (MEK) inhibitor PD 098059 inhibits the production of TNF-alpha induced by NGF	SEN:10029566	11404390
BEL:20058234	p(MGI:Ngf) increases r(MGI:Cdkn1a)	NAB2 overexpression blocked NGF-dependent differentiation and prevented NGF induction of TGF-beta1, MMP3 and p21waf1	SEN:10029560	10734128
BEL:20058236	p(MGI:Ngf) increases r(MGI:Chn1)	alpha chimaerin which has 91% homology to human alpha2 chimaerin, was also up-regulated following exposure to BDNF figure shows NGF also induces	SEN:10025402	15447672
BEL:20058238	p(MGI:Ngf) increases r(MGI:Chn2)	An increase in the expression of beta chimaerin mRNA by the BDNF treatment was found during the observation period, Expression of beta chimaerin mRNA is induced transiently by NGF as well as BDNF	SEN:10025404	15447672
BEL:20058240	p(MGI:Ngf) increases r(MGI:Mmp3)	NAB2 overexpression blocked NGF-dependent differentiation and prevented NGF induction of TGF-beta1, MMP3 and p21waf1	SEN:10029560	10734128
BEL:20058248	p(MGI:Ngf) increases r(MGI:Tgfb1)	NAB2 overexpression blocked NGF-dependent differentiation and prevented NGF induction of TGF-beta1, MMP3 and p21waf1	SEN:10029560	10734128
BEL:20058250	p(MGI:Ngf) increases r(MGI:Tnf)	The induction of TNF-alpha production by NGF was blocked by K252a, an inhibitor of the TrkA receptor.	SEN:10009676	11404390
BEL:20058252	p(MGI:Nif3l1) increases tscript(p(MGI:Cops2))	Luciferase reporter assay showed that Nif3l1 could act as a transcriptional repressor and synergized the transcriptional repression by Trip15/CSN2.	SEN:10009678	12522100
BEL:20058254	p(MGI:"Nkx2-1") increases bp(GOBP:"inflammatory response")	Increased expression of TTF-1 in alveolar type II cells caused dose-dependent alterations in alveolar morphology, epithelial cell hyperplasia, emphysema, and pulmonary inflammation.	SEN:10029570	11820807
BEL:20058258	p(MGI:"Nkx2-1") increases path(MESHD:Emphysema)	Increased expression of TTF-1 in alveolar type II cells caused dose-dependent alterations in alveolar morphology, epithelial cell hyperplasia, emphysema, and pulmonary inflammation.	SEN:10029570	11820807
BEL:20058274	p(MGI:"Nkx2-5") increases tscript(p(MGI:Gata4))	Within the proximal A1AR promoter, putative binding sites for cardiac transcription factors GATA and Nkx2.5 were identified. Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression	SEN:10027152	10318839
BEL:20058290	p(MGI:Nlrc4) increases cat(p(MGI:Casp1))	Macrophages from Ipaf-null mice are specifically deficient in caspase-1 activation and IL-1 secretion in response to flagellin	SEN:10029586	17641058
BEL:20058292	p(MGI:Nlrp3) increases sec(p(MGI:Il1b))	we measured the abundance of IL-1beta in the lesional skin of these animals and observed that there was no increase in IL-1beta in cryopyrin null mice as compared with controls	SEN:10029588	19258328
BEL:20058294	p(MGI:Nlrp3) increases sec(p(MGI:Il1b))	we next examined whether HA can directly induce IL-1beta release. Peritoneal macrophages of WT mice, but not cryopyrin null mice (Nlrp3-/-), showed a large increase in IL-1beta release	SEN:10015752	19258328
BEL:20058306	p(MGI:Nmu) increases bp(GOBP:"cell proliferation")	Exogenous NmU rescued growth suppression in K562-MERT cells and stimulated the growth of primary AML cells.	SEN:10029590	15187020
BEL:20058316	p(MGI:Nmu) increases cat(p(MGI:Nmur1))	Significantly, only AML cells expressed the cognate receptor of NmU, NMU1R, suggesting the presence of a novel autocrine loop.	SEN:10029592	15187020
BEL:20058326	p(MGI:Nod1) decreases bp(GOBP:"inflammatory response")	In mouse models, Nod1 or Nod2 deficiency results in enhanced intestinal inflammation upon bacterial infection as a result of the disruption of innate immune responses.	SEN:10029594	20548099
BEL:20058334	p(MGI:Nod2) decreases bp(GOBP:"inflammatory response")	In mouse models, Nod1 or Nod2 deficiency results in enhanced intestinal inflammation upon bacterial infection as a result of the disruption of innate immune responses.	SEN:10029594	20548099
BEL:20058344	p(MGI:Nos2) increases deg(p(MGI:Irs1))	Here we demonstrate that exposure to NO donor or iNOS transfection reduced insulin receptor substrate (IRS)-1 protein expression without altering the mRNA level in cultured skeletal muscle cells. NO donor increased IRS-1 ubiquitination, and proteasome inhibitors blocked NO donor-induced reduction in IRS-1 expression in cultured skeletal muscle cells.	SEN:10003508	15805118
BEL:20058348	p(MGI:Nos2) decreases path(MESHD:Tachycardia)	The basal heart rate was higher in iNOS knockout mice compared with controls (465+/-8 vs 415+/-13 beat/min P<0.05),	SEN:10029600	16790251
BEL:20058352	p(MGI:Nos2) increases r(EGID:20755)	Comparison of both mouse genotypes showed that basal lung expression of several genes, including some cytoskeletal proteins (e.g., actin, myosin, and keratin) and cell surface proteins (e.g., CD3, CD8, and T cell receptor), was suppressed in NOS2-/- mice compared with wild-type mice (Fig. 6C, Table 3).	SEN:10029604	12972406
BEL:20058358	p(MGI:Nos2) increases r(MGI:Sprr3)	Comparison of both mouse genotypes showed that basal lung expression of several genes, including some cytoskeletal proteins (e.g., actin, myosin, and keratin) and cell surface proteins (e.g., CD3, CD8, and T cell receptor), was suppressed in NOS2-/- mice compared with wild-type mice (Fig. 6C, Table 3).	SEN:10029604	12972406
BEL:20058360	p(MGI:Nos2) increases r(MGI:Thy1)	Comparison of both mouse genotypes showed that basal lung expression of several genes, including some cytoskeletal proteins (e.g., actin, myosin, and keratin) and cell surface proteins (e.g., CD3, CD8, and T cell receptor), was suppressed in NOS2-/- mice compared with wild-type mice (Fig. 6C, Table 3).	SEN:10029604	12972406
BEL:20058362	p(MGI:Nos3) decreases a(CHEBI:hydroxyproline)	Subpleural fibrotic changes and hydroxyproline content in the eNOS-TG mice were significantly reduced compared with those of the wild-type (WT) mice by day 56	SEN:10009708	16916326
BEL:20058374	p(MGI:Nos3) decreases path(MESHD:Atherosclerosis)	both apoE//prostacyclin receptor/164 and apoE//eNOS/163 mice showed accelerated atherosclerosis compared with apoE/ mice.	SEN:10029614	17332437
BEL:20058376	p(MGI:Nos3) decreases path(MESHD:Fibrosis)	In previous animal experiments, chronic inhibition of NOS induced myocardial fibrosis and limited LV preload reserve.	SEN:10009714	12485814
BEL:20058378	p(MGI:Nos3) decreases path(MESHD:Fibrosis)	Subpleural fibrotic changes and hydroxyproline content in the eNOS-TG mice were significantly reduced compared with those of the wild-type (WT) mice by day 56	SEN:10009708	16916326
BEL:20058390	p(MGI:Nos3) decreases p(MGI:Madcam1)	Disease activity was dramatically increased in eNOS-/- mice compared to wild types. Histologically, eNOS-deficient mice had greater leukocyte infiltration, gut injury, and expressed higher levels of the mucosal addressin, MAdCAM-1.	SEN:10009716	14680690
BEL:20058396	p(MGI:Nos3) increases p(MGI:Timp1)	in contrast, the level of tissue inhibitor of metalloproteinases-1 (TIMP-1), an endogenous MMP-9 inhibitor, was increased in the bleomycin-treated eNOS-TG mice compared with WT.	SEN:10009720	16916326
BEL:20058400	p(MGI:Nos3,pmod(P,S,1176)) directlyIncreases cat(p(MGI:Nos3))	Akt, a serine/threonine kinase that is a major target of phosphatidylinositol 3-kiniase (PI3K), phosphorylates eNOS at Ser1177, and this phosphorylation enhances eNOS activity and increases NO production in vascular endothelial cells.	SEN:10019394	17000928
BEL:20058404	p(MGI:Nos3) decreases r(MGI:Cyp2c29)	Microarray analysis indicated a significant upregulation of CYP2C29 and retinoid X receptor gamma (RXRgamma) in isolated mesenteric arteries/arterioles of female endothelial nitric oxide synthase-knockout mice, a result that was validated by real-time RT-PCR.	SEN:10009724	20130225
BEL:20058406	p(MGI:Nos3) decreases r(MGI:Rxrg)	Microarray analysis indicated a significant upregulation of CYP2C29 and retinoid X receptor gamma (RXRgamma) in isolated mesenteric arteries/arterioles of female endothelial nitric oxide synthase-knockout mice, a result that was validated by real-time RT-PCR.	SEN:10009724	20130225
BEL:20058418	p(MGI:Notch1) decreases bp(GOBP:"Wnt receptor signaling pathway")	Notch1 can also function as a tumour suppressor in mouse skin by inducing Waf1 and repressing Shh and Wnt signalling.	SEN:10029626	14570040
BEL:20058428	p(MGI:Notch1) decreases p(MGI:Shh)	Notch1 can also function as a tumour suppressor in mouse skin by inducing Waf1 and repressing Shh and Wnt signalling.	SEN:10029626	14570040
BEL:20058430	p(MGI:Notch1) increases r(MGI:Adam17)	NOTCH1 activation, indicated by tumor necrosis factor alpha-converting enzyme, TACE [Adam17], and presenilin-mediated processing, also increased	SEN:10028408	12629177
BEL:20058434	p(MGI:Notch1) increases r(MGI:Cdkn1a)	Notch1 can also function as a tumour suppressor in mouse skin by inducing Waf1 and repressing Shh and Wnt signalling.	SEN:10029626	14570040
BEL:20058436	p(MGI:Notch1) increases r(MGI:Gata2)	Taken together, these data strongly suggest that activation of Gata2 expression by Notch1/RBPjkappa is a crucial event for the onset of definitive hematopoiesis in the embryo.	SEN:10009730	15689374
BEL:20058442	p(MGI:Notch1) increases r(MGI:Hey1)	Furthermore, both EC network formation and expression of activated notch 1 or notch 4 induce expression of the bHLH transcription factor HESR-1 and downregulate the known HESR-1 target VEGFR-2 (KDR).	SEN:10009732	12453432
BEL:20058446	p(MGI:Notch1) increases tscript(p(MGI:Stat3))	Expression of an active form of Notch (Notch?E; the transmembrane and intracellular domains of mouse Notch1, comprising residues 1,704–2,531)15, significantly induced activation of a STAT-dependent reporter gene (APRE-Luc)16 in mouse cortical neuroepithelial cells derived on embryonic day (E) 13 or in the rat neural precursor MNS-70 cells17	SEN:10029634	15156153
BEL:20058456	p(MGI:Notch4) increases r(MGI:Hey1)	Furthermore, both EC network formation and expression of activated notch 1 or notch 4 induce expression of the bHLH transcription factor HESR-1 and downregulate the known HESR-1 target VEGFR-2 (KDR).	SEN:10009732	12453432
BEL:20058458	p(MGI:Nox1) increases a(CHEBI:"reactive oxygen species")	Taken together, these findings suggest that CpG ODN stimulates Nox1-mediated ROS generation through the NFkB signaling pathway.	SEN:10029636	18817866
BEL:20058460	p(MGI:Nox1) increases a(CHEBI:"reactive oxygen species")	ROS were markedly increased in the lungs of hyperoxia-exposed WT mice compared with air-exposed WT mice. This hyperoxiainduced increase in ROS was significantly attenuated in NOX1- deficient mice but not in NOX2-deficient mice (Figure 3A).	SEN:10029638	19661248
BEL:20058462	p(MGI:Nox1) increases a(CHEBI:"reactive oxygen species")	These results indicate that NOX1 but not NOX2 is mainly responsible for ROS formation in lungs and in primary type II AECs and MLECs	SEN:10029640	19661248
BEL:20058464	p(MGI:Nox1) increases bp(GOBP:"apoptotic process")	Hyperoxia increased significantly the number of TUNEL-positive cells in the lungs of WT mice and NOX2-deficient mice. By contrast, a much lower number of cells was positive when derived from NOX1-deficient mice under hyperoxia (Figures 5A and 5B).	SEN:10029642	19661248
BEL:20058492	p(MGI:Noxo1) increases cat(p(MGI:Nox1))	NOXO1...is an organizer protein that activates NADPH oxidase (NOX1)...NADPH oxidase is a major source of reactive oxygen species, and oxidative stress is considered to play an important role in the pathogenesis of COPD	SEN:10019400	16717027
BEL:20058502	p(MGI:Npnt) increases bp(GOBP:"cell adhesion")	These results suggest that POEM is a novel ligand for alpha(8)beta(1) integrin and that POEM may be involved in the development and function of various tissues, such as kidney, bone, muscles, and endocrine organs.	SEN:10004212	11546798
BEL:20058506	p(MGI:Npnt) increases cat(complex(p(MGI:Itga8),p(MGI:Itgb1)))	These results suggest that POEM is a novel ligand for alpha(8)beta(1) integrin and that POEM may be involved in the development and function of various tissues, such as kidney, bone, muscles, and endocrine organs.	SEN:10004212	11546798
BEL:20058516	p(MGI:Nppc) increases cat(p(MGI:Npr3))	Voltage-clamp measurements in enzymatically isolated single pacemaker myocytes revealed that CNP (10(-8) M) and cANF (10(-8) M) significantly inhibited L-type Ca2+ current [ICa(L)]. These findings suggest that the CNP effect on this current is mediated by NPR-C.	SEN:10019412	14704228
BEL:20058522	p(MGI:Npr3) decreases p(MGI:Nppa)	Mesangial cells from nonobese diabetic (NOD) mice (D-NOD) that develop diabetes at 2-4 mo express an increased density of atrial natriuretic peptide (ANP) clearance receptors [natriuretic peptide C receptor (NPR-C)] and produce less GMP in response to ANP than their nondiabetic counterparts (ND-NOD).	SEN:10005548	11457715
BEL:20058544	p(MGI:Nr0b2) decreases cat(p(MGI:Cyp7a1))	since Lrh1 is required for transcription of Cyp7a1, one net result of activating Fxr and Shp expression was a decrease in the mRNA, protein and activity of Cyp7a1	SEN:10029662	11792716
BEL:20058546	p(MGI:Nr0b2) decreases p(MGI:Cyp7a1)	since Lrh1 is required for transcription of Cyp7a1, one net result of activating Fxr and Shp expression was a decrease in the mRNA, protein and activity of Cyp7a1	SEN:10029662	11792716
BEL:20058548	p(MGI:Nr0b2) decreases r(MGI:Cyp7a1)	since Lrh1 is required for transcription of Cyp7a1, one net result of activating Fxr and Shp expression was a decrease in the mRNA, protein and activity of Cyp7a1	SEN:10029662	11792716
BEL:20058552	p(MGI:Nr1d1) increases p(MGI:Cyp7a1)	Expression of CYP7A1, the rate-limiting enzyme of the neutral pathway, is decreased in livers of Rev-erbalpha-deficient mice, whereas adenovirus-mediated hepatic Rev-erbalpha overexpression induces its expression. Moreover, bile acid feeding resulted in a more pronounced suppression of hepatic CYP7A1 expression in Rev-erbalpha-deficient mice.	SEN:10029664	18565334
BEL:20058562	p(MGI:Nr1h2) increases p(MGI:Abca1)	Ligand-induced activation of PPAR has been reported to regulate cholesterol efflux from macrophages through an induction of another nuclear receptor, liver X receptor (LXR), which is a critical regulator of the ATP-binding cassette protein-1 (ABCA-1).114,115	SEN:10029672	14732733
BEL:20058564	p(MGI:Nr1h2) increases r(MGI:Abcg5)	In the Enterocyte LXRa and LXRb activity increases the expression of ABCA1 and likely also ABCG5 and ABCG8, while FXR activity positively regulated I-BABP (a cytosolic factor involved in the hepatic/portal reciruclation of bile acids in and out of the gut lumen (see Figure 3C)	SEN:10029674	12021839
BEL:20058566	p(MGI:Nr1h2) increases r(MGI:Abcg8)	In the Enterocyte LXRa and LXRb activity increases the expression of ABCA1 and likely also ABCG5 and ABCG8, while FXR activity positively regulated I-BABP (a cytosolic factor involved in the hepatic/portal reciruclation of bile acids in and out of the gut lumen (see Figure 3C)	SEN:10029674	12021839
BEL:20058568	p(MGI:Nr1h2) increases r(MGI:Cyp7a1)	activated Pxr, like activated Fxr, results in repression of Cyp7a1 Cyp7a1 expression is repressed by both bile acid-activated Pxr and Fxr, and induced by oxysterol-activated Lxr	SEN:10029676	11792716
BEL:20058576	p(MGI:Nr1h3) increases r(MGI:Abca1)	In the Enterocyte LXRa and LXRb activity increases the expression of ABCA1 and likely also ABCG5 and ABCG8, while FXR activity positively regulated I-BABP (a cytosolic factor involved in the hepatic/portal reciruclation of bile acids in and out of the gut lumen (see Figure 3C)	SEN:10029674	12021839
BEL:20058578	p(MGI:Nr1h3) increases r(MGI:Cyp7a1)	activated Pxr, like activated Fxr, results in repression of Cyp7a1 Cyp7a1 expression is repressed by both bile acid-activated Pxr and Fxr, and induced by oxysterol-activated Lxr	SEN:10029676	11792716
BEL:20058600	p(MGI:Nr1h4) increases r(MGI:Abcc2)	MRP2 [multidrug resistance-associated protein 2] was identified in a screen designed to isolate genes that are regulated by Fxr Mrp2 mRNA levels were induced following treatment of hepatocytes with either chenodeoxycholic acid or synthetic Fxr ligands	SEN:10029686	11706036
BEL:20058602	p(MGI:Nr1h4) increases r(MGI:Abcc2)	identified 1 gene Mrp2 involved in this excretion process that, surprisingly, is activated by Pxr, Fxr and Car [constitutive androstane receptor], emphasizes the overlapping roles of multiple nuclear receptors	SEN:10029688	11792716
BEL:20058604	p(MGI:Nr1h4) increases r(MGI:Apoc2)	Fxr induces gene expression in response to several bile acids, including chenodeoxycholic acid identify apoC2 as an Fxr target gene	SEN:10029690	11579204
BEL:20058606	p(MGI:Nr1h4) increases r(MGI:Apoc2)	hepatic expression of both apoC2 and phospholipid transfer protein mRNAs increases when mice are fed diets supplemented with cholic acid, an Fxr ligand, and this induction is attenuated in Fxr null mice	SEN:10000240	11579204
BEL:20058612	p(MGI:Nr1h4) increases r(MGI:Nr0b2)	the repression of Cyp7a1 was indirect and involved 2 other nuclear hormone receptors names Shp [Nr0b2] and Lrh-1 [Nr5a2] the gene encoding Shp was activated directly by Fxr	SEN:10029694	11792716
BEL:20058614	p(MGI:Nr1h4) increases r(MGI:Pltp)	hepatic expression of both apoC2 and phospholipid transfer protein mRNAs increases when mice are fed diets supplemented with cholic acid, an Fxr ligand, and this induction is attenuated in Fxr null mice	SEN:10000240	11579204
BEL:20058616	p(MGI:Nr1h4) increases r(MGI:Scarb1)	mice lacking Fxr have increased plasma HDL cholesterol and a markedly reduced rate of plasma HDL cholesterol ester clearance mice lacking Fxr exhibit reduced expression of hepatic genes involved in reverse cholesterol transport, most notably, that for scavenger receptor BI	SEN:10029684	12421815
BEL:20058622	p(MGI:Nr1i2) increases r(MGI:Abcc2)	Mrp2 expression is regulated by the pregnane X receptor [Pxr, Nr1I2] and constitutive androstane receptor [Car, Nr1I3]	SEN:10009746	11706036
BEL:20058624	p(MGI:Nr1i2) increases r(MGI:Abcc2)	identified 1 gene Mrp2 involved in this excretion process that, surprisingly, is activated by Pxr, Fxr and Car [constitutive androstane receptor], emphasizes the overlapping roles of multiple nuclear receptors	SEN:10029688	11792716
BEL:20058626	p(MGI:Nr1i2) decreases r(MGI:Cyp7a1)	activated Pxr, like activated Fxr, results in repression of Cyp7a1 Cyp7a1 expression is repressed by both bile acid-activated Pxr and Fxr, and induced by oxysterol-activated Lxr	SEN:10029676	11792716
BEL:20058630	p(MGI:Nr1i3) increases r(MGI:Abcc2)	Mrp2 expression is regulated by the pregnane X receptor [Pxr, Nr1I2] and constitutive androstane receptor [Car, Nr1I3]	SEN:10009746	11706036
BEL:20058632	p(MGI:Nr1i3) increases r(MGI:Abcc2)	identified 1 gene Mrp2 involved in this excretion process that, surprisingly, is activated by Pxr, Fxr and Car [constitutive androstane receptor], emphasizes the overlapping roles of multiple nuclear receptors	SEN:10029688	11792716
BEL:20058634	p(MGI:Nr2c2) increases p(MGI:Cd36)	By using semiquantitative PCR, real-time quantitative PCR, and Western blotting analysis, we found that CD36 mRNA and protein expression in peritoneal macrophages isolated from TR4-/- mice was significantly lower as compared to that from TR4+/+ mice (Fig. 2A).	SEN:10029698	19666541
BEL:20058640	p(MGI:Nr2c2) increases r(MGI:Cd36)	By using semiquantitative PCR, real-time quantitative PCR, and Western blotting analysis, we found that CD36 mRNA and protein expression in peritoneal macrophages isolated from TR4-/- mice was significantly lower as compared to that from TR4+/+ mice (Fig. 2A).	SEN:10029698	19666541
BEL:20058660	p(MGI:Nr3c1) increases cat(p(MGI:Lpl))	Inhibition of LPL activity by Wy-14643 did not reduce the ability of insulin plus dexamethasone to stimulate cellular and heparin-releasable LPL activities. A similar inhibitory effect on cellular and heparin-releasable LPL activity was observed when cardiomyocytes were cultured with 60 microM linoleic acid.	SEN:10015610	11454595
BEL:20058664	p(MGI:Nr3c1) increases r(MGI:Cebpd)	DEX activates the gene encoding C/EBP delta. Likewise, MIX is a direct inducer of C/EBP beta gene expression	SEN:10009756	7531665
BEL:20058666	p(MGI:Nr3c1) increases r(MGI:Cebpd)	DEX activates the gene encoding C/EBP delta. Likewise, MIX is a direct inducer of C/EBP beta gene expression.	SEN:10009758	7531665
BEL:20058680	p(MGI:Nr3c1) decreases r(MGI:Serpina6)	This treatment completely suppressed both endogenous plasma corticosterone and hepatic corticosterone-binding globulin (CBG) mRNA	SEN:10009770	8039608
BEL:20058694	p(MGI:Nr4a1) decreases bp(GOBP:"cell growth")	Finally, we show that Nur77 expression inhibits mitotic clonal expansion of preadipocytes, providing an additional mechanism by which Nur77 may inhibit adipogenesis.	SEN:10009774	18945812
BEL:20058708	p(MGI:Nr5a1) increases r(MGI:Abcb11)	The expression of Bsep, which is responsible for the export of the majority of BA into the bile canaliculi, was also reduced (Fig. 6C).	SEN:10029712	17908794
BEL:20058710	p(MGI:Nr5a1) increases r(MGI:Abcc3)	Consistent with earlier studies proposing LRH-1 as a transcriptional regulator of Mrp3 under cholestatic conditions, Mrp3 was also reduced in the livers of LRH-1hep-/- mice (Fig. 6B).	SEN:10029714	17908794
BEL:20058712	p(MGI:Nr5a1) increases r(MGI:Abcg5)	Among the apical/canalicular transporters, the expression of Abcg8 and Abcg5, both involved in the biliary excretion of sterols, was decreased in the livers of LRH-1hep-/- mice (Fig. 6C).	SEN:10029716	17908794
BEL:20058714	p(MGI:Nr5a1) increases r(MGI:Abcg8)	Among the apical/canalicular transporters, the expression of Abcg8 and Abcg5, both involved in the biliary excretion of sterols, was decreased in the livers of LRH-1hep-/- mice (Fig. 6C).	SEN:10029716	17908794
BEL:20058716	p(MGI:Nr5a1) increases r(MGI:Star)	a role for steroidogenic factor-1, SF1, in basal as well as trophic hormone-dependent expression of the Star gene	SEN:10029718	11145563
BEL:20058722	p(MGI:Nr5a2) increases r(MGI:Cyp8b1)	bile acids also repress the synthesis of cholic acid by repressing the transcription of Cyp8b1 [sterol 12alpha-hydroxylase] via a similar mechanism that also involves the inactivation of Lrh1 by Shp	SEN:10029722	11792716
BEL:20058740	p(MGI:Nrg1) increases p(MGI:Errfi1)	These observations were extended to HC-11 cells, a murine cell line derived from breast epithelium. In these cells TGF-a, an activator of EGFR, and HRG- 1b, which triggers ErbB-2/ErbB-3 dimers (Marte et al., 1995a,b), are able to induce RALT expression (Fiorentino et al., 2000).	SEN:10029724	12226756
BEL:20058756	p(MGI:Nsmaf) increases bp(GOBP:"apoptotic process")	bC also downregulated the expression of the pro-apoptotic gene Fan, and induced expression of the anti-apoptotic Sphk1a.	SEN:10022168	17707332
BEL:20058758	p(MGI:Ntf3) increases bp(GOBP:"cell differentiation")	Here we provide evidence that both the mitogenic effect of bFGF and the differentiation-promoting effect of NT3 are linked with modifications of cell cycle kinetics in mouse cortical precursor cells	SEN:10000274	12151540
BEL:20058760	p(MGI:Ntf3) increases cat(p(MGI:Cdkn1b))	bFGF downregulates p27(kip1) and upregulates cyclin D2 expression. This contrasts with NT3, which upregulates p27(kip1) and downregulates cyclin D2 expression	SEN:10008708	12151540
BEL:20058762	p(MGI:Ntf3) decreases r(MGI:Calb2)	As for BDNF and NT-4, incubation of cortical neurons with neurotrophin-3 (NT-3) also led to a decrease in calretinin expression.	SEN:10009792	10800929
BEL:20058764	p(MGI:Ntf3) decreases r(MGI:Ccnd2)	bFGF downregulates p27(kip1) and upregulates cyclin D2 expression. This contrasts with NT3, which upregulates p27(kip1) and downregulates cyclin D2 expression	SEN:10008708	12151540
BEL:20058770	p(MGI:Ntn1) increases cat(p(MGI:Unc5b))	Stimulation of UNC5B-expressing neovessels with an agonist (Netrin-1) inhibits sprouting angiogenesis. Genetic loss of function of unc5b reduces Netrin-1-mediated angiogenesis inhibition.	SEN:10019804	17908930
BEL:20058778	p(MGI:Oaz1) decreases cat(p(MGI:Odc1))	From introduction Az1 binds the ODC monomer, dissociating the enzymatically active ODC homodimer and thereby inhibiting its activity	SEN:10020406	12562772
BEL:20058804	p(MGI:Ormdl3) increases p(MGI:Il13)	Levels of BAL IL-13 (Fig. 5E) and lung IL-13 (Fig. 5F) were significantly increased in hORMDL3zp3-Cre mice at 8 and 26 wk of age as assessed by ELISA. Levels of BAL IL-5 (Fig. 5G) were significantly increased in hORMDL3zp3-Cre mice at 8 and 26 wk of age, whereas levels of lung IL-5 were only increased at 8 wk (Fig. 5H).	SEN:10029746	24623133
BEL:20058806	p(MGI:Ormdl3) increases p(MGI:Il5)	Levels of BAL IL-13 (Fig. 5E) and lung IL-13 (Fig. 5F) were significantly increased in hORMDL3zp3-Cre mice at 8 and 26 wk of age as assessed by ELISA. Levels of BAL IL-5 (Fig. 5G) were significantly increased in hORMDL3zp3-Cre mice at 8 and 26 wk of age, whereas levels of lung IL-5 were only increased at 8 wk (Fig. 5H).	SEN:10029746	24623133
BEL:20058810	p(MGI:Ormdl3) increases r(MGI:Cxcl10)	hORMDL3zp3-Cre mice had significantly increased levels of lung CXC chemokine mRNA, including CXCL10 in bronchial epithelial cells (Fig. 4I), as well as increased levels of CXCL11 mRNA in BAL macrophages (Fig. 4J), whereas levels of lung KC mRNA, the murine equivalent of IL-8, was not increased (data not shown).	SEN:10029750	24623133
BEL:20058812	p(MGI:Ormdl3) increases r(MGI:Cxcl11)	hORMDL3zp3-Cre mice had significantly increased levels of lung CXC chemokine mRNA, including CXCL10 in bronchial epithelial cells (Fig. 4I), as well as increased levels of CXCL11 mRNA in BAL macrophages (Fig. 4J), whereas levels of lung KC mRNA, the murine equivalent of IL-8, was not increased (data not shown).	SEN:10029750	24623133
BEL:20058818	p(MGI:Ormdl3) increases tscript(p(MGI:Atf6))	hORMDL3zp3-Cre mouse macrophages, but not WT macrophages, spontaneously activated the ATF6 pathway as assessed by translocation of ATF6 from being dispersed in the ER to the nucleus using immunofluorescence microscopy (Fig. 3A, 3B).	SEN:10029752	24623133
BEL:20058824	p(MGI:Osm) decreases bp(GOBP:"cell proliferation")	These data demonstrate that OSM induces up-regulation of C/EBPdelta via a Stat3-dependent pathway in mammary epithelial cells and that the growth inhibition induced by OSM depends on the presence of C/EBPdelta.	SEN:10029758	12479220
BEL:20058830	p(MGI:Osm) increases bp(GOBP:"osteoclast differentiation")	Il6, leukemia inhibitory factor [LIF}, and oncostatin M [OSM] are Il6-type cytokines that stimulate osteoclast formation and function	SEN:10028344	12218157
BEL:20058832	p(MGI:Osm) increases p(MGI:Ccl11)	Recombinant murine OSM stimulated eotaxin protein production and mRNA levels in the NIH 3T3 fibroblast cell line	SEN:10009810	12496442
BEL:20058834	p(MGI:Osm) increases p(MGI:Ccl11)	We and others have shown that OSM can induce eotaxin-1 in mouse lung fibroblasts (MLF) (28) and lung smooth muscle cells (29).	SEN:10029762	16547273
BEL:20058836	p(MGI:Osm) increases p(MGI:Cebpd)	Oncostatin M (OSM), an interleukin 6-type cytokine, induces sustained up-regulation of CCAAT/enhancer-binding protein (C/EBP) delta mRNA and protein	SEN:10029764	12479220
BEL:20058838	p(MGI:Osm) increases p(MGI:Il6)	We also compared the effects of mOSM on IL-6 expression in both wt and STAT6-/- MLF (Fig. 5, B and D) and show that STAT6-/- MLF respond similarly to wt MLF in IL-6 expression at both the mRNA and protein levels.	SEN:10029766	16547273
BEL:20058840	p(MGI:Osm) increases p(MGI:Il6st,pmod(P))	tryosine phosphorylation of gp130 was observed in fibroblasts after stimulation with all the cytokines	SEN:10027898	11820727
BEL:20058842	p(MGI:Osm) increases p(MGI:Stat1,pmod(P,Y,701))	mOSM induced STAT1 (Y701), STAT3 (Y705), and STAT5 (Y694) phosphorylation as reported by others (57, 58, 59).	SEN:10029768	16547273
BEL:20058844	p(MGI:Osm) increases p(MGI:Stat3,pmod(P,Y,705))	mOSM induced STAT1 (Y701), STAT3 (Y705), and STAT5 (Y694) phosphorylation as reported by others (57, 58, 59).	SEN:10029768	16547273
BEL:20058846	p(MGI:Osm) increases p(MGI:Stat5a,pmod(P,Y,694))	mOSM induced STAT1 (Y701), STAT3 (Y705), and STAT5 (Y694) phosphorylation as reported by others (57, 58, 59).	SEN:10029768	16547273
BEL:20058852	p(MGI:Osm) increases p(MGI:Vcam1)	Levels of VCAM-1 in STAT-6-deficient MLF were somewhat reduced compared with those observed in wt MLF, however, the ability of mOSM or mTNF-{alpha} to induce VCAM-1 was maintained (Fig. 7B).	SEN:10029770	16547273
BEL:20058854	p(MGI:Osm) increases r(MGI:Ccl11)	Twenty-four hour stimulation with 25.0 ng/ml mOSM induced detectable increases in eotaxin-1 expression at the mRNA and protein level in both wt and STAT6-/- MLF (Fig. 5, A and C). Stimulation of wt MLF using 10.0 ng/ml mIL-4 induced eotaxin mRNA expression and protein production that was nondetectable in STAT6-/- MLF (Fig. 5, A and C)	SEN:10028294	16547273
BEL:20058856	p(MGI:Osm) increases r(MGI:Cebpd)	Oncostatin M (OSM), an interleukin 6-type cytokine, induces sustained up-regulation of CCAAT/enhancer-binding protein (C/EBP) delta mRNA and protein	SEN:10029764	12479220
BEL:20058858	p(MGI:Osm) increases r(MGI:Cebpd)	% Oncostatin M (OSM), an interleukin 6-type cytokine, induces sustained up-regulation of CCAAT/enhancer-binding protein (C/EBP) delta mRNA and protein in nonneoplastic HC11 mouse mammary epithelial cells.	SEN:10029772	12479220
BEL:20058860	p(MGI:Osm) increases r(MGI:Il6)	We also compared the effects of mOSM on IL-6 expression in both wt and STAT6-/- MLF (Fig. 5, B and D) and show that STAT6-/- MLF respond similarly to wt MLF in IL-6 expression at both the mRNA and protein levels.	SEN:10029766	16547273
BEL:20058864	p(MGI:Osm) increases r(MGI:Tnfrsf11b)	OSM also stimulated Ca release and enhanced the mRNA expression of RANKL and OPG in mouse calcaria, but have no effect on the expression of RANK	SEN:10029756	12218157
BEL:20058866	p(MGI:Osm) increases r(MGI:Tnfsf11)	OSM also stimulated Ca release and enhanced the mRNA expression of RANKL and OPG in mouse calcaria, but have no effect on the expression of RANK	SEN:10029756	12218157
BEL:20058870	p(MGI:Osm) increases tscript(p(MGI:Stat3))	This up-regulation is dependent on signaling by phospho-Stat3 (signal transducers and activators of transcription).	SEN:10029776	12479220
BEL:20058872	p(MGI:Osm) increases tscript(p(MGI:Stat3))	To verify the absence of the STAT6-signaling cascade in STAT6-/- MLF, we assessed mOSM and mIL-4 induced responses with respect to STAT3 and STAT6 activation. Fig. 6 confirms the absence of STAT6 protein and STAT6 induction in STAT6-/- MLF but equivalent activation of STAT3 in both wt and STAT6-/- MLF.	SEN:10028276	16547273
BEL:20058874	p(MGI:Osm) increases tscript(p(MGI:Stat6))	To verify the absence of the STAT6-signaling cascade in STAT6-/- MLF, we assessed mOSM and mIL-4 induced responses with respect to STAT3 and STAT6 activation. Fig. 6 confirms the absence of STAT6 protein and STAT6 induction in STAT6-/- MLF but equivalent activation of STAT3 in both wt and STAT6-/- MLF.	SEN:10028276	16547273
BEL:20058878	p(MGI:P2rx7) increases sec(p(MGI:Casp1))	At 5 min post-ATP, most of the intracellular pro-IL-1 was processed into mature IL-1 and ?50% of the procaspase-1 was converted to active tetramer ... A similar 5-min lag preceded the extracellular accumulation of cathepsin B, a soluble cysteine protease normally packaged within lysosomes, as well as LAMP-1,	SEN:10029778	17641058
BEL:20058880	p(MGI:P2rx7) increases sec(p(MGI:Ctsb))	At 5 min post-ATP, most of the intracellular pro-IL-1 was processed into mature IL-1 and ?50% of the procaspase-1 was converted to active tetramer ... A similar 5-min lag preceded the extracellular accumulation of cathepsin B, a soluble cysteine protease normally packaged within lysosomes, as well as LAMP-1,	SEN:10029778	17641058
BEL:20058882	p(MGI:P2rx7) increases sec(p(MGI:Il1b))	At 5 min post-ATP, most of the intracellular pro-IL-1 was processed into mature IL-1 and ?50% of the procaspase-1 was converted to active tetramer ... A similar 5-min lag preceded the extracellular accumulation of cathepsin B, a soluble cysteine protease normally packaged within lysosomes, as well as LAMP-1,	SEN:10029778	17641058
BEL:20058884	p(MGI:P2rx7) increases sec(p(MGI:Lamp1))	At 5 min post-ATP, most of the intracellular pro-IL-1 was processed into mature IL-1 and ?50% of the procaspase-1 was converted to active tetramer ... A similar 5-min lag preceded the extracellular accumulation of cathepsin B, a soluble cysteine protease normally packaged within lysosomes, as well as LAMP-1,	SEN:10029778	17641058
BEL:20058890	p(MGI:P4ha2) increases path(MESHD:"Myocardial Infarction")	The infarct size decreased from 40.8 1.5 in the saline-treated I/R control group to 14.8 1.6 in the P4HA2 siRNA treated group (%of risk area, mean SE, P 0.001, P4HA2 I/R vs. I/R).	SEN:10029784	17545479
BEL:20058938	p(MGI:Parp1) decreases bp(GOBP:"cell proliferation")	PARP-1-deficient mice exhibited significantly higher lung cell hyperplasia and proliferation than PARP-1 +/+ animals after 5 and 10 days of recovery.	SEN:10009822	17575013
BEL:20058956	p(MGI:Pawr) decreases bp(GOBP:"cell migration")	PKCzeta down-regulation is shown to be a critical determinant of cell migration. Transfection of high-motility cells with either wild-type PKCzeta or its regulatory domain suppresses migration.	SEN:10029810	11682463
BEL:20058960	p(MGI:Pawr) decreases kin(p(MGI:Gsk3b))	results show that direct physical association with ceramide and PAR-4 regulates the activity of PKCzeta. They also indicate that this interaction regulates the activity of glycogen synthase kinase-3beta and NF-kappaB.	SEN:10009832	15901738
BEL:20058962	p(MGI:Pawr) decreases kin(p(MGI:Prkcz))	Elevated expression and activation of PKCzeta increased cell survival, whereas expression of PAR-4 promoted apoptosis.	SEN:10006344	15901738
BEL:20058986	p(MGI:Pax3) increases p(MGI:Eya2)	Expression of the dominant negative Pax3 resulted in a loss of expression of Six1, Eya2, and endogenous Pax3 as well as a down-regulation in the expression of Mox1.	SEN:10009834	11262400
BEL:20058988	p(MGI:Pax3) increases p(MGI:Meox1)	Expression of the dominant negative Pax3 resulted in a loss of expression of Six1, Eya2, and endogenous Pax3 as well as a down-regulation in the expression of Mox1.	SEN:10009834	11262400
BEL:20058990	p(MGI:Pax3) increases p(MGI:Six1)	Expression of the dominant negative Pax3 resulted in a loss of expression of Six1, Eya2, and endogenous Pax3 as well as a down-regulation in the expression of Mox1.	SEN:10009834	11262400
BEL:20059000	p(MGI:Pax6) increases r(MGI:Ntn1)	We demonstrate that in Pax6-/- brains, cells with early dorsal thalamic projection at the internal capsule are more dispersed. In addition, alterations in the structure of the PSPB were observed, together with the failure of expression of axon attractive molecules Sema3c, Sema5a and netrin 1	SEN:10029824	12397112
BEL:20059002	p(MGI:Pax6) increases r(MGI:Sema5a)	We demonstrate that in Pax6-/- brains, cells with early dorsal thalamic projection at the internal capsule are more dispersed. In addition, alterations in the structure of the PSPB were observed, together with the failure of expression of axon attractive molecules Sema3c, Sema5a and netrin 1	SEN:10029824	12397112
BEL:20059010	p(MGI:Pax9) increases r(MGI:Bmp4)	Pax9 is required for the mesenchymal expression of Bmp4, Msx1, and Lef1 at a critical stage of tooth development	SEN:10029832	9732271
BEL:20059012	p(MGI:Pax9) decreases r(MGI:Krt10)	In contrast, the microarray data indicated that three keratin genes involved in the formation of ‘soft’ orthokeratin (Krt1-10, Krt2-1, Krt2-17) were up-regulated.	SEN:10029834	15454262
BEL:20059014	p(MGI:Pax9) decreases r(MGI:Krt1)	In contrast, the microarray data indicated that three keratin genes involved in the formation of ‘soft’ orthokeratin (Krt1-10, Krt2-1, Krt2-17) were up-regulated.	SEN:10029834	15454262
BEL:20059016	p(MGI:Pax9) decreases r(MGI:Krt2)	In contrast, the microarray data indicated that three keratin genes involved in the formation of ‘soft’ orthokeratin (Krt1-10, Krt2-1, Krt2-17) were up-regulated.	SEN:10029834	15454262
BEL:20059018	p(MGI:Pax9) increases r(MGI:Lef1)	Pax9 is required for the mesenchymal expression of Bmp4, Msx1, and Lef1 at a critical stage of tooth development	SEN:10029832	9732271
BEL:20059020	p(MGI:Pax9) increases r(MGI:Msx1)	Pax9 is required for the mesenchymal expression of Bmp4, Msx1, and Lef1 at a critical stage of tooth development	SEN:10029832	9732271
BEL:20059028	p(MGI:Pcsk7) increases cat(p(MGI:Adam17))	It is thought that ADAM17 maturation (activation by the cleavage of the propeptide by proprotein convertases, such as furin and PC7) occurs during transit or on arrival at the cell surface (FIG. 4a), and this may be similar for other ADAMs.	SEN:10027084	19005493
BEL:20059042	p(MGI:Pcyt1a) increases a(CHEBI:lecithin)	the synthesis of phosphatidylcholine by the CDP-choline pathway is under the control of the rate-limiting enzyme CTP-phosphocholine cytidylyltransferase [CCT] Srebps have been proposed to regulate CCT at the transcriptional level, or via the synthesis of lipid activators or substrates of the CDP-choline pathway	SEN:10029838	12659631
BEL:20059044	p(MGI:Pcyt1b) increases a(CHEBI:lecithin)	the synthesis of phosphatidylcholine by the CDP-choline pathway is under the control of the rate-limiting enzyme CTP-phosphocholine cytidylyltransferase [CCT] Srebps have been proposed to regulate CCT at the transcriptional level, or via the synthesis of lipid activators or substrates of the CDP-choline pathway	SEN:10029838	12659631
BEL:20059052	p(MGI:Pde3b) decreases r(MGI:G6pc)	Expression of PGC-1?, PEPCK, and glucose-6-phosphatase mRNAs were also significantly increased in fasted KO compared with fasted WT livers (Table 2), consistent with enhanced glucose production in KO livers.	SEN:10029844	17143332
BEL:20059054	p(MGI:Pde3b) decreases r(MGI:Il6)	As analyzed by real-time RT-PCR, levels of SOCS-3 mRNA and mRNAs of proinflammatory cytokines IL-1, IL-6, TNF-?, and plasminogen activator inhibitor–1 (PAI-1) were increased in fasted KO liver (Table 2).	SEN:10029846	17143332
BEL:20059056	p(MGI:Pde3b) decreases r(MGI:Pck1)	Expression of PGC-1?, PEPCK, and glucose-6-phosphatase mRNAs were also significantly increased in fasted KO compared with fasted WT livers (Table 2), consistent with enhanced glucose production in KO livers.	SEN:10029844	17143332
BEL:20059058	p(MGI:Pde3b) decreases r(MGI:Ppargc1a)	Expression of PGC-1?, PEPCK, and glucose-6-phosphatase mRNAs were also significantly increased in fasted KO compared with fasted WT livers (Table 2), consistent with enhanced glucose production in KO livers.	SEN:10029844	17143332
BEL:20059060	p(MGI:Pde3b) decreases r(MGI:Serpine1)	As analyzed by real-time RT-PCR, levels of SOCS-3 mRNA and mRNAs of proinflammatory cytokines IL-1, IL-6, TNF-?, and plasminogen activator inhibitor–1 (PAI-1) were increased in fasted KO liver (Table 2).	SEN:10029846	17143332
BEL:20059062	p(MGI:Pde3b) decreases r(MGI:Socs3)	As analyzed by real-time RT-PCR, levels of SOCS-3 mRNA and mRNAs of proinflammatory cytokines IL-1, IL-6, TNF-?, and plasminogen activator inhibitor–1 (PAI-1) were increased in fasted KO liver (Table 2).	SEN:10029846	17143332
BEL:20059064	p(MGI:Pde3b) decreases r(MGI:Tnf)	As analyzed by real-time RT-PCR, levels of SOCS-3 mRNA and mRNAs of proinflammatory cytokines IL-1, IL-6, TNF-?, and plasminogen activator inhibitor–1 (PAI-1) were increased in fasted KO liver (Table 2).	SEN:10029846	17143332
BEL:20059066	p(MGI:Pde3b) decreases r(MGI:Trib3)	In addition, expression of tribbles 3 (TRB3) protein (Figure 8C) and mRNA (Table 2) was increased in fasted KO livers.	SEN:10029848	17143332
BEL:20059070	p(MGI:Pde4b) increases bp(GOBP:"neutrophil chemotaxis")	In a paradigm of mouse lung injury induced by endotoxin inhalation, the number of neutrophils recovered in the bronchoalveolar lavage was markedly decreased in PDE4D(-/-) and PDE4B(-/-) mice 4 and 24 h after exposure to LPS.	SEN:10029850	15585880
BEL:20059076	p(MGI:Pde4d) increases bp(GOBP:"neutrophil chemotaxis")	In a paradigm of mouse lung injury induced by endotoxin inhalation, the number of neutrophils recovered in the bronchoalveolar lavage was markedly decreased in PDE4D(-/-) and PDE4B(-/-) mice 4 and 24 h after exposure to LPS.	SEN:10029850	15585880
BEL:20059078	p(MGI:Pde4d) increases p(MGI:Tnf)	the levels of TNF alpha were significantly reduced in PDE4D-deficient mice compared with wild-type mice at 2 h and remained lower for up to 4 h.	SEN:10029854	15585880
BEL:20059080	p(MGI:Pde7a) increases p(MGI:Ifng)	Stimulation of isolated murine NKT cells with anti-CD3 antibody plus IL-2 induced not only cell proliferation but production of cytokines including IFN-gamma, TNF-alpha, IL-17 and IL-22. ASB16165 significantly inhibited the CD3/IL-2-stimulated cell proliferation and production of all the cytokines examined	SEN:10029856	19477436
BEL:20059082	p(MGI:Pde7a) increases p(MGI:Il17a)	Stimulation of isolated murine NKT cells with anti-CD3 antibody plus IL-2 induced not only cell proliferation but production of cytokines including IFN-gamma, TNF-alpha, IL-17 and IL-22. ASB16165 significantly inhibited the CD3/IL-2-stimulated cell proliferation and production of all the cytokines examined	SEN:10029856	19477436
BEL:20059084	p(MGI:Pde7a) increases p(MGI:Il22)	Stimulation of isolated murine NKT cells with anti-CD3 antibody plus IL-2 induced not only cell proliferation but production of cytokines including IFN-gamma, TNF-alpha, IL-17 and IL-22. ASB16165 significantly inhibited the CD3/IL-2-stimulated cell proliferation and production of all the cytokines examined	SEN:10029856	19477436
BEL:20059086	p(MGI:Pde7a) increases p(MGI:Tnf)	Stimulation of isolated murine NKT cells with anti-CD3 antibody plus IL-2 induced not only cell proliferation but production of cytokines including IFN-gamma, TNF-alpha, IL-17 and IL-22. ASB16165 significantly inhibited the CD3/IL-2-stimulated cell proliferation and production of all the cytokines examined	SEN:10029856	19477436
BEL:20059088	p(MGI:Pdgfa) increases bp(GOBP:chemotaxis)	we introduced Iba1 into Swiss 3T3 fibroblasts and demonstrated the enhancement of platelet-derived growth factor (PDGF)-induced membrane ruffling and chemotaxis	SEN:10007946	11916959
BEL:20059098	p(MGI:Pdgfa) increases r(MGI:Fgf10)	In the present experiments, PDGF-A and -B siRNA completely abrogated the mRNA expression of PDGF-A and -B (Fig. 6, C and D) and inhibited the expression of Fgf7 and -10 (Fig. 6, C and D).	SEN:10029862	18559345
BEL:20059100	p(MGI:Pdgfa) increases r(MGI:Fgf7)	In the present experiments, PDGF-A and -B siRNA completely abrogated the mRNA expression of PDGF-A and -B (Fig. 6, C and D) and inhibited the expression of Fgf7 and -10 (Fig. 6, C and D).	SEN:10029862	18559345
BEL:20059106	p(MGI:Pdgfb) increases complex(p(MGI:Eif2ak2),p(MGI:Stat3))	Immunoblotting with anti-Stat3 as well as anti-PKR anti bodies (Figure2E) showed an increase in interaction within 5?15 min of treatment with the growth factor, followed by a decrease to below basal level at later time points.	SEN:10029866	11350938
BEL:20059108	p(MGI:Pdgfb) increases kin(p(MGI:Eif2ak2))	Accordingly, nuclear extracts prepared from PDGF-treated PKR- null cells were severely deficient in Stat3 containing DNA-binding complexes compared with wild-type MEFs (data not shown). Taken together, we conclude that PDGF-induced activation of Stat3 DNA binding is PKR dependent.	SEN:10021666	11350938
BEL:20059110	p(MGI:Pdgfb) increases kin(p(MGI:Mapk14))	PDGF-BB induces phosphorylation of alphaB-crystallin via p38 MAP kinase during myocardial infarction	SEN:10006254	15907784
BEL:20059114	p(MGI:Pdgfb) increases p(MGI:Stat3,pmod(P,S,727))	Whereas PKR+/+ cells exhibited a clear induction in phospho-Ser727 Stat3, PKR-null cells were defective in this process (Figure1B)	SEN:10021664	11350938
BEL:20059116	p(MGI:Pdgfb) increases p(MGI:Stat3,pmod(P,Y,705))	PDGF treatment induced two Tyr705-phosphorylated forms of Stat3 in PKR+/+ cells, a faster migrating species termed Stat3fm and a slower migrating species termed Stat3sm (Figure1A).....Importantly, PDGF treatment did not induce either form of tyrosine-phosphorylated Stat3 in PKR-null cells (Figure1A), implicating a requirement for PKR in both tyrosine and serine phosphorylation of Stat3.	SEN:10026648	11350938
BEL:20059120	p(MGI:Pdgfb) increases r(MGI:Fgf10)	In the present experiments, PDGF-A and -B siRNA completely abrogated the mRNA expression of PDGF-A and -B (Fig. 6, C and D) and inhibited the expression of Fgf7 and -10 (Fig. 6, C and D).	SEN:10029862	18559345
BEL:20059122	p(MGI:Pdgfb) increases r(MGI:Fgf7)	In the present experiments, PDGF-A and -B siRNA completely abrogated the mRNA expression of PDGF-A and -B (Fig. 6, C and D) and inhibited the expression of Fgf7 and -10 (Fig. 6, C and D).	SEN:10029862	18559345
BEL:20059124	p(MGI:Pdgfb) increases r(MGI:Fos)	The results (Figure4A and B) showed a 16-fold induction in PKR wild-type cells in contrast to a 0.8-fold induction in c-fos message in PKR-null cells at 15 min of PDGF treatment	SEN:10026650	11350938
BEL:20059156	p(MGI:Pdpk1) increases p(MGI:Rps6kb1,pmod(P,T,412))	Consistent with previously published data (Williams et al, 2000), phosphorylation of S6K T389 and rpS6 S240/244 is abrogated in PDK1 null cells (Figure 3A, lanes 5–8).	SEN:10029872	16763566
BEL:20059158	p(MGI:Pdpk1) increases p(MGI:Rps6,pmod(P,S,240))	Consistent with previously published data (Williams et al, 2000), phosphorylation of S6K T389 and rpS6 S240/244 is abrogated in PDK1 null cells (Figure 3A, lanes 5–8).	SEN:10029872	16763566
BEL:20059160	p(MGI:Pdpk1) increases p(MGI:Rps6,pmod(P,S,244))	Consistent with previously published data (Williams et al, 2000), phosphorylation of S6K T389 and rpS6 S240/244 is abrogated in PDK1 null cells (Figure 3A, lanes 5–8).	SEN:10029872	16763566
BEL:20059166	p(MGI:Pdpk1,sub(R,238,E)) directlyDecreases complex(p(MGI:Pdpk1),p(MGI:Ywhaq))	Substitution of Arg-238, equivalent to conserved Arg in the 14-3-3 binding motif, with Glu (R238E) decreased 14-3-3theta binding to PDK1 (Fig. 3 C, upper panel, lane 4). In contrast, substitution of Val-243 with Pro (V243P), a residue conserved in many 14-3-3 targets, such as Raf-1 and Bad (Fig.3 A), dramatically increased the amount of 14-3-3theta bound to PDK1	SEN:10029876	12177059
BEL:20059168	p(MGI:Pdpk1,sub(S,241,A)) directlyDecreases complex(p(MGI:Pdpk1),p(MGI:Ywhah))	Co-immunoprecipitation analysis indicated that mutation at Ser-241 impairs the PDK1 binding ability for 14-3-3theta and 14-3-3eta (Fig. 3 B, upper panel, lane 3, and data not shown).	SEN:10029878	12177059
BEL:20059170	p(MGI:Pdpk1,sub(S,241,A)) directlyDecreases complex(p(MGI:Pdpk1),p(MGI:Ywhaq))	Co-immunoprecipitation analysis indicated that mutation at Ser-241 impairs the PDK1 binding ability for 14-3-3theta and 14-3-3eta (Fig. 3 B, upper panel, lane 3, and data not shown).	SEN:10029878	12177059
BEL:20059172	p(MGI:Pdpk1,sub(V,243,P)) directlyIncreases complex(p(MGI:Pdpk1),p(MGI:Ywhaq))	Substitution of Arg-238, equivalent to conserved Arg in the 14-3-3 binding motif, with Glu (R238E) decreased 14-3-3theta binding to PDK1 (Fig. 3 C, upper panel, lane 4). In contrast, substitution of Val-243 with Pro (V243P), a residue conserved in many 14-3-3 targets, such as Raf-1 and Bad (Fig.3 A), dramatically increased the amount of 14-3-3theta bound to PDK1	SEN:10029876	12177059
BEL:20059174	p(MGI:Pdpk1,sub(Y,546,F)) decreases p(MGI:Pdpk1,pmod(P,Y,580))	Y542F-expressing cells exhibited an ?50% decrease in Tyr-580 phosphorylation (Fig. 3C, right panel).	SEN:10029880	12923167
BEL:20059186	p(MGI:Pecam1) decreases bp(GOBP:"apoptotic process")	the APN KO lung showed enhanced endothelial dysfunction, reflected as an increase in endothelial apoptosis, which resulted from a decrease in VEGFR-2 and PECAM-1 expression	SEN:10024928	21239691
BEL:20059194	p(MGI:Pecam1) increases tloc(p(MGI:Cdkn1a),GOCCID:0005737,GOCCID:0005634)	p21 was found to be mainly localized to the nucleus in PECAM-1 transgenic mammary sections (Fig. 5D), similar to that of STAT5a localization (Fig. 5B).	SEN:10029888	11254359
BEL:20059196	p(MGI:Pecam1) increases tloc(p(MGI:Stat5a),GOCCID:0005737,GOCCID:0005634)	STAT5a was mainly localized to the nucleus in PECAM-1 transgenics (Fig. 5B), suggesting an increase in STAT5a tyrosine phosphorylation level.	SEN:10029890	11254359
BEL:20059236	p(MGI:Phox2b) decreases r(MGI:Hes5)	By a separate pathway, Phox2b represses expression of the inhibitors of neurogenesis Hes5 and Id2. The role of Phox2b in the specification of neuronal subtype identity appears to depend in part on its capacity to act as a patterning gene in the progenitor domain.	SEN:10009870	12399315
BEL:20059238	p(MGI:Phox2b) decreases r(MGI:Id2)	By a separate pathway, Phox2b represses expression of the inhibitors of neurogenesis Hes5 and Id2. The role of Phox2b in the specification of neuronal subtype identity appears to depend in part on its capacity to act as a patterning gene in the progenitor domain.	SEN:10009870	12399315
BEL:20059240	p(MGI:Phox2b) decreases r(MGI:"Nkx6-1")	Phox2b misexpression represses the Pax6 and Olig2 genes, which should inhibit a branchiomotor fate, and induces Nkx6.1 and Nkx6.2, which are expressed in branchiomotor progenitors.	SEN:10029906	12399315
BEL:20059242	p(MGI:Phox2b) decreases r(MGI:"Nkx6-2")	Phox2b misexpression represses the Pax6 and Olig2 genes, which should inhibit a branchiomotor fate, and induces Nkx6.1 and Nkx6.2, which are expressed in branchiomotor progenitors.	SEN:10029906	12399315
BEL:20059244	p(MGI:Phox2b) increases r(MGI:Olig2)	Phox2b misexpression represses the Pax6 and Olig2 genes, which should inhibit a branchiomotor fate, and induces Nkx6.1 and Nkx6.2, which are expressed in branchiomotor progenitors.	SEN:10029906	12399315
BEL:20059246	p(MGI:Phox2b) increases r(MGI:Pax6)	Phox2b misexpression represses the Pax6 and Olig2 genes, which should inhibit a branchiomotor fate, and induces Nkx6.1 and Nkx6.2, which are expressed in branchiomotor progenitors.	SEN:10029906	12399315
BEL:20059254	p(MGI:Pias2) increases r(MGI:Ddx24)	As assessed by quantitative RT-PCR, the Gfer mRNA was decreased by 2.4-fold in PIASx -/- mice compared with PIASx +/+ mice	SEN:10029912	15956336
BEL:20059256	p(MGI:Pias2) increases r(MGI:Ddx24)	DEAD box polypeptide 24 (Ddx24), DNA polymerase gamma, trafficking protein particle complex 2, tissue plasminogen activator, and growth factor/erv1-like were downregulated in mutant mice.	SEN:10029914	15956336
BEL:20059270	p(MGI:Pik3r1) increases path(MESHD:"Insulin Resistance")	Data coming from mice lacking p110a regulatory subunits have shed light on the dual role of p85 in PI3K regulation in response to insulin (Katso et al., 2001). Heterozygous deletion of either p85a or b in mice leads, surprisingly, to increased sensitivity to insulin, whereas compound heterozygous mutants fail to activate PI3K in response to insulin.	SEN:10029920	18794886
BEL:20059274	p(MGI:Pik3r1) increases phos(p(MGI:Pten))	The loss of the regulatory subunit of PI3K1A, p85, results in the decrease of Pten activity in p85 liver conditional knockout mice (Barber et al., 2006).	SEN:10029924	18794886
BEL:20059280	p(MGI:Pik3r2) increases path(MESHD:"Insulin Resistance")	Data coming from mice lacking p110a regulatory subunits have shed light on the dual role of p85 in PI3K regulation in response to insulin (Katso et al., 2001). Heterozygous deletion of either p85a or b in mice leads, surprisingly, to increased sensitivity to insulin, whereas compound heterozygous mutants fail to activate PI3K in response to insulin.	SEN:10029920	18794886
BEL:20059284	p(MGI:Pim1) increases bp(GOBP:"cell proliferation")	Our data demonstrate that enforced expression of the Pim-l protein is associated with enhanced IL-3-independent survival and clonogenic proliferation in murine myeloid cells.	SEN:10029926	9393759
BEL:20059288	p(MGI:Pim1) decreases bp(GOBP:"apoptotic process")	This effect of Pim-1 expression was associated with a decrease in apoptotic cells and an increase in G0/G1-phase cells, and the increase in G0/G1-phase cells caused by enforced expression of Pim-1 was due to a decrease in apoptosis rather than to a decrease in transit of the G1-S-phase checkpoint	SEN:10009880	9393759
BEL:20059292	p(MGI:Pim1) decreases complex(p(MGI:Akt1s1),p(MGI:Mtor))	This data suggests that PIM1 phosphorylates PRAS40 reducing the interaction between PRAS40 and mTORC1 especially under serum and IL-3 starvation.	SEN:10029930	19276681
BEL:20059294	p(MGI:Pim1) increases p(MGI:Eif4ebp1,pmod(P,T,37))	Overexpression of PIM1 increases 4EBP1 and S6K phosphorylation...Overexpression of the 44 kd PIM1 kinase in FDCP1 cells increased 4EBP1 phosphorylation on Thr37/46 a known mTOR phosphorylation site (Fig. 5A)	SEN:10029932	19276681
BEL:20059296	p(MGI:Pim1) increases p(MGI:Eif4ebp1,pmod(P,T,46))	Overexpression of PIM1 increases 4EBP1 and S6K phosphorylation...Overexpression of the 44 kd PIM1 kinase in FDCP1 cells increased 4EBP1 phosphorylation on Thr37/46 a known mTOR phosphorylation site (Fig. 5A)	SEN:10029932	19276681
BEL:20059298	p(MGI:Pim1) increases p(MGI:Ifng)	Assays of BAL cytokine concentrations demonstrated that IL-4, IL-5, IL-13, and IFN-g were decreased in Pim1 kinase inhibitor (100 mg/kg)–treated mice that had been sensitized and challenged with OVA (Figure 3C).	SEN:10029934	22074702
BEL:20059300	p(MGI:Pim1) increases p(MGI:Il13)	Assays of BAL cytokine concentrations demonstrated that IL-4, IL-5, IL-13, and IFN-g were decreased in Pim1 kinase inhibitor (100 mg/kg)–treated mice that had been sensitized and challenged with OVA (Figure 3C).	SEN:10029934	22074702
BEL:20059302	p(MGI:Pim1) increases p(MGI:Il4)	Assays of BAL cytokine concentrations demonstrated that IL-4, IL-5, IL-13, and IFN-g were decreased in Pim1 kinase inhibitor (100 mg/kg)–treated mice that had been sensitized and challenged with OVA (Figure 3C).	SEN:10029934	22074702
BEL:20059304	p(MGI:Pim1) increases p(MGI:Il5)	Assays of BAL cytokine concentrations demonstrated that IL-4, IL-5, IL-13, and IFN-g were decreased in Pim1 kinase inhibitor (100 mg/kg)–treated mice that had been sensitized and challenged with OVA (Figure 3C).	SEN:10029934	22074702
BEL:20059306	p(MGI:Pim1) increases p(MGI:Myc)	The Pim-1 and Pim-2 transfectants have lower levels of serine/threonine protein phosphatase 2A (PP2A) activity and the alpha- and beta-subunit B56gamma of the PP2A phosphatase do not coimmunoprecipitate in these cells. Thus, the effects of Pim on PP2A activity may mediate the levels of c-Myc and the phosphorylation of proteins needed for increased protein synthesis.	SEN:10029936	16123140
BEL:20059308	p(MGI:Pim1) increases p(MGI:Rps6kb1,pmod(P))	Overexpression of PIM1 increases 4EBP1 and S6K phosphorylation...Overexpression of the 44 kd PIM1 kinase in FDCP1 cells increased 4EBP1 phosphorylation on Thr37/46 a known mTOR phosphorylation site (Fig. 5A)	SEN:10029932	19276681
BEL:20059314	p(MGI:Pim2) increases p(MGI:Myc)	The Pim-1 and Pim-2 transfectants have lower levels of serine/threonine protein phosphatase 2A (PP2A) activity and the alpha- and beta-subunit B56gamma of the PP2A phosphatase do not coimmunoprecipitate in these cells. Thus, the effects of Pim on PP2A activity may mediate the levels of c-Myc and the phosphorylation of proteins needed for increased protein synthesis.	SEN:10029936	16123140
BEL:20059318	p(MGI:Pkd1) decreases p(MGI:Gab1,pmod(P,Y))	The level of tyrosine-phosphorylated Gab1 was greater in Pkd1-/- kidneys at E16.5 than in wild-type kidneys,	SEN:10029942	12095915
BEL:20059320	p(MGI:Pkd1) increases p(MGI:Pecam1)	Basolateral expression of PECAM-1 (CD 31), another component of AJ, was also reduced in Pkd1-/- tubules	SEN:10029944	12095915
BEL:20059330	p(MGI:Pla2g4a) increases bp(GOBP:"necrotic cell death")	Knockdown of cPLA2 or a chaperone involved in the assembly of mitochondrial complex I, the NADH dehydrogenase (ubiquinone) 1-? subcomplex assembly factor 1 (NDUFAF1), resulted in a similar inhibition of TNF-induced necroptosis (Supplementary Figure 5c and d),	SEN:10029450	20010783
BEL:20059334	p(MGI:Pla2g4a) increases r(MGI:Ifnb1)	Total RNA was isolated from infected and uninfected wild-type and cPLA2-/- MEFs and the levels of IFN-? mRNAs assessed by RT-PCR. As previously reported, Chamydia infection led to the induction of IFN-beta mRNAs.However, this increase in expression was significantly lower in infected cPLA2-/- MEFs	SEN:10029952	20452986
BEL:20059336	p(MGI:Pla2g6) decreases a(CHEBI:phospholipid)	both Pla2g6 and cPLA2 are activated during apoptosis Pla2g6 is involved in the hydrolysis of plasma membrane phospholipids and exposure of the epitope recognized by IgM	SEN:10018288	12208880
BEL:20059346	p(MGI:Pla2g6) increases cat(p(MGI:Ighm))	both Pla2g6 and cPLA2 are activated during apoptosis Pla2g6 is involved in the hydrolysis of plasma membrane phospholipids and exposure of the epitope recognized by IgM	SEN:10018288	12208880
BEL:20059354	p(MGI:Pla2g7) decreases a(CHEBI:lipid)	ApoE-deficient mice overexpressing human plasma PAF-AH develop less atherosclerosis due to reduced lipid accumulation, inhibition of neo-intima formation, and reduced macrophage attraction (108).	SEN:10029958	16046792
BEL:20059356	p(MGI:Pla2g7) decreases path(MESHD:Atherosclerosis)	ApoE-deficient mice overexpressing human plasma PAF-AH develop less atherosclerosis due to reduced lipid accumulation, inhibition of neo-intima formation, and reduced macrophage attraction (108).	SEN:10029958	16046792
BEL:20059358	p(MGI:Pla2r1) increases p(MGI:Il1b)	The decreased TNF and IL-1 plasma levels in PLA2R knockout mice indicate a potential role for PLA2R in the onset and progression of endotoxic shock (127).	SEN:10029960	16046792
BEL:20059360	p(MGI:Pla2r1) increases p(MGI:Tnf)	The decreased TNF and IL-1 plasma levels in PLA2R knockout mice indicate a potential role for PLA2R in the onset and progression of endotoxic shock (127).	SEN:10029960	16046792
BEL:20059364	p(MGI:Plaa) increases r(MGI:"mt-Co2")	The PLAA peptide and melittin increased the expression of genes encoding the proinflammatory cytokine tumor necrosis factor alpha (TNFalpha) and cyclooxygenase-2 (COX-2), which is involved in PGE(2) production.	SEN:10009886	11821123
BEL:20059366	p(MGI:Plaa) increases r(MGI:Tnf)	The PLAA peptide and melittin increased the expression of genes encoding the proinflammatory cytokine tumor necrosis factor alpha (TNFalpha) and cyclooxygenase-2 (COX-2), which is involved in PGE(2) production.	SEN:10009886	11821123
BEL:20059368	p(MGI:Plat) increases cat(p(MGI:F2r))	exogenously applied serine proteases thrombin, plasmin, and tissue plasminogen activator can activate PAR1 signaling in brain tissue	SEN:10004760	14559973
BEL:20059370	p(MGI:Plau) increases bp(GOBP:"cell migration")	In uPA deficient mice, wound healing is impaired at least partly due to suppressed migration of leukocytes, fibroblasts, and smooth muscle cells.	SEN:10029962	11841347
BEL:20059374	p(MGI:Plaur) increases bp(GOBP:chemotaxis)	Antibodies to uPAR or selective blockade of uPAR expression by antisense oligonucleotides completely abrogates monocyte chemotaxis (Okada et al. 1996; Gyetko et al. 1995).	SEN:10029964	19064999
BEL:20059380	p(MGI:Plcg1) increases gtp(p(MGI:Rac1))	enhancement is mediated through a phosphatidylinositol 3-kinase (PI3K)-independent signaling pathway These results indicate the existence of a novel signaling pathway where PLC-gamma activates Rac1 in a manner dependent on Iba1.	SEN:10025028	11916959
BEL:20059382	p(MGI:Plcg1,pmod(P)) directlyDecreases cat(p(MGI:Plcg1))	These findings suggest that protein kinase C phosphorylates PI-PLC, resulting in a decrease in PI-PLC activity	SEN:10022362	7981246
BEL:20059390	p(MGI:Pln) decreases r(MGI:Fkbp1a)	PLN overexpression was associated with depressed rates of contraction and relaxation, which were not linked to reduced SERCA2a abundance, although the levels of other key Ca2+-handling proteins, including ryanodine receptor, FKBP12, and L-type Ca2+ channel, were significantly decreased.	SEN:10029972	15059971
BEL:20059392	p(MGI:Pln) decreases r(MGI:Ryr1)	PLN overexpression was associated with depressed rates of contraction and relaxation, which were not linked to reduced SERCA2a abundance, although the levels of other key Ca2+-handling proteins, including ryanodine receptor, FKBP12, and L-type Ca2+ channel, were significantly decreased.	SEN:10029972	15059971
BEL:20059402	p(MGI:Pmaip1) increases cat(p(MGI:Bak1))	Reversibly, overexpression of NOXA or PUMA induces apoptosis as evidenced by the activation of BAK and caspase-7.	SEN:10008070	16407291
BEL:20059404	p(MGI:Pmaip1) increases cat(p(MGI:Casp7))	Reversibly, overexpression of NOXA or PUMA induces apoptosis as evidenced by the activation of BAK and caspase-7.	SEN:10008070	16407291
BEL:20059412	p(MGI:Polb) decreases bp(GOBP:"apoptotic process")	The death of mutants such as Xrcc1/, LigIII/ and Polb/ was preceded by elevated levels of apoptosis (Gu et al, 1994; Tebbs et al, 1999; Sugo et al, 2000; Puebla-Osorio et al, 2006).	SEN:10028866	18285820
BEL:20059420	p(MGI:Pomc) directlyIncreases cat(p(MGI:Mc2r))	Acth in turn activates Acth receptors in the adrenal cortex to increase synthesis and release of glucocorticoids.	SEN:10029982	10742108
BEL:20059422	p(MGI:Pon2) decreases a(CHEBI:"reactive oxygen species")	Macrophages from PC Tg mice can express high level of human PON2 besides intrinsic mouse PON2 and PON3 ... PC Tg macrophages maintained significantly lower levels of ROS for at least 2 hours than macrophages from Wt mice ... Inflammatory factors such as TNF-alpha and IL-6 are expressed at lower levels in PC Tg MPMs compared with Wt MPMs.	SEN:10029984	19359600
BEL:20059424	p(MGI:Pon2) decreases bp(GOBP:"macrophage chemotaxis")	LDL from PON2-deficient mice induced significantly more monocyte chemotaxis than LDL from their control littermates	SEN:10029986	16891303
BEL:20059434	p(MGI:Pon2) decreases p(MGI:Il6)	Macrophages from PC Tg mice can express high level of human PON2 besides intrinsic mouse PON2 and PON3 ... PC Tg macrophages maintained significantly lower levels of ROS for at least 2 hours than macrophages from Wt mice ... Inflammatory factors such as TNF-alpha and IL-6 are expressed at lower levels in PC Tg MPMs compared with Wt MPMs.	SEN:10029984	19359600
BEL:20059436	p(MGI:Pon2) decreases p(MGI:Tnf)	Macrophages from PC Tg mice can express high level of human PON2 besides intrinsic mouse PON2 and PON3 ... PC Tg macrophages maintained significantly lower levels of ROS for at least 2 hours than macrophages from Wt mice ... Inflammatory factors such as TNF-alpha and IL-6 are expressed at lower levels in PC Tg MPMs compared with Wt MPMs.	SEN:10029984	19359600
BEL:20059452	p(MGI:Por) decreases p(MGI:Cyp2b10)	CYP2B, CYP2C, CYP3A and CYP7A1 levels increased profoundly as a function of time and in association with the decrease in POR expression.	SEN:10029998	18778245
BEL:20059454	p(MGI:Por) decreases p(MGI:Cyp2c29)	CYP2B, CYP2C, CYP3A and CYP7A1 levels increased profoundly as a function of time and in association with the decrease in POR expression.	SEN:10029998	18778245
BEL:20059456	p(MGI:Por) decreases p(MGI:Cyp3a11)	CYP2B, CYP2C, CYP3A and CYP7A1 levels increased profoundly as a function of time and in association with the decrease in POR expression.	SEN:10029998	18778245
BEL:20059458	p(MGI:Por) decreases p(MGI:Cyp7a1)	CYP2B, CYP2C, CYP3A and CYP7A1 levels increased profoundly as a function of time and in association with the decrease in POR expression.	SEN:10029998	18778245
BEL:20059460	p(MGI:Por) decreases r(MGI:Abcd1)	the liver is adapting to increases in localized lipid content by inducing both peroxisomal and mitochondrial oxidation pathways. Abcd1 and Abcd2, involved in peroxisomal fatty acid oxidation, are up-regulated 1.3- and 1.6-fold, respectively.	SEN:10030000	17722906
BEL:20059462	p(MGI:Por) decreases r(MGI:Abcd2)	the liver is adapting to increases in localized lipid content by inducing both peroxisomal and mitochondrial oxidation pathways. Abcd1 and Abcd2, involved in peroxisomal fatty acid oxidation, are up-regulated 1.3- and 1.6-fold, respectively.	SEN:10030000	17722906
BEL:20059464	p(MGI:Por) decreases r(MGI:Acacb)	Mitochondrial ?-oxidation is also induced via the induction of several key genes, such as Acox1, Acsl4, and Cpt1a by 1.2-, 1.6-, and 1.7-fold, respectively; however, the 1.5-fold up-regulation of Acc2 may counteract mitochondrial oxidation by leading to increases in cellular content of malonyl-CoA, an allosteric inhibitor of CPT1a.	SEN:10030002	17722906
BEL:20059466	p(MGI:Por) decreases r(MGI:Acox1)	Mitochondrial ?-oxidation is also induced via the induction of several key genes, such as Acox1, Acsl4, and Cpt1a by 1.2-, 1.6-, and 1.7-fold, respectively; however, the 1.5-fold up-regulation of Acc2 may counteract mitochondrial oxidation by leading to increases in cellular content of malonyl-CoA, an allosteric inhibitor of CPT1a.	SEN:10030002	17722906
BEL:20059468	p(MGI:Por) decreases r(MGI:Acsl4)	Mitochondrial ?-oxidation is also induced via the induction of several key genes, such as Acox1, Acsl4, and Cpt1a by 1.2-, 1.6-, and 1.7-fold, respectively; however, the 1.5-fold up-regulation of Acc2 may counteract mitochondrial oxidation by leading to increases in cellular content of malonyl-CoA, an allosteric inhibitor of CPT1a.	SEN:10030002	17722906
BEL:20059470	p(MGI:Por) decreases r(MGI:Cpt1a)	Mitochondrial ?-oxidation is also induced via the induction of several key genes, such as Acox1, Acsl4, and Cpt1a by 1.2-, 1.6-, and 1.7-fold, respectively; however, the 1.5-fold up-regulation of Acc2 may counteract mitochondrial oxidation by leading to increases in cellular content of malonyl-CoA, an allosteric inhibitor of CPT1a.	SEN:10030002	17722906
BEL:20059472	p(MGI:Por) decreases r(MGI:Cyp51)	hese findings are similarly found in the colon, where cholesterol biosynthetic genes are up-regulated: Cyp51a1, Fdft1, Idi1, and Lss were induced 1.4-, 1.8-, 1.9-, and 1.3-fold, respectively. Lldr was induced to a lesser extent, but retained significance (1.4-fold).	SEN:10030004	17722906
BEL:20059474	p(MGI:Por) decreases r(MGI:Fdft1)	hese findings are similarly found in the colon, where cholesterol biosynthetic genes are up-regulated: Cyp51a1, Fdft1, Idi1, and Lss were induced 1.4-, 1.8-, 1.9-, and 1.3-fold, respectively. Lldr was induced to a lesser extent, but retained significance (1.4-fold).	SEN:10030004	17722906
BEL:20059476	p(MGI:Por) increases r(MGI:Hnf4a)	the expression of both Shp and hepatocyte nuclear factor 4 ? (Hnf4?) was decreased 1.8- and 1.4-fold, respectively.	SEN:10030006	17722906
BEL:20059478	p(MGI:Por) decreases r(MGI:Idi1)	hese findings are similarly found in the colon, where cholesterol biosynthetic genes are up-regulated: Cyp51a1, Fdft1, Idi1, and Lss were induced 1.4-, 1.8-, 1.9-, and 1.3-fold, respectively. Lldr was induced to a lesser extent, but retained significance (1.4-fold).	SEN:10030004	17722906
BEL:20059480	p(MGI:Por) decreases r(MGI:Lss)	hese findings are similarly found in the colon, where cholesterol biosynthetic genes are up-regulated: Cyp51a1, Fdft1, Idi1, and Lss were induced 1.4-, 1.8-, 1.9-, and 1.3-fold, respectively. Lldr was induced to a lesser extent, but retained significance (1.4-fold).	SEN:10030004	17722906
BEL:20059482	p(MGI:Por) increases r(MGI:Nr0b2)	the expression of both Shp and hepatocyte nuclear factor 4 ? (Hnf4?) was decreased 1.8- and 1.4-fold, respectively.	SEN:10030006	17722906
BEL:20059484	p(MGI:Por) decreases r(MGI:Scd1)	The abundance of medium-chain fatty acids would then serve as ideal substrates for Scd1 and Scd2, both of which are increased 2.2- and 1.5-fold respectively.	SEN:10030008	17722906
BEL:20059486	p(MGI:Por) decreases r(MGI:Scd2)	The abundance of medium-chain fatty acids would then serve as ideal substrates for Scd1 and Scd2, both of which are increased 2.2- and 1.5-fold respectively.	SEN:10030008	17722906
BEL:20059488	p(MGI:Pot1a) decreases bp(GOBP:"cellular response to DNA damage stimulus")	Here we show that conditional deletion of Pot1a elicits a DNA damage response at telomeres, resulting in p53-dependent replicative senescence.	SEN:10030010	16839876
BEL:20059490	p(MGI:Pot1a) decreases bp(GOBP:"replicative cell aging")	Here we show that conditional deletion of Pot1a elicits a DNA damage response at telomeres, resulting in p53-dependent replicative senescence.	SEN:10030010	16839876
BEL:20059492	p(MGI:Pou2f1,pmod(P)) directlyDecreases tscript(p(MGI:Pou2f1))	reconstitution of Rb-defective tumor cells with functional Rb results in hyperphosphorylation of Oct1 and disruption of Oct1 interaction with H2A octamer element Oct1 can be posttranslationally modified by phosphorylation, and this modification has been shown to reduce the binding of Oct1 to DNA	SEN:10030012	11533238
BEL:20059512	p(MGI:Ppara) decreases bp(GOBP:"inflammatory response")	Devchand et al. (11) showed that absence of PPARa expression in mice prolonged the inflammatory response.	SEN:10030022	10542237
BEL:20059514	p(MGI:Ppara) decreases bp(GOBP:"inflammatory response")	PPARa elicits most of its anti-inflammatory effects at the vascular wall by negatively interfering with the NF-kB transcriptional pathway [25,26,28,29].	SEN:10030024	14561188
BEL:20059516	p(MGI:Ppara) decreases bp(GOBP:"inflammatory response")	The first evidence of the involvement of PPARs in inflammation came from the demonstration that PPARa absence in mice prolonged the duration of the inflammatory response [9].	SEN:10030026	14561188
BEL:20059520	p(MGI:Ppara) decreases complex(p(MGI:Nr1h2),p(MGI:Rxra))	Ppara activation can suppress Lxr-Srebf1c pathway through reduction of Lxr/Rxr formation, proposing a novel transcription factor cross-talk between Lxr and Ppara in hepatic lipid homeostasis	SEN:10030028	12730331
BEL:20059522	p(MGI:Ppara) decreases complex(p(MGI:Nr1h3),p(MGI:Rxra))	Ppara activation can suppress Lxr-Srebf1c pathway through reduction of Lxr/Rxr formation, proposing a novel transcription factor cross-talk between Lxr and Ppara in hepatic lipid homeostasis	SEN:10030028	12730331
BEL:20059526	p(MGI:Ppara) decreases p(MGI:Il1b)	Lung levels of TNF-[alpha] and IL-1[beta] were significantly higher in PPAR-[alpha]-deficient mice in comparison with those of PPAR-[alpha] WT animals (Fig. 3).	SEN:10030030	16317386
BEL:20059528	p(MGI:Ppara) decreases p(MGI:Il6)	These investigators went on to demonstrate that interleukin-6 production is increased in aortic explants of PPAR-–deficient mice.95	SEN:10030032	12957325
BEL:20059530	p(MGI:Ppara) decreases p(MGI:Tnf)	Lung levels of TNF-[alpha] and IL-1[beta] were significantly higher in PPAR-[alpha]-deficient mice in comparison with those of PPAR-[alpha] WT animals (Fig. 3).	SEN:10030030	16317386
BEL:20059534	p(MGI:Ppara,pmod(P)) directlyIncreases tscript(p(MGI:Ppara))	p38 MAPK has been reported to activate PPAR-a through increased phosphorylation of PPAR-a and increased co-activation specifically by PGC-1 (refs 22, 23), thereby stimulating fatty-acid oxidation.	SEN:10021968	12802337
BEL:20059542	p(MGI:Ppard) decreases r(MGI:Apoe)	Therefore the profound repression of CYP27 and apoE expressoin by activatoin or overexpression of PPARd might contribute to the lipid accumulation observed in these cells in culture	SEN:10030036	11557774
BEL:20059544	p(MGI:Ppard) decreases r(MGI:Cyp27a1)	Therefore the profound repression of CYP27 and apoE expressoin by activatoin or overexpression of PPARd might contribute to the lipid accumulation observed in these cells in culture	SEN:10030036	11557774
BEL:20059552	p(MGI:Ppargc1a) increases tscript(complex(p(MGI:Ppargc1a),p(MGI:Mef2c)))	PGC-1 mediates this increased GLUT4 expression, in large part, by binding to and coactivating the muscle-selective transcription factor MEF2C.	SEN:10030042	11274399
BEL:20059566	p(MGI:Pparg,pmod(P,S,82)) directlyDecreases tscript(p(MGI:Pparg))	Overexpression of wild-type Bcr kinase did not inhibit ligand-mediated PPARgamma1 S82A mutant transcriptional activity, indicating that Bcr regulates PPARgamma activity via S82 phosphorylation.	SEN:10021564	19023129
BEL:20059568	p(MGI:Pparg,pmod(P)) directlyDecreases tscript(p(MGI:Pparg))	PGF2alpha is able to inhibit Pparg functions in adipogenesis. This occurs through subsequent Pparg phosphorylation and inhibition of its transcriptional activity.	SEN:10016824	12088279
BEL:20059570	p(MGI:Pparg) increases r(MGI:Abcg1)	The basal levels of PPARgamma and its target genes CD36 and ABCG1 were dramatically reduced in macrophage-specific PPARgamma knockout mice	SEN:10030048	18422969
BEL:20059572	p(MGI:Pparg) decreases r(MGI:Ccr7)	Target genes regulated basally by PPARgamma expression greater than twofold are listed in Table 1.	SEN:10030050	18422969
BEL:20059574	p(MGI:Pparg) increases r(MGI:Cd36)	The basal levels of PPARgamma and its target genes CD36 and ABCG1 were dramatically reduced in macrophage-specific PPARgamma knockout mice	SEN:10030048	18422969
BEL:20059576	p(MGI:Pparg) decreases r(MGI:Il2ra)	Target genes regulated basally by PPARgamma expression greater than twofold are listed in Table 1.	SEN:10030050	18422969
BEL:20059600	p(MGI:Ppp1r15a) increases phos(p(MGI:Ppp1cc))	GADD34 was recently identified as the factor that activates the type 1 protein serine/threonine phosphatase (PP1), which dephosphorylates eIF-2 alpha during cellular stresses.	SEN:10007854	12840028
BEL:20059602	p(MGI:Ppp1r15a) increases p(MGI:Ppp1cc)	GADD34 was recently identified as the factor that activates the type 1 protein serine/threonine phosphatase (PP1), which dephosphorylates eIF-2 alpha during cellular stresses.	SEN:10007854	12840028
BEL:20059610	p(MGI:Prdm16) increases r(MGI:Dio2)	Moreover, PRDM16-transduced cells expressed several of the important thermogenic genes in a cAMP-dependent manner, similar to what bona fide brown fat cells do in culture and in vivo. The mRNA levels of UCP1, deiodinase-d2 and PGC-1alpha were increased by PRDM16 in unstimulated fat cells and induced to very high levels by PRDM16 in response to cAMP	SEN:10030058	17618855
BEL:20059612	p(MGI:Prdm16) increases r(MGI:Fabp4)	At the molecular level, expression of genes common to both white and brown fat lineages were either not affected (PPAR? and adiponectin) or moderately elevated (aP2) by PRDM16 expression (Figure 2A).	SEN:10030060	17618855
BEL:20059614	p(MGI:Prdm16) increases r(MGI:Ppargc1a)	Moreover, PRDM16-transduced cells expressed several of the important thermogenic genes in a cAMP-dependent manner, similar to what bona fide brown fat cells do in culture and in vivo. The mRNA levels of UCP1, deiodinase-d2 and PGC-1alpha were increased by PRDM16 in unstimulated fat cells and induced to very high levels by PRDM16 in response to cAMP	SEN:10030058	17618855
BEL:20059616	p(MGI:Prdm16) decreases r(MGI:Psat1)	Interestingly, the mRNA levels of several genes that are preferentially expressed in white relative to brown fat cells were significantly repressed by PRDM16 expression, including psat1, serpin3ak and resistin	SEN:10030062	17618855
BEL:20059618	p(MGI:Prdm16) decreases r(MGI:Retn)	Interestingly, the mRNA levels of several genes that are preferentially expressed in white relative to brown fat cells were significantly repressed by PRDM16 expression, including psat1, serpin3ak and resistin	SEN:10030062	17618855
BEL:20059620	p(MGI:Prdm16) decreases r(MGI:Serpina3k)	Interestingly, the mRNA levels of several genes that are preferentially expressed in white relative to brown fat cells were significantly repressed by PRDM16 expression, including psat1, serpin3ak and resistin	SEN:10030062	17618855
BEL:20059622	p(MGI:Prdm16) increases r(MGI:Ucp1)	Moreover, PRDM16-transduced cells expressed several of the important thermogenic genes in a cAMP-dependent manner, similar to what bona fide brown fat cells do in culture and in vivo. The mRNA levels of UCP1, deiodinase-d2 and PGC-1alpha were increased by PRDM16 in unstimulated fat cells and induced to very high levels by PRDM16 in response to cAMP	SEN:10030058	17618855
BEL:20059626	p(MGI:Prdm1) increases bp(GOBP:"wound healing")	TGF-beta1 treatment led to more rapid wound closure by both MDA-MB-231 and NMuMG cells. Blimp-1 knockdown reduced the basal level of wound closure and prevented its acceleration by TGF-beta1 in MDA-MB-231 (Figs. 1E and 1F and Supplementary Fig. S2) and NMuMG cells (Fig. 1G).	SEN:10030066	23054396
BEL:20059630	p(MGI:Prdm1) decreases p(MGI:Cdh2)	TGF-beta1 treatment of NMuMG cells has been shown to lead to EMT, as judged by the upregulation of mesenchymal markers Fibronectin, N-Cadherin and Vimentin (15). Knockdown of Blimp-1 overrode the characteristic upregulation of all three mesenchymal makers by TGF-beta1 (Fig. 1C).	SEN:10030068	23054396
BEL:20059632	p(MGI:Prdm1) decreases p(MGI:Fn1)	TGF-beta1 treatment of NMuMG cells has been shown to lead to EMT, as judged by the upregulation of mesenchymal markers Fibronectin, N-Cadherin and Vimentin (15). Knockdown of Blimp-1 overrode the characteristic upregulation of all three mesenchymal makers by TGF-beta1 (Fig. 1C).	SEN:10030068	23054396
BEL:20059634	p(MGI:Prdm1) increases p(MGI:Snai1)	Moreover, ectopic Blimp-1 expression was sufficient to increase levels of Snail in NMuMG and multiple breast cancer lines (Fig. 4B).	SEN:10030070	23054396
BEL:20059636	p(MGI:Prdm1) decreases p(MGI:Vim)	TGF-beta1 treatment of NMuMG cells has been shown to lead to EMT, as judged by the upregulation of mesenchymal markers Fibronectin, N-Cadherin and Vimentin (15). Knockdown of Blimp-1 overrode the characteristic upregulation of all three mesenchymal makers by TGF-beta1 (Fig. 1C).	SEN:10030068	23054396
BEL:20059666	p(MGI:Prkaa2) decreases a(CHEBI:"reactive oxygen species")	Aortic ROS levels measured by dihydroethidium (DHE)/HPLC were greater in AMPKalpha2-/- mice than WT mice (Figure 1H), and this elevation in ROS was inhibited by either tempol or apocynin.	SEN:10030080	20167927
BEL:20059668	p(MGI:Prkaa2) decreases a(CHEBI:"reactive oxygen species")	Increased ROS production in AMPKalpha2-/- mice aortic endothelium was further confirmed by DHE/vWF double staining (Online Figure II, A).	SEN:10030082	20167927
BEL:20059670	p(MGI:Prkaa2) decreases a(CHEBI:"reactive oxygen species")	The increased oxidative stress in LDLr-/-/AMPKalpha2-/- mice was further confirmed by increased ROS productions assayed by DHE/ HPLC (Figure 6B), and 3-NT by Western blot (Figure 6C).	SEN:10030084	20167927
BEL:20059686	p(MGI:Prkaa2) decreases p(MGI:Cybb)	Compared to WT MAECs, AMPKalpha2-/- MAECs exhibited elevated expression of p47phox, p67phox, and gp91phox (Figure 3A).	SEN:10030090	20167927
BEL:20059688	p(MGI:Prkaa2) decreases p(MGI:Ifng)	The proinflammatory cytokines interleukin (IL)-2 and interferon-gamma in serum were significantly increased in LDLr-/-/ AMPKalpha2-/- mice (Online Table II).	SEN:10030092	20167927
BEL:20059690	p(MGI:Prkaa2) decreases p(MGI:Il10)	Interestingly, the antiinflammatory cytokines IL-5 and IL-10 were also significantly increased in LDLr-/-/ AMPKalpha2-/- mice and were downregulated by MG132 treatment (Online Table II).	SEN:10030094	20167927
BEL:20059692	p(MGI:Prkaa2) decreases p(MGI:Il2)	The proinflammatory cytokines interleukin (IL)-2 and interferon-gamma in serum were significantly increased in LDLr-/-/ AMPKalpha2-/- mice (Online Table II).	SEN:10030092	20167927
BEL:20059694	p(MGI:Prkaa2) decreases p(MGI:Il5)	Interestingly, the antiinflammatory cytokines IL-5 and IL-10 were also significantly increased in LDLr-/-/ AMPKalpha2-/- mice and were downregulated by MG132 treatment (Online Table II).	SEN:10030094	20167927
BEL:20059696	p(MGI:Prkaa2) decreases p(MGI:Ncf1)	Compared to WT MAECs, AMPKalpha2-/- MAECs exhibited elevated expression of p47phox, p67phox, and gp91phox (Figure 3A).	SEN:10030090	20167927
BEL:20059698	p(MGI:Prkaa2) decreases p(MGI:Ncf2)	Compared to WT MAECs, AMPKalpha2-/- MAECs exhibited elevated expression of p47phox, p67phox, and gp91phox (Figure 3A).	SEN:10030090	20167927
BEL:20059700	p(MGI:Prkaa2) increases p(MGI:Nfkbia)	As shown in Figure 3B, AMPKalpha2-/- MAECs contained reduced IkBalpha levels and exhibited increased IkBalpha phosphorylation, which is required for proteasome-dependent degradation of IkBalpha.	SEN:10030096	20167927
BEL:20059702	p(MGI:Prkaa2) decreases p(MGI:Rela,pmod(P,S,536))	Compared to LDLr-/-, the levels of P-p65 at Ser536 were dramatically increased in the aortas of LDLr-/-/AMPKalpha2-/- mice (Figure 8A).	SEN:10030098	20167927
BEL:20059704	p(MGI:Prkaa2,pmod(P,T,172)) directlyIncreases kin(p(MGI:Prkaa2))	We show that LKB1 directly phosphorylates Thr-172 of AMPKalpha in vitro and activates its kinase activity.	SEN:10022208	14985505
BEL:20059706	p(MGI:Prkaa2) decreases tloc(p(MGI:Nfkb1),GOCCID:0005737,GOCCID:0005634)	Further, nuclear levels of p65 and p50 were significantly higher in AMPKalpha2-/- MAECs than in WT MAECs (Figure 3C).	SEN:10030100	20167927
BEL:20059708	p(MGI:Prkaa2) decreases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	Further, nuclear levels of p65 and p50 were significantly higher in AMPKalpha2-/- MAECs than in WT MAECs (Figure 3C).	SEN:10030100	20167927
BEL:20059720	p(MGI:Prkca) increases r(MGI:Fgf2)	Taken together, regulation of Fgf-2 expression by OCCM-30 cells is via both PKCdependent and PKC-independent mechanisms,	SEN:10030106	20542497
BEL:20059772	p(MGI:Prkcz) decreases bp(GOBP:"cell migration")	PKCzeta down-regulation is shown to be a critical determinant of cell migration. Transfection of high-motility cells with either wild-type PKCzeta or its regulatory domain suppresses migration.	SEN:10029810	11682463
BEL:20059778	p(MGI:Prkcz,pmod(P)) directlyIncreases kin(p(MGI:Prkcz))	Ceramide and its analogs activated PKCzeta prior to binding to PAR-4, as determined by increased levels of phosphorylated PKCzeta and glycogen synthase kinase-3beta and emergence of a PAR-4-to-phosphorylated PKCzeta fluorescence resonance energy transfer signal that co-localizes with ceramide.	SEN:10015532	15901738
BEL:20059804	p(MGI:Prkg1) decreases path(MESHD:Hypertension)	These findings clearly show that ablation of the cGKI gene abolishes the NO-dependent modulation of blood pressure under physiological conditions and leads to hypertension.	SEN:10030150	9606187
BEL:20059806	p(MGI:Prkg1) decreases path(MESHD:Hypertrophy)	Autopsies of cGKI?/? mice revealed a gross intestinal distension, especially of the caecum, and signs of pyloric stenosis, and the histological analysis of the cGKI?/? mice showed a marked hypertrophy of the gastric fundus and pylorus muscle (not shown).	SEN:10030152	9606187
BEL:20059810	p(MGI:Prl) increases kin(p(MGI:Jak2))	PRL treatment of HC11 cells increased phosphorylation of STAT5. The JAK2 inhibitor AG490 blocked phosphorylation of STAT5 and PRL-induced, but not PGE1-induced, Cl- transport	SEN:10006208	11117534
BEL:20059814	p(MGI:Prl) decreases r(MGI:Fasn)	In this study, we demonstrate that GH and PRL decrease the mRNA and protein levels of FAS in 3T3-L1 adipocytes.	SEN:10027204	15983196
BEL:20059818	p(MGI:Prl) decreases r(MGI:Inhba)	PRL and placental lactogens caused an inhibition of activin A mRNA expression in primary decidual cells.	SEN:10009916	12606360
BEL:20059844	p(MGI:Prok2) increases bp(GOBP:angiogenesis)	FROM FULL TEXT: we tested recombinant Bv8 on mouse tumour-associated endothelial cells and found that it induces mitogen-activated protein (MAP) kinase phosphorylation and tube formation (Supplementary Fig. 8a?c).	SEN:10030162	18064003
BEL:20059846	p(MGI:Prok2) increases bp(GOBP:"MAPK cascade")	FROM FULL TEXT: we tested recombinant Bv8 on mouse tumour-associated endothelial cells and found that it induces mitogen-activated protein (MAP) kinase phosphorylation and tube formation (Supplementary Fig. 8a?c).	SEN:10030162	18064003
BEL:20059862	p(MGI:Psmc2) increases a(CHEBI:"nitric oxide")	We hypothesized that silencing MSS1 gene expression might inhibit microglial inflammation. Using RNA interference (RNAi), we showed significant reduction of IkB? degradation and NF-kB activation. The production of lipopolysaccharides-induced pro-inflammatory mediators such as inducible nitric oxide synthase (iNOS), nitric oxide, cyclooxygenase-2, and prostaglandin E2 were also reduced by MSS1 gene knockdown.	SEN:10009928	22629310
BEL:20059866	p(MGI:Psmc2) increases cat(p(MGI:Nfkb1))	We hypothesized that silencing MSS1 gene expression might inhibit microglial inflammation. Using RNA interference (RNAi), we showed significant reduction of IkB? degradation and NF-kB activation. The production of lipopolysaccharides-induced pro-inflammatory mediators such as inducible nitric oxide synthase (iNOS), nitric oxide, cyclooxygenase-2, and prostaglandin E2 were also reduced by MSS1 gene knockdown.	SEN:10009928	22629310
BEL:20059868	p(MGI:Psmc2) increases p(MGI:Ptgs2)	We hypothesized that silencing MSS1 gene expression might inhibit microglial inflammation. Using RNA interference (RNAi), we showed significant reduction of IkB? degradation and NF-kB activation. The production of lipopolysaccharides-induced pro-inflammatory mediators such as inducible nitric oxide synthase (iNOS), nitric oxide, cyclooxygenase-2, and prostaglandin E2 were also reduced by MSS1 gene knockdown.	SEN:10009928	22629310
BEL:20059872	p(MGI:Pten) decreases bp(GOBP:"cell proliferation")	Pten loss induces glial cell proliferation but does not have any effect on neurons (Fraser et al., 2004, 2008; Endersby and Baker, 2008).	SEN:10030170	18794886
BEL:20059876	p(MGI:Pten) increases bp(GOBP:"apoptotic process")	Administration of PTEN-specific siRNA reversed PKB/Akt inhibition and mitigated apoptosis in diabetic mouse aortas. These findings therefore suggest that hyperglycaemia may promote apoptosis in endothelial cells through PKB/Akt downregulation, via a peroxynitrite-mediated, LKB1-dependent PTEN activation (46).	SEN:10030174	19273391
BEL:20059878	p(MGI:Pten) increases path(MESHD:"Insulin Resistance")	Our results demonstrate that in vivo PTEN is a potent negative regulator of insulin signaling and insulin sensitivity in adipose tissue.	SEN:10007858	15743841
BEL:20059880	p(MGI:Pten) increases path(MESHD:"Insulin Resistance")	Pten-deleted muscle, liver or fat tissue exhibits increased glucose sensitivity (Stiles et al., 2004; Kurlawalla-Martinez et al., 2005; Wijesekara et al., 2005).	SEN:10030176	18794886
BEL:20059896	p(MGI:Pten) decreases p(MGI:Akt1,pmod(P,S,473))	Western blot analyses revealed that PTEN deficiency enhanced collagen-induced phosphorylation of Akt at Ser473 (Figure 1H).	SEN:10030188	20554973
BEL:20059898	p(MGI:Pten) decreases p(MGI:Hes1)	We first investigated whether hyperactive mTOR could cause abnormal Notch signaling by monitoring the levels of Hes1, a direct target of Notch. We found that Hes1 protein expression was dramatically elevated in cells with constitutively active mTOR caused by loss of the Tsc2 or Pten tumor suppressor gene or oncogenic myristoylation of AKT1 (myrAKT1) (34) (Figure 2A).	SEN:10021528	20038814
BEL:20059908	p(MGI:Pten) decreases p(MGI:Trp63)	Both TA-p63 and deltaN-p63 were overexpressed in cells with mTOR activation because of either a lack of Tsc2 or Pten or expression of AKT1-E17K, and were repressed by rapamycin	SEN:10021534	20038814
BEL:20059926	p(MGI:Ptgir) decreases bp(GOBP:"cell proliferation")	Mice lacking the PGI2 receptor exhibit increased platelet activation and vascular proliferation after injury of the vessel walls (181).	SEN:10030200	16046792
BEL:20059930	p(MGI:Ptgir) decreases path(MESHD:Atherosclerosis)	both apoE//prostacyclin receptor/164 and apoE//eNOS/163 mice showed accelerated atherosclerosis compared with apoE/ mice.	SEN:10029614	17332437
BEL:20059934	p(MGI:Ptgs2) decreases a(CHEBI:lipid)	Aortas from COX-2?/? mice on atherogenic diet after 3 weeks had significantly larger areas of neutral lipid content as measured by Oil Red O staining (Fig. 1A).	SEN:10030204	17643885
BEL:20059936	p(MGI:Ptgs2) decreases a(CHEBI:"thromboxane B2")	Serum TXB2 is significantly increased in COX-2?/? mice on chow compared to wild-type littermates (Fig. 4A).	SEN:10030206	17643885
BEL:20059940	p(MGI:Ptgs2) decreases bp(GOBP:"cell proliferation")	DCs cultured in TSN from COX-2-inhibited cells showed augmentation in the number of proliferating clusters as well as the number of cells staining positively for DEC-205	SEN:10030210	12631593
BEL:20059946	p(MGI:Ptgs2) decreases p(MGI:Il6)	Interestingly, COX-2?/? mice on atherogenic diet showed more systemic inflammation with higher levels of TNF (Fig. 5B) and IL-6 (Fig. 5D) than wild-type controls. Furthermore, IL-12 was significantly increased by atherogenic diet in wild-type controls, while COX-2 depletion completely abolished this induction (Fig. 5E).	SEN:10030216	17643885
BEL:20059948	p(MGI:Ptgs2) decreases p(MGI:Ly75)	DCs cultured in TSN from COX-2-inhibited cells showed augmentation in the number of proliferating clusters as well as the number of cells staining positively for DEC-205	SEN:10030210	12631593
BEL:20059950	p(MGI:Ptgs2) decreases p(MGI:Relb)	TSN-cultured DCs demonstrated a COX-2-dependent reduction of both cytoplasmic and nuclear RelB (Fig. 3A)	SEN:10030218	12631593
BEL:20059952	p(MGI:Ptgs2) decreases p(MGI:Tnf)	Interestingly, COX-2?/? mice on atherogenic diet showed more systemic inflammation with higher levels of TNF (Fig. 5B) and IL-6 (Fig. 5D) than wild-type controls. Furthermore, IL-12 was significantly increased by atherogenic diet in wild-type controls, while COX-2 depletion completely abolished this induction (Fig. 5E).	SEN:10030216	17643885
BEL:20059970	p(MGI:Pth) increases cat(p(MGI:Sox4))	the presence of Sox4 mRNA in hypertrophic chrondrocytes within the mouse epiphyseal growth plate at sites that overlap or are adjacent to target cells for TPH and PTHrP, and its strong up-regulation via activated PTH/PTHrP receptors in OHS cells, makes it a promising candidate for mediated downstream effects of PTH and PTHrP in bone	SEN:10030226	11127205
BEL:20059976	p(MGI:Pthlh) increases cat(p(MGI:Sox4))	the presence of Sox4 mRNA in hypertrophic chrondrocytes within the mouse epiphyseal growth plate at sites that overlap or are adjacent to target cells for TPH and PTHrP, and its strong up-regulation via activated PTH/PTHrP receptors in OHS cells, makes it a promising candidate for mediated downstream effects of PTH and PTHrP in bone	SEN:10030226	11127205
BEL:20059980	p(MGI:Pthlh) increases p(MGI:Tnfsf11)	TGF? stimulates PTHrP secretion without appearing to increase PTHrP mRNA levels. PTHrP stimulates the production of RANK ligand (RANKL) in osteoblasts, which in turn promotes the differentiation of osteoclast precursors and bone resorption. Administration of anti-PTHrP neutralizing antibodies inhibits TGF?-dependent osteolytic bone metastasis in mice (Kakonen et al., 2002).	SEN:10030232	18662538
BEL:20059986	p(MGI:Pthlh) increases r(MGI:Il6)	Specifically, PTH and PTHrP rapidly and transiently induce expression of the mRNAs encoding IL-6 and LIF.	SEN:10030236	8725172
BEL:20059990	p(MGI:Pthlh) increases r(MGI:Lif)	Specifically, PTH and PTHrP rapidly and transiently induce expression of the mRNAs encoding IL-6 and LIF.	SEN:10030236	8725172
BEL:20059998	p(MGI:Pth) increases r(MGI:Il6)	Specifically, PTH and PTHrP rapidly and transiently induce expression of the mRNAs encoding IL-6 and LIF.	SEN:10030236	8725172
BEL:20060000	p(MGI:Pth) increases r(MGI:Lif)	Specifically, PTH and PTHrP rapidly and transiently induce expression of the mRNAs encoding IL-6 and LIF.	SEN:10030236	8725172
BEL:20060042	p(MGI:Ptpn2) decreases p(MGI:Stat1,pmod(P,Y))	Immunoblotting with a phospho-STAT1 antibody revealed an increase in STAT1 phosphorylation in TCPTP-deficient thymocytes	SEN:10030256	11909529
BEL:20060046	p(MGI:Ptpra) increases kin(p(MGI:Kit))	PTP? is required for SCF-induced c-Kit and Fyn activation, and in this way regulates a Fyn-based c-Kit signaling axis (Fyn/Gab2/Shp2/Vav/PAK/Rac/JNK) that mediates mast cell migration.	SEN:10019126	20944008
BEL:20060070	p(MGI:Pycard) increases cat(p(MGI:Casp1))	ASC is essential for activation of caspase-1 and production of mature IL-1 in response to all of these inflammatory stimuli	SEN:10030268	17641058
BEL:20060072	p(MGI:Pycard) increases p(MGI:Il1b)	ASC is essential for activation of caspase-1 and production of mature IL-1 in response to all of these inflammatory stimuli	SEN:10030268	17641058
BEL:20060074	p(MGI:Pycard) increases p(MGI:Il1b)	IL-1? production into the lung was attenuated in ASC–/– in comparison with ASC+/+ control littermates 24 hours after BLM administration (Figure 9D).	SEN:10030264	17992263
BEL:20060076	p(MGI:Pycard) increases p(MGI:Il6)	IL-6 production into the lung 24 hours after BLM treatment was attenuated in ASC–/– in comparison with ASC+/+ control littermates (Figure 9E). Comparable reductions of IL-1? and IL-6 were obtained in the BALF	SEN:10030266	17992263
BEL:20060078	p(MGI:Pycard) increases sec(p(MGI:Casp1))	Fig. 4A shows that ASC–/– BMDM were completely deficient in ATP-induced activation of inflammasome complexes as well as the coupled release of mature IL-1 and active caspase-1.	SEN:10030270	17641058
BEL:20060080	p(MGI:Pycard) increases sec(p(MGI:Il1b))	Fig. 4A shows that ASC–/– BMDM were completely deficient in ATP-induced activation of inflammasome complexes as well as the coupled release of mature IL-1 and active caspase-1.	SEN:10030270	17641058
BEL:20060082	p(MGI:Pycard) increases sec(p(MGI:Lamp1))	release of the endosomal/lysosomal membrane marker protein, LAMP-1, was strongly inhibited in the ASC-deficient BMDM	SEN:10030272	17641058
BEL:20060084	p(MGI:Pygl) increases a(CHEBI:"reactive oxygen species")	Knockdown of PYGL, GLUL, or GLUD1 partially reduced the degree of TNF- and zVAD-fmk–mediated ROS production and necrosis.	SEN:10027244	20354226
BEL:20060102	p(MGI:Rac1) increases a(CHEBI:"reactive oxygen species")	OS of Rac1+/– ECs under H/R was substantially decreased compared to that of Rac1+/+ ECs; indeed, OS of Rac1+/– ECs subjected to H/R was ~30% lower than that of Rac1+/+ ECs at baseline.	SEN:10030280	19278959
BEL:20060108	p(MGI:Rac1) increases bp(GOBP:angiogenesis)	Rac1+/– ECs exhibited decreased proliferation and capillary formation compared to Rac1+/+ ECs (fig. S2A).	SEN:10030284	19278959
BEL:20060110	p(MGI:Rac1) increases bp(GOBP:"cell migration")	Rac1-deficient cells migrated more slowly (Figure 3A). Rac1-deficient cells also showed a reduction in proliferation (Figure 3B).	SEN:10030286	19349358
BEL:20060112	p(MGI:Rac1) increases bp(GOBP:"cell proliferation")	Rac1+/– ECs exhibited decreased proliferation and capillary formation compared to Rac1+/+ ECs (fig. S2A).	SEN:10030284	19278959
BEL:20060114	p(MGI:Rac1) increases bp(GOBP:"cell proliferation")	Rac1-deficient cells migrated more slowly (Figure 3A). Rac1-deficient cells also showed a reduction in proliferation (Figure 3B).	SEN:10030286	19349358
BEL:20060116	p(MGI:Rac1) increases bp(GOBP:"wound healing")	Figure 1 Conditional deletion of Rac1 in fibroblasts results in impaired cutaneous wound healing.	SEN:10030288	19349358
BEL:20060118	p(MGI:Rac1) increases bp(GOBP:"apoptotic process")	In line with the decrease in ROS and the increase in HSP abundance, apoptotic death of Rac1+/– ECs, at both baseline and H/R, was ~50% less than that of Rac1+/+ ECs (Fig. 3B).	SEN:10030290	19278959
BEL:20060124	p(MGI:Rac1) decreases p(MGI:Cryab)	In addition, crystallin {alpha}B immunolabeling was more intense with Rac1+/– than with Rac1+/+ ECs	SEN:10030292	19278959
BEL:20060128	p(MGI:Rac1) increases r(MGI:Acta2)	To investigate whether Rac1-deficient cells showed defects in myofibroblast differentiation, we used real-time PCR analysis to show that Rac1-deficient cells possessed reduced mRNA expression for alpha-SMA and type I collagen (Figure 4A).	SEN:10030294	19349358
BEL:20060130	p(MGI:Rac1) increases r(MGI:Tgfb2)	To begin to assess whether altered responses to TGFbeta may play a role in the phenotype of Rac1-deficient fibroblasts, we first used real time PCR analysis to show that Rac1-deficient fibroblasts possessed a modest, yet significant, reduction in TGFbeta2 mRNA expression (Figure 6B) suggesting that the primary defect in Rac1-deficient fibroblasts was not a defect in TGFbeta signaling.	SEN:10030296	19349358
BEL:20060134	p(MGI:Rac2) increases kin(p(MGI:Mapk1))	rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation	SEN:10030298	10072071
BEL:20060136	p(MGI:Rac2) increases kin(p(MGI:Mapk14))	rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation	SEN:10030298	10072071
BEL:20060138	p(MGI:Rac2) increases kin(p(MGI:Mapk3))	rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation	SEN:10030298	10072071
BEL:20060144	p(MGI:Rae1) increases bp(GOBP:"apoptotic process")	We tested whether the expression of Rae-1 in primary lymphomas derived from an E-Myc animal would result in NK-mediated killing of cancer cells. Using an in vivo cytotoxicity assay, we observed significant killing of lymphoma cells that was largely perforin dependent [supporting information (SI) Fig. 6A].	SEN:10030304	18223157
BEL:20060156	p(MGI:Rag1) decreases bp(GOBP:"inflammatory response")	Control T cell-reconstituted RAG2/2 mice demonstrated mild inflammation of the lungs....Ag sensitization induced peribronchiolar, perivascular, and alveolar inflammation of similar type and extent in wild-type and in T cell-reconstituted RAG2/2 mice.	SEN:10030310	11466402
BEL:20060170	p(MGI:Rapgef1) increases cat(p(MGI:Rap1a))	it is likely that Chat-induced Rap1 activation was mediated by upregulation of the Cas-Crk-C3G signaling pathway rather than direct guanine nucleotide exchange factor activity of Chat	SEN:10025366	12432078
BEL:20060172	p(MGI:Rara) increases deg(p(MGI:Prkch))	furthermore, both receptors [RARA and RARG] cause a late upregulation and apparent cleavage of the squamous differentiation marker protein kinase C (PKC)-eta.	SEN:10030314	11751425
BEL:20060176	p(MGI:Rara) increases r(MGI:Prkch)	furthermore, both receptors [RARA and RARG] cause a late upregulation and apparent cleavage of the squamous differentiation marker protein kinase C (PKC)-eta.	SEN:10030314	11751425
BEL:20060180	p(MGI:Rarg) increases deg(p(MGI:Prkch))	furthermore, both receptors [RARA and RARG] cause a late upregulation and apparent cleavage of the squamous differentiation marker protein kinase C (PKC)-eta.	SEN:10030314	11751425
BEL:20060182	p(MGI:Rarg) increases r(MGI:Prkch)	furthermore, both receptors [RARA and RARG] cause a late upregulation and apparent cleavage of the squamous differentiation marker protein kinase C (PKC)-eta.	SEN:10030314	11751425
BEL:20060196	p(MGI:Rassf1) increases p(MGI:Cdkn1a)	In addition, immunohistochemical analysis of conditional A549 xenograft tumors from doxycycline-fed mice revealed enhanced expression and nuclear accumulation of p21Cip1/Waf1 (Figs. 2D and 6D).	SEN:10030320	19223555
BEL:20060198	p(MGI:Rassf1) increases p(MGI:Cdkn1a)	Moreover, tumors with conditionally expressed RASSF1A exhibited SAh-gal activity (Fig. 2C), which serves as an indicator for senescence occurring in vivo (8, 9), as well as enhanced p21Cip1/Waf1 expression (Fig. 2D).	SEN:10030322	19223555
BEL:20060200	p(MGI:Rassf1) increases p(MGI:H2afx,pmod(P,S,140))	Interestingly, we detected an increase in g-H2AX–positive cells in tumors conditionally expressing RASSF1A (Fig. 2D).	SEN:10030324	19223555
BEL:20060224	p(MGI:Rb1) increases p(MGI:Pou2f1,pmod(P))	reconstitution of Rb-defective tumor cells with functional Rb results in hyperphosphorylation of Oct1 and disruption of Oct1 interaction with H2A octamer element Oct1 can be posttranslationally modified by phosphorylation, and this modification has been shown to reduce the binding of Oct1 to DNA	SEN:10030012	11533238
BEL:20060238	p(MGI:Rb1) decreases r(MGI:Ranbp1)	in addition, both pRb and its relative p107 inhibited transcription from the Htf9-a promoter. These results link the control of Htf9-a/RanBP-1 expression to the cell cycle progression.	SEN:10009984	8845298
BEL:20060242	p(MGI:Rb1) decreases tscript(p(MGI:Hbp1))	In addition, E1A can repress the activity of HBP1 via conserved region 1 sequences in a manner independent of the CBP co-activator.	SEN:10030344	9178770
BEL:20060244	p(MGI:Rb1) directlyDecreases tscript(p(MGI:Yy1))	These observations suggest that the interaction of YY1 with hypophosphorylated Rb in resting B cells prevents interaction of YY1 with DNA. After stimulation with class-switching activators, such as LPS, Rb becomes hyperphosphorylated and YY1 is released and can then bind to the hs3 enhancer and E mu.	SEN:10005624	12759432
BEL:20060252	p(MGI:Rbl1) decreases r(MGI:Ranbp1)	in addition, both pRb and its relative p107 inhibited transcription from the Htf9-a promoter. These results link the control of Htf9-a/RanBP-1 expression to the cell cycle progression.	SEN:10009984	8845298
BEL:20060254	p(MGI:Rbl1) decreases tscript(p(MGI:Hbp1))	In addition, E1A can repress the activity of HBP1 via conserved region 1 sequences in a manner independent of the CBP co-activator.	SEN:10030344	9178770
BEL:20060258	p(MGI:Rbl2) decreases tscript(p(MGI:Hbp1))	In addition, E1A can repress the activity of HBP1 via conserved region 1 sequences in a manner independent of the CBP co-activator.	SEN:10030344	9178770
BEL:20060262	p(MGI:Rbms1) increases bp(GOBP:"apoptotic process")	These results indicate that Fas-mediated apoptosis induced by MSSP occurs independently of mitochondria.	SEN:10030350	16211301
BEL:20060266	p(MGI:Rbms1) decreases r(MGI:Acta2)	MSSP has been identified as a transcription factor that regulates the c-myc gene and was later found to positively or negatively regulate a variety of genes, including alpha-smooth actin, MHC class I, MHC class 2 and the thyrotropin receptor.	SEN:10009986	16211301
BEL:20060274	p(MGI:Rbp4) increases path(MESHD:"Insulin Resistance")	We find that elevation of serum RBP4 causes systemic insulin resistance, and that reduction of serum RBP4 improves insulin action.	SEN:10030356	16034410
BEL:20060278	p(MGI:Rbpj) increases r(MGI:Gata2)	Taken together, these data strongly suggest that activation of Gata2 expression by Notch1/RBPjkappa is a crucial event for the onset of definitive hematopoiesis in the embryo.	SEN:10009730	15689374
BEL:20060280	p(MGI:Rbpj) increases r(MGI:Hes1)	Here we show that activated forms of mNotch associate with the human analogue of Su(H), KBF2/RBP-J kappa (refs 8,9) and act as transcriptional activators through the KBF2-binding sites of the HES-1 promoter.	SEN:10009988	7566092
BEL:20060286	p(MGI:Rela,pmod(A,K,310)) directlyIncreases tscript(p(MGI:Rela))	These findings indicate that the acetylation of RelA at lysine 310 is importantly regulated by prior phosphorylation of serines 276 and 536. Such phosphorylated and acetylated forms of RelA display enhanced transcriptional activity.	SEN:10030362	16135789
BEL:20060288	p(MGI:Rela,pmod(P,S,276)) directlyIncreases complex(p(MGI:Ep300),p(MGI:Rela))	Furthermore, phosphorylation of RelA on serine 276 or serine 536 increased assembly of phospho-RelA with p300, which enhanced acetylation on lysine 310.	SEN:10019052	16135789
BEL:20060290	p(MGI:Rela,pmod(P,S,276)) decreases p(MGI:Rela,pmod(A,K,310))	Coexpression of catalytically inactive mutants of the catalytic subunit of protein kinase A/mitogen- and stress-activated kinase 1 or IKK1/IKK2, which phosphorylate RelA on serine 276 or serine 536, respectively, sharply inhibited RelA acetylation on lysine 310.	SEN:10006104	16135789
BEL:20060292	p(MGI:Rela,pmod(P,S,276)) directlyIncreases tscript(p(MGI:Rela))	These findings indicate that the acetylation of RelA at lysine 310 is importantly regulated by prior phosphorylation of serines 276 and 536. Such phosphorylated and acetylated forms of RelA display enhanced transcriptional activity.	SEN:10030362	16135789
BEL:20060308	p(MGI:Rela,pmod(P,S,536)) directlyIncreases complex(p(MGI:Ep300),p(MGI:Rela))	Furthermore, phosphorylation of RelA on serine 276 or serine 536 increased assembly of phospho-RelA with p300, which enhanced acetylation on lysine 310.	SEN:10019052	16135789
BEL:20060314	p(MGI:Rela,pmod(P,S,536)) directlyIncreases tscript(p(MGI:Rela))	These findings indicate that the acetylation of RelA at lysine 310 is importantly regulated by prior phosphorylation of serines 276 and 536. Such phosphorylated and acetylated forms of RelA display enhanced transcriptional activity.	SEN:10030362	16135789
BEL:20060334	p(MGI:Rel) increases r(MGI:Bcl2l1)	Expression of the cancer-related NF-kappaB target genes cyclin D1, c-myc, and bcl-xl was significantly increased in grossly normal transgenic mammary glands starting the first cycle of pregnancy and increased further in mammary carcinomas compared to mammary glands from wild-type mice or virgin transgenic mice.	SEN:10030374	12897145
BEL:20060336	p(MGI:Rel) increases r(MGI:Ccnd1)	Expression of the cancer-related NF-kappaB target genes cyclin D1, c-myc, and bcl-xl was significantly increased in grossly normal transgenic mammary glands starting the first cycle of pregnancy and increased further in mammary carcinomas compared to mammary glands from wild-type mice or virgin transgenic mice.	SEN:10030374	12897145
BEL:20060338	p(MGI:Rel) increases r(MGI:Myc)	Expression of the cancer-related NF-kappaB target genes cyclin D1, c-myc, and bcl-xl was significantly increased in grossly normal transgenic mammary glands starting the first cycle of pregnancy and increased further in mammary carcinomas compared to mammary glands from wild-type mice or virgin transgenic mice.	SEN:10030374	12897145
BEL:20060342	p(MGI:Repin1) increases r(MGI:Fcgr2b)	Our data imply that because of the deficient AP-4 binding, the NZB-type Fcgr2b allele polymorphism results in up-regulation of IgG Ab responses through down-regulation of FcgammaRIIB1 expression levels in germinal center B cells, and that such polymorphism may possibly form the basis of autoimmune susceptibility in combination with other background contributing genes.	SEN:10010000	12370366
BEL:20060344	p(MGI:Rest) decreases p(MGI:Bdnf)	Our results therefore indicate that it is possible to restore Bdnf protein levels in HD cells by attenuation of REST/NRSF binding at the Bdnf locus.	SEN:10030376	17596446
BEL:20060346	p(MGI:Rest) decreases r(MGI:Bdnf)	These experiments showed that 48 h after delivery of DN:REST into Hdh109/109 cells, Bdnf mRNA was increased to similar levels to that seen in untreated wild-type Hdh7/7 cells (Fig. 3a).	SEN:10030378	17596446
BEL:20060350	p(MGI:Retnla) increases bp(GOBP:angiogenesis)	HIMF-stimulated RPSM proliferation. Thus, the PI3K/Akt pathway, at least in part, mediates the proliferative effect of HIMF. Further studies showed that HIMF had angiogenic and vasoconstrictive properties. HIMF increased pulmonary arterial pressure and vascular resistance more potently than either endothelin-1 or angiotensin II	SEN:10010002	12714564
BEL:20060352	p(MGI:Retnla) increases bp(GOBP:"cell proliferation")	HIMF-stimulated RPSM proliferation. Thus, the PI3K/Akt pathway, at least in part, mediates the proliferative effect of HIMF. Further studies showed that HIMF had angiogenic and vasoconstrictive properties. HIMF increased pulmonary arterial pressure and vascular resistance more potently than either endothelin-1 or angiotensin II	SEN:10010002	12714564
BEL:20060368	p(MGI:Retnlb) increases bp(GOBP:"cell proliferation")	FIZZ2 significantly (p < 0.001) stimulated fibroblast proliferation at doses as low as 10 ng/ml, which appears to be maximal because no further significant increase was noted at higher doses (Fig. 5A).	SEN:10030386	21602491
BEL:20060370	p(MGI:Retnlb) increases kin(p(MGI:Akt1))	Inhibition of phosphatidylinositol 3-kinase (see {601232}) inhibited Retnlb-activated Akt phosphorylation and also inhibited RPSM proliferation.	SEN:10030388	12714564
BEL:20060372	p(MGI:Retnlb) increases kin(p(MGI:Akt1))	Phosphorylation status of the three key MAPKs (ERK, JNK, and p38) and AKT in FIZZ2-treated MLFs were analyzed by Western blotting. The results showed rapid (10 min) marked activation of ERK by FIZZ2, with lesser effects on AKT and p38 (Fig. 5B). JNK was not activated by FIZZ2 treatment.	SEN:10030390	21602491
BEL:20060378	p(MGI:Retnlb) increases p(MGI:Acta2)	The results showed that MLF ?-SMA protein expression was also stimulated by FIZZ2 at doses as low as 25 ng/ml (Fig. 4C).	SEN:10030392	21602491
BEL:20060380	p(MGI:Retnlb) increases r(MGI:Col1a1)	type I procollagen gene was induced >3-fold by FIZZ2 as early as 2 h posttreatment and remained 1.5-fold elevated at 6 h.	SEN:10030394	21602491
BEL:20060382	p(MGI:Retnlb) increases sec(p(MGI:Ccl5))	However, RELMbeta stimulated naive bone marrow-derived macrophages to secrete significant amounts of TNF-alpha, IL-6, and RANTES	SEN:10010006	17982092
BEL:20060384	p(MGI:Retnlb) increases sec(p(MGI:Il6))	However, RELMbeta stimulated naive bone marrow-derived macrophages to secrete significant amounts of TNF-alpha, IL-6, and RANTES	SEN:10010006	17982092
BEL:20060386	p(MGI:Retnlb) increases sec(p(MGI:Tnf))	However, RELMbeta stimulated naive bone marrow-derived macrophages to secrete significant amounts of TNF-alpha, IL-6, and RANTES	SEN:10010006	17982092
BEL:20060396	p(MGI:Ret,pmod(P,Y,752)) increases p(MGI:Stat3,pmod(P,S,727))	Over- expression of MEN2A-RET mutants reduced STAT3 ser727 phosphorylation to basal levels, suggesting that STAT3 tyr705 phosphorylation is a prerequisite for maximal MEN2A-RET induced STAT3 ser727 phos- phorylation (Figure 3b).	SEN:10030396	11536047
BEL:20060398	p(MGI:Ret,pmod(P,Y,752)) increases p(MGI:Stat3,pmod(P,Y,705))	STAT3 tyr705 phosphoryla- tion was reduced when the MEN2A-RET single mutants tyr752phe or tyr928phe were overexpressed, while no STAT3 tyr705 phosphorylation was observed in the presence of the MEN2A-RET double mutant (Figure 3b).	SEN:10030398	11536047
BEL:20060400	p(MGI:Ret,pmod(P,Y,928)) increases p(MGI:Stat3,pmod(P,S,727))	Over- expression of MEN2A-RET mutants reduced STAT3 ser727 phosphorylation to basal levels, suggesting that STAT3 tyr705 phosphorylation is a prerequisite for maximal MEN2A-RET induced STAT3 ser727 phos- phorylation (Figure 3b).	SEN:10030396	11536047
BEL:20060402	p(MGI:Ret,pmod(P,Y,928)) increases p(MGI:Stat3,pmod(P,Y,705))	STAT3 tyr705 phosphoryla- tion was reduced when the MEN2A-RET single mutants tyr752phe or tyr928phe were overexpressed, while no STAT3 tyr705 phosphorylation was observed in the presence of the MEN2A-RET double mutant (Figure 3b).	SEN:10030398	11536047
BEL:20060404	p(MGI:Ret,pmod(P,Y,928)) increases tscript(p(MGI:Stat3))	As depicted in Figure 3a, mutation of tyr928 (RET) reduced STAT3 transactivation approximately 1.5-fold, indicating that other STAT3 docking sites must be present in MEN2A-RET as well.	SEN:10030400	11536047
BEL:20060406	p(MGI:Ret) increases tscript(p(MGI:Stat3))	As depicted in Figure 1a,b, over- expression of both MEN2A-RET and STAT3 strongly enhanced IRE transactivation, while overexpression of STAT3 alone did not affect reporter activation.	SEN:10030402	11536047
BEL:20060414	p(MGI:Rgs1) decreases bp(GOBP:"cell adhesion")	RGS1, RGS3, and RGS4 also reduced rapid chemoattractant-triggered adhesion, although the proadhesive response appears quantitatively less sensitive to RGS action than chemotaxis.	SEN:10010010	9774420
BEL:20060420	p(MGI:Rgs2) increases tport(p(MGI:Slc2a4))	As shown in Fig. 1B, single-cell microinjection of Galpha q/11 antibody or RGS2 protein into 3T3-L1 adipocytes markedly inhibited (70 and 81%, respectively) insulin induced-GLUT4 translocation.	SEN:10027248	10490615
BEL:20060422	p(MGI:Rgs3) decreases bp(GOBP:"cell adhesion")	RGS1, RGS3, and RGS4 also reduced rapid chemoattractant-triggered adhesion, although the proadhesive response appears quantitatively less sensitive to RGS action than chemotaxis.	SEN:10010010	9774420
BEL:20060426	p(MGI:Rgs4) decreases bp(GOBP:"cell adhesion")	RGS1, RGS3, and RGS4 also reduced rapid chemoattractant-triggered adhesion, although the proadhesive response appears quantitatively less sensitive to RGS action than chemotaxis.	SEN:10010010	9774420
BEL:20060438	p(MGI:Ripk1) increases bp(GOBP:"apoptotic process")	As shown in supplementary Fig 1 online, both TNFR1- and RIP-null MEFs are more resistant than WT MEF cells to ER stress-induced apoptosis.	SEN:10030408	16680093
BEL:20060442	p(MGI:Ripk1) decreases cat(p(MGI:Casp8))	This resulted in processing of p100 NF-kB2 to p52, a decrease in levels of cFLIP(L), and activation of caspase-8, culminating in cell death. Therefore, the pro-survival effect of RIPK1 is mediated by stabilization of TRAF2 and cIAP1.	SEN:10030412	21339290
BEL:20060446	p(MGI:Ripk1) increases p(MGI:Birc2)	Although TRAF2 levels remained constant in TNF-treated wild-type cells, TNF stimulation of RIPK1(-/-) cells caused TRAF2 and cIAP1 to be rapidly degraded by the proteasome, which led to an increase in NIK levels.	SEN:10002746	21339290
BEL:20060448	p(MGI:Ripk1) increases p(MGI:Cflar)	This resulted in processing of p100 NF-kB2 to p52, a decrease in levels of cFLIP(L), and activation of caspase-8, culminating in cell death. Therefore, the pro-survival effect of RIPK1 is mediated by stabilization of TRAF2 and cIAP1.	SEN:10030412	21339290
BEL:20060450	p(MGI:Ripk1) decreases p(MGI:Map3k14)	Although TRAF2 levels remained constant in TNF-treated wild-type cells, TNF stimulation of RIPK1(-/-) cells caused TRAF2 and cIAP1 to be rapidly degraded by the proteasome, which led to an increase in NIK levels.	SEN:10002746	21339290
BEL:20060452	p(MGI:Ripk1) increases p(MGI:Traf2)	Although TRAF2 levels remained constant in TNF-treated wild-type cells, TNF stimulation of RIPK1(-/-) cells caused TRAF2 and cIAP1 to be rapidly degraded by the proteasome, which led to an increase in NIK levels.	SEN:10002746	21339290
BEL:20060464	p(MGI:Rnf2) increases p(MGI:Il13)	The production of IL-4, IL-5, and IL-13 in the in vitro-generated Ring1B-/- Th2 cells as in Fig. 2A was significantly decreased (Fig. 2C).	SEN:10030420	20237291
BEL:20060466	p(MGI:Rnf2) increases p(MGI:Il4)	The production of IL-4, IL-5, and IL-13 in the in vitro-generated Ring1B-/- Th2 cells as in Fig. 2A was significantly decreased (Fig. 2C).	SEN:10030420	20237291
BEL:20060468	p(MGI:Rnf2) increases p(MGI:Il5)	The production of IL-4, IL-5, and IL-13 in the in vitro-generated Ring1B-/- Th2 cells as in Fig. 2A was significantly decreased (Fig. 2C).	SEN:10030420	20237291
BEL:20060470	p(MGI:Rnf2) decreases r(MGI:Bax)	In addition, mRNA expression of several proapoptotic genes Bim, Noxa, Bax, and Perp were significantly increased in Ring1B-/- Th2 cells, whereas no decrease in the expression of the antiapoptotic genes Mcl1, Bcl2, and Bcl-xL was detected (Fig. 5C).	SEN:10030422	20237291
BEL:20060472	p(MGI:Rnf2) decreases r(MGI:Bcl2l11)	In addition, mRNA expression of several proapoptotic genes Bim, Noxa, Bax, and Perp were significantly increased in Ring1B-/- Th2 cells, whereas no decrease in the expression of the antiapoptotic genes Mcl1, Bcl2, and Bcl-xL was detected (Fig. 5C).	SEN:10030422	20237291
BEL:20060474	p(MGI:Rnf2) decreases r(MGI:Perp)	In addition, mRNA expression of several proapoptotic genes Bim, Noxa, Bax, and Perp were significantly increased in Ring1B-/- Th2 cells, whereas no decrease in the expression of the antiapoptotic genes Mcl1, Bcl2, and Bcl-xL was detected (Fig. 5C).	SEN:10030422	20237291
BEL:20060476	p(MGI:Rnf2) decreases r(MGI:Pmaip1)	In addition, mRNA expression of several proapoptotic genes Bim, Noxa, Bax, and Perp were significantly increased in Ring1B-/- Th2 cells, whereas no decrease in the expression of the antiapoptotic genes Mcl1, Bcl2, and Bcl-xL was detected (Fig. 5C).	SEN:10030422	20237291
BEL:20060478	p(MGI:Rock1) increases bp(GOBP:angiogenesis)	Figure 2. Rho/ROCK inhibition disrupts vasculogenesis, ex vivo angiogenesis, and in vitro angiogenesis.	SEN:10030424	20400538
BEL:20060482	p(MGI:Rock1) decreases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	Furthermore, ROK expression alone in the cells appeared to inhibit basal NF-kB nuclear translocation (Fig. 7D).	SEN:10030428	15705584
BEL:20060488	p(MGI:Rock2) increases bp(GOBP:angiogenesis)	Figure 2. Rho/ROCK inhibition disrupts vasculogenesis, ex vivo angiogenesis, and in vitro angiogenesis.	SEN:10030424	20400538
BEL:20060502	p(MGI:Rps6kb1) decreases cat(p(MGI:Irs1))	S6K can phosphorylate IRS-1 on a different residue, Ser1101, thus reducing its function and leading to insulin resistance in vivo in skeletal muscle (Tremblay et al., 2007).	SEN:10028538	18794886
BEL:20060504	p(MGI:Rps6kb1) decreases p(MGI:Irs1)	(Harrington et al., 2004). The mechanism of this transcriptional repression depends on the activation of mTORC1 signaling, as rapamycin treatment and silencing of S6K genes restores IRS-1 levels.	SEN:10017410	18794886
BEL:20060506	p(MGI:Rps6kb1) directlyIncreases p(MGI:Irs1,pmod(P,S,1101))	S6K can phosphorylate IRS-1 on a different residue, Ser1101, thus reducing its function and leading to insulin resistance in vivo in skeletal muscle (Tremblay et al., 2007).	SEN:10028538	18794886
BEL:20060522	p(MGI:Rspo1) increases bp(GOBP:"Wnt receptor signaling pathway")	secreted proteins such as Norrin and R?Spondin were shown to be activators of the canonical Wnt pathway owing to their interaction with Frizzled–LRP receptors79,80.	SEN:10030448	18432252
BEL:20060532	p(MGI:Runx3) increases p(MGI:Ifng)	Even under these conditions, Runx3-deficient TH1 cultures showed a substantial defect in IFN-g production (Fig. 2a).	SEN:10030450	17195845
BEL:20060534	p(MGI:Runx3) decreases p(MGI:Il4)	Simultaneous analysis of IFN-g and IL-4 expression showed defective Il4 silencing in Runx3-deficient TH1 cells, manifested by an increase in the percentage of cells either producing IL-4 alone or aberrantly producing both IL-4 and IFN-g (Fig. 4a).	SEN:10030452	17195845
BEL:20060550	p(MGI:Rxra) directlyIncreases tscript(p(MGI:Pparg))	The gel mobility shift assay showed the direct binding of PPARgamma-retinoid Xreceptor alpha complex to the PPRE.	SEN:10020422	11679588
BEL:20060552	p(MGI:Rxra) increases tscript(p(MGI:Pparg))	activation of PPARgamma-RXR initiates a potent apoptotic signaling cascade in B cells, potentially through NF-kappaB activation	SEN:10010028	12471115
BEL:20060558	p(MGI:Rxrb) increases tscript(p(MGI:Pparg))	activation of PPARgamma-RXR initiates a potent apoptotic signaling cascade in B cells, potentially through NF-kappaB activation	SEN:10010028	12471115
BEL:20060566	p(MGI:Rxrg) increases r(MGI:Cyp2c29)	Knockdown of RXRgamma in these vessels significantly inhibited the production of EETs, parallel to a reduced vasodilation. RXRgamma siRNA not only silenced the vascular RXRgamma expression, but synchronously downregulated CYP2C29 expression, leading to a reduced EET synthesis	SEN:10010030	20130225
BEL:20060570	p(MGI:Ryk) increases bp(GOBP:"cell growth")	Ryk is required for neurite outgrowth induced by Wnt-3a and in the activation of T cell factor (TCF) induced by Wnt-1.	SEN:10030462	15454084
BEL:20060572	p(MGI:Ryk) increases bp(GOBP:"T cell activation")	Ryk is required for neurite outgrowth induced by Wnt-3a and in the activation of T cell factor (TCF) induced by Wnt-1.	SEN:10030462	15454084
BEL:20060580	p(MGI:S100a6) increases bp(GOBP:"insulin secretion")	In addition to calbindin, calmodulin (45) and calcyclin (46) are two other calcium-binding proteins present in the cell that have been reported to play a role, through their interaction with Ca2+, in modulating the insulin secretory response. Calcyclin, unlike calbindin, which acts as a Ca2+ buffer, was reported to enhance insulin release by a mechanism involving Ca2+-induced exocytosis (46).	SEN:10016692	10567411
BEL:20060582	p(MGI:S100a8) increases bp(GOBP:"neutrophil chemotaxis")	Finally, injection of S100A8, S100A9, or S100A8/A9 into a murine air pouch model led to rapid, transient accumulation of neutrophils confirming their activities in vivo.	SEN:10030464	12626582
BEL:20060584	p(MGI:S100a8) directlyIncreases cat(p(MGI:Tlr4))	The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.	SEN:10002754	20473308
BEL:20060586	p(MGI:S100a9) increases bp(GOBP:"neutrophil chemotaxis")	Finally, injection of S100A8, S100A9, or S100A8/A9 into a murine air pouch model led to rapid, transient accumulation of neutrophils confirming their activities in vivo.	SEN:10030464	12626582
BEL:20060588	p(MGI:S100a9) directlyIncreases cat(p(MGI:Tlr4))	The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.	SEN:10002754	20473308
BEL:20060604	p(MGI:S1pr2) decreases bp(GOBP:angiogenesis)	S1P2-deficient mice show enhanced angiogenesis with stimulated mural cell recruitment in endothelial growth factor-containing Matrigel plugs	SEN:10030470	20068174
BEL:20060606	p(MGI:S1pr2) decreases gtp(p(MGI:Rac1))	Comparison of cultured lung ECs isolated from S1P2+/+ and S1P2-/- mice showed that Rac activity, cell proliferation, migration, and tube formation were enhanced in S1P2-deficient MLECs in vitro (Fig. 4B-D; Supplementary Fig. S6D).	SEN:10030472	20068174
BEL:20060610	p(MGI:S1pr2) decreases r(MGI:Cdh5)	Consistently with increased MVD in tumors grown in S1P2-/- mice, the mRNA levels of CD31, VE-cadherin, VEGFR2, and Notch1, which are expressed in vascular ECs, were elevated in tumors of S1P2-/- mice (Supplementary Fig. S4).	SEN:10030476	20068174
BEL:20060612	p(MGI:S1pr2) decreases r(MGI:Kdr)	Consistently with increased MVD in tumors grown in S1P2-/- mice, the mRNA levels of CD31, VE-cadherin, VEGFR2, and Notch1, which are expressed in vascular ECs, were elevated in tumors of S1P2-/- mice (Supplementary Fig. S4).	SEN:10030476	20068174
BEL:20060614	p(MGI:S1pr2) decreases r(MGI:Notch1)	Consistently with increased MVD in tumors grown in S1P2-/- mice, the mRNA levels of CD31, VE-cadherin, VEGFR2, and Notch1, which are expressed in vascular ECs, were elevated in tumors of S1P2-/- mice (Supplementary Fig. S4).	SEN:10030476	20068174
BEL:20060616	p(MGI:S1pr2) decreases r(MGI:Pecam1)	Consistently with increased MVD in tumors grown in S1P2-/- mice, the mRNA levels of CD31, VE-cadherin, VEGFR2, and Notch1, which are expressed in vascular ECs, were elevated in tumors of S1P2-/- mice (Supplementary Fig. S4).	SEN:10030476	20068174
BEL:20060640	p(MGI:Scarb1) decreases cat(p(MGI:Pon1))	SR-BI deficiency resulted in 1.4-fold (P<0.001) and 1.6-fold (P<0.01) lower serum paraoxonase and arylesterase activity of PON1	SEN:10030488	17717299
BEL:20060642	p(MGI:Scarb1) decreases path(MESHD:Atherosclerosis)	bone marrow transplantation from SR-BI-deficient mice into LDLR-deficient (19) or apoE-deficient (20) mice resulted in increased atherosclerosis, consistent with an atheroprotective role of hematopoetic SR-BI (which could extend beyond promotion of macrophage cholesterol efflux).	SEN:10030490	19064999
BEL:20060654	p(MGI:Scd1) decreases cat(p(MGI:Cpt1a))	Increased Mitochondrial Fatty Acid Oxidation in Mice with Disruptions in SCD1. A fall in malonyl-CoA would be expected to result in increased activities of CPT1 and CPT2, enzymes responsible for activated fatty acid transport into mitochondria for b-oxidation. CPT1 activity was 63% higher in SCD1-/- mice relative to wild-type controls. CPT2 activity was also higher in SCD1-/- mice relative to wild-type controls.	SEN:10018956	15096593
BEL:20060656	p(MGI:Scd1) decreases cat(p(MGI:Cpt2))	Increased Mitochondrial Fatty Acid Oxidation in Mice with Disruptions in SCD1. A fall in malonyl-CoA would be expected to result in increased activities of CPT1 and CPT2, enzymes responsible for activated fatty acid transport into mitochondria for b-oxidation. CPT1 activity was 63% higher in SCD1-/- mice relative to wild-type controls. CPT2 activity was also higher in SCD1-/- mice relative to wild-type controls.	SEN:10018956	15096593
BEL:20060664	p(MGI:Scgb1a1) decreases p(MGI:Socs3)	The results show that while low levels of SOCS-3 mRNA (Fig. 4A, bar 1) and SOCS-3 protein (Fig. 4B, lane 1) are expressed in the lungs of WT mice, these levels are appreciably higher in their UG-KO littermates (Fig. 4A, bar 3 & 4B, lane 3).	SEN:10030500	17046755
BEL:20060666	p(MGI:Scgb1a1) decreases r(MGI:Socs3)	The results show that while low levels of SOCS-3 mRNA (Fig. 4A, bar 1) and SOCS-3 protein (Fig. 4B, lane 1) are expressed in the lungs of WT mice, these levels are appreciably higher in their UG-KO littermates (Fig. 4A, bar 3 & 4B, lane 3).	SEN:10030500	17046755
BEL:20060668	p(MGI:Scn5a) decreases path(MESHD:Bradycardia)	The role of Nav1.5 channels in SAN pacemaking has been described in heterozygous Scn5a+/? mice (276). Scn5a+/? mice display major age-dependent dysfunction in atrioventricular conduction and a moderate reduction of the mean heart rate (381). Intact atrial-SAN preparations from Scn5a+/? mice have shown normal pacemaking in the SAN center, but demonstrated slower intranodal SAN conduction and exit block (276) (Fig. 17C).	SEN:10030502	18626064
BEL:20060670	p(MGI:Scn5a) decreases path(MESHD:"Heart Block")	The role of Nav1.5 channels in SAN pacemaking has been described in heterozygous Scn5a+/? mice (276). Scn5a+/? mice display major age-dependent dysfunction in atrioventricular conduction and a moderate reduction of the mean heart rate (381). Intact atrial-SAN preparations from Scn5a+/? mice have shown normal pacemaking in the SAN center, but demonstrated slower intranodal SAN conduction and exit block (276) (Fig. 17C).	SEN:10030502	18626064
BEL:20060684	p(MGI:Scp2) increases deg(a(CHEBI:"phytanic acid"))	mammalian type-II thiolase, or SCP2-3-oxoacyl-CoA thiolase, is located in the peroxisomes and involved in phytanic acid degradation and most probably in bile acid synthesis	SEN:10030506	10491098
BEL:20060698	p(MGI:Sdc1) increases bp(GOBP:"cell adhesion")	Conversely, short interfering RNA-mediated suppression of Fkbp1a increases tumor cell invasion and MMP9 levels, while down-regulating Sdc1. anti-Fkbp1a RNAi significantly reduced Sdc1 protein levels Sdc1 blocks tumor cell invasion directly, by increasing cell adhesion to ECM (19, 20), and by inhibiting the expression of matrix metalloproteinase 9 (MMP9), which degrades ECM substrates	SEN:10019350	14612567
BEL:20060708	p(MGI:Sdc1) decreases r(MGI:Mmp9)	Conversely, short interfering RNA-mediated suppression of Fkbp1a increases tumor cell invasion and MMP9 levels, while down-regulating Sdc1. anti-Fkbp1a RNAi significantly reduced Sdc1 protein levels Sdc1 blocks tumor cell invasion directly, by increasing cell adhesion to ECM (19, 20), and by inhibiting the expression of matrix metalloproteinase 9 (MMP9), which degrades ECM substrates	SEN:10019350	14612567
BEL:20060710	p(MGI:Sdc4) increases a(CHEBI:"nitric oxide")	transgenic mice show that overexpression of Sdc4 in cardiac myocytes had a significant increase in NO release and more pronouced vasodilation in the coronary elleuent in response to bFGF	SEN:10026892	15179029
BEL:20060716	p(MGI:Selp) increases bp(GOBP:"cell adhesion")	Platelets deficient in P-selectin exhibited low levels of adhesion comparable to that in sham-treated animals. In the absence of endothelial P-selectin, platelet adhesion was reduced by 65%. Treatment with a blocking antibody against PSGL-1 reduced adhesion by 57%.	SEN:10030520	12736150
BEL:20060748	p(MGI:Selp) increases r(MGI:Ido1)	We found that P-selectin-treated LCs showed a significant induction of different genes involved in immune tolerance, as TGF-beta, IL-10, and IDO (Fig. 2C).	SEN:10030540	18025190
BEL:20060750	p(MGI:Selp) increases r(MGI:Il10)	We found that P-selectin-treated LCs showed a significant induction of different genes involved in immune tolerance, as TGF-beta, IL-10, and IDO (Fig. 2C).	SEN:10030540	18025190
BEL:20060754	p(MGI:Selp) increases r(MGI:Tgfb1)	We found that P-selectin-treated LCs showed a significant induction of different genes involved in immune tolerance, as TGF-beta, IL-10, and IDO (Fig. 2C).	SEN:10030540	18025190
BEL:20060764	p(MGI:Sepp1) increases bp(GOBP:"cell growth")	We generated SePP-knockout mice that were viable, but exhibited reduced growth and developed ataxia.	SEN:10010060	12521380
BEL:20060766	p(MGI:Sepp1) decreases path(MESHD:Ataxia)	We generated SePP-knockout mice that were viable, but exhibited reduced growth and developed ataxia.	SEN:10010060	12521380
BEL:20060796	p(MGI:Serpina1b) decreases cat(p(MGI:Plg))	As well, A1AT suppresses smoke-mediated increases in TNFa release by inhibiting the serine proteases thrombin and plasmin that leak into the air spaces after smoke exposure (31, 35);	SEN:10019562	18223159
BEL:20060798	p(MGI:Serpinb3a) decreases cat(p(MGI:Cma1))	SQN-5 is a mouse serpin that is highly similar to the human serpins SCCA1 (SERPINB3) and SCCA2 (SERPINB4). Previous studies characterizing the biochemical activity of SQN-5 showed that this serpin, like SCCA2, inhibited the chymotrypsin-like enzymes mast cell chymase and cathepsin G.	SEN:10030550	11863458
BEL:20060800	p(MGI:Serpinb3a) decreases cat(p(MGI:Ctsg))	SQN-5 is a mouse serpin that is highly similar to the human serpins SCCA1 (SERPINB3) and SCCA2 (SERPINB4). Previous studies characterizing the biochemical activity of SQN-5 showed that this serpin, like SCCA2, inhibited the chymotrypsin-like enzymes mast cell chymase and cathepsin G.	SEN:10030550	11863458
BEL:20060802	p(MGI:Serpinb3a) decreases cat(p(MGI:Ctsk))	Using an expanded panel of papain-like cysteine proteinases, we now show that SQN-5, like SCCA1, inhibited cathepsins K, L, S, and V but not cathepsin B or H.	SEN:10010064	11863458
BEL:20060804	p(MGI:Serpinb3a) decreases cat(p(MGI:Ctsl))	Using an expanded panel of papain-like cysteine proteinases, we now show that SQN-5, like SCCA1, inhibited cathepsins K, L, S, and V but not cathepsin B or H.	SEN:10010064	11863458
BEL:20060806	p(MGI:Serpinb3a) decreases cat(p(MGI:Ctss))	Using an expanded panel of papain-like cysteine proteinases, we now show that SQN-5, like SCCA1, inhibited cathepsins K, L, S, and V but not cathepsin B or H.	SEN:10010064	11863458
BEL:20060810	p(MGI:Serpine1) decreases bp(GOBP:"cell migration")	Net represses PAI-1 promoter activity and binds to a specific region of the promoter containing Ets binding sites in the absence of SRF. We conclude that Net is a negative regulator of PAI-1 expression and is thereby involved in cell migration.	SEN:10010068	16314510
BEL:20060814	p(MGI:Serpine1) decreases cat(p(MGI:Fgb))	Fibrinogen (Fgb), the tissue activator of plasminogen (t-PA) and its inhibitor (PAI-1) are described as so-called cardiovascular risk factors.	SEN:10008684	8681360
BEL:20060816	p(MGI:Serpine1) decreases cat(p(MGI:Mmp2))	TGF-beta reduces the activity of MMPs through increasing plasminogen activator inhibitor (PAI)-1, we tested whether BMP7 interferes with this TGF-beta effect. BMP7 reduces, by about two-thirds, the activation of a PAI-1	SEN:10025526	12676736
BEL:20060818	p(MGI:Serpine1) decreases path(MESHD:Atherosclerosis)	Carmeliet et al. showed that Apo-E-deficient mice that were also PAI-1 deficient developed accelerated atherosclerosis. 44	SEN:10030552	16462725
BEL:20060824	p(MGI:Serpine1) decreases p(MGI:Cxcl1)	4 h after exposure to LPS, which corresponds to the peak in KC levels in our model (43). Intravascular KC levels are increased in PAI-1-deficient mice compared with C57BL/6J wt controls	SEN:10015934	16148154
BEL:20060826	p(MGI:Serpine1) decreases r(MGI:Apob)	In line with these findings, expression of ApoB mRNA was only found to be increased in fructose-fed PAI-1-/- mice (plus ~3.1-fold in comparison with wild-type and plus ~2.3-fold in comparison with PAI-1-/- mice fed with water), whereas those of fructose-fed wild-type mice remained at the level of controls (Figure 3b).	SEN:10030554	21423135
BEL:20060828	p(MGI:Serpine1) decreases r(MGI:Cd3e)	In line with these findings, expressions of the iNKT cell markers CD3-epsilon and natural killer 1.1 (NK1.1) were also found to be significantly higher in livers of PAI-1?/? mice in comparison with wild-type mice regardless of additional treatments (Figure 5b and c).	SEN:10030556	21423135
BEL:20060834	p(MGI:Serpine1) decreases r(MGI:Klrb1c)	In line with these findings, expressions of the iNKT cell markers CD3-epsilon and natural killer 1.1 (NK1.1) were also found to be significantly higher in livers of PAI-1?/? mice in comparison with wild-type mice regardless of additional treatments (Figure 5b and c).	SEN:10030556	21423135
BEL:20060840	p(MGI:Sfn) decreases p(MGI:Mdm2)	In studying the molecular mechanism of this increased stabilization of p53, we found that 14-3-3 sigma antagonized the biological functions of Mdm2 by blocking Mdm2-mediated p53 ubiquitination and nuclear export. In addition, we found that 14-3-3 sigma facilitated the oligomerization of p53 and enhanced p53's transcriptional activity.	SEN:10002758	14517281
BEL:20060842	p(MGI:Sfn) increases tscript(p(MGI:Trp53))	In studying the molecular mechanism of this increased stabilization of p53, we found that 14-3-3 sigma antagonized the biological functions of Mdm2 by blocking Mdm2-mediated p53 ubiquitination and nuclear export. In addition, we found that 14-3-3 sigma facilitated the oligomerization of p53 and enhanced p53's transcriptional activity.	SEN:10002758	14517281
BEL:20060856	p(MGI:Sftpa1) increases r(MGI:Ccl2)	As shown in Figure 4A, exogenous SP-A treatment increased the expression of M1-related genes, such as CCL5, CCL2, TNF-?, and IL-1?, in mouse PMs. The expression of M2 markers did not change significantly. M1-related gene expression on human peripheral blood monocytes was also up-regulated by SP-A (Figure 4B).	SEN:10030560	23499372
BEL:20060858	p(MGI:Sftpa1) increases r(MGI:Ccl5)	As shown in Figure 4A, exogenous SP-A treatment increased the expression of M1-related genes, such as CCL5, CCL2, TNF-?, and IL-1?, in mouse PMs. The expression of M2 markers did not change significantly. M1-related gene expression on human peripheral blood monocytes was also up-regulated by SP-A (Figure 4B).	SEN:10030560	23499372
BEL:20060860	p(MGI:Sftpa1) increases r(MGI:Il1b)	As shown in Figure 4A, exogenous SP-A treatment increased the expression of M1-related genes, such as CCL5, CCL2, TNF-?, and IL-1?, in mouse PMs. The expression of M2 markers did not change significantly. M1-related gene expression on human peripheral blood monocytes was also up-regulated by SP-A (Figure 4B).	SEN:10030560	23499372
BEL:20060862	p(MGI:Sftpa1) increases r(MGI:Tnf)	As shown in Figure 4A, exogenous SP-A treatment increased the expression of M1-related genes, such as CCL5, CCL2, TNF-?, and IL-1?, in mouse PMs. The expression of M2 markers did not change significantly. M1-related gene expression on human peripheral blood monocytes was also up-regulated by SP-A (Figure 4B).	SEN:10030560	23499372
BEL:20060868	p(MGI:Sftpd) decreases a(CHEBI:"lipid hydroperoxide")	To determine whether oxidant stress was increased in the lungs of SP-D2/2 mice, LPO concentrations were assessed. LPO content of lung homogenates was increased significantly in lungs of SP-D2/2 compared with those from WT mice (Fig. 1).	SEN:10030562	11390505
BEL:20060870	p(MGI:Sftpd) decreases a(CHEBI:"reactive oxygen species")	Intracellular ROS in AMs were determined by CDCFH, an indicator of intracellular peroxides, including H2O2 and lipid peroxides. Increased CDCFH fluorescence was observed in AMs from SP-D2/2 compared with those from control mice (Fig. 3).	SEN:10030564	11390505
BEL:20060882	p(MGI:Sftpd) decreases p(MGI:Ccl17)	Consistent with increased pulmonary accumulation of CD4+ T cells, lung levels of TARC (CCL17) were increased in Sftpd -/- mice	SEN:10030572	18355911
BEL:20060884	p(MGI:Sftpd) decreases p(MGI:Mmp12)	Emphysema in SP-D2/2 mice was associated with increased production of matrix metalloproteinases (MMP)-2, -9, and -12, hydrogen peroxide, and increased proinflammatory cytokine production after pulmonary infection (4, 5)	SEN:10030574	11390505
BEL:20060886	p(MGI:Sftpd) decreases p(MGI:Mmp2)	Emphysema in SP-D2/2 mice was associated with increased production of matrix metalloproteinases (MMP)-2, -9, and -12, hydrogen peroxide, and increased proinflammatory cytokine production after pulmonary infection (4, 5)	SEN:10030574	11390505
BEL:20060888	p(MGI:Sftpd) decreases p(MGI:Mmp9)	Emphysema in SP-D2/2 mice was associated with increased production of matrix metalloproteinases (MMP)-2, -9, and -12, hydrogen peroxide, and increased proinflammatory cytokine production after pulmonary infection (4, 5)	SEN:10030574	11390505
BEL:20060896	p(MGI:Sftpd) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	Immunofluorescence staining analysis with anti-NF-kB p65 Ab demonstrated that the p65 subunit of NF-kB was present in the cytoplasm of AM from both WT and SP-D2/2 mice (Fig. 4A). However, in AMs from SP-D2/2 mice, increased staining for NF-kB p65 was observed; furthermore, nuclear staining was markedly increased in AMs from SP-D2/2 mice and was almost never detected in AMs from WT mice.	SEN:10030580	11390505
BEL:20060902	p(MGI:Sftpd) decreases tscript(p(MGI:Nfkb1))	NF-kB activity was determined in nuclear extracts from SP-D2/2 mice by assessing binding to a consensus NF-kB oligonucleotide in EMSA (Fig. 4B). Increased NF-kB binding was observed in nuclear extracts from AMs of SP-D2/2 mice. (EMSA)...Supershift assay for NF-kB showed that the protein/DNA complex contained both components of NF-kB p50 and p65,	SEN:10030584	11390505
BEL:20060904	p(MGI:Sftpd) increases tscript(p(MGI:Rela))	Immunofluorescence staining analysis with anti-NF-kB p65 Ab demonstrated that the p65 subunit of NF-kB was present in the cytoplasm of AM from both WT and SP-D2/2 mice (Fig. 4A). However, in AMs from SP-D2/2 mice, increased staining for NF-kB p65 was observed; furthermore, nuclear staining was markedly increased in AMs from SP-D2/2 mice and was almost never detected in AMs from WT mice.	SEN:10030580	11390505
BEL:20060906	p(MGI:Sftpd) decreases tscript(p(MGI:Rela))	NF-kB activity was determined in nuclear extracts from SP-D2/2 mice by assessing binding to a consensus NF-kB oligonucleotide in EMSA (Fig. 4B). Increased NF-kB binding was observed in nuclear extracts from AMs of SP-D2/2 mice. (EMSA)...Supershift assay for NF-kB showed that the protein/DNA complex contained both components of NF-kB p50 and p65,	SEN:10030584	11390505
BEL:20060930	p(MGI:Shc1) increases a(CHEBI:"reactive oxygen species")	ROS formation is reduced in cells lacking p66Shc, and that systemic and intracellular markers of oxidative stress are diminished in p66Shc–/– mice [39, 62, 76].	SEN:10030590	19307700
BEL:20060940	p(MGI:Shc1) increases bp(GOBP:"apoptotic process")	When compared to wild type littermates, hypercholesterolemic p66Shc–/– mice displayed reduced levels of isoprostane and oxidized LDL, a decreased number of foam cells, and a reduction in the extent of both apoptosis and early atherogenic lesions.	SEN:10030594	19307700
BEL:20060946	p(MGI:Shc1,pmod(P,Y,317)) increases bp(GOBP:"MAPK cascade")	Among others, TRK-T3 binds and phosphorylates the Shc and SNT1/FRS2 adaptor proteins both involved in coupling the receptor tyrosine kinase to the mitogen-activated protein kinase pathway by recruiting Grb2/SOS.	SEN:10030600	12237775
BEL:20060954	p(MGI:Shh) increases p(MGI:Kdr)	Interestingly, we found that the level of endothelial cell differentiation in the E15.5 Shh-/- lung mesenchyme is reduced, based on PECAM-1 and Flk-1 staining, while Shh-/-;Gli3-/- lung mesenchyme displays a relatively increased distribution of PECAM-1- and Flk-1-positive cells (Figs. 6A-b–c,h–i).	SEN:10027230	15136151
BEL:20060956	p(MGI:Shh) increases p(MGI:Notch1)	Recombinant VEGF-A increased Hrt-3 mRNA levels while siRNA knockdown abolished rShh stimulated VEGF-A expression while concomitantly inhibiting Shh-induced increases in Hrt-3 mRNA levels, proliferating cell nuclear antigen (PCNA), and Notch 1 IC expression, respectively	SEN:10010086	19407245
BEL:20060958	p(MGI:Shh) increases p(MGI:Pcna)	Recombinant VEGF-A increased Hrt-3 mRNA levels while siRNA knockdown abolished rShh stimulated VEGF-A expression while concomitantly inhibiting Shh-induced increases in Hrt-3 mRNA levels, proliferating cell nuclear antigen (PCNA), and Notch 1 IC expression, respectively	SEN:10010086	19407245
BEL:20060960	p(MGI:Shh) increases p(MGI:Pecam1)	Interestingly, we found that the level of endothelial cell differentiation in the E15.5 Shh-/- lung mesenchyme is reduced, based on PECAM-1 and Flk-1 staining, while Shh-/-;Gli3-/- lung mesenchyme displays a relatively increased distribution of PECAM-1- and Flk-1-positive cells (Figs. 6A-b–c,h–i).	SEN:10027230	15136151
BEL:20060968	p(MGI:Shh) increases r(MGI:Bmp4)	Shh upregulates several mesenchymal cell markers, including its target gene Patched (Ptc), intercellular signaling genes Bone Morphogenetic Protein-4 (Bmp4) and Noggin (Nog), and smooth muscle actin and myosin.	SEN:10010088	12781691
BEL:20060974	p(MGI:Shh) increases r(MGI:Foxf1)	Indeed, Foxf1 is downregulated in Shh-/- lung mesenchyme (Fig. 5A-k, E12.5 and Fig. 5B-b, E15.5), although its expression in the Shh-/- lung has been previously reported absent (Mahlapuu et al., 2001a).	SEN:10030608	15136151
BEL:20060978	p(MGI:Shh) increases r(MGI:Gli2)	REN also impairs both Gli2-dependent gene transcription and Shh-enhanced expression of the target Gli1 mRNA, thus antagonizing the Shh-induced effects on the proliferation and differentiation of cultured GCPs.	SEN:10009406	16148242
BEL:20060984	p(MGI:Shh) increases r(MGI:Heyl)	Recombinant VEGF-A increased Hrt-3 mRNA levels while siRNA knockdown abolished rShh stimulated VEGF-A expression while concomitantly inhibiting Shh-induced increases in Hrt-3 mRNA levels, proliferating cell nuclear antigen (PCNA), and Notch 1 IC expression, respectively	SEN:10010086	19407245
BEL:20060992	p(MGI:Shh) increases r(MGI:Nog)	Shh upregulates several mesenchymal cell markers, including its target gene Patched (Ptc), intercellular signaling genes Bone Morphogenetic Protein-4 (Bmp4) and Noggin (Nog), and smooth muscle actin and myosin.	SEN:10010088	12781691
BEL:20060994	p(MGI:Shh) increases r(MGI:Nr2f2)	In conclusion, our results provide a novel target gene (COUP-TFII) and a novel target element (ShhRE) that seem to mediate Shh-induced COUP-TFII expression in P19 mouse embryocarcinoma cells.	SEN:10030614	9280061
BEL:20060996	p(MGI:Shh) increases r(MGI:Ptch1)	Shh upregulates several mesenchymal cell markers, including its target gene Patched (Ptc), intercellular signaling genes Bone Morphogenetic Protein-4 (Bmp4) and Noggin (Nog), and smooth muscle actin and myosin.	SEN:10010088	12781691
BEL:20061000	p(MGI:Shh) increases r(MGI:Runx2)	Runx2 was only modestly induced by Hh during 3 days of treatment (Fig. 6F), whereas expression of Osx was increased approximately threefold	SEN:10030618	15576404
BEL:20061002	p(MGI:Shh) increases r(MGI:Sp7)	Runx2 was only modestly induced by Hh during 3 days of treatment (Fig. 6F), whereas expression of Osx was increased approximately threefold	SEN:10030618	15576404
BEL:20061004	p(MGI:Shh) increases r(MGI:Tbx2)	In contrast, Tbx2 and Tbx3 expressions are significantly repressed in Shh-/- and enhanced in Shh-/-;Gli3-/- lungs (Figs. 5B-e,h,f,i).	SEN:10027236	15136151
BEL:20061006	p(MGI:Shh) increases r(MGI:Tbx3)	In contrast, Tbx2 and Tbx3 expressions are significantly repressed in Shh-/- and enhanced in Shh-/-;Gli3-/- lungs (Figs. 5B-e,h,f,i).	SEN:10027236	15136151
BEL:20061008	p(MGI:Shh) increases r(MGI:Wnt5a)	Wnt5a, Wnt7b and Wnt9a were consistently induced over control levels following 24 or 48 hours of Hh treatment	SEN:10030620	15576404
BEL:20061010	p(MGI:Shh) increases r(MGI:Wnt7b)	Wnt5a, Wnt7b and Wnt9a were consistently induced over control levels following 24 or 48 hours of Hh treatment	SEN:10030620	15576404
BEL:20061012	p(MGI:Shh) increases r(MGI:Wnt9a)	Wnt5a, Wnt7b and Wnt9a were consistently induced over control levels following 24 or 48 hours of Hh treatment	SEN:10030620	15576404
BEL:20061034	p(MGI:Sik1,pmod(P,S,577)) increases tloc(p(MGI:Sik1),GOCCID:0005634,GOCCID:0005737)	A mutant SIK whose Ser-577, the cAMP-dependent protein kinase (PKA)-dependent phosphorylation site, was replaced with Ala could not move out of the nucleus under stimulation by ACTH.	SEN:10022352	12200423
BEL:20061038	p(MGI:Sik1) decreases tscript(p(MGI:Creb1))	Overexpression of SIK repressed ACTH-mediated expression of CYP11A- and Steroidogenic acute regulatory (StAR)-genes by inhibiting CREB bound to their promoters.	SEN:10010094	12530631
BEL:20061040	p(MGI:Sik2,pmod(P,S,358)) directlyIncreases kin(p(MGI:Sik2))	Insulin disrupts TORC2 activity by induction of the Ser/Thr kinase SIK2, which we show here undergoes AKT2-mediated phosphorylation at Ser 358.	SEN:10030632	17805301
BEL:20061062	p(MGI:Sirpa,pmod(P,Y)) directlyIncreases complex(p(MGI:Sirpa),p(MGI:Ptpn11),p(MGI:Gab1))	We have identified that the 120 kDa complex consists of the SHP-2 substrate-1 (SHPS-1) and the Grb2-associated binder-1 (Gab-1). SHPS-1, but not Gab-1, undergoes tyrosyl phosphorylation and association with SHP-2 during myogenesis,	SEN:10030640	11493654
BEL:20061070	p(MGI:Sirpa) decreases r(MGI:Ccnd1)	Overexpression of SHP-1 in intestinal epithelial crypt cells significantly inhibited dhfr, c-myc, and cyclin D1 gene expression but did not interfere with c-fos gene expression.	SEN:10010100	12571228
BEL:20061072	p(MGI:Sirpa) decreases r(MGI:Dhfr)	Overexpression of SHP-1 in intestinal epithelial crypt cells significantly inhibited dhfr, c-myc, and cyclin D1 gene expression but did not interfere with c-fos gene expression.	SEN:10010100	12571228
BEL:20061076	p(MGI:Sirpa) decreases r(MGI:Myc)	Overexpression of SHP-1 in intestinal epithelial crypt cells significantly inhibited dhfr, c-myc, and cyclin D1 gene expression but did not interfere with c-fos gene expression.	SEN:10010100	12571228
BEL:20061090	p(MGI:Sirt1) decreases r(MGI:Ero1l)	Suppression of SIRT1 or activation of PPAR gamma enhances Ero1-L alpha expression and stimulates secretion of high-molecular-weight complexes of adiponectin in mature adipocytes.	SEN:10010108	17452443
BEL:20061092	p(MGI:Sirt1) decreases r(MGI:Mmp9)	SIRT1-mediaetd inhibition of AP-1 was demonstrated in the MMP9 gene expression at the gene promoter, mRNA and protein levels. In mouse embryonic fibroblast (MEF) with SIRT1 deficiency (SIRT1(-/-)), mRNA and protein of MMP9 were increased in the basal condition, and the inhibitory activity of Resveratrol was significantly attenuated. Glucose-induced MMP9 expression was also inhibited by SIRT1 in response to Resveratrol.	SEN:10010110	18823944
BEL:20061098	p(MGI:Sirt1) decreases sec(p(MGI:Adipoq))	Suppression of SIRT1 or activation of PPAR gamma enhances Ero1-L alpha expression and stimulates secretion of high-molecular-weight complexes of adiponectin in mature adipocytes.	SEN:10010108	17452443
BEL:20061118	p(MGI:Slc13a1) decreases path(MESHD:Colitis)	Nas1(-/-) mice exhibited reduced intestinal sulfomucin content, enhanced intestinal permeability and DSS-induced colitis, and developed systemic infections when challenged orally with C jejuni. The transcriptional profile of 41 genes was altered in Nas1(-/-) mice, with the most upregulated gene being pancreatic lipase-related protein 2 and the most downregulated gene being carbonic anhydrase 1 (Car1).	SEN:10010120	19201772
BEL:20061122	p(MGI:Slc13a1) increases r(MGI:Car1)	Nas1(-/-) mice exhibited reduced intestinal sulfomucin content, enhanced intestinal permeability and DSS-induced colitis, and developed systemic infections when challenged orally with C jejuni. The transcriptional profile of 41 genes was altered in Nas1(-/-) mice, with the most upregulated gene being pancreatic lipase-related protein 2 and the most downregulated gene being carbonic anhydrase 1 (Car1).	SEN:10010120	19201772
BEL:20061124	p(MGI:Slc13a1) decreases r(MGI:Pnliprp2)	Nas1(-/-) mice exhibited reduced intestinal sulfomucin content, enhanced intestinal permeability and DSS-induced colitis, and developed systemic infections when challenged orally with C jejuni. The transcriptional profile of 41 genes was altered in Nas1(-/-) mice, with the most upregulated gene being pancreatic lipase-related protein 2 and the most downregulated gene being carbonic anhydrase 1 (Car1).	SEN:10010120	19201772
BEL:20061186	p(MGI:Slc3a2) increases bp(GOBP:"cell adhesion")	Furthermore, CD98hc is required for efficient adhesion-induced activation of Akt and Rac GTPase, major contributors to the integrin-dependent signals involved in cell survival and cell migration.	SEN:10010132	15625115
BEL:20061188	p(MGI:Slc3a2) increases bp(GOBP:"cell migration")	Here we report that CD98hc contributes to integrin-dependent cell spreading, cell migration, and protection from apoptosis.	SEN:10030676	15625115
BEL:20061190	p(MGI:Slc6a4) decreases path(MESHD:Colitis)	Our observations indicate that colitis associated with IL-10 deficient mice is enhanced when the IL-10 deficiency is combined with a SERT deficiency.	SEN:10010134	20219086
BEL:20061220	p(MGI:Smad3) increases a(CHEBI:hydroxyproline)	Mice deficient in Smad3 demonstrated suppressed type I procollagen mRNA expression and reduced hydroxyproline content in the lungs compared with wild-type mice treated with bleomycin	SEN:10002770	11839555
BEL:20061222	p(MGI:Smad3) decreases bp(GOBP:"inflammatory response")	TGF?1-defective mice and Smad3-deficient mice develop precancerous colon lesions with submucosal inflammation, which frequently progress to colon carcinoma (Engle et al., 2002; Maggio-Price et al., 2006).	SEN:10030692	18662538
BEL:20061234	p(MGI:Smad3) increases p(MGI:Il23a)	ATF-2 or SMAD-3, but not IRF-3, short-hairpin RNA reduced p19 promoter activity and protein expression in RAW264.7 cells responding to TMEV.	SEN:10025246	18802055
BEL:20061236	p(MGI:Smad3) decreases p(MGI:Mmp12)	Smad3-null mice also developed emphysema at postnatal day 28, associated with increased MMP-9 and -12 expression (22, 41).	SEN:10030696	17615396
BEL:20061238	p(MGI:Smad3) decreases p(MGI:Mmp9)	Smad3-null mice also developed emphysema at postnatal day 28, associated with increased MMP-9 and -12 expression (22, 41).	SEN:10030696	17615396
BEL:20061246	p(MGI:Smad3) increases r(MGI:Ctgf)	CTGF mRNA expression at basal level was 2-fold lower in Smad3 KO lung fibroblasts than in WT....PAI-1 mRNA expression was also lower in untreated Smad3 KO lung fibroblasts	SEN:10030704	15265946
BEL:20061250	p(MGI:Smad3) increases r(MGI:Il23a)	ATF-2 or SMAD-3, but not IRF-3, short-hairpin RNA reduced p19 promoter activity and protein expression in RAW264.7 cells responding to TMEV.	SEN:10025246	18802055
BEL:20061252	p(MGI:Smad3) decreases r(MGI:Mmp12)	Cells harvested from BAL fluid from adult Smad3 KO mice (95% macrophages) showed an 8.5-fold increase ( p 0.05) in MMP-12 mRNA expression compared with WT animals (Fig. 2B).	SEN:10030706	15265946
BEL:20061254	p(MGI:Smad3) decreases r(MGI:Mmp12)	Quantitative PCR analysis showed no difference in MMP-2 mRNA expression in total lung RNA between Smad3 KO and WT mice, whereas MMP-9 mRNA expression was significantly higher (2-fold, p 0.05) as was MMP-12 expression (2.5-fold, p 0.05) in Smad3 KO mice compared with WT	SEN:10030708	15265946
BEL:20061256	p(MGI:Smad3) decreases r(MGI:Mmp9)	Quantitative PCR analysis showed no difference in MMP-2 mRNA expression in total lung RNA between Smad3 KO and WT mice, whereas MMP-9 mRNA expression was significantly higher (2-fold, p 0.05) as was MMP-12 expression (2.5-fold, p 0.05) in Smad3 KO mice compared with WT	SEN:10030708	15265946
BEL:20061258	p(MGI:Smad3) increases r(MGI:Serpine1)	CTGF mRNA expression at basal level was 2-fold lower in Smad3 KO lung fibroblasts than in WT....PAI-1 mRNA expression was also lower in untreated Smad3 KO lung fibroblasts	SEN:10030704	15265946
BEL:20061272	p(MGI:Smad4) increases r(MGI:Ccnd1)	Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos.	SEN:10010150	17585069
BEL:20061274	p(MGI:Smad4) increases r(MGI:Ccnd2)	Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos.	SEN:10010150	17585069
BEL:20061276	p(MGI:Smad4) increases r(MGI:Id2)	Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos.	SEN:10010150	17585069
BEL:20061278	p(MGI:Smad4) increases r(MGI:Mycn)	Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos.	SEN:10010150	17585069
BEL:20061282	p(MGI:Smad5) increases bp(GOBP:angiogenesis)	Smad5-deficient mice die between E.9- E.11.5 with defects consisting of enlarged blood vessels surrounding by decreased numbers of VSMCs and are not capable of angiogenesis in vitro.160, 16	SEN:10030716	16462725
BEL:20061294	p(MGI:Smad7) decreases p(MGI:Ccna1)	In accord with the level of Smad7 which accumulated time-dependently, the amount of each of the cyclins (cyclin D1, cyclin E and cyclin A) drastically decreased by 60 h postplating (Fig. 5A).	SEN:10030724	16287485
BEL:20061296	p(MGI:Smad7) decreases p(MGI:Ccnd1)	In accord with the level of Smad7 which accumulated time-dependently, the amount of each of the cyclins (cyclin D1, cyclin E and cyclin A) drastically decreased by 60 h postplating (Fig. 5A).	SEN:10030724	16287485
BEL:20061298	p(MGI:Smad7) decreases p(MGI:Ccne1)	In accord with the level of Smad7 which accumulated time-dependently, the amount of each of the cyclins (cyclin D1, cyclin E and cyclin A) drastically decreased by 60 h postplating (Fig. 5A).	SEN:10030724	16287485
BEL:20061306	p(MGI:Smad7) decreases r(MGI:Acaca)	Intriguingly, we found that the expression levels of SREBP1c as well as the critical lipogenic genes controlled by SREBP1c (including fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl-CoA carboxylase-1) were all upregulated by ethanol treatment and by Smad7 deletion (Figure 7A).	SEN:10030726	21386907
BEL:20061308	p(MGI:Smad7) increases r(MGI:Adh1)	However, the expression level of ADH1 was significantly reduced in Smad7-deleted hepatocytes under both basal and alcohol-treated conditions (Figure 6C), further indicating that Smad7 deletion can reduce AHD1 expression in the liver.	SEN:10030728	21386907
BEL:20061310	p(MGI:Smad7) decreases r(MGI:Fasn)	Intriguingly, we found that the expression levels of SREBP1c as well as the critical lipogenic genes controlled by SREBP1c (including fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl-CoA carboxylase-1) were all upregulated by ethanol treatment and by Smad7 deletion (Figure 7A).	SEN:10030726	21386907
BEL:20061320	p(MGI:Smad7) decreases r(MGI:Scd1)	Intriguingly, we found that the expression levels of SREBP1c as well as the critical lipogenic genes controlled by SREBP1c (including fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl-CoA carboxylase-1) were all upregulated by ethanol treatment and by Smad7 deletion (Figure 7A).	SEN:10030726	21386907
BEL:20061324	p(MGI:Smad7) decreases r(MGI:Srebf1)	Intriguingly, we found that the expression levels of SREBP1c as well as the critical lipogenic genes controlled by SREBP1c (including fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl-CoA carboxylase-1) were all upregulated by ethanol treatment and by Smad7 deletion (Figure 7A).	SEN:10030726	21386907
BEL:20061370	p(MGI:Smo) increases r(MGI:Hes5)	Notch2 and the Notch target gene, HES5, were also significantly elevated in Smoothened-induced tumors showing that Shh pathway activation is sufficient to induce Notch pathway signaling.	SEN:10010158	15520185
BEL:20061374	p(MGI:Smo) increases r(MGI:Notch2)	Notch2 and the Notch target gene, HES5, were also significantly elevated in Smoothened-induced tumors showing that Shh pathway activation is sufficient to induce Notch pathway signaling.	SEN:10010158	15520185
BEL:20061376	p(MGI:Smurf1) decreases complex(p(MGI:Smad1),p(MGI:Nup98))	Phosphorylation of these sites in Smad1 enables the binding of the E3 ubiquitin ligase Smurf1, which bars Smad1 interaction with nucleoporins and leads to Smad1 polyubiquitination and degradation (Sapkota et al., 2007).	SEN:10030762	18662538
BEL:20061378	p(MGI:Smurf1) increases deg(p(MGI:Smad1))	Phosphorylation of these sites in Smad1 enables the binding of the E3 ubiquitin ligase Smurf1, which bars Smad1 interaction with nucleoporins and leads to Smad1 polyubiquitination and degradation (Sapkota et al., 2007).	SEN:10030762	18662538
BEL:20061380	p(MGI:Smurf1) increases p(MGI:Smad1,pmod(U))	Phosphorylation of these sites in Smad1 enables the binding of the E3 ubiquitin ligase Smurf1, which bars Smad1 interaction with nucleoporins and leads to Smad1 polyubiquitination and degradation (Sapkota et al., 2007).	SEN:10030762	18662538
BEL:20061382	p(MGI:Snai1) increases bp(GOBP:"epithelial to mesenchymal transition")	Taken together, overexpression of SNAI transcription factors is able to induce EMT in ATII cells, even in the absence of TGFb1.	SEN:10030764	19850962
BEL:20061384	p(MGI:Snai2) increases bp(GOBP:"epithelial to mesenchymal transition")	Taken together, overexpression of SNAI transcription factors is able to induce EMT in ATII cells, even in the absence of TGFb1.	SEN:10030764	19850962
BEL:20061386	p(MGI:Snai2) increases bp(GOBP:"wound healing")	The reepithelialization component of excisional wound healing was reduced 1.7-fold and expression of the Slug target genes keratin 8 and E-cadherin was increased at wound margins in Slug null compared to wild type mice.	SEN:10010160	19643582
BEL:20061388	p(MGI:Snai2) increases r(MGI:Cdh1)	The reepithelialization component of excisional wound healing was reduced 1.7-fold and expression of the Slug target genes keratin 8 and E-cadherin was increased at wound margins in Slug null compared to wild type mice.	SEN:10010160	19643582
BEL:20061390	p(MGI:Snai2) increases r(MGI:Krt8)	The reepithelialization component of excisional wound healing was reduced 1.7-fold and expression of the Slug target genes keratin 8 and E-cadherin was increased at wound margins in Slug null compared to wild type mice.	SEN:10010160	19643582
BEL:20061404	p(MGI:Socs1) decreases p(MGI:Ccl11)	IFN-gamma-induced inhibition of STAT6 phosphorylation and eotaxin production were mediated by SOCS-1 induced in STAT1-dependent manner.	SEN:10002780	14733929
BEL:20061414	p(MGI:Socs1) increases p(MGI:Ppargc1a)	FROM FULL TEXT FULL TEXT after suppression of SOCS-3 and a tendency to improvement after reduction of SOCS-1. Furthermore, the high levels of expression of PGC-1Î± in the livers of db/db mice that contribute to the increased gluconeogenesis in obese diabetic animals (20) were almost normalized by either single antisense treatment or combined therapy SHOWN EXPERIMENTALLY IN FIGURE 3	SEN:10030770	15240880
BEL:20061416	p(MGI:Socs1) decreases p(MGI:Stat3,pmod(P))	Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.	SEN:10030772	15240880
BEL:20061418	p(MGI:Socs1) decreases tscript(p(MGI:Stat3))	Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.	SEN:10030772	15240880
BEL:20061420	p(MGI:Socs1) decreases tscript(p(MGI:Stat6))	IFN-gamma-induced inhibition of STAT6 phosphorylation and eotaxin production were mediated by SOCS-1 induced in STAT1-dependent manner.	SEN:10002780	14733929
BEL:20061432	p(MGI:Socs2) decreases p(MGI:Ifna1)	Furthermore, overexpression of SOCS2 or SOCS3 inhibited IFN-alpha-induced reporter activity in hepatic cells	SEN:10010172	11034314
BEL:20061444	p(MGI:Socs2) decreases r(MGI:Igf1)	decreased production of major urinary protein, increased local IGF-I production, and collagen accumulation in the dermis, were observed in SOCS-2-deficient mice	SEN:10030778	10890450
BEL:20061446	p(MGI:Socs2) increases r(MGI:Mup1)	decreased production of major urinary protein, increased local IGF-I production, and collagen accumulation in the dermis, were observed in SOCS-2-deficient mice	SEN:10030778	10890450
BEL:20061452	p(MGI:Socs3) increases bp(GOBP:"myoblast differentiation")	SOCS-3 overexpression induced skeletal alpha-actin transcription in a myoblast cell line that cannot respond to endogenous IGF-I, indicating that SOCS-3 can contribute to the myoblast differentiation process in the absence of IGF-I.	SEN:10010174	15653674
BEL:20061460	p(MGI:Socs3) decreases p(MGI:Ifna1)	Furthermore, overexpression of SOCS2 or SOCS3 inhibited IFN-alpha-induced reporter activity in hepatic cells	SEN:10010172	11034314
BEL:20061466	p(MGI:Socs3) decreases p(MGI:Il10)	We show that loss of suppressor of cytokine signaling (SOCS) 3 in T cells increases both interleukin (IL)-17 and IL-10 production, induces an antiinflammatory macrophage phenotype, and leads to unexpected IL-17-dependent reduction in lesion development and vascular inflammation	SEN:10030780	19737863
BEL:20061468	p(MGI:Socs3) decreases p(MGI:Il17a)	We show that loss of suppressor of cytokine signaling (SOCS) 3 in T cells increases both interleukin (IL)-17 and IL-10 production, induces an antiinflammatory macrophage phenotype, and leads to unexpected IL-17-dependent reduction in lesion development and vascular inflammation	SEN:10030780	19737863
BEL:20061472	p(MGI:Socs3) increases p(MGI:Ppargc1a)	FROM FULL TEXT FULL TEXT after suppression of SOCS-3 and a tendency to improvement after reduction of SOCS-1. Furthermore, the high levels of expression of PGC-1Î± in the livers of db/db mice that contribute to the increased gluconeogenesis in obese diabetic animals (20) were almost normalized by either single antisense treatment or combined therapy SHOWN EXPERIMENTALLY IN FIGURE 3	SEN:10030770	15240880
BEL:20061474	p(MGI:Socs3) decreases p(MGI:Stat3,pmod(P))	Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.	SEN:10030772	15240880
BEL:20061478	p(MGI:Socs3) increases r(MGI:Acta1)	Overexpression of SOCS-3 cDNA significantly increased transcriptional activation of the 2.0-kb skeletal alpha-actin promoter in differentiating C2C12 myoblasts.	SEN:10010180	15653674
BEL:20061482	p(MGI:Socs3) decreases r(MGI:Tgfb1)	The expression of TGF-beta1, a mediator of fibrosis, was enhanced by SOCS3 gene deletion, but suppressed by the overexpression of a dominant-negative STAT3 or SOCS3 both in vivo and in vitro. These data suggest that TGF-beta1 is a target gene of STAT3 and could be one of the mechanisms for enhanced fibrosis in SOCS3-deficient mice.	SEN:10030784	16474852
BEL:20061484	p(MGI:Socs3) increases tscript(p(MGI:Srf))	overexpression of SOCS-3 specifically increased serum response factor-driven transcriptional activity but had no effect on nuclear-factor of activated T cell-driven transcriptional activity.	SEN:10030786	15653674
BEL:20061488	p(MGI:Socs3) decreases tscript(p(MGI:Stat3))	Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.	SEN:10030772	15240880
BEL:20061490	p(MGI:Socs3) decreases tscript(p(MGI:Stat3))	We demonstrated that SOCS3 deletion in the liver resulted in hyperactivation of STAT3 and promoted ConA- and chemical-induced liver fibrosis.	SEN:10002786	16474852
BEL:20061504	p(MGI:Sod1) decreases cat(p(MGI:Nos2))	These results indicate that superoxide dismutase overexpression blocks the PDGF-induced release of PGE2 by blocking induction of nitric oxide synthase.	SEN:10005128	7574691
BEL:20061510	p(MGI:Sod2) increases a(CHEBI:ATP)	The Sod2(-/-) MEFs produced less cellular ATP, had lower O(2) consumption, generated more superoxide, and expressed less Prdx3 protein.	SEN:10010186	20638473
BEL:20061512	p(MGI:Sod2) decreases a(CHEBI:lipid)	Homozygous SOD2 -/- mice die within the first 10 days of life with a dilated cardiomyopathy, accumulation of lipid in liver and skeletal muscle, and metabolic acidosis.	SEN:10030792	7493016
BEL:20061520	p(MGI:Sod2) decreases bp(GOBP:"cellular response to DNA damage stimulus")	The Sod2 mutant mice exhibit a tissue-specific inhibition of the respiratory chain enzymes NADH-dehydrogenase (complex I) and succinate dehydrogenase (complex II), inactivation of the tricarboxylic acid cycle enzyme aconitase, development of a urine organic aciduria in conjunction with a partial defect in 3-hydroxy-3-methylglutaryl-CoA lyase, and accumulation of oxidative DNA damage	SEN:10010188	9927656
BEL:20061522	p(MGI:Sod2) decreases bp(GOBP:"inflammatory response")	Relative to wild-type mice, lung inflammation and damage was attenuated in mice that overexpressed either SOD2 or SOD3 (Ho et al., 1998; Folz et al., 1999).	SEN:10030796	19646463
BEL:20061532	p(MGI:Sod2) increases cat(p(MGI:Aco2))	Cytochemical analysis revealed a severe reduction in succinate dehydrogenase (complex II; 600857) and aconitase (a tricarboxylic acid cycle enzyme; 100850) activities in the heart and to a lesser extent in other organs.	SEN:10030800	7493016
BEL:20061534	p(MGI:Sod2) increases cat(p(MGI:Aco2))	The Sod2 mutant mice exhibit a tissue-specific inhibition of the respiratory chain enzymes NADH-dehydrogenase (complex I) and succinate dehydrogenase (complex II), inactivation of the tricarboxylic acid cycle enzyme aconitase, development of a urine organic aciduria in conjunction with a partial defect in 3-hydroxy-3-methylglutaryl-CoA lyase, and accumulation of oxidative DNA damage	SEN:10010188	9927656
BEL:20061536	p(MGI:Sod2) increases kin(p(MGI:Mtor))	Finally, the ratio of microtubule-associated protein light chain 3 (LC3)-II/LC3-I, an index of autophagic activity, was increased in Sod2(-/-) MEFs, consistent with a reduction in mTOR signal transduction.	SEN:10030802	20638473
BEL:20061538	p(MGI:Sod2) decreases path(MESHD:Acidosis)	Homozygous SOD2 -/- mice die within the first 10 days of life with a dilated cardiomyopathy, accumulation of lipid in liver and skeletal muscle, and metabolic acidosis.	SEN:10030792	7493016
BEL:20061540	p(MGI:Sod2) decreases path(MESHD:Atherosclerosis)	Mitochondrial dysfunction, resulting from manganese superoxide dismutase (SOD2) deficiency, increased mtDNA damage and accelerated atherosclerosis in apoE knockout mice, consistent with the notion that increased ROS production and DNA damage in mitochondria is an early event in the initiation of atherosclerosis.	SEN:10030804	17332437
BEL:20061552	p(MGI:Sod2) increases p(MGI:Akt1,pmod(P,S,473))	Furthermore, the loss of MnSOD dramatically altered several markers involved in cell proliferation and growth, including decreased growth stimulatory function of mTOR signaling and enhanced growth inhibitory function of GSK-3B signaling... We first detected significantly reduced phosphorylation of Akt (Ser473) in Sod2-/- MEFs.	SEN:10025064	20638473
BEL:20061558	p(MGI:Sod2) increases p(MGI:Gsk3b,pmod(P,S,9))	Furthermore, the loss of MnSOD dramatically altered several markers involved in cell proliferation and growth, including decreased growth stimulatory function of mTOR signaling and enhanced growth inhibitory function of GSK-3B signaling... We first detected significantly reduced phosphorylation of Akt (Ser473) in Sod2-/- MEFs.	SEN:10025064	20638473
BEL:20061560	p(MGI:Sod2) increases p(MGI:Hspa1a)	Figure 6 - Western blot showing the lack of mature MnSOD protein, a reduced level of HSP70-1, and increased levels of TXNIP and MT1/2 in Sod2-/- brains.	SEN:10030810	15721992
BEL:20061564	p(MGI:Sod2) decreases p(MGI:Map1lc3a)	Finally, the ratio of microtubule-associated protein light chain 3 (LC3)-II/LC3-I, an index of autophagic activity, was increased in Sod2(-/-) MEFs, consistent with a reduction in mTOR signal transduction.	SEN:10030802	20638473
BEL:20061566	p(MGI:Sod2) decreases p(MGI:Mt1)	Figure 6 - Western blot showing the lack of mature MnSOD protein, a reduced level of HSP70-1, and increased levels of TXNIP and MT1/2 in Sod2-/- brains.	SEN:10030810	15721992
BEL:20061568	p(MGI:Sod2) decreases p(MGI:Mt2)	Figure 6 - Western blot showing the lack of mature MnSOD protein, a reduced level of HSP70-1, and increased levels of TXNIP and MT1/2 in Sod2-/- brains.	SEN:10030810	15721992
BEL:20061572	p(MGI:Sod2) increases p(MGI:Prdx3)	The Sod2(-/-) MEFs produced less cellular ATP, had lower O(2) consumption, generated more superoxide, and expressed less Prdx3 protein.	SEN:10010186	20638473
BEL:20061576	p(MGI:Sod2) decreases p(MGI:Txnip)	Figure 6 - Western blot showing the lack of mature MnSOD protein, a reduced level of HSP70-1, and increased levels of TXNIP and MT1/2 in Sod2-/- brains.	SEN:10030810	15721992
BEL:20061580	p(MGI:Sod3) decreases bp(GOBP:"inflammatory response")	Relative to wild-type mice, lung inflammation and damage was attenuated in mice that overexpressed either SOD2 or SOD3 (Ho et al., 1998; Folz et al., 1999).	SEN:10030796	19646463
BEL:20061582	p(MGI:Sod3) decreases bp(GOBP:"inflammatory response")	Sod3 null mice had more severe inflammation and fibrosis than their wildtype counterparts which was attributed to bleomycin-induced oxidative fragmentation of ECM proteins (Fattman et al., 2003).	SEN:10030814	19646463
BEL:20061586	p(MGI:Sorbs1) decreases a(CHEBI:glycogen)	overexpression of the amino-terminal domain of CAP in 3T3-L1 cells abrogates insulin-stimulated glucose uptake and glycogen and lipid synthesis without affecting PI 3-kinase-dependent signaling events.	SEN:10030816	14607781
BEL:20061594	p(MGI:Sorbs1) decreases bp(GOBP:"lipid biosynthetic process")	overexpression of the amino-terminal domain of CAP in 3T3-L1 cells abrogates insulin-stimulated glucose uptake and glycogen and lipid synthesis without affecting PI 3-kinase-dependent signaling events.	SEN:10030816	14607781
BEL:20061598	p(MGI:Sos1) increases r(MGI:Plau)	Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.	SEN:10008888	10347197
BEL:20061600	p(MGI:Sost) directlyDecreases cat(p(MGI:Bmp6))	Sclerostin inhibited the BMP6 and BMP7 activity but not the BMP2 and BMP4 activity. Sclerostin bound to BMP6 and BMP7	SEN:10010190	12702725
BEL:20061602	p(MGI:Sost) directlyDecreases cat(p(MGI:Bmp7))	Sclerostin inhibited the BMP6 and BMP7 activity but not the BMP2 and BMP4 activity. Sclerostin bound to BMP6 and BMP7	SEN:10010190	12702725
BEL:20061604	p(MGI:Sostdc1) decreases cat(p(MGI:Bmp2))	Ectodin inhibited the activity of BMP2, BMP4, BMP6, and BMP7 for mouse preosteoblastic MC3T3-E1 cells, and bound to these BMPs with high affinity	SEN:10010192	14623234
BEL:20061606	p(MGI:Sostdc1) decreases cat(p(MGI:Bmp4))	Ectodin inhibited the activity of BMP2, BMP4, BMP6, and BMP7 for mouse preosteoblastic MC3T3-E1 cells, and bound to these BMPs with high affinity	SEN:10010192	14623234
BEL:20061608	p(MGI:Sostdc1) decreases cat(p(MGI:Bmp6))	Ectodin inhibited the activity of BMP2, BMP4, BMP6, and BMP7 for mouse preosteoblastic MC3T3-E1 cells, and bound to these BMPs with high affinity	SEN:10010192	14623234
BEL:20061610	p(MGI:Sostdc1) decreases cat(p(MGI:Bmp7))	Ectodin inhibited the activity of BMP2, BMP4, BMP6, and BMP7 for mouse preosteoblastic MC3T3-E1 cells, and bound to these BMPs with high affinity	SEN:10010192	14623234
BEL:20061616	p(MGI:Sox15) increases r(MGI:Ctgf)	However, the expression of Otx2 (37), Ctgf (38), and Ebaf (39) were significantly decreased, whereas Hrc (40) was increased in Sox15-null ES cells.	SEN:10030820	15863505
BEL:20061618	p(MGI:Sox15) decreases r(MGI:Hrc)	However, the expression of Otx2 (37), Ctgf (38), and Ebaf (39) were significantly decreased, whereas Hrc (40) was increased in Sox15-null ES cells.	SEN:10030820	15863505
BEL:20061620	p(MGI:Sox15) increases r(MGI:Lefty2)	However, the expression of Otx2 (37), Ctgf (38), and Ebaf (39) were significantly decreased, whereas Hrc (40) was increased in Sox15-null ES cells.	SEN:10030820	15863505
BEL:20061622	p(MGI:Sox15) increases r(MGI:Otx2)	However, the expression of Otx2 (37), Ctgf (38), and Ebaf (39) were significantly decreased, whereas Hrc (40) was increased in Sox15-null ES cells.	SEN:10030820	15863505
BEL:20061630	p(MGI:Sox17) increases r(MGI:Col4a1)	To determine whether Sox17 overexpression could directly activate its target genes, we treated Sox17- inducible ES cells with doxycycline, collected RNA, and performed genome-wide transcriptional analysis and quantitative RT–PCR. Following Sox17 induction, we found increased expression of both the Lama1 gene and genes encoding basement membrane components Col4a1 and Col4a2	SEN:10030824	20123909
BEL:20061632	p(MGI:Sox17) increases r(MGI:Col4a2)	To determine whether Sox17 overexpression could directly activate its target genes, we treated Sox17- inducible ES cells with doxycycline, collected RNA, and performed genome-wide transcriptional analysis and quantitative RT–PCR. Following Sox17 induction, we found increased expression of both the Lama1 gene and genes encoding basement membrane components Col4a1 and Col4a2	SEN:10030824	20123909
BEL:20061634	p(MGI:Sox17) increases r(MGI:Lama1)	To determine whether Sox17 overexpression could directly activate its target genes, we treated Sox17- inducible ES cells with doxycycline, collected RNA, and performed genome-wide transcriptional analysis and quantitative RT–PCR. Following Sox17 induction, we found increased expression of both the Lama1 gene and genes encoding basement membrane components Col4a1 and Col4a2	SEN:10030824	20123909
BEL:20061640	p(MGI:Sox2) increases p(MGI:Muc5ac)	In contrast, goblet cells were absent in Sox2-/- bronchiolar epithelium. Neither Spdef (an Ets-like factor required for goblet cell differentiation) nor Muc5AC (a pulmonary mucin) were induced (Fig. 4F,H).	SEN:10030828	20011520
BEL:20061642	p(MGI:Sox2) increases p(MGI:Spdef)	In contrast, goblet cells were absent in Sox2-/- bronchiolar epithelium. Neither Spdef (an Ets-like factor required for goblet cell differentiation) nor Muc5AC (a pulmonary mucin) were induced (Fig. 4F,H).	SEN:10030828	20011520
BEL:20061658	p(MGI:Sox7) increases r(MGI:Lama1)	The laminin alpha1 expression levels were significantly reduced in cells silenced for Sox7, Gata-6, or Gata-4/6 compared to those in control cells, indicating that either Sox7 or Gata-6 is indispensable for the induction of laminin alpha1 expression in F9 cells treated with RA/Bt2cAMP (Fig. 2 ).	SEN:10027164	15542856
BEL:20061664	p(MGI:Sp1) increases path(MESHD:Fibrosis)	A semiquantitative score of the severity of lung fibrosis was reduced in group with the treatment of ring-type Sp1 decoy ODNs, compared with the groups with the treatment of only bleomycin and scramble decoy ODNs (Table 1).	SEN:10030838	17869213
BEL:20061666	p(MGI:Sp1) increases p(MGI:Fn1)	Compared with the mice of scramble decoy ODNs injected group, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of proteins, resulting in 70% for TGF-beta1, 61% for fibronectin, and 66% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3A).	SEN:10030840	17869213
BEL:20061668	p(MGI:Sp1) increases p(MGI:Mmp13)	Compared with the mice of scramble decoy ODNs injected group, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of proteins, resulting in 70% for TGF-beta1, 61% for fibronectin, and 66% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3A).	SEN:10030840	17869213
BEL:20061670	p(MGI:Sp1) increases p(MGI:Tgfb1)	Compared with the mice of scramble decoy ODNs injected group, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of proteins, resulting in 70% for TGF-beta1, 61% for fibronectin, and 66% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3A).	SEN:10030840	17869213
BEL:20061674	p(MGI:Sp1) increases r(MGI:Fn1)	Compared with the mice with treatment of scramble decoy ODNs, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of mRNA, resulting in 47% for TGF-?1, 32% for fibronectin, and 13% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3B).	SEN:10030844	17869213
BEL:20061676	p(MGI:Sp1) increases r(MGI:Mmp13)	Compared with the mice with treatment of scramble decoy ODNs, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of mRNA, resulting in 47% for TGF-?1, 32% for fibronectin, and 13% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3B).	SEN:10030844	17869213
BEL:20061680	p(MGI:Sp1) increases r(MGI:Tgfb1)	Compared with the mice with treatment of scramble decoy ODNs, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of mRNA, resulting in 47% for TGF-?1, 32% for fibronectin, and 13% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3B).	SEN:10030844	17869213
BEL:20061700	p(MGI:Spdef) decreases p(MGI:Foxa2)	FOXA2 staining was absent at sites of goblet cell hyperplasia induced by SPDEF (Figure 9, C and D).	SEN:10030852	17347682
BEL:20061712	p(MGI:Sphk1) decreases bp(GOBP:"apoptotic process")	We demonstrate that inactivation of the S1P producing enzyme, sphingosine kinase, leads to cell death in cardiac tissue which is rescued by exogenous S1P treatment.	SEN:10000534	16434032
BEL:20061736	p(MGI:Spp1) decreases a(CHEBI:"nitric oxide")	LPS-induced NO synthesis feedback regulates itself through up-regulation of OPN promoter activity and gene transcription.	SEN:10000156	11145688
BEL:20061748	p(MGI:Spp1) increases bp(GOBP:"inflammatory response")	hepatic lobular and portal inflammation were significantly less in OPNminus minus mice compared with OPNplus plus mice. However, MCD diet induced similar degree of macrovesicular steatosis in OPNplus plus and OPNminus minus mice (Fig. 9B), and the diet-induced increases in liver triglyceride content were not different between OPNplus plus and OPNminus minus mice	SEN:10030872	15044174
BEL:20061750	p(MGI:Spp1) increases bp(GOBP:"macrophage chemotaxis")	OPN stimulates T cell proliferation and induces T cells and macrophages to express other Th1 cytokines...it is involved in macrophage recruitment during inflammation	SEN:10030874	15044174
BEL:20061754	p(MGI:Spp1) increases bp(GOBP:"T cell proliferation")	OPN stimulates T cell proliferation and induces T cells and macrophages to express other Th1 cytokines...it is involved in macrophage recruitment during inflammation	SEN:10030874	15044174
BEL:20061760	p(MGI:Spp1) increases cat(p(MGI:Mmp9))	OPN and tumor necrosis factor (TNF)-alpha preferentially upregulate pro-matrix metalloproteinase 9 (pro-MMP9) activity.	SEN:10030876	16709900
BEL:20061764	p(MGI:Spp1) increases kin(p(MGI:Rock2))	ROK-{alpha} was coprecipitated with CD44, and ROK-{alpha} autophosphorylation was stimulated by OPN treatment	SEN:10030880	12730217
BEL:20061768	p(MGI:Spp1) increases path(MESHD:Fibrosis)	Cholangiocyte-conditioned media augmented HSC expression of ?SMA (Fig. 3A) and collagen (Fig. 3B); RNA aptamer treatment repressed ?SMA induction by 50% and returned collagen expression to basal values, proving that paracrine signaling involving OPN promoted fibrogenic gene expression in HSCs.	SEN:10030884	20967826
BEL:20061776	p(MGI:Spp1) increases p(MGI:Ccl2)	Lack of OPN reduced atherosclerotic lesion formation by 65%, which was associated with decreased accumulation of macrophages in the vessel wall, despite a robust increase in monocyte chemoattractant protein-1 (MCP-1; Figure 1).	SEN:10030886	14732733
BEL:20061780	p(MGI:Spp1) decreases p(MGI:Mmp13)	collagenase-3 gene expression increases in the presence of an anti-osteopontin monoclonal antibody that binds near the RGD motif of this protein, whereas osteocalcin expression is inhibited.	SEN:10010218	11964409
BEL:20061782	p(MGI:Spp1) increases r(EGID:12096)	collagenase-3 gene expression increases in the presence of an anti-osteopontin monoclonal antibody that binds near the RGD motif of this protein, whereas osteocalcin expression is inhibited.	SEN:10010218	11964409
BEL:20061788	p(MGI:Spp1) decreases r(MGI:"mt-Co1")	mitochondrial protein, CCOI, is significantly decreased in the setting of OPN stimulation. This effect is blocked by the CD44 competitive ligand,	SEN:10004664	12943672
BEL:20061800	p(MGI:Spry2) increases bp(GOBP:"cell growth")	When we decreased expression of Spry2, using a Spry2-specific shRNA, the H-Ras(V12)-transformed fibroblasts could no longer form large colonies in agarose, grow in reduced levels of serum, or form tumors in athymic mice. The level of active H-Ras in these cells remained unaltered.	SEN:10030892	18048363
BEL:20061802	p(MGI:Spry2) increases complex(p(MGI:Hras),p(MGI:Cbl))	Co-immunoprecipitation studies with H-Ras-transformed cells revealed that Spry2 and H-Ras interact and that H-Ras interacts with Spry2-binding partners, c-Cbl and CIN85, in a Spry2-dependent manner.	SEN:10010226	18048363
BEL:20061804	p(MGI:Spry2) increases complex(p(MGI:Hras),p(MGI:Sh3kbp1))	Co-immunoprecipitation studies with H-Ras-transformed cells revealed that Spry2 and H-Ras interact and that H-Ras interacts with Spry2-binding partners, c-Cbl and CIN85, in a Spry2-dependent manner.	SEN:10010226	18048363
BEL:20061816	p(MGI:Spry2,pmod(P,Y,55)) decreases complex(p(MGI:Frs2),p(MGI:Grb2))	both xSpry1Y53F and mSpry2Y55F were unable to inhibit the binding of Grb2 to FRS2 or Shp2 in response to FGF stimulation (Fig. 2a, b) or the recruitment of Grb2–Sos complex to FRS2 (Fig. 2c).	SEN:10030896	12402043
BEL:20061818	p(MGI:Spry2,pmod(P,Y,55)) decreases complex(p(MGI:Grb2),p(MGI:Ptpn11))	both xSpry1Y53F and mSpry2Y55F were unable to inhibit the binding of Grb2 to FRS2 or Shp2 in response to FGF stimulation (Fig. 2a, b) or the recruitment of Grb2–Sos complex to FRS2 (Fig. 2c).	SEN:10030896	12402043
BEL:20061820	p(MGI:Spry2,pmod(P,Y,55)) decreases complex(p(MGI:Grb2),p(MGI:Sos1),p(MGI:Frs2))	both xSpry1Y53F and mSpry2Y55F were unable to inhibit the binding of Grb2 to FRS2 or Shp2 in response to FGF stimulation (Fig. 2a, b) or the recruitment of Grb2–Sos complex to FRS2 (Fig. 2c).	SEN:10030896	12402043
BEL:20061822	p(MGI:Spry2,pmod(P,Y,55)) increases complex(p(MGI:Grb2),p(MGI:Spry2))	We investigated the ability of the Spry mutants to bind to Grb2. Both xSpry1Y53F and mSpry2Y55F failed to bind to Grb2 in response to FGF stimulation (Fig. 5c).	SEN:10030898	12402043
BEL:20061824	p(MGI:Spry2,pmod(P,Y)) directlyIncreases complex(p(MGI:Grb2),p(MGI:Spry2))	We also found that the tyrosine- phosphorylated, endogenous Spry2 binds to endogenous Grb2 in a manner dependent on FGF stimulation (Fig. 4c).	SEN:10030900	12402043
BEL:20061842	p(MGI:Sptlc1) increases p(MGI:Abca1)	we found that heterozygous Sptlc1 (a subunit of SPT) KO mice also absorbed significantly less cholesterol than controls. To understand the mechanism, we measured protein levels of Niemann-Pick C1-like 1 (NPC1L1), ABCG5, and ABCA1, three key factors involved in intestinal cholesterol absorption. We found that NPC1L1 and ABCA1 were decreased, whereas ABCG5 was increased in the SPT deficient small intestine.	SEN:10010230	19416652
BEL:20061844	p(MGI:Sptlc1) decreases p(MGI:Abcg5)	we found that heterozygous Sptlc1 (a subunit of SPT) KO mice also absorbed significantly less cholesterol than controls. To understand the mechanism, we measured protein levels of Niemann-Pick C1-like 1 (NPC1L1), ABCG5, and ABCA1, three key factors involved in intestinal cholesterol absorption. We found that NPC1L1 and ABCA1 were decreased, whereas ABCG5 was increased in the SPT deficient small intestine.	SEN:10010230	19416652
BEL:20061846	p(MGI:Sptlc1) increases p(MGI:Npc1l1)	we found that heterozygous Sptlc1 (a subunit of SPT) KO mice also absorbed significantly less cholesterol than controls. To understand the mechanism, we measured protein levels of Niemann-Pick C1-like 1 (NPC1L1), ABCG5, and ABCA1, three key factors involved in intestinal cholesterol absorption. We found that NPC1L1 and ABCA1 were decreased, whereas ABCG5 was increased in the SPT deficient small intestine.	SEN:10010230	19416652
BEL:20061848	p(MGI:Sqstm1) increases p(MGI:Ccl11)	In addition, IL-13, IL-5 and eotaxin levels in BAL (Figure 6C), which were dramatically increased in OVA-challenged WT mice, were severely reduced in similarly treated p62-/- mice.	SEN:10030908	16874300
BEL:20061850	p(MGI:Sqstm1) increases p(MGI:Gata3)	When extracts prepared from these cell cultures were analyzed by immunoblotting, it was apparent that GATA3 levels were reduced in the p62-/- Th2 cells as compared to the WT controls (Figure 3B).	SEN:10030910	16874300
BEL:20061852	p(MGI:Sqstm1) increases p(MGI:Il10)	Interestingly, whereas IFN-gamma secretion is not affected (Figure 1A, left panel), IL-4 secretion is significantly reduced in p62-/- cells (Figure 1A, right panel). The synthesis of three other Th2 cytokines such as IL-5, IL-10 and IL-13 was also inhibited in p62-/- Th2 cells (Figure 1B).	SEN:10030912	16874300
BEL:20061854	p(MGI:Sqstm1) increases p(MGI:Il13)	In addition, IL-13, IL-5 and eotaxin levels in BAL (Figure 6C), which were dramatically increased in OVA-challenged WT mice, were severely reduced in similarly treated p62-/- mice.	SEN:10030908	16874300
BEL:20061856	p(MGI:Sqstm1) increases p(MGI:Il13)	Interestingly, whereas IFN-gamma secretion is not affected (Figure 1A, left panel), IL-4 secretion is significantly reduced in p62-/- cells (Figure 1A, right panel). The synthesis of three other Th2 cytokines such as IL-5, IL-10 and IL-13 was also inhibited in p62-/- Th2 cells (Figure 1B).	SEN:10030912	16874300
BEL:20061858	p(MGI:Sqstm1) increases p(MGI:Il5)	In addition, IL-13, IL-5 and eotaxin levels in BAL (Figure 6C), which were dramatically increased in OVA-challenged WT mice, were severely reduced in similarly treated p62-/- mice.	SEN:10030908	16874300
BEL:20061860	p(MGI:Sqstm1) increases p(MGI:Il5)	Interestingly, whereas IFN-gamma secretion is not affected (Figure 1A, left panel), IL-4 secretion is significantly reduced in p62-/- cells (Figure 1A, right panel). The synthesis of three other Th2 cytokines such as IL-5, IL-10 and IL-13 was also inhibited in p62-/- Th2 cells (Figure 1B).	SEN:10030912	16874300
BEL:20061862	p(MGI:Sqstm1) increases sec(p(MGI:Il4))	Interestingly, whereas IFN-gamma secretion is not affected (Figure 1A, left panel), IL-4 secretion is significantly reduced in p62-/- cells (Figure 1A, right panel). The synthesis of three other Th2 cytokines such as IL-5, IL-10 and IL-13 was also inhibited in p62-/- Th2 cells (Figure 1B).	SEN:10030912	16874300
BEL:20061872	p(MGI:Src) increases p(MGI:Abl1)	c-Abl function was dispensable in cells deficient in active p53 and inhibition of c-Abl reduced mitogen-induced c-myc expression. These data identify a novel function of cytoplasmic c-Abl in the signalling pathways regulating growth factor-induced c-myc expression and we propose the existence of a tyrosine kinase signalling cascade (PDGFR/c-Src/c-Abl) important for mitogenesis.	SEN:10007892	11847100
BEL:20061876	p(MGI:Src) decreases p(MGI:Trp53)	Finally, we found that p53 inactivation and c-myc expression, two cell cycle events regulated by Src during mitogenesis,	SEN:10010234	11847100
BEL:20061878	p(MGI:Src,pmod(P,Y,416)) directlyIncreases kin(p(MGI:Src))	TNF (1ng/ml, 15min) stimulated SRC phosphorylation (Tyr 416) and activation through TNFR2 in Young adult mouse colon cells (YAMC) and Mouse colon epithelial (MCER1-/-) cells (lacking TNFR1). Src specific inhibitors PD-161430, PP1 or PP2 blocked TNF induced cell migration. Loss of TNFR2 (MCER2-/- cells) inhibited SRC activation.	SEN:10019764	12466150
BEL:20061884	p(MGI:Src) increases r(MGI:Myc)	Finally, we found that p53 inactivation and c-myc expression, two cell cycle events regulated by Src during mitogenesis,	SEN:10010234	11847100
BEL:20061886	p(MGI:Srebf1) increases r(MGI:Acaca)	However, the absence of SREBP-1 severely impaired the marked induction of hepatic mRNAs of fatty acid synthetic genes, such as acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase,	SEN:10010236	10585467
BEL:20061888	p(MGI:Srebf1) increases r(MGI:Acly)	As depicted in Fig. 4, the genes for glycerol-3-phosphate acyltransferase, ATP citrate lyase, glucose-6-phosphate dehydrogenase, and S14 were markedly activated by refeeding in the wild-type mice (Fig. 4 and Table II). In contrast, these refeeding responses were severely reduced inSREBP-1 ?/? mice.	SEN:10030916	10585467
BEL:20061890	p(MGI:Srebf1) increases r(MGI:Cdkn1a)	Consistent with these results, the amelioration of hepatic steatosis caused by Srebp-1 gene disruption in ob/ob mice lowered the p21 expression in a triglyceride content-dependent manner.	SEN:10010238	14985341
BEL:20061892	p(MGI:Srebf1) increases r(MGI:Fasn)	However, the absence of SREBP-1 severely impaired the marked induction of hepatic mRNAs of fatty acid synthetic genes, such as acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase,	SEN:10010236	10585467
BEL:20061894	p(MGI:Srebf1) increases r(MGI:Gpam)	As depicted in Fig. 4, the genes for glycerol-3-phosphate acyltransferase, ATP citrate lyase, glucose-6-phosphate dehydrogenase, and S14 were markedly activated by refeeding in the wild-type mice (Fig. 4 and Table II). In contrast, these refeeding responses were severely reduced inSREBP-1 ?/? mice.	SEN:10030916	10585467
BEL:20061896	p(MGI:Srebf1) increases r(MGI:H6pd)	As depicted in Fig. 4, the genes for glycerol-3-phosphate acyltransferase, ATP citrate lyase, glucose-6-phosphate dehydrogenase, and S14 were markedly activated by refeeding in the wild-type mice (Fig. 4 and Table II). In contrast, these refeeding responses were severely reduced inSREBP-1 ?/? mice.	SEN:10030916	10585467
BEL:20061898	p(MGI:Srebf1) increases r(MGI:Me1)	Furthermore, the refeeding responses of other lipogenic enzymes, glycerol-3-phosphate acyltransferase, ATP citrate lyase, malic enzyme, glucose-6-phosphate dehydrogenase, and S14 mRNAs, were completely abolished in SREBP-1(-/-) mice.	SEN:10010240	10585467
BEL:20061900	p(MGI:Srebf1) increases r(MGI:Scd1)	However, the absence of SREBP-1 severely impaired the marked induction of hepatic mRNAs of fatty acid synthetic genes, such as acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase,	SEN:10010236	10585467
BEL:20061902	p(MGI:Srebf1) decreases r(MGI:Srebf2)	The surviving -/- mice appeared normal at birth and throughout life. Their livers expressed no functional SREBP-1. There was a 1.5-fold upregulation of SREBP-2 at the level of mRNA and a two- to threefold increase in the amount of mature SREBP-2 in liver nuclei.	SEN:10010242	9329978
BEL:20061904	p(MGI:Srebf1) increases r(MGI:Thrsp)	As depicted in Fig. 4, the genes for glycerol-3-phosphate acyltransferase, ATP citrate lyase, glucose-6-phosphate dehydrogenase, and S14 were markedly activated by refeeding in the wild-type mice (Fig. 4 and Table II). In contrast, these refeeding responses were severely reduced inSREBP-1 ?/? mice.	SEN:10030916	10585467
BEL:20061906	p(MGI:Srebf1) decreases tscript(p(MGI:Trp53))	Here we demonstrate that p53 is involved in the molecular mechanisms of hepatocellular injury associated with steatosis. We found that p53 in the nucleus is induced in the liver from two mouse models of fatty liver disease, ob/ob and a transgenic mouse model that overexpresses an active form of sterol regulatory element-binding protein-1 in the liver (TgSREBP-1), the one with obesity and the other without obesity.	SEN:10030918	14985341
BEL:20061908	p(MGI:Srebf2,pmod(A)) directlyDecreases deg(p(MGI:Srebf2))	aceylation-dependent stabilization of transcription factors is a novel mechanism for coactivators to regulate gene expression	SEN:10030920	12640139
BEL:20061922	p(MGI:Stap2) directlyIncreases tscript(p(MGI:Stat3))	These data suggest that STAP-2 is a new class of adaptor molecule that modulates STAT3 activity through its YXXQ motif.	SEN:10010250	12540842
BEL:20061930	p(MGI:Stat1) increases bp(GOBP:"megakaryocyte differentiation")	We show that ectopic expression of STAT1 or its downstream transcriptional target IRF-1 promotes features of megakaryocytic differentiation of G1ME cells, a Gata1-null erythromegakaryocytic cell line (25),	SEN:10028492	18060035
BEL:20061954	p(MGI:Stat1) decreases p(MGI:Stat3)	STAT3 activation is much stronger and more prolonged in STAT1-null mouse embryo fibroblasts than in wild-type cells.	SEN:10030936	15284232
BEL:20061958	p(MGI:Stat1,pmod(P,S,727)) directlyIncreases tscript(p(MGI:Stat1))	Phosphorylation at Ser727 in signal transducer and activator of transcription 1 (STAT1) is essential for its activation and signal transduction.	SEN:10030938	14963018
BEL:20061968	p(MGI:Stat1) increases r(MGI:Tbx21)	However, in Stat1-/- primary B cells, there was no synergistic activation of T-bet by IFN-g plus anti-IgM and no induction by IFN-g alone (Fig. 4)	SEN:10030942	16301649
BEL:20061974	p(MGI:Stat2) increases r(MGI:Socs1)	The ensuing studies revealed that deletion of Stat2, which uniquely transduces signals for IFN-Is, leads to a loss in the IFN-I-dependent induction of suppressor of cytokine signaling-1.	SEN:10010258	17579067
BEL:20061980	p(MGI:Stat3) decreases bp(GOBP:"cell migration")	In a wound healing assay in which a scratch of wound was introduced to cell monolayer by a pipette tip and the cells were allowed to migrate to the wound gap, we observed that KO (STAT3 -/-) cells were able to move faster to the open wound than WT cells when only EGFP was expressed (Fig. 6C).	SEN:10030944	15705584
BEL:20061992	p(MGI:Stat3) decreases bp(GOBP:"apoptotic process")	Recently, STAT3-deficient mice were shown to develop emphysema with evidence of apoptosis and caspase-3 expression when infected by adenovirus (209).	SEN:10030948	17615396
BEL:20062018	p(MGI:Stat3) decreases p(MGI:Casp3)	Recently, STAT3-deficient mice were shown to develop emphysema with evidence of apoptosis and caspase-3 expression when infected by adenovirus (209).	SEN:10030948	17615396
BEL:20062022	p(MGI:Stat3) increases p(MGI:Hes1)	Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined.	SEN:10030956	20038814
BEL:20062024	p(MGI:Stat3) increases p(MGI:Jag1)	Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined.	SEN:10030956	20038814
BEL:20062026	p(MGI:Stat3) increases p(MGI:Trp63)	Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined.	SEN:10030956	20038814
BEL:20062032	p(MGI:Stat3,pmod(P,S)) directlyIncreases tscript(p(MGI:Stat3))	IRAK1 can directly use Stat3 as a substrate and cause Stat3 serine 727 phosphorylation. Splenocytes from IRAK1-deficient mice fail to exhibit LPS-induced Stat3 serine phosphorylation and IL-10 gene expression	SEN:10021774	15465816
BEL:20062034	p(MGI:Stat3,pmod(P,S)) directlyIncreases tscript(p(MGI:Stat3))	Insulin reduces the tyrosine phosphorylation and increases the serine phosphorylation of STAT3, thereby reducing its nuclear localization and transcriptional activity	SEN:10015842	17267401
BEL:20062036	p(MGI:Stat3,pmod(P,S)) directlyDecreases tscript(p(MGI:Stat3))	Insulin reduces the tyrosine phosphorylation and increases the serine phosphorylation of STAT3, thereby reducing its nuclear localization and transcriptional activity	SEN:10015842	17267401
BEL:20062038	p(MGI:Stat3,pmod(P,Y,705)) directlyIncreases tscript(p(MGI:Stat3))	Fig. 1 Ashows that phosphorylation of STAT3 at Tyr705 was detected after 5 min of exposure to 10 ng/ml IL-6, reached a maximum at 15 min, and then declined within 1 h. These results demonstrate that IL-6 activates a STAT3 signaling in adult rat ventricular myocytes.	SEN:10028368	12595539
BEL:20062040	p(MGI:Stat3,pmod(P,Y)) directlyIncreases tscript(p(MGI:Stat3))	tyrosine phosphorylation of SHP2, a phosphotyrosine phosphatase, and that of STAT3 depend on the second tyrosine residue Y2 from the membrane in gp130	SEN:10028412	12110143
BEL:20062042	p(MGI:Stat3) decreases r(MGI:Foxp3)	STAT3 deficiency impaired RORgamma t expression and led to elevated expression of T-box expressed in T cells (T-bet) and Forkhead box P3 (Foxp3).	SEN:10030958	17277312
BEL:20062044	p(MGI:Stat4) increases p(MGI:Ifng)	In addition to growth and survival effects, STAT4 also induces higher levels of IFN-g in individual cells, reflected by an increased fluorescence intensity of IFN-g staining (Figs. 1 and 2).	SEN:10030960	11397944
BEL:20062046	p(MGI:Stat4,pmod(P,Y,693)) directlyDecreases tscript(p(MGI:Stat4))	In addition, we show that mutation of tyrosine 693 abrogates IL-12-induced STAT4 tyrosine phosphorylation and transcriptional activity.	SEN:10030962	10961885
BEL:20062050	p(MGI:Stat5a) increases bp(GOBP:"inflammatory response")	These results indicate that Stat5a plays an indispensable role in Stat6-independent Th2 cell differentiation and subsequent Th2 cell-mediated allergic airway inflammation	SEN:10010272	15749913
BEL:20062052	p(MGI:Stat5a) increases bp(GOBP:"T-helper 2 cell differentiation")	These results indicate that Stat5a plays an indispensable role in Stat6-independent Th2 cell differentiation and subsequent Th2 cell-mediated allergic airway inflammation	SEN:10010272	15749913
BEL:20062064	p(MGI:Stat6) increases bp(GOBP:"T-helper 2 cell differentiation")	These results indicate that Stat5a plays an indispensable role in Stat6-independent Th2 cell differentiation and subsequent Th2 cell-mediated allergic airway inflammation	SEN:10010272	15749913
BEL:20062066	p(MGI:Stat6) increases path(MESHD:Fibrosis)	As expected, we found that tg-IL-13+Stat6+/- mice had substantial fibrosis as demonstrated by elevated levels of lung hydroxyproline, a constituent of collagen (Fig. 3b). This increase was dependent on STAT6 expression, but expression of hSTAT6 in epithelial cells did not result in reconstitution of the fibrotic response.	SEN:10027930	12091879
BEL:20062098	p(MGI:Stat6) increases p(MGI:Spdef)	Likewise, intratracheal IL-13 treatment caused goblet cell hyperplasia in association with increased SPDEF staining in control but not in Stat-6-/- mice (Figure 11, A and B).	SEN:10027962	17347682
BEL:20062100	p(MGI:Stat6) increases r(MGI:Aicda)	Northern blot analysis shows that IL-4 induction of AID mRNA expression was completely abolished in B cells from STAT6-/- mice (Fig. 6A).	SEN:10030980	14978013
BEL:20062102	p(MGI:Stat6) increases r(MGI:Ccl11)	Twenty-four hour stimulation with 25.0 ng/ml mOSM induced detectable increases in eotaxin-1 expression at the mRNA and protein level in both wt and STAT6-/- MLF (Fig. 5, A and C). Stimulation of wt MLF using 10.0 ng/ml mIL-4 induced eotaxin mRNA expression and protein production that was nondetectable in STAT6-/- MLF (Fig. 5, A and C)	SEN:10028294	16547273
BEL:20062110	p(MGI:Stat6) increases r(MGI:Ormdl3)	In studies of bronchial epithelial cells derived by bronchial brushing, levels of ORMDL3 mRNA expression were significantly reduced in STAT6-deficient mice compared with WT mice challenged with Alternaria (Fig. S3C).	SEN:10030986	23011799
BEL:20062198	p(MGI:Suv39h1) decreases path(MESHD:Lymphoma)	Previous studies demonstrate that the SUV39-h proteins are preferentially targeted to the pericentric heterochromatin, and mice lacking both Suv39-h genes show cytogenetic abnormalities and an increased incidence of lymphoma.	SEN:10010284	14993285
BEL:20062200	p(MGI:Suv39h2) decreases path(MESHD:Lymphoma)	Previous studies demonstrate that the SUV39-h proteins are preferentially targeted to the pericentric heterochromatin, and mice lacking both Suv39-h genes show cytogenetic abnormalities and an increased incidence of lymphoma.	SEN:10010284	14993285
BEL:20062210	p(MGI:Tac1) increases bp(GOBP:"neutrophil chemotaxis")	Airway hyper-reactivity was significantly reduced in the TAC1(-/-) as well as the TAC1(-/-)/NK1(-/-) groups. However, LPS-induced histological inflammatory changes (perivascular/peribronchial oedema, neutrophil infiltration and goblet cell hyperplasia), MPO activity and TNF-alpha concentration were markedly diminished only in TAC1(-/-) mice	SEN:10010288	20579732
BEL:20062212	p(MGI:Tac1) increases cat(p(MGI:Mpo))	Airway hyper-reactivity was significantly reduced in the TAC1(-/-) as well as the TAC1(-/-)/NK1(-/-) groups. However, LPS-induced histological inflammatory changes (perivascular/peribronchial oedema, neutrophil infiltration and goblet cell hyperplasia), MPO activity and TNF-alpha concentration were markedly diminished only in TAC1(-/-) mice	SEN:10010288	20579732
BEL:20062214	p(MGI:Tac1) increases p(MGI:Tnf)	Airway hyper-reactivity was significantly reduced in the TAC1(-/-) as well as the TAC1(-/-)/NK1(-/-) groups. However, LPS-induced histological inflammatory changes (perivascular/peribronchial oedema, neutrophil infiltration and goblet cell hyperplasia), MPO activity and TNF-alpha concentration were markedly diminished only in TAC1(-/-) mice	SEN:10010288	20579732
BEL:20062230	p(MGI:Taf4b) increases r(MGI:Bard1)	Genes involved in meiosis that commences at day 9 in the mouse testes are lower in the Taf4b-null testes at post-natal day 8 including Dmc1, Scp3, and Stag3 (Fig. 6D; Prieto et al. 2001; Hunt and Hassold 2002). Bard1, which has recently been identified as a pro-apoptotic factor in the testes (Feki et al. 2004), is low in day 8 Taf4b-null testes.	SEN:10031032	15774719
BEL:20062232	p(MGI:Taf4b) increases r(MGI:Bmp8b)	Bmp8b, which is required for gonocyte proliferation (Zhao et al. 1996), is expressed at lower levels in Taf4b-null testes by RT–PCR at day 8 but not at day 0 or day 3 (Fig. 6E; data not shown). JAGGED2, the ligand for NOTCH1, is also expressed at lower levels in Taf4b-null males.	SEN:10031034	15774719
BEL:20062236	p(MGI:Taf4b) increases r(MGI:Dmc1)	Genes involved in meiosis that commences at day 9 in the mouse testes are lower in the Taf4b-null testes at post-natal day 8 including Dmc1, Scp3, and Stag3 (Fig. 6D; Prieto et al. 2001; Hunt and Hassold 2002). Bard1, which has recently been identified as a pro-apoptotic factor in the testes (Feki et al. 2004), is low in day 8 Taf4b-null testes.	SEN:10031032	15774719
BEL:20062242	p(MGI:Taf4b) increases r(MGI:Gfra1)	Gdnf is expressed at normal levels in Taf4b-null males, however, the GDNF receptor Gfr1? and its effector tyrosine kinase receptor c-Ret are deficient in day 8,	SEN:10031040	15774719
BEL:20062244	p(MGI:Taf4b) increases r(MGI:Jag2)	Bmp8b, which is required for gonocyte proliferation (Zhao et al. 1996), is expressed at lower levels in Taf4b-null testes by RT–PCR at day 8 but not at day 0 or day 3 (Fig. 6E; data not shown). JAGGED2, the ligand for NOTCH1, is also expressed at lower levels in Taf4b-null males.	SEN:10031034	15774719
BEL:20062250	p(MGI:Taf4b) increases r(MGI:Ret)	At birth, testes of Taf4b-null males appear histologically normal; however, at post-natal day 3 gonocyte proliferation is impaired and expression of spermatogonial stem cell markers c-Ret, Plzf, and Stra8 is reduced. {RT-PCR}	SEN:10031042	15774719
BEL:20062252	p(MGI:Taf4b) increases r(MGI:Stag3)	Genes involved in meiosis that commences at day 9 in the mouse testes are lower in the Taf4b-null testes at post-natal day 8 including Dmc1, Scp3, and Stag3 (Fig. 6D; Prieto et al. 2001; Hunt and Hassold 2002). Bard1, which has recently been identified as a pro-apoptotic factor in the testes (Feki et al. 2004), is low in day 8 Taf4b-null testes.	SEN:10031032	15774719
BEL:20062254	p(MGI:Taf4b) increases r(MGI:Stra8)	At birth, testes of Taf4b-null males appear histologically normal; however, at post-natal day 3 gonocyte proliferation is impaired and expression of spermatogonial stem cell markers c-Ret, Plzf, and Stra8 is reduced. {RT-PCR}	SEN:10031042	15774719
BEL:20062256	p(MGI:Taf4b) increases r(MGI:Sycp3)	Genes involved in meiosis that commences at day 9 in the mouse testes are lower in the Taf4b-null testes at post-natal day 8 including Dmc1, Scp3, and Stag3 (Fig. 6D; Prieto et al. 2001; Hunt and Hassold 2002). Bard1, which has recently been identified as a pro-apoptotic factor in the testes (Feki et al. 2004), is low in day 8 Taf4b-null testes.	SEN:10031032	15774719
BEL:20062258	p(MGI:Taf4b) increases r(MGI:Zbtb16)	At birth, testes of Taf4b-null males appear histologically normal; however, at post-natal day 3 gonocyte proliferation is impaired and expression of spermatogonial stem cell markers c-Ret, Plzf, and Stra8 is reduced. {RT-PCR}	SEN:10031042	15774719
BEL:20062262	p(MGI:Taf9) directlyIncreases tscript(p(MGI:Trp53))	TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts.	SEN:10020470	11278372
BEL:20062264	p(MGI:Tagln) decreases path(MESHD:Atherosclerosis)	Another study by Feil, et al bred SM22?-CreERT2(ki) mice to each other, generating inducible SM22? knockouts. They found that the lack of SM22? significantly increased the amount of atherosclerosis in these animals 79.	SEN:10031044	18276911
BEL:20062266	p(MGI:Tal1,pmod(P,S,122)) directlyIncreases deg(p(MGI:Tal1))	Tryptic phosphopeptide mapping and chemical inhibitor studies showed that hypoxia induced the mitogen-activated protein kinase-mediated phosphorylation of a single serine residue, Ser(122), in the protein, and site-directed mutagenesis demonstrated that Ser(122) phosphorylation was necessary for hypoxic acceleration of TAL1 turnover in an immortalized murine endothelial cell line.	SEN:10031046	11904294
BEL:20062272	p(MGI:Tardbp) increases p(MGI:Atg7)	As shown in Fig. 1C, the Atg7 mRNA level was down-regulated in both types of cells treated with siRNA-1 oligonucleotide (Fig. 1C, compare lanes 2 and 4 with lanes 1 and 3, respectively). ##siRNA KD of Tardbp in NIH3T3 cells##	SEN:10031050	22052911
BEL:20062274	p(MGI:Tardbp) increases p(MGI:Atg7)	The down-regulation of ATG7 was also confirmed at the protein level in TDP-43-depleted cells (compare lanes 1 and 2 of Fig. 1A, lower left panel, and Fig. 1B, right panel). ##siRNA KD of Tardbp##	SEN:10031052	22052911
BEL:20062276	p(MGI:Tardbp) increases r(MGI:Atg7)	As shown by semi-quantitative RT-PCR in Fig. 1A, the Atg7 mRNA level was significantly down-regulated, by 3-fold, upon treatment of the cells with siRNA-1 oligonucleotide, as shown (Fig. 1A, compare lanes 1 and 2, left upper panel). ##siRNA KD of Tardbp##	SEN:10031054	22052911
BEL:20062294	p(MGI:Tbp) increases bp(GOBP:"cell proliferation")	The stable cell lines engineered to express increased amounts of TBP accumulated at a faster rate relative to wildtype cells (Fig. 5B, left panel).	SEN:10031058	17074809
BEL:20062296	p(MGI:Tbp) increases bp(GOBP:"DNA replication")	wild-type cells expressing increased amounts of TBP incorporated 11% more BrdU compared to the parental wild-type cells	SEN:10031060	17074809
BEL:20062298	p(MGI:Tbp) increases p(MGI:Jun)	wild-type stably transfected MEFs expressing increased amounts of TBP also contained increased amounts of c-Jun (Fig. 5B, right panel)	SEN:10031062	17074809
BEL:20062300	p(MGI:Tbp) increases r(MGI:Jun)	Increased expression of TBP into wild-type MEFs resulted in a modest stimulation of the c-Jun promoter.	SEN:10031064	17074809
BEL:20062304	p(MGI:Tbx21) increases p(MGI:Ighg2b)	T-bet-deficient B lymphocytes demonstrate impaired production of IgG2a, IgG2b, and IgG3 and, most strikingly, are unable to generate germ-line or postswitch IgG2a transcripts in response to IFN-g. (Fig. 4)	SEN:10031068	11960012
BEL:20062306	p(MGI:Tbx21) decreases p(EGID:16020)	T-bet-deficient B cells produced excess amounts of the Th2-related isotypes IgG1 and IgE (Fig. ?4)	SEN:10031070	11960012
BEL:20062308	p(MGI:Tbx21) increases p(EGID:380793)	T-bet-deficient B lymphocytes demonstrate impaired production of IgG2a, IgG2b, and IgG3 and, most strikingly, are unable to generate germ-line or postswitch IgG2a transcripts in response to IFN-g. (Fig. 4)	SEN:10031068	11960012
BEL:20062310	p(MGI:Tbx21) increases p(MGI:Ifng)	Runx3 induced a moderate quantity of IFN-g in T-bet-deficient cells cultured under TH1 conditions (Fig. 2e)	SEN:10031072	17195845
BEL:20062312	p(MGI:Tbx21) decreases p(MGI:Ighg1)	T-bet-deficient B cells produced excess amounts of the Th2-related isotypes IgG1 and IgE (Fig. ?4)	SEN:10031070	11960012
BEL:20062316	p(MGI:Tbx21) decreases p(MGI:Il4)	By contrast, strong overexpression of T-bet repressed IL-4 production in wild-type TH2 cells10,16, but this repression was completely dependent on Runx3 (Fig. 5c). T-bet-mediated repression of another TH2 cytokine, IL-5, was independent of Runx3 (Fig. 5d),	SEN:10031076	17195845
BEL:20062318	p(MGI:Tbx21) decreases p(MGI:Il5)	By contrast, strong overexpression of T-bet repressed IL-4 production in wild-type TH2 cells10,16, but this repression was completely dependent on Runx3 (Fig. 5c). T-bet-mediated repression of another TH2 cytokine, IL-5, was independent of Runx3 (Fig. 5d),	SEN:10031076	17195845
BEL:20062320	p(MGI:Tbx21) increases r(EGID:380793)	T-bet-deficient B lymphocytes demonstrate impaired production of IgG2a, IgG2b, and IgG3 and, most strikingly, are unable to generate germ-line or postswitch IgG2a transcripts in response to IFN-g. (Fig. 4)	SEN:10031068	11960012
BEL:20062322	p(MGI:Tbx21) increases r(MGI:Il12rb2)	Finally, we also found that ectopic T-bet specifically induced robust transcription of both endogenous (cellular) T-bet and IL-12 receptor beta 2 (IL-12Rbeta 2) (Fig. 2C).	SEN:10031078	11397944
BEL:20062344	p(MGI:Tcf3) increases r(MGI:Cd4)	Mammalian two-hybrid analysis and luciferase assay suggested that excess LYL1 blocked the dimerization of E2A and thus inhibited the regulatory activity of E2A on the CD4 promoter.	SEN:10028958	17486074
BEL:20062348	p(MGI:Tcf4) increases bp(GOBP:"cell proliferation")	The expression of Tcf-4, a transcription factor known to be required for intestinal epithelial stem cell proliferation, was increased and mislocalized in the intestinal epithelia of the beta1 integrin-deleted mice	SEN:10009372	17088430
BEL:20062350	p(MGI:Terf2) increases bp(GOBP:"stress-induced premature senescence")	Figure 1 TRF2 (myc-tagged) induces telomere dysfunction and cellular senescence in p53 P/P primary mouse embryonic fibroblasts.	SEN:10031084	17396137
BEL:20062352	p(MGI:Terf2) increases p(MGI:Cdkn1a)	overexpression of TRF2 in p53 P/P MEFs resulted in upregulation of p21 (Fig 1D). In addition, reduction of BrdU incorporation, induction of p21 level and increased number of SA-beta-gal-positive senescent cells were also observed when oncogenic H-Ras was overexpressed in p53 P/P MEFs (Fig 1A?C).	SEN:10031086	17396137
BEL:20062382	p(MGI:Tgfa) increases bp(GOBP:"epithelial to mesenchymal transition")	In addition to oncogenic Ras (Oft et al., 1996), hepatocyte growth factor (HGF)/scatter factor (SF), fibroblast growth factor (FGF), and TGF alone induce mesenchymal features in diverse epithelial cell systems (Brinkmann et al., 1995; Piek et al., 1999; Thiery and Chopin, 1999).	SEN:10026880	11790801
BEL:20062384	p(MGI:Tgfa) decreases bp(GOBP:"fat cell differentiation")	TGF-alpha repressed the differentiation of the preadipocyte cell line 3T3-F442A in a dose-dependent and reversible manner as judged by morphological conversion and diminished expression of mRNAs encoding the adipocyte-specific markers adipsin and glycerophosphate dehydrogenase.	SEN:10010306	8466858
BEL:20062386	p(MGI:Tgfa) decreases path(MESHD:Obesity)	Transgenic mice overexpressing transforming growth factor alpha (TGF-alpha) under control of the metallothionein promoter had, on average, 20% reductions in body and carcass weights compared to nontransgenic littermates	SEN:10010308	8466858
BEL:20062390	p(MGI:Tgfa) directlyIncreases kin(p(MGI:Egfr))	Transforming growth factor (TGF)-alpha is a ligand for the epidermal growth factor receptor (EGFR).	SEN:10002820	19244201
BEL:20062400	p(MGI:Tgfa) increases p(MGI:Errfi1)	These observations were extended to HC-11 cells, a murine cell line derived from breast epithelium. In these cells TGF-a, an activator of EGFR, and HRG- 1b, which triggers ErbB-2/ErbB-3 dimers (Marte et al., 1995a,b), are able to induce RALT expression (Fiorentino et al., 2000).	SEN:10029724	12226756
BEL:20062402	p(MGI:Tgfa) increases p(MGI:Pcna)	Using a doxycycline-regulatable transgenic mouse model of lung-specific TGF-alpha expression, we observed increased PCNA protein and phosphorylation of Akt and p70S6K in whole lung homogenates in association with induction of TGF-alpha. Induction in the lung of TGF-alpha caused progressive pulmonary fibrosis over a 7-week period.	SEN:10010312	19244201
BEL:20062408	p(MGI:Tgfa) decreases r(MGI:Cfd)	TGF-alpha repressed the differentiation of the preadipocyte cell line 3T3-F442A in a dose-dependent and reversible manner as judged by morphological conversion and diminished expression of mRNAs encoding the adipocyte-specific markers adipsin and glycerophosphate dehydrogenase.	SEN:10010306	8466858
BEL:20062412	p(MGI:Tgfa) decreases r(MGI:Gpd1)	TGF-alpha repressed the differentiation of the preadipocyte cell line 3T3-F442A in a dose-dependent and reversible manner as judged by morphological conversion and diminished expression of mRNAs encoding the adipocyte-specific markers adipsin and glycerophosphate dehydrogenase.	SEN:10010306	8466858
BEL:20062420	p(MGI:Tgfa) increases r(MGI:Tff1)	TFF1 mRNA levels were detectable in the pancreas in four of five transgenic mice overexpressing TGF-alpha.	SEN:10010314	10369712
BEL:20062426	p(MGI:Tgfb1) increases a(CHEBI:"hydrogen peroxide")	TGF-b1 also stimulates H2O2 production in bovine pulmonary artery endothelial cells (22), vascular endothelial cells (23), mouse osteoblastic cells (24), and human lung fibroblast (HLF) cells (25, 26).	SEN:10024430	10925306
BEL:20062428	p(MGI:Tgfb1) increases a(CHEBI:hydroxyproline)	WT mice treated with AdTGF-1223/225 had a significantly higher hydroxyproline content in the lung (65% increase, p 0.05) at day 28 compared with mice treated with control vector.	SEN:10031106	15265946
BEL:20062438	p(MGI:Tgfb1) increases bp(GOBP:angiogenesis)	TGF-B can function either as a proangiogenic or antiangiogenic factor in vitro; however, the preponderance of evidence supports a proangiogenic role for TGF-B in vivo.93 Several lines of evidence support a prominent role for the TGF-B signaling pathway in stimulating angiogenesis. First, targeted deletion of members of this pathway in mice, including TGF-B1, TBRI, and TBRII, all result in aberrant angiogenesis.	SEN:10031116	15774796
BEL:20062440	p(MGI:Tgfb1) decreases bp(GOBP:"cell adhesion")	In agreement with this possibility, we observed that TGFbeta1 inhibited cell adhesion, and transfection of TbetaRI further enhanced this inhibition (Figure 8C, D).	SEN:10022238	17203972
BEL:20062442	p(MGI:Tgfb1) increases bp(GOBP:"cell differentiation")	TGF? promotes the differentiation of mesenchymal precursors into fibroblasts and myofibroblasts at the expense of adipocyte, myocyte, and osteoblast fates (Figure 6) (Derynck and Akhurst, 2007).	SEN:10031118	18662538
BEL:20062446	p(MGI:Tgfb1) increases bp(GOBP:"cell migration")	We found that TGFbeta1 enhanced Mv1Lu cell migration, which was strongly increased upon expression of TâRI (Figure 8A, B). Coexpression of Epac1 with TbetaRI significantly decreased cell migration, as compared to cells transfected with TbetaRI only.	SEN:10019528	17203972
BEL:20062448	p(MGI:Tgfb1) decreases bp(GOBP:"cell migration")	Interestingly, compared with untreated controls, TGFbeta treatment reduced wild type VSMC migration by ?50%, whereas Csrp2-/- VSMC migration was not affected (Fig. 1C), indicating that up-regulation of CRP2 correlated with a blunted VSMC motility	SEN:10026204	18387947
BEL:20062450	p(MGI:Tgfb1) increases bp(GOBP:"epithelial to mesenchymal transition")	Ha-Ras cooperates with transforming growth factor beta (TGFbeta) to cause epithelial mesenchymal transition (EMT) characterized by spindle-like cell morphology, loss of epithelial markers, and induction of mesenchymal markers.	SEN:10027514	11790801
BEL:20062452	p(MGI:Tgfb1) increases bp(GOBP:"epithelial to mesenchymal transition")	TGF? is a potent inducer of EMT (first reported in mouse heart formation and palate fusion, in some mammary cell lines, and in mouse models of skin carcinogenesis; Derynck and Akhurst, 2007; Thiery, 2003).	SEN:10031122	18662538
BEL:20062456	p(MGI:Tgfb1) increases bp(GOBP:"inflammatory response")	transgenic TGF-1 caused a mononuclear cellpredominant inflammatory response and a significant increase in lung collagen content in mice that expressed Bax normally (p 0.001) (Fig. 2, A–C).	SEN:10031108	17209037
BEL:20062458	p(MGI:Tgfb1) decreases bp(GOBP:"inflammatory response")	TGF?1-defective mice and Smad3-deficient mice develop precancerous colon lesions with submucosal inflammation, which frequently progress to colon carcinoma (Engle et al., 2002; Maggio-Price et al., 2006).	SEN:10030692	18662538
BEL:20062460	p(MGI:Tgfb1) decreases bp(GOBP:"inflammatory response")	TGF? can also suppress gastrointestinal inflammatory activity by stimulating the expression of the prostaglandin-degrading enzyme 15-PGDH, which antagonizes the proinflammatory action of COX2 (Yan et al., 2004).	SEN:10027510	18662538
BEL:20062464	p(MGI:Tgfb1) decreases bp(GOBP:"T-helper 1 type immune response")	As shown in Figure 5A, reduced production of Th I -type cytokines (IFN-y, not detected; IL-2, 38.0 -t 10.0%) by EL4-T was significantly rcstored by treatmcnt with anti-TGF-P (IFN-y, 191.0 i 21.9%; IL-2, 8 I . 1 i 17.5%), while anti-IL- IO treatment had little etfect	SEN:10031126	8598496
BEL:20062470	p(MGI:Tgfb1) increases bp(GOBP:"apoptotic process")	Raf/mitogen-activated protein kinase (MAPK) is required for EMT, whereas activation of phosphatidylinositol 3-kinase (PI3K) causes scattering and protects from TGFbeta-induced apoptosis.	SEN:10021076	11790801
BEL:20062474	p(MGI:Tgfb1) increases bp(GOBP:"apoptotic process")	Transgenic TGF-1 caused an impressive increase in TUNEL staining in mice with WT Bax loci (Fig. 4A). These TUNEL() cells were largely epithelial cells as evidenced by their histologic location and morphology	SEN:10031128	17209037
BEL:20062478	p(MGI:Tgfb1) increases cat(p(MGI:Serpine1))	TGF-beta reduces the activity of MMPs through increasing plasminogen activator inhibitor (PAI)-1, we tested whether BMP7 interferes with this TGF-beta effect. BMP7 reduces, by about two-thirds, the activation of a PAI-1	SEN:10025526	12676736
BEL:20062486	p(MGI:Tgfb1) increases gtp(p(MGI:Rhoa))	Reorganization of the actin cytoskeleton in response to growth factor signaling, such as transforming growth factor beta (TGF-beta), controls cell adhesion, motility, and growth of diverse cell types. In Swiss3T3 fibroblasts, a widely used model for studies of actin reorganization, TGF-beta1 induced rapid actin polymerization into stress fibers and concomitantly activated RhoA and RhoB small GTPases.	SEN:10010324	15647284
BEL:20062488	p(MGI:Tgfb1) increases gtp(p(MGI:Rhob))	Reorganization of the actin cytoskeleton in response to growth factor signaling, such as transforming growth factor beta (TGF-beta), controls cell adhesion, motility, and growth of diverse cell types. In Swiss3T3 fibroblasts, a widely used model for studies of actin reorganization, TGF-beta1 induced rapid actin polymerization into stress fibers and concomitantly activated RhoA and RhoB small GTPases.	SEN:10010324	15647284
BEL:20062496	p(MGI:Tgfb1) increases kin(p(MGI:Limk2))	Cofilin and LIMK2 co-precipitated and cofilin became phosphorylated in response to TGF-beta1, whereas RNA interference against LIMK2 blocked formation of new stress fibers by TGF-beta1.	SEN:10021818	15647284
BEL:20062498	p(MGI:Tgfb1) increases kin(p(MGI:Limk2))	Consequently, dominant-negative RhoA and RhoB mutants blocked TGF-beta1-induced actin reorganization. Because Rho GTPases are known to regulate the activity of LIM-kinases (LIMK), we found that TGF-beta1 induced LIMK2 phosphorylation with similar kinetics to Rho activation.	SEN:10020966	15647284
BEL:20062502	p(MGI:Tgfb1) increases kin(p(MGI:Mapk14))	TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation.	SEN:10021846	12374793
BEL:20062506	p(MGI:Tgfb1) directlyIncreases kin(p(MGI:Tgfbr1))	Further work revealed that TGF-R signaling (Massague and Wotton, 2000) was required for EMT, invasion in vitro, and metastasis in vivo,	SEN:10020476	11790801
BEL:20062508	p(MGI:Tgfb1) directlyIncreases kin(p(MGI:Tgfbr2))	In analogous fashion, TGFB1 binds TGFBR2, which recruits and phosphorylates TGFBR1 (also known as ALK5).	SEN:10031134	16384533
BEL:20062512	p(MGI:Tgfb1) increases path(MESHD:Fibrosis)	following treatment with the adenoviral vector expressing active TGF-1 (AdTGF-1223/225), histology of lungs from WT mice showed a fibrotic pattern characterized	SEN:10031136	15265946
BEL:20062516	p(MGI:Tgfb1) increases path(MESHD:Fibrosis)	Transgenic mice overexpressing a constitutively active human TGF-beta1 under control of the rat phosphoenolpyruvate carboxykinase regulatory sequences developed fibrosis of the liver, kidney, and adipose tissue, and exhibited a severe reduction in body fat.	SEN:10010328	9389733
BEL:20062534	p(MGI:Tgfb1) decreases phos(p(MGI:Cdc25a))	Further, evidence is presented for TGF-beta-stimulated p160ROCK translocation to the nucleus and inhibitory phosphorylation of the cyclin-dependent kinase-activating phosphatase, Cdc25A.	SEN:10010332	14657354
BEL:20062536	p(MGI:Tgfb1) increases p(MGI:Angptl4)	Blocking TGF? signaling with a dominant-negative form of TGFBRI or SMAD4 knockdown in an ER? human breast cancer cell line decreased the ability of these cells to generate lung metastases when implanted as mammary tumors in mice. Central to this process was the induction of angiopoietin-like 4 (ANGPTL4) by TGF? via the Smad signaling pathway	SEN:10031144	18662538
BEL:20062540	p(MGI:Tgfb1) increases p(MGI:Bax)	These studies demonstrate that TGF-1 is a potent stimulator of Bax mRNA and protein accumulation in lungs from doxycyclinetreated Tg mice (Fig. 1).	SEN:10031146	17209037
BEL:20062542	p(MGI:Tgfb1) decreases p(MGI:Ccl2)	ex vivo studies of macro-phages derived from Smad3–/– mice demonstrated a more activated phenotype with enhanced induction of MCP-1 secretion in response to LPS. Importantly, while TGF-?1 inhibited LPS-stimulated MCP-1 production from Smad3+/+ mice, this TGF-?1 inhibition was completely blocked in macrophages from Smad3–/– mice.79	SEN:10031148	16462725
BEL:20062544	p(MGI:Tgfb1) increases p(MGI:Cd80)	TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.	SEN:10002836	16517699
BEL:20062546	p(MGI:Tgfb1) decreases p(MGI:Cdh1)	the spindle-like phenotype induced by TGF treatment (Fig. 1 A, inset) persisted after factor removal (Fig. 1 B, inset) and involved loss of E-cadherin/4-integrin, whereas vimentin was strongly induced	SEN:10031150	11790801
BEL:20062548	p(MGI:Tgfb1) increases p(MGI:Cdkn1a)	In epithelial cells, TGF? induces expression of p15Ink4b, which inhibits cyclinD-cdk4/6 complexes, and of p21Cip1, which inhibits cyclinE/A-cdk2 complexes...(Gomis et al., 2006b; Seoane et al., 2004).	SEN:10031152	18662538
BEL:20062550	p(MGI:Tgfb1) increases p(MGI:Cdkn2b)	In epithelial cells, TGF? induces expression of p15Ink4b, which inhibits cyclinD-cdk4/6 complexes, and of p21Cip1, which inhibits cyclinE/A-cdk2 complexes...(Gomis et al., 2006b; Seoane et al., 2004).	SEN:10031152	18662538
BEL:20062558	p(MGI:Tgfb1) increases p(MGI:Csrp2)	TGFbeta induced CRP2 protein expression as early as 2 h, and the induction continued at the 4 h time point (Fig. 1A). Similar to the protein results, Northern blot analysis revealed that TGF? induced CRP2 mRNA expression in a time-dependent manner (Fig. 1B).	SEN:10031158	18387947
BEL:20062560	p(MGI:Tgfb1) increases p(MGI:Ctla4)	TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.	SEN:10002836	16517699
BEL:20062564	p(MGI:Tgfb1) increases p(MGI:Foxp3)	Similarly, TGF-{beta} stimulation regulated Foxp3 expression in anti-CD3/CD28-stimulated human CD4+ T lymphocytes at the mRNA and protein level, suggesting that TGF-{beta} controls expression of this key regulatory protein both in human and murine T cells (Fig. 1, B and C).	SEN:10031160	15100250
BEL:20062566	p(MGI:Tgfb1) increases p(MGI:Foxp3)	TGF-beta-induced Foxp3 expression is inhibited by IL-6 (ref. 17), IL-21 (ref. 10) and IL-23 (Supplementary Fig. 8).	SEN:10020310	18368049
BEL:20062572	p(MGI:Tgfb1) increases p(MGI:Hif1a)	we demonstrate that TGFbeta acts on HIF-1alpha accumulation and activity by increasing HIF-1alpha protein stability	SEN:10006406	16815840
BEL:20062574	p(MGI:Tgfb1) increases p(MGI:Hpgd)	TGF? can also suppress gastrointestinal inflammatory activity by stimulating the expression of the prostaglandin-degrading enzyme 15-PGDH, which antagonizes the proinflammatory action of COX2 (Yan et al., 2004).	SEN:10027510	18662538
BEL:20062576	p(MGI:Tgfb1) increases p(MGI:Il10)	in a TGF-?1 dependent manner, functional interaction of Smad3 and GATA-3 stimulated production of IL-10,86 a Th2 cytokine shown to have anti-inflammatory effects in various experimental atherosclerotic models.89-96	SEN:10020774	16462725
BEL:20062578	p(MGI:Tgfb1) decreases p(MGI:Il2)	both CD4+ and CD8+ T cells from Smad3-deficient mice had impaired ability of TGF-?1 to inhibit IL-2 production.85	SEN:10031164	16462725
BEL:20062580	p(MGI:Tgfb1) increases p(MGI:Il23a)	Neutralizing Ab to TGF-beta1 eliminated TMEV-induced IL-23 production and SMAD-3 activation in RAW264.7 cells, BMM, and SPM.	SEN:10002872	18802055
BEL:20062586	p(MGI:Tgfb1) increases p(MGI:Irf8)	To clarify how TH17-polarizing conditions induce stable IRF8 expression, CD4+ cells were stimulated with TGF-B in the absence of TCR activation and the results showed that TGF-B clearly induced IRF8 expression at both 48 and 72 h (Supplementary Fig. S1c).	SEN:10031166	21587231
BEL:20062588	p(MGI:Tgfb1) decreases p(MGI:Itga4)	the spindle-like phenotype induced by TGF treatment (Fig. 1 A, inset) persisted after factor removal (Fig. 1 B, inset) and involved loss of E-cadherin/4-integrin, whereas vimentin was strongly induced	SEN:10031150	11790801
BEL:20062596	p(MGI:Tgfb1) increases p(MGI:Mif)	This was demonstrated for in vitro recombinant MIF in fibroblasts, where growth-factor-induced stimulation of these cells resulted in increased MIF concentrations, activation of the ERK-MAP kinase pathway and subsequent increase in cell proliferation [50] . This was also shown in a colon cancer cell line where the addition of TGF resulted in increased MIF expression [51] .	SEN:10031172	18791328
BEL:20062598	p(MGI:Tgfb1) increases p(MGI:Mmp12)	The former studies demonstrate that TGF-1 and bleomycin are potent stimulators of the propeptide and mature forms of MMP-12 (Fig. 10,Aand B).	SEN:10015486	17209037
BEL:20062600	p(MGI:Tgfb1) decreases p(MGI:Myc)	Immunoblotting revealed that addition of TGF-beta decreased the amount of not only endogenous but also of the retrovirally expressed Myc proteins; whether this is caused by enhanced proteolysis or inhibition of translation is currently unknown (Fig. 1 G).	SEN:10031174	16391002
BEL:20062602	p(MGI:Tgfb1) decreases p(MGI:Myc)	In keratinocytes and mammary epithelial cells, c-MYC downregulation is mediated by a TGF?-induced protein complex containing Smad3/4, p107, E2F4/5, and C/EBP? (Chen et al., 2002; Gomis et al., 2006b).	SEN:10031176	18662538
BEL:20062606	p(MGI:Tgfb1) decreases p(MGI:Runx2)	Figure 5 Runx2/Cbfa1 expression in preosteoblasts by Western blot analysis. Caspase-3–deficient (Casp3–/– and Casp3+/–) preosteoblasts showed decreased Runx2/Cbfa1 expression and altered expression pattern of Runx2/Cbfa1 in response to TGF-? treatment when compared with WT preosteoblasts. (Western Blot)	SEN:10025620	15599395
BEL:20062610	p(MGI:Tgfb1) increases p(MGI:Snai1)	In addition, SNAI1 and SNAI2 protein expression was increased by TGFb1 in a time-dependent manner, as assessed by western blot analysis.	SEN:10031180	19850962
BEL:20062612	p(MGI:Tgfb1) increases p(MGI:Snai2)	In addition, SNAI1 and SNAI2 protein expression was increased by TGFb1 in a time-dependent manner, as assessed by western blot analysis.	SEN:10031180	19850962
BEL:20062620	p(MGI:Tgfb1) increases p(MGI:Tcf3)	In contrast, downregulation of Id expression by TGF-beta generates E2A that is free from Id proteins, thus allowing E2A to become active and induce EMT through repression of E-cadherin expression.	SEN:10031186	15181457
BEL:20062622	p(MGI:Tgfb1) decreases p(MGI:Tgfbr1)	in the absence of exogenous TGF-?1, the VSMCs receptor expression profile switched from predominantly type II to type I	SEN:10031188	16462725
BEL:20062624	p(MGI:Tgfb1) increases p(MGI:Tgfbr2)	in the absence of exogenous TGF-?1, the VSMCs receptor expression profile switched from predominantly type II to type I	SEN:10031188	16462725
BEL:20062626	p(MGI:Tgfb1) increases p(MGI:Vim)	the spindle-like phenotype induced by TGF treatment (Fig. 1 A, inset) persisted after factor removal (Fig. 1 B, inset) and involved loss of E-cadherin/4-integrin, whereas vimentin was strongly induced	SEN:10031150	11790801
BEL:20062630	p(MGI:Tgfb1) decreases r(EGID:387222)	Figure 2(C) Real-time PCR analysis indicates that all three miR-29 family members are down-regulated in fibroblasts after exposure to TGF? for 48 h. *, P < 0.05 compared with untreated fibroblasts.	SEN:10031190	18723672
BEL:20062632	p(MGI:Tgfb1) decreases r(EGID:387222)	Stimulation of primary murine HSC (Fig. 3E) as well as immortalized murine HSC (GRX-HSC; Supporting Fig. S3B) with recombinant TGF-beta led to a significant decrease of miR-29 expression, correlating with an increase in collagen expression in these cells.	SEN:10031192	20890893
BEL:20062634	p(MGI:Tgfb1) decreases r(EGID:387223)	Figure 2(C) Real-time PCR analysis indicates that all three miR-29 family members are down-regulated in fibroblasts after exposure to TGF? for 48 h. *, P < 0.05 compared with untreated fibroblasts.	SEN:10031190	18723672
BEL:20062636	p(MGI:Tgfb1) decreases r(EGID:387223)	Stimulation of primary murine HSC (Fig. 3E) as well as immortalized murine HSC (GRX-HSC; Supporting Fig. S3B) with recombinant TGF-beta led to a significant decrease of miR-29 expression, correlating with an increase in collagen expression in these cells.	SEN:10031192	20890893
BEL:20062638	p(MGI:Tgfb1) decreases r(EGID:387224)	Figure 2(C) Real-time PCR analysis indicates that all three miR-29 family members are down-regulated in fibroblasts after exposure to TGF? for 48 h. *, P < 0.05 compared with untreated fibroblasts.	SEN:10031190	18723672
BEL:20062640	p(MGI:Tgfb1) decreases r(EGID:387224)	Stimulation of primary murine HSC (Fig. 3E) as well as immortalized murine HSC (GRX-HSC; Supporting Fig. S3B) with recombinant TGF-beta led to a significant decrease of miR-29 expression, correlating with an increase in collagen expression in these cells.	SEN:10031192	20890893
BEL:20062642	p(MGI:Tgfb1) decreases r(EGID:69717)	Moreover, TGF-beta 1 markedly suppressed the expression of antigen peresenting molecule Ia and co-stimulatory molecule CD86 on the surface of cultured Lin- c-kit+ HPCs. Examination of RT-PCR showed that TGF-beta 1 could also inhibit the expression of MHC class II trans-activator (CTIIA) mRNA	SEN:10031194	11601034
BEL:20062646	p(MGI:Tgfb1) increases r(MGI:Bax)	These studies demonstrate that TGF-1 is a potent stimulator of Bax mRNA and protein accumulation in lungs from doxycyclinetreated Tg mice (Fig. 1).	SEN:10031146	17209037
BEL:20062648	p(MGI:Tgfb1) increases r(MGI:Ccnd2)	Smad3 is an important mediator of the TGF beta signaling pathway Smad3-/- follicles have impaired growth, increased atresia, and altered differentiation in the presence of high FSH levels, normal expression of FSHR, and lower expression of cyclin D2	SEN:10031198	15192076
BEL:20062652	p(MGI:Tgfb1) decreases r(MGI:Cd86)	Moreover, TGF-beta 1 markedly suppressed the expression of antigen peresenting molecule Ia and co-stimulatory molecule CD86 on the surface of cultured Lin- c-kit+ HPCs. Examination of RT-PCR showed that TGF-beta 1 could also inhibit the expression of MHC class II trans-activator (CTIIA) mRNA	SEN:10031194	11601034
BEL:20062654	p(MGI:Tgfb1) decreases r(MGI:Ciita)	Moreover, TGF-beta 1 markedly suppressed the expression of antigen peresenting molecule Ia and co-stimulatory molecule CD86 on the surface of cultured Lin- c-kit+ HPCs. Examination of RT-PCR showed that TGF-beta 1 could also inhibit the expression of MHC class II trans-activator (CTIIA) mRNA	SEN:10031194	11601034
BEL:20062656	p(MGI:Tgfb1) increases r(MGI:Col1a1)	TGF-beta1 selectively activated the p38 MAPK isoforms p38alpha and p38delta in wild-type (Mkk3+/+) mesangial cells MKK3 deficiency resulted in a selective disruption of TGF-beta1-stimulated up-regulation of pro-alpha1(I) collagen expression	SEN:10029002	12374793
BEL:20062660	p(MGI:Tgfb1) increases r(MGI:Col1a2)	COL1A2 promoter activity was dose dependently induced by TGF-beta1, which was further augmented by adenoviral overexpression of Smad3, but was downregulated by Smad7.	SEN:10010340	16126788
BEL:20062664	p(MGI:Tgfb1) increases r(MGI:Csrp2)	Northern analysis revealed that in the absence of actinomycin D, TGF? substantially induced CRP2 mRNA expression, whereas actinomycin D blocked induction of CRP2 mRNA (Fig. 2A).	SEN:10016776	18387947
BEL:20062666	p(MGI:Tgfb1) increases r(MGI:Csrp2)	TGFbeta induced CRP2 protein expression as early as 2 h, and the induction continued at the 4 h time point (Fig. 1A). Similar to the protein results, Northern blot analysis revealed that TGF? induced CRP2 mRNA expression in a time-dependent manner (Fig. 1B).	SEN:10031158	18387947
BEL:20062668	p(MGI:Tgfb1) increases r(MGI:Ctgf)	After treatment with rTGF-1, there was a significantly increased expression of CTGF in WT fibroblasts at 3, 6, and 24 h	SEN:10031204	15265946
BEL:20062670	p(MGI:Tgfb1) decreases r(MGI:Fgfbp1)	We demonstrate here that TGF-beta signaling significantly represses FGF-BP1 expression in mesenchymal and neural crest cells undergoing in vitro smooth muscle differentiation.	SEN:10010342	16690027
BEL:20062672	p(MGI:Tgfb1) increases r(MGI:Foxa1)	We also found that TGF-beta can stimulate the expression of Foxa1 in Hnf6(+/+) cells and that inhibition of TGF-beta signaling in Hnf6(-/-) cells down-regulates the expression of Foxa1.	SEN:10020478	15562441
BEL:20062674	p(MGI:Tgfb1) increases r(MGI:Foxp3)	Similarly, TGF-{beta} stimulation regulated Foxp3 expression in anti-CD3/CD28-stimulated human CD4+ T lymphocytes at the mRNA and protein level, suggesting that TGF-{beta} controls expression of this key regulatory protein both in human and murine T cells (Fig. 1, B and C).	SEN:10031160	15100250
BEL:20062682	p(MGI:Tgfb1) increases r(MGI:Il10)	TGF-?1 can induce IL-10 production (an anti-inflammatory cytokine) in T cells through a Smad4 dependent mechanism by Smad4 DNA-binding to the IL-10 promoter suggesting a unique role for Smad4 in regulating TGF-?1’s antiinflammatory effects in T cells.133	SEN:10031208	16462725
BEL:20062694	p(MGI:Tgfb1) increases r(MGI:Il23a)	Neutralizing Ab to TGF-beta1 eliminated TMEV-induced IL-23 production and SMAD-3 activation in RAW264.7 cells, BMM, and SPM.	SEN:10002872	18802055
BEL:20062700	p(MGI:Tgfb1) increases r(MGI:Itgae)	Exposure of a T-cell line to TGF-beta strongly up-regulated alphaE mRNA levels within 30 min, and nuclear run-on experiments established that regulation occurred at the level of transcription.	SEN:10010348	11412301
BEL:20062708	p(MGI:Tgfb1) increases r(MGI:Mcpt1)	Because in vitro expression of this chymase is regulated by TGF-beta(1), these data indicate that in the absence of alpha(v)beta(6) epithelially expressed TGF-beta(1) may not be activated, with a consequent absence of expression of mouse mast cell protease-1 and down-regulation of the mucosal mast cell response.	SEN:10031212	12213704
BEL:20062710	p(MGI:Tgfb1) increases r(MGI:Mif)	This was demonstrated for in vitro recombinant MIF in fibroblasts, where growth-factor-induced stimulation of these cells resulted in increased MIF concentrations, activation of the ERK-MAP kinase pathway and subsequent increase in cell proliferation [50] . This was also shown in a colon cancer cell line where the addition of TGF resulted in increased MIF expression [51] .	SEN:10031172	18791328
BEL:20062720	p(MGI:Tgfb1) decreases r(MGI:Pparg)	We observed that certain cytokine and growth factors [such as TNF alpha, basic fibroblast growth factor, transforming growth factor beta, and protein kinase C-activating agents plus calcium ionophore], when added to differentiated adipocytes, cause rapid down-regulation of PPARgamma mRNA expression	SEN:10008716	9202217
BEL:20062722	p(MGI:Tgfb1) increases r(MGI:Prdm1)	Incubation of MDA-MB-231 or NMuMG cells with TGF-beta1 resulted in robust increases in Blimp1 RNA and Blimp-1 protein levels (Fig. 1A).	SEN:10031214	23054396
BEL:20062728	p(MGI:Tgfb1) increases r(MGI:Rhob)	Expression of RohB mRNA was upregulated in NMuMG cells after treatment with 4 ng/ml TGF-beta1 for 1, 6 to 24 hours.	SEN:10031218	14580254
BEL:20062734	p(MGI:Tgfb1) increases r(MGI:Scgb1a1)	This is in contrast to the result observed for transgenic lungs overexpressing TGFb1 under the control of the SP-C promoter/enhancer in which CC-10 expression was inhibited (Zhou et al., 1996).	SEN:10031220	9006067
BEL:20062744	p(MGI:Tgfb1) increases r(MGI:Smad7)	Analysis of Smad7 mRNA levels showed Smad7 induction upon TGF-{beta} stimulation in control-transfected cells while overexpression of Foxp3 completely abrogated TGF-{beta}-induced Smad7 expression in CD4+ T cells (Fig. 5A).	SEN:10027064	15100250
BEL:20062748	p(MGI:Tgfb1) increases r(MGI:Syp)	We report that lack of TGF-beta1 expression in neonatal Tgfb1(-/-) mice results in a widespread increase in degenerating neurons accompanied by reduced expression of synaptophysin	SEN:10010362	14687548
BEL:20062756	p(MGI:Tgfb1) increases r(MGI:Tgfb1)	However, at 6 h after treatment with rTGF- 1, there was a significant (1.7-fold) increased (TIMP1) expression ( p 0.03) in WT fibroblasts that was not seen in KO fibroblasts. .. whereas there was a significant increase in TGF-1 gene expression in WT fibroblasts at 6 and 24 h ( p 0.03).	SEN:10031224	15265946
BEL:20062758	p(MGI:Tgfb1) increases r(MGI:Timp1)	However, at 6 h after treatment with rTGF- 1, there was a significant (1.7-fold) increased (TIMP1) expression ( p 0.03) in WT fibroblasts that was not seen in KO fibroblasts. .. whereas there was a significant increase in TGF-1 gene expression in WT fibroblasts at 6 and 24 h ( p 0.03).	SEN:10031224	15265946
BEL:20062760	p(MGI:Tgfb1) increases r(MGI:Tnfsf13b)	We found that TGF-beta1 stimulated mouse macrophages to express BAFF and that a typical TGF-beta signaling pathway was involved.	SEN:10010364	18334541
BEL:20062766	p(MGI:Tgfb1) decreases sec(p(MGI:Ifng))	TGF-{beta}-stimulated CD4+CD25– cells contained TGF-{beta} mRNA but produced low levels of IL-10 and little or no IFN-{gamma} and IL-4.	SEN:10031226	15100250
BEL:20062768	p(MGI:Tgfb1) decreases sec(p(MGI:Il10))	TGF-{beta}-stimulated CD4+CD25– cells contained TGF-{beta} mRNA but produced low levels of IL-10 and little or no IFN-{gamma} and IL-4.	SEN:10031226	15100250
BEL:20062770	p(MGI:Tgfb1) decreases sec(p(MGI:Il4))	TGF-{beta}-stimulated CD4+CD25– cells contained TGF-{beta} mRNA but produced low levels of IL-10 and little or no IFN-{gamma} and IL-4.	SEN:10031226	15100250
BEL:20062772	p(MGI:Tgfb1) increases sec(p(MGI:Il4))	In the case of Th2-type cytokines, enhanced production of IL-4 and IL-6 was reduced by treatment with anti-TGF-/3 or anti-IL- IO (Fig. 5B).	SEN:10027892	8598496
BEL:20062774	p(MGI:Tgfb1) increases sec(p(MGI:Il6))	In the case of Th2-type cytokines, enhanced production of IL-4 and IL-6 was reduced by treatment with anti-TGF-/3 or anti-IL- IO (Fig. 5B).	SEN:10027892	8598496
BEL:20062776	p(MGI:Tgfb1) increases sec(p(MGI:Pthlh))	TGF? stimulates PTHrP secretion without appearing to increase PTHrP mRNA levels. PTHrP stimulates the production of RANK ligand (RANKL) in osteoblasts, which in turn promotes the differentiation of osteoclast precursors and bone resorption. Administration of anti-PTHrP neutralizing antibodies inhibits TGF?-dependent osteolytic bone metastasis in mice (Kakonen et al., 2002).	SEN:10030232	18662538
BEL:20062782	p(MGI:Tgfb1) increases tloc(p(MGI:Rock1),GOCCID:0005737,GOCCID:0005634)	Further, evidence is presented for TGF-beta-stimulated p160ROCK translocation to the nucleus and inhibitory phosphorylation of the cyclin-dependent kinase-activating phosphatase, Cdc25A.	SEN:10010332	14657354
BEL:20062790	p(MGI:Tgfb1) increases tscript(p(MGI:Atf2))	Western blot analysis revealed that TGF? increased ATF2 phosphorylation as early as 5 min after stimulation but did not alter total ATF2 levels (Fig. 6).	SEN:10031230	18387947
BEL:20062794	p(MGI:Tgfb1) increases tscript(p(MGI:Csrp2))	To evaluate the functional role of CREB and ATF2 in the induction of CRP2, we cotransfected ?795Csrp2-luc construct with expression plasmids in transient transfection assays. CREB did not increase Csrp2 promoter activity (Fig. 8A). In contrast, ATF2 expression increased Csrp2 promoter activity by ?3-fold (Fig. 8A), and TGF? further enhanced the transcriptional activation by ATF2 7-fold (Fig. 8A).	SEN:10025250	18387947
BEL:20062798	p(MGI:Tgfb1) increases tscript(p(MGI:Egr1))	The transcription factor early growth response-1 (Egr-1) mediates the stimulation of collagen transcription elicited by TGF-beta and is necessary for the development of pulmonary fibrosis in mice.	SEN:10031234	18772333
BEL:20062800	p(MGI:Tgfb1) increases tscript(p(MGI:Foxo1))	Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.	SEN:10031236	20439537
BEL:20062802	p(MGI:Tgfb1) increases tscript(p(MGI:Foxo3))	Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.	SEN:10031236	20439537
BEL:20062806	p(MGI:Tgfb1) increases tscript(p(MGI:Smad2))	Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine	SEN:10002864	15972691
BEL:20062814	p(MGI:Tgfb1) increases tscript(p(MGI:Smad3))	Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine	SEN:10002864	15972691
BEL:20062816	p(MGI:Tgfb1) increases tscript(p(MGI:Smad3))	FIGURE 9. TGF-beta1 induces snail-1 in hepatocytes in EMT state and lack of evidence for Akt/Erk1/2 activation	SEN:10031240	17513865
BEL:20062818	p(MGI:Tgfb1) increases tscript(p(MGI:Smad3))	Neutralizing Ab to TGF-beta1 eliminated TMEV-induced IL-23 production and SMAD-3 activation in RAW264.7 cells, BMM, and SPM.	SEN:10002872	18802055
BEL:20062820	p(MGI:Tgfb1) increases tscript(p(MGI:Smad4))	ELF activates and modulates Smad4 activation of TGF-beta to confer cell polarity, to maintain cell architecture, and to inhibit epithelial-to-mesenchymal transition. This study indicates that by modulating Smad 4, ELF has a key role in TGF-beta signaling in the suppression of early colon cancer.	SEN:10019620	15899814
BEL:20062826	p(MGI:Tgfb2) increases r(MGI:Ptafr)	transforming growth factor-b2 (TGF-b2) was shown to upregulate the transcription rate of PAFR transcript 1 in Ramos human lymphoblastoid cells	SEN:10031242	10729607
BEL:20062828	p(MGI:Tgfb3) decreases bp(GOBP:"cell proliferation")	This finding suggests that TGF-beta3 is required for inhibiting MEE proliferation during palatal fusion. The inhibition of MEE proliferation may be mediated by TGF-beta3-dependent phosphorylation of SMAD2	SEN:10010376	12815624
BEL:20062834	p(MGI:Tgfbr1) increases bp(GOBP:angiogenesis)	TGF-B can function either as a proangiogenic or antiangiogenic factor in vitro; however, the preponderance of evidence supports a proangiogenic role for TGF-B in vivo.93 Several lines of evidence support a prominent role for the TGF-B signaling pathway in stimulating angiogenesis. First, targeted deletion of members of this pathway in mice, including TGF-B1, TBRI, and TBRII, all result in aberrant angiogenesis.	SEN:10031116	15774796
BEL:20062842	p(MGI:Tgfbr2) increases bp(GOBP:angiogenesis)	TGF-B can function either as a proangiogenic or antiangiogenic factor in vitro; however, the preponderance of evidence supports a proangiogenic role for TGF-B in vivo.93 Several lines of evidence support a prominent role for the TGF-B signaling pathway in stimulating angiogenesis. First, targeted deletion of members of this pathway in mice, including TGF-B1, TBRI, and TBRII, all result in aberrant angiogenesis.	SEN:10031116	15774796
BEL:20062844	p(MGI:Tgfbr2) decreases bp(GOBP:"cell proliferation")	Targeted deletion of TGFBRII in the mouse mammary epithelium resulted in excessive lobular-alveolar cell proliferation (hyperplasia; Forrester et al., 2005).	SEN:10031250	18662538
BEL:20062856	p(MGI:Tgfbr3) decreases tscript(p(MGI:Smad2))	WtTGFbetaRIII inhibited phosphorylation of Smad 2 and 3 (Fig. 3A) as well as Akt and ERK by TGF-beta (Fig. 3B).	SEN:10031258	20359848
BEL:20062858	p(MGI:Tgfbr3) decreases tscript(p(MGI:Smad3))	WtTGFbetaRIII inhibited phosphorylation of Smad 2 and 3 (Fig. 3A) as well as Akt and ERK by TGF-beta (Fig. 3B).	SEN:10031258	20359848
BEL:20062860	p(MGI:Tgm1) increases bp(GOBP:"wound healing")	Similar injuries to TGase 1 knockout mouse skins grafted on athymic nude mice showed substantial delays in wound healing concomitant with sustained K6alpha mRNA induction.	SEN:10002886	11106560
BEL:20062862	p(MGI:Tgm1) decreases r(MGI:Krt17)	Similar injuries to TGase 1 knockout mouse skins grafted on athymic nude mice showed substantial delays in wound healing concomitant with sustained K6alpha mRNA induction.	SEN:10002886	11106560
BEL:20062878	p(MGI:Thbs1) decreases bp(GOBP:"cell migration")	Cyclin D1 promotes cellular motility through inhibiting ROCK signaling and repressing the metastasis suppressor TSP-1	SEN:10006372	16705174
BEL:20062880	p(MGI:Thbs1) decreases bp(GOBP:"cell proliferation")	TSP-1, a major constituent of alpha-granules, acts as a potent inhibitor of endothelial cell proliferation and stimulates endothelial cell apoptosis.186	SEN:10031268	19450911
BEL:20062886	p(MGI:Thbs1) decreases bp(GOBP:"apoptotic process")	TSP-1, a major constituent of alpha-granules, acts as a potent inhibitor of endothelial cell proliferation and stimulates endothelial cell apoptosis.186	SEN:10031268	19450911
BEL:20062896	p(MGI:Thbs1) decreases sec(p(MGI:Cxcl12))	The proangiogenic activity in TSP-deficient mice is directly related to increased platelet secretion of CXCL12.186	SEN:10031272	19450911
BEL:20062904	p(MGI:Thbs2) decreases cat(p(MGI:Mmp2))	As determined by immunohistochemistry, the amount of matrix metalloproteinase 2 (MMP2) in the cervix of TSP2-null mice increased 11-fold on Day 14 of pregnancy and 19-fold on Day 18.	SEN:10010388	14561659
BEL:20062938	p(MGI:Ticam1) increases cat(p(MGI:Nlrp3))	Macrophages deficient in MyD88 or TRIF responded normally to LPS and ATP with cleavage of caspase-1, while macrophages doubly deficient in both MyD88 and TRIF or TLR4 failed to respond (Supplementary Fig. 2A). These results show that both TRIF-and MyD88-dependent signaling pathways can compensate for each other in their ability to induce priming for NLRP3 activation.	SEN:10031282	19570822
BEL:20062944	p(MGI:Ticam1) decreases r(MGI:Ddit3)	from full ext - The marked suppression of CHOP by LPS in wild-type macrophage was almost completely absent in Tlr4?/? and Trif?/? macrophages, but not in Myd88?/? macrophages (Fig. 2a?c).	SEN:10019676	19855386
BEL:20062956	p(MGI:Timp1) decreases path(MESHD:Fibrosis)	TIMP-1 knockout mice also displayed greater degree of liver fibrosis after chronic CCl4 injection when compared with wild-type mice.	SEN:10002900	21711826
BEL:20062962	p(MGI:Timp2) decreases bp(GOBP:angiogenesis)	TIMP-2 and Ala+TIMP-2 A549 xenografts exhibited reduced tumor growth (70-95% inhibition), decreased angiogenesis and increased apoptosis in both nude and NOD-SCID mice	SEN:10031292	23847723
BEL:20062966	p(MGI:Timp2) increases bp(GOBP:"apoptotic process")	TIMP-2 and Ala+TIMP-2 A549 xenografts exhibited reduced tumor growth (70-95% inhibition), decreased angiogenesis and increased apoptosis in both nude and NOD-SCID mice	SEN:10031292	23847723
BEL:20062974	p(MGI:Timp2) increases p(MGI:Cdh1)	Immunohistochemical analysis of tumor tissue revealed increased E-cadherin expression in TIMP-2 and Ala+TIMP-2 xenografts (Fig.3C)	SEN:10031298	23847723
BEL:20062976	p(MGI:Timp2) decreases r(MGI:Igf1r)	More specifically, when compared to EV tumors, TIMP-2 or Ala+TIMP-2 caused down-regulation of IGF-1 receptor (IGF-1R) expression (4.8 fold) and an increase in IGF binding proteins (including IGFBP-5 (4.0 fold) and -7 (3.5 fold)), proteins that limit the bioavailability of IGF ligands	SEN:10031300	23847723
BEL:20062978	p(MGI:Timp2) increases r(MGI:Igfbp5)	More specifically, when compared to EV tumors, TIMP-2 or Ala+TIMP-2 caused down-regulation of IGF-1 receptor (IGF-1R) expression (4.8 fold) and an increase in IGF binding proteins (including IGFBP-5 (4.0 fold) and -7 (3.5 fold)), proteins that limit the bioavailability of IGF ligands	SEN:10031300	23847723
BEL:20062980	p(MGI:Timp2) increases r(MGI:Igfbp7)	More specifically, when compared to EV tumors, TIMP-2 or Ala+TIMP-2 caused down-regulation of IGF-1 receptor (IGF-1R) expression (4.8 fold) and an increase in IGF binding proteins (including IGFBP-5 (4.0 fold) and -7 (3.5 fold)), proteins that limit the bioavailability of IGF ligands	SEN:10031300	23847723
BEL:20062982	p(MGI:Timp3) decreases cat(p(MGI:Adam17))	TIMP3 is also an inhibitor of ADAM17, it was of interest that ablation of Timp3 in mice led to an enhancement of tumorigenesis99 and regulated TnF?-dependent systemic inflammation98	SEN:10031302	19005493
BEL:20062990	p(MGI:Timp3) decreases p(MGI:Tnf)	Generation of Timp3–/– mice and the establishment of mouse models of inflammation yields phenotypes with increased levels of circulating TnF?98	SEN:10031306	19005493
BEL:20062992	p(MGI:Timp4) decreases cat(p(MGI:Mmp2))	Here, we establish that Timp4-/- mice are specifically predisposed to LV rupture after MI, which is prevented by MMPi-treatment or the loss of Mmp2.	SEN:10031308	20516072
BEL:20062996	p(MGI:Tll1) decreases bp(GOBP:"fat cell differentiation")	Remarkably, retroviral expression of either Gja1 or Tll1 in 3T3-L1 preadipocytes also inhibited adipocyte differentiation	SEN:10008850	18945812
BEL:20063002	p(MGI:Tlr2) decreases bp(GOBP:"neutrophil chemotaxis")	Notably, CXCR2 expression and chemotaxis to CXCL2 were significantly higher in neutrophils from TLR2-/- mice compared with those from WT mice subjected to S-CLP (Fig. 2 C and D).	SEN:10031312	19234125
BEL:20063018	p(MGI:Tlr2) decreases r(EGID:12765)	Notably, CXCR2 expression and chemotaxis to CXCL2 were significantly higher in neutrophils from TLR2-/- mice compared with those from WT mice subjected to S-CLP (Fig. 2 C and D).	SEN:10031312	19234125
BEL:20063020	p(MGI:Tlr2) increases r(MGI:Ccl5)	Wound areas in TLR2(-/-), TLR4(-/-), and TLR2/4(-/-) mice were larger than wild-type mice both at days 3 and 7 after wounding, accompanied by decreased numbers of infiltrating macrophages in the dermis and decreased TGF-beta and CCL5 mRNA expression in the wounded skin	SEN:10010402	24252748
BEL:20063022	p(MGI:Tlr2) increases r(MGI:Tgfb1)	Wound areas in TLR2(-/-), TLR4(-/-), and TLR2/4(-/-) mice were larger than wild-type mice both at days 3 and 7 after wounding, accompanied by decreased numbers of infiltrating macrophages in the dermis and decreased TGF-beta and CCL5 mRNA expression in the wounded skin	SEN:10010402	24252748
BEL:20063026	p(MGI:Tlr3) increases bp(GOBP:"wound healing")	Wound healing parameters, including re-epithelialization, granulation formation, and neovascularization, were decreased in TLR3-/- mice.	SEN:10010404	21317384
BEL:20063028	p(MGI:Tlr3) increases p(MGI:Ccl2)	In contrast, the protein level of MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 in TLR3-/- skin wounds was significantly decreased compared with WT mice (Fig. 5B–D).	SEN:10031322	21317384
BEL:20063030	p(MGI:Tlr3) increases p(MGI:Ccl3)	In contrast, the protein level of MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 in TLR3-/- skin wounds was significantly decreased compared with WT mice (Fig. 5B–D).	SEN:10031322	21317384
BEL:20063032	p(MGI:Tlr3) increases p(MGI:Cxcl2)	In contrast, the protein level of MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 in TLR3-/- skin wounds was significantly decreased compared with WT mice (Fig. 5B–D).	SEN:10031322	21317384
BEL:20063034	p(MGI:Tlr3) increases r(MGI:Ccl2)	However, the expression of the genes for MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 was significantly reduced in TLR3-/- mice compared with WT controls (Fig. 5A).	SEN:10031324	21317384
BEL:20063036	p(MGI:Tlr3) increases r(MGI:Ccl3)	However, the expression of the genes for MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 was significantly reduced in TLR3-/- mice compared with WT controls (Fig. 5A).	SEN:10031324	21317384
BEL:20063038	p(MGI:Tlr3) increases r(MGI:Cxcl2)	However, the expression of the genes for MIP-2/CXCL2, MIP-1alpha/CCL3, and MCP-1/CCL2 was significantly reduced in TLR3-/- mice compared with WT controls (Fig. 5A).	SEN:10031324	21317384
BEL:20063040	p(MGI:Tlr4) increases a(CHEBI:glutathione)	levels of reduced glutathione (GSH), the major antioxidant in the lung, were markedly decreased in BAL from Tlr4–/– mice (Figure 3B).	SEN:10031326	17053835
BEL:20063052	p(MGI:Tlr4) decreases bp(GOBP:"cellular response to DNA damage stimulus")	Therefore, we evaluated Tlr4–/– mice for DNA strand breaks in situ by fluorescent TUNEL staining and found an increased number of TUNEL-positive cells in the lungs of Tlr4–/– mice compared with WT lungs (Figure 3, G and H).	SEN:10031332	17053835
BEL:20063054	p(MGI:Tlr4) increases bp(GOBP:"macrophage activation")	To obtain direct evidence of TLR activation upon THP engagement, we isolated bone marrow–derived macrophages from MyD88 and TLR2, TLR4, and TLR9 KO mice as well as from WT mice. While THP potently stimulated TNF-? production in APCs obtained from WT, TLR2–/–, and TLR9–/– mice, cells from TLR4–/– and MyD88–/– mice were completely resistant to THP or LPS stimulation (Figure ?(Figure6A).6A)	SEN:10019686	15650774
BEL:20063056	p(MGI:Tlr4) decreases bp(GOBP:"response to oxidative stress")	In the mouse, TLR4 has a role for maintaining normal lung architecture by inhibiting oxidant stress.	SEN:10031334	22983353
BEL:20063058	p(MGI:Tlr4) decreases bp(GOBP:"apoptotic process")	annexin V–propidium iodide (annexin V–PI) staining in isolated lung cells of Tlr4–/– mice, which showed significantly increased lung cell death (Supplemental Figure 11).	SEN:10031336	17053835
BEL:20063060	p(MGI:Tlr4) decreases bp(GOBP:"apoptotic process")	The basal and CSE-inducible expression of LC3B and cleaved caspase-3 were elevated in pulmonary alveolar type II (ATII) cells from Tlr4-deficient mice...These findings suggest that TLR exerts an inhibitory effect on the expression of the autophagic protein LC3B, and also on the apoptotic response to CSE	SEN:10031338	22983353
BEL:20063062	p(MGI:Tlr4) decreases cat(p(MGI:Nox3))	Next, we examined Nox3 mRNA expression in MLECs and found that, similar to the lung lysates, Tlr4–/– MLECs expressed increased Nox3 mRNA expression (Figure 7C).	SEN:10031340	17053835
BEL:20063064	p(MGI:Tlr4) decreases deg(p(MGI:Eln))	Tlr4–/– mice showed a marked decrease in their elastase inhibitory capacity (EIC) in BAL (Figure 2A), as well as in serum (data not shown), compared with WT mice	SEN:10031342	17053835
BEL:20063068	p(MGI:Tlr4) decreases path(MESHD:Emphysema)	Furthermore, TLR4 deficiency has been shown to cause age-related pulmonary emphysema by increased oxidant stress and cell death in aged mice, in the absence of smoking	SEN:10031344	17615396
BEL:20063078	p(MGI:Tlr4) decreases p(MGI:Casp3)	The basal and CSE-inducible expression of LC3B and cleaved caspase-3 were elevated in pulmonary alveolar type II (ATII) cells from Tlr4-deficient mice...These findings suggest that TLR exerts an inhibitory effect on the expression of the autophagic protein LC3B, and also on the apoptotic response to CSE	SEN:10031338	22983353
BEL:20063080	p(MGI:Tlr4) decreases p(MGI:Casp3)	The Tlr4-mutated or Tlr4-deficient mice showed higher levels of LC3B under basal conditions and after CS exposure. The expression of cleaved caspase-3 was markedly increased in Tlr4-deficient mice exposed to CS. We describe a protective regulatory function of TLR4 against emphysematous changes of the lung in response to CS	SEN:10031348	22983353
BEL:20063082	p(MGI:Tlr4) increases p(MGI:Ccl2)	This was the first direct evidence of an atheroprotective effect of TLR deficiency. These mice had a reduction in plasma monocyte chemotactic protein-1 (MCP-1), an important mediator of tissue macrophage infiltration, as well as a reduction in plaque lipid content and macrophage infiltration. The same changes were found in MyD88–/–apoE–/– mice, in accordance with Bjorkbacka et al. (42).	SEN:10029382	16891671
BEL:20063086	p(MGI:Tlr4) increases p(MGI:Il1b)	selective lack in IL-1beta increase but not Cxcl2/MIP-2 in cryopyrin null mice contrasts with Tlr4-/- mice that have much less IL-1beta	SEN:10031350	19258328
BEL:20063088	p(MGI:Tlr4) decreases p(MGI:Map1lc3b)	In epithelial cells subjected to TLR4 knockdown, as well as in primary epithelial cells isolated from Tlr4-deficient mice, we have observed elevated expression of the autophagic protein LC3B and increased markers of cell death in response to CS exposure, relative to control cells with wild-type TLR4 expression.	SEN:10031352	22983353
BEL:20063090	p(MGI:Tlr4) decreases p(MGI:Map1lc3b)	The basal and CSE-inducible expression of LC3B and cleaved caspase-3 were elevated in pulmonary alveolar type II (ATII) cells from Tlr4-deficient mice...These findings suggest that TLR exerts an inhibitory effect on the expression of the autophagic protein LC3B, and also on the apoptotic response to CSE	SEN:10031338	22983353
BEL:20063092	p(MGI:Tlr4) decreases p(MGI:Map1lc3b)	The Tlr4-mutated or Tlr4-deficient mice showed higher levels of LC3B under basal conditions and after CS exposure. The expression of cleaved caspase-3 was markedly increased in Tlr4-deficient mice exposed to CS. We describe a protective regulatory function of TLR4 against emphysematous changes of the lung in response to CS	SEN:10031348	22983353
BEL:20063094	p(MGI:Tlr4) decreases p(MGI:Nox3)	we examined mRNA expression of various Nox proteins in lung lysates from Tlr4–/– and WT mice. Nox3 was present at a very low level in WT lungs, whereas Tlr4–/– lung lysates showed increased expression of Nox3 mRNA and protein (Figure 7, A and B).	SEN:10031354	17053835
BEL:20063096	p(MGI:Tlr4) decreases p(MGI:Nox3)	The expression of NOX-3 was increased because of loss of Toll-like receptor 4. Furthermore, these mice had increased alveolar cell apoptosis and loss of antielastolytic properties in lung lysates	SEN:10031356	17615396
BEL:20063100	p(MGI:Tlr4) increases r(MGI:Ccl5)	Wound areas in TLR2(-/-), TLR4(-/-), and TLR2/4(-/-) mice were larger than wild-type mice both at days 3 and 7 after wounding, accompanied by decreased numbers of infiltrating macrophages in the dermis and decreased TGF-beta and CCL5 mRNA expression in the wounded skin	SEN:10010402	24252748
BEL:20063102	p(MGI:Tlr4) increases r(MGI:Il1b)	In contrast to the cryopyrin null mice, IL-1beta release and transcription were suppressed in macrophages derived from Tlr4-deficient mice	SEN:10031358	19258328
BEL:20063104	p(MGI:Tlr4) decreases r(MGI:Nox3)	TLR4 deficiency led to the upregulation of what we believe to be a novel NADPH oxidase (Nox), Nox3, in lungs and endothelial cells, resulting in increased oxidant generation and elastolytic activity.	SEN:10031360	17053835
BEL:20063106	p(MGI:Tlr4) decreases r(MGI:Nox3)	we examined mRNA expression of various Nox proteins in lung lysates from Tlr4–/– and WT mice. Nox3 was present at a very low level in WT lungs, whereas Tlr4–/– lung lysates showed increased expression of Nox3 mRNA and protein (Figure 7, A and B).	SEN:10031354	17053835
BEL:20063108	p(MGI:Tlr4) increases r(MGI:Tgfb1)	Wound areas in TLR2(-/-), TLR4(-/-), and TLR2/4(-/-) mice were larger than wild-type mice both at days 3 and 7 after wounding, accompanied by decreased numbers of infiltrating macrophages in the dermis and decreased TGF-beta and CCL5 mRNA expression in the wounded skin	SEN:10010402	24252748
BEL:20063110	p(MGI:Tlr4) increases sec(p(MGI:Il13))	In contrast, LPS from Escherichia coli stimulated mast cells in a TLR4-dependent manner to produce TNF-alpha, IL-1beta, IL-6, and IL-13, but not IL-4 nor IL-5.	SEN:10010412	12021251
BEL:20063112	p(MGI:Tlr4) increases sec(p(MGI:Il1b))	In contrast, LPS from Escherichia coli stimulated mast cells in a TLR4-dependent manner to produce TNF-alpha, IL-1beta, IL-6, and IL-13, but not IL-4 nor IL-5.	SEN:10010412	12021251
BEL:20063114	p(MGI:Tlr4) increases sec(p(MGI:Il1b))	In contrast to the cryopyrin null mice, IL-1beta release and transcription were suppressed in macrophages derived from Tlr4-deficient mice	SEN:10031358	19258328
BEL:20063116	p(MGI:Tlr4) increases sec(p(MGI:Il6))	In contrast, LPS from Escherichia coli stimulated mast cells in a TLR4-dependent manner to produce TNF-alpha, IL-1beta, IL-6, and IL-13, but not IL-4 nor IL-5.	SEN:10010412	12021251
BEL:20063118	p(MGI:Tlr4) increases sec(p(MGI:Tnf))	In contrast, LPS from Escherichia coli stimulated mast cells in a TLR4-dependent manner to produce TNF-alpha, IL-1beta, IL-6, and IL-13, but not IL-4 nor IL-5.	SEN:10010412	12021251
BEL:20063120	p(MGI:Tlr5) decreases path(MESHD:Colitis)	Mice lacking TLR5 (TLR5KO mice) developed spontaneous colitis, as assessed by well-defined clinical, serologic, and histopathologic indicators of this disorder.	SEN:10010414	18008007
BEL:20063136	p(MGI:Tlr7) increases r(MGI:Ifna2)	Expression of both IFN-a2 and IFN-b mRNA was found to be profoundly abrogated in TLR7-deficient mice	SEN:10031368	21115688
BEL:20063138	p(MGI:Tlr7) increases r(MGI:Ifnb1)	Expression of both IFN-a2 and IFN-b mRNA was found to be profoundly abrogated in TLR7-deficient mice	SEN:10031368	21115688
BEL:20063144	p(MGI:Tlr9) increases p(MGI:Nox1)	To confirm that TLR9 was involved in the CpG ODN-induced signaling, a siRNA approach was used, and TLR9 siRNA was found to attenuate CpG ODN-induced Lox-1 mRNA and protein expression, Nox1 mRNA and protein expression, and foam cell formation (Fig. 4A-F).	SEN:10016738	18817866
BEL:20063148	p(MGI:Tlr9) increases r(MGI:Nox1)	To confirm that TLR9 was involved in the CpG ODN-induced signaling, a siRNA approach was used, and TLR9 siRNA was found to attenuate CpG ODN-induced Lox-1 mRNA and protein expression, Nox1 mRNA and protein expression, and foam cell formation (Fig. 4A-F).	SEN:10016738	18817866
BEL:20063154	p(MGI:Tmbim6) decreases bp(GOBP:"apoptotic process")	BI-1-mediated protection from apoptosis induced by ER stress correlated with inhibition of Bax activation and translocation to mitochondria, preservation of mitochondrial membrane potential, and suppression of caspase activation. BI-1 overexpression also reduces releasable Ca(2+) from the ER.	SEN:10010418	15304216
BEL:20063162	p(MGI:Tnc) increases bp(GOBP:angiogenesis)	Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Seven days after transplantation of the A375-GFP, capillary nets became far more abundant in the tumors grown in WT mice than those in TNKO mice. Interestingly, VEGF and TN-C expressions showed antithetical expression patterns between the tumors in WT mice and those in TNKO mice.	SEN:10031380	14618612
BEL:20063166	p(MGI:Tnc) increases r(MGI:Vegfa)	Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Seven days after transplantation of the A375-GFP, capillary nets became far more abundant in the tumors grown in WT mice than those in TNKO mice. Interestingly, VEGF and TN-C expressions showed antithetical expression patterns between the tumors in WT mice and those in TNKO mice.	SEN:10031380	14618612
BEL:20063168	p(MGI:Tnf) decreases a(CHEBI:calcitriol)	Likely, this down-regulation of Ca(2+) transporters in TNP(DeltaARE/+) mice is mediated by the 58 +/- 9% reduction in serum 1,25(OH)(2)D(3) levels	SEN:10031384	18266230
BEL:20063184	p(MGI:Tnf) increases a(CHEBI:"nitric oxide")	A significant dose-dependent increase in the inducible nitric oxide synthase (NOS2) expression and NO production were observed by various concentrations of TNF-alpha (1, 5, and 10 ng/mL) and LPS (1 and 5 microg/mL) which was completely inhibited by a NOS2 inhibitor, L-N6-(1-iminoethyl) lysine (L-NIL) (1 mM).	SEN:10003472	17588258
BEL:20063192	p(MGI:Tnf) increases a(CHEBI:"reactive oxygen species")	By activating key enzymes of metabolic pathways, RIP3 regulates TNF-induced reactive oxygen species production, which partially accounts for RIP3's ability to promote necrosis.	SEN:10010424	19498109
BEL:20063204	p(MGI:Tnfaip6) increases p(MGI:Ptgs2)	TSG-6 protein up-regulates the expression of inducible cyclooxygenase-2 (COX-2), a key enzyme in inflammation and immune responses. This action of TSG-6 protein was abolished by heat denaturation, trypsin digestion, or anti-TSG-6 antibodies. TSG-6 treatment also resulted in a rapid increase in COX-2 mRNA levels, suggesting that TSG-6 up-regulates COX-2 gene expression	SEN:10010426	15809059
BEL:20063206	p(MGI:Tnfaip6) increases r(MGI:Ptgs2)	TSG-6 protein up-regulates the expression of inducible cyclooxygenase-2 (COX-2), a key enzyme in inflammation and immune responses. This action of TSG-6 protein was abolished by heat denaturation, trypsin digestion, or anti-TSG-6 antibodies. TSG-6 treatment also resulted in a rapid increase in COX-2 mRNA levels, suggesting that TSG-6 up-regulates COX-2 gene expression	SEN:10010426	15809059
BEL:20063228	p(MGI:Tnf) increases bp(GOBP:"cell adhesion")	In the absence of stimulation, CD44-deficient macrophages had significantly attenuated adhesion to endothelial cells (Figure 5). This difference was accentuated in the presence of TNF-alpha stimulation	SEN:10025856	17446529
BEL:20063234	p(MGI:Tnf) decreases bp(GOBP:"fat cell differentiation")	We further demonstrate that inflammatory signals that antagonize differentiation, such as TNFalpha and lipopolysaccharide, acutely induce Nur77 expression both in vitro and in vivo.	SEN:10010434	18945812
BEL:20063236	p(MGI:Tnf) increases bp(GOBP:"fatty acid beta-oxidation")	fatty acid beta-oxidation and uncoupling protein (UCP)-2 expression decreased after treatment with VSL#3 or anti-TNF antibodies.	SEN:10010436	12540784
BEL:20063238	p(MGI:Tnf) increases bp(GOBP:"inflammatory response")	Several pro-inflammatory mediators up-regulate SAA transcription, including Il1, Il6, TNFalpha, and Lif.	SEN:10028334	11798191
BEL:20063240	p(MGI:Tnf) increases bp(GOBP:"inflammatory response")	We recently showed that mice lacking tumor necrosis factor- (TNF-) receptors do not develop smoke-induced inflammation,	SEN:10031406	12522030
BEL:20063242	p(MGI:Tnf) increases bp(GOBP:"inflammatory response")	Here we demonstrate that \"LDL(-)\" increases TNFa-induced inflammatory responses through NFkappaB and AP-1 activation, with corresponding increases in endothelial vascular adhesion molecule-1 (VCAM1) expression. LDL receptor overexpression increases these effects.	SEN:10031408	12878589
BEL:20063244	p(MGI:Tnf) increases bp(GOBP:"inflammatory response")	Transgenic overexpression of TNF-{alpha} led to emphysema and exaggerated alveolar inflammation (82)	SEN:10031410	17615396
BEL:20063246	p(MGI:Tnf) increases bp(GOBP:"inflammatory response")	Mice carrying a deletion in the tumor necrosis factor (TNF) AU-rich elements (ARE) are reported as a model for human CD and are characterized by elevated TNF-alpha levels and inflammations in the terminal ileum	SEN:10002912	18266230
BEL:20063248	p(MGI:Tnf) increases bp(GOBP:"inflammatory response")	Levels of TNF?, a central mediator of inflammation in DSS colitis (Kojouharoff et al., 1997), were elevated in DSS treated XBP1?/? vs XBP1+/+ colonic tissues with intermediate TNF? expression in XBP1+/? mice (Fig. 5E).	SEN:10017728	18775308
BEL:20063258	p(MGI:Tnf) increases bp(GOBP:"myeloid dendritic cell activation")	In both human (49) and mouse models (45, 51), the local production of TNF-alpha by neutrophils physically associated or close to DCs is required to induce DC activation	SEN:10031414	19273148
BEL:20063260	p(MGI:Tnf) increases bp(GOBP:"neutrophil chemotaxis")	LPS-induced neutrophil accumulation into the lung was significantly inhibited by prior intraperitoneal administration of neutralizing antibody against murine TNF-?, suggesting that TNF-? plays a critical role in the LPS-mediated neutrophil trafficking into the airway	SEN:10016014	15489375
BEL:20063268	p(MGI:Tnf) increases bp(GOBP:"T-helper 1 type immune response")	CyCAP is a widely expressed secreted glycoprotein that modulates the host response to endotoxin gene-targeted CyCAP-deficient mice are more sensitive to the lethal effects of endotoxin in response to endotoxin, CyCAP-deficient mice overproduce interleukin 12 and interferon-gamma systemically and tumor necrosis factor alpha locally, these are proinflammatory molecules that also promote T helper 1 responses	SEN:10020288	10077627
BEL:20063272	p(MGI:Tnf) increases bp(GOBP:"apoptotic process")	Furthermore, apoptosis induced by TNF or CD95 (Fas/APO-1) was associated with proteolysis of TXBP151.	SEN:10010442	10435631
BEL:20063274	p(MGI:Tnf) increases bp(GOBP:"apoptotic process")	Like A20, overexpression of TXBP151 could inhibit apoptosis induced by tumour necrosis factor (TNF) in NIH3T3 cells.	SEN:10010292	10435631
BEL:20063276	p(MGI:Tnf) increases bp(GOBP:"apoptotic process")	Transient transfection of rat calbindin-D(28k) cDNA blocked tumor necrosis factor alpha (TNFalpha)-induced apoptosis in osteoblastic MC3T3-E1 cells,	SEN:10025598	10835428
BEL:20063280	p(MGI:Tnf) increases bp(GOBP:"apoptotic process")	Among TTP/TIS11 proteins, TTP alone also promotes apoptosis synergistically with TNFalpha...We also demonstrate that TTP acts through an additional pathway to sensitize cells to the pro-apoptotic stimulus of TNFalpha.	SEN:10031416	12082611
BEL:20063284	p(MGI:Tnf) increases bp(GOBP:"apoptotic process")	PITSLRE kinases are a superfamily of Cdc2-like kinases that have been implicated in apoptotic signaling and tumorigenesis. In this paper we report that tumor necrosis factor (TNF)-mediated apoptosis is associated with a CrmA- and Bcl-2-inhibitable cleavage of PITSLRE kinases, indicating a role for CASPs.	SEN:10031418	9115219
BEL:20063288	p(MGI:Tnf) increases cat(p(MGI:Bid))	BID, a proapoptotic BCL-2 family member, plays an essential role in the tumor necrosis factor alpha (TNF-alpha)/Fas death receptor pathway in vivo.	SEN:10031420	15899861
BEL:20063290	p(MGI:Tnf) increases cat(p(MGI:Casp1))	We further observed that priming with a cytokine stimulus (TNF-a) was sufficient to induce caspase-1 activation by ATP.	SEN:10031422	19570822
BEL:20063292	p(MGI:Tnf) increases cat(p(MGI:Ctsb))	In WEHI-S fibrosarcoma cells, tumor necrosis factor (TNF) induced an increase in cytosolic cathepsin B activity followed by death with apoptotic features.	SEN:10010446	11381085
BEL:20063294	p(MGI:Tnf) decreases cat(p(MGI:Edn1))	TNF-alpha-induced desensitization of endothelin-1-stimulated GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes is due, at least in part, to a decreased expression of Galphaq/11,	SEN:10031424	12773307
BEL:20063298	p(MGI:Tnf) decreases cat(p(MGI:Mmp2))	TNFalpha, but not IGF-I, induced tissue inhibitor of metalloproteinase-1 (TIMP-1) expression and reduced matrix metalloproteinases-2 activity and collagen degradation. TNFalpha also activated ERK1/2.	SEN:10010448	16141211
BEL:20063300	p(MGI:Tnf) increases cat(p(MGI:Mmp9))	TNF-a also elicited enhanced MMP-9 activity (Fig. 6, middle) and TGF-b release (Fig. 6, bottom) in BALFs.	SEN:10031426	11907182
BEL:20063302	p(MGI:Tnf) increases cat(p(MGI:Parp1))	Western blotting of whole-cell lysates prepared from untreated or TNFalpha/CHX-treated NIH 3T3 cells showed no detectable cleavage of ROCK II (Fig. 2a) but significant cleavage of ROCK I, as well as cleavage of the well characterized caspase substrate poly-ADP ribose polymerase (PARP) after treatment with TNFalpha ( Fig. 2b).	SEN:10031428	11283606
BEL:20063304	p(MGI:Tnf) decreases cat(p(MGI:Pde3b))	Treatment of 3T3-L1 adipocytes with 10 ng/ml TNF-alpha for 24 h produced a maximal (50%) decrease in PDE3B activity, protein and mRNA, which was well correlated with both activation of protein kinase A (PKA) and stimulation of lipolysis, presumably reflecting an increase in intracellular cAMP concentration.	SEN:10031430	10677351
BEL:20063310	p(MGI:Tnf) directlyIncreases cat(p(MGI:Tnfrsf1a))	Fig. 4. Both cIAP1 and 2 are recruited to TNF-R1 upon TNFa treatment and are required for Rip1 polyubiquitination.	SEN:10031434	18697935
BEL:20063326	p(MGI:Tnf) increases complex(p(MGI:Irak1),p(MGI:Irs1))	In NIH-3T3(IR) cells, wild-type mPLK (but not mPLK-KD) co-immunoprecipitated with IRS-1. This association was% increased by treatment of cells with TNF-alpha.	SEN:10031442	15849359
BEL:20063332	p(MGI:Tnf) increases complex(p(MGI:Tnfrsf1a),p(MGI:Birc2))	Fig. 4. Both cIAP1 and 2 are recruited to TNF-R1 upon TNFa treatment and are required for Rip1 polyubiquitination.	SEN:10031434	18697935
BEL:20063334	p(MGI:Tnf) increases complex(p(MGI:Tnfrsf1a),p(MGI:Birc3))	Fig. 4. Both cIAP1 and 2 are recruited to TNF-R1 upon TNFa treatment and are required for Rip1 polyubiquitination.	SEN:10031434	18697935
BEL:20063356	p(MGI:Tnf) increases kin(p(MGI:Mapk14))	TNF-alpha represses the promoter activity of the 250-bp region, and the repression is mediated by p38 MAP kinase independent of NF-kappaB	SEN:10006264	9607817
BEL:20063360	p(MGI:Tnf) increases kin(p(MGI:Mapk3))	the recruitment of c-Jun was strongly enhanced following TNF-a treatment (Fig. 10B, lanes 3 and 4). In contrast, the binding of c-Jun to the fra-1 promoter was significantly diminished in MEFS lacking the erk1-/- signaling (cf lanes 7 and 8 with lanes 3 and 4).	SEN:10021978	17082637
BEL:20063362	p(MGI:Tnf) increases kin(p(MGI:Mapk3))	TNF-a strongly stimulated FRA-1 promoter activity in WT MEFs as compared with the erk1-/- MEFs (Fig. 9B).	SEN:10021974	17082637
BEL:20063366	p(MGI:Tnf) increases kin(p(MGI:Mapk8))	Whereas UV treatment led to robust JNK activation in both WT and TNFR1-/- cells, TNF activates JNK only in WT and not in TNFR1-/- cells.	SEN:10018248	16680093
BEL:20063368	p(MGI:Tnf) increases kin(p(MGI:Rock1))	Western blotting of whole-cell lysates prepared from untreated or TNFalpha/CHX-treated NIH 3T3 cells showed no detectable cleavage of ROCK II (Fig. 2a) but significant cleavage of ROCK I, as well as cleavage of the well characterized caspase substrate poly-ADP ribose polymerase (PARP) after treatment with TNFalpha ( Fig. 2b).	SEN:10031428	11283606
BEL:20063406	p(MGI:Tnf) increases p(MGI:Ccl3)	Treatment of bleomycin-challenged mice with soluble TNF receptor (sTNFr) or anti-IL-6 antibodies significantly decreased MIP-1alpha protein expression in the lungs.	SEN:10002564	9766634
BEL:20063414	p(MGI:Tnf) increases p(MGI:Creb1,pmod(P,S,133))	whereas exposure of neutrophils to LPS or TNF-a resulted in increased levels of the transcriptionally active serine 133-phosphorylated form of CREB	SEN:10015930	14656721
BEL:20063416	p(MGI:Tnf) increases p(MGI:Csf2)	anti–TNF-alpha treatment significantly decreased epithelial GM-CSF expression in LPS-treated cocultures, both on mRNA and protein level	SEN:10031468	19590023
BEL:20063422	p(MGI:Tnf) increases p(MGI:Ctsk)	overexpression of TNF produced an increase in neutrophils, parenchymal B cell nodules, MMP-12, cathepsin K, and emphysema in the absence of smoke (176).	SEN:10031472	18223159
BEL:20063430	p(MGI:Tnf) increases p(MGI:Erbb4,pmod(P))	In YAMC cells, TNF induced ErbB4 messenger RNA, protein, and phosphorylation; nuclear factor kappaB activation also stimulated ErbB4 accumulation.	SEN:10031476	18973758
BEL:20063432	p(MGI:Tnf) increases p(MGI:Icam1)	TNF-a induction of epithelial ICAM-1 was blocked in mice rendered deficient in IL-12 production by disruption of the IL-12 p35 gene (Fig. 1, B and C).	SEN:10027902	11157054
BEL:20063434	p(MGI:Tnf) increases p(MGI:Icam1)	TNF-a was still capable of stimulating ICAM-1 expression on capillary endothelium consistent with TNF-a responsiveness of isolated endothelial cells (4, 5).	SEN:10031478	11157054
BEL:20063436	p(MGI:Tnf) increases p(MGI:Icam1)	treatment with both IFN-g and TNF-a resulted in equivalent ICAM-1 induction by immunostaining (Fig. 1, B and C)	SEN:10027684	11157054
BEL:20063438	p(MGI:Tnf) increases p(MGI:Ifng)	TNF-a–driven induction of IL-12 release proceeded as expected in the IFN-g–deficient mouse, whereas induction of IFN-g was blocked in the IL- 12 p35–deficient mouse (Fig. 2).	SEN:10027904	11157054
BEL:20063442	p(MGI:Tnf) decreases p(MGI:Il10)	Intranasal administration of TNF- induced a significant increase in the total cell and neutrophil numbers in BALs, which was partially but significantly inhibited by a 30 mg/kg RP 73-401 pretreatment (Table 3). TNF- induced a decrease in BALF IL-10, which was restored by RP 73-401 pretreatment (30 mg/kg) (Fig. 6, top).	SEN:10016438	11907182
BEL:20063444	p(MGI:Tnf) increases p(MGI:Il12b)	However, when we submitted tracheal and lung tissue from TNF-a–treated mice to immunohistochemistry, we found that airway epithelial cells were the predominant site of induction of IL-12 p40 expression (Fig. 3).	SEN:10031482	11157054
BEL:20063446	p(MGI:Tnf) increases p(MGI:Il12b)	it appears that induction of IL-12, at least as assessed in BAL fluid, is induced to a level that overcomes any antagonistic action of endogenous IL-12 p40 (Fig. 2).	SEN:10027906	11157054
BEL:20063464	p(MGI:Tnf) increases p(MGI:Mapk1,pmod(P,T,183))	As shown in Fig. 9A, TNF-a strongly stimulated both ERK1 and ERK2 phosphorylation in WT cells (cf lanes 1 and 2).	SEN:10031490	17082637
BEL:20063466	p(MGI:Tnf) increases p(MGI:Mapk1,pmod(P,Y,187))	As shown in Fig. 9A, TNF-a strongly stimulated both ERK1 and ERK2 phosphorylation in WT cells (cf lanes 1 and 2).	SEN:10031490	17082637
BEL:20063468	p(MGI:Tnf) increases p(MGI:Mapk3,pmod(P,T,203))	As shown in Fig. 9A, TNF-a strongly stimulated both ERK1 and ERK2 phosphorylation in WT cells (cf lanes 1 and 2).	SEN:10031490	17082637
BEL:20063470	p(MGI:Tnf) increases p(MGI:Mapk3,pmod(P,Y,205))	As shown in Fig. 9A, TNF-a strongly stimulated both ERK1 and ERK2 phosphorylation in WT cells (cf lanes 1 and 2).	SEN:10031490	17082637
BEL:20063472	p(MGI:Tnf) increases p(MGI:Mmp12)	overexpression of TNF produced an increase in neutrophils, parenchymal B cell nodules, MMP-12, cathepsin K, and emphysema in the absence of smoke (176).	SEN:10031472	18223159
BEL:20063474	p(MGI:Tnf) increases p(MGI:Mmp13)	The capacity of TNF to induce MMP expression in chondrocytes was not altered by the deficiency of c-fos, since MMP-3, MMP-9, and MMP-13 were similarly induced in hTNFtg and c-fos-/-hTNFtg mice (Table 3).	SEN:10031492	12438440
BEL:20063476	p(MGI:Tnf) increases p(MGI:Mmp14)	The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9	SEN:10031494	11773040
BEL:20063478	p(MGI:Tnf) increases p(MGI:Mmp3)	The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9	SEN:10031494	11773040
BEL:20063480	p(MGI:Tnf) increases p(MGI:Mmp3)	The capacity of TNF to induce MMP expression in chondrocytes was not altered by the deficiency of c-fos, since MMP-3, MMP-9, and MMP-13 were similarly induced in hTNFtg and c-fos-/-hTNFtg mice (Table 3).	SEN:10031492	12438440
BEL:20063482	p(MGI:Tnf) increases p(MGI:Mmp9)	The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9	SEN:10031494	11773040
BEL:20063484	p(MGI:Tnf) increases p(MGI:Mmp9)	The capacity of TNF to induce MMP expression in chondrocytes was not altered by the deficiency of c-fos, since MMP-3, MMP-9, and MMP-13 were similarly induced in hTNFtg and c-fos-/-hTNFtg mice (Table 3).	SEN:10031492	12438440
BEL:20063486	p(MGI:Tnf) increases p(MGI:Mmp9)	Whereas TNF-? and other cytokines up-regulate MMP-9 expression, interferons (IFNs) inhibit MMP-9 expression. We found that IFN-? treatment or forced expression of the IFN-induced GTPase, mGBP-2, inhibit TNF-?-induced MMP-9 expression in NIH 3T3 fibroblasts, by inhibiting MMP-9 transcription. The NF-?B transcription factor is required for full induction of MMP-9 by TNF-?.	SEN:10031496	21502320
BEL:20063490	p(MGI:Tnf) increases p(MGI:Nfkb2)	Whereas TNF treatment (24 hours) markedly increased cytoplasmic p100 and RelB levels without inducing nuclear translocation, combined TNFR-1/LTbR stimulation resulted in p100 degradation and significantly increased nuclear accumulation of p52 and RelB compared to LTbR signaling alone	SEN:10020800	20139367
BEL:20063492	p(MGI:Tnf) increases p(MGI:Nos2)	A significant dose-dependent increase in the inducible nitric oxide synthase (NOS2) expression and NO production were observed by various concentrations of TNF-alpha (1, 5, and 10 ng/mL) and LPS (1 and 5 microg/mL) which was completely inhibited by a NOS2 inhibitor, L-N6-(1-iminoethyl) lysine (L-NIL) (1 mM).	SEN:10003472	17588258
BEL:20063498	p(MGI:Tnf) decreases p(MGI:Pde3b)	Treatment of 3T3-L1 adipocytes with 10 ng/ml TNF-alpha for 24 h produced a maximal (50%) decrease in PDE3B activity, protein and mRNA, which was well correlated with both activation of protein kinase A (PKA) and stimulation of lipolysis, presumably reflecting an increase in intracellular cAMP concentration.	SEN:10031430	10677351
BEL:20063502	p(MGI:Tnf) increases p(MGI:Rela,pmod(A,K,310))	Genetic complementation of RelA/p65-/- cells with wild type and non-acetylatable mutants of RelA/p65 (K314R and K315R) revealed that neither shuttling, DNA binding nor the induction of anti-apoptotic genes by tumor necrosis factor alpha was affected by acetylation on these residues.	SEN:10031502	18263619
BEL:20063504	p(MGI:Tnf) increases p(MGI:Rela,pmod(A,K,314))	Genetic complementation of RelA/p65-/- cells with wild type and non-acetylatable mutants of RelA/p65 (K314R and K315R) revealed that neither shuttling, DNA binding nor the induction of anti-apoptotic genes by tumor necrosis factor alpha was affected by acetylation on these residues.	SEN:10031502	18263619
BEL:20063506	p(MGI:Tnf) increases p(MGI:Rela,pmod(A,K,315))	Genetic complementation of RelA/p65-/- cells with wild type and non-acetylatable mutants of RelA/p65 (K314R and K315R) revealed that neither shuttling, DNA binding nor the induction of anti-apoptotic genes by tumor necrosis factor alpha was affected by acetylation on these residues.	SEN:10031502	18263619
BEL:20063512	p(MGI:Tnf) increases p(MGI:Relb)	Whereas TNF treatment (24 hours) markedly increased cytoplasmic p100 and RelB levels without inducing nuclear translocation, combined TNFR-1/LTbR stimulation resulted in p100 degradation and significantly increased nuclear accumulation of p52 and RelB compared to LTbR signaling alone	SEN:10020800	20139367
BEL:20063514	p(MGI:Tnf) increases p(MGI:Spp1)	TNF-alpha upregulated pro-MMP9 in AMFs isolated from wild-type (OPN(+/+)) mice, but pro-MMP9 induction was abrogated in AMFs from OPN(-/-) mice	SEN:10010468	16709900
BEL:20063520	p(MGI:Tnf) increases p(MGI:Vcam1)	Intratracheal instillation of TNF-? elicited a rapid increase in VCAM-1 expression within lung tissue	SEN:10031504	15489375
BEL:20063522	p(MGI:Tnf) increases p(MGI:Vcam1)	Levels of VCAM-1 in STAT-6-deficient MLF were somewhat reduced compared with those observed in wt MLF, however, the ability of mOSM or mTNF-{alpha} to induce VCAM-1 was maintained (Fig. 7B).	SEN:10029770	16547273
BEL:20063524	p(MGI:Tnf) increases p(MGI:Vcam1)	TNF- stimulated the monocyte adhesion (Fig. 11C), which was associated with VCAM-1 expression (Fig. 11B).	SEN:10031462	18981156
BEL:20063526	p(MGI:Tnf) increases p(MGI:Zfp36)	Expression of the immediate early protein tristetraprolin (TTP) is induced by numerous stimuli, including tumor necrosis factor-alpha (TNFalpha).	SEN:10010472	12082611
BEL:20063528	p(MGI:Tnf) decreases r(EGID:387223)	Stimulation with tumor necrosis factor (TNF) but not interleukin-1 led to a strong decrease in miR-29b expression (Fig. 5D).	SEN:10031506	20890893
BEL:20063534	p(MGI:Tnf) increases r(MGI:Bdkrb1)	Further, kinin B1 receptor upregulation in this inflammatory model is partially dependent on TNF-alpha, a recognized target for IBD pharmacotherapy.	SEN:10010474	18536746
BEL:20063536	p(MGI:Tnf) increases r(MGI:Ccl1)	Expression levels of chemokines such as CCL1 (TCA-3), CCL2 (MCP-1), and CCL6 (C10) have been shown to be dependent on hemopoietically derived TNF-alpha production (40).	SEN:10031508	15294957
BEL:20063538	p(MGI:Tnf) increases r(MGI:Ccl2)	Expression levels of chemokines such as CCL1 (TCA-3), CCL2 (MCP-1), and CCL6 (C10) have been shown to be dependent on hemopoietically derived TNF-alpha production (40).	SEN:10031508	15294957
BEL:20063540	p(MGI:Tnf) increases r(MGI:Ccl2)	LPC markedly increased mRNA levels of VCAM-1 (2.7-fold) and MCP-1 (3.7-fold) in WT-EC 24 hours after addition of LPC, whereas, interestingly, this effect was blocked by pretreatment with anti-TNFalpha antibody (1 ug/mL in final concentration) or p21Cip1 small interfering RNA (siRNA)	SEN:10025928	21372295
BEL:20063542	p(MGI:Tnf) increases r(MGI:Ccl6)	Expression levels of chemokines such as CCL1 (TCA-3), CCL2 (MCP-1), and CCL6 (C10) have been shown to be dependent on hemopoietically derived TNF-alpha production (40).	SEN:10031508	15294957
BEL:20063548	p(MGI:Tnf) increases r(MGI:Cdkn1a)	siRNA-mediated knockdown of p21Cip1 (75% reduction in the p21Cip1 protein level compared with control RNA-treated group, Figure 4D) markedly inhibited TNFalpha-mediated (Figure 4E) and LPC-mediated (data not shown) VCAM-1 and MCP-1 mRNA expression in WT-EC but did not affect the LPC-mediated increase in TNFalpha mRNA and protein levels (Figure 4A). In fact, TNFalpha induced the expression of p21Cip1 in WT-EC	SEN:10031514	21372295
BEL:20063554	p(MGI:Tnf) increases r(MGI:Clec4e)	Mincle mRNA expression was strongly induced in response to several inflammatory stimuli, such as LPS, TNF-alpha, IL-6, and IFN-gamma in wild-type macrophages.	SEN:10009080	10528209
BEL:20063558	p(MGI:Tnf) increases r(MGI:Csf2)	anti–TNF-alpha treatment significantly decreased epithelial GM-CSF expression in LPS-treated cocultures, both on mRNA and protein level	SEN:10031468	19590023
BEL:20063564	p(MGI:Tnf) increases r(MGI:Dcn)	In addition to FOXc2 and MKP-1, TNF has previously been reported to increase the expression of WNT10A and decorin (DCN) while repressing aquaporin.	SEN:10031522	15051727
BEL:20063566	p(MGI:Tnf) increases r(MGI:Dusp1)	In addition to FOXc2 and MKP-1, TNF has previously been reported to increase the expression of WNT10A and decorin (DCN) while repressing aquaporin.	SEN:10031522	15051727
BEL:20063572	p(MGI:Tnf) increases r(MGI:Erbb4)	In YAMC cells, TNF induced ErbB4 messenger RNA, protein, and phosphorylation; nuclear factor kappaB activation also stimulated ErbB4 accumulation.	SEN:10031476	18973758
BEL:20063574	p(MGI:Tnf) increases r(MGI:Foxc2)	In addition to FOXc2 and MKP-1, TNF has previously been reported to increase the expression of WNT10A and decorin (DCN) while repressing aquaporin.	SEN:10031522	15051727
BEL:20063576	p(MGI:Tnf) decreases r(MGI:Gnaq)	TNF-alpha-induced desensitization of endothelin-1-stimulated GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes is due, at least in part, to a decreased expression of Galphaq/11,	SEN:10031424	12773307
BEL:20063602	p(MGI:Tnf) decreases r(MGI:Lox)	Further analyses revealed that the mRNA expression for lysyl oxidase, the determining enzyme required for collagen cross-linking, is down-regulated by TNF-alpha in a concentration- and time-dependent manner by up to 50%.	SEN:10031530	15138266
BEL:20063606	p(MGI:Tnf) increases r(MGI:Mmp13)	the wild-type MEFs responded to the induction of MMP-13 by TNF, whereas the heterozygotes did not.	SEN:10030812	11297530
BEL:20063616	p(MGI:Tnf) increases r(MGI:Nr4a1)	We further demonstrate that inflammatory signals that antagonize differentiation, such as TNFalpha and lipopolysaccharide, acutely induce Nur77 expression both in vitro and in vivo.	SEN:10010434	18945812
BEL:20063620	p(MGI:Tnf) decreases r(MGI:Pde3b)	Treatment of 3T3-L1 adipocytes with 10 ng/ml TNF-alpha for 24 h produced a maximal (50%) decrease in PDE3B activity, protein and mRNA, which was well correlated with both activation of protein kinase A (PKA) and stimulation of lipolysis, presumably reflecting an increase in intracellular cAMP concentration.	SEN:10031430	10677351
BEL:20063624	p(MGI:Tnf) decreases r(MGI:Pparg)	it has been shown that high glucose stimulates macrophage tumor necrosis factor a secretion and that this cytokine, in turn, exerts a suppressive effect on Pparg mRNA expression.	SEN:10031536	10634806
BEL:20063626	p(MGI:Tnf) decreases r(MGI:Pparg)	genes that are positively regulated by PPARgamma, such as adipocyte lipid-binding protein 2 (aP2) or lipoprotein lipase-(LPL). PPARgamma mRNA levels were also downregulated by tumor necrosis factor alpha (TNFalpha)	SEN:10031538	11172472
BEL:20063632	p(MGI:Tnf) decreases r(MGI:Pparg)	We observed that certain cytokine and growth factors [such as TNF alpha, basic fibroblast growth factor, transforming growth factor beta, and protein kinase C-activating agents plus calcium ionophore], when added to differentiated adipocytes, cause rapid down-regulation of PPARgamma mRNA expression	SEN:10008716	9202217
BEL:20063638	p(MGI:Tnf) increases r(MGI:Psmc2)	The genes expression of 19S regulator's subunits Psmc2, Psmc5, Psmd1, and Psmd2 were examined by the use of reverse-transcription polymerase chain reaction... TNF-alpha and burn can markedly increased the activities and contents of 26S proteasome and 19S regulator in mice skeletal muscle. In addition, the expression levels of the 19S regulator's subunits also were remarkably increased.	SEN:10010488	16566573
BEL:20063640	p(MGI:Tnf) increases r(MGI:Psmc5)	The genes expression of 19S regulator's subunits Psmc2, Psmc5, Psmd1, and Psmd2 were examined by the use of reverse-transcription polymerase chain reaction... TNF-alpha and burn can markedly increased the activities and contents of 26S proteasome and 19S regulator in mice skeletal muscle. In addition, the expression levels of the 19S regulator's subunits also were remarkably increased.	SEN:10010488	16566573
BEL:20063642	p(MGI:Tnf) increases r(MGI:Psmd1)	The genes expression of 19S regulator's subunits Psmc2, Psmc5, Psmd1, and Psmd2 were examined by the use of reverse-transcription polymerase chain reaction... TNF-alpha and burn can markedly increased the activities and contents of 26S proteasome and 19S regulator in mice skeletal muscle. In addition, the expression levels of the 19S regulator's subunits also were remarkably increased.	SEN:10010488	16566573
BEL:20063644	p(MGI:Tnf) increases r(MGI:Psmd2)	The genes expression of 19S regulator's subunits Psmc2, Psmc5, Psmd1, and Psmd2 were examined by the use of reverse-transcription polymerase chain reaction... TNF-alpha and burn can markedly increased the activities and contents of 26S proteasome and 19S regulator in mice skeletal muscle. In addition, the expression levels of the 19S regulator's subunits also were remarkably increased.	SEN:10010488	16566573
BEL:20063650	p(MGI:Tnf) decreases r(MGI:Rxrb)	a part of the H2-Ke4 genomic region (1.9-kb), as well as the 250-bp promoter, was transcriptionally active as an Rxrb promoter; TNF)-alpha significantly repressed the %activity of the 250-bp promoter	SEN:10031544	9607817
BEL:20063656	p(MGI:Tnf) increases r(MGI:Serpine1)	Both LPS and TNF-? increased total PAI-1 levels in RAW264.7 supernatants, and this up-regulation in PAI-1 levels was decreased in a dose-dependent manner by SP600125 pretreatment	SEN:10031548	16148154
BEL:20063664	p(MGI:Tnf) decreases r(MGI:Slc39a7)	a part of the H2-Ke4 genomic region (1.9-kb), as well as the 250-bp promoter, was transcriptionally active as an Rxrb promoter; TNF)-alpha significantly repressed the %activity of the 250-bp promoter	SEN:10031544	9607817
BEL:20063672	p(MGI:Tnf) increases r(MGI:Syvn1)	Real-time RT-PCR revealed that IL-1beta induced SYN expression at the transcriptional level, because the mRNA level of SYN was upregulated by IL-1?. TNF-? had a weaker effect on SYN transcription, whereas IL-6 had no effect	SEN:10028156	17105652
BEL:20063676	p(MGI:Tnf) increases r(MGI:Timp1)	TNFalpha, but not IGF-I, induced tissue inhibitor of metalloproteinase-1 (TIMP-1) expression and reduced matrix metalloproteinases-2 activity and collagen degradation. TNFalpha also activated ERK1/2.	SEN:10010448	16141211
BEL:20063680	p(MGI:Tnf) increases r(MGI:Tlr2)	Using RT-PCR, the enhanced TLR2 and TLR4 mRNA expression was shown to be completely dependent on the action of IFN-gamma and TNF-alpha.	SEN:10009092	11801667
BEL:20063688	p(MGI:Tnf) increases r(MGI:Ucp2)	fatty acid beta-oxidation and uncoupling protein (UCP)-2 expression decreased after treatment with VSL#3 or anti-TNF antibodies.	SEN:10010436	12540784
BEL:20063690	p(MGI:Tnf) increases r(MGI:Vcam1)	LPC markedly increased mRNA levels of VCAM-1 (2.7-fold) and MCP-1 (3.7-fold) in WT-EC 24 hours after addition of LPC, whereas, interestingly, this effect was blocked by pretreatment with anti-TNFalpha antibody (1 ug/mL in final concentration) or p21Cip1 small interfering RNA (siRNA)	SEN:10025928	21372295
BEL:20063692	p(MGI:Tnf) increases r(MGI:Wnt10a)	In addition to FOXc2 and MKP-1, TNF has previously been reported to increase the expression of WNT10A and decorin (DCN) while repressing aquaporin.	SEN:10031522	15051727
BEL:20063696	p(MGI:Tnfrsf10b) decreases path(MESHD:Fibrosis)	Lack of Trailr also increased bronchopneumonia and fibrosis in lung, indicating that Trailr suppresses chronic inflammation	SEN:10031560	18079962
BEL:20063714	p(MGI:Tnfrsf1a) increases bp(GOBP:"apoptotic process")	As shown in supplementary Fig 1 online, both TNFR1- and RIP-null MEFs are more resistant than WT MEF cells to ER stress-induced apoptosis.	SEN:10030408	16680093
BEL:20063716	p(MGI:Tnfrsf1a) increases kin(p(MGI:Mapk8))	As shown in Fig 2E, JNK activation by Tg was reconstituted when Flag–TNFR1 was presented in TNFR1-/- cells.	SEN:10031574	16680093
BEL:20063726	p(MGI:Tnfrsf1a) increases p(MGI:Xbp1)	We also examined Bip/GRP78 expression and XBP1 protein in TNFR1-/- cells after Tg treatment. Bip/GRP78 messenger RNA level and the level of the spliced form of XBP1 protein are decreased in TNFR1-/- cells (supplementary Fig 2 online).	SEN:10031566	16680093
BEL:20063730	p(MGI:Tnfrsf1a) increases r(MGI:Hspa5)	We also examined Bip/GRP78 expression and XBP1 protein in TNFR1-/- cells after Tg treatment. Bip/GRP78 messenger RNA level and the level of the spliced form of XBP1 protein are decreased in TNFR1-/- cells (supplementary Fig 2 online).	SEN:10031566	16680093
BEL:20063732	p(MGI:Tnfrsf1a) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	Early TNFR-1–induced and delayed LTbR-induced nuclear translocation of RelA and RelB, respectively, was confirmed by immunofluorescence staining of SMC (Figure I).	SEN:10031578	20139367
BEL:20063760	p(MGI:Tnf) increases sec(p(MGI:Il1b))	Elevated levels of human TNF-alpha were accompanied by increases in synovial cell expression of murine IL-1beta and IL-6	SEN:10010502	9300710
BEL:20063762	p(MGI:Tnf) increases sec(p(MGI:Il6))	Elevated levels of human TNF-alpha were accompanied by increases in synovial cell expression of murine IL-1beta and IL-6	SEN:10010502	9300710
BEL:20063766	p(MGI:Tnf) increases sec(p(MGI:Mif))	Since macrophages activated by lipopolysaccharide, tumor necrosis factor (TNF)-?, and interferon-? have been shown to secret substantial amounts of preformed MIF [17], it is reasonable to assume that macrophage-derived MIF could be involved in atherogenesis.	SEN:10016024	18385967
BEL:20063768	p(MGI:Tnf) increases sec(p(MGI:Mmp14))	The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9	SEN:10031494	11773040
BEL:20063772	p(MGI:Tnf) increases sec(p(MGI:Tgfb1))	TNF-a also elicited enhanced MMP-9 activity (Fig. 6, middle) and TGF-b release (Fig. 6, bottom) in BALFs.	SEN:10031426	11907182
BEL:20063774	p(MGI:Tnf) increases sec(p(MGI:Ucn))	In addition, the secretion of Ucn I from HL-1 cardiomyocytes was stimulated by LPS and TNF-alpha.	SEN:10016036	19318426
BEL:20063788	p(MGI:Tnfsf11) increases bp(GOBP:"osteoclast differentiation")	Infection of mouse primary bone marrow cells with retroviruses expressing JDP2-facilitated sRANKL-mediated formation of TRAP-positive multinuclear osteoclasts. Importantly, antisense oligonucleotide to JDP2 strongly suppressed sRANKL-induced osteoclast formation of RAW264.7 cells.	SEN:10028614	12707301
BEL:20063792	p(MGI:Tnfsf11) increases complex(p(MGI:Sqstm1),p(MGI:Traf6))	In addition, RANK-L stimulation leads to the inducible formation of a ternary complex involving TRAF6, p62, and the aPKCs. These observations demonstrate that p62 is an important mediator during osteoclastogenesis and induced bone remodeling.	SEN:10010506	14960283
BEL:20063808	p(MGI:Tnfsf11) increases r(MGI:Sqstm1)	Here we show that p62, like TRAF6, is upregulated during RANK-L-induced osteoclastogenesis and that the genetic inactivation of p62 in mice leads to impaired osteoclastogenesis in vitro and in vivo, as well as inhibition of IKK activation and NF-kappa B nuclear translocation.	SEN:10019624	14960283
BEL:20063832	p(MGI:Tnfsf15) directlyIncreases cat(p(MGI:Tnfrsf25))	We show that the expression of a tumor necrosis factor receptor family member, death receptor 3 (DR3; also known as TNFRSF25), is selectively elevated in Th17 cells, and that TL1A, its cognate ligand, can promote the proliferation of effector Th17 cells.	SEN:10031610	18411337
BEL:20063842	p(MGI:Tnf) increases tloc(p(MGI:Rela),GOCCID:0005737,GOCCID:0005634)	TNF strongly induced nuclear translocation of RelA within 30 minutes, as shown by Western blotting of nuclear extracts (Figure 1B, left).	SEN:10031614	20139367
BEL:20063872	p(MGI:Tnf) increases tscript(p(MGI:Rela))	Electrophoretic mobility shift assay supershift analysis confirmed TNF-induced RelA but not RelB NF-bB binding within 30 minutes (Figure 1C, left). In contrast, a-LTbR induced both RelA and RelB complexes, although with slower kinetics (Figure 1C, right).	SEN:10028954	20139367
BEL:20063874	p(MGI:Tnf) decreases tscript(p(MGI:Trp53))	we analyzed p53 promoter activity by reporter assay system. Contrary to enhanced binding activity, the transcriptional activity was attenuated in a TNFalpha concentration-dependent manner	SEN:10031628	12165799
BEL:20063910	p(MGI:Tnxb) increases r(MGI:Col1a1)	It was found that the mRNA expression levels of type I collagen and collagen fibril-associated molecules other than decorin were decreased and that the expression level of decorin was increased in TNX-null fibroblasts.	SEN:10010532	15194424
BEL:20063912	p(MGI:Tnxb) increases r(MGI:Col1a2)	It was found that the mRNA expression levels of type I collagen and collagen fibril-associated molecules other than decorin were decreased and that the expression level of decorin was increased in TNX-null fibroblasts.	SEN:10010532	15194424
BEL:20063914	p(MGI:Tnxb) increases r(MGI:Col6a2)	Differential display analysis of wild-type and TNX-null fibroblasts revealed that mRNA expression level of type VI collagen alpha3 is predominantly decreased in TNX-null fibroblasts. Expression levels of mRNAs of other subunits of type VI collagen, alpha2 and alpha3 chains, were also remarkably decreased in TNX-null fibroblasts.	SEN:10010534	15194424
BEL:20063916	p(MGI:Tnxb) increases r(MGI:Col6a3)	Differential display analysis of wild-type and TNX-null fibroblasts revealed that mRNA expression level of type VI collagen alpha3 is predominantly decreased in TNX-null fibroblasts. Expression levels of mRNAs of other subunits of type VI collagen, alpha2 and alpha3 chains, were also remarkably decreased in TNX-null fibroblasts.	SEN:10010534	15194424
BEL:20063918	p(MGI:Tnxb) decreases r(MGI:Dcn)	It was found that the mRNA expression levels of type I collagen and collagen fibril-associated molecules other than decorin were decreased and that the expression level of decorin was increased in TNX-null fibroblasts.	SEN:10010532	15194424
BEL:20063922	p(MGI:Tollip) directlyDecreases cat(p(MGI:Tlr4))	Tollip has been shown to associate directly with TLR-4 and inhibit TLR-4-mediated activation of NF- kB luciferase reporter vectors in a mouse macrophage cell line (RAW-264.7).	SEN:10031640	19842832
BEL:20063936	p(MGI:Tpo) increases bp(GOBP:"megakaryocyte differentiation")	TPO is necessary for megakaryocyte maturation in that TPO deficient mice display greatly reduced megakaryocyte production as well as reduced numbers of mature megakaryocytes	SEN:10031646	17127443
BEL:20063938	p(MGI:Tpo) increases tscript(p(MGI:Stat1))	In most cell types, STAT1 is primarily triggered by interferon signaling (21). However, TPO signaling phosphorylates STAT1 in WT megakaryocytes (10).	SEN:10031648	18060035
BEL:20063940	p(MGI:Tppp2) increases p(MGI:Kcnj8)	In electrophoretic mobility-shift assays, FoxO1 binds to the FoxO concensus site of the KATP channel subunit KIR6.1 promoter. In primary atrial culture, targeting FoxO1 and FoxO3 with siRNA specifically reduces mRNA expression of FoxO1 and -O3 and KIR6.1.	SEN:10008774	18202312
BEL:20063942	p(MGI:Traf1) decreases bp(GOBP:"apoptotic process")	bC enhanced the CS-induced downregulation of several anti-apoptotic genes. This applies in particular to Traf1.	SEN:10016614	17707332
BEL:20063964	p(MGI:Traf2) increases kin(p(MGI:Map3k5))	Consistent with our previous findings that TRAF2 and TRAF6 activate ASK1, H(2)O(2)-induced ASK1 activation and cell death were strongly reduced in the cells derived from Traf2-/- and Traf6-/- mice.	SEN:10031662	16129676
BEL:20063978	p(MGI:Traf3) increases kin(p(MGI:Prkcd))	TRAF3-/- B cells showed vastly prolonged survival ex vivo, markedly increased constitutive activation of NF-?B2 and decreased PKC? nuclear translocation independent of BAFF.	SEN:10031672	17723217
BEL:20063980	p(MGI:Traf3) decreases p(MGI:Cr2)	Additional in vivo evidence for the elevated constitutive NF-?B2 activity in TRAF3-/- B cells may be the enhanced expression of CD21 and CD23 on splenic and LN B cells in B-TRAF3-/- mice,	SEN:10031674	17723217
BEL:20063982	p(MGI:Traf3) decreases p(MGI:Fcer2a)	Additional in vivo evidence for the elevated constitutive NF-?B2 activity in TRAF3-/- B cells may be the enhanced expression of CD21 and CD23 on splenic and LN B cells in B-TRAF3-/- mice,	SEN:10031674	17723217
BEL:20063984	p(MGI:Traf3) decreases tscript(p(MGI:Nfkb2))	TRAF3-/- B cells showed vastly prolonged survival ex vivo, markedly increased constitutive activation of NF-?B2 and decreased PKC? nuclear translocation independent of BAFF.	SEN:10031672	17723217
BEL:20063996	p(MGI:Traf6) increases kin(p(MGI:Map3k5))	Consistent with our previous findings that TRAF2 and TRAF6 activate ASK1, H(2)O(2)-induced ASK1 activation and cell death were strongly reduced in the cells derived from Traf2-/- and Traf6-/- mice.	SEN:10031662	16129676
BEL:20064000	p(MGI:Trap1) increases cat(p(MGI:Tgfbr1))	While TRAP1 has only a small stimulatory effect on TGF-beta signaling in functional assays, deletion constructs of TRAP1 inhibit TGF-beta signaling and diminish the interaction of Smad4 with Smad2.	SEN:10010538	11278302
BEL:20064002	p(MGI:Trap1) increases cat(p(MGI:Tgfbr2))	While TRAP1 has only a small stimulatory effect on TGF-beta signaling in functional assays, deletion constructs of TRAP1 inhibit TGF-beta signaling and diminish the interaction of Smad4 with Smad2.	SEN:10010538	11278302
BEL:20064004	p(MGI:Trib3) decreases kin(p(MGI:Akt1))	upregulation of TRB3 through direct transcriptional control by Ppara...TRB3 is an inhibitor of Akt?protein kinase B	SEN:10031676	16511610
BEL:20064006	p(MGI:Trib3) decreases kin(p(MGI:Akt1))	MLKB1KO mice had increased insulin-stimulated Akt phosphorylation and a 80% decrease in muscle expression of TRB3, a recently identified Akt inhibitor	SEN:10022204	16966378
BEL:20064026	p(MGI:Trp53) decreases bp(GOBP:"cell cycle")	An increase in the level of the tumor suppressor protein p53 can induce cell cycle arrest or cell death	SEN:10031686	10747965
BEL:20064028	p(MGI:Trp53) decreases bp(GOBP:"cell cycle")	In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis.	SEN:10004158	12192050
BEL:20064030	p(MGI:Trp53) increases bp(GOBP:"cell death")	An increase in the level of the tumor suppressor protein p53 can induce cell cycle arrest or cell death	SEN:10031686	10747965
BEL:20064032	p(MGI:Trp53) decreases bp(GOBP:"cell proliferation")	As shown in a number of in vivo studies using atherosclerosis-prone mice, a deficiency in p53, one of the main factors involved in senescence signaling (Fig 1), accelerates atherosclerosis development, possibly by increasing macrophage proliferation in atherosclerotic lesions.86-88	SEN:10031688	18155543
BEL:20064042	p(MGI:Trp53) increases bp(GOBP:"replicative cell aging")	Here we show that conditional deletion of Pot1a elicits a DNA damage response at telomeres, resulting in p53-dependent replicative senescence.	SEN:10030010	16839876
BEL:20064050	p(MGI:Trp53) increases bp(GOBP:"apoptotic process")	Significantly, inhibition of p53-mediated transcriptional repression with TSA markedly inhibits apoptosis induction by p53.	SEN:10003630	10521394
BEL:20064052	p(MGI:Trp53) increases bp(GOBP:"apoptotic process")	In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis.	SEN:10004158	12192050
BEL:20064056	p(MGI:Trp53) increases bp(GOBP:"apoptotic process")	The reduced level of p53 protein in myr-Akt1 salivary glands corresponds with an increase in MDM2 phosphorylation in vivo, suggesting that the Akt/MDM2/p53 pathway is responsible for suppression of apoptosis. Dominant-negative Akt blocked phosphorylation of MDM2 in salivary acinar cells from myr-Akt1 transgenic mice.	SEN:10021532	16982679
BEL:20064060	p(MGI:Trp53) increases path(MESHD:"Insulin Resistance")	upregulation of p53 in adipose tissue caused an inflammatory response that led to insulin resistance.	SEN:10010544	19718037
BEL:20064064	p(MGI:Trp53inp1) increases bp(GOBP:"apoptotic process")	The SIP gene is alternatively spliced, generating two proteins (SIP'8 and SIP27). Both proteins, located mainly in the nucleus, promote cell death when overexpressed in vitro.	SEN:10010546	12067065
BEL:20064066	p(MGI:Trp53) decreases path(MESHD:Atherosclerosis)	As shown in a number of in vivo studies using atherosclerosis-prone mice, a deficiency in p53, one of the main factors involved in senescence signaling (Fig 1), accelerates atherosclerosis development, possibly by increasing macrophage proliferation in atherosclerotic lesions.86-88	SEN:10031688	18155543
BEL:20064082	p(MGI:Trp53) increases p(MGI:Bcl2l1)	in p53-null MEFs, only Bcl-X(L) expression was suppressed, and Bcl-X(L) overexpression blocked apoptosis (Maclean et al., 2003).	SEN:10031702	18955973
BEL:20064108	p(MGI:Trp63) increases bp(GOBP:"cell aging")	Whereas gain of TAp63 induces senescence, loss of p63 enhances sarcoma development in mice lacking p53.	SEN:10031710	19898465
BEL:20064110	p(MGI:Trp63) increases p(MGI:Hes1)	reduction of the expression of all the p63 isoforms using pan siRNA for p63 (39, 45, 46) decreased the expression of both Jagged1 and Hes1 in WT MEFs, MEFs without Tsc1 or Tsc2, and WT MEFs expressing myrAKT1 (Figure 6B).	SEN:10031712	20038814
BEL:20064112	p(MGI:Trp63) increases p(MGI:Jag1)	reduction of the expression of all the p63 isoforms using pan siRNA for p63 (39, 45, 46) decreased the expression of both Jagged1 and Hes1 in WT MEFs, MEFs without Tsc1 or Tsc2, and WT MEFs expressing myrAKT1 (Figure 6B).	SEN:10031712	20038814
BEL:20064124	p(MGI:Trpv1) increases r(MGI:Ddit3)	Gadd153 induction (~2.5-fold) was also observed in C57BL/6 lungs following LPS treatment, which was attenuated in Trpv1-/- mouse lungs	SEN:10031714	21949157
BEL:20064128	p(MGI:Tsc1) decreases bp(GOBP:"response to endoplasmic reticulum stress")	These cells also exhibit a marked increase in PERK phosphorylation compared to a littermate-derived wild-type (WT) control cell line (Figure 1A, triplicates shown), indicating the presence of ER stress.	SEN:10031718	18342602
BEL:20064136	p(MGI:Tsc1) decreases kin(p(MGI:Eif2ak3))	These cells also exhibit a marked increase in PERK phosphorylation compared to a littermate-derived wild-type (WT) control cell line (Figure 1A, triplicates shown), indicating the presence of ER stress.	SEN:10031718	18342602
BEL:20064138	p(MGI:Tsc1) decreases kin(p(MGI:Rps6kb1))	Whereas treatment of wild type MEFs with insulin induced a marked increase in S6K1 activity, the basal activity of S6K1 isolated from Tsc1- and Tsc2-null MEFs was high and was not increased further by insulin (Fig. 1B).	SEN:10015826	14993219
BEL:20064142	p(MGI:Tsc1) decreases p(MGI:Rps6kb1,pmod(P,T,412))	Importantly, whereas phosphorylation of Thr- 389 (RPS6KB1 P@T412) in Tsc1- and Tsc2-null MEFs was inhibited by rapamycin, phosphorylation of this site was strongly resistant to inhibition by wortmannin.	SEN:10031726	14993219
BEL:20064144	p(MGI:Tsc1) decreases p(MGI:Rps6kb1,pmod(P,T,412))	As shown in Figure 1A, Tsc1-/- mouse embryonic fibroblasts (MEFs) exhibited constitutive mTORC1 activity, as indicated by robust rapamycinsensitive S6K1 (Thr389) and ribosomal protein S6 (Ser235/236) phosphorylation under basal, unstimulated conditions.	SEN:10031722	18342602
BEL:20064146	p(MGI:Tsc1) decreases p(MGI:Rps6,pmod(P,S,235))	As shown in Figure 1A, Tsc1-/- mouse embryonic fibroblasts (MEFs) exhibited constitutive mTORC1 activity, as indicated by robust rapamycinsensitive S6K1 (Thr389) and ribosomal protein S6 (Ser235/236) phosphorylation under basal, unstimulated conditions.	SEN:10031722	18342602
BEL:20064148	p(MGI:Tsc1) decreases p(MGI:Rps6,pmod(P,S,236))	As shown in Figure 1A, Tsc1-/- mouse embryonic fibroblasts (MEFs) exhibited constitutive mTORC1 activity, as indicated by robust rapamycinsensitive S6K1 (Thr389) and ribosomal protein S6 (Ser235/236) phosphorylation under basal, unstimulated conditions.	SEN:10031722	18342602
BEL:20064150	p(MGI:Tsc22d3) decreases bp(GOBP:"inflammatory response")	GILZ appears to play a key role in the anti-inflammatory and immunosuppressive effects of glucocorticoids and IL-10	SEN:10010554	12393603
BEL:20064152	p(MGI:Tsc22d3) decreases bp(GOBP:"macrophage activation")	GILZ appears to play a key role in the anti-inflammatory and immunosuppressive effects of glucocorticoids and IL-10	SEN:10010554	12393603
BEL:20064162	p(MGI:Tsc2) decreases kin(p(MGI:Eif2ak3))	Similar to the TSC1 deficiency, Tsc2-/- cells also exhibited increased PERK phosphorylation and XBP-1 splicing as well as increased GRP78 and CHOP expression compared to WT controls (see Figures S1A and S1B available online).	SEN:10031730	18342602
BEL:20064168	p(MGI:Tsc2) decreases kin(p(MGI:Rps6kb1))	Whereas treatment of wild type MEFs with insulin induced a marked increase in S6K1 activity, the basal activity of S6K1 isolated from Tsc1- and Tsc2-null MEFs was high and was not increased further by insulin (Fig. 1B).	SEN:10015826	14993219
BEL:20064176	p(MGI:Tsc2) decreases p(MGI:Hes1)	The upregulation of Hes1 by mTOR was also observed in vivo, as mouse kidney tumors with hyperactive mTOR due to Tsc2 exon 3 deletion (35) exhibited enhanced Hes1 expression (Figure 2B).	SEN:10031738	20038814
BEL:20064178	p(MGI:Tsc2) decreases p(MGI:Hes1)	We first investigated whether hyperactive mTOR could cause abnormal Notch signaling by monitoring the levels of Hes1, a direct target of Notch. We found that Hes1 protein expression was dramatically elevated in cells with constitutively active mTOR caused by loss of the Tsc2 or Pten tumor suppressor gene or oncogenic myristoylation of AKT1 (myrAKT1) (34) (Figure 2A).	SEN:10021528	20038814
BEL:20064184	p(MGI:Tsc2) decreases p(MGI:Nfkbia,pmod(P,S,32))	Because the enhanced NF-kB signaling in Tsc2-/- MEFs was abolished by rapamycin treatment, NF-kB signaling appeared to be downstream of mTORC1 (Figure 10A).	SEN:10017424	20038814
BEL:20064186	p(MGI:Tsc2) decreases p(MGI:Rela,pmod(P,S,536))	Because the enhanced NF-kB signaling in Tsc2-/- MEFs was abolished by rapamycin treatment, NF-kB signaling appeared to be downstream of mTORC1 (Figure 10A).	SEN:10017424	20038814
BEL:20064188	p(MGI:Tsc2) decreases p(MGI:Rps6kb1,pmod(P,T,412))	Importantly, whereas phosphorylation of Thr- 389 (RPS6KB1 P@T412) in Tsc1- and Tsc2-null MEFs was inhibited by rapamycin, phosphorylation of this site was strongly resistant to inhibition by wortmannin.	SEN:10031726	14993219
BEL:20064192	p(MGI:Tsc2) decreases p(MGI:Trp63)	Both TA-p63 and deltaN-p63 were overexpressed in cells with mTOR activation because of either a lack of Tsc2 or Pten or expression of AKT1-E17K, and were repressed by rapamycin	SEN:10021534	20038814
BEL:20064194	p(MGI:Tsc2) decreases p(MGI:Xbp1)	Similar to the TSC1 deficiency, Tsc2-/- cells also exhibited increased PERK phosphorylation and XBP-1 splicing as well as increased GRP78 and CHOP expression compared to WT controls (see Figures S1A and S1B available online).	SEN:10031730	18342602
BEL:20064196	p(MGI:Tsc2) decreases r(MGI:Ddit3)	Similar to the TSC1 deficiency, Tsc2-/- cells also exhibited increased PERK phosphorylation and XBP-1 splicing as well as increased GRP78 and CHOP expression compared to WT controls (see Figures S1A and S1B available online).	SEN:10031730	18342602
BEL:20064198	p(MGI:Tsc2) decreases r(MGI:Hes1)	Promoter reporter assays and quantitative real-time PCR analysis showed increased Hes1 promoter activity and transcript levels, indicating that the upregulation of Hes1 expression likely occurs at the transcriptional level in an mTOR-dependent manner (Figure 2C).	SEN:10031742	20038814
BEL:20064200	p(MGI:Tsc2) decreases r(MGI:Hspa5)	Similar to the TSC1 deficiency, Tsc2-/- cells also exhibited increased PERK phosphorylation and XBP-1 splicing as well as increased GRP78 and CHOP expression compared to WT controls (see Figures S1A and S1B available online).	SEN:10031730	18342602
BEL:20064202	p(MGI:Tsc2) decreases r(MGI:Jag1)	upregulation of Jagged1 by mTOR was due, at least in part, to higher levels of Jagged1 mRNA in the Tsc2-null and mutant AKT-expressing cell lines (Figure 3B) and appeared to be directly responsible for Notch activation and Hes1 expression, as these were blocked by decreased Jagged1 expression using siRNA (Figure 3C).	SEN:10021538	20038814
BEL:20064218	p(MGI:Tspo) decreases r(MGI:Nrf1)	Morpholino-based gene knockdown of Nrf1 (anti-NRF1) produced a sequence-specific decrease in 16S rRNA insensitive to PK11195. These functional relationships suggest that peripheral benzodiazepine receptor (Bzrp) Bzrp-dependent signals regulate the Nrf1 -- Tfam1 -- mtDNA -- 16S rRNA pathway in response to oxygen levels.	SEN:10031752	12849846
BEL:20064220	p(MGI:Tssk6) increases bp(GOBP:"cell motility")	Targeted deletion of the SSTK gene in mice resulted in male sterility due to profound impairment in motility and morphology of spermatozoa. A defect in DNA condensation in SSTK null mutants occurred in elongating spermatids at a step in spermiogenesis coincident with chromatin displacement of histones by transition proteins.	SEN:10010560	15870294
BEL:20064238	p(MGI:Twist1) decreases bp(GOBP:"skeletal muscle tissue development")	These findings demonstrate that M-Twist interacts with MyoD through the basic domains, thereby inhibiting MyoD.	SEN:10031764	9343420
BEL:20064244	p(MGI:Twist1) decreases r(MGI:Ifng)	Expression of twist1 in Th1 lymphocytes limited the expression of the cytokines interferon-gamma, IL-2, and tumor necrosis factor-alpha, and ameliorated Th1-mediated immunopathology in delayed-type hypersensitivity and antigen-induced arthritis.	SEN:10010566	18663125
BEL:20064246	p(MGI:Twist1) decreases r(MGI:Il2)	Expression of twist1 in Th1 lymphocytes limited the expression of the cytokines interferon-gamma, IL-2, and tumor necrosis factor-alpha, and ameliorated Th1-mediated immunopathology in delayed-type hypersensitivity and antigen-induced arthritis.	SEN:10010566	18663125
BEL:20064256	p(MGI:Twist1) decreases r(MGI:Tnf)	Expression of twist1 in Th1 lymphocytes limited the expression of the cytokines interferon-gamma, IL-2, and tumor necrosis factor-alpha, and ameliorated Th1-mediated immunopathology in delayed-type hypersensitivity and antigen-induced arthritis.	SEN:10010566	18663125
BEL:20064260	p(MGI:Twist1) directlyDecreases tscript(p(MGI:Myod1))	Ectopically expressed mouse Twist (Mtwist) was shown to inhibit myogenesis by blocking DNA binding by MyoD, by titrating E proteins, and by inhibiting trans-activation by MEF2	SEN:10031770	8633239
BEL:20064262	p(MGI:Twist1) directlyDecreases tscript(p(MGI:Myod1))	These findings demonstrate that M-Twist interacts with MyoD through the basic domains, thereby inhibiting MyoD.	SEN:10031764	9343420
BEL:20064270	p(MGI:Twist2) decreases tscript(p(MGI:Myod1))	Both the N- and C-terminal domains of Dermo-1, but not the bHLH domain, were required for the inhibition of MEF2, suggesting that Dermo-1 inhibits both MyoD- and MEF2-dependent transactivation but through different mechanisms.	SEN:10031772	11809751
BEL:20064274	p(MGI:Twsg1) decreases cat(p(EGID:109899))	Osteocalcin (OCN) mRNA levels decrease following both Tsg and Chd treatment. Tsg and Chd also inhibit alkaline phosphatase (ALP) activity in a dose-dependent manner	SEN:10026036	15780974
BEL:20064282	p(MGI:Twsg1) decreases r(MGI:Bglap2)	Osteocalcin (OCN) mRNA levels decrease following both Tsg and Chd treatment. Tsg and Chd also inhibit alkaline phosphatase (ALP) activity in a dose-dependent manner	SEN:10026036	15780974
BEL:20064292	p(MGI:Txn1) increases r(MGI:Hif1a)	The redox regulator thioredoxin-1 also exerts a positive effect on HIF-1a expression. Thioredoxin inhibitors block HIF-1a expression and xenograft growth.	SEN:10016362	13130303
BEL:20064294	p(MGI:Txndc5) increases p(HGNC:INS)	Most importantly, siRNA-mediated knockdown of ERp46 in cultured beta-cells led to a significant decrease in the insulin content; however, no alterations in insulin mRNA levels were observed under these conditions.	SEN:10010574	19622788
BEL:20064296	p(MGI:Txndc5) decreases p(MGI:Ddit3)	In addition, reduced expression of ERp46 by siRNA increased the expression of CHOP and peIF2a, indicating development of ER stress.	SEN:10010576	19622788
BEL:20064302	p(MGI:Tyk2) decreases r(MGI:Crat)	Table 2 Comparison of expression ratios between microarray and RT-qPCR, lipid and mixed annotated genes ## WT vs Tyk2-/- peritoneal macrophages ##	SEN:10031778	20338026
BEL:20064304	p(MGI:Tyk2) decreases r(MGI:Fasn)	Table 2 Comparison of expression ratios between microarray and RT-qPCR, lipid and mixed annotated genes ## WT vs Tyk2-/- peritoneal macrophages ##	SEN:10031778	20338026
BEL:20064312	p(MGI:Tyk2) decreases r(MGI:Zbp1)	Table 2 Comparison of expression ratios between microarray and RT-qPCR, lipid and mixed annotated genes ## WT vs Tyk2-/- peritoneal macrophages ##	SEN:10031778	20338026
BEL:20064318	p(MGI:Tyrobp) decreases r(MGI:Cd274)	from full text - Reduction of DAP12 mRNA in both liver and splenic DC resulted in significantly increased expression of CD80 and CD86 as well as of the coregulatory molecules B7-H1 (programmed death ligand-1) and B7- H2 (programmed death ligand-2) relative to DC transfected with ctl siRNA (Fig. 2B, 2C)	SEN:10031782	21257958
BEL:20064320	p(MGI:Tyrobp) decreases r(MGI:Cd80)	from full text - Reduction of DAP12 mRNA in both liver and splenic DC resulted in significantly increased expression of CD80 and CD86 as well as of the coregulatory molecules B7-H1 (programmed death ligand-1) and B7- H2 (programmed death ligand-2) relative to DC transfected with ctl siRNA (Fig. 2B, 2C)	SEN:10031782	21257958
BEL:20064322	p(MGI:Tyrobp) decreases r(MGI:Cd86)	from full text - Reduction of DAP12 mRNA in both liver and splenic DC resulted in significantly increased expression of CD80 and CD86 as well as of the coregulatory molecules B7-H1 (programmed death ligand-1) and B7- H2 (programmed death ligand-2) relative to DC transfected with ctl siRNA (Fig. 2B, 2C)	SEN:10031782	21257958
BEL:20064324	p(MGI:Tyrobp) increases r(MGI:Cdh1)	We also present evidence that DAP12 is a general macrophage fusion regulator and is involved in modulating the expression of several macrophage-associated genes, including those encoding known mediators of macrophage fusion, such as DC-STAMP and Cadherin 1.	SEN:10010580	18957693
BEL:20064326	p(MGI:Tyrobp) increases r(MGI:Dcstamp)	We also present evidence that DAP12 is a general macrophage fusion regulator and is involved in modulating the expression of several macrophage-associated genes, including those encoding known mediators of macrophage fusion, such as DC-STAMP and Cadherin 1.	SEN:10010580	18957693
BEL:20064328	p(MGI:Tyrobp) decreases r(MGI:Icosl)	from full text - Reduction of DAP12 mRNA in both liver and splenic DC resulted in significantly increased expression of CD80 and CD86 as well as of the coregulatory molecules B7-H1 (programmed death ligand-1) and B7- H2 (programmed death ligand-2) relative to DC transfected with ctl siRNA (Fig. 2B, 2C)	SEN:10031782	21257958
BEL:20064330	p(MGI:Tyrobp) increases r(MGI:Irak3)	from full text - FIGURE 7. DAP12 silencing diminishes IRAK-M expression in liver but not splenic DC	SEN:10031784	21257958
BEL:20064332	p(MGI:Uaca) increases bp(GOBP:"cell death")	We show here that Nucling was up-regulated by proapoptotic stimuli and important for the induction of apoptosis after cytotoxic stress. We further demonstrated that overexpressed Nucling was able to induce apoptosis.	SEN:10031786	15271982
BEL:20064334	p(MGI:Uaca) increases cat(p(MGI:Casp9))	This is also the case in the translocation of caspase-9 or Apaf-1 to the nucleus (17, 29). Here we propose that Nucling may be a key molecule for the retention of the caspase-9/Apaf-1 complex, its translocation to the nucleus, and its activation.	SEN:10031788	15271982
BEL:20064340	p(MGI:Uaca) increases p(MGI:Apaf1)	Nucling induced translocation of Apaf-1 to the nucleus, thereby distributing the Nucling/Apaf-1/pro-caspase-9 complex to the nuclear fraction. These findings suggest that Nucling recruits and transports the apoptosome complex during stress-induced apoptosis.	SEN:10010582	15271982
BEL:20064354	p(MGI:Ucp2) decreases a(CHEBI:"nitric oxide")	We found that levels of nitric oxide measured in either plasma or isolated macrophages from Ucp2-/- mice are significantly elevated in response to bacterial lipopolysaccharide challenge compared with similarly treated Ucp2+/+ mice.	SEN:10031794	15757894
BEL:20064358	p(MGI:Ucp2) decreases a(CHEBI:"reactive oxygen species")	One of the phenotypes of mice with targeted disruption of the uncoupling protein-2 gene (Ucp2-/-) is greater macrophage phagocytic activity and free radical production, resulting in a striking resistance to infectious microorganisms.	SEN:10010588	15757894
BEL:20064364	p(MGI:Ucp2) decreases bp(GOBP:"macrophage activation")	One of the phenotypes of mice with targeted disruption of the uncoupling protein-2 gene (Ucp2-/-) is greater macrophage phagocytic activity and free radical production, resulting in a striking resistance to infectious microorganisms.	SEN:10010588	15757894
BEL:20064366	p(MGI:Ucp2) decreases path(MESHD:Obesity)	B6.Cg-Ay carrying the UCP2/UCP3 transgene from Line 32 were significantly leaner than nontransgenic B6.Cg-Ay mice... Moderate overexpression of UCP2 and 3 reduced fat mass and increased LDL cholesterol in two independent lines of transgenic mice.	SEN:10031798	12664076
BEL:20064370	p(MGI:Ucp2) increases path(MESHD:Infection)	One of the phenotypes of mice with targeted disruption of the uncoupling protein-2 gene (Ucp2-/-) is greater macrophage phagocytic activity and free radical production, resulting in a striking resistance to infectious microorganisms.	SEN:10010588	15757894
BEL:20064374	p(MGI:Ucp2) decreases p(MGI:Nos2)	Protein levels of iNOS and {beta}-actin were measured by Western blotting. (increased Nos2 expression)	SEN:10031802	15757894
BEL:20064378	p(MGI:Ucp2) decreases r(MGI:Ifng)	nduction of inflammatory cytokines by LPS is increased in Ucp2-/- mice. A, Northern blotting. Spleen total RNA was isolated from mice treated with 4 µg/g bw LPS or PBS. RNA for IFNg, IL1b, TNF and IL6 were elevated in Ucp2-/- mice in response to LPS.	SEN:10031804	15757894
BEL:20064380	p(MGI:Ucp2) decreases r(MGI:Il1b)	nduction of inflammatory cytokines by LPS is increased in Ucp2-/- mice. A, Northern blotting. Spleen total RNA was isolated from mice treated with 4 µg/g bw LPS or PBS. RNA for IFNg, IL1b, TNF and IL6 were elevated in Ucp2-/- mice in response to LPS.	SEN:10031804	15757894
BEL:20064382	p(MGI:Ucp2) decreases r(MGI:Il6)	nduction of inflammatory cytokines by LPS is increased in Ucp2-/- mice. A, Northern blotting. Spleen total RNA was isolated from mice treated with 4 µg/g bw LPS or PBS. RNA for IFNg, IL1b, TNF and IL6 were elevated in Ucp2-/- mice in response to LPS.	SEN:10031804	15757894
BEL:20064384	p(MGI:Ucp2) decreases r(MGI:Tnf)	nduction of inflammatory cytokines by LPS is increased in Ucp2-/- mice. A, Northern blotting. Spleen total RNA was isolated from mice treated with 4 µg/g bw LPS or PBS. RNA for IFNg, IL1b, TNF and IL6 were elevated in Ucp2-/- mice in response to LPS.	SEN:10031804	15757894
BEL:20064390	p(MGI:Ucp3) decreases path(MESHD:Obesity)	B6.Cg-Ay carrying the UCP2/UCP3 transgene from Line 32 were significantly leaner than nontransgenic B6.Cg-Ay mice... Moderate overexpression of UCP2 and 3 reduced fat mass and increased LDL cholesterol in two independent lines of transgenic mice.	SEN:10031798	12664076
BEL:20064396	p(MGI:Uhrf1) increases bp(GOBP:"DNA replication")	In NIH-3T3 cells, the expression of Np95 was tightly regulated during the cell cycle, and its functional ablation resulted in abrogation of DNA synthesis.	SEN:10031810	12058012
BEL:20064404	p(MGI:Umod) increases cat(p(MGI:Tlr4))	Bone marrow-derived macrophages from TLR4- and MyD88-deficient mice were nonresponsive to THP in contrast to those from TLR2- and TLR9-deficient mice.	SEN:10031816	15650774
BEL:20064406	p(MGI:Umod) increases cat(p(MGI:Tlr4))	We demonstrate that THP activates myeloid DCs via Toll-like receptor-4 (TLR4) to acquire a fully mature DC phenotype.	SEN:10010596	15650774
BEL:20064408	p(MGI:Ung) decreases path(MESHD:Lymphoma)	after a long latency, Ung/ and Mutyh/ mice developed B-cell lymphomas and intestinal tumors, respectively (Nilsen et al, 2003; Sakamoto et al, 2007).	SEN:10029342	18285820
BEL:20064412	p(MGI:Usf2) increases p(MGI:Pklr)	we observed a significant diminution of the L-PK and S14 gene expression 18 h after glucose refeeding, whereas in ad libitum fed mice, no difference was detected. This result, obtained in adult liver of USF2 ?/? mice, was consistent with the 64% reduction in the amount of L-PK protein	SEN:10031818	9268329
BEL:20064414	p(MGI:Usf2) increases r(MGI:Pklr)	we observed a significant diminution of the L-PK and S14 gene expression 18 h after glucose refeeding, whereas in ad libitum fed mice, no difference was detected. This result, obtained in adult liver of USF2 ?/? mice, was consistent with the 64% reduction in the amount of L-PK protein	SEN:10031818	9268329
BEL:20064416	p(MGI:Usf2) increases r(MGI:Thrsp)	we observed a significant diminution of the L-PK and S14 gene expression 18 h after glucose refeeding, whereas in ad libitum fed mice, no difference was detected. This result, obtained in adult liver of USF2 ?/? mice, was consistent with the 64% reduction in the amount of L-PK protein	SEN:10031818	9268329
BEL:20064418	p(MGI:Usp9x) directlyIncreases p(MGI:Ctnnb1)	We found that Fam interacted with beta-catenin both in vivo and in vitro. The Fam-binding site of beta-catenin mapped to the region close to the APC or Axin-binding site of beta-catenin. Over-expression of Fam in mouse L cells resulted in an elevation of beta-catenin levels and in an elongation of the half-life of beta-catenin.	SEN:10031820	10620020
BEL:20064420	p(MGI:Vav3) decreases a(CHEBI:catecholamine)	We detected two-fold higher catecholamine plasma levels in Ahr-/- mice than in wild type animals (Fig. 3A,B). These levels were, however, significantly lower than those found in the plasma of Vav3-deficient mice (Fig. 3A,B).	SEN:10024976	21115475
BEL:20064422	p(MGI:Vav3) decreases bp(GOBP:"cell adhesion")	As shown in Figure 11A, the vav3 knockdown increased the attachment efficiency of TFGM AhR+/+ in the presence of EGTA to values significantly higher than those observed in untransfected wildtype cells	SEN:10031822	19158396
BEL:20064424	p(MGI:Vav3) increases gtp(p(MGI:Rac1))	down-modulation of Vav3 protein levels by vav3 siRNAs had an effect on these GTPases, and thus RhoA activation was increased, whereas Rac1 activation was decreased in transfected T-FGM AhR+/+ cells (Figure 10C).	SEN:10031824	19158396
BEL:20064426	p(MGI:Vav3) decreases gtp(p(MGI:Rhoa))	down-modulation of Vav3 protein levels by vav3 siRNAs had an effect on these GTPases, and thus RhoA activation was increased, whereas Rac1 activation was decreased in transfected T-FGM AhR+/+ cells (Figure 10C).	SEN:10031824	19158396
BEL:20064428	p(MGI:Vav3) decreases path(MESHD:Tachycardia)	In agreement with our hypothesis, we observed that Ahr–/– animals displayed tachypnea, showing inspiratory/expiratory cycles very similar to those observed in Vav3-deficient mice (Fig. 1A,B). Likewise, as in the case of the latter mouse strain (38,40), we detected high blood pressure (Fig. 1C,E) and tachycardia (Fig. 1D,F) in Ahr–/– animals both under sentient (Fig. 1C,D) and unconscious (Fig. 1E,F) conditions.	SEN:10024996	21115475
BEL:20064436	p(MGI:Vav3) increases p(MGI:Th)	Immunohistochemical analyses of serial sections also revealed that, similar to what happens in Vav3-/- animals (40), neurons located in the RVLM of Ahr-/- mice contained higher levels of tyrosine hydroxylase than those present in the RVLM of wild type mice (Fig. 5C,D).	SEN:10025006	21115475
BEL:20064440	p(MGI:Vcam1) increases bp(GOBP:"cell adhesion")	VCAM-1 has, based on in vivo experiments with knockout mice, been singled out as being the crucial adhesion molecule in the initiation of atherosclerosis [8]	SEN:10031826	18930708
BEL:20064450	p(MGI:Vegfa) increases bp(GOBP:angiogenesis)	Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Seven days after transplantation of the A375-GFP, capillary nets became far more abundant in the tumors grown in WT mice than those in TNKO mice. Interestingly, VEGF and TN-C expressions showed antithetical expression patterns between the tumors in WT mice and those in TNKO mice.	SEN:10031380	14618612
BEL:20064464	p(MGI:Vegfa) increases gtp(p(MGI:Rhoa))	We demonstrate that vascular endothelial growth factor-A (VEGF) rapidly induces RhoA activation in endothelial cells (ECs).	SEN:10031832	20400538
BEL:20064466	p(MGI:Vegfa) directlyIncreases kin(p(MGI:Kdr))	Pharmacological intervention with a VEGFR-2-neutralizing Ab (anti-Flk1 mAb) abolished the production of IL-6 (but not IL-12p70) and the subsequent development of allergen-specific Th17 cell response.	SEN:10003016	20921519
BEL:20064468	p(MGI:Vegfa) increases path(MESHD:Hypertrophy)	Phosphorylation of Thr37,46 in 4E-BP1 is required for VEGF-induced protein synthesis and hypertrophy in MCT cells	SEN:10008594	12846742
BEL:20064480	p(MGI:Vegfa) increases r(MGI:Anxa2)	Hypoxia, desferrioxamine (hypoxia mimetic), and recombinant VEGF all increased AnxA2 mRNA and protein levels in osteoblastic cells	SEN:10010602	20817051
BEL:20064492	p(MGI:Vegfa) increases r(MGI:Flt1)	Treatment with vascular endothelial cell growth factor (VEGF) gave rise to endothelial-like cells, expressing Flt-1, Flk-1, von Willebrand Factor (vWF), CD31	SEN:10010604	16143325
BEL:20064494	p(MGI:Vegfa) increases r(MGI:Heyl)	Recombinant VEGF-A increased Hrt-3 mRNA levels while siRNA knockdown abolished rShh stimulated VEGF-A expression while concomitantly inhibiting Shh-induced increases in Hrt-3 mRNA levels, proliferating cell nuclear antigen (PCNA), and Notch 1 IC expression, respectively	SEN:10010086	19407245
BEL:20064500	p(MGI:Vegfa) increases r(MGI:Kdr)	Treatment with vascular endothelial cell growth factor (VEGF) gave rise to endothelial-like cells, expressing Flt-1, Flk-1, von Willebrand Factor (vWF), CD31	SEN:10010604	16143325
BEL:20064502	p(MGI:Vegfa) increases r(MGI:Pecam1)	Treatment with vascular endothelial cell growth factor (VEGF) gave rise to endothelial-like cells, expressing Flt-1, Flk-1, von Willebrand Factor (vWF), CD31	SEN:10010604	16143325
BEL:20064508	p(MGI:Vegfa) increases r(MGI:Vwf)	Treatment with vascular endothelial cell growth factor (VEGF) gave rise to endothelial-like cells, expressing Flt-1, Flk-1, von Willebrand Factor (vWF), CD31	SEN:10010604	16143325
BEL:20064512	p(MGI:Vegfb) increases bp(GOBP:"cell growth")	Despite appearing overtly normal, Vegfb(-/-) hearts are reduced in size and display vascular dysfunction after coronary occlusion and impaired recovery from experimentally induced myocardial ischemia.	SEN:10031840	10666423
BEL:20064514	p(MGI:Vegfb) decreases bp(GOBP:"response to hypoxia")	The hearts of these mice had fewer coronary microvessels, thinned ventricular walls, depressed basal contractile function, induction of hypoxia-responsive genes involved in energy metabolism, and an abnormal response to beta-adrenergic stimulation.	SEN:10010608	11331753
BEL:20064538	p(MGI:Vhl) decreases r(MGI:Nos2)	Rt-Pcr analysis of endothelial cell lines from normal and hypoxic EC from wt and vhl-/- and vhl-/-.hif1a-/- mice. Hypoxia treatment .5% for 8 hours.	SEN:10031852	16537898
BEL:20064540	p(MGI:Vhl) decreases r(MGI:Pgk1)	Rt-Pcr analysis of endothelial cell lines from normal and hypoxic EC from wt and vhl-/- and vhl-/-.hif1a-/- mice. Hypoxia treatment .5% for 8 hours.	SEN:10031852	16537898
BEL:20064542	p(MGI:Vhl) decreases r(MGI:Slc2a1)	Rt-Pcr analysis of endothelial cell lines from normal and hypoxic EC from wt and vhl-/- and vhl-/-.hif1a-/- mice. Hypoxia treatment .5% for 8 hours.	SEN:10031852	16537898
BEL:20064548	p(MGI:Vip) decreases bp(GOBP:"apoptotic process")	We reported previously that VIP/PACAP protect T cells from activation-induced cell death through down-regulation of Fas ligand (FasL).	SEN:10007916	11145682
BEL:20064552	p(MGI:Vip) decreases r(MGI:Fasl)	We reported previously that VIP/PACAP protect T cells from activation-induced cell death through down-regulation of Fas ligand (FasL).	SEN:10007916	11145682
BEL:20064554	p(MGI:Vwf) increases bp(GOBP:"endothelial cell activation")	mice embryos deficient in tissue factor have an impaired pattern of extraembryonic angiogenesis and VWF increases endothelial cell activation	SEN:10026812	11350732
BEL:20064584	p(MGI:Wnt1) increases kin(p(MGI:Ilk))	Wnt-1 overexpression in mammary epithelial cells induced cyclin D1 mRNA and targeted overexpression of Wnt-1 in the mammary gland of transgenic mice increased both ILK activity and cyclin D1 levels.	SEN:10007774	10915780
BEL:20064590	p(MGI:Wnt1) increases r(MGI:Ptgs2)	The inducible prostaglandin synthase cyclooxygenase-2 (COX-2) is aberrantly expressed in intestinal tumors resulting from APC mutation, and is also transcriptionally up-regulated in mouse mammary epithelial cells in response to Wnt1 expression.	SEN:10010618	11274170
BEL:20064594	p(MGI:Wnt2b) increases bp(GOBP:"Wnt receptor signaling pathway")	In recent years, other mechanisms of activation of the canonical Wnt pathway in tumours have been discovered; for example, silencing of the genes that encode the inhibitory Wnt ligands SFRPs and DKKs by hypermethylation, or by overexpression of Wnt proteins (WNT2B for example), Frizzleds (FZD10 for example) or Dishevelled142–149	SEN:10026466	18432252
BEL:20064598	p(MGI:Wnt3a) increases bp(GOBP:"cell proliferation")	The growth and proliferation induced by Wnt3a were blocked by treatments of the PI3K inhibitors. Furthermore, Wnt3a-induced proliferation was blocked by Akt siRNA. These results reveal that the PI3K-Akt pathway mediates the Wnt3a-induced growth and proliferation of NIH3T3 cells.	SEN:10010622	17011750
BEL:20064620	p(MGI:Wnt3a) increases r(EGID:12096)	Col1a1, osteopontin (OP; Spp1 - Mouse Genome Informatics) and OC were all significantly induced within 48 hours of Wnt3a stimulation	SEN:10031876	15576404
BEL:20064622	p(MGI:Wnt3a) increases r(MGI:Ccnd1)	Moreover, co-immunoprecipitation assays using Wnt3a-conditioned medium reveals that while Wnt stimulation leads to the dissociation of beta-catenin from axin and casein kinase Ialpha (CKIalpha), Wnt treatment promotes an increase in CCND1 level and the association of beta-catenin with CCND1-CDK6.	SEN:10031870	17208333
BEL:20064624	p(MGI:Wnt3a) increases r(MGI:Col1a1)	Col1a1, osteopontin (OP; Spp1 - Mouse Genome Informatics) and OC were all significantly induced within 48 hours of Wnt3a stimulation	SEN:10031876	15576404
BEL:20064626	p(MGI:Wnt3a) increases r(MGI:Spp1)	Col1a1, osteopontin (OP; Spp1 - Mouse Genome Informatics) and OC were all significantly induced within 48 hours of Wnt3a stimulation	SEN:10031876	15576404
BEL:20064640	p(MGI:Wnt5a) directlyIncreases kin(p(MGI:Ror2))	Interestingly, Wnt5a and Ror2 activate the non-canonical Wnt pathway, as assessed by activation of JNK in cultured cells a	SEN:10031882	12839624
BEL:20064646	p(MGI:Wnt5a) increases p(MGI:Sox9)	Sox9 protein levels were decreased in both Wnt5a–/– and Col2a1- Wnt5a mice, and no alteration was observed in Col2a1-Wnt5b mice when compared with the wild-type littermate (Fig. 8A).	SEN:10031884	12538525
BEL:20064648	p(MGI:Wnt5a) decreases p(MGI:Sox9)	Sox9 protein levels were decreased in both Wnt5a–/– and Col2a1- Wnt5a mice, and no alteration was observed in Col2a1-Wnt5b mice when compared with the wild-type littermate (Fig. 8A).	SEN:10031884	12538525
BEL:20064650	p(MGI:Wnt5a) decreases r(MGI:Ccnd1)	when Wnt5a was overexpressed in chondrocytes, cyclin D1 expression was suppressed, but p130 expression remained high (Fig. 7B,C),	SEN:10031886	12538525
BEL:20064652	p(MGI:Wnt5a) increases r(MGI:Col10a1)	This was confirmed by our observation that the expression of Pthrpr and Cbfa1 in the prehypertrophic chondrocytes was reduced and delayed and the expression of Col10a1, a hypertrophic chondrocyte marker, was absent in the Wnt5a–/– limb from 12.5 dpc to 15.5 dpc (Fig. 2B,C).	SEN:10031888	12538525
BEL:20064654	p(MGI:Wnt5a) decreases r(MGI:Col10a1)	Wnt5a was expressed in non-hypertrophic chondrocytes under the control of rat Col2a1 promoter and enhancer (Nakata et al., 1993). At 14.5 dpc, Col10a1 expression domain was either reduced (Col2a1-Wnt5a number 17) or absent (Col2a1-Wnt5a number 25).	SEN:10031890	12538525
BEL:20064656	p(MGI:Wnt5a) decreases r(MGI:Col2a1)	Col2a1 expression was increased in the cartilage of the Wnt5a–/– and Col2a1-Wnt5b mice, but decreased in the Col2a1-Wnt5a mice (Fig. 8B).	SEN:10031892	12538525
BEL:20064658	p(MGI:Wnt5a) increases r(MGI:Ihh)	At 11.5 dpc, Ihh expression was detected in the future humerus, radius and ulna in the wild-type embryo. In the Wnt5a mutant, Ihh expression was only weakly detected in the humerus and absent in the radius and ulna (Fig. 2A),	SEN:10031894	12538525
BEL:20064660	p(MGI:Wnt5a) increases r(MGI:Pthlh)	This was confirmed by our observation that the expression of Pthrpr and Cbfa1 in the prehypertrophic chondrocytes was reduced and delayed and the expression of Col10a1, a hypertrophic chondrocyte marker, was absent in the Wnt5a–/– limb from 12.5 dpc to 15.5 dpc (Fig. 2B,C).	SEN:10031888	12538525
BEL:20064662	p(MGI:Wnt5a) increases r(MGI:Rbl2)	p130 expression was decreased in chondrocytes undergoing hypertrophy in the Wnt5a mutant (Fig. 7A).	SEN:10031896	12538525
BEL:20064664	p(MGI:Wnt5a) increases r(MGI:Runx2)	Cbfa1 expression was significantly reduced in both chondrocytes and perichondrium in the Wnt5a mutants (Fig. 2B,C).	SEN:10031898	12538525
BEL:20064666	p(MGI:Wnt5a) increases r(MGI:Runx2)	This was confirmed by our observation that the expression of Pthrpr and Cbfa1 in the prehypertrophic chondrocytes was reduced and delayed and the expression of Col10a1, a hypertrophic chondrocyte marker, was absent in the Wnt5a–/– limb from 12.5 dpc to 15.5 dpc (Fig. 2B,C).	SEN:10031888	12538525
BEL:20064668	p(MGI:Wnt5a) increases r(MGI:Sox9)	We found that the expression of Sox9, the earliest marker for mesenchymal condensation, was not detected in the distalmost limb mesenchyme in the Wnt5a mutant.	SEN:10031900	12538525
BEL:20064670	p(MGI:Wnt5a) decreases tscript(p(MGI:Col2a1))	luciferase assay of the Col2a1 reporter was performed in mouse primary chondrocytes (Fig. 8C). Col2a1-luciferase activity was suppressed by Wnt5a but increased by Wnt5b in a dosedependent manner.	SEN:10031902	12538525
BEL:20064674	p(MGI:Wnt5b) increases r(MGI:Ccnd1)	when Wnt5b was overexpressed, cyclin D1 expression was upregulated in all undifferentiated chondrocytes	SEN:10031906	12538525
BEL:20064678	p(MGI:Wnt5b) increases r(MGI:Col2a1)	Col2a1 expression was increased in the cartilage of the Wnt5a–/– and Col2a1-Wnt5b mice, but decreased in the Col2a1-Wnt5a mice (Fig. 8B).	SEN:10031892	12538525
BEL:20064682	p(MGI:Wnt5b) decreases r(MGI:Ihh)	To test whether Wnt5b plays a similar role as Wnt5a in regulating chondrocyte proliferation and differentiation, Col2a1-Wnt5b transgenic mice were generated. When the long bone phenotype of Col2a1-Wnt5b was further analyzed, we found that expression of both Ihh and ColX was undetectable at 15.5 dpc (Fig. 6C)	SEN:10031910	12538525
BEL:20064692	p(MGI:Wnt5b) increases tscript(p(MGI:Col2a1))	luciferase assay of the Col2a1 reporter was performed in mouse primary chondrocytes (Fig. 8C). Col2a1-luciferase activity was suppressed by Wnt5a but increased by Wnt5b in a dosedependent manner.	SEN:10031902	12538525
BEL:20064702	p(MGI:Wrn) decreases a(CHEBI:"reactive oxygen species")	Wrn Delta hel/Delta hel mutant mouse embryonic fibroblasts exhibit increased oxidative stress. This was reflected by increased intracellular reactive oxygen species (ROS), increased oxidative damage in genomic DNA, changes in ATP/ADP ratios, and a disruption of the inner mitochondrial transmembrane potential when compared to wild type mouse embryonic fibroblasts.	SEN:10031916	20175907
BEL:20064704	p(MGI:Wrn) decreases bp(GOBP:"cellular response to DNA damage stimulus")	Wrn Delta hel/Delta hel mutant mouse embryonic fibroblasts exhibit increased oxidative stress. This was reflected by increased intracellular reactive oxygen species (ROS), increased oxidative damage in genomic DNA, changes in ATP/ADP ratios, and a disruption of the inner mitochondrial transmembrane potential when compared to wild type mouse embryonic fibroblasts.	SEN:10031916	20175907
BEL:20064706	p(MGI:Wrn) decreases bp(GOBP:"response to oxidative stress")	Wrn Delta hel/Delta hel mutant mouse embryonic fibroblasts exhibit increased oxidative stress. This was reflected by increased intracellular reactive oxygen species (ROS), increased oxidative damage in genomic DNA, changes in ATP/ADP ratios, and a disruption of the inner mitochondrial transmembrane potential when compared to wild type mouse embryonic fibroblasts.	SEN:10031916	20175907
BEL:20064718	p(MGI:Xbp1) decreases bp(GOBP:autophagy)	Mice lacking XBP1 in neurons exhibit increased levels of baseline autophagy, which leads to increased turnover of an autophagic substrate, mutant superoxide dismutase-1 (SOD1), and protection against mutant SOD1-induced amyotrophic lateral sclerosis (Hetz et al., 2009).	SEN:10031920	20965422
BEL:20064722	p(MGI:Xbp1) decreases bp(GOBP:"inflammatory response")	We report that Xbp1 deletion in intestinal epithelial cells (IECs) results in spontaneous enteritis	SEN:10010634	18775308
BEL:20064724	p(MGI:Xbp1) decreases bp(GOBP:"response to endoplasmic reticulum stress")	Elevated basal grp78 levels in XBP1-/- small intestinal epithelia indicated increased ER stress (Fig. 1B) that was confirmed by microarray analysis showing both increased grp78 (Haspa5) and Chop (Ddit3) (P=0.02) (Supplementary Table 1 and Supplementary Fig. 2A).	SEN:10031924	18775308
BEL:20064726	p(MGI:Xbp1) decreases cat(p(MGI:Ern1))	Virtually complete splicing of mutant XBP1 mRNAs in XBP1-/- small and large intestine and partial splicing in XBP1+/- small intestine was observed in contrast to barely detectable splicing in XBP1+/+ mice (Fig. 4A) indicating IRE1 hyperactivation.	SEN:10031926	18775308
BEL:20064728	p(MGI:Xbp1) decreases kin(p(MGI:Eif2ak3))	expression of XBP-1s in Tsc2-/- cells using an adenoviral expression system resulted in decreased PERK phosphorylation validating this approach to reduce ER stress and UPR signaling (Figure 5G).	SEN:10031928	18342602
BEL:20064730	p(MGI:Xbp1) decreases kin(p(MGI:Mapk8))	JNK phosphorylation was increased in XBP1-/- small intestinal epithelia compared to controls consistent with the described TRAF2-dependent function of IRE1 to activate JNK (Urano et al., 2000) (Fig. 4B).	SEN:10031930	18775308
BEL:20064732	p(MGI:Xbp1) decreases kin(p(MGI:Mapk9))	JNK phosphorylation was increased in XBP1-/- small intestinal epithelia compared to controls consistent with the described TRAF2-dependent function of IRE1 to activate JNK (Urano et al., 2000) (Fig. 4B).	SEN:10031930	18775308
BEL:20064736	p(MGI:Xbp1) increases p(MGI:Akt1,pmod(P,S,473))	In contrast, upon introduction of XBP-1s, Akt phosphorylation was readily detectable in Tsc2-/- cells. There was also an increase in IRS-1 protein levels in XBP-1sexpressing cells.	SEN:10031932	18342602
BEL:20064738	p(MGI:Xbp1) increases p(MGI:Cebpa)	Indeed, C/EBPalpha protein levels were significantly decreased in differentiating XBP1-/- MEFs while C/EBPbeta levels remained largely unaffected (Figure 4A). Similar observations were obtained in 3T3-L1 adipocytes (Figure S4A).	SEN:10031934	19490910
BEL:20064742	p(MGI:Xbp1) increases p(MGI:Irs1)	In contrast, upon introduction of XBP-1s, Akt phosphorylation was readily detectable in Tsc2-/- cells. There was also an increase in IRS-1 protein levels in XBP-1sexpressing cells.	SEN:10031932	18342602
BEL:20064744	p(MGI:Xbp1) increases r(EGID:13216)	XBP1-/- intestine was completely devoid of Paneth cells (Fig. 1DE), compared to XBP1+/+ and XBP1+/- mice (Fig. 1E and Supplementary Fig. 2B). mRNA expression of cryptdins-1, -4, and -5 and lysozyme, but not cathelicidin, were substantially reduced (Fig. 1A).	SEN:10031936	18775308
BEL:20064746	p(MGI:Xbp1) increases r(EGID:13238)	XBP1-/- intestine was completely devoid of Paneth cells (Fig. 1DE), compared to XBP1+/+ and XBP1+/- mice (Fig. 1E and Supplementary Fig. 2B). mRNA expression of cryptdins-1, -4, and -5 and lysozyme, but not cathelicidin, were substantially reduced (Fig. 1A).	SEN:10031936	18775308
BEL:20064748	p(MGI:Xbp1) increases r(EGID:13239)	XBP1-/- intestine was completely devoid of Paneth cells (Fig. 1DE), compared to XBP1+/+ and XBP1+/- mice (Fig. 1E and Supplementary Fig. 2B). mRNA expression of cryptdins-1, -4, and -5 and lysozyme, but not cathelicidin, were substantially reduced (Fig. 1A).	SEN:10031936	18775308
BEL:20064750	p(MGI:Xbp1) increases r(MGI:Ccnd1)	Among the genes selectively altered in E-xbp-1s B cells are those with known relevance to human MM pathogenesis, such as Cyclin D1, Cyclin D2, MAF, and MAFB (Figure6A and data not shown)	SEN:10031938	17418411
BEL:20064752	p(MGI:Xbp1) increases r(MGI:Ccnd2)	Among the genes selectively altered in E-xbp-1s B cells are those with known relevance to human MM pathogenesis, such as Cyclin D1, Cyclin D2, MAF, and MAFB (Figure6A and data not shown)	SEN:10031938	17418411
BEL:20064754	p(MGI:Xbp1) increases r(MGI:Cebpa)	Furthermore, Cebpa mRNA levels on both d4 and d6 were significantly reduced by over 90% in 3T3-L1 XBP1i cells compared with CONi cells.	SEN:10031940	19490910
BEL:20064756	p(MGI:Xbp1) decreases r(MGI:Ddit3)	Elevated basal grp78 levels in XBP1-/- small intestinal epithelia indicated increased ER stress (Fig. 1B) that was confirmed by microarray analysis showing both increased grp78 (Haspa5) and Chop (Ddit3) (P=0.02) (Supplementary Table 1 and Supplementary Fig. 2A).	SEN:10031924	18775308
BEL:20064760	p(MGI:Xbp1) decreases r(MGI:Hspa5)	Elevated basal grp78 levels in XBP1-/- small intestinal epithelia indicated increased ER stress (Fig. 1B) that was confirmed by microarray analysis showing both increased grp78 (Haspa5) and Chop (Ddit3) (P=0.02) (Supplementary Table 1 and Supplementary Fig. 2A).	SEN:10031924	18775308
BEL:20064762	p(MGI:Xbp1) increases r(MGI:Lyz2)	XBP1-/- intestine was completely devoid of Paneth cells (Fig. 1DE), compared to XBP1+/+ and XBP1+/- mice (Fig. 1E and Supplementary Fig. 2B). mRNA expression of cryptdins-1, -4, and -5 and lysozyme, but not cathelicidin, were substantially reduced (Fig. 1A).	SEN:10031936	18775308
BEL:20064764	p(MGI:Xbp1) increases r(MGI:Maf)	Among the genes selectively altered in E-xbp-1s B cells are those with known relevance to human MM pathogenesis, such as Cyclin D1, Cyclin D2, MAF, and MAFB (Figure6A and data not shown)	SEN:10031938	17418411
BEL:20064766	p(MGI:Xbp1) increases r(MGI:Mafb)	Among the genes selectively altered in E-xbp-1s B cells are those with known relevance to human MM pathogenesis, such as Cyclin D1, Cyclin D2, MAF, and MAFB (Figure6A and data not shown)	SEN:10031938	17418411
BEL:20064768	p(MGI:Xbp1) increases r(MGI:Muc2)	We also noted reduced numbers and size of goblet cells within the small intestine but not colon with reduced secretory granules by EM and reduced mRNA for the goblet cell protein Muc2 in XBP1-/- small intestinal epithelia (Fig. 1AF and Supplementary Fig. 2C).	SEN:10031944	18775308
BEL:20064776	p(MGI:Xpo1) directlyIncreases tloc(complex(p(MGI:Mlx),p(MGI:Mlxip)),GOCCID:0005634,GOCCID:0005737)	Dimerization between MondoA and Mlx inactivates the cytoplasmic localization activity of their C termini and is necessary for the heterocomplex to accumulate in the nucleus.	SEN:10031950	12446771
BEL:20064778	p(MGI:Xrcc1) decreases bp(GOBP:"apoptotic process")	The death of mutants such as Xrcc1/, LigIII/ and Polb/ was preceded by elevated levels of apoptosis (Gu et al, 1994; Tebbs et al, 1999; Sugo et al, 2000; Puebla-Osorio et al, 2006).	SEN:10028866	18285820
BEL:20064780	p(MGI:Xrcc5) decreases bp(GOBP:"apoptotic process")	Increased apoptosis and proliferative arrest of pro-B cells in Ku80/ mice were rescued by a p53-null background (Difilippantonio et al, 2000).	SEN:10031706	18285820
BEL:20064818	p(MGI:Zbtb7b) decreases r(MGI:Col1a1)	In contrast to this result, Widom et al . ( 83 ) demonstrated that human c-Krox binds differentially to human and mouse COL1A1 gene promoters, and overexpressed human c-Krox represses the human, mouse, and rat COL1A1 promoter activity in NIH-3T3 cells.	SEN:10031966	11976400
BEL:20064822	p(MGI:Zfp36) increases bp(GOBP:"apoptotic process")	TTP, TIS11b, and TIS11d each also induce apoptosis through the mitochondrial pathway analogously to certain oncogenes, suggesting that they influence growth or survival signals.	SEN:10010644	12082611
BEL:20064824	p(MGI:Zfp36l1) increases bp(GOBP:"apoptotic process")	TTP, TIS11b, and TIS11d each also induce apoptosis through the mitochondrial pathway analogously to certain oncogenes, suggesting that they influence growth or survival signals.	SEN:10010644	12082611
BEL:20064826	p(MGI:Zfp36l2) increases bp(GOBP:"apoptotic process")	TTP, TIS11b, and TIS11d each also induce apoptosis through the mitochondrial pathway analogously to certain oncogenes, suggesting that they influence growth or survival signals.	SEN:10010644	12082611
BEL:20064832	p(MGI:Zfp36) decreases p(MGI:Tnf)	Evidence indicates that TTP limits production of TNFalpha and other cytokines by directly binding and destabilizing their mRNAs.	SEN:10031972	12082611
BEL:20064842	p(MGI:Zfp521) increases tscript(p(MGI:Ebf1))	We show that the Evi3 gene is overexpressed in several tumors with viral insertions at Evi3, which results in the upregulation of Early B-cell Factor (EBF)-target gene expression, suggesting that Evi3 modulates EBF activity.	SEN:10031978	15580294
BEL:20064844	p(MGI:Zfpm1) increases bp(GOBP:"megakaryocyte differentiation")	Several transcription factors have also been implicated in megakaryopoiesis including, GATA-1, friend of GATA-1 (FOG-1), nuclear factor-erythroid 2 (NF-E2), and Fli-1.	SEN:10003208	17127443
BEL:20064850	p(MGI:Zfpm1) increases r(MGI:Esr1)	. Importantly, the levels of several genes linked to the control of cancerous transformation in the breast (Esr1, Prg and Foxa1) are significantly reduced upon Fog2 excision	SEN:10031984	17310981
BEL:20064852	p(MGI:Zfpm1) increases r(MGI:Foxa1)	. Importantly, the levels of several genes linked to the control of cancerous transformation in the breast (Esr1, Prg and Foxa1) are significantly reduced upon Fog2 excision	SEN:10031984	17310981
BEL:20064854	p(MGI:Zfpm1) increases r(MGI:"Hba-a1")	Northern blot analysis was consistent with these results, revealing that 6–24 hr after induction, ?- and ?-globin mRNAs were induced to levels 3- to 4-fold higher in FOG- infected G1ER cells compared to control infected cells ( Figure 6C).	SEN:10031986	9230307
BEL:20064856	p(MGI:Zfpm1) increases r(MGI:"Hbb-b1")	Northern blot analysis was consistent with these results, revealing that 6–24 hr after induction, ?- and ?-globin mRNAs were induced to levels 3- to 4-fold higher in FOG- infected G1ER cells compared to control infected cells ( Figure 6C).	SEN:10031986	9230307
BEL:20064862	p(MGI:Zfpm1) increases r(MGI:Nfe2)	Figure 5. Synergistic Activation of Transcription by FOG and GATA-1 from p45 NF-E2 Regulatory Sequences	SEN:10027132	9230307
BEL:20064864	p(MGI:Zfpm1) increases r(MGI:Srgn)	. Importantly, the levels of several genes linked to the control of cancerous transformation in the breast (Esr1, Prg and Foxa1) are significantly reduced upon Fog2 excision	SEN:10031984	17310981
BEL:20065052	r(EGID:387243) decreases p(MGI:Nfat5)	Paralleling the trend of mRNA down-regulation, OREBP protein exhibited significant reduction in cells overexpressing either miR-200b or miR-717 (Figure 4C).	SEN:10032044	20852262
BEL:20065054	r(EGID:387243) decreases tscript(p(MGI:Nfat5))	overexpression of miR-200b or miR-717 resulted in significant reductions in its (OREBP) transactivation activity (Figure 4D).	SEN:10032046	20852262
BEL:20065056	r(EGID:751531) decreases p(MGI:Nfat5)	Paralleling the trend of mRNA down-regulation, OREBP protein exhibited significant reduction in cells overexpressing either miR-200b or miR-717 (Figure 4C).	SEN:10032044	20852262
BEL:20065058	r(EGID:751531) decreases tscript(p(MGI:Nfat5))	overexpression of miR-200b or miR-717 resulted in significant reductions in its (OREBP) transactivation activity (Figure 4D).	SEN:10032046	20852262
BEL:20065068	r(HGNC:PTPRC) increases p(HGNC:PTPRC)	reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKCdelta activation.	SEN:10007832	11124968
BEL:20065076	r(MGI:Cdh1) increases p(MGI:Sdc1)	In invasive NM-e-ras-MAC1 cells, where E-cadherin was partially downregulated by specific antisense RNA, syndecan-1 expression was suppressed.	SEN:10010670	8799827
BEL:20065082	r(MGI:Fbxo32) increases p(MGI:Fbxo32)	we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.	SEN:10021546	15109499
BEL:20065084	r(MGI:Il6) increases p(MGI:Il6)	results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program.	SEN:10002578	15507530
BEL:20065104	r(MGI:Mir155) decreases p(MGI:Il10)	By contrast, increased commitment to the Th2 pathway was evident in bicm2/m2 Th2 cell cultures as higher numbers of IL-4?producing cells were observed (Fig. 3A). In support of this result, enhanced levels of the Th2 cytokines IL-4, IL-5, and IL-10 were generated by bicm2/m2 cells after culture in Th2 polarizing conditions (Fig. 3C).	SEN:10032060	17463290
BEL:20065106	r(MGI:Mir155) decreases p(MGI:Il4)	By contrast, increased commitment to the Th2 pathway was evident in bicm2/m2 Th2 cell cultures as higher numbers of IL-4?producing cells were observed (Fig. 3A). In support of this result, enhanced levels of the Th2 cytokines IL-4, IL-5, and IL-10 were generated by bicm2/m2 cells after culture in Th2 polarizing conditions (Fig. 3C).	SEN:10032060	17463290
BEL:20065108	r(MGI:Mir155) decreases p(MGI:Il5)	By contrast, increased commitment to the Th2 pathway was evident in bicm2/m2 Th2 cell cultures as higher numbers of IL-4?producing cells were observed (Fig. 3A). In support of this result, enhanced levels of the Th2 cytokines IL-4, IL-5, and IL-10 were generated by bicm2/m2 cells after culture in Th2 polarizing conditions (Fig. 3C).	SEN:10032060	17463290
BEL:20065122	r(MGI:Prrx1) increases p(MGI:Prrx1)	These results appear to be relevant in vivo because Prx1 and TN-C expression levels were reduced in FAK-null embryos.	SEN:10022108	12741393
BEL:20065132	r(MGI:Src) increases p(MGI:Egfr,pmod(P,Y,920))	In mouse keratinocytes, it was however shown to result in Src kinase-mediated phosphorylation of EGF-R, presumably on Tyr920 (Calautti et al., 2005).	SEN:10032064	18268536
BEL:20065182	sec(p(MGI:Ager)) decreases p(MGI:F3)	Vascular inflammatory phenotypes such as accelerated expression of VCAM-1, tissue factor, or matrix metalloproteinases in mice are also prevented by sRAGE treatment (95).	SEN:10032104	19273137
BEL:20065184	sec(p(MGI:Ager)) decreases p(MGI:Vcam1)	Vascular inflammatory phenotypes such as accelerated expression of VCAM-1, tissue factor, or matrix metalloproteinases in mice are also prevented by sRAGE treatment (95).	SEN:10032104	19273137
BEL:20065198	sec(p(MGI:Il6ra)) decreases bp(GOBP:"neutrophil extravasation")	These data confirm that sIL-6R-mediated signaling primarily limits neutrophil influx; however, induction of CXCL5 and CXCL6 may regulate other neutrophil responses.	SEN:10032108	15100312
BEL:20065200	sec(p(MGI:Il6ra)) increases r(MGI:Cxcl5)	These data confirm that sIL-6R-mediated signaling primarily limits neutrophil influx; however, induction of CXCL5 and CXCL6 may regulate other neutrophil responses.	SEN:10032108	15100312
BEL:20065202	sec(p(MGI:Jam2)) increases bp(GOBP:"cell migration")	The endothelial expression of JAM-2 not only increased the permeability of monolayers but also promoted the migration of human leukocytes, which also express JAM-2 [118].	SEN:10032110	12545245
BEL:20065216	surf(p(MGI:Slc12a3)) directlyIncreases cat(p(MGI:Slc12a3))	Functional assessment of NCC by using thiazide-sensitive (22)Na(+) uptakes revealed that TPA completely suppresses NCC function. Biotinylation experiments demonstrated that this result was primarily because of decreased surface expression of NCC.	SEN:10032114	18077438
BEL:20065218	surf(p(MGI:Sort1)) directlyIncreases complex(p(MGI:Sort1),p(MGI:Lpl))	The results demonstrate that sortilin is a multifunctional receptor that binds lipoprotein lipase and, when expressed on the cell surface, mediates its endocytosis and degradation.	SEN:10005588	10085125
BEL:20065220	surf(p(MGI:Sort1)) increases deg(p(MGI:Lpl))	The results demonstrate that sortilin is a multifunctional receptor that binds lipoprotein lipase and, when expressed on the cell surface, mediates its endocytosis and degradation.	SEN:10005588	10085125
BEL:20065222	surf(p(MGI:Thy1)) increases cat(p(MGI:Thy1))	When c-H-ras expression was induced with heavy metal ions there was a marked reduction in the expression of two glycosylphosphatidylinositol (GPI) anchored proteins, TAP/Ly-6A.2 and Thy-1, on the plasma membrane of the transformed cells.	SEN:10020916	1679532
BEL:20065224	tloc(p(HGNC:ATF6),GOCCID:0005737,GOCCID:0005634) increases tscript(p(HGNC:ATF6))	ATF6 has been implicated in the endoplasmic reticulum (ER) stress response pathway since it can activate expression of GRP78 and other genes induced by the ER stress response. ER stress appears to activate ATF6 by cleavage from the ER membrane and translocation to the nucleus	SEN:10018104	10856300
BEL:20065230	tloc(p(HGNC:CBL,pmod(P,Y)),GOCCID:0005886,GOCCID:0045121) increases cat(p(HGNC:RHOQ))	The translocation of phosphorylated cbl recruits additional signaling proteins to the lipid raft, resulting in the activation of the G protein TC10.	SEN:10032116	11239409
BEL:20065232	tloc(p(HGNC:DAPK3),GOCCID:0005634,GOCCID:0005737) increases bp(GOBP:"apoptotic process")	Strikingly, coexpression of Dlk and Par-4 lead to relocation of Dlk from the nucleus to the cytoplasm, particularly to actin filaments. These interactions provoked a dramatic reorganization of the cytoskeleton and morphological symptoms of apoptosis, thus suggesting a functional relationship between Dlk and Par-4 in the control of apoptosis.	SEN:10005296	10602480
BEL:20065248	tloc(p(MGI:Alox5),GOCCID:0005737,GOCCID:0005634) increases cat(p(MGI:Alox5))	(WHI-P97) is a rationally designed potent inhibitor of Janus kinase (JAK)-3. Treatment of mast cells with WHI-P97 inhibited the translocation of 5-lipoxygenase (5-LO) from the nucleoplasm to the nuclear membrane and consequently 5-LO-dependent leukotriene (LT) synthesis	SEN:10021798	11082424
BEL:20065250	tloc(p(MGI:Apob),GOCCID:0005737,GOCCID:0005788) decreases deg(p(MGI:Apob))	putative pause-transfer sequences interrupted apoB translocation but not translation an alternative view of translocational pausing proposes transient difficulties posed by the secondary structure of apoB mRNA inefficient translocation, together with continued translation, could result in the escape of the nascent polypeptide from the translocon into the cytosol	SEN:10032124	12006608
BEL:20065252	tloc(p(MGI:Apob),GOCCID:0005737,GOCCID:0005788) directlyIncreases sec(p(MGI:Apob))	regulation at the level of elongation a profound decrease in apoB synthesis with no change in apoB mRNA abundance decreased synthesis could be explained by a prolonged elongation rate for apoB the elongation of apoB mRNA in HepG2 cells slows when translocation of nascent apoB across the endoplasmic reticulum is inhibited by preventing Mttp-associated transfer of lipids to the nascent polypeptide	SEN:10020186	12006608
BEL:20065256	tloc(p(MGI:Ctnnb1),GOCCID:0005737,GOCCID:0005634) increases tscript(p(MGI:Ctnnb1))	While most beta-catenin protein is localized to the cell membrane and is involved in cell-cell adhesion, accumulation of free cytoplasmic beta-catenin will translocate into the nucleus where it functions in a bipartite transcription factor complex, whose targets include invasion and metastasis promoting endopeptidases, matrix metalloproteinases (MMP).	SEN:10027112	14647429
BEL:20065260	tloc(p(MGI:Ctnnb1),GOCCID:0005737,GOCCID:0005634) directlyIncreases tscript(p(MGI:Ctnnb1))	Here we report that delivery of the human HGF gene delivery in mice led to hepatomegaly via beta-catenin activation in the liver in 1- and 4-week studies. The mechanisms of beta-catenin activation in the 1-week study included loss of c-Met-beta-catenin association as well as canonical beta-catenin activation, leading to its nuclear translocation.	SEN:10027382	17006939
BEL:20065264	tloc(p(MGI:Erf),GOCCID:0005634,GOCCID:0005737) decreases tscript(p(MGI:Erf))	We have shown previously that ERF is phosphorylated in vitro and in vivo by Erks at multiple sites. This phosphorylation determines its cytoplasmic localization and inactivation.....ERF nuclear export is dependent on extensive phosphorylation and is a CRM1-dependent process.	SEN:10026738	14729966
BEL:20065288	tloc(p(MGI:Trp53),GOCCID:0005634,GOCCID:0005737) increases deg(p(MGI:Trp53))	We showed that after 4-nitroquinoline 1-oxide-induced DNA damage, IGF-I induced exclusion of the p53 protein from the nucleus and led to its degradation in the cytoplasm, whereas p53 mRNA was unaffected.	SEN:10027800	11877395
BEL:20065312	tport(p(HGNC:XPO1)) directlyIncreases tloc(p(HGNC:HNF4A),GOCCID:0005634,GOCCID:0005737)	CBP-mediated acetylation is crucial for the proper nuclear retention of HNF-4, which is otherwise transported out to the cytoplasm via the CRM1 pathway.	SEN:10007010	10882110
BEL:20065328	tport(p(MGI:Abcg1)) decreases a(CHEBI:cholesterol)	In macrophages from WT mice, but not from GPR109A-deficient animals, nicotinic acid induced expression of the cholesterol transporter ABCG1 and promoted cholesterol efflux.	SEN:10003836	21317532
BEL:20065330	tport(p(MGI:Abcg1)) increases sec(a(CHEBI:cholesterol))	In macrophages from WT mice, but not from GPR109A-deficient animals, nicotinic acid induced expression of the cholesterol transporter ABCG1 and promoted cholesterol efflux.	SEN:10003836	21317532
BEL:20065366	tport(p(MGI:Mtch2)) increases bp(GOBP:"apoptotic process")	Our results demonstrate that Mimp is a novel mitochondrial carrier homologue upregulated by Met-HGF/SF signal transduction, which leads to mitochondrial depolarization, and suggest novel links among tyrosine kinase signaling, mitochondrial function, and cellular bioenergetics.	SEN:10010716	12407445
BEL:20065368	tport(p(MGI:Mtch2)) increases bp(GOBP:"apoptotic process")	These results implicate Mtch2 as a mitochondrial target of tBID and raise the possibility that the Mtch2-resident complex participates in the mitochondrial apoptotic program.	SEN:10004604	15899861
BEL:20065376	tport(p(MGI:Slc22a3)) decreases a(CHEBI:dopamine)	Two uptake systems that control the extracellular concentrations of released monoamine neurotransmitters such as noradrenaline and adrenaline have been described. The gene encoding the uptake-2 transporter has recently been identified in humans (EMT), rats (OCT3), and mice (Orct3/Slc22a3).	SEN:10032146	11390648
BEL:20065378	tport(p(MGI:Slc22a3)) decreases a(CHEBI:serotonin)	Two uptake systems that control the extracellular concentrations of released monoamine neurotransmitters such as noradrenaline and adrenaline have been described. The gene encoding the uptake-2 transporter has recently been identified in humans (EMT), rats (OCT3), and mice (Orct3/Slc22a3).	SEN:10032146	11390648
BEL:20065394	tport(p(MGI:Slc6a6)) increases bp(GOBP:"response to osmotic stress")	The present observations point to a decreased sensitivity of mature erythrocytes from taut-/- mice to osmotic shock and oxidative stress, rendering them more resistant to apoptosis	SEN:10010726	14631140
BEL:20065396	tport(p(MGI:Slc6a6)) increases bp(GOBP:"response to oxidative stress")	The present observations point to a decreased sensitivity of mature erythrocytes from taut-/- mice to osmotic shock and oxidative stress, rendering them more resistant to apoptosis	SEN:10010726	14631140
BEL:20065398	tport(p(MGI:Slc6a6)) increases bp(GOBP:"apoptotic process")	The present observations point to a decreased sensitivity of mature erythrocytes from taut-/- mice to osmotic shock and oxidative stress, rendering them more resistant to apoptosis	SEN:10010726	14631140
BEL:20065416	tport(p(MGI:Xpo1)) directlyIncreases tloc(p(MGI:Hdac7),GOCCID:0005634,GOCCID:0005737)	We have also observed a nucleocytoplasmic shuttling of HDAC7 and dissected the mechanism involved. In NIH3T3 cells, HDAC7 was primarily localized in the cytoplasm, essentially due to an active CRM1-dependent export of the protein from the nucleus.	SEN:10032156	11585834
BEL:20065418	tscript(complex(p(HGNC:ARNT),p(HGNC:AHR))) directlyIncreases r(HGNC:CYP1A1)	The minimal XRE bound by AHR-ARNT is 59-TNGCGTG-39, with the specific binding sites for AHR and ARNT being (59)T(C/T)GC and GTG (39), respectively (7). Binding of AHR/ARNT acti-vates the expression of a battery of genes involved in drug and hormone metabolism, e.g., CYP1A1, CYP1B1, GST A2, and NADPH quinone reductase (8).	SEN:10032158	10620335
BEL:20065420	tscript(complex(p(HGNC:ARNT),p(HGNC:AHR))) directlyIncreases r(HGNC:CYP1B1)	The minimal XRE bound by AHR-ARNT is 59-TNGCGTG-39, with the specific binding sites for AHR and ARNT being (59)T(C/T)GC and GTG (39), respectively (7). Binding of AHR/ARNT acti-vates the expression of a battery of genes involved in drug and hormone metabolism, e.g., CYP1A1, CYP1B1, GST A2, and NADPH quinone reductase (8).	SEN:10032158	10620335
BEL:20065422	tscript(complex(p(HGNC:ARNT),p(HGNC:AHR))) directlyIncreases r(HGNC:GSTA2)	The minimal XRE bound by AHR-ARNT is 59-TNGCGTG-39, with the specific binding sites for AHR and ARNT being (59)T(C/T)GC and GTG (39), respectively (7). Binding of AHR/ARNT acti-vates the expression of a battery of genes involved in drug and hormone metabolism, e.g., CYP1A1, CYP1B1, GST A2, and NADPH quinone reductase (8).	SEN:10032158	10620335
BEL:20065426	tscript(complex(p(HGNC:CLOCK),p(HGNC:ARNTL2))) increases r(HGNC:SERPINE1)	Overexpression of Clock and CLIF Induce PAI-1 mRNA Expression. CLOCK and CLIF transactivate the PAI-1 promoter through two E-box sites. (Figure 3D shows that CLOCK by itself, but not CLIF, also induces PAI-1 mRNA expression).	SEN:10032162	11018023
BEL:20065432	tscript(complex(p(HGNC:MYC),p(HGNC:MAX))) directlyIncreases r(HGNC:CDC25A)	<C35> Cdc25A may be transcriptionally activated by c-Myc; the Myc:Max heterodimer binds to elements in the Cdc25A gene and activates its transcription (Galaktionov et al., 1996).	SEN:10032164	10436023
BEL:20065434	tscript(complex(p(HGNC:PATZ1),p(HGNC:BACH2))) directlyIncreases r(HGNC:FGF4)	together, these data indicated that a complex generated between MAZR and Bach2 functions as an activator of the fgf4 gene promoter.	SEN:10032166	10669750
BEL:20065436	tscript(complex(p(HGNC:TCF3),p(HGNC:PBX1))) increases r(HGNC:NDRG1)	our results overall are consistent with the notion that induction of NDRG1 by E2a-Pbx1 may represent part of an apoptotic or cytostatic cellular response to oncogene activation.	SEN:10010734	11237058
BEL:20065442	tscript(complex(p(MGI:Cebpa),p(MGI:Ep300),p(MGI:Crebbp))) directlyIncreases r(MGI:Retn)	C/EBPalpha binds specifically to a site that is essential for expression of the resistin promoter C/EBPalpha binding was associated with the recruitment of coactivators p300 and CREB-binding protein and a dramatic increase in histone acetylation in the vicinity of the resistin promoter	SEN:10032168	11901161
BEL:20065446	tscript(complex(p(MGI:Clock),p(MGI:Arntl))) directlyIncreases r(MGI:Cry1)	heterodimer transcription factors CLOCK and BMAL1 stimulate transcription of CRY1 and CRY2 and PER1 and PER2	SEN:10032170	14551421
BEL:20065450	tscript(complex(p(MGI:Clock),p(MGI:Arntl))) directlyIncreases r(MGI:Cry2)	heterodimer transcription factors CLOCK and BMAL1 stimulate transcription of CRY1 and CRY2 and PER1 and PER2	SEN:10032170	14551421
BEL:20065454	tscript(complex(p(MGI:Clock),p(MGI:Arntl))) directlyIncreases r(MGI:Nr1d1)	clock and bmal1 also activate transcription of rev-erb-alpha, which in turn represses the transcription of bmal1	SEN:10032174	14551421
BEL:20065456	tscript(complex(p(MGI:Clock),p(MGI:Arntl))) directlyIncreases r(MGI:Per1)	heterodimer transcription factors CLOCK and BMAL1 stimulate transcription of CRY1 and CRY2 and PER1 and PER2	SEN:10032170	14551421
BEL:20065458	tscript(complex(p(MGI:Clock),p(MGI:Arntl))) directlyIncreases r(MGI:Per2)	heterodimer transcription factors CLOCK and BMAL1 stimulate transcription of CRY1 and CRY2 and PER1 and PER2	SEN:10032170	14551421
BEL:20065468	tscript(complex(p(MGI:Foxo1),p(MGI:Smpx))) decreases r(MGI:Hes1)	in response to Notch signaling, FoxO1 binds to the transcription factor Csl and releases the repressive action of this transcription factor on the Hes1 gene in muscle cells (Kitamura et al., 2007).	SEN:10018080	18391970
BEL:20065480	tscript(complex(p(MGI:Ppargc1a),p(MGI:Mef2c))) increases r(MGI:Slc2a4)	PGC-1 mediates this increased GLUT4 expression, in large part, by binding to and coactivating the muscle-selective transcription factor MEF2C.	SEN:10030042	11274399
BEL:20065492	tscript(complex(p(MGI:Tcf3),p(MGI:Tcf12))) directlyIncreases r(MGI:Smarcc1)	FIG. 3. E2A/HEB complex activates the SRG3 promoter activity through E84 element, which is inhibited by Id proteins.	SEN:10032184	15016815
BEL:20065498	tscript(complex(p(MGI:Zbtb17),p(MGI:Myc))) directlyDecreases r(MGI:Itgb4)	Finally, we found 67 genes, including Igals1, which were induced by TGF-Ãƒ??Ãƒ?Ã‚Â¸ in control cells and in cells expressing MycV394D, but not in cells expressing wild-type Myc, arguing that they were repressed by Myc via binding to Miz1 (Fig. 2 A). (Table S1)	SEN:10032190	16391002
BEL:20065500	tscript(complex(p(MGI:Zbtb17),p(MGI:Myc))) directlyDecreases r(MGI:Lgals1)	Finally, we found 67 genes, including Igals1, which were induced by TGF-Ãƒ??Ãƒ?Ã‚Â¸ in control cells and in cells expressing MycV394D, but not in cells expressing wild-type Myc, arguing that they were repressed by Myc via binding to Miz1 (Fig. 2 A). (Table S1)	SEN:10032190	16391002
BEL:20065502	tscript(complex(p(MGI:Zbtb17),p(MGI:Myc))) directlyDecreases r(MGI:Mkrn1)	Finally, we found 67 genes, including Igals1, which were induced by TGF-Ãƒ??Ãƒ?Ã‚Â¸ in control cells and in cells expressing MycV394D, but not in cells expressing wild-type Myc, arguing that they were repressed by Myc via binding to Miz1 (Fig. 2 A). (Table S1)	SEN:10032190	16391002
BEL:20065540	tscript(p(HGNC:AHR)) increases r(HGNC:CDKN1B)	AhR-mediated expression of p27Kip1 inhibits cell cycle progression by repressing CDK2 activity, thus preventing pRb phosphorylation.	SEN:10032206	11302926
BEL:20065542	tscript(p(HGNC:AHR)) directlyIncreases r(HGNC:CYP1A1)	Estradiol reportedly blocked TCDD-induced accumulation of CYP1A1 mRNA and AHR-mediated activation of the CYP1A1 gene promoter in MCF-7 cells (32).	SEN:10015660	10620335
BEL:20065570	tscript(p(HGNC:ATF2)) increases r(HGNC:CCND1)	Dominant negative mutants of CREB and ATF-2 but not c-Jun inhibited pp60(v-src) induction of cyclin D1.	SEN:10010770	10066798
BEL:20065572	tscript(p(HGNC:ATF2)) increases r(HGNC:RHOB)	Overall, the data strongly indicate that transcriptional activation of the rhoB gene by genotoxic stress is regulated via a CCAAT box and that interaction of CCAAT-binding factor and ATF-2 triggers the stress-inducible expression of rhoB.	SEN:10010772	11160903
BEL:20065574	tscript(p(HGNC:ATF4)) increases r(HGNC:HMOX1)	CdCl(2), a potent inducer of HO-1, increased expression of ATF4 in mouse hepatoma cells, and detectable induction of ATF4 protein preceded that of HO-1 (30 min versus 2 h). A dominant-negative mutant of ATF4 inhibited basal and CdCl(2)-stimulated expression of a StRE-dependent/luciferase fusion construct (pE1-luc) in hepatoma cells but only basal expression in mammary epithelial MCF-7 cells	SEN:10032210	11274184
BEL:20065580	tscript(p(HGNC:ATF6)) increases r(HGNC:HSPA5)	ATF6 has been implicated in the endoplasmic reticulum (ER) stress response pathway since it can activate expression of GRP78 and other genes induced by the ER stress response. ER stress appears to activate ATF6 by cleavage from the ER membrane and translocation to the nucleus	SEN:10018104	10856300
BEL:20065582	tscript(p(HGNC:BARX2)) directlyIncreases tscript(p(HGNC:SRF))	novel homeodomain-containing transcription factor, called Barx2b, was identified that specifically interacts with SRF and promotes the DNA binding activity of SRF	SEN:10010774	11278942
BEL:20065592	tscript(p(HGNC:CEBPA)) increases r(HGNC:APOE)	Important factors for apoE gene regulation appear to be SP1 on the proximal promoter, and possibly HNF-3, C/EBP and hormone nuclear receptors on the enhancers.	SEN:10010776	11229886
BEL:20065600	tscript(p(HGNC:CEBPB)) increases r(HGNC:GADD45G)	the amount of Gadd45gamma transcripts became maximal when both C/EBPbeta and C/EBPdelta levels were high	SEN:10010778	11012671
BEL:20065604	tscript(p(HGNC:CEBPB)) increases r(HGNC:LDLR)	cotransfection of a human C/EBPbeta expression vector (pEF-NFIL6) with the LDLR promoter construct pLDLR234 increases LDLR promoter activity	SEN:10010780	10671569
BEL:20065606	tscript(p(HGNC:CEBPB)) increases r(HGNC:MSR1)	The increase in SR-A expression correlates with activation of the redox-sensitive transcription factors activating protein-1 c-Jun and CCAAT enhancer-binding protein beta	SEN:10010782	10837497
BEL:20065608	tscript(p(HGNC:CEBPB)) decreases r(HGNC:OXTR)	Contrary to the hypothesis, both IL-1beta and IL-6 treatment resulted in a significant decrease in OT receptor messenger RNA measured by ribonuclease protection analysis.	SEN:10023582	11250916
BEL:20065610	tscript(p(HGNC:CEBPD)) increases r(HGNC:GADD45G)	the amount of Gadd45gamma transcripts became maximal when both C/EBPbeta and C/EBPdelta levels were high	SEN:10010778	11012671
BEL:20065612	tscript(p(HGNC:CEBPD)) increases r(HGNC:LDLR)	The results thus suggest that C/EBP-delta binds to the SIRE (Sterol-independent regulatory element, -17 to -1) region of the LDLR and regulates its transcription.	SEN:10032220	10671569
BEL:20065618	tscript(p(HGNC:CEBPD)) increases r(HGNC:PLA2G2A)	Interleukin-1beta increased the levels of C/EBPdelta mRNA as soon as 2 h and up to 24 h without affecting those of C/EBPbeta. Higher amounts of C/EBPdelta proteins correlate with the stimulation of C/EBPdelta mRNA.	SEN:10007186	10791956
BEL:20065626	tscript(p(HGNC:CLOCK)) increases r(HGNC:SERPINE1)	Overexpression of Clock and CLIF Induce PAI-1 mRNA Expression. CLOCK and CLIF transactivate the PAI-1 promoter through two E-box sites. (Figure 3D shows that CLOCK by itself, but not CLIF, also induces PAI-1 mRNA expression).	SEN:10032162	11018023
BEL:20065630	tscript(p(HGNC:CREB1)) increases r(HGNC:BDNF)	One of the two elements binds to the cyclic adenosine monophosphate (AMP) response element binding protein (CREB) transcription factor, and interfering with CREB or related family members inhibits calcium-dependent BDNF transcription.	SEN:10010788	10823240
BEL:20065632	tscript(p(HGNC:CREB1)) increases r(HGNC:CCND1)	Dominant negative mutants of CREB and ATF-2 but not c-Jun inhibited pp60(v-src) induction of cyclin D1.	SEN:10010770	10066798
BEL:20065636	tscript(p(HGNC:CREB1)) increases r(HGNC:PDE4B)	Dominant negative mutants of CREB suppressed PDE4B2 promoter activity and a constitutively active form of CREB robustly stimulated it.	SEN:10032226	10693932
BEL:20065640	tscript(p(HGNC:CREBBP)) increases r(HGNC:COL1A2)	We now report that IFN-gamma abrogates TGF-beta-stimulated COL1A2 transcription in fibroblasts by inhibiting Smad activities. IFN-gamma appears to induce competition between activated Stat1alpha and Smad3 for interaction with limiting amounts of cellular p300/CBP.	SEN:10010790	11134049
BEL:20065646	tscript(p(HGNC:CTNNB1)) directlyIncreases r(HGNC:ABCB1)	Corresponding to the accumulation of beta-catenin, expression of the MDR1 gene product was steadily up-regulated in adenomas and adenocarcinomas of 10 patients with familial adenomatous polyposis.	SEN:10032232	10987283
BEL:20065652	tscript(p(HGNC:CTNNB1)) directlyIncreases r(HGNC:GAST)	We show here that the gastrin gene is a downstream target of the beta-catenin/TCF-4 signaling pathway and that cotransfection of a constitutively active beta-catenin expression construct causes a threefold increase in gastrin promoter activity.	SEN:10032238	10953028
BEL:20065656	tscript(p(HGNC:CTNNB1)) directlyIncreases r(HGNC:MMP7)	Here we report the identification of the matrix metalloproteinase MMP-7 as another target gene of beta-catenin/TCF-4. MMP-7 is overexpressed in 80% of human colorectal cancers and known to be an important factor for early tumor growth, with a potential function also for later progression steps, like invasion and metastasis.	SEN:10023924	10514384
BEL:20065668	tscript(p(HGNC:DMTF1)) directlyIncreases r(HGNC:ANPEP)	<C11b> DMTF1 activates transcription from the p19ARF promoter and induces cell cycle arrest and p21Cip1 accumulation in a p19ARF- and p53-dependent manner (Inoue et al., 1999). Another DMTF1-regulated gene is CD13/aminopeptidase N, which is activated cooperatively by DMTF1 and c-Myb; its activation by DMTF1 is inhibited by cyclin D independent of Cdk4/6.	SEN:10022908	10436023
BEL:20065670	tscript(p(HGNC:E2F1)) increases bp(GOBP:"cell cycle")	The mechanism for the cell cycle downregulation appeared to be a transcriptional downregulation of E2F-1, a transcription factor that regulates genes required for cell cycle progression beyond the G1/S interphase.	SEN:10010796	10634932
BEL:20065682	tscript(p(HGNC:E2F1)) directlyIncreases r(HGNC:CDKN1A)	We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promoter.	SEN:10032250	10030670
BEL:20065688	tscript(p(HGNC:E2F1)) directlyIncreases r(HGNC:POLA1)	expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.	SEN:10032256	11313881
BEL:20065690	tscript(p(HGNC:E2F1)) increases r(HGNC:POLA1)	expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.	SEN:10032256	11313881
BEL:20065692	tscript(p(HGNC:E2F1)) directlyIncreases r(HGNC:POLA1)	In addition, expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.	SEN:10010802	11313881
BEL:20065694	tscript(p(HGNC:E2F1)) increases r(HGNC:RPA2)	E2F-1 up-regulates the expression of a number of genes coding for components of the DNA replication machinery. Among them is the gene coding for the 32 Kd subunit of replication protein A (RPA2).	SEN:10010804	11313881
BEL:20065696	tscript(p(HGNC:E2F1)) directlyIncreases r(HGNC:RPA2)	E2F-1 up-regulates the expression We demonstrate that RPA2 is a novel E2F target gene whose expression can be directly regulated by E2F-1 via E2F binding sites in its promoter.	SEN:10032258	11313881
BEL:20065698	tscript(p(HGNC:E2F1)) directlyIncreases r(HGNC:RPA2)	We show that E2F-1 up-regulates the expression of a number of genes coding for components of the DNA replication machinery. Among them is the gene coding for the 32 Kd subunit of replication protein A (RPA2). We demonstrate that RPA2 is a novel E2F target gene whose expression can be directly regulated by E2F-1 via E2F binding sites in its promoter.	SEN:10010806	11313881
BEL:20065702	tscript(p(HGNC:E2F1)) directlyIncreases r(HGNC:TOP2A)	expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.	SEN:10032256	11313881
BEL:20065704	tscript(p(HGNC:E2F1)) increases r(HGNC:TOP2A)	expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.	SEN:10032256	11313881
BEL:20065706	tscript(p(HGNC:E2F1)) increases r(HGNC:TOP2A)	In addition, expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.	SEN:10010802	11313881
BEL:20065708	tscript(p(HGNC:E2F3)) increases bp(GOBP:"cell cycle")	We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promoter.	SEN:10032250	10030670
BEL:20065710	tscript(p(HGNC:E2F3)) directlyIncreases r(HGNC:CDKN1A)	We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promoter.	SEN:10032250	10030670
BEL:20065714	tscript(p(HGNC:E2F4)) directlyIncreases r(HGNC:CCND1)	<C1> The Cyclin D1 promoter is activated by E2F4, but it is repressed by E2F1 via pRb (Watanabe et al., 1998). In pRb deficient cells, E2F1 stimulates this promoter. An Sp1 site close to the E2F element also participates in the regulation. (Overexpression of pRb can increase the expression of Cyclin D1 by an unknown mechanism [Watanabe et al., 1998].)	SEN:10032260	10436023
BEL:20065722	tscript(p(HGNC:EDF1)) increases tscript(p(HGNC:NR5A1))	Both isoforms bound to TBP and Ad4BP/SF-1, a mammalian counterpart of FTZ-F1, and mediated Ad4BP/SF-1-dependent transcriptional activation.	SEN:10005672	10567391
BEL:20065726	tscript(p(HGNC:EGR1)) increases r(HGNC:CST6)	Guanylate cyclase b1 subunit (3.3) Proteases/protease inhibitors ----------------------------------------- Cystatin M/CST6 (216)	SEN:10022992	10984481
BEL:20065728	tscript(p(HGNC:EGR1)) increases r(HGNC:EMP2)	Membrane-associated proteins ----------------------------------------- Epithelial membrane protein 2/XMP (16.9)	SEN:10022996	10984481
BEL:20065734	tscript(p(HGNC:EGR1)) increases r(HGNC:GJB2)	Lysates from LAPC4 cells infected with Ad-EGR1 observed EGR1 expression which leads to the fold induction of the Connexin 26 gene by 9.0+/-0.1	SEN:10032268	10984481
BEL:20065736	tscript(p(HGNC:EGR1)) increases r(HGNC:IGF2)	Cotransfection of HepG2 cells with an Egr-1 expression vector and an IGF-II P3 promoter-luciferase reporter plasmid showed that the transcription of IGF-II was activated by Egr-1 in a dose-dependent manner.	SEN:10010810	10606246
BEL:20065738	tscript(p(HGNC:EGR1)) increases r(HGNC:PDGFA)	A variety of stimuli, including TPA, PDGF, and mechanical injury, induce Egr-1 expression in smooth muscle cells; the induced Egr-1 displaces members of the Sp family and activates the PDGF-A promoter further (431). Egr-1 is also involved in activation of a shear-stress-response element in the A-chain promoter in endothelial cells (239).	SEN:10022488	10508235
BEL:20065744	tscript(p(HGNC:EHF)) directlyIncreases r(HGNC:KRT8)	Finally ESE-3b and ESE-1 activate the EndoA enhancer Ets site oligo equally well (Fig. 8e)....ESE-3 can also bind to the promoter and the enhancer SPRR2A and EndoA sites respectively, as does ESE-1.	SEN:10032274	10644770
BEL:20065746	tscript(p(HGNC:EHF)) directlyIncreases r(HGNC:MET)	A potential role in branching morphogenesis is suggested, since ESE-3 transactivates the c-MET promoter via three high affinity binding sites.	SEN:10010812	10644770
BEL:20065750	tscript(p(HGNC:EHF)) directlyIncreases r(HGNC:SPRR2A)	both ESE-1 and ESE-3 transactivate the SPRR2A oligo but to a different extent (Fig. 8d)....ESE-3 can also bind to the promoter and the enhancer SPRR2A and EndoA sites respectively, as does ESE-1.	SEN:10032278	10644770
BEL:20065754	tscript(p(HGNC:ELF3)) directlyIncreases r(HGNC:KRT8)	Finally ESE-3b and ESE-1 activate the EndoA enhancer Ets site oligo equally well (Fig. 8e)....ESE-3 can also bind to the promoter and the enhancer SPRR2A and EndoA sites respectively, as does ESE-1.	SEN:10032274	10644770
BEL:20065758	tscript(p(HGNC:ELF3)) directlyIncreases r(HGNC:SPRR2A)	both ESE-1 and ESE-3 transactivate the SPRR2A oligo but to a different extent (Fig. 8d)....ESE-3 can also bind to the promoter and the enhancer SPRR2A and EndoA sites respectively, as does ESE-1.	SEN:10032278	10644770
BEL:20065770	tscript(p(HGNC:ENO1)) increases bp(GOBP:"cell death")	Subsequent studies on the biological role of MBP-1 demonstrated induction of cell death in fibroblasts	SEN:10010816	10082554
BEL:20065772	tscript(p(HGNC:ENO1)) decreases r(HGNC:MYC)	We initially identified c-myc promoter binding protein 1 (MBP-1), which negatively regulates c-myc promoter activity	SEN:10010818	10082554
BEL:20065776	tscript(p(HGNC:EP300)) increases r(HGNC:COL1A2)	We now report that IFN-gamma abrogates TGF-beta-stimulated COL1A2 transcription in fibroblasts by inhibiting Smad activities. IFN-gamma appears to induce competition between activated Stat1alpha and Smad3 for interaction with limiting amounts of cellular p300/CBP.	SEN:10010790	11134049
BEL:20065778	tscript(p(HGNC:EP300)) increases r(HGNC:NR4A1)	We report here that NFATp synergizes with MEF2D to recruit the coactivator p300 for the transcription of Nur77	SEN:10010820	10944115
BEL:20065780	tscript(p(HGNC:EPAS1)) increases r(HGNC:EPO)	EPAS1 shares high homology with hypoxia-inducible factor-1alpha (HIF-1alpha) and, like HIF-1alpha, has been shown to bind to the HIF-1-binding site and to activate its downstream genes such as vascular endothelial growth factor (VEGF) and erythropoietin.	SEN:10010822	10531360
BEL:20065782	tscript(p(HGNC:EPAS1)) increases r(HGNC:VEGFA)	EPAS1 shares high homology with hypoxia-inducible factor-1alpha (HIF-1alpha) and, like HIF-1alpha, has been shown to bind to the HIF-1-binding site and to activate its downstream genes such as vascular endothelial growth factor (VEGF) and erythropoietin.	SEN:10010822	10531360
BEL:20065786	tscript(p(HGNC:ESR1)) decreases p(HGNC:NDRG1)	It was increased in mammary carcinoma MCF-7 cells treated by retinoids and by the anti-estrogen ICI 182,780 but not by 4-hydroxytamoxifen.	SEN:10015684	10395947
BEL:20065788	tscript(p(HGNC:ESR1)) directlyIncreases r(EGID:9687)	This result is consistent with the hypothesis that tamoxifen acts as an antiestrogen in breast tissue and that the pattern of expression resulting from estrogen withdrawal is identical to the pattern of expression induced by tamoxifen treatment...	SEN:10016314	11103799
BEL:20065790	tscript(p(HGNC:ESR1)) directlyIncreases r(EGID:9687)	Treatment with cycloheximide indicated that ER directly controls GREB1 expression...The pattern of expression suggests a critical role for these two genes in the response of tissues and tumors to beta-estradiol.	SEN:10015666	11103799
BEL:20065794	tscript(p(HGNC:ESR1)) directlyIncreases r(HGNC:CTSD)	In addition, BRCA1 blocked the expression of two endogenous estrogen-regulated gene products in human breast cancer cells: pS2 and cathepsin D	SEN:10022676	11244506
BEL:20065798	tscript(p(HGNC:ESR1)) decreases r(HGNC:NDRG1)	It was increased in mammary carcinoma MCF-7 cells treated by retinoids and by the anti-estrogen ICI 182,780 but not by 4-hydroxytamoxifen.	SEN:10015684	10395947
BEL:20065802	tscript(p(HGNC:ESR1)) directlyIncreases r(HGNC:PDZK1)	This result is consistent with the hypothesis that tamoxifen acts as an antiestrogen in breast tissue and that the pattern of expression resulting from estrogen withdrawal is identical to the pattern of expression induced by tamoxifen treatment...	SEN:10016314	11103799
BEL:20065804	tscript(p(HGNC:ESR1)) directlyIncreases r(HGNC:TFF1)	In addition, BRCA1 blocked the expression of two endogenous estrogen-regulated gene products in human breast cancer cells: pS2 and cathepsin D	SEN:10022676	11244506
BEL:20065808	tscript(p(HGNC:ETS1)) directlyIncreases r(HGNC:COL1A2)	We demonstrate that the expression of collagenous proteins and collagen alpha2(I) (COL1A2) mRNA was inhibited following stable transfection of Fli-1 in dermal fibroblasts..... In contrast, Ets-1 stimulates COL1A2 promoter activity. In vitro binding assays demonstrate that both Fli-1 and Ets-1 form DNA-protein complexes with sequences present in COL1A2 promoter.	SEN:10032292	11278621
BEL:20065810	tscript(p(HGNC:ETS1)) directlyIncreases r(HGNC:COL1A2)	We demonstrate that the expression of collagenous proteins and collagen alpha2(I) (COL1A2) mRNA was inhibited following stable transfection of Fli-1 in dermal fibroblasts. We propose that Fli-1 inhibits COL1A2 promoter activity by competition with Ets-1.	SEN:10032294	11278621
BEL:20065818	tscript(p(HGNC:ETS1)) directlyIncreases r(HGNC:MGAT2)	We now report that co-transfection into HepG2 or COS-1 cells of either ets-1 or ets-2 expression plasmids together with chimaeric GnT II promoter-chloramphenicol acetyltransferase plasmids results in a 2-4-fold stimulation of promoter activity.	SEN:10010828	10749681
BEL:20065822	tscript(p(HGNC:ETS1)) decreases r(HGNC:PPP1R12A)	In this region the putative cis element binding factor, AML1a \"(RUNX1)\", was detected [20]. Further deletion of 31 bp from nucleotide positions 3229 to 3199 resulted in increased luciferase activity, indicating the possibility of negative cis element(s) located between 3229 and 3199. Two putative cis element binding factors, STATx [21] and c-Ets-1 [22], were demonstrated in this region.	SEN:10032298	11342221
BEL:20065824	tscript(p(HGNC:ETS2)) directlyIncreases r(HGNC:BCL2L1)	The bcl-x promoter contains potential Ets binding sites, and we show that the transcription factor, Ets2, first identified by its sequence identity to v-ets of the E26 retrovirus, can transactivate the bcl-x promoter. Transient expression of Ets2 results in the upregulation of Bcl-xL but not of Bcl-xS, an alternatively spliced gene product which induces apoptosis	SEN:10032300	10082528
BEL:20065830	tscript(p(HGNC:ETS2)) directlyIncreases r(HGNC:MGAT2)	We now report that co-transfection into HepG2 or COS-1 cells of either ets-1 or ets-2 expression plasmids together with chimaeric GnT II promoter-chloramphenicol acetyltransferase plasmids results in a 2-4-fold stimulation of promoter activity.	SEN:10010828	10749681
BEL:20065832	tscript(p(HGNC:FLI1)) directlyDecreases r(HGNC:COL1A2)	We demonstrate that the expression of collagenous proteins and collagen alpha2(I) (COL1A2) mRNA was inhibited following stable transfection of Fli-1 in dermal fibroblasts. We propose that Fli-1 inhibits COL1A2 promoter activity by competition with Ets-1.	SEN:10032294	11278621
BEL:20065838	tscript(p(HGNC:FLII)) directlyDecreases r(HGNC:COL1A2)	We demonstrate that the expression of collagenous proteins and collagen alpha2(I) (COL1A2) mRNA was inhibited following stable transfection of Fli-1 in dermal fibroblasts..... In contrast, Ets-1 stimulates COL1A2 promoter activity. In vitro binding assays demonstrate that both Fli-1 and Ets-1 form DNA-protein complexes with sequences present in COL1A2 promoter.	SEN:10032292	11278621
BEL:20065842	tscript(p(HGNC:FOS)) increases r(HGNC:EDN1)	Results from transactivation studies with c-Jun and c-Fos expression plasmids confirmed a strong activation of the ET-1 promoter by c-Jun and c-Fos. 16 Cotransfection of PPARs in the presence of c-Jun and c-Fos repressed the strong transactivation of the ET-1 promoter as well as the transactivation of a heterologous AP-1driven promoter.	SEN:10032302	10473669
BEL:20065846	tscript(p(HGNC:FOXA2)) increases r(HGNC:APOE)	Important factors for apoE gene regulation appear to be SP1 on the proximal promoter, and possibly HNF-3, C/EBP and hormone nuclear receptors on the enhancers.	SEN:10010776	11229886
BEL:20065852	tscript(p(HGNC:FOXO1)) directlyIncreases r(HGNC:IGFBP1)	Reporter gene studies in HepG2 hepatoma cells show that FKHR stimulates insulin-like growth factor-binding protein-1 promoter activity through an IRS, and introduction of IRSs confers this effect on a heterologous promoter.	SEN:10032308	10358076
BEL:20065862	tscript(p(HGNC:GATA1)) increases r(HGNC:ALAS2)	Both the ALAS-E expression level and the porphyrin content were significantly reduced in erythroid cells of the GATA-1.05 mutant mice, suggesting that ALAS-E is an important GATA-1 gene target (Suwabe et al. , 1998) .	SEN:10032312	10562540
BEL:20065866	tscript(p(HGNC:GATA1)) increases r(HGNC:EPOR)	In the development of the erythroid lineage, the transcription factor, GATA-1, and EpoR are closely linked and GATA-1 can transactivate the EpoR promoter.	SEN:10032316	10995753
BEL:20065868	tscript(p(HGNC:GATA1)) directlyIncreases r(HGNC:NFE2)	To test this possibility we performed cotransfection assays in NIH-3T3 cells and HeLa cells with three different reporter constructs containing either synthetic (M1?, Fig. ?Fig.4A,B4A,B and ?D3; Fig. ?Fig.4C)4C) or natural (p45 NF-E2; Fig. ?Fig.4D)4D) GATA-1-dependent promoters. The p45 NF-E2 promoter requires the synergistic action of GATA-1 and FOG as a cofactor (Tsang et al. 1997).	SEN:10032318	10364157
BEL:20065872	tscript(p(HGNC:GATA4)) increases r(HGNC:ADORA1)	Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression. These observations suggest that embryonic A1AR expression involves activation of the A1AR promoter by GATA-4 and Nkx2.5.	SEN:10010836	10318839
BEL:20065874	tscript(p(HGNC:GATA4)) increases r(HGNC:PDGFRA)	The alpha -receptor promoter has been isolated (4, 232, 489) and shown to contain a binding site for the transcription factor GATA-4, which is responsible for parietal endoderm-specific alpha -receptor expression (488).	SEN:10032322	10508235
BEL:20065880	tscript(p(HGNC:GFI1)) increases r(HGNC:FOS)	Gfi-1 was also able to enhance STAT3-mediated transactivation of the c- fos promoter ( Hill and Treisman, 1995 ; Leaman et al ., 1996 ), which contains a STAT3 binding site within the sis- inducible element (SIE, Figure 8 C).	SEN:10032324	11060035
BEL:20065884	tscript(p(HGNC:GTF3A)) directlyIncreases r(HGNC:LOX)	The binding of transcription factor AP2 to sites predicted in the control region was confirmed by DNase footprinting.	SEN:10032326	10391127
BEL:20065886	tscript(p(HGNC:GTF3A)) directlyIncreases r(HGNC:MMP2)	Electrophoretic gel shift analysis demonstrates binding of specific DNA-protein complexes to the Sp1 and AP-2 sites: Sp1 and Sp3 bind to the Sp1 site, while the AP-2 transcription factor binds the AP-2 element.	SEN:10032328	10506168
BEL:20065890	tscript(p(HGNC:HBP1)) directlyDecreases r(HGNC:CDKN1A)	In contrast, HBP1 (HMG-box protein-1), a novel retinoblastoma protein-binding protein, can repress the p21 promoter and inhibit induction of p21 expression by E2F	SEN:10010844	10030670
BEL:20065902	tscript(p(HGNC:HNF1A)) increases bp(GOBP:"insulin secretion")	hepatocyte nuclear factor (HNF)-4a, HNF-1a, insulin promoter factor-1, and HNF-1b in MODY1, -3, -4, and -5, respectively (Yamagata et al., 1996a, 1996b; Stoffers et al., 1997; Horikawa et al., 1997). These transcription factors are expressed in pancreatic b cells, and the mutations are believed to cause insulin deficiency by impairing b cell function.	SEN:10032332	10199397
BEL:20065904	tscript(p(HGNC:HNF1A)) increases p(HGNC:UGT2B17)	In HepG2 cells, HNF1alpha bound to this region and activated the UGT2B17 promoter, as assessed by functional and gel shift assays.	SEN:10010846	11191885
BEL:20065908	tscript(p(HGNC:HNF1A)) directlyIncreases r(HGNC:UGT2B17)	In HepG2 cells, HNF1alpha bound to this region and activated the UGT2B17 promoter, as assessed by functional and gel shift assays.	SEN:10010846	11191885
BEL:20065910	tscript(p(HGNC:HNF1B)) increases bp(GOBP:"insulin secretion")	hepatocyte nuclear factor (HNF)-4a, HNF-1a, insulin promoter factor-1, and HNF-1b in MODY1, -3, -4, and -5, respectively (Yamagata et al., 1996a, 1996b; Stoffers et al., 1997; Horikawa et al., 1997). These transcription factors are expressed in pancreatic b cells, and the mutations are believed to cause insulin deficiency by impairing b cell function.	SEN:10032332	10199397
BEL:20065912	tscript(p(HGNC:HNF1B)) increases p(HGNC:UGT2B17)	The UGT2B17 promoter could also be activated by exogenous HNF1alpha in LNCaP cells. However, because these cells do not contain HNF1alpha, other transcription factors must regulate the UGT2B17 promoter. Cotransfection experiments showed that HNF1beta, elevates promoter activity in LNCaP cells.	SEN:10010848	11191885
BEL:20065914	tscript(p(HGNC:HNF1B)) directlyIncreases r(HGNC:UGT2B17)	The UGT2B17 promoter could also be activated by exogenous HNF1alpha in LNCaP cells. However, because these cells do not contain HNF1alpha, other transcription factors must regulate the UGT2B17 promoter. Cotransfection experiments showed that HNF1beta, elevates promoter activity in LNCaP cells.	SEN:10010848	11191885
BEL:20065916	tscript(p(HGNC:HNF1B)) directlyIncreases r(HGNC:UGT2B17)	UGT2B17 promoter. Cotransfection experiments showed that HNF1beta, elevates promoter activity in LNCaP cells	SEN:10010850	11191885
BEL:20065918	tscript(p(HGNC:HNF4A)) increases bp(GOBP:"insulin secretion")	hepatocyte nuclear factor (HNF)-4a, HNF-1a, insulin promoter factor-1, and HNF-1b in MODY1, -3, -4, and -5, respectively (Yamagata et al., 1996a, 1996b; Stoffers et al., 1997; Horikawa et al., 1997). These transcription factors are expressed in pancreatic b cells, and the mutations are believed to cause insulin deficiency by impairing b cell function.	SEN:10032332	10199397
BEL:20065924	tscript(p(HGNC:HNF4A)) increases r(HGNC:CYP7A1)	Hepatocyte nuclear factor 4 (HNF4) and chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) synergistically activate transcription of the CYP7A1 promoter	SEN:10032336	10627496
BEL:20065926	tscript(p(HGNC:HNF4A)) increases r(HGNC:CYP7A1)	Transactivation of CYP7A1 by HNF4 in the human hepatoma cell line, HepG2, was enhanced by cotransfection with COUP-TFII or the basal transcription element binding protein (BTEB)	SEN:10010854	10627496
BEL:20065928	tscript(p(HGNC:HOXA10)) directlyIncreases r(HGNC:CDKN1A)	In this paper, we describe a mechanism by which p21 and HOXA10 may act in concert, where HOXA10 can bind directly to the p21 promoter and, together with its trimeric partners PBX1 and MEIS1, activate p21 transcription, resulting in cell cycle arrest and differentiation.	SEN:10010856	11040212
BEL:20065938	tscript(p(HGNC:HOXB1)) directlyIncreases r(HGNC:COL5A2)	DNA binding assays and cell transfection experiments revealed that the bipartite core sequence of FPB (5'-ATCAATCA-3') binds the PBX1/2, PREP1, and HOXB1 proteins, and this in turn leads to promoter transactivation.	SEN:10010860	10748126
BEL:20065958	tscript(p(HGNC:JUNB)) directlyIncreases r(HGNC:NQO1)	In addition to Nrf2 and c-Jun, other nuclear transcription factors including Nrf1, Jun-B, and Jun-D also bind to the ARE and regulate expression and induction of NQO1 gene.	SEN:10032346	11035254
BEL:20065960	tscript(p(HGNC:JUND)) directlyIncreases r(HGNC:NQO1)	In addition to Nrf2 and c-Jun, other nuclear transcription factors including Nrf1, Jun-B, and Jun-D also bind to the ARE and regulate expression and induction of NQO1 gene.	SEN:10032346	11035254
BEL:20065970	tscript(p(HGNC:JUN)) increases r(HGNC:EDN1)	Results from transactivation studies with c-Jun and c-Fos expression plasmids confirmed a strong activation of the ET-1 promoter by c-Jun and c-Fos. 16 Cotransfection of PPARs in the presence of c-Jun and c-Fos repressed the strong transactivation of the ET-1 promoter as well as the transactivation of a heterologous AP-1driven promoter.	SEN:10032302	10473669
BEL:20065976	tscript(p(HGNC:JUN)) increases r(HGNC:IL6)	Furthermore, activation of PPARalpha represses both c-Jun- and p65-induced transcription of the human IL-6 promoter.	SEN:10032350	10542237
BEL:20065978	tscript(p(HGNC:JUN)) increases r(HGNC:MMP13)	Furthermore, overexpression of c-Fos, c-Jun, and core-binding factor a1 synergistically increased collagenase-3 promoter activity.	SEN:10010868	10601295
BEL:20065980	tscript(p(HGNC:JUN)) increases r(HGNC:MSR1)	The increase in SR-A expression correlates with activation of the redox-sensitive transcription factors activating protein-1 c-Jun and CCAAT enhancer-binding protein beta	SEN:10010782	10837497
BEL:20065984	tscript(p(HGNC:JUN)) decreases tscript(p(HGNC:PPARA))	Transcriptional interference between PPARalpha and both c-Jun and p65 occurs reciprocally, since c-Jun and p65 also inhibit PPARalpha-mediated activation of a PPAR response element-driven promoter.	SEN:10010870	10542237
BEL:20065986	tscript(p(HGNC:KAT2B)) decreases bp(GOBP:"cell proliferation")	indicate a direct physical and functional interplay between two negative regulators of cell proliferation, Smad3 and P/CAF.	SEN:10032352	11058129
BEL:20065990	tscript(p(HGNC:KLF10)) increases bp(GOBP:"apoptotic process")	ectopic overexpression of TIEG is sufficient to trigger the apoptotic cell program in these cells, which is preceded by a decrease of Bcl-2 protein levels	SEN:10032356	10471833
BEL:20065994	tscript(p(HGNC:KLF10)) decreases r(HGNC:BCL2)	ectopic overexpression of TIEG is sufficient to trigger the apoptotic cell program in these cells, which is preceded by a decrease of Bcl-2 protein levels	SEN:10032356	10471833
BEL:20066006	tscript(p(HGNC:KLF13)) increases r(HGNC:HBB)	In luciferase assays, FKLF-2 activates predominantly the gamma, and to a lesser degree, the epsilon and beta globin gene promoters.	SEN:10010872	10828046
BEL:20066008	tscript(p(HGNC:KLF13)) increases r(HGNC:HBE1)	In luciferase assays, FKLF-2 activates predominantly the gamma, and to a lesser degree, the epsilon and beta globin gene promoters.	SEN:10010872	10828046
BEL:20066010	tscript(p(HGNC:KLF13)) increases r(HGNC:HBG1)	In luciferase assays, FKLF-2 activates predominantly the gamma, and to a lesser degree, the epsilon and beta globin gene promoters.	SEN:10010872	10828046
BEL:20066012	tscript(p(HGNC:KLF13)) increases r(HGNC:HBG2)	In luciferase assays, FKLF-2 activates predominantly the gamma, and to a lesser degree, the epsilon and beta globin gene promoters.	SEN:10010872	10828046
BEL:20066014	tscript(p(HGNC:KLF1)) increases r(HGNC:HBB)	The erythroid cell-specific transcription factor erythroid Kruppel-like factor (EKLF) is an important activator of beta-globin gene expression.	SEN:10032360	11287616
BEL:20066024	tscript(p(HGNC:LHX3)) directlyIncreases r(HGNC:CGA)	In these experiments, both Lhx3-EGFP and EGFP-Lhx3 activated the alpha GSU promoter in similar fashion to Lhx3 controls (Fig. 1 A ). 7708713 shows binding to the Cga promoter-DD	SEN:10032362	10818088
BEL:20066038	tscript(p(HGNC:MAFK)) increases r(HGNC:DLD)	Overexpression of an MafK dominant negative mutant decreased Nrf2 binding to GCS EpRE sequences, inhibited the inducible expression of GCS(h) and GCS(l) promoter/reporter transgenes, and reduced endogenous GCS gene induction	SEN:10010880	10559251
BEL:20066040	tscript(p(HGNC:MAFK)) increases r(HGNC:GCSH)	Overexpression of an MafK dominant negative mutant decreased Nrf2 binding to GCS EpRE sequences, inhibited the inducible expression of GCS(h) and GCS(l) promoter/reporter transgenes, and reduced endogenous GCS gene induction	SEN:10010880	10559251
BEL:20066044	tscript(p(HGNC:MAP2K5)) directlyIncreases tscript(p(HGNC:MEF2D))	The transcriptional activation domain of ERK5 is required for maximal MEF2 activity in response to calcium flux in T cells, and it can activate the endogenous Nur77 gene when constitutively recruited to the Nur77 promoter via MEF2 sites.	SEN:10010882	11046135
BEL:20066058	tscript(p(HGNC:MEF2D)) increases r(HGNC:NR4A1)	We report here that NFATp synergizes with MEF2D to recruit the coactivator p300 for the transcription of Nur77	SEN:10010820	10944115
BEL:20066060	tscript(p(HGNC:MEF2D)) directlyIncreases r(HGNC:NR4A1)	The transcriptional activation domain of ERK5 is required for maximal MEF2 activity in response to calcium flux in T cells, and it can activate the endogenous Nur77 gene when constitutively recruited to the Nur77 promoter via MEF2 sites.	SEN:10010882	11046135
BEL:20066062	tscript(p(HGNC:MEIS1)) increases r(HGNC:CDKN1A)	In this paper, we describe a mechanism by which p21 and HOXA10 may act in concert, where HOXA10 can bind directly to the p21 promoter and, together with its trimeric partners PBX1 and MEIS1, activate p21 transcription, resulting in cell cycle arrest and differentiation.	SEN:10010856	11040212
BEL:20066068	tscript(p(HGNC:MYB)) decreases bp(GOBP:"cell differentiation")	We have shown that the c-Maf and c-Myb transcription factors physically interact in myeloid cells to form inhibitory complexes that hinder transactivation of c-Myb target genes through direct binding to Myb consensus sites.	SEN:10020058	10477683
BEL:20066076	tscript(p(HGNC:MYBL2)) increases r(HGNC:CLU)	Endogenous ApoJ/Clusterin expression is induced in mammalian cell lines following transient transfection of a B-MYB cDNA.	SEN:10010888	10770937
BEL:20066078	tscript(p(HGNC:MYB)) increases r(HGNC:CD34)	Both hypotheses are in agreement with the studies in which overexpression of c-myb activated the endogenous CD34 gene in CD34-cells. 8 , 9 How is the CD34 gene expression abolished as the cells differentiate?	SEN:10032374	10572091
BEL:20066090	tscript(p(HGNC:MYC)) directlyIncreases r(HGNC:DDX21)	Mutation of a putative c-Myc/USF binding site in the region between -110 and -85 caused a decrease in the promoter activity by 2- to 3-fold.	SEN:10032378	11237763
BEL:20066100	tscript(p(HGNC:MYF6)) increases r(HGNC:ACACB)	transient expression of Myf6 induced significant activation on the ACCbeta promoter or an artificial promoter harboring this novel cis-element.	SEN:10032386	11076940
BEL:20066102	tscript(p(HGNC:MYOD1)) increases r(HGNC:ACACB)	These findings suggest that muscle regulatory factors, such as MyoD, Myf4, and Myf6, contribute to the muscle-specific expression of ACCbeta via E-boxes and the novel cis-element GCCTGTCA.	SEN:10010896	11076940
BEL:20066110	tscript(p(HGNC:MYOG)) increases r(HGNC:ACACB)	These findings suggest that muscle regulatory factors, such as MyoD, Myf4, and Myf6, contribute to the muscle-specific expression of ACCbeta via E-boxes and the novel cis-element GCCTGTCA.	SEN:10010896	11076940
BEL:20066112	tscript(p(HGNC:MYOG)) increases r(HGNC:ACHE)	Co-transfection experiments using AChE promoter-reporter gene constructs and a myogenin expression vector showed that expression of this regulatory factor increased expression of the reporter gene in myotubes	SEN:10010900	11279154
BEL:20066118	tscript(p(HGNC:NCOA1)) directlyIncreases r(HGNC:ERBB2)	hus, in oestrogenic conditions SRC-1 preferentially binds to the ER which effectively sequesters it thereby reducing enhancer activity, but in antioestrogenic media the cofactor is released from the ER and is therefore available to activate the ERBB2 enhancer.	SEN:10003618	10698518
BEL:20066120	tscript(p(HGNC:NCOA1)) increases tscript(p(HGNC:PGR))	This is consistent with our finding that EGF, an upstream activator of MAPK, enhances the effect of SRC-1 on PR-dependent gene transcription (50).	SEN:10019986	11073973
BEL:20066138	tscript(p(HGNC:NFATC2)) increases r(HGNC:NR4A1)	We report here that NFATp synergizes with MEF2D to recruit the coactivator p300 for the transcription of Nur77	SEN:10010820	10944115
BEL:20066142	tscript(p(HGNC:NFE2L2)) directlyIncreases r(HGNC:DLD)	Increased expression was associated with an increase in the binding of Nrf2 to electrophile response elements (EpRE) in the promoters of these genes. Nrf2 overexpression increased the activity of GCS(h) and GCS(l) promoter/reporter transgenes.	SEN:10010906	10559251
BEL:20066144	tscript(p(HGNC:NFE2L2)) directlyIncreases r(HGNC:GCSH)	Increased expression was associated with an increase in the binding of Nrf2 to electrophile response elements (EpRE) in the promoters of these genes. Nrf2 overexpression increased the activity of GCS(h) and GCS(l) promoter/reporter transgenes.	SEN:10010906	10559251
BEL:20066148	tscript(p(HGNC:NFE2L2)) directlyIncreases r(HGNC:GSTA1)	Nrf2 regulates expression of genes encoding enzymes with antioxidant (e.g. heme oxygenase-1 (HO-1)) or xenobiotic detoxification (e.g. NAD(P)H:quinone oxidoreductase, glutathione S-transferase) functions via the stress- or antioxidant-response elements (StRE/ARE)	SEN:10010908	11274184
BEL:20066152	tscript(p(HGNC:NFE2L2)) directlyIncreases r(HGNC:HMOX1)	Furthermore, Nrf2.ATF4 dimers bound to an StRE sequence from the ho-1 gene. CdCl(2), a potent inducer of HO-1, increased expression of ATF4 in mouse hepatoma cells, and detectable induction of ATF4 protein preceded that of HO-1	SEN:10020072	11274184
BEL:20066156	tscript(p(HGNC:NFE2L2)) directlyIncreases r(HGNC:NQO1)	Nrf2 regulates expression of genes encoding enzymes with antioxidant (e.g. heme oxygenase-1 (HO-1)) or xenobiotic detoxification (e.g. NAD(P)H:quinone oxidoreductase, glutathione S-transferase) functions via the stress- or antioxidant-response elements (StRE/ARE)	SEN:10010908	11274184
BEL:20066160	tscript(p(HGNC:NFE2)) directlyIncreases r(HGNC:TBXAS1)	Finally, a direct interaction between PPARgamma and NRF2 was confirmed by glutathione S-transferase pull-down assay. In conclusion, the NRF2-binding site (-98/-88) is the major promoter of 5'FL-TXS which can be suppressed by activated PPARgamma via a protein-protein interaction with NRF2 in macrophages.	SEN:10020074	10930400
BEL:20066164	tscript(p(HGNC:NFKB1)) directlyIncreases r(HGNC:CRP)	Unexpectedly, transactivation assays in transiently transfected Hep 3B cells showed p50 overexpression to markedly induce CRP transcription, acting in a region 3' to -86... EMSA studies demonstrated that recombinant p50 bound to a nonconsensus kappaB site overlapping the proximal C/EBP binding site on the CRP promoter.	SEN:10032402	11035101
BEL:20066172	tscript(p(HGNC:"NKX2-5")) increases r(HGNC:ADORA1)	Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression. These observations suggest that embryonic A1AR expression involves activation of the A1AR promoter by GATA-4 and Nkx2.5.	SEN:10010836	10318839
BEL:20066174	tscript(p(HGNC:"NKX3-1")) increases r(HGNC:ACTG2)	Nkx3-1 facilitated SRF binding to the complex Nkx-binding site (NKE) of SMGA. Expression of mNkx3-1 in heterologous CV-1 fibroblasts was unable to elicit SMGA promoter activity but required the coexpression of serum response factor (SRF) to activate robust SMGA transcription. Thus, SMGA is a novel target for Nkx3-1, and the activity of Nkx3-1 on the SMGA promoter is dependent upon SRF.	SEN:10032408	10993896
BEL:20066178	tscript(p(HGNC:NR0B1)) decreases r(HGNC:CYP17A1)	In constructs containing all three functional SF-1 elements, DAX1 inhibited this activation by > or =55%.	SEN:10032412	11145739
BEL:20066190	tscript(p(HGNC:NR2C1)) directlyDecreases r(HGNC:HRH1)	We have identified a DNA response element (TR2RE-HR) in the 3' flanking region of the human histamine H1 receptor gene as a target for the TR2 orphan receptor the expression of the human histamine H1 receptor gene was differentially repressed by the TR2 orphan receptor	SEN:10032418	10391141
BEL:20066202	tscript(p(HGNC:NR2F2)) decreases bp(GOBP:"cell growth")	Introduction of COUP-TFII to MDA-MB-435 cells resulted in reduced growth and plating efficiency. Interestingly, COUP-TFII increased the expression of cyclin D1 and p21(WAF1/CIP1) in MDA-MB-435 cells	SEN:10010920	10772965
BEL:20066204	tscript(p(HGNC:NR2F2)) decreases kin(p(HGNC:CDK2))	The activity of cdk2 required for G2/M progression was reduced in COUP-TFII cells compared to parental cells	SEN:10010922	10772965
BEL:20066208	tscript(p(HGNC:NR2F2)) increases r(HGNC:CCND1)	Introduction of COUP-TFII to MDA-MB-435 cells resulted in reduced growth and plating efficiency. Interestingly, COUP-TFII increased the expression of cyclin D1 and p21(WAF1/CIP1) in MDA-MB-435 cells	SEN:10010920	10772965
BEL:20066210	tscript(p(HGNC:NR2F2)) increases r(HGNC:CDKN1A)	Introduction of COUP-TFII to MDA-MB-435 cells resulted in reduced growth and plating efficiency. Interestingly, COUP-TFII increased the expression of cyclin D1 and p21(WAF1/CIP1) in MDA-MB-435 cells	SEN:10010920	10772965
BEL:20066212	tscript(p(HGNC:NR2F2)) increases r(HGNC:CYP7A1)	Hepatocyte nuclear factor 4 (HNF4) and chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) synergistically activate transcription of the CYP7A1 promoter	SEN:10032336	10627496
BEL:20066236	tscript(p(HGNC:NR3C1)) decreases r(HGNC:HMOX1)	We have shown that the inflammatory cytokines, interleukin-6 (IL-6) and heme-induced HO-1 gene expression, were suppressed by dexamethasone (Dex) in a sustained manner.	SEN:10010930	10564544
BEL:20066238	tscript(p(HGNC:NR3C1)) decreases r(HGNC:IL6)	We have shown that the inflammatory cytokines, interleukin-6 (IL-6) and heme-induced HO-1 gene expression, were suppressed by dexamethasone (Dex) in a sustained manner.	SEN:10010930	10564544
BEL:20066240	tscript(p(HGNC:NR3C1)) increases r(HGNC:LOX)	Lysyl oxidase transcription was stimulated by dexamethasone treatment of cells, but this effect could not be assigned within the approximately 3 kb region tested in reporter gene constructs.	SEN:10015624	10391127
BEL:20066242	tscript(p(HGNC:NR3C1)) increases r(HGNC:MYOC)	Treatment of TM cell cultures with dexamethasone for 1 day markedly increased expression of myocilin/TIGR mRNA	SEN:10010932	10509652
BEL:20066246	tscript(p(HGNC:NR3C1)) decreases r(HGNC:PDGFA)	The expression of PDGF-A is repressed by several stimuli, such as glucocorticoid treatment of smooth muscle cells (318) and aging of human fibroblasts (226).	SEN:10032426	10508235
BEL:20066258	tscript(p(HGNC:NR3C2)) increases r(HGNC:SGK1)	Sgk (serum- and glucocorticoid-induced protein kinase) is a serine/threonine-specific protein kinase that is transcriptionally regulated by serum, glucorticoids, and mineralocorticoids.	SEN:10010938	11096081
BEL:20066262	tscript(p(HGNC:NR5A1)) increases r(HGNC:CYP17A1)	The 5'-flanking region of the human CYP17 gene contains three functional SF-1 elements that collectively mediate a > or =25-fold induction of promoter activity by SF-1.	SEN:10032428	11145739
BEL:20066270	tscript(p(HGNC:NRF1)) decreases r(HGNC:E2F1)	The mechanism for the cell cycle downregulation appeared to be a transcriptional downregulation of E2F-1, a transcription factor that regulates genes required for cell cycle progression beyond the G1/S interphase.	SEN:10010796	10634932
BEL:20066272	tscript(p(HGNC:NRF1)) increases r(HGNC:EIF2S1)	The mechanism for the increased protein synthesis and growth appeared to be a transcriptional upregulation of the eIF-2alpha and eIF-2beta genes.	SEN:10032432	10634932
BEL:20066274	tscript(p(HGNC:NRF1)) increases r(HGNC:EIF2S2)	The mechanism for the increased protein synthesis and growth appeared to be a transcriptional upregulation of the eIF-2alpha and eIF-2beta genes.	SEN:10032432	10634932
BEL:20066284	tscript(p(HGNC:PBX1)) increases r(HGNC:CDKN1A)	In this paper, we describe a mechanism by which p21 and HOXA10 may act in concert, where HOXA10 can bind directly to the p21 promoter and, together with its trimeric partners PBX1 and MEIS1, activate p21 transcription, resulting in cell cycle arrest and differentiation.	SEN:10010856	11040212
BEL:20066286	tscript(p(HGNC:PBX1)) directlyIncreases r(HGNC:COL5A2)	DNA binding assays and cell transfection experiments revealed that the bipartite core sequence of FPB (5'-ATCAATCA-3') binds the PBX1/2, PREP1, and HOXB1 proteins, and this in turn leads to promoter transactivation.	SEN:10010860	10748126
BEL:20066288	tscript(p(HGNC:PBX2)) directlyIncreases r(HGNC:COL5A2)	DNA binding assays and cell transfection experiments revealed that the bipartite core sequence of FPB (5'-ATCAATCA-3') binds the PBX1/2, PREP1, and HOXB1 proteins, and this in turn leads to promoter transactivation.	SEN:10010860	10748126
BEL:20066290	tscript(p(HGNC:PDX1)) increases bp(GOBP:"insulin secretion")	hepatocyte nuclear factor (HNF)-4a, HNF-1a, insulin promoter factor-1, and HNF-1b in MODY1, -3, -4, and -5, respectively (Yamagata et al., 1996a, 1996b; Stoffers et al., 1997; Horikawa et al., 1997). These transcription factors are expressed in pancreatic b cells, and the mutations are believed to cause insulin deficiency by impairing b cell function.	SEN:10032332	10199397
BEL:20066302	tscript(p(HGNC:PKNOX1)) directlyIncreases r(HGNC:COL5A2)	DNA binding assays and cell transfection experiments revealed that the bipartite core sequence of FPB (5'-ATCAATCA-3') binds the PBX1/2, PREP1, and HOXB1 proteins, and this in turn leads to promoter transactivation.	SEN:10010860	10748126
BEL:20066308	tscript(p(HGNC:POU4F1)) increases r(HGNC:POU3F2)	Transfection of expression plasmids for Brn3a, Brn3b, and Brn3c (Pou4f1, 2, and 3) transactivated the Brn3b promoter by 3- to 10-fold in 293T cells or ND7 cells.	SEN:10032450	11172005
BEL:20066310	tscript(p(HGNC:POU4F2)) increases r(HGNC:POU3F2)	Transfection of expression plasmids for Brn3a, Brn3b, and Brn3c (Pou4f1, 2, and 3) transactivated the Brn3b promoter by 3- to 10-fold in 293T cells or ND7 cells.	SEN:10032450	11172005
BEL:20066312	tscript(p(HGNC:POU4F3)) increases r(HGNC:POU3F2)	Transfection of expression plasmids for Brn3a, Brn3b, and Brn3c (Pou4f1, 2, and 3) transactivated the Brn3b promoter by 3- to 10-fold in 293T cells or ND7 cells.	SEN:10032450	11172005
BEL:20066322	tscript(p(HGNC:PPARA)) increases r(HGNC:APOA1)	PPARalpha activation increases plasma HDL cholesterol via the induction of hepatic apolipoprotein A-I and apolipoprotein A-II expression in humans	SEN:10010946	10774955
BEL:20066324	tscript(p(HGNC:PPARA)) increases r(HGNC:APOA2)	PPARalpha activation increases plasma HDL cholesterol via the induction of hepatic apolipoprotein A-I and apolipoprotein A-II expression in humans	SEN:10010946	10774955
BEL:20066326	tscript(p(HGNC:PPARA)) decreases r(HGNC:APOC3)	PPARalpha down-regulates hepatic apolipoprotein C-III and increases lipoprotein lipase gene expression	SEN:10010948	10774955
BEL:20066332	tscript(p(HGNC:PPARA)) decreases r(HGNC:EDN1)	Furthermore, cotransfection with either a PPAR{alpha} or a PPAR{gamma} expression vector significantly repressed both basal (P=0.002 and P=0.007, respectively) and thrombin-induced ET-1 promoter activity, an effect which was further enhanced in the presence of their respective ligands (P=0.001 and P=0.002, respectively) (Figure 5ADown and 5BDown).	SEN:10032454	10473669
BEL:20066340	tscript(p(HGNC:PPARA)) increases r(HGNC:LPL)	PPARalpha down-regulates hepatic apolipoprotein C-III and increases lipoprotein lipase gene expression	SEN:10010948	10774955
BEL:20066350	tscript(p(HGNC:PPARA)) decreases r(HGNC:VCAM1)	Both PPARalpha activators decreased cytokine-induced VCAM-1 mRNA expression without altering its mRNA half-life	SEN:10010958	10377075
BEL:20066362	tscript(p(HGNC:PPARA)) decreases tscript(p(HGNC:JUN))	Transcriptional interference between PPARalpha and both c-Jun and p65 occurs reciprocally, since c-Jun and p65 also inhibit PPARalpha-mediated activation of a PPAR response element-driven promoter.	SEN:10010870	10542237
BEL:20066366	tscript(p(HGNC:PPARA)) decreases tscript(p(HGNC:RELA))	Transcriptional interference between PPARalpha and both c-Jun and p65 occurs reciprocally, since c-Jun and p65 also inhibit PPARalpha-mediated activation of a PPAR response element-driven promoter.	SEN:10010870	10542237
BEL:20066382	tscript(p(HGNC:PPARG)) decreases r(HGNC:AGTR1)	Accumulated observations have shown, however, that activation of PPARgamma can suppress transcription of some genes, including the angiotensin AT 1 receptor ( 43 ) and endothelin-1 ( 17 ) genes	SEN:10032466	10930400
BEL:20066392	tscript(p(HGNC:PPARG)) decreases r(HGNC:EDN1)	Furthermore, cotransfection with either a PPAR{alpha} or a PPAR{gamma} expression vector significantly repressed both basal (P=0.002 and P=0.007, respectively) and thrombin-induced ET-1 promoter activity, an effect which was further enhanced in the presence of their respective ligands (P=0.001 and P=0.002, respectively) (Figure 5ADown and 5BDown).	SEN:10032454	10473669
BEL:20066394	tscript(p(HGNC:PPARG)) decreases r(HGNC:EDN1)	Accumulated observations have shown, however, that activation of PPARgamma can suppress transcription of some genes, including the angiotensin AT 1 receptor ( 43 ) and endothelin-1 ( 17 ) genes	SEN:10032466	10930400
BEL:20066402	tscript(p(HGNC:PPARG)) decreases r(HGNC:ITGB2)	proliferator-activated receptor gamma (PPARgamma) agonist, 15-deoxy-delta12,4-prostaglandin J2 (15d-PGJ2), which also inhibited the IFNgamma induction of the beta2 integrin	SEN:10010964	11132183
BEL:20066426	tscript(p(HGNC:PPARG)) increases r(HGNC:SORBS1)	Thiazolidinediones (TZDs), the class of insulin sensitizers that act through the nuclear receptor PPAR-g, increase CAP expression levels and c-Cbl phosphorylation significantly in adipocytes (54), possibly contributing to their insulin sensitizing effect	SEN:10017828	10194465
BEL:20066428	tscript(p(HGNC:PPARG)) decreases r(HGNC:TBXAS1)	Finally, a direct interaction between PPARgamma and NRF2 was confirmed by glutathione S-transferase pull-down assay. In conclusion, the NRF2-binding site (-98/-88) is the major promoter of 5'FL-TXS which can be suppressed by activated PPARgamma via a protein-protein interaction with NRF2 in macrophages.	SEN:10020074	10930400
BEL:20066446	tscript(p(HGNC:RARA)) increases r(HGNC:CYP26A1)	Treatment of HTBE cells with retinoids that selectively bind and activate the RARalpha, beta, or gamma receptor also increased the level of CYP26 expression (Fig.4A).	SEN:10032480	10953040
BEL:20066448	tscript(p(HGNC:RARA)) increases r(HGNC:MUC2)	RAR-, RARalpha- and RARgamma-selective agonists strongly induced mucin mRNAs in a dose-dependent manner, while the RARbeta-selective retinoid only weakly induced mucin gene expression at very high concentrations (1 microM).	SEN:10032482	10024510
BEL:20066450	tscript(p(HGNC:RARA)) increases r(HGNC:MUC5AC)	RAR-, RARalpha- and RARgamma-selective agonists strongly induced mucin mRNAs in a dose-dependent manner, while the RARbeta-selective retinoid only weakly induced mucin gene expression at very high concentrations (1 microM).	SEN:10032482	10024510
BEL:20066452	tscript(p(HGNC:RARA)) decreases tscript(p(HGNC:NR4A1))	transactivation activity of Nur77 was significantly inhibited by cotransfection of RARalpha or RXRalpha	SEN:10032484	10772826
BEL:20066454	tscript(p(HGNC:RARB)) increases r(HGNC:CYP26A1)	Treatment of HTBE cells with retinoids that selectively bind and activate the RARalpha, beta, or gamma receptor also increased the level of CYP26 expression (Fig.4A).	SEN:10032480	10953040
BEL:20066462	tscript(p(HGNC:RARG)) increases r(HGNC:CYP26A1)	Treatment of HTBE cells with retinoids that selectively bind and activate the RARalpha, beta, or gamma receptor also increased the level of CYP26 expression (Fig.4A).	SEN:10032480	10953040
BEL:20066464	tscript(p(HGNC:RARG)) increases r(HGNC:MUC2)	RAR-, RARalpha- and RARgamma-selective agonists strongly induced mucin mRNAs in a dose-dependent manner, while the RARbeta-selective retinoid only weakly induced mucin gene expression at very high concentrations (1 microM).	SEN:10032482	10024510
BEL:20066466	tscript(p(HGNC:RARG)) increases r(HGNC:MUC5AC)	RAR-, RARalpha- and RARgamma-selective agonists strongly induced mucin mRNAs in a dose-dependent manner, while the RARbeta-selective retinoid only weakly induced mucin gene expression at very high concentrations (1 microM).	SEN:10032482	10024510
BEL:20066472	tscript(p(HGNC:RB1)) directlyDecreases r(HGNC:CCNE1)	<E15> E2F-regulated genes include many that are involved in cell cycle progression and control. Individual genes are differently regulated. Dyhydrofolate reductase (DHFR) is activated via the E2F transactivation domain, whereas B-myb, Cyclin E, E2F-1, E2F-2, and Cdc2 are regulated via the repression domain of pRb family proteins (Dyson, 1998).	SEN:10032488	10436023
BEL:20066474	tscript(p(HGNC:RB1)) directlyIncreases tscript(p(HGNC:CEBPB))	<E16> pRb binds and activates C/EBP (Chen et al., 1996a,b). The binding of C/EBP to its DNA recognition elements is enhanced.	SEN:10020124	10436023
BEL:20066476	tscript(p(HGNC:RELA)) increases r(HGNC:IL6)	Furthermore, activation of PPARalpha represses both c-Jun- and p65-induced transcription of the human IL-6 promoter.	SEN:10032350	10542237
BEL:20066482	tscript(p(HGNC:RELA)) decreases tscript(p(HGNC:PPARA))	Transcriptional interference between PPARalpha and both c-Jun and p65 occurs reciprocally, since c-Jun and p65 also inhibit PPARalpha-mediated activation of a PPAR response element-driven promoter.	SEN:10010870	10542237
BEL:20066488	tscript(p(HGNC:RORA)) decreases r(HGNC:IL6)	We demonstrated that ROR alpha is expressed in human primary smooth-muscle cells and that ectopic expression of ROR alpha1 inhibits TNFalpha-induced IL-6, IL-8 and COX-2 expression in these cells.	SEN:10032494	11252722
BEL:20066490	tscript(p(HGNC:RORA)) decreases r(HGNC:IL8)	We demonstrated that ROR alpha is expressed in human primary smooth-muscle cells and that ectopic expression of ROR alpha1 inhibits TNFalpha-induced IL-6, IL-8 and COX-2 expression in these cells.	SEN:10032494	11252722
BEL:20066494	tscript(p(HGNC:RORA)) decreases r(HGNC:PTGS2)	We demonstrated that ROR alpha is expressed in human primary smooth-muscle cells and that ectopic expression of ROR alpha1 inhibits TNFalpha-induced IL-6, IL-8 and COX-2 expression in these cells.	SEN:10032494	11252722
BEL:20066498	tscript(p(HGNC:RUNX1)) increases r(HGNC:PPP1R12A)	In this region the putative cis element binding factor, AML1a \"(RUNX1)\", was detected [20]. Further deletion of 31 bp from nucleotide positions 3229 to 3199 resulted in increased luciferase activity, indicating the possibility of negative cis element(s) located between 3229 and 3199. Two putative cis element binding factors, STATx [21] and c-Ets-1 [22], were demonstrated in this region.	SEN:10032298	11342221
BEL:20066510	tscript(p(HGNC:RXRA)) decreases tscript(p(HGNC:NR4A1))	transactivation activity of Nur77 was significantly inhibited by cotransfection of RARalpha or RXRalpha	SEN:10032484	10772826
BEL:20066514	tscript(p(HGNC:SMAD3)) decreases bp(GOBP:"cell proliferation")	indicate a direct physical and functional interplay between two negative regulators of cell proliferation, Smad3 and P/CAF.	SEN:10032352	11058129
BEL:20066520	tscript(p(HGNC:SMAD3)) directlyIncreases r(HGNC:ITGB5)	Furthermore, expression of dominant negative Smad3 or Smad4 in cells decreased or abolished the stimulation of beta(5) promoter activity by TGF-beta. Smad4 mutant also inhibited the up-regulation of surface beta(5) level by TGF-beta. Thus, TGF-beta increases expression of the integrin beta(5) gene by mechanisms involving Sp1/Sp3 and Smad transcription factors.	SEN:10024480	10964912
BEL:20066526	tscript(p(HGNC:SMAD3)) increases tscript(p(HGNC:STK16))	TSF1 did not directly activate a Smads-dependent promoter from plasminogen activator inhibitor 1 gene, but it showed enhancement in co-operation with Smad3 and Smad4.	SEN:10010980	10947953
BEL:20066530	tscript(p(HGNC:SMAD4)) directlyIncreases r(HGNC:ITGB5)	Furthermore, expression of dominant negative Smad3 or Smad4 in cells decreased or abolished the stimulation of beta(5) promoter activity by TGF-beta. Smad4 mutant also inhibited the up-regulation of surface beta(5) level by TGF-beta. Thus, TGF-beta increases expression of the integrin beta(5) gene by mechanisms involving Sp1/Sp3 and Smad transcription factors.	SEN:10024480	10964912
BEL:20066536	tscript(p(HGNC:SMAD4)) increases tscript(p(HGNC:STK16))	TSF1 did not directly activate a Smads-dependent promoter from plasminogen activator inhibitor 1 gene, but it showed enhancement in co-operation with Smad3 and Smad4.	SEN:10010980	10947953
BEL:20066548	tscript(p(HGNC:SNAI1)) decreases r(HGNC:CDH1)	The mRNA levels of E-cadherin were also stimulated and snail mRNA expression was inhibited upon inhibition of ILK as determined by Northern blot analysis. These data establish that ILK regulates the transcription of snail which in turn regulates the expression of E cadherin.	SEN:10032500	11244511
BEL:20066550	tscript(p(HGNC:SNF8)) directlyDecreases tscript(p(HGNC:ELL))	This hypothesis was confirmed when EAP30 was cloned and shown to interact directly with ELL in vitro and to prevent it from inhibiting transcription initiation	SEN:10032502	11278625
BEL:20066552	tscript(p(HGNC:SOX10)) increases r(HGNC:MITF)	Promoter deletion and mutational analyses indicate that SOX10 can activate MITF expression through binding to a region that is evolutionarily conserved between the mouse and human MITF promoters.	SEN:10010984	10982026
BEL:20066558	tscript(p(HGNC:SP1)) increases r(HGNC:APOE)	Important factors for apoE gene regulation appear to be SP1 on the proximal promoter, and possibly HNF-3, C/EBP and hormone nuclear receptors on the enhancers.	SEN:10010776	11229886
BEL:20066580	tscript(p(HGNC:SP1)) directlyIncreases r(HGNC:MMP2)	Co-transfection expression experiments in Drosophilia SL2 cells lacking endogenous Sp factors demonstrate that Sp1 and Sp3 function as activators of the MMP-2 promoter and synergize for enhanced MMP-2 activation. Overexpression of AP-2 in AP-2-deficient HepG2 cells enhances MMP-2 promoter activation.	SEN:10011000	10506168
BEL:20066590	tscript(p(HGNC:SP1)) increases r(HGNC:PPP1R12A)	Basal promoter activity was due to the GC-rich region that contained one Sp1 transcription factor binding site, thus demonstrating that the MYPT1 gene is a housekeeping gene.	SEN:10011002	11342221
BEL:20066600	tscript(p(HGNC:SP1)) directlyIncreases r(HGNC:VEGFA)	It has been shown through electrophoretic mobility shift assay that Ras promoted the PKCzeta-induced binding of Sp1 to the VPF/VEGF promoter.	SEN:10006004	11060301
BEL:20066602	tscript(p(HGNC:SP2)) increases r(HGNC:MAT2A)	Supershift assays showed that the transcription factors Sp2 and Sp3 are part of the complexes formed at the Sp1-3 site, and that Sp1 does not appear to be directly involved. The data indicate that complex formation is initiated at site Sp1-3, which appears to be essential for promoter activity. However, other regions of the proximal promoter may also contribute to the regulation of MAT2A gene expression.	SEN:10032516	11124935
BEL:20066606	tscript(p(HGNC:SP3)) increases r(HGNC:MAT2A)	Supershift assays showed that the transcription factors Sp2 and Sp3 are part of the complexes formed at the Sp1-3 site, and that Sp1 does not appear to be directly involved. The data indicate that complex formation is initiated at site Sp1-3, which appears to be essential for promoter activity. However, other regions of the proximal promoter may also contribute to the regulation of MAT2A gene expression.	SEN:10032516	11124935
BEL:20066608	tscript(p(HGNC:SP3)) directlyIncreases r(HGNC:MMP2)	Co-transfection expression experiments in Drosophilia SL2 cells lacking endogenous Sp factors demonstrate that Sp1 and Sp3 function as activators of the MMP-2 promoter and synergize for enhanced MMP-2 activation. Overexpression of AP-2 in AP-2-deficient HepG2 cells enhances MMP-2 promoter activation.	SEN:10011000	10506168
BEL:20066620	tscript(p(HGNC:SREBF1)) directlyIncreases r(HGNC:APOA2)	SREBP-1 and SREBP-2 bind to five and four sites respectively and transactivate the apoA-II promoter	SEN:10011008	11229886
BEL:20066640	tscript(p(HGNC:SRF)) increases r(HGNC:ACTG2)	Nkx3-1 facilitated SRF binding to the complex Nkx-binding site (NKE) of SMGA. Expression of mNkx3-1 in heterologous CV-1 fibroblasts was unable to elicit SMGA promoter activity but required the coexpression of serum response factor (SRF) to activate robust SMGA transcription. Thus, SMGA is a novel target for Nkx3-1, and the activity of Nkx3-1 on the SMGA promoter is dependent upon SRF.	SEN:10032408	10993896
BEL:20066648	tscript(p(HGNC:STAT1)) increases r(HGNC:MMP2)	The STAT-1 inhibitor fludarabine significantly reduced MMP-2 expression, but not MMP-9 expression, in FIV-infected macrophages. Analysis of MMP mRNA and protein levels in brain samples from HIV-infected persons or FIV-infected cats showed that MMP-2 and -9 levels were significantly increased in lentivirus-infected brains compared to those of uninfected controls.	SEN:10011014	10906175
BEL:20066650	tscript(p(HGNC:STAT1)) increases r(HGNC:SOCS3)	CIS and SOCS-2 expression was induced either via STAT1 and/or STAT3 or via STAT5 but only STAT1 and/or STAT3 were involved in SOCS-3 expression.	SEN:10007314	11115404
BEL:20066654	tscript(p(HGNC:STAT2)) increases tscript(p(HGNC:STAT4))	in contrast to the direct recruitment of Stat4 by the IL-12 receptor, Stat4 activation by the human IFN-alpha receptor occurs through indirect recruitment by intermediates involving Stat2	SEN:10023316	10644731
BEL:20066656	tscript(p(HGNC:STAT3)) increases bp(GOBP:"G1/S transition of mitotic cell cycle")	The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. #[JL] IL6ST is gp130	SEN:10023710	10626893
BEL:20066658	tscript(p(HGNC:STAT3)) decreases bp(GOBP:"apoptotic process")	The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. #[JL] IL6ST is gp130	SEN:10023710	10626893
BEL:20066664	tscript(p(HGNC:STAT3)) directlyIncreases r(HGNC:HMOX1)	STAT3-specific probe inhibited nuclear binding protein to the putative HO-1-STAT3 sequence. This suggests that IL-6 induction of human HO-1 is mediated via the JAK-STAT pathway and that Dex inhibition of gene expression is carried out by activation of a transcriptional protein in competition with the STAT3 binding site.	SEN:10011020	10564544
BEL:20066666	tscript(p(HGNC:STAT3)) increases r(HGNC:SOCS3)	CIS and SOCS-2 expression was induced either via STAT1 and/or STAT3 or via STAT5 but only STAT1 and/or STAT3 were involved in SOCS-3 expression.	SEN:10007314	11115404
BEL:20066670	tscript(p(HGNC:STAT4)) increases bp(GOBP:"T-helper 1 cell differentiation")	Interleukin 12 (IL-12)-induced T helper 1 (Th1) development requires Stat4 activation. Using subtractive cloning, we identified ERM, an Ets transcription factor, to be a Th1-specific, IL-12-induced gene. IL-12-induction of ERM occurred in wild-type and Stat1-deficient, but not Stat4-deficient, T cells, suggesting ERM is Stat4-inducible.	SEN:10019898	10097133
BEL:20066672	tscript(p(HGNC:STAT4)) increases r(HGNC:ETV5)	Interleukin 12 (IL-12)-induced T helper 1 (Th1) development requires Stat4 activation. Using subtractive cloning, we identified ERM, an Ets transcription factor, to be a Th1-specific, IL-12-induced gene. IL-12-induction of ERM occurred in wild-type and Stat1-deficient, but not Stat4-deficient, T cells, suggesting ERM is Stat4-inducible.	SEN:10019898	10097133
BEL:20066680	tscript(p(HGNC:STAT5B)) directlyIncreases r(HGNC:SOCS3)	Stat5B from insulin-stimulated cells binds directly to a Stat element present in the SOCS3 promoter	SEN:10032534	10821852
BEL:20066682	tscript(p(HGNC:STAT6)) decreases p(HGNC:CD40)	Using transient transfection and EMSA, we demonstrate that IL-4-activated STAT-6 binds to two different SBEs in the human CD40 promoter to inhibit STAT-1 -mediated CD40 promoter activity.	SEN:10032536	11086058
BEL:20066684	tscript(p(HGNC:STAT6)) increases r(HGNC:ALOX12)	These data indicate that the human 12/15-lipoxygenase gene is induced in airway epithelial cells through Stat6-dependent transcriptional mechanisms mediated by a specific Stat6 response element in the 5'-flanking region	SEN:10011022	10657944
BEL:20066686	tscript(p(HGNC:STAT6)) increases r(HGNC:ALOX15)	These data indicate that the human 12/15-lipoxygenase gene is induced in airway epithelial cells through Stat6-dependent transcriptional mechanisms mediated by a specific Stat6 response element in the 5'-flanking region	SEN:10011022	10657944
BEL:20066694	tscript(p(HGNC:STK16)) increases r(HGNC:NPPC)	In this paper, we report on a novel factor which regulates the TGF-beta response promoter. This factor, named TSF1 (TGF-beta stimulated factor 1), possessed DNA-binding ability and activated the TGF-beta responsive CNP promoter or vascular endothelial growth factor gene promoter which possesses a sequence element analogous to the TGF-beta responsive GC-rich element of the CNP promoter.	SEN:10032036	10947953
BEL:20066698	tscript(p(HGNC:TCF20)) increases tscript(p(HGNC:JUN))	Using cotransfection experiments, we find that SPBP enhances the transcriptional activity of various transcription factors such as c-Jun, Ets1, Sp1, and Pax6. Hence, SPBP seems to act as a transcriptional coactivator.	SEN:10032542	10995766
BEL:20066700	tscript(p(HGNC:TCF20)) increases tscript(p(HGNC:PAX6))	Using cotransfection experiments, we find that SPBP enhances the transcriptional activity of various transcription factors such as c-Jun, Ets1, Sp1, and Pax6. Hence, SPBP seems to act as a transcriptional coactivator.	SEN:10032542	10995766
BEL:20066702	tscript(p(HGNC:TCF20)) increases tscript(p(HGNC:SP1))	Using cotransfection experiments, we find that SPBP enhances the transcriptional activity of various transcription factors such as c-Jun, Ets1, Sp1, and Pax6. Hence, SPBP seems to act as a transcriptional coactivator.	SEN:10032542	10995766
BEL:20066708	tscript(p(HGNC:TCF7L2)) directlyIncreases r(HGNC:ABCB1)	Corresponding to the accumulation of beta-catenin, expression of the MDR1 gene product was steadily up-regulated in adenomas and adenocarcinomas of 10 patients with familial adenomatous polyposis.	SEN:10032232	10987283
BEL:20066716	tscript(p(HGNC:TFAP2A)) directlyIncreases r(HGNC:ERBB2)	Further characterization of this protein has identified a family of three related genes, AP-2alpha, beta and gamma (Bosher et al., 1996). All three of these proteins, but particularly AP-2alpha and gamma, can activate the ERBB2 promoter and can be found at elevated levels in breast tumour-derived cell lines.	SEN:10032550	10698518
BEL:20066726	tscript(p(HGNC:TFAP2C)) directlyIncreases r(HGNC:ERBB2)	Further characterization of this protein has identified a family of three related genes, AP-2alpha, beta and gamma (Bosher et al., 1996). All three of these proteins, but particularly AP-2alpha and gamma, can activate the ERBB2 promoter and can be found at elevated levels in breast tumour-derived cell lines.	SEN:10032550	10698518
BEL:20066742	tscript(p(HGNC:TP53)) decreases r(HGNC:ABL1)	The suppressed genes include mainly cell cycle regulators like cyclin B1, cyclin H and kinases like c-abl, CLK1 and others.	SEN:10011030	10722849
BEL:20066746	tscript(p(HGNC:TP53)) increases r(HGNC:BAX)	Endogenous bcl-2 protein level decreased 12 fold and bax increased approximately 4 fold in PC3 vector control cells following Ad-p53 infection.	SEN:10032558	11146439
BEL:20066748	tscript(p(HGNC:TP53)) decreases r(HGNC:CCNB1)	The suppressed genes include mainly cell cycle regulators like cyclin B1, cyclin H and kinases like c-abl, CLK1 and others.	SEN:10011030	10722849
BEL:20066750	tscript(p(HGNC:TP53)) decreases r(HGNC:CCNH)	The suppressed genes include mainly cell cycle regulators like cyclin B1, cyclin H and kinases like c-abl, CLK1 and others.	SEN:10011030	10722849
BEL:20066756	tscript(p(HGNC:TP53)) decreases r(HGNC:CLK1)	The suppressed genes include mainly cell cycle regulators like cyclin B1, cyclin H and kinases like c-abl, CLK1 and others.	SEN:10011030	10722849
BEL:20066760	tscript(p(HGNC:TP53)) decreases r(HGNC:GDF15)	The most notable induced gene was MIC-1, encoding a TGF-beta-related secretory protein, suggesting a potential paracrine component for p53 growth suppression.	SEN:10011038	10722849
BEL:20066770	tscript(p(HGNC:TP53)) directlyIncreases r(HGNC:PCNA)	<r12> p53 binds and transiently transactivates the PCNA promoter (when p53 reaches high levels, transactivation seems to stop) (Shivakumar et al., 1995; Morris et al., 1996; Xu and Morris, 1999).	SEN:10032562	10436023
BEL:20066776	tscript(p(HGNC:TP53)) directlyDecreases r(HGNC:PTGS2)	Levels of Cox-2 protein and mRNA were markedly suppressed by wt p53 but not by mutant p53. Electrophoretic mobility shift assay revealed that p53 competed with TATA-binding protein for binding to mouse Cox-2 or human Cox-2 promoter extending from -50 to +52 base pairs.	SEN:10032566	10196169
BEL:20066786	tscript(p(HGNC:TP53)) increases r(HGNC:TNFRSF10B)	HPV-16 E6 expression suppresses CD437-induced CPP32 activation (A), PARP cleavage (B), and cytochrome c (C) in H460 cells.	SEN:10024610	10383141
BEL:20066788	tscript(p(HGNC:TP53)) increases r(HGNC:TPO)	Conversely, introduction of wild-type p53 into undifferentiated thyroid carcinoma cell line induced reexpression of TPO gene ( 52 ).	SEN:10032572	11108245
BEL:20066792	tscript(p(HGNC:TP73)) directlyIncreases r(HGNC:CDKN1A)	endogenous p73 alpha and beta proteins are up-regulated in p53-deficient tumor cells in response to overexpressed E2F1, c-Myc, and E1A. E2F1, c-Myc, and E1A-mediated p73 up-regulation leads to activation of the p73 transcription function, as shown by p73-responsive reporter activity and by induction of known endogenous p73 target gene products such as p21 and HDM2.	SEN:10011052	11115495
BEL:20066794	tscript(p(HGNC:TP73)) directlyIncreases r(HGNC:MDM2)	endogenous p73 alpha and beta proteins are up-regulated in p53-deficient tumor cells in response to overexpressed E2F1, c-Myc, and E1A. E2F1, c-Myc, and E1A-mediated p73 up-regulation leads to activation of the p73 transcription function, as shown by p73-responsive reporter activity and by induction of known endogenous p73 target gene products such as p21 and HDM2.	SEN:10011052	11115495
BEL:20066814	tscript(p(HGNC:WT1)) decreases r(HGNC:CTGF)	Our results indicate that CTGF is a bona fide target of WT1 transcriptional suppression and likely plays a role in Wilms tumorigenesis and associated disease syndromes.	SEN:10032588	10973960
BEL:20066830	tscript(p(HGNC:YY1)) decreases r(HGNC:FDPS)	the induction of 2 other reporter genes, FPPS and LDLR, in response to cellular sterol depletion, was attenuated by coexpressed wild-type Yy1	SEN:10032600	10318878
BEL:20066832	tscript(p(HGNC:YY1)) decreases r(HGNC:FDPS)	Yy1 inhibits the transcription of specific SREBP-dependent genes and that, in the case of the HMG-CoA synthase gene, this involves displacement of nuclear factor Y from the promoter Yy1 plays a regulatory role in the transcriptional regulation of specific SREBP-responsive genes	SEN:10032602	10318878
BEL:20066834	tscript(p(HGNC:YY1)) decreases r(HGNC:HMGCS1)	induction was attenuated approximately 80 percent when cell were cotransfected with low levels of a plasmid encoding wild-type Yy1	SEN:10032604	10318878
BEL:20066836	tscript(p(HGNC:YY1)) decreases r(HGNC:HMGCS1)	Yy1 inhibits the transcription of specific SREBP-dependent genes and that, in the case of the HMG-CoA synthase gene, this involves displacement of nuclear factor Y from the promoter Yy1 plays a regulatory role in the transcriptional regulation of specific SREBP-responsive genes	SEN:10032602	10318878
BEL:20066838	tscript(p(HGNC:YY1)) decreases r(HGNC:HMGCS2)	induction was attenuated approximately 80 percent when cell were cotransfected with low levels of a plasmid encoding wild-type Yy1	SEN:10032604	10318878
BEL:20066840	tscript(p(HGNC:YY1)) decreases r(HGNC:HMGCS2)	Yy1 inhibits the transcription of specific SREBP-dependent genes and that, in the case of the HMG-CoA synthase gene, this involves displacement of nuclear factor Y from the promoter Yy1 plays a regulatory role in the transcriptional regulation of specific SREBP-responsive genes	SEN:10032602	10318878
BEL:20066842	tscript(p(HGNC:YY1)) decreases r(HGNC:LDLR)	the induction of 2 other reporter genes, FPPS and LDLR, in response to cellular sterol depletion, was attenuated by coexpressed wild-type Yy1	SEN:10032600	10318878
BEL:20066844	tscript(p(HGNC:YY1)) decreases r(HGNC:LDLR)	Yy1 inhibits the transcription of specific SREBP-dependent genes and that, in the case of the HMG-CoA synthase gene, this involves displacement of nuclear factor Y from the promoter Yy1 plays a regulatory role in the transcriptional regulation of specific SREBP-responsive genes	SEN:10032602	10318878
BEL:20066858	tscript(p(HGNC:ZNF202)) directlyDecreases r(HGNC:ABCA1)	Overexpression of ZNF202 m1 in RAW264.7 macrophages prevented the induction of ABCA1 gene expression by 20( S )OH-cholesterol and 9- cis -retinoic acid, further substantiating the interference of ZNF202 in critical elements of transcriptional activation......ZNF202 Binds Specific ABCA1 and ABCG1 Promotor Sequences....ZNF202m1 Represses ABCA1 and ABCG1 Promotors	SEN:10032608	11279031
BEL:20066860	tscript(p(HGNC:ZNF202)) directlyDecreases r(HGNC:ABCG1)	Overexpression of ZNF202 m1 in RAW264.7 macrophages prevented the induction of ABCA1 gene expression by 20( S )OH-cholesterol and 9- cis -retinoic acid, further substantiating the interference of ZNF202 in critical elements of transcriptional activation......ZNF202 Binds Specific ABCA1 and ABCG1 Promotor Sequences....ZNF202m1 Represses ABCA1 and ABCG1 Promotors	SEN:10032608	11279031
BEL:20066862	tscript(p(HGNC:ZNF202)) directlyDecreases r(HGNC:APOA4)	Fig. 6. Repression of apoAIV and apoE promoters by ZNF202 m1 in HepG2 cells. ......we used several reporter constructs containing portions of the apoE and apoAIV genes; these fragments all had been shown to bind ZNF202 in gel shift experiments.	SEN:10032610	10748193
BEL:20066864	tscript(p(HGNC:ZNF202)) directlyDecreases r(HGNC:APOC3)	Additional fragments derived from the promoters of phospholipid transfer protein and hepatic nuclear factor-4 (HNF4) and the apoCIII enhancer that had been shown to bind GST.ZF3-8 in vitro were also used in reporter assays. Transcriptional repression in the presence of ZNF202 was similar to the one observed for the apoE and apoAIV promoters (Table I)	SEN:10032612	10748193
BEL:20066866	tscript(p(HGNC:ZNF202)) directlyDecreases r(HGNC:APOE)	Fig. 6. Repression of apoAIV and apoE promoters by ZNF202 m1 in HepG2 cells. ......we used several reporter constructs containing portions of the apoE and apoAIV genes; these fragments all had been shown to bind ZNF202 in gel shift experiments.	SEN:10032610	10748193
BEL:20066868	tscript(p(HGNC:ZNF202)) directlyDecreases r(HGNC:HNF4A)	Additional fragments derived from the promoters of phospholipid transfer protein and hepatic nuclear factor-4 (HNF4) and the apoCIII enhancer that had been shown to bind GST.ZF3-8 in vitro were also used in reporter assays. Transcriptional repression in the presence of ZNF202 was similar to the one observed for the apoE and apoAIV promoters (Table I)	SEN:10032612	10748193
BEL:20066870	tscript(p(HGNC:ZNF202)) directlyDecreases r(HGNC:PLTP)	Additional fragments derived from the promoters of phospholipid transfer protein and hepatic nuclear factor-4 (HNF4) and the apoCIII enhancer that had been shown to bind GST.ZF3-8 in vitro were also used in reporter assays. Transcriptional repression in the presence of ZNF202 was similar to the one observed for the apoE and apoAIV promoters (Table I)	SEN:10032612	10748193
BEL:20066876	tscript(p(MGI:Ahr)) decreases a(CHEBI:"reactive oxygen species")	These findings demonstrate that ET-1 activation of ET(A) receptors mediates an increase in ROS that is associated with cardiac hypertrophy in AhR null mice. In addition, the ET-1-mediated increase in ROS appears to be initiated via increased NAD(P)H oxidase activity.	SEN:10019040	16107552
BEL:20066880	tscript(p(MGI:Ahr)) increases bp(GOBP:"T-helper 17 cell differentiation")	Th17 development from wild-type mice is suboptimal in the presence of the AhR antagonist CH-223191, similar to the situation in AhR-deficient mice, which show attenuated IL-17 production and no IL-22 production.	SEN:10032616	19114668
BEL:20066882	tscript(p(MGI:Ahr)) increases p(MGI:Il17a)	Th17 development from wild-type mice is suboptimal in the presence of the AhR antagonist CH-223191, similar to the situation in AhR-deficient mice, which show attenuated IL-17 production and no IL-22 production.	SEN:10032616	19114668
BEL:20066884	tscript(p(MGI:Ahr)) increases p(MGI:Il22)	Th17 development from wild-type mice is suboptimal in the presence of the AhR antagonist CH-223191, similar to the situation in AhR-deficient mice, which show attenuated IL-17 production and no IL-22 production.	SEN:10032616	19114668
BEL:20066906	tscript(p(MGI:Ahr)) increases r(MGI:Nfe2l2)	In mice, TCDD induction of Nrf2 and Nrf2 target, Nqo1, is dependent on AhR, and thus TCDD induction of drug-processing genes may be routed through an AhR-Nrf2 sequence.	SEN:10011066	19474220
BEL:20066914	tscript(p(MGI:Ahr)) directlyIncreases r(MGI:Vav3)	In agreement with an AhR-dependent process, vav3 promoter activity was higher in wild-type 1c1c7 than in AhR-deficient c2 hepatoma cells (Figure 9A, right).....AhR binding to the XRE1, XRE2, and XRE3-4 elements was analyzed by PCR in AhR immunoprecipitates.	SEN:10032628	19158396
BEL:20066920	tscript(p(MGI:Akt2)) increases p(MGI:Sik2,pmod(P,S,358))	Insulin disrupts TORC2 activity by induction of the Ser/Thr kinase SIK2, which we show here undergoes AKT2-mediated phosphorylation at Ser 358.	SEN:10030632	17805301
BEL:20066924	tscript(p(MGI:Ar)) decreases bp(GOBP:"fat cell differentiation")	Therefore, testosterone and DHT regulate lineage determination in mesenchymal pluripotent cells by promoting their commitment to the myogenic lineage and inhibiting their differentiation into the adipogenic lineage through an androgen receptor-mediated pathway.	SEN:10032632	12960001
BEL:20066926	tscript(p(MGI:Ar)) increases bp(GOBP:"inflammatory response")	Further analysis indicated that AR suppressed wound healing by enhancing the inflammatory response through a localized increase in TNF-alpha expression (mRNA and protein).	SEN:10032634	19907077
BEL:20066932	tscript(p(MGI:Ar)) decreases bp(GOBP:"wound healing")	Further analysis indicated that AR suppressed wound healing by enhancing the inflammatory response through a localized increase in TNF-alpha expression (mRNA and protein).	SEN:10032634	19907077
BEL:20066942	tscript(p(MGI:Arnt)) directlyIncreases tscript(p(MGI:Epas1))	EPAS1 forms a heterodimeric complex with the aryl hydrocarbon nuclear transporter prior to transcriptional activation of target genes. EPAS1 expression is limited to the endothelium of mouse embryos and, in agreement with its cell type-specific expression pattern, is capable of specifically activating the transcription of the endothelial tyrosine kinase gene Tie-2.	SEN:10032636	9000051
BEL:20066944	tscript(p(MGI:Ar)) increases p(MGI:Tnf)	Further analysis indicated that AR suppressed wound healing by enhancing the inflammatory response through a localized increase in TNF-alpha expression (mRNA and protein).	SEN:10032634	19907077
BEL:20066946	tscript(p(MGI:Ar)) increases r(MGI:Ar)	Therefore, testosterone and DHT regulate lineage determination in mesenchymal pluripotent cells by promoting their commitment to the myogenic lineage and inhibiting their differentiation into the adipogenic lineage through an androgen receptor-mediated pathway.	SEN:10032632	12960001
BEL:20066948	tscript(p(MGI:Ar)) decreases r(MGI:Cebpa)	Therefore, testosterone and DHT regulate lineage determination in mesenchymal pluripotent cells by promoting their commitment to the myogenic lineage and inhibiting their differentiation into the adipogenic lineage through an androgen receptor-mediated pathway.	SEN:10032632	12960001
BEL:20066952	tscript(p(MGI:Ar)) directlyIncreases r(MGI:Pbsn)	AR stimulation on the probasin core promoter could be partially induced with BRG1, but BRM strongly stimulated AR activity	SEN:10032638	12775722
BEL:20066954	tscript(p(MGI:Ar)) decreases r(MGI:Pparg)	Therefore, testosterone and DHT regulate lineage determination in mesenchymal pluripotent cells by promoting their commitment to the myogenic lineage and inhibiting their differentiation into the adipogenic lineage through an androgen receptor-mediated pathway.	SEN:10032632	12960001
BEL:20066958	tscript(p(MGI:Ar)) increases r(MGI:Tnf)	Further analysis indicated that AR suppressed wound healing by enhancing the inflammatory response through a localized increase in TNF-alpha expression (mRNA and protein).	SEN:10032634	19907077
BEL:20066960	tscript(p(MGI:Arx)) directlyDecreases r(MGI:Ebf3)	Additionally, we found Arx directly repressed three of the identified transcription factors: Lmo1, Ebf3 and Shox2 {Promoter activation, ChIP and EMSA}.	SEN:10032640	18799476
BEL:20066962	tscript(p(MGI:Arx)) directlyDecreases r(MGI:Lmo1)	Additionally, we found Arx directly repressed three of the identified transcription factors: Lmo1, Ebf3 and Shox2 {Promoter activation, ChIP and EMSA}.	SEN:10032640	18799476
BEL:20066966	tscript(p(MGI:Arx)) directlyDecreases r(MGI:Shox2)	Additionally, we found Arx directly repressed three of the identified transcription factors: Lmo1, Ebf3 and Shox2 {Promoter activation, ChIP and EMSA}.	SEN:10032640	18799476
BEL:20066968	tscript(p(MGI:Ascl1)) directlyIncreases r(MGI:Ckm)	Unexpectedly, however, MASH1 and MASH2 also activate transcription of both exogenous and endogenous MCK in transfected C3H/10T1/2 fibroblasts.	SEN:10011076	1314394
BEL:20066970	tscript(p(MGI:Ascl2)) directlyIncreases r(MGI:Ckm)	Unexpectedly, however, MASH1 and MASH2 also activate transcription of both exogenous and endogenous MCK in transfected C3H/10T1/2 fibroblasts.	SEN:10011076	1314394
BEL:20066972	tscript(p(MGI:Atf1)) decreases bp(GOBP:"apoptotic process")	These results indicate that CREB and ATF1 act in concert to mediate signals essential for maintaining cell viability during early embryonic development.	SEN:10032644	11865068
BEL:20067000	tscript(p(MGI:Atf2)) directlyIncreases r(MGI:Il23a)	Chromosomal DNA immunoprecipitation assays revealed that SMAD-3 and ATF-2 bind to the endogenous p19 promoter in RAW264.7 cells and SJL/J SPM following challenge with TMEV.	SEN:10011082	18802055
BEL:20067002	tscript(p(MGI:Atf2)) increases r(MGI:Jun)	Activating transcription factor 2 (ATF-2) and p300 cooperate in the activation of transcription of the c-jun gene during the differentiation of F9 cells.	SEN:10032654	12052888
BEL:20067006	tscript(p(MGI:Atf2)) increases r(MGI:Plau)	In addition, ATF-2 binds to the -2.4-kb element even without induction and c-Fos to the -6.9-kb element only after induction. Accordingly, overexpression of c-Fos caused induction from the -6.9-kb element, but reduced induction from the -2.4-kb element. The involvement of the Ets-2 transcription factor was shown by using expression plasmids for wild-type and dominant negative Ets-2.	SEN:10011084	9409785
BEL:20067008	tscript(p(MGI:Atf2)) increases r(MGI:Ppargc1a)	Activation of ATF-2 by p38 MAPK additionally serves as the cAMP sensor that increases expression of the PGC-1alpha gene itself in brown adipose tissue.	SEN:10006268	15024092
BEL:20067020	tscript(p(MGI:Atf4)) increases bp(GOBP:"osteoblast differentiation")	SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation	SEN:10011092	16751105
BEL:20067024	tscript(p(MGI:Atf4)) increases path(MESHD:"Retinal Neovascularization")	The OIR ATF4(+/-) retinas demonstrated reprogramming of the UPR seen at both the mRNA (Atf6 and Bip) and protein (pATF6 and peIf2alpha) levels, as well as a reduction in vascularization-associated gene expression (Flt1, Vegf1, Hif1, and Tgb1). These changes corresponded to the decline in the rate of neovascularization.	SEN:10032662	23942974
BEL:20067032	tscript(p(MGI:Atf4)) increases r(MGI:Bglap2)	ATF4 increased the levels of Ocn mRNA and mOG2 promoter activity in Runx2-containing osteoblasts but not in non-osteoblastic cells that lack detectable Runx2 protein	SEN:10011094	16000305
BEL:20067034	tscript(p(MGI:Atf4)) directlyIncreases r(MGI:Cdkn1a)	Overexpression of ATF4 severely impaired normal development of the mammary gland, which was associated with reduced proliferation and differentiation of mammary alveolar epithelium and up-regulation of p21(WAF1) and p27(Kip1).	SEN:10011096	12611881
BEL:20067036	tscript(p(MGI:Atf4)) increases r(MGI:Cdkn1a)	Overexpression of ATF4 severely impaired normal development of the mammary gland, which was associated with reduced proliferation and differentiation of mammary alveolar epithelium and up-regulation of p21(WAF1) and p27(Kip1).	SEN:10011096	12611881
BEL:20067038	tscript(p(MGI:Atf4)) directlyIncreases r(MGI:Cdkn1b)	Overexpression of ATF4 severely impaired normal development of the mammary gland, which was associated with reduced proliferation and differentiation of mammary alveolar epithelium and up-regulation of p21(WAF1) and p27(Kip1).	SEN:10011096	12611881
BEL:20067040	tscript(p(MGI:Atf4)) increases r(MGI:Cdkn1b)	Overexpression of ATF4 severely impaired normal development of the mammary gland, which was associated with reduced proliferation and differentiation of mammary alveolar epithelium and up-regulation of p21(WAF1) and p27(Kip1).	SEN:10011096	12611881
BEL:20067044	tscript(p(MGI:Atf4)) increases r(MGI:Ddit3)	Phosphorylation of eIF2alpha in mouse embryo fibroblast (MEF) cells subjected to proteasome inhibition leads to a significant reduction in protein synthesis, concomitant with induced expression of the bZIP transcription regulator, ATF4, and its target gene CHOP/GADD153	SEN:10008592	15684420
BEL:20067048	tscript(p(MGI:Atf4)) increases r(MGI:Hmox1)	from full text - Expression of the murine homologue of HO-1 was increased 90-fold in arsenite treated ATF4+/- MEF cells. ATF4-/- MEF cells exhibited a greatly diminished HO-1 response, with a 13-fold induction. Thus, ATF4 also plays a very substantial role in the arsenite induction of HO-1 in these cells.	SEN:10025274	15788408
BEL:20067052	tscript(p(MGI:Atf4)) directlyIncreases r(MGI:Hspa5)	We report here that ATF4, a transcription factor whose translation is up-regulated by the PERK-eIF2alpha pathway, can activate the Grp78 promoter independent of the ERSE.	SEN:10011098	12871976
BEL:20067056	tscript(p(MGI:Atf4)) increases r(MGI:Igfbp5)	The concentration of the proapoptotic molecule caspase-3 was increased during lactation in ATF4-transgenic animal. Mammary glands from ATF4-transgenic mice also showed significant nuclear translocation of activated STAT3 and up-regulation of one of its target genes, insulin-like growth factor-binding protein-5, which is thought to facilitate apoptosis by sequestering insulin-like growth factor	SEN:10009142	12611881
BEL:20067060	tscript(p(MGI:Atf4)) directlyIncreases r(MGI:Vegfa)	The ability of ATF4-/- MEF cells to increase VEGF mRNA levels following arsenite treatment was considerably less, with only a 2-fold induction.....Therefore, the screen of the putative AAREs in the sequence contexts appearing in the VEGF promoter demonstrated that only the +1767 AARE was capable of binding an ATF4-containing complex.	SEN:10032672	15788408
BEL:20067064	tscript(p(MGI:Atf4)) increases tscript(p(MGI:Stat3))	The concentration of the proapoptotic molecule caspase-3 was increased during lactation in ATF4-transgenic animal. Mammary glands from ATF4-transgenic mice also showed significant nuclear translocation of activated STAT3 and up-regulation of one of its target genes, insulin-like growth factor-binding protein-5, which is thought to facilitate apoptosis by sequestering insulin-like growth factor	SEN:10009142	12611881
BEL:20067066	tscript(p(MGI:Atf6)) increases bp(GOBP:"apoptotic process")	These results suggest that specific ER stress signaling transmitted by ATF6 leads to naturally occurring apoptosis during muscle development.	SEN:10000742	15897261
BEL:20067070	tscript(p(MGI:Atf6)) increases r(MGI:Hsp90b1)	The UPR-mediated activation of ATF6 (Activation of Transcription Factor 6) induces cytoprotective ER stress proteins, including GRP78 and GRP94	SEN:10018232	16601230
BEL:20067072	tscript(p(MGI:Atf6)) increases r(MGI:Hspa5)	While the activation of the Grp78 promoter by the ATF6 pathway through the endoplasmic reticulum stress elements (ERSEs) is well documented	SEN:10011102	12871976
BEL:20067074	tscript(p(MGI:Atf6)) increases r(MGI:Hspa5)	The UPR-mediated activation of ATF6 (Activation of Transcription Factor 6) induces cytoprotective ER stress proteins, including GRP78 and GRP94	SEN:10018232	16601230
BEL:20067076	tscript(p(MGI:Atf6)) increases r(MGI:Xbp1)	We concluded that ATF6-mediated induction of XBP1 mRNA is important to the production of pXBP1(S), activation of XBP1-target genes, and protection of cells from ER stress.	SEN:10011104	17110785
BEL:20067082	tscript(p(MGI:Bach1)) directlyIncreases cat(p(MGI:Hdac1))	These results suggest that Bach1 impedes p53-mediated transactivation by binding to a subset of target genes along with p53 and by recruiting Hdac1.	SEN:10019176	19011633
BEL:20067086	tscript(p(MGI:Bach1)) decreases r(MGI:Cdkn1a)	Expression of p21, which is implicated in cellular senescence6, was inhibited by overexpression of Bach1, even in the presence of RasV12 (Fig. 4c).	SEN:10032678	19011633
BEL:20067088	tscript(p(MGI:Bach1)) directlyDecreases r(MGI:Hmox1)	These data indicate that, under normal conditions, the chromatin structure of ho-1 is in a preactivation state, but transcription is repressed by Bach1.	SEN:10032680	14747657
BEL:20067090	tscript(p(MGI:Bach1)) directlyDecreases r(MGI:Hmox1)	Heterodimers of the small Maf proteins and NF-E2– related factor 2 (Nrf2), which belongs to the basic leucin zipper (bZip) family of transcriptional factors, activate HO-1 through binding to MAREs (16–19). In contrast, heterodimers of small Maf and Bach1 or Bach2 repress MAREdependent transcription (20).	SEN:10032682	18633191
BEL:20067094	tscript(p(MGI:Bach1)) directlyDecreases r(MGI:Il6)	unexpectedly, however, the levels of IL-6 in bronchoalveolar lavage (BAL) fluid from Bach1(-/-) mice were significantly higher than those of WT mice. ..... In addition, a chromatin immunoprecipitation analysis revealed the binding of Bach1 to the IL-6 promoter and its detachment after oxidative stress.	SEN:10032684	19439223
BEL:20067096	tscript(p(MGI:Bach1)) decreases r(MGI:Pmp22)	p53 apoptosis effector related to PMP22 (Perp), another target gene of p53 (see below), was also inhibited by Bach1.	SEN:10032686	19011633
BEL:20067100	tscript(p(MGI:Bach1)) decreases tscript(p(MGI:Trp53))	These results suggest that Bach1 is a negative regulator of the p53-mediated senescence program in response to oxidative stress, although Bach1 could be either parallel or upstream to p53 in this process.	SEN:10018212	19011633
BEL:20067102	tscript(p(MGI:Bach2)) directlyDecreases r(MGI:Hmox1)	Heterodimers of the small Maf proteins and NF-E2– related factor 2 (Nrf2), which belongs to the basic leucin zipper (bZip) family of transcriptional factors, activate HO-1 through binding to MAREs (16–19). In contrast, heterodimers of small Maf and Bach1 or Bach2 repress MAREdependent transcription (20).	SEN:10032682	18633191
BEL:20067106	tscript(p(MGI:Bach2)) decreases tscript(p(MGI:Maf))	Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies.	SEN:10004170	11923289
BEL:20067116	tscript(p(MGI:Bcl6)) decreases bp(GOBP:"cell proliferation")	results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program.	SEN:10002578	15507530
BEL:20067122	tscript(p(MGI:Bcl6)) decreases r(MGI:Ccl2)	We identified three chemokines, MCP-1, MCP-3 and MRP-1, which are negatively regulated by BCL-6 in macrophages.	SEN:10011110	10973278
BEL:20067124	tscript(p(MGI:Bcl6)) decreases r(MGI:Ccl6)	We identified three chemokines, MCP-1, MCP-3 and MRP-1, which are negatively regulated by BCL-6 in macrophages.	SEN:10011110	10973278
BEL:20067126	tscript(p(MGI:Bcl6)) decreases r(MGI:Ccl7)	We identified three chemokines, MCP-1, MCP-3 and MRP-1, which are negatively regulated by BCL-6 in macrophages.	SEN:10011110	10973278
BEL:20067128	tscript(p(MGI:Bcl6)) decreases r(MGI:Il6)	Crucial to this enhanced proliferation is spontaneous interleukin 6 (IL-6) production and signal transducer and activator of transcription 3 (STAT3) activation in BCL-6(-/-) macrophages. Gene expression studies demonstrate that BCL-6 binds to several sequence motifs scattered in the IL-6 locus and can repress IL-6 transcription both in 293T cells and in macrophages.	SEN:10032694	15507530
BEL:20067130	tscript(p(MGI:Bhlhe40)) directlyDecreases r(MGI:Bdnf)	We discovered a sequence within Bdnf promoter 4 that binds the basic helix-loop-helix protein BHLHB2 and is a target for BHLHB2-mediated transcriptional repression.	SEN:10032696	18234890
BEL:20067138	tscript(p(MGI:Bhlhe41)) decreases r(MGI:Cebpa)	Although expression of the early marker CCAAT/enhancer binding protein beta (C/EBPbeta) is not altered, its crucial downstream targets C/EBPalpha and peroxisome proliferator-activated receptor gamma (PPARgamma) are downregulated by SHARP1.	SEN:10011116	19029947
BEL:20067144	tscript(p(MGI:Bhlhe41)) decreases r(MGI:Pparg)	Although expression of the early marker CCAAT/enhancer binding protein beta (C/EBPbeta) is not altered, its crucial downstream targets C/EBPalpha and peroxisome proliferator-activated receptor gamma (PPARgamma) are downregulated by SHARP1.	SEN:10011116	19029947
BEL:20067178	tscript(p(MGI:Cebpa)) increases bp(GOBP:"fat cell differentiation")	Experiments designed to uncover the potential role of LXR alpha in adipogenesis revealed that this transcription factor, unlike CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma, is not adipogenic but rather inhibits adipogenesis if inappropriately expressed and activated. However, LXR alpha has several important roles in adipocyte function.	SEN:10032710	12138207
BEL:20067196	tscript(p(MGI:Cebpa)) directlyIncreases r(MGI:Adipoq)	Foxo1 interacts with CCAAT/enhancer-binding protein a (C/EBPa) to form a transcription complex at the mouse adiponectin promoter and up-regulate adiponectin gene transcription.	SEN:10032720	17090532
BEL:20067198	tscript(p(MGI:Cebpa)) increases r(MGI:Cebpb)	Introduction of an inducible C/EBP alpha gene into the line revealed that conditional expression of C/EBP alpha induced the C/EBP family members C/EBP beta and C/EBP epsilon	SEN:10011132	12036869
BEL:20067200	tscript(p(MGI:Cebpa)) increases r(MGI:Cebpe)	Introduction of an inducible C/EBP alpha gene into the line revealed that conditional expression of C/EBP alpha induced the C/EBP family members C/EBP beta and C/EBP epsilon	SEN:10011132	12036869
BEL:20067202	tscript(p(MGI:Cebpa)) increases r(MGI:Cfd)	There was also dramatically reduced expression of some adipocyte genes, such as those encoding leptin and adipsin, while others like Glut4 and Fabp4 were not altered.	SEN:10032722	15936931
BEL:20067206	tscript(p(MGI:Cebpa)) increases r(MGI:Gadd45a)	We report here that C/EBP alpha directly regulates gadd45 through a C/EBP-binding site in the proximal promoter.	SEN:10011134	10025511
BEL:20067208	tscript(p(MGI:Cebpa)) increases r(MGI:Hmox1)	The most potent inducer of the HO-1 promoter was C/EBPa (3.4-fold; P 0.05), followed to a lesser extent by C/EBPd (2.0-fold) and no significant induction by C/EBPb (Fig. 7B).	SEN:10032726	20348279
BEL:20067210	tscript(p(MGI:Cebpa)) directlyIncreases r(MGI:Hmox1)	This revealed that the C/EBPa antibody disrupted the 3rd DNAprotein complex (Fig. 7C, “”) and supershifted the complex (Fig. 7C, arrow), whereas rabbit IgG had no effect. These results indicated that the binding of C/EBPa to the C/EBP binding site on the HO-1 promoter is specific and increased by PGN.	SEN:10016152	20348279
BEL:20067212	tscript(p(MGI:Cebpa)) directlyIncreases r(MGI:Hsd11b1)	C/EBPalpha is a potent activator of the 11beta-HSD1 gene in hepatoma cells and that mice deficient in C/EBPalpha have reduced hepatic 11beta-HSD1 expression	SEN:10011136	10906322
BEL:20067214	tscript(p(MGI:Cebpa)) increases r(MGI:Irs1)	The reason for this is at least in part due to reduced expression of insulin receptor and IRS-1 in the absence of C/EBPa, as well as a poorly characterized post-receptor defect that prevents optimal tyrosine phosphorylation of proximal components of the insulin signaling cascade.	SEN:10032728	15936931
BEL:20067216	tscript(p(MGI:Cebpa)) directlyIncreases r(MGI:Itih3)	CCAAT/enhancer-binding protein site (C/EBP, -1344 to -1305) which interacts with C/EBPalpha and C/EBPbeta factors. The latter factors control the transcription of the ITIH3 gene positively.	SEN:10011138	9756925
BEL:20067218	tscript(p(MGI:Cebpa)) increases r(MGI:Lep)	There was also dramatically reduced expression of some adipocyte genes, such as those encoding leptin and adipsin, while others like Glut4 and Fabp4 were not altered.	SEN:10032722	15936931
BEL:20067222	tscript(p(MGI:Cebpa)) increases r(MGI:Retn)	Furthermore, ectopic expression of ADD1/SREBP1c by adenovirus significantly increased the expression of resistin mRNA in adipocytes. Human resistin promoter was also activated by C/EBP alpha expression	SEN:10011140	12730330
BEL:20067224	tscript(p(MGI:Cebpa)) directlyIncreases r(MGI:Scgb1a1)	C/EBPalpha and C/EBPdelta activate the Clara cell secretory protein gene through interaction with two adjacent C/EBP-binding sites	SEN:10011142	12959923
BEL:20067236	tscript(p(MGI:Cebpb)) decreases cat(p(MGI:Pde3a))	Our data show a 25% increase in both mRNA levels for PDE3A and PDE3B and a 25% increase in PDE activity in the livers of fasted C/EBPb-/- mice	SEN:10032734	11024029
BEL:20067238	tscript(p(MGI:Cebpb)) decreases cat(p(MGI:Pde3b))	Our data show a 25% increase in both mRNA levels for PDE3A and PDE3B and a 25% increase in PDE activity in the livers of fasted C/EBPb-/- mice	SEN:10032734	11024029
BEL:20067242	tscript(p(MGI:Cebpb)) increases path(MESHD:Fibrosis)	after Bleomycin treatment, C/EBPbwt mice had moderate to severe lung fibrosis (mean score 2.8+/20.4; n: 10) compared to controls , while C/EBPb-Ala217 mice of the same genetic background had mild or moderate lung fibrosis (mean score: 1.5+/20.5; n: 10; P,0.001; Wilcoxon U Test)	SEN:10032736	21998664
BEL:20067246	tscript(p(MGI:Cebpb)) increases p(MGI:Acta2)	the protein expression of lung fibrogenic indicators a- SMA, present in activated myofibroblasts (NM_007392.2) and TGF-b1, a fibrogenic cytokine [27] (NM_009370.2) were induced by Bleomycin in C/EBPbwt mice ,5-fold (n: 7 per group; a-SMA: 5.2+/20.3, P,0.0001; TGF-b1: 5.9+/20.3 P,0.0001) but not in C/EBPb-Ala217 mice (n: 6 per group; a-SMA: 1.2+/20.2, P = 0.15; TGF-b1: 0.7+/20.2, P = 0.013)	SEN:10032738	21998664
BEL:20067250	tscript(p(MGI:Cebpb)) increases p(MGI:Tgfb1)	the protein expression of lung fibrogenic indicators a- SMA, present in activated myofibroblasts (NM_007392.2) and TGF-b1, a fibrogenic cytokine [27] (NM_009370.2) were induced by Bleomycin in C/EBPbwt mice ,5-fold (n: 7 per group; a-SMA: 5.2+/20.3, P,0.0001; TGF-b1: 5.9+/20.3 P,0.0001) but not in C/EBPb-Ala217 mice (n: 6 per group; a-SMA: 1.2+/20.2, P = 0.15; TGF-b1: 0.7+/20.2, P = 0.013)	SEN:10032738	21998664
BEL:20067258	tscript(p(MGI:Cebpb)) increases r(MGI:Cebpa)	These gain-of-function studies have demonstrated the sufficiency of these proteins for adipogenesis, and combined with the temporal sequence of the appearance of these factors already mentioned, suggests a transcriptional cascade whereby C/EBPb and d induce PPARg and C/EBPa, which in turn promote the terminally differentiated state.	SEN:10032742	15936931
BEL:20067260	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Cebpa)	Pointing to a direct regulatory role for XBP1 in vivo, XBP1 was enriched on the Cebpa promoter on d4 (Figure 4D); this binding was comparable with that of C/EBPbeta on d4 and was completely abolished in XBP1i 3T3-L1 cells (Figures 4D and S4B).	SEN:10032744	19490910
BEL:20067262	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Clec4e)	The mouse Mincle proximal promoter region contains an indispensable NF-IL6 binding element, demonstrating that Mincle is a direct target of NF-IL6.	SEN:10011148	10528209
BEL:20067264	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Crp)	presence of type 1 Il6R, which is a binding site for NF-IL-6, IL-6DBP, and CEBPbeta has been confirmed in the genes for CRP, hemoplexin A and haptoglobin binding activity of NF-IL-6 is probably induced by Il6 through the increased expression of the NF-IL-6 gene	SEN:10032746	12110143
BEL:20067266	tscript(p(MGI:Cebpb)) directlyDecreases r(MGI:Dspp)	Nrf1 has also been reported to function as a repressor of transcription. The dentin sialophosphoprotein (DSPP) gene encodes DSP and DPP, which are expressed in terminally differentiated odontoblast. In undifferentiated odontoblast, Nrf1 interacts with C/EBP-? to repress DSPP expression.	SEN:10020236	19665035
BEL:20067268	tscript(p(MGI:Cebpb)) decreases r(MGI:Fosl2)	Mouse embryo fibroblasts nullizygous for C/EBPbeta had a proliferative advantage over cells with one or two functional copies of this gene. C/EBP inhibition enhanced the expression of the three major components of AP-1 in cycling CEF, namely c-Jun, JunD, and Fra-2, and stimulated AP-1 activity. In contrast, the over-expression of C/EBPbeta caused a dramatic reduction in the levels of AP-1 proteins.	SEN:10032748	12896981
BEL:20067270	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Hp)	presence of type 1 Il6R, which is a binding site for NF-IL-6, IL-6DBP, and CEBPbeta has been confirmed in the genes for CRP, hemoplexin A and haptoglobin binding activity of NF-IL-6 is probably induced by Il6 through the increased expression of the NF-IL-6 gene	SEN:10032746	12110143
BEL:20067272	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Hpx)	presence of type 1 Il6R, which is a binding site for NF-IL-6, IL-6DBP, and CEBPbeta has been confirmed in the genes for CRP, hemoplexin A and haptoglobin binding activity of NF-IL-6 is probably induced by Il6 through the increased expression of the NF-IL-6 gene	SEN:10032746	12110143
BEL:20067274	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Hsp90ab1)	The hsp90beta gene promoter contains binding sites for the transcription factors nuclear factor IL-6 (\"NF-IL6\") and signal transducer and activator of transcription 3 (STAT-3), which are activated respectively by the mitogen-activated-protein-kinase and Jak-kinase pathways following IL-6 treatment.	SEN:10018046	9461509
BEL:20067278	tscript(p(MGI:Cebpb)) increases r(MGI:Il6)	We here report that the NFkappaB and C/EBP beta controlled gene IL6 is upregulated in DDIT3- and FUS-DDIT3-expressing fibrosarcoma cell lines	SEN:10011152	15688424
BEL:20067280	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Itih3)	CCAAT/enhancer-binding protein site (C/EBP, -1344 to -1305) which interacts with C/EBPalpha and C/EBPbeta factors. The latter factors control the transcription of the ITIH3 gene positively.	SEN:10011138	9756925
BEL:20067282	tscript(p(MGI:Cebpb)) decreases r(MGI:Jun)	Mouse embryo fibroblasts nullizygous for C/EBPbeta had a proliferative advantage over cells with one or two functional copies of this gene. C/EBP inhibition enhanced the expression of the three major components of AP-1 in cycling CEF, namely c-Jun, JunD, and Fra-2, and stimulated AP-1 activity. In contrast, the over-expression of C/EBPbeta caused a dramatic reduction in the levels of AP-1 proteins.	SEN:10032748	12896981
BEL:20067284	tscript(p(MGI:Cebpb)) decreases r(MGI:Jund)	Mouse embryo fibroblasts nullizygous for C/EBPbeta had a proliferative advantage over cells with one or two functional copies of this gene. C/EBP inhibition enhanced the expression of the three major components of AP-1 in cycling CEF, namely c-Jun, JunD, and Fra-2, and stimulated AP-1 activity. In contrast, the over-expression of C/EBPbeta caused a dramatic reduction in the levels of AP-1 proteins.	SEN:10032748	12896981
BEL:20067288	tscript(p(MGI:Cebpb)) decreases r(MGI:Pde3a)	Our data show a 25% increase in both mRNA levels for PDE3A and PDE3B and a 25% increase in PDE activity in the livers of fasted C/EBPb-/- mice	SEN:10032734	11024029
BEL:20067290	tscript(p(MGI:Cebpb)) decreases r(MGI:Pde3b)	Our data show a 25% increase in both mRNA levels for PDE3A and PDE3B and a 25% increase in PDE activity in the livers of fasted C/EBPb-/- mice	SEN:10032734	11024029
BEL:20067296	tscript(p(MGI:Cebpb)) increases r(MGI:Pparg)	These gain-of-function studies have demonstrated the sufficiency of these proteins for adipogenesis, and combined with the temporal sequence of the appearance of these factors already mentioned, suggests a transcriptional cascade whereby C/EBPb and d induce PPARg and C/EBPa, which in turn promote the terminally differentiated state.	SEN:10032742	15936931
BEL:20067298	tscript(p(MGI:Cebpb)) increases r(MGI:Pparg)	Induction of C/EBP beta DNA-binding activity in NIH-3T3 beta 2 cells exposed to dexamethasone in the presence of insulin and fetal bovine serum activates the expression of an adipocyte-specific nuclear hormone receptor, PPAR gamma, that stimulates the conversion of these fibroblasts into committed preadipocytes	SEN:10000006	7557387
BEL:20067300	tscript(p(MGI:Cebpb)) directlyIncreases r(MGI:Xbp1)	Chromatin immunoprecipitation (ChIP) experiments showed enrichment of C/EBPbeta proteins on the Xbp1 proximal promoter at 8 hr postinduction and on d4 (Figure 2D).	SEN:10032752	19490910
BEL:20067310	tscript(p(MGI:Cebpd)) decreases bp(GOBP:"cell proliferation")	These data demonstrate that OSM induces up-regulation of C/EBPdelta via a Stat3-dependent pathway in mammary epithelial cells and that the growth inhibition induced by OSM depends on the presence of C/EBPdelta.	SEN:10029758	12479220
BEL:20067320	tscript(p(MGI:Cebpd)) increases r(MGI:Cebpa)	These gain-of-function studies have demonstrated the sufficiency of these proteins for adipogenesis, and combined with the temporal sequence of the appearance of these factors already mentioned, suggests a transcriptional cascade whereby C/EBPb and d induce PPARg and C/EBPa, which in turn promote the terminally differentiated state.	SEN:10032742	15936931
BEL:20067326	tscript(p(MGI:Cebpd)) increases r(MGI:Hmox1)	The most potent inducer of the HO-1 promoter was C/EBPa (3.4-fold; P 0.05), followed to a lesser extent by C/EBPd (2.0-fold) and no significant induction by C/EBPb (Fig. 7B).	SEN:10032726	20348279
BEL:20067336	tscript(p(MGI:Cebpd)) increases r(MGI:Pparg)	These gain-of-function studies have demonstrated the sufficiency of these proteins for adipogenesis, and combined with the temporal sequence of the appearance of these factors already mentioned, suggests a transcriptional cascade whereby C/EBPb and d induce PPARg and C/EBPa, which in turn promote the terminally differentiated state.	SEN:10032742	15936931
BEL:20067340	tscript(p(MGI:Cebpd)) directlyIncreases r(MGI:Scgb1a1)	C/EBPalpha and C/EBPdelta activate the Clara cell secretory protein gene through interaction with two adjacent C/EBP-binding sites	SEN:10011142	12959923
BEL:20067346	tscript(p(MGI:Cebpe)) increases bp(GOBP:"apoptotic process")	Cell cycle analysis revealed that induction of C/EBPE activity led to a rapid accumulation of cells in G0/G1 (Fig. 2C). Notably, this was accompanied by enhanced cell death with apoptosis as revealed by the cell morphology, an increased percentage of cells in sub-G0/G1, and DNA ladder formation (Fig. 2, C and D).	SEN:10032762	16531405
BEL:20067348	tscript(p(MGI:Cebpe)) decreases p(MGI:Bcl2)	Interestingly, the anti-apoptotic proteins Bcl-2 and Bcl-x were clearly down-regulated after induction of C/EBPE activity in LG/CEBPE-ER cells even though the cells were being cultured in IL-3.	SEN:10032764	16531405
BEL:20067350	tscript(p(MGI:Cebpe)) decreases p(MGI:Bcl2l1)	Interestingly, the anti-apoptotic proteins Bcl-2 and Bcl-x were clearly down-regulated after induction of C/EBPE activity in LG/CEBPE-ER cells even though the cells were being cultured in IL-3.	SEN:10032764	16531405
BEL:20067352	tscript(p(MGI:Cebpe)) decreases p(MGI:Ccnd2)	The most striking difference induced by C/EBPE-ER induction is the robust up-regulation of p27. In sharp contrast, cyclin D2, cyclin A, cyclin E, cdk4, and cdk6 were clearly down-regulated after 4 days of 4-HT treatment.	SEN:10032766	16531405
BEL:20067354	tscript(p(MGI:Cebpe)) decreases p(MGI:Cdk4)	The most striking difference induced by C/EBPE-ER induction is the robust up-regulation of p27. In sharp contrast, cyclin D2, cyclin A, cyclin E, cdk4, and cdk6 were clearly down-regulated after 4 days of 4-HT treatment.	SEN:10032766	16531405
BEL:20067356	tscript(p(MGI:Cebpe)) decreases p(MGI:Cdk6)	The most striking difference induced by C/EBPE-ER induction is the robust up-regulation of p27. In sharp contrast, cyclin D2, cyclin A, cyclin E, cdk4, and cdk6 were clearly down-regulated after 4 days of 4-HT treatment.	SEN:10032766	16531405
BEL:20067358	tscript(p(MGI:Cebpe)) increases p(MGI:Cdkn1b)	The most striking difference induced by C/EBPE-ER induction is the robust up-regulation of p27. In sharp contrast, cyclin D2, cyclin A, cyclin E, cdk4, and cdk6 were clearly down-regulated after 4 days of 4-HT treatment.	SEN:10032766	16531405
BEL:20067372	tscript(p(MGI:Cited2)) increases bp(GOBP:"cell proliferation")	Relative to the control stably transfected or CITED2-cells, CITED2+ cells had an increased rate of cell proliferation	SEN:10011166	15051727
BEL:20067374	tscript(p(MGI:Cited2)) increases r(MGI:Lefty2)	Cited2(-/-) mice lack expression of the Nodal target genes Pitx2c, Nodal and Ebaf in the left lateral plate mesoderm, where they are required for establishing laterality and cardiovascular development. CITED2 and TFAP2 were detected at the Pitx2c promoter in embryonic hearts, and they activate Pitx2c transcription in transient transfection assays	SEN:10032772	15475956
BEL:20067376	tscript(p(MGI:Cited2)) increases r(MGI:Nodal)	Cited2(-/-) mice lack expression of the Nodal target genes Pitx2c, Nodal and Ebaf in the left lateral plate mesoderm, where they are required for establishing laterality and cardiovascular development. CITED2 and TFAP2 were detected at the Pitx2c promoter in embryonic hearts, and they activate Pitx2c transcription in transient transfection assays	SEN:10032772	15475956
BEL:20067378	tscript(p(MGI:Cited2)) increases r(MGI:Pitx2)	Cited2(-/-) mice lack expression of the Nodal target genes Pitx2c, Nodal and Ebaf in the left lateral plate mesoderm, where they are required for establishing laterality and cardiovascular development. CITED2 and TFAP2 were detected at the Pitx2c promoter in embryonic hearts, and they activate Pitx2c transcription in transient transfection assays	SEN:10032772	15475956
BEL:20067384	tscript(p(MGI:Cited2)) increases tscript(p(MGI:Ppara))	CITED2 acted as a dose-dependent coactivator of PPARalpha-dependent transcriptional regulation in the presence of several exogenous ligands. CITED2 also increased PPARgamma-dependent regulation of reporter genes but had no effect on PPARbeta activity	SEN:10011168	15051727
BEL:20067386	tscript(p(MGI:Cited2)) directlyIncreases tscript(p(MGI:Ppara))	The results described here suggest that CIT-ED2 is a coactivator of PPARalpha and that both proteins may participate in signaling cascades of hypoxic response and angiogenesis.	SEN:10011170	15051727
BEL:20067390	tscript(p(MGI:Cited2)) increases tscript(p(MGI:Pparg))	CITED2 acted as a dose-dependent coactivator of PPARalpha-dependent transcriptional regulation in the presence of several exogenous ligands. CITED2 also increased PPARgamma-dependent regulation of reporter genes but had no effect on PPARbeta activity	SEN:10011168	15051727
BEL:20067392	tscript(p(MGI:Clock)) increases r(MGI:Serpine1)	Leptin-deficient obesity did not affect PAI-1 mRNA expression in the heart, but the Clock mutation significantly reduced mRNA levels in both ob/ob mice and in lean compartments (Fig. 3A).	SEN:10032778	16879220
BEL:20067394	tscript(p(MGI:Clock)) increases r(MGI:Serpine1)	Obesity also did not induce PAI-1 mRNA expression in the lungs, but the Clock mutation significantly reduced the mRNA levels in ob/ob mice (Fig. 3B).	SEN:10032780	16879220
BEL:20067396	tscript(p(MGI:Clock)) increases r(MGI:Wee1)	from full text - However, in Clock mutant (Clock/Clock) mice (26), which carry dominantnegative Clock mutations (27), wee1 expression was low at both ZTs	SEN:10032782	12934012
BEL:20067400	tscript(p(MGI:Creb1)) decreases bp(GOBP:"apoptotic process")	These results indicate that CREB and ATF1 act in concert to mediate signals essential for maintaining cell viability during early embryonic development.	SEN:10032644	11865068
BEL:20067408	tscript(p(MGI:Creb1)) increases r(MGI:Avpi1)	Furthermore, DDAVP-stimulated VIT32 promoter-reporter activity was inhibited by H89 and by a dominant negative CREB construct.	SEN:10032786	15140762
BEL:20067414	tscript(p(MGI:Creb1)) increases r(MGI:Cartpt)	Additionally, forskolin-induced transcription was inhibited by a dominant-negative mutant of CRE-binding protein (CREB) in CATH.a cells.	SEN:10011174	15207912
BEL:20067416	tscript(p(MGI:Creb1)) increases r(MGI:Cpt1a)	cAMP response unit of the Cpt1a gene is composed of a cAMP-response element motif and a Dr1 sequence located upstream of the transcription start site the coactivator Pgc-1 is involved in the regulation of this gene expression by cAMP in conbination with Hnf4 alpha and Creb	SEN:10032790	12107181
BEL:20067418	tscript(p(MGI:Creb1)) directlyIncreases r(MGI:Cyp11a1)	Overexpression of SIK repressed ACTH-mediated expression of CYP11A- and Steroidogenic acute regulatory (StAR)-genes by inhibiting CREB bound to their promoters.	SEN:10010094	12530631
BEL:20067428	tscript(p(MGI:Creb1)) increases r(MGI:"H2-Eb2")	the transactivators RFX, X2BP [CREB] and NFY are required factors for MHC class II gene activation and bind the X1, X2, and Y boxes, respectively	SEN:10032800	11533238
BEL:20067432	tscript(p(MGI:Creb1)) increases r(MGI:Mitf)	The transcription factors implicated to date in regulation of the Mitf promoter include Pax3, CREB, Sox10, and Lef1 (Fig. 2A), with each factor able to confer on the Mitf promoter the capacity to respond to specific signals.	SEN:10032802	10898786
BEL:20067434	tscript(p(MGI:Creb1)) increases r(MGI:Nr4a2)	Nurr1 expression was induced by forskolin, an adenylate cyclase activator, via activation of CREB in both N2A and C6 cells	SEN:10005208	15106839
BEL:20067446	tscript(p(MGI:Creb1)) increases r(MGI:Ppargc1a)	CaMKIV activates PGC-1alpha largely through the binding of cAMP response element-binding protein to the PGC-1alpha promoter.	SEN:10006084	12764228
BEL:20067448	tscript(p(MGI:Creb1)) directlyIncreases r(MGI:Pvrl2)	% Overexpressions of CREB and c-Jun, but not c-Fos, also significantly increased the promoter activity, which suggests that CREB and c-Jun are the crucial transcription factors involved in regulating nectin-2 gene transcription.	SEN:10011182	16250013
BEL:20067450	tscript(p(MGI:Creb1)) directlyIncreases r(MGI:Star)	Overexpression of SIK repressed ACTH-mediated expression of CYP11A- and Steroidogenic acute regulatory (StAR)-genes by inhibiting CREB bound to their promoters.	SEN:10010094	12530631
BEL:20067452	tscript(p(MGI:Creb1)) increases r(MGI:Tnfsf13b)	IFN-gamma caused phosphorylation of CREB, and overexpression of CREB increased IFN-gamma-induced BAFF promoter activity.	SEN:10009096	18334541
BEL:20067466	tscript(p(MGI:Crebbp)) increases tscript(p(MGI:Hif1a))	from full ext - Figure 2 (D–F) Transient transfection assays showing that Gal-HIF-1a function is reduced in MEFs with multiple DCH1 alleles (mean7s.e.m., N¼3) (D), and can be rescued by WT CBP (E, F) or p300 (F), but not by CBPDCH1 (E) (mean7s.e.m., N¼2–4). (G, H) Transactivation by factors utilizing other domains of p300 and CBP or other coactivators is unimpaired (mean7s.d., N¼4).	SEN:10032810	16237459
BEL:20067470	tscript(p(MGI:Crebbp)) directlyIncreases tscript(p(MGI:Pparg))	These data suggest that both CBP and p300 are indispensable for the full activation of PPARgamma and adipocyte differentiation and that CBP and p300 do not mutually complement in the process.	SEN:10011186	11884404
BEL:20067478	tscript(p(MGI:Crem)) decreases r(MGI:Crh)	Using real-time quantitative PCR, we establish that hypothalamic CRF expression is significantly reduced after swim exposure in DMI-treated wild-type mice, however DMI is unable to blunt hypothalamic CRF expression in ICER-deficient mice.	SEN:10003356	14985439
BEL:20067480	tscript(p(MGI:Ctbp1)) increases r(MGI:Cebpa)	We find that C/ebpalpha is derepressed in Klf3 and Ctbp knockout fibroblasts and adipocytes from Klf3 knockout mice.	SEN:10011188	18391014
BEL:20067490	tscript(p(MGI:Ctnnb1)) increases r(MGI:Ccnd1)	Surplus ??catenin then translocates to the nucleus, interacts with the LEF and TCF transcription factors, and persistently transactivates genes associated with the regulation of cell proliferation, such as MYC and cyclin D1 (Refs 30,32,106,135–137).	SEN:10032820	18432252
BEL:20067492	tscript(p(MGI:Ctnnb1)) increases r(MGI:Col1a1)	In CKO littermates however, only a low level of Col1a1 expression was detected in the perichondrium (Fig. 1F', arrow), with no Col1a1 expression in the marrow cavity	SEN:10032822	15576404
BEL:20067496	tscript(p(MGI:Ctnnb1)) directlyIncreases r(MGI:Lect2)	leukocyte cell-derived chemotaxin 2 (LECT2) gene as a direct target of beta-catenin LECT2 expression is specifically induced in different mouse models that express activated beta-catenin in the liver	SEN:10032826	15239100
BEL:20067498	tscript(p(MGI:Ctnnb1)) increases r(MGI:Myc)	Surplus ??catenin then translocates to the nucleus, interacts with the LEF and TCF transcription factors, and persistently transactivates genes associated with the regulation of cell proliferation, such as MYC and cyclin D1 (Refs 30,32,106,135–137).	SEN:10032820	18432252
BEL:20067500	tscript(p(MGI:Ctnnb1)) increases r(MGI:Myc)	The identification of the protooncogene MYC as a direct transcriptional target of Wnt–?-catenin signalling in 1998 shed light on the transforming activity of the Wnt pathway in cancer106	SEN:10032828	18432252
BEL:20067512	tscript(p(MGI:Ctnnb1)) increases r(MGI:Sp7)	Osx was normally expressed at high levels in the perichondrium flanking the prehypertrophic and hypertrophic chondrocytes (Fig. 2D, arrow) in addition to a lower level in the prehypertrophic cells (Fig. 2D, asterisk). However, it was not detectable in the CKO embryo	SEN:10032834	15576404
BEL:20067516	tscript(p(MGI:Cux1)) directlyDecreases r(MGI:Runx2)	Our studies further show regulation of the Runx2 gene by several homeodomain proteins: MSX2 and CDP/cut repress whereas DLX3 and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	SEN:10032836	17060321
BEL:20067522	tscript(p(MGI:Ddit3)) increases r(EGID:765)	In accordance with published results (18), amino acid depletion induced CA-VI and advillin mRNA in NIH-3T3 cells in a CHOP-dependent manner.	SEN:10018220	11145585
BEL:20067524	tscript(p(MGI:Ddit3)) increases r(MGI:Avil)	In accordance with published results (18), amino acid depletion induced CA-VI and advillin mRNA in NIH-3T3 cells in a CHOP-dependent manner.	SEN:10018220	11145585
BEL:20067528	tscript(p(MGI:Ddit3)) increases r(MGI:Il6)	We here report that the NFkappaB and C/EBP beta controlled gene IL6 is upregulated in DDIT3- and FUS-DDIT3-expressing fibrosarcoma cell lines	SEN:10011152	15688424
BEL:20067536	tscript(p(MGI:Ddit3)) increases tscript(p(MGI:Cebpb))	Knockdown experiments using siRNA against CEBPB transcripts showed that the effect of FUS-DDIT3 on IL6 expression is C/EBP beta dependent	SEN:10011196	15688424
BEL:20067560	tscript(p(MGI:Dlx3)) directlyIncreases r(MGI:Runx2)	Our studies further show regulation of the Runx2 gene by several homeodomain proteins: MSX2 and CDP/cut repress whereas DLX3 and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	SEN:10032836	17060321
BEL:20067562	tscript(p(MGI:Dlx5)) directlyIncreases r(MGI:Ibsp)	We further found that the Dlx5 homeoprotein, which is able to regulate the osteoblast-specific osteocalcin promoter, can bind this element and stimulate its enhancer activity when overexpressed in COS7 cells.	SEN:10011202	10788516
BEL:20067566	tscript(p(MGI:Dlx5)) directlyIncreases r(MGI:Runx2)	Our studies further show regulation of the Runx2 gene by several homeodomain proteins: MSX2 and CDP/cut repress whereas DLX3 and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	SEN:10032836	17060321
BEL:20067578	tscript(p(MGI:E2f1)) increases bp(GOBP:"cell cycle")	Expression of either E2F1 or E2F2 can induce postmitotic lens fiber cells to re-enter the cell cycle.	SEN:10032854	11095619
BEL:20067582	tscript(p(MGI:E2f1)) directlyIncreases r(MGI:Bbc3)	Bcl-2 homology 3 (BH3)-only proteins are pro-apoptotic members of the Bcl-2 protein family that trigger apoptosis in response to diverse stimuli. We show here that E2F1 up-regulates the expression of the pro-apoptotic BH3-only proteins PUMA, Noxa, Bim, and Hrk/DP5 through a direct transcriptional mechanism.	SEN:10032858	14684737
BEL:20067584	tscript(p(MGI:E2f1)) directlyIncreases r(MGI:Bcl2l11)	Bcl-2 homology 3 (BH3)-only proteins are pro-apoptotic members of the Bcl-2 protein family that trigger apoptosis in response to diverse stimuli. We show here that E2F1 up-regulates the expression of the pro-apoptotic BH3-only proteins PUMA, Noxa, Bim, and Hrk/DP5 through a direct transcriptional mechanism.	SEN:10032858	14684737
BEL:20067590	tscript(p(MGI:E2f1)) directlyIncreases r(MGI:Brca1)	The Brca1 gene is identified as an in vivo target of E2F1 in a transgenic mouse model. The Brca1 promoter contains E2F DNA-binding sites that mediate transcriptional activation by E2F1 and repression by Rb	SEN:10011216	10660629
BEL:20067596	tscript(p(MGI:E2f1)) decreases r(MGI:Ckm)	MCK promoter activity is also inhibited by ectopic E2F1 expression, but this inhibition is not reversed by the co-expression of p21.	SEN:10011220	8995365
BEL:20067602	tscript(p(MGI:E2f1)) decreases r(MGI:Dmtf1)	Subsets of E2Fs were specifically bound to the Dmp1 promoter upon mitogenic signaling and E2Fs 1-4 inhibited the Dmp1 promoter in a reporter assay.	SEN:10032862	16878159
BEL:20067606	tscript(p(MGI:E2f1)) directlyIncreases r(MGI:Hrk)	Bcl-2 homology 3 (BH3)-only proteins are pro-apoptotic members of the Bcl-2 protein family that trigger apoptosis in response to diverse stimuli. We show here that E2F1 up-regulates the expression of the pro-apoptotic BH3-only proteins PUMA, Noxa, Bim, and Hrk/DP5 through a direct transcriptional mechanism.	SEN:10032858	14684737
BEL:20067610	tscript(p(MGI:E2f1)) directlyIncreases r(MGI:Pmaip1)	Bcl-2 homology 3 (BH3)-only proteins are pro-apoptotic members of the Bcl-2 protein family that trigger apoptosis in response to diverse stimuli. We show here that E2F1 up-regulates the expression of the pro-apoptotic BH3-only proteins PUMA, Noxa, Bim, and Hrk/DP5 through a direct transcriptional mechanism.	SEN:10032858	14684737
BEL:20067620	tscript(p(MGI:E2f2)) increases bp(GOBP:"cell cycle")	Expression of either E2F1 or E2F2 can induce postmitotic lens fiber cells to re-enter the cell cycle.	SEN:10032854	11095619
BEL:20067624	tscript(p(MGI:E2f2)) decreases r(MGI:Dmtf1)	Subsets of E2Fs were specifically bound to the Dmp1 promoter upon mitogenic signaling and E2Fs 1-4 inhibited the Dmp1 promoter in a reporter assay.	SEN:10032862	16878159
BEL:20067630	tscript(p(MGI:E2f3)) decreases r(MGI:Dmtf1)	Subsets of E2Fs were specifically bound to the Dmp1 promoter upon mitogenic signaling and E2Fs 1-4 inhibited the Dmp1 promoter in a reporter assay.	SEN:10032862	16878159
BEL:20067632	tscript(p(MGI:E2f4)) increases bp(GOBP:"cell cycle")	In both the E2F3a and E2F4 transgenic lenses, cyclin A2 and cyclin B1 expression were upregulated. E2F3a and E2F4, but not E2F5, function to induce cell cycle entry, although E2F4 has more modest activity.	SEN:10032868	15855772
BEL:20067638	tscript(p(MGI:E2f4)) increases r(MGI:Ccna2)	In both the E2F3a and E2F4 transgenic lenses, cyclin A2 and cyclin B1 expression were upregulated. E2F3a and E2F4, but not E2F5, function to induce cell cycle entry, although E2F4 has more modest activity.	SEN:10032868	15855772
BEL:20067640	tscript(p(MGI:E2f4)) increases r(MGI:Ccnb1)	In both the E2F3a and E2F4 transgenic lenses, cyclin A2 and cyclin B1 expression were upregulated. E2F3a and E2F4, but not E2F5, function to induce cell cycle entry, although E2F4 has more modest activity.	SEN:10032868	15855772
BEL:20067644	tscript(p(MGI:E2f4)) decreases r(MGI:Dmtf1)	Subsets of E2Fs were specifically bound to the Dmp1 promoter upon mitogenic signaling and E2Fs 1-4 inhibited the Dmp1 promoter in a reporter assay.	SEN:10032862	16878159
BEL:20067662	tscript(p(MGI:Ebf1)) increases p(MGI:Cd19)	Reconstitution of primary leukemia cells showed that these tumors express high densities of the B-cell surface proteins CD19 and CD38, which are EBF targets.	SEN:10011230	15580294
BEL:20067664	tscript(p(MGI:Ebf1)) increases p(MGI:Cd38)	Reconstitution of primary leukemia cells showed that these tumors express high densities of the B-cell surface proteins CD19 and CD38, which are EBF targets.	SEN:10011230	15580294
BEL:20067666	tscript(p(MGI:Ebf1)) increases r(MGI:Cd19)	Reconstitution of primary leukemia cells showed that these tumors express high densities of the B-cell surface proteins CD19 and CD38, which are EBF targets.	SEN:10011230	15580294
BEL:20067668	tscript(p(MGI:Ebf1)) increases r(MGI:Cd38)	Reconstitution of primary leukemia cells showed that these tumors express high densities of the B-cell surface proteins CD19 and CD38, which are EBF targets.	SEN:10011230	15580294
BEL:20067674	tscript(p(MGI:Egr1)) increases path(MESHD:Fibrosis)	The transcription factor early growth response-1 (Egr-1) mediates the stimulation of collagen transcription elicited by TGF-beta and is necessary for the development of pulmonary fibrosis in mice.	SEN:10031234	18772333
BEL:20067676	tscript(p(MGI:Egr1)) directlyIncreases r(MGI:Ccnd2)	provide newinsights of Egr1 involvement in proliferation and survival of TRAMP C2 prostatecancer cells by the identification of several new target genes controllinggrowth, cell cycle progression, and apoptosis such as cyclin D2, P19ink4d, andFas.	SEN:10032886	12556466
BEL:20067678	tscript(p(MGI:Egr1)) directlyIncreases r(MGI:Cdkn2d)	provide newinsights of Egr1 involvement in proliferation and survival of TRAMP C2 prostatecancer cells by the identification of several new target genes controllinggrowth, cell cycle progression, and apoptosis such as cyclin D2, P19ink4d, andFas.	SEN:10032886	12556466
BEL:20067680	tscript(p(MGI:Egr1)) directlyIncreases r(MGI:Fas)	provide newinsights of Egr1 involvement in proliferation and survival of TRAMP C2 prostatecancer cells by the identification of several new target genes controllinggrowth, cell cycle progression, and apoptosis such as cyclin D2, P19ink4d, andFas.	SEN:10032886	12556466
BEL:20067682	tscript(p(MGI:Egr1)) directlyIncreases r(MGI:Lhb)	Erg1 transcription factor directly activates the luteinizing hormone beta LHbeta subuit promoter, and female mice lacking Egr1 are infertile due to LHbeta deficiency	SEN:10026618	10734128
BEL:20067684	tscript(p(MGI:Egr1)) increases r(MGI:Pdgfa)	Egr-1 has been characterized as a transcriptional regulator of both PDGF-A and PDGF-C gene expression (18, 19).	SEN:10032888	16951379
BEL:20067686	tscript(p(MGI:Egr1)) increases r(MGI:Pdgfc)	Egr-1 has been characterized as a transcriptional regulator of both PDGF-A and PDGF-C gene expression (18, 19).	SEN:10032888	16951379
BEL:20067688	tscript(p(MGI:Egr1)) directlyIncreases r(MGI:Trp53)	Egr1-null mouse embryo fibroblasts bypass replicative senescence and exhibit a loss of DNA damage response and an apparent immortal growth, suggesting loss of p53 functions. .......... Electrophoretic mobility shift assay as well as chromatin immunoprecipitation confirmed that p53 is a direct target of Egr1.	SEN:10032890	15958557
BEL:20067694	tscript(p(MGI:Egr2)) directlyIncreases r(MGI:Cebpb)	Knockdown of KLF4 inhibits adipogenesis and downregulates C/EBPbeta levels. KLF4 binds directly to the C/EBPbeta (Cebpb) promoter as shown by chromatin immunoprecipitation and gel shift assays and, together with Krox20, cooperatively transactivates a C/EBPbeta reporter.	SEN:10009426	18396140
BEL:20067696	tscript(p(MGI:Egr2)) directlyIncreases r(MGI:Fasl)	promoter for the Fas ligand, which has been implicated as a target gene for Egr2 and Egr3, demonstrated robust NAB coactivation similar to Lhb	SEN:10029414	10734128
BEL:20067702	tscript(p(MGI:Egr3)) directlyIncreases r(MGI:Fasl)	promoter for the Fas ligand, which has been implicated as a target gene for Egr2 and Egr3, demonstrated robust NAB coactivation similar to Lhb	SEN:10029414	10734128
BEL:20067706	tscript(p(MGI:Egr4)) increases r(MGI:Slc12a5)	Electrophoretic mobility shift assay confirmed specific Egr4 binding to Egr4(KCC2). Interference RNA-mediated knock-down of Egr4 and a dominant-negative isoform of Egr4 significantly inhibited KCC2 reporter induction and endogenous KCC2 expression in cultured neurons. Together, the results indicate an important role for Egr4 in the developmental upregulation of KCC2 gene expression.	SEN:10011236	17192429
BEL:20067712	tscript(p(MGI:Elf1)) directlyIncreases r(MGI:Csf1r)	Both the model promoter and the macrophage-specific mouse and human c-fms promoters were activated in RAW264 cells by other Ets family transcription factors, Ets-2 and Elf-1.	SEN:10032896	9506963
BEL:20067724	tscript(p(MGI:Elk1)) directlyIncreases r(MGI:Ache)	Two Elk-1 binding site sequences present in the AChE gene promoter were jointly sufficient to drive ATP-induced reporter gene transcription.	SEN:10004984	12805285
BEL:20067730	tscript(p(MGI:Elk1)) increases r(MGI:Egr1)	We show here that for the mouse Egr1 gene, controlled largely by MAP kinase phosphorylation of the ELK1 transcription factor, the MED23 Mediator subunit that interacts with phospho-ELK1 is also required to stimulate Pol II initiation at a step subsequent to preinitiation complex assembly.	SEN:10020364	15749018
BEL:20067732	tscript(p(MGI:Elk1)) increases r(MGI:Fos)	In NIH3T3HERc cells treated with EGF, activation of the corresponding reporter construct (el2CAT) - reporter containing c-fos SRE - is dependent on co-transfection of Gal-Elk.	SEN:10026590	7889942
BEL:20067734	tscript(p(MGI:Elk1)) directlyIncreases r(MGI:Fos)	The observation that Elk-1 is phosphorylated directly and activated by p46SAPK and p54SAPK further implicates it in the stress-response induction of the c-fos gene.	SEN:10032900	8548291
BEL:20067738	tscript(p(MGI:Elk1)) increases r(MGI:Hmox1)	In the absence of PGN (Fig. 5, open bars), Elk-1 and Ets-2 were the most potent inducers of the HO-1 promoter (P < 0.05; Fig. 5A).	SEN:10032902	20348279
BEL:20067746	tscript(p(MGI:Elk3)) decreases p(MGI:Nos2)	Elk-3 (Net/Erp/Sap-2a) markedly repressed NOS2 promoter activity in a dose-dependent fashion, and overexpression of Elk-3 blunted the induction of endogenous NOS2 message.	SEN:10032904	12896968
BEL:20067750	tscript(p(MGI:Elk3)) decreases r(MGI:Egr1)	In normoxia, at 0 h, Net is a transcriptional repressor of PAI-1, c-fos, and egr-1 and an activator of VEGF (Fig. 7B, panel a),	SEN:10032906	17403894
BEL:20067752	tscript(p(MGI:Elk3)) decreases r(MGI:Fos)	In normoxia, at 0 h, Net is a transcriptional repressor of PAI-1, c-fos, and egr-1 and an activator of VEGF (Fig. 7B, panel a),	SEN:10032906	17403894
BEL:20067756	tscript(p(MGI:Elk3)) decreases r(MGI:Serpine1)	Net represses PAI-1 promoter activity and binds to a specific region of the promoter containing Ets binding sites in the absence of SRF. We conclude that Net is a negative regulator of PAI-1 expression and is thereby involved in cell migration.	SEN:10010068	16314510
BEL:20067758	tscript(p(MGI:Elk3)) decreases r(MGI:Serpine1)	In normoxia, at 0 h, Net is a transcriptional repressor of PAI-1, c-fos, and egr-1 and an activator of VEGF (Fig. 7B, panel a),	SEN:10032906	17403894
BEL:20067762	tscript(p(MGI:Elk3)) increases r(MGI:Vegfa)	In normoxia, at 0 h, Net is a transcriptional repressor of PAI-1, c-fos, and egr-1 and an activator of VEGF (Fig. 7B, panel a),	SEN:10032906	17403894
BEL:20067766	tscript(p(MGI:Eno1)) increases bp(GOBP:"cell death")	We previously demonstrated that exogenous expression of MBP-1 induces rapid cell death in murine fibroblasts	SEN:10011244	9074493
BEL:20067768	tscript(p(MGI:Eno1)) decreases r(MGI:Myc)	recent findings indicate that the a enolase mRNA encodes two distinct proteins, alpha enolase and Myc-binding protein (MBP)-1 (ENO1)protein, due to alternative usage of translation initiation sites MBP-1 protein down-regulates c-Myc oncoprotein expression.	SEN:10032912	12562761
BEL:20067770	tscript(p(MGI:Eno1)) decreases r(MGI:Myc)	amino-terminal half (amino acids 1-178) of MBP-1 possesses the c-myc P2 promoter binding activity. The same domain of MBP-1 also showed transcriptional repressor activity on c-myc promoter	SEN:10011246	9074493
BEL:20067772	tscript(p(MGI:Eomes)) directlyIncreases r(MGI:Gzmb)	It has been shown that EOMES directly regulates expression of perforin (PRF1), granzyme B (GZMB), and IFN ? (IFNG), and promotes effector function in CD8 T cells (5)	SEN:10032914	18523274
BEL:20067774	tscript(p(MGI:Eomes)) directlyIncreases r(MGI:Ifng)	It has been shown that EOMES directly regulates expression of perforin (PRF1), granzyme B (GZMB), and IFN ? (IFNG), and promotes effector function in CD8 T cells (5)	SEN:10032914	18523274
BEL:20067776	tscript(p(MGI:Eomes)) directlyIncreases r(MGI:Prf1)	It has been shown that EOMES directly regulates expression of perforin (PRF1), granzyme B (GZMB), and IFN ? (IFNG), and promotes effector function in CD8 T cells (5)	SEN:10032914	18523274
BEL:20067778	tscript(p(MGI:Ep300)) increases r(MGI:Jun)	Activating transcription factor 2 (ATF-2) and p300 cooperate in the activation of transcription of the c-jun gene during the differentiation of F9 cells.	SEN:10032654	12052888
BEL:20067784	tscript(p(MGI:Ep300)) increases tscript(p(MGI:Ets1))	Taken together, these data indicate that PYK2-induced p21Cip1 activates p300, which promotes Ets-1 binding to the MCP-1 promoter, leading to enhancement of MCP-1 transcription.	SEN:10025934	21372295
BEL:20067786	tscript(p(MGI:Ep300)) increases tscript(p(MGI:Hif1a))	from full ext - Figure 2 (D–F) Transient transfection assays showing that Gal-HIF-1a function is reduced in MEFs with multiple DCH1 alleles (mean7s.e.m., N¼3) (D), and can be rescued by WT CBP (E, F) or p300 (F), but not by CBPDCH1 (E) (mean7s.e.m., N¼2–4). (G, H) Transactivation by factors utilizing other domains of p300 and CBP or other coactivators is unimpaired (mean7s.d., N¼4).	SEN:10032810	16237459
BEL:20067790	tscript(p(MGI:Epas1)) increases a(CHEBI:lipid)	The induction of EPAS1-(1-485) allowed the cells to accumulate only minimum amounts of intracellular lipid droplets.	SEN:10011248	15258146
BEL:20067792	tscript(p(MGI:Epas1)) increases bp(GOBP:"fat cell differentiation")	During adipose differentiation in 3T3-L1 cells, the level of EPAS1 mRNA began to increase 6 days after the induction, Ectopic Expression of EPAS1 in NIH 3T3 Cells Stimulates Adipose Differentiation	SEN:10032916	15258146
BEL:20067796	tscript(p(MGI:Epas1)) increases r(MGI:Cebpa)	a minimum amount of aP2 and PPARgamma2 mRNA was induced in the EPAS1-(1-485) cells. , minimum amounts of PPAR{gamma}2 and C/EBP family were induced in the EPAS1(1-485)-expressing cells	SEN:10032918	15258146
BEL:20067798	tscript(p(MGI:Epas1)) increases r(MGI:Cebpb)	a minimum amount of aP2 and PPARgamma2 mRNA was induced in the EPAS1-(1-485) cells. , minimum amounts of PPAR{gamma}2 and C/EBP family were induced in the EPAS1(1-485)-expressing cells	SEN:10032918	15258146
BEL:20067804	tscript(p(MGI:Epas1)) directlyIncreases r(MGI:Irs3)	Overexpression of EPAS1(1-485) in 3T3-L1 adipocytes dramatically suppressed the expression of GLUT1, GLUT4, and IRS3 EPAS1 activates the promoter activity of GLUT1 (A), GLUT4 (B), and IRS3	SEN:10032924	15258146
BEL:20067808	tscript(p(MGI:Epas1)) increases r(MGI:Pparg)	a minimum amount of aP2 and PPARgamma2 mRNA was induced in the EPAS1-(1-485) cells. , minimum amounts of PPAR{gamma}2 and C/EBP family were induced in the EPAS1(1-485)-expressing cells	SEN:10032918	15258146
BEL:20067810	tscript(p(MGI:Epas1)) directlyIncreases r(MGI:Slc2a1)	Overexpression of EPAS1(1-485) in 3T3-L1 adipocytes dramatically suppressed the expression of GLUT1, GLUT4, and IRS3 EPAS1 activates the promoter activity of GLUT1 (A), GLUT4 (B), and IRS3	SEN:10032924	15258146
BEL:20067812	tscript(p(MGI:Epas1)) directlyIncreases r(MGI:Slc2a4)	Overexpression of EPAS1(1-485) in 3T3-L1 adipocytes dramatically suppressed the expression of GLUT1, GLUT4, and IRS3 EPAS1 activates the promoter activity of GLUT1 (A), GLUT4 (B), and IRS3	SEN:10032924	15258146
BEL:20067818	tscript(p(MGI:Epas1)) increases r(MGI:Tek)	EPAS1 forms a heterodimeric complex with the aryl hydrocarbon nuclear transporter prior to transcriptional activation of target genes. EPAS1 expression is limited to the endothelium of mouse embryos and, in agreement with its cell type-specific expression pattern, is capable of specifically activating the transcription of the endothelial tyrosine kinase gene Tie-2.	SEN:10032636	9000051
BEL:20067822	tscript(p(MGI:Epas1)) increases r(MGI:Vegfa)	Subsequently, HIF-alpha proteins accumulate and enhance the transcription of VEGF-A, a potent proangiogenic factor.	SEN:10011252	15369676
BEL:20067824	tscript(p(MGI:Epas1)) increases surf(complex(p(MGI:Itgav),p(MGI:Itgb3)))	Furthermore, this defect is associated with decreased cell surface expression of integrin alphavbeta3 and significantly decreased expression of this integrin in focal adhesions.	SEN:10025218	15689487
BEL:20067830	tscript(p(MGI:Esr1)) decreases r(EGID:100124672)	RNA levels for TCR{beta}, IFN-{gamma}, TNF-alpha, and lymphotoxin-alpha were strongly up-regulated within the spinal cord of ERalpha-{Delta}2-/- mice and their WT littermate controls. Interestingly, while E2 treatment abolished the expression of these transcripts to nearly basal levels in ERalpha-{Delta}2+/+ mice, it had no effect in ERalpha-{Delta}2-/- mice for both doses of E2 tested.	SEN:10032930	15294957
BEL:20067844	tscript(p(MGI:Esr1)) decreases r(MGI:Ifng)	RNA levels for TCR{beta}, IFN-{gamma}, TNF-alpha, and lymphotoxin-alpha were strongly up-regulated within the spinal cord of ERalpha-{Delta}2-/- mice and their WT littermate controls. Interestingly, while E2 treatment abolished the expression of these transcripts to nearly basal levels in ERalpha-{Delta}2+/+ mice, it had no effect in ERalpha-{Delta}2-/- mice for both doses of E2 tested.	SEN:10032930	15294957
BEL:20067846	tscript(p(MGI:Esr1)) increases r(MGI:Lgals1)	Treatment with 17b-estradiol raised galectin-1 mRNA level as early as 6 hr and the high level of galectin-1 mRNA remained up to 24 hr (Fig. 2A).	SEN:10032938	9291476
BEL:20067848	tscript(p(MGI:Esr1)) decreases r(MGI:Lta)	RNA levels for TCR{beta}, IFN-{gamma}, TNF-alpha, and lymphotoxin-alpha were strongly up-regulated within the spinal cord of ERalpha-{Delta}2-/- mice and their WT littermate controls. Interestingly, while E2 treatment abolished the expression of these transcripts to nearly basal levels in ERalpha-{Delta}2+/+ mice, it had no effect in ERalpha-{Delta}2-/- mice for both doses of E2 tested.	SEN:10032930	15294957
BEL:20067850	tscript(p(MGI:Esr1)) increases r(MGI:Mthfd2)	In addition, the dehydrogenase Mthfd2 (cluster M), which may provide the formyltetrahydrofolate for formylmethionyl-tRNA synthesis, was also induced (75).	SEN:10032940	12915738
BEL:20067860	tscript(p(MGI:Esr1)) decreases r(MGI:Tnf)	RNA levels for TCR{beta}, IFN-{gamma}, TNF-alpha, and lymphotoxin-alpha were strongly up-regulated within the spinal cord of ERalpha-{Delta}2-/- mice and their WT littermate controls. Interestingly, while E2 treatment abolished the expression of these transcripts to nearly basal levels in ERalpha-{Delta}2+/+ mice, it had no effect in ERalpha-{Delta}2-/- mice for both doses of E2 tested.	SEN:10032930	15294957
BEL:20067868	tscript(p(MGI:Esr2)) increases r(MGI:Mthfd2)	In addition, the dehydrogenase Mthfd2 (cluster M), which may provide the formyltetrahydrofolate for formylmethionyl-tRNA synthesis, was also induced (75).	SEN:10032940	12915738
BEL:20067870	tscript(p(MGI:Esrra)) increases bp(GOBP:"fatty acid oxidation")	From text: In addition, medium-chain acyl-CoA dehydrogenase (MCAD), a known PPARalpha target that catalyzes the initial step in mitochodrial fatty acid beta-oxidation, is also regulated by ERRalpha (Sladek et al. 1997; Vega and Kelly 1997; Huss et al 2002).	SEN:10032944	15004004
BEL:20067884	tscript(p(MGI:Ets1)) increases r(MGI:Ccl2)	Furthermore, siRNA knockdown of p21Cip1 (88+/-3% inhibition in p21Cip1 protein levels, n=4, P,0.05) attenuated TNFa-mediated Ets-1 binding to MCP-1 promoter in WT-EC (Figure 5D). Thus, TNFa actually induced the transcription of MCP-1 gene by activating Ets-1 binding to the promoter region.	SEN:10025936	21372295
BEL:20067886	tscript(p(MGI:Ets1)) increases r(MGI:Ccl2)	Taken together, these data indicate that PYK2-induced p21Cip1 activates p300, which promotes Ets-1 binding to the MCP-1 promoter, leading to enhancement of MCP-1 transcription.	SEN:10025934	21372295
BEL:20067892	tscript(p(MGI:Ets1)) increases r(MGI:Fli1)	The transcripts levels of the ETS transcription factor fli-1 are specifically up-regulated in endothelial cells, which overexpress Ets-1, but not in fibroblasts. Analysis of the promoter of the mouse fli-1 gene reveals that the 1-kb region that comprises the transcription starts and part of exon 1 is responsible for the response of the promoter to Ets-1.	SEN:10032950	11991951
BEL:20067894	tscript(p(MGI:Ets1)) increases r(MGI:Flot1)	The fP-2 segment, with a second Sp1 binding site, a CAAT box and putative specific binding sites for myeloid zinc finger protein 1 (MZF1), acute myeloid leukemia 1a (AML-1a) and cellular progenitor of viral oncogene from E26 acute leukemia retrovirus (c-Ets-1) produced about twice as much luciferase activity as fP-4.	SEN:10032952	14644419
BEL:20067896	tscript(p(MGI:Ets1)) increases r(MGI:Hmox1)	Ets-1 and Ets-2 both induce HO-1 promoter activity; however, Ets-2 was a more potent transactivator of HO-1 in macrophages.	SEN:10003484	15590657
BEL:20067910	tscript(p(MGI:Ets1)) increases r(MGI:Nr2f2)	the COUP-TFII promoter activity is indeed regulated by Ets-1 Ets-1 to enhance the COUP-TFII promoter activity. Furthermore, other members of the ETS family such as Ets-2 or ETV1 are also potent regulators of the COUP-TFII promoter.	SEN:10032956	15541767
BEL:20067922	tscript(p(MGI:Ets2)) decreases bp(GOBP:"apoptotic process")	The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism.	SEN:10011282	10082528
BEL:20067926	tscript(p(MGI:Ets2)) directlyIncreases r(MGI:Csf1r)	Both the model promoter and the macrophage-specific mouse and human c-fms promoters were activated in RAW264 cells by other Ets family transcription factors, Ets-2 and Elf-1.	SEN:10032896	9506963
BEL:20067928	tscript(p(MGI:Ets2)) increases r(MGI:Hmox1)	Ets-1 and Ets-2 both induce HO-1 promoter activity; however, Ets-2 was a more potent transactivator of HO-1 in macrophages.	SEN:10003484	15590657
BEL:20067930	tscript(p(MGI:Ets2)) directlyIncreases r(MGI:Hmox1)	Ets-1 and Ets-2 both induce HO-1 promoter activity; however, Ets-2 was a more potent transactivator of HO-1 in macrophages.....Promoter sequence analysis revealed two putative Ets binding sites (EBSs) in this region, and mutation of these sites showed that EBS -93, more than EBS -125, was critical for full HO-1 promoter activity.	SEN:10011286	15590657
BEL:20067932	tscript(p(MGI:Ets2)) increases r(MGI:Hmox1)	In the absence of PGN (Fig. 5, open bars), Elk-1 and Ets-2 were the most potent inducers of the HO-1 promoter (P < 0.05; Fig. 5A).	SEN:10032902	20348279
BEL:20067936	tscript(p(MGI:Ets2)) increases r(MGI:Nr2f2)	the COUP-TFII promoter activity is indeed regulated by Ets-1 Ets-1 to enhance the COUP-TFII promoter activity. Furthermore, other members of the ETS family such as Ets-2 or ETV1 are also potent regulators of the COUP-TFII promoter.	SEN:10032956	15541767
BEL:20067938	tscript(p(MGI:Ets2)) increases r(MGI:Plau)	The involvement of AP1 as well as Ets transcription factors was confirmed by examining different promoter constructs containing deletions in either the AP-1 or the PEA3 element, and by using an expression plasmid for dominant negative Ets-2.	SEN:10011288	9409785
BEL:20067942	tscript(p(MGI:Etv1)) increases r(MGI:Nr2f2)	the COUP-TFII promoter activity is indeed regulated by Ets-1 Ets-1 to enhance the COUP-TFII promoter activity. Furthermore, other members of the ETS family such as Ets-2 or ETV1 are also potent regulators of the COUP-TFII promoter.	SEN:10032956	15541767
BEL:20067944	tscript(p(MGI:Etv1)) increases r(MGI:Ptgs2)	In contrast to the weak response to eta-catenin, PEA3 and the related factors ER81 and ERM potently activated the COX-2 promoter (Figs. 1 and 3 ).	SEN:10032960	11274170
BEL:20067946	tscript(p(MGI:Etv2)) directlyIncreases r(MGI:Mmp13)	Furthermore, TSGA impairs the ability of ER71 to activate transcription from the matrix metalloproteinase-1 promoter.	SEN:10004230	16619273
BEL:20067950	tscript(p(MGI:Etv4)) increases r(MGI:Ptgs2)	Strikingly, PEA3 alone was also sufficient to activate transcription of the endogenous COX-2 gene.	SEN:10032964	11274170
BEL:20067960	tscript(p(MGI:Fli1)) increases bp(GOBP:"megakaryocyte differentiation")	Several transcription factors have also been implicated in megakaryopoiesis including, GATA-1, friend of GATA-1 (FOG-1), nuclear factor-erythroid 2 (NF-E2), and Fli-1.	SEN:10003208	17127443
BEL:20067962	tscript(p(MGI:Fli1)) decreases r(EGID:15127)	We show here that FLI-1 represses the transcriptional activity of the beta-globin gene promoter in MEL cells and interacts with two of its critical transactivators, GATA-1 and EKLF.	SEN:10032972	12556498
BEL:20067964	tscript(p(MGI:Fli1)) increases r(MGI:Fli1)	Furthermore, endogenous Fli-1 was found to be bound to its own gene promoter and to be able to promote the transactivation of its gene.	SEN:10011290	11991951
BEL:20067966	tscript(p(MGI:Fli1)) increases r(MGI:Gp9)	Reciprocally, we also show that EKLF itself represses the FLI-1-dependent megakaryocytic GPIX gene promoter, thus further suggesting that functional cross-antagonism between FLI-1 and EKLF might be involved in the control of the erythrocytic versus megakaryocytic differentiation of bipotential progenitors.	SEN:10009424	12556498
BEL:20067970	tscript(p(MGI:Fli1)) increases tscript(p(MGI:Gata1))	Transcriptional output by the GATA-1-FOG-1 complex is determined by the hematopoietic Ets protein Fli-1 that binds to an adjacent Ets element.	SEN:10011292	12356738
BEL:20067978	tscript(p(MGI:Fosb)) increases r(MGI:Cdk5)	Here we identify cyclin-dependent kinase 5 (Cdk5) as a downstream target gene of DeltaFosB by use of DNA array analysis of striatal material from inducible transgenic mice. Overexpression of DeltaFosB, or chronic cocaine administration, raised levels of Cdk5 messenger RNA, protein, and activity in the striatum.	SEN:10011294	11268215
BEL:20067980	tscript(p(MGI:Fosl1)) increases path(MESHD:Mesothelioma)	In asbestos-associated transformation of rodent mesothelial cells, the use of dominant negative ERK1 or Fra-1 constructs reverses the phenotype of mesothelioma cells to that of normal mesothelial cells (12). Moreover, Fra-1 expression is increased in human mesotheliomas and in other tumor types.	SEN:10021972	16484683
BEL:20067986	tscript(p(MGI:Fos)) increases r(MGI:Plau)	In addition, ATF-2 binds to the -2.4-kb element even without induction and c-Fos to the -6.9-kb element only after induction. Accordingly, overexpression of c-Fos caused induction from the -6.9-kb element, but reduced induction from the -2.4-kb element. The involvement of the Ets-2 transcription factor was shown by using expression plasmids for wild-type and dominant negative Ets-2.	SEN:10011084	9409785
BEL:20067988	tscript(p(MGI:Fos)) directlyIncreases r(MGI:Pvrl2)	% Overexpressions of CREB and c-Jun, but not c-Fos, also significantly increased the promoter activity, which suggests that CREB and c-Jun are the crucial transcription factors involved in regulating nectin-2 gene transcription.	SEN:10011182	16250013
BEL:20067990	tscript(p(MGI:Fos)) decreases r(MGI:S100a8)	By comparing S100A8 and S100A9 mRNA levels in wild type and c-Fos deficient mice (c-fos(-/-)) we found that expression is negatively regulated by c-Fos/AP-1.	SEN:10011296	12082614
BEL:20067992	tscript(p(MGI:Fos)) decreases r(MGI:S100a9)	By comparing S100A8 and S100A9 mRNA levels in wild type and c-Fos deficient mice (c-fos(-/-)) we found that expression is negatively regulated by c-Fos/AP-1.	SEN:10011296	12082614
BEL:20068002	tscript(p(MGI:Foxa2)) increases bp(GOBP:gluconeogenesis)	We conclude that Foxa2 is required for execution of the hepatic gluconeogenic program by integrating the transcriptional response of the hepatocyte to hormonal stimulation.	SEN:10011300	16098831
BEL:20068004	tscript(p(MGI:Foxa2)) decreases r(MGI:Abcc8)	induction of DN-Foxa2 also reduces the expression of beta-cell K(ATP) channel subunits Sur1 and Kir6.2 by 70%.	SEN:10011302	11875061
BEL:20068008	tscript(p(MGI:Foxa2)) increases r(MGI:Gcg)	The expression of insulin and islet amyloid polypeptide is markedly suppressed after induction of Foxa2, while the glucagon mRNA levels are significantly increased.	SEN:10011304	11875061
BEL:20068010	tscript(p(MGI:Foxa2)) decreases r(MGI:Gck)	loss of Foxa2 function leads to up-regulation of hexokinase (HK) I and II and glucokinase (HK-IV) mRNA expression.	SEN:10011306	11875061
BEL:20068012	tscript(p(MGI:Foxa2)) increases r(MGI:Hadh)	We utilized expression profiling to identify additional targets of Foxa2. Strikingly, one of these genes, Hadhsc, encodes short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase, deficiency of which has been shown to cause PHHI in humans. Hadhsc is a direct target of Foxa2, as demonstrated by cotransfection as well as in vivo chromatin immunoprecipitation experiments using isolated islets.	SEN:10011308	15314688
BEL:20068014	tscript(p(MGI:Foxa2)) decreases r(MGI:Hk1)	loss of Foxa2 function leads to up-regulation of hexokinase (HK) I and II and glucokinase (HK-IV) mRNA expression.	SEN:10011306	11875061
BEL:20068016	tscript(p(MGI:Foxa2)) decreases r(MGI:Hk2)	loss of Foxa2 function leads to up-regulation of hexokinase (HK) I and II and glucokinase (HK-IV) mRNA expression.	SEN:10011306	11875061
BEL:20068020	tscript(p(MGI:Foxa2)) decreases r(MGI:Iapp)	The expression of insulin and islet amyloid polypeptide is markedly suppressed after induction of Foxa2, while the glucagon mRNA levels are significantly increased.	SEN:10011304	11875061
BEL:20068022	tscript(p(MGI:Foxa2)) directlyIncreases r(MGI:Igfbp1)	Foxa2 occupied its binding sites in all three target genes... Therefore, the decreased activation of the PEPCK, TAT, and IGFBP-1 genes in Foxa2-deficient hepatocytes that we observed solely in the fasted state (Figure 2) indicates that Foxa2 is essential to the transcriptional response to food deprivation.	SEN:10032984	16098831
BEL:20068024	tscript(p(MGI:Foxa2)) decreases r(MGI:Ins2)	The expression of insulin and islet amyloid polypeptide is markedly suppressed after induction of Foxa2, while the glucagon mRNA levels are significantly increased.	SEN:10011304	11875061
BEL:20068026	tscript(p(MGI:Foxa2)) decreases r(MGI:Kcnj11)	induction of DN-Foxa2 also reduces the expression of beta-cell K(ATP) channel subunits Sur1 and Kir6.2 by 70%.	SEN:10011302	11875061
BEL:20068030	tscript(p(MGI:Foxa2)) directlyIncreases r(MGI:Pck1)	Foxa2 occupied its binding sites in all three target genes... Therefore, the decreased activation of the PEPCK, TAT, and IGFBP-1 genes in Foxa2-deficient hepatocytes that we observed solely in the fasted state (Figure 2) indicates that Foxa2 is essential to the transcriptional response to food deprivation.	SEN:10032984	16098831
BEL:20068038	tscript(p(MGI:Foxa2)) increases r(MGI:Shh)	beta1 integrins were found to drive the expression of Hedgehogs in intestinal epithelial cells in an HNF-3beta (Foxa2)-dependent fashion.	SEN:10028568	17088430
BEL:20068040	tscript(p(MGI:Foxa2)) directlyIncreases r(MGI:Tat)	Foxa2 occupied its binding sites in all three target genes... Therefore, the decreased activation of the PEPCK, TAT, and IGFBP-1 genes in Foxa2-deficient hepatocytes that we observed solely in the fasted state (Figure 2) indicates that Foxa2 is essential to the transcriptional response to food deprivation.	SEN:10032984	16098831
BEL:20068042	tscript(p(MGI:Foxc2)) directlyIncreases r(MGI:Itgb3)	We found that Itgb3 expression is directly regulated by Foxc2 through multiple Forkhead-binding elements within two high homology regions in the Itgb3 promoter	SEN:10011316	18579532
BEL:20068058	tscript(p(MGI:Foxf2)) increases r(MGI:Bmp4)	We first compared Bmp4 expression in Foxf2-/- and wild-type using a Bmp4lacZ knock in. ß-galactosidase activity in the intestine of Foxf2-/-; Bmp4lacZ/+ embryos (E15.5) was reduced (Fig. 6B,C) in the gut, whereas tissues without Foxf expression, such as eye lids and hair follicles, retained normal Bmp4-driven ß-galactosidase activity (Fig. 6D,E).	SEN:10032994	16439479
BEL:20068060	tscript(p(MGI:Foxf2)) decreases r(MGI:Wnt5a)	Whole-mount in situ hybridization with candidate Wnt genes (Wnt4, Wnt5a and Wnt11) showed Wnt5a to be upregulated in Foxf2-/- embryos (Fig. 6A).	SEN:10032996	16439479
BEL:20068062	tscript(p(MGI:Foxh1)) increases r(MGI:Pitx2)	This element contains three binding sites for the transcription factor FAST. The FAST binding sites function as Nodal-responsive elements and are sufficient for the initiation but not for the maintenance of asymmetric expression. The maintenance requires an Nkx2-5 binding site also present within the ASE	SEN:10032998	11172719
BEL:20068118	tscript(p(MGI:Foxo1)) increases r(MGI:Abcg5)	Disinhibition of the forkhead transcription factor FoxO1, increases expression of the biliary cholesterol transporters Abcg5 and Abcg8, resulting in an increase in biliary cholesterol secretion.	SEN:10011334	18587407
BEL:20068120	tscript(p(MGI:Foxo1)) increases r(MGI:Abcg8)	Disinhibition of the forkhead transcription factor FoxO1, increases expression of the biliary cholesterol transporters Abcg5 and Abcg8, resulting in an increase in biliary cholesterol secretion.	SEN:10011334	18587407
BEL:20068124	tscript(p(MGI:Foxo1)) increases r(MGI:Apoc3)	Furthermore, elevated Foxo1 production in liver augmented hepatic apoC-III expression, resulting in increased plasma triglyceride levels	SEN:10011336	15546000
BEL:20068128	tscript(p(MGI:Foxo1)) increases r(MGI:Foxp3)	Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.	SEN:10031236	20439537
BEL:20068130	tscript(p(MGI:Foxo1)) directlyIncreases r(MGI:G6pc)	Remarkably, Foxo1 interacted with SHP in vivo and in vitro, which led to the repression of Foxo1-mediated G6Pase transcription by competition with a coactivator cAMP response element-binding protein-binding protein. These findings reveal a novel mechanism by which bile acids regulate gluconeogenic gene expression via an SHP-dependent regulatory pathway.	SEN:10011338	15047713
BEL:20068142	tscript(p(MGI:Foxo1)) increases sec(a(CHEBI:cholesterol))	Disinhibition of the forkhead transcription factor FoxO1, increases expression of the biliary cholesterol transporters Abcg5 and Abcg8, resulting in an increase in biliary cholesterol secretion.	SEN:10011334	18587407
BEL:20068144	tscript(p(MGI:Foxo3)) increases bp(GOBP:autophagy)	LC3-II was increased in FoxO3MyHC cardiomyocytes after ex vivo transgene activation (Figure 4F; see Supplementary material online, Figure S6C). Treatment with lysosomal inhibitors revealed that LC3-II levels could still be stimulated in FoxO3MyHC cardiomyocytes, indicating an activation of autophagy rather than a disturbance in autophagic flux.	SEN:10028990	21628326
BEL:20068146	tscript(p(MGI:Foxo3)) decreases bp(GOBP:"apoptotic process")	Figure 8. Inhibition of FKHR-L1 transcriptional activity protects cells from apoptosis induced by cytokine withdrawal.	SEN:10033018	11815629
BEL:20068148	tscript(p(MGI:Foxo3)) increases p(MGI:Map1lc3b)	LC3-II was increased in FoxO3MyHC cardiomyocytes after ex vivo transgene activation (Figure 4F; see Supplementary material online, Figure S6C). Treatment with lysosomal inhibitors revealed that LC3-II levels could still be stimulated in FoxO3MyHC cardiomyocytes, indicating an activation of autophagy rather than a disturbance in autophagic flux.	SEN:10028990	21628326
BEL:20068150	tscript(p(MGI:Foxo3)) directlyIncreases r(MGI:Btg1)	We identified B cell translocation gene 1 (BTG1)/antiproliferative protein 2 as a FoxO3a target gene in erythroid progenitors. Promoter studies indicated BTG1 as a direct target of FoxO3a.	SEN:10033020	14734530
BEL:20068154	tscript(p(MGI:Foxo3)) increases r(MGI:Fbxo32)	we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.	SEN:10021546	15109499
BEL:20068156	tscript(p(MGI:Foxo3)) increases r(MGI:Foxp3)	Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.	SEN:10031236	20439537
BEL:20068162	tscript(p(MGI:Foxp2)) directlyDecreases r(MGI:Scgb1a1)	We show that Foxp1 and Foxp2 act as transcriptional repressors that are able to repress the mouse CC10 and human SP-C promoters to differing degrees.	SEN:10033028	11358962
BEL:20068164	tscript(p(MGI:Foxp2)) directlyDecreases r(MGI:Sftpc)	We show that Foxp1 and Foxp2 act as transcriptional repressors that are able to repress the mouse CC10 and human SP-C promoters to differing degrees.	SEN:10033028	11358962
BEL:20068170	tscript(p(MGI:Foxp3)) decreases p(MGI:Il17a)	Examination of IL-17 expression in heterozygous RORgammat–GFP knock-in mice revealed that RORgammat+Foxp3+ lamina propria T cells produced much less IL-17 than RORgammat+Foxp3- cells, suggesting that Foxp3 may interfere with the ability of RORgammat to induce IL-17 (Fig. 1c).	SEN:10033032	18368049
BEL:20068172	tscript(p(MGI:Foxp3)) decreases r(MGI:Il17a)	As shown in Fig. 4C, transient overexpression of WT Foxp3, but not {Delta}2 or {Delta}FKH, inhibited induction of IL-17A transcription (Fig. 4C). Taken together, these observations suggest that Foxp3 interacts with ROR{gamma}t in the exon 2 region and that the FKH domain plays a critical role in the suppression of ROR{gamma}t-mediated IL-17A transcription.	SEN:10033034	18434325
BEL:20068174	tscript(p(MGI:Foxp3)) decreases r(MGI:Tnfaip3)	Foxp3 inhibits NF-?B transcriptional activity and represses the endogenous expression of the NF-?B target gene, A20.	SEN:10033036	15790681
BEL:20068184	tscript(p(MGI:Foxs1)) increases r(MGI:Ucp1)	In support of this, we observed increased levels of uncoupling protein 1 mRNA in Foxs1beta-gal/beta-gal mice.	SEN:10011350	15964817
BEL:20068188	tscript(p(MGI:Gabpa)) increases r(MGI:Il2)	Blocking both ERK and JNK/SAPK pathways abolishes the DSE induction. Our data suggest that GABP is targeted by signaling events from both ERK and JNK/SAPK pathways. GABP therefore is a candidate for signal integration and regulation of IL-2 transcription in T lymphocytes.	SEN:10033042	9553058
BEL:20068190	tscript(p(MGI:Gabpa)) increases r(MGI:Skp2)	\"Supershift\" analysis indicated that the protein-probe complexes detected by electrophoretic mobility shift assays contain GABP. Endogenous GABP bound to Skp2 promoter element in a cell cycle-dependent manner. Furthermore, overexpression of GABPbeta increased Skp2 promoter activity, and suppression of GABPalpha or GABPbeta by a small interfering RNA resulted in the reduction of Skp2 promoter activity.	SEN:10011352	12907639
BEL:20068192	tscript(p(MGI:Gabpb1)) increases r(MGI:Il2)	Blocking both ERK and JNK/SAPK pathways abolishes the DSE induction. Our data suggest that GABP is targeted by signaling events from both ERK and JNK/SAPK pathways. GABP therefore is a candidate for signal integration and regulation of IL-2 transcription in T lymphocytes.	SEN:10033042	9553058
BEL:20068194	tscript(p(MGI:Gabpb1)) increases r(MGI:Skp2)	\"Supershift\" analysis indicated that the protein-probe complexes detected by electrophoretic mobility shift assays contain GABP. Endogenous GABP bound to Skp2 promoter element in a cell cycle-dependent manner. Furthermore, overexpression of GABPbeta increased Skp2 promoter activity, and suppression of GABPalpha or GABPbeta by a small interfering RNA resulted in the reduction of Skp2 promoter activity.	SEN:10011352	12907639
BEL:20068196	tscript(p(MGI:Gabpb2)) increases r(MGI:Actb)	Double-point mutant analysis indicated a major role for the NRF2/GABP site in the enhancer capacity of this element in brown fat cells. It is proposed that NRF2/GABP plays a pivotal role in the co-ordinated enhancement of OXPHOS gene expression associated with mitochondrial biogenesis in brown adipocyte differentiation.	SEN:10011354	9512469
BEL:20068200	tscript(p(MGI:Gabpb2)) increases r(MGI:Cox4i1)	Double-point mutant analysis indicated a major role for the NRF2/GABP site in the enhancer capacity of this element in brown fat cells. It is proposed that NRF2/GABP plays a pivotal role in the co-ordinated enhancement of OXPHOS gene expression associated with mitochondrial biogenesis in brown adipocyte differentiation.	SEN:10011354	9512469
BEL:20068202	tscript(p(MGI:Gabpb2)) increases r(MGI:"mt-Co2")	Double-point mutant analysis indicated a major role for the NRF2/GABP site in the enhancer capacity of this element in brown fat cells. It is proposed that NRF2/GABP plays a pivotal role in the co-ordinated enhancement of OXPHOS gene expression associated with mitochondrial biogenesis in brown adipocyte differentiation.	SEN:10011354	9512469
BEL:20068204	tscript(p(MGI:Gabpb2)) increases r(MGI:Ucp1)	Double-point mutant analysis indicated a major role for the NRF2/GABP site in the enhancer capacity of this element in brown fat cells. It is proposed that NRF2/GABP plays a pivotal role in the co-ordinated enhancement of OXPHOS gene expression associated with mitochondrial biogenesis in brown adipocyte differentiation.	SEN:10011354	9512469
BEL:20068206	tscript(p(MGI:Gata1)) increases bp(GOBP:"megakaryocyte differentiation")	Several transcription factors have also been implicated in megakaryopoiesis including, GATA-1, friend of GATA-1 (FOG-1), nuclear factor-erythroid 2 (NF-E2), and Fli-1.	SEN:10003208	17127443
BEL:20068210	tscript(p(MGI:Gata1)) decreases r(MGI:Ccnd2)	GATA-1 inhibited expression of cyclin-dependent kinase (Cdk) 6 and cyclin D2 and induced the Cdk inhibitors p18(INK4C) and p27(Kip1) with associated inactivation of all G(1) Cdks.	SEN:10033046	12832487
BEL:20068212	tscript(p(MGI:Gata1)) decreases r(MGI:Cdk6)	GATA-1 inhibited expression of cyclin-dependent kinase (Cdk) 6 and cyclin D2 and induced the Cdk inhibitors p18(INK4C) and p27(Kip1) with associated inactivation of all G(1) Cdks.	SEN:10033046	12832487
BEL:20068214	tscript(p(MGI:Gata1)) increases r(MGI:Cdkn1b)	GATA-1 inhibited expression of cyclin-dependent kinase (Cdk) 6 and cyclin D2 and induced the Cdk inhibitors p18(INK4C) and p27(Kip1) with associated inactivation of all G(1) Cdks.	SEN:10033046	12832487
BEL:20068216	tscript(p(MGI:Gata1)) increases r(MGI:Cdkn2c)	GATA-1 inhibited expression of cyclin-dependent kinase (Cdk) 6 and cyclin D2 and induced the Cdk inhibitors p18(INK4C) and p27(Kip1) with associated inactivation of all G(1) Cdks.	SEN:10033046	12832487
BEL:20068218	tscript(p(MGI:Gata1)) increases r(MGI:Itga2b)	FOG-1 stimulates GATA-1-dependent alphaIIb gene expression in a manner that requires their direct physical interaction.	SEN:10033048	12356738
BEL:20068224	tscript(p(MGI:Gata1)) decreases r(MGI:Myc)	These effects were dependent on GATA-1-mediated repression of the c-myc (Myc) proto-oncogene. GATA-1 inhibited Myc expression within 3 h, and chromatin immunoprecipitation studies indicated that GATA-1 occupies the Myc promoter in vivo, suggesting a direct mechanism for gene repression.	SEN:10033054	12832487
BEL:20068226	tscript(p(MGI:Gata1)) directlyIncreases r(MGI:Nfe2)	To test this possibility we performed cotransfection assays in NIH-3T3 cells and HeLa cells with three different reporter constructs containing either synthetic (M1?, Fig. ?Fig.4A,B4A,B and ?D3; Fig. ?Fig.4C)4C) or natural (p45 NF-E2; Fig. ?Fig.4D)4D) GATA-1-dependent promoters. The p45 NF-E2 promoter requires the synergistic action of GATA-1 and FOG as a cofactor (Tsang et al. 1997).	SEN:10032318	10364157
BEL:20068228	tscript(p(MGI:Gata1)) directlyIncreases r(MGI:Nfil3)	Phosphorylation of GATA-1 increases GATA-1-mediated transcription of the E4bp4 survival gene without significantly changing the DNA-binding affinity of GATA-1.	SEN:10008796	15967790
BEL:20068232	tscript(p(MGI:Gata1)) directlyIncreases r(MGI:Stat1)	Moreover, GATA-1 transactivated the Stat1 promoter in luciferase reporter assays (Supplemental Figure 1). STAT1 and IRF-1 reciprocally activated each other’s transcription, as previously reported (Figure ?(Figure1D1D and Supplemental Table 1; also reviewed in ref. 26).	SEN:10033056	18060035
BEL:20068242	tscript(p(MGI:Gata3)) decreases bp(GOBP:"T-helper 1 cell differentiation")	In vitro deletion of Gata3 diminished both interleukin 4 (IL-4)-dependent and IL-4-independent T(H)2 cell differentiation; without GATA-3, T(H)1 differentiation occurred in the absence of IL-12 and interferon-gamma.	SEN:10011358	15475959
BEL:20068246	tscript(p(MGI:Gata3)) increases bp(GOBP:"T-helper 2 cell differentiation")	In vitro deletion of Gata3 diminished both interleukin 4 (IL-4)-dependent and IL-4-independent T(H)2 cell differentiation; without GATA-3, T(H)1 differentiation occurred in the absence of IL-12 and interferon-gamma.	SEN:10011358	15475959
BEL:20068264	tscript(p(MGI:Gata3)) increases r(MGI:Gata3)	Although Gata-3 can autoinduce itself and remodel the IL-4 locus without assistance from STAT6 (7), neither selection nor enhancement of IL-4 gene expression have yet been implicated as critical roles for STAT6 (4,7–9).	SEN:10033066	11397944
BEL:20068266	tscript(p(MGI:Gata3)) increases r(MGI:Gfi1b)	Gfi1b mRNA was decreased approximately 3-fold 48 hours after infection of lymphomas with Gata3siRNA virus (Figure 7A). To further test the ability of Gata3 to promote Gfi1b mRNA expression we used a Gata3-producing retrovirus to ectopically express Gata3 protein (Figure 7C). Gata3 induced Gfi1b mRNA by 12- or 6-fold over control virus-infected cells in 1.F9 or 0531 lymphomas, respectively (Figure 7D).	SEN:10027144	17272506
BEL:20068278	tscript(p(MGI:Gata4)) directlyIncreases r(MGI:Adora1)	Within the proximal A1AR promoter, putative binding sites for cardiac transcription factors GATA and Nkx2.5 were identified. Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression	SEN:10027152	10318839
BEL:20068280	tscript(p(MGI:Gata4)) directlyIncreases r(MGI:Fgf3)	By contrast, SOX2 was a poor activator of Fgf-3 transcription, and when Sox2 was coexpressed with Gata4, it negatively modulated the strong activation mediated by GATA-4....Previous studies identified GATA-4 as a transcription factor that binds the key regulatory element PS4A of the Fgf-3 promoter and stimulates transcription.	SEN:10030830	15082719
BEL:20068286	tscript(p(MGI:Gata4)) directlyIncreases r(MGI:Mef2c)	This conserved enhancer contains two consensus GATA binding sites that are efficiently bound by the zinc finger transcription factor GATA4	SEN:10033070	15253934
BEL:20068288	tscript(p(MGI:Gata4)) directlyIncreases r(MGI:Myl3)	GATA protein consensus sequence in the proximal MLC3 promoter but not the MLC1 promoter binds with high affinity to GATA-4, a cardiac muscle- and gut-specific transcription factor. Mutation of either the MEF2 or GATA motifs in the MLC3 promoter attenuates its activity in both heart and skeletal muscles, demonstrating that MLC3 expression in these two diverse muscle types is dependent on common regulatory elements.	SEN:10011372	8754853
BEL:20068298	tscript(p(MGI:Gata6)) directlyIncreases r(MGI:Fzd2)	Gata6 was also able to transactivate the –1.5-kb proximal mouse Fzd2 promoter in NIH-3T3 cells (Fig. 4m). Moreover, chromatin immunoprecipitation (ChIP) assays showed a direct association of Gata6 with the mouse Fzd2 promoter in the lung (Fig. 4n,o). Thus, mouse Fzd2 is a direct target of Gata6.	SEN:10033076	18536717
BEL:20068300	tscript(p(MGI:Gata6)) increases r(MGI:Fzd2)	pronounced increase in canonical Wnt signaling in lung epithelium upon loss of Gata6. Expression of the noncanonical Wnt receptor Fzd2 was downregulated in Gata6 mutants	SEN:10003188	18536717
BEL:20068304	tscript(p(MGI:Gfi1)) decreases bp(GOBP:"cell death")	Mice lacking Gfi1 show reduced thymic cellularity due to an increased cell death rate, lack of proliferation, and a differentiation block	SEN:10011376	12682108
BEL:20068306	tscript(p(MGI:Gfi1)) increases bp(GOBP:"cell differentiation")	Mice lacking Gfi1 show reduced thymic cellularity due to an increased cell death rate, lack of proliferation, and a differentiation block	SEN:10011376	12682108
BEL:20068308	tscript(p(MGI:Gfi1)) increases bp(GOBP:"cell proliferation")	Mice lacking Gfi1 show reduced thymic cellularity due to an increased cell death rate, lack of proliferation, and a differentiation block	SEN:10011376	12682108
BEL:20068310	tscript(p(MGI:Gfi1b)) decreases r(MGI:Gata3)	Gfi1b represses expression of Gata3, a transcription factor whose appropriate regulation is required for survival of lymphomas and T-lymphocyte progenitors.	SEN:10011378	17272506
BEL:20068314	tscript(p(MGI:Gfi1)) decreases r(MGI:Id1)	Absence of Gfi1 correlates with high level expression of the genes for lung Kruppel-like factor (LKLF), inhibitor of DNA binding (Id)1 and Id2	SEN:10033078	12682108
BEL:20068316	tscript(p(MGI:Gfi1)) decreases r(MGI:Id2)	Absence of Gfi1 correlates with high level expression of the genes for lung Kruppel-like factor (LKLF), inhibitor of DNA binding (Id)1 and Id2	SEN:10033078	12682108
BEL:20068318	tscript(p(MGI:Gfi1)) decreases r(MGI:Klf2)	Absence of Gfi1 correlates with high level expression of the genes for lung Kruppel-like factor (LKLF), inhibitor of DNA binding (Id)1 and Id2	SEN:10033078	12682108
BEL:20068330	tscript(p(MGI:Gtf2ird1)) increases r(EGID:111507)	Dominant-negative and RNAi-mediated knockdown experiments indicate that BEN can both positively and negatively regulate IgH promoter activity, depending on the cell line.	SEN:10011386	14645227
BEL:20068332	tscript(p(MGI:Gtf2ird1)) decreases r(EGID:111507)	Dominant-negative and RNAi-mediated knockdown experiments indicate that BEN can both positively and negatively regulate IgH promoter activity, depending on the cell line.	SEN:10011386	14645227
BEL:20068344	tscript(p(MGI:Hbp1)) decreases p(MGI:Myc)	Our detailed investigation showed that both Cyclin D1 and c-MYC expression was extinguished upon HBP1 expression.	SEN:10033088	15225871
BEL:20068346	tscript(p(MGI:Hbp1)) decreases r(MGI:Ccnd1)	Our detailed investigation showed that both Cyclin D1 and c-MYC expression was extinguished upon HBP1 expression.	SEN:10033088	15225871
BEL:20068348	tscript(p(MGI:Hbp1)) increases r(MGI:H1f0)	2.3.3.2. Histone H10 Lemercier et al. (2000) reported the Histone H10 gene as another RB-regulated HBP1 target that is also cell cycle regulated. Using a cell cycle regulated DNA element in a one-hybrid screen, HBP1 was identified as a regulator of the Histone H10 gene. HBP1 appears to be an activator for this gene.	SEN:10033090	15225871
BEL:20068358	tscript(p(MGI:Hey1)) directlyDecreases r(MGI:Kdr)	Furthermore, both EC network formation and expression of activated notch 1 or notch 4 induce expression of the bHLH transcription factor HESR-1 and downregulate the known HESR-1 target VEGFR-2 (KDR).	SEN:10009732	12453432
BEL:20068372	tscript(p(MGI:Hif1a)) decreases path(MESHD:"Myocardial Infarction")	HIF-1 activation in reperfusing myocardium resulted in tissue preservation, as demonstrated by significant reductions in infarct size (Fig. 5A).	SEN:10033098	17545479
BEL:20068374	tscript(p(MGI:Hif1a)) increases p(MGI:Cxcl12)	For example, aging decreases the stability of hypoxia-inducible factor 1? (HIF-1? )—a transcription factor that mediates the adaptive response to hypoxia— resulting in decreased expression of stromalcell- derived factor and vascular endothelial growth factor.65,66	SEN:10017948	18762784
BEL:20068376	tscript(p(MGI:Hif1a)) increases p(MGI:Shh)	Indeed, pharmacological inhibition, knockdown or genetic ablation of HIF-1alpha abolished hedgehog pathway activation.	SEN:10011394	18774959
BEL:20068380	tscript(p(MGI:Hif1a)) increases p(MGI:Vegfa)	For example, aging decreases the stability of hypoxia-inducible factor 1? (HIF-1? )—a transcription factor that mediates the adaptive response to hypoxia— resulting in decreased expression of stromalcell- derived factor and vascular endothelial growth factor.65,66	SEN:10017948	18762784
BEL:20068382	tscript(p(MGI:Hif1a)) directlyIncreases r(EGID:387206)	The MEFs that were positive for HIF-1? were capable of inducing miR-210, which is in contrast to the MEFs that were deficient in HIF-1? ( Fig. 2B, top). In parallel, the hypoxia-inducible gene DEC1 was seen to be up-regulated only in the HIF-1??expressing MEFs ( Fig. 2B, bottom).	SEN:10018174	19141645
BEL:20068386	tscript(p(MGI:Hif1a)) increases r(MGI:Apln)	Moreover, hypoxia-, CoCl(2)-, DMOG-, and insulin-induced apelin expression were all attenuated in differentiated HIF-1alpha-deficient MEFs.	SEN:10003444	17878221
BEL:20068388	tscript(p(MGI:Hif1a)) increases r(MGI:Aqp5)	Cotransfections of AQP5-luciferase with HIF-1alpha and HIF-1beta expression plasmids in MLE-15 cells led to dose-dependent transcriptional enhancement, which was partially abrogated by mutagenesis of putative HIF-1alpha binding sites in the proximal AQP5 promoter.Importantly, hypertonic induction of AQP5 was significantly inhibited by preventing HIF-1alpha induction with small interfering RNA.	SEN:10004082	17108010
BEL:20068390	tscript(p(MGI:Hif1a)) increases r(MGI:Bhlhe40)	The MEFs that were positive for HIF-1? were capable of inducing miR-210, which is in contrast to the MEFs that were deficient in HIF-1? ( Fig. 2B, top). In parallel, the hypoxia-inducible gene DEC1 was seen to be up-regulated only in the HIF-1??expressing MEFs ( Fig. 2B, bottom).	SEN:10018174	19141645
BEL:20068392	tscript(p(MGI:Hif1a)) directlyDecreases r(MGI:Cftr)	Chromatin immunoprecipitation identified a previously unappreciated binding site for the hypoxia inducible factor-1 (HIF-1), and promoter studies established its relevance by loss of repression following point mutation.	SEN:10033102	18779379
BEL:20068398	tscript(p(MGI:Hif1a)) increases r(MGI:Ero1l)	As shown in Figure 4d, Ero1-La was also strongly induced by hypoglycemia under normoxic conditions. Furthermore, this response was abrogated in the absence of a functional HIF-1.	SEN:10022422	15592500
BEL:20068408	tscript(p(MGI:Hif1a)) increases r(MGI:Mif)	Evidence of the importance of MIF in the interaction between HIF-1 and tumorigenesis is provided by Winner et al. [59] . MIF is necessary for binding and stabilization of HIF-1 by CSN5. After stabilization, HIF-1 leads to transcription of oncogenes and growth factors and also of MIF.	SEN:10033108	18791328
BEL:20068450	tscript(p(MGI:Hnf1a)) directlyIncreases r(MGI:Slc17a1)	We show that Npt1 and Npt4 genes were expressed at reduced levels in the kidneys of HNF1alpha -/- mice,	SEN:10011414	12367519
BEL:20068452	tscript(p(MGI:Hnf1a)) directlyIncreases r(MGI:Slc17a3)	We show that Npt1 and Npt4 genes were expressed at reduced levels in the kidneys of HNF1alpha -/- mice,	SEN:10011414	12367519
BEL:20068470	tscript(p(MGI:Hnf4a)) increases bp(GOBP:"cell proliferation")	Using a physiological model of beta-cell expansion, we show that HNF-4alpha is required for beta-cell replication and the activation of the Ras/ERK signaling cascade in islets	SEN:10033128	17403778
BEL:20068474	tscript(p(MGI:Hnf4a)) directlyIncreases r(MGI:Abcc6)	By using reporter assays and chromatin immunoprecipitations, we showed that HNF4alpha and surprisingly, NF-E2, enhanced the mAbcc6 promoter activity.	SEN:10011418	16997394
BEL:20068482	tscript(p(MGI:Hnf4a)) increases r(MGI:Cpt1a)	cAMP response unit of the Cpt1a gene is composed of a cAMP-response element motif and a Dr1 sequence located upstream of the transcription start site the coactivator Pgc-1 is involved in the regulation of this gene expression by cAMP in conbination with Hnf4 alpha and Creb	SEN:10032790	12107181
BEL:20068486	tscript(p(MGI:Hnf4a)) directlyDecreases r(MGI:F12)	In transient transfection assays in NIH3T3 cells, HNF-4 significantly inhibited (70%) estrogen induction of FXII promoter while not affecting basal promoter activity. In gel shift assays, HNF-4, either present in HepG2 nuclear extracts or generated by in vitro transcription/translation, specifically bound FXII promoter.	SEN:10033126	9794469
BEL:20068496	tscript(p(MGI:Hnf4a)) increases r(MGI:St5)	This phenotype correlates with the down-regulation of suppression of tumorigenicity 5 (ST5) in HNF-4alpha mutants, which we identify as a novel regulator of ERK phosphorylation in beta-cells and a direct transcriptional target of HNF-4alpha in vivo.	SEN:10011422	17403778
BEL:20068500	tscript(p(MGI:Hnrnpab)) decreases r(MGI:Spp1)	OPN gene transcription is regulated by a constitutive transcriptional repressor protein, heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B)	SEN:10011424	14722087
BEL:20068502	tscript(p(MGI:Hoxa10)) increases r(MGI:Ccng1)	Pharmacological and genetic studies provide evidence that the expression of cyclin G1, not cyclin G2, is regulated by progesterone via its nuclear receptor. Furthermore, the expression of these genes is aberrantly up-regulated in homeo box A-10 mutant uteri, suggesting that cyclin G1 and cyclin G2 genes act as downstream targets of homeobox A-10 and negatively impact uterine cell proliferation.	SEN:10025752	15661853
BEL:20068504	tscript(p(MGI:Hoxa10)) increases r(MGI:Ccng2)	Pharmacological and genetic studies provide evidence that the expression of cyclin G1, not cyclin G2, is regulated by progesterone via its nuclear receptor. Furthermore, the expression of these genes is aberrantly up-regulated in homeo box A-10 mutant uteri, suggesting that cyclin G1 and cyclin G2 genes act as downstream targets of homeobox A-10 and negatively impact uterine cell proliferation.	SEN:10025752	15661853
BEL:20068528	tscript(p(MGI:Hoxb5)) increases r(MGI:Fgf10)	Western blots showed that siRNA-down regulation of Hoxb-5 led to decreased tenascin-C and FGF10 and was associated with increased Hoxb-4 and decreased Hoxb-6 protein levels.	SEN:10011432	17127343
BEL:20068532	tscript(p(MGI:Hoxb5)) increases r(MGI:Tnc)	Western blots showed that siRNA-down regulation of Hoxb-5 led to decreased tenascin-C and FGF10 and was associated with increased Hoxb-4 and decreased Hoxb-6 protein levels.	SEN:10011432	17127343
BEL:20068542	tscript(p(MGI:Hoxc13)) increases r(MGI:Itm2b)	Fig. 5. Identification of genes differentially expressed in HOXC13 overexpressing skin upregulated	SEN:10033156	11290294
BEL:20068544	tscript(p(MGI:Hoxc13)) increases r(MGI:Krt1)	Fig. 5. Identification of genes differentially expressed in HOXC13 overexpressing skin upregulated	SEN:10033156	11290294
BEL:20068546	tscript(p(MGI:Hoxc13)) increases r(MGI:Stfa3)	Fig. 5. Identification of genes differentially expressed in HOXC13 overexpressing skin upregulated	SEN:10033156	11290294
BEL:20068548	tscript(p(MGI:Hoxc13)) increases r(MGI:Ywhab)	Fig. 5. Identification of genes differentially expressed in HOXC13 overexpressing skin upregulated	SEN:10033156	11290294
BEL:20068552	tscript(p(MGI:Hoxd13)) directlyIncreases r(MGI:Epha7)	FIGURE 2. The exogenous expression of HOXD13 up-regulates EphA7 transcription in NIH3T3 and C3H10T1/2 cells.	SEN:10033158	16314414
BEL:20068556	tscript(p(MGI:Hoxd9)) directlyIncreases r(MGI:Hoxd9)	The HOXD9 protein activates transcription of the HOXD9 promoter by interacting with the HCR sequence.	SEN:10011438	7926763
BEL:20068568	tscript(p(MGI:Hsf1)) decreases tport(p(MGI:Slc25a4))	Con sequently, superoxide was generated at a higher rate, and several mitochondrial proteins, including adenine nucleotide translocase 1 (ANT1), were more oxidized by HSF1 deficiency in vivo.	SEN:10011440	12356732
BEL:20068578	tscript(p(MGI:Ikzf1)) increases r(MGI:Flot1)	including the putative Sp1 transcription factor (Sp1) and zinc finger protein, subfamily 1a, 1 (Ikaros) (Lyf-1) binding sites led to only basal transcription.	SEN:10033172	14644419
BEL:20068592	tscript(p(MGI:Irf1)) increases r(MGI:Gbp2)	Both the 65-kDa family members, mGBP-2 and mag-2, were absolutely IRF-1 dependent, as documented elsewhere also for the promoters of mGBP-1 and mGBP-2	SEN:10033180	9862701
BEL:20068594	tscript(p(MGI:Irf1)) increases r(MGI:Gbp2b)	Both the 65-kDa family members, mGBP-2 and mag-2, were absolutely IRF-1 dependent, as documented elsewhere also for the promoters of mGBP-1 and mGBP-2	SEN:10033180	9862701
BEL:20068596	tscript(p(MGI:Irf1)) increases r(MGI:Gp1ba)	In addition, STAT1 or IRF-1 induced the expression of CD42, a late marker of megakaryocyte maturation, albeit to a much lesser extent than GATA-1 (Figure ?(Figure1C).1C).	SEN:10033182	18060035
BEL:20068598	tscript(p(MGI:Irf1)) increases r(MGI:Ifi47)	IRG-47 promoter in which an IFN-stimulated regulatory element was described and which concluded that IRF-1 was an essential transcription factor for this gene (36).	SEN:10033184	9862701
BEL:20068600	tscript(p(MGI:Irf1)) decreases r(MGI:Il23a)	Functionally, IRF-1 is a negative regulator of Il23a in LPS-stimulated BMMs. IRF-1(-/-) BMMs demonstrated enhanced LPS-induced Il23a expression compared with WT BMMs. Moreover, IRF-1 deficiency resulted in prolonged occupancy of RelA on the Il23a promoter.	SEN:10033186	21097874
BEL:20068602	tscript(p(MGI:Irf1)) directlyIncreases r(MGI:Stat1)	Moreover, GATA-1 transactivated the Stat1 promoter in luciferase reporter assays (Supplemental Figure 1). STAT1 and IRF-1 reciprocally activated each other’s transcription, as previously reported (Figure ?(Figure1D1D and Supplemental Table 1; also reviewed in ref. 26).	SEN:10033056	18060035
BEL:20068628	tscript(p(MGI:Irf5)) increases r(MGI:Il12a)	Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-alpha. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired	SEN:10033196	15665823
BEL:20068630	tscript(p(MGI:Irf5)) increases r(MGI:Il12b)	Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-alpha. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired	SEN:10033196	15665823
BEL:20068632	tscript(p(MGI:Irf5)) increases r(MGI:Il6)	Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-alpha. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired	SEN:10033196	15665823
BEL:20068634	tscript(p(MGI:Irf5)) increases r(MGI:Tnf)	Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-alpha. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired	SEN:10033196	15665823
BEL:20068640	tscript(p(MGI:Irf8)) decreases r(MGI:Bcl2)	Using reporter gene assays and electrophoretic mobility shift assays we identified that the bcl-2 promoter activity was inhibited by ICSBP by way of a fragment containing 2 characteristic ICSBP-responsive elements. An inverse correlation between ICSBP and bcl-2 expression was confirmed in vivo.	SEN:10033198	14656881
BEL:20068658	tscript(p(MGI:Isl1)) directlyIncreases r(MGI:Mef2c)	This enhancer also contains two perfect consensus sites for the LIM-homeodomain protein ISL1. We show that these elements are specifically bound by ISL1 establish Mef2c as the first direct transcriptional target of ISL1 in the anterior heart field	SEN:10033202	15253934
BEL:20068664	tscript(p(MGI:Jdp2)) decreases r(MGI:Fus)	3.2. JDP2 binds CHOP AARE as a homodimer or heterodimer with ATF2 3.3. JDP2 suppresses the amino acid-dependent transcription of CHOP 3.4. JDP2 inhibits CHOP transcription in an HDAC-dependent manner	SEN:10033206	18396163
BEL:20068670	tscript(p(MGI:Junb)) increases bp(GOBP:"cell cycle")	Cells lacking JunB show severely delayed kinetics of cyclin A mRNA expression due to the loss of proper transcriptional activation mediated via binding of JunB to the CRE element in the cyclin A promoter. Thus, cyclin A is a direct transcriptional target of JunB driving cell proliferation.	SEN:10033210	12121977
BEL:20068672	tscript(p(MGI:Jun)) increases bp(GOBP:"cell proliferation")	These results are consistent with previous data showing that loss of JNK1/JNK2 in MEFs results in reduced proliferation17 and that inactivation of c-Jun in MEFs results in premature senescence and impaired proliferation19.	SEN:10029098	15039780
BEL:20068674	tscript(p(MGI:Junb)) directlyIncreases r(MGI:Ccna1)	Cells lacking JunB show severely delayed kinetics of cyclin A mRNA expression due to the loss of proper transcriptional activation mediated via binding of JunB to the CRE element in the cyclin A promoter. Thus, cyclin A is a direct transcriptional target of JunB driving cell proliferation.	SEN:10033210	12121977
BEL:20068678	tscript(p(MGI:Junb)) increases r(MGI:Relb)	AP-1 complexes with c-Jun, JunD, or JunB synergize with p50/c-Rel to potently transactivate the relB promoter in NIH 3T3 cells.	SEN:10020394	17446175
BEL:20068682	tscript(p(MGI:Jund)) decreases bp(GOBP:angiogenesis)	In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS.	SEN:10020900	15369676
BEL:20068686	tscript(p(MGI:Jund)) increases r(MGI:Relb)	AP-1 complexes with c-Jun, JunD, or JunB synergize with p50/c-Rel to potently transactivate the relB promoter in NIH 3T3 cells.	SEN:10020394	17446175
BEL:20068692	tscript(p(MGI:Jun)) directlyIncreases r(EGID:12534)	Over-expression of c-Jun in mkk7-/- MEFs restored CDC2 expression (Fig. 6c) and transactivation of the cdc2 AP-1 promoter construct to levels observed in wild-type MEFs (Fig. 6d).	SEN:10033214	15039780
BEL:20068694	tscript(p(MGI:Jun)) directlyIncreases r(MGI:Dcn)	Overexpression of c-Jun potentiates PDGF- or serum-induced luciferase expression from a reporter construct containing the first 371 nucleotides of the PGS2 promoter.	SEN:10010666	8940199
BEL:20068696	tscript(p(MGI:Jun)) increases r(MGI:Dkk1)	We further show that normal expression of Dkk-1 is dependent on the Ap-1 family member c-Jun and that overexpression of Dkk-1 enhances Bmp-triggered apoptosis in the vertebrate limb.	SEN:10026468	11867524
BEL:20068698	tscript(p(MGI:Jun)) directlyIncreases r(MGI:Dmp1)	In this paper, we demonstrate a regulatory mechanism by which JunB transcriptionally controls the expression of DMP1 during osteoblast differentiation. The cooperative interaction of JunB with p300 has been shown to dramatically modulate the DMP1 promoter activity during mineralization.	SEN:10008608	15308641
BEL:20068702	tscript(p(MGI:Jun)) increases r(MGI:Il12b)	Spacing between the C/EBP and AP-1 site is important for promoter activation, suggesting cooperativity between these elements. c-Jun and a mutant c-Jun molecule activate the IL-12 p40 promoter and synergistically activate the promoter when co-expressed with C/EBPeta.	SEN:10011458	11279072
BEL:20068706	tscript(p(MGI:Jun)) directlyIncreases r(MGI:Ptgs2)	c-Jun mediates v-src-induced pgs2 gene expression. Antibody supershift experiments demonstrate that c-Jun can participate in a complex with the pgs2 promoter CRE site	SEN:10011460	7499226
BEL:20068708	tscript(p(MGI:Jun)) directlyIncreases r(MGI:Pvrl2)	% Overexpressions of CREB and c-Jun, but not c-Fos, also significantly increased the promoter activity, which suggests that CREB and c-Jun are the crucial transcription factors involved in regulating nectin-2 gene transcription.	SEN:10011182	16250013
BEL:20068710	tscript(p(MGI:Jun)) increases r(MGI:Relb)	AP-1 complexes with c-Jun, JunD, or JunB synergize with p50/c-Rel to potently transactivate the relB promoter in NIH 3T3 cells.	SEN:10020394	17446175
BEL:20068718	tscript(p(MGI:Klf10)) increases bp(GOBP:"bone mineralization")	TIEG1 expression in OBs is critical for both osteoblast-mediated mineralization and osteoblast support of osteoclast differentiation	SEN:10011462	15657444
BEL:20068720	tscript(p(MGI:Klf10)) increases bp(GOBP:"osteoclast differentiation")	TIEG1 expression in OBs is critical for both osteoblast-mediated mineralization and osteoblast support of osteoclast differentiation	SEN:10011462	15657444
BEL:20068722	tscript(p(MGI:Klf10)) decreases r(MGI:Tnfrsf11b)	Examination of gene expression in the TIEG(-/-) OBs revealed decreased RANKL and increased OPG expression compared to TIEG(+/+) OBs	SEN:10011464	15657444
BEL:20068724	tscript(p(MGI:Klf10)) increases r(MGI:Tnfsf11)	Examination of gene expression in the TIEG(-/-) OBs revealed decreased RANKL and increased OPG expression compared to TIEG(+/+) OBs	SEN:10011464	15657444
BEL:20068730	tscript(p(MGI:Klf15)) increases bp(GOBP:"fat cell differentiation")	Inhibition of the function of KLF15, either by expression of a dominant negative mutant or by RNA interference, both reduced the expression of peroxisome proliferator-activated receptor gamma (PPARgamma) and blocked adipogenesis in 3T3-L1 preadipocytes exposed to inducers of adipocyte differentiation.	SEN:10033222	15664998
BEL:20068738	tscript(p(MGI:Klf15)) decreases r(MGI:Ctgf)	Our result implicates KLF15 as a novel negative regulator of CTGF expression and cardiac fibrosis.	SEN:10011466	18586263
BEL:20068740	tscript(p(MGI:Klf15)) increases r(MGI:Pparg)	Inhibition of the function of KLF15, either by expression of a dominant negative mutant or by RNA interference, both reduced the expression of peroxisome proliferator-activated receptor gamma (PPARgamma) and blocked adipogenesis in 3T3-L1 preadipocytes exposed to inducers of adipocyte differentiation.	SEN:10033222	15664998
BEL:20068764	tscript(p(MGI:Klf2)) increases r(MGI:S1pr1)	In addition, KLF2(-/-) MEFs exhibit a significant growth defect, indicating that KLF2 is required to maintain the viability of MEF cells. The PDGF signal is mediated through the Src signaling pathway, and a downstream target of KLF2 is sphingosine 1-phosphate receptor 1.	SEN:10022198	18063572
BEL:20068766	tscript(p(MGI:Klf3)) decreases bp(GOBP:"fat cell differentiation")	Klf3 knockout mice have less white adipose tissue, and their fat pads contain smaller and fewer cells.	SEN:10011474	18391014
BEL:20068768	tscript(p(MGI:Klf3)) increases r(MGI:Cebpa)	We find that C/ebpalpha is derepressed in Klf3 and Ctbp knockout fibroblasts and adipocytes from Klf3 knockout mice.	SEN:10011188	18391014
BEL:20068772	tscript(p(MGI:Klf4)) decreases bp(GOBP:"cell proliferation")	Mechanism studies indicated that promoter hypermethylation and hemizygous deletion contributed to the down-regulation of KLF4 expression and the induction of apoptosis contributed to the antitumor activity of KLF4.	SEN:10011476	15805274
BEL:20068778	tscript(p(MGI:Klf4)) increases bp(GOBP:"apoptotic process")	Mechanism studies indicated that promoter hypermethylation and hemizygous deletion contributed to the down-regulation of KLF4 expression and the induction of apoptosis contributed to the antitumor activity of KLF4.	SEN:10011476	15805274
BEL:20068780	tscript(p(MGI:Klf4)) decreases path(MESHD:Neoplasms)	Here we show that KLF4 protein expression was decreased or lost in primary tumors and, in particular, lymph node metastases when compared with that in normal gastric mucosa.	SEN:10033238	15805274
BEL:20068788	tscript(p(MGI:Klf4)) directlyIncreases r(MGI:Cebpb)	Knockdown of KLF4 inhibits adipogenesis and downregulates C/EBPbeta levels. KLF4 binds directly to the C/EBPbeta (Cebpb) promoter as shown by chromatin immunoprecipitation and gel shift assays and, together with Krox20, cooperatively transactivates a C/EBPbeta reporter.	SEN:10009426	18396140
BEL:20068804	tscript(p(MGI:Klf4)) directlyDecreases r(MGI:Trp53)	Conversely, KLF4 suppresses the expression of p53 by directly acting on its promoter, thereby allowing for RAS(V12)-mediated transformation and causing resistance to DNA-damage-induced apoptosis.	SEN:10033236	16244670
BEL:20068810	tscript(p(MGI:Klf5)) increases kin(p(EGID:12534))	KLF5 accelerates mitotic entry in H-Ras-transformed cells by transcriptionally activating cyclin B1 and Cdc2, which leads to an increase in cyclin B1/Cdc2 kinase activity	SEN:10011486	16102754
BEL:20068812	tscript(p(MGI:Klf5)) directlyIncreases r(EGID:12534)	KLF5 accelerates mitotic entry in H-Ras-transformed cells by transcriptionally activating cyclin B1 and Cdc2, which leads to an increase in cyclin B1/Cdc2 kinase activity	SEN:10011486	16102754
BEL:20068814	tscript(p(MGI:Klf5)) directlyIncreases r(MGI:Ccnb1)	KLF5 accelerates mitotic entry in H-Ras-transformed cells by transcriptionally activating cyclin B1 and Cdc2, which leads to an increase in cyclin B1/Cdc2 kinase activity	SEN:10011486	16102754
BEL:20068816	tscript(p(MGI:Klf5)) directlyIncreases r(MGI:Pdgfa)	angiotensin II induced expression of KLF5, which in turn activated platelet-derived growth factor-A (PDGF-A) and transforming growth factor-beta (TGF-beta) expression.	SEN:10011488	12101409
BEL:20068818	tscript(p(MGI:Klf5)) increases r(MGI:Tgfb1)	angiotensin II induced expression of KLF5, which in turn activated platelet-derived growth factor-A (PDGF-A) and transforming growth factor-beta (TGF-beta) expression.	SEN:10011488	12101409
BEL:20068822	tscript(p(MGI:Klf7)) directlyIncreases r(MGI:Gap43)	Cell transfection experiments, on the other hand, demonstrated that the promoters of the genes encoding the OSN-specific OMP and the adhesion molecule L1 are both activated by KLF7 binding to CACCC motifs.	SEN:10011490	17123745
BEL:20068824	tscript(p(MGI:Klf7)) directlyIncreases r(MGI:L1cam)	Cell transfection experiments, on the other hand, demonstrated that the promoters of the genes encoding the OSN-specific OMP and the adhesion molecule L1 are both activated by KLF7 binding to CACCC motifs.	SEN:10011490	17123745
BEL:20068826	tscript(p(MGI:Klf7)) directlyIncreases r(MGI:Omp)	Cell transfection experiments, on the other hand, demonstrated that the promoters of the genes encoding the OSN-specific OMP and the adhesion molecule L1 are both activated by KLF7 binding to CACCC motifs.	SEN:10011490	17123745
BEL:20068838	tscript(p(MGI:Kmt2a)) directlyIncreases r(MGI:Cdkn1b)	Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27Kip1 and p18Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27Kip1 and p18Ink4c expression and deregulated cell growth.	SEN:10033256	15640349
BEL:20068840	tscript(p(MGI:Kmt2a)) directlyIncreases r(MGI:Cdkn2c)	Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27Kip1 and p18Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27Kip1 and p18Ink4c expression and deregulated cell growth.	SEN:10033256	15640349
BEL:20068848	tscript(p(MGI:Lef1)) increases r(MGI:Mitf)	The transcription factors implicated to date in regulation of the Mitf promoter include Pax3, CREB, Sox10, and Lef1 (Fig. 2A), with each factor able to confer on the Mitf promoter the capacity to respond to specific signals.	SEN:10032802	10898786
BEL:20068854	tscript(p(MGI:Lhx9)) directlyIncreases r(MGI:Sf1)	Using biochemical and genetic experiments, we demonstrate here that WT1 and LHX9 function as direct activatorsof the Sf1 gene.	SEN:10033264	12130543
BEL:20068856	tscript(p(MGI:Litaf)) decreases r(MGI:Cxcl12)	In MTEC1 cells that express the transfected sense mEET, the SDF-1alpha transcription and its chemotactic activity were profoundly inhibited.	SEN:10011496	12914755
BEL:20068862	tscript(p(MGI:Litaf)) increases r(MGI:Tnf)	upon LPS stimulation, we show that: (i) LITAF expression is increased in a mouse monocyte/macrophage cell line; and (ii) TNF-alpha expression is reduced in ES cell-derived macrophages lacking one copy of LITAF gene. Taken together, these results highlight the important role of LITAF in the regulation of TNF-alpha gene expression and suggest a potential role of LITAF in mouse organogenesis.	SEN:10033270	15025820
BEL:20068872	tscript(p(MGI:Lmx1a)) directlyIncreases r(MGI:Ins1)	When the intact rat insulin I enhancer/promoter (-410 to + 1 bp relative to the transcription start site) is inserted in place of the minienhancer-prolactin promoter in the luciferase reporter plasmid, shPan-1 alone cannot activate luciferase expression. Cotransfected lmx-1, however, activates the intact enhancer/promoter, and shPan-1 plus lmx-1 causes further activation (Fig. 8B).	SEN:10033276	1358758
BEL:20068896	tscript(p(MGI:Mafg)) increases r(MGI:"Hba-a1")	Human MafG heterodimerizes with p45 NF-E2 and binds DNA with specificity identical to that of purified NF-E2 DNA binding activity. A tethered heterodimer of p45 and MafG is fully functional in supporting expression of alpha- and beta-globin, and in promoting erythroid differentiation in CB3, a p45-deficient mouse erythroleukemia cell line	SEN:10005544	9166829
BEL:20068898	tscript(p(MGI:Mafg)) increases r(MGI:"Hbb-b1")	Human MafG heterodimerizes with p45 NF-E2 and binds DNA with specificity identical to that of purified NF-E2 DNA binding activity. A tethered heterodimer of p45 and MafG is fully functional in supporting expression of alpha- and beta-globin, and in promoting erythroid differentiation in CB3, a p45-deficient mouse erythroleukemia cell line	SEN:10005544	9166829
BEL:20068906	tscript(p(MGI:Maf)) increases r(MGI:Ccnd2)	Because c-Maf is a transcription factor, it is of interest to identify downstream target genes of its action that might contribute to malignant transformation of T cells. We used RT-PCR analysis to show that cyclin D2, integrin ß7, and ARK5 were up-regulated in c-Maf transgenic thymocytes and T lymphoma cells.	SEN:10033286	16424013
BEL:20068910	tscript(p(MGI:Maf)) increases r(MGI:Il10)	c-Maf-null macrophages exhibit strongly impaired IL-10 protein production and mRNA expression upon LPS stimulation.	SEN:10009264	15749884
BEL:20068912	tscript(p(MGI:Maf)) increases r(MGI:Itgb7)	Because c-Maf is a transcription factor, it is of interest to identify downstream target genes of its action that might contribute to malignant transformation of T cells. We used RT-PCR analysis to show that cyclin D2, integrin ß7, and ARK5 were up-regulated in c-Maf transgenic thymocytes and T lymphoma cells.	SEN:10033286	16424013
BEL:20068914	tscript(p(MGI:Maf)) increases r(MGI:Nuak1)	Because c-Maf is a transcription factor, it is of interest to identify downstream target genes of its action that might contribute to malignant transformation of T cells. We used RT-PCR analysis to show that cyclin D2, integrin ß7, and ARK5 were up-regulated in c-Maf transgenic thymocytes and T lymphoma cells.	SEN:10033286	16424013
BEL:20068916	tscript(p(MGI:Max)) decreases r(MGI:Odc1)	c-Myc results in efficient activation of the ODC promoter, whereas overexpression of Max exerts a repressive effect.	SEN:10011506	7478599
BEL:20068918	tscript(p(MGI:Maz)) increases r(MGI:Iapp)	Pur-1 (for purine binding), binds to the GAGA boxes of the rat insulin I and II genes and the human islet amyloid polypeptide gene.	SEN:10011508	1454839
BEL:20068920	tscript(p(MGI:Maz)) increases r(MGI:Ins1)	Pur-1 (for purine binding), binds to the GAGA boxes of the rat insulin I and II genes and the human islet amyloid polypeptide gene.	SEN:10011508	1454839
BEL:20068922	tscript(p(MGI:Maz)) increases r(MGI:Ins2)	Pur-1 (for purine binding), binds to the GAGA boxes of the rat insulin I and II genes and the human islet amyloid polypeptide gene.	SEN:10011508	1454839
BEL:20068934	tscript(p(MGI:Mef2a)) directlyIncreases r(MGI:Meox2)	The third is the MADS box factor referred to as MEF2 or RSRF. overexpression of MEF2A transactivated the Gax promoter	SEN:10033296	7623821
BEL:20068936	tscript(p(MGI:Mef2a)) directlyIncreases r(MGI:Myl2)	(ResnetDB) In this in vivo study, overexpressing MEF2 (both MEF2A and MEF2C) enhanced MLC2slow promoter activity in the SOL+ muscles.	SEN:10033298	10207035
BEL:20068938	tscript(p(MGI:Mef2a)) directlyIncreases r(MGI:Myl3)	GATA protein consensus sequence in the proximal MLC3 promoter but not the MLC1 promoter binds with high affinity to GATA-4, a cardiac muscle- and gut-specific transcription factor. Mutation of either the MEF2 or GATA motifs in the MLC3 promoter attenuates its activity in both heart and skeletal muscles, demonstrating that MLC3 expression in these two diverse muscle types is dependent on common regulatory elements.	SEN:10011372	8754853
BEL:20068944	tscript(p(MGI:Mef2a)) increases tscript(p(MGI:Meox2))	Mutagenesis and protein-DNA binding assays suggested that at least three positive factors interact with this (GAX) fragment and are required for transcriptional activity. One of these factors, HRF-1, recognizes a cis element consisting of an inverted palindromic motif. A second factor is Sp1, that binds to a G/C- rich element. The third is the MADS box factor referred to as MEF2 or RSRF	SEN:10011516	7623821
BEL:20068950	tscript(p(MGI:Mef2c)) directlyIncreases r(MGI:Mstn)	The results show that MEF2C enhanced the myostatin promoter activity by threefold (Fig. 5A, panel i) indicating that MEF2C can transactivate the myostatin promoter in C2C12 cells.	SEN:10033306	12242286
BEL:20068952	tscript(p(MGI:Mef2c)) directlyIncreases r(MGI:Myl2)	(ResnetDB) In this in vivo study, overexpressing MEF2 (both MEF2A and MEF2C) enhanced MLC2slow promoter activity in the SOL+ muscles.	SEN:10033298	10207035
BEL:20068956	tscript(p(MGI:Mef2c)) directlyIncreases r(MGI:Srpk3)	we performed a microarray analysis using Mef2c-null mouse embryos and identified a novel MEF2-regulated gene encoding a muscle-specific protein kinase, Srpk3,	SEN:10033310	16140986
BEL:20068958	tscript(p(MGI:Mef2c)) increases r(MGI:Xirp1)	The expression of mXinalpha in Nkx2.5 or MEF2C knockout mouse embryos was drastically reduced, suggesting that mXinalpha is a downstream target of the Nkx2.5 and MEF2C transcription factors.	SEN:10033312	16708114
BEL:20068968	tscript(p(MGI:Men1)) directlyIncreases r(MGI:Cdkn1b)	Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27Kip1 and p18Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27Kip1 and p18Ink4c expression and deregulated cell growth.	SEN:10033256	15640349
BEL:20068970	tscript(p(MGI:Men1)) directlyIncreases r(MGI:Cdkn2c)	Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27Kip1 and p18Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27Kip1 and p18Ink4c expression and deregulated cell growth.	SEN:10033256	15640349
BEL:20068992	tscript(p(MGI:Mitf)) increases r(MGI:Dct)	Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.	SEN:10011524	10770922
BEL:20068994	tscript(p(MGI:Mitf)) increases r(MGI:Dct)	The role of Mitf must therefore be to regulate genes required for melanoblast survival, proliferation, or the maintenance of melanoblast identity. Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.	SEN:10011526	10770922
BEL:20068998	tscript(p(MGI:Mitf)) increases r(MGI:Fos)	We found that the microphthalmia-associated transcription factor (MITF), an essential transcription factor for melanocyte development and pigmentation, induces anchorage-independent growth of NIH-3T3 cells in cooperation with STAT3C. Microarray analysis revealed that c-fos is highly expressed in transformants expressing STAT3C and MITF.	SEN:10011528	14737107
BEL:20069002	tscript(p(MGI:Mitf)) increases r(MGI:Ndst2)	The amount of NDST-2 mRNA decreased significantly in CMCs derived from mi/mi mice when compared to the values of +/+ and tg/tg mice, suggesting that the defective form of MITF inhibited the expression of the NDST-2 transcript.	SEN:10011530	11342428
BEL:20069004	tscript(p(MGI:Mitf)) increases r(MGI:Tbx2)	Here we provide several lines of evidence to suggest that Mitf may regulate the expression of the Tbx2 transcription factor, a member of the T-box family of proteins implicated in the maintenance of cell identity.	SEN:10011532	10770922
BEL:20069006	tscript(p(MGI:Mitf)) increases r(MGI:Tbx2)	murine Tbx2 gene revealed that the Tbx2 promoter contains a full consensus Mitf recognition element; second, Mitf could bind the promoter in vitro and activate Tbx2 expression in vivo in an E box-dependent fashion; and third, Tbx2 is expressed in melanoma cell lines expressing Mitf, but not in a line in which Mitf expression was not detectable.	SEN:10011534	10770922
BEL:20069008	tscript(p(MGI:Mitf)) increases r(MGI:Tpsab1)	The binding of +-MITF to c-Jun enhanced the transactivation of MMCP-7 gene, and that of mi-MITF suppressed the transactivation.	SEN:10005520	11157480
BEL:20069014	tscript(p(MGI:Mitf)) increases r(MGI:Tyr)	Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.	SEN:10011524	10770922
BEL:20069016	tscript(p(MGI:Mitf)) increases r(MGI:Tyr)	The role of Mitf must therefore be to regulate genes required for melanoblast survival, proliferation, or the maintenance of melanoblast identity. Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.	SEN:10011526	10770922
BEL:20069018	tscript(p(MGI:Mitf)) increases r(MGI:Tyrp1)	Previous work has established that the melanocyte-specific tyrosinase-related protein-1 (TRP-1) promoter is regulated positively by the microphthalmia-associated transcription factor Mitf, acting through the conserved M box and negatively by the T-box factor Tbx2,	SEN:10011536	10480898
BEL:20069020	tscript(p(MGI:Mitf)) increases r(MGI:Tyrp1)	Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.	SEN:10011524	10770922
BEL:20069022	tscript(p(MGI:Mitf)) increases r(MGI:Tyrp1)	The role of Mitf must therefore be to regulate genes required for melanoblast survival, proliferation, or the maintenance of melanoblast identity. Mitf has been shown to regulate genes such as Tyrosinase, Tyrp-1, and Dct, which are required for pigmentation, a differentiation-specific process.	SEN:10011526	10770922
BEL:20069024	tscript(p(MGI:Mlxipl)) increases r(MGI:Acaca)	Decreased ChREBP gene expression, achieved using small interfering RNA, results in a loss of glucose effect on endogenous glycolytic (l-PK) and lipogenic (FAS, ACC) gene expression,	SEN:10011538	14985368
BEL:20069028	tscript(p(MGI:Mlxipl)) increases r(MGI:Fasn)	Decreased ChREBP gene expression, achieved using small interfering RNA, results in a loss of glucose effect on endogenous glycolytic (l-PK) and lipogenic (FAS, ACC) gene expression,	SEN:10011538	14985368
BEL:20069038	tscript(p(MGI:Mlxipl)) increases r(MGI:Pklr)	Decreased ChREBP gene expression, achieved using small interfering RNA, results in a loss of glucose effect on endogenous glycolytic (l-PK) and lipogenic (FAS, ACC) gene expression,	SEN:10011538	14985368
BEL:20069052	tscript(p(MGI:Msx1)) decreases r(MGI:Bmp4)	Msx1/2 mutants also exhibited increased Bmp4 expression in migratory cranial neural crest and pharyngeal arches.	SEN:10011542	16221730
BEL:20069068	tscript(p(MGI:Msx2)) decreases r(MGI:Bmp4)	Msx1/2 mutants also exhibited increased Bmp4 expression in migratory cranial neural crest and pharyngeal arches.	SEN:10011542	16221730
BEL:20069076	tscript(p(MGI:Msx2)) directlyDecreases r(MGI:Runx2)	Our studies further show regulation of the Runx2 gene by several homeodomain proteins: MSX2 and CDP/cut repress whereas DLX3 and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	SEN:10032836	17060321
BEL:20069082	tscript(p(MGI:Msx3)) decreases r(MGI:Msx1)	Furthermore, the repression of Msx1 promoter by Msx3 could be relieved by treating transfected cells with trichostatin A, an inhibitor of HDAC(s).	SEN:10000144	11115394
BEL:20069084	tscript(p(MGI:Mta3)) decreases r(MGI:Wnt4)	Here we show that expression of MTA3 inhibits ductal branching in virgin and pregnant murine transgenic mammary glands. MTA3 also suppresses the Wnt4 pathway and, thus, these findings parallel phenotypic changes in Wnt4-null mice. MTA3 represses Wnt4 transcription and Wnt4 secretion, inhibiting Wnt-target genes in mammary epithelial cells	SEN:10009604	17050676
BEL:20069092	tscript(p(MGI:Mtf1)) increases r(MGI:Mt1)	these studies demonstrated that MTF-1 is essential for the heightened expression of MT-I in the visceral endoderm of the developing mouse embryo and suggest that zinc modulates the ability of MTF-1 to transactivate gene expression in these cells. It was also found that MTF-1 cooperates with USF1 to regulate endoderm-specific expression of the mouse MT-I gene.	SEN:10033346	11230134
BEL:20069094	tscript(p(MGI:Mtf1)) increases r(MGI:Mt1)	Unexpectedly, it was found that MTF-1 is absolutely essential for expression of MT-I in the endoderm cells of the visceral yolk sac.	SEN:10033348	11230134
BEL:20069114	tscript(p(MGI:Mybl1)) directlyIncreases r(MGI:Cat)	A-myb protein is nuclear and that it activates transcription from the KHK-CAT reporter 6-%10 times more strongly than c-myb	SEN:10011552	8058310
BEL:20069116	tscript(p(MGI:Mybl1)) directlyIncreases r(MGI:Khk)	A-myb protein is nuclear and that it activates transcription from the KHK-CAT reporter 6-%10 times more strongly than c-myb	SEN:10011552	8058310
BEL:20069122	tscript(p(MGI:Myb)) directlyIncreases r(MGI:Cat)	A-myb protein is nuclear and that it activates transcription from the KHK-CAT reporter 6-%10 times more strongly than c-myb	SEN:10011552	8058310
BEL:20069126	tscript(p(MGI:Myb)) directlyIncreases r(MGI:Khk)	A-myb protein is nuclear and that it activates transcription from the KHK-CAT reporter 6-%10 times more strongly than c-myb	SEN:10011552	8058310
BEL:20069128	tscript(p(MGI:Myb)) directlyIncreases r(MGI:Mat2a)	binding sites for c-Myb and Sp1 on Mat2a, promoter activity increased expression of c-Myb and Sp1 and binding to the Mat2a promoter contribute to transcriptional up-regulation of Mat2a	SEN:10033354	11427482
BEL:20069130	tscript(p(MGI:Myb)) increases r(MGI:Nmu)	we used transcript profiling in K562 cells expressing a dominant-negative Myb (MERT) protein. A total of 105 potential Myb gene targets were identified. Neuromedin U (NmU), a peptide affecting calcium transport, underwent the greatest expression change (approximately 5-fold decrease).	SEN:10011556	15187020
BEL:20069144	tscript(p(MGI:Myc)) increases bp(GOBP:"cell cycle")	The c-Myc oncoprotein is strongly induced during the G0 to S-phase transition and is an important regulator of cell cycle entry.	SEN:10033360	15866886
BEL:20069148	tscript(p(MGI:Myc)) increases cat(p(MGI:Casp8))	Using both chromatin immunoprecipitation and luciferase reporter analyses, c-MYC was shown to repress FLIP transcription, causing increased caspase-8 activation (Ricci et al., 2004).	SEN:10033364	18955973
BEL:20069150	tscript(p(MGI:Myc)) increases kin(p(MGI:Cdk2))	Kinase activation by Myc is blocked by inhibitors of transcription and requires intact DNA binding and heterodimerization domains of Myc. The first is induced by Myc and involves the release of a 120 kDa cyclin E-cdk2 complex from a 250 kDa inactive complex that is present in starved cells.	SEN:10033366	7588611
BEL:20069152	tscript(p(MGI:Myc)) increases kin(p(MGI:Cdk2))	Our data show that two distinct signals, one of which is supplied by Myc, are necessary for consecutive steps during growth factor-induced formation of active cyclin E-cdk2 complexes in G(o)-arrested rodent fibroblasts.	SEN:10011562	7588611
BEL:20069154	tscript(p(MGI:Myc)) decreases p(MGI:Bcl2)	In primary cultures of lymphoid cells from Em-myc transgenic mice, MYC activation suppresses Bcl-X(L) RNA and protein, and Bcl-X(L) and Bcl-2 expression are inhibited by MYC in precancerous B cells from these mice. That suppression of Bcl-X(L) RNA levels by MYC requires de novo protein synthesis indicates that repression is indirect (Eischen et al., 2001a).	SEN:10033368	18955973
BEL:20069156	tscript(p(MGI:Myc)) decreases p(MGI:Bcl2l1)	In primary cultures of lymphoid cells from Em-myc transgenic mice, MYC activation suppresses Bcl-X(L) RNA and protein, and Bcl-X(L) and Bcl-2 expression are inhibited by MYC in precancerous B cells from these mice. That suppression of Bcl-X(L) RNA levels by MYC requires de novo protein synthesis indicates that repression is indirect (Eischen et al., 2001a).	SEN:10033368	18955973
BEL:20069158	tscript(p(MGI:Myc)) increases p(MGI:Rb1,pmod(P))	induction of Myc in density-arrested fibroblasts triggers rapid hyperphosphorylation of the retinoblastoma protein and activation of both cyclin D1- and cyclin E-associated kinase activities in the absence of significant changes in the amounts of cyclin-cdk complexes.	SEN:10033370	7588611
BEL:20069164	tscript(p(MGI:Myc)) increases r(EGID:19368)	We assayed for transcriptional induction of Rae-1 (Raet1) in E-Myc preneoplastic B cells and E-Myc tumor B cells. Raet1 mRNA was strongly induced in tumor cells and moderately induced in preneoplastic cells, suggesting transcriptional control as at least one level of regulation (Fig. 1C).	SEN:10033374	18223157
BEL:20069166	tscript(p(MGI:Myc)) decreases r(MGI:Bcl2l1)	In primary cultures of lymphoid cells from Em-myc transgenic mice, MYC activation suppresses Bcl-X(L) RNA and protein, and Bcl-X(L) and Bcl-2 expression are inhibited by MYC in precancerous B cells from these mice. That suppression of Bcl-X(L) RNA levels by MYC requires de novo protein synthesis indicates that repression is indirect (Eischen et al., 2001a).	SEN:10033368	18955973
BEL:20069172	tscript(p(MGI:Myc)) increases r(MGI:Ccnd2)	These effects were dependent on GATA-1-mediated repression of the c-myc (Myc) proto-oncogene. GATA-1 inhibited Myc expression within 3 h, and chromatin immunoprecipitation studies indicated that GATA-1 occupies the Myc promoter in vivo, suggesting a direct mechanism for gene repression.	SEN:10033054	12832487
BEL:20069178	tscript(p(MGI:Myc)) increases r(MGI:Cdk6)	These effects were dependent on GATA-1-mediated repression of the c-myc (Myc) proto-oncogene. GATA-1 inhibited Myc expression within 3 h, and chromatin immunoprecipitation studies indicated that GATA-1 occupies the Myc promoter in vivo, suggesting a direct mechanism for gene repression.	SEN:10033054	12832487
BEL:20069180	tscript(p(MGI:Myc)) directlyDecreases r(MGI:Cdkn1a)	c-MYC was shown to be directly recruited to the p21(Cip1) promoter by the DNA-binding protein Miz-1, blocking p21(Cip1) induction by p53 (Seoane et al., 2002; Wu et al., 2003).	SEN:10033378	18955973
BEL:20069182	tscript(p(MGI:Myc)) increases r(MGI:Cdkn2a)	Sustained Myc signaling induces Arf expression, resulting in apoptosis through the inhibition of Mdm2 and stabilization of the p53 tumor suppressor protein (37, 38).	SEN:10025952	18223157
BEL:20069186	tscript(p(MGI:Myc)) decreases r(MGI:Cflar)	Using both chromatin immunoprecipitation and luciferase reporter analyses, c-MYC was shown to repress FLIP transcription, causing increased caspase-8 activation (Ricci et al., 2004).	SEN:10033364	18955973
BEL:20069190	tscript(p(MGI:Myc)) directlyIncreases r(MGI:Emp1)	Tmp promoter region and identified a putative c-Myc binding element the c-Myc-Max protein complex can bind to this element an inducible form of c-Myc, the MycER fusion protein, can activate the endogenous Tmp gene	SEN:10033382	10207076
BEL:20069192	tscript(p(MGI:Myc)) increases r(MGI:Fas)	MYC can upregulate expression of the TRAIL receptor DR5 at the cell surface (Wang et al., 2004). Furthermore, c-MYC has also been shown to transcriptionally induce expression of FasL (Amanullah et al., 2002; Brunner et al., 2000; Kasibhatla et al., 2000).	SEN:10033384	18955973
BEL:20069196	tscript(p(MGI:Myc)) increases r(MGI:Tnfrsf10b)	MYC can upregulate expression of the TRAIL receptor DR5 at the cell surface (Wang et al., 2004). Furthermore, c-MYC has also been shown to transcriptionally induce expression of FasL (Amanullah et al., 2002; Brunner et al., 2000; Kasibhatla et al., 2000).	SEN:10033384	18955973
BEL:20069202	tscript(p(MGI:Myf5)) increases bp(GOBP:"myoblast differentiation")	The myogenic basic helix-loop-helix (bHLH) proteins, MyoD and Myf5, are required for myoblast specification	SEN:10011570	14550531
BEL:20069206	tscript(p(MGI:Myf5)) increases r(MGI:Ckm)	Whereas all four myogenic factors bound with similar affinities to the MCK enhancer in the presence of the widely expressed HLH protein E12, only MyoD1, myogenin, and myf-5 efficiently trans-activated the enhancer in transiently transfected 10T1/2 and 3T3 cells.	SEN:10033390	1847137
BEL:20069210	tscript(p(MGI:Myf5)) increases r(MGI:Fgf4)	We previously identified the Hom3a region as the major DNA element responsible for Fgf4 expression in the myotomes and AER, and showed that a conserved E-box is a target for the myogenic bHLH transcription factors MYF5 and MYOD	SEN:10011572	15183731
BEL:20069212	tscript(p(MGI:Myf5)) directlyIncreases r(MGI:Mef2c)	This control region is a direct target for the binding of myogenic bHLH and MEF2 proteins. Mutagenesis of the Mef2c control region shows that a binding site for myogenic bHLH proteins is essential for expression at all stages of skeletal muscle development, whereas an adjacent MEF2 binding site is required for maintenance but not for initiation of Mef2c transcription.	SEN:10033394	11714687
BEL:20069214	tscript(p(MGI:Myf5)) directlyIncreases r(MGI:Mstn)	RESULTS Myf5, MyoD, and MEF2 transactivate the myostatin promoter. The results show that both MyoD and Myf5 induced the activation of the myostatin promoter (Fig. 5A, panel i).	SEN:10033396	12242286
BEL:20069216	tscript(p(MGI:Myf5)) increases r(MGI:Myf6)	in 10T1/2 fibroblasts the MRF4 promoter is trans-activated by myogenin, MyoD, myf5, and by the MEF2 factors, but that MRF4 does not activate expression of its own promoter. Myogenin activated the MRF4 promoter directly by an E box-dependent mechanism, while MEF2 factors activated the promoter through an indirect pathway.	SEN:10033398	7852366
BEL:20069218	tscript(p(MGI:Myf5)) increases r(MGI:Myh4)	mRNA concentration of MYF5, a member of the bHLH family of myogenic transcription factors (TFs), was increased 3-fold. MyoD, was increased MYF5 and MyoD preferentially activate the skeletal MHCIIb gene, specifying the myosin isoform that is highest expressed in the glycolytic fast-type fiber IIB. In parallel, a role for MyoD has been proposed in the maintenance of fast-fiber characteristics	SEN:10033400	12562761
BEL:20069224	tscript(p(MGI:Myf6)) directlyIncreases r(MGI:Mef2c)	This control region is a direct target for the binding of myogenic bHLH and MEF2 proteins. Mutagenesis of the Mef2c control region shows that a binding site for myogenic bHLH proteins is essential for expression at all stages of skeletal muscle development, whereas an adjacent MEF2 binding site is required for maintenance but not for initiation of Mef2c transcription.	SEN:10033394	11714687
BEL:20069228	tscript(p(MGI:Myocd)) increases r(MGI:Acta2)	Most importantly, forced expression of myocardin activated expression of the SM22 alpha, smooth muscle alpha-actin, and calponin-h1 genes in undifferentiated mouse ES cells.	SEN:10033402	12640126
BEL:20069230	tscript(p(MGI:Myocd)) increases r(MGI:Cnn1)	Most importantly, forced expression of myocardin activated expression of the SM22 alpha, smooth muscle alpha-actin, and calponin-h1 genes in undifferentiated mouse ES cells.	SEN:10033402	12640126
BEL:20069234	tscript(p(MGI:Myod1)) increases bp(GOBP:"myoblast differentiation")	DISCUSSION It is well established that differentiating myotubes express higher levels of MyoD, which subsequently activates terminal differentiation- specific markers.	SEN:10033404	12242286
BEL:20069236	tscript(p(MGI:Myod1)) increases bp(GOBP:"myoblast differentiation")	The myogenic basic helix-loop-helix (bHLH) proteins, MyoD and Myf5, are required for myoblast specification	SEN:10011570	14550531
BEL:20069242	tscript(p(MGI:Myod1)) increases complex(p(MGI:Sirpa),p(MGI:Ptpn11))	Either constitutive expression or inducible activation of MyoD in 10T(1/2) fibroblasts promotes SHPS-1 tyrosyl phosphorylation and its association with SHP-2.	SEN:10011578	11493654
BEL:20069248	tscript(p(MGI:Myod1)) increases r(MGI:Ckm)	Whereas all four myogenic factors bound with similar affinities to the MCK enhancer in the presence of the widely expressed HLH protein E12, only MyoD1, myogenin, and myf-5 efficiently trans-activated the enhancer in transiently transfected 10T1/2 and 3T3 cells.	SEN:10033390	1847137
BEL:20069250	tscript(p(MGI:Myod1)) increases r(MGI:Ckm)	Transfection experiments indicate that over-expression of Id inhibits the trans-activation of the muscle creatine kinase enhancer by MyoD.	SEN:10006530	2156629
BEL:20069252	tscript(p(MGI:Myod1)) increases r(MGI:Fgf4)	We previously identified the Hom3a region as the major DNA element responsible for Fgf4 expression in the myotomes and AER, and showed that a conserved E-box is a target for the myogenic bHLH transcription factors MYF5 and MYOD	SEN:10011572	15183731
BEL:20069258	tscript(p(MGI:Myod1)) increases r(MGI:Itga7)	In 10T1/2 fibroblasts the approximately 2.8-kb alpha7 promoter was trans-activated by the myogenic basic helix-loop-helix proteins myogenin and MyoD but not by MRF4 and myf5.	SEN:10011582	8798472
BEL:20069260	tscript(p(MGI:Myod1)) directlyIncreases r(MGI:Mef2c)	This control region is a direct target for the binding of myogenic bHLH and MEF2 proteins. Mutagenesis of the Mef2c control region shows that a binding site for myogenic bHLH proteins is essential for expression at all stages of skeletal muscle development, whereas an adjacent MEF2 binding site is required for maintenance but not for initiation of Mef2c transcription.	SEN:10033394	11714687
BEL:20069262	tscript(p(MGI:Myod1)) increases r(MGI:Mef2c)	We show that mef2c is a direct transcriptional target of the MyoD family in vivo via an essential E box in the skeletal muscle enhancer of mef2c,	SEN:10011584	14550531
BEL:20069264	tscript(p(MGI:Myod1)) directlyIncreases r(MGI:Mstn)	RESULTS Myf5, MyoD, and MEF2 transactivate the myostatin promoter. The results show that both MyoD and Myf5 induced the activation of the myostatin promoter (Fig. 5A, panel i).	SEN:10033396	12242286
BEL:20069266	tscript(p(MGI:Myod1)) increases r(MGI:Myf6)	in 10T1/2 fibroblasts the MRF4 promoter is trans-activated by myogenin, MyoD, myf5, and by the MEF2 factors, but that MRF4 does not activate expression of its own promoter. Myogenin activated the MRF4 promoter directly by an E box-dependent mechanism, while MEF2 factors activated the promoter through an indirect pathway.	SEN:10033398	7852366
BEL:20069268	tscript(p(MGI:Myod1)) increases r(MGI:Myh4)	mRNA concentration of MYF5, a member of the bHLH family of myogenic transcription factors (TFs), was increased 3-fold. MyoD, was increased MYF5 and MyoD preferentially activate the skeletal MHCIIb gene, specifying the myosin isoform that is highest expressed in the glycolytic fast-type fiber IIB. In parallel, a role for MyoD has been proposed in the maintenance of fast-fiber characteristics	SEN:10033400	12562761
BEL:20069274	tscript(p(MGI:Myod1)) increases r(MGI:Ngfr)	By means of MyoD-mutants we have found that both the amino terminus of the MyoD molecule as well as the bHLH-region are essential for transcriptional activity on the p75NGFR promoter.	SEN:10033302	9588207
BEL:20069280	tscript(p(MGI:Myod1)) increases r(MGI:Sp7)	Ectopic expression of MyoD increased alkaline phosphatase activity and Osterix mRNA expression in response to BMP treatment.	SEN:10011592	15020674
BEL:20069282	tscript(p(MGI:Myod1)) directlyIncreases r(MGI:Srpk3)	MEF2C and MyoD significantly activated the expression of a luciferase reporter controlled by a 2.9-kb DNA fragment encompassing the 5' Srpk3 promoter region,	SEN:10033408	16140986
BEL:20069294	tscript(p(MGI:Myog)) increases r(MGI:Ckm)	Whereas all four myogenic factors bound with similar affinities to the MCK enhancer in the presence of the widely expressed HLH protein E12, only MyoD1, myogenin, and myf-5 efficiently trans-activated the enhancer in transiently transfected 10T1/2 and 3T3 cells.	SEN:10033390	1847137
BEL:20069298	tscript(p(MGI:Myog)) increases r(MGI:Itga7)	In 10T1/2 fibroblasts the approximately 2.8-kb alpha7 promoter was trans-activated by the myogenic basic helix-loop-helix proteins myogenin and MyoD but not by MRF4 and myf5.	SEN:10011582	8798472
BEL:20069302	tscript(p(MGI:Myog)) directlyIncreases r(MGI:Mef2c)	This control region is a direct target for the binding of myogenic bHLH and MEF2 proteins. Mutagenesis of the Mef2c control region shows that a binding site for myogenic bHLH proteins is essential for expression at all stages of skeletal muscle development, whereas an adjacent MEF2 binding site is required for maintenance but not for initiation of Mef2c transcription.	SEN:10033394	11714687
BEL:20069304	tscript(p(MGI:Myog)) directlyIncreases r(MGI:Myf6)	in 10T1/2 fibroblasts the MRF4 promoter is trans-activated by myogenin, MyoD, myf5, and by the MEF2 factors, but that MRF4 does not activate expression of its own promoter. Myogenin activated the MRF4 promoter directly by an E box-dependent mechanism, while MEF2 factors activated the promoter through an indirect pathway.	SEN:10033398	7852366
BEL:20069312	tscript(p(MGI:Mzf1)) increases r(MGI:Flot1)	The fP-2 segment, with a second Sp1 binding site, a CAAT box and putative specific binding sites for myeloid zinc finger protein 1 (MZF1), acute myeloid leukemia 1a (AML-1a) and cellular progenitor of viral oncogene from E26 acute leukemia retrovirus (c-Ets-1) produced about twice as much luciferase activity as fP-4.	SEN:10032952	14644419
BEL:20069314	tscript(p(MGI:Nanog)) directlyIncreases r(MGI:Pou5f1)	Among the Nanog-bound genes, notable ones are Pou5f1, Sox2, Rif1 and REST. Depletion of Nanog resulted in downregulation of their expression (Fig. 6f),	SEN:10033414	16518401
BEL:20069316	tscript(p(MGI:Nanog)) directlyIncreases r(MGI:Rest)	Among the Nanog-bound genes, notable ones are Pou5f1, Sox2, Rif1 and REST. Depletion of Nanog resulted in downregulation of their expression (Fig. 6f),	SEN:10033414	16518401
BEL:20069318	tscript(p(MGI:Nanog)) directlyIncreases r(MGI:Rif1)	Among the Nanog-bound genes, notable ones are Pou5f1, Sox2, Rif1 and REST. Depletion of Nanog resulted in downregulation of their expression (Fig. 6f),	SEN:10033414	16518401
BEL:20069320	tscript(p(MGI:Nanog)) directlyIncreases r(MGI:Sox2)	Among the Nanog-bound genes, notable ones are Pou5f1, Sox2, Rif1 and REST. Depletion of Nanog resulted in downregulation of their expression (Fig. 6f),	SEN:10033414	16518401
BEL:20069332	tscript(p(MGI:Ncor1)) directlyDecreases tscript(p(MGI:Ppard))	NCoR expression led to a dose-dependent reduciton of ligand-induced Ppard-RXRa-mediated transactivation. Confirming previously published resuts, NcoR coexpression also led to repression of the ligand-induced transcriptional activity of Ppara and Pparg.	SEN:10033424	11903058
BEL:20069350	tscript(p(MGI:Nfatc1)) directlyIncreases r(MGI:Atp6v0d2)	We show that NFATc1 binds to the promoter regions of Atp6v0d2 and DC-STAMP in osteoclasts and directly induces their expression. Furthermore, overexpression of Atp6v0d2 and DC-STAMP rescues cell-cell fusion of preosteoclasts despite reduced NFATc1 activity.	SEN:10033430	17885208
BEL:20069352	tscript(p(MGI:Nfatc1)) directlyIncreases r(MGI:Dcstamp)	We show that NFATc1 binds to the promoter regions of Atp6v0d2 and DC-STAMP in osteoclasts and directly induces their expression. Furthermore, overexpression of Atp6v0d2 and DC-STAMP rescues cell-cell fusion of preosteoclasts despite reduced NFATc1 activity.	SEN:10033430	17885208
BEL:20069364	tscript(p(MGI:Nfatc2)) increases r(MGI:Mmp2)	Ischemia also activated the expression and binding of p53 to an adjacent enhancer site (RE-1) and increased expression and binding of nuclear factor of activated T-cells-c2 to consensus sequences within the first intron. Deletion of either the 5' AP-1/RE-1 region of the promoter or substitution of the first intron abolished ischemia-induced MMP-2 transcription in vivo.	SEN:10022426	16258061
BEL:20069372	tscript(p(MGI:Nfatc3)) decreases p(MGI:Sell)	The number of transgenic CD4+ T cells expressing low levels of CD62L upon PMA stimulation was much higher than that of wild-type T cells, indicating that NFATx down-regulate CD62L expression.	SEN:10033438	12626567
BEL:20069376	tscript(p(MGI:Nfatc3)) decreases r(MGI:Il10)	In naive CD4(+) T cells, NFATx up-regulated the expression of several cytokine genes and activation markers and suppressed the expression of CD154. Th1 cytokines IFN-{gamma} and TNF-{alpha} were up-regulated in transgenic Th1 cells (a), while Th2 cytokines IL-4, IL-5, IL-10, and IL-13 were suppressed in transgenic Th2 cells	SEN:10033440	12626567
BEL:20069378	tscript(p(MGI:Nfatc3)) decreases r(MGI:Il13)	In naive CD4(+) T cells, NFATx up-regulated the expression of several cytokine genes and activation markers and suppressed the expression of CD154. Th1 cytokines IFN-{gamma} and TNF-{alpha} were up-regulated in transgenic Th1 cells (a), while Th2 cytokines IL-4, IL-5, IL-10, and IL-13 were suppressed in transgenic Th2 cells	SEN:10033440	12626567
BEL:20069380	tscript(p(MGI:Nfatc3)) decreases r(MGI:Il4)	In naive CD4(+) T cells, NFATx up-regulated the expression of several cytokine genes and activation markers and suppressed the expression of CD154. Th1 cytokines IFN-{gamma} and TNF-{alpha} were up-regulated in transgenic Th1 cells (a), while Th2 cytokines IL-4, IL-5, IL-10, and IL-13 were suppressed in transgenic Th2 cells	SEN:10033440	12626567
BEL:20069382	tscript(p(MGI:Nfatc3)) decreases r(MGI:Il5)	In naive CD4(+) T cells, NFATx up-regulated the expression of several cytokine genes and activation markers and suppressed the expression of CD154. Th1 cytokines IFN-{gamma} and TNF-{alpha} were up-regulated in transgenic Th1 cells (a), while Th2 cytokines IL-4, IL-5, IL-10, and IL-13 were suppressed in transgenic Th2 cells	SEN:10033440	12626567
BEL:20069386	tscript(p(MGI:Nfatc3)) increases r(MGI:Sftpd)	Full-length NFATs Fu-NFATc3 and Fu-NFATc4 also activated the ?600/+79 Sftpd promoter, albeit to a much lesser extent ( Fig. 1 D , lanes 2 and 3 ), suggesting endogenous but weak calcineurin activity in respiratory epithelial cells.	SEN:10033444	15173172
BEL:20069388	tscript(p(MGI:Nfatc4)) increases bp(GOBP:"fat cell differentiation")	Stable expression of Ala(168,170) NFATc4, but not of wild-type NFATc4, in NIH 3T3 cells promotes adipocyte formation under differentiation conditions.	SEN:10011608	11997522
BEL:20069390	tscript(p(MGI:Nfatc4)) increases r(MGI:Adssl1)	Activation of the Adss1 gene involves the calcineurin-mediated dephosphorylation of NFAT3, allowing its translocation to the nucleus, where it can directly participate in Adss1 gene activation.	SEN:10007792	10636885
BEL:20069392	tscript(p(MGI:Nfatc4)) increases r(MGI:Pparg)	Stable expression of Ala(168,170) NFATc4, but not of wild-type NFATc4, increases the expression of PPAR gamma, which contributes in part to increased adipocyte formation.	SEN:10011610	11997522
BEL:20069394	tscript(p(MGI:Nfe2)) increases bp(GOBP:"megakaryocyte differentiation")	Several transcription factors have also been implicated in megakaryopoiesis including, GATA-1, friend of GATA-1 (FOG-1), nuclear factor-erythroid 2 (NF-E2), and Fli-1.	SEN:10003208	17127443
BEL:20069396	tscript(p(MGI:Nfe2l1)) decreases a(CHEBI:"reactive oxygen species")	Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants.	SEN:10033446	12968018
BEL:20069400	tscript(p(MGI:Nfe2l1)) decreases bp(GOBP:"response to oxidative stress")	Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants.	SEN:10033446	12968018
BEL:20069402	tscript(p(MGI:Nfe2l1)) decreases r(MGI:Cyp4a10)	RT-PCR showed a significant induction of cytochrome P450 4a10 and 4a14 (CYP4a10 and CYP4a14) in Nrf1LKO livers.	SEN:10033450	15738389
BEL:20069404	tscript(p(MGI:Nfe2l1)) decreases r(MGI:Cyp4a14)	RT-PCR showed a significant induction of cytochrome P450 4a10 and 4a14 (CYP4a10 and CYP4a14) in Nrf1LKO livers.	SEN:10033450	15738389
BEL:20069406	tscript(p(MGI:Nfe2l1)) directlyDecreases r(MGI:Dspp)	Nrf1 has also been reported to function as a repressor of transcription. The dentin sialophosphoprotein (DSPP) gene encodes DSP and DPP, which are expressed in terminally differentiated odontoblast. In undifferentiated odontoblast, Nrf1 interacts with C/EBP-? to repress DSPP expression.	SEN:10020236	19665035
BEL:20069410	tscript(p(MGI:Nfe2l1)) directlyIncreases r(MGI:Gclm)	Fibroblasts derived from Nrf1 null embryos showed reduced expression of GCLM and GSS, and Nrf1 has been shown to bind and activate the GCLM promoter	SEN:10029474	19665035
BEL:20069412	tscript(p(MGI:Nfe2l1)) increases r(MGI:Hmbs)	Figure 2. TCF11 transactivates expression through the PBGD erythroid-specific promoter in a variety of cell lines as indicated	SEN:10033454	9421508
BEL:20069414	tscript(p(MGI:Nfe2l1)) increases r(MGI:Prdx1)	Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.	SEN:10011612	10821856
BEL:20069418	tscript(p(MGI:Nfe2l1)) directlyIncreases r(MGI:Sp7)	Microarray analysis of bones from a mutant mouse strain (sfx) that develops spontaneous fractures has identified osterix as another Nrf1 target gene...The promoter region of osterix has a well-conserved ARE that mediates ascorbic acid-induced expression and is bound by Nrf1 as indicated by gel shift and chromatin immunoprecipitation assays	SEN:10033456	19665035
BEL:20069422	tscript(p(MGI:Nfe2l2)) decreases a(CHEBI:glutathione)	Nrf2(-/-) MEFs exhibited greater accumulation of glutathione disulfide and cytotoxicity compared to Nrf2(+/+) MEFs in response to t-butylhydroquinone, which was rescued by restoring GSR	SEN:10001020	19028565
BEL:20069424	tscript(p(MGI:Nfe2l2)) decreases a(CHEBI:"reactive oxygen species")	Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants.	SEN:10033446	12968018
BEL:20069432	tscript(p(MGI:Nfe2l2)) decreases bp(GOBP:"cell death")	Nrf2(-/-) MEFs exhibited greater accumulation of glutathione disulfide and cytotoxicity compared to Nrf2(+/+) MEFs in response to t-butylhydroquinone, which was rescued by restoring GSR	SEN:10001020	19028565
BEL:20069434	tscript(p(MGI:Nfe2l2)) increases bp(GOBP:"cell proliferation")	NRF2 (or Nrf2) activation also stimulated growth of lung cancer-derived cell lines expressing KEAP1 at low levels in KEAP1 mutant cell lines and in Keap1-null mouse embryonic fibroblasts under homeostatic conditions (Singh et al., 2006).	SEN:10033460	19646463
BEL:20069438	tscript(p(MGI:Nfe2l2)) decreases bp(GOBP:"response to oxidative stress")	Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants.	SEN:10033446	12968018
BEL:20069440	tscript(p(MGI:Nfe2l2)) decreases bp(GOBP:"apoptotic process")	Whereas disruption of nrf2 increased the number of apoptotic cells following UVA irradiation by 1.7-fold, disruption of keap1 decreased the apoptotic cell number by half as compared with wild-type controls.	SEN:10011616	15816842
BEL:20069442	tscript(p(MGI:Nfe2l2)) decreases bp(GOBP:"apoptotic process")	Microinjection of glutathione disulfide induced greater apoptosis in Nrf2(-/-) MEFs compared to Nrf2(+/+) MEFs	SEN:10011618	19028565
BEL:20069448	tscript(p(MGI:Nfe2l2)) increases p(MGI:Srxn1)	Western blot analysis of lung proteins showed that Srx1 proteinwas present constitutively, and its level increased significantly on exposure to CS in Nrf2+/+ mice. By contrast, expression of Srx1 protein was low in Nrf2?/? mice and did not change significantly with CS exposure (Figs. 1B and C).	SEN:10017590	19027064
BEL:20069450	tscript(p(MGI:Nfe2l2)) increases r(EGID:110309)	In the oesophagus of Keap1-/- mice, the expression of keratin 6 is greatly increased in an NRF2-dependent manner (44).	SEN:10028694	19608619
BEL:20069454	tscript(p(MGI:Nfe2l2)) increases r(MGI:Akr1b3)	beta-Naphthoflavone, an Nrf2 activator, elevated the level of AR mRNA in HepG2 cells...and increased the promoter activity of the mouse AR (AKR1B3) gene	SEN:10011622	15655294
BEL:20069470	tscript(p(MGI:Nfe2l2)) increases r(MGI:Gsr)	In response to oxidants, lungs and embryonic fibroblasts (MEFs) from Nrf2-deficient (Nrf2(-/-)) mice showed lower levels of GSR mRNA, protein, and enzyme activity relative to wild type (Nrf2(+/+))	SEN:10011624	19028565
BEL:20069472	tscript(p(MGI:Nfe2l2)) directlyIncreases r(MGI:Gsr)	Reporter analysis, site-directed mutagenesis, and chromatin immunoprecipitation assays demonstrated binding of Nrf2 to two AREs distal to the transcription start site (in combination with Nrf2 KO lowering GSR mRNA above)	SEN:10033466	19028565
BEL:20069478	tscript(p(MGI:Nfe2l2)) increases r(MGI:Hmox1)	Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.	SEN:10011612	10821856
BEL:20069480	tscript(p(MGI:Nfe2l2)) increases r(MGI:Hmox1)	Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements.	SEN:10015726	14747657
BEL:20069484	tscript(p(MGI:Nfe2l2)) directlyIncreases r(MGI:Hmox1)	Heterodimers of the small Maf proteins and NF-E2– related factor 2 (Nrf2), which belongs to the basic leucin zipper (bZip) family of transcriptional factors, activate HO-1 through binding to MAREs (16–19). In contrast, heterodimers of small Maf and Bach1 or Bach2 repress MAREdependent transcription (20).	SEN:10032682	18633191
BEL:20069492	tscript(p(MGI:Nfe2l2)) increases r(MGI:Prdx1)	Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.	SEN:10011612	10821856
BEL:20069498	tscript(p(MGI:Nfe2l2)) increases r(MGI:Sqstm1)	Using peritoneal macrophages from Nrf2-deficient mice, we show here that Nrf2 also controls the expression of a group of electrophile- and oxidative stress-inducible proteins and activities, which includes heme oxygenase-1, A170, peroxiredoxin MSP23, and cystine membrane transport (system x(c)(-)) activity.	SEN:10011612	10821856
BEL:20069500	tscript(p(MGI:Nfe2l2)) increases r(MGI:Srxn1)	Nrf2+/+ and Nrf2-/- mice were exposed to CS for 5 h and then examined for expression of Srx1 by real-time RT-PCR. Srx1 mRNA level was upregulated by eight-fold in response to CS in Nrf2+/+ mice. No induction was observed in the lungs of CS-exposed Nrf2-/- mice (Fig. 1A).	SEN:10017644	19027064
BEL:20069502	tscript(p(MGI:Nfe2l2)) increases r(MGI:Srxn1)	This hyperoxia-induced expression of Srx was not evident in mice deficient in the transcription factor Nrf2, indicating an essential role for an Nrf2 signaling pathway in this effect	SEN:10011628	19086807
BEL:20069512	tscript(p(MGI:Nfe2)) directlyIncreases r(MGI:Abcc6)	By using reporter assays and chromatin immunoprecipitations, we showed that HNF4alpha and surprisingly, NF-E2, enhanced the mAbcc6 promoter activity.	SEN:10011418	16997394
BEL:20069528	tscript(p(MGI:Nfia)) directlyIncreases tscript(p(MGI:"Nkx2-1"))	As shown in Fig. 3, all NFI family members increased SP-C promoter transactivation by TTF-1.....All NFI family members interact with TTF-1.	SEN:10033482	14645514
BEL:20069530	tscript(p(MGI:Nfib)) directlyIncreases tscript(p(MGI:"Nkx2-1"))	As shown in Fig. 3, all NFI family members increased SP-C promoter transactivation by TTF-1.....All NFI family members interact with TTF-1.	SEN:10033482	14645514
BEL:20069534	tscript(p(MGI:Nfkb1)) increases r(MGI:Myc)	Expression of LO in ras-transformed NIH 3T3 cells led to decreased NF-kappa B binding and activity, as well as the expression of the NF-kappa B target gene c-myc.	SEN:10009486	12640111
BEL:20069536	tscript(p(MGI:Nfkb1)) increases tscript(p(MGI:Nfkbid))	IkappaBNS was recruited to the IL-6 promoter, but not to the TNF-alpha promoter, together with p50.	SEN:10011636	15749903
BEL:20069540	tscript(p(MGI:Nfkbid)) directlyDecreases r(MGI:Il6)	IkappaBNS resulted in impaired LPS-induced IL-6 production, but not TNF-alpha production in the murine macrophage cell line RAW264.7.	SEN:10011638	15749903
BEL:20069554	tscript(p(MGI:"Nkx2-1")) increases r(MGI:Sftpd)	NFATc3 and TTF-1 activated the Sftpd promoter, synergized transcription, co-immunoprecipitated from mouse lung epithelial cells, and physically interacted in vitro.	SEN:10033488	15173172
BEL:20069572	tscript(p(MGI:"Nkx2-5")) directlyIncreases r(MGI:Adora1)	Within the proximal A1AR promoter, putative binding sites for cardiac transcription factors GATA and Nkx2.5 were identified. Co-expression studies revealed that GATA-4 and Nkx2.5 could individually drive A1AR promoter activity and act synergistically to activate A1AR expression	SEN:10027152	10318839
BEL:20069574	tscript(p(MGI:"Nkx2-5")) increases r(MGI:Pitx2)	This element contains three binding sites for the transcription factor FAST. The FAST binding sites function as Nodal-responsive elements and are sufficient for the initiation but not for the maintenance of asymmetric expression. The maintenance requires an Nkx2-5 binding site also present within the ASE	SEN:10032998	11172719
BEL:20069578	tscript(p(MGI:"Nkx2-5")) increases r(MGI:Xirp1)	The expression of mXinalpha in Nkx2.5 or MEF2C knockout mouse embryos was drastically reduced, suggesting that mXinalpha is a downstream target of the Nkx2.5 and MEF2C transcription factors.	SEN:10033312	16708114
BEL:20069586	tscript(p(MGI:Nobox)) increases r(MGI:Gdf9)	Genes preferentially expressed in oocytes, including Oct4 and Gdf9, are down-regulated in Nobox-/- mice, whereas ubiquitous genes such as Bmp4, Kit, and Bax remain unaffected.	SEN:10011650	15326356
BEL:20069588	tscript(p(MGI:Nobox)) increases r(MGI:Pou5f1)	Genes preferentially expressed in oocytes, including Oct4 and Gdf9, are down-regulated in Nobox-/- mice, whereas ubiquitous genes such as Bmp4, Kit, and Bax remain unaffected.	SEN:10011650	15326356
BEL:20069592	tscript(p(MGI:Notch1)) increases bp(GOBP:angiogenesis)	It is therefore likely that activation of Notch signaling in macrophages because of interactions with ligand-expressing endothelial cells affects expression of target genes that mediate both macrophage and endothelial cell function during retinal angiogenesis.	SEN:10033500	21795743
BEL:20069606	tscript(p(MGI:Nr0b2)) directlyDecreases tscript(p(MGI:Foxo1))	Remarkably, Foxo1 interacted with SHP in vivo and in vitro, which led to the repression of Foxo1-mediated G6Pase transcription by competition with a coactivator cAMP response element-binding protein-binding protein. These findings reveal a novel mechanism by which bile acids regulate gluconeogenic gene expression via an SHP-dependent regulatory pathway.	SEN:10011338	15047713
BEL:20069608	tscript(p(MGI:Nr0b2)) directlyDecreases tscript(p(MGI:Hnf4a))	Mice were sacrificed 12 h after fasting, and the livers were removed for Northern blot analysis. Bile acid homeostasis is tightly controlled by the feedback mechanism in which an atypical orphan nuclear receptor (NR) small heterodimer partner (SHP) inactivates several NRs such as liver receptor homologue-1 and hepatocyte nuclear factor 4.	SEN:10015474	15047713
BEL:20069610	tscript(p(MGI:Nr0b2)) directlyDecreases tscript(p(MGI:Nr5a2))	Mice were sacrificed 12 h after fasting, and the livers were removed for Northern blot analysis. Bile acid homeostasis is tightly controlled by the feedback mechanism in which an atypical orphan nuclear receptor (NR) small heterodimer partner (SHP) inactivates several NRs such as liver receptor homologue-1 and hepatocyte nuclear factor 4.	SEN:10015474	15047713
BEL:20069612	tscript(p(MGI:Nr1d1)) decreases r(MGI:Arntl)	clock and bmal1 also activate transcription of rev-erb-alpha, which in turn represses the transcription of bmal1	SEN:10032174	14551421
BEL:20069618	tscript(p(MGI:Nr1d1)) directlyDecreases r(MGI:Nfil3)	Hepatic expression of E4BP4 and the orphan nuclear receptor small heterodimer partner (SHP), both negative regulators of CYP7A1 expression, is increased in Rev-erbalpha-deficient mice. Promoter analysis and chromatin immunoprecipitation experiments demonstrated that SHP and E4BP4 are direct Rev-erbalpha target genes.	SEN:10033506	18565334
BEL:20069620	tscript(p(MGI:Nr1d1)) directlyDecreases r(MGI:Nr0b2)	Hepatic expression of E4BP4 and the orphan nuclear receptor small heterodimer partner (SHP), both negative regulators of CYP7A1 expression, is increased in Rev-erbalpha-deficient mice. Promoter analysis and chromatin immunoprecipitation experiments demonstrated that SHP and E4BP4 are direct Rev-erbalpha target genes.	SEN:10033506	18565334
BEL:20069624	tscript(p(MGI:Nr1d2)) increases r(MGI:Cd36)	Exogenous expression of a dominant negative version of mouse Rev-erbbeta decreases the expression of many genes involved in fatty acid/lipid absorption (including Cd36, and Fabp-3 and -4). Interestingly, we observed a robust induction (15-fold) in mRNA expression of interleukin-6	SEN:10033508	15623503
BEL:20069628	tscript(p(MGI:Nr1d2)) increases r(MGI:Fabp3)	Exogenous expression of a dominant negative version of mouse Rev-erbbeta decreases the expression of many genes involved in fatty acid/lipid absorption (including Cd36, and Fabp-3 and -4). Interestingly, we observed a robust induction (15-fold) in mRNA expression of interleukin-6	SEN:10033508	15623503
BEL:20069630	tscript(p(MGI:Nr1d2)) increases r(MGI:Fabp4)	Exogenous expression of a dominant negative version of mouse Rev-erbbeta decreases the expression of many genes involved in fatty acid/lipid absorption (including Cd36, and Fabp-3 and -4). Interestingly, we observed a robust induction (15-fold) in mRNA expression of interleukin-6	SEN:10033508	15623503
BEL:20069632	tscript(p(MGI:Nr1d2)) decreases r(MGI:Il6)	Exogenous expression of a dominant negative version of mouse Rev-erbbeta decreases the expression of many genes involved in fatty acid/lipid absorption (including Cd36, and Fabp-3 and -4). Interestingly, we observed a robust induction (15-fold) in mRNA expression of interleukin-6	SEN:10033508	15623503
BEL:20069634	tscript(p(MGI:Nr1d2)) decreases tscript(p(MGI:Rora))	Rev-erbbeta is an orphan nuclear receptor that selectively blocks trans-activation mediated by the retinoic acid-related orphan receptor-alpha (RORalpha)	SEN:10011656	15623503
BEL:20069636	tscript(p(MGI:Nr1h2)) decreases path(MESHD:Atherosclerosis)	Tontonoz and colleagues119 working with our team demonstrated that LXR agonists attenuate atherosclerosis; however, the same group also recently demonstrated that LXR ligands exert multiple vascular anti-inflammatory effects.120	SEN:10033510	14732733
BEL:20069642	tscript(p(MGI:Nr1h2)) decreases r(MGI:Hsd11b1)	treatment of adipocytes derived from 3T3-L1 cells and mouse embryonic fibroblasts in vitro with synthetic or natural LXR agonists decreases mRNA expression of 11beta-HSD-1 by approximately 50%, paralleled by a significant decline in 11beta-HSD-1 enzyme activity.	SEN:10033514	12145154
BEL:20069646	tscript(p(MGI:Nr1h2)) increases r(MGI:Srebf1)	We cloned and identified the oxysterol receptors liver X receptor (LXRalpha) and LXRbeta as strong activators of the mouse SREBP-1c promoter	SEN:10011660	11287605
BEL:20069648	tscript(p(MGI:Nr1h3)) increases a(CHEBI:cholesterol)	However, LXR alpha has several important roles in adipocyte function. Our studies show that this nuclear receptor increases basal glucose uptake and glycogen synthesis in 3T3-L1 adipocytes. In addition, LXR alpha increases cholesterol synthesis and release of nonesterified fatty acids. F	SEN:10011662	12138207
BEL:20069652	tscript(p(MGI:Nr1h3)) decreases bp(GOBP:"fat cell differentiation")	Experiments designed to uncover the potential role of LXR alpha in adipogenesis revealed that this transcription factor, unlike CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma, is not adipogenic but rather inhibits adipogenesis if inappropriately expressed and activated. However, LXR alpha has several important roles in adipocyte function.	SEN:10032710	12138207
BEL:20069654	tscript(p(MGI:Nr1h3)) increases bp(GOBP:"glucose import")	However, LXR alpha has several important roles in adipocyte function. Our studies show that this nuclear receptor increases basal glucose uptake and glycogen synthesis in 3T3-L1 adipocytes. In addition, LXR alpha increases cholesterol synthesis and release of nonesterified fatty acids. F	SEN:10011662	12138207
BEL:20069658	tscript(p(MGI:Nr1h3)) increases r(MGI:Abca1)	In addition to its regulatory role in inflammation processes, and in association with Pparg, Ppara was shown to mediate cholesterol efflux from human macrophages. This is likely due to the induction of the nuclear receptor LXR (NR1H3) expression, which in turn upregulates the expression of the reverse cholesterol transporter ABCA1.	SEN:10033516	12088279
BEL:20069662	tscript(p(MGI:Nr1h3)) decreases r(MGI:Abcd2)	Cholesterol lowering activates human ABCD2 in cultured cells... a sterol regulatory element (SRE) in the murine Abcd2 promoter that is directly bound by SRE-binding proteins (SREBPs)... Abcd2 is induced by SREBP1c	SEN:10033518	16249184
BEL:20069664	tscript(p(MGI:Nr1h3)) increases r(MGI:Abcg5)	Lxralpha(-/-) mice were not able to induce expression of hepatic Abcg5/Abcg8, and massive accumulation of free cholesterol and cholesteryl esters (CEs) occurred. Interestingly, despite the inability to upregulate Abcg5/Abcg8,	SEN:10011664	17088263
BEL:20069666	tscript(p(MGI:Nr1h3)) increases r(MGI:Abcg8)	Lxralpha(-/-) mice were not able to induce expression of hepatic Abcg5/Abcg8, and massive accumulation of free cholesterol and cholesteryl esters (CEs) occurred. Interestingly, despite the inability to upregulate Abcg5/Abcg8,	SEN:10011664	17088263
BEL:20069674	tscript(p(MGI:Nr1h3)) decreases r(MGI:G6pc)	In the liver, activation of LXR led to the suppression of the gluconeogenic program including down-regulation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1),phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase expression	SEN:10033520	12697904
BEL:20069676	tscript(p(MGI:Nr1h3)) decreases r(MGI:Hsd11b1)	treatment of adipocytes derived from 3T3-L1 cells and mouse embryonic fibroblasts in vitro with synthetic or natural LXR agonists decreases mRNA expression of 11beta-HSD-1 by approximately 50%, paralleled by a significant decline in 11beta-HSD-1 enzyme activity.	SEN:10033514	12145154
BEL:20069684	tscript(p(MGI:Nr1h3)) decreases r(MGI:Pck1)	In the liver, activation of LXR led to the suppression of the gluconeogenic program including down-regulation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1),phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase expression	SEN:10033520	12697904
BEL:20069688	tscript(p(MGI:Nr1h3)) decreases r(MGI:Ppargc1a)	In the liver, activation of LXR led to the suppression of the gluconeogenic program including down-regulation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1),phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase expression	SEN:10033520	12697904
BEL:20069692	tscript(p(MGI:Nr1h3)) increases r(MGI:Slc2a4)	In adipose tissue, activation of LXR led to the transcriptional induction of the insulin-sensitive glucose transporter, GLUT4.	SEN:10011674	12697904
BEL:20069694	tscript(p(MGI:Nr1h3)) increases r(MGI:Srebf1)	We cloned and identified the oxysterol receptors liver X receptor (LXRalpha) and LXRbeta as strong activators of the mouse SREBP-1c promoter	SEN:10011660	11287605
BEL:20069702	tscript(p(MGI:Nr1h4)) directlyIncreases r(MGI:Slc13a1)	These results demonstrate that mouse Slc13a1 is a novel Fxralpha target gene expressed in the kidney and intestine	SEN:10011676	17545158
BEL:20069720	tscript(p(MGI:Nr1i2)) increases r(MGI:Slco1c1)	Two PXR ligands [pregnenolone-16alpha-carbonitrile (PCN) and spironolactone] increased Oatp1a4 mRNA expression in liver,	SEN:10016292	15919853
BEL:20069734	tscript(p(MGI:Nr1i3)) increases r(MGI:Papss2)	activation of CAR was also associated with an increased expression of the 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2), Analysis of gene knockout mice revealed that CAR is also indispensable for ligand-dependent activation of SULT and PAPSS2 in vivo.	SEN:10033532	14742670
BEL:20069736	tscript(p(MGI:Nr1i3)) decreases r(MGI:Slco1a1)	CAR activators [phenobarbital, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, and diallyl sulfide] decreased Oatp1a1 mRNA expression.	SEN:10016168	15919853
BEL:20069738	tscript(p(MGI:Nr1i3)) increases r(MGI:Sult2a1)	CAR, robust induction of SULT gene expression CAR regulates SULT expression by binding to the CAR response elements found within the SULT gene promoters	SEN:10033534	14742670
BEL:20069766	tscript(p(MGI:Nr2f2)) decreases r(MGI:Apoa1)	Measurements of apoA-I regulatory protein-1 (ARP-1) mRNA, a negative regulator of the apoA-I gene in the mouse liver showed that CA increased the ARP-1 mRNA levels	SEN:10011690	10866832
BEL:20069778	tscript(p(MGI:Nr3c1)) decreases a(CHEBI:"reactive oxygen species")	Several other anomalies were noted including abnormal leukocyte adhesion molecule expression, an increased spontaneous migratory behaviour of PMN in Anx-1(-/-) mice and a resistance in Anx-1(-/-) macrophages to glucocorticoid inhibition of superoxide generation.	SEN:10025122	12516535
BEL:20069782	tscript(p(MGI:Nr3c1)) increases bp(GOBP:"fat cell differentiation")	Insulin/dexamethasone/methylisobutylxanthine (hormones/IBMX) induce 3T3-L1 fibroblasts to differentiate into adipocytes	SEN:10011694	7981246
BEL:20069788	tscript(p(MGI:Nr3c1)) increases bp(GOBP:"apoptotic process")	dig2 appears to have a pro-survival function as overexpression of dig2 reduces the sensitivity of cells to dexamethasone-induced apoptosis	SEN:10033554	12736248
BEL:20069790	tscript(p(MGI:Nr3c1)) increases cat(p(MGI:Gpd1))	Both activation of glycerophosphate dehydrogenase and stimulation of insulin-dependent 2-deoxyglucose uptake induced by hormones/IBMX were enhanced in protein kinase C-depleted cells exposed to phorbol 12-myristate 13-acetate (PMA)	SEN:10015606	7981246
BEL:20069798	tscript(p(MGI:Nr3c1)) decreases p(MGI:Tnxb)	We have identified glucocorticoids as physiological inhibitors of tenascin-X and suggest that glucocorticoids may in part participate in the downregulation of tenascin-X in fibroblasts in vivo.	SEN:10000018	8856503
BEL:20069816	tscript(p(MGI:Nr3c1)) increases r(MGI:Azgp1)	the glucocorticoid receptor antagonist RU38486 (25 mg kg(-1)) attenuated both the loss of body weight and ZAG expression in WAT	SEN:10011704	15714206
BEL:20069822	tscript(p(MGI:Nr3c1)) increases r(MGI:Cdkn1a)	The abundance of p21 mRNA increases about 5-fold within 2 h after addition of dexamethasone.This effect does not obtain in L929 mutants that are null for the glucocorticoid receptor, and a variant that expresses the glucocorticoid receptor from a tetracycline-repressible expression vector demonstrates induction of p21 mRNA only in the absence of tetracycline.	SEN:10011708	9139801
BEL:20069824	tscript(p(MGI:Nr3c1)) increases r(MGI:Cebpd)	DEX activates the gene encoding C/EBP delta. Likewise, MIX is a direct inducer of C/EBP beta gene expression	SEN:10009756	7531665
BEL:20069826	tscript(p(MGI:Nr3c1)) increases r(MGI:Cebpd)	DEX activates the gene encoding C/EBP delta. Likewise, MIX is a direct inducer of C/EBP beta gene expression.	SEN:10009758	7531665
BEL:20069830	tscript(p(MGI:Nr3c1)) increases r(MGI:Ddit4)	the induction of dig2 mRNA by dexamethasone appears to be mediated through the glucocorticoid receptor	SEN:10011710	12736248
BEL:20069838	tscript(p(MGI:Nr3c1)) directlyIncreases r(MGI:Gpx3)	In contrast, the newly identified target genes in skin, plasma glutathione peroxidase and HSP-27, were induced by GC in wild-type, but not in GR(dim) mice. Thus, these data suggest that the DNA binding-independent function of the GR is dispensable for repression of AP-1 activity in vivo and responsible for the antitumor promoting activity of GCs.	SEN:10033564	10613894
BEL:20069840	tscript(p(MGI:Nr3c1)) directlyIncreases r(MGI:Hspb2)	In contrast, the newly identified target genes in skin, plasma glutathione peroxidase and HSP-27, were induced by GC in wild-type, but not in GR(dim) mice. Thus, these data suggest that the DNA binding-independent function of the GR is dispensable for repression of AP-1 activity in vivo and responsible for the antitumor promoting activity of GCs.	SEN:10033564	10613894
BEL:20069842	tscript(p(MGI:Nr3c1)) directlyIncreases r(MGI:Igfbp1)	glucocorticoid receptor occupies the promoter of the IGFBP-1 gene and the -2.5 kb enhancer of the TAT gene in wild-type liver, and this binding is enhanced more than 4-fold during fasting	SEN:10033566	16098831
BEL:20069844	tscript(p(MGI:Nr3c1)) increases r(MGI:Kat2b)	In contrast, activated glucocorticoid receptor (GR) preferentially associated with SRC-2 (TIF-2/GRIP-1), which subsequently recruited pCAF and led to specific modification of histone H3, suggesting that specific coactivators recruit distinct histone acetyltransferases to modulate the transcription of steroid-responsive genes.	SEN:10020402	12748280
BEL:20069850	tscript(p(MGI:Nr3c1)) increases r(MGI:Lox)	Thirty-five differentially expressed cDNAs were isolated, subcloned, sequenced, and identified through BLAST searches. One of these cDNAs, termed Dex2, with enhanced expression in Dex-treated lungs, had 100% similarity with ras-recision gene (rrg), also known as the lysyl oxidase (LOX) gene that encodes lysyl oxidase.	SEN:10011716	10926554
BEL:20069860	tscript(p(MGI:Nr3c1)) directlyDecreases r(MGI:Nr1h3)	Several putative binding sites of the glucocorticoid receptor (GR) were identified in the LXRalpha promoter and transient cotransfections of the GR and LXRalpha promoter deletion constructs induced reporter gene activity.	SEN:10011720	14680824
BEL:20069862	tscript(p(MGI:Nr3c1)) increases r(MGI:Pck1)	An attractive mode of regulation, especially in light of the coordinated effects of glucocorticoids in maintaining homeostasis, is the opposing control of the same gene in different tissues by GR. PEPCK-C gene provides an optimal model for studying this mode of regulation. The transcription of this gene is stimulated by glucocorticoids in the liver and kidney (6, 7) but is repressed in the adipose tissue (8).	SEN:10033572	12560325
BEL:20069864	tscript(p(MGI:Nr3c1)) decreases r(MGI:Pck1)	An attractive mode of regulation, especially in light of the coordinated effects of glucocorticoids in maintaining homeostasis, is the opposing control of the same gene in different tissues by GR. PEPCK-C gene provides an optimal model for studying this mode of regulation. The transcription of this gene is stimulated by glucocorticoids in the liver and kidney (6, 7) but is repressed in the adipose tissue (8).	SEN:10033572	12560325
BEL:20069870	tscript(p(MGI:Nr3c1)) decreases r(MGI:Serpina6)	This treatment completely suppressed both endogenous plasma corticosterone and hepatic corticosterone-binding globulin (CBG) mRNA	SEN:10009770	8039608
BEL:20069874	tscript(p(MGI:Nr3c1)) directlyIncreases r(MGI:Tat)	glucocorticoid receptor occupies the promoter of the IGFBP-1 gene and the -2.5 kb enhancer of the TAT gene in wild-type liver, and this binding is enhanced more than 4-fold during fasting	SEN:10033566	16098831
BEL:20069880	tscript(p(MGI:Nr3c1)) decreases sec(p(MGI:Apob))	other examples of apoB degradation that appear to occur post-ER include regulation by choline deficiency, dexamethasone, and the interaction of newly assembled apoB lipoproteins with LDL receptors in the secretory pathway or at the cell surface cell surface heparin sulfate proteoglycans may also serve an LDL receptor-like function	SEN:10015558	12006608
BEL:20069882	tscript(p(MGI:Nr3c1)) increases tscript(p(MGI:Cebpb))	Induction of C/EBP beta DNA-binding activity in NIH-3T3 beta 2 cells exposed to dexamethasone in the presence of insulin and fetal bovine serum activates the expression of an adipocyte-specific nuclear hormone receptor, PPAR gamma, that stimulates the conversion of these fibroblasts into committed preadipocytes	SEN:10000006	7557387
BEL:20069884	tscript(p(MGI:Nr3c1)) decreases tscript(p(MGI:Irf3))	The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation	SEN:10005552	16143103
BEL:20069886	tscript(p(MGI:Nr3c1)) decreases tscript(p(MGI:Irf7))	The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation	SEN:10005552	16143103
BEL:20069888	tscript(p(MGI:Nr3c2)) increases bp(GOBP:"fat cell differentiation")	aldosterone promotes acquisition of the adipose phenotype of 3T3-L1 and 3T3-F442A cells in a time-, dose-, and MR-dependent manner.	SEN:10011726	17384139
BEL:20069898	tscript(p(MGI:Nr4a1)) increases r(MGI:Gja1)	Transcriptional profiling of Nur77-expressing preadipocytes led to the identification of gap-junction protein alpha1 (Gja1) and tolloid-like 1 (Tll1) as Nur77-responsive genes.	SEN:10011730	18945812
BEL:20069900	tscript(p(MGI:Nr4a1)) increases r(MGI:Insl3)	In the present study, we have identified the orphan nuclear receptor NR4A1 as a novel regulator of INSL3 transcription in Leydig cells. Using RT-PCR, we found that Nr4a1 is coexpressed with Insl3 in purified Leydig cells and in several Leydig cell lines.	SEN:10033584	16237153
BEL:20069904	tscript(p(MGI:Nr4a1)) increases r(MGI:Tll1)	Transcriptional profiling of Nur77-expressing preadipocytes led to the identification of gap-junction protein alpha1 (Gja1) and tolloid-like 1 (Tll1) as Nur77-responsive genes.	SEN:10011730	18945812
BEL:20069912	tscript(p(MGI:Nr4a2)) increases p(MGI:Th)	Co-expression of PIASgamma with Nurr1 results in a potent repression of Nurr1-dependent transcriptional activation of an artificial NGFI-B response element (NBRE) reporter as well as of a reporter driven by the native tyrosine hydroxylase promoter.	SEN:10005554	14559918
BEL:20069914	tscript(p(MGI:Nr4a2)) increases r(MGI:Cdkn1c)	p57Kip2 (Cdkn1c) is expressed in postmitotic differentiating midbrain dopamine cells. Induction of p57Kip2 expression depends on Nurr1,	SEN:10033588	14671317
BEL:20069934	tscript(p(MGI:Nr5a1)) directlyIncreases r(MGI:Lhb)	LHbeta promoter has binding sites for SF1, which synergizes with EGR1 to dramatically up-regulate LHbeta transcription	SEN:10029720	10734128
BEL:20069936	tscript(p(MGI:Nr5a2)) increases r(MGI:Cyp7a1)	since Lrh1 is required for transcription of Cyp7a1, one net result of activating Fxr and Shp expression was a decrease in the mRNA, protein and activity of Cyp7a1	SEN:10029662	11792716
BEL:20069948	tscript(p(MGI:Nrf1)) increases r(MGI:Alas1)	Cytochrome c expression was increased approximately twofold and delta- aminolevulinate synthase was increased approximately 50% in NRF-1 transgenic muscle	SEN:10011736	12958173
BEL:20069950	tscript(p(MGI:Nrf1)) increases r(MGI:Cycs)	Activation of NRF-1 in fibroblasts has been shown to induce increases in cytochrome c expression and mitochondrial respiratory capacity	SEN:10011738	12958173
BEL:20069952	tscript(p(MGI:Nrf1)) increases r(MGI:Cycs)	Cytochrome c expression was increased approximately twofold and delta- aminolevulinate synthase was increased approximately 50% in NRF-1 transgenic muscle	SEN:10011736	12958173
BEL:20069962	tscript(p(MGI:Onecut1)) decreases r(MGI:Foxa1)	% We observed that Foxa1 expression was upregulated in the liver of Hnf6(-/-) mouse embryos and in bipotential mouse embryonic liver (BMEL) cell lines derived from embryonic Hnf6(-/-) liver, suggesting that HNF-6 inhibits the expression of Foxa1.	SEN:10011746	15562441
BEL:20069964	tscript(p(MGI:Onecut1)) increases r(MGI:Foxa2)	In transfection experiments HNF-6 stimulated the expression of HNF-4 and of HNF-3 beta, two transcription factors known to be involved in liver	SEN:10011748	9441665
BEL:20069966	tscript(p(MGI:Onecut1)) increases r(MGI:Hnf4a)	In transfection experiments HNF-6 stimulated the expression of HNF-4 and of HNF-3 beta, two transcription factors known to be involved in liver	SEN:10011748	9441665
BEL:20069968	tscript(p(MGI:Onecut1)) decreases r(MGI:Tgfbr2)	we demonstrated that TGF-beta signaling was increased in the absence of HNF-6, and that this resulted from upregulation of TGF-beta receptor II expression.	SEN:10033602	15562441
BEL:20069972	tscript(p(MGI:Otx2)) directlyIncreases r(MGI:Tyr)	OTX2 binds specifically to a bicoid motif present in the promoter regions of three Mitf target genes, QNR71, TRP-1, and tyrosinase, leading to their transactivation.	SEN:10033606	12663655
BEL:20069974	tscript(p(MGI:Otx2)) directlyIncreases r(MGI:Tyrp1)	OTX2 binds specifically to a bicoid motif present in the promoter regions of three Mitf target genes, QNR71, TRP-1, and tyrosinase, leading to their transactivation.	SEN:10033606	12663655
BEL:20069976	tscript(p(MGI:Otx2)) directlyIncreases tscript(p(MGI:Mitf))	OTX2 and MITF co-localize in the nuclei of RPE cells and physically interact, and their co-expression results in a cooperative activation of QNR71 and tyrosinase promoters.	SEN:10011750	12663655
BEL:20069994	tscript(p(MGI:Pax3)) increases r(MGI:Eya2)	Pax3 induced the expression of the transcription factor Six1, its cofactor Eya2, and the transcription factor Mox1 prior to inducing the expression of MyoD and myogenin.	SEN:10011756	11262400
BEL:20069996	tscript(p(MGI:Pax3)) increases r(MGI:Meox1)	Pax3 induced the expression of the transcription factor Six1, its cofactor Eya2, and the transcription factor Mox1 prior to inducing the expression of MyoD and myogenin.	SEN:10011756	11262400
BEL:20069998	tscript(p(MGI:Pax3)) increases r(MGI:Mitf)	In humans, mutation of the Mitf gene can give rise to Waardenburg syndrome type 2 (WS2) (Tassabehji et al. 1994), which is characterized by pigmentary disorders and hearing loss, reflecting the role of melanocytes in the function of the inner ear. observation that Mitf expression is indeed subject to regulation by PAX3	SEN:10033610	10898786
BEL:20070000	tscript(p(MGI:Pax3)) increases r(MGI:Mitf)	The transcription factors implicated to date in regulation of the Mitf promoter include Pax3, CREB, Sox10, and Lef1 (Fig. 2A), with each factor able to confer on the Mitf promoter the capacity to respond to specific signals.	SEN:10032802	10898786
BEL:20070002	tscript(p(MGI:Pax3)) increases r(MGI:Six1)	Pax3 induced the expression of the transcription factor Six1, its cofactor Eya2, and the transcription factor Mox1 prior to inducing the expression of MyoD and myogenin.	SEN:10011756	11262400
BEL:20070006	tscript(p(MGI:Pax3)) increases r(MGI:Tyrp1)	Consistent with Pax3 being able to bind the TRP-1 promoter, Pax3 is expressed in melanocytes and melanomas, and TRP-1 promoter activity is up-regulated by Pax3.	SEN:10011758	10480898
BEL:20070014	tscript(p(MGI:Pax4)) decreases r(MGI:Gcgr)	In addition to a general repressor activity on basal glucagon gene promoter activity of 30-50%, a specific 90% inhibition of Pax-6 mediated transactivation was observed.	SEN:10011760	11845228
BEL:20070022	tscript(p(MGI:Pax5)) directlyIncreases r(MGI:Blnk)	Here we identified BLNK as a direct target of the transcription factor Pax5 (BSAP). Restoration of BLNK expression in Ig(mu) transgenic Pax5(--) pro-B cells resulted in constitutive pre-BCR signaling and increased cell proliferation without inducing progression to the pre-B cell stage.....Pax5 Activates BLNK by Binding to the Transcription Initiation Region	SEN:10025456	12387741
BEL:20070030	tscript(p(MGI:Pax6)) increases r(MGI:F11r)	This study revealed that the transcript levels were significantly altered for 508 of the 9700 genes analysed, including five genes encoding the cell adhesion molecules beta1-integrin, JAM1, L1 CAM, NCAM-140 and neogenin.	SEN:10011764	12485166
BEL:20070032	tscript(p(MGI:Pax6)) increases r(MGI:L1cam)	This study revealed that the transcript levels were significantly altered for 508 of the 9700 genes analysed, including five genes encoding the cell adhesion molecules beta1-integrin, JAM1, L1 CAM, NCAM-140 and neogenin.	SEN:10011764	12485166
BEL:20070034	tscript(p(MGI:Pax6)) decreases r(MGI:Lhx6)	The results indicate that Pax6 controls the lateral limit of the expression of Nkx2.1, Shh, and Lhx6 in the prechordal neural tube, the telencephalon.	SEN:10011766	11050125
BEL:20070038	tscript(p(MGI:Pax6)) increases r(MGI:Ncam1)	This study revealed that the transcript levels were significantly altered for 508 of the 9700 genes analysed, including five genes encoding the cell adhesion molecules beta1-integrin, JAM1, L1 CAM, NCAM-140 and neogenin.	SEN:10011764	12485166
BEL:20070040	tscript(p(MGI:Pax6)) increases r(MGI:Neo1)	This study revealed that the transcript levels were significantly altered for 508 of the 9700 genes analysed, including five genes encoding the cell adhesion molecules beta1-integrin, JAM1, L1 CAM, NCAM-140 and neogenin.	SEN:10011764	12485166
BEL:20070042	tscript(p(MGI:Pax6)) decreases r(MGI:"Nkx2-1")	The results indicate that Pax6 controls the lateral limit of the expression of Nkx2.1, Shh, and Lhx6 in the prechordal neural tube, the telencephalon.	SEN:10011766	11050125
BEL:20070044	tscript(p(MGI:Pax6)) increases r(MGI:Sema3c)	We demonstrate that in Pax6-/- brains, cells with early dorsal thalamic projection at the internal capsule are more dispersed. In addition, alterations in the structure of the PSPB were observed, together with the failure of expression of axon attractive molecules Sema3c, Sema5a and netrin 1	SEN:10029824	12397112
BEL:20070046	tscript(p(MGI:Pax6)) increases r(MGI:Sfrp2)	Pax-6 mutants lack SFRP-2 expression in the PSB and diencephalon. Pax-6 mutants also lack Wnt-7b expression in the PSB Furthermore, in the spinal cord of Pax-6 mutants, SFRP-2 and Wnt-7b expression was greatly reduced.	SEN:10033622	11222670
BEL:20070048	tscript(p(MGI:Pax6)) decreases r(MGI:Shh)	The results indicate that Pax6 controls the lateral limit of the expression of Nkx2.1, Shh, and Lhx6 in the prechordal neural tube, the telencephalon.	SEN:10011766	11050125
BEL:20070052	tscript(p(MGI:Pax6)) increases r(MGI:Wnt7b)	Pax-6 mutants lack SFRP-2 expression in the PSB and diencephalon. Pax-6 mutants also lack Wnt-7b expression in the PSB Furthermore, in the spinal cord of Pax-6 mutants, SFRP-2 and Wnt-7b expression was greatly reduced.	SEN:10033622	11222670
BEL:20070072	tscript(p(MGI:Per1)) increases r(MGI:Scnn1a)	Figure 10 Per1 mediates regulation of alphaENaC expression in the outer medulla. (A) The induction of alphaENaC by aldosterone is attenuated in OMCD1 cells after Per1 knockdown...(B) In the absence of aldosterone, Per1 knockdown results in a 2-fold decrease in alphaENaC mRNA levels in OMCD1 cells.	SEN:10033630	19587447
BEL:20070076	tscript(p(MGI:Pgr)) increases r(MGI:Lgals1)	Galectin-1 gene expression increased from 12 hr and stayed at a high level until 48 hr after progesterone treatment.	SEN:10033634	9291476
BEL:20070080	tscript(p(MGI:Phox2b)) directlyIncreases r(MGI:Ascl1)	We show that Phox2b has a dual action on pan-neuronal differentiation. It upregulates the expression of proneural genes (Ngn2) when expressed alone and upregulates the expression of Mash1 when expressed in combination with Nkx2.2.	SEN:10029574	12399315
BEL:20070082	tscript(p(MGI:Phox2b)) directlyIncreases r(MGI:Neurog2)	We show that Phox2b has a dual action on pan-neuronal differentiation. It upregulates the expression of proneural genes (Ngn2) when expressed alone and upregulates the expression of Mash1 when expressed in combination with Nkx2.2.	SEN:10029574	12399315
BEL:20070086	tscript(p(MGI:Pias2)) increases r(MGI:Gfer)	As assessed by quantitative RT-PCR, the Gfer mRNA was decreased by 2.4-fold in PIASx -/- mice compared with PIASx +/+ mice	SEN:10029912	15956336
BEL:20070100	tscript(p(MGI:Pitx2)) directlyIncreases r(MGI:Plod1)	We show these elements to bind PITX2 specifically in vitro. The PLOD-1 promoter induces the expression of a luciferase reporter gene in the presence of PITX2 in cotransfection experiments.	SEN:10033644	11157981
BEL:20070102	tscript(p(MGI:Pitx2)) directlyIncreases r(MGI:Plod2)	We show these elements to bind PITX2 specifically in vitro. The PLOD-1 promoter induces the expression of a luciferase reporter gene in the presence of PITX2 in cotransfection experiments.	SEN:10033644	11157981
BEL:20070110	tscript(p(MGI:Plagl1)) directlyIncreases r(MGI:Igf2)	the PLAG1- and PLAGL2-induced transformation is accompanied by a drastic up-regulation of insulin-like growth factor-II, which we prove is a target of PLAG1 and PLAGL2	SEN:10011776	11888928
BEL:20070114	tscript(p(MGI:Plagl2)) directlyIncreases r(MGI:Igf2)	the PLAG1- and PLAGL2-induced transformation is accompanied by a drastic up-regulation of insulin-like growth factor-II, which we prove is a target of PLAG1 and PLAGL2	SEN:10011776	11888928
BEL:20070118	tscript(p(MGI:Pou2af1)) directlyDecreases r(MGI:Idh2)	We have identified genes both induced and repressed by BOB.1/OBF.1. Using different genetic systems, we demonstrate regulation of a selection of these genes. Identified targets included genes encoding Ahd2-like, AKR1C13, Rbp1, Sdh, Idh2, protocadherin gamma, alpha-catenin, Ptprs, Id3, and Creg.	SEN:10005564	12947107
BEL:20070134	tscript(p(MGI:Pou3f4)) directlyIncreases r(MGI:Gcg)	Cdx-2 and Brn-4 are recognized as transcriptional activators for the proglucagon gene. These two homeodomain (HD) proteins are able to interact with the correspondent motifs on the G1 enhancer element of proglucagon promoter, separated by only 8 bp.	SEN:10033660	16373422
BEL:20070148	tscript(p(MGI:Pou5f1)) directlyIncreases r(MGI:Nanog)	More interestingly, we further show that Zfp143 regulates Nanog expression through modulation of Oct4 binding. Coimmunoprecipitation experiments revealed that Zfp143 and Oct4 physically interact with each other. This interaction is important because Oct4 binding to the Nanog promoter is promoted by Zfp143.	SEN:10020418	18687992
BEL:20070174	tscript(p(MGI:Ppara)) increases bp(GOBP:"fatty acid beta-oxidation")	Fibrates induce the peroxisomal b-oxidation system of fatty acids in rodents, resulting in proliferation of peroxisomes, hepatomegaly and eventually hepatocarcinoma.	SEN:10033678	11798191
BEL:20070176	tscript(p(MGI:Ppara)) increases bp(GOBP:"fatty acid beta-oxidation")	LXRs activate expression of Srebp1c, a dominant lipogenic gene regulator, whereas Ppara promotes fatty acid beta-oxidation genes	SEN:10033680	12730331
BEL:20070178	tscript(p(MGI:Ppara)) increases bp(GOBP:"fatty acid oxidation")	p38 MAPK has been reported to activate PPAR-a through increased phosphorylation of PPAR-a and increased co-activation specifically by PGC-1 (refs 22, 23), thereby stimulating fatty-acid oxidation.	SEN:10021968	12802337
BEL:20070180	tscript(p(MGI:Ppara)) increases bp(GOBP:"fatty acid oxidation")	From text: In addition, medium-chain acyl-CoA dehydrogenase (MCAD), a known PPARalpha target that catalyzes the initial step in mitochodrial fatty acid beta-oxidation, is also regulated by ERRalpha (Sladek et al. 1997; Vega and Kelly 1997; Huss et al 2002).	SEN:10032944	15004004
BEL:20070182	tscript(p(MGI:Ppara)) increases bp(GOBP:"fatty acid oxidation")	PPAR-alpha activators increase hepatic uptake and esterification of free fatty acids, in addition to increasing mitochondrial free fatty acid uptake and the resulting free fatty acid oxidation.	SEN:10033682	16511610
BEL:20070184	tscript(p(MGI:Ppara)) decreases bp(GOBP:"inflammatory response")	Here, we show that aortic explants isolated from PPARalpha-null mice display an exacerbated response to inflammatory stimuli, such as lipopolysaccharide (LPS), as demonstrated by increased IL-6 secretion.	SEN:10033684	10542237
BEL:20070190	tscript(p(MGI:Ppara)) increases bp(GOBP:"apoptotic process")	In macrophages, PPARs inhibit inflammatory cytokine-induced activation [17], promote apoptosis [13] and control lipid homeostasis through their effects on the expression of several key genes including SR-A, CD36, SR-BI and ABCA1.	SEN:10033688	11852057
BEL:20070192	tscript(p(MGI:Ppara)) decreases path(MESHD:"Insulin Resistance")	Treatment of obese mice with Ppara agonists improves insulin sensitivity and decreases blood glucose and insulin levels	SEN:10033672	16511610
BEL:20070194	tscript(p(MGI:Ppara)) increases cat(p(MGI:Lpl))	PPAR-alpha-dependent stimulation of lipoprotein lipase and of apolipoprotein (apo)A-V and to an inhibition of apoC-III expression,	SEN:10033690	16511610
BEL:20070196	tscript(p(MGI:Ppara)) increases cat(p(MGI:Lpl))	The therapeutic benefit of fibrates is due in part to reduced VLDL production and enhanced catabolism if TG-rich particles, which indirectly decreases small LDL particles, enhancing the formation of HDL particles	SEN:10033668	16511610
BEL:20070198	tscript(p(MGI:Ppara)) decreases complex(p(MGI:Nr1h3),p(MGI:Rxra))	supplementation with RXR attenuated these inhibitions by Ppars implicating receptor interaction among LXR, Ppar and RXR as a plausible mechanism Pparalpha activation can suppress LXR-Srebp1c pathway through reduction of LXR/RXR formation, proposing a novel transcription factor cross-talk between LXR and Pparalpha in hepatic lipid homeostasis	SEN:10033692	12730331
BEL:20070200	tscript(p(MGI:Ppara)) decreases complex(p(MGI:Nr1h3),p(MGI:Rxrb))	supplementation with RXR attenuated these inhibitions by Ppars implicating receptor interaction among LXR, Ppar and RXR as a plausible mechanism Pparalpha activation can suppress LXR-Srebp1c pathway through reduction of LXR/RXR formation, proposing a novel transcription factor cross-talk between LXR and Pparalpha in hepatic lipid homeostasis	SEN:10033692	12730331
BEL:20070202	tscript(p(MGI:Ppara)) decreases complex(p(MGI:Nr1h3),p(MGI:Rxrg))	supplementation with RXR attenuated these inhibitions by Ppars implicating receptor interaction among LXR, Ppar and RXR as a plausible mechanism Pparalpha activation can suppress LXR-Srebp1c pathway through reduction of LXR/RXR formation, proposing a novel transcription factor cross-talk between LXR and Pparalpha in hepatic lipid homeostasis	SEN:10033692	12730331
BEL:20070204	tscript(p(MGI:Ppara)) increases path(MESHD:Neoplasms)	Sustained activation of PPARalpha by these agents leads to the development of liver tumors in rats and mice.	SEN:10011788	11764000
BEL:20070210	tscript(p(MGI:Ppara)) decreases p(MGI:Il10)	Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.	SEN:10000450	16313356
BEL:20070212	tscript(p(MGI:Ppara)) decreases p(MGI:Il12b)	Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.	SEN:10000450	16313356
BEL:20070214	tscript(p(MGI:Ppara)) decreases r(EGID:20493)	By using the various transcription factor-null mice, PPAR-alpha was shown to play a central role in the down-regulation of Oatp1a1, 1a4, 1b2, and Ntcp by PFDA.	SEN:10011790	18703564
BEL:20070218	tscript(p(MGI:Ppara)) directlyIncreases r(MGI:Abca1)	It has recently been demonstrated that Ppara activatio by fenofibrate induces ATP-binding casette transporter1 gener expression in human macrophages.	SEN:10033698	11788127
BEL:20070220	tscript(p(MGI:Ppara)) decreases r(MGI:Abca1)	Treatment of cells with the PPAR alpha agonist GW7647 (2.5 mg/kg/d) significantly inhibited the expression of ABCA1	SEN:10033700	15578089
BEL:20070226	tscript(p(MGI:Ppara)) decreases r(MGI:Abcg1)	Treatment of cells with PPAR alpha agonist showed a decrease in ABCG1 mRNA expression in wild type macrophages.	SEN:10033704	15578089
BEL:20070236	tscript(p(MGI:Ppara)) increases r(MGI:Acadm)	PPARa activation stimulates fatty acids catabolism in these organella by increasing the transcription of proteins involved in its transport into the mitochondria (carnitine palmitoyltransferase I) [15-17] and in the mitochondrial b-oxidation cycle (medium-chain acyl- CoA dehydrogenase) [18].	SEN:10033710	14561188
BEL:20070244	tscript(p(MGI:Ppara)) increases r(MGI:Acox1)	In addition to its activation in response to peroxisome proliferators such as Wy14,643, Ppara is also activated by a variety of medium and long-chain fatty acids and has been shown to stimulate lipid metabolism by teh induction of peroxisomal B-oxidation and faty acid w-hydroxylation.	SEN:10016192	11867749
BEL:20070252	tscript(p(MGI:Ppara)) directlyIncreases r(MGI:Acss2)	The hypotriglyceridemic action of fibrates and fatty acids also involves PPARs and can be summarized as follows: ... (2) a stimulation of cellular fatty acid uptake and their conversion to acyl-CoA derivatives by the induction of FAT, FATP and ACS activity, (3) an induction of fatty acid beta-oxidation pathways, (4) a reduction in fatty acid and triglyceride synthesis, and finally (5) a decrease in VLDL production.	SEN:10033676	8695669
BEL:20070254	tscript(p(MGI:Ppara)) increases r(MGI:Adipor1)	Importantly, Wy-14,643 treatment upregulated expression of the adiponectin receptor (AdipoR)-1 and AdipoR2 in WAT	SEN:10011796	16306350
BEL:20070256	tscript(p(MGI:Ppara)) increases r(MGI:Adipor2)	Importantly, Wy-14,643 treatment upregulated expression of the adiponectin receptor (AdipoR)-1 and AdipoR2 in WAT	SEN:10011796	16306350
BEL:20070258	tscript(p(MGI:Ppara)) increases r(MGI:Agpat3)	mRNA expression of cardiac mAGPAT3 appeared to be regulated by PPARalpha activation...mAGPAT3 mRNA expression was increased by 51% (P<0.05) in wild-type mice fed with clofibrate [ppara agonist] compared with controls	SEN:10033712	15367102
BEL:20070260	tscript(p(MGI:Ppara)) increases r(MGI:Apoa5)	PPAR-alpha-dependent stimulation of lipoprotein lipase and of apolipoprotein (apo)A-V and to an inhibition of apoC-III expression,	SEN:10033690	16511610
BEL:20070262	tscript(p(MGI:Ppara)) decreases r(MGI:Apoc3)	PPAR-alpha-dependent stimulation of lipoprotein lipase and of apolipoprotein (apo)A-V and to an inhibition of apoC-III expression,	SEN:10033690	16511610
BEL:20070264	tscript(p(MGI:Ppara)) increases r(MGI:Ccnd1)	Hepatic expression of Ccnd1, cMyc, IL-1r1, and IL-6r was induced in wild-type mice, but not Pparalpha-null mice, after acute exposure to the potent Pparalpha agonist Wy-14,643, indicating a role for Pparalpha in regulating the expression of these genes.	SEN:10011798	12198646
BEL:20070266	tscript(p(MGI:Ppara)) increases r(MGI:Cd36)	Northern blot analysis confirmed the differential expression of some of the genes identified in the present study, and also some genes identified previously as PPARalpha regulated, such as CD36, lymphocyte antigen 6 complex locus (Ly-6D), and C3f.	SEN:10011800	12771043
BEL:20070268	tscript(p(MGI:Ppara)) decreases r(MGI:Cd36)	Treatment of cells with the PPAR alpha agonist GW7647 (2.5 mg/kg/d) significantly inhibited the expression of CD36.	SEN:10033714	15578089
BEL:20070270	tscript(p(MGI:Ppara)) increases r(MGI:Cd68)	PPAR alpha agonist significantly increase the expression of marcosialin (CD68), consistent with an increased presence of intimal macrophages	SEN:10033716	15578089
BEL:20070272	tscript(p(MGI:Ppara)) increases r(MGI:Cpt1a)	PPARa activation stimulates fatty acids catabolism in these organella by increasing the transcription of proteins involved in its transport into the mitochondria (carnitine palmitoyltransferase I) [15-17] and in the mitochondrial b-oxidation cycle (medium-chain acyl- CoA dehydrogenase) [18].	SEN:10033710	14561188
BEL:20070284	tscript(p(MGI:Ppara)) increases r(MGI:Dffa)	we identified several genes that are upregulated in the Wy-14,643-treated mouse liver. These include CD36, monoglyceride lipase, Ly-6D, cell death- inducing DNA fragmentation factor alpha, PDK4, C3f and others	SEN:10033722	11551940
BEL:20070288	tscript(p(MGI:Ppara)) increases r(MGI:Dusp1)	Evidence for such a gene would be an increase in [Pparalpha] ligand inducibility in the CITED2+ cells with an absence (or significant diminution) of this regulation in the CITED2- hepatocytes. Perhaps the gene that comes closest to this pattern is MKP-1	SEN:10032776	15051727
BEL:20070292	tscript(p(MGI:Ppara)) decreases r(MGI:Eif1)	Heat stress in PPAR{alpha}-null but not wild-type mice led to an increase in one gene (Sui1-rs1) and decreases in three genes (Gspt1, Tcea1, and 2300002G02Rik).	SEN:10033726	15375163
BEL:20070298	tscript(p(MGI:Ppara)) increases r(MGI:Fabp4)	Exposure of these stimulated cells to a PPAR activator 5,8,11,14-eicosatetraynoic acid (ETYA) results in the accumulation of fat droplets and expression of the adipocyte-enriched genes aP2 and glycerol phosphate dehydrogenase (GPD)	SEN:10033732	7557387
BEL:20070308	tscript(p(MGI:Ppara)) increases r(MGI:Gpd1)	Exposure of these stimulated cells to a PPAR activator 5,8,11,14-eicosatetraynoic acid (ETYA) results in the accumulation of fat droplets and expression of the adipocyte-enriched genes aP2 and glycerol phosphate dehydrogenase (GPD)	SEN:10033732	7557387
BEL:20070312	tscript(p(MGI:Ppara)) increases r(MGI:Gspt1)	Heat stress in PPAR{alpha}-null but not wild-type mice led to an increase in one gene (Sui1-rs1) and decreases in three genes (Gspt1, Tcea1, and 2300002G02Rik).	SEN:10033726	15375163
BEL:20070316	tscript(p(MGI:Ppara)) increases r(MGI:Il1r1)	Hepatic expression of Ccnd1, cMyc, IL-1r1, and IL-6r was induced in wild-type mice, but not Pparalpha-null mice, after acute exposure to the potent Pparalpha agonist Wy-14,643, indicating a role for Pparalpha in regulating the expression of these genes.	SEN:10011798	12198646
BEL:20070318	tscript(p(MGI:Ppara)) increases r(MGI:Il6)	the preincubation of RAW264.7 cells with a specific PPARalpha agonist, K-111 (2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid). K-111 reduced both the IL-6 production and mRNA expression in RAW264.7 cells	SEN:10011808	17320860
BEL:20070320	tscript(p(MGI:Ppara)) increases r(MGI:Il6ra)	Hepatic expression of Ccnd1, cMyc, IL-1r1, and IL-6r was induced in wild-type mice, but not Pparalpha-null mice, after acute exposure to the potent Pparalpha agonist Wy-14,643, indicating a role for Pparalpha in regulating the expression of these genes.	SEN:10011798	12198646
BEL:20070322	tscript(p(MGI:Ppara)) increases r(MGI:Lpcat3)	Northern blot analysis confirmed the differential expression of some of the genes identified in the present study, and also some genes identified previously as PPARalpha regulated, such as CD36, lymphocyte antigen 6 complex locus (Ly-6D), and C3f.	SEN:10011800	12771043
BEL:20070326	tscript(p(MGI:Ppara)) directlyIncreases r(MGI:Lpl)	Incubation of human MDM with PPAR alpha and gamma ligands stimulated, in a time- and dose-dependent manner, human MDM LPL mass and activity. These agents also significantly increased macrophage LPL mRNA expression.	SEN:10033736	12208475
BEL:20070336	tscript(p(MGI:Ppara)) increases r(MGI:Ly6d)	Northern blot analysis confirmed the differential expression of some of the genes identified in the present study, and also some genes identified previously as PPARalpha regulated, such as CD36, lymphocyte antigen 6 complex locus (Ly-6D), and C3f.	SEN:10011800	12771043
BEL:20070338	tscript(p(MGI:Ppara)) decreases r(MGI:Mapk1)	We identified a novel target in liver, mitogen-activated phosphokinase phosphatase 1, whose down-regulation by PPAR-alpha agonists may improve insulin sensitivity in that tissue by prolonging insulin responses.	SEN:10033742	11474486
BEL:20070340	tscript(p(MGI:Ppara)) increases r(MGI:Myc)	Hepatic expression of Ccnd1, cMyc, IL-1r1, and IL-6r was induced in wild-type mice, but not Pparalpha-null mice, after acute exposure to the potent Pparalpha agonist Wy-14,643, indicating a role for Pparalpha in regulating the expression of these genes.	SEN:10011798	12198646
BEL:20070344	tscript(p(MGI:Ppara)) increases r(MGI:Nr1h3)	in addition, the Lxra gene is induced by Pparg and Ppara that may in turn be activated by the newly synthesized unsaturated fatty acids	SEN:10033746	11792716
BEL:20070346	tscript(p(MGI:Ppara)) increases r(MGI:Nr1h3)	In addition to its regulatory role in inflammation processes, and in association with Pparg, Ppara was shown to mediate cholesterol efflux from human macrophages. This is likely due to the induction of the nuclear receptor LXR (NR1H3) expression, which in turn upregulates the expression of the reverse cholesterol transporter ABCA1.	SEN:10033516	12088279
BEL:20070356	tscript(p(MGI:Ppara)) directlyIncreases r(MGI:Ptgs2)	Experiments investigating endogenous and overexpressed PPARalpha and PPARgamma activation of COX-2 mRNA and protein	SEN:10011814	11840453
BEL:20070360	tscript(p(MGI:Ppara)) increases r(MGI:Rxra)	Nuclear RXRalpha level was constitutively lower in PPARalpha-null mice than in wild-type mice. The level was also increased by clofibrate treatment in wild-type mice without a concomitant increase of RXRalpha mRNA,	SEN:10011816	12753917
BEL:20070362	tscript(p(MGI:Ppara)) increases r(MGI:Rxra)	Nuclear RXRalpha level was constitutively lower in PPARalpha-null mice than in wild-type mice. The level was also increased by clofibrate treatment in wild-type mice without a concomitant increase of RXRalpha mRNA, but not in PPARalpha-null mice.	SEN:10003344	12753917
BEL:20070364	tscript(p(MGI:Ppara)) increases r(MGI:Slc27a1)	expression of the fatty acid transport protein, an integral membrane protein involved in FA uptake, is upregulated by Ppara activation in hepatocytes.	SEN:10033752	16511610
BEL:20070366	tscript(p(MGI:Ppara)) directlyIncreases r(MGI:Slc27a1)	The hypotriglyceridemic action of fibrates and fatty acids also involves PPARs and can be summarized as follows: ... (2) a stimulation of cellular fatty acid uptake and their conversion to acyl-CoA derivatives by the induction of FAT, FATP and ACS activity, (3) an induction of fatty acid beta-oxidation pathways, (4) a reduction in fatty acid and triglyceride synthesis, and finally (5) a decrease in VLDL production.	SEN:10033676	8695669
BEL:20070368	tscript(p(MGI:Ppara)) decreases r(MGI:Slco1a1)	By using the various transcription factor-null mice, PPAR-alpha was shown to play a central role in the down-regulation of Oatp1a1, 1a4, 1b2, and Ntcp by PFDA.	SEN:10011790	18703564
BEL:20070370	tscript(p(MGI:Ppara)) decreases r(MGI:Slco1a4)	By using the various transcription factor-null mice, PPAR-alpha was shown to play a central role in the down-regulation of Oatp1a1, 1a4, 1b2, and Ntcp by PFDA.	SEN:10011790	18703564
BEL:20070372	tscript(p(MGI:Ppara)) decreases r(MGI:Slco1b2)	By using the various transcription factor-null mice, PPAR-alpha was shown to play a central role in the down-regulation of Oatp1a1, 1a4, 1b2, and Ntcp by PFDA.	SEN:10011790	18703564
BEL:20070374	tscript(p(MGI:Ppara)) increases r(MGI:Tcea1)	Heat stress in PPAR{alpha}-null but not wild-type mice led to an increase in one gene (Sui1-rs1) and decreases in three genes (Gspt1, Tcea1, and 2300002G02Rik).	SEN:10033726	15375163
BEL:20070376	tscript(p(MGI:Ppara)) increases r(MGI:Trib3)	upregulation of TRB3 through direct transcriptional control by Ppara...TRB3 is an inhibitor of Akt?protein kinase B	SEN:10031676	16511610
BEL:20070378	tscript(p(MGI:Ppara)) increases r(MGI:Tufm)	Heat stress in PPAR{alpha}-null but not wild-type mice led to an increase in one gene (Sui1-rs1) and decreases in three genes (Gspt1, Tcea1, and 2300002G02Rik).	SEN:10033726	15375163
BEL:20070386	tscript(p(MGI:Ppara)) decreases sec(p(MGI:Il6))	Here, we show that aortic explants isolated from PPARalpha-null mice display an exacerbated response to inflammatory stimuli, such as lipopolysaccharide (LPS), as demonstrated by increased IL-6 secretion.	SEN:10033684	10542237
BEL:20070392	tscript(p(MGI:Ppard)) increases bp(GOBP:"fatty acid beta-oxidation")	From FullPaper Introduction In corroboration with these in vivo findings, we demonstrate that activation of PPARd stimulates B-oxidation and triglyceride utilization in adipocytes and myocytes.	SEN:10033760	12705865
BEL:20070398	tscript(p(MGI:Ppard)) directlyIncreases r(EGID:11520)	Results Adipocyte-differentiation-related protein (ADRP) is a lipid droplet coating protein and its expression is induced by PPARd activation.	SEN:10033762	12705865
BEL:20070406	tscript(p(MGI:Ppard)) increases r(MGI:Lipe)	We also observed a mild but significant induction of hormone-sensitve lipase (HSL;1.7fold), which catalyzes triglyceride hydrolysis in adipocytes.	SEN:10033764	12705865
BEL:20070410	tscript(p(MGI:Ppard)) increases r(MGI:Ucp1)	All three UCPs are expressed in brown fat with IUCP1 being most abundant.Activation of Ppard induces expression of UCP1 and UCP3 in brown fat by 3.0- and 2.8-fold, respecitvely, but ahs no effect on the expression of UCP2	SEN:10033766	12705865
BEL:20070412	tscript(p(MGI:Ppard)) increases r(MGI:Ucp1)	In white adipsoe tissue, we observed no difference for most of these genes, except for UCP1, which shows a robuset induction.	SEN:10033768	12705865
BEL:20070414	tscript(p(MGI:Ppard)) increases r(MGI:Ucp3)	All three UCPs are expressed in brown fat with IUCP1 being most abundant.Activation of Ppard induces expression of UCP1 and UCP3 in brown fat by 3.0- and 2.8-fold, respecitvely, but ahs no effect on the expression of UCP2	SEN:10033766	12705865
BEL:20070440	tscript(p(MGI:Pparg)) increases bp(GOBP:"fat cell differentiation")	PPARalpha (NR1C1) controls lipid oxidation and clearance in hepatocytes and PPARgamma (NR1C3) promotes preadipocyte differentiation and lipogenesis.	SEN:10011824	11557774
BEL:20070442	tscript(p(MGI:Pparg)) increases bp(GOBP:"fat cell differentiation")	Experiments designed to uncover the potential role of LXR alpha in adipogenesis revealed that this transcription factor, unlike CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma, is not adipogenic but rather inhibits adipogenesis if inappropriately expressed and activated. However, LXR alpha has several important roles in adipocyte function.	SEN:10032710	12138207
BEL:20070444	tscript(p(MGI:Pparg)) increases bp(GOBP:"fat cell differentiation")	Induction of C/EBP beta DNA-binding activity in NIH-3T3 beta 2 cells exposed to dexamethasone in the presence of insulin and fetal bovine serum activates the expression of an adipocyte-specific nuclear hormone receptor, PPAR gamma, that stimulates the conversion of these fibroblasts into committed preadipocytes	SEN:10000006	7557387
BEL:20070446	tscript(p(MGI:Pparg)) increases bp(GOBP:"lipid biosynthetic process")	PPARalpha (NR1C1) controls lipid oxidation and clearance in hepatocytes and PPARgamma (NR1C3) promotes preadipocyte differentiation and lipogenesis.	SEN:10011824	11557774
BEL:20070456	tscript(p(MGI:Ppargc1a)) increases bp(GOBP:"fatty acid oxidation")	Introduction PGC-1a has been shown to induce mitochondrial fatty acid oxidation in cardiac myocytes	SEN:10033790	12651943
BEL:20070458	tscript(p(MGI:Ppargc1a)) increases bp(GOBP:gluconeogenesis)	We have shown previously that the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) is induced in fasted or diabetic liver and activates the entire program of gluconeogenesis.	SEN:10033792	12651943
BEL:20070464	tscript(p(MGI:Ppargc1a)) increases r(MGI:Acadm)	Results CPT1 and MCAD are two enzymes essential for te mitochondrial transport and B-oxidation of fatty acids. As seen in Fig.2, the infection of primary hepatocytes with adenoviral PGC-1a strongly induces mRNAs for both of these genes.	SEN:10033798	12651943
BEL:20070466	tscript(p(MGI:Ppargc1a)) increases r(MGI:Acat1)	Fig.2 demonstrates that the expression of PGC-1a potently increases mRNA levels for 3-keto-thiolase (Acat1)and HMG-Co-lyase.	SEN:10033800	12651943
BEL:20070472	tscript(p(MGI:Ppargc1a)) increases r(MGI:Cpt1a)	cAMP response unit of the Cpt1a gene is composed of a cAMP-response element motif and a Dr1 sequence located upstream of the transcription start site the coactivator Pgc-1 is involved in the regulation of this gene expression by cAMP in conbination with Hnf4 alpha and Creb	SEN:10032790	12107181
BEL:20070474	tscript(p(MGI:Ppargc1a)) increases r(MGI:Cpt1a)	Results CPT1 and MCAD are two enzymes essential for te mitochondrial transport and B-oxidation of fatty acids. As seen in Fig.2, the infection of primary hepatocytes with adenoviral PGC-1a strongly induces mRNAs for both of these genes.	SEN:10033798	12651943
BEL:20070478	tscript(p(MGI:Ppargc1a)) increases r(MGI:Hmgcl)	Fig.2 demonstrates that the expression of PGC-1a potently increases mRNA levels for 3-keto-thiolase (Acat1)and HMG-Co-lyase.	SEN:10033800	12651943
BEL:20070482	tscript(p(MGI:Ppargc1a)) increases r(MGI:Nrf1)	Second, forced expression studies in adipogenic and myogenic mammalian cell lines demonstrated that PGC-1{alpha} markedly induces the expression of NRF-1, NRF-2, and Tfam (Wu et al. 1999Go).	SEN:10033804	15004004
BEL:20070484	tscript(p(MGI:Ppargc1a)) increases r(MGI:Pck1)	Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output.	SEN:10033806	11557972
BEL:20070486	tscript(p(MGI:Ppargc1a)) increases r(MGI:Slc2a4)	coactivator PGC-1, which is expressed in muscle in vivo but is also deficient in cultured muscle cells, causes the total restoration of GLUT4 mRNA levels to those observed in vivo.	SEN:10011826	11274399
BEL:20070488	tscript(p(MGI:Ppargc1a)) increases r(MGI:Tfam)	Second, forced expression studies in adipogenic and myogenic mammalian cell lines demonstrated that PGC-1{alpha} markedly induces the expression of NRF-1, NRF-2, and Tfam (Wu et al. 1999Go).	SEN:10033804	15004004
BEL:20070490	tscript(p(MGI:Ppargc1a)) increases r(MGI:Ucp1)	Peroxisome proliferator-activated receptor gamma (PPAR gamma) and PPAR gamma coactivator 1 alpha (PGC-1 alpha) activate mouse UCP1 gene transcription. We show here that human PGC-1 alpha induced the activation of the human UCP1 promoter by PPAR gamma	SEN:10011828	12807871
BEL:20070494	tscript(p(MGI:Ppargc1a)) increases tscript(p(MGI:Hnf4a))	Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1.	SEN:10011830	11557972
BEL:20070498	tscript(p(MGI:Ppargc1a)) increases tscript(p(MGI:Nr3c1))	Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1.	SEN:10011830	11557972
BEL:20070500	tscript(p(MGI:Ppargc1a)) increases tscript(p(MGI:Nrf1))	PGC-1a has been shown to coactivate nuclear respiratory factor 1 (NRF-1), a critical regulator of nuclear and mitochondrial genes involved in respiratory function and mitochondrial DNA replication	SEN:10033812	15262994
BEL:20070504	tscript(p(MGI:Ppargc1a)) increases tscript(p(MGI:Ppara))	PGC-1a has also been shown to coactivate the nuclear receptor peroxisome proliferator-activated receptor a (PPARA), a transcriptional regulator of genes involved in cellular fatty acid utilization	SEN:10033814	15262994
BEL:20070518	tscript(p(MGI:Ppargc1b)) increases cat(p(MGI:Thrb))	Human PGC1beta-1a and -2a isoforms localized to the cell nucleus and, specifically, the isoform PGC1beta-1a co-activated peroxisome-proliferator-activated receptor-gamma, -alpha and the thyroid hormone receptor beta1.	SEN:10033816	12678921
BEL:20070520	tscript(p(MGI:Ppargc1b)) increases tscript(p(MGI:Ppara))	Cisplatin diminished the expression of PGC-1 mRNA levels in mouse kidney and also in LLCPK1 cells. Transient expression of PGC-1 shows the nuclear localization of PGC-1 protein and increased PPARalpha transcriptional activity in LLCPK1 cells.	SEN:10011838	12234291
BEL:20070522	tscript(p(MGI:Ppargc1b)) increases tscript(p(MGI:Ppara))	Human PGC1beta-1a and -2a isoforms localized to the cell nucleus and, specifically, the isoform PGC1beta-1a co-activated peroxisome-proliferator-activated receptor-gamma, -alpha and the thyroid hormone receptor beta1.	SEN:10033816	12678921
BEL:20070524	tscript(p(MGI:Ppargc1b)) increases tscript(p(MGI:Pparg))	Human PGC1beta-1a and -2a isoforms localized to the cell nucleus and, specifically, the isoform PGC1beta-1a co-activated peroxisome-proliferator-activated receptor-gamma, -alpha and the thyroid hormone receptor beta1.	SEN:10033816	12678921
BEL:20070526	tscript(p(MGI:Pparg)) decreases complex(p(MGI:Il12a),p(MGI:Il12b))	PPARgamma agonists inhibited EAE in association with a decrease in IL-12 production and differentiation of neural antigen-specific Th1 cells.	SEN:10033818	11960303
BEL:20070534	tscript(p(MGI:Pparg)) decreases p(MGI:Il1b)	However, plaque formation is also appreciated to be an inflammoratory response and it has been shown that activators of Pparg inhibit the production of inflammoratory cytokines such as TNFa, Il6 and Il1b.	SEN:10033822	11557774
BEL:20070536	tscript(p(MGI:Pparg)) decreases p(MGI:Il6)	However, plaque formation is also appreciated to be an inflammoratory response and it has been shown that activators of Pparg inhibit the production of inflammoratory cytokines such as TNFa, Il6 and Il1b.	SEN:10033822	11557774
BEL:20070546	tscript(p(MGI:Pparg)) increases p(MGI:Sirt1)	Treatment of 3T3-L1 adipocytes with the PPAR{gamma} ligand troglitazone significantly increases the amount of secreted HMW adiponectin and attenuates secretion of adipsin, whereas T0070907, a PPAR{gamma} antagonist, has the opposite effect (Fig. 3A and B). Interestingly, activation of PPAR{gamma} induces expression of SIRT1 (Fig. 3A), consistent with the fact that SIRT1 expression is enhanced during adipogenesis (26).	SEN:10016372	17452443
BEL:20070548	tscript(p(MGI:Pparg)) decreases p(MGI:Tnf)	However, plaque formation is also appreciated to be an inflammoratory response and it has been shown that activators of Pparg inhibit the production of inflammoratory cytokines such as TNFa, Il6 and Il1b.	SEN:10033822	11557774
BEL:20070550	tscript(p(MGI:Pparg)) increases r(MGI:Abca1)	Furthermore, it has been shown that activation of PPARg by the thiozolidinedione, rosiglitazaone, decreased scavenger receptor class A expresion.	SEN:10016262	11557774
BEL:20070552	tscript(p(MGI:Pparg)) increases r(MGI:Abca1)	PPARgamma activation also resulted in the up-regulation of ABCA1 expression, thereby stimulating cholesterol efflux	SEN:10033826	12021839
BEL:20070554	tscript(p(MGI:Pparg)) increases r(MGI:Abcg1)	activation of PPARgamma reduced cholesterol esterification, induced expression of ABCG1, and stimulated HDL-dependent cholesterol efflux in an LXR-independent manner	SEN:10033828	15578089
BEL:20070556	tscript(p(MGI:Pparg)) increases r(MGI:Adipoq)	Expression of adipocyte-secreted proteins, ACRP30 and resistin, which areare also regulated by Pparg and are implicated in fatty acid and glucose metabolism.	SEN:10033830	12705865
BEL:20070562	tscript(p(MGI:Pparg)) directlyIncreases r(MGI:Aqp7)	The gel mobility shift assay showed the direct binding of PPARgamma-retinoid Xreceptor alpha complex to the PPRE.	SEN:10020422	11679588
BEL:20070564	tscript(p(MGI:Pparg)) increases r(MGI:Aqp7)	The gel mobility shift assay showed the direct binding of PPARgamma-retinoid Xreceptor alpha complex to the PPRE.	SEN:10020422	11679588
BEL:20070566	tscript(p(MGI:Pparg)) directlyIncreases r(MGI:Aqp7)	We conclude that AQPap is a novel adipose-specific target gene of PPARgamma through the binding of PPARgamma-retinoid X receptor complex to the PPRE region in its promoter.	SEN:10011840	11679588
BEL:20070572	tscript(p(MGI:Pparg)) decreases r(MGI:Ccnd1)	Ciglitazone (1, 10, and 20 micromol/L) also inhibited cyclin D1 expression by 37 +/- 8%, 79 +/- 15%, and 87 +/- 12%, respectively (P < 0.001 to 0.001), and p21 expression	SEN:10033836	12787395
BEL:20070576	tscript(p(MGI:Pparg)) increases r(MGI:Cd36)	As expected, we found that rosiglitazone, a TZD, strongly promotes TR4-induced CD36 transactivation (Fig. 6C). Similar induction was also found when we replaced TR4 with PPARgamma/RXR (Fig. 6C).	SEN:10033840	19666541
BEL:20070580	tscript(p(MGI:Pparg)) decreases r(MGI:Cdkn1a)	Ciglitazone (1, 10, and 20 micromol/L) also inhibited cyclin D1 expression by 37 +/- 8%, 79 +/- 15%, and 87 +/- 12%, respectively (P < 0.001 to 0.001), and p21 expression	SEN:10033836	12787395
BEL:20070590	tscript(p(MGI:Pparg)) increases r(MGI:Cidec)	A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue of obese mice showed a 2.5 to 5 fold increase in the mRNA of fatty acid transporter protein, lipoprotein lipase, fat specific gene 27, cytochrome C oxidase polypeptide VIB and Ras like Rap1b protein	SEN:10033848	11916924
BEL:20070592	tscript(p(MGI:Pparg)) increases r(MGI:Col1a1)	A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue and muscle cells of obese mice showed a 5 to 10 fold and 10 to 20 fold increase in the mRNA of alpha1 type 1 procollagen and PK-120 precursor protein.	SEN:10033850	11916924
BEL:20070594	tscript(p(MGI:Pparg)) increases r(MGI:Cox6b1)	A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue of obese mice showed a 2.5 to 5 fold increase in the mRNA of fatty acid transporter protein, lipoprotein lipase, fat specific gene 27, cytochrome C oxidase polypeptide VIB and Ras like Rap1b protein	SEN:10033848	11916924
BEL:20070598	tscript(p(MGI:Pparg)) increases r(MGI:Ctnnb1)	Beta-catenin itself was overexpressed in the majority of the tumors studied, as was the Wnt receptor Frizzled homolog 4 (Fzd4). In contrast, the levels of Wnt5a and Fzd9 were down-regulated in PyV/Vp PPARG tumors	SEN:10033854	15037548
BEL:20070600	tscript(p(MGI:Pparg)) increases r(MGI:Dbi)	Here we report that ACBP is a novel peroxisome proliferator-activated receptor (PPAR)gamma target gene	SEN:10011842	12015306
BEL:20070602	tscript(p(MGI:Pparg)) increases r(MGI:Ero1l)	Suppression of SIRT1 or activation of PPAR gamma enhances Ero1-L alpha expression and stimulates secretion of high-molecular-weight complexes of adiponectin in mature adipocytes.	SEN:10010108	17452443
BEL:20070604	tscript(p(MGI:Pparg)) directlyIncreases r(MGI:Fabp4)	genes that are positively regulated by PPARgamma, such as adipocyte lipid-binding protein 2 (aP2) or lipoprotein lipase-(LPL). PPARgamma mRNA levels were also downregulated by tumor necrosis factor alpha (TNFalpha)	SEN:10031538	11172472
BEL:20070606	tscript(p(MGI:Pparg)) increases r(MGI:Fas)	Furthermore, the PPARgamma2-regulated induction of both SREBP-1 and FAS parallels an increase in de novo triacylglycerol synthesis in hepatocytes.	SEN:10011844	15644454
BEL:20070608	tscript(p(MGI:Pparg)) increases r(MGI:Fasn)	Pparg, which is activated by 15-deoxy-D12,14-prostaglandin J2 and the thiazolidione class of insulin-sensitizing drugs,...Among its known target genes are adipocyte factty-acid binidng protein and fatty acid synthase, which are efeeectors of lipid accumulaiton during adipogeesis.	SEN:10016418	11557774
BEL:20070610	tscript(p(MGI:Pparg)) increases r(MGI:Flg)	treatment of hairless mice with ciglitazone or troglitazone increases loricrin, involucrin, and filaggrin expression	SEN:10033856	15245430
BEL:20070612	tscript(p(MGI:Pparg)) decreases r(MGI:Fos)	Ciglitazone (1 to 20 micromol/L) did not affect extracellular signal-regulated protein kinase (ERK) activation but inhibited the activation of serum response element (SRE) by 85 +/- 6% (P < 0.01). This effect was associated with a reduction in c-fos expression (80 +/- 9%, P < 0.01).	SEN:10033858	12787395
BEL:20070614	tscript(p(MGI:Pparg)) increases r(MGI:Fosl1)	A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue and muscle cells of obese mice showed a 2.5 to 10 fold increase in the mRNA of fos-related antigen 1 fos-related antigen 1 = Fosl1	SEN:10033860	11916924
BEL:20070616	tscript(p(MGI:Pparg)) increases r(MGI:Fzd4)	Beta-catenin itself was overexpressed in the majority of the tumors studied, as was the Wnt receptor Frizzled homolog 4 (Fzd4). In contrast, the levels of Wnt5a and Fzd9 were down-regulated in PyV/Vp PPARG tumors	SEN:10033854	15037548
BEL:20070618	tscript(p(MGI:Pparg)) decreases r(MGI:Fzd9)	Beta-catenin itself was overexpressed in the majority of the tumors studied, as was the Wnt receptor Frizzled homolog 4 (Fzd4). In contrast, the levels of Wnt5a and Fzd9 were down-regulated in PyV/Vp PPARG tumors	SEN:10033854	15037548
BEL:20070634	tscript(p(MGI:Pparg)) increases r(MGI:Itih4)	A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue and muscle cells of obese mice showed a 5 to 10 fold and 10 to 20 fold increase in the mRNA of alpha1 type 1 procollagen and PK-120 precursor protein.	SEN:10033850	11916924
BEL:20070636	tscript(p(MGI:Pparg)) increases r(MGI:Ivl)	treatment of hairless mice with ciglitazone or troglitazone increases loricrin, involucrin, and filaggrin expression	SEN:10033856	15245430
BEL:20070640	tscript(p(MGI:Pparg)) increases r(MGI:Lor)	treatment of hairless mice with ciglitazone or troglitazone increases loricrin, involucrin, and filaggrin expression	SEN:10033856	15245430
BEL:20070644	tscript(p(MGI:Pparg)) directlyIncreases r(MGI:Lpl)	genes that are positively regulated by PPARgamma, such as adipocyte lipid-binding protein 2 (aP2) or lipoprotein lipase-(LPL). PPARgamma mRNA levels were also downregulated by tumor necrosis factor alpha (TNFalpha)	SEN:10031538	11172472
BEL:20070646	tscript(p(MGI:Pparg)) increases r(MGI:Lpl)	A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue of obese mice showed a 2.5 to 5 fold increase in the mRNA of fatty acid transporter protein, lipoprotein lipase, fat specific gene 27, cytochrome C oxidase polypeptide VIB and Ras like Rap1b protein	SEN:10033848	11916924
BEL:20070664	tscript(p(MGI:Pparg)) decreases r(MGI:Msr1)	Furthermore, it has been shown that activation of PPARg by the thiozolidinedione, rosiglitazaone, decreased scavenger receptor class A expresion.	SEN:10016262	11557774
BEL:20070670	tscript(p(MGI:Pparg)) increases r(MGI:Nr1h3)	in addition, the Lxra gene is induced by Pparg and Ppara that may in turn be activated by the newly synthesized unsaturated fatty acids	SEN:10033746	11792716
BEL:20070672	tscript(p(MGI:Pparg)) increases r(MGI:Nr1h3)	Pparg mediated upregulation of the reverse cholesterol transporter ABCA1 expression, probably through the enhanced expression of the nuclear receptor LXR.	SEN:10033872	12088279
BEL:20070676	tscript(p(MGI:Pparg)) increases r(MGI:Paqr7)	To focus attention on the uncharacterized genes in the up-regulated category, we cloned the full-length cDNAs of two novel candidates, which we designated as promethin and PGLP.	SEN:10011856	15589683
BEL:20070686	tscript(p(MGI:Pparg)) directlyIncreases r(MGI:Ptgs2)	Experiments investigating endogenous and overexpressed PPARalpha and PPARgamma activation of COX-2 mRNA and protein	SEN:10011814	11840453
BEL:20070688	tscript(p(MGI:Pparg)) increases r(MGI:Rab1b)	A comparison between rosiglitazone, a PPARgamma agonist treated and untreated white adipose tissue of obese mice showed a 2.5 to 5 fold increase in the mRNA of fatty acid transporter protein, lipoprotein lipase, fat specific gene 27, cytochrome C oxidase polypeptide VIB and Ras like Rap1b protein	SEN:10033848	11916924
BEL:20070690	tscript(p(MGI:Pparg)) increases r(MGI:Rara)	PPAR gamma, in the presence of RXR, formed a strong complex with a retinoic acid response element (beta retinoic acid response element) in the RAR beta promoter.	SEN:10030460	12839938
BEL:20070692	tscript(p(MGI:Pparg)) increases r(MGI:Rarb)	PPAR gamma, in the presence of RXR, formed a strong complex with a retinoic acid response element (beta retinoic acid response element) in the RAR beta promoter.	SEN:10030460	12839938
BEL:20070694	tscript(p(MGI:Pparg)) increases r(MGI:Retn)	The antidiabetic thiazolidinedione (TZD) drug rosiglitazone reduced resistin expression with an ED(50) similar to its K(d) for binding to peroxisome proliferator activated receptor gamma (PPARgamma)	SEN:10003984	11901161
BEL:20070696	tscript(p(MGI:Pparg)) increases r(MGI:Retn)	Expression of adipocyte-secreted proteins, ACRP30 and resistin, which areare also regulated by Pparg and are implicated in fatty acid and glucose metabolism.	SEN:10033830	12705865
BEL:20070698	tscript(p(MGI:Pparg)) increases r(MGI:Scarb1)	These studies started with the observation that Pparg up-regulates CD36 (savenger receptor calss-B) expression in macrophages.	SEN:10033878	11557774
BEL:20070702	tscript(p(MGI:Pparg)) decreases r(MGI:Sftpb)	In this report, the functional role of the neutral lipid metabolites, 15-deoxy-D12,14prostaglandin J2 and 9-hydroxyoctadecanoic acids, and peroxisome proliferator-activated receptor gamma (PPARg) was evaluated in surfactant protein B (SP-B) gene regulation. These reagents down-regulated SP-B gene expression in respiratory epithelial cells at the transcriptional level in both cell line and whole lung explant systems.	SEN:10033882	12829715
BEL:20070710	tscript(p(MGI:Pparg)) increases r(MGI:Srebf1)	Furthermore, the PPARgamma2-regulated induction of both SREBP-1 and FAS parallels an increase in de novo triacylglycerol synthesis in hepatocytes.	SEN:10011844	15644454
BEL:20070712	tscript(p(MGI:Pparg)) increases r(MGI:Tmem159)	To focus attention on the uncharacterized genes in the up-regulated category, we cloned the full-length cDNAs of two novel candidates, which we designated as promethin and PGLP.	SEN:10011856	15589683
BEL:20070718	tscript(p(MGI:Pparg)) increases r(MGI:Ucp1)	we measured peroxisome proliferator-activated receptor (PPAR)-gamma mRNA and protein in BAT, because PPAR-gamma agonist can elevate UCPs mRNA levels in BAT.	SEN:10033890	12706490
BEL:20070720	tscript(p(MGI:Pparg)) increases r(MGI:Ucp1)	Peroxisome proliferator-activated receptor gamma (PPAR gamma) and PPAR gamma coactivator 1 alpha (PGC-1 alpha) activate mouse UCP1 gene transcription. We show here that human PGC-1 alpha induced the activation of the human UCP1 promoter by PPAR gamma	SEN:10011828	12807871
BEL:20070728	tscript(p(MGI:Pparg)) increases r(MGI:Ucp2)	we measured peroxisome proliferator-activated receptor (PPAR)-gamma mRNA and protein in BAT, because PPAR-gamma agonist can elevate UCPs mRNA levels in BAT.	SEN:10033890	12706490
BEL:20070730	tscript(p(MGI:Pparg)) increases r(MGI:Ucp3)	we measured peroxisome proliferator-activated receptor (PPAR)-gamma mRNA and protein in BAT, because PPAR-gamma agonist can elevate UCPs mRNA levels in BAT.	SEN:10033890	12706490
BEL:20070732	tscript(p(MGI:Pparg)) decreases r(MGI:Wnt5a)	Beta-catenin itself was overexpressed in the majority of the tumors studied, as was the Wnt receptor Frizzled homolog 4 (Fzd4). In contrast, the levels of Wnt5a and Fzd9 were down-regulated in PyV/Vp PPARG tumors	SEN:10033854	15037548
BEL:20070734	tscript(p(MGI:Pparg)) increases sec(p(MGI:Adipoq))	Suppression of SIRT1 or activation of PPAR gamma enhances Ero1-L alpha expression and stimulates secretion of high-molecular-weight complexes of adiponectin in mature adipocytes.	SEN:10010108	17452443
BEL:20070736	tscript(p(MGI:Pparg)) increases sec(p(MGI:Adipoq))	Treatment of 3T3-L1 adipocytes with the PPAR{gamma} ligand troglitazone significantly increases the amount of secreted HMW adiponectin and attenuates secretion of adipsin, whereas T0070907, a PPAR{gamma} antagonist, has the opposite effect (Fig. 3A and B). Interestingly, activation of PPAR{gamma} induces expression of SIRT1 (Fig. 3A), consistent with the fact that SIRT1 expression is enhanced during adipogenesis (26).	SEN:10016372	17452443
BEL:20070740	tscript(p(MGI:Pparg)) increases tscript(p(MGI:Rel))	PPARgamma agonists activated NF-kappaB (p50, Rel A, c-Rel) binding to the upstream kappaB regulatory element site of c-myc. Only doses of agonists that induced apoptosis stimulated NF-kappaB-DNA binding.	SEN:10033896	12471115
BEL:20070742	tscript(p(MGI:Pparg)) increases tscript(p(MGI:Rela))	PPARgamma agonists activated NF-kappaB (p50, Rel A, c-Rel) binding to the upstream kappaB regulatory element site of c-myc. Only doses of agonists that induced apoptosis stimulated NF-kappaB-DNA binding.	SEN:10033896	12471115
BEL:20070750	tscript(p(MGI:Prox1)) increases r(MGI:Pdpn)	Within the vascular system, the mucin-type transmembrane glycoprotein T1alpha/podoplanin is predominantly expressed by lymphatic endothelium, and recent studies have shown that it is regulated by the lymphatic-specific homeobox gene Prox1.	SEN:10011862	12853470
BEL:20070752	tscript(p(MGI:Prrx1)) increases bp(GOBP:"cell migration")	Paired-related homeobox 1 (Prx1) encodes a homeobox transcription factor that induces TN-C by interacting with a binding site within the TN-C promoter, and it also promotes fibroblast migration.	SEN:10011864	12741393
BEL:20070754	tscript(p(MGI:Prrx1)) directlyIncreases r(MGI:Tnc)	Paired-related homeobox 1 (Prx1) encodes a homeobox transcription factor that induces TN-C by interacting with a binding site within the TN-C promoter, and it also promotes fibroblast migration.	SEN:10011864	12741393
BEL:20070772	tscript(p(MGI:Rb1)) increases phos(p(MGI:Alpl))	Following confluence, BMP-2was added tomedium at 200 ng/mL for 2-3 weeks, causing a 6-fold induction of ALP activity in wild-type MEFs. In RB/ MEFs, we observed a reduction in both basal and BMP-2-induced ALP activity as compared to that in wild-type MEFs, although BMP-2 still stimulated activity 3-fold in these cells (Figure 2A).	SEN:10025486	11545733
BEL:20070774	tscript(p(MGI:Rb1)) increases r(EGID:12096)	Consistent with a requirement for pRb in osteocalcin expression, weobserved using RT-PCR that osteocalcin mRNA was induced by BMP-2 in wild-type but not RB/ MEFs (Figure 2C, inset).	SEN:10025492	11545733
BEL:20070776	tscript(p(MGI:Rb1)) increases r(MGI:Bglap2)	Consistent with a requirement for pRb in osteocalcin expression, weobserved using RT-PCR that osteocalcin mRNA was induced by BMP-2 in wild-type but not RB/ MEFs (Figure 2C, inset).	SEN:10025492	11545733
BEL:20070780	tscript(p(MGI:Rb1)) decreases r(MGI:Ranbp1)	in addition, both pRb and its relative p107 inhibited transcription from the Htf9-a promoter. These results link the control of Htf9-a/RanBP-1 expression to the cell cycle progression.	SEN:10009984	8845298
BEL:20070782	tscript(p(MGI:Rb1)) increases sec(p(EGID:12096))	blastic differentiation induced by BMP-2. In contrast, secretion of the late marker osteocalcin was undetect( able in RB/ MEFs, while clearly induced in wild-type MEFs as well as in p107/ and p130/ MEFs (Figure 2C).	SEN:10025514	11545733
BEL:20070784	tscript(p(MGI:Rb1)) increases sec(p(MGI:Bglap2))	blastic differentiation induced by BMP-2. In contrast, secretion of the late marker osteocalcin was undetect( able in RB/ MEFs, while clearly induced in wild-type MEFs as well as in p107/ and p130/ MEFs (Figure 2C).	SEN:10025514	11545733
BEL:20070790	tscript(p(MGI:Rbl1)) decreases phos(p(MGI:Alpl))	Loss of either p107 or p130 resulted in a consistently greater increase in ALP due to BMP-2 than was observed in wild-type cells. Furthermore, CBFA1 mRNA levels were increased by BMP-2 treatment in both wild-type and RB/ MEFs	SEN:10025508	11545733
BEL:20070794	tscript(p(MGI:Rbl2)) decreases phos(p(MGI:Alpl))	Loss of either p107 or p130 resulted in a consistently greater increase in ALP due to BMP-2 than was observed in wild-type cells. Furthermore, CBFA1 mRNA levels were increased by BMP-2 treatment in both wild-type and RB/ MEFs	SEN:10025508	11545733
BEL:20070796	tscript(p(MGI:Rbp2)) directlyIncreases r(MGI:Igf2)	Figure 4. Rbp2 is required for the repression of PRC2 target genes. Importantly, ChIP experiments performed in the same cells showed that inhibition of Rbp2 expression also correlates with decreased binding of Rbp2 to its target promoters	SEN:10033910	18483221
BEL:20070798	tscript(p(MGI:Rbp2)) directlyIncreases r(MGI:Irx3)	Figure 4. Rbp2 is required for the repression of PRC2 target genes. Importantly, ChIP experiments performed in the same cells showed that inhibition of Rbp2 expression also correlates with decreased binding of Rbp2 to its target promoters	SEN:10033910	18483221
BEL:20070800	tscript(p(MGI:Rbp2)) directlyIncreases r(MGI:Wnt5a)	Figure 4. Rbp2 is required for the repression of PRC2 target genes. Importantly, ChIP experiments performed in the same cells showed that inhibition of Rbp2 expression also correlates with decreased binding of Rbp2 to its target promoters	SEN:10033910	18483221
BEL:20070804	tscript(p(MGI:Rbpj)) directlyIncreases p(MGI:Hey2)	NICD activates the HERP1 promoter in an RBP-J kappa-dependent manner, and induces expression of endogenous HERP1 mRNA as well as HERP1 protein in A10 cells.	SEN:10033912	11741889
BEL:20070808	tscript(p(MGI:Rbpj)) directlyIncreases r(MGI:Hes1)	Notch signaling is involved in many cell fate determination events in metazoans. Ligand binding results in proteolytic cleavage to release the signal-transducing Notch intracellular domain (NICD). The nuclear protein RBP-J kappa, when complexed with NICD, acts as a transcriptional activator which, in turn, induces a target gene of Notch such as the repressors HES/E(spl) and HERP2.	SEN:10032022	11741889
BEL:20070810	tscript(p(MGI:Rbpj)) increases r(MGI:Hes5)	RBP-Jkappa binding to its target sequence is important not only for Notch signaling, but also for BMP2 signaling, to activate the Hes-5 gene promoter	SEN:10008132	14500836
BEL:20070814	tscript(p(MGI:Rbpj)) directlyIncreases r(MGI:Hey1)	Notch signaling is involved in many cell fate determination events in metazoans. Ligand binding results in proteolytic cleavage to release the signal-transducing Notch intracellular domain (NICD). The nuclear protein RBP-J kappa, when complexed with NICD, acts as a transcriptional activator which, in turn, induces a target gene of Notch such as the repressors HES/E(spl) and HERP2.	SEN:10032022	11741889
BEL:20070818	tscript(p(MGI:Rbpj)) directlyIncreases r(MGI:Hey2)	NICD activates the HERP1 promoter in an RBP-J kappa-dependent manner, and induces expression of endogenous HERP1 mRNA as well as HERP1 protein in A10 cells.	SEN:10033912	11741889
BEL:20070830	tscript(p(MGI:Rela)) decreases bp(GOBP:"cell proliferation")	Mice lacking colonic RelA were sensitive to dextran sodium sulfate-induced colitis. Although experimental colitis enhanced proliferation in cells lacking RelA, sustained epithelial cell apoptosis precluded mucosal healing and decreased animal survival.	SEN:10033918	18250470
BEL:20070832	tscript(p(MGI:Rela)) decreases bp(GOBP:"apoptotic process")	Mice lacking colonic RelA were sensitive to dextran sodium sulfate-induced colitis. Although experimental colitis enhanced proliferation in cells lacking RelA, sustained epithelial cell apoptosis precluded mucosal healing and decreased animal survival.	SEN:10033918	18250470
BEL:20070836	tscript(p(MGI:Rela)) decreases path(MESHD:Colitis)	Mice lacking colonic RelA were sensitive to dextran sodium sulfate-induced colitis. Although experimental colitis enhanced proliferation in cells lacking RelA, sustained epithelial cell apoptosis precluded mucosal healing and decreased animal survival.	SEN:10033918	18250470
BEL:20070838	tscript(p(MGI:Rela)) increases p(MGI:Nfkbia)	IkappaBalpha and IkappaBbeta were significantly diminished in RelA-null epithelia, and endotoxin challenge revealed elevated p50 and c-Rel DNA binding activity as compared with controls.	SEN:10011878	18250470
BEL:20070840	tscript(p(MGI:Rela)) increases p(MGI:Nfkbib)	IkappaBalpha and IkappaBbeta were significantly diminished in RelA-null epithelia, and endotoxin challenge revealed elevated p50 and c-Rel DNA binding activity as compared with controls.	SEN:10011878	18250470
BEL:20070844	tscript(p(MGI:Rela)) increases r(MGI:Bcl2l1)	Antiapoptotic Bcl-xL expression was significantly decreased in isolated RelA-null colonocytes (Fig. 4E). Other NF-{kappa}B-target genes such as XIAP, cellular inhibitor of apoptosis 2, Casp8 and FADD-like apoptosis regulator (CFLAR, also called cFLIP), and survivin were not affected. We also found a notable decrease of IL-11 and IL-18 expression in isolated colonocytes of IEC-RelA?/? mice.	SEN:10033920	18250470
BEL:20070846	tscript(p(MGI:Rela)) increases r(MGI:Il11)	Antiapoptotic Bcl-xL expression was significantly decreased in isolated RelA-null colonocytes (Fig. 4E). Other NF-{kappa}B-target genes such as XIAP, cellular inhibitor of apoptosis 2, Casp8 and FADD-like apoptosis regulator (CFLAR, also called cFLIP), and survivin were not affected. We also found a notable decrease of IL-11 and IL-18 expression in isolated colonocytes of IEC-RelA?/? mice.	SEN:10033920	18250470
BEL:20070848	tscript(p(MGI:Rela)) increases r(MGI:Il18)	Antiapoptotic Bcl-xL expression was significantly decreased in isolated RelA-null colonocytes (Fig. 4E). Other NF-{kappa}B-target genes such as XIAP, cellular inhibitor of apoptosis 2, Casp8 and FADD-like apoptosis regulator (CFLAR, also called cFLIP), and survivin were not affected. We also found a notable decrease of IL-11 and IL-18 expression in isolated colonocytes of IEC-RelA?/? mice.	SEN:10033920	18250470
BEL:20070850	tscript(p(MGI:Rela)) directlyIncreases r(MGI:Il23a)	Functionally, IRF-1 is a negative regulator of Il23a in LPS-stimulated BMMs. IRF-1(-/-) BMMs demonstrated enhanced LPS-induced Il23a expression compared with WT BMMs. Moreover, IRF-1 deficiency resulted in prolonged occupancy of RelA on the Il23a promoter.	SEN:10033186	21097874
BEL:20070852	tscript(p(MGI:Rela)) decreases r(MGI:Nod2)	Of note, a significant elevation in NOD2 expression was found in ceca of IEC-RelA–/– mice, and TLR4 and TLR9 levels trended upward (p = 0.07).	SEN:10033922	18250470
BEL:20070862	tscript(p(MGI:Relb)) increases r(MGI:Birc5)	MnSOD and Survivin are RelB targets in WEHI 231 cells. Knockdown of RelB caused a decrease in MnSod and Survivin gene and protein expression levels.	SEN:10033924	17446175
BEL:20070864	tscript(p(MGI:Relb)) directlyIncreases r(MGI:Ccl19)	(from text): Both basal expression and induction of BLC, SDF-1, ELC and SLC mRNAs were defective in IkkalphaAA/AA (nonactivatable form) stromal cells. Similar defects in expression of these chemokines have been described in RelB-/- and Nfkb2-/- mice (Poljak et al, 1999; Weih et al, 2001)...(Figure 3 - legend): IKKalpha is required for recruitment of RelB to the Blc, Sdf-1, Elc and Slc promoters.	SEN:10033926	15470505
BEL:20070866	tscript(p(MGI:Relb)) directlyIncreases r(MGI:Ccl21a)	(from text): Both basal expression and induction of BLC, SDF-1, ELC and SLC mRNAs were defective in IkkalphaAA/AA (nonactivatable form) stromal cells. Similar defects in expression of these chemokines have been described in RelB-/- and Nfkb2-/- mice (Poljak et al, 1999; Weih et al, 2001)...(Figure 3 - legend): IKKalpha is required for recruitment of RelB to the Blc, Sdf-1, Elc and Slc promoters.	SEN:10033926	15470505
BEL:20070868	tscript(p(MGI:Relb)) directlyIncreases r(MGI:Cxcl12)	(from text): Both basal expression and induction of BLC, SDF-1, ELC and SLC mRNAs were defective in IkkalphaAA/AA (nonactivatable form) stromal cells. Similar defects in expression of these chemokines have been described in RelB-/- and Nfkb2-/- mice (Poljak et al, 1999; Weih et al, 2001)...(Figure 3 - legend): IKKalpha is required for recruitment of RelB to the Blc, Sdf-1, Elc and Slc promoters.	SEN:10033926	15470505
BEL:20070870	tscript(p(MGI:Relb)) directlyIncreases r(MGI:Cxcl13)	(from text): Both basal expression and induction of BLC, SDF-1, ELC and SLC mRNAs were defective in IkkalphaAA/AA (nonactivatable form) stromal cells. Similar defects in expression of these chemokines have been described in RelB-/- and Nfkb2-/- mice (Poljak et al, 1999; Weih et al, 2001)...(Figure 3 - legend): IKKalpha is required for recruitment of RelB to the Blc, Sdf-1, Elc and Slc promoters.	SEN:10033926	15470505
BEL:20070872	tscript(p(MGI:Relb)) increases r(MGI:Sod2)	MnSOD and Survivin are RelB targets in WEHI 231 cells. Knockdown of RelB caused a decrease in MnSod and Survivin gene and protein expression levels.	SEN:10033924	17446175
BEL:20070882	tscript(p(MGI:Rorc)) decreases bp(GOBP:"cell proliferation")	Our studies indicate that loss of RORgamma disturbs homeostasis in the thymus by enhancing apoptosis and cellular proliferation.	SEN:10011888	11830550
BEL:20070886	tscript(p(MGI:Rorc)) decreases bp(GOBP:"apoptotic process")	Our studies indicate that loss of RORgamma disturbs homeostasis in the thymus by enhancing apoptosis and cellular proliferation.	SEN:10011888	11830550
BEL:20070892	tscript(p(MGI:Rorc)) increases p(MGI:Il17a)	Both mouse and human Foxp3 blocked RORgammat-directed IL-17 expression, but full suppression required the presence of the exon 2-encoded sequence in Foxp3, suggesting that the interaction between Foxp3 and RORgammat is essential (Fig. 3c and Supplementary Fig. 5).	SEN:10027066	18368049
BEL:20070894	tscript(p(MGI:Rorc)) increases r(MGI:Bcl2l1)	As in ROR{gamma}-/- thymocytes, expression of Bcl-XL mRNA was barely detectable in ROR{gamma}-/- lymphoblastic cells (Fig. 6)	SEN:10033934	11830550
BEL:20070896	tscript(p(MGI:Rorc)) directlyIncreases r(MGI:Il17a)	Then, IL-17A promoter activity was examined with or without an ROR{gamma}t expression vector in the HEK 293T cells in which ROR{gamma}t was not expressed. In the presence of ROR{gamma}t, the promoter activity was significantly increased (Fig. 2A).	SEN:10033936	18434325
BEL:20070932	tscript(p(MGI:Runx2)) increases bp(GOBP:"osteoblast differentiation")	SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation	SEN:10011092	16751105
BEL:20070938	tscript(p(MGI:Runx2)) increases r(MGI:Bglap2)	ATF4 increased the levels of Ocn mRNA and mOG2 promoter activity in Runx2-containing osteoblasts but not in non-osteoblastic cells that lack detectable Runx2 protein	SEN:10011094	16000305
BEL:20070956	tscript(p(MGI:Runx3)) directlyIncreases r(MGI:Ifng)	both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 (Il4) in T(H)1 cells.	SEN:10011898	17195845
BEL:20070958	tscript(p(MGI:Runx3)) directlyDecreases r(MGI:Il4)	both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 (Il4) in T(H)1 cells.	SEN:10011898	17195845
BEL:20070960	tscript(p(MGI:Rxra)) directlyIncreases r(MGI:Aqp7)	We conclude that AQPap is a novel adipose-specific target gene of PPARgamma through the binding of PPARgamma-retinoid X receptor complex to the PPRE region in its promoter.	SEN:10011840	11679588
BEL:20070966	tscript(p(MGI:Rxra)) increases r(MGI:Srebf1)	Coexpression of retinoid X receptor (RXR), a heterodimeric partner, and its ligand 9-cis-retinoic acid also synergistically activated the SREBP-1c promoter	SEN:10033954	11287605
BEL:20070972	tscript(p(MGI:Sall4)) directlyIncreases r(MGI:Pou5f1)	Sall4 regulates transcription of Pou5f1 which encodes Oct4. Sall4 binds to the highly conserved regulatory region of the Pou5f1 distal enhancer and activates Pou5f1 expression in vivo and in vitro.	SEN:10011900	16980957
BEL:20070976	tscript(p(MGI:Satb2)) directlyIncreases r(MGI:Ighm)	We found that SATB2 can bind to MAR sequences of the endogenous immunoglobulin mu enhancer region and activate gene transcription.	SEN:10033960	14701874
BEL:20070980	tscript(p(MGI:Satb2)) directlyDecreases r(MGI:Hoxa2)	SATB2 was found to repress the expression of several Hox genes including Hoxa2, an inhibitor of bone formation	SEN:10033144	16751105
BEL:20070982	tscript(p(MGI:Satb2)) increases tscript(p(MGI:Atf4))	SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation	SEN:10011092	16751105
BEL:20070984	tscript(p(MGI:Satb2)) increases tscript(p(MGI:Runx2))	SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation	SEN:10011092	16751105
BEL:20070986	tscript(p(MGI:Sin3a)) directlyDecreases r(MGI:Map4)	Consistent with this finding, we report that p53 physically associates in vivo with HDACs. This interaction is not direct but, rather, is mediated by the corepressor mSin3a. Both wild-type p53 and mSin3a, but not mutant p53, can be found bound to the Map4 promoter at times when this promoter preferentially associates with deacetylated histones in vivo.	SEN:10033962	10521394
BEL:20070990	tscript(p(MGI:Sin3a)) directlyDecreases r(MGI:Stmn1)	Consistent with this finding, we report that p53 physically associates in vivo with HDACs. This interaction is not direct but, rather, is mediated by the corepressor mSin3a. Both wild-type p53 and mSin3a, but not mutant p53, can be found bound to the Map4 promoter at times when this promoter preferentially associates with deacetylated histones in vivo.	SEN:10033962	10521394
BEL:20071012	tscript(p(MGI:Smad1)) increases r(MGI:"Nkx2-5")	A similar BRE element is present within the BMP-responsive Nkx2-5 gene promoter (52, 55), suggesting that the Hex BRE represents a common response element for genes regulated by BMP signaling in the foregut region of the embryo.	SEN:10033974	12270938
BEL:20071016	tscript(p(MGI:Smad2)) decreases r(MGI:Fgfbp1)	Analysis of the downstream signaling pathways shows that Smad2/3 are crucial for efficient FGF-BP1 repression by TGF-beta.	SEN:10011906	16690027
BEL:20071018	tscript(p(MGI:Smad2)) increases r(MGI:Mmp2)	Moreover, TGF-beta1-mediated induction of matrix metalloproteinase-2 was selectively dependent on Smad2,	SEN:10011908	11262418
BEL:20071020	tscript(p(MGI:Smad3)) decreases bp(GOBP:"macrophage activation")	ex vivo studies of macro-phages derived from Smad3–/– mice demonstrated a more activated phenotype with enhanced induction of MCP-1 secretion in response to LPS. Importantly, while TGF-?1 inhibited LPS-stimulated MCP-1 production from Smad3+/+ mice, this TGF-?1 inhibition was completely blocked in macrophages from Smad3–/– mice.79	SEN:10031148	16462725
BEL:20071022	tscript(p(MGI:Smad3)) decreases path(MESHD:Hyperplasia)	we found that cardiac allografts transplanted into Smad3-deficient mice developed accelerated intimal hyperplasia with increased infiltration of macrophages that expressed MCP-1.79	SEN:10033976	16462725
BEL:20071032	tscript(p(MGI:Smad3)) increases r(MGI:Ccnd2)	Smad3 is an important mediator of the TGF beta signaling pathway Smad3-/- follicles have impaired growth, increased atresia, and altered differentiation in the presence of high FSH levels, normal expression of FSHR, and lower expression of cyclin D2	SEN:10031198	15192076
BEL:20071034	tscript(p(MGI:Smad3)) increases r(MGI:Col1a2)	COL1A2 promoter activity was dose dependently induced by TGF-beta1, which was further augmented by adenoviral overexpression of Smad3, but was downregulated by Smad7.	SEN:10010340	16126788
BEL:20071036	tscript(p(MGI:Smad3)) increases r(MGI:Csrp2)	We cotransfected –795Csrp2-luc with Smad3?C, a dominant negative Smad3 expression plasmid that lacks C-terminal phosphorylation and activation sites (30). In transient transfection assays, Smad3?C decreased Csrp2 promoter activity by 43% in the absence of TGF? (Fig. 9A). Furthermore, Smad3?C reduced TGF? induction from 350 to 139% (Fig. 9A).	SEN:10033978	18387947
BEL:20071038	tscript(p(MGI:Smad3)) decreases r(MGI:Fgfbp1)	Analysis of the downstream signaling pathways shows that Smad2/3 are crucial for efficient FGF-BP1 repression by TGF-beta.	SEN:10011906	16690027
BEL:20071040	tscript(p(MGI:Smad3)) directlyIncreases r(MGI:Il23a)	Chromosomal DNA immunoprecipitation assays revealed that SMAD-3 and ATF-2 bind to the endogenous p19 promoter in RAW264.7 cells and SJL/J SPM following challenge with TMEV.	SEN:10011082	18802055
BEL:20071044	tscript(p(MGI:Smad3)) directlyIncreases r(MGI:Tnfsf13b)	Overexpression of Smad3/4 enhanced the TGF-?1-induced BAFF mRNA expression, and overexpression of a DN-Smad3 abrogated BAFF transcription in a dose-dependent manner (Fig. 2A ).	SEN:10033980	18334541
BEL:20071048	tscript(p(MGI:Smad3)) decreases sec(p(MGI:Ccl2))	ex vivo studies of macro-phages derived from Smad3–/– mice demonstrated a more activated phenotype with enhanced induction of MCP-1 secretion in response to LPS. Importantly, while TGF-?1 inhibited LPS-stimulated MCP-1 production from Smad3+/+ mice, this TGF-?1 inhibition was completely blocked in macrophages from Smad3–/– mice.79	SEN:10031148	16462725
BEL:20071062	tscript(p(MGI:Smad4)) increases r(MGI:Il10)	TGF-?1 can induce IL-10 production (an anti-inflammatory cytokine) in T cells through a Smad4 dependent mechanism by Smad4 DNA-binding to the IL-10 promoter suggesting a unique role for Smad4 in regulating TGF-?1’s antiinflammatory effects in T cells.133	SEN:10031208	16462725
BEL:20071064	tscript(p(MGI:Smad4)) increases r(MGI:"Nkx2-5")	A similar BRE element is present within the BMP-responsive Nkx2-5 gene promoter (52, 55), suggesting that the Hex BRE represents a common response element for genes regulated by BMP signaling in the foregut region of the embryo.	SEN:10033974	12270938
BEL:20071066	tscript(p(MGI:Smad4)) increases r(MGI:Tnfsf13b)	Overexpression of Smad3/4 enhanced the TGF-?1-induced BAFF mRNA expression, and overexpression of a DN-Smad3 abrogated BAFF transcription in a dose-dependent manner (Fig. 2A ).	SEN:10033980	18334541
BEL:20071072	tscript(p(MGI:Smad7)) decreases r(MGI:Col1a2)	COL1A2 promoter activity was dose dependently induced by TGF-beta1, which was further augmented by adenoviral overexpression of Smad3, but was downregulated by Smad7.	SEN:10010340	16126788
BEL:20071076	tscript(p(MGI:Smarca2)) increases r(MGI:Pbsn)	AR stimulation on the probasin core promoter could be partially induced with BRG1, but BRM strongly stimulated AR activity	SEN:10032638	12775722
BEL:20071078	tscript(p(MGI:Smarca2)) increases tscript(p(MGI:Ar))	AR stimulation on the probasin core promoter could be partially induced with BRG1, but BRM strongly stimulated AR activity	SEN:10032638	12775722
BEL:20071082	tscript(p(MGI:Smarca4)) increases r(MGI:Pbsn)	AR stimulation on the probasin core promoter could be partially induced with BRG1, but BRM strongly stimulated AR activity	SEN:10032638	12775722
BEL:20071092	tscript(p(MGI:Sox10)) increases r(MGI:Mitf)	The transcription factors implicated to date in regulation of the Mitf promoter include Pax3, CREB, Sox10, and Lef1 (Fig. 2A), with each factor able to confer on the Mitf promoter the capacity to respond to specific signals.	SEN:10032802	10898786
BEL:20071094	tscript(p(MGI:Sox15)) decreases bp(GOBP:"skeletal muscle tissue development")	When overexpressed in C2C12 myoblasts, wild type SOX15, but not a C-terminal truncated form or the related protein SOX11, specifically inhibited activation of muscle-specific genes and expression of the basic helix-loop-helix myogenic factors myogenin and MyoD	SEN:10011918	10821863
BEL:20071098	tscript(p(MGI:Sox15)) decreases r(MGI:Myod1)	When overexpressed in C2C12 myoblasts, wild type SOX15, but not a C-terminal truncated form or the related protein SOX11, specifically inhibited activation of muscle-specific genes and expression of the basic helix-loop-helix myogenic factors myogenin and MyoD	SEN:10011918	10821863
BEL:20071102	tscript(p(MGI:Sox15)) decreases r(MGI:Myog)	When overexpressed in C2C12 myoblasts, wild type SOX15, but not a C-terminal truncated form or the related protein SOX11, specifically inhibited activation of muscle-specific genes and expression of the basic helix-loop-helix myogenic factors myogenin and MyoD	SEN:10011918	10821863
BEL:20071104	tscript(p(MGI:Sox1)) increases r(MGI:Cryab)	Gel shift assays showed that the Sox1 and Sox2 proteins preferentially bound to E2 and E4. Moreover, disruption of E2 and E4 abolished the reporter gene expression in the lens. These results indicate that the newly identified enhancer with Sox elements activates the alphaB-crystallin promoter in the lens,	SEN:10033986	15113840
BEL:20071108	tscript(p(MGI:Sox2)) increases bp(GOBP:"epithelial cell differentiation")	Sox2 is required for proliferation and differentiation of Clara cells that serve as the progenitor cells from which Clara, ciliated, and goblet cells are derived.	SEN:10003240	20011520
BEL:20071112	tscript(p(MGI:Sox2)) increases r(MGI:Cryab)	Gel shift assays showed that the Sox1 and Sox2 proteins preferentially bound to E2 and E4. Moreover, disruption of E2 and E4 abolished the reporter gene expression in the lens. These results indicate that the newly identified enhancer with Sox elements activates the alphaB-crystallin promoter in the lens,	SEN:10033986	15113840
BEL:20071144	tscript(p(MGI:Sp1)) increases p(MGI:Acta2)	Figure 5. R-Sp1 decoy ODN suppressed TGF-beta1, fibronectin and alpha-SMA expression at 4, 6 and 8 weeks after transfection. (A) Western blot shows the inhibition of TGF-beta1, fibronectin and alpha-SMA expression by R-Sp1 decoy ODN injection.	SEN:10034000	19554625
BEL:20071146	tscript(p(MGI:Sp1)) increases p(MGI:Fn1)	Figure 5. R-Sp1 decoy ODN suppressed TGF-beta1, fibronectin and alpha-SMA expression at 4, 6 and 8 weeks after transfection. (A) Western blot shows the inhibition of TGF-beta1, fibronectin and alpha-SMA expression by R-Sp1 decoy ODN injection.	SEN:10034000	19554625
BEL:20071148	tscript(p(MGI:Sp1)) increases p(MGI:Mmp13)	Figure 6. R-Sp1 decoy ODN suppressed MMP-13 and TIMP-1 expression. (A) Western blot shows the inhibition of MMP-13 and TIMP-1 expression by R-Sp1 decoy ODN injection. CCl4+ Scr: hepatic damage treated with scramble decoy ODN; CCl4+ Sp1: hepatic damage treated with R-Sp1 decoy ODN.	SEN:10034002	19554625
BEL:20071150	tscript(p(MGI:Sp1)) increases p(MGI:Tgfb1)	Figure 5. R-Sp1 decoy ODN suppressed TGF-beta1, fibronectin and alpha-SMA expression at 4, 6 and 8 weeks after transfection. (A) Western blot shows the inhibition of TGF-beta1, fibronectin and alpha-SMA expression by R-Sp1 decoy ODN injection.	SEN:10034000	19554625
BEL:20071152	tscript(p(MGI:Sp1)) increases p(MGI:Timp1)	Figure 6. R-Sp1 decoy ODN suppressed MMP-13 and TIMP-1 expression. (A) Western blot shows the inhibition of MMP-13 and TIMP-1 expression by R-Sp1 decoy ODN injection. CCl4+ Scr: hepatic damage treated with scramble decoy ODN; CCl4+ Sp1: hepatic damage treated with R-Sp1 decoy ODN.	SEN:10034002	19554625
BEL:20071160	tscript(p(MGI:Sp1)) directlyIncreases r(MGI:Abcc6)	We also demonstrated that the proximal region is a TATA-less promoter requiring an intact CCAAT-box and Sp1 binding for its basal activity.	SEN:10034004	16997394
BEL:20071178	tscript(p(MGI:Sp1)) directlyIncreases r(MGI:Col3a1)	These data indicate that sequences from -96 to +16bp of the Col3a1 promoter play an important role in the upregulated expression of this gene in Tsk2/+ fibroblasts and that the promoter contains sequences which bind the trans-acting nuclear factors, Sp1(like) and NF-1(like).	SEN:10011934	12659831
BEL:20071186	tscript(p(MGI:Sp1)) directlyIncreases r(MGI:Dnm1)	Gel shift analysis demonstrated that in addition to Sp1, Sp3 could interact with this Sp1 element. The requirement for Sp family transcription factors in dynamin I gene expression was confirmed by using mithramycin, an inhibitor of Sp1/Sp3 binding. Mithramycin repressed dynamin I gene expression and resulted in blocking of neuronal differentiation of N1E-115 cells.	SEN:10011938	11809758
BEL:20071192	tscript(p(MGI:Sp1)) increases r(MGI:Flot1)	including the putative Sp1 transcription factor (Sp1) and zinc finger protein, subfamily 1a, 1 (Ikaros) (Lyf-1) binding sites led to only basal transcription.	SEN:10033172	14644419
BEL:20071208	tscript(p(MGI:Sp1)) directlyIncreases r(MGI:Mapk1)	Sp1-mediated transcription is one of the mechanisms, which is responsible for BMP2-induced up-regulation of Erk2 expression.	SEN:10008134	12220517
BEL:20071210	tscript(p(MGI:Sp1)) directlyIncreases r(MGI:Mat2a)	binding sites for c-Myb and Sp1 on Mat2a, promoter activity increased expression of c-Myb and Sp1 and binding to the Mat2a promoter contribute to transcriptional up-regulation of Mat2a	SEN:10033354	11427482
BEL:20071214	tscript(p(MGI:Sp1)) increases r(MGI:Mybl1)	Two Sp1 binding sites are present upstream from the CCAAT box which can bind Spl and contribute to A-myb promoter activity by 70 and 30%, respectively. The two Sp1 sites and CCAAT box together contribute to over 80% of A-myb basal promoter activity and are therefore the major regulatory elements.	SEN:10034024	10951586
BEL:20071222	tscript(p(MGI:Sp1)) increases r(MGI:Tyr)	A simple promoter such as that of the tyrosinase gene, comprising two E box motifs and an SP1 site, should in principle be active in all cell types, yet it is active specifically in melanocytes.	SEN:10034026	10898786
BEL:20071226	tscript(p(MGI:Sp1)) decreases r(MGI:Vegfa)	In vitro, IFN-alpha decreased transcription of VEGF gene expression through an Sp1- and/or Sp3-dependent inhibition of VEGF promoter activity.	SEN:10009052	12644537
BEL:20071230	tscript(p(MGI:Sp1)) increases tscript(p(MGI:Meox2))	Mutagenesis and protein-DNA binding assays suggested that at least three positive factors interact with this (GAX) fragment and are required for transcriptional activity. One of these factors, HRF-1, recognizes a cis element consisting of an inverted palindromic motif. A second factor is Sp1, that binds to a G/C- rich element. The third is the MADS box factor referred to as MEF2 or RSRF	SEN:10011516	7623821
BEL:20071242	tscript(p(MGI:Sp3)) directlyIncreases r(MGI:Dnm1)	Gel shift analysis demonstrated that in addition to Sp1, Sp3 could interact with this Sp1 element. The requirement for Sp family transcription factors in dynamin I gene expression was confirmed by using mithramycin, an inhibitor of Sp1/Sp3 binding. Mithramycin repressed dynamin I gene expression and resulted in blocking of neuronal differentiation of N1E-115 cells.	SEN:10011938	11809758
BEL:20071244	tscript(p(MGI:Sp3)) directlyIncreases r(MGI:Gabra4)	Both Sp3 and Sp4 transcription factors can interact with the two Sp1 binding sites within the minimal promoter and are critical for maximal activity of the promoter in neurons.	SEN:10011958	15265862
BEL:20071248	tscript(p(MGI:Sp3)) decreases r(MGI:Vegfa)	In vitro, IFN-alpha decreased transcription of VEGF gene expression through an Sp1- and/or Sp3-dependent inhibition of VEGF promoter activity.	SEN:10009052	12644537
BEL:20071250	tscript(p(MGI:Sp4)) directlyIncreases r(MGI:Gabra4)	Both Sp3 and Sp4 transcription factors can interact with the two Sp1 binding sites within the minimal promoter and are critical for maximal activity of the promoter in neurons.	SEN:10011958	15265862
BEL:20071262	tscript(p(MGI:Spi1)) increases phos(p(MGI:Ptprc))	retrovirus-mediated restoration of PU.1 expression to PU.1-deficient myeloid cells resulted in expression of cell surface CD45 and restored phosphatase activity, confirming the role of PU.1 in the positive regulation of this well known signaling molecule.	SEN:10034036	11114304
BEL:20071274	tscript(p(MGI:Spi1)) increases r(MGI:Epx)	MBP and EPX mRNAs were absent in a PU.1-null myeloid cell line established from the embryonic liver of PU.1(-/-) mice. Restitution of PU.1 protein expression restored MBP and EPX protein expression.	SEN:10011966	12515729
BEL:20071276	tscript(p(MGI:Spi1)) increases r(MGI:Fli1)	The -270/-41 fragment contains two known Spi-1-responding Ets binding sites (EBS), which are also necessary for the activation by Ets-1.	SEN:10011968	11991951
BEL:20071282	tscript(p(MGI:Spi1)) decreases r(MGI:"Hbb-b2")	After induction of MEL cell differentiation by treatment with dimethylsulfoxide (DMSO), expression of the PU.1/Spi-1 gene decreased before induction of beta-globin gene expression.	SEN:10034042	9028962
BEL:20071290	tscript(p(MGI:Spi1)) increases r(MGI:Ptprc)	Although CD45 is normally expressed in all leukocyte lineages, it is critically regulated by PU.1 only in myeloid cells. Whereas myeloid cells from PU.1 null mice failed to express CD45, lymphoid cells were CD45(+) by flow cytometry. Additionally, mRNA for CD45 was absent from PU.1-deficient myeloid cells.	SEN:10011972	11114304
BEL:20071312	tscript(p(MGI:Srebf1)) increases bp(GOBP:"lipid biosynthetic process")	Srebf1c ... imparts its selectivity towards activating genes involved in lipogenesis. Srebf2 ... is more restricted to regulating genes involved in cholesterol homeostasis... Srebf2 is absolutely required for the normal cholesterol homeostasis.	SEN:10034056	12440980
BEL:20071314	tscript(p(MGI:Srebf1)) increases bp(GOBP:"lipid biosynthetic process")	We have previously shown that sterol regulatory element-binding protein-1 (SREBP-1), a key transcriptional regulator of triglyceride synthesis, and the lipogenic enzymes under its control are markedly suppressed in adipocytes from genetically obese ob/ob mice.	SEN:10011974	12734185
BEL:20071324	tscript(p(MGI:Srebf1)) increases r(MGI:Acaca)	Our results demonstrate that the synergistic action of SREBP-1c and glucose metabolism via GK is necessary for the maximal induction of l-PK, ACC, FAS, and Spot 14 gene expression.	SEN:10034062	14985368
BEL:20071326	tscript(p(MGI:Srebf1)) increases r(MGI:Acly)	mRNA abundance of lipogenic enzymes, FAS, glycerol -3-phosphate acyltransferase, ATP citrate lyase, Spot14, was markedly reduced by SREBP1 deletion in Leptin deficient mice.	SEN:10034064	11923308
BEL:20071332	tscript(p(MGI:Srebf1)) increases r(MGI:Csad)	At least 10 additional genes involved in the detoxification of oxidized lipids (8 glutathione S-transferase family members; cysteine sulfinic acid decarboxylase; and M-LP, Mpv17-like protein) were also induced in TgSREBP-1a mouse livers	SEN:10034066	14512514
BEL:20071334	tscript(p(MGI:Srebf1)) increases r(MGI:Elovl6)	Srebflc preferentially activates the long-chain fatty acyl elongase, a microsomal enzyme that carries out the rate-limiting condensation reaction required for elongating palmitate to stearate, and stearoyl-CoA desaturatase-1.	SEN:10019048	12440980
BEL:20071338	tscript(p(MGI:Srebf1)) increases r(MGI:Fads1)	The delta 5 desaturase and delta 6 desaturase enzymes carry out the desaturation reactions both genes are transcriptionally activated by SREBP-1c isoforms.	SEN:10034070	12440980
BEL:20071342	tscript(p(MGI:Srebf1)) increases r(MGI:Fads2)	The delta 5 desaturase and delta 6 desaturase enzymes carry out the desaturation reactions both genes are transcriptionally activated by SREBP-1c isoforms.	SEN:10034070	12440980
BEL:20071344	tscript(p(MGI:Srebf1)) increases r(MGI:Fasn)	mRNA abundance of lipogenic enzymes, FAS, glycerol -3-phosphate acyltransferase, ATP citrate lyase, Spot14, was markedly reduced by SREBP1 deletion in Leptin deficient mice.	SEN:10034064	11923308
BEL:20071350	tscript(p(MGI:Srebf1)) increases r(MGI:Fasn)	Our results demonstrate that the synergistic action of SREBP-1c and glucose metabolism via GK is necessary for the maximal induction of l-PK, ACC, FAS, and Spot 14 gene expression.	SEN:10034062	14985368
BEL:20071356	tscript(p(MGI:Srebf1)) increases r(MGI:Gpam)	mRNA abundance of lipogenic enzymes, FAS, glycerol -3-phosphate acyltransferase, ATP citrate lyase, Spot14, was markedly reduced by SREBP1 deletion in Leptin deficient mice.	SEN:10034064	11923308
BEL:20071362	tscript(p(MGI:Srebf1)) directlyIncreases r(MGI:Ldlr)	Srebf1a expression had a dose-dependent increase in both LDL receptor and Star promoter activities	SEN:10034078	11145563
BEL:20071366	tscript(p(MGI:Srebf1)) increases r(MGI:Mpv17l)	At least 10 additional genes involved in the detoxification of oxidized lipids (8 glutathione S-transferase family members; cysteine sulfinic acid decarboxylase; and M-LP, Mpv17-like protein) were also induced in TgSREBP-1a mouse livers	SEN:10034066	14512514
BEL:20071370	tscript(p(MGI:Srebf1)) increases r(MGI:Pklr)	Our results demonstrate that the synergistic action of SREBP-1c and glucose metabolism via GK is necessary for the maximal induction of l-PK, ACC, FAS, and Spot 14 gene expression.	SEN:10034062	14985368
BEL:20071372	tscript(p(MGI:Srebf1)) increases r(MGI:Pparg)	This may occur in part through direct actions of SREBP1c on target promoters (including that of PPARg, and also indirectly by inducing the generation of a ligand for PPARg [21,22].	SEN:10034082	15936931
BEL:20071374	tscript(p(MGI:Srebf1)) increases r(MGI:Retn)	Furthermore, ectopic expression of ADD1/SREBP1c by adenovirus significantly increased the expression of resistin mRNA in adipocytes. Human resistin promoter was also activated by C/EBP alpha expression	SEN:10011140	12730330
BEL:20071380	tscript(p(MGI:Srebf1)) increases r(MGI:Scd1)	Srebflc preferentially activates the long-chain fatty acyl elongase, a microsomal enzyme that carries out the rate-limiting condensation reaction required for elongating palmitate to stearate, and stearoyl-CoA desaturatase-1.	SEN:10019048	12440980
BEL:20071390	tscript(p(MGI:Srebf1)) directlyIncreases r(MGI:Star)	Srebf1a expression had a dose-dependent increase in both LDL receptor and Star promoter activities	SEN:10034078	11145563
BEL:20071392	tscript(p(MGI:Srebf1)) increases r(MGI:Thrsp)	mRNA abundance of lipogenic enzymes, FAS, glycerol -3-phosphate acyltransferase, ATP citrate lyase, Spot14, was markedly reduced by SREBP1 deletion in Leptin deficient mice.	SEN:10034064	11923308
BEL:20071394	tscript(p(MGI:Srebf1)) increases r(MGI:Thrsp)	Our results demonstrate that the synergistic action of SREBP-1c and glucose metabolism via GK is necessary for the maximal induction of l-PK, ACC, FAS, and Spot 14 gene expression.	SEN:10034062	14985368
BEL:20071396	tscript(p(MGI:Srebf2)) increases a(CHEBI:lecithin)	induction of either Srebp resulted in increased expression of mRNAs for sterol-regulated genes, elevated fatty acid and cholesterol synthesis and increased phosphatidylcholine synthesis	SEN:10034092	12659631
BEL:20071422	tscript(p(MGI:Srebf2)) directlyIncreases r(MGI:Ldlr)	Srebf2 was relatively ineffective in stimulating Star promoter activity compared with Srebf1a Srebf1a and Srebf2 both stimulated LDL receptor promoter activity to a similar extent	SEN:10034106	11145563
BEL:20071426	tscript(p(MGI:Srebf2)) increases r(MGI:Pcyt1a)	CCTalpha mRNA was increased 2-fold by enforced expression of Srebp1a or Srebp2 stimulation of phosphatidylcholine synthesis by Srebps in cells is due primarily to increased fatty acid synthesis	SEN:10034108	12659631
BEL:20071452	tscript(p(MGI:Srf)) increases r(MGI:Myh11)	Using a serum response factor (SRF) antibody, we demonstrate that SRF is part of the protein complex. In addition, we show that cotransfection with the SRF dominant-negative mutant expression vector abolishes SMHC promoter activity, suggesting that SRF protein plays a critical role in SMHC gene regulation.	SEN:10011992	9529161
BEL:20071454	tscript(p(MGI:Srf)) increases r(MGI:Srf)	Regulation of actin dynamics is necessary for serum induction of a subset of SRF target genes, including vinculin, cytoskeletal actin, and srf itself, and also suffices for their activation.	SEN:10011994	10428028
BEL:20071456	tscript(p(MGI:Srf)) increases r(MGI:Vcl)	Regulation of actin dynamics is necessary for serum induction of a subset of SRF target genes, including vinculin, cytoskeletal actin, and srf itself, and also suffices for their activation.	SEN:10011994	10428028
BEL:20071466	tscript(p(MGI:Stat1)) increases bp(GOBP:"megakaryocyte differentiation")	enforced STAT1 expression promoted several features of megakaryocytic differentiation of G1ME cells, as evidenced by increased cell size (forward scatter) and increased DNA content, reflecting polyploidization (Figure ?(Figure1,1, A and B). Similar effects were produced by enforced expression of IRF-1, a major STAT1 effector (reviewed in ref. 26).	SEN:10034122	18060035
BEL:20071478	tscript(p(MGI:Stat1)) increases p(MGI:Socs1)	IFN-gamma-induced inhibition of STAT6 phosphorylation and eotaxin production were mediated by SOCS-1 induced in STAT1-dependent manner.	SEN:10002780	14733929
BEL:20071486	tscript(p(MGI:Stat1)) increases r(MGI:Gp1ba)	In addition, STAT1 or IRF-1 induced the expression of CD42, a late marker of megakaryocyte maturation, albeit to a much lesser extent than GATA-1 (Figure ?(Figure1C).1C).	SEN:10033182	18060035
BEL:20071488	tscript(p(MGI:Stat1)) directlyIncreases r(MGI:Hmox1)	Electromobility shift assays show increased STAT1, STAT3, STAT5, and AP-1 DNA binding activity in RAW 264.7 cells after hyperoxia. Taken together, our data suggest that the 5' distal enhancer elements of the HO-1 gene in concert with the promoter regulate HO-1 gene induction and highlight the complexity of HO-1 gene transcription in response to hyperoxia.	SEN:10011998	10893216
BEL:20071490	tscript(p(MGI:Stat1)) directlyIncreases r(MGI:Irf1)	Moreover, GATA-1 transactivated the Stat1 promoter in luciferase reporter assays (Supplemental Figure 1). STAT1 and IRF-1 reciprocally activated each other’s transcription, as previously reported (Figure ?(Figure1D1D and Supplemental Table 1; also reviewed in ref. 26).	SEN:10033056	18060035
BEL:20071492	tscript(p(MGI:Stat1)) increases r(MGI:Nos2)	In this current study, using a system of LPS-treated RAW264.7 macrophages, we go on to demonstrate that OPN increases STAT1 ubiquitination and subsequent 26s proteasome-mediated degradation to inhibit STAT1 dependent iNOS promoter activity, transcription, and protein expression.	SEN:10005138	17237438
BEL:20071498	tscript(p(MGI:Stat1)) increases tscript(p(MGI:Irf1))	enforced STAT1 expression promoted several features of megakaryocytic differentiation of G1ME cells, as evidenced by increased cell size (forward scatter) and increased DNA content, reflecting polyploidization (Figure ?(Figure1,1, A and B). Similar effects were produced by enforced expression of IRF-1, a major STAT1 effector (reviewed in ref. 26).	SEN:10034122	18060035
BEL:20071504	tscript(p(MGI:Stat3)) increases bp(GOBP:angiogenesis)	Results show that GQ-ODN T40214 and T40231 significantly suppress the growth of NSCLC tumors in nude mice by selectively inhibiting the activation of Stat3 and its downstream proteins Bcl-2, Bcl-xL, Mcl-1, survivin, VEGF, Cyclin D1 and c-myc; thereby, promoting apoptosis and reducing angiogenesis and cell proliferation.	SEN:10034128	17549413
BEL:20071508	tscript(p(MGI:Stat3)) increases bp(GOBP:"cell proliferation")	These data indicate that MEN2A-RET enhances proliferation via STAT3, and that a full length STAT3 is required to mediate the MEN2A-RET induced proliferation.	SEN:10022126	11536047
BEL:20071514	tscript(p(MGI:Stat3)) increases bp(GOBP:"macrophage differentiation")	Although STAT3 is essential for IL-6-induced macrophage differentiation of M1 cells, GATA-1 had little or no effect on tyrosine phosphorylation, DNA binding, and transcriptional activities of STAT3 in Western blot analysis, electropholic mobility shift assay (EMSA), and luciferase assays.	SEN:10028424	10666199
BEL:20071534	tscript(p(MGI:Stat3)) increases r(MGI:Bcl2)	events lead to activation of Stat signaling and result in the induction of proteins, such as bcl-2 and cMyc, both of which are critical regulators of cell cycle progression and apoptosis	SEN:10034138	11779161
BEL:20071536	tscript(p(MGI:Stat3)) increases r(MGI:Ccnd1)	Overexpression of both MEN2A-RET and STAT3 strongly enhanced reporter activation, indicating that MEN2A-RET induces cyclin-D1 gene expression via STAT3 (Figure 4a).	SEN:10022124	11536047
BEL:20071540	tscript(p(MGI:Stat3)) decreases r(MGI:Ccnd1)	the down-regulation of D1 and D2 cyclins by OSM was mediated by STAT3 but not by SHP2/Ras STAT3 activation is necessary and sufficient for down-regulation of D1 and D2 cyclins in fetal hepatocytes	SEN:10034134	12147685
BEL:20071542	tscript(p(MGI:Stat3)) decreases r(MGI:Ccnd2)	the down-regulation of D1 and D2 cyclins by OSM was mediated by STAT3 but not by SHP2/Ras STAT3 activation is necessary and sufficient for down-regulation of D1 and D2 cyclins in fetal hepatocytes	SEN:10034134	12147685
BEL:20071550	tscript(p(MGI:Stat3)) increases r(MGI:Cebpd)	This up-regulation is dependent on signaling by phospho-Stat3 (signal transducers and activators of transcription).	SEN:10029776	12479220
BEL:20071552	tscript(p(MGI:Stat3)) increases r(MGI:Fos)	We found that the microphthalmia-associated transcription factor (MITF), an essential transcription factor for melanocyte development and pigmentation, induces anchorage-independent growth of NIH-3T3 cells in cooperation with STAT3C. Microarray analysis revealed that c-fos is highly expressed in transformants expressing STAT3C and MITF.	SEN:10011528	14737107
BEL:20071554	tscript(p(MGI:Stat3)) decreases r(MGI:Gata3)	Moreover, STAT3 overactivation also reduced GATA3 and T-bet expression but increased the expression of RORgammat, a transcription regulator of THi differentiation (20).	SEN:10034142	17277312
BEL:20071556	tscript(p(MGI:Stat3)) increases r(MGI:Hes1)	Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined	SEN:10034144	20038814
BEL:20071558	tscript(p(MGI:Stat3)) increases r(MGI:Hmox1)	Electromobility shift assays show increased STAT1, STAT3, STAT5, and AP-1 DNA binding activity in RAW 264.7 cells after hyperoxia. Taken together, our data suggest that the 5' distal enhancer elements of the HO-1 gene in concert with the promoter regulate HO-1 gene induction and highlight the complexity of HO-1 gene transcription in response to hyperoxia.	SEN:10011998	10893216
BEL:20071560	tscript(p(MGI:Stat3)) directlyIncreases r(MGI:Hsp90ab1)	The hsp90beta gene promoter contains binding sites for the transcription factors nuclear factor IL-6 (\"NF-IL6\") and signal transducer and activator of transcription 3 (STAT-3), which are activated respectively by the mitogen-activated-protein-kinase and Jak-kinase pathways following IL-6 treatment.	SEN:10018046	9461509
BEL:20071562	tscript(p(MGI:Stat3)) directlyIncreases r(MGI:Igfbp5)	The concentration of the proapoptotic molecule caspase-3 was increased during lactation in ATF4-transgenic animal. Mammary glands from ATF4-transgenic mice also showed significant nuclear translocation of activated STAT3 and up-regulation of one of its target genes, insulin-like growth factor-binding protein-5, which is thought to facilitate apoptosis by sequestering insulin-like growth factor	SEN:10009142	12611881
BEL:20071568	tscript(p(MGI:Stat3)) increases r(MGI:Jag1)	Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined	SEN:10034144	20038814
BEL:20071572	tscript(p(MGI:Stat3)) increases r(MGI:Myc)	events lead to activation of Stat signaling and result in the induction of proteins, such as bcl-2 and cMyc, both of which are critical regulators of cell cycle progression and apoptosis	SEN:10034138	11779161
BEL:20071576	tscript(p(MGI:Stat3)) increases r(MGI:Rorc)	Moreover, STAT3 overactivation also reduced GATA3 and T-bet expression but increased the expression of RORgammat, a transcription regulator of THi differentiation (20).	SEN:10034142	17277312
BEL:20071582	tscript(p(MGI:Stat3)) decreases r(MGI:Tbx21)	Moreover, STAT3 overactivation also reduced GATA3 and T-bet expression but increased the expression of RORgammat, a transcription regulator of THi differentiation (20).	SEN:10034142	17277312
BEL:20071584	tscript(p(MGI:Stat3)) directlyIncreases r(MGI:Tgfb1)	The expression of TGF-beta1, a mediator of fibrosis, was enhanced by SOCS3 gene deletion, but suppressed by the overexpression of a dominant-negative STAT3 or SOCS3 both in vivo and in vitro. These data suggest that TGF-beta1 is a target gene of STAT3 and could be one of the mechanisms for enhanced fibrosis in SOCS3-deficient mice.	SEN:10030784	16474852
BEL:20071586	tscript(p(MGI:Stat3)) increases r(MGI:Trp63)	Inactivation of STAT3 by either the STAT3 inhibitor AG490 (Figure 7B) or knockdown by siRNA (Figure 7C) led to reductions in p63, Jagged1, and Hes1 in all the mTOR-activated cells examined	SEN:10034144	20038814
BEL:20071590	tscript(p(MGI:Stat4)) increases bp(GOBP:"T-helper 1 cell differentiation")	IL-12 activates STAT4, which is a critical regulator of inflammation and T helper type I (Th1) lineage development in murine systems.	SEN:10019892	19359411
BEL:20071592	tscript(p(MGI:Stat4)) increases r(MGI:Ccl11)	In addition, pulmonary levels of chemokines were decreased in the STAT4(-/-) mice, including CC chemokine ligand (CCL)5, CCL6, CCL11, and CCL17.	SEN:10012008	12646654
BEL:20071594	tscript(p(MGI:Stat4)) increases r(MGI:Ccl17)	In addition, pulmonary levels of chemokines were decreased in the STAT4(-/-) mice, including CC chemokine ligand (CCL)5, CCL6, CCL11, and CCL17.	SEN:10012008	12646654
BEL:20071596	tscript(p(MGI:Stat4)) increases r(MGI:Ccl5)	In addition, pulmonary levels of chemokines were decreased in the STAT4(-/-) mice, including CC chemokine ligand (CCL)5, CCL6, CCL11, and CCL17.	SEN:10012008	12646654
BEL:20071598	tscript(p(MGI:Stat4)) increases r(MGI:Ccl6)	In addition, pulmonary levels of chemokines were decreased in the STAT4(-/-) mice, including CC chemokine ligand (CCL)5, CCL6, CCL11, and CCL17.	SEN:10012008	12646654
BEL:20071600	tscript(p(MGI:Stat4)) increases r(MGI:Twist1)	When CD4+ T lymphocytes of STAT4-deficient mice were stimulated in the presence of IL-12 and IFN-{gamma}, no induction of twist1 expression was detectable (Fig. 2 C).	SEN:10034152	18663125
BEL:20071602	tscript(p(MGI:Stat5a)) increases bp(GOBP:"megakaryocyte differentiation")	Second, mice deficient for both STAT5A and STAT5B are thrombocytopenic, likely due to a reduction in functional hematopoietic progenitors (18).	SEN:10034154	18060035
BEL:20071612	tscript(p(MGI:Stat5a)) increases r(MGI:Cebpa)	Overexpression of wt-Stat5A resulted in earlier induction of C/EBP in L1-wt-Stat5 (Fig. 4A , compare lanes 35 and lanes 810), whereas induction of dn-Stat5A decreased C/EBP expression in L1-dn-Stat5 cells by d 9 (Fig. 4A , compare lanes 5 and 10).	SEN:10034160	12089351
BEL:20071614	tscript(p(MGI:Stat5a)) directlyDecreases r(MGI:Fasn)	Taken together, these data strongly suggest that PRL directly represses expression of FAS in adipocytes through STAT5A binding to the -908 to -893 site.	SEN:10012012	15983196
BEL:20071620	tscript(p(MGI:Stat5a)) increases r(MGI:Pparg)	Notably, Stat5 regulated expression of peroxisome proliferator-activated receptor-gamma, which plays crucial roles in adipogenesis.	SEN:10012016	12089351
BEL:20071622	tscript(p(MGI:Stat5b)) increases bp(GOBP:"megakaryocyte differentiation")	Second, mice deficient for both STAT5A and STAT5B are thrombocytopenic, likely due to a reduction in functional hematopoietic progenitors (18).	SEN:10034154	18060035
BEL:20071626	tscript(p(MGI:Stat5b)) decreases r(MGI:Ppara)	Previous in vitro studies have shown that growth hormone (GH) can inhibit PPARalpha-dependent gene expression by down-regulation of PPARalpha expression and by a novel inhibitory cross-talk involving the GH-activated transcription factor STAT5b. ...A corresponding increase in mRNA, was observed in the STAT5b-deficient mice, suggesting a transcriptional mechanism for the observed increases.	SEN:10027210	12127257
BEL:20071628	tscript(p(MGI:Stat6)) increases bp(GOBP:"inflammatory response")	IL-4 develops Th2-biased immunity or allergic inflammation through activation of STAT6-dependent signaling.	SEN:10034162	19419769
BEL:20071630	tscript(p(MGI:Stat6)) increases bp(GOBP:"T-helper 2 cell differentiation")	early studies have indicated that Stat6 (8, 9, 10), a cytosolic latent transcription factor that is rapidly activated after cellular exposure to IL-4 and IL-13, is essential for Th2 cell differentiation through the induction of GATA3 (5, 6, 7),	SEN:10027138	15749913
BEL:20071636	tscript(p(MGI:Stat6)) decreases r(MGI:Cd40)	These results suggest that IL-4 inhibition of IFN-gamma-induced CD40 gene expression is mediated by direct STAT-6 binding to the CD40 promoter.	SEN:10002556	11086058
BEL:20071638	tscript(p(MGI:Stat6)) increases r(MGI:Gata3)	early studies have indicated that Stat6 (8, 9, 10), a cytosolic latent transcription factor that is rapidly activated after cellular exposure to IL-4 and IL-13, is essential for Th2 cell differentiation through the induction of GATA3 (5, 6, 7),	SEN:10027138	15749913
BEL:20071640	tscript(p(MGI:Stat6)) decreases r(MGI:Tbx21)	Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6.	SEN:10028280	11397944
BEL:20071652	tscript(p(MGI:Taf4b)) directlyIncreases r(MGI:Ccnd2)	Elevated c-jun mRNA and Rapid Pregnant Mare Serum Gonadotropin (PMSG)-Responsiveness in the Mouse Ovary. TAF4b Knockdown in SIGCs Decreases c-jun {mRNA} Expression. Taf4b bound to the c-jun promoter via ChIP analysis. Importantly, we also detected the binding of TAF4b to the core promoter regions of the Ccnd2, Fst, Inhba genes but not to the 5? distal AP-1 enhancer region of the Vim promoter.	SEN:10034166	16473943
BEL:20071654	tscript(p(MGI:Taf4b)) directlyIncreases r(MGI:Fst)	Elevated c-jun mRNA and Rapid Pregnant Mare Serum Gonadotropin (PMSG)-Responsiveness in the Mouse Ovary. TAF4b Knockdown in SIGCs Decreases c-jun {mRNA} Expression. Taf4b bound to the c-jun promoter via ChIP analysis. Importantly, we also detected the binding of TAF4b to the core promoter regions of the Ccnd2, Fst, Inhba genes but not to the 5? distal AP-1 enhancer region of the Vim promoter.	SEN:10034166	16473943
BEL:20071656	tscript(p(MGI:Taf4b)) directlyIncreases r(MGI:Inhba)	Elevated c-jun mRNA and Rapid Pregnant Mare Serum Gonadotropin (PMSG)-Responsiveness in the Mouse Ovary. TAF4b Knockdown in SIGCs Decreases c-jun {mRNA} Expression. Taf4b bound to the c-jun promoter via ChIP analysis. Importantly, we also detected the binding of TAF4b to the core promoter regions of the Ccnd2, Fst, Inhba genes but not to the 5? distal AP-1 enhancer region of the Vim promoter.	SEN:10034166	16473943
BEL:20071658	tscript(p(MGI:Taf4b)) directlyIncreases r(MGI:Jun)	Elevated c-jun mRNA and Rapid Pregnant Mare Serum Gonadotropin (PMSG)-Responsiveness in the Mouse Ovary. TAF4b Knockdown in SIGCs Decreases c-jun {mRNA} Expression. Taf4b bound to the c-jun promoter via ChIP analysis. Importantly, we also detected the binding of TAF4b to the core promoter regions of the Ccnd2, Fst, Inhba genes but not to the 5? distal AP-1 enhancer region of the Vim promoter.	SEN:10034166	16473943
BEL:20071662	tscript(p(MGI:Tal1)) directlyIncreases r(MGI:Nfe2)	Quantitative real-time polymerase chain reaction showed that Scl-null platelets lacked NF-E2, and chromatin immunoprecipitation analysis demonstrated Scl binding to the NF-E2 promoter in the human megakaryoblastic-cell line Meg-01	SEN:10012022	16763211
BEL:20071678	tscript(p(MGI:Tbx21)) increases bp(GOBP:"T-helper 1 cell differentiation")	Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.	SEN:10003254	10761931
BEL:20071680	tscript(p(MGI:Tbx21)) increases bp(GOBP:"T-helper 1 cell differentiation")	Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6.	SEN:10028280	11397944
BEL:20071682	tscript(p(MGI:Tbx21)) increases bp(GOBP:"T-helper 1 cell differentiation")	T-bet is required for the progression to the Th1 phenotype, because Tbx21-/- Th1beta cultures maintain the IL-17-secreting phenotype after 2 weeks of culture. Addition of IFN-gamma to Tbx21-/- Th1beta cultures cannot recover the progression to the Th1 phenotype, suggesting T-bet, rather than IFN-gamma, mediates Th1beta to Th1 progression.	SEN:10034170	16670261
BEL:20071686	tscript(p(MGI:Tbx21)) decreases bp(GOBP:"T-helper 2 cell differentiation")	Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.	SEN:10003254	10761931
BEL:20071690	tscript(p(MGI:Tbx21)) increases cat(p(MGI:Gzmb))	In addition to the secretion of IFN{gamma}, overexpression of T-bet in T-bet–/– V{alpha}14i NKT cells was sufficient to induce granzyme B protein (Figure 4C) and the capacity to kill antigen-loaded CD1d+ target cells (Figure 5).	SEN:10034176	16357323
BEL:20071696	tscript(p(MGI:Tbx21)) increases p(MGI:Ifng)	Ectopic expression of T-bet both transactivates the IFNgamma gene and induces endogenous IFNgamma production.	SEN:10034182	10761931
BEL:20071712	tscript(p(MGI:Tbx21)) decreases p(MGI:Il4)	Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.	SEN:10003254	10761931
BEL:20071716	tscript(p(MGI:Tbx21)) decreases p(MGI:Il5)	Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.	SEN:10003254	10761931
BEL:20071720	tscript(p(MGI:Tbx21)) increases p(MGI:Runx3)	Our data indicate that cytokine gene expression in T(H)1 cells may be controlled by a feed-forward regulatory circuit in which T-bet induces Runx3 and then 'partners' with Runx3 to direct lineage-specific gene activation and silencing.	SEN:10034198	17195845
BEL:20071726	tscript(p(MGI:Tbx21)) increases r(MGI:Ccr5)	As was observed when T-bet was introduced into T-bet–/– V{alpha}14i NKT cells, introduction of T-bet into wild-type immature V{alpha}14i NKT cells induced the up-regulation of CCR5, CxCR3, FasL, and CD122 mRNA levels, while the expression of IFN{gamma} and granzyme B mRNA were unchanged (Figure 3D).	SEN:10034204	16357323
BEL:20071728	tscript(p(MGI:Tbx21)) increases r(MGI:Ccr5)	To assess whether TCR signaling could account for these differences, T-bet–/– V{alpha}14i NKT cells were infected as previously, sorted, placed on anti-CD3/CD28–coated plates for 2 days, and expanded in IL-2 for several days. Under these in vitro experimental conditions, CxCR3, CCR5, CD122, and CD95L mRNA levels were up-regulated in the T-bet–expressing cells, in agreement with our previous results.	SEN:10034206	16357323
BEL:20071730	tscript(p(MGI:Tbx21)) increases r(MGI:Cxcr3)	As was observed when T-bet was introduced into T-bet–/– V{alpha}14i NKT cells, introduction of T-bet into wild-type immature V{alpha}14i NKT cells induced the up-regulation of CCR5, CxCR3, FasL, and CD122 mRNA levels, while the expression of IFN{gamma} and granzyme B mRNA were unchanged (Figure 3D).	SEN:10034204	16357323
BEL:20071732	tscript(p(MGI:Tbx21)) increases r(MGI:Cxcr3)	To assess whether TCR signaling could account for these differences, T-bet–/– V{alpha}14i NKT cells were infected as previously, sorted, placed on anti-CD3/CD28–coated plates for 2 days, and expanded in IL-2 for several days. Under these in vitro experimental conditions, CxCR3, CCR5, CD122, and CD95L mRNA levels were up-regulated in the T-bet–expressing cells, in agreement with our previous results.	SEN:10034206	16357323
BEL:20071736	tscript(p(MGI:Tbx21)) increases r(MGI:Fasl)	As was observed when T-bet was introduced into T-bet–/– V{alpha}14i NKT cells, introduction of T-bet into wild-type immature V{alpha}14i NKT cells induced the up-regulation of CCR5, CxCR3, FasL, and CD122 mRNA levels, while the expression of IFN{gamma} and granzyme B mRNA were unchanged (Figure 3D).	SEN:10034204	16357323
BEL:20071738	tscript(p(MGI:Tbx21)) increases r(MGI:Fasl)	To assess whether TCR signaling could account for these differences, T-bet–/– V{alpha}14i NKT cells were infected as previously, sorted, placed on anti-CD3/CD28–coated plates for 2 days, and expanded in IL-2 for several days. Under these in vitro experimental conditions, CxCR3, CCR5, CD122, and CD95L mRNA levels were up-regulated in the T-bet–expressing cells, in agreement with our previous results.	SEN:10034206	16357323
BEL:20071744	tscript(p(MGI:Tbx21)) directlyIncreases r(MGI:Ifng)	Ectopic expression of T-bet both transactivates the IFNgamma gene and induces endogenous IFNgamma production.	SEN:10034182	10761931
BEL:20071746	tscript(p(MGI:Tbx21)) increases r(MGI:Ifng)	T-bet, also known as T-box 21 (Tbx21) (24), was recently described as a trans-activator specific to IFN-g–expressing lineages that is sufficient to induce IFN-g even under TH2-polarizing conditions (5).	SEN:10034212	11397944
BEL:20071748	tscript(p(MGI:Tbx21)) directlyIncreases r(MGI:Ifng)	both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 (Il4) in T(H)1 cells.	SEN:10011898	17195845
BEL:20071750	tscript(p(MGI:Tbx21)) directlyIncreases r(MGI:Ifng)	T-bet directly activates Ifng transcription through the Ifng promoter and two distal regulatory elements (CNS1 and CNS2) in the Ifng locus	SEN:10034214	17195845
BEL:20071752	tscript(p(MGI:Tbx21)) increases r(MGI:Il12rb2)	Finally, we also found that ectopic T-bet specifically induced robust transcription of both endogenous (cellular) T-bet and IL-12 receptor beta 2 (IL-12Rbeta 2) (Fig. 2C).	SEN:10031078	11397944
BEL:20071758	tscript(p(MGI:Tbx21)) increases r(MGI:Il2rb)	As was observed when T-bet was introduced into T-bet–/– V{alpha}14i NKT cells, introduction of T-bet into wild-type immature V{alpha}14i NKT cells induced the up-regulation of CCR5, CxCR3, FasL, and CD122 mRNA levels, while the expression of IFN{gamma} and granzyme B mRNA were unchanged (Figure 3D).	SEN:10034204	16357323
BEL:20071760	tscript(p(MGI:Tbx21)) increases r(MGI:Il2rb)	To assess whether TCR signaling could account for these differences, T-bet–/– V{alpha}14i NKT cells were infected as previously, sorted, placed on anti-CD3/CD28–coated plates for 2 days, and expanded in IL-2 for several days. Under these in vitro experimental conditions, CxCR3, CCR5, CD122, and CD95L mRNA levels were up-regulated in the T-bet–expressing cells, in agreement with our previous results.	SEN:10034206	16357323
BEL:20071762	tscript(p(MGI:Tbx21)) directlyDecreases r(MGI:Il4)	both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 (Il4) in T(H)1 cells.	SEN:10011898	17195845
BEL:20071768	tscript(p(MGI:Tbx21)) increases r(MGI:Tbx21)	Finally, we also found that ectopic T-bet specifically induced robust transcription of both endogenous (cellular) T-bet and IL-12 receptor beta 2 (IL-12Rbeta 2) (Fig. 2C).	SEN:10031078	11397944
BEL:20071776	tscript(p(MGI:Tbx21)) increases sec(p(MGI:Ifng))	In addition to the secretion of IFN{gamma}, overexpression of T-bet in T-bet–/– V{alpha}14i NKT cells was sufficient to induce granzyme B protein (Figure 4C) and the capacity to kill antigen-loaded CD1d+ target cells (Figure 5).	SEN:10034176	16357323
BEL:20071778	tscript(p(MGI:Tbx21)) increases sec(p(MGI:Ifng))	Ectopic T-bet expression in Th1beta cells promotes IFN-gamma secretion but decreases IL-17 production.	SEN:10034224	16670261
BEL:20071780	tscript(p(MGI:Tbx21)) decreases sec(p(MGI:Il17a))	Ectopic T-bet expression in Th1beta cells promotes IFN-gamma secretion but decreases IL-17 production.	SEN:10034224	16670261
BEL:20071782	tscript(p(MGI:Tbx21)) decreases sec(p(MGI:Il17a))	Th1 or Th1beta Tbx21-/- cultures secrete higher than WT levels of IL-17 in response to T-cell receptor (TCR) or IL-23 + IL-18 stimulation.	SEN:10034226	16670261
BEL:20071788	tscript(p(MGI:Tbx2)) directlyDecreases r(MGI:Cdkn2a)	Transcriptional regulators that have been reported to repress the INK4A and ARF genes expression include the T-box transcription factor TBX2, a potent repressor of mouse ARF (Jacobs et al., 2000), and the transcriptional co-repressor CtBP, which has been implicated as a direct repressor of human INK4A expression (Mroz et al., 2008).	SEN:10034232	21383691
BEL:20071790	tscript(p(MGI:Tbx2)) decreases r(MGI:Gja1)	Hearts of transgenic embryos that expressed Tbx2 in the prechamber myocardium completely failed to form chambers and to express the chamber myocardium-specific genes Nppa, Cx40, and Chisel, whereas other cardiac genes were normally expressed.	SEN:10034234	15042700
BEL:20071792	tscript(p(MGI:Tbx2)) decreases r(MGI:Gja5)	Hearts of transgenic embryos that expressed Tbx2 in the prechamber myocardium completely failed to form chambers and to express the chamber myocardium-specific genes Nppa, Cx40, and Chisel, whereas other cardiac genes were normally expressed.	SEN:10034234	15042700
BEL:20071794	tscript(p(MGI:Tbx2)) decreases r(MGI:Nppa)	Hearts of transgenic embryos that expressed Tbx2 in the prechamber myocardium completely failed to form chambers and to express the chamber myocardium-specific genes Nppa, Cx40, and Chisel, whereas other cardiac genes were normally expressed.	SEN:10034234	15042700
BEL:20071796	tscript(p(MGI:Tbx2)) decreases r(MGI:Tyrp1)	Previous work has established that the melanocyte-specific tyrosinase-related protein-1 (TRP-1) promoter is regulated positively by the microphthalmia-associated transcription factor Mitf, acting through the conserved M box and negatively by the T-box factor Tbx2,	SEN:10011536	10480898
BEL:20071818	tscript(p(MGI:Tcf12)) directlyIncreases r(MGI:Smarcc1)	FIG. 3. E2A/HEB complex activates the SRG3 promoter activity through E84 element, which is inhibited by Id proteins.	SEN:10032184	15016815
BEL:20071826	tscript(p(MGI:Tcf3)) increases bp(GOBP:"epithelial to mesenchymal transition")	In contrast, downregulation of Id expression by TGF-beta generates E2A that is free from Id proteins, thus allowing E2A to become active and induce EMT through repression of E-cadherin expression.	SEN:10031186	15181457
BEL:20071836	tscript(p(MGI:Tcf3)) directlyIncreases r(MGI:Smarcc1)	FIG. 3. E2A/HEB complex activates the SRG3 promoter activity through E84 element, which is inhibited by Id proteins.	SEN:10032184	15016815
BEL:20071838	tscript(p(MGI:Tcf3)) directlyIncreases tscript(p(MGI:Lmx1a))	When the intact rat insulin I enhancer/promoter (-410 to + 1 bp relative to the transcription start site) is inserted in place of the minienhancer-prolactin promoter in the luciferase reporter plasmid, shPan-1 alone cannot activate luciferase expression. Cotransfected lmx-1, however, activates the intact enhancer/promoter, and shPan-1 plus lmx-1 causes further activation (Fig. 8B).	SEN:10033276	1358758
BEL:20071846	tscript(p(MGI:Tcf7)) directlyIncreases r(MGI:Runx2)	By chromatin immunoprecipitation, recruitment of beta-catenin and TCF1 to the endogenous Runx2 gene is shown. Coexpression of TCF1 with canonical WNT proteins resulted in a 2-5-fold activation of Runx2 promoter activity and a 7-8-fold induction of endogenous mRNA in mouse pluripotent mesenchymal and osteoprogenitor cells.	SEN:10012034	16043491
BEL:20071852	tscript(p(MGI:Tead4)) increases p(MGI:Ppp1cb)	PP1ß expression is upregulated (3.1±0.6-fold versus control) in heart of RTEF-1 mice by Western blot analysis.	SEN:10034250	15520314
BEL:20071854	tscript(p(MGI:Tead4)) increases r(MGI:Ppp1cb)	PP1ß mRNA is upregulated 1.9±0.2-fold in RTEF-1 mice by Northern blot analysis of whole-heart RNA using phosphatase-specific cDNA probes.	SEN:10034252	15520314
BEL:20071856	tscript(p(MGI:Tef)) increases a(CHEBI:dopamine)	PAR bZip-deficient mice show decreased brain levels of PLP, serotonin, and dopamine, and such changes have previously been reported to cause epilepsies in other systems.	SEN:10012038	15175240
BEL:20071858	tscript(p(MGI:Tef)) increases a(CHEBI:serotonin)	PAR bZip-deficient mice show decreased brain levels of PLP, serotonin, and dopamine, and such changes have previously been reported to cause epilepsies in other systems.	SEN:10012038	15175240
BEL:20071868	tscript(p(MGI:Thra)) increases r(MGI:Igfbp4)	Responsiveness of the IGFBP-4 promoter activity was tested with thyroid hormone and found only within extended constructs but not when a potential TRalpha1-binding site had been deleted.	SEN:10012042	9468222
BEL:20071872	tscript(p(MGI:Thra)) decreases tscript(p(MGI:Ppara))	thyroid hormone, which controls some fatty acid metabolism genes via its nuclear receptor (TR), seems to act negatively on Ppar action.	SEN:10034256	12088279
BEL:20071874	tscript(p(MGI:Thra)) decreases tscript(p(MGI:Pparg))	thyroid hormone, which controls some fatty acid metabolism genes via its nuclear receptor (TR), seems to act negatively on Ppar action.	SEN:10034256	12088279
BEL:20071882	tscript(p(MGI:Thrb)) decreases tscript(p(MGI:Ppara))	thyroid hormone, which controls some fatty acid metabolism genes via its nuclear receptor (TR), seems to act negatively on Ppar action.	SEN:10034256	12088279
BEL:20071884	tscript(p(MGI:Thrb)) decreases tscript(p(MGI:Pparg))	thyroid hormone, which controls some fatty acid metabolism genes via its nuclear receptor (TR), seems to act negatively on Ppar action.	SEN:10034256	12088279
BEL:20071888	tscript(p(MGI:Tlx3)) increases r(MGI:Acsl1)	In undifferentiated ES cells, there was no significant difference in gene expression in the presence or absence of Tlx3, even after ES cells were cultured for an extensive time period. In contrast, expression levels of Mash1, Ngn1, and NeuroD were significantly higher in Tlx3-expressing cells after neural induction for 4 days compared with those in cells expressing the control vector.	SEN:10004058	18391221
BEL:20071890	tscript(p(MGI:Tlx3)) increases r(MGI:Gria2)	Moreover, the expression level of the transcription factor Brn3a, the AMPA receptors, GluR2, and GluR4, and VGLUT2 in Tlx3-expressing ES-derived cells became significantly higher than that in control cells after 4 days of neural induction, and this trend continued at neural induction day 7.	SEN:10034258	18391221
BEL:20071892	tscript(p(MGI:Tlx3)) increases r(MGI:Gria4)	Moreover, the expression level of the transcription factor Brn3a, the AMPA receptors, GluR2, and GluR4, and VGLUT2 in Tlx3-expressing ES-derived cells became significantly higher than that in control cells after 4 days of neural induction, and this trend continued at neural induction day 7.	SEN:10034258	18391221
BEL:20071894	tscript(p(MGI:Tlx3)) increases r(MGI:Neurod1)	In undifferentiated ES cells, there was no significant difference in gene expression in the presence or absence of Tlx3, even after ES cells were cultured for an extensive time period. In contrast, expression levels of Mash1, Ngn1, and NeuroD were significantly higher in Tlx3-expressing cells after neural induction for 4 days compared with those in cells expressing the control vector.	SEN:10004058	18391221
BEL:20071896	tscript(p(MGI:Tlx3)) increases r(MGI:Neurog1)	In undifferentiated ES cells, there was no significant difference in gene expression in the presence or absence of Tlx3, even after ES cells were cultured for an extensive time period. In contrast, expression levels of Mash1, Ngn1, and NeuroD were significantly higher in Tlx3-expressing cells after neural induction for 4 days compared with those in cells expressing the control vector.	SEN:10004058	18391221
BEL:20071898	tscript(p(MGI:Tlx3)) increases r(MGI:Pou4f1)	Moreover, the expression level of the transcription factor Brn3a, the AMPA receptors, GluR2, and GluR4, and VGLUT2 in Tlx3-expressing ES-derived cells became significantly higher than that in control cells after 4 days of neural induction, and this trend continued at neural induction day 7.	SEN:10034258	18391221
BEL:20071900	tscript(p(MGI:Tlx3)) increases r(MGI:Slc17a6)	Moreover, the expression level of the transcription factor Brn3a, the AMPA receptors, GluR2, and GluR4, and VGLUT2 in Tlx3-expressing ES-derived cells became significantly higher than that in control cells after 4 days of neural induction, and this trend continued at neural induction day 7.	SEN:10034258	18391221
BEL:20071904	tscript(p(MGI:Trp53)) decreases bp(GOBP:"cell cycle")	TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts.	SEN:10020470	11278372
BEL:20071908	tscript(p(MGI:Trp53)) decreases bp(GOBP:"cell proliferation")	TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts.	SEN:10020470	11278372
BEL:20071912	tscript(p(MGI:Trp53)) increases bp(GOBP:"lipid biosynthetic process")	In fact, disruption of p53 in ob/ob mice completely suppressed the p53-regulated genes to wild-type levels and partially restored expression of lipogenic enzymes.	SEN:10012052	12734185
BEL:20071914	tscript(p(MGI:Trp53)) increases bp(GOBP:"stress-induced premature senescence")	Figure 1 TRF2 (myc-tagged) induces telomere dysfunction and cellular senescence in p53 P/P primary mouse embryonic fibroblasts.	SEN:10031084	17396137
BEL:20071916	tscript(p(MGI:Trp53)) increases bp(GOBP:"stress-induced premature senescence")	These results suggest that Bach1 is a negative regulator of the p53-mediated senescence program in response to oxidative stress, although Bach1 could be either parallel or upstream to p53 in this process.	SEN:10018212	19011633
BEL:20071918	tscript(p(MGI:Trp53)) increases bp(GOBP:"apoptotic process")	These results suggest that the lowered viability in MEFPERK-/- and MEFGCN2-/- cells was due to the upregulated apoptosis, which was mediated by p53 signaling pathways.	SEN:10034264	20072654
BEL:20071920	tscript(p(MGI:Trp53)) decreases path(MESHD:Obesity)	Thus, the activation of p53 might constitute a negative feedback loop against excess fat accumulation in adipocytes	SEN:10012054	12734185
BEL:20071928	tscript(p(MGI:Trp53)) decreases path(MESHD:Atherosclerosis)	39. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR (2005) Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 96:667–674	SEN:10034266	18385967
BEL:20071932	tscript(p(MGI:Trp53)) increases p(MGI:Cdkn1a)	overexpression of TRF2 in p53 P/P MEFs resulted in upregulation of p21 (Fig 1D). In addition, reduction of BrdU incorporation, induction of p21 level and increased number of SA-beta-gal-positive senescent cells were also observed when oncogenic H-Ras was overexpressed in p53 P/P MEFs (Fig 1A?C).	SEN:10031086	17396137
BEL:20071934	tscript(p(MGI:Trp53)) increases p(MGI:Pmaip1)	Compound mutant cells also show increased levels of p53 and induction of Noxa, a death effector p53 target gene, suggesting that cell death is potentially mediated by reactive oxygen species activation of p53.	SEN:10034268	12968018
BEL:20071948	tscript(p(MGI:Trp53)) directlyIncreases r(MGI:Cdkn1a)	This activation of the p53 pathway leads to the elevation of p21 mRNA expression, which can be considered an indicator of p53 activity,	SEN:10012060	14985341
BEL:20071950	tscript(p(MGI:Trp53)) increases r(MGI:Cdkn1a)	In addition to repressing transcription of c-MYC, p53 induces expression of the cyclin-dependent kinase inhibitor p21, a major mediator of p53-induced G1 growth arrest.	SEN:10034274	18955973
BEL:20071956	tscript(p(MGI:Trp53)) decreases r(MGI:Cxcr5)	Table 3. Alteration of Gene Expression Specially Associated with p53 and H-ras Status in Skin Tumorigenesis upregulated	SEN:10034278	16254190
BEL:20071960	tscript(p(MGI:Trp53)) directlyIncreases r(MGI:Gadd45a)	Finally, IR induction of the human GADD45 gene, an induction that is also defective in AT cells, was dependent on wild-type p53 function. Wild-type but not mutant p53 bound strongly to a conserved element in the GADD45 gene, and a p53-containing nuclear factor, which bound this element, was detected in extracts from irradiated cells.	SEN:10012064	1423616
BEL:20071966	tscript(p(MGI:Trp53)) directlyDecreases r(MGI:Map4)	Consistent with this finding, we report that p53 physically associates in vivo with HDACs. This interaction is not direct but, rather, is mediated by the corepressor mSin3a. Both wild-type p53 and mSin3a, but not mutant p53, can be found bound to the Map4 promoter at times when this promoter preferentially associates with deacetylated histones in vivo.	SEN:10033962	10521394
BEL:20071968	tscript(p(MGI:Trp53)) increases r(MGI:Mapk1)	By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.	SEN:10021950	15383658
BEL:20071970	tscript(p(MGI:Trp53)) increases r(MGI:Mapk3)	By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.	SEN:10021950	15383658
BEL:20071974	tscript(p(MGI:Trp53)) directlyDecreases r(MGI:Myc)	It has been shown that c-MYC expression is transcriptionally repressed by p53, where p53 is bound to the c-MYC promoter and there is a decrease in the level of acetlylated histone H4 at the c-MYC promoter (Ho et al., 2005).	SEN:10034270	18955973
BEL:20071976	tscript(p(MGI:Trp53)) increases r(MGI:Pmaip1)	Compound mutant cells also show increased levels of p53 and induction of Noxa, a death effector p53 target gene, suggesting that cell death is potentially mediated by reactive oxygen species activation of p53.	SEN:10034268	12968018
BEL:20072002	tscript(p(MGI:Trp53)) directlyIncreases r(MGI:Spp1)	Furthermore, we found that Opn expression was upregulated by DNA damage-induced Tp53 activity and by adenovirus-mediated transfer of the human TP53 gene. In addition, a luciferase assay showed that the Opn gene has a functional Tp53-responsive element in its promoter region, and a chromatin immunoprecipitation assay confirmed interaction between the Opn promoter and Tp53 protein in vivo.	SEN:10012078	11807984
BEL:20072004	tscript(p(MGI:Trp53)) directlyDecreases r(MGI:Stmn1)	Consistent with this finding, we report that p53 physically associates in vivo with HDACs. This interaction is not direct but, rather, is mediated by the corepressor mSin3a. Both wild-type p53 and mSin3a, but not mutant p53, can be found bound to the Map4 promoter at times when this promoter preferentially associates with deacetylated histones in vivo.	SEN:10033962	10521394
BEL:20072006	tscript(p(MGI:Trp53)) increases r(MGI:Trp53inp1)	That hypothesis is consistent with the presence of a functional p53-response element within the promoter region of the mouse SIP gene and confirmed by the induction of SIP mRNA expression in mouse embryo fibroblasts upon activation of a p53-dependent pathway by transfection with rasV12 or rasV12/E1A	SEN:10012080	12067065
BEL:20072008	tscript(p(MGI:Trp53)) decreases tscript(p(MGI:Srebf1))	Consistently, reporter gene analysis showed that p53 overexpression suppressed the promoter activity of the SREBP-1c gene and its downstream genes.	SEN:10012082	12734185
BEL:20072010	tscript(p(MGI:Trp53)) decreases tscript(p(MGI:Srebf1))	Here we demonstrate that p53 and its target genes are highly induced in adipocytes of ob/ob mice in a fed state, leading to the negative regulation of SREBP-1 and thereby lipogenic genes.	SEN:10034286	12734185
BEL:20072014	tscript(p(MGI:Trp63)) increases r(MGI:Ddit4)	During embryogenesis, REDD1 expression mirrors the tissue-specific pattern of the p53 family member p63, and TP63 null embryos show virtually no expression of REDD1, which is restored in mouse embryo fibroblasts following p63 expression.	SEN:10012086	12453409
BEL:20072028	tscript(p(MGI:Tsc22d3)) decreases r(MGI:Cd80)	Transfection of the macrophagelike cell line THP-1 with the GILZ gene inhibited the expression of CD80 and CD86	SEN:10012092	12393603
BEL:20072030	tscript(p(MGI:Tsc22d3)) decreases r(MGI:Cd86)	Transfection of the macrophagelike cell line THP-1 with the GILZ gene inhibited the expression of CD80 and CD86	SEN:10012092	12393603
BEL:20072032	tscript(p(MGI:Ttf1)) directlyIncreases r(MGI:Sftpd)	NFATc3 and TTF-1 activated the Sftpd promoter, synergized transcription, co-immunoprecipitated from mouse lung epithelial cells, and physically interacted in vitro	SEN:10034292	15173172
BEL:20072034	tscript(p(MGI:Twist1)) decreases r(MGI:Il1a)	Twist-1 and -2 inhibited both basal and inducible activity of the IL-1 promoter (Figure 6A). Basal activity of the TNF promoter was also inhibited by both twists (Figure 6A).	SEN:10034294	12553906
BEL:20072036	tscript(p(MGI:Twist1)) decreases r(MGI:Tnf)	Twist-1 and -2 inhibited both basal and inducible activity of the IL-1 promoter (Figure 6A). Basal activity of the TNF promoter was also inhibited by both twists (Figure 6A).	SEN:10034294	12553906
BEL:20072038	tscript(p(MGI:Twist1)) decreases tscript(p(MGI:Mef2a))	Ectopically expressed mouse Twist (Mtwist) was shown to inhibit myogenesis by blocking DNA binding by MyoD, by titrating E proteins, and by inhibiting trans-activation by MEF2	SEN:10031770	8633239
BEL:20072040	tscript(p(MGI:Twist2)) decreases r(MGI:Il1a)	Twist-1 and -2 inhibited both basal and inducible activity of the IL-1 promoter (Figure 6A). Basal activity of the TNF promoter was also inhibited by both twists (Figure 6A).	SEN:10034294	12553906
BEL:20072042	tscript(p(MGI:Twist2)) decreases r(MGI:Tnf)	Twist-1 and -2 inhibited both basal and inducible activity of the IL-1 promoter (Figure 6A). Basal activity of the TNF promoter was also inhibited by both twists (Figure 6A).	SEN:10034294	12553906
BEL:20072052	tscript(p(MGI:Usf1)) directlyIncreases r(MGI:Cd2)	Moreover, Cha inhibited USF-1-stimulated transcription of CD2 (a USF-1-dependent gene) and E-box promoter reporter plasmids.	SEN:10012036	12923186
BEL:20072060	tscript(p(MGI:Usf1)) increases r(MGI:Mt1)	Several transcription factors modulate MT-I gene expression (Carthew et al., 1987; Dalton et al., 1994; Li et al., 1998). Of particular importance here is USF1.	SEN:10034302	11230134
BEL:20072062	tscript(p(MGI:Usf1)) increases r(MGI:Mt1)	these studies demonstrated that MTF-1 is essential for the heightened expression of MT-I in the visceral endoderm of the developing mouse embryo and suggest that zinc modulates the ability of MTF-1 to transactivate gene expression in these cells. It was also found that MTF-1 cooperates with USF1 to regulate endoderm-specific expression of the mouse MT-I gene.	SEN:10033346	11230134
BEL:20072064	tscript(p(MGI:Usf1)) increases r(MGI:Pdx1)	As point mutation within the -104 E-box that disrupt USF binding correspondingly impair STF-1 promoter activity, our results demonstrate that USF is an important component of the regulatory apparatus which directs STF-1 expression to pancreatic islet cells.	SEN:10012098	8567692
BEL:20072068	tscript(p(MGI:Usf1)) increases r(MGI:Prnd)	The activation capacity of the related USF-2, c-Myc and HIF-2alpha proteins was lower compared to USF-1 suggesting that USF-1 is the major E-box-binding transcription factor regulating the Prnd promoter.	SEN:10012100	16297464
BEL:20072078	tscript(p(MGI:Vdr)) increases r(MGI:Ednrb)	Moreover, immunostaining and reverse transcription-polymerase chain reaction analysis revealed that endothelin B receptor expression was induced in NCC-/melb4 cells following treatment with 1,25-dihydroxyvitamin D3. The induction of endothelin B receptor by 1,25-dihydroxyvitamin D3 was also demonstrated in neural crest cell primary cultures, but not in mature melanocytes.	SEN:10034310	12230499
BEL:20072080	tscript(p(MGI:Wt1)) directlyIncreases r(MGI:Sf1)	Using biochemical and genetic experiments, we demonstrate here that WT1 and LHX9 function as direct activatorsof the Sf1 gene.	SEN:10033264	12130543
BEL:20072090	tscript(p(MGI:Xbp1)) directlyIncreases r(MGI:Cebpa)	Pointing to a direct regulatory role for XBP1 in vivo, XBP1 was enriched on the Cebpa promoter on d4 (Figure 4D); this binding was comparable with that of C/EBPbeta on d4 and was completely abolished in XBP1i 3T3-L1 cells (Figures 4D and S4B).	SEN:10032744	19490910
BEL:20072116	tscript(p(MGI:Ybx3)) decreases r(MGI:Prm1)	Translational repression of protamine 1 (Prm1) mRNA requires sequences present in its 3' untranslated region (UTR) and substantial evidence suggests a role for the murine Y-box protein MSY4 in this process	SEN:10012112	12117816
BEL:20072118	tscript(p(MGI:Ybx3)) decreases r(MGI:Prm2)	Altered translational activation resulted in defective processing of protamine 2 and severe defects in sperm morphogenesis	SEN:10012110	12117816
BEL:20072124	tscript(p(MGI:Yy1)) directlyDecreases r(MGI:Star)	the putative Srebf-binding site could also act as a recognition site for Yy1 mutations of the Yy1-binding site enhanced Srebf1a-dependent Star promoter activity	SEN:10034320	11145563
BEL:20072146	tscript(p(MGI:Zeb1)) decreases r(MGI:Cd4)	ZEB also binds to the promoter of pivotal hematopoietic genes (including those encoding interleukin-2, CD4, GATA-3, and alpha(4)-integrin), and mice in which ZEB has been genetically targeted show thymic atrophy, severe defects in lymphocyte differentiation, and increased expression of the alpha(4)-integrin and CD4.	SEN:10034332	10567522
BEL:20072152	tscript(p(MGI:Zeb1)) decreases r(MGI:Gata3)	ZEB also binds to the promoter of pivotal hematopoietic genes (including those encoding interleukin-2, CD4, GATA-3, and alpha(4)-integrin), and mice in which ZEB has been genetically targeted show thymic atrophy, severe defects in lymphocyte differentiation, and increased expression of the alpha(4)-integrin and CD4.	SEN:10034332	10567522
BEL:20072154	tscript(p(MGI:Zeb1)) decreases r(MGI:Il2)	ZEB also binds to the promoter of pivotal hematopoietic genes (including those encoding interleukin-2, CD4, GATA-3, and alpha(4)-integrin), and mice in which ZEB has been genetically targeted show thymic atrophy, severe defects in lymphocyte differentiation, and increased expression of the alpha(4)-integrin and CD4.	SEN:10034332	10567522
BEL:20072156	tscript(p(MGI:Zeb1)) decreases r(MGI:Itga4)	ZEB also binds to the promoter of pivotal hematopoietic genes (including those encoding interleukin-2, CD4, GATA-3, and alpha(4)-integrin), and mice in which ZEB has been genetically targeted show thymic atrophy, severe defects in lymphocyte differentiation, and increased expression of the alpha(4)-integrin and CD4.	SEN:10034332	10567522
BEL:20072160	tscript(p(MGI:Zfp143)) directlyIncreases r(MGI:Nanog)	Chromatin immunoprecipitation and electrophoretic mobility shift assays show the direct binding of Zfp143 to the Nanog proximal promoter. Knockdown of Zfp143 or mutation of the Zfp143 binding motif significantly downregulates Nanog proximal promoter activity. Importantly, enforced expression of Nanog is able to rescue the Zfp143 knockdown phenotype, indicating that Nanog is one of the key downstream effectors of Zfp143.	SEN:10012120	18687992
BEL:20072164	tscript(p(MGI:Zfp277)) decreases r(MGI:Cdkn2a)	Interestingly, transcription factors have also been implicated in the regulation of the INK4A-ARF locus. For example, the zinc-finger protein Zfp277 is reported to be involved in the transcriptional repression of the INK4A and ARF genes through recruitment of PRC1, by direct interaction with Bmi1 (Negishi et al., 2010).	SEN:10031968	21383691
BEL:20072166	tscript(p(MGI:Zfp346)) decreases bp(GOBP:"cell cycle")	JAZ associates with p53 to stimulate its transcriptional activity in p53-expressing cells, but not in p53-null cells unless complemented with p53. JAZ functions to mediate G1 cell-cycle arrest followed by apoptosis in a p53-dependent mechanism	SEN:10020506	16931621
BEL:20072168	tscript(p(MGI:Zfp346)) increases bp(GOBP:"apoptotic process")	JAZ associates with p53 to stimulate its transcriptional activity in p53-expressing cells, but not in p53-null cells unless complemented with p53. JAZ functions to mediate G1 cell-cycle arrest followed by apoptosis in a p53-dependent mechanism	SEN:10020506	16931621
BEL:20072170	tscript(p(MGI:Zfp346)) directlyIncreases tscript(p(MGI:Trp53))	JAZ associates with p53 to stimulate its transcriptional activity in p53-expressing cells, but not in p53-null cells unless complemented with p53. JAZ functions to mediate G1 cell-cycle arrest followed by apoptosis in a p53-dependent mechanism	SEN:10020506	16931621
BEL:20072176	tscript(p(MGI:Zfpm1)) increases r(MGI:Itga2b)	FOG-1 stimulates GATA-1-dependent alphaIIb gene expression in a manner that requires their direct physical interaction.	SEN:10033048	12356738
BEL:20072178	tscript(p(MGI:Zfpm1)) directlyIncreases tscript(p(MGI:Gata1))	FOG-1 stimulates GATA-1-dependent alphaIIb gene expression in a manner that requires their direct physical interaction.	SEN:10033048	12356738
BEL:20072180	tscript(p(MGI:Zfpm2)) increases r(MGI:Lhx9)	We conclude that in the E11.5 heart GATA4/FOG2 complex directly binds Lhx9 cis-regulatory regions...... Thereafter in the control hearts Lhx9alpha/beta epicardial expression is promptly down-regulated; in contrast, mouse mutants with Fog2 gene loss fail to repress Lhx9alpha/beta expression.	SEN:10034338	18577233
BEL:20072202	a(CHEBI:acetylcholine) increases a(CHEBI:"leukotriene B4")	Treatment of sputum cells from COPD patients with acetylcholine produced increased amounts of LTB4, which was sensitive both to treatment with a muscarinic receptor antagonist and to the inhibition of ERK- 1/2 phosphorylation. This increased LTB4 synthesis also directly correlated with increased neutrophil chemotaxis.	SEN:10034344	19842832
BEL:20072206	a(CHEBI:acrolein) decreases a(CHEBI:glutathione)	In NCI-H292 cells, the threshold concentration of acrolein was 10 Mormore, with 30 M significantly decreasing GSH levels (Figure 1).	SEN:10034348	15531749
BEL:20072210	a(CHEBI:acrolein) increases kin(p(HGNC:EGFR))	The increase in tyrosine phosphorylation was reduced by pretreating the cells with AG1478, an EGFR tyrosine kinase inhibitor (Figure 2A). Pretreatment with AG1478 decreased the levels of MUC5AC mRNAinduced by acrolein or EGF (Figures 2B and 2C).	SEN:10034352	15531749
BEL:20072212	a(CHEBI:acrolein) increases kin(p(HGNC:EGFR))	Upon exposure of J774A.1 cells to acrolein, EGFR phosphorylation increased significantly within minutes, and further increased up to 10 min (Fig. 6A), confirming a direct effect of acrolein on the activation of the EGFR pathway.	SEN:10015398	20153347
BEL:20072214	a(CHEBI:acrolein) increases p(HGNC:ATF3)	Treatment with 2 to 10 uM acrolein led to a significant increase in ATF3 expression. This increase was detectable in cells treated with 2 uM acrolein and was maximal at 10 uM.	SEN:10034354	18951912
BEL:20072216	a(CHEBI:acrolein) increases p(HGNC:ATF4)	Treatment with 10 uM acrolein led to a 3-fold increase in ATF4 protein 4h after treatment, which was comparable to the increase in AFT4 protein in thapsigargin-treated cells (Fig. 3A).	SEN:10034356	18951912
BEL:20072220	a(CHEBI:acrolein) increases p(HGNC:MAPK14,pmod(P,T,180))	The levels of phospho-p38 were increased 2-fold within 5 min of acrolein exposure.	SEN:10034360	18951912
BEL:20072222	a(CHEBI:acrolein) increases p(HGNC:MAPK14,pmod(P,Y,182))	The levels of phospho-p38 were increased 2-fold within 5 min of acrolein exposure.	SEN:10034360	18951912
BEL:20072224	a(CHEBI:acrolein) increases p(HGNC:MAPK1,pmod(P,T,185))	A similar rapid response was observed with ERK, which was modestly (1.2 to 2.0-fold) stimulated 5 to 15 min of acrolein exposure (Fig. 4B).	SEN:10034362	18951912
BEL:20072226	a(CHEBI:acrolein) increases p(HGNC:MAPK1,pmod(P,Y,187))	A similar rapid response was observed with ERK, which was modestly (1.2 to 2.0-fold) stimulated 5 to 15 min of acrolein exposure (Fig. 4B).	SEN:10034362	18951912
BEL:20072228	a(CHEBI:acrolein) increases p(HGNC:MAPK8,pmod(P,T,183))	After 30 min, treatment with 10 uM acrolein resulted in a 3.4- and 5.6-fold increase in the phosphorylation of p54 and p46, respectively.	SEN:10034364	18951912
BEL:20072230	a(CHEBI:acrolein) increases p(HGNC:MAPK8,pmod(P,Y,185))	After 30 min, treatment with 10 uM acrolein resulted in a 3.4- and 5.6-fold increase in the phosphorylation of p54 and p46, respectively.	SEN:10034364	18951912
BEL:20072232	a(CHEBI:acrolein) increases p(HGNC:MAPK9,pmod(P,T,183))	After 30 min, treatment with 10 uM acrolein resulted in a 3.4- and 5.6-fold increase in the phosphorylation of p54 and p46, respectively.	SEN:10034364	18951912
BEL:20072234	a(CHEBI:acrolein) increases p(HGNC:MAPK9,pmod(P,Y,185))	After 30 min, treatment with 10 uM acrolein resulted in a 3.4- and 5.6-fold increase in the phosphorylation of p54 and p46, respectively.	SEN:10034364	18951912
BEL:20072238	a(CHEBI:acrolein) increases tscript(p(HGNC:XBP1))	As shown in Fig. 2A, treatment with 5-10 uM acrolein for 2h resulted in a 3.5- to 16-fold increase in the alternatively spliced form of XBP-1.	SEN:10034368	18951912
BEL:20072286	a(CHEBI:bilirubin) decreases a(CHEBI:"reactive oxygen species")	 Bilirubin was only recently recognized as a potentially important anti-oxidant of physiological significance (Stocker et al., 1987), although this property had already been known for some time (Bernard et al., 1954). Administration of bilirubin demonstrated to be cytoprotective in models of ischemic heart injury and oxidative damage (Dore et al., 1999; Clark et al., 2000).	SEN:10034386	12869663
BEL:20072288	a(CHEBI:bilirubin) decreases a(CHEBI:"reactive oxygen species")	HO-1 is a cytoprotective enzyme (6) that degrades the potent prooxidant heme to generate CO and bilirubin. CO is a vasodilatory gas that has anti-proliferative effects on vascular smooth muscle cells (VSMCs) (7) and has anti-inflammatory properties (8). Bilirubin is a scavenger for reactive oxygen species (ROS) (9). In addition, ferrous ion, another product of HO-1, upregulates ferritin, which also has scavenger activity.	SEN:10034388	18633191
BEL:20072314	a(CHEBI:ceramide) increases bp(GOBP:"necrotic cell death")	Other mediators of TNF-induced necroptosis are calcium, ceramide, cytosolic phospholipase A2 (cPLA2) and lysosomal membrane permeabilization (LMP).	SEN:10034408	20010783
BEL:20072336	a(CHEBI:cholesterol) increases bp(GOBP:"neutrophil chemotaxis")	Here we demonstrate that cholesterol was absolutely required for polarized redistribution of key chemotactic mediators in human neutrophils in response to all chemoattractants tested (fMet-Leu-Phe, and the chemokines CXCL1, CXCL8 and CXCL12).	SEN:10034424	18311596
BEL:20072348	a(CHEBI:curcumin) increases p(HGNC:NFE2L2)	Also, studies in renal epithelial and MDA-MB468 breast cells showed the parallel increase in Nrf2 nuclear protein and hemoxygenase-1 in response to curcumin (18,19).	SEN:10034434	18321868
BEL:20072356	a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))	Dexamethasone time-dependently increased the levels of HSP27, while having no effect on the levels of HSP70 or HSP90.	SEN:10034440	12112005
BEL:20072362	a(CHEBI:dexamethasone) increases tscript(p(HGNC:NR3C1))	Treatment of the cells with the beta2-AR agonists, salbutamol or salmeterol, resulted in translocation of GR into the nucleus beginning at 30 min activation of GR induced by the corticosteroids dexamethasone and fluticasone occurred at the same time after treatment (30 min)	SEN:10034444	9873044
BEL:20072364	a(CHEBI:"double-stranded DNA") increases cat(p(HGNC:MYD88))	Finally, we determined that bacterial DNA stimulated CD11b up-regulation in TLR9(-/-) but not in MyD88(-/-) mouse neutrophils, supporting that bacterial DNA induces neutrophil activation through a TLR9-independent and MyD88-dependent pathway.	SEN:10015644	16951367
BEL:20072374	a(CHEBI:heme) directlyDecreases tscript(p(HGNC:BACH1))	Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of ho-1, promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements. 	SEN:10034454	14747657
BEL:20072376	a(CHEBI:heme) increases kin(p(HGNC:EGFR))	In addition, heme-induced IL-8 expression utilizes a novel pathway involving meprin, EGF receptor, and MyD88.	SEN:10034456	21193404
BEL:20072390	a(CHEBI:"hyaluronic acid") directlyIncreases cat(p(HGNC:TLR2))	Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).	SEN:10034464	16891671
BEL:20072394	a(CHEBI:"hyaluronic acid") directlyIncreases cat(p(HGNC:TLR4))	Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).	SEN:10034464	16891671
BEL:20072398	a(CHEBI:"hydrogen peroxide") decreases cat(p(HGNC:SIRT1))	Human umbilical vein endothelial cells (HUVECs) exposed to cigarette smoke extract (CSE) and H(2)O(2) showed decreased SIRT1 levels, activity, but increased phosphorylation concomitant with increased eNOS acetylation.	SEN:10034470	20102704
BEL:20072404	a(CHEBI:"hydrogen peroxide") increases bp(GOBP:"necrotic cell death")	Therefore, this study analyzed, by high-resolution live-cell imaging, the occurrence of ROS generation, changes in mitochondrial transmembrane potential (MTP), LMP and plasma membrane permeabilization (PMP) during TNF-mediated necroptosis, H2O2-induced necrosis and anti-Fas-mediated secondary necrosis in the same cellular context, that is, in L929sAhFas cells.	SEN:10034474	20010783
BEL:20072422	a(CHEBI:"hydrogen peroxide") increases p(HGNC:EGFR,pmod(P,Y))	we show that exposure to cigarette smoke over the indicated time points or doses results in an increase in total EGFR phosphorylation in a timeand dose-dependent manner (Fig. 1). As with EGF and H2O2, cigarette smoke is able to induce EGFR phosphorylation significantly compared to nontreated cells. Note: human airway epithelial (HAE; A549 or HBE1) were used in the paper	SEN:10034486	17971399
BEL:20072442	a(CHEBI:"leukotriene B4") decreases p(HGNC:IL12B)	Consistent with the effects of leukotriene antagonists, exogenous LTB(4) enhanced LPS-stimulated IL-10 release by approximately 39% and inhibited IL-12 p40 release by approximately 22%	SEN:10015866	16313356
BEL:20072444	a(CHEBI:"leukotriene B4") directlyIncreases tscript(p(HGNC:PPARA))	hypolipidemic fibrates and eicosanoids such as leukotriene B4 and 8(S)-hydroxyeicosatetraenoic acid (8(S)-HETE) are synthetic and natural ligands respectively for PPARa.	SEN:10015870	11852057
BEL:20072448	a(CHEBI:"leukotriene B4") increases cat(p(HGNC:LTB4R))	Leukotriene B4 receptor (BLT1-receptor, LTB4R) antagonists, such as LY29311 (typo in manuscript - should be LY293111)  have been developed.	SEN:10034494	15602009
BEL:20072464	a(CHEBI:lipopolysaccharide) directlyIncreases cat(p(HGNC:TLR4))	Lipopolysaccharides (LPS), which activate Toll-like receptor 4 (TLR4), reduced PPARgamma expression and function in peritoneal macrophages and macrophage cell lines	SEN:10015902	18422969
BEL:20072492	a(CHEBI:lipopolysaccharide) increases p(HGNC:ITGAM)	PMNs incubated with LOS for 30 min increased surface expression of cyt b558  by 128 ± 40.3%, whereas NFA-treated PMNs showed virtually no increase after LOS (Fig. 5A). CD11b expression was similarly affected (Fig. 5B).	SEN:10034522	17908687
BEL:20072496	a(CHEBI:"lipoxin A4") decreases bp(GOBP:"neutrophil chemotaxis")	Lipoxin A4 and lipoxin B4 inhibit neutrophil entry into inflamed sites and counter-regulate the main aspects of inflammation.	SEN:10034524	18437155
BEL:20072504	a(CHEBI:"lipoxin A4") increases bp(GOBP:phagocytosis)	LipoxinA4 rapidly stimulates macrophages to phagocytose apoptotic neutrophils, induces RhoA- and Rac-dependent cytoskeleton re-organization of macrophages and inhibits macrophage CXCL8 release, supporting macrophage-mediated resolution of inflammation. In turn,as a result of engulfment of apoptotic neutrophils, macrophages themselves become a primary source of lipoxins  	SEN:10034532	22566854
BEL:20072506	a(CHEBI:"lipoxin A4") increases gtp(p(HGNC:RHOA))	LipoxinA4 rapidly stimulates macrophages to phagocytose apoptotic neutrophils, induces RhoA- and Rac-dependent cytoskeleton re-organization of macrophages and inhibits macrophage CXCL8 release, supporting macrophage-mediated resolution of inflammation. In turn,as a result of engulfment of apoptotic neutrophils, macrophages themselves become a primary source of lipoxins  	SEN:10034532	22566854
BEL:20072534	a(CHEBI:ozone) increases p(HGNC:FOSL1)	Ozone and beta-epoxide were strong inducers of nuclear factor erythroid 2-related factor 2, heat shock protein 70, and Fos-related antigen 1 protein expression. 	SEN:10034552	20219673
BEL:20072572	a(CHEBI:"reactive oxygen species") increases bp(GOBP:"necrotic cell death")	Reactive oxygen species (ROS) derived from mitochondria are required for TNF- and double-strand RNA-induced necroptosis in L929 cells N-type NIH 3T3 cells, macrophages, and mouse embryonic fibroblasts.	SEN:10034582	19632174
BEL:20072580	a(CHEBI:"reactive oxygen species") increases bp(GOBP:"response to oxidative stress")	Newly synthesized heme can be incorporated into heme proteins or, alternatively, can be degraded. Accumulation of intracellular or exogenous (e.g., in blood clot) heme can be detrimental to cells, since heme catalyzes the formation of ROS, resulting in oxidative stress.	SEN:10034590	12869663
BEL:20072592	a(CHEBI:"reactive oxygen species") increases cat(p(HGNC:ADAM17))	The smoke-triggered mechanism includes the generation of oxygen radicals, which in turn stimulate tumor necrosis factor alpha-converting enzyme (a disintegrin and metalloproteinase (ADAM) 17) to cleave transmembrane amphiregulin, a ligand for the epidermal growth factor receptor (EGFR).	SEN:10034598	12711607
BEL:20072594	a(CHEBI:"reactive oxygen species") increases cat(p(HGNC:ADAM17))	We conclude that multiple TLR ligands induce airway epithelial cell production of IL-8 and VEGF via a Duox1--> ROS--> TACE--> TGF-alpha--> EGFR phosphorylation pathway. 	SEN:10034600	18375743
BEL:20072608	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:EGFR))	activated neutrophils secrete TNF, which induces EGFR expression in airway epithelial cells, activated neutrophils release reactive oxygen species, which activate EGFR , neutrophil elastase cleaves the EGFR proligand, pro-transforming growth factor (TGF)-alpha, releasing mature TGF alpha which activates EGFR in a ligand-dependent fashion , neutrophil elastase causes potent goblet cell degranulation 	SEN:10034612	15219174
BEL:20072612	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:EGFR))	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on hyaluronan depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation (ERK activation).	SEN:10034616	18757307
BEL:20072614	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAP3K5))	Apoptosis signal-regulating kinase 1 (ASK1), also called mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 5 (MEKK5), can be activated in response to various stress signals, including genotoxic stress (21), oxidative stress, reactive oxygen species (ROS) (22), and laminar flow (23).	SEN:10034618	12566458
BEL:20072618	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAP3K5))	Apoptosis signal-regulating kinase-1 (MAP3K5) is held in an inactive conformation by thioredoxin and when oxidized by ROS, this triggers the apoptotic pathway.	SEN:10034622	15602009
BEL:20072620	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAPK1))	These data demonstrate that it is the hemin-induced surge in cellular ROS levels, in particular the superoxide generated most likely from NADPH oxidase activity, and consequent oxidative stress which mediates Egr-1 upregulation via ERK-1/2 activation.	SEN:10034624	17967787
BEL:20072628	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:MAPK3))	These data demonstrate that it is the hemin-induced surge in cellular ROS levels, in particular the superoxide generated most likely from NADPH oxidase activity, and consequent oxidative stress which mediates Egr-1 upregulation via ERK-1/2 activation.	SEN:10034624	17967787
BEL:20072636	a(CHEBI:"reactive oxygen species") increases kin(p(HGNC:SRC))	c-Src has also been shown to be activated in response to ROS, including H2O2, in different cell types (19,20, 33,37,50).	SEN:10034632	17406055
BEL:20072662	a(CHEBI:"reactive oxygen species") increases p(HGNC:IL8)	These effects (TLR2,3,5,6 activation of VEGF and IL8) were prevented by treatment with a selective inhibitor of EGFR phosphorylation (AG-1478), a metalloprotease (MP) inhibitor, a reactive oxygen species (ROS) scavenger, and an NADPH oxidase inhibitor. 	SEN:10034644	18375743
BEL:20072712	a(CHEBI:rosiglitazone) directlyIncreases tscript(p(HGNC:PPARG))	To confirm that the PPARg/RXR transcriptional activation system was active in lung fibroblasts, primary cultures were transfected with a PPARg-dependent luciferase reporter con-struct and treated with 15d-PGJ2 or rosiglitazone. Both PPARg agonists activated the reporter, demonstrating that primary human lung fibroblasts are competent to carry out PPARg- dependent transcriptional activation (Fig. 1B).	SEN:10034674	15734787
BEL:20072720	a(CHEBI:thapsigargin) increases bp(GOBP:"response to endoplasmic reticulum stress")	Lower levels of eIF2alpha phosphorylation in Nck-overexpressing cells were still observed for up to 24 h of treatment with Tn (data not shown) or with the calcium ATPase inhibitor thapsigargin, which also induces ER stress (Tg) (Fig. 1, B  and D), demonstrating that Nck overexpression causes a long-lasting inhibition of eIF2alpha Ser51 phosphorylation. 	SEN:10034680	16835242
BEL:20072722	a(CHEBI:thapsigargin) increases bp(GOBP:"response to endoplasmic reticulum stress")	The ATF4+/- MEF cells experiencing an ER stress (thapsigargin) increased VEGF expression 2.0-fold. This induction was completely abolished in the ATF4-/- MEF strain, indicating the importance of ATF4 in VEGF regulation during ER stress.	SEN:10025270	15788408
BEL:20072724	a(CHEBI:thapsigargin) increases bp(GOBP:"response to endoplasmic reticulum stress")	transcription from the human C/EBPbeta gene is induced in response to endoplasmic reticulum stress, such as glucose deprivation, or treatment of cells with tunicamycin or thapsigargin.	SEN:10034682	15102854
BEL:20072734	a(CHEBI:"vitamin E") decreases a(CHEBI:"reactive oxygen species")	Furthermore, in many types of cells, antioxidants diminish or completely eliminate NF-kB activation (Table 1). For example, H2O2, UV, and ionizing radiation have all been observed to stimulate degradation of IkB (Table 1). Conversely, antioxidants and reductants such as BHA, NGA, a-tocopherol, NAC, and PDTC decrease NF-kB activity and translocation [12,253].	SEN:10034686	10699758
BEL:20073268	bp(GOBP:"cell aging") increases p(HGNC:IL8)	We veri?ed the secretion levels of several SASP proteins by ELISAs (Figure S1 and Text S1). Further, because secretion increased greater than 10-fold for some SASP factors, we could verify up-regulation by intracellular immunostaining. For example, IL-6 and IL-8 were barely visible in PRE cells but clearly detectable in SEN cells (Figure 1B, Figure S2, and Text S1).	SEN:10034990	19053174
BEL:20073320	bp(GOBP:"hyperosmotic response") increases kin(p(HGNC:ATM))	Reconstitution of the AT cells with wild-type ATM increases TonEBP/OREBP transactivating activity both at 300 and 500 mosmol/kg, but the inactive mutant, ATM S1981A, does not (Fig. 3E). We conclude that ATM regulates transactivating activity of TonEBP/OREBP.	SEN:10035008	15173573
BEL:20073322	bp(GOBP:"hyperosmotic response") increases kin(p(HGNC:MAPK14))	NMuMg mammary epithelial cells exposed to hyperosmotic stress induced by the organic osmolyte sorbitol, heat shock, ultraviolet irradiation, oxidative stress induced by hydrogen peroxide... The environmental stresses, but not dexamethasone, stimulatedSgk expression through a p38/MAPK-dependent pathway.	SEN:10035010	12488318
BEL:20073344	bp(GOBP:"mast cell activation") increases a(CHEBI:"leukotriene C4")	Ag stimulation of Lyn unique domain transfectants was accompanied by enhanced phosphorylation of MEK and ERK-2, which are required for leukotriene C4 (LTC4) release, and production of LTC4 was increased 3- to 5-fold, compared with cells transfected with vector alone. 	SEN:10035020	16177098
BEL:20073346	bp(GOBP:"mast cell activation") increases p(HGNC:IL13)	Jaffe et al. [22,23] reported IL-5 and IL-13 production from human lung mast cells following IgE-mediated activation.	SEN:10018050	10971465
BEL:20073348	bp(GOBP:"mast cell activation") increases p(HGNC:IL5)	Using immunocytochemistry, Bradding et al. [1±4] reported that interleukin (IL)-4, IL-5, IL-6, and tumour necrosis factor (TNF)-a were present within mast cells in nasal and bronchial mucosa taken from both normal subjects and patients with allergic perennial rhinitis,	SEN:10018052	10971465
BEL:20073374	bp(GOBP:"necrotic cell death") increases p(HGNC:S100A12)	Calgranulins comprise three proteins, S100A8 (calgranulin A), S100A9 (calgranulin B), and S100A12 (calgranulin C), that are predominantly released by necrotic neutrophils, monocytes, and activated macrophages, respectively, and stimulate TLR4 or RAGE (receptor for advanced glycation end-products)	SEN:10035024	20823910
BEL:20073376	bp(GOBP:"necrotic cell death") increases p(HGNC:S100A8)	Calgranulins comprise three proteins, S100A8 (calgranulin A), S100A9 (calgranulin B), and S100A12 (calgranulin C), that are predominantly released by necrotic neutrophils, monocytes, and activated macrophages, respectively, and stimulate TLR4 or RAGE (receptor for advanced glycation end-products)	SEN:10035024	20823910
BEL:20073378	bp(GOBP:"necrotic cell death") increases p(HGNC:S100A9)	Calgranulins comprise three proteins, S100A8 (calgranulin A), S100A9 (calgranulin B), and S100A12 (calgranulin C), that are predominantly released by necrotic neutrophils, monocytes, and activated macrophages, respectively, and stimulate TLR4 or RAGE (receptor for advanced glycation end-products)	SEN:10035024	20823910
BEL:20073390	bp(GOBP:"neutrophil activation") increases p(HGNC:MUC5AC)	Multiple agents, including cigarette smoke (15), activated eosinophils (16), interleukin-13 (17), neutrophil elastase (18), Pseudomonas aeruginosa (19), and phorbol 12-myristate 13- acetate (PMA) (20) increase MUC5AC in airway epithelial cells (NCI-H292)...	SEN:10035026	15531749
BEL:20073414	bp(GOBP:"replicative cell aging") increases p(HGNC:IGFBP2)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073418	bp(GOBP:"replicative cell aging") increases p(HGNC:IGFBP3)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)  	SEN:10035038	19053174
BEL:20073422	bp(GOBP:"replicative cell aging") increases p(HGNC:IRF5)	By Western blot analysis of senescing MDAH041 cells (PD 23), we observed increased expression of IRF5, IRF7, and STAT1 proteins during senescence, as well as an increase in STAT1 phosphorylation at Tyr701 (Fig. 1  ).	SEN:10035040	18505922
BEL:20073434	bp(GOBP:"replicative cell aging") increases p(HGNC:SERPINE1)	In senescent endothelial cells, PAI-1 mRNA and protein are constitutively high, but uninducible by exogenous interleukin 1 alpha as well as by the phorbol ester TPA. Interestingly the increase of PAI-1 levels correlates with the upregulation of interleukin 1 alpha, which characterizes endothelial cell senescence.	SEN:10035048	7628547
BEL:20073436	bp(GOBP:"replicative cell aging") increases p(HGNC:SERPINE1)	 Prostacyclin production shows a significant decrease with the in vitro aging of endothelial cells (87), while senescent endothelial cells display upregulation of plasminogen activator inhibitor-1 (88).	SEN:10035050	17981770
BEL:20073442	bp(GOBP:"replicative cell aging") increases p(HGNC:STAT1,pmod(P,Y,701))	By Western blot analysis of senescing MDAH041 cells (PD 23), we observed increased expression of IRF5, IRF7, and STAT1 proteins during senescence, as well as an increase in STAT1 phosphorylation at Tyr701 (Fig. 1  ).	SEN:10035040	18505922
BEL:20073450	bp(GOBP:"cellular response to DNA damage stimulus") increases bp(GOBP:"stress-induced premature senescence")	 In the present study, we found that when RSK4 is inhibited in vitro using short hairpin RNA technology, cells can bypass stress-induced senescence and oncogene-induced senescence: normal human fibroblasts grew following oxidative stress, induction of DNA damage and KRAS(V12) or BRAF(E600) overexpression.	SEN:10035054	21239520
BEL:20073454	bp(GOBP:"cellular response to DNA damage stimulus") increases bp(GOBP:"stress-induced premature senescence")	Oxidative stress and DNA damage can induce premature senescence in vascular cells, and it has been theorized that both processes contribute to atherogenesis.33,34	SEN:10035058	18762784
BEL:20073458	bp(GOBP:"cellular response to DNA damage stimulus") increases kin(p(HGNC:ATM))	activation of the G2 checkpoint begins with the detection of DNA damage by the sensory molecules ATM and ATR	SEN:10035062	15286739
BEL:20073470	bp(GOBP:"cellular response to DNA damage stimulus") increases kin(p(HGNC:ATR))	activation of the G2 checkpoint begins with the detection of DNA damage by the sensory molecules ATM and ATR	SEN:10035062	15286739
BEL:20073480	bp(GOBP:"response to endoplasmic reticulum stress") increases bp(GOBP:"cell death")	Excessive and prolonged ER stress triggers cell suicide, usually in the form of apoptosis, representing a last resort of multicellular organisms to dispense of dysfunctional cells. Progress in understanding the mechanisms underlying these 3 phases of adaptation, alarm, and apoptosis has improved our knowledge of ER stress, and its role in disease.	SEN:10035074	16200199
BEL:20073486	bp(GOBP:"response to endoplasmic reticulum stress") increases bp(GOBP:"apoptotic process")	Cells from mice deficient in caspase-12 were partially resistant to ER stress-induced apoptosis but still succumbed to other death stimuli.	SEN:10018846	14561771
BEL:20073488	bp(GOBP:"response to endoplasmic reticulum stress") increases bp(GOBP:"apoptotic process")	Endoplasmic reticulum (ER) stress-induced apoptosis has been implicated in the development of multiple diseases.	SEN:10035080	16407291
BEL:20073490	bp(GOBP:"response to endoplasmic reticulum stress") increases bp(GOBP:"apoptotic process")	Excessive and prolonged ER stress triggers cell suicide, usually in the form of apoptosis, representing a last resort of multicellular organisms to dispense of dysfunctional cells. Progress in understanding the mechanisms underlying these 3 phases of adaptation, alarm, and apoptosis has improved our knowledge of ER stress, and its role in disease.	SEN:10035074	16200199
BEL:20073494	bp(GOBP:"response to endoplasmic reticulum stress") increases kin(p(HGNC:EIF2AK3))	ER stress triggers PERK-dependent Nrf2 nuclear import.	SEN:10035082	14517290
BEL:20073500	bp(GOBP:"response to endoplasmic reticulum stress") increases kin(p(HGNC:EIF2AK3))	Yeast GCN2 and mammalian PKR and PERK have been shown to be required for autophagy induced by starvation, viral infection, and ER stress, respectively (He and Klionsky, 2009).	SEN:10035088	20965422
BEL:20073562	bp(GOBP:"response to hypoxia") increases a(CHEBI:"reactive oxygen species")	Exposure of PASMC to CH (48 h), however, significantly increased superoxide production [27.6 ± 1.2 a.u. (n = 111) control, 47.1 ± 3.0 a.u. (n = 49) CH; P < 0.01] (Fig. 4A). 	SEN:10035108	17693484
BEL:20073570	bp(GOBP:"response to hypoxia") increases bp(GOBP:glycolysis)	under hypoxic conditions, cells switch their methods of glucose metabolism from the oxygen-dependent TCA cycle to glycolysis	SEN:10035116	11902584
BEL:20073576	bp(GOBP:"response to hypoxia") increases bp(GOBP:"apoptotic process")	most of the hypoxia-induced pathways promote tumor growth, but apoptosis is also induced by hypoxia	SEN:10035122	11902584
BEL:20073578	bp(GOBP:"response to hypoxia") increases bp(GOBP:"apoptotic process")	Suppression of NPM expression by small interfering RNA targeting NPM increases hypoxia-induced apoptosis	SEN:10035124	15310764
BEL:20073590	bp(GOBP:"response to hypoxia") increases kin(p(HGNC:EIF2AK3))	PERK mediates the transcriptional activation of the proteins LC3 and Atg5 in hypoxic responses through the action of the transcription factors ATF4 and CHOP, respectively (Rouschop et al., 2010).	SEN:10035134	20965422
BEL:20073604	bp(GOBP:"response to hypoxia") increases p(HGNC:IL6)	Hypoxia exposure of IL-6+/+ mice led to marked increases in IL-6 mRNA and protein levels within the first week, with positive IL-6 immunostaining in the pulmonary vessel walls  ...In vitro studies of cultured human pulmonary-artery smooth-muscle-cells (PA-SMCs) and microvascular endothelial cells revealed prominent synthesis of IL-6 by PA-SMCs, with further stimulation by hypoxia.	SEN:10035140	19173740
BEL:20073612	bp(GOBP:"response to hypoxia") increases p(HGNC:TGFB1)	Collectively, these results demonstrate that hypoxic hepatocytes activate latent TGF-beta1 and that this stimulates hepatocyte EMT. 	SEN:10035148	20158611
BEL:20073616	bp(GOBP:"response to hypoxia") increases p(HGNC:VEGFA)	67,68 and of multidrug- resistance-associated proteins69. So, there is a complexity of opposing factors that are involved in the hypoxia response. In a normal tissue, hypoxia leads to induction of VEGF RNA stability, transcription and translation58,70,71.	SEN:10035150	12778130
BEL:20073622	bp(GOBP:"response to hypoxia") increases p(HGNC:VEGFA)	Table I - Gene expression by macrophages under hypoxic conditions {this table is a literature review with many primary references}  -- some genes are not modeled because the species is not evident by respective paper's title and abstract	SEN:10035156	16272275
BEL:20073626	bp(GOBP:"response to hypoxia") increases p(HGNC:VEGFA)	VEGF endogenous production may be upregulated in vascular smooth muscle cells by hypoxia, growth factors (bFGF and PDGF-BB), and cytokines	SEN:10018124	11350732
BEL:20073634	bp(GOBP:"response to hypoxia") increases r(HGNC:MIR210)	In these experiments, we analyzed the expression levels of these miRs in HeLa, as well as in MCF-7 cells, after 48 hours of hypoxia or normoxia, which is a time point that we have previously shown to be biologically relevant for changes in DNA repair activity ( 11). Both MCF-7 and HeLa cells had increased levels of miR-210; these were induced ?10- to 12-fold above basal levels in both cell lines ( Fig. 1C).	SEN:10035166	19141645
BEL:20073646	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:CREB1))	several other transcription factors are activated by hypoxia, CREB and NFKB	SEN:10035174	11902584
BEL:20073650	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	Here, we demonstrate that p38alpha-/- cells fail to activate HIF-1 under hypoxic conditions.	SEN:10035178	15923604
BEL:20073652	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	HIF1A, induces angiogenesis by activation of VEGFA transcription under hypoxic conditions	SEN:10035180	12778130
BEL:20073660	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	Intratumoral hypoxia and genetic alterations can lead to HIF-1a overexpression, which has been associated with increased patient mortality in several cancer types. In preclinical studies, inhibition of HIF-1 activity has marked effects on tumour growth. Efforts are underway to identify inhibitors of HIF-1 and to test their efficacy as anticancer therapeutics.	SEN:10035186	13130303
BEL:20073662	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	one way that cells respond to reduced oxygen levels is through hypoxia-inducible transcription factor-1 HIF1 is a heterodimer that consists of HIF1A and the constituitvely expressed ARNT	SEN:10035188	11902584
BEL:20073664	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	The MEFs that were positive for HIF-1? were capable of inducing miR-210, which is in contrast to the MEFs that were deficient in HIF-1? ( Fig. 2B, top). In parallel, the hypoxia-inducible gene DEC1 was seen to be up-regulated only in the HIF-1??expressing MEFs ( Fig. 2B, bottom).	SEN:10018174	19141645
BEL:20073668	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	Thus hypoxia or DMOG exposure potently stabilizes HIF-1 and induces HIF-1-dependent transactivation in HL-1 cardiomyocytes.	SEN:10018168	17545479
BEL:20073670	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	Under hypoxic condition, HIF proteins enhance this transcriptional activation response by co-occupying Notch target genes together with Notch ICD[30] (Fig. 2).	SEN:10018170	17885420
BEL:20073674	bp(GOBP:"response to hypoxia") increases tscript(p(HGNC:HIF1A))	With regard to miR-373 expression, the HIF-1A-shRNA vector suppressed the induction of miR-373 in hypoxic cells, indicating a role for HIF-1A in the up-regulation of miR-373 in response to hypoxia ( Fig. 2C)	SEN:10035194	19141645
BEL:20073694	bp(GOBP:"response to oxidative stress") increases bp(GOBP:"cellular response to DNA damage stimulus")	Cigarette smoke is a complex mixture of over 4000 compounds and high levels of oxidants and reactive oxygen species (ROS) have been detected in both mainstream and sidestream smoke. Oxidative stress that ensues, when the antioxidant defences are depleted, is accompanied by increases in ROS production in lung epithelial cells. Cigarette smoke-mediated oxidative stress produces DNA damage	SEN:10035206	19604067
BEL:20073696	bp(GOBP:"response to oxidative stress") increases bp(GOBP:"cellular response to DNA damage stimulus")	Oxidative stress induces DNA damage.	SEN:10035208	16120194
BEL:20073698	bp(GOBP:"response to oxidative stress") increases bp(GOBP:"response to endoplasmic reticulum stress")	Many disturbances, including those of cellular redox regulation, cause accumulation of unfolded proteins in the ER, triggering an evolutionarily conserved response, termed the unfolded protein response (UPR).	SEN:10035078	16200199
BEL:20073702	bp(GOBP:"response to oxidative stress") increases bp(GOBP:"stress-induced premature senescence")	 In the present study, we found that when RSK4 is inhibited in vitro using short hairpin RNA technology, cells can bypass stress-induced senescence and oncogene-induced senescence: normal human fibroblasts grew following oxidative stress, induction of DNA damage and KRAS(V12) or BRAF(E600) overexpression.	SEN:10035054	21239520
BEL:20073706	bp(GOBP:"response to oxidative stress") increases bp(GOBP:"stress-induced premature senescence")	Oxidative stress and DNA damage can induce premature senescence in vascular cells, and it has been theorized that both processes contribute to atherogenesis.33,34	SEN:10035058	18762784
BEL:20073714	bp(GOBP:"response to oxidative stress") increases kin(p(HGNC:MAP3K5))	Under conditions of oxidative stress, oxidation of the Trx dithiol induces dissociation of the Trx ASK1 complex, resulting in ASK1 activation and downstream MAP kinase signaling (Saitoh et al., 1998).	SEN:10035214	15480426
BEL:20073728	bp(GOBP:"response to oxidative stress") increases tscript(p(HGNC:TP53))	These results suggest that Bach1 is a negative regulator of the p53-mediated senescence program in response to oxidative stress, although Bach1 could be either parallel or upstream to p53 in this process.	SEN:10018212	19011633
BEL:20073748	bp(GOBP:"response to UV") increases bp(GOBP:"cellular response to DNA damage stimulus")	DNA damage caused by UV irradiation ... from full text, HeLa cells and normal human fibroblasts	SEN:10035230	17567951
BEL:20073770	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:CCL5)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073774	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:CXCL5)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073778	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:IGFBP2)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073784	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:IGFBP3)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073786	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:IGFBP5)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073796	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:IL1A)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073798	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:KITLG)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073810	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:TNFRSF1B)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073814	bp(GOBP:"stress-induced premature senescence") increases p(HGNC:VEGFA)	SASP components included inflammatory and immune-modulatory cytokines and chemokines (e.g., IL-6, ?7, and ?8, MCP-2, and MIP-3a). They also included growth factors (e.g., GRO, HGF, and IGFBPs), shed cell surface molecules (e.g., ICAMs, uPAR, and TNF receptors), and survival factors (Figure 1A and Table S2)	SEN:10035034	19053174
BEL:20073836	bp(GOBP:"protein metabolic process") increases bp(GOBP:"response to endoplasmic reticulum stress")	Importantly, cycloheximide treatment also completely suppressed PERK (Thr980) phosphorylation in both Tsc1-/- and Tsc2-/- cells (Figure S1C), supporting the hypothesis that increased protein synthesis is likely the underlying mechanism for activation of UPR in TSC1- and TSC2-deficient cells.	SEN:10015590	18342602
BEL:20073926	cat(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) increases bp(GOBP:"cell adhesion")	VEGF enhanced cell adhesion, migration, soluble ligand binding, and adenovirus gene transfer mediated by alphavbeta3 and also activated other integrins, alphavbeta5, alpha5beta1, and alpha2beta1, involved in angiogenesis.  The major findings of our studies are as follows. First, VEGF165 can activate integrin aVb3, leading to enhanced adhesion of endothelial cells to a variety of ligands.	SEN:10035282	11090623
BEL:20073928	cat(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) increases cat(p(HGNC:MMP14))	Major functions of the alpha2beta1 receptor include the induction of MMP1, % MMP13 and MT1-MMP, as well as activation of proMMP2	SEN:10035284	11701397
BEL:20073930	cat(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) increases cat(p(HGNC:MMP1))	Major functions of the alpha2beta1 receptor include the induction of MMP1, % MMP13 and MT1-MMP, as well as activation of proMMP2	SEN:10035284	11701397
BEL:20073932	cat(complex(p(HGNC:ITGA2),p(HGNC:ITGB1))) increases cat(p(HGNC:MMP2))	Major functions of the alpha2beta1 receptor include the induction of MMP1, % MMP13 and MT1-MMP, as well as activation of proMMP2	SEN:10035284	11701397
BEL:20073940	cat(complex(p(HGNC:ITGA3),p(HGNC:ITGB1))) decreases bp(GOBP:"cell adhesion")	TGF-B is a potent regulator of cellular adhesion, motility, and the extracellular matrix. TGF-B regulates the adhesive properties of cells by decreasing the expression of E-cadherin59 to decrease cell adhesion, by increasing the expression of invasion-associated integrins including AIIIB1 integrin, and by increasing the expression of integrin-binding proteins including fibulin	SEN:10035290	15774796
BEL:20073942	cat(complex(p(HGNC:ITGA5),p(HGNC:ITGB1))) increases bp(GOBP:"cell adhesion")	VEGF enhanced cell adhesion, migration, soluble ligand binding, and adenovirus gene transfer mediated by alphavbeta3 and also activated other integrins, alphavbeta5, alpha5beta1, and alpha2beta1, involved in angiogenesis.  The major findings of our studies are as follows. First, VEGF165 can activate integrin aVb3, leading to enhanced adhesion of endothelial cells to a variety of ligands.	SEN:10035282	11090623
BEL:20073948	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) directlyIncreases cat(p(HGNC:MMP2))	MMP-2 binds to ?v?3 at the cell surface, and blocking this binding inhibits MMP-2 protease activity in cultured cells, suppressing angiogenesis and tumour growth in chorioallantoic membrane assays43.Conversely, the membrane MMP (MT-1) cleaves ?v?3, enhancing the ligand binding activity of this integrin44. So,?v?3 seems to be important in regulating angiogenesis in adult animals.	SEN:10035292	12635171
BEL:20073952	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) increases bp(GOBP:"cell adhesion")	VEGF enhanced cell adhesion, migration, soluble ligand binding, and adenovirus gene transfer mediated by alphavbeta3 and also activated other integrins, alphavbeta5, alpha5beta1, and alpha2beta1, involved in angiogenesis.  The major findings of our studies are as follows. First, VEGF165 can activate integrin aVb3, leading to enhanced adhesion of endothelial cells to a variety of ligands.	SEN:10035282	11090623
BEL:20073954	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) increases kin(p(HGNC:KDR))	Finally, the ?v?3 integrin physically associates with VEGFR2, and the binding of ?v?3 to its ECM ligands increases VEGF signalling in cell cultures38,39.	SEN:10035296	12635171
BEL:20073958	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3))) increases kin(p(HGNC:KDR))	VEGFR-2 phosphorylation and mitogenicity induced by VEGF-A165 were enhanced in cells plated on the alphavbeta3 ligand, vitronectin	SEN:10035300	10022831
BEL:20073962	cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB6))) increases bp(GOBP:"cell migration")	For example, integrin a5b1 binding to fibronectin suppresses cell migration [48], while aVb6-mediated fibronectin binding promotes it [49].	SEN:10035302	14984767
BEL:20073968	cat(complex(p(HGNC:TSC1),p(HGNC:TSC2))) directlyDecreases gtp(p(HGNC:RHEB))	The tuberin-hamartin complex is active as a GTPase-activating protein (GAP) towards Rheb, causing hydrolysis of GTP by Rheb and conversion from the active GTP-bound form to the inactive GDP-bound form. Active proteins are denoted with an asterisk	SEN:10035306	14607085
BEL:20073974	cat(p(EGID:3579)) increases a(CHEBI:"reactive oxygen species")	The location of CXCR2 in endosomes can be considered as a surrogate marker for CXCR2 activation (Sai et al., 2006 and Figure S12) and correlates with other effects caused by CXCR2 activation such as production of reactive oxygen species (ROS) (Figure S13).	SEN:10035310	18555777
BEL:20073978	cat(p(EGID:8260)) directlyIncreases p(HGNC:TSC2)	ARD1 acetylates TSC2 at Met1, thereby stabilizing TSC2 and increasing its abundance.	SEN:10035314	20145209
BEL:20073982	cat(p(HGNC:ADAM10)) increases p(HGNC:HBEGF)	from full text - Stimulation of cells with bombesin increased the amount of shed HB-EGF in the medium. KUZ enhanced the ability of bombesin to release HB-EGF into the medium (Fig. 3 A).	SEN:10035316	12119356
BEL:20073984	cat(p(HGNC:ADAM10)) increases p(HGNC:HBEGF)	it was recently shown that the metalloproteinase with a disintegrin domain (ADAM)-10 mediates ErbB1 transactivation after bombesin treatment	SEN:10035318	12648469
BEL:20073992	cat(p(HGNC:ADAM17)) increases p(HGNC:AREG)	# sentences for pubmedID=12743035: # GeneRif: Data show that in squamous cell carcinoma cells, stimulation with G protein-coupled receptor agonists specifically results in cleavage and release of amphiregulin (AR) by TACE.	SEN:10035320	12743035
BEL:20073994	cat(p(HGNC:ADAM17)) increases p(HGNC:NRG1)	Mechanistic studies revealed that HER2 trans-activation by IL-1?? required a disintegrin and metalloprotease 17 (ADAM17)-dependent shedding of the ligand neuregulin-1 (NRG-1). In murine models of ALI, NRG-1-HER2 signaling was activated, and ADAM17 blockade resulted in decreased NRG-1 shedding, HER2 activation, and lung injury in vivo.	SEN:10035322	21247898
BEL:20073996	cat(p(HGNC:ADAM17)) increases p(HGNC:TGFA)	EGFR appear to play a key role in the regulation of mucus hypersecretion, with increased expression of mucin genes (MUC5AC, MUCB. EGFRs are activated by TGF-{alpha}, which is in turn activated by TACE activated via release of oxidants from cigarette smoke and neutrophils. TGF-{alpha} may also be activated by IL-13 and IL-9.	SEN:10035324	15602009
BEL:20073998	cat(p(HGNC:ADAM17)) increases p(HGNC:TGFA)	We conclude that multiple TLR ligands induce airway epithelial cell production of IL-8 and VEGF via a Duox1--> ROS--> TACE--> TGF-alpha--> EGFR phosphorylation pathway. 	SEN:10034600	18375743
BEL:20074024	cat(p(HGNC:AGER)) increases kin(p(HGNC:MAPK1))	In addition to NF-?B, among the known pathways that can be activated by RAGE are phosphoinositide 3-kinases (PI3K)/Akt (also termed as protein kinase B), and mitogen-activated protein kinase members (MAPKs) (52,53). The latter group includes Jun-N-terminal kinase (JNK), p38, and extracellular signal-regulated kinases (ERK) (54,55) (Figure 2).	SEN:10035340	19273137
BEL:20074030	cat(p(HGNC:AGER)) increases kin(p(HGNC:MAPK3))	In addition to NF-?B, among the known pathways that can be activated by RAGE are phosphoinositide 3-kinases (PI3K)/Akt (also termed as protein kinase B), and mitogen-activated protein kinase members (MAPKs) (52,53). The latter group includes Jun-N-terminal kinase (JNK), p38, and extracellular signal-regulated kinases (ERK) (54,55) (Figure 2).	SEN:10035340	19273137
BEL:20074060	cat(p(HGNC:APEX1)) increases bp(GOBP:"single strand break repair")	In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A	SEN:10035358	17289756
BEL:20074072	cat(p(HGNC:BAD)) increases bp(GOBP:"apoptotic process")	another family share only the short BH3 domain, which is necessary and probably sufficient for their killing activity this family contains Bim, Bik, Bad, Puma, Bid, Noxa, Hrk, and Bmf	SEN:10035364	14561771
BEL:20074086	cat(p(HGNC:BAX)) increases bp(GOBP:"apoptotic process")	either Bax or Bak is required for ER stress-induced apoptosis	SEN:10035376	14561771
BEL:20074090	cat(p(HGNC:BAX)) increases bp(GOBP:"apoptotic process")	MAP-1 is a mitochondria-enriched protein that associates with Bax only upon apoptotic induction, which coincides with the release of cytochrome c from mitochondria. Small interfering RNAs that diminish MAP-1 levels in mammalian cell lines confer selective inhibition of Bax-mediated apoptosis.	SEN:10035380	16199525
BEL:20074098	cat(p(HGNC:BBC3)) directlyIncreases cat(p(HGNC:BAX))	In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells. 	SEN:10035386	17507791
BEL:20074100	cat(p(HGNC:BBC3)) increases cat(p(HGNC:BAK1))	In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells. 	SEN:10035386	17507791
BEL:20074106	cat(p(HGNC:BCL2)) decreases bp(GOBP:"apoptotic process")	Bcl2 and 4 relatives, Bcl-xl, Bcl-w, A1 and Mcl-1, promote cell survival	SEN:10035392	14561771
BEL:20074112	cat(p(HGNC:BCL2)) decreases bp(GOBP:"apoptotic process")	from full text - STAT-3 itself induces the anti-apoptotic factors Bcl-2 and Bcl-xL	SEN:10035398	18666314
BEL:20074114	cat(p(HGNC:BCL2)) decreases bp(GOBP:"apoptotic process")	Phosphorylation of MCL-1 by GSK3b induces ubiquitinylation and subsequent degradation of this anti-apoptotic Bcl-2 protein,92,9	SEN:10035400	19506320
BEL:20074116	cat(p(HGNC:BCL2)) decreases bp(GOBP:"apoptotic process")	Pro-death Bcl-2 family members are sequestered in the cytoplasm until activated, at which time they complex with Bcl-2 or Bcl-xL and inhibit their function	SEN:10035402	12044776
BEL:20074122	cat(p(HGNC:BCL2L11)) directlyIncreases cat(p(HGNC:BAK1))	We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).	SEN:10035408	21041309
BEL:20074124	cat(p(HGNC:BCL2L11)) directlyIncreases cat(p(HGNC:BAX))	We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).	SEN:10035408	21041309
BEL:20074126	cat(p(HGNC:BCL2L11)) increases bp(GOBP:"apoptotic process")	another family share only the short BH3 domain, which is necessary and probably sufficient for their killing activity this family contains Bim, Bik, Bad, Puma, Bid, Noxa, Hrk, and Bmf	SEN:10035364	14561771
BEL:20074136	cat(p(HGNC:BCL2L1)) decreases bp(GOBP:"apoptotic process")	Bcl2 and 4 relatives, Bcl-xl, Bcl-w, A1 and Mcl-1, promote cell survival	SEN:10035392	14561771
BEL:20074140	cat(p(HGNC:BCL2L1)) decreases bp(GOBP:"apoptotic process")	from full text - STAT-3 itself induces the anti-apoptotic factors Bcl-2 and Bcl-xL	SEN:10035398	18666314
BEL:20074142	cat(p(HGNC:BCL2L1)) decreases bp(GOBP:"apoptotic process")	Pro-death Bcl-2 family members are sequestered in the cytoplasm until activated, at which time they complex with Bcl-2 or Bcl-xL and inhibit their function	SEN:10035402	12044776
BEL:20074148	cat(p(HGNC:BCL2L1)) directlyDecreases cat(p(HGNC:BAK1))	We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A). 	SEN:10035418	21041309
BEL:20074150	cat(p(HGNC:BCL2L1)) directlyDecreases cat(p(HGNC:BAX))	NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).	SEN:10035420	12559172
BEL:20074152	cat(p(HGNC:BCL2L1)) directlyDecreases cat(p(HGNC:BAX))	We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A). 	SEN:10035418	21041309
BEL:20074156	cat(p(HGNC:BID)) directlyIncreases cat(p(HGNC:BAK1))	We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).	SEN:10035408	21041309
BEL:20074158	cat(p(HGNC:BID)) directlyIncreases cat(p(HGNC:BAX))	We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).	SEN:10035408	21041309
BEL:20074160	cat(p(HGNC:BID)) increases bp(GOBP:"apoptotic process")	another family share only the short BH3 domain, which is necessary and probably sufficient for their killing activity this family contains Bim, Bik, Bad, Puma, Bid, Noxa, Hrk, and Bmf	SEN:10035364	14561771
BEL:20074164	cat(p(HGNC:BID)) increases bp(GOBP:"apoptotic process")	Oxaliplatin-induced apoptosis, potentiated by kinase-defective c-Src mutants, was dependent on activation of caspase 8 and associated with Bid cleavage.	SEN:10035422	15326164
BEL:20074166	cat(p(HGNC:BID)) increases bp(GOBP:"apoptotic process")	STAT3 is also able to prevent cell death through inhibition of the extrinsic apoptotic pathway. This pathway is activated upon binding of extracellular ligands such as FAS ligand (FAS-L) to cell-surface death receptors. Upon interaction with FAS-L, the FAS death receptor induces cell death through caspase-8 activation and truncation of the death agonist BID.	SEN:10035424	17118707
BEL:20074176	cat(p(HGNC:CASP1)) increases p(HGNC:IL1B)	Activation of the inflammasome is responsible for the generation of active caspase-1, which cleaves a number of pro-inflammatory cytokines into their bio-active form, including IL-1B , IL-18, and IL-33.	SEN:10035430	19262504
BEL:20074180	cat(p(HGNC:CASP1)) increases p(HGNC:IL1B)	from full text - Increased levels of IL-1 in IBD may be result of stimulation of colonic macrophages that can activate interleukin (IL)-1 converting enzyme (ICE) and hence release mature IL-1beta into the colonic mucosa[20].	SEN:10035432	18666314
BEL:20074184	cat(p(HGNC:CASP1)) increases p(HGNC:IL1B)	Upon activation, NLRP3 forms a so-called inflammasome complex with the adaptor molecule ASC, which controls the activation of caspase-1. Activated caspase-1, in turn, cleaves pro-IL-1b and pro-IL-18 into the biologically active, secreted forms (9).	SEN:10035434	19570822
BEL:20074186	cat(p(HGNC:CASP1)) increases p(HGNC:IL8)	Upon activation, NLRP3 forms a so-called inflammasome complex with the adaptor molecule ASC, which controls the activation of caspase-1. Activated caspase-1, in turn, cleaves pro-IL-1b and pro-IL-18 into the biologically active, secreted forms (9).	SEN:10035434	19570822
BEL:20074188	cat(p(HGNC:CASP2)) increases bp(GOBP:"apoptotic process")	initiator caspases - casp8,10,9,1,5a,4a,12a,2	SEN:10035436	14561771
BEL:20074190	cat(p(HGNC:CASP2)) increases bp(GOBP:"apoptotic process")	we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3beta inhibitors lithium chloride and SB216763, and by GSK-3beta knockdown using short interfering RNA. 	SEN:10035438	17666435
BEL:20074200	cat(p(HGNC:CASP3)) directlyIncreases deg(p(HGNC:LMNB1))	figure 1 - conservation of caspase clevage sites	SEN:10035446	11973607
BEL:20074202	cat(p(HGNC:CASP3)) directlyIncreases deg(p(HGNC:LMNB2))	figure 1 - conservation of caspase clevage sites	SEN:10035446	11973607
BEL:20074212	cat(p(HGNC:CASP3)) increases bp(GOBP:"apoptotic process")	by Western analysis, electron microscopy, and immunoflourescence, there is increased expression of the autophagic proteins LC3B-II/LC3B-I, Atg4, Atg5-artg12, and Atg7, as well as increased numbers of different stages of autophagic vacuoles in the lungs of COPD patients in all GOLD categories, with a corresponding increase in caspase 3 activity, a marker of apoptosis in GOLD 3/4 patients.54	SEN:10035456	21857781
BEL:20074226	cat(p(HGNC:CASP3)) increases bp(GOBP:"apoptotic process")	Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice. 	SEN:10035470	19570263
BEL:20074232	cat(p(HGNC:CASP3)) increases bp(GOBP:"apoptotic process")	The anti-caspase-3 effect of A1AT was further tested in vivo in the mouse lung...intramuscular administration of hA1AT-AAV serotype 5, which leads to persistent hA1AT expression,(27) inhibited apoptotic airspace destruction and oxidative stress (measured by catalase activity assay) caused by subsequent direct instillation of active caspase-3 into the mouse lung28 (Figure 7, a? d).	SEN:10018860	17003475
BEL:20074234	cat(p(HGNC:CASP3)) increases bp(GOBP:"apoptotic process")	Through cleavage of a distinct subset of cellular substrates, caspase-3 initiates many of the key changes witnessed during apoptosis, thus explaining how a diverse range of stimuli manifest identical phenotypic outcomes during cell death (13).	SEN:10035472	12748058
BEL:20074240	cat(p(HGNC:CASP3)) increases deg(p(HGNC:LMNA))	Finally, PD exposure induced apoptosis in U937 cells through caspase-3-dependent PARP and lamin A cleavage. 	SEN:10035476	18351645
BEL:20074242	cat(p(HGNC:CASP3)) increases kin(p(HGNC:ROCK1))	Two potential sites of caspase cleavage, resembling the prototypical caspase-3 cleavage sequence DEVD, are situated in this region in both human and mouse ROCK I, at positions 1110-1113 (DETD) and 1155-1158 (DEQD), respectively.	SEN:10018868	11283606
BEL:20074244	cat(p(HGNC:CASP3)) increases path(MESHD:Emphysema)	Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice. 	SEN:10035470	19570263
BEL:20074246	cat(p(HGNC:CASP4)) increases bp(GOBP:"apoptotic process")	initiator caspases - casp8,10,9,1,5a,4a,12a,2	SEN:10035436	14561771
BEL:20074248	cat(p(HGNC:CASP6)) increases bp(GOBP:"cell proliferation")	The fact that caspase-6 inhibitors block the induction of both cdk4 and d-type cyclins suggests that caspase-6 activity is required for resting B cells to enter the G1 phase of the cell cycle. 	SEN:10035478	12794135
BEL:20074254	cat(p(HGNC:CASP8)) directlyIncreases cat(p(HGNC:CASP3))	when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10035484	15286739
BEL:20074256	cat(p(HGNC:CASP8)) increases bp(GOBP:"apoptotic process")	casp8 can initiate robust proteolysis in many cell types, i.e. lymphocytes, by directly processing casp3	SEN:10035486	14561771
BEL:20074262	cat(p(HGNC:CASP8)) increases bp(GOBP:"apoptotic process")	c-Flip inhibits apoptosis by blocking the activation of caspase-8.	SEN:10035488	17707332
BEL:20074266	cat(p(HGNC:CASP8)) increases bp(GOBP:"apoptotic process")	initiator caspases - casp8,10,9,1,5a,4a,12a,2	SEN:10035436	14561771
BEL:20074270	cat(p(HGNC:CASP8)) increases bp(GOBP:"apoptotic process")	Oxaliplatin-induced apoptosis, potentiated by kinase-defective c-Src mutants, was dependent on activation of caspase 8 and associated with Bid cleavage.	SEN:10035422	15326164
BEL:20074274	cat(p(HGNC:CASP8)) increases cat(p(HGNC:BID))	in certain cell types, i.e. hepatocytes, casp8 acts in addition by cleaving Bid which can then promote mitochondrial permeabilization and thus casp9 activation	SEN:10035494	14561771
BEL:20074276	cat(p(HGNC:CASP8)) increases cat(p(HGNC:BID))	Oxaliplatin-induced apoptosis, potentiated by kinase-defective c-Src mutants, was dependent on activation of caspase 8 and associated with Bid cleavage.	SEN:10035422	15326164
BEL:20074278	cat(p(HGNC:CASP8)) increases cat(p(HGNC:BID))	STAT3 is also able to prevent cell death through inhibition of the extrinsic apoptotic pathway. This pathway is activated upon binding of extracellular ligands such as FAS ligand (FAS-L) to cell-surface death receptors. Upon interaction with FAS-L, the FAS death receptor induces cell death through caspase-8 activation and truncation of the death agonist BID.	SEN:10035424	17118707
BEL:20074280	cat(p(HGNC:CASP8)) increases cat(p(HGNC:BID))	The activation of caspase 8 led to the cleavage of Bid in wild-type mice under various regimes (Fig. 3  C and data not shown). 	SEN:10035496	11369777
BEL:20074290	cat(p(HGNC:CASP9)) directlyIncreases cat(p(HGNC:CASP3))	when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10035484	15286739
BEL:20074292	cat(p(HGNC:CASP9)) directlyIncreases cat(p(HGNC:CASP6))	when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10035484	15286739
BEL:20074296	cat(p(HGNC:CASP9)) directlyIncreases cat(p(HGNC:CASP7))	when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7	SEN:10035484	15286739
BEL:20074304	cat(p(HGNC:CAT)) decreases a(CHEBI:"hydrogen peroxide")	Superoxide anions are generated by NADPH oxidase and this is converted to hydrogen peroxide by superoxide dismutases and catalase converts hydrogen peroxide to water.	SEN:10035270	15602009
BEL:20074336	cat(p(HGNC:CD44)) directlyIncreases kin(p(HGNC:EGFR))	We found that ROS promotes CD44/EGFR interaction, EGFR/MAPK {ERK} activation, and MUC5B up-regulation that are prevented by blocking CD44 and/or EGFR	SEN:10035532	18757307
BEL:20074356	cat(p(HGNC:ACKR3)) increases bp(GOBP:angiogenesis)	CXCR7 mediated EPCs tube formation and matrix metalloproteinase-2 (MMP-2) production 	SEN:10035536	22173725
BEL:20074364	cat(p(HGNC:DOCK1)) directlyIncreases gtp(p(HGNC:RAC1))	DOCK180, via its DHR-1 and DHR-2 domains, couples PtdIns(3,4,5)P(3) signalling to Rac GTP-loading, which is essential for directional cell movement.	SEN:10035540	16025104
BEL:20074366	cat(p(HGNC:DOCK1)) directlyIncreases gtp(p(HGNC:RAC1))	FA-CRKL induced cotranslocation of a Rac1 activator, Dock1, to focal adhesions. These results therefore indicate a role for CrkL in mediating Src signaling by activating small G proteins at focal adhesions. Furthermore, MEFs lacking CrkL show impaired integrin-induced migration despite expression of a closely related protein, Crk-II, in these cells. 	SEN:10035542	12665586
BEL:20074370	cat(p(HGNC:DUOX1)) increases p(HGNC:MMP9)	Indeed, a number of downstream effects of P2 receptor activation, such as expression of MUC5AC, MMP-9 or IL-8 and stimulated cell migration, have been linked to activation of DUOX1 (87,105,107,108), suggesting a common association of DUOX with epithelial purinergic signaling.	SEN:10035544	18164271
BEL:20074374	cat(p(HGNC:EGLN1)) increases deg(p(HGNC:HIF1A))	Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF) alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction.	SEN:10035548	15741220
BEL:20074384	cat(p(HGNC:EGLN2)) increases deg(p(HGNC:HIF1A))	Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF) alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction.	SEN:10035548	15741220
BEL:20074394	cat(p(HGNC:EGLN3)) increases deg(p(HGNC:HIF1A))	Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF) alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction.	SEN:10035548	15741220
BEL:20074410	cat(p(HGNC:EIF4E)) increases p(HGNC:HIF1A)	growth factors, cytokines and other signalling molecules stimulate HIF-1a synthesis via activation of the phosphatidylinositol 3-kinase (PI3K) or mitogen- activated protein kinase (MAPK) pathways (FIG. 1).	SEN:10035564	13130303
BEL:20074422	cat(p(HGNC:EP300)) directlyIncreases tscript(p(HGNC:TP53))	We demonstrate that Skp2 forms a complex with p300 through the CH1 and the CH3 domains of p300 to which p53 is thought to bind and antagonizes the interaction between p300 and p53 in cells and in vitro. As Skp2 antagonizes the interaction between p300 and p53, Skp2 suppresses p300-mediated acetylation of p53 and the transactivation ability of p53. 	SEN:10035574	18243116
BEL:20074436	cat(p(HGNC:ERCC6)) increases bp(GOBP:"base-excision repair")	Recently, evidence for a role of CSB in base excision repair of oxidative DNA lesions has accumulated.	SEN:10035578	16107709
BEL:20074438	cat(p(HGNC:ERN1)) directlyIncreases p(HGNC:XBP1)	IRE1 is a bifunctional transmembrane kinase/endoribonuclease that induces the non-conventional splicing of Xbp1 mRNA to produce another b-ZIP transcription activator, XBP1 . 	SEN:10035580	19137072
BEL:20074450	cat(p(HGNC:F2R)) increases p(HGNC:IL6)	Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-êB activation 	SEN:10035586	10343541
BEL:20074454	cat(p(HGNC:FADD)) directlyIncreases cat(p(HGNC:CASP8))	At such low concentration, ethanol-induced apoptosis in human hepatocellular carcinoma (HepG2) cells is triggered by activation of the Fas receptor, a member of the tumor necrosis family, with subsequent activation of the intracellular adapter protein FADD (Fas Associated Death Domain) and caspase-8.	SEN:10035590	17088943
BEL:20074458	cat(p(HGNC:FADD)) increases cat(p(HGNC:CASP8))	It also associates with death domain-containing adaptor proteins, such as TNF-receptor-associated death domain  (TRADD) and Fas-associated death domain (FADD), that are required for caspase-8  activation and apoptosis ([Schutze et al., 2008] and [Wilson et al., 2009])	SEN:10035594	19632174
BEL:20074462	cat(p(HGNC:FADD)) increases kin(p(HGNC:RIPK1))	cIAP ablation prevents RIP1 ubiquitination and favors the formation of an alternative complex II, containing RIP1, FADD, and caspase- 8, which leads to RIP1 kinase–dependent activation of caspase-8 and subsequent apoptosis (37, 46).	SEN:10035596	20354226
BEL:20074464	cat(p(HGNC:FAS)) directlyIncreases cat(p(HGNC:FADD))	At such low concentration, ethanol-induced apoptosis in human hepatocellular carcinoma (HepG2) cells is triggered by activation of the Fas receptor, a member of the tumor necrosis family, with subsequent activation of the intracellular adapter protein FADD (Fas Associated Death Domain) and caspase-8.	SEN:10035590	17088943
BEL:20074472	cat(p(HGNC:FPR2)) decreases bp(GOBP:"neutrophil chemotaxis")	in neutrophils, lipoxin?A4?ALX interactions stop neutrophil migration, 	SEN:10035604	9054386
BEL:20074474	cat(p(HGNC:FPR2)) increases bp(GOBP:"macrophage chemotaxis")	 in monocytes lipoxin?A4?ALX interactions stimulate monocyte chemotaxis and non-phlogistic responses	SEN:10035606	9054386
BEL:20074490	cat(p(HGNC:GGT1)) decreases a(CHEBI:glutathione)	As mentioned above, GGT is the only enzyme located on the external surface of epithelial cells that is able to hydrolyze the peptidic bond of GSH to provide a continuous source of cysteine through the ?-glutamyl cycle. As such GGT plays an integral role in GSH homeostasis and has been traditionally regarded as a component of the cellular defense system against oxidative stress (Pompella et al., 2007). 	SEN:10035616	18601945
BEL:20074492	cat(p(HGNC:GGT1)) increases a(CHEBI:cysteine)	As mentioned above, GGT is the only enzyme located on the external surface of epithelial cells that is able to hydrolyze the peptidic bond of GSH to provide a continuous source of cysteine through the ?-glutamyl cycle. As such GGT plays an integral role in GSH homeostasis and has been traditionally regarded as a component of the cellular defense system against oxidative stress (Pompella et al., 2007). 	SEN:10035616	18601945
BEL:20074496	cat(p(HGNC:GLUD1)) increases a(CHEBI:"reactive oxygen species")	Depletion of PYGL, GLUL, and GLUD1 by means of siRNA reduced TNF+zVAD–induced accumulation of ROS (Fig. 4C and fig. S11), which correlated with cell death (Fig. 3F and figs. S7D and S8D).	SEN:10019152	19498109
BEL:20074498	cat(p(HGNC:GLUD1)) increases a(CHEBI:"reactive oxygen species")	Importantly, knockdown of PYGL, GLUL, or GLUD1  partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells	SEN:10035620	19632174
BEL:20074500	cat(p(HGNC:GLUD1)) increases a(CHEBI:"reactive oxygen species")	RIP3 increases the activities of glycogen phosphorylase, glutamate ammonia ligase, and glutamate dehydrogenase 1. This stimulates the production of reactive oxygen species (ROS) due to increased oxidative phosphorylation. In some cells, ROS production as a consequence of RIP3 signaling is required for necroptosis	SEN:10035622	19632174
BEL:20074502	cat(p(HGNC:GLUL)) increases a(CHEBI:"reactive oxygen species")	Depletion of PYGL, GLUL, and GLUD1 by means of siRNA reduced TNF+zVAD–induced accumulation of ROS (Fig. 4C and fig. S11), which correlated with cell death (Fig. 3F and figs. S7D and S8D).	SEN:10019152	19498109
BEL:20074504	cat(p(HGNC:GLUL)) increases a(CHEBI:"reactive oxygen species")	Importantly, knockdown of PYGL, GLUL, or GLUD1  partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells	SEN:10035620	19632174
BEL:20074506	cat(p(HGNC:GLUL)) increases a(CHEBI:"reactive oxygen species")	RIP3 increases the activities of glycogen phosphorylase, glutamate ammonia ligase, and glutamate dehydrogenase 1. This stimulates the production of reactive oxygen species (ROS) due to increased oxidative phosphorylation. In some cells, ROS production as a consequence of RIP3 signaling is required for necroptosis	SEN:10035622	19632174
BEL:20074528	cat(p(HGNC:HDAC3)) directlyDecreases tscript(p(HGNC:SPI1))	we provide evidence that Ski-mediated repression of PU.1 is due to Ski's ability to recruit histone deacetylase 3 to PU.1 bound to DNA.	SEN:10035632	17621263
BEL:20074530	cat(p(HGNC:HIF1AN)) directlyDecreases complex(p(HGNC:EPAS1),p(HGNC:EP300))	GST-p300 does associate with the CAD (HIF-2? residues 774?874). However, preincubation of the CAD with recombinant wild-type FIH-1, expressed as a maltose-binding protein (MBP) fusion, severely inhibits association with GST-p300 (Fig.3A, lane 5). .....DMOG and Co(II), competitive inhibitors of hydroxylase activity, also prevent FIH-1 from disrupting the CAD–p300 interaction (Fig. 3A,B). 	SEN:10035634	12080085
BEL:20074554	cat(p(HGNC:IL1RL1)) increases kin(p(HGNC:MAPK1))	p38 MAPK was required for the IL-33-mediated responses of endothelial cells, whereas ERK was required for IL-33-mediated IL-8 production by epithelial cells.	SEN:10035652	20926795
BEL:20074556	cat(p(HGNC:IL1RL1)) increases kin(p(HGNC:MAPK1))	we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).	SEN:10035654	20200353
BEL:20074560	cat(p(HGNC:IL1RL1)) increases kin(p(HGNC:MAPK3))	p38 MAPK was required for the IL-33-mediated responses of endothelial cells, whereas ERK was required for IL-33-mediated IL-8 production by epithelial cells.	SEN:10035652	20926795
BEL:20074562	cat(p(HGNC:IL1RL1)) increases kin(p(HGNC:MAPK3))	we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).	SEN:10035654	20200353
BEL:20074564	cat(p(HGNC:IL23R)) directlyIncreases kin(p(HGNC:JAK2))	IL-23 activates the same Jak-stat signaling molecules as IL-12: Jak2, Tyk2, and stat1, -3, -4, and -5, but stat4 activation is substantially weaker and different DNA-binding stat complexes form in response to IL-23 compared with IL-12. IL-23R associates constitutively with Jak2 and in a ligand-dependent manner with stat3.	SEN:10035656	12023369
BEL:20074580	cat(p(HGNC:IL6ST)) directlyIncreases kin(p(HGNC:JAK2))	binding of Il6 to Il6R induces homodimerization ofgp130, activating JAK associated with gp130 at Box1.......Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]	SEN:10035664	12110143
BEL:20074586	cat(p(HGNC:ITGAM)) increases bp(GOBP:"cell adhesion")	we used an alternative strategy of inhibiting leukocyte recruitment by activating CD11b/CD18 with small-molecule agonists, which we term leukadherins. These compounds increased the extent of CD11b/CD18-dependent cell adhesion of transfected cells and of primary human and mouse neutrophils	SEN:10019262	21900205
BEL:20074604	cat(p(HGNC:LTB4R)) increases a(CHEBI:"reactive oxygen species")	At low concentrations of immune complexes, loss of PI3K beta alone substantially inhibited the production of reactive oxygen species (ROS) by neutrophils...  Activation of PI3Kbeta by immune complexes involved cooperation between FcgammaRs and BLT1, the receptor for the endogenous proinflammatory lipid leukotriene B4.	SEN:10035672	21487107
BEL:20074608	cat(p(HGNC:LTB4R)) increases bp(GOBP:"neutrophil chemotaxis")	BLT1-receptor (LTB4R) antagonists inhibit the neutrophil chemotactic activity in sputum of COPD patients.	SEN:10035674	15602009
BEL:20074618	cat(p(HGNC:MCL1)) directlyDecreases cat(p(HGNC:BAK1))	We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A). 	SEN:10035418	21041309
BEL:20074620	cat(p(HGNC:MCL1)) directlyDecreases cat(p(HGNC:BAX))	We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A). 	SEN:10035418	21041309
BEL:20074630	cat(p(HGNC:MMP14)) increases cat(complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	MMP-2 binds to ?v?3 at the cell surface, and blocking this binding inhibits MMP-2 protease activity in cultured cells, suppressing angiogenesis and tumour growth in chorioallantoic membrane assays43.Conversely, the membrane MMP (MT-1) cleaves ?v?3, enhancing the ligand binding activity of this integrin44. So,?v?3 seems to be important in regulating angiogenesis in adult animals.	SEN:10035292	12635171
BEL:20074642	cat(p(HGNC:MMP14)) increases p(HGNC:TGFB1)	from full text - The avb6 integrin mediates activation of TGF-b through a mechanism involving the conformational alteration of TGF-b; the avb8 integrin mediates activation of TGF-b through the transmembrane matrix-metalloprotease- 1 (MT1-MMP)-dependent cleavage	SEN:10035684	16877343
BEL:20074646	cat(p(HGNC:MMP1)) increases deg(p(HGNC:COL1A1))	This gene encodes a secreted enzyme which breaks down the interstitial collagens, types I, II, and III.	SEN:10035686	11701397
BEL:20074650	cat(p(HGNC:MMP1)) increases deg(p(HGNC:COL1A2))	This gene encodes a secreted enzyme which breaks down the interstitial collagens, types I, II, and III.	SEN:10035686	11701397
BEL:20074652	cat(p(HGNC:MMP1)) increases deg(p(HGNC:COL2A1))	Figure 2. Inhibition by doxycycline (DOXY) of digestion of type II collagen by collagenases 1, 2, or 3. 	SEN:10035688	10366106
BEL:20074658	cat(p(HGNC:MMP1)) increases deg(p(HGNC:COL2A1))	This gene encodes a secreted enzyme which breaks down the interstitial collagens, types I, II, and III.	SEN:10035686	11701397
BEL:20074664	cat(p(HGNC:MMP1)) increases deg(p(HGNC:COL3A1))	This gene encodes a secreted enzyme which breaks down the interstitial collagens, types I, II, and III.	SEN:10035686	11701397
BEL:20074668	cat(p(HGNC:MMP2)) increases bp(GOBP:"cell migration")	It induces SMC proliferation (205) and up-regulates MMP2 and MMP-9 in macrophages (159,206,207). These MMPs facilitate macrophage migration and may decrease plaque stability (208–210).	SEN:10035694	16046792
BEL:20074672	cat(p(HGNC:MMP2)) increases deg(p(HGNC:COL4A1))	This gene encodes an enzyme which degrades type IV collagen, the major structural component of basement membranes. The enzyme plays a role in endometrial menstrual breakdown, regulation of vascularization and the inflammatory response.	SEN:10035696	11701397
BEL:20074674	cat(p(HGNC:MMP2)) increases deg(p(HGNC:COL4A2))	This gene encodes an enzyme which degrades type IV collagen, the major structural component of basement membranes. The enzyme plays a role in endometrial menstrual breakdown, regulation of vascularization and the inflammatory response.	SEN:10035696	11701397
BEL:20074696	cat(p(HGNC:MMP8)) increases deg(p(HGNC:COL2A1))	Figure 2. Inhibition by doxycycline (DOXY) of digestion of type II collagen by collagenases 1, 2, or 3. 	SEN:10035688	10366106
BEL:20074714	cat(p(HGNC:MPL)) increases kin(p(HGNC:JAK2))	TPO to c-Mpl (a receptor tyrosine kinase) activates both Janus Kinase 2 (JAK2) and Tyk2	SEN:10035706	17127443
BEL:20074716	cat(p(HGNC:MPL)) increases kin(p(HGNC:TYK2))	TPO to c-Mpl (a receptor tyrosine kinase) activates both Janus Kinase 2 (JAK2) and Tyk2	SEN:10035706	17127443
BEL:20074722	cat(p(HGNC:MYD88)) directlyIncreases kin(p(HGNC:IRAK4))	MyD88 promotes association with IRAK4 and IRAK1.  During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK1, which then induces interaction of TRAF6 with the complex.	SEN:10035712	12893815
BEL:20074724	cat(p(HGNC:MYD88)) increases kin(p(HGNC:AKT1))	Pretreatment of PMN with MyD88 inhibitor prevented HMGB1-induced activation of both Akt and p38 MAPK (Fig. 6, C  and D), indicating that the activation of both Akt and p38 MAPK are downstream events that depend on MyD88 activation.	SEN:10035714	17475888
BEL:20074742	cat(p(HGNC:NOS2)) directlyIncreases a(CHEBI:"nitric oxide")	NO is generated in COPD by iNOS, which is expressed in macrophages and lung parenchyma.	SEN:10035726	15602009
BEL:20074748	cat(p(HGNC:NOS3)) directlyIncreases a(CHEBI:"nitric oxide")	Akt, a serine/threonine kinase that is a major target of phosphatidylinositol 3-kiniase (PI3K), phosphorylates eNOS at Ser1177, and this phosphorylation enhances eNOS activity and increases NO production in vascular endothelial cells.	SEN:10019394	17000928
BEL:20074774	cat(p(HGNC:NOX1)) increases a(CHEBI:"reactive oxygen species")	Hyperoxia-dependent ROS production was strongly reduced in lung sections, in isolated epithelial type II cells, and lung endothelial cells from NOX1-deficient mice.	SEN:10019402	19661248
BEL:20074776	cat(p(HGNC:NOX1)) increases a(CHEBI:"reactive oxygen species")	Moreover, in vascular SMCs, uPA increases ROS production (Menshikov et al. 2006b). Using small interfering RNA (siRNA), we proved that the NAD(P)H oxidases Nox1 and Nox4 are the primary source of ROS generation stimulated by uPA in vascular SMCs	SEN:10035748	19064999
BEL:20074778	cat(p(HGNC:NOX1)) increases a(CHEBI:"reactive oxygen species")	NOXO1...is an organizer protein that activates NADPH oxidase (NOX1)...NADPH oxidase is a major source of reactive oxygen species, and oxidative stress is considered to play an important role in the pathogenesis of COPD	SEN:10019400	16717027
BEL:20074786	cat(p(HGNC:NOX4)) increases a(CHEBI:"reactive oxygen species")	Moreover, in vascular SMCs, uPA increases ROS production (Menshikov et al. 2006b). Using small interfering RNA (siRNA), we proved that the NAD(P)H oxidases Nox1 and Nox4 are the primary source of ROS generation stimulated by uPA in vascular SMCs	SEN:10035748	19064999
BEL:20074788	cat(p(HGNC:NOX4)) increases a(CHEBI:"reactive oxygen species")	NOX4-mediated ROS production in human pulmonary artery smooth muscle cells in response to TGF-? occurs primarily intracellularly, and NOX4 appears to localize to the ER or the nucleus (186).	SEN:10035750	18164271
BEL:20074792	cat(p(HGNC:NQO1)) decreases a(CHEBI:"reactive oxygen species")	All of these findings suggest a more direct role for NQO1 in protection against oxidative stress than considered previously. In this work, we demonstrate that NQO1 has the ability to directly scavenge superoxide. 	SEN:10035754	15102952
BEL:20074804	cat(p(HGNC:PARP1)) decreases a(CHEBI:ATP)	The activation of PARP-1 also leads to ATP depletion, a condition that is permissive for necrosis (81, 82).	SEN:10019430	20354226
BEL:20074816	cat(p(HGNC:PLA2G4A)) increases a(CHEBI:"arachidonic acid")	Phospholipase A2 (PLA2) is an esterase that produces AA from arachidonate-containing phospholipids (84).	SEN:10035774	20354226
BEL:20074820	cat(p(HGNC:PLAU)) directlyIncreases complex(p(HGNC:PDGFRB),p(HGNC:PLAUR))	Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.We provide evidence that uPAR activation by uPA induces its association with platelet-derived growth factor receptor (PDGFR)-beta. The interaction results in PDGF-independent PDGFR-beta activation by phosphorylation of cytoplasmic tyrosine kinase domains and receptor dimerization.	SEN:10035776	15889147
BEL:20074842	cat(p(HGNC:PMAIP1)) increases cat(p(HGNC:BAK1))	In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells. 	SEN:10035386	17507791
BEL:20074844	cat(p(HGNC:PMAIP1)) increases cat(p(HGNC:BAX))	In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells. 	SEN:10035386	17507791
BEL:20074846	cat(p(HGNC:POLA1)) increases bp(GOBP:"single strand break repair")	In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A	SEN:10035358	17289756
BEL:20074848	cat(p(HGNC:POLB)) increases bp(GOBP:"base-excision repair")	POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates. 	SEN:10035786	10583946
BEL:20074850	cat(p(HGNC:POLB)) increases bp(GOBP:"single strand break repair")	In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A	SEN:10035358	17289756
BEL:20074860	cat(p(HGNC:POLE)) increases bp(GOBP:"single strand break repair")	In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A	SEN:10035358	17289756
BEL:20074862	cat(p(HGNC:PTCH1)) directlyDecreases cat(p(HGNC:SMO))	Current models suggest that binding of Shh to PTCH prevents the normal inhibition of the seven-transmembrane-protein Smoothened (SMO) by PTCH.	SEN:10035788	9811851
BEL:20074902	cat(p(HGNC:PTGS2)) increases a(CHEBI:"prostaglandin D2")	PGD2, is synthesized from arachidonic acid via the catalytic activities of COX in epithelial cells and mast cells.	SEN:10035802	22500183
BEL:20074904	cat(p(HGNC:PTGS2)) increases a(CHEBI:"reactive oxygen species")	In conclusion, the results suggest that ROS generation, through COX-2 up-regulation, may contribute to the active oncogenicity of mutant K-ras in the lung as a result of DNA damage	SEN:10019506	15284181
BEL:20074928	cat(p(HGNC:PTGS2)) increases bp(GOBP:"stress-induced premature senescence")	 Inhibition of cyclooxygenase-2 activity by specific chemical inhibitor or siRNA attenuates the H(2)O(2)-induced increase of senescence associated beta-galactosidase positive cells and attenuates growth arrest. In this work, p38(MAPK) activation and increased DNA binding activities of ATF-2 and p53 are shown to mediate cyclooxygenase-2 overexpression in premature senescence.	SEN:10035820	19082758
BEL:20074932	cat(p(HGNC:PYGL)) increases a(CHEBI:"reactive oxygen species")	Depletion of PYGL, GLUL, and GLUD1 by means of siRNA reduced TNF+zVAD–induced accumulation of ROS (Fig. 4C and fig. S11), which correlated with cell death (Fig. 3F and figs. S7D and S8D).	SEN:10019152	19498109
BEL:20074934	cat(p(HGNC:PYGL)) increases a(CHEBI:"reactive oxygen species")	Importantly, knockdown of PYGL, GLUL, or GLUD1  partially inhibits TNF/zVAD-induced ROS levels and necroptosis in N-type NIH 3T3 cells	SEN:10035620	19632174
BEL:20074936	cat(p(HGNC:PYGL)) increases a(CHEBI:"reactive oxygen species")	RIP3 increases the activities of glycogen phosphorylase, glutamate ammonia ligase, and glutamate dehydrogenase 1. This stimulates the production of reactive oxygen species (ROS) due to increased oxidative phosphorylation. In some cells, ROS production as a consequence of RIP3 signaling is required for necroptosis	SEN:10035622	19632174
BEL:20074944	cat(p(HGNC:SERPINA1)) decreases cat(p(HGNC:ELANE))	Neutrophil elastase (Ela2) is a serine protease that is inhibited by alpha-1-antitrypsin (SerpinA1) in the lung parenchyma. There is an increase in Ela1:SerpinA1 complexes in the bronchoalveolar lavage fluid of COPD patients.	SEN:10035822	15602009
BEL:20074960	cat(p(HGNC:SKI)) directlyIncreases cat(p(HGNC:HDAC3))	we provide evidence that Ski-mediated repression of PU.1 is due to Ski's ability to recruit histone deacetylase 3 to PU.1 bound to DNA.	SEN:10035632	17621263
BEL:20074974	cat(p(HGNC:SMO)) increases tscript(p(HGNC:GLI1))	Smo is targeted to cilia and activates Gli proteins in a cilia-dependent manner.	SEN:10035840	16339192
BEL:20074976	cat(p(HGNC:SMO)) increases tscript(p(HGNC:GLI2))	Smo is targeted to cilia and activates Gli proteins in a cilia-dependent manner.	SEN:10035840	16339192
BEL:20074978	cat(p(HGNC:SMO)) increases tscript(p(HGNC:GLI3))	Smo is targeted to cilia and activates Gli proteins in a cilia-dependent manner.	SEN:10035840	16339192
BEL:20074980	cat(p(HGNC:SMPD1)) increases a(CHEBI:ceramide)	As a result of sphingomyelin catabolism, aSMase produces ceramide (a lipid second messenger) (91).	SEN:10035842	20354226
BEL:20074994	cat(p(HGNC:SOD1)) decreases a(CHEBI:"reactive oxygen species")	As shown in Fig. 1B, overexpression of either CuZnSOD or MnSOD  decreased ROS production in hyperoxia by 35–40% compared to LacZ controls. 	SEN:10035848	18692129
BEL:20074996	cat(p(HGNC:SOD1)) decreases a(CHEBI:"reactive oxygen species")	Copper-Zinc (Cu-Zn), manganese (Mn), and extracellular (EC) superoxide dismutase (SOD) are three main isoforms of the enzymatic system that catalyzes superoxide to hydrogen peroxide. These enzymes play a central role in the protection against oxidative stress originated from cellular oxygenases and from mitochondrial sources.	SEN:10035850	17615396
BEL:20074998	cat(p(HGNC:SOD1)) decreases a(CHEBI:"reactive oxygen species")	Increases of up to two fold in Gpx or total SOD activity protected NIT-1 cells from H(2)O(2) and menadione. Expression of Gpx-1 significantly increased NIT-1 survival following hypoxia-reoxygenation	SEN:10035852	14962293
BEL:20075008	cat(p(HGNC:SOD2)) decreases a(CHEBI:"reactive oxygen species")	Copper-Zinc (Cu-Zn), manganese (Mn), and extracellular (EC) superoxide dismutase (SOD) are three main isoforms of the enzymatic system that catalyzes superoxide to hydrogen peroxide. These enzymes play a central role in the protection against oxidative stress originated from cellular oxygenases and from mitochondrial sources.	SEN:10035850	17615396
BEL:20075010	cat(p(HGNC:SOD2)) decreases a(CHEBI:"reactive oxygen species")	Incubation of endothelial cells with high concentrations of FFAs, similar to those found in insulin-resistant subjects, has been shown to increase O2 . production several fold.153. The increase in ROS production was inhibited by overexpression of either UCP-1 or SOD2, which indicates that mitochondrial ETC is the source of FFA-induced ROS production.	SEN:10035856	17332437
BEL:20075016	cat(p(HGNC:SOD2)) decreases a(CHEBI:"reactive oxygen species")	These results indicate that the increase in mitochondrial reactive oxygen species from knockout of SOD2 activity can result in biochemical aberrations with features reminiscent of mitochondrial myopathy	SEN:10000028	9927656
BEL:20075026	cat(p(HGNC:SOD3)) decreases a(CHEBI:"reactive oxygen species")	Copper-Zinc (Cu-Zn), manganese (Mn), and extracellular (EC) superoxide dismutase (SOD) are three main isoforms of the enzymatic system that catalyzes superoxide to hydrogen peroxide. These enzymes play a central role in the protection against oxidative stress originated from cellular oxygenases and from mitochondrial sources.	SEN:10035850	17615396
BEL:20075040	cat(p(HGNC:TICAM1)) increases tscript(p(HGNC:IRF3))	TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway	SEN:10035872	16143103
BEL:20075042	cat(p(HGNC:TICAM1)) increases tscript(p(HGNC:IRF3))	while TRAM recruits TRIF to TLR4 for activation of IRF3.	SEN:10035876	21108806
BEL:20075046	cat(p(HGNC:TLR1)) increases cat(p(HGNC:MYD88))	Interestingly, signaling through TLR1 or TLR3 induced similar responses, despite their use of different adaptor proteins, MydD88 for TLR1 and Trif for TLR3.	SEN:10019646	18772134
BEL:20075048	cat(p(HGNC:TLR2)) increases cat(p(HGNC:MYD88))	Bacterial lipoproteins (BLPs), which are expressed by all bacteria, are potent activators of Toll-like receptor-2 (TLR2). Here we show that the adaptor molecule, myeloid differentiation factor 88 (MyD88), mediates both apoptosis and nuclear factor-kappaB (NF-kappaB) activation by BLP-stimulated TLR2.	SEN:10035878	10880445
BEL:20075056	cat(p(HGNC:TLR2)) increases kin(p(HGNC:MAPK1))	To determine if the ERK-MAPK pathway was also activated by TLR2 in megakaryocytes, lysates of Meg-01 cells were treated with 1 ?g/mL Pam3CSK4 for up to 1 hour and were immunoblotted for phosphorylated ERK1/2. As shown in Figure 1A, there was an increase in the phosphorylation of ERK beginning at 5 minutes that peaks at 30 minutes (105.8% ±3.9).	SEN:10035882	21454454
BEL:20075058	cat(p(HGNC:TLR2)) increases kin(p(HGNC:MAPK3))	To determine if the ERK-MAPK pathway was also activated by TLR2 in megakaryocytes, lysates of Meg-01 cells were treated with 1 ?g/mL Pam3CSK4 for up to 1 hour and were immunoblotted for phosphorylated ERK1/2. As shown in Figure 1A, there was an increase in the phosphorylation of ERK beginning at 5 minutes that peaks at 30 minutes (105.8% ±3.9).	SEN:10035882	21454454
BEL:20075060	cat(p(HGNC:TLR2)) increases p(HGNC:GP1BA)	GP1b is part of the GPIb-IX-V complex that binds vWF and thrombin. Its expression level was significantly increased by 162% and cell surface expression, as determined by flow cytometry, was also increased by 114% with Pam3CSK4 treatment (Figure 5A and Supplemental Figure 4C).	SEN:10035884	21454454
BEL:20075062	cat(p(HGNC:TLR2)) increases p(HGNC:IL6)	Figure 1. Activation of toll-like receptor (TLR) 2 signaling induces interleukin (IL) 6 production and kinase phosphorylation in VSMCs. 	SEN:10035886	22995520
BEL:20075068	cat(p(HGNC:TLR2)) increases p(HGNC:ITGA2B)	CD41, also known as integrin ?IIb, part of the ?IIb?III receptor that binds fibrinogen, was also significantly increased in the presence of Pam3CSK4 by 123% (Figure 5B). Surface expression of CD41 was increased by 125% as shown by flow cytometry (Supplemental Figure 4D).	SEN:10035890	21454454
BEL:20075086	cat(p(HGNC:TLR3)) increases cat(p(HGNC:TICAM1))	Interestingly, signaling through TLR1 or TLR3 induced similar responses, despite their use of different adaptor proteins, MydD88 for TLR1 and Trif for TLR3.	SEN:10019646	18772134
BEL:20075088	cat(p(HGNC:TLR3)) increases cat(p(HGNC:TICAM1))	TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway	SEN:10035872	16143103
BEL:20075110	cat(p(HGNC:TLR3)) increases tscript(p(HGNC:IRF3))	F ig. 2. Effect of Toll-like receptor signalling on macrophage cholesterol metabolism. Stimulation of TLR3 or TLR4 leads to TRIFdependent activation of IRF3, which inhibits transcription of liver X receptor-dependent genes, many of which (e.g. ATP-binding cassette transporter A1, PLTP, apoE and ABCG-1) are critically involved in the efflux of cholesterol from macrophages. 	SEN:10035908	20375591
BEL:20075114	cat(p(HGNC:TLR3)) increases tscript(p(HGNC:IRF3))	TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway	SEN:10035872	16143103
BEL:20075130	cat(p(HGNC:TLR4)) increases cat(p(HGNC:MYD88))	An impaired IRAK4 activation was observed with TLR4 mutant PMN, in which the HMGB1-induced IRAK4 activity was attenuated by 64% compared with that in TLR4 WT PMN (Fig. 5B).	SEN:10019700	17475888
BEL:20075132	cat(p(HGNC:TLR4)) increases cat(p(HGNC:MYD88))	MyD88 also interacts with IRF5 and IRF1 and is required for the activation of these IRFs. IRF5 was identified as being crucial for the induction of proinflammatory cytokines and type I IFNs by all TLRs tested...other TLR4-mediated MyD88-dependent signals, such as IRF5 activation,	SEN:10035916	17457343
BEL:20075134	cat(p(HGNC:TLR4)) increases cat(p(HGNC:MYD88))	TLR4, in addition, activates NF-kappaB and MAP kinases via the MyD88-dependent pathway	SEN:10035718	16143103
BEL:20075136	cat(p(HGNC:TLR4)) increases cat(p(HGNC:MYD88))	TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4).	SEN:10019702	18772134
BEL:20075144	cat(p(HGNC:TLR4)) increases cat(p(HGNC:TICAM1))	These results indicate that LPS induces autophagy through a TRIF-dependent TLR4 signaling pathway.	SEN:10019638	17658277
BEL:20075146	cat(p(HGNC:TLR4)) increases cat(p(HGNC:TICAM1))	TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway	SEN:10035872	16143103
BEL:20075148	cat(p(HGNC:TLR4)) increases cat(p(HGNC:TICAM1))	TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4).	SEN:10019702	18772134
BEL:20075150	cat(p(HGNC:TLR4)) increases cat(p(HGNC:TICAM1))	while TRAM recruits TRIF to TLR4 for activation of IRF3.	SEN:10035876	21108806
BEL:20075160	cat(p(HGNC:TLR4)) increases p(HGNC:MYD88)	MyD88 also interacts with IRF5 and IRF1 and is required for the activation of these IRFs. IRF5 was identified as being crucial for the induction of proinflammatory cytokines and type I IFNs by all TLRs tested...other TLR4-mediated MyD88-dependent signals, such as IRF5 activation,	SEN:10035916	17457343
BEL:20075192	cat(p(HGNC:TLR4)) increases tscript(p(HGNC:IRF3))	F ig. 2. Effect of Toll-like receptor signalling on macrophage cholesterol metabolism. Stimulation of TLR3 or TLR4 leads to TRIFdependent activation of IRF3, which inhibits transcription of liver X receptor-dependent genes, many of which (e.g. ATP-binding cassette transporter A1, PLTP, apoE and ABCG-1) are critically involved in the efflux of cholesterol from macrophages. 	SEN:10035908	20375591
BEL:20075196	cat(p(HGNC:TLR4)) increases tscript(p(HGNC:IRF3))	TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway	SEN:10035872	16143103
BEL:20075200	cat(p(HGNC:TLR9)) directlyIncreases cat(p(HGNC:MYD88))	All TLRs (except for TLR3) and IL-1 receptor family members signal through MyD88.	SEN:10035940	19052556
BEL:20075204	cat(p(HGNC:TLR9)) increases cat(p(HGNC:MYD88))	TLR9 primarily induces ISRE gene expression through IRF7...TLR9, which exclusively couples to the MyD88-dependent pathway	SEN:10019378	16143103
BEL:20075218	cat(p(HGNC:TNFRSF1A)) increases bp(GOBP:"inflammatory response")	from full text - Proinflammatory functions of TNF are mediated by the p55TNF receptor	SEN:10035942	17075348
BEL:20075254	cat(p(HGNC:TRADD)) increases cat(p(HGNC:CASP8))	It also associates with death domain-containing adaptor proteins, such as TNF-receptor-associated death domain  (TRADD) and Fas-associated death domain (FADD), that are required for caspase-8  activation and apoptosis ([Schutze et al., 2008] and [Wilson et al., 2009])	SEN:10035594	19632174
BEL:20075258	cat(p(HGNC:TRADD)) increases cat(p(HGNC:TRAF2))	The TNFR1-containing fibroblasts had significantly higher levels of JNK activation than the TNFR2-containing fibroblasts ( Figure 5A), substantiating TRADD as the more effective initiator of TRAF2 signaling. 	SEN:10035960	10892748
BEL:20075272	cat(p(HGNC:TRAF6)) directlyIncreases tscript(p(HGNC:IRF7))	Furthermore, the adaptor molecule TRAF6 also bound and activated IRF7.	SEN:10035972	15361868
BEL:20075292	cat(p(HGNC:TXNRD1)) decreases a(CHEBI:"reactive oxygen species")	TR plays an important role in protecting against oxidative stress	SEN:10035984	12033457
BEL:20075294	cat(p(HGNC:TXNRD1)) increases p(HGNC:TXN)	Fig. 9  shows the reduction of wild type and mutant Trx1 by thioredoxin reductase and NADPH according to the reaction NADPH + H+  + oxidized Trx1 ? NADP+ + reduced Trx1.	SEN:10035986	12816947
BEL:20075296	cat(p(HGNC:UNC5B)) decreases bp(GOBP:"patterning of blood vessels")	Stimulation of UNC5B-expressing neovessels with an agonist (Netrin-1) inhibits sprouting angiogenesis. Genetic loss of function of unc5b reduces Netrin-1-mediated angiogenesis inhibition.	SEN:10019804	17908930
BEL:20075298	cat(p(HGNC:UNG)) increases bp(GOBP:"single strand break repair")	In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A	SEN:10035358	17289756
BEL:20075300	cat(p(HGNC:USP11)) increases p(HGNC:BMI1)	Regulation of the stability of the PRC1 complex also appears to be another facet, as the de-ubiquitination of the PRC1 components BMI1 and MEL18 by the ubiquitin-specific proteases 7 and 11 has been shown to increase their abundance (Maertens et al., 2010), whereas the loss of these ubiquitin-specific proteases promotes INK4A transcriptional activation.	SEN:10035988	21383691
BEL:20075302	cat(p(HGNC:USP11)) increases p(HGNC:PCGF2)	Regulation of the stability of the PRC1 complex also appears to be another facet, as the de-ubiquitination of the PRC1 components BMI1 and MEL18 by the ubiquitin-specific proteases 7 and 11 has been shown to increase their abundance (Maertens et al., 2010), whereas the loss of these ubiquitin-specific proteases promotes INK4A transcriptional activation.	SEN:10035988	21383691
BEL:20075304	cat(p(HGNC:USP7)) increases p(HGNC:BMI1)	Regulation of the stability of the PRC1 complex also appears to be another facet, as the de-ubiquitination of the PRC1 components BMI1 and MEL18 by the ubiquitin-specific proteases 7 and 11 has been shown to increase their abundance (Maertens et al., 2010), whereas the loss of these ubiquitin-specific proteases promotes INK4A transcriptional activation.	SEN:10035988	21383691
BEL:20075306	cat(p(HGNC:USP7)) increases p(HGNC:PCGF2)	Regulation of the stability of the PRC1 complex also appears to be another facet, as the de-ubiquitination of the PRC1 components BMI1 and MEL18 by the ubiquitin-specific proteases 7 and 11 has been shown to increase their abundance (Maertens et al., 2010), whereas the loss of these ubiquitin-specific proteases promotes INK4A transcriptional activation.	SEN:10035988	21383691
BEL:20075334	cat(p(HGNC:XRCC1)) increases bp(GOBP:"single strand break repair")	In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A	SEN:10035358	17289756
BEL:20075428	complex(p(HGNC:APAF1),p(HGNC:CYCS),p(HGNC:CASP9)) increases cat(p(HGNC:CASP9))	Consisting of APAF-1, cytochrome-c, and caspase-9, in the presence of dATP, formation of the apoptosome results in the autoactivation of caspase-9 and again, activation of the effector caspase-3 (17).	SEN:10036022	12748058
BEL:20075462	complex(p(HGNC:CD40LG),p(HGNC:CD40)) increases p(HGNC:CCL2)	Upon stimulation with soluble CD154, cultured fibroblasts induced to express CD40 by adenoviral gene transfer proliferated and showed up-regulation of the genes for intercellular adhesion molecule 1, interleukin-6 (IL-6), IL-8, monocyte chemoattractant protein 1 (MCP-1), and RANTES, as well as up-regulation of their proteins.	SEN:10036028	18975310
BEL:20075464	complex(p(HGNC:CD40LG),p(HGNC:CD40)) increases p(HGNC:CCL5)	Upon stimulation with soluble CD154, cultured fibroblasts induced to express CD40 by adenoviral gene transfer proliferated and showed up-regulation of the genes for intercellular adhesion molecule 1, interleukin-6 (IL-6), IL-8, monocyte chemoattractant protein 1 (MCP-1), and RANTES, as well as up-regulation of their proteins.	SEN:10036028	18975310
BEL:20075466	complex(p(HGNC:CD40LG),p(HGNC:CD40)) increases p(HGNC:IL6)	Upon stimulation with soluble CD154, cultured fibroblasts induced to express CD40 by adenoviral gene transfer proliferated and showed up-regulation of the genes for intercellular adhesion molecule 1, interleukin-6 (IL-6), IL-8, monocyte chemoattractant protein 1 (MCP-1), and RANTES, as well as up-regulation of their proteins.	SEN:10036028	18975310
BEL:20075468	complex(p(HGNC:CD40LG),p(HGNC:CD40)) increases p(HGNC:IL8)	Upon stimulation with soluble CD154, cultured fibroblasts induced to express CD40 by adenoviral gene transfer proliferated and showed up-regulation of the genes for intercellular adhesion molecule 1, interleukin-6 (IL-6), IL-8, monocyte chemoattractant protein 1 (MCP-1), and RANTES, as well as up-regulation of their proteins.	SEN:10036028	18975310
BEL:20075474	complex(p(HGNC:CDH1),p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	In human HaCaT keratinocytes for instance, ERK1/2 phosphorylation increases in dependence of EGF-R recruitment to transadhering E-cadherin, and E-cadherin-mediated activation of MAPK was also reported in intestinal epithelial cells (Pece and Gutkind, 2000; Laprise et al., 2004).    	SEN:10036030	18268536
BEL:20075476	complex(p(HGNC:CDH1),p(HGNC:EGFR)) increases kin(p(HGNC:MAPK3))	In human HaCaT keratinocytes for instance, ERK1/2 phosphorylation increases in dependence of EGF-R recruitment to transadhering E-cadherin, and E-cadherin-mediated activation of MAPK was also reported in intestinal epithelial cells (Pece and Gutkind, 2000; Laprise et al., 2004).    	SEN:10036030	18268536
BEL:20075524	complex(p(HGNC:CTNNB1),p(HGNC:CDH1)) directlyDecreases tscript(p(HGNC:CTNNB1))	By expressing E-cadherin subdomains, we show that the growth-suppressive effect of E-cadherin required the presence of its cytoplasmic beta-catenin interaction domain and/or correlated strictly with the ability to negatively interfere with beta-catenin transcriptional activity.	SEN:10036034	11564756
BEL:20075550	complex(p(HGNC:EIF4EBP1),p(HGNC:EIF4E)) directlyDecreases cat(p(HGNC:EIF4E))	Phosphorylation of 4E-BP1 relieves its binding to and inhibition of eIF-4E, which, along with S6K1 activity, leads to increased protein synthesis and cell growth	SEN:10036050	14607085
BEL:20075552	complex(p(HGNC:EIF4E),p(HGNC:EIF3A)) increases bp(GOBP:"protein metabolic process")	S6K and RSK phosphorylate eIF4B at Ser422, thus enhancing its interaction with the eIF3 and promoting protein translation (Shahbazian et al., 2006).	SEN:10036052	18794886
BEL:20075574	complex(p(HGNC:HIF1A),p(HGNC:ARNT)) directlyIncreases tscript(p(HGNC:HIF1A))	Intratumoral hypoxia and genetic alterations can lead to HIF-1a overexpression, which has been associated with increased patient mortality in several cancer types. In preclinical studies, inhibition of HIF-1 activity has marked effects on tumour growth. Efforts are underway to identify inhibitors of HIF-1 and to test their efficacy as anticancer therapeutics.	SEN:10035186	13130303
BEL:20075586	complex(p(HGNC:IL12A),p(HGNC:IL12B)) increases tscript(p(HGNC:STAT4))	from full text - Both cytokines (IL-12 and IL-23) activate TYK2 and JAK2 as well as STAT1, STAT3, STAT4, and STAT5 [60].	SEN:10036060	18666314
BEL:20075608	complex(p(HGNC:ITGA5),p(HGNC:ITGB1)) directlyIncreases kin(p(HGNC:EGFR))	These results suggest that integrin alpha5/beta1 mediates fibronectin-induced epithelial cell proliferation through activation of the EGFR.    	SEN:10036070	10888683
BEL:20075610	complex(p(HGNC:ITGA5),p(HGNC:ITGB1)) increases kin(p(HGNC:PTK2))	Upon attachment to fibronectin, ECV 304 cells transfected with dn Cdc42 or dn Rac1 mutants exhibited the phosphorylated form of FAK. FAK phosphorylated at Tyr397 appeared within 60 minutes and was detected even in the presence of dn Cdc42 or dn Rac1, indicating that these integrin-induced signaling components are still activated by attachment when Cdc42 and Rac1 are blocked.	SEN:10036072	12052868
BEL:20075630	complex(p(HGNC:ITGAV),p(HGNC:ITGB3)) increases kin(p(HGNC:SRC))	FIGURE 6. TGFbeta1-induced and alphavbeta3 integrin-mediated c-Src activation is required for the increase in integrin and alphavbeta3 cell surface expression	SEN:10036080	18353785
BEL:20075636	complex(p(HGNC:ITGAV),p(HGNC:ITGB6)) increases p(HGNC:TGFB1)	from full text - The avb6 integrin mediates activation of TGF-b through a mechanism involving the conformational alteration of TGF-b; the avb8 integrin mediates activation of TGF-b through the transmembrane matrix-metalloprotease- 1 (MT1-MMP)-dependent cleavage	SEN:10035684	16877343
BEL:20075640	complex(p(HGNC:ITGAV),p(HGNC:ITGB8)) increases cat(p(HGNC:MMP14))	from full text - The avb6 integrin mediates activation of TGF-b through a mechanism involving the conformational alteration of TGF-b; the avb8 integrin mediates activation of TGF-b through the transmembrane matrix-metalloprotease- 1 (MT1-MMP)-dependent cleavage	SEN:10035684	16877343
BEL:20075644	complex(p(HGNC:JUNB),p(HGNC:NFE2L1)) directlyIncreases tscript(p(HGNC:NFE2L1))	In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.	SEN:10036086	9872330
BEL:20075646	complex(p(HGNC:JUNB),p(HGNC:NFE2L2)) directlyIncreases tscript(p(HGNC:NFE2L2))	In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.	SEN:10036086	9872330
BEL:20075648	complex(p(HGNC:JUND),p(HGNC:NFE2L1)) directlyIncreases tscript(p(HGNC:NFE2L1))	In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.	SEN:10036086	9872330
BEL:20075650	complex(p(HGNC:JUND),p(HGNC:NFE2L2)) directlyIncreases tscript(p(HGNC:NFE2L2))	In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.	SEN:10036086	9872330
BEL:20075654	complex(p(HGNC:JUN),p(HGNC:NFE2L1)) directlyIncreases tscript(p(HGNC:NFE2L1))	In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.	SEN:10036086	9872330
BEL:20075656	complex(p(HGNC:JUN),p(HGNC:NFE2L2)) directlyIncreases tscript(p(HGNC:NFE2L2))	In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to upregulate ARE-mediated expression and coordinated induction of detoxifying enzymes in response to antioxidants and xenobiotics.	SEN:10036086	9872330
BEL:20075662	complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) directlyIncreases kin(p(HGNC:ATM))	MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2	SEN:10036090	15064416
BEL:20075664	complex(p(HGNC:MXI1),p(HGNC:MYC)) decreases tscript(p(HGNC:MYC))	Mutational inactivation of the MYCantagonist Mxi-1 in prostate carcinoma may be another mechanism of MYC activation [54]. Mxi-1 inactivation would presumably shift the equilibrium between Mxi-1/MAX and c-MYC/MAX in prostate cells towards c- MYC/MAX hetero-dimers, and therefore lead to elevated expression of c-MYC-target genes.	SEN:10036092	12769686
BEL:20075680	complex(p(HGNC:PDGFRB),p(HGNC:PLAUR)) directlyIncreases kin(p(HGNC:PDGFRB))	Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.We provide evidence that uPAR activation by uPA induces its association with platelet-derived growth factor receptor (PDGFR)-beta. The interaction results in PDGF-independent PDGFR-beta activation by phosphorylation of cytoplasmic tyrosine kinase domains and receptor dimerization.	SEN:10035776	15889147
BEL:20075692	complex(p(HGNC:SH3GLB1),p(HGNC:UVRAG)) increases complex(p(HGNC:PIK3C3),p(HGNC:BECN1))	Bif-1 interacts with Beclin 1 through UVRAG and functions as a positive mediator of the class III PI3K, and its knockout significantly enhances the development of spontaneous tumors in mice.	SEN:10036100	21709535
BEL:20075696	complex(p(HGNC:SMAD2),p(HGNC:SMAD3),p(HGNC:SMAD4)) directlyIncreases tscript(p(HGNC:SMAD2))	from full text - Smad2 and Smad3 are bound to SARA (SMAD anchor for receptor activation) in the cytoplasm (Tsukazaki et al., 1998) which presents Smad2 and Smad3 to the activated TGF-b receptor complex. TbRI then directly phosphorylates the carboxy terminal of Smad2 and Smad3, resulting in decreased affinity to SARA and heterotrimerization of Smad2 and Smad3 with Smad4  (SARA = ZFYVE9)   	SEN:10036104	15715939
BEL:20075700	complex(p(HGNC:SMAD2),p(HGNC:SMAD3),p(HGNC:SMAD4)) directlyIncreases tscript(p(HGNC:SMAD3))	from full text - Smad2 and Smad3 are bound to SARA (SMAD anchor for receptor activation) in the cytoplasm (Tsukazaki et al., 1998) which presents Smad2 and Smad3 to the activated TGF-b receptor complex. TbRI then directly phosphorylates the carboxy terminal of Smad2 and Smad3, resulting in decreased affinity to SARA and heterotrimerization of Smad2 and Smad3 with Smad4  (SARA = ZFYVE9)   	SEN:10036104	15715939
BEL:20075710	complex(p(HGNC:SQSTM1),p(HGNC:KEAP1)) directlyDecreases complex(p(HGNC:KEAP1),p(HGNC:NFE2L2))	Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. 	SEN:10036106	20452972
BEL:20075720	complex(p(HGNC:TLR4),p(HGNC:LY96)) increases cat(p(HGNC:TLR4))	Finally, the structure of the TLR4-MD-2-LPS complex shows that TLR4 employs the co-receptor MD-2 to recognise LPS and that no direct contacts between the receptor and the ligand take place [52–54]. 	SEN:10036110	20706656
BEL:20075728	complex(p(HGNC:TXN),p(HGNC:MAP3K5)) decreases kin(p(HGNC:MAP3K5))	Binding of Trx inactivates ASK1 catalytic activity.	SEN:10036116	15480426
BEL:20075736	complex(p(HGNC:YWHAQ),p(HGNC:WEE1)) increases tloc(p(HGNC:WEE1),GOCCID:0005634,GOCCID:0005737)	Serine-642 was identified as an Akt-dependent phosphorylation site. WEE1Hu kinase activity was not affected by serine-642 phosphorylation. We revealed that serine-642 phosphorylation promoted cytoplasmic localization of WEE1Hu. The nuclear-to-cytoplasmic translocation was mediated by phosphorylation-dependent WEE1Hu binding to 14-3-3theta but not 14-3-3beta or -sigma preventing Y15 phosphorylation of Cdc2 by WEE1. 	SEN:10036122	15964826
BEL:20076268	gtp(p(HGNC:HRAS)) increases kin(p(HGNC:MAPK1))	Expression of N17Ras attenuated activation of ERK (Figure 4A) and JNK (Figure 4B). In contrast, selective activation of Ras was sufficient for ERK but not JNK activation.	SEN:10036488	12600818
BEL:20076276	gtp(p(HGNC:HRAS)) increases kin(p(HGNC:MAPK3))	Expression of N17Ras attenuated activation of ERK (Figure 4A) and JNK (Figure 4B). In contrast, selective activation of Ras was sufficient for ERK but not JNK activation.	SEN:10036488	12600818
BEL:20076284	gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))	HER2/Neu overexpression stimulates the ability of p300 to acetylate ER81, likely by inducing phosphorylation of p300 through the Ras--Raf--mitogen-activated protein kinase pathway.	SEN:10036498	12917345
BEL:20076290	gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))	Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.	SEN:10036504	10898786
BEL:20076296	gtp(p(HGNC:KRAS)) directlyIncreases kin(p(HGNC:RAF1))	Figure 1 | The ErbB signalling network.	SEN:10035784	11252954
BEL:20076312	gtp(p(HGNC:RAC1)) increases bp(GOBP:"cell proliferation")	Overexpression of dominant negative N17Rac1 significantly inhibits VEGF-induced ROS production that is involved in VEGFR2 activation, EC migration, and proliferation (100).	SEN:10036510	17511588
BEL:20076314	gtp(p(HGNC:RAC1)) increases bp(GOBP:phagocytosis)	Furthermore, Iba1 colocalized with a small GTPase Rac in the membrane ruffles and the phagocytic cups.   The Iba1 mutants also suppressed membrane ruffling induced by dominant active Rac1V12	SEN:10036512	10934045
BEL:20076336	gtp(p(HGNC:RAC1)) increases tscript(p(HGNC:STAT3))	Finally, we determined that STAT3 expression is required for PDGF-mediated regulation of cell cycle targets cyclin D3 and p27. These data define a novel mitogenic signaling pathway in airway smooth muscle cells leading from PDGF to Rac1 and STAT3 and subsequent cell cycle gene regulation	SEN:10036524	18310224
BEL:20076340	gtp(p(HGNC:RAC2)) increases a(CHEBI:"reactive oxygen species")	Rac GTPases regulate cytoskeletal structure, gene expression, and reactive oxygen species (ROS) production. Rac2-deficient neutrophils cannot chemotax, produce ROS, or degranulate upon G protein-coupled receptor (GPCR) activation.	SEN:10020950	16243035
BEL:20076342	gtp(p(HGNC:RAC2)) increases bp(GOBP:"neutrophil chemotaxis")	Rac GTPases regulate cytoskeletal structure, gene expression, and reactive oxygen species (ROS) production. Rac2-deficient neutrophils cannot chemotax, produce ROS, or degranulate upon G protein-coupled receptor (GPCR) activation.	SEN:10020950	16243035
BEL:20076344	gtp(p(HGNC:RAP1A)) decreases bp(GOBP:"cell proliferation")	inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1. PGE(2) and Epac-1 inhibited cell proliferation through activation of the small GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or the dominant-negative Rap1N17 prevented, and transfection with the constitutively active Rap1V12 mimicked, the anti-proliferative effects of PGE(2)	SEN:10036526	18421013
BEL:20076360	gtp(p(HGNC:RHEB)) increases kin(p(EGID:2475))	Rheb-GTP then activates mammalian (m)TOR, either directly or indirectly, through an unknown effector (question mark).	SEN:10036538	14607085
BEL:20076386	gtp(p(HGNC:RHOA)) increases kin(p(HGNC:SRC))	Activated Rho induces tyrosine phosphorylation of beta and gamma catenin and p120ctn through a Fyn/Src-dependent mechanism	SEN:10036550	11777936
BEL:20076514	kin(p(EGID:2475)) directlyIncreases kin(p(HGNC:RPS6KB1))	TOR activity leads to phosphorylation and activation of ribosomal S6 kinase-1 (S6K1), and phosphorylation and inhibition of translation initiation factor eIF-4E binding protein-1 (4E-BP1).	SEN:10036604	14607085
BEL:20076520	kin(p(EGID:2475)) directlyIncreases p(HGNC:RPS6KB1,pmod(P,S,424))	Recently, it has been demonstrated that Thr229 phosphorylation is mediated by PDK1 (15, 16), whereas Thr389 as well as Ser411, Thr421, and Ser424 phosphorylation have been shown to be regulated by mTOR (17).	SEN:10036608	11914378
BEL:20076524	kin(p(EGID:2475)) directlyIncreases p(HGNC:RPS6KB1,pmod(P,T,389))	Recently, it has been demonstrated that Thr229 phosphorylation is mediated by PDK1 (15, 16), whereas Thr389 as well as Ser411, Thr421, and Ser424 phosphorylation have been shown to be regulated by mTOR (17).	SEN:10036608	11914378
BEL:20076526	kin(p(EGID:2475)) directlyIncreases p(HGNC:RPS6KB1,pmod(P,T,412))	11914378;16099428;15809305;15718470;15388791	SEN:10036612	15212693
BEL:20076528	kin(p(EGID:2475)) directlyIncreases p(HGNC:RPS6KB1,pmod(P,T,421))	Recently, it has been demonstrated that Thr229 phosphorylation is mediated by PDK1 (15, 16), whereas Thr389 as well as Ser411, Thr421, and Ser424 phosphorylation have been shown to be regulated by mTOR (17).	SEN:10036608	11914378
BEL:20076560	kin(p(HGNC:ACVRL1)) increases tscript(p(HGNC:SMAD1))	TGF-? activated ALK1 can phosphorylate Smad1 and Smad5, and consequently, promote endothelial migration, an effect mediated through induction of the dominant-negative helixloop- helix transcription factor Id1 which can promote cell proliferation.151, 154	SEN:10036622	16462725
BEL:20076566	kin(p(HGNC:ACVRL1)) increases tscript(p(HGNC:SMAD5))	TGF-? activated ALK1 can phosphorylate Smad1 and Smad5, and consequently, promote endothelial migration, an effect mediated through induction of the dominant-negative helixloop- helix transcription factor Id1 which can promote cell proliferation.151, 154	SEN:10036622	16462725
BEL:20076572	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:GSK3B,pmod(P,S,9))	GSK3b phosphorylation of Bcl3 has previously been shown to result in its degradation (Viatour et al., 2004), whereas GSK3b activity can be repressed by Akt (PKB) induced phosphorylation on serine 9 (Emamian et al., 2004).	SEN:10036626	20513428
BEL:20076574	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:TSC2,pmod(P,S,939))	Akt then phosphorylates tuberin on three residues (S939, S1130 and T1462 of full length human tuberin), and this inhibits the tuberin-hamartin complex through an as-yet-undefined mechanism (reviewed in [8]).	SEN:10036628	14607085
BEL:20076576	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:TSC2,pmod(P,S,939))	Figure 4. S939 and T1462 Are the Major PI3K-Dependent Phosphorylation Sites on Tuberin	SEN:10036630	12150915
BEL:20076580	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:TSC2,pmod(P,T,1462))	Akt then phosphorylates tuberin on three residues (S939, S1130 and T1462 of full length human tuberin), and this inhibits the tuberin-hamartin complex through an as-yet-undefined mechanism (reviewed in [8]).	SEN:10036628	14607085
BEL:20076582	kin(p(HGNC:AKT1)) directlyIncreases p(HGNC:TSC2,pmod(P,T,1462))	Figure 4. S939 and T1462 Are the Major PI3K-Dependent Phosphorylation Sites on Tuberin	SEN:10036630	12150915
BEL:20076584	kin(p(HGNC:AKT1)) increases a(CHEBI:"reactive oxygen species")	ROS production with ischemia was significantly reduced in lungs with knockout of Akt1 while the response of Akt2 null lungs to ischemia was similar to wild type (Fig. 4A and B). Thus, Akt1 is required for activation of endothelial ROS production with ischemia.	SEN:10021512	22003059
BEL:20076588	kin(p(HGNC:AKT1)) increases bp(GOBP:"cell migration")	VEGFR2 forms a complex with VE-cadherin, -catenin, and PI3 kinase that is required for phosphorylation of Akt, which plays an important role in EC survival (15) and migration (27, 28, 80).	SEN:10036636	17511588
BEL:20076596	kin(p(HGNC:AKT1)) increases kin(p(EGID:2475))	Reduced Akt phosphorylation/activation may be responsible for the decreased mTOR signaling, as indicated by down-regulation of the phosphorylation of mTOR downstream target proteins, including 4EBP1 (Thr37/46), S6K1 (Thr389), and S6 (Ser235/236).	SEN:10036644	20638473
BEL:20076638	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1387))	we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells	SEN:10036660	10866324
BEL:20076642	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))	we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells	SEN:10036660	10866324
BEL:20076646	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1457))	we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells	SEN:10036660	10866324
BEL:20076680	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))	MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2	SEN:10036090	15064416
BEL:20076684	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))	Thr383 (Fig. 5C) or Thr387 (data not shown). This suggests that ATM phosphorylation of Thr68 is required for the subsequent phosphorylation of Thr383 and Thr387 in vivo.	SEN:10036674	11390408
BEL:20076696	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))	histone H2AX, 53BP1, BRCA1 and NBS1 are all targets of ATM and ATR	SEN:10036678	15286739
BEL:20076698	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))	MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2	SEN:10036090	15064416
BEL:20076702	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))	The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)	SEN:10036680	16880517
BEL:20076714	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))	MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2	SEN:10036090	15064416
BEL:20076716	kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))	<p2> ATM phosphorylates P53 at Ser15	SEN:10036686	10436023
BEL:20076726	kin(p(HGNC:ATM)) directlyIncreases tscript(p(HGNC:NFAT5))	Reconstitution of the AT cells with wild-type ATM increases TonEBP/OREBP transactivating activity both at 300 and 500 mosmol/kg, but the inactive mutant, ATM S1981A, does not (Fig. 3E). We conclude that ATM regulates transactivating activity of TonEBP/OREBP.	SEN:10035008	15173573
BEL:20076728	kin(p(HGNC:ATM)) directlyIncreases tscript(p(HGNC:NFAT5))	Wild-typeATMincreases TonEBP/OREBP transcriptional activity both at 300 and 500 mosmol/kg, whereas ATMS1981A does not (Fig. 3D).....anti-ATM antibody coimmunoprecipitates TonEBP/OREBP and ATM both at 300 and 500 mosmol/kg (Fig. 4A Lower).	SEN:10036692	15173573
BEL:20076730	kin(p(HGNC:ATM)) increases kin(p(HGNC:CHEK2))	Activated ATM and ATR mediate the phosphorylation and subsequent activation of Chk2 and Chk1, respectively; this process is necessary in the induction of phosphorylation of CDC25A, marking it for proteosomal degradation (Su, 2006).	SEN:10036694	18285820
BEL:20076732	kin(p(HGNC:ATM)) increases kin(p(HGNC:CHEK2))	activation of ATM and ATR in turn activates CHK2 and CHK1, respectively	SEN:10036696	15286739
BEL:20076736	kin(p(HGNC:ATM)) increases kin(p(HGNC:CHEK2))	from full text - Consistent with a role of ATM in the phosphorylation of Chk2, Thr68 phosphorylation and Chk2 activation were not detected in ATM-deficient FT169A cells after IR, while Chk2 was phosphorylated and activated in the isogenic, wild-type ATM-reconstituted YZ5 cells 	SEN:10036698	11668173
BEL:20076750	kin(p(HGNC:ATM)) increases tscript(p(HGNC:TP53))	The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNA–PK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.	SEN:10036136	18285820
BEL:20076752	kin(p(HGNC:ATM)) increases tscript(p(HGNC:TP53))	We show here that E2F-1 elevates ATM promoter activity and induces an increase in ATM mRNA and protein levels. This is accompanied by an E2F-induced increase in p53 phosphorylation ... ATM activates the tumor suppressor p53	SEN:10036704	12527885
BEL:20076766	kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))	ATR phosphorylates Chk1 at Ser317 and Ser345 in vitro, and phosphorylation of these sites in human cells in response to UV and hydroxyurea is ATR-dependent [16–19].	SEN:10036706	15707391
BEL:20076770	kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))	Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.	SEN:10036708	16137618
BEL:20076818	kin(p(HGNC:CDK2)) directlyIncreases p(HGNC:CTNNB1,pmod(P,S))	cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin	SEN:10036198	14985333
BEL:20076828	kin(p(HGNC:CDK4)) directlyIncreases p(HGNC:RB1,pmod(P,S))	\"progression through G1 phase of cell cycle requires phosphorylation of the retinoblastoma gene product (pRb) by the cyclin D-dependent serine-threonine kinases CDK4 and CDK6	SEN:10036730	11278443
BEL:20076836	kin(p(HGNC:CDK4)) increases p(HGNC:RBL1,pmod(P,S))	The primary substrates of CDK4/6 and CDK2 in G1 progression are the members of the retinoblastoma protein family  RB,p107 and p130 The activity of the RB proteins is modulated by sequential phosphorylation by CDK4/6cyclinD and CDK2cyclinE complexes	SEN:10036732	11902577
BEL:20076840	kin(p(HGNC:CDK6)) directlyIncreases p(HGNC:RB1,pmod(P,S))	\"progression through G1 phase of cell cycle requires phosphorylation of the retinoblastoma gene product (pRb) by the cyclin D-dependent serine-threonine kinases CDK4 and CDK6	SEN:10036730	11278443
BEL:20076842	kin(p(HGNC:CDK6)) increases p(HGNC:RBL1,pmod(P,S))	The primary substrates of CDK4/6 and CDK2 in G1 progression are the members of the retinoblastoma protein family  RB,p107 and p130 The activity of the RB proteins is modulated by sequential phosphorylation by CDK4/6cyclinD and CDK2cyclinE complexes	SEN:10036732	11902577
BEL:20076850	kin(p(HGNC:CHEK1)) directlyIncreases p(HGNC:TP73,pmod(P,S,47))	Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha. 	SEN:10036736	14585975
BEL:20076854	kin(p(HGNC:CHEK1)) increases tscript(p(HGNC:TP53))	The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNA–PK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.	SEN:10036136	18285820
BEL:20076868	kin(p(HGNC:CHEK2)) increases tscript(p(HGNC:TP53))	The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNA–PK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.	SEN:10036136	18285820
BEL:20076872	kin(p(HGNC:CHUK)) directlyDecreases p(HGNC:NFKBIA)	This finding agrees with previous studies that showed that IkBa is a better substrate for the IKKs than IkBb (17). The kinetics of IkBa and IkBb phosphorylation were coincident with the degradation of endogenous IkBa as well as the appearance of DNA-binding NF-kB complexes in the nucleus at approximately 15–30 min (Fig. 1B, bottom three panels).	SEN:10021614	10553070
BEL:20076874	kin(p(HGNC:CHUK)) increases deg(p(HGNC:NFKBIA))	Inducers of NF-kB, which include inflammatory cytokines, reactive oxygen species, and viral products, activate a dimeric IkB kinase (IKK) complex, which phophorylates IkBa leading to subsequent ubiquitination and degradation of IkBa and release of NF-kB proteins [33,34].	SEN:10036356	14561188
BEL:20076888	kin(p(HGNC:CSNK1D)) increases p(HGNC:PER1,pmod(P))	human casein kinase Idelta (hCKIdelta), the closest homologue to hCKIepsilon, associates with and phosphorylates hPER1 and causes protein instability	SEN:10036416	11165242
BEL:20076914	kin(p(HGNC:CSNK1E)) increases tscript(p(HGNC:ARNTL))	overexpression of dominant-negative CKI-epsilon leads to decreased BMAL1-driven transcription. 	SEN:10036746	11875063
BEL:20076926	kin(p(HGNC:EGFR)) increases cat(p(HGNC:ADAM17))	ATP-mediated ADAM17 activation was also suppressed by the EGFR kinase inhibitor AG1478 and, to a lesser extent, by preincubation with ?-EGFR antibody (Fig. 6B), indicating a role for EGFR in ADAM17 activation. 	SEN:10036754	19386603
BEL:20076932	kin(p(HGNC:EGFR)) increases gtp(p(HGNC:RAC1))	Figure 1 | The ErbB signalling network.	SEN:10035784	11252954
BEL:20076934	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).	SEN:10036758	19273391
BEL:20076936	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	addition of AG1478 also suppressed ATP-mediated phosphorylation of ERK1/2 and I-?B? (Fig. 4A), indicating the involvement of EGFR activation in these signaling events. 	SEN:10036760	19386603
BEL:20076938	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	An important finding is that intact BRCA1 also prevents EGF and IGF-I signaling through ERK to cell proliferation. EGF and IGF-1 are strongly implicated in the biology of human breast cancer, where they signal through this member of the MAP kinase family to cell growth (27, 52).	SEN:10036762	15199145
BEL:20076940	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	As previously reported, expression of Dok-R in EGF-stimulated cells resulted in a dramatic decrease in the induction of Erk-2 activation as well as a delay in the activation kinetics (Fig. 1), while Dok-R {Delta}PRR completely lost this Erk-2 attenuating capacity, which demonstrates that the key residues for mediating this attenuation are found within the PRR.	SEN:10036764	15831486
BEL:20076944	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK1))	Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.	SEN:10036768	16636672
BEL:20076948	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK3))	activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).	SEN:10036758	19273391
BEL:20076950	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK3))	addition of AG1478 also suppressed ATP-mediated phosphorylation of ERK1/2 and I-?B? (Fig. 4A), indicating the involvement of EGFR activation in these signaling events. 	SEN:10036760	19386603
BEL:20076954	kin(p(HGNC:EGFR)) increases kin(p(HGNC:MAPK3))	Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.	SEN:10036768	16636672
BEL:20076974	kin(p(HGNC:EGFR)) increases tscript(p(HGNC:STAT3))	Experiments in primary mammary epithelial cells and transfected COS-7 cells revealed a p44/42 MAPK and EGFR-dependent Stat3 activation.	SEN:10021658	15292206
BEL:20076978	kin(p(HGNC:EGFR)) increases tscript(p(HGNC:STAT3))	In vivo, b4-integrin amplifies proproliferative signals in basal epidermal keratinocytes (Nikolopoulos et al., 2005), where STAT3 is expressed and can be activated by EGF/EGF-R (Nishio et al., 2001; Chan et al., 2004; Li et al., 2007)	SEN:10021660	18268536
BEL:20076996	kin(p(HGNC:EIF2AK3)) directlyIncreases p(HGNC:EIF2S1,pmod(P))	The enhanced transcription of folding and degradation machinery messages is initiated by IRE1 through its endonuclease activity and ATF6, which is itself a transcription factor. In addition, the kinase PERK attenuates general protein synthesis through its phosphorylation of eIF2a.	SEN:10036786	16973428
BEL:20077028	kin(p(HGNC:FLT1)) increases bp(GOBP:angiogenesis)	However, the selective dependence of angiogenic vessels on the activation of these receptors by VEGF might be more important than the quantity of VEGFRs expressed, as angiogenic vessels are highly vulnerable to inhibition of VEGF activity.	SEN:10036800	12635171
BEL:20077034	kin(p(HGNC:FYN)) directlyIncreases p(HGNC:NFE2L2,pmod(P,Y,576))	Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. This leads to nuclear export, ubiquitination, and degradation of Nrf2	SEN:10036806	17403689
BEL:20077038	kin(p(HGNC:GSK3B)) decreases p(HGNC:CCND1)	AKTactivates cell proliferation by inactivating p27 (Fujita et al., 2002) and inhibiting glycogen synthase kinase 3 (GSK3)- mediated Myc and cyclin D1 inhibition (Vivanco and Sawyers, 2002).	SEN:10036810	18794886
BEL:20077044	kin(p(HGNC:GSK3B)) decreases p(HGNC:CTNNB1)	The accumulation of beta-catenin results from the inhibition of the GSK3b kinase, which normally would phosphorylate beta-catenin as a degradation signal.	SEN:10018280	15225871
BEL:20077058	kin(p(HGNC:GSK3B)) increases tscript(p(HGNC:TP53))	p53-mediated regulation of mPTP might be suppressed by inhibition of GSK-3b activity. Activation of p53 by GSK-3b enhances its functional activity and translocation to the nucleus and mitochondria.52	SEN:10036818	19506320
BEL:20077082	kin(p(HGNC:IKBKB)) directlyDecreases p(HGNC:NFKBIA)	Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005	SEN:10036370	17322026
BEL:20077108	kin(p(HGNC:ILK)) increases bp(GOBP:"cell adhesion")	Here we demonstrate, using several different approaches, that inhibiting ILK kinase activity, or expression, results in the inhibition of cell attachment, cell migration, F-actin organization, and the specific cytoskeletal localization of CH-ILKBP and paxillin in human cells.	SEN:10036844	12960424
BEL:20077110	kin(p(HGNC:ILK)) increases bp(GOBP:"cell migration")	Here we demonstrate, using several different approaches, that inhibiting ILK kinase activity, or expression, results in the inhibition of cell attachment, cell migration, F-actin organization, and the specific cytoskeletal localization of CH-ILKBP and paxillin in human cells.	SEN:10036844	12960424
BEL:20077122	kin(p(HGNC:IRAK1)) increases cat(p(HGNC:TRAF6))	FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined. 	SEN:10035974	16951367
BEL:20077124	kin(p(HGNC:IRAK1)) increases cat(p(HGNC:TRAF6))	IRAK-1 activation and recruitment is essential for activation of TRAF6 (TNF-associated factor 6), which is an essential adaptor for MyD88-dependent NF-kB activation.	SEN:10036854	19842832
BEL:20077144	kin(p(HGNC:IRAK4)) increases kin(p(HGNC:IRAK1))	MyD88 promotes association with IRAK4 and IRAK1.  During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK1, which then induces interaction of TRAF6 with the complex.	SEN:10035712	12893815
BEL:20077146	kin(p(HGNC:IRAK4)) increases kin(p(HGNC:IRAK1))	Then, IRAK4 activates IRAK1 and IRAK2. 	SEN:10036866	22661952
BEL:20077164	kin(p(HGNC:JAK2)) directlyIncreases tscript(p(HGNC:STAT3))	ligand-receptor binding activated STAT3, STAT5 and STAT6	SEN:10036876	12020765
BEL:20077166	kin(p(HGNC:JAK2)) directlyIncreases tscript(p(HGNC:STAT4))	IL-12 activates the Janus family tyrosine kinases JAK2 and Tyk2, which in turn phosphorylate STAT4 on tyrosine 693. 	SEN:10036878	16324152
BEL:20077168	kin(p(HGNC:JAK2)) directlyIncreases tscript(p(HGNC:STAT5B))	ligand-receptor binding activated STAT3, STAT5 and STAT6	SEN:10036876	12020765
BEL:20077170	kin(p(HGNC:JAK2)) increases kin(p(HGNC:RAF1))	1) STAT proteins play an essential role in angiotensin II-induced vascular smooth muscle cell proliferation, 2) JAK2 plays an essential role in the tyrosine phosphorylation of Raf-1, and 3) convergent mitogenic signaling cascades involving the cytosolic kinases JAK2, MEK1, and ERK1 mediate vascular smooth muscle cell proliferation 	SEN:10036880	9305939
BEL:20077174	kin(p(HGNC:JAK2)) increases tscript(p(HGNC:STAT1))	In response to IFNgamma, SRC-family kinases are required to activate STAT3 (but not STAT1) through tyrosine phosphorylation, whereas the receptor-bound kinases JAK1 and JAK2 are required to activate both STATs.	SEN:10036882	15284232
BEL:20077182	kin(p(HGNC:JAK2)) increases tscript(p(HGNC:STAT5A))	The expression of MUP2 is known to be stimulated by growth hormone (GH), through the GH receptor (GHR), Janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5) signal transduction pathway.	SEN:10036890	14759523
BEL:20077194	kin(p(HGNC:JAK3)) directlyIncreases tscript(p(HGNC:STAT3))	ligand-receptor binding activated STAT3, STAT5 and STAT6	SEN:10036876	12020765
BEL:20077208	kin(p(HGNC:KDR)) decreases bp(GOBP:"apoptotic process")	Blockade of VEGF receptors (VEGFR2- official Gene symbol KDR) in rats induces apoptosis of alveolar cells	SEN:10036910	15602009
BEL:20077210	kin(p(HGNC:KDR)) increases bp(GOBP:"cell migration")	Interestingly, the RhoA activation can be partially inhibited by overexpression of Rac1-17N, but overexpression of RhoA-19N has no effect on Rac1 activation. Finally, Gq/11 and Gbetagamma subunits are also required for VPF/VEGF-stimulated HUVEC migration.	SEN:10036912	12244099
BEL:20077216	kin(p(HGNC:KDR)) increases bp(GOBP:"cell proliferation")	VEGFR-2 phosphorylation and mitogenicity induced by VEGF-A165 were enhanced in cells plated on the alphavbeta3 ligand, vitronectin	SEN:10035300	10022831
BEL:20077228	kin(p(HGNC:KIT)) increases kin(p(HGNC:PIK3CD))	FIGURE 6 | Integration of the signalling pathways induced by the G-protein-coupled receptors FcepsilonRI and KIT.	SEN:10036724	16470226
BEL:20077236	kin(p(HGNC:LYN)) increases kin(p(HGNC:MAPK1))	Ag stimulation of Lyn unique domain transfectants was accompanied by enhanced phosphorylation of MEK and ERK-2, which are required for leukotriene C4 (LTC4) release, and production of LTC4 was increased 3- to 5-fold, compared with cells transfected with vector alone. 	SEN:10035020	16177098
BEL:20077250	kin(p(HGNC:MAP2K1)) directlyIncreases kin(p(HGNC:MAPK1))	Once activated, Raf-1 phosphorylates serines in the catalytic sites of MKK/MEK [345,367]. MKK1/MEK1 and MKK2/MEK2 activate members of the MAP kinase family (ERK-1/ERK-2),	SEN:10036926	10699758
BEL:20077252	kin(p(HGNC:MAP2K1)) directlyIncreases kin(p(HGNC:MAPK1))	Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)	SEN:10036928	10490027
BEL:20077258	kin(p(HGNC:MAP2K1)) directlyIncreases kin(p(HGNC:MAPK3))	For comparison, ElkC was also phosphorylated using recombinant ERK1 that had been activated by phosphorylation with a constitutively active mutant of the MAPK/ERK kinase MKK1 [23].	SEN:10036930	8548291
BEL:20077264	kin(p(HGNC:MAP2K1)) directlyIncreases kin(p(HGNC:MAPK3))	Once activated, Raf-1 phosphorylates serines in the catalytic sites of MKK/MEK [345,367]. MKK1/MEK1 and MKK2/MEK2 activate members of the MAP kinase family (ERK-1/ERK-2),	SEN:10036926	10699758
BEL:20077266	kin(p(HGNC:MAP2K1)) directlyIncreases kin(p(HGNC:MAPK3))	Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)	SEN:10036928	10490027
BEL:20077268	kin(p(HGNC:MAP2K1)) directlyIncreases kin(p(HGNC:MAPK3))	The activated GST-MEK1 was then used to activate the purified recombinant extracellular signal-regulated kinase 1, whose activity was measured by the [32P-g]ATP incorporation into MBP, an extracellular signal-regulated kinase 1 substrate.	SEN:10036932	8621729
BEL:20077270	kin(p(HGNC:MAP2K1)) directlyIncreases p(HGNC:MAPK1,pmod(P,Y,187))	1378617;15592455;16094384;11971971;15972258;15935618	SEN:10036934	15212693
BEL:20077284	kin(p(HGNC:MAP2K3)) directlyIncreases p(HGNC:MAPK14,pmod(P,T,180))	7750576;16083285;15674326;15735648;10781613;15972258	SEN:10036940	15212693
BEL:20077286	kin(p(HGNC:MAP2K3)) directlyIncreases p(HGNC:MAPK14,pmod(P,Y,182))	15592455;16083285;15659558;15674326;10781613;15972258;15735649;17081983	SEN:10036942	15212693
BEL:20077288	kin(p(HGNC:MAP2K4)) directlyIncreases kin(p(HGNC:MAPK8))	Figure 1 | The ErbB signalling network.	SEN:10035784	11252954
BEL:20077290	kin(p(HGNC:MAP2K4)) directlyIncreases kin(p(HGNC:MAPK8))	\"Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.\" Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183)	SEN:10036944	11062067
BEL:20077292	kin(p(HGNC:MAP2K4)) directlyIncreases kin(p(HGNC:MAPK9))	Figure 1 | The ErbB signalling network.	SEN:10035784	11252954
BEL:20077294	kin(p(HGNC:MAP2K4)) directlyIncreases kin(p(HGNC:MAPK9))	\"Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.\" Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183)	SEN:10036944	11062067
BEL:20077318	kin(p(HGNC:MAP2K6)) directlyIncreases p(HGNC:MAPK14,pmod(P,T,180))	7750576;16083285;15674326;15735648;10781613;15972258	SEN:10036940	15212693
BEL:20077320	kin(p(HGNC:MAP2K6)) directlyIncreases p(HGNC:MAPK14,pmod(P,Y,182))	15592455;16083285;15659558;15674326;10781613;15972258;15735649;17081983	SEN:10036942	15212693
BEL:20077332	kin(p(HGNC:MAP3K14)) directlyIncreases p(HGNC:CHUK,pmod(P,S,176))	# full text # Akt phosphorylates threonine-23 in IKK{alpha} (35), whereas NIK phosphorylates serine-176 in the kinase loop of IKK{alpha} (54)	SEN:10036958	16613850
BEL:20077338	kin(p(HGNC:MAP3K1)) increases kin(p(HGNC:IKBKB))	Expression of kinase-inactive MEKK1 attenuated TNF-–induced IKK activation, whereas expression of active MEKK1 was sufficient for IKK activation (Figure 6C).	SEN:10036962	12600818
BEL:20077344	kin(p(HGNC:MAP3K1)) increases kin(p(HGNC:IKBKB))	We also show that MEKK1 can induce the activation of both IKK-alpha and IKK-beta in vivo. Finally, we show that IKK-alpha is present in the MEKK1-inducible, high molecular weight IkappaB kinase complex and treatment of this complex with MEKK1 induces phosphorylation of IKK-alpha in vitro. 	SEN:10036966	9689078
BEL:20077346	kin(p(HGNC:MAP3K1)) increases kin(p(HGNC:MAPK8))	Expression of MEKK1-KM attenuated activation of ERK and JNK (Figures 6A and 6B). Selective activation of MEKK1 was sufficient for the activation of both MAP kinases.	SEN:10036968	12600818
BEL:20077368	kin(p(HGNC:MAP3K5)) increases bp(GOBP:"apoptotic process")	MAP3K5 mediates rapamycin induced apoptosis via phosphorylation of c-Jun in p53- deficient mouse embryonic fibroblasts	SEN:10036978	16530485
BEL:20077410	kin(p(HGNC:MAPK11)) directlyIncreases kin(p(HGNC:MAPKAPK2))	prominent p38 MAPK target, the Ser/Thr kinase MAPKAP2, is also activated by PM, as evidenced by phosphorylation of the actin-binding protein, HSP27. These events are again consistent with PM-mediated activation of p38 MAPK (10)	SEN:10037006	19520919
BEL:20077412	kin(p(HGNC:MAPK11)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))	As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). 	SEN:10037008	16951197
BEL:20077420	kin(p(HGNC:MAPK12)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))	As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). 	SEN:10037008	16951197
BEL:20077424	kin(p(HGNC:MAPK13)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))	As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). 	SEN:10037008	16951197
BEL:20077430	kin(p(HGNC:MAPK14)) directlyIncreases p(HGNC:NFE2L2,pmod(P,S))	As shown in Fig. 6A  , stimulation of all p38 MAPK isoforms by anisomycin strongly phosphorylated Nrf2 protein (lanes 2-5), whereas no phosphorylation was detected in the control immunoprecipitates (lane 1). 	SEN:10037008	16951197
BEL:20077434	kin(p(HGNC:MAPK14)) increases bp(GOBP:"cell aging")	Several papers have now linked the p38 MAPK signaling pathway to senescence (Haq et al., 2002; Wang et al., 2002 and Iwasa et al., 2003). In these reports, the activation of the upstream kinases MKK 6 and MKK 3 lead to a senescent phenotype that was dependent on p38 MAPK activity.	SEN:10037016	15225871
BEL:20077444	kin(p(HGNC:MAPK14)) increases tscript(p(HGNC:STAT1))	In vitro kinase assays using the combined STAT1 proteins as substrates from immunoprecipitation and glutathione S-transferase pull down show that active ERK1, JNK1, p38 kinase, MEK1 and MSK1 stimulated phosphorylation of STAT1 (Ser727) indirectly through an unidentified factor or a downstream kinase.	SEN:10037018	14963018
BEL:20077448	kin(p(HGNC:MAPK14)) increases tscript(p(HGNC:STAT3))	We hypothesized that Rituximab may inhibit p38 MAPK activity that regulates IL-10 expression via Sp1. Treatment of 2F7 cells with Rituximab or the p38 inhibitor SB203580 inhibited the constitutive p38 MAPK activity and resulted in the inhibition of Sp1, IL-10, STAT3, and Bcl-2.	SEN:10037020	15077178
BEL:20077460	kin(p(HGNC:MAPK1)) directlyIncreases tscript(p(HGNC:ELK1))	It is known that there are two isoforms of ERK, ERK1 and ERK2, and they phosphorylate and activate various transcription factors, such as Elk-1 and Elk-2. These transcription factors regulate expression of diverse genes that relates to the proliferation and growth of the cells.	SEN:10037026	16287813
BEL:20077466	kin(p(HGNC:MAPK1)) increases bp(GOBP:"cell proliferation")	An important finding is that intact BRCA1 also prevents EGF and IGF-I signaling through ERK to cell proliferation. EGF and IGF-1 are strongly implicated in the biology of human breast cancer, where they signal through this member of the MAP kinase family to cell growth (27, 52).	SEN:10036762	15199145
BEL:20077468	kin(p(HGNC:MAPK1)) increases bp(GOBP:"cell proliferation")	In many cells PKA inhibits the extracellular receptor kinase (ERK1/2) cascade of the mitogen-activated protein kinase (MAPK) pathway leading to inhibition of cell proliferation.	SEN:10037028	12812976
BEL:20077476	kin(p(HGNC:MAPK1)) increases bp(GOBP:"mast cell activation")	Ag stimulation of Lyn unique domain transfectants was accompanied by enhanced phosphorylation of MEK and ERK-2, which are required for leukotriene C4 (LTC4) release, and production of LTC4 was increased 3- to 5-fold, compared with cells transfected with vector alone. 	SEN:10035020	16177098
BEL:20077478	kin(p(HGNC:MAPK1)) increases p(HGNC:ALOX5)	acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).	SEN:10037036	20153347
BEL:20077480	kin(p(HGNC:MAPK1)) increases p(HGNC:IFNG)	MAPK activation appears to play a prominent role in IL-18 signaling, being involved in transcription and translation of IL-18-induced IFN-gamma mRNA and IL-18-induced cytolytic effects.	SEN:10037032	10903731
BEL:20077482	kin(p(HGNC:MAPK1)) increases p(HGNC:IL8)	p38 MAPK was required for the IL-33-mediated responses of endothelial cells, whereas ERK was required for IL-33-mediated IL-8 production by epithelial cells.	SEN:10035652	20926795
BEL:20077484	kin(p(HGNC:MAPK1)) increases p(HGNC:IL8)	SDF-1alpha-induced chemokine expression was abrogated upon inclusion of U0126, a pharmacological inhibitor of ERK1/2, indicating that the ERK signaling cascade is involved in this response.	SEN:10037038	11160334
BEL:20077486	kin(p(HGNC:MAPK1)) increases p(HGNC:ITGAM)	FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined. 	SEN:10035974	16951367
BEL:20077494	kin(p(HGNC:MAPK1)) increases tscript(p(HGNC:CREB1))	These results suggest that ERK2 has a regulatory role in activating CREB in vivo in lung neutrophils after hemorrhage or endotoxemia. 	SEN:10037042	11123332
BEL:20077508	kin(p(HGNC:MAPK3)) directlyIncreases tscript(p(HGNC:ELK1))	It is known that there are two isoforms of ERK, ERK1 and ERK2, and they phosphorylate and activate various transcription factors, such as Elk-1 and Elk-2. These transcription factors regulate expression of diverse genes that relates to the proliferation and growth of the cells.	SEN:10037026	16287813
BEL:20077512	kin(p(HGNC:MAPK3)) increases bp(GOBP:"cell proliferation")	1) STAT proteins play an essential role in angiotensin II-induced vascular smooth muscle cell proliferation, 2) JAK2 plays an essential role in the tyrosine phosphorylation of Raf-1, and 3) convergent mitogenic signaling cascades involving the cytosolic kinases JAK2, MEK1, and ERK1 mediate vascular smooth muscle cell proliferation 	SEN:10036880	9305939
BEL:20077516	kin(p(HGNC:MAPK3)) increases bp(GOBP:"cell proliferation")	In many cells PKA inhibits the extracellular receptor kinase (ERK1/2) cascade of the mitogen-activated protein kinase (MAPK) pathway leading to inhibition of cell proliferation.	SEN:10037028	12812976
BEL:20077526	kin(p(HGNC:MAPK3)) increases p(HGNC:ALOX5)	acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).	SEN:10037036	20153347
BEL:20077528	kin(p(HGNC:MAPK3)) increases p(HGNC:IFNG)	MAPK activation appears to play a prominent role in IL-18 signaling, being involved in transcription and translation of IL-18-induced IFN-gamma mRNA and IL-18-induced cytolytic effects.	SEN:10037032	10903731
BEL:20077530	kin(p(HGNC:MAPK3)) increases p(HGNC:IL8)	p38 MAPK was required for the IL-33-mediated responses of endothelial cells, whereas ERK was required for IL-33-mediated IL-8 production by epithelial cells.	SEN:10035652	20926795
BEL:20077532	kin(p(HGNC:MAPK3)) increases p(HGNC:IL8)	SDF-1alpha-induced chemokine expression was abrogated upon inclusion of U0126, a pharmacological inhibitor of ERK1/2, indicating that the ERK signaling cascade is involved in this response.	SEN:10037038	11160334
BEL:20077534	kin(p(HGNC:MAPK3)) increases p(HGNC:ITGAM)	FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined. 	SEN:10035974	16951367
BEL:20077544	kin(p(HGNC:MAPK3)) increases tscript(p(HGNC:NFE2L2))	Overexpression of the ERK-1 mutant, but not the ERK-2 mutant, significantly inhibited hyperoxia-induced ARE transcription, suggesting that ERK-1 at least in part mediates Nrf2 translocation and its downstream target expression (Fig. 7B).	SEN:10037048	15292179
BEL:20077554	kin(p(HGNC:MAPK8)) directlyIncreases p(HGNC:JUN,pmod(P,S,73))	8137421;15302935;11971971;15378002;12531896	SEN:10037058	15212693
BEL:20077564	kin(p(HGNC:MAPK8)) directlyIncreases tscript(p(HGNC:JUN))	Figure 1 | The ErbB signalling network.	SEN:10035784	11252954
BEL:20077572	kin(p(HGNC:MAPK9)) directlyIncreases tscript(p(HGNC:JUN))	Figure 1 | The ErbB signalling network.	SEN:10035784	11252954
BEL:20077576	kin(p(HGNC:MAPKAPK2)) directlyIncreases p(HGNC:HSPB1,pmod(P,S,78))	93076920;15302935;1730670;10383393;12096113;11383510;17081983	SEN:10037068	15212693
BEL:20077580	kin(p(HGNC:MAPKAPK2)) directlyIncreases p(HGNC:HSPB1,pmod(P,S))	prominent p38 MAPK target, the Ser/Thr kinase MAPKAP2, is also activated by PM, as evidenced by phosphorylation of the actin-binding protein, HSP27. These events are again consistent with PM-mediated activation of p38 MAPK (10)	SEN:10037006	19520919
BEL:20077590	kin(p(HGNC:MET)) directlyIncreases p(HGNC:MET,pmod(P,Y,1349))	12475979;9444958;9252406;7513258;7731718;7687741;9826708	SEN:10037074	15212693
BEL:20077610	kin(p(HGNC:PAK2)) increases bp(GOBP:"apoptotic process")	Caspase-dependent activation of kinases including PAK2, MEKK1, and PKCd also promotes cytoplasmic and nuclear apoptosis. Interestingly, MEKK1 activation enhances caspase activation, suggesting that kinases may amplify or initiate the caspase cascade.	SEN:10037086	10400609
BEL:20077612	kin(p(HGNC:PDGFRA)) increases kin(p(HGNC:MAP2K1))	In Rat1/vector cells, PDGF-induced phosphorylation of ERK was completely inhibited by pretreatment with PD98059, a MEK inhibitor.	SEN:10037088	15115658
BEL:20077620	kin(p(HGNC:PDGFRB)) increases kin(p(HGNC:MAPK1))	Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].	SEN:10022040	19742316
BEL:20077626	kin(p(HGNC:PDGFRB)) increases kin(p(HGNC:MAPK3))	Because PDGFRb activation, through transphosphorylation of tyrosine residues in its cytoplasmic domain, triggers a cascade of phosphorylation events which eventually lead to the activation of extracellular regulated-protein kinases (Erks), phosphorylated- Erk1/2 was used as an indicator of PDGFRb activation [7].	SEN:10022040	19742316
BEL:20077634	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:PRKCZ))	Our findings suggest that insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T410 loop phosphorylation, (b) T560 autophosphorylation	SEN:10037098	11141077
BEL:20077642	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:RPS6KB1))	Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways.	SEN:10022014	16640565
BEL:20077646	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:RPS6KB2))	PDK1 also phosphorylates several AGC kinase members at the conserved activation-loop Ser or Thr residue, some PKC isoforms and p70 S6K	SEN:10037104	12044776
BEL:20077648	kin(p(HGNC:PDPK1)) directlyIncreases kin(p(HGNC:RPS6KB2))	Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways.	SEN:10022014	16640565
BEL:20077666	kin(p(HGNC:PDPK1)) directlyIncreases p(HGNC:PRKCZ,pmod(P,T,410))	Our findings suggest that insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T410 loop phosphorylation, (b) T560 autophosphorylation	SEN:10037098	11141077
BEL:20077678	kin(p(HGNC:PFKFB3)) increases bp(GOBP:glycolysis)	The activated monocytes express inducible 6-phosphofructo-2-kinase (iPFK-2), which synthesizes fructose 2,6-bisphosphate, a stimulator of glycolysis.	SEN:10037118	12065600
BEL:20077680	kin(p(HGNC:PIK3C3)) increases bp(GOBP:autophagy)	class-3 PI3K activity is particularly important for the early stages of autophagic vesicle formation	SEN:10037120	15286739
BEL:20077682	kin(p(HGNC:PIK3CD)) increases kin(p(HGNC:BTK))	FIGURE 6 | Integration of the signalling pathways induced by the G-protein-coupled receptors FcepsilonRI and KIT.	SEN:10036724	16470226
BEL:20077684	kin(p(HGNC:PIK3CG)) increases gtp(p(HGNC:RAC2))	P-Rex1, a guanine-nucleotide exchange factor (GEF) for Rac, is believed to link GPCRs and PI3Kgamma to Rac-dependent neutrophil responses.	SEN:10022060	16243035
BEL:20077688	kin(p(HGNC:PKMYT1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))	Inhibitory phosphorylation of adjacent threonine and tyrosine residues (T14/Y15 in CDK1) is mediated by dualspecificity kinases (such as WEE1 and MYT1). This inhibition is relieved when the CDC25 phosphatases (CDC25A,CDC25B and CDC25C) dephosphorylate these residues, which triggers entry into mitosis	SEN:10037122	11902577
BEL:20077726	kin(p(HGNC:PRKCA)) directlyIncreases p(HGNC:PRKD1,pmod(P,S,738))	10867018;15383279;11741879;15024053;11948398	SEN:10037138	15212693
BEL:20077728	kin(p(HGNC:PRKCA)) directlyIncreases p(HGNC:PRKD1,pmod(P,S,742))	10867018;15383279;11741879;15024053;11948398	SEN:10037138	15212693
BEL:20077732	kin(p(HGNC:PRKCA)) increases cat(p(HGNC:DUOX1))	Recent studies of DUOX1 activation in airway epithelial cells by LPS suggested the involvement of Ca2+- dependent isoforms of protein kinase C (PKC?,?) alpha and beta (108), although other stimuli appear to activate DUOX1 via activation of PKC? delta (105,106). 	SEN:10037142	18164271
BEL:20077742	kin(p(HGNC:PRKCD)) directlyIncreases p(HGNC:PRKD1,pmod(P,S,738))	10867018;15383279;11741879;15024053;11948398	SEN:10037138	15212693
BEL:20077746	kin(p(HGNC:PRKCD)) directlyIncreases p(HGNC:PRKD1,pmod(P,S,742))	10867018;15383279;11741879;15024053;11948398	SEN:10037138	15212693
BEL:20077762	kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))	The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)	SEN:10036680	16880517
BEL:20077784	kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))	<p6> DNA-PK phosphorylates P53 at Ser15 and Ser37 dependent on DNA double-strand ends	SEN:10037166	10436023
BEL:20077786	kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,37))	<p6> DNA-PK phosphorylates P53 at Ser15 and Ser37 dependent on DNA double-strand ends	SEN:10037166	10436023
BEL:20077808	kin(p(HGNC:RAF1)) directlyIncreases kin(p(HGNC:MAP2K1))	c-Raf activates MEK1 by phosphorylating at serine residues 218 and 222 (30–32).	SEN:10037176	8621729
BEL:20077814	kin(p(HGNC:RAF1)) directlyIncreases kin(p(HGNC:MAP2K1))	Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)	SEN:10036928	10490027
BEL:20077818	kin(p(HGNC:RAF1)) increases kin(p(HGNC:MAPK3))	activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).	SEN:10036758	19273391
BEL:20077826	kin(p(HGNC:RAF1)) increases kin(p(HGNC:MAPK3))	we reported in H9C2 cardiomyocytes that peroxynitritemediated activation of ERK, although dependent on Raf-1 and MEK, was not due to upstream activation of p21ras (63).	SEN:10037186	19273391
BEL:20077842	kin(p(HGNC:RIPK1)) increases a(CHEBI:"reactive oxygen species")	In addition, RIP1, which plays a pivotal role in receptor-induced necroptosis, exerts its effects by generation of ROS [31]	SEN:10037196	20963496
BEL:20077848	kin(p(HGNC:RIPK1)) increases bp(GOBP:"necrotic cell death")	Moreover, it has been reported that H2O2-induced necrosis is also reduced in RIP1-deficient mouse embryonic fibroblasts (MEF).21	SEN:10022130	20010783
BEL:20077856	kin(p(HGNC:RIPK3)) increases bp(GOBP:"necrotic cell death")	Moreover, overexpression of catalytically active RIP3 can trigger necroptosis irrespective of the presence of RIP1 (Ref. 12)	SEN:10022134	20823910
BEL:20077858	kin(p(HGNC:RIPK3)) increases cat(p(HGNC:GLUD1))	RIP3 increases the activities of glycogen phosphorylase, glutamate ammonia ligase, and glutamate dehydrogenase 1. This stimulates the production of reactive oxygen species (ROS) due to increased oxidative phosphorylation. In some cells, ROS production as a consequence of RIP3 signaling is required for necroptosis	SEN:10035622	19632174
BEL:20077860	kin(p(HGNC:RIPK3)) increases cat(p(HGNC:GLUL))	RIP3 increases the activities of glycogen phosphorylase, glutamate ammonia ligase, and glutamate dehydrogenase 1. This stimulates the production of reactive oxygen species (ROS) due to increased oxidative phosphorylation. In some cells, ROS production as a consequence of RIP3 signaling is required for necroptosis	SEN:10035622	19632174
BEL:20077862	kin(p(HGNC:RIPK3)) increases cat(p(HGNC:GLUL))	Wild-type, but not kinase-dead, RIP3 enhances the activity of PYGL, GLUL, and GLUD1 in vitro and in cells (55), which suggests that these metabolic enzymes could be direct substrates of RIP3.	SEN:10022140	20354226
BEL:20077864	kin(p(HGNC:RIPK3)) increases cat(p(HGNC:PYGL))	RIP3 increases the activities of glycogen phosphorylase, glutamate ammonia ligase, and glutamate dehydrogenase 1. This stimulates the production of reactive oxygen species (ROS) due to increased oxidative phosphorylation. In some cells, ROS production as a consequence of RIP3 signaling is required for necroptosis	SEN:10035622	19632174
BEL:20077866	kin(p(HGNC:RIPK3)) increases cat(p(HGNC:PYGL))	Wild-type, but not kinase-dead, RIP3 enhances the activity of PYGL, GLUL, and GLUD1 in vitro and in cells (55), which suggests that these metabolic enzymes could be direct substrates of RIP3.	SEN:10022140	20354226
BEL:20077874	kin(p(HGNC:ROCK1)) increases bp(GOBP:"apoptotic process")	In contrast, inhibition of ROCK activity using the small-molecule inhibitor Y-27632 (ref. 19) resulted in a marked reduction in formation of membrane blebs (Fig. 1a)	SEN:10022148	11283606
BEL:20077884	kin(p(HGNC:RPS6KA1)) directlyIncreases p(HGNC:EIF4E,pmod(P,S,422))	S6K and RSK phosphorylate eIF4B at Ser422, thus enhancing its interaction with the eIF3 and promoting protein translation (Shahbazian et al., 2006).	SEN:10036052	18794886
BEL:20077894	kin(p(HGNC:RPS6KB1)) directlyIncreases p(HGNC:EIF4E,pmod(P,S,422))	S6K and RSK phosphorylate eIF4B at Ser422, thus enhancing its interaction with the eIF3 and promoting protein translation (Shahbazian et al., 2006).	SEN:10036052	18794886
BEL:20077898	kin(p(HGNC:RPS6KB1)) increases bp(GOBP:"protein metabolic process")	The kinase activity of this protein leads to an increase in protein synthesis and cell proliferation	SEN:10037222	15240005
BEL:20077906	kin(p(HGNC:RPS6KB2)) directlyIncreases p(HGNC:HSPB1,pmod(P,S,78))	93076920;15302935;1730670;10383393;12096113;11383510;17081983	SEN:10037068	15212693
BEL:20077914	kin(p(HGNC:SRC)) directlyIncreases kin(p(HGNC:PTK2))	In the first case, recruited FAK autophosphorylates at 397Y and associates with c-Src or Fyn, which further phosphorylates it at 925Y. Phosphorylated FAK binds to the Grb2-Sos complex and activates the Ras-ERK cascade [60,61].	SEN:10037230	14984767
BEL:20077936	kin(p(HGNC:SRC)) increases cat(p(HGNC:ADAM17))	In the present study, we demonstrate that TNF-alpha converting enzyme (TACE), a disintegrin and metalloproteinse-17, undergoes a Src-dependent phosphorylation that regulates release of the EGFR ligand amphiregulin upon GRP treatment. 	SEN:10037236	16641105
BEL:20077942	kin(p(HGNC:SRC)) increases cat(p(HGNC:PLCG1))	short-term NO production induced by VEGF is mediated via increased cytosolic Ca, resulting from activation of PLCG1 and subsequent generation of IP3 Src has been implicated in signaling upstream of PLCG1	SEN:10037242	11350732
BEL:20077950	kin(p(HGNC:SRC)) increases kin(p(HGNC:MAPK1))	activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).	SEN:10036758	19273391
BEL:20077960	kin(p(HGNC:SRC)) increases kin(p(HGNC:MAPK3))	activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).	SEN:10036758	19273391
BEL:20077994	kin(p(HGNC:TEK)) decreases tscript(p(HGNC:FOXO1))	It has been reported that inhibition of FoxO activity is an important mechanism for Ang1-stimulated Tie2-mediated endothelial function. Consistent with this, we found that phosphorylation of FoxO mediated by Tie2 activation was attenuated by lipid raft disruption. Therefore, we propose that lipid rafts serve as signaling platforms for Tie2 receptor tyrosine kinase in vascular endothelial cells	SEN:10037260	19615361
BEL:20077996	kin(p(HGNC:TEK)) decreases tscript(p(HGNC:FOXO3))	It has been reported that inhibition of FoxO activity is an important mechanism for Ang1-stimulated Tie2-mediated endothelial function. Consistent with this, we found that phosphorylation of FoxO mediated by Tie2 activation was attenuated by lipid raft disruption. Therefore, we propose that lipid rafts serve as signaling platforms for Tie2 receptor tyrosine kinase in vascular endothelial cells	SEN:10037260	19615361
BEL:20077998	kin(p(HGNC:TEK)) increases bp(GOBP:"cell migration")	Furthermore, exposure of aortic rings from p47(phox-/-) mice to Ang-1 demonstrated fewer vessel sprouts than WT mice. Inhibition of the Tie-2 receptor inhibited Ang-1-induced endothelial migration and vessel sprouting	SEN:10022236	16679392
BEL:20078002	kin(p(HGNC:TEK)) increases bp(GOBP:"cell migration")	This is accompanied by the loosening of PERICYTE covering,which is thought to be a function of ANG2 (REF. 23) - a ligand of TIE2. TIE2 is a tyrosine kinase receptor that is selectively expressed in endothelial cells24.	SEN:10037264	12778130
BEL:20078010	kin(p(HGNC:TGFBR1)) directlyIncreases tscript(p(HGNC:SMAD2))	P/CAF potentiated the transcriptional activity of heterologous Gal4-Smad2 and Gal4-Smad3 fusion proteins. In addition, P/CAF potentiated the TGF-beta/Smad3-induced transcriptional responses, which could be further enhanced by co-activators p300 and Smad4.	SEN:10037266	11058129
BEL:20078012	kin(p(HGNC:TGFBR1)) directlyIncreases tscript(p(HGNC:SMAD3))	P/CAF potentiated the transcriptional activity of heterologous Gal4-Smad2 and Gal4-Smad3 fusion proteins. In addition, P/CAF potentiated the TGF-beta/Smad3-induced transcriptional responses, which could be further enhanced by co-activators p300 and Smad4.	SEN:10037266	11058129
BEL:20078040	kin(p(HGNC:TYK2)) directlyIncreases tscript(p(HGNC:STAT4))	IL-12 activates the Janus family tyrosine kinases JAK2 and Tyk2, which in turn phosphorylate STAT4 on tyrosine 693. 	SEN:10036878	16324152
BEL:20078052	kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))	96108162;7743995;15592455;16083285;15964826	SEN:10037284	15212693
BEL:20078062	kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))	Inhibitory phosphorylation of adjacent threonine and tyrosine residues (T14/Y15 in CDK1) is mediated by dualspecificity kinases (such as WEE1 and MYT1). This inhibition is relieved when the CDC25 phosphatases (CDC25A,CDC25B and CDC25C) dephosphorylate these residues, which triggers entry into mitosis	SEN:10037122	11902577
BEL:20078066	kin(p(HGNC:ZAP70)) directlyIncreases p(HGNC:PLCG1,pmod(P,Y))	dual phosphorylation by ZAP70 and Itk triggers the activation of PLCg1	SEN:10037294	12044776
BEL:20078574	path(MESHD:Hyperoxia) increases a(CHEBI:"reactive oxygen species")	Hyperoxia-dependent ROS production was strongly reduced in lung sections, in isolated epithelial type II cells, and lung endothelial cells from NOX1-deficient mice.	SEN:10019402	19661248
BEL:20078580	path(MESHD:Hyperoxia) increases a(CHEBI:"reactive oxygen species")	Progressive lung pathology caused by inhaled hyperoxia has been described in detail in adult animals (Crapo et al., 1984; Crapo, 1986; Fracica et al., 1988). Hyperoxia induces a pattern of toxicity that includes excess ROS production in the lung and diffuse pulmonary damage developed slowly in alveolar epithelium and pulmonary capillary endothelium.	SEN:10037498	19646463
BEL:20078582	path(MESHD:Hyperoxia) increases a(CHEBI:"reactive oxygen species")	ROS were markedly increased in the lungs of hyperoxia-exposed WT mice compared with air-exposed WT mice. This hyperoxiainduced increase in ROS was significantly attenuated in NOX1- deficient mice but not in NOX2-deficient mice (Figure 3A).	SEN:10029638	19661248
BEL:20078584	path(MESHD:Hyperoxia) increases a(CHEBI:"reactive oxygen species")	These results suggest that hyperoxia  increases the generation of ROS, resulting in enhanced AP-1 activation and elevated IL-8 production.	SEN:10034662	18692129
BEL:20078588	path(MESHD:Hyperoxia) increases kin(p(HGNC:MAPK1))	hyperoxia stimulated ERK-1 and ERK-2 phosphorylation {SE: Canonical ERK phosphorylation leading directly to activation}	SEN:10022402	15292179
BEL:20078592	path(MESHD:Hyperoxia) increases kin(p(HGNC:MAPK3))	hyperoxia stimulated ERK-1 and ERK-2 phosphorylation {SE: Canonical ERK phosphorylation leading directly to activation}	SEN:10022402	15292179
BEL:20078596	path(MESHD:Hyperoxia) increases kin(p(HGNC:MAPK3))	Overexpression of the ERK-1 mutant, but not the ERK-2 mutant, significantly inhibited hyperoxia-induced ARE transcription, suggesting that ERK-1 at least in part mediates Nrf2 translocation and its downstream target expression (Fig. 7B).	SEN:10037048	15292179
BEL:20078608	path(MESHD:Ischemia) increases a(CHEBI:"reactive oxygen species")	ROS production with ischemia was significantly reduced in lungs with knockout of Akt1 while the response of Akt2 null lungs to ischemia was similar to wild type (Fig. 4A and B). Thus, Akt1 is required for activation of endothelial ROS production with ischemia.	SEN:10021512	22003059
BEL:20078770	p(EGID:1991) increases p(HGNC:MUC5AC)	A549 cells were incubated with agonist for 24 h or preincubated with SLPI for 1 h and then stimulated with agonists..MUC5AC mRNA expression and protein production using reverse transcriptase polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA).... All of the agonists tested (NE, LPS, ... increased MUC5AC expression significantly compared with the control (Fig. 1A?D).	SEN:10037568	17026478
BEL:20078772	p(EGID:1991) increases p(HGNC:MUC5AC)	Here we show that in human airway epithelial cells HNE increases TGF-alpha release, EGFR phosphorylation, and MUC5AC mucin expression, effects that were attenuated by TACE inhibitor TAPI-1 and by specific knockdown of TACE expression with small interfering RNA, implicating TACE in HNE-induced responses.	SEN:10037570	16148149
BEL:20078774	p(EGID:1991) increases p(HGNC:MUC5AC)	Multiple agents, including cigarette smoke (15), activated eosinophils (16), interleukin-13 (17), neutrophil elastase (18), Pseudomonas aeruginosa (19), and phorbol 12-myristate 13- acetate (PMA) (20) increase MUC5AC in airway epithelial cells (NCI-H292)...	SEN:10035026	15531749
BEL:20078776	p(EGID:1991) increases p(HGNC:MUC5AC)	NE also upregulated MUC5AC in A549 cells in a time-dependent manner (Fig. 2A)	SEN:10037572	10330040
BEL:20078836	p(HGNC:ADAM10) directlyIncreases p(HGNC:HBEGF)	In contrast, EGFR activation by gram-positive bacteria occurred through cleavage of the transmembrane ligand HBEGF by ADAM 10. 	SEN:10037584	16484683
BEL:20078862	p(HGNC:AIFM1) increases bp(GOBP:"apoptotic process")	endonuclease G and apoptosis-inducing factor (AIP) might induce cell death independently of caspase activation	SEN:10037594	15286739
BEL:20078882	p(HGNC:AKT1,pmod(P,S,473)) directlyIncreases kin(p(HGNC:AKT1))	mTORC2 can be activated by PI3K directly and phosphorylates Akt at S473, which together with phosphorylation at T308 results in the full activation of Akt [12,13].	SEN:10037610	17200144
BEL:20078886	p(HGNC:AKT1,pmod(P,S,473)) directlyIncreases kin(p(HGNC:AKT1))	Phosphorylation at Ser473 in the hydrophobic motif, along with Thr308 in its activation loop, is considered necessary for Akt function.	SEN:10037614	20691662
BEL:20078890	p(HGNC:AKT1,pmod(P,S,473)) directlyIncreases kin(p(HGNC:AKT1))	The impact of IL-8 binding to AAT or HSA on its ability to stimulate Akt Ser473 phosphorylation, a key step in IL-8? mediated neutrophil chemotaxis (27), was explored. Figure 7D shows that IL-8 (1 ng) stimulated adequate Akt phosphorylation after just 10 minutes and that this effect was unaffected by prebinding of IL-8 to HSA (27.5 uM).	SEN:10037616	21060150
BEL:20078892	p(HGNC:AKT1,pmod(P,S,473)) directlyIncreases kin(p(HGNC:AKT1))	three isoforms, AKT1 (PKBalpha), AKT2 (PKBbeta) and AKT3 (PKBgamma) they all contain a central kinase domain with an activation-loop phosphorylation site, Thr308, and a conserved, regulatory C-terminal phosphorylation site, Ser473	SEN:10037618	12044776
BEL:20078908	p(HGNC:AKT1,pmod(P,T,308)) directlyIncreases kin(p(HGNC:AKT1))	Conversely, the H157 cells, which showed decreased T308 phosphorylation with serum deprivation, exhibited less kinase activity in low serum.	SEN:10037624	11358816
BEL:20078916	p(HGNC:AKT1,pmod(P,T,308)) directlyIncreases kin(p(HGNC:AKT1))	mTORC2 can be activated by PI3K directly and phosphorylates Akt at S473, which together with phosphorylation at T308 results in the full activation of Akt [12,13].	SEN:10037610	17200144
BEL:20078918	p(HGNC:AKT1,pmod(P,T,308)) directlyIncreases kin(p(HGNC:AKT1))	Phosphorylation at Ser473 in the hydrophobic motif, along with Thr308 in its activation loop, is considered necessary for Akt function.	SEN:10037614	20691662
BEL:20078922	p(HGNC:AKT1,pmod(P,T,308)) directlyIncreases kin(p(HGNC:AKT1))	three isoforms, AKT1 (PKBalpha), AKT2 (PKBbeta) and AKT3 (PKBgamma) they all contain a central kinase domain with an activation-loop phosphorylation site, Thr308, and a conserved, regulatory C-terminal phosphorylation site, Ser473	SEN:10037618	12044776
BEL:20078930	p(HGNC:ALOX5) increases a(CHEBI:"leukotriene B4")	acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).	SEN:10037036	20153347
BEL:20078960	p(HGNC:ANGPT2) directlyDecreases kin(p(HGNC:TEK))	this is accompanied by the loosening of pericyte covering (basement membrane degradation), which is thought to be a function of ANG2, a ligand of TIE2 TIE2 is a tyrosine kinase receptor that is selectively expressed in endothelial cells	SEN:10037642	12778130
BEL:20078968	p(HGNC:APCS) decreases p(HGNC:COL1A1)	human SAP also significantly reduced the histopathological extent of bleomycin-induced collagen deposition (Fig. 3 A) and the generation of collagen at the protein (Fig. 3 B) and gene level (Fig. 3 C).	SEN:10025150	20300636
BEL:20078970	p(HGNC:APCS) increases p(HGNC:CXCL10)	Moreover, SAP treatment increased the level of the M1 macrophage-associated chemokine IP10/CXCL10, in the circulation of mice treated with SAP, in comparison to control treated bleomycin-challenged animals (Fig. 3 G).	SEN:10025152	20300636
BEL:20078992	p(HGNC:AREG) increases kin(p(HGNC:EGFR))	Moreover, AR gene silencing by siRNA or inhibition of AR biological activity by neutralizing antibodies and heparin prevents GPCR-induced EGFR tyrosine phosphorylation, downstream mitogenic signalling events, cell proliferation, migration and activation of the survival mediator Akt/PKB.	SEN:10037648	12743035
BEL:20078996	p(HGNC:ARRB1) increases kin(p(HGNC:MAPK1))	from full text - Furthermore, the decreased expression of either b-arrestin 1 or b-arrestin 2 (via siRNA) resulted in a decrease in ERK1/2 activity	SEN:10037650	16492667
BEL:20078998	p(HGNC:ARRB1) increases kin(p(HGNC:MAPK3))	from full text - Furthermore, the decreased expression of either b-arrestin 1 or b-arrestin 2 (via siRNA) resulted in a decrease in ERK1/2 activity	SEN:10037650	16492667
BEL:20079002	p(HGNC:ARRB2) increases kin(p(HGNC:MAPK1))	from full text - Furthermore, the decreased expression of either b-arrestin 1 or b-arrestin 2 (via siRNA) resulted in a decrease in ERK1/2 activity	SEN:10037650	16492667
BEL:20079004	p(HGNC:ARRB2) increases kin(p(HGNC:MAPK3))	from full text - Furthermore, the decreased expression of either b-arrestin 1 or b-arrestin 2 (via siRNA) resulted in a decrease in ERK1/2 activity	SEN:10037650	16492667
BEL:20079022	p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))	Consistent with this, both Gal4-c-Jun- and Gal4-ATF2-fusion proteins were activated by RalA signalling through phosphorylation of their activation domains at Ser63 and Ser73 of c-Jun or Thr69 and Thr71 of ATF2.	SEN:10037662	11313929
BEL:20079040	p(HGNC:ATG4A) increases bp(GOBP:autophagy)	by Western analysis, electron microscopy, and immunoflourescence, there is increased expression of the autophagic proteins LC3B-II/LC3B-I, Atg4, Atg5-artg12, and Atg7, as well as increased numbers of different stages of autophagic vacuoles in the lungs of COPD patients in all GOLD categories, with a corresponding increase in caspase 3 activity, a marker of apoptosis in GOLD 3/4 patients.54	SEN:10035456	21857781
BEL:20079044	p(HGNC:ATG5) increases bp(GOBP:autophagy)	Atgs such as Atg5, Atg7, and Atg16L1 are required for the induction of autophagy in human DCs and the subsequent promotion of antigen presentation by MDP (Cooney et al., 2010).	SEN:10037666	20548099
BEL:20079046	p(HGNC:ATG5) increases bp(GOBP:autophagy)	by Western analysis, electron microscopy, and immunoflourescence, there is increased expression of the autophagic proteins LC3B-II/LC3B-I, Atg4, Atg5-artg12, and Atg7, as well as increased numbers of different stages of autophagic vacuoles in the lungs of COPD patients in all GOLD categories, with a corresponding increase in caspase 3 activity, a marker of apoptosis in GOLD 3/4 patients.54	SEN:10035456	21857781
BEL:20079050	p(HGNC:ATG7) increases bp(GOBP:autophagy)	Atgs such as Atg5, Atg7, and Atg16L1 are required for the induction of autophagy in human DCs and the subsequent promotion of antigen presentation by MDP (Cooney et al., 2010).	SEN:10037666	20548099
BEL:20079052	p(HGNC:ATG7) increases bp(GOBP:autophagy)	by Western analysis, electron microscopy, and immunoflourescence, there is increased expression of the autophagic proteins LC3B-II/LC3B-I, Atg4, Atg5-artg12, and Atg7, as well as increased numbers of different stages of autophagic vacuoles in the lungs of COPD patients in all GOLD categories, with a corresponding increase in caspase 3 activity, a marker of apoptosis in GOLD 3/4 patients.54	SEN:10035456	21857781
BEL:20079054	p(HGNC:ATG7) increases bp(GOBP:autophagy)	TDP-43 positively regulated the autophagy as mediated through ATG7.	SEN:10037668	22052911
BEL:20079056	p(HGNC:ATM,pmod(P,S,1981)) directlyIncreases kin(p(HGNC:ATM))	Figure 3 Nbs1 modulates ATMactivation after low doses of IR. Human NBS-Tert cells expressing different Nbs1 mutant forms and the cells infected with empty vector were irradiated with 2Gy and lysed at the indicated times (5 min to 8 h) after irradiation. Phosphorylation of S1981 of ATMand S966 of SMC1 and the total level of SMC1 were examined by immunoblotting as described in Figure 1	SEN:10037670	15048089
BEL:20079066	p(HGNC:BAD,pmod(P,S,75)) directlyDecreases cat(p(HGNC:BAD))	NNK enhanced the levels of phospho-Bad (Ser112, Ser136 and Ser155; fig. 3c and d), which indicates that Bad was inactivated by NNK.	SEN:10037676	18508827
BEL:20079068	p(HGNC:BAD,pmod(P,S,99)) directlyDecreases cat(p(HGNC:BAD))	NNK enhanced the levels of phospho-Bad (Ser112, Ser136 and Ser155; fig. 3c and d), which indicates that Bad was inactivated by NNK.	SEN:10037676	18508827
BEL:20079076	p(HGNC:BAX) increases bp(GOBP:"apoptotic process")	Further support for the importance of Bax, but not Bak, inMYC-mediated apoptosis was obtained using a switchable mouse model of MYC-induced apoptosis in pancreatic beta cells, where it was shown that c-MYC induces apoptosis in vivo exclusively through Bax (Dansen et al., 2006).	SEN:10025356	18955973
BEL:20079078	p(HGNC:BAX) increases bp(GOBP:"apoptotic process")	However, in neurons, where BAX is a major mediator of apoptosis during development and disease [45], both the c-Jun N-terminal protein kinase (JNK)/c-Jun and the p53 pathways form distinct death-signaling modules that culminate in BAX dependent apoptosis.	SEN:10037682	16530485
BEL:20079080	p(HGNC:BAX) increases bp(GOBP:"apoptotic process")	if Bak or Bax is present, Bid then triggers cytochrome c release and apoptosis, apparently by inducing Bax and Bak to oligomerize and breach membrane integrity	SEN:10037684	14561771
BEL:20079084	p(HGNC:BAX) increases bp(GOBP:"apoptotic process")	These genes can be divided in three classes: one that controls cell-cycle arrest and senescence, one that controls apoptosis and one that regulates glucose metabolism and autophagy [42]. p53 is essentially known as a pro-apoptotic transcription factor that upregulates the expression of proteins such as BCL2-associated X protein (BAX), p53 upregulated modulator of apoptosis (PUMA) or NOXA.	SEN:10037686	17118707
BEL:20079092	p(HGNC:BBC3) increases bp(GOBP:"apoptotic process")	BH3-only proteins are members of the BCL- 2 protein family; they trigger apoptosis and integrate diverse apoptotic stimuli into a common cell-death pathway that is governed by other multidomain BCL-2 family members.	SEN:10037692	16530485
BEL:20079096	p(HGNC:BBC3) increases bp(GOBP:"apoptotic process")	These genes can be divided in three classes: one that controls cell-cycle arrest and senescence, one that controls apoptosis and one that regulates glucose metabolism and autophagy [42]. p53 is essentially known as a pro-apoptotic transcription factor that upregulates the expression of proteins such as BCL2-associated X protein (BAX), p53 upregulated modulator of apoptosis (PUMA) or NOXA.	SEN:10037686	17118707
BEL:20079102	p(HGNC:BCL2A1) decreases bp(GOBP:"apoptotic process")	hydrogen peroxide (H2O2) upregulates the expression of Bfl-1, an antiapoptotic member of the Bcl-2 family, and that this is responsible for the antiapoptotic activity of ROS	SEN:10037700	15592513
BEL:20079104	p(HGNC:BCL2A1) decreases bp(GOBP:"apoptotic process")	longer term effects of VEGF on cell survival may be mediated through the upregulation of the antiapoptotic proteins BCL2 and A1	SEN:10037702	11350732
BEL:20079110	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	Bcl-2 inhibits MYC-mediated apoptosis in some but not all cell systems, although having no effect on the proliferative function of c-MYC (Hoffman and Liebermann, 1998; Nilsson and Cleveland, 2003).	SEN:10025372	18955973
BEL:20079114	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	c-MYC overexpression accelerated apoptosis when these cells were deprived of IL-3 (Eischen et al., 2001b). Furthermore, c-MYC overexpression suppresses Bcl-2 protein and RNA levels, and restoration of Bcl-2 protein blocks this accelerated apoptosis.	SEN:10025374	18955973
BEL:20079120	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	Figure 1. Bcl-2 and Bcl-xL inhibit caspase-3 processing and cell death in CD95-stimulated cells. 	SEN:10037712	11801595
BEL:20079124	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	longer term effects of VEGF on cell survival may be mediated through the upregulation of the antiapoptotic proteins BCL2 and A1	SEN:10037702	11350732
BEL:20079128	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	# Pubmed:gene: A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.	SEN:10037716	11126360
BEL:20079134	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	Serum deprived peripheral blood monocytes rapidly undergo apoptosis, but when co-cultured with human SMCs, the monocytes survive 51. This effect was found to be mediated by an increase in Bcl-2 expression and increased activity of the Akt and MAPK pathways. Furthermore, the effect was blocked by a neutralizing antibody to VCAM-1, suggesting that the VCAM-1/VLA4 interaction may be essential 51.	SEN:10037314	18276911
BEL:20079136	p(HGNC:BCL2) decreases bp(GOBP:"apoptotic process")	These reported that overexpression of E2F1 suppresses the expression of two apoptotic antagonists, BCL-2 and its family member MCL-1 (myeloid leukaemia cell differentiation protein 1), thereby leading to apoptosis.In both cases, transcriptional repression is direct and dependent on the DNA-binding domain of E2F1.	SEN:10037722	16530485
BEL:20079142	p(HGNC:BCL2L11) increases bp(GOBP:"apoptotic process")	BH3-only proteins are members of the BCL- 2 protein family; they trigger apoptosis and integrate diverse apoptotic stimuli into a common cell-death pathway that is governed by other multidomain BCL-2 family members.	SEN:10037692	16530485
BEL:20079144	p(HGNC:BCL2L11) increases bp(GOBP:"apoptotic process")	FoxO and RUNX3, a Runt domain-containing transcription factor, interact and bind concomitantly to the promoter of BIM, a pro-apoptotic Bcl-2 family member, which contains one FoxO binding site and two RUNX3- binding domains in close proximity (Figure 5). FoxO and RUNX3 cooperate to upregulate this pro-apoptotic gene and consequently promote apoptosis in gastric cancer cells (Yamamura et al., 2006).	SEN:10037728	18391970
BEL:20079146	p(HGNC:BCL2L11) increases bp(GOBP:"apoptotic process")	Here, we show that RhoB activity increases in human breast and cervical cancer cell lines after treatment with DNA damaging agents. Furthermore, RhoB activity is necessary for DNA damage-induced cell death, as the stable loss of RhoB protein expression using shRNA partially protects cells and prevents the phosphorylation of c-Jun N-terminal kinases (JNKs) and the induction of the pro-apoptotic protein Bim after IR. 	SEN:10037730	21373644
BEL:20079160	p(HGNC:BCL2L11,pmod(P,T,116)) directlyIncreases cat(p(HGNC:BCL2L11))	These data demonstrate that BimL is phosphorylated in vivo on Thr-56 and that JNK also phosphorylates BimL on at least one serine residue (Ser-44 and/or Ser-58)...JNK Phosphorylation of Bim on Thr-56 Increases Apoptotic Activity. 	SEN:10037398	12591950
BEL:20079166	p(HGNC:BCL2L1) decreases bp(GOBP:"apoptotic process")	Figure 1. Bcl-2 and Bcl-xL inhibit caspase-3 processing and cell death in CD95-stimulated cells. 	SEN:10037712	11801595
BEL:20079168	p(HGNC:BCL2L1) decreases bp(GOBP:"apoptotic process")	# Pubmed:gene: A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.	SEN:10037716	11126360
BEL:20079170	p(HGNC:BCL2L1) decreases bp(GOBP:"apoptotic process")	tBID-induced cell death was inhibited completely by BclxL and zVAD-fmk, partially by Bcl2, but not at all by CrmA.	SEN:10037742	9727492
BEL:20079180	p(HGNC:BECN1) increases bp(GOBP:autophagy)	 A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy. 	SEN:10037746	21179212
BEL:20079182	p(HGNC:BECN1) increases bp(GOBP:autophagy)	BECN1 interacts with PI3K and participates in the induction of autophagy in response to starvation	SEN:10037748	15286739
BEL:20079188	p(HGNC:BIRC2) decreases bp(GOBP:"apoptotic process")	Antisense-mediated reductions in IAP-family members XIAP, cIAP1, Survivin, or Apollon can induce apoptosis of tumor cell lines in culture, or sensitize cells to cytotoxic anticancer drugs, thus providing proof-of-concept evidence that the pathological elevations of IAPs found in cancers are important for maintaining tumor cell survival and resistance to chemotherapy (Table 1C).	SEN:10037750	12559172
BEL:20079192	p(HGNC:BIRC3) decreases bp(GOBP:"apoptotic process")	(2) Inhibitor of apoptosis protein (IAP) family members, inhibitor of apoptosis protein1 (cIAP1), and X-chromosome-linked IAP, are expressed in rat hepatocytes. cIAP2 is induced by cytokines in an NF-kappaB-dependent manner and overexpression of cIAP2 inhibits apoptosis.	SEN:10037754	12044523
BEL:20079194	p(HGNC:BIRC3) directlyDecreases cat(p(HGNC:CASP3))	Table 1 Apparent inhibitory constants (KI,app in M) for IAPs against selected human caspases	SEN:10037756	12042762
BEL:20079196	p(HGNC:BIRC5) decreases bp(GOBP:"apoptotic process")	Antisense-mediated reductions in IAP-family members XIAP, cIAP1, Survivin, or Apollon can induce apoptosis of tumor cell lines in culture, or sensitize cells to cytotoxic anticancer drugs, thus providing proof-of-concept evidence that the pathological elevations of IAPs found in cancers are important for maintaining tumor cell survival and resistance to chemotherapy (Table 1C).	SEN:10037750	12559172
BEL:20079198	p(HGNC:BIRC5) decreases bp(GOBP:"apoptotic process")	from full text - survivin is one of the most tumour-specific molecules (19), which antagonizes apoptosis (7), promotes tumour-associated angiogenesis (20) (BIRC5 = survivin)	SEN:10037758	18075512
BEL:20079204	p(HGNC:BIRC5) decreases bp(GOBP:"apoptotic process")	reduced survivin levels by combined genistein and tamoxifen was attributed to apoptosis in breast cancer cells [30] 	SEN:10037764	20517637
BEL:20079216	p(HGNC:BLNK) increases bp(GOBP:"cell proliferation")	Here we identified BLNK as a direct target of the transcription factor Pax5 (BSAP). Restoration of BLNK expression in Ig(mu) transgenic Pax5(--) pro-B cells resulted in constitutive pre-BCR signaling and increased cell proliferation without inducing progression to the pre-B cell stage.....Pax5 Activates BLNK by Binding to the Transcription  Initiation Region	SEN:10037774	12387741
BEL:20079230	p(HGNC:BNIP3) increases bp(GOBP:autophagy)	 A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy. 	SEN:10037746	21179212
BEL:20079236	p(HGNC:BNIP3) increases bp(GOBP:"necrotic cell death")	HIF1A activates expression of 2 pro-apoptotic proteins, NIX and NIP3 the mechanism by which NIP3 causes cell death seems to be a combination of both necrosis and apoptosis	SEN:10037784	11902584
BEL:20079246	p(HGNC:BRAF,sub(V,600,E)) increases kin(p(HGNC:RPS6KA6))	Two days after BRAFE600 selection, we seeded cells at low density and performed growth curves. RSK4 inhibition partially rescued BRAFE600-induced senescence in both TIG3 and TIG3 p16-null (Figure 4A).	SEN:10037214	21239520
BEL:20079260	p(HGNC:BRCA1) directlyIncreases tscript(p(HGNC:TP53))	<p47> p53 binds BRCA1. This binding enhances the transcriptional activity of P53	SEN:10037792	10436023
BEL:20079272	p(HGNC:BRCA1) increases cat(p(HGNC:PARP1))	We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis ... from full text, embryonic stem cells	SEN:10037802	15829967
BEL:20079286	p(HGNC:BRCA2) increases cat(p(HGNC:PARP1))	We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis ... from full text, embryonic stem cells	SEN:10037802	15829967
BEL:20079288	p(HGNC:BTC) directlyIncreases complex(p(HGNC:EGFR),p(HGNC:ERBB3))	the second group betacellulin (BTC), heparin-binding EGF (HB-EGF), and epiregulin (EPR), which exhibit dual specificity in that they bind ErbB1 and ErbB4. 	SEN:10037804	12648469
BEL:20079298	p(HGNC:BTC) directlyIncreases complex(p(HGNC:ERBB4),p(HGNC:ERBB4))	the second group betacellulin (BTC), heparin-binding EGF (HB-EGF), and epiregulin (EPR), which exhibit dual specificity in that they bind ErbB1 and ErbB4. 	SEN:10037804	12648469
BEL:20079312	p(HGNC:C3) increases p(HGNC:ICAM1)	In WT mice CH induced an approximate 2-fold increase in IL-6 mRNA at three weeks that was abrogated in C3 -/- mice... We observed increases in lung intracellular adhesion molecule 1 (ICAM-1)...the increase in ICAM-1 was abrogated in C3 -/- mice (Fig. 7).	SEN:10025580	22194859
BEL:20079340	p(HGNC:CCL11) increases bp(GOBP:"neutrophil activation")	On day 7 after blm treatment, pulmonary eosinophil and neutrophil numbers were significantly increased in rCCL11-administered mice (200 ng) in comparison to the corresponding control group (0.1% of serum) (Table 2). 	SEN:10037816	16314464
BEL:20079348	p(HGNC:CCL16) increases cat(p(HGNC:CCR1))	Here we report that CCL16 activates an angiogenic program in vascular endothelial cells by activating CCR1.	SEN:10037818	12958070
BEL:20079368	p(HGNC:CCL2) increases bp(GOBP:"macrophage chemotaxis")	Peritoneal macrophages pre-attached to Transwell membranes were exposed to media, fMLP, GM-CSF, or MCP-1. After 21 h incubation, the concentration of migrated CD44-deficient macrophages was significantly less than that of migrated C57BL/6 macrophages under all conditions 	SEN:10037826	17446529
BEL:20079380	p(HGNC:CCL3) directlyIncreases cat(p(HGNC:CCR1))	MIP1alpha is released by macrophages and has chemotactic activity for monocytes and neutrophils via CCR1.	SEN:10037838	15602009
BEL:20079388	p(HGNC:CCL3) increases bp(GOBP:"macrophage activation")	 Wounds of mice treated with anti-MIP-1alpha antiserum had significantly fewer macrophages than control (41% decrease, P < 0. 01). This decrease in wound macrophages was paralleled by decreased angiogenic activity and collagen synthesis. 	SEN:10037842	9541500
BEL:20079410	p(HGNC:CCL5) increases cat(p(HGNC:CCR1))	The identification of the heptahelical receptors CXCR1 and CXCR2 for IL-8 and its homologues [14, 15], as well as CCR1 and CCR2 for the CC chemokines MIP-1?/regulated on activation normal T cell expressed and secreted (RANTES; CC ligand 5) and monocyte chemotactic protein (MCP) 1 [16, 17],	SEN:10037852	12545245
BEL:20079412	p(HGNC:CCL5) increases cat(p(HGNC:CCR1))	Using selective receptor antagonist, it was demonstrated that RANTESinduced monocyte arrest is mediated via its receptor CCR1 but not CCR5.	SEN:10037854	12545245
BEL:20079428	p(HGNC:CCNA1) directlyIncreases kin(p(HGNC:CDK2))	CDK2 is sequentially activated by the E-type cyclins  cyclin E1 and E2  during the G1/S transition, and the A-type cyclins  cyclin A1 and A2 during S phase	SEN:10037858	11902577
BEL:20079430	p(HGNC:CCNA1) increases bp(GOBP:"cell cycle")	Active Cyclin D ? Cdk6 then phosphorylates and inactivates Rb , thereby enhancing the expression of Cyclin A and Cyclin E , and thereby promoting G1-to-S transition . 	SEN:10037860	17941990
BEL:20079432	p(HGNC:CCNA2) directlyIncreases kin(p(HGNC:CDK2))	CCNA2_CDK2=^E2F1{P@?} CNA2_CDK2=^E2F2{P@?} CCNA2_CDK2=^E2F3{P@?}	SEN:10037862	10436023
BEL:20079434	p(HGNC:CCNA2) directlyIncreases kin(p(HGNC:CDK2))	CDK2 is sequentially activated by the E-type cyclins  cyclin E1 and E2  during the G1/S transition, and the A-type cyclins  cyclin A1 and A2 during S phase	SEN:10037858	11902577
BEL:20079436	p(HGNC:CCNA2) increases bp(GOBP:"single strand break repair")	In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A	SEN:10035358	17289756
BEL:20079450	p(HGNC:CCND1) directlyIncreases kin(p(HGNC:CDK4))	Breaking down CDKx:CCNDx to just CDK so modulation of CDKs is consolidated to the CDKx node. CDK4&CCND1 CDK4_CCND1=CDK4:CCND1 \"PD 0183812\"-|kaof(CDK4_CCND1) CDK6&CCND2 CDK6_CCND2=CDK6:CCND2 \"PD 0183812\"-|kaof(CDK6_CCND2) CDK6&CCND3 CDK6_CCND3=CDK6:CCND3 \"PD 0183812\"-|kaof(CDK6_CCND3)	SEN:10037864	11278443
BEL:20079452	p(HGNC:CCND1) directlyIncreases kin(p(HGNC:CDK4))	expression of CDK4/cyclin D1, which stimulated RB phosphorylation	SEN:10037866	10939590
BEL:20079472	p(HGNC:CCND2) directlyIncreases kin(p(HGNC:CDK4))	Breaking down CDKx:CCNDx to just CDK so modulation of CDKs is consolidated to the CDKx node. CDK4&CCND1 CDK4_CCND1=CDK4:CCND1 \"PD 0183812\"-|kaof(CDK4_CCND1) CDK6&CCND2 CDK6_CCND2=CDK6:CCND2 \"PD 0183812\"-|kaof(CDK6_CCND2) CDK6&CCND3 CDK6_CCND3=CDK6:CCND3 \"PD 0183812\"-|kaof(CDK6_CCND3)	SEN:10037864	11278443
BEL:20079476	p(HGNC:CCND3) directlyIncreases kin(p(HGNC:CDK4))	Breaking down CDKx:CCNDx to just CDK so modulation of CDKs is consolidated to the CDKx node. CDK4&CCND1 CDK4_CCND1=CDK4:CCND1 \"PD 0183812\"-|kaof(CDK4_CCND1) CDK6&CCND2 CDK6_CCND2=CDK6:CCND2 \"PD 0183812\"-|kaof(CDK6_CCND2) CDK6&CCND3 CDK6_CCND3=CDK6:CCND3 \"PD 0183812\"-|kaof(CDK6_CCND3)	SEN:10037864	11278443
BEL:20079478	p(HGNC:CCND3) increases kin(p(HGNC:CDK6))	We found that cyclin D3 is increased in old livers and activates cdk4/cdk6, resulting in stabilization of the C/EBPalpha-Brm complex.	SEN:10037882	16537903
BEL:20079480	p(HGNC:CCNE1) directlyIncreases kin(p(HGNC:CDK2))	<C31> Cyclin D:Cdk4 phosphorylates pRb at a subset of sites, P(D), but this does not suffice to abrogate the inhibition of E2F. <C32> Cyclin E:Cdk2 phosphorylates pRb at additional sites, P(E), after the Cyclin D:Cdk4-specific sites have been phosphorylated. (Cyclin E, in addition to acting on pRb, has actions that can induce S phase independent of pRb [Lukas et al., 1997; Lundberg and Weinberg, 1998].)	SEN:10037884	10436023
BEL:20079482	p(HGNC:CCNE1) directlyIncreases kin(p(HGNC:CDK2))	CDK2 is sequentially activated by the E-type cyclins  cyclin E1 and E2  during the G1/S transition, and the A-type cyclins  cyclin A1 and A2 during S phase	SEN:10037858	11902577
BEL:20079488	p(HGNC:CCNE1) directlyIncreases kin(p(HGNC:CDK2))	We show that expression of cyclin E-CDK2 in murine fibroblasts causes phosphorylation of the CDK inhibitor p27Kip1 on T187, and that cyclin E-CDK2 can directly phosphorylate p27 T187 in vitro.	SEN:10021588	9192873
BEL:20079490	p(HGNC:CCNE2) directlyIncreases kin(p(HGNC:CDK2))	CDK2 is sequentially activated by the E-type cyclins  cyclin E1 and E2  during the G1/S transition, and the A-type cyclins  cyclin A1 and A2 during S phase	SEN:10037858	11902577
BEL:20079500	p(HGNC:CD40) decreases bp(GOBP:"apoptotic process")	Following activation with proliferative stimuli, including ligation of CD40, dense human tonsillar B cells (>98% cells in G(0)) have increased cleavage and activation of caspase-8 and -6 accompanied by decreased caspase-3 activation and apoptosis.	SEN:10037890	12794135
BEL:20079502	p(HGNC:CD40) decreases cat(p(HGNC:CASP3))	Following activation with proliferative stimuli, including ligation of CD40, dense human tonsillar B cells (>98% cells in G(0)) have increased cleavage and activation of caspase-8 and -6 accompanied by decreased caspase-3 activation and apoptosis.	SEN:10037890	12794135
BEL:20079506	p(HGNC:CD40) increases cat(p(HGNC:CASP6))	Following activation with proliferative stimuli, including ligation of CD40, dense human tonsillar B cells (>98% cells in G(0)) have increased cleavage and activation of caspase-8 and -6 accompanied by decreased caspase-3 activation and apoptosis.	SEN:10037890	12794135
BEL:20079510	p(HGNC:CD40) increases p(HGNC:VEGFA)	VEGF production induced by IL-1beta, TNF-alpha, and TGF-beta was further increased when CD40L+ L cells were coincubated, by factors of 5.9, 5.5, and 9.6, respectively, which indicated that these cytokines had an additive effect on VEGF production driven by CD40L.	SEN:10023540	10799861
BEL:20079518	p(HGNC:CD40LG) directlyIncreases cat(p(HGNC:CD40))	Stimulation of human primary HUVECs by CD40 with its physiological ligand CD40L not only augmented MMP-1, -9 secretion and promoted MMP-1, -9 activities, but also induced endothelial cell apoptosis and death.	SEN:10037896	18495129
BEL:20079522	p(HGNC:CD40LG) increases tscript(p(HGNC:REL))	Stimulation of cells isolated from atherosclerotic plaques with soluble CD40L (10 microgram/ml) induced the NFkB (c-Rel) DNA binding activity and TNF alpha production was significantly inhibited by dominant negative IKK-2, indicating that CD40L induced TNF alpha expression was via c-Rel.	SEN:10037900	15064395
BEL:20079524	p(HGNC:CD44) increases p(HGNC:IL1B)	IL-1beta release was inhibited in peritoneal macrophages derived from CD44-deficient mice, in an MH-S macrophage cell line treated with antibodies to CD44, or by inhibitors of lysosome function.	SEN:10025862	19258328
BEL:20079562	p(HGNC:CDKN1A) directlyDecreases kin(p(HGNC:CDK4))	The encoded protein (CDKN1A) binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes	SEN:10037908	12769686
BEL:20079584	p(HGNC:CDKN1B) directlyDecreases kin(p(HGNC:CDK2))	TGF-beta inhibits Cdk2-cyclin E kinase activity by promoting the binding of cell cycle inhibitor Kip1 protein to the kinase complexes.	SEN:10020210	14676846
BEL:20079586	p(HGNC:CDKN1B) directlyDecreases kin(p(HGNC:CDK2))	The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes	SEN:10037918	12769686
BEL:20079590	p(HGNC:CDKN1B) directlyDecreases kin(p(HGNC:CDK4))	The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes	SEN:10037918	12769686
BEL:20079592	p(HGNC:CDKN1B) increases kin(p(HGNC:CDK4))	In a later complementary study, Cheng et al. (1999) observed that assembly of cyclin D1/D2-CDK4 complexes was impaired in primary mouse embryo fibroblast (MEF) strains taken from animals lacking the p21 gene, the p27 gene, or both. 	SEN:10037920	10385618
BEL:20079602	p(HGNC:CDKN2A) decreases kin(p(HGNC:CDK4))	There are several ways to achieve de-regulation of the RB network and the activation of E2F. There are clear loss-of-function RB mutations that are deficient in E2F binding, and p16 mutations that are defective in Cyclin D/CDK4 inhibition (Sherr, 2001).	SEN:10025954	15225871
BEL:20079606	p(HGNC:CDKN2A) directlyDecreases tscript(p(HGNC:TFDP1))	Interestingly, binding of ARF to DP1 results in an inhibition of the interaction between DP1 and E2F1.	SEN:10020472	16135794
BEL:20079614	p(HGNC:CDKN2B) directlyDecreases kin(p(HGNC:CDK4))	CKIs are of two types(reviewed in REF. 17). The four members of the INK4 family  INK4A (also known as p16),INK4B(also known as p15),INK4C (also known as p18) and INK4D (also known as p19)  exert their inhibitory activity by binding to the CDK4 and CDK6 kinases and preventing their association with D-type cyclins	SEN:10037928	11902577
BEL:20079636	p(HGNC:CFLAR) decreases bp(GOBP:"apoptotic process")	cFLIP expression was necessary for the inhibition of poly-IC- induced apoptosis by insulin, because FLIP knockdown with siRNA efficiently restored poly-IC-induced apoptosis in HBECs in the presence of insulin (Fig. 6C, 6D).	SEN:10037934	21646299
BEL:20079644	p(HGNC:CFLAR) decreases cat(p(HGNC:CASP8))	c-Flip inhibits apoptosis by blocking the activation of caspase-8.	SEN:10035488	17707332
BEL:20079650	p(HGNC:CFLAR) decreases cat(p(HGNC:FADD))	NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).	SEN:10035420	12559172
BEL:20079662	p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))	Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.	SEN:10036708	16137618
BEL:20079714	p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))	pp60(v-src) induction of CREB was blocked by the p38 inhibitor SB203580 or by mutation of CREB at Ser133.	SEN:10037956	10066798
BEL:20079724	p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))	We found that the intracellular domain of Notch2 interacted with a phosphorylated form of the transcription factor CREB1, and together these proteins bound the transcriptional coactivator p300 to form a complex on the promoter of the gene encoding granzyme B. Our results suggest that the highly regulated, dynamic control of T cell cytotoxicity depends on the integration of Notch2 and CREB1 signals.	SEN:10037964	18724371
BEL:20079728	p(HGNC:CREBBP) directlyIncreases tscript(p(HGNC:EPAS1))	The transactivation activity of HIF complexes requires the recruitment of p300/CREB-binding protein (CBP) by HIF-1 alpha and HIF-2 alpha that undergo oxygen-dependent degradation.	SEN:10037966	12588875
BEL:20079730	p(HGNC:CREBBP) directlyIncreases tscript(p(HGNC:HIF1A))	O2-dependent hydroxylation of asparagine (N) residue 803 in HIF-1a by the enzyme FIH-1 (factor inhibiting HIF-1) blocks the binding of p300 and CBP to HIF-1a and therefore inhibits HIF-1-mediated gene transcription.	SEN:10000316	13130303
BEL:20079732	p(HGNC:CREBBP) directlyIncreases tscript(p(HGNC:HIF1A))	The transactivation activity of HIF complexes requires the recruitment of p300/CREB-binding protein (CBP) by HIF-1 alpha and HIF-2 alpha that undergo oxygen-dependent degradation.	SEN:10037966	12588875
BEL:20079738	p(HGNC:CRY1) increases bp(GOBP:"cell cycle")	from full text - Furthermore, Cdc2 kinase activity was reduced (Figs. 2B and 1C). Therefore, the cell cycle progression from S to M phase was impaired during liver regeneration in Cry-deficient mice	SEN:10026132	12934012
BEL:20079754	p(HGNC:CSF2) increases bp(GOBP:angiogenesis)	Table 1. Production of pro- and anti-angiogenic mediators by DCs Pro-angiogenic mediators: VEGF, FGF2, TNF-a, IL-6, TGF-b, CXCL8, CXCL5, CXCL1, 2, 3, CCL2, GM-CSF, ET-1, OPN,  Anti-angiogenic mediators: IL-12, IL-18, IL-10, TSP-1, PTX3, IFN-a/b, CXCL9, CXCL10, CXCL13, CCL21	SEN:10037970	17692569
BEL:20079762	p(HGNC:CSF2) increases p(HGNC:IFNG)	In sharp contrast, there was a significant induction of IFNg in the lung of the GM-CSF group, which peaked at day 7 and remained high at day 12 and markedly declined by day 19 (Figure 8).	SEN:10026170	10733504
BEL:20079768	p(HGNC:CSF3) increases bp(GOBP:"neutrophil chemotaxis")	The migration rate of G-CSF-stimulated cells was significantly greater than that of unstimulated control cells (Fig. 1b). 	SEN:10037976	16903868
BEL:20079780	p(HGNC:CTGF) increases path(MESHD:Fibrosis)	These data indicate that epithelial overexpression of CTGF results in excessive pulmonary vascular remodeling.	SEN:10026214	21239535
BEL:20079790	p(HGNC:CTNNB1) increases deg(p(HGNC:PER2))	On the other hand, co-expression of wildtype b-catenin or b-catenin S37A mutant markedly shortens PER2 protein half-life in 293T cells (Fig. 2C).	SEN:10037982	19106159
BEL:20079804	p(HGNC:CTNNB1,pmod(P,S,33)) directlyIncreases deg(p(HGNC:CTNNB1))	cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin	SEN:10036198	14985333
BEL:20079812	p(HGNC:CTNNB1,pmod(P,S,37)) directlyIncreases deg(p(HGNC:CTNNB1))	cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin	SEN:10036198	14985333
BEL:20079820	p(HGNC:CTNNB1,pmod(P,S,45)) directlyIncreases deg(p(HGNC:CTNNB1))	cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin	SEN:10036198	14985333
BEL:20079834	p(HGNC:CTNNB1,pmod(P,T,41)) directlyIncreases deg(p(HGNC:CTNNB1))	cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin	SEN:10036198	14985333
BEL:20079838	p(HGNC:CTNNB1,pmod(P,Y,654)) directlyIncreases tscript(p(HGNC:CTNNB1))	(from text) The phosphorylation of tyrosine 654 increases the ability of ?-catenin to bind the basal transcription factor TATA-binding protein, and mutation of Y654 to glutamate results in enhanced transcriptional activity [33]	SEN:10037988	16099633
BEL:20079860	p(HGNC:CXCL10) directlyIncreases cat(p(HGNC:CXCR3))	 T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.	SEN:10037996	15602009
BEL:20079862	p(HGNC:CXCL10) increases p(HGNC:MMP12)	IP-10 was also shown to induce the production of MMP-12 in human alveolar macrophages (16).	SEN:10037998	17548647
BEL:20079868	p(HGNC:CXCL11) directlyIncreases cat(p(HGNC:CXCR3))	 T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.	SEN:10037996	15602009
BEL:20079876	p(HGNC:CXCL1) increases bp(GOBP:angiogenesis)	Gro I is a member of the C–X–C chemokine family and is associated with inflammation, angiogenesis, chemotaxis, and growth or survival of tumor cells	SEN:10026304	17707332
BEL:20079878	p(HGNC:CXCL1) increases bp(GOBP:angiogenesis)	Table 1. Production of pro- and anti-angiogenic mediators by DCs Pro-angiogenic mediators: VEGF, FGF2, TNF-a, IL-6, TGF-b, CXCL8, CXCL5, CXCL1, 2, 3, CCL2, GM-CSF, ET-1, OPN,  Anti-angiogenic mediators: IL-12, IL-18, IL-10, TSP-1, PTX3, IFN-a/b, CXCL9, CXCL10, CXCL13, CCL21	SEN:10037970	17692569
BEL:20079888	p(HGNC:CXCL1) increases bp(GOBP:"neutrophil chemotaxis")	Here we demonstrate that cholesterol was absolutely required for polarized redistribution of key chemotactic mediators in human neutrophils in response to all chemoattractants tested (fMet-Leu-Phe, and the chemokines CXCL1, CXCL8 and CXCL12).	SEN:10034424	18311596
BEL:20079898	p(HGNC:CXCL2) increases bp(GOBP:angiogenesis)	Table 1. Production of pro- and anti-angiogenic mediators by DCs Pro-angiogenic mediators: VEGF, FGF2, TNF-a, IL-6, TGF-b, CXCL8, CXCL5, CXCL1, 2, 3, CCL2, GM-CSF, ET-1, OPN,  Anti-angiogenic mediators: IL-12, IL-18, IL-10, TSP-1, PTX3, IFN-a/b, CXCL9, CXCL10, CXCL13, CCL21	SEN:10037970	17692569
BEL:20079902	p(HGNC:CXCL2) increases cat(p(EGID:3579))	they do express the GROa homologue KC, and the GROb,g homologue MIP-2, which are known to bind and activate mIL-8RH (43, 44).	SEN:10026308	9435307
BEL:20079904	p(HGNC:CXCL2) increases cat(p(EGID:3579))	We confirmed the ability of CXCL2 to induce neutrophil chemotaxis through CXCR2, using antibodies to CXCR2 and the CXCR2 antagonist RPX (Fig. 4B). The decreased surface expression of CXCR2 by LTA was accompanied by reduced F-actin polymerization in response to CXCL2 (Fig. 4D).	SEN:10026312	19234125
BEL:20079912	p(HGNC:CXCL5) directlyIncreases cat(p(EGID:3579))	ENA-78 is derived predominantly from endothelial cells and also {binds to and} activates CXCR2. ENA-78 is increased in BAL fluid of COPD patients compared with normal subjects. BAL from smokers release more ENA-78 than non-smokers.	SEN:10038018	15602009
BEL:20079918	p(HGNC:CXCL9) directlyIncreases cat(p(HGNC:CXCR3))	 T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.	SEN:10037996	15602009
BEL:20079920	p(HGNC:CYCS) increases bp(GOBP:"apoptotic process")	the classical induction of AICD is mediated via CD95, ligation of CD95 by CD95L leads to the recruitment of adapter proteins such as FADD, resulting in the activation of caspase 8, which in turn activates downstream caspases, including caspase 3, 6 and 7, and initates apoptosis independently of the apoptosome, although cytochrome C release and apoptosome activation are required for efficient cell death	SEN:10038022	12044776
BEL:20079922	p(HGNC:CYCS) increases bp(GOBP:"apoptotic process")	The \"intrinsic\" mitochondrial pathway can be activated in response to stimuli such as ultraviolet light and oxidative stress, and results in the release of mitochondrial cytochrome-c, initiating formation of the apoptosome complex (15, 16)	SEN:10038024	12748058
BEL:20079932	p(HGNC:DDIT3) increases p(HGNC:BAX)	To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.	SEN:10026404	19109422
BEL:20079934	p(HGNC:DDIT3) increases p(HGNC:BBC3)	To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.	SEN:10026404	19109422
BEL:20079936	p(HGNC:DDIT3) increases p(HGNC:BCL2L11)	To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.	SEN:10026404	19109422
BEL:20079938	p(HGNC:DDIT3) increases p(HGNC:ERO1L)	In Chop-/- macrophages, the increase in Ero1a mRNA and both basal and ER stress–induced ERO1-alpha protein were diminished.	SEN:10026392	19752026
BEL:20079942	p(HGNC:DDIT4) decreases kin(p(EGID:2475))	In contrast to energy depletion, mTOR inhibition by hypoxia does not require AMPK or LKB1. Down-regulation of mTOR activity by hypoxia requires de novo mRNA synthesis and correlates with increased expression of the hypoxia-inducible REDD1 gene.	SEN:10026408	15545625
BEL:20079948	p(HGNC:DKK1) decreases a(CHEBI:hydroxyproline)	Overexpression of Dkk-1 prevented the profibrotic effects of Wnt-10b on dermal thickening and normalized both hydroxyproline content and myofibroblast counts at 12 weeks to the levels of wild-type control mice	SEN:10026460	22415826
BEL:20079950	p(HGNC:DKK1) decreases cat(p(HGNC:LRP5))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079952	p(HGNC:DKK1) decreases cat(p(HGNC:LRP5))	we generated retroviruses that express either Dkk1, a secreted antagonist that prevents Wnt ligands from binding to the LRP5/6 co-receptor (Mao et al., 2001aGo), or a dominant-negative form of Tcf4	SEN:10026462	15576404
BEL:20079954	p(HGNC:DKK1) decreases cat(p(HGNC:LRP6))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079956	p(HGNC:DKK1) decreases cat(p(HGNC:LRP6))	we generated retroviruses that express either Dkk1, a secreted antagonist that prevents Wnt ligands from binding to the LRP5/6 co-receptor (Mao et al., 2001aGo), or a dominant-negative form of Tcf4	SEN:10026462	15576404
BEL:20079960	p(HGNC:DKK2) decreases cat(p(HGNC:LRP5))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079962	p(HGNC:DKK2) decreases cat(p(HGNC:LRP6))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079964	p(HGNC:DKK3) decreases cat(p(HGNC:LRP5))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079966	p(HGNC:DKK3) decreases cat(p(HGNC:LRP6))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079968	p(HGNC:DKK4) decreases cat(p(HGNC:LRP5))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079970	p(HGNC:DKK4) decreases cat(p(HGNC:LRP6))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079972	p(HGNC:DKKL1) decreases cat(p(HGNC:LRP5))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079974	p(HGNC:DKKL1) decreases cat(p(HGNC:LRP6))	Dickkopf (Dkk) genes comprise an evolutionary conserved small gene family of four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). They encode secreted proteins that typically antagonize Wnt/beta-catenin signaling, by inhibiting the Wnt coreceptors Lrp5 and 6. 	SEN:10035670	17143291
BEL:20079988	p(HGNC:DNAJC3) decreases p(HGNC:EIF2S1,pmod(P))	Levels of phosphorylated eIF2alpha were lower in ER-stressed P58(IPK)-overexpressing cells and were enhanced in P58(IPK) mutant cells	SEN:10038046	12446838
BEL:20080000	p(HGNC:DPP4) decreases p(HGNC:IL13)	IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group.  po0.05, po0.01 as determined by unpaired, two-tailed Student’s t-test. Results shown are representative of three independent experiments.	SEN:10038050	22101691
BEL:20080002	p(HGNC:DPP4) decreases p(HGNC:IL4)	IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group.  po0.05, po0.01 as determined by unpaired, two-tailed Student’s t-test. Results shown are representative of three independent experiments.	SEN:10038050	22101691
BEL:20080004	p(HGNC:DPP4) decreases p(HGNC:IL5)	IL-4, IL-5, and IL-13 concentrations were measured by ELISA in BAL ?uid 24 h after challenge. The values represent the mean1SD of eight mice for each group.  po0.05, po0.01 as determined by unpaired, two-tailed Student’s t-test. Results shown are representative of three independent experiments.	SEN:10038050	22101691
BEL:20080008	p(HGNC:DUOX1) increases a(CHEBI:"hydrogen peroxide")	DUOX1/2 and NOX4 appear to directly generate H2O2 as the primary product, without detectable intermediate production of O2 •? (1,10,17).	SEN:10038054	18164271
BEL:20080010	p(HGNC:DUOX1) increases cat(p(HGNC:ADAM17))	As shown in Fig. 6A, both ATP and ?-ASGM1 indeed resulted in enhanced ADAM17 activity, measured by increased cleavage of a fluorogenic ADAM17 substrate, and this was attenuated after siRNA silencing of DUOX1 (Fig. 6A	SEN:10038056	19386603
BEL:20080012	p(HGNC:DUOX1) increases p(HGNC:TGFA)	Silencing of DUOX1 attenuated the ATP- and ?-ASGM1-induced TGF-? production observed in the presence of EGFR mAb (Fig. 5B), indicating the involvement of DUOX1 activation in ATP-induced TGF-? production and EGFR activation. 	SEN:10038058	19386603
BEL:20080018	p(HGNC:EDN1) increases a(CHEBI:"reactive oxygen species")	Furthermore, chronic treatment with endothelin-1, a potent vasoconstrictor and mitogen, caused a significant increase in ROS production in both PASMC and CASMC.	SEN:10038064	17693484
BEL:20080022	p(HGNC:EDN1) increases kin(p(HGNC:MAPK1))	Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B. 	SEN:10038068	23343326
BEL:20080026	p(HGNC:EDN1) increases kin(p(HGNC:MAPK3))	Engagement of Gi- and Gq-protein-coupled ETB receptors by ET-1 led to phosphorylation of ERK1/2, p38 MAPK, and JNK1/2 and then activated transcription factor NF-?B. 	SEN:10038068	23343326
BEL:20080042	p(HGNC:EGF) directlyIncreases complex(p(HGNC:EGFR),p(HGNC:ERBB2))	Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt. 	SEN:10038074	11297548
BEL:20080052	p(HGNC:EGF) directlyIncreases kin(p(HGNC:EGFR))	Studies using inhibitors of the EGF receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI3-kinase) and protein kinase C (PKC) revealed that all of the cell surface agonists could activate PAK1 through pathways independent of PKC, that EGF stimulated a PI3-kinase dependent pathway to stimulate PAK1, and that muscarinic receptor stimulation of PAK1 was predominantly mediated through this EGF-R-dependent mechanism	SEN:10038078	14575865
BEL:20080064	p(HGNC:EGF) increases a(CHEBI:"hydrogen peroxide")	This crosstalk was physiologically relevant since EGF-induced H2O2 production was inhibited by K252a and by the presence of anti-NGF antibodies added in the culture medium (Fig. 3G).	SEN:10038086	20566383
BEL:20080082	p(HGNC:EGF) increases p(HGNC:EGFR,pmod(P,Y))	we show that exposure to cigarette smoke over the indicated time points or doses results in an increase in total EGFR phosphorylation in a timeand dose-dependent manner (Fig. 1). As with EGF and H2O2, cigarette smoke is able to induce EGFR phosphorylation significantly compared to nontreated cells. Note: human airway epithelial (HAE; A549 or HBE1) were used in the paper	SEN:10034486	17971399
BEL:20080124	p(HGNC:EGR1) increases p(HGNC:TNF)	Reynolds et al. (137) investigated the expression of Egr-1 (early growth response gene 1) in NZW and AKR mice. Egr-1 gene induces IL-1b and TNFa, cytokines that contribute to the recruitment of inflammatory cells after smoke exposure.	SEN:10026622	18223159
BEL:20080144	p(HGNC:EIF2S1,pmod(P,S,52)) increases p(HGNC:ATF4)	eIF2alpha phosphorylation at serine 51 promotes expression of stress-induced genes, such as the transcription factors ATF4 and CHOP (Scheuner et al., 2001). Expression of these genes, as well as GADD34, under conditions of ER stress or amino acid deprivation, requires activity of the upstream eIF2alpha kinases PERK and GCN2 (Harding et al., 2000a; Novoa et al., 2001). 	SEN:10038108	12606582
BEL:20080164	p(HGNC:EIF4E,pmod(P,S,422)) increases complex(p(HGNC:EIF4E),p(HGNC:EIF3A))	S6K and RSK phosphorylate eIF4B at Ser422, thus enhancing its interaction with the eIF3 and promoting protein translation (Shahbazian et al., 2006).	SEN:10036052	18794886
BEL:20080172	p(HGNC:ELANE) increases p(HGNC:TGFA)	activated neutrophils secrete TNF, which induces EGFR expression in airway epithelial cells, activated neutrophils release reactive oxygen species, which activate EGFR , neutrophil elastase cleaves the EGFR proligand, pro-transforming growth factor (TGF)-alpha, releasing mature TGF alpha which activates EGFR in a ligand-dependent fashion , neutrophil elastase causes potent goblet cell degranulation 	SEN:10034612	15219174
BEL:20080174	p(HGNC:ELANE) increases p(HGNC:TGFA)	Here we show that in human airway epithelial cells HNE increases TGF-alpha release, EGFR phosphorylation, and MUC5AC mucin expression, effects that were attenuated by TACE inhibitor TAPI-1 and by specific knockdown of TACE expression with small interfering RNA, implicating TACE in HNE-induced responses.	SEN:10037570	16148149
BEL:20080190	p(HGNC:ENDOG) increases bp(GOBP:"apoptotic process")	endonuclease G and apoptosis-inducing factor (AIP) might induce cell death independently of caspase activation	SEN:10037594	15286739
BEL:20080196	p(HGNC:EP300) directlyIncreases tscript(p(HGNC:EPAS1))	The transactivation activity of HIF complexes requires the recruitment of p300/CREB-binding protein (CBP) by HIF-1 alpha and HIF-2 alpha that undergo oxygen-dependent degradation.	SEN:10037966	12588875
BEL:20080198	p(HGNC:EP300) directlyIncreases tscript(p(HGNC:EPAS1))	To identify the modified residue, the relevant tryptic peptides from each sample were further analyzed by tandem mass spectrometry. Comparison of the fragment patterns revealed that Asn 851 contained the additional oxygen atom (Fig. 4B). Together these data show that FIH-1 is an asparaginyl hydroxylase that inhibits HIF transcriptional activity by preventing CAD association with the coactivator p300. 	SEN:10038130	12080085
BEL:20080200	p(HGNC:EP300) directlyIncreases tscript(p(HGNC:HIF1A))	O2-dependent hydroxylation of asparagine (N) residue 803 in HIF-1a by the enzyme FIH-1 (factor inhibiting HIF-1) blocks the binding of p300 and CBP to HIF-1a and therefore inhibits HIF-1-mediated gene transcription.	SEN:10000316	13130303
BEL:20080202	p(HGNC:EP300) directlyIncreases tscript(p(HGNC:HIF1A))	The transactivation activity of HIF complexes requires the recruitment of p300/CREB-binding protein (CBP) by HIF-1 alpha and HIF-2 alpha that undergo oxygen-dependent degradation.	SEN:10037966	12588875
BEL:20080220	p(HGNC:EREG) directlyIncreases complex(p(HGNC:EGFR),p(HGNC:ERBB3))	the second group betacellulin (BTC), heparin-binding EGF (HB-EGF), and epiregulin (EPR), which exhibit dual specificity in that they bind ErbB1 and ErbB4. 	SEN:10037804	12648469
BEL:20080248	p(HGNC:ERN1) increases tscript(p(HGNC:XBP1))	Here we demonstrate that the IRE1alpha-XBP1 pathway, the most conserved branch of the unfolded protein response (UPR), is indispensable for adipogenesis. Indeed, XBP1-deficient mouse embryonic fibroblasts and 3T3-L1 cells with XBP1 or IRE1alpha knockdown exhibit profound defects in adipogenesis	SEN:10018230	19490910
BEL:20080264	p(HGNC:F2) increases bp(GOBP:"neutrophil chemotaxis")	Concentrations of tumour necrosis factor-alpha (TNF-alpha) were elevated in BAL fluid from thrombin-treated mice, and a TNF-alpha-neutralising antibody inhibited the influx of neutrophils in response to thrombin.	SEN:10026804	15302675
BEL:20080268	p(HGNC:F2) increases cat(p(HGNC:MMP2))	thrombin can activate pro-MMP-2 in ASM cells	SEN:10038154	17189319
BEL:20080308	p(HGNC:FASLG) directlyIncreases cat(p(HGNC:FAS))	Necroptosis can be induced by the ligation of death receptors, including CD95 (also known as FAS; which binds the ligand CD95L (also known as FASL))29, TNF receptor 1 (TNFR1), TNFR2 (Refs 6, 13, 30), TNF-related apoptosis-inducing ligand receptor 1 (TRAILR1) and TRAILR2 (Ref. 9.)	SEN:10038172	20823910
BEL:20080318	p(HGNC:FGF2) directlyIncreases kin(p(HGNC:FGFR1))	FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.	SEN:10026898	10896947
BEL:20080332	p(HGNC:FGF2) increases kin(p(HGNC:MAPK1))	Activated ERK enters the nucleus to promote transcription [64]. The MAPK pathway is critically involved in controlling proliferation, survival, and migration of endothelial cells. Angiogenesis in the chorio-allantoid membrane (CAM) model requires two waves of ERK activation, the first one being dependent on FGF-2, and the second one on aVh3 integrin ligation [65].	SEN:10038184	14984767
BEL:20080334	p(HGNC:FGF2) increases kin(p(HGNC:MAPK1))	After bFGF was added to pulmonary fibroblasts, the kinase activities of p44/p42 ERK1/2 were determined by an in-gel assay at various times after exposure (Fig. 1). The data demonstrate that the addition of bFGF results in activation of ERK1/2 within 5 min, with the highest activity at 30 min, followed by a lower level of activity that persists for 8-12 h. 	SEN:10038186	11557580
BEL:20080336	p(HGNC:FGF2) increases kin(p(HGNC:MAPK1))	FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.	SEN:10026898	10896947
BEL:20080338	p(HGNC:FGF2) increases kin(p(HGNC:MAPK3))	Activated ERK enters the nucleus to promote transcription [64]. The MAPK pathway is critically involved in controlling proliferation, survival, and migration of endothelial cells. Angiogenesis in the chorio-allantoid membrane (CAM) model requires two waves of ERK activation, the first one being dependent on FGF-2, and the second one on aVh3 integrin ligation [65].	SEN:10038184	14984767
BEL:20080340	p(HGNC:FGF2) increases kin(p(HGNC:MAPK3))	After bFGF was added to pulmonary fibroblasts, the kinase activities of p44/p42 ERK1/2 were determined by an in-gel assay at various times after exposure (Fig. 1). The data demonstrate that the addition of bFGF results in activation of ERK1/2 within 5 min, with the highest activity at 30 min, followed by a lower level of activity that persists for 8-12 h. 	SEN:10038186	11557580
BEL:20080342	p(HGNC:FGF2) increases kin(p(HGNC:MAPK3))	FGF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.	SEN:10026898	10896947
BEL:20080354	p(HGNC:FHIT) decreases kin(p(HGNC:ATR))	We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.	SEN:10026918	16204026
BEL:20080358	p(HGNC:FN1) increases bp(GOBP:"cell migration")	Fibronectin - through its integrin receptors - promotes cell adhesion, migration, growth and survival23. The specific function of the ED-B-containing form is not known.	SEN:10038194	12635171
BEL:20080360	p(HGNC:FN1) increases complex(p(HGNC:ITGA5),p(HGNC:ITGB1))	For example, integrin a5b1 binding to fibronectin suppresses cell migration [48], while aVb6-mediated fibronectin binding promotes it [49].	SEN:10035302	14984767
BEL:20080362	p(HGNC:FN1) increases complex(p(HGNC:ITGAV),p(HGNC:ITGB6))	For example, integrin a5b1 binding to fibronectin suppresses cell migration [48], while aVb6-mediated fibronectin binding promotes it [49].	SEN:10035302	14984767
BEL:20080404	p(HGNC:FZD4) increases bp(GOBP:"patterning of blood vessels")	Administration of 1.99.25 inhibited physiological and pathologic sprouting angiogenesis within the retina	SEN:10027092	21743011
BEL:20080410	p(HGNC:GABARAP) increases bp(GOBP:autophagy)	 A robust increase in the autophagosomal membrane-bound form of LC3 (LC3-II) and in several other autophagy-related proteins such as GABARAP (gamma-aminobutyric acid receptor-associated protein), Beclin-1, and BNIP3 (Bcl-2/E1B 19 kDa interacting protein) all point to an up-regulation of autophagy. 	SEN:10037746	21179212
BEL:20080416	p(HGNC:GADD45A) directlyDecreases kin(p(HGNC:AURKA))	Furthermore Gadd45a was demonstrated to strongly inhibit Aurora-A kinase activity and to antagonize Aurora-A-induced centrosome amplification.	SEN:10027106	16772293
BEL:20080438	p(HGNC:GATA1) increases p(HGNC:CCND1)	During IL-6-induced macrophage differentiation of M1 cells, IL-6 down-regulated cyclin D1 expression and induced p19(INK4D) expression, leading to reduction in cdk4 activities. In contrast, sustained expression of cyclin D1 and a significantly lesser amount of p19(INK4D) induction were observed in IL-6-treated M1 cells overexpressing GATA-1.	SEN:10038222	10666199
BEL:20080442	p(HGNC:GDF2) directlyIncreases kin(p(HGNC:ACVRL1))	Combined blockade of Alk1 and Notch signaling further exacerbates hypervascularization, whereas activation of Alk1 by its high-affinity ligand BMP9 rescues hypersprouting induced by Notch inhibition	SEN:10021504	22421041
BEL:20080446	p(HGNC:GRP) directlyIncreases cat(p(HGNC:GRPR))	Both EGFR and GRPR are activated in NSCLC by their corresponding ligands, TGF-a and GRP, in an autocrine manner.	SEN:10038226	15967120
BEL:20080454	p(HGNC:GSK3B,pmod(P,S,9)) directlyDecreases kin(p(HGNC:GSK3B))	##from text## p70S6Ks down-regulates the activity of GSK3beta by phosphorylating Ser9 residue [33].	SEN:10038234	19575820
BEL:20080460	p(HGNC:GSK3B,pmod(P,S,9)) directlyDecreases kin(p(HGNC:GSK3B))	GSK3b phosphorylation of Bcl3 has previously been shown to result in its degradation (Viatour et al., 2004), whereas GSK3b activity can be repressed by Akt (PKB) induced phosphorylation on serine 9 (Emamian et al., 2004).	SEN:10036626	20513428
BEL:20080474	p(HGNC:GSK3B,pmod(P,S,9)) directlyDecreases kin(p(HGNC:GSK3B))	, whereas no significant changes were observed in the total amount of this protein (Fig. 5, D and E). Therefore, the phosphorylation of p90rsk may be the link between ERK activation and GSK3{beta} phosphorylation. The stimulation of glycogen synthesis by insulin is triggered by the phosphorylation of GSK3{beta} at serine 9 and its concomitant inactivation.	SEN:10038240	12925525
BEL:20080478	p(HGNC:GSK3B,pmod(P,S)) directlyDecreases kin(p(HGNC:GSK3B))	AKT was shown to phosphorylate and inactivate GSK3, thereby activating the nuclear translocation of NFAT	SEN:10038242	12044776
BEL:20080490	p(HGNC:GSK3B,pmod(P,S)) directlyDecreases kin(p(HGNC:GSK3B))	Upon its activation downstream of PI(3)K, Akt phosphorylates and inactivates GSK-3, decreasing the rate of phosphorylation of glycogen synthase, thus increasing its activity state59.	SEN:10038246	11742412
BEL:20080494	p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))	Glycogen synthase kinase 3 (GSK3), a key component of the insulin and wnt signaling pathways, is unusual, as it is constitutively active and is inhibited in response to upstream signals. Kinase activity is thought to be increased by intramolecular phosphorylation of a tyrosine in the activation loop (Y216 in GSK3beta), whose timing and mechanism is undefined. 	SEN:10038248	17188038
BEL:20080500	p(HGNC:GSK3B,pmod(P,Y,216)) directlyIncreases kin(p(HGNC:GSK3B))	We further demonstrate that hydrogen peroxide phosphorylates tyrosine 216 of GSK-3beta. This leads to activation of GSK-3beta.	SEN:10038252	17403689
BEL:20080516	p(HGNC:H2AFX,pmod(P,S,140)) increases complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))	phosphorylated H2AX recruits 53BP1, BRCA1, MDC1 and the MRE11-RAD50-NBS1 complex to the site of DNA damage	SEN:10038256	15286739
BEL:20080518	p(HGNC:HBEGF) directlyIncreases complex(p(HGNC:EGFR),p(HGNC:ERBB3))	the second group betacellulin (BTC), heparin-binding EGF (HB-EGF), and epiregulin (EPR), which exhibit dual specificity in that they bind ErbB1 and ErbB4. 	SEN:10037804	12648469
BEL:20080536	p(HGNC:HBEGF) directlyIncreases kin(p(HGNC:EGFR))	Thrombin-induced migration of smooth muscle cells is dependent upon HB-EGF-mediated ErbB1 activity [55]	SEN:10038260	12648469
BEL:20080544	p(HGNC:HES5) increases bp(GOBP:"cell proliferation")	We show a mechanistic link from NOTCH3 receptor signaling through the Hairy and enhancer of Split-5 (HES-5) protein to smooth muscle cell proliferation	SEN:10038264	19855400
BEL:20080548	p(HGNC:HEY1) decreases bp(GOBP:"patterning of blood vessels")	 siRNA-mediated knockdown of HEY1 and HEY2 (Figure S4E) suppressed BMP9-mediated inhibition of tube formation and effects on downstream gene expression (Figures 4A, 4D, 4E, and 4G)	SEN:10038268	22421041
BEL:20080550	p(HGNC:HEY2) decreases bp(GOBP:"patterning of blood vessels")	 siRNA-mediated knockdown of HEY1 and HEY2 (Figure S4E) suppressed BMP9-mediated inhibition of tube formation and effects on downstream gene expression (Figures 4A, 4D, 4E, and 4G)	SEN:10038268	22421041
BEL:20080554	p(HGNC:HGF) directlyIncreases kin(p(HGNC:MET))	The c-met protooncogene product (Met), which is a high-affinity receptor for hepatocyte growth factor, plays an important role in controlling the invasion of many types of cells.	SEN:10038272	16099863
BEL:20080558	p(HGNC:HGF) increases bp(GOBP:"epithelial cell differentiation")	These results confirm that subepithelial fibroblasts secrete HGF in sufficient concentrations to support epithelial differentiation. 	SEN:10038276	17307814
BEL:20080562	p(HGNC:HGF) increases kin(p(HGNC:MAPK1))	HGF induced activation of ERK1 and ERK2 was shown to be dependent on the presence of HS moieties.	SEN:10038280	12524227
BEL:20080564	p(HGNC:HGF) increases kin(p(HGNC:MAPK3))	HGF induced activation of ERK1 and ERK2 was shown to be dependent on the presence of HS moieties.	SEN:10038280	12524227
BEL:20080576	p(HGNC:HMGB1) directlyIncreases cat(p(HGNC:TLR2))	For example, the high mobility group box protein 1 (HMGB1) protein that normally resides in the cell nucleus can activate TLR2 and induce hallmarks of lupus-like disease when released from apoptotic cells as a complex with nucleosomes [18].	SEN:10038284	21108806
BEL:20080580	p(HGNC:HMGB1) directlyIncreases cat(p(HGNC:TLR2))	Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).	SEN:10034464	16891671
BEL:20080584	p(HGNC:HMGB1) directlyIncreases cat(p(HGNC:TLR4))	Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).	SEN:10034464	16891671
BEL:20080636	p(HGNC:ICAM1) increases cat(p(HGNC:ITGB2))	the same agonists triggered a sustained activation of the ?2 integrin Mac-1 for its ligand intercellular adhesion molecule (ICAM) 1,	SEN:10038302	12545245
BEL:20080658	p(HGNC:IFNB1) increases tscript(p(HGNC:IRF1))	In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12.	SEN:10019900	8920893
BEL:20080662	p(HGNC:IFNG) decreases tscript(p(HGNC:STAT6))	Socs1 is essential for inhibition of IFN-gamma-induced inhibition of STAT6	SEN:10038318	12110143
BEL:20080668	p(HGNC:IFNG) increases bp(GOBP:"T-helper 1 type immune response")	CyCAP is a widely expressed secreted glycoprotein that modulates the host response to endotoxin gene-targeted CyCAP-deficient mice are more sensitive to the lethal effects of endotoxin in response to endotoxin, CyCAP-deficient mice overproduce interleukin 12 and interferon-gamma systemically and tumor necrosis factor alpha locally, these are proinflammatory molecules that also promote T helper 1 responses	SEN:10020288	10077627
BEL:20080672	p(HGNC:IFNG) increases bp(GOBP:"T-helper 1 type immune response")	TH1 cells express IFN-g and mediate cellular immunity. TH2 cells express IL-4, IL-5, and IL-13 and mediate nonphagocytic immunity.	SEN:10038326	11397944
BEL:20080674	p(HGNC:IFNG) increases bp(GOBP:"T-helper 1 type immune response")	Th1 cells produce interleukin (IL)-2, interferon-gamma (IFN-gamma) and lymphotoxin-beta, which mediate pro-inflammatory functions critical for the development of cell-mediated immune responses, whereas Th2 cells secrete cytokines such as IL-4, IL-5 and IL-10 that enhance humoral immunity.	SEN:10038328	11057672
BEL:20080676	p(HGNC:IFNG) increases bp(GOBP:"apoptotic process")	dox induction of IFN-? caused a significant increase in TUNEL staining in lungs from Tg+ mice (Figure 8, A and B).	SEN:10027650	16284650
BEL:20080682	p(HGNC:IFNG) increases bp(GOBP:"apoptotic process")	islet cell viability, DNA synthetic rate, and insulin release were reduced after incubation with interleukin-1beta, tumor necrosis factor, or interferon-gamma. Cytokine-mediated islet cell death involved the induction of apoptosis	SEN:10038334	9607811
BEL:20080684	p(HGNC:IFNG) increases bp(GOBP:"apoptotic process")	Overexpression of IFN- in transgenic mice results in apoptosis, inflammation, and emphysema (15).	SEN:10038336	17548647
BEL:20080686	p(HGNC:IFNG) increases bp(GOBP:"apoptotic process")	PKR is required for poly IC- and poly IC plus interferon gamma (IFNg)-induced islet cell apoptosis, implicating a role of PKR in the etiology of type 1 diabetes (43).	SEN:10026644	12588811
BEL:20080688	p(HGNC:IFNG) increases bp(GOBP:"apoptotic process")	Selective cathepsin S inhibition and a null mutation of cathepsin S also decreased IFN-gamma-induced DNA injury, apoptosis, emphysema, inflammation, and protease accumulation.	SEN:10038338	15944319
BEL:20080692	p(HGNC:IFNG) increases bp(GOBP:"apoptotic process")	The majority of these cells were airway epithelial cells and type I and type II alveolar epithelial cells on light microscopic evaluations (Fig. 1, B and C)....In accord with these observations, double staining with TUNEL and anti-SP-C Abs revealed a large number of alveolar type II epithelial cells that were TUNEL positive and SP-C positive (Fig. 1, D).	SEN:10027648	15944319
BEL:20080694	p(HGNC:IFNG) increases bp(GOBP:"apoptotic process")	The same group demonstrated just recently that mast cells actively participate in the formation of aortic aneurysms by release of IL-6 and IFN?, which induced apoptosis of smooth muscle cells and protease expression [111].	SEN:10027652	19238385
BEL:20080698	p(HGNC:IFNG) increases p(HGNC:CCL5)	In contrast, IFN-? was a potent stimulator of MIP-1?/CCL-3, MIP-1?/CCL-4, and RANTES/CCL-5 mRNA and protein in lungs from Tg+ mice.	SEN:10038342	16284650
BEL:20080700	p(HGNC:IFNG) increases p(HGNC:CCL5)	RANTES mRNA and protein expression was induced by CD40L and IFN-gamma. CD40L induced RANTES expression was potentiated by IFN-gamma.	SEN:10038344	11839576
BEL:20080702	p(HGNC:IFNG) increases p(HGNC:CCR5)	the levels of CCR5 mRNA and protein were markedly increased in dox-treated IFN-?– transgenic animals (Figure 2, A and B).	SEN:10027678	16284650
BEL:20080704	p(HGNC:IFNG) increases p(HGNC:CXCL10)	It is of interest that IFNG stimulates dendritic cells to produce IP-10 and Mig.	SEN:10038346	15602009
BEL:20080706	p(HGNC:IFNG) increases p(HGNC:CXCL10)	the CXC chemokines Mig and interferon-? inducible protein 10 can be expressed and bound by endothelium stimulated with interferon-? and tumor necrosis factor (TNF) ?, and can induce the firm adhesion of T lymphocyte in shear flow via CXCR3.	SEN:10038348	12545245
BEL:20080712	p(HGNC:IFNG) increases p(HGNC:MMP12)	since transgenic mice overexpressing IFNg increased MMP-12 production (92).	SEN:10038350	18223159
BEL:20080722	p(HGNC:IGF1) directlyIncreases kin(p(HGNC:IGF1R))	LDL, in pathophysiological concentrations, affect the IGF-I signaling pathway at multiple levels: 1) they induce phosphorylation of IGF-I receptor beta and IRS-1 in a time- and dose-dependent manner; 2) they up-regulate IRS-1-associated PI3 kinase/Akt activation in response to IGF-I at early times; and 3) they show additive effects with IGF-I on extracellular signal-regulated MAPK 1/2 phosphorylation.	SEN:10038354	11606453
BEL:20080738	p(HGNC:IGF1) increases p(HGNC:HIF1A)	In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways.	SEN:10038362	12778166
BEL:20080760	p(HGNC:IL10) decreases bp(GOBP:"T-helper 1 cell differentiation")	Thus, while IL-10 can reduce Th2 recall immune responses, its major effect evident during the primary response is to inhibit the development of Th1 responses, thereby favoring Th2 development.	SEN:10027850	16940042
BEL:20080768	p(HGNC:IL10) increases p(HGNC:CCL18)	 IL-4, IL-13, and IL-10 significantly up-regulated CCL18 production by AMs (Figure 4).	SEN:10038368	16415274
BEL:20080788	p(HGNC:IL13) increases p(HGNC:CCL18)	 IL-4, IL-13, and IL-10 significantly up-regulated CCL18 production by AMs (Figure 4).	SEN:10038368	16415274
BEL:20080790	p(HGNC:IL13) increases p(HGNC:CLCA1)	Immunohistochemical staining revealed that both hCLCA1 and MUC5AC proteins increased in NHBE cells cultured with IL-13 for 14 days at an air-liquid interface (fig. 4).	SEN:10038372	16465045
BEL:20080792	p(HGNC:IL13) increases p(HGNC:EGR1)	IL-13 increased Egr-1 mRNA levels in a biphasic manner in Stat6/ fibroblasts; early induction of Egr-1 mRNA was observed 30 min following exposure to IL-13 and declined after 3–6 h (Fig. 6A). Egr-1 protein was increased in Stat6/ fibroblasts as compared with Stat6/ fibroblasts from 30 min to 3 h after IL-13 treatment (Fig. 6, B and C).	SEN:10027948	16951379
BEL:20080794	p(HGNC:IL13) increases p(HGNC:EGR1)	IL-13 stimulation of EGR-1 was completely abrogated by the null mutation of Stat6 (Fig. 1C).	SEN:10038374	16439363
BEL:20080798	p(HGNC:IL13) increases p(HGNC:IL8)	IL-13 increased expression of the proinflammatory cytokines MCP-1 and IL-8 in TNF?? challenged VSMC [105].	SEN:10038378	19601851
BEL:20080802	p(HGNC:IL13) increases p(HGNC:MMP12)	Previous studies from our laboratory demonstrated that the levels of MMP-2, MMP-9, MMP-12, and cathepsins B, S, K, and L are increased in IL-13 transgene mice ... animals (13).	SEN:10038380	11884467
BEL:20080804	p(HGNC:IL13) increases p(HGNC:MMP12)	Western blot analysis confirmed the induction of MMP-2, MMP-12, MMP-13, and MMP-14 (Figure 7a, and data not shown) and immunohistochemistry demonstrated that MMP-12 was seen predominantly in macrophages, and MMP-9 was seen in parenchymal locations in epithelial cells and interstitial fibroblast-like cells (Figure 7, b–f, and data not shown).	SEN:10038382	11067861
BEL:20080806	p(HGNC:IL13) increases p(HGNC:MUC5AC)	Immunohistochemical staining revealed that both hCLCA1 and MUC5AC proteins increased in NHBE cells cultured with IL-13 for 14 days at an air-liquid interface (fig. 4).	SEN:10038372	16465045
BEL:20080808	p(HGNC:IL13) increases p(HGNC:MUC5AC)	Multiple agents, including cigarette smoke (15), activated eosinophils (16), interleukin-13 (17), neutrophil elastase (18), Pseudomonas aeruginosa (19), and phorbol 12-myristate 13- acetate (PMA) (20) increase MUC5AC in airway epithelial cells (NCI-H292)...	SEN:10035026	15531749
BEL:20080812	p(HGNC:IL13) increases p(HGNC:TGFB1)	Egr-1 did, however, play a critical role in the activation of TGF-B1  because the ability of IL-13 to activate TGF-B1 was markedly diminished in comparisons of BAL fluids from Tg (+) mice with wild type and null mutant Egr-1 loci (Fig. 8B).	SEN:10038386	16439363
BEL:20080814	p(HGNC:IL13) increases p(HGNC:TGFB1)	In contrast, significant amounts of total and activated TGF-1 were seen in BAL from Tg mice (Fig. 7, A and B).	SEN:10027924	16849505
BEL:20080818	p(HGNC:IL13) increases tscript(p(HGNC:STAT6))	Western blot analysis demonstrated that PD98059 blocked IL-13-induced phosphorylation of ERK1/2 (Fig. 8A) yet enhanced the phosphorylation of Stat6 and increased protein expression of Egr-1 in a time-dependent manner after IL-13 treatment (Fig. 8, B and C).  	SEN:10038388	16951379
BEL:20080820	p(HGNC:IL15) directlyIncreases cat(p(HGNC:IL15RA))	IL-15 is a common gamma chain cytokine sharing overlapping signaling and biological properties with IL-2 as a result of their mutual usage of the IL-2/15b and common gamma chain (gc) receptor subunits (7,8).	SEN:10038390	21098221
BEL:20080836	p(HGNC:IL17A) increases a(CHEBI:"nitric oxide")	from full text - Table 3.  IL-17 markedly augments production of proangiogenic factors of fibroblast	SEN:10038394	12411307
BEL:20080840	p(HGNC:IL17A) increases p(HGNC:VEGFA)	from full text - Table 3.  IL-17 markedly augments production of proangiogenic factors of fibroblast	SEN:10038394	12411307
BEL:20080858	p(HGNC:IL1A) increases bp(GOBP:"inflammatory response")	the 2 cytokines most intensively involved in eliciting the acute phase response are IL6 and IL1	SEN:10038400	2472096
BEL:20080874	p(HGNC:IL1B) increases cat(p(HGNC:ADAM17))	Mechanistic studies revealed that HER2 trans-activation by IL-1?? required a disintegrin and metalloprotease 17 (ADAM17)-dependent shedding of the ligand neuregulin-1 (NRG-1). In murine models of ALI, NRG-1-HER2 signaling was activated, and ADAM17 blockade resulted in decreased NRG-1 shedding, HER2 activation, and lung injury in vivo.	SEN:10035322	21247898
BEL:20080882	p(HGNC:IL1B) increases p(HGNC:CXCL2)	c-Ets1 overexpression suppressed IL-1b-induced MIP2 and tumor necrosis factor (TNF)-a production,	SEN:10038412	22294049
BEL:20080884	p(HGNC:IL1B) increases p(HGNC:CXCL2)	IL-1b increased the production of neutrophil chemoattractants such as Gro-alpha (CXCL1) and MIP-2 (CXCL2) in lungs.	SEN:10028124	19842832
BEL:20080890	p(HGNC:IL1B) increases p(HGNC:IL6)	The addition of IL-1b (100 pg/ml) alone significantly increased the levels of IL-6, and approximately to the same level as 160 lg/cm2 silica.	SEN:10038416	19580863
BEL:20080892	p(HGNC:IL1B) increases p(HGNC:IL6)	Thus, IL-6 release was substantially increased by both IL-1 and to a lesser extent by TNF. In each case, prior infection with the null adenovirus showed no significant effect, whereas dominant IBN reduced IL-6 release to near-background levels. Likewise, the dominant-negative IKK2 adenovirus prevented IL-6 release	SEN:10038418	17322026
BEL:20080896	p(HGNC:IL1B) increases p(HGNC:MMP12)	IL-1beta induced the expression of MMP-12 mRNA via activation of JNK and PI3K (357). IL-1beta-mediated expression of MMP-9 and -12 was demonstrated in IL-1beta overexpressing transgenic mice as well (175).	SEN:10038422	17615396
BEL:20080906	p(HGNC:IL1B) increases p(HGNC:MMP9)	IL-1beta induced the expression of MMP-12 mRNA via activation of JNK and PI3K (357). IL-1beta-mediated expression of MMP-9 and -12 was demonstrated in IL-1beta overexpressing transgenic mice as well (175).	SEN:10038422	17615396
BEL:20080908	p(HGNC:IL1B) increases p(HGNC:MMP9)	IL1B stimulates the expression of MMP9	SEN:10038428	15602009
BEL:20080910	p(HGNC:IL1B) increases p(HGNC:MMP9)	It has also been shown that IL-1b stimulates the release and activity of MMP-9 (matrix metalloproteinase-9) from AM obtained from COPD smokers, which is significantly higher in comparison with those obtained from healthy smokers and non-smokers [155].	SEN:10038430	19842832
BEL:20080942	p(HGNC:IL1B) increases tscript(p(HGNC:FOS))	Of note, in OA chondrocytes, IL-17 and IL-1beta induced collagenase-3 production through AP-1 occurred with differential protein complexes: IL-17 stimulation resulted in FosB activation, while IL-1beta stimulated c-Fos.	SEN:10038458	12064845
BEL:20080946	p(HGNC:IL1B) increases tscript(p(HGNC:JUN))	There was a distinct additive effect on c-jun binding to CXCL8 gene when cells were costimulated with smoke plus IL-1 (Fig. 9B)	SEN:10038462	16061772
BEL:20080958	p(HGNC:IL25) increases p(HGNC:GATA3)	The enhanced functions of Th2 memory cells induced by IL-25 are associated with sustained expression of GATA-3, c-MAF, and JunB in an IL-4-independent manner.	SEN:10038468	17635955
BEL:20080960	p(HGNC:IL25) increases p(HGNC:JUNB)	The enhanced functions of Th2 memory cells induced by IL-25 are associated with sustained expression of GATA-3, c-MAF, and JunB in an IL-4-independent manner.	SEN:10038468	17635955
BEL:20080962	p(HGNC:IL25) increases p(HGNC:MAF)	The enhanced functions of Th2 memory cells induced by IL-25 are associated with sustained expression of GATA-3, c-MAF, and JunB in an IL-4-independent manner.	SEN:10038468	17635955
BEL:20080968	p(HGNC:IL27) increases tscript(p(HGNC:STAT1))	STAT5, which is downstream of IL-2 signalling, and STAT1, which is downstream of IL-27 signalling, as well as ETS1, are negative regulators of TH17-cell differentiation.	SEN:10038472	18408735
BEL:20080972	p(HGNC:IL2) increases bp(GOBP:"T-helper 1 type immune response")	Th1 cells produce interleukin (IL)-2, interferon-gamma (IFN-gamma) and lymphotoxin-beta, which mediate pro-inflammatory functions critical for the development of cell-mediated immune responses, whereas Th2 cells secrete cytokines such as IL-4, IL-5 and IL-10 that enhance humoral immunity.	SEN:10038328	11057672
BEL:20080978	p(HGNC:IL2) increases tscript(p(HGNC:IRF1))	In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12.	SEN:10019900	8920893
BEL:20080982	p(HGNC:IL2) increases tscript(p(HGNC:STAT5A))	STAT5, which is downstream of IL-2 signalling, and STAT1, which is downstream of IL-27 signalling, as well as ETS1, are negative regulators of TH17-cell differentiation.	SEN:10038472	18408735
BEL:20080992	p(HGNC:IL33) directlyIncreases cat(p(HGNC:IL1RL1))	These results indicate that the endogenous IL-33/ST2 signaling pathway enhances the expression of CCR3 on eosinophils.	SEN:10019238	20693421
BEL:20080994	p(HGNC:IL33) increases cat(p(HGNC:IL1RL1))	We report a member of the IL-1 family, IL-33, which mediates its biological effects via IL-1 receptor ST 2	SEN:10038482	16286016
BEL:20080998	p(HGNC:IL4) decreases bp(GOBP:"T-helper 1 cell differentiation")	In addition to their positive effects on TH2 and TH1 development, IL-4 (Fig. 1) and IL-12 (7, 30), acting via STAT proteins, potently suppress induction of T-bet and Gata-3, thereby limiting differentiation of TH1 and TH2 subsets, respectively.	SEN:10028258	11397944
BEL:20081000	p(HGNC:IL4) decreases kin(p(HGNC:MAPK1))	IL-4 can inhibit the p44/42 pathway in stimulated monocytes [47].	SEN:10038484	19601851
BEL:20081002	p(HGNC:IL4) decreases p(HGNC:C3AR1)	In addition to its effects on human cells, IL-4 reduced C5a receptors in murine bone marrow-derived DC and impaired recruitment of labeled bone marrow-derived DC in syngeneic BALB/c mice to i.p. injected C5a. Overall, these data suggest that inhibition of a rapid anaphylatoxin-induced mobilization of monocytes and DC to inflamed tissues represents an important anti-inflammatory activity of the Th2 cytokine IL-4.	SEN:10028266	12626590
BEL:20081004	p(HGNC:IL4) decreases p(HGNC:C5AR1)	In addition to its effects on human cells, IL-4 reduced C5a receptors in murine bone marrow-derived DC and impaired recruitment of labeled bone marrow-derived DC in syngeneic BALB/c mice to i.p. injected C5a. Overall, these data suggest that inhibition of a rapid anaphylatoxin-induced mobilization of monocytes and DC to inflamed tissues represents an important anti-inflammatory activity of the Th2 cytokine IL-4.	SEN:10028266	12626590
BEL:20081010	p(HGNC:IL4) directlyIncreases cat(p(HGNC:IL4R))	The intracellular signaling induced by IL-4/IL-4R interactions on CD4  T cells has been characterized in great detail. The binding of IL-4 to the Type I receptor in CD4  T cells induces the activation of the nonreceptor tyrosine kinase Jak1, which promotes the phosphorylation of STAT6.	SEN:10038486	17200144
BEL:20081028	p(HGNC:IL4) increases p(HGNC:CCL18)	 IL-4, IL-13, and IL-10 significantly up-regulated CCL18 production by AMs (Figure 4).	SEN:10038368	16415274
BEL:20081034	p(HGNC:IL4) increases p(HGNC:CTGF)	In normal fibroblasts, IL-4 stimulates proliferation, chemotaxis, and collagen synthesis and enhances the production of TGF-B1 and CTGF (82).	SEN:10038496	17332883
BEL:20081048	p(HGNC:IL4) increases p(HGNC:TGFB1)	In normal fibroblasts, IL-4 stimulates proliferation, chemotaxis, and collagen synthesis and enhances the production of TGF-B1 and CTGF (82).	SEN:10038496	17332883
BEL:20081054	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	Cytokines control the outcome of TH immunity, with IL-12, acting via signal transducer and activator of transcription 4 (STAT4), to promote TH1 development, whereas IL-4 promotes TH2 development via the actions of STAT6 (2).	SEN:10038504	11397944
BEL:20081056	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	Fig. 4. IL-4 induces STAT6 binding to a site in the 5' upstream regulatory region of the AID gene.	SEN:10028310	14978013
BEL:20081058	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	Finally, reconstitution of Stat6-deficient splenic B cells with Bcl-xL was able to protect those cells from Fas-induced cell death.  These results suggest that the anti-apoptotic activity of IL-4 in B cells is mediated through the activation of Stat6 and subsequent transcription of Bcl-xL	SEN:10038506	12023955
BEL:20081062	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	IL-4 has been documented to regulate the expression of eotaxin-1 (41), eotaxin-2 (42), and eotaxin-3 (34) in endothelial cells and fibroblasts in a STAT6-dependent manner (42, 43, 44, 45). IL-4 signal transduction includes activation of STAT6 (46, 47, 48, 49, 50). 	SEN:10038510	16547273
BEL:20081064	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6. 	SEN:10038512	11397944
BEL:20081068	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	SOCS-1 and SOCS-3 inhibit interleukin (IL)-4-dependent signal transducer and activator of transcription 6 (Stat6) activation of and subsequent gene induction. By contrast, SOCS-2 and cytokine-inducible Src homology domain 2 (SH2)-containing protein up-regulate these processes	SEN:10038514	10950967
BEL:20081070	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	Socs1 inhibits activation of STAT6 by Il4 stimulation	SEN:10038516	12110143
BEL:20081074	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	This unconventional interaction of SOCS5 protein with the IL-4R resulted in the inhibition of IL-4-mediated signal transducer and activator of transcription-6 activation.	SEN:10020328	12242343
BEL:20081076	p(HGNC:IL4) increases tscript(p(HGNC:STAT6))	To verify the absence of the STAT6-signaling cascade in STAT6-/-  MLF, we assessed mOSM and mIL-4 induced responses with respect to STAT3 and STAT6 activation. Fig. 6 confirms the absence of STAT6 protein and STAT6 induction in STAT6-/- MLF but equivalent activation of STAT3 in both wt and STAT6-/- MLF.	SEN:10038520	16547273
BEL:20081082	p(HGNC:IL5) increases p(HGNC:CCL2)	Immunostaining with anti-TGF-b and anti-MCP-1 antibodies revealed similar results. As previously reported [8, 9, 16], there was a substantial increase in the number of cells expressing these cytokines in bleomycin-injured lungs, which was also inhibited by treatment with anti-IL-5 antibody as confirmed by morphometric counting of cytokine-positive cells (Fig. 7, B and C, respectively).	SEN:10028320	9823772
BEL:20081084	p(HGNC:IL5) increases p(HGNC:IL13)	TNF-alpha, IL-1beta, and IFN-gamma expression were slightly decreased in cultures from blm-treated IL-5-/- mice relative to cultures from blm-treated IL-5+/+ mice (Table IV?), whereas TGF-beta levels were significantly increased. Anti-CD3-induced expression of IL-4 and IL-13 were dramatically diminished in IL-5?/? T cells in comparison to IL-5+/+ T cells. 	SEN:10038522	14607953
BEL:20081088	p(HGNC:IL5) increases p(HGNC:IL4)	TNF-alpha, IL-1beta, and IFN-gamma expression were slightly decreased in cultures from blm-treated IL-5-/- mice relative to cultures from blm-treated IL-5+/+ mice (Table IV?), whereas TGF-beta levels were significantly increased. Anti-CD3-induced expression of IL-4 and IL-13 were dramatically diminished in IL-5?/? T cells in comparison to IL-5+/+ T cells. 	SEN:10038522	14607953
BEL:20081090	p(HGNC:IL5) increases p(HGNC:TGFB1)	Immunostaining with anti-TGF-b and anti-MCP-1 antibodies revealed similar results. As previously reported [8, 9, 16], there was a substantial increase in the number of cells expressing these cytokines in bleomycin-injured lungs, which was also inhibited by treatment with anti-IL-5 antibody as confirmed by morphometric counting of cytokine-positive cells (Fig. 7, B and C, respectively).	SEN:10028320	9823772
BEL:20081092	p(HGNC:IL5) increases p(HGNC:TGFB1)	Indeed at each time point examined, levels of lung hydroxyproline, soluble collagen, fibronectin, and TGF-? were higher in blm-treated IL-5TG relative to IL-5WT mice (Fig. 2?, A–D).	SEN:10028314	14607953
BEL:20081094	p(HGNC:IL6) decreases p(HGNC:CCND1)	During IL-6-induced macrophage differentiation of M1 cells, IL-6 down-regulated cyclin D1 expression and induced p19(INK4D) expression, leading to reduction in cdk4 activities. In contrast, sustained expression of cyclin D1 and a significantly lesser amount of p19(INK4D) induction were observed in IL-6-treated M1 cells overexpressing GATA-1.	SEN:10038222	10666199
BEL:20081098	p(HGNC:IL6) increases bp(GOBP:"inflammatory response")	Il6 can elicit proinflammatory or anti-inflammatory effects, depending on the in vivo environmental circumstances	SEN:10028336	12687404
BEL:20081100	p(HGNC:IL6) increases bp(GOBP:"inflammatory response")	IL-6 controls macrophage and T cell activation, SMC proliferation, and migration and is a major regulator of the acute phase response (5).	SEN:10038526	10542237
BEL:20081102	p(HGNC:IL6) increases bp(GOBP:"inflammatory response")	More importantly, persistent activation of IL-6 downstream Stat3 in AT II epithelial cellsdirec tly induced lung inflammation and bronchioalveolar adenocarcinoma (22).	SEN:10028338	19706765
BEL:20081104	p(HGNC:IL6) increases bp(GOBP:"inflammatory response")	Several pro-inflammatory mediators up-regulate SAA transcription, including Il1, Il6, TNFalpha, and Lif.	SEN:10028334	11798191
BEL:20081112	p(HGNC:IL6) increases p(HGNC:CDKN2D)	During IL-6-induced macrophage differentiation of M1 cells, IL-6 down-regulated cyclin D1 expression and induced p19(INK4D) expression, leading to reduction in cdk4 activities. In contrast, sustained expression of cyclin D1 and a significantly lesser amount of p19(INK4D) induction were observed in IL-6-treated M1 cells overexpressing GATA-1.	SEN:10038222	10666199
BEL:20081114	p(HGNC:IL6) increases p(HGNC:EGFR)	Pretreatment of cells with EGF receptor specific inhibitor CGP59326 or with the bispecific EGF receptor/ERBB2  inhibitor PD153035, diminished IL6 induced MAPK activation. Even the PKB phosphorylation was also affected by these two inhibitors.	SEN:10038528	11196191
BEL:20081116	p(HGNC:IL6) increases p(HGNC:IL6ST)	Ariadne: GRP58 is a  major target for tyrosine phosphorylation by the Lyn kinase ( 76 ), a kinase  that can be activated by IL-6 through gp130 signaling	SEN:10038530	10464281
BEL:20081124	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	Although STAT3 is essential for IL-6-induced macrophage differentiation of M1 cells, GATA-1 had little or no effect on tyrosine phosphorylation, DNA binding, and transcriptional activities of STAT3 in Western blot analysis, electropholic mobility shift assay (EMSA), and luciferase assays.	SEN:10028424	10666199
BEL:20081132	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	Fig. 1  Ashows that phosphorylation of STAT3 at Tyr705 was detected after 5 min of exposure to 10 ng/ml IL-6, reached a maximum at 15 min, and then declined within 1 h. These results demonstrate that IL-6 activates a STAT3 signaling in adult rat ventricular myocytes. 	SEN:10038542	12595539
BEL:20081134	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	from full text - IL-6 signalling through signal transducer and activator of transcription- 3 (STAT3)	SEN:10038544	18666314
BEL:20081138	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	Il6 activates STAT1 and STAT5 in addition to STAT3	SEN:10038548	12110143
BEL:20081142	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	IL-6 induced STAT3 transactivation was reduced from sixfold to 2.5-fold when cells were pre- treated with the JAK2 inhibitor (Figure 2b).	SEN:10016526	11536047
BEL:20081150	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	Stat3 controls cell death and tissue remodeling in the mouse mammary gland during involution, which is partially induced by IL6 and LIF.	SEN:10028426	15292206
BEL:20081152	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	that IL-6 and IL-10, two cytokines that are known to activate STAT3, confer a drug-resistant phenotype in renal carcinomas, which was subsequently confirmed in different cancer cell lines such as multiple myeloma [72,73].	SEN:10038556	17118707
BEL:20081156	p(HGNC:IL6) increases tscript(p(HGNC:STAT3))	We next determined whether the ?EGFR-expressing MCF-10A cells produced high levels of IL-6, leading to activation of STAT3, as was observed in lung adenocarcinoma–derived cell lines harboring mutant EGFR. The ?EGFR–MCF-10A cells were treated with P6, gp130, and IL-6 blocking antibodies, which inhibited STAT3 activation.	SEN:10038560	18060032
BEL:20081164	p(HGNC:IL6ST) increases tscript(p(HGNC:STAT3))	Il6 promotes the growth arrest and differentiation of M1 cells through gp130-mediated Stat3 activation, whereas the Y759/SHP-2-mediated cascade by gp130 stimulation has growth-enhancing effects	SEN:10038564	12687404
BEL:20081168	p(HGNC:IL6ST) increases tscript(p(HGNC:STAT3))	We next determined whether the ?EGFR-expressing MCF-10A cells produced high levels of IL-6, leading to activation of STAT3, as was observed in lung adenocarcinoma–derived cell lines harboring mutant EGFR. The ?EGFR–MCF-10A cells were treated with P6, gp130, and IL-6 blocking antibodies, which inhibited STAT3 activation.	SEN:10038560	18060032
BEL:20081186	p(HGNC:IL8) increases bp(GOBP:"cell migration")	In Transwell migration assays, the migration of human monocytes was specifically induced towards higher MIF concentrations, similar to CCL2 and CXCL8 [40].	SEN:10038570	18385967
BEL:20081188	p(HGNC:IL8) increases bp(GOBP:"cell migration")	Seven chemokines (CXCL1, CXCL5, CXCL8, CXCL14, CX3CL1, CCL5 and CCL11) have been shown to act on some of these receptors and to induce mast cell migration	SEN:10038572	16107768
BEL:20081194	p(HGNC:IL8) increases bp(GOBP:"neutrophil activation")	Interestingly, activated DCs in turn produce high amounts of CXCL-8 that mediates both recruitment and activation of neutrophils.	SEN:10038576	19273148
BEL:20081204	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	CXCL8 plays a major role to stimulate neutrophil migration in IL-17-conditioned LMVEC medium	SEN:10038580	20228195
BEL:20081208	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	Here we demonstrate that cholesterol was absolutely required for polarized redistribution of key chemotactic mediators in human neutrophils in response to all chemoattractants tested (fMet-Leu-Phe, and the chemokines CXCL1, CXCL8 and CXCL12).	SEN:10034424	18311596
BEL:20081210	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	IL8 and Leukotriene B4 are neutrophil chemoattractants in the lung.	SEN:10038584	15602009
BEL:20081214	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	Nevertheless, cell pre-treatment with F1 or F2 completely blocked the chemotactic response to IL-8 (Fig. 2B).	SEN:10038586	17951099
BEL:20081216	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	Omeprazole is able to inhibit neutrophil chemotaxis to fMLP and IL-8... The addition of a potassium ionophore, nigericin, restored the migratory ability, as well as the intracellular calcium levels. The activity of p38 MAP Kinase was decreased in neutrophils pretreated with omeprazole.	SEN:10034938	17406807
BEL:20081220	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	Results revealed that in response to IL-8 (10 ng), ZZ neutrophils exhibited a 2- or 8-fold increase in chemotactic activity when experiments were performed in PBS or serum (50% v/v), respectively (Figure 1A).	SEN:10038590	21060150
BEL:20081222	p(HGNC:IL8) increases bp(GOBP:"neutrophil chemotaxis")	Similarly, preincubation with F(ab')2 fragments of a monoclonal anti-human IL-8 antibody inhibited neutrophil chemotaxis to CB sputum supernatants by 75% [30].	SEN:10038592	19842832
BEL:20081294	p(HGNC:JUN) decreases p(HGNC:DDIT3)	Interestingly, c-Jun Re cells had dramatically lower Grp78 and Gadd153 expression in response to TG treatment compared to c-jun–/– cells (Fig. 2C).	SEN:10028658	18641051
BEL:20081296	p(HGNC:JUN) decreases p(HGNC:HSPA5)	Interestingly, c-Jun Re cells had dramatically lower Grp78 and Gadd153 expression in response to TG treatment compared to c-jun–/– cells (Fig. 2C).	SEN:10028658	18641051
BEL:20081298	p(HGNC:JUN) increases p(HGNC:RCAN1)	Intriguingly, Adapt78 expression was up-regulated in response to TG treatment in c-Jun Re cells but not in c-jun–/– cells (Fig. 2C).	SEN:10028662	18641051
BEL:20081320	p(HGNC:KITLG) directlyIncreases kin(p(HGNC:KIT))	FIGURE 6 | Integration of the signalling pathways induced by the G-protein-coupled receptors FcepsilonRI and KIT.	SEN:10036724	16470226
BEL:20081322	p(HGNC:KITLG) directlyIncreases kin(p(HGNC:KIT))	Y721-c-Kit is autophosphorylated in response to stem cell factor (SCF).	SEN:10038622	20200353
BEL:20081332	p(HGNC:KNG1) directlyIncreases cat(p(HGNC:BDKRB1))	Bradykinin (BK) is a potent inflammatory mediator, which can release other inflammatory mediators by interacting with bradykinin B1 and B2 receptors ... It is concluded that BK causes increased leak by inducing PMN elastase release via activation of both B1 and B2 receptors	SEN:10038626	8856176
BEL:20081336	p(HGNC:KNG1) directlyIncreases cat(p(HGNC:BDKRB2))	Bradykinin (BK) is a potent inflammatory mediator, which can release other inflammatory mediators by interacting with bradykinin B1 and B2 receptors ... It is concluded that BK causes increased leak by inducing PMN elastase release via activation of both B1 and B2 receptors	SEN:10038626	8856176
BEL:20081362	p(HGNC:LGALS3) increases bp(GOBP:"epithelial to mesenchymal transition")	Primary lung alveolar epithelial cells (AEC) from galectin-3?/? mice show reduced epithelial to mesenchymal transition (EMT) in response to transforming growth factor (TGF)-?1 in vitro compared with wild-type (WT) AECs. 	SEN:10038636	22095546
BEL:20081364	p(HGNC:LGALS3) increases p(HGNC:ACTA2)	Immunofluorescence staining for ?-smooth muscle actin (?-SMA) (green) and collagen-1 (red) showing reduced ?-SMA and collagen-1 expression in galectin-3?/? fibroblasts after TGF-?1	SEN:10028838	22095546
BEL:20081368	p(HGNC:LTB) increases bp(GOBP:"T-helper 1 type immune response")	Th1 cells produce interleukin (IL)-2, interferon-gamma (IFN-gamma) and lymphotoxin-beta, which mediate pro-inflammatory functions critical for the development of cell-mediated immune responses, whereas Th2 cells secrete cytokines such as IL-4, IL-5 and IL-10 that enhance humoral immunity.	SEN:10038328	11057672
BEL:20081376	p(HGNC:MAP1LC3A) increases bp(GOBP:autophagy)	by Western analysis, electron microscopy, and immunoflourescence, there is increased expression of the autophagic proteins LC3B-II/LC3B-I, Atg4, Atg5-artg12, and Atg7, as well as increased numbers of different stages of autophagic vacuoles in the lungs of COPD patients in all GOLD categories, with a corresponding increase in caspase 3 activity, a marker of apoptosis in GOLD 3/4 patients.54	SEN:10035456	21857781
BEL:20081378	p(HGNC:MAP1LC3B) increases bp(GOBP:autophagy)	LC3-II was increased in FoxO3MyHC cardiomyocytes after ex vivo transgene activation (Figure 4F; see Supplementary material online, Figure S6C). Treatment with lysosomal inhibitors revealed that LC3-II levels could still be stimulated in FoxO3MyHC cardiomyocytes, indicating an activation of autophagy rather than a disturbance in autophagic flux.	SEN:10028990	21628326
BEL:20081398	p(HGNC:MAP3K5,pmod(P,S,83)) directlyDecreases kin(p(HGNC:MAP3K5))	AKT phosphorylates and inhibits apoptosis signal-regulating kinase 1 (ASK1) at Ser83, thereby promoting cell survival (Yuan et al., 2003; Zhang et al., 2005; Wu et al., 2006).	SEN:10038642	18794886
BEL:20081538	p(HGNC:MDM2) directlyDecreases tscript(p(HGNC:TP53))	Upregulation of IGF-1 in myocytes was associated with a protein-to-protein interaction between Mdm2 and p53, which attenuated p53 transcriptional activity for bax, Aogen, and AT1 receptor. Similarly, the amount of Bax, Aogen, and AT1 receptor proteins in these cells decreased	SEN:10038674	10205143
BEL:20081562	p(HGNC:MMP12) increases p(HGNC:IL6)	As shown in Fig. 4A, IL-6 concentration in BALF of doxycycline-treated mice was steadily increased compared with those in untreated bitransgenic mice in a time-dependent fashion,	SEN:10029252	19706765
BEL:20081572	p(HGNC:MST1) directlyIncreases kin(p(HGNC:MST1R))	hepatocyte growth factor-like protein (HGFL), the RON-specific ligand (HGFL = MST1, RON = MST1R)	SEN:10038686	17616662
BEL:20081600	p(HGNC:MYC) increases bp(GOBP:"cell proliferation")	BrdU incorporation showed that although there was increased proliferation in c-MYC overexpressing cells compared with control cells	SEN:10029352	18955973
BEL:20081604	p(HGNC:MYC) increases bp(GOBP:"cell proliferation")	In the p53-dependent pathway, p53 accumulates following E2F1 expression [29] through activation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) transcript p14ARF, which in turn interacts with mouse double minutes (MDM2), thereby preventing MDM2 from targeting p53 for ubiquitination and subsequent degradation	SEN:10038694	16530485
BEL:20081610	p(HGNC:MYC,pmod(P,S,62)) directlyIncreases tscript(p(HGNC:MYC))	Exposure to H2O2 enhances c-Myc recruitment to gamma-GCS regulatory regions through ERK-dependent phosphorylation. Phosphorylation at Ser-62 is required for c-Myc recruitment to gamma-GCS promoters and determines the cellular response to oxidative stress induced by different stimuli.	SEN:10038696	16483932
BEL:20081626	p(HGNC:MYD88) increases p(HGNC:IL6)	In response to hepatocyte cell death, MyD88 signalling was responsible for the activation of NF-?B and for the production of factors such as IL-6 (ReF. 122).	SEN:10029386	19052556
BEL:20081660	p(HGNC:NFE2L2,pmod(P,S,40)) directlyIncreases tloc(p(HGNC:NFE2L2),GOCCID:0005737,GOCCID:0005634)	In related experiments, the majority of the Nrf2S40-phosphorylated protein was found localized in the nucleus (Fig. 5D, lower panel).	SEN:10038714	19920073
BEL:20081666	p(HGNC:NFE2L2,pmod(P,Y,576)) directlyDecreases tloc(p(HGNC:NFE2L2),GOCCID:0005737,GOCCID:0005634)	Phosphorylated Fyn accumulates in the nucleus and phosphorylates Nrf2 at tyrosine 568. This leads to nuclear export, ubiquitination, and degradation of Nrf2	SEN:10036806	17403689
BEL:20081686	p(HGNC:NFKBIA,pmod(P,S,32)) directlyIncreases deg(p(HGNC:NFKBIA))	Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.	SEN:10036364	10398585
BEL:20081688	p(HGNC:NFKBIA,pmod(P,S,32)) directlyIncreases deg(p(HGNC:NFKBIA))	Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005	SEN:10036370	17322026
BEL:20081698	p(HGNC:NFKBIA,pmod(P,S,36)) directlyIncreases deg(p(HGNC:NFKBIA))	Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.	SEN:10036364	10398585
BEL:20081700	p(HGNC:NFKBIA,pmod(P,S,36)) directlyIncreases deg(p(HGNC:NFKBIA))	Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005	SEN:10036370	17322026
BEL:20081712	p(HGNC:NFKBIA,pmod(P,S)) directlyIncreases deg(p(HGNC:NFKBIA))	# from full text # Here we show that UVC radiation leads to activation of a signaling pathway, distinct from the IKK pathway, which induces I?B? degradation in a manner dependent on phosphorylation of a cluster of C-terminal sites. The kinase that phosphorylates these sites is CK2.	SEN:10036344	14580335
BEL:20081720	p(HGNC:NFKBIA,pmod(P,S)) directlyIncreases deg(p(HGNC:NFKBIA))	phosphorylation and ubiquitination-dependent degradation of IkappaBalpha, the cytoplasmic inhibitor of NFkappaB, via the inducible IkappaB kinase (IKK) complex, liberates NFkappaB to translocate into the nucleus and to transcriptionally activate its target genes, including the IL2 gene	SEN:10036362	12044776
BEL:20081746	p(HGNC:NOTCH1) increases bp(GOBP:"epithelial cell differentiation")	Figure 4. Notch Gain of Function Promotes Luminal Differentiation of Mouse Airway BCs In Vivo	SEN:10038726	21624809
BEL:20081750	p(HGNC:NOTCH1) increases bp(GOBP:"epithelial cell differentiation")	Together, these data support a model in which Notch promotes the luminal differentiation of human airway BCs.	SEN:10038728	21624809
BEL:20081788	p(HGNC:NRG1) increases kin(p(HGNC:ERBB2))	Exogenously added heregulin induced Erk activation, which was blocked by herceptin, which is an antibody against HER-2/neu.	SEN:10024060	10376522
BEL:20081790	p(HGNC:NRG1) increases kin(p(HGNC:ERBB2))	Mechanistic studies revealed that HER2 trans-activation by IL-1?? required a disintegrin and metalloprotease 17 (ADAM17)-dependent shedding of the ligand neuregulin-1 (NRG-1). In murine models of ALI, NRG-1-HER2 signaling was activated, and ADAM17 blockade resulted in decreased NRG-1 shedding, HER2 activation, and lung injury in vivo.	SEN:10035322	21247898
BEL:20081820	p(HGNC:NRP1) increases kin(p(HGNC:FLT1))	Recently, neuropilin-1 (NP-1), a cell surface glycoprotein that binds semaphorin/collapsins, mediators of neuronal guidance, has been identified as VEGF165 receptor. NP-1 is expressed in endothelial cells and enhances the mitogenic effects of Flk-1 upon VEGF165stimulation (222)	SEN:10038738	11172729
BEL:20081840	p(HGNC:PDGFC) directlyIncreases kin(p(HGNC:KDR))	VEGF-E bound KDR/Flk-1 (VEGFR-2) and induced its autophosphorylation to almost the same extent as VEGF165, but did not bind Flt-1 (VEGFR-1) nor induce autophosphorylation of Flt-1 (from full text, Fig 6, NIH3T3 cells)	SEN:10038748	9813035
BEL:20081858	p(HGNC:PER1,pmod(P,S)) directlyIncreases deg(p(HGNC:PER1))	The inhibition of hPER1 phosphorylation by CKI-7 [ N -(2-aminoethyl)-5-chloro-isoquinoline-8-sulphonamide], a CKI inhibitor, disturbed hPER1 degradation, delayed the nuclear entry of hPER1 and allowed it to persist for longer in the nucleus.	SEN:10036418	14750904
BEL:20081884	p(HGNC:PLAU) increases kin(p(HGNC:PDGFRB))	Kiyan, J., Kiyan, R., Haller, H., and Dumler, I. 2005. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. EMBO J. 24: 1787–1797. doi:10. 1038/sj.emboj.7600669. PMID:15889147	SEN:10038752	19064999
BEL:20081894	p(HGNC:PLCG1,pmod(P,Y)) directlyIncreases cat(p(HGNC:PLCG1))	dual phosphorylation by ZAP70 and Itk triggers the activation of PLCg1	SEN:10037294	12044776
BEL:20081902	p(HGNC:PML) increases tscript(p(HGNC:TP53))	Here, we show that the mechanism by which PML induces a permanent cell cycle exit and activates p53 and senescence involves a recruitment of E2F transcription factors bound to their promoters and the retinoblastoma (Rb) proteins to PML nuclear bodies enriched in heterochromatin proteins and protein phosphatase 1.	SEN:10038760	21205865
BEL:20081904	p(HGNC:PPARA) decreases p(HGNC:IL1B)	Lung levels of TNF-[alpha] and IL-1[beta] were significantly higher in PPAR-[alpha]-deficient mice in comparison with those of PPAR-[alpha] WT animals (Fig. 3). 	SEN:10038762	16317386
BEL:20081906	p(HGNC:PPARA) decreases p(HGNC:JUN)	In human aortic smooth muscle cells, fibrates inhibit the IL-1b?induced expression of cyclooxygenase (COX)-2 and IL-6 by inhibiting the NF-kB and AP-1 signaling pathway.9,10 	SEN:10038764	11208678
BEL:20081910	p(HGNC:PPARA) decreases p(HGNC:TNF)	Lung levels of TNF-[alpha] and IL-1[beta] were significantly higher in PPAR-[alpha]-deficient mice in comparison with those of PPAR-[alpha] WT animals (Fig. 3). 	SEN:10038762	16317386
BEL:20081956	p(HGNC:PRKCZ,pmod(P,T,410)) directlyIncreases kin(p(HGNC:PRKCZ))	Our findings suggest that insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T410 loop phosphorylation, (b) T560 autophosphorylation	SEN:10037098	11141077
BEL:20081964	p(HGNC:PRKD1,pmod(P,S,738)) directlyIncreases kin(p(HGNC:PRKD1))	PKCm/PKD binds to PKCh selectively through its PH domain PKCh acts as a direct activator for PKCm/PKD to trigger downstream cellular processes	SEN:10038786	12473186
BEL:20081980	p(HGNC:PTEN) decreases kin(p(HGNC:MAPK1))	PTEN inhibits MAPK through the negative regulation of integrin signaling (Gu et al., 1998).	SEN:10038788	18794886
BEL:20081982	p(HGNC:PTEN) decreases kin(p(HGNC:MAPK3))	PTEN inhibits MAPK through the negative regulation of integrin signaling (Gu et al., 1998).	SEN:10038788	18794886
BEL:20081986	p(HGNC:PTEN,pmod(P,S,380)) directlyDecreases phos(p(HGNC:PTEN))	Moreover, substituting Ser-380/Thr-382/Thr-383 to phosphomimic residues reversed the phosphatase activity of the S385A mutation. 	SEN:10038790	17565999
BEL:20081992	p(HGNC:PTEN,pmod(P,T,382)) directlyDecreases phos(p(HGNC:PTEN))	Moreover, substituting Ser-380/Thr-382/Thr-383 to phosphomimic residues reversed the phosphatase activity of the S385A mutation. 	SEN:10038790	17565999
BEL:20081998	p(HGNC:PTEN,pmod(P,T,383)) directlyDecreases phos(p(HGNC:PTEN))	Moreover, substituting Ser-380/Thr-382/Thr-383 to phosphomimic residues reversed the phosphatase activity of the S385A mutation. 	SEN:10038790	17565999
BEL:20082010	p(HGNC:PTGS1) increases bp(GOBP:"wound healing")	we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin.  Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells	SEN:10038794	11159024
BEL:20082012	p(HGNC:PTGS2) increases bp(GOBP:"wound healing")	we hypothesized that COX products may regulate wound healing in AECs. To investigate this role, we inhibited COX activity with indomethacin.  Figure 1 shows a dose-dependent decrease in the rate of wound closure in CTE (Fig. 1A) and 16HBE14o2 (Fig. 1B) cells	SEN:10038794	11159024
BEL:20082014	p(HGNC:PTK2,pmod(P,Y,925)) directlyIncreases kin(p(HGNC:PTK2))	In the first case, recruited FAK autophosphorylates at 397Y and associates with c-Src or Fyn, which further phosphorylates it at 925Y. Phosphorylated FAK binds to the Grb2-Sos complex and activates the Ras-ERK cascade [60,61].	SEN:10037230	14984767
BEL:20082048	p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))	Raf itself is negatively regulated by phosphorylation at Ser259 through Akt, an important effector of phosphoinositide 3-kinase (PI3K) signaling (30, 44).	SEN:10038810	19223555
BEL:20082050	p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))	The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. 	SEN:10037446	11971957
BEL:20082052	p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))	the phosphorylation of Raf-1 on Ser-259 induced by paclitaxel he region surrounding Ser-259 in Raf-1 conforms to a consensus sequence for phosphorylation by Akt	SEN:10038812	12087097
BEL:20082054	p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))	This inhibitory phosphorylation on Raf reduces the activity of MAPK pathway (Zimmermann and Moelling, 1999).	SEN:10038814	18794886
BEL:20082074	p(HGNC:RAF1,pmod(P,S,43)) directlyDecreases kin(p(HGNC:RAF1))	The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. 	SEN:10037446	11971957
BEL:20082078	p(HGNC:RAP1B) increases bp(GOBP:"patterning of blood vessels")	aortas isolated from Rap1b-deficient animals had a reduced microvessel sprouting response	SEN:10038818	17993608
BEL:20082092	p(HGNC:RASSF1) increases p(HGNC:CDKN1A)	Moreover, tumors with conditionally expressed RASSF1A exhibited SAh-gal activity (Fig. 2C), which serves as an indicator for senescence occurring in vivo (8, 9), as well as enhanced p21Cip1/Waf1 expression (Fig. 2D).	SEN:10030322	19223555
BEL:20082094	p(HGNC:RASSF1) increases p(HGNC:CDKN1A)	Serum stimulation of p53-deficient NCI-H1299 lung cancer cells conditionally expressing RASSF1A equally led to enhanced ERK phosphorylation and up-regulation of p21Cip1/Waf1 (Fig. 5B).	SEN:10038828	19223555
BEL:20082108	p(HGNC:RB1,pmod(P,S,780)) directlyDecreases tscript(p(HGNC:RB1))	PD 0183812 blocks phosphorylation on pRb in tumor cells PD 0183812 inhibits phosphorylation of pRb at serine 780	SEN:10038834	11278443
BEL:20082110	p(HGNC:RB1,pmod(P,S,780)) directlyDecreases tscript(p(HGNC:RB1))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082118	p(HGNC:RB1,pmod(P,S,807)) directlyDecreases tscript(p(HGNC:RB1))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082122	p(HGNC:RB1,pmod(P,S,811)) directlyDecreases tscript(p(HGNC:RB1))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082126	p(HGNC:RB1,pmod(P,S)) directlyDecreases tscript(p(HGNC:RB1))	\"progression through G1 phase of cell cycle requires phosphorylation of the retinoblastoma gene product (pRb) by the cyclin D-dependent serine-threonine kinases CDK4 and CDK6	SEN:10036730	11278443
BEL:20082136	p(HGNC:RBL1) decreases tscript(p(HGNC:E2F4))	p107 interacts with and modulates the activity of the transcription factor, E2F-4.	SEN:10038842	8643455
BEL:20082152	p(HGNC:RETNLB) increases kin(p(HGNC:AKT1))	Inhibition of phosphatidylinositol 3-kinase (see {601232}) inhibited Retnlb-activated Akt phosphorylation and also inhibited RPSM proliferation.	SEN:10030388	12714564
BEL:20082154	p(HGNC:RETNLB) increases kin(p(HGNC:AKT1))	Phosphorylation status of the three key MAPKs (ERK, JNK, and p38) and AKT in FIZZ2-treated MLFs were analyzed by Western blotting. The results showed rapid (10 min) marked activation of ERK by FIZZ2, with lesser effects on AKT and p38 (Fig. 5B). JNK was not activated by FIZZ2 treatment. 	SEN:10038848	21602491
BEL:20082156	p(HGNC:RETNLB) increases path(MESHD:Fibrosis)	As expected, WT mice exhibited significant fibrosis as manifested by an approximate doubling in lung hydroxyproline content along with elevations in extracellular matrix, ?-SMA, FIZZ1, telomerase reverse transcriptase (TERT), and cytokine expression (Fig. 3A?C). However, in FIZZ2 KO mice, these responses to BLM treatment were all significantly diminished with virtual complete suppression in certain parameters.	SEN:10038850	21602491
BEL:20082158	p(HGNC:RETNLB) increases p(HGNC:ACTA2)	The results showed that MLF ?-SMA protein expression was also stimulated by FIZZ2 at doses as low as 25 ng/ml (Fig. 4C). 	SEN:10038852	21602491
BEL:20082172	p(HGNC:RPS6KB1,pmod(P,S,424)) directlyIncreases kin(p(HGNC:RPS6KB1))	from full text - T229 is situated in the catalytic domain of p70S6K, and in addition to T389, its phosphorylation is necessary for full activation of the protein. Residues T421 and S424 are situated in the autoinhibitory/pseudosubstrate domain of the C-terminus, and phosphorylation of these residues is proposed to be one of the early steps of p70S6K activation (2).	SEN:10038856	16262259
BEL:20082186	p(HGNC:RPS6KB1,pmod(P,T,389)) directlyIncreases kin(p(HGNC:RPS6KB1))	from full text - Collectively, these data suggest that p70S6K phosphorylated at T389 is among the most hyperphosphorylated isoforms and is a reliable marker of full p70S6K activation as suggested previously (22, 23).	SEN:10038862	16262259
BEL:20082190	p(HGNC:RPS6KB1,pmod(P,T,389)) directlyIncreases kin(p(HGNC:RPS6KB1))	Furthermore, overexpression of either hVps34 or the associated hVps15 protein kinase in the insulin-responsive Chinese hamster ovary line GRC+LR-73 (42) lead to an increase in phosphorylation of S6K1 at Thr389 (Fig. 1B), which correlates with S6K1 activation (45).	SEN:10038866	16049009
BEL:20082206	p(HGNC:RPS6KB1,pmod(P,T,421)) directlyIncreases kin(p(HGNC:RPS6KB1))	from full text - T229 is situated in the catalytic domain of p70S6K, and in addition to T389, its phosphorylation is necessary for full activation of the protein. Residues T421 and S424 are situated in the autoinhibitory/pseudosubstrate domain of the C-terminus, and phosphorylation of these residues is proposed to be one of the early steps of p70S6K activation (2).	SEN:10038856	16262259
BEL:20082220	p(HGNC:S100A8) increases bp(GOBP:"neutrophil chemotaxis")	Finally, injection of S100A8, S100A9, or S100A8/A9 into a murine air pouch model led to rapid, transient accumulation of neutrophils confirming their activities in vivo.	SEN:10030464	12626582
BEL:20082224	p(HGNC:S100A8) increases cat(p(HGNC:ITGAM))	S100A8 induced activation of Mac1 which was tested using the reporter monoclonal antibody mAb24.	SEN:10038882	12626582
BEL:20082228	p(HGNC:S100A9) increases bp(GOBP:"neutrophil chemotaxis")	Finally, injection of S100A8, S100A9, or S100A8/A9 into a murine air pouch model led to rapid, transient accumulation of neutrophils confirming their activities in vivo.	SEN:10030464	12626582
BEL:20082232	p(HGNC:S100A9) increases cat(p(HGNC:ITGAM))	S100A9 induced activation of Mac1 which was tested using the reporter mAb24.	SEN:10038884	12626582
BEL:20082250	p(HGNC:SFN) increases p(HGNC:TP53)	We found that 14-3-3 sigma interacted with p53 in response to the DNA-damaging agent adriamycin. Importantly, 14-3-3 sigma expression led to stabilized expression of p53.	SEN:10036476	14517281
BEL:20082262	p(HGNC:SH3GLB1) increases kin(p(HGNC:PIK3C3))	Bif-1 interacts with Beclin 1 through UVRAG and functions as a positive mediator of the class III PI3K, and its knockout significantly enhances the development of spontaneous tumors in mice.	SEN:10036100	21709535
BEL:20082264	p(HGNC:SHH) directlyDecreases cat(p(HGNC:PTCH1))	Ptc inhibits association of beta-arrestin 2 with Smo, and this inhibition is relieved in cells treated with Shh.	SEN:10038896	15618519
BEL:20082272	p(HGNC:SHH) increases bp(GOBP:"cell differentiation")	These findings demonstrate that Shh potently induces differentiation of resting fibroblasts into metabolically active myofibroblasts.	SEN:10038898	22354771
BEL:20082282	p(HGNC:SHH) increases p(HGNC:ACTA2)	Stimulation with Shh increased the protein levels of ?SMA in resting dermal fibroblasts in a dose5dependent manner by 807 ± 327 % (p = 0.007) (Fig. 5A and 5C).	SEN:10038904	22354771
BEL:20082336	p(HGNC:SMAD7) directlyDecreases kin(p(HGNC:TGFBR1))	TGFbeta-induced Smad7 binds to type I receptor (TGFbeta type I receptor; TbetaRI) functioning as a receptor kinase antagonist.	SEN:10038918	14718519
BEL:20082354	p(HGNC:SOCS1) decreases tscript(p(HGNC:STAT6))	SOCS-1 and SOCS-3 inhibit interleukin (IL)-4-dependent signal transducer and activator of transcription 6 (Stat6) activation of and subsequent gene induction. By contrast, SOCS-2 and cytokine-inducible Src homology domain 2 (SH2)-containing protein up-regulate these processes	SEN:10038514	10950967
BEL:20082356	p(HGNC:SOCS3) decreases p(HGNC:IL17A)	We show that loss of suppressor of cytokine signaling (SOCS) 3 in T cells increases both interleukin (IL)-17 and IL-10 production, induces an antiinflammatory macrophage phenotype, and leads to unexpected IL-17-dependent reduction in lesion development and vascular inflammation	SEN:10030780	19737863
BEL:20082360	p(HGNC:SOCS3) decreases tscript(p(HGNC:STAT3))	Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.	SEN:10030772	15240880
BEL:20082362	p(HGNC:SOCS3) decreases tscript(p(HGNC:STAT6))	SOCS-1 and SOCS-3 inhibit interleukin (IL)-4-dependent signal transducer and activator of transcription 6 (Stat6) activation of and subsequent gene induction. By contrast, SOCS-2 and cytokine-inducible Src homology domain 2 (SH2)-containing protein up-regulate these processes	SEN:10038514	10950967
BEL:20082366	p(HGNC:SOX2) increases p(HGNC:SPDEF)	In contrast, goblet cells were absent in Sox2-/- bronchiolar epithelium. Neither Spdef (an Ets-like factor required for goblet cell differentiation) nor Muc5AC (a pulmonary mucin) were induced (Fig. 4F,H).	SEN:10030828	20011520
BEL:20082368	p(HGNC:SP1) increases p(HGNC:FN1)	Compared with the mice of scramble decoy ODNs injected group, the ring-type Sp1 decoy ODNs injected mice showed the reduced expression of proteins, resulting in 70% for TGF-beta1, 61% for fibronectin, and 66% for MMP-13 on day 49 after the last administration of bleomycin (Fig. 1, Fig. 2 and Fig. 3A).	SEN:10030840	17869213
BEL:20082374	p(HGNC:SPDEF) decreases p(HGNC:FOXA2)	FOXA2 staining was absent at sites of goblet cell hyperplasia induced by SPDEF (Figure 9, C and D).	SEN:10030852	17347682
BEL:20082388	p(HGNC:STAT1) increases p(HGNC:IFNG)	NK cell IFN-gamma production was dependent on distinct signals mediated by the IL-21R and the FcR and was abrogated in STAT1-deficient NK cells.	SEN:10038930	16785506
BEL:20082416	p(HGNC:STAT3,pmod(P,S,727)) directlyIncreases tscript(p(HGNC:STAT3))	 . Furthermore, the bFGF-induced activation of ERK1/2 seems to enhance the transcriptional activity of STAT3. Co-stimulation of KMS-11 with bFGF and IL-6 leads to marked expression of STAT3 target genes, such as c-myc and bcl-2, further suggesting the relevance of STAT3 phosphorylated at both Tyr705 and Ser727 for the full activation as a transcription factor (Fig. 5). In addition, the	SEN:10038942	17142955
BEL:20082418	p(HGNC:STAT3,pmod(P,S,727)) directlyIncreases tscript(p(HGNC:STAT3))	leads to phosphorylation of MITF at S73 and of STAT3 at both tyrosine 705 and S727. This phosphorylation increases the transcriptional activity of MITF and STAT3 as indicated by mRNA accumulation of their target genes such as Bcl-2, granzyme B, and c-Myc	SEN:10038944	16034081
BEL:20082436	p(HGNC:STAT3,pmod(P,Y,705)) directlyIncreases tscript(p(HGNC:STAT3))	 . Furthermore, the bFGF-induced activation of ERK1/2 seems to enhance the transcriptional activity of STAT3. Co-stimulation of KMS-11 with bFGF and IL-6 leads to marked expression of STAT3 target genes, such as c-myc and bcl-2, further suggesting the relevance of STAT3 phosphorylated at both Tyr705 and Ser727 for the full activation as a transcription factor (Fig. 5). In addition, the	SEN:10038942	17142955
BEL:20082440	p(HGNC:STAT3,pmod(P,Y,705)) directlyIncreases tscript(p(HGNC:STAT3))	leads to phosphorylation of MITF at S73 and of STAT3 at both tyrosine 705 and S727. This phosphorylation increases the transcriptional activity of MITF and STAT3 as indicated by mRNA accumulation of their target genes such as Bcl-2, granzyme B, and c-Myc	SEN:10038944	16034081
BEL:20082458	p(HGNC:STAT6) increases path(MESHD:Fibrosis)	As expected, we found that tg-IL-13+Stat6+/- mice had substantial fibrosis as demonstrated by elevated levels of lung hydroxyproline, a constituent of collagen (Fig. 3b). This increase was dependent on STAT6 expression, but expression of hSTAT6 in epithelial cells did not result in reconstitution of the fibrotic response. 	SEN:10038954	12091879
BEL:20082470	p(HGNC:STIL) decreases p(HGNC:SUFU)	RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation	SEN:10034818	19860666
BEL:20082472	p(HGNC:SUFU) decreases tscript(p(HGNC:GLI1))	RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation	SEN:10034818	19860666
BEL:20082474	p(HGNC:SUFU) decreases tscript(p(HGNC:GLI2))	RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation	SEN:10034818	19860666
BEL:20082476	p(HGNC:SUFU) decreases tscript(p(HGNC:GLI3))	RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation	SEN:10034818	19860666
BEL:20082508	p(HGNC:TGFA) directlyIncreases kin(p(HGNC:EGFR))	Both EGFR and GRPR are activated in NSCLC by their corresponding ligands, TGF-a and GRP, in an autocrine manner.	SEN:10038226	15967120
BEL:20082522	p(HGNC:TGFB1) decreases p(HGNC:ATF1,pmod(P))	TGFB1 prevents cell cycle progression  and down regulates cyclin A promoter activity by decreasing phosphorylation of ATF1  in mink lung epithelial cells 	SEN:10038964	9268374
BEL:20082528	p(HGNC:TGFB1) decreases p(HGNC:CDH1)	TGF-?1 induced a marked up-regulation of mesenchymal markers ?-SMA and vimentin and down-regulation of the epithelial marker E-cadherin in WT AECs, which was evident after 48 hours. 	SEN:10037582	22095546
BEL:20082530	p(HGNC:TGFB1) decreases p(HGNC:CDH1)	TGF-B is a potent regulator of cellular adhesion, motility, and the extracellular matrix. TGF-B regulates the adhesive properties of cells by decreasing the expression of E-cadherin59 to decrease cell adhesion, by increasing the expression of invasion-associated integrins including AIIIB1 integrin, and by increasing the expression of integrin-binding proteins including fibulin	SEN:10035290	15774796
BEL:20082532	p(HGNC:TGFB1) decreases p(HGNC:CDH1)	the spindle-like phenotype induced by TGF treatment (Fig. 1 A, inset) persisted after factor removal (Fig. 1 B, inset) and involved loss of E-cadherin/4-integrin, whereas vimentin was strongly induced	SEN:10031150	11790801
BEL:20082538	p(HGNC:TGFB1) decreases p(HGNC:DKK1)	Stimulation with TGF-? reduced the levels of Dkk-1 mRNA and protein in dermal fibroblasts by 60 and 80%, respectively (Fig. 5e and f).	SEN:10038970	22415826
BEL:20082542	p(HGNC:TGFB1) decreases p(HGNC:TGFBR3)	TGFbetaRIII protein expression was significantly decreased 8 h after TGF-beta1 treatment	SEN:10038974	20359848
BEL:20082544	p(HGNC:TGFB1) decreases r(HGNC:MIR29B1)	We found that all miR-29 family members were down-regulated by TGFB1, with more than a two-fold reduction of miR- 29b (Fig.6A). These results were further confirmed by qRT-PCR and northern blot analysis (Fig.6B&C).	SEN:10038976	20971881
BEL:20082546	p(HGNC:TGFB1) directlyIncreases kin(p(HGNC:TGFBR1))	Further work revealed that TGF-R signaling (Massague and Wotton, 2000) was required for EMT, invasion in vitro, and metastasis in vivo,	SEN:10020476	11790801
BEL:20082554	p(HGNC:TGFB1) directlyIncreases kin(p(HGNC:TGFBR2))	In analogous fashion, TGFB1 binds TGFBR2, which recruits and phosphorylates TGFBR1 (also known as ALK5). 	SEN:10038980	16384533
BEL:20082564	p(HGNC:TGFB1) increases complex(p(HGNC:SMAD4),p(HGNC:SMAD3),p(HGNC:E2F4),p(HGNC:TFDP1),p(HGNC:RBL1))	A complex containing Smad3, the transcription factors E2F4/5 and DP1, and the corepressor p107 preexists in the cytoplasm. In response to TGFbeta, this complex moves into the nucleus and associates with Smad4, recognizing a composite Smad-E2F site on c-myc for repression	SEN:10038986	12150994
BEL:20082566	p(HGNC:TGFB1) increases complex(p(HGNC:SMAD4),p(HGNC:SMAD3),p(HGNC:E2F5),p(HGNC:TFDP1),p(HGNC:RBL1))	A complex containing Smad3, the transcription factors E2F4/5 and DP1, and the corepressor p107 preexists in the cytoplasm. In response to TGFbeta, this complex moves into the nucleus and associates with Smad4, recognizing a composite Smad-E2F site on c-myc for repression	SEN:10038986	12150994
BEL:20082576	p(HGNC:TGFB1) increases p(HGNC:ACTA2)	TGF-?1 induced a marked up-regulation of mesenchymal markers ?-SMA and vimentin and down-regulation of the epithelial marker E-cadherin in WT AECs, which was evident after 48 hours. 	SEN:10037582	22095546
BEL:20082578	p(HGNC:TGFB1) increases p(HGNC:ACTA2)	TGF1-induced increase in -smooth muscle actin expression in fibroblasts was completely abolished by Smad7 overexpression,	SEN:10038992	18353785
BEL:20082580	p(HGNC:TGFB1) increases p(HGNC:ACTA2)	TGF-beta1-mediated phenotypic modulation of 10T1/2 mesenchymal cells to SMCs characterized by the expression of SMC-specific markers, including smooth muscle alpha-actin (SMalpha-actin), myosin heavy chain (SM-MHC), and protein 22-alpha (SM22alpha)....Fig. 1. TGF-?1 induces protein (A) and mRNA (B) expressions of SM?-actin and SM-MHC in 10T1/2 cells in a time-dependent manner.	SEN:10038994	16310342
BEL:20082590	p(HGNC:TGFB1) increases p(HGNC:EIF4EBP1,pmod(P,T,37))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082592	p(HGNC:TGFB1) increases p(HGNC:EIF4EBP1,pmod(P,T,46))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082594	p(HGNC:TGFB1) increases p(HGNC:ELN)	In the absence of TGF--neutralizing antibody, tropoelastin protein levels were upregulated by TGF-1 but downregulated by EGF.	SEN:10038998	18441095
BEL:20082596	p(HGNC:TGFB1) increases p(HGNC:FN1)	FN expression induced by TGF1 was enhanced in the presence of echistatin	SEN:10039000	18353785
BEL:20082606	p(HGNC:TGFB1) increases p(HGNC:FOS)	Stimulation of healthy fibroblasts with TGF increased mRNA and protein levels of c-Jun (E and G) and c-Fos (F and H) in a time-dependent manner	SEN:10039008	22139817
BEL:20082612	p(HGNC:TGFB1) increases p(HGNC:ITGB3)	As can be seen in Fig. 1A, 3 protein levels significantly increased after 24 h of exposure to TGF1 at a concentration of 10 ng/ml	SEN:10039012	18353785
BEL:20082616	p(HGNC:TGFB1) increases p(HGNC:JUN)	Stimulation of healthy fibroblasts with TGF increased mRNA and protein levels of c-Jun (E and G) and c-Fos (F and H) in a time-dependent manner	SEN:10039008	22139817
BEL:20082618	p(HGNC:TGFB1) increases p(HGNC:MMP12)	The former studies demonstrate that TGF-1 and bleomycin are potent stimulators of the propeptide and mature forms of MMP-12 (Fig. 10,Aand B).	SEN:10015486	17209037
BEL:20082620	p(HGNC:TGFB1) increases p(HGNC:RB1,pmod(P,S,780))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082622	p(HGNC:TGFB1) increases p(HGNC:RB1,pmod(P,S,807))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082624	p(HGNC:TGFB1) increases p(HGNC:RB1,pmod(P,S,811))	TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4	SEN:10038836	17369289
BEL:20082628	p(HGNC:TGFB1) increases p(HGNC:TGFBR1,pmod(P))	As a control, we monitored phosphorylation of transfected TbetaRI, and observed phosphorylation of the receptor upon treatment of cells with TGFbeta1, as expected (Figure 6C, second from the top panel).	SEN:10039014	17203972
BEL:20082636	p(HGNC:TGFB1) increases p(HGNC:VEGFA)	The TGF-beta inhibits in vitro proliferation of endothelial cells inducing their apoptosis but stimulates in vivo angiogenesis [176]. TGF-beta also stimulates VEGF expression in fibroblasts, especially under conditions of hypoxia that often occurs in tumors or in tissue ischemia caused by disorders in the main blood flow [177].	SEN:10039018	11841347
BEL:20082640	p(HGNC:TGFB1) increases p(HGNC:VIM)	TGF-?1 induced a marked up-regulation of mesenchymal markers ?-SMA and vimentin and down-regulation of the epithelial marker E-cadherin in WT AECs, which was evident after 48 hours. 	SEN:10037582	22095546
BEL:20082644	p(HGNC:TGFB1) increases p(HGNC:VIM)	the spindle-like phenotype induced by TGF treatment (Fig. 1 A, inset) persisted after factor removal (Fig. 1 B, inset) and involved loss of E-cadherin/4-integrin, whereas vimentin was strongly induced	SEN:10031150	11790801
BEL:20082664	p(HGNC:TGFB1) increases tscript(p(HGNC:CTNNB1))	TGF-beta1 stimulated beta-catenin activation in tubular epithelial cells and ectopic expression of beta-catenin induced PAI-1 expression, whereas inhibition of beta-catenin abolished its induction.	SEN:10039034	20519507
BEL:20082666	p(HGNC:TGFB1) increases tscript(p(HGNC:FOXO1))	Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.	SEN:10031236	20439537
BEL:20082668	p(HGNC:TGFB1) increases tscript(p(HGNC:FOXO3))	Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.	SEN:10031236	20439537
BEL:20082672	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	By RT-PCR we have shown that TGFbeta up-regulates expression not only of plasminogen activator inhibitor type-1 (PAI-1), but also of the urokinase-type plasminogen activator receptor (uPAR), whose inhibition by specific antibodies blunted the TGFbeta angiogenic response in vitro. The SMAD2/3 and FAK signaling pathways were activated by TGFbeta in MVEC	SEN:10039038	19041849
BEL:20082674	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	FIGURE 11. TGF-beta1 induces activation of Smad2/3 pathway in AML12 cell line	SEN:10039040	17513865
BEL:20082676	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	In our previous studies we have shown that both Smad2 and p38 MAPK were activated in human lung fibroblasts within 10 min of TGF1 stimulation, and peak activation was reached at 1 h (19).	SEN:10039042	18353785
BEL:20082678	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.	SEN:10039044	20548029
BEL:20082686	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))	The changes in glucocorticoid binding were associated with identical changes in GR protein and mRNA levels Functional inactivation of Smad 2/3 and AP-1 limited the response to TGF-beta 1, indicating a role for these transcription factors TGF-beta 1 increases glucocorticoid binding and signaling in inflammatory cells through a Smad 2/3- and AP-1-mediated process	SEN:10039030	12753290
BEL:20082690	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	By RT-PCR we have shown that TGFbeta up-regulates expression not only of plasminogen activator inhibitor type-1 (PAI-1), but also of the urokinase-type plasminogen activator receptor (uPAR), whose inhibition by specific antibodies blunted the TGFbeta angiogenic response in vitro. The SMAD2/3 and FAK signaling pathways were activated by TGFbeta in MVEC	SEN:10039038	19041849
BEL:20082692	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	FIGURE 9. TGF-beta1 induces snail-1 in hepatocytes in EMT state and lack of evidence for Akt/Erk1/2 activation	SEN:10031240	17513865
BEL:20082696	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.	SEN:10039044	20548029
BEL:20082700	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	Second, silencing of SMAD protein levels using short interfering RNAs revealed that TGFbeta-induced activation of the endogenous gadd45beta gene required SMAD3 and SMAD4 but not SMAD2	SEN:10039052	14630914
BEL:20082708	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	The changes in glucocorticoid binding were associated with identical changes in GR protein and mRNA levels Functional inactivation of Smad 2/3 and AP-1 limited the response to TGF-beta 1, indicating a role for these transcription factors TGF-beta 1 increases glucocorticoid binding and signaling in inflammatory cells through a Smad 2/3- and AP-1-mediated process	SEN:10039030	12753290
BEL:20082710	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	The expression of JunD colocalised with pSmad 3 in fibrotic skin and silencing of Smad 3 or Smad 4 by siRNA prevented the induction of JunD by TGFbeta......The expression of JunD was analysed by real-time PCR, immunofluorescence, western blotting and immunohistochemistry. 	SEN:10039056	21515915
BEL:20082714	p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))	Wnt and TGF-B pathways cooperate to suppress colon 125 and pancreatic 126 tumorigenesis through several direct interactions between these pathways: Axin, a negative regulator of the Wnt pathway, activates TGF-B signaling through binding Smad3	SEN:10039058	15774796
BEL:20082716	p(HGNC:TGFB1) increases tscript(p(HGNC:SRF))	 LY294002 and the Akt-specific siRNA inhibited the TGF-beta1-induced SM22alpha gene expression and promoter activity, suggesting that the TGF-beta1-induced gene expression was mediated by PI3K/Akt at the transcriptional level. (5) LY294002 inhibited the TGF-beta1-induced gene expression and DNA binding activity of serum response factor (SRF).	SEN:10039060	16310342
BEL:20082728	p(HGNC:TGFBR3) decreases tscript(p(HGNC:SMAD2))	WtTGFbetaRIII inhibited phosphorylation of Smad 2 and 3 (Fig. 3A) as well as Akt and ERK by TGF-beta (Fig. 3B).	SEN:10031258	20359848
BEL:20082730	p(HGNC:TGFBR3) decreases tscript(p(HGNC:SMAD3))	WtTGFbetaRIII inhibited phosphorylation of Smad 2 and 3 (Fig. 3A) as well as Akt and ERK by TGF-beta (Fig. 3B).	SEN:10031258	20359848
BEL:20082732	p(HGNC:TGIF1) decreases p(HGNC:ELN)	cells that overexpress human TGIF (hTGIF) wild-type (hTGIF WT) or hTGIF mutant (hTGIF 1-148:177- 262), which is devoid of the Smad interaction domain and is not able to interact with Smad2/3 (35). As shown in Fig. 4D, tropoelastin expression was inhibited by overexpression of hTGIF WT in a dose-dependent manner	SEN:10039062	18441095
BEL:20082746	p(HGNC:THPO) directlyIncreases cat(p(HGNC:MPL))	TPO functions through binding its receptor, c-Mpl, to activate JAK2, STAT1, STAT3, and STAT5 in megakaryocytes and other hematopoietic cells (10–12).	SEN:10039068	18060035
BEL:20082752	p(HGNC:TIAM1) increases gtp(p(HGNC:RAC1))	Expression of CA-PI3K caused a significant increase in membrane-associated Tiam1 (Fig. 5B), whereas expression of DN-PI3K caused increased cytosolic Tiam1 (Fig. 5A). CS did not affect the distribution of Tiam1 when either CA-PI3K or DN-PI3K was expressed. We also found that treatment with the Tiam1 inhibitor NSC23766 caused increased cytosolic localization of Tiam1, decreased Rac1 activity, and decreased cell migration	SEN:10039070	20018857
BEL:20082758	p(HGNC:TIMP1) decreases bp(GOBP:"cell migration")	TIMPs 1-4 all reduced ASM migration, with TIMP-4 being the most potent, resulting in a 50% reduction in migration (Fig. 7C). 	SEN:10039074	17189319
BEL:20082772	p(HGNC:TIMP3) decreases bp(GOBP:"cell migration")	TIMPs 1-4 all reduced ASM migration, with TIMP-4 being the most potent, resulting in a 50% reduction in migration (Fig. 7C). 	SEN:10039074	17189319
BEL:20082774	p(HGNC:TIMP4) decreases cat(p(HGNC:MMP2))	Here, we establish that Timp4-/- mice are specifically predisposed to LV rupture after MI, which is prevented by MMPi-treatment or the loss of Mmp2. 	SEN:10039080	20516072
BEL:20082782	p(HGNC:TLR4) decreases bp(GOBP:"response to oxidative stress")	In the mouse, TLR4 has a role for maintaining normal lung architecture by inhibiting oxidant stress.	SEN:10031334	22983353
BEL:20082784	p(HGNC:TLR4) decreases path(MESHD:Emphysema)	Furthermore, TLR4 deficiency has been shown to cause age-related pulmonary emphysema by increased oxidant stress and cell death in aged mice, in the absence of smoking	SEN:10031344	17615396
BEL:20082786	p(HGNC:TLR4) decreases p(HGNC:CASP3)	The basal and CSE-inducible expression of LC3B and cleaved caspase-3 were elevated in pulmonary alveolar type II (ATII) cells from Tlr4-deficient mice...These findings suggest that TLR exerts an inhibitory effect on the expression of the autophagic protein LC3B, and also on the apoptotic response to CSE	SEN:10031338	22983353
BEL:20082788	p(HGNC:TLR4) decreases p(HGNC:CASP3)	The Tlr4-mutated or Tlr4-deficient mice showed higher levels of LC3B under basal conditions and after CS exposure. The expression of cleaved caspase-3 was markedly increased in Tlr4-deficient mice exposed to CS. We describe a protective regulatory function of TLR4 against emphysematous changes of the lung in response to CS	SEN:10031348	22983353
BEL:20082790	p(HGNC:TLR4) decreases p(HGNC:MAP1LC3B)	The basal and CSE-inducible expression of LC3B and cleaved caspase-3 were elevated in pulmonary alveolar type II (ATII) cells from Tlr4-deficient mice...These findings suggest that TLR exerts an inhibitory effect on the expression of the autophagic protein LC3B, and also on the apoptotic response to CSE	SEN:10031338	22983353
BEL:20082792	p(HGNC:TLR4) decreases p(HGNC:MAP1LC3B)	The Tlr4-mutated or Tlr4-deficient mice showed higher levels of LC3B under basal conditions and after CS exposure. The expression of cleaved caspase-3 was markedly increased in Tlr4-deficient mice exposed to CS. We describe a protective regulatory function of TLR4 against emphysematous changes of the lung in response to CS	SEN:10031348	22983353
BEL:20082808	p(HGNC:TNF) directlyIncreases cat(p(HGNC:TNFRSF1A))	Fig. 4. Both cIAP1 and 2 are recruited to TNF-R1 upon TNFa treatment and are required for Rip1 polyubiquitination.	SEN:10031434	18697935
BEL:20082832	p(HGNC:TNF) increases bp(GOBP:"endothelial cell activation")	We further found that IL-17-mediated endothelial activation was as strong as that of TNF-a and the b form of pro-IL-1	SEN:10039098	20228195
BEL:20082834	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	Here we demonstrate that \"LDL(-)\" increases TNFa-induced inflammatory responses through NFkappaB and AP-1 activation, with corresponding increases in endothelial vascular adhesion molecule-1 (VCAM1) expression. LDL receptor overexpression increases these effects.	SEN:10031408	12878589
BEL:20082836	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	Levels of TNF?, a central mediator of inflammation in DSS colitis (Kojouharoff et al., 1997), were elevated in DSS treated XBP1?/? vs XBP1+/+ colonic tissues with intermediate TNF? expression in XBP1+/? mice (Fig. 5E).	SEN:10017728	18775308
BEL:20082840	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	Senescent lymphocytes also produce increased amounts of proinflammatory cytokines, such as tumor necrosis factor , which may contribute to the inflammatory atherosclerotic process.79,80	SEN:10039102	18155543
BEL:20082842	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	Several pro-inflammatory mediators up-regulate SAA transcription, including Il1, Il6, TNFalpha, and Lif.	SEN:10028334	11798191
BEL:20082848	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	The harmful effects of pro-inflammatory cytokines such as TNF?? and IFN??, on the vascular pathophysiology characteristic of atherosclerosis, interventional restenosis, and transplant vasculopathy have been the subject of intense study, and the subject of several excellent reviews [10-12].	SEN:10039106	19601851
BEL:20082852	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	Transgenic overexpression of TNF-{alpha} led to emphysema and exaggerated alveolar inflammation (82)	SEN:10031410	17615396
BEL:20082854	p(HGNC:TNF) increases bp(GOBP:"inflammatory response")	We recently showed that mice lacking tumor necrosis factor- (TNF-) receptors do not develop smoke-induced inflammation,	SEN:10031406	12522030
BEL:20082856	p(HGNC:TNF) increases bp(GOBP:"neutrophil activation")	Human neutrophils activated by various stimuli -TNF-alpha , IFN-gamma, bacteria, or bacterial-derived products (LPS, fMLP)-, release a large pattern of chemotactic factors including CCL19 and CCL20 chemokines (33, 40-42) and beta- defensins	SEN:10039108	19273148
BEL:20082858	p(HGNC:TNF) increases cat(p(HGNC:NOX1))	NOX1 is activated within minutes of the administration of TNF, and it is possible that NOX1?generated ROS trigger or sustain the subsequent production of ROS by the mitochondrial respiratory chain92	SEN:10039110	20823910
BEL:20082898	p(HGNC:TNF) increases p(HGNC:BNIP3)	Consistent with the RT-PCR data, protein levels increased approximately 4.5-fold (dimer) and 2.7-fold (monomer) compared with levels observed in control cells after 48 h of TNF treatment (Fig. 2b, left panel). Representative blots are shown in the right panel. However, neither mRNA nor protein levels of HIF-1?, a key transcriptional regulator of BNip3 in response to hypoxia, were significantly altered (Fig. 2c).	SEN:10039136	20963496
BEL:20082906	p(HGNC:TNF) increases p(HGNC:CCL5)	Similar levels of RANTES and MCP-1 release were induced by IL-1 and TNF treatments. However, the induction of IL-6, IL-8, and GMCSF by TNF was 50 to 80% lower than for IL-1, whereas TNF-induced GRO was some 35- to 40-fold lower than that for IL-1. In all instances, preincubation with PS-1145 or ML120B resulted in a significant attenuation of cytokine release (Fig. 6).	SEN:10039144	17322026
BEL:20082910	p(HGNC:TNF) increases p(HGNC:CXCL10)	the CXC chemokines Mig and interferon-? inducible protein 10 can be expressed and bound by endothelium stimulated with interferon-? and tumor necrosis factor (TNF) ?, and can induce the firm adhesion of T lymphocyte in shear flow via CXCR3.	SEN:10038348	12545245
BEL:20082916	p(HGNC:TNF) increases p(HGNC:IL6)	from full text - TNF-alpha exerts its pro-inflammatory effects through increased production of IL-1beta and IL-6, expression of adhesion molecules, proliferation of fibroblasts and procoagulant factors, as well as initiation of cytotoxic, apoptotic, acute-phase responses, and inhibition of apoptosis [8,9].	SEN:10039148	18666314
BEL:20082922	p(HGNC:TNF) increases p(HGNC:IL6)	Thus, IL-6 release was substantially increased by both IL-1 and to a lesser extent by TNF. In each case, prior infection with the null adenovirus showed no significant effect, whereas dominant IBN reduced IL-6 release to near-background levels. Likewise, the dominant-negative IKK2 adenovirus prevented IL-6 release	SEN:10038418	17322026
BEL:20082924	p(HGNC:TNF) increases p(HGNC:IL6)	TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts 	SEN:10039152	10362713
BEL:20082926	p(HGNC:TNF) increases p(HGNC:IL6)	TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).   	SEN:10039154	10362713
BEL:20082928	p(HGNC:TNF) increases p(HGNC:MMP12)	overexpression of TNF produced an increase in neutrophils, parenchymal B cell nodules, MMP-12, cathepsin K, and emphysema in the absence of smoke (176).	SEN:10031472	18223159
BEL:20082932	p(HGNC:TNF) increases p(HGNC:MMP14)	 The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9	SEN:10039158	11773040
BEL:20082938	p(HGNC:TNF) increases p(HGNC:MMP9)	The capacity of TNF to induce MMP expression in chondrocytes was not altered by the deficiency of c-fos, since MMP-3, MMP-9, and MMP-13 were similarly induced in hTNFtg and c-fos-/-hTNFtg mice (Table 3).	SEN:10031492	12438440
BEL:20082940	p(HGNC:TNF) increases p(HGNC:MMP9)	 The role of TNFalpha in stimulating retinal microvascular endothelial cell (RMVEC) proteinase production was evaluated using isolated murine RMVECs...TNFalpha increased the expression (production) of MT1-MMP, MMP-3, and MMP-9	SEN:10039158	11773040
BEL:20082944	p(HGNC:TNF) increases p(HGNC:MMP9)	Whereas TNF-? and other cytokines up-regulate MMP-9 expression, interferons (IFNs) inhibit MMP-9 expression. We found that IFN-? treatment or forced expression of the IFN-induced GTPase, mGBP-2, inhibit TNF-?-induced MMP-9 expression in NIH 3T3 fibroblasts, by inhibiting MMP-9 transcription. The NF-?B transcription factor is required for full induction of MMP-9 by TNF-?. 	SEN:10039164	21502320
BEL:20082948	p(HGNC:TNF) increases p(HGNC:MUC5AC)	Exogenous hydrogen peroxide and neutrophils activated by IL-8, FMLP, or TNF-alpha increased EGFR tyrosine phosphorylation and subsequent activation of p44/42mapk and up-regulated the expression of MUC5AC at both mRNA and protein levels in NCI-H292 cells. These effects were blocked by selective EGFR tyrosine kinase inhibitors (AG1478, BIBX1522) and by a selective MEK inhibitor (PD98059)	SEN:10039166	10640773
BEL:20082950	p(HGNC:TNF) increases p(HGNC:SELE)	HUVECs were exposed to 2 ng/mLTNF-a for 5 hours or left untreated. This early time point was chosen to minimize indirect autocrine or paracrine effects. Efficacy of endothelial activation was controlled by flow cytometric analysis of E-selectin and ICAM-1 expression (Figure 1).	SEN:10039168	14715628
BEL:20082952	p(HGNC:TNF) increases p(HGNC:SELE)	In primary cultures of HUVEC, TNF? induced a strong activation of the expression of endothelial adhesion proteins that include E-selectin and ICAM (Fig.1, A—D, and data not shown).	SEN:10039170	11448946
BEL:20082958	p(HGNC:TNF) increases p(HGNC:SELE)	TNF-alpha-induced secretion of cytokines such as IL-1beta and IL-8, as well as the expression of adhesion molecules such as ICAM-1, VCAM-1 and E-selction in HUVECs.	SEN:10039176	19634686
BEL:20082966	p(HGNC:TNF) increases p(HGNC:TNFRSF10A)	TNF increased the expression of TRAIL-R1 and TRAILR2 proteins in A549 cells (Figure 6).	SEN:10039178	18511705
BEL:20082970	p(HGNC:TNF) increases p(HGNC:TNFRSF10B)	TNF increased the expression of TRAIL-R1 and TRAILR2 proteins in A549 cells (Figure 6).	SEN:10039178	18511705
BEL:20082982	p(HGNC:TNF) increases p(HGNC:VCAM1)	Intratracheal instillation of TNF-? elicited a rapid increase in VCAM-1 expression within lung tissue	SEN:10031504	15489375
BEL:20082984	p(HGNC:TNF) increases p(HGNC:VCAM1)	Levels of VCAM-1 in STAT-6-deficient MLF were somewhat reduced compared with those observed in wt MLF, however, the ability of mOSM or mTNF-{alpha} to induce VCAM-1 was maintained (Fig. 7B). 	SEN:10039184	16547273
BEL:20082986	p(HGNC:TNF) increases p(HGNC:VCAM1)	Members of the immunoglobulin superfamily mediate heterophilic cell-cell adhesion. Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are expressed on quiescent endothelium, but are upregulated after stimulation with TNF-a, IL-1 or interferon-g (IFN-g) (24).	SEN:10039186	11172729
BEL:20082990	p(HGNC:TNF) increases p(HGNC:VCAM1)	TNF-alpha-induced secretion of cytokines such as IL-1beta and IL-8, as well as the expression of adhesion molecules such as ICAM-1, VCAM-1 and E-selction in HUVECs.	SEN:10039176	19634686
BEL:20082992	p(HGNC:TNF) increases p(HGNC:VCAM1)	TNF- stimulated the monocyte adhesion (Fig. 11C), which was associated with VCAM-1 expression (Fig. 11B).	SEN:10031462	18981156
BEL:20083002	p(HGNC:TNF) increases p(HGNC:VEGFA)	VEGF production induced by IL-1beta, TNF-alpha, and TGF-beta was further increased when CD40L+ L cells were coincubated, by factors of 5.9, 5.5, and 9.6, respectively, which indicated that these cytokines had an additive effect on VEGF production driven by CD40L.	SEN:10023540	10799861
BEL:20083102	p(HGNC:TNF) increases tscript(p(HGNC:JUN))	The -318 TRE mediates c-Jun-dependent, TNF-alpha-inducible FRA-1 promoter activity.....Consistent with this result, ectopic expression of a c-Jun mutant lacking the transactivation domain greatly reduced (~80%) TNF-alpha-stimulated promoter activity (Fig. 2B)....However, TNF-a induced the binding of c-Jun to the promoter as early as 30 min (Fig. 3A, lane 2), and it remained high through 60 min (Fig. 3A, lane 3).	SEN:10039256	17082637
BEL:20083122	p(HGNC:TNFSF10) increases cat(p(HGNC:TNFRSF10A))	The chemotherapeutic drugs (paclitaxel, vincristine, vinblastine, etoposide, camptothecin, and Adriamycin) induced death receptors (DRs) TRAIL receptor 1/DR4 and TRAIL receptor 2/DR5, and successive treatment with TRAIL resulted in apoptosis of both TRAIL-sensitive and -resistant cells.	SEN:10039270	14500373
BEL:20083124	p(HGNC:TNFSF10) increases cat(p(HGNC:TNFRSF10A))	TRAIL binds to five cognate cell surface receptors, but only two of these receptors TRAIL-R1 and TRAIL-R2	SEN:10039272	18437894
BEL:20083130	p(HGNC:TNFSF10) increases cat(p(HGNC:TNFRSF10B))	The chemotherapeutic drugs (paclitaxel, vincristine, vinblastine, etoposide, camptothecin, and Adriamycin) induced death receptors (DRs) TRAIL receptor 1/DR4 and TRAIL receptor 2/DR5, and successive treatment with TRAIL resulted in apoptosis of both TRAIL-sensitive and -resistant cells.	SEN:10039270	14500373
BEL:20083132	p(HGNC:TNFSF10) increases cat(p(HGNC:TNFRSF10B))	TRAIL binds to five cognate cell surface receptors, but only two of these receptors TRAIL-R1 and TRAIL-R2	SEN:10039272	18437894
BEL:20083142	p(HGNC:TOPBP1) directlyIncreases kin(p(HGNC:ATR))	We show that recombinant TopBP1 induces a large increase in the kinase activity of both Xenopus and human ATR	SEN:10039276	16530042
BEL:20083146	p(HGNC:TP53BP2) directlyIncreases tscript(p(HGNC:TP73))	Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.	SEN:10039278	16530485
BEL:20083194	p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))	TP53INP1 mediates phosphorylation of p53 on serine 46 (S46). ASPP-1 and ASPP-2 modulate the cellular apoptotic threshold by direct interaction with p53, thereby enhancing the DNA binding and trans-activation function of p53 on the promoters of pro-apoptotic genes in vivo	SEN:10039282	16530485
BEL:20083200	p(HGNC:TP73,pmod(P,S,47)) directlyIncreases tscript(p(HGNC:TP73))	Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha. 	SEN:10036736	14585975
BEL:20083218	p(HGNC:TSC2,pmod(P,S,939)) directlyDecreases cat(p(HGNC:TSC2))	Figure 4. S939 and T1462 Are the Major PI3K-Dependent Phosphorylation Sites on Tuberin	SEN:10036630	12150915
BEL:20083226	p(HGNC:TSC2,pmod(P,T,1462)) directlyDecreases cat(complex(p(HGNC:TSC1),p(HGNC:TSC2)))	Akt then phosphorylates tuberin on three residues (S939, S1130 and T1462 of full length human tuberin), and this inhibits the tuberin-hamartin complex through an as-yet-undefined mechanism (reviewed in [8]).	SEN:10036628	14607085
BEL:20083232	p(HGNC:TSLP) directlyIncreases cat(p(HGNC:CRLF2))	Combined deletion of IL-7 and TSLP receptor greatly reduced Treg cell development in the thymus but was not required for survival of mature peripheral Treg cells.	SEN:10038568	18664628
BEL:20083264	p(HGNC:UVRAG) increases complex(p(HGNC:PIK3C3),p(HGNC:BECN1))	Ultraviolet irradiation resistance-associated gene (UVRAG), a positive regulator of the Beclin 1-PI3K complex, promotes autophagy in a manner that is interdependent with Beclin 1.	SEN:10039298	21709535
BEL:20083286	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:FLT1))	from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)	SEN:10039306	16835467
BEL:20083290	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:FLT1))	VEGF actions are mediated through binding to 2 receptor tyrosine kinases, VEGFR1 (FLT1) and VEGFR2 (KDR)	SEN:10039310	15178810
BEL:20083292	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:FLT1))	VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).	SEN:10039312	11172729
BEL:20083296	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:KDR))	as well as VEGFA, other VEGF-family members are produced by human tumors, including VEGFC and VEGFD, which both bind to VEGFR2 and activate many of the same pathways as VEGFA	SEN:10039316	12778130
BEL:20083298	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:KDR))	from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)	SEN:10039306	16835467
BEL:20083306	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:KDR))	VEGF actions are mediated through binding to 2 receptor tyrosine kinases, VEGFR1 (FLT1) and VEGFR2 (KDR)	SEN:10039310	15178810
BEL:20083308	p(HGNC:VEGFA) directlyIncreases kin(p(HGNC:KDR))	VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).	SEN:10039312	11172729
BEL:20083312	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	activators of endothelial-cell proliferation and migration are mainly receptor tyrosine kinase ligands, such as VEGF, FGFs, PDGF and EGF, but can also be of very different origin, such as lysophosphatidic acid	SEN:10039322	12778130
BEL:20083322	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	HIF1A-activated genes include VEGF, which promotes angiogenesis; GLUT1, which activates glucose transport; LDH-A, which is involved in the glycolytic pathway; and EPO, which induces erythropoiesis	SEN:10039328	11902584
BEL:20083324	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	In an ex vivo rat aortic ring model, platelet-derived VEGF, bFGF, and PDGF promote sprouting of new blood vessels.184 	SEN:10039330	19450911
BEL:20083328	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	It was shown that the soluble uPAR or uPA-neutralizing antibody nearly completely suppressed the formation of capillary-like tubes in a fibrin matrix [166]. Moreover, an antibody that blocked the binding of uPA to uPAR suppressed bFGF- and VEGF-induced tube formation in fibrin matrix, despite the fact that sufficient uPA was present in the conditioned medium around the cells.	SEN:10039334	11841347
BEL:20083336	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	linomide inhibits angiogenesis induction by various pro-angiogenic factors, such as VEGF, FGF and TNFalpha	SEN:10039342	12778130
BEL:20083340	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	Neovascularization also plays a critical role in successful wound healing that is probably regulated by IL-8 and the growth factors FGF-2 (177) and VEGF (170). Macrophages, known cellular components of the accompanying inflammatory response, may contribute to the healing process by releasing these angiogenic factors (228).	SEN:10039346	11172729
BEL:20083346	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	Proliferating cells express VEGF, which stimulates angiogenesis to provide the additional perfusion that is required to maintain oxygenation of an increased number of cells. In addition, proliferating cells preferentially use GLYCOLYTIC rather than OXIDATIVE METABOLISM to generate ATP. The concomitant induction of angiogenesis and glycolysis with cell proliferation is mediated partly by activating HIF-1	SEN:10039352	13130303
BEL:20083350	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	Table 1. Production of pro- and anti-angiogenic mediators by DCs Pro-angiogenic mediators: VEGF, FGF2, TNF-a, IL-6, TGF-b, CXCL8, CXCL5, CXCL1, 2, 3, CCL2, GM-CSF, ET-1, OPN,  Anti-angiogenic mediators: IL-12, IL-18, IL-10, TSP-1, PTX3, IFN-a/b, CXCL9, CXCL10, CXCL13, CCL21	SEN:10037970	17692569
BEL:20083352	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Seven days after transplantation of the A375-GFP, capillary nets became far more abundant in the tumors grown in WT mice than those in TNKO mice. Interestingly, VEGF and TN-C expressions showed antithetical expression patterns between the tumors in WT mice and those in TNKO mice.	SEN:10031380	14618612
BEL:20083354	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	TGF-B induces the expression of vascular endothelial growth factor, which then directly promotes angiogenesis.102	SEN:10039356	15774796
BEL:20083360	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	tumor-expressed VEGF is particularly attractive as a target for anticancer therapy because its angiogenesis-promoting activity is at the level of the endothelial cell and, compared with agents that directly target tumor cells, tumor penetration is less critical for VEGF inhibitors	SEN:10039362	15178810
BEL:20083362	p(HGNC:VEGFA) increases bp(GOBP:angiogenesis)	VEGF is a pro-angiogenic molecule that promotes angiogenesis in many tumors. Thus, it is possible that the decrease of vascularity observed with increased expression of RKIP may be due to a modulation of VEGF expression	SEN:10039364	12813171
BEL:20083380	p(HGNC:VEGFA) increases bp(GOBP:"regulation of vascular permeability")	In vitro, VEGF stimulates ECM degradation, proliferation, migration and tube formation of endothelial cells and induces in these cells the expression of uPA, PAI-1, uPAR and MMP-1 (148, 182, 183, 243). In vivo, VEGF has been shown to regulate vascular permeability, which is considered important for the initiation of angiogenesis (57).	SEN:10039378	11172729
BEL:20083382	p(HGNC:VEGFA) increases bp(GOBP:"regulation of vascular permeability")	other actions of VEGF include increasing vascular permeability, inhibition of dendritic cell differentiation, upregulation of hexose transport into endothelial cells, induction of tissue factor, and induction of monocyte migration	SEN:10039380	15178810
BEL:20083390	p(HGNC:VEGFA) increases bp(GOBP:"regulation of vascular permeability")	VEGF/VPF and positive controls (platelet-activating factor [PAF], histamine, and bradykinin) all increased vascular permeability.	SEN:10034708	9443437
BEL:20083400	p(HGNC:VEGFA) increases p(HGNC:NOS3)	an important mechanism through which VEGF could induce prolonged NO production is increased expression of eNOS mRNA and protein the mechanism mediating VEGF-stimulated eNOS expression is unclear, but the effect appears to occur via activation of VEGFR2	SEN:10039394	11350732
BEL:20083406	p(HGNC:VEGFB) directlyIncreases kin(p(HGNC:FLT1))	from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)	SEN:10039306	16835467
BEL:20083410	p(HGNC:VEGFB) directlyIncreases kin(p(HGNC:FLT1))	PIGF and VEGFB bind with high affinity only to VEGFR1	SEN:10039400	11350732
BEL:20083414	p(HGNC:VEGFB) directlyIncreases kin(p(HGNC:FLT1))	VEGF-B and PIGF binding and activating only VEGFR1	SEN:10039402	15178810
BEL:20083416	p(HGNC:VEGFB) directlyIncreases kin(p(HGNC:FLT1))	VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).	SEN:10039312	11172729
BEL:20083418	p(HGNC:VEGFC) directlyIncreases kin(p(HGNC:FLT4))	from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)	SEN:10039306	16835467
BEL:20083422	p(HGNC:VEGFC) directlyIncreases kin(p(HGNC:FLT4))	VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).	SEN:10039312	11172729
BEL:20083424	p(HGNC:VEGFC) directlyIncreases kin(p(HGNC:KDR))	as well as VEGFA, other VEGF-family members are produced by human tumors, including VEGFC and VEGFD, which both bind to VEGFR2 and activate many of the same pathways as VEGFA	SEN:10039316	12778130
BEL:20083426	p(HGNC:VEGFC) directlyIncreases kin(p(HGNC:KDR))	from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)	SEN:10039306	16835467
BEL:20083430	p(HGNC:VEGFC) directlyIncreases kin(p(HGNC:KDR))	VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).	SEN:10039312	11172729
BEL:20083432	p(HGNC:VHL) directlyIncreases deg(p(HGNC:HIF3A))	Under normoxia, HIFs are targeted for proteasomal degradation by the von Hippel–Lindau (VHL) tumor suppressor, pVHL. It has been shown that pVHL is the substrate recognition component of an E3 ubiquitin ligase complex that interacts with HIF-a in an oxygen-dependent manner.	SEN:10036246	18259193
BEL:20083436	p(HGNC:VHL) increases deg(p(HGNC:EPAS1))	Under normoxia, HIFs are targeted for proteasomal degradation by the von Hippel–Lindau (VHL) tumor suppressor, pVHL. It has been shown that pVHL is the substrate recognition component of an E3 ubiquitin ligase complex that interacts with HIF-a in an oxygen-dependent manner.	SEN:10036246	18259193
BEL:20083442	p(HGNC:VHL) increases deg(p(HGNC:HIF1A))	this interaction causes HIF1A to become ubiquitylated and targeted to the proteasome, where it is degraded	SEN:10036274	11902584
BEL:20083446	p(HGNC:VHL) increases deg(p(HGNC:HIF1A))	Under normoxia, HIFs are targeted for proteasomal degradation by the von Hippel–Lindau (VHL) tumor suppressor, pVHL. It has been shown that pVHL is the substrate recognition component of an E3 ubiquitin ligase complex that interacts with HIF-a in an oxygen-dependent manner.	SEN:10036246	18259193
BEL:20083450	p(HGNC:VIP) directlyIncreases cat(p(HGNC:VIPR1))	The PAC1 receptor is more selective for PACAP while the VPAC1 and VPAC2 receptors can be potently activated by VIP or PACAP .	SEN:10039406	16483357
BEL:20083454	p(HGNC:VIP) directlyIncreases cat(p(HGNC:VIPR2))	The PAC1 receptor is more selective for PACAP while the VPAC1 and VPAC2 receptors can be potently activated by VIP or PACAP .	SEN:10039406	16483357
BEL:20083460	p(HGNC:WEE1,pmod(P,S,642)) directlyIncreases complex(p(HGNC:YWHAQ),p(HGNC:WEE1))	Serine-642 was identified as an Akt-dependent phosphorylation site. WEE1Hu kinase activity was not affected by serine-642 phosphorylation. We revealed that serine-642 phosphorylation promoted cytoplasmic localization of WEE1Hu. The nuclear-to-cytoplasmic translocation was mediated by phosphorylation-dependent WEE1Hu binding to 14-3-3theta but not 14-3-3beta or -sigma preventing Y15 phosphorylation of Cdc2 by WEE1. 	SEN:10036122	15964826
BEL:20083486	p(HGNC:WNT1) increases p(HGNC:ACTA2)	Incubation of resting fibroblasts with Wnt-1 increased the levels of ?-smooth muscle actin (?SMA) protein and mRNA (Fig. 3c and d) and induced the formation of stress fibres (Fig. 3e), demonstrating increased differentiation of resting fibroblasts into myofibroblasts. 	SEN:10039416	22415826
BEL:20083498	p(HGNC:WNT3A) increases p(HGNC:CTNNB1)	 MM cell lines responded to the Wnt ligand Wnt3A, the GSK3beta-inhibitor lithium chloride, and an active mutant form of beta-catenin with both significantly increased proliferation and higher levels of nonphosphorylated nuclear beta-catenin.	SEN:10039422	17452641
BEL:20083504	p(HGNC:WNT5B) increases cat(p(HGNC:FZD6))	WNT5A, WNT5B, and WNT11 are representative non-canonical WNTs transducing PCP signals through FZD3 or FZD6 receptors, and ROR1, ROR2 or PTK7 co-receptors.	SEN:10039428	16273260
BEL:20083514	p(HGNC:WWOX) directlyDecreases tscript(p(HGNC:TP73))	We recently showed that WWOX interacts with p73 and AP-2gamma and suppresses their transcriptional activity. 	SEN:10039434	16061658
BEL:20083516	p(HGNC:XIAP) decreases bp(GOBP:"apoptotic process")	Antisense-mediated reductions in IAP-family members XIAP, cIAP1, Survivin, or Apollon can induce apoptosis of tumor cell lines in culture, or sensitize cells to cytotoxic anticancer drugs, thus providing proof-of-concept evidence that the pathological elevations of IAPs found in cancers are important for maintaining tumor cell survival and resistance to chemotherapy (Table 1C).	SEN:10037750	12559172
BEL:20083520	p(HGNC:XIAP) decreases bp(GOBP:"apoptotic process")	from full text - XIAP, which binds the pool of survivin released from mitochondria in response to cell-death stimuli (59), resulting in increased XIAP stability against proteasomal degradation and inhibition of apoptosis in vivo (31)	SEN:10039436	18075512
BEL:20083524	p(HGNC:YAP1) directlyIncreases tscript(p(HGNC:TP73))	Yes-associated protein (YAP), also containing WW domains, was shown to associate with p73 and enhance its transcriptional activity.	SEN:10039438	16061658
BEL:20083552	phos(p(HGNC:PPP1R13B)) directlyIncreases tscript(p(HGNC:TP73))	Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.	SEN:10039278	16530485
BEL:20083594	phos(p(HGNC:PTPN11)) directlyDecreases p(HGNC:STAT1,pmod(P,Y,701))	Consistently, purified GST-SHP-2 dephosphorylated Stat1 at both tyrosine and serine residues when immunoprecipitated phospho-Stat1 or a peptide corresponding to the sequence surrounding Tyr(P)(701) or Ser(P)(727) of Stat1 was used as the substrate. 	SEN:10039476	12270932
BEL:20083598	phos(p(HGNC:PTPN12)) directlyDecreases p(HGNC:BCAR1)	Two cytoplasmic protein tyrosine phosphatases, PTP-PEST and PTP-1B, target p130CAS and may specifically inhibit some of the signals downstream of FAK (20).	SEN:10039480	10446041
BEL:20083600	phos(p(HGNC:PTPN1)) directlyDecreases p(HGNC:BCAR1)	Two cytoplasmic protein tyrosine phosphatases, PTP-PEST and PTP-1B, target p130CAS and may specifically inhibit some of the signals downstream of FAK (20).	SEN:10039480	10446041
BEL:20083604	phos(p(HGNC:PTPN6)) decreases kin(p(HGNC:KIT))	The protein tyrosine phosphatase SHP-1 interacts with Y570 of c-Kit and negatively regulates c-Kit signaling	SEN:10039484	15526160
BEL:20083920	r(HGNC:MIR15B) decreases p(HGNC:DCN)	We demonstrated that overexpression of miR-15b in a bronchial epithelial cell line reduced SMAD7, SMURF2 and downstream decorin protein. Conversely, knockdown of miR-15b resulted in increased SMAD7, decorin and SMURF2 proteins. Functionally, miR-15b manipulation altered early SMAD3 phosphorylation in response to TGFb treatment. 	SEN:10039528	21940491
BEL:20083922	r(HGNC:MIR15B) decreases p(HGNC:SMAD7)	We demonstrated that overexpression of miR-15b in a bronchial epithelial cell line reduced SMAD7, SMURF2 and downstream decorin protein. Conversely, knockdown of miR-15b resulted in increased SMAD7, decorin and SMURF2 proteins. Functionally, miR-15b manipulation altered early SMAD3 phosphorylation in response to TGFb treatment. 	SEN:10039528	21940491
BEL:20083924	r(HGNC:MIR15B) decreases p(HGNC:SMURF2)	We demonstrated that overexpression of miR-15b in a bronchial epithelial cell line reduced SMAD7, SMURF2 and downstream decorin protein. Conversely, knockdown of miR-15b resulted in increased SMAD7, decorin and SMURF2 proteins. Functionally, miR-15b manipulation altered early SMAD3 phosphorylation in response to TGFb treatment. 	SEN:10039528	21940491
BEL:20083934	r(HGNC:MIR29B1) decreases p(HGNC:COL1A1)	Native gel western blot analysis of protein samples from IMR-90 cells revealed that knocking down miR-29 resulted in a 3-fold increase of COL1A1 protein. In contrast, increased miR-29 by a mimic oligo (Dharmacan) resulted in a 5-fold reduction in COL1A1 protein level (Fig. 4C).	SEN:10039532	20971881
BEL:20084128	tport(p(HGNC:CFTR)) decreases a(CHEBI:glutathione)	glutathione levels decreased faster in cells expressing normal CFTR than in cells with defective CFTR during incubation with H(2)O(2).	SEN:10039616	12023951
BEL:20084350	tscript(p(HGNC:AHR)) increases a(CHEBI:"reactive oxygen species")	In our study, we found that AhR activation upregulates the expression of MUC5AC and mucin secretion in a NCIH292 cell line that was derived from a bronchiolar Clara cell [14] (Figure 1). Moreover, we concurrently showed that AhR activation induced ROS generation, and the antioxidant agent NAC inhibited B[a]P-induced MUC5AC upregulation.	SEN:10039658	22500183
BEL:20084360	tscript(p(HGNC:AHR)) increases p(HGNC:IL8)	AhR-derived inflammatory mediators in airway epithelial cells, such as IL-8 and leukotriene B4, may have a chemotactic effect.	SEN:10039660	22500183
BEL:20084362	tscript(p(HGNC:AHR)) increases p(HGNC:NFE2L2)	There may be bidirectional regulation; recent studies suggest that Nrf2 is an AhR target gene, and the Nrf2 expression is directly modulated by AhR activation	SEN:10039662	19185948
BEL:20084366	tscript(p(HGNC:ARNT)) directlyIncreases tscript(p(HGNC:EPAS1))	EPAS1 forms a heterodimeric complex with the aryl hydrocarbon nuclear transporter prior to transcriptional activation of target genes. EPAS1 expression is limited to the endothelium of mouse embryos and, in agreement with its cell type-specific expression pattern, is capable of specifically activating the transcription of the endothelial tyrosine kinase gene Tie-2.	SEN:10032636	9000051
BEL:20084372	tscript(p(HGNC:ARNT)) directlyIncreases tscript(p(HGNC:HIF1A))	in the absence of oxygen, HIF1 binds to hypoxia-response elements, thereby activating the expression of numerous hypoxia-response genes, such as VEGF	SEN:10039668	11902584
BEL:20084376	tscript(p(HGNC:ATF2)) increases cat(p(HGNC:PTGS2))	 Inhibition of cyclooxygenase-2 activity by specific chemical inhibitor or siRNA attenuates the H(2)O(2)-induced increase of senescence associated beta-galactosidase positive cells and attenuates growth arrest. In this work, p38(MAPK) activation and increased DNA binding activities of ATF-2 and p53 are shown to mediate cyclooxygenase-2 overexpression in premature senescence.	SEN:10035820	19082758
BEL:20084400	tscript(p(HGNC:BACH1)) directlyDecreases tscript(p(HGNC:TP53))	Bach1 repressed the p53-mediated activation of the Perp promoter (Fig. 7c).	SEN:10039672	19011633
BEL:20084434	tscript(p(HGNC:CEBPB)) increases path(MESHD:Fibrosis)	after Bleomycin treatment, C/EBPbwt mice had moderate to severe lung fibrosis (mean score 2.8+/20.4; n: 10) compared to controls , while C/EBPb-Ala217 mice of the same genetic background had mild or moderate lung fibrosis (mean score: 1.5+/20.5; n: 10; P,0.001; Wilcoxon U Test)	SEN:10032736	21998664
BEL:20084444	tscript(p(HGNC:CEBPB)) increases p(HGNC:TGFB1)	the protein expression of lung fibrogenic indicators a- SMA, present in activated myofibroblasts (NM_007392.2) and TGF-b1, a fibrogenic cytokine [27] (NM_009370.2) were induced by Bleomycin in C/EBPbwt mice ,5-fold (n: 7 per group; a-SMA: 5.2+/20.3, P,0.0001; TGF-b1: 5.9+/20.3 P,0.0001) but not in C/EBPb-Ala217 mice (n: 6 per group; a-SMA: 1.2+/20.2, P = 0.15; TGF-b1: 0.7+/20.2, P = 0.013)	SEN:10032738	21998664
BEL:20084462	tscript(p(HGNC:CREBBP)) increases tscript(p(HGNC:HIF1A))	from full ext - Figure 2 (D–F) Transient transfection assays showing that Gal-HIF-1a function is reduced in MEFs with multiple DCH1 alleles (mean7s.e.m., N¼3) (D), and can be rescued by WT CBP (E, F) or p300 (F), but not by CBPDCH1 (E) (mean7s.e.m., N¼2–4). (G, H) Transactivation by factors utilizing other domains of p300 and CBP or other coactivators is unimpaired (mean7s.d., N¼4).	SEN:10032810	16237459
BEL:20084464	tscript(p(HGNC:CREBBP)) increases tscript(p(HGNC:HIF1A))	HIF-1a N-TAD partially overlaps with the oxygenregulated degradation box and consequently, when transiently expressed in cells, the minimal N-TAD fragment is completely degraded under normoxic conditions (under which no N-TAD-mediated transactivation activity is observed [16,17]). Functional data indicate that the activity of this domain can be enhanced by the transcriptional coactivator CBP/p300 [16].	SEN:10039678	17885420
BEL:20084570	tscript(p(HGNC:EP300)) directlyIncreases tscript(p(HGNC:CREB1))	stimulate gene expression by promoting the phosphorylation of CREB (P-CREB), thereby enhancing its association with the histone acetylase paralogs p300 and CBP (CBP/p300)	SEN:10039690	17476304
BEL:20084586	tscript(p(HGNC:ETS1)) decreases bp(GOBP:"T-helper 17 cell differentiation")	STAT5, which is downstream of IL-2 signalling, and STAT1, which is downstream of IL-27 signalling, as well as ETS1, are negative regulators of TH17-cell differentiation.	SEN:10038472	18408735
BEL:20084628	tscript(p(HGNC:FOXO1)) decreases bp(GOBP:angiogenesis)	Gene expression profiling showed that Foxo1 and Foxo3a specifically regulate a nonredundant but overlapping set of angiogenesis- and vascular remodeling-related genes.	SEN:10039698	16100571
BEL:20084654	tscript(p(HGNC:FOXO3)) increases p(HGNC:MAP1LC3B)	LC3-II was increased in FoxO3MyHC cardiomyocytes after ex vivo transgene activation (Figure 4F; see Supplementary material online, Figure S6C). Treatment with lysosomal inhibitors revealed that LC3-II levels could still be stimulated in FoxO3MyHC cardiomyocytes, indicating an activation of autophagy rather than a disturbance in autophagic flux.	SEN:10028990	21628326
BEL:20084752	tscript(p(HGNC:HIF1A)) directlyIncreases r(HGNC:MIR210)	HIF-1A-shRNA expression also reduced the induction of miR-210 in hypoxia ( Fig. 2D)	SEN:10039712	19141645
BEL:20084754	tscript(p(HGNC:HIF1A)) increases bp(GOBP:angiogenesis)	in the absence of VHL function, continuous activation of HIF1alpha promotes angiogenesis	SEN:10039714	15286739
BEL:20084778	tscript(p(HGNC:HIF1A)) increases p(HGNC:TGFA)	The latter is a bona fide renal-cell mitogen that activates the Ras Raf MAP kinase signalling cascade through its cognate epidermal growth factor (EGF) cell surface receptor [26]. The overproduction of TGFa in RCC cells is, at least in part, HIF-dependent and a major contributory event that confers a growth advantage to these cells [25,27].	SEN:10039718	15350900
BEL:20084874	tscript(p(HGNC:MYC)) increases bp(GOBP:"cell cycle")	The c-Myc oncoprotein is strongly induced during the G0 to S-phase transition and is an important regulator of cell cycle entry.	SEN:10033360	15866886
BEL:20084930	tscript(p(HGNC:NFE2L2)) decreases a(CHEBI:"reactive oxygen species")	Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants.	SEN:10033446	12968018
BEL:20084978	tscript(p(HGNC:NFE2L2)) increases p(HGNC:SRXN1)	Western blot analysis of lung proteins showed that Srx1 proteinwas present constitutively, and its level increased significantly on exposure to CS in Nrf2+/+ mice. By contrast, expression of Srx1 protein was low in Nrf2?/? mice and did not change significantly with CS exposure (Figs. 1B and C).	SEN:10017590	19027064
BEL:20084984	tscript(p(HGNC:NOTCH3)) increases p(HGNC:HES5)	We show a mechanistic link from NOTCH3 receptor signaling through the Hairy and enhancer of Split-5 (HES-5) protein to smooth muscle cell proliferation	SEN:10038264	19855400
BEL:20085060	tscript(p(HGNC:RBPJ)) directlyIncreases p(HGNC:HEY2)	NICD activates the HERP1 promoter in an RBP-J kappa-dependent manner, and induces expression of endogenous HERP1 mRNA as well as HERP1 protein in A10 cells.	SEN:10033912	11741889
BEL:20085062	tscript(p(HGNC:REL)) increases p(HGNC:TNF)	Stimulation of cells isolated from atherosclerotic plaques with soluble CD40L (10 microgram/ml) induced the NFkB (c-Rel) DNA binding activity and TNF alpha production was significantly inhibited by dominant negative IKK-2, indicating that CD40L induced TNF alpha expression was via c-Rel.	SEN:10037900	15064395
BEL:20085072	tscript(p(HGNC:SMAD2)) decreases bp(GOBP:"cell migration")	endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.	SEN:10039744	16462725
BEL:20085074	tscript(p(HGNC:SMAD2)) decreases bp(GOBP:"cell proliferation")	endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.	SEN:10039744	16462725
BEL:20085092	tscript(p(HGNC:SMAD3)) decreases bp(GOBP:"cell migration")	endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.	SEN:10039744	16462725
BEL:20085094	tscript(p(HGNC:SMAD3)) decreases bp(GOBP:"cell proliferation")	endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.	SEN:10039744	16462725
BEL:20085132	tscript(p(HGNC:SMAD7)) decreases p(HGNC:TGFB1)	from full text - Defective transforming growth factor TGF-beta1 signaling due to high levels of Smad7 is a feature of IBD[55]. UC patients have exhibited increased production of TGF-beta1 by LPMC as compared with both CD patients and controls	SEN:10039746	18666314
BEL:20085134	tscript(p(HGNC:SMARCA4)) decreases tscript(p(HGNC:E2F1))	# Ariadne: TopBP1 recruits Brg1/Brm, a central component of the SWI/SNF chromatin-remodeling complex, to E2F1-responsive promoters and represses the activities of E2F1, but not E2F2 or E2F3. [Binding]	SEN:10039748	15075294
BEL:20085164	tscript(p(HGNC:SP1)) increases p(HGNC:TGFB1)	Figure 5. R-Sp1 decoy ODN suppressed TGF-beta1, fibronectin and alpha-SMA expression at 4, 6 and 8 weeks after transfection. (A) Western blot shows the inhibition of TGF-beta1, fibronectin and alpha-SMA expression by R-Sp1 decoy ODN injection.	SEN:10034000	19554625
BEL:20085172	tscript(p(HGNC:STAT1)) decreases bp(GOBP:"T-helper 17 cell differentiation")	STAT5, which is downstream of IL-2 signalling, and STAT1, which is downstream of IL-27 signalling, as well as ETS1, are negative regulators of TH17-cell differentiation.	SEN:10038472	18408735
BEL:20085190	tscript(p(HGNC:STAT1)) increases tscript(p(HGNC:IRF1))	enforced STAT1 expression promoted several features of megakaryocytic differentiation of G1ME cells, as evidenced by increased cell size (forward scatter) and increased DNA content, reflecting polyploidization (Figure ?(Figure1,1, A and B). Similar effects were produced by enforced expression of IRF-1, a major STAT1 effector (reviewed in ref. 26). 	SEN:10039758	18060035
BEL:20085208	tscript(p(HGNC:STAT3)) increases bp(GOBP:"cell proliferation")	These data indicate that MEN2A-RET enhances proliferation via STAT3, and that a full length STAT3 is required to mediate the MEN2A-RET induced proliferation.	SEN:10022126	11536047
BEL:20085216	tscript(p(HGNC:STAT3)) increases bp(GOBP:"macrophage differentiation")	Although STAT3 is essential for IL-6-induced macrophage differentiation of M1 cells, GATA-1 had little or no effect on tyrosine phosphorylation, DNA binding, and transcriptional activities of STAT3 in Western blot analysis, electropholic mobility shift assay (EMSA), and luciferase assays.	SEN:10028424	10666199
BEL:20085224	tscript(p(HGNC:STAT3)) increases p(HGNC:AKT1)	Importantly, the expression of survivin correlates with STAT3 activation in breast tumors, and the inhibition of this signaling pathway induces apoptosis [47,48]. Finally, it has also been shown that AKT is a direct target gene of STAT3, which binds directly to its promoter to enhance its expression [49].	SEN:10039772	17118707
BEL:20085226	tscript(p(HGNC:STAT3)) increases p(HGNC:CCND3)	Finally, we determined that STAT3 expression is required for PDGF-mediated regulation of cell cycle targets cyclin D3 and p27. These data define a novel mitogenic signaling pathway in airway smooth muscle cells leading from PDGF to Rac1 and STAT3 and subsequent cell cycle gene regulation	SEN:10036524	18310224
BEL:20085228	tscript(p(HGNC:STAT3)) increases p(HGNC:CDKN1B)	Finally, we determined that STAT3 expression is required for PDGF-mediated regulation of cell cycle targets cyclin D3 and p27. These data define a novel mitogenic signaling pathway in airway smooth muscle cells leading from PDGF to Rac1 and STAT3 and subsequent cell cycle gene regulation	SEN:10036524	18310224
BEL:20085236	tscript(p(HGNC:STAT4)) increases bp(GOBP:"T-helper 1 cell differentiation")	Cytokines control the outcome of TH immunity, with IL-12, acting via signal transducer and activator of transcription 4 (STAT4), to promote TH1 development, whereas IL-4 promotes TH2 development via the actions of STAT6 (2).	SEN:10038504	11397944
BEL:20085238	tscript(p(HGNC:STAT4)) increases bp(GOBP:"T-helper 1 cell differentiation")	IL-12 activates STAT4, which is a critical regulator of inflammation and T helper type I (Th1) lineage development in murine systems.	SEN:10019892	19359411
BEL:20085252	tscript(p(HGNC:STAT5A)) decreases bp(GOBP:"T-helper 17 cell differentiation")	STAT5, which is downstream of IL-2 signalling, and STAT1, which is downstream of IL-27 signalling, as well as ETS1, are negative regulators of TH17-cell differentiation.	SEN:10038472	18408735
BEL:20085266	tscript(p(HGNC:STAT6)) increases bp(GOBP:"inflammatory response")	IL-4 develops Th2-biased immunity or allergic inflammation through activation of STAT6-dependent signaling.	SEN:10034162	19419769
BEL:20085270	tscript(p(HGNC:STAT6)) increases bp(GOBP:"T-helper 2 cell differentiation")	Cytokines control the outcome of TH immunity, with IL-12, acting via signal transducer and activator of transcription 4 (STAT4), to promote TH1 development, whereas IL-4 promotes TH2 development via the actions of STAT6 (2).	SEN:10038504	11397944
BEL:20085272	tscript(p(HGNC:STAT6)) increases bp(GOBP:"T-helper 2 cell differentiation")	early studies have indicated that Stat6 (8, 9, 10), a cytosolic latent transcription factor that is rapidly activated after cellular exposure to IL-4 and IL-13, is essential for Th2 cell differentiation through the induction of GATA3 (5, 6, 7),	SEN:10027138	15749913
BEL:20085292	tscript(p(HGNC:TBX21)) increases bp(GOBP:"T-helper 1 cell differentiation")	Induction of T-bet was, however, suppressed by IL-4 (Fig. 1D) acting via STAT6 (17). Thus, T-bet expression and TH1 differentiation are coordinately induced without requiring IL-12/STAT4 and are coordinately suppressed by IL-4/STAT6. 	SEN:10038512	11397944
BEL:20085294	tscript(p(HGNC:TBX21)) increases bp(GOBP:"T-helper 1 cell differentiation")	T-bet is required for the progression to the Th1 phenotype, because Tbx21-/- Th1beta cultures maintain the IL-17-secreting phenotype after 2 weeks of culture. Addition of IFN-gamma to Tbx21-/- Th1beta cultures cannot recover the progression to the Th1 phenotype, suggesting T-bet, rather than IFN-gamma, mediates Th1beta to Th1 progression.	SEN:10034170	16670261
BEL:20085302	tscript(p(HGNC:TBX21)) increases p(HGNC:RUNX3)	Our data indicate that cytokine gene expression in T(H)1 cells may be controlled by a feed-forward regulatory circuit in which T-bet induces Runx3 and then 'partners' with Runx3 to direct lineage-specific gene activation and silencing.	SEN:10034198	17195845
BEL:20085308	tscript(p(HGNC:TP53)) decreases p(HGNC:BCL2)	Endogenous bcl-2 protein level decreased 12 fold and bax increased approximately 4 fold in PC3 vector control cells following Ad-p53 infection.	SEN:10032558	11146439
BEL:20085312	tscript(p(HGNC:TP53)) decreases p(HGNC:BCL2)	NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).	SEN:10035420	12559172
BEL:20085378	tscript(p(HGNC:TP53)) increases cat(p(HGNC:PTGS2))	 Inhibition of cyclooxygenase-2 activity by specific chemical inhibitor or siRNA attenuates the H(2)O(2)-induced increase of senescence associated beta-galactosidase positive cells and attenuates growth arrest. In this work, p38(MAPK) activation and increased DNA binding activities of ATF-2 and p53 are shown to mediate cyclooxygenase-2 overexpression in premature senescence.	SEN:10035820	19082758
BEL:20085410	tscript(p(HGNC:TP63)) increases bp(GOBP:"apoptotic process")	The full-length transcriptionally active TAp63 isoforms are capable of transactivating the majority of the p53 target promoters thus inducing cell cycle arrest and apoptosis.	SEN:10039794	16007146
BEL:20085436	tscript(p(HGNC:ZFPM1)) directlyIncreases tscript(p(HGNC:GATA1))	FOG-1 stimulates GATA-1-dependent alphaIIb gene expression in a manner that requires their direct physical interaction.	SEN:10033048	12356738
BEL:20085514	r(MGI:Cd72) decreases a(CHEBI:"calcium(2+)")	In this paper we demonstrate that expression of CD72 down-modulates both extracellular signal-related kinase (ERK) activation and Ca2+ mobilization induced by BCR ligation in the mouse B lymphoma line K46^mA, whereas BCR-mediated ERK activation was not reduced by the ITIM-mutated form of CD72.	SEN:10039802	10640734
BEL:20085516	r(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	In this paper we demonstrate that expression of CD72 down-modulates both extracellular signal-related kinase (ERK) activation and Ca2+ mobilization induced by BCR ligation in the mouse B lymphoma line K46^mA, whereas BCR-mediated ERK activation was not reduced by the ITIM-mutated form of CD72.	SEN:10039802	10640734
BEL:20085518	r(MGI:Cd72) decreases p(MGI:Mapk1,pmod(P))	In this paper we demonstrate that expression of CD72 down-modulates both extracellular signal-related kinase (ERK) activation and Ca2+ mobilization induced by BCR ligation in the mouse B lymphoma line K46^mA, whereas BCR-mediated ERK activation was not reduced by the ITIM-mutated form of CD72.	SEN:10039802	10640734
BEL:20085520	r(MGI:Cd72) decreases kin(p(MGI:Mapk3))	Results CD72 negatively regulates both ERK activation and Ca2+ mobilization induced by BCR ligation in the K46^mk B lymphoma cells To investigate the signaling function of CD72, we assessed CD72 expression on the surface of B cell lines by flow cytometry.	SEN:10039804	10640734
BEL:20085522	r(MGI:Cd72) decreases kin(p(MGI:Mapk1))	Results CD72 negatively regulates both ERK activation and Ca2+ mobilization induced by BCR ligation in the K46^mk B lymphoma cells To investigate the signaling function of CD72, we assessed CD72 expression on the surface of B cell lines by flow cytometry.	SEN:10039804	10640734
BEL:20085532	r(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	However, both of the CD72 transfectants showed reduced phosphorylation of ERK1 and ERK2 compared to that of the parent cells regardless of the duration of Ag stimulation.	SEN:10039810	10640734
BEL:20085534	r(MGI:Cd72) decreases p(MGI:Mapk1,pmod(P))	However, both of the CD72 transfectants showed reduced phosphorylation of ERK1 and ERK2 compared to that of the parent cells regardless of the duration of Ag stimulation.	SEN:10039810	10640734
BEL:20085536	r(MGI:Cd72) decreases p(MGI:Mapk1,pmod(P))	Taken together, expression of CD72 most probably down-modu-lates phosphorylation of ERK induced by BCR signaling.	SEN:10039812	10640734
BEL:20085538	r(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	Taken together, expression of CD72 most probably down-modu-lates phosphorylation of ERK induced by BCR signaling.	SEN:10039812	10640734
BEL:20085540	p(MGI:Cd72) decreases kin(p(MGI:Mapk1))	Indeed, in vitro kinase assay showed that the activity of ERK2 in Ag-stimulated K46^mA CD72 transfectants was lower than that of Ag-stimulated K46^mA (Fig. 3).	SEN:10039814	10640734
BEL:20085542	p(MGI:Cd72) decreases kin(p(MGI:Mapk3))	Indeed, in vitro kinase assay showed that the activity of ERK2 in Ag-stimulated K46^mA CD72 transfectants was lower than that of Ag-stimulated K46^mA (Fig. 3).	SEN:10039814	10640734
BEL:20085546	p(MGI:Cd72) decreases a(CHEBI:"calcium(2+)")	However, the CD72 transfectants showed less increase in the intracellular Ca2+ concentration than the parent K46^mA cells did.	SEN:10039818	10640734
BEL:20085548	p(MGI:Cd72) decreases a(CHEBI:"calcium(2+)")	Thus, expression of CD72 appears to negatively regulate BCR-mediated Ca2+ mobilization in K46^mA cells.	SEN:10039820	10640734
BEL:20085550	p(MGI:Cd72) decreases a(CHEBI:"calcium(2+)")	Taken together, CD72 down-modulates both ERK activation and Ca2+ mobilization induced by BCR ligation, strongly suggesting that CD72 negatively regulates BCR signaling in K46^mA cells.	SEN:10039822	10640734
BEL:20085552	p(MGI:Cd72) decreases p(MGI:Mapk1,pmod(P))	Taken together, CD72 down-modulates both ERK activation and Ca2+ mobilization induced by BCR ligation, strongly suggesting that CD72 negatively regulates BCR signaling in K46^mA cells.	SEN:10039822	10640734
BEL:20085554	p(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	Taken together, CD72 down-modulates both ERK activation and Ca2+ mobilization induced by BCR ligation, strongly suggesting that CD72 negatively regulates BCR signaling in K46^mA cells.	SEN:10039822	10640734
BEL:20085558	p(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	Western blotting of total cell lysates using anti-phospho-ERK Ab showed that both ERK1 and ERK2 were phosphorylated by either BCR ligation alone or coligation of BCR and CD72 (Fig. 6B).	SEN:10039824	10640734
BEL:20085560	p(MGI:Cd72) decreases p(MGI:Mapk1,pmod(P))	However, BCR ligation induced stronger ERK phosphorylation than coligation of CD72 with BCR did, indicating that BCR ligation-induced phosphorylation of ERK is down-modulated when CD72 is coligated with BCR.	SEN:10039826	10640734
BEL:20085562	p(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	However, BCR ligation induced stronger ERK phosphorylation than coligation of CD72 with BCR did, indicating that BCR ligation-induced phosphorylation of ERK is down-modulated when CD72 is coligated with BCR.	SEN:10039826	10640734
BEL:20085564	p(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	Phosphorylation of both ERK1 and ERK2 induced by coligation of BCR and CD72 was weaker than that induced by BCR ligation alone (Fig. 6 C), indicating that coligation with CD72 reduced BCR ligation-mediated phosphorylation of ERK in DBA/2 spleen cells.	SEN:10039828	10640734
BEL:20085566	p(MGI:Cd72) decreases a(CHEBI:"calcium(2+)")	Coligation of CD72 with BCR showed a reduced Ca2+ flux compared to that with BCR ligation alone in spleen B cells (Fig. 6D).	SEN:10039830	10640734
BEL:20085568	p(MGI:Cd72) decreases p(MGI:Mapk3,pmod(P))	Taken together, these results indicate that coligation with CD72 negatively regulates BCR-induced ERK activation and Ca2+ concentration in normal spleen B cells.	SEN:10039832	10640734
BEL:20085570	p(MGI:Cd72) decreases p(MGI:Mapk1,pmod(P))	Taken together, these results indicate that coligation with CD72 negatively regulates BCR-induced ERK activation and Ca2+ concentration in normal spleen B cells.	SEN:10039832	10640734
BEL:20085572	p(MGI:Cd72) decreases a(CHEBI:"calcium(2+)")	Taken together, these results indicate that coligation with CD72 negatively regulates BCR-induced ERK activation and Ca2+ concentration in normal spleen B cells.	SEN:10039832	10640734
BEL:20085574	p(MGI:Cd40) increases sec(p(MGI:Il10))	Sorted WT B cells produced more IL-10 than CD40 knockout (CD40KO) B cells when cocultured with EL-4 gag or D5 (but not MCA304).	SEN:10039834	16885377
BEL:20085582	bp(GOBP:"natural killer cell activation") increases sec(p(MGI:Ifng))	Most IFN-g-producing cells from BKO spleen cells at day 3 or 4 were NK-1.1 positive (Fig. 1B).	SEN:10039842	16885377
BEL:20085584	bp(GOBP:"response to tumor cell") increases bp(GOBP:"natural killer cell activation")	These results indicate that substantially enhanced IFN-g responses by CD8 T cells and NK cells are induced by EL-4 gag cells or D5 tumor cells but not MCA304 sarcoma cells (Fig. 1D).	SEN:10039844	16885377
BEL:20085604	p(MGI:Cd40lg) increases sec(p(MGI:Il10))	CD40L was expressed on tumor cells that induced IL-10 from B cells (Fig. 4A) but not on MCA304 cells.	SEN:10039856	16885377
BEL:20085606	complex(p(MGI:Cd40lg),p(MGI:Cd40)) increases sec(p(MGI:Il10))	IL-10 production was significantly attenuated when tumor cells were cultured with CD40KO B cells compared with WT B cells, whereas differences in IL-10 levels were also observed between IL-10KO and CD40KO B cells (Fig. 4B).	SEN:10039858	16885377
BEL:20085608	complex(p(MGI:Cd40lg),p(MGI:Cd40)) increases sec(p(MGI:Il10))	These results indicate that B-cell IL-10 production is partially dependent on CD40-CD40L interactions.	SEN:10039860	16885377
BEL:20085610	complex(p(MGI:Cd40lg),p(MGI:Cd40)) increases sec(p(MGI:Il10))	Furthermore, IL-10 production by B cells was attenuated by anti-CD40L blocking antibody (Fig. 4C).	SEN:10039862	16885377
BEL:20085614	p(MGI:Il10) decreases p(MGI:Ifng)	IFN-g production was diminished in BKO spleen cells by rIL-10 (Fig. 4D).	SEN:10039864	16885377
BEL:20085618	sec(p(MGI:Il10)) decreases sec(p(MGI:Ifng))	These results indicate that B cells may reduce IFN-g production by producing IL-10.	SEN:10039866	16885377
BEL:20085620	sec(p(MGI:Il10)) decreases sec(p(MGI:Ifng))	These results suggest that (a) IL-10 produced from B cells lowers IFN-g production and (b) this effect is partially CD40-CD40L dependent.	SEN:10039868	16885377
BEL:20085622	complex(p(MGI:Cd40lg),p(MGI:Cd40)) increases sec(p(MGI:Il10))	These results suggest that (a) IL-10 produced from B cells lowers IFN-g production and (b) this effect is partially CD40-CD40L dependent.	SEN:10039868	16885377
BEL:20085624	complex(p(MGI:Cd40lg),p(MGI:Cd40)) decreases sec(p(MGI:Ifng))	After washing, these “CD40-stimulating antibody-expressing'' MCA304 cells induced IFN-g from NK (Fig. 4G) and CD8 T cells (Fig. 4H), indicating that CD40-CD40L interactions can trigger IFN-g production.	SEN:10039870	16885377
BEL:20085630	bp(GOBP:"response to tumor cell") decreases sec(p(HGNC:TNFSF13B))	The transition from normal to neoplastic glands in prostate cancer (PCa) is marked by a dramatic decline of IL-7 and BAFF/ BLyS production.	SEN:10039876	19366834
BEL:20085632	bp(GOBP:"response to tumor cell") decreases sec(p(HGNC:IL7))	The transition from normal to neoplastic glands in prostate cancer (PCa) is marked by a dramatic decline of IL-7 and BAFF/ BLyS production.	SEN:10039876	19366834
BEL:20085634	bp(GOBP:"response to tumor cell") decreases r(HGNC:BCL2)	B-cell andT-cell expression of bcl-2 decrease, whereas the apoptotic events increase.	SEN:10039878	19366834
BEL:20085644	bp(GOBP:"response to tumor cell") decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	Prostate-infiltrating lymphocytes display low proliferation but wide expression of the antiapoptotic protein bcl-2.	SEN:10039884	19366834
BEL:20085646	bp(GOBP:"response to tumor cell") increases p(HGNC:BCL2)	Prostate-infiltrating lymphocytes display low proliferation but wide expression of the antiapoptotic protein bcl-2.	SEN:10039884	19366834
BEL:20085648	bp(GOBP:"response to tumor cell") increases r(HGNC:BCL2)	The vast majority of prostatic lymphocytes, both stromal (organized in LFs, that is, CD20+ B-cell follicle encircled by parafollicular T-cell area, Fig. 4C-H, or not organized, Fig. 4I-K) and intraepithelial lymphocytes (Fig. 4L), strongly expressed the antiapoptotic protein bcl-2.	SEN:10039886	19366834
BEL:20085652	r(HGNC:IL7) increases a(HGNC:TNFSF13B)	Loss of IL-7 and BAFF production in neoplastic prostatic glands is accompanied by reduction of CD8+ and CD20+ cell infiltrates.	SEN:10039888	19366834
BEL:20085656	bp(GOBP:"response to tumor cell") decreases r(HGNC:IL7)	Real-time RT-PCR revealed that, in contrast to normal prostatic glands, malignant glands showed low to absent, ~ 60 times lower than in the normal glands (Fig. 5A), IL-7 mRNA expression.	SEN:10039890	19366834
BEL:20085658	bp(GOBP:"response to tumor cell") decreases p(HGNC:CXCL13)	Expression of the chemokines B lymphocyte chemo-attractant, also called CXCL13, and secondary lymphoid tissue chemokine, also known as CCL21, which we previously found (2) associated with LFs, was lost too (Fig. 5B, c-e).	SEN:10039892	19366834
BEL:20085660	bp(GOBP:"response to tumor cell") decreases r(HGNC:CCL21)	Expression of the chemokines B lymphocyte chemo-attractant, also called CXCL13, and secondary lymphoid tissue chemokine, also known as CCL21, which we previously found (2) associated with LFs, was lost too (Fig. 5B, c-e).	SEN:10039892	19366834
BEL:20085662	bp(GOBP:"response to tumor cell") decreases p(HGNC:BCL2)	At the same time, the percentage of CD8+ cells with positive cytoplasmic staining for the antiapoptotic protein bcl-2 was decreased in PCa (85.1 + 5.3%; Fig. 5D, a and b), in comparison with the normal prostate (97.0 + 2.4%), as assessed by double CD8/bcl-2 staining on paraffin sections.	SEN:10039894	19366834
BEL:20085666	bp(GOBP:"response to tumor cell") decreases r(HGNC:TNFSF13B)	LCM followed by real-time RT-PCR examination of neoplastic glands versus normal glands revealed a low to absent, about five times lower than in the normal glands, BAFF mRNA expression (Fig. 5E).	SEN:10039898	19366834
BEL:20085730	act(p(MGI:Tlr9)) decreases bp(GOBP:"regulatory T cell differentiation")	In contrast, the adoptive transfer of CpG-activated B cells induced tumor arrest, associated with a reduced suppressive immune environment due to the lower recruitment of regulatory T cells, myeloid-derived suppressor cells, and CD81 regulatory T cells along with the reduced expression of suppressive cytokines such as IL-10 and transforming growth factor-(b.	SEN:10039934	21278302
BEL:20085758	act(p(MGI:Tlr9)) increases r(MGI:Tnfsf10)	Moreover, the expression of DR5, one of TNF-related apoptosis-inducing ligand (TRAIL) receptors, was also increased in the lungs of mice transferred with CpG-pulsed B cells (Figure E4A).	SEN:10039952	21278302
BEL:20085760	act(p(MGI:Tlr9)) increases sec(p(MGI:Il18))	Similarly, we observed a higher release of IL-18 (Figure E4B) and TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling)-positive cells (data not shown) in the lungs of tumor-bearing mice adoptively transferred with CpG-pulsed B cells than in the other group of animals.	SEN:10039954	21278302
BEL:20085762	act(p(MGI:Tlr9)) increases bp(GOBP:"apoptotic process")	Similarly, we observed a higher release of IL-18 (Figure E4B) and TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling)-positive cells (data not shown) in the lungs of tumor-bearing mice adoptively transferred with CpG-pulsed B cells than in the other group of animals.	SEN:10039954	21278302
BEL:20085764	act(p(MGI:Tlr9)) increases r(HGNC:IFNB1)	CpG treatment of B cells increased the levels of IFN-b (Figure 3B), lymphotoxin-b (LTb) (Figure 3C), IL-1b (Figure 3D), and IL-12p40 (Figure 3E) but reduced those of TNF-a (Figure 3F) and IL-10 (Figure 3G).	SEN:10039956	21278302
BEL:20085766	act(p(MGI:Tlr9)) increases r(MGI:Ltb)	CpG treatment of B cells increased the levels of IFN-b (Figure 3B), lymphotoxin-b (LTb) (Figure 3C), IL-1b (Figure 3D), and IL-12p40 (Figure 3E) but reduced those of TNF-a (Figure 3F) and IL-10 (Figure 3G).	SEN:10039956	21278302
BEL:20085768	act(p(MGI:Tlr9)) increases r(MGI:Il1b)	CpG treatment of B cells increased the levels of IFN-b (Figure 3B), lymphotoxin-b (LTb) (Figure 3C), IL-1b (Figure 3D), and IL-12p40 (Figure 3E) but reduced those of TNF-a (Figure 3F) and IL-10 (Figure 3G).	SEN:10039956	21278302
BEL:20085770	act(p(MGI:Tlr9)) increases r(HGNC:IL12B)	CpG treatment of B cells increased the levels of IFN-b (Figure 3B), lymphotoxin-b (LTb) (Figure 3C), IL-1b (Figure 3D), and IL-12p40 (Figure 3E) but reduced those of TNF-a (Figure 3F) and IL-10 (Figure 3G).	SEN:10039956	21278302
BEL:20085772	act(p(MGI:Tlr9)) decreases p(MGI:Il10)	CpG treatment of B cells increased the levels of IFN-b (Figure 3B), lymphotoxin-b (LTb) (Figure 3C), IL-1b (Figure 3D), and IL-12p40 (Figure 3E) but reduced those of TNF-a (Figure 3F) and IL-10 (Figure 3G).	SEN:10039956	21278302
BEL:20085774	act(p(MGI:Tlr9)) decreases p(MGI:Tnf)	CpG treatment of B cells increased the levels of IFN-b (Figure 3B), lymphotoxin-b (LTb) (Figure 3C), IL-1b (Figure 3D), and IL-12p40 (Figure 3E) but reduced those of TNF-a (Figure 3F) and IL-10 (Figure 3G).	SEN:10039956	21278302
BEL:20085866	act(p(MGI:Tlr9)) increases p(MGI:Ms4a1)	In contrast, only TLR7-9 ligands (single-stranded RNA and unmethylated CpG-ODN) reversed the phenotype (upregu-lated CD20 and downregulated CD25+CD81High; Fig. 4A; Supplementary Fig. S3A and S3B) and blocked the regulatory activity of murine and human tBregs (Fig. 4B and Supplementary Fig. S3A-S3C).	SEN:10040020	23365136
BEL:20085872	act(p(MGI:Tlr9)) increases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	Instead, B cells from these mice activated T-cell responses, as they induced proliferation of T cells (Fig. 5C and Supplementary Fig. S4A) and expanded GrzB-expressing CD8+ T cells (Supplementary Fig. S4B and S4C) that readily and significantly lysed 4T1.2 cancer cells (Fig. 5D).	SEN:10040024	23365136
BEL:20085874	act(p(MGI:Tlr9)) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Instead, B cells from these mice activated T-cell responses, as they induced proliferation of T cells (Fig. 5C and Supplementary Fig. S4A) and expanded GrzB-expressing CD8+ T cells (Supplementary Fig. S4B and S4C) that readily and significantly lysed 4T1.2 cancer cells (Fig. 5D).	SEN:10040024	23365136
BEL:20085878	bp(GOBP:"response to tumor cell") decreases p(MGI:Tnfsf9)	However, we found that, compared with B-LPS or even with normal B cells, expression of 4-1BBL, an immunostimulatory receptor that activates CD8+ T cells and NK cells via4-1BB (37,38), was significantly reduced on murine and human tBregs (Fig. 6 and Supplementary Fig. S6A and S6B).	SEN:10040028	23365136
BEL:20085880	act(p(MGI:Tlr9)) increases p(MGI:Tnfsf9)	However, BLC-arp/CpG treatment reversed the reduced expression of 4-1BBL on murine and human tBregs (Fig. 6C) as well as in vivo in tumor-bearing mice (Fig. 6D).	SEN:10040030	23365136
BEL:20085996	act(p(MGI:Tgfb1)) increases bp(GOBP:"regulatory T cell differentiation")	RSV inhibits tBreg-mediated Treg conversion by blocking TGF-b1.	SEN:10040102	24043896
BEL:20086002	bp(GOBP:"regulatory T cell differentiation") increases bp(GOBP:"regulatory T cell differentiation")	Unlike control B cells from naive BALB/c mice, which did not induce Foxp3 in non-Tregs, regardless of the presence or absence of the inhibitor (Fig. 6A), tBregs or tumor B cells only converted Foxp3+ Tregs in the absence of SB431542 (Fig. 6A).	SEN:10040104	24043896
BEL:20086006	act(p(MGI:Tgfb1)) increases bp(GOBP:"regulatory T cell differentiation")	Unlike control B cells from naive BALB/c mice, which did not induce Foxp3 in non-Tregs, regardless of the presence or absence of the inhibitor (Fig. 6A), tBregs or tumor B cells only converted Foxp3+ Tregs in the absence of SB431542 (Fig. 6A).	SEN:10040104	24043896
BEL:20086014	bp(GOBP:"response to tumor cell") increases act(p(MGI:Tgfb1))	Similarly, in vivo, B cells from tumor-bearing mice treated with 50 mg RSV also failed to secrete significant amounts of TGF-P1 (RSV, Fig. 6D), whereas B cells from mock-treated mice with 4T1.2 cancer produced abundant TGF-b (p < 0.01, Mock versus RSV, Fig. 6D).	SEN:10040108	24043896
BEL:20086020	p(MGI:Stat3,pmod(P)) increases p(MGI:Tgfb1)	Importantly, like RSV, Stat3 inhibitors also inhibited TGF-P1 expression in tBregs (Fig. 7C), a key factor required for tBreg-mediated conversion of Foxp3+ Tregs from non-Treg cells (13).	SEN:10040112	24043896
BEL:20086104	act(p(MGI:Arg1)) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	Nor-NOHA treatment partially reversed suppression by both 4T1 and 4T1/IL-10 MSC, whereas l-NMMA treatment had no effect.	SEN:10040170	16365420
BEL:20086118	act(p(MGI:Arg1)) increases a(CHEBI:"reactive oxygen species")	Therefore, 4T1/IL-1fi MSC express more ROS on a per cell basis than 4T1 MSC, and a significant amount of this ROS production is affected by arginase production.	SEN:10040180	16365420
BEL:20086166	act(p(MGI:Arg1)) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	To determine if 4T1-induced MDSC from EP2_/~ mice inhibit by the same mechanism, nor-NOHA, an inhibitor of arginase, was added to some of the D011.10 and clone 4 transgenic T-cell cultures of Fig. 4. Nor-NOHA reverses the suppression CD4+ and CD8+ T cells by both BALB/c and EP2_/~ MDSC, although it is more effective in reducing suppression of CD4+ T cells than of CD8+ T cells.	SEN:10040208	17483367
BEL:20086168	act(p(MGI:Arg1)) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	To determine if 4T1-induced MDSC from EP2_/~ mice inhibit by the same mechanism, nor-NOHA, an inhibitor of arginase, was added to some of the D011.10 and clone 4 transgenic T-cell cultures of Fig. 4. Nor-NOHA reverses the suppression CD4+ and CD8+ T cells by both BALB/c and EP2_/~ MDSC, although it is more effective in reducing suppression of CD4+ T cells than of CD8+ T cells.	SEN:10040208	17483367
BEL:20086180	p(MGI:Il1r1) increases path(MESHD:Inflammation)	Results Tumor-associated inflammation is reduced in IL-1R—/— mice.	SEN:10040216	17942936
BEL:20086182	bp(GOBP:"response to tumor cell") increases sec(p(MGI:Ccl2))	Canonical proinflammatory cytokines, such as IL-6, MCP-1, TGFh, and IL-1h were significantly elevated in 4T1 tumor tissue.	SEN:10040218	17942936
BEL:20086184	bp(GOBP:"response to tumor cell") increases sec(p(MGI:Il6))	Canonical proinflammatory cytokines, such as IL-6, MCP-1, TGFh, and IL-1h were significantly elevated in 4T1 tumor tissue.	SEN:10040218	17942936
BEL:20086186	bp(GOBP:"response to tumor cell") increases sec(p(MGI:Il1b))	Canonical proinflammatory cytokines, such as IL-6, MCP-1, TGFh, and IL-1h were significantly elevated in 4T1 tumor tissue.	SEN:10040218	17942936
BEL:20086188	bp(GOBP:"response to tumor cell") increases sec(p(MGI:Tgfb1))	Canonical proinflammatory cytokines, such as IL-6, MCP-1, TGFh, and IL-1h were significantly elevated in 4T1 tumor tissue.	SEN:10040218	17942936
BEL:20086196	p(MGI:Il1r1) decreases sec(p(MGI:Tgfb1))	Additionally, IL-1R—/— tumor tissue had less IL-12p70 and more TGFh and IFNg than tumor tissue from wild-type BALB/c mice.	SEN:10040222	17942936
BEL:20086198	p(MGI:Il1r1) increases sec(p(MGI:Il12a))	Additionally, IL-1R—/— tumor tissue had less IL-12p70 and more TGFh and IFNg than tumor tissue from wild-type BALB/c mice.	SEN:10040222	17942936
BEL:20086200	act(p(MGI:Il1r1)) decreases sec(p(MGI:Ifng))	Additionally, IL-1R—/— tumor tissue had less IL-12p70 and more TGFh and IFNg than tumor tissue from wild-type BALB/c mice.	SEN:10040222	17942936
BEL:20086226	p(MGI:Il1r1) increases sec(p(MGI:Il6))	A potential downstream candidate is the proinflammatory cytokine, IL-6, the production of which is reduced in IL-1R—/— tumor tissue (Fig. 1B).	SEN:10040248	17942936
BEL:20086254	sec(p(MGI:Il12b)) increases p(MGI:Ifng)	In the presence of IL-12, NK cells produced larger amounts of IFN-g.	SEN:10040272	18753637
BEL:20086262	act(p(MGI:Klrk1)) increases sec(p(MGI:Ifng))	Addition of Fab fragments of anti-NKG2D mAb to the cocultures significantly reduced the secretion of IFN-7, whereas Fab fragments of the isotype-matched control mAb had no effect (Figure 5D).	SEN:10040278	18753637
BEL:20086284	p(MGI:S100a9) increases p(MGI:Nfkb1, pmod(P,S,536))	However, NF-kB was phosphorylated in MDSC from both tumor-bearing and tumor-free mice within the first 10 min of incubation at a level comparable to activation by TNF-a, a NF-KB-dependent gene that is known to be activated by S100A8/A9 (22) (Fig. 3E).	SEN:10040294	18802069
BEL:20086286	p(MGI:S100a8) increases p(MGI:Nfkb1, pmod(P,S,536))	However, NF-kB was phosphorylated in MDSC from both tumor-bearing and tumor-free mice within the first 10 min of incubation at a level comparable to activation by TNF-a, a NF-KB-dependent gene that is known to be activated by S100A8/A9 (22) (Fig. 3E).	SEN:10040294	18802069
BEL:20086288	bp(GOBP:"response to tumor cell") increases sec(p(MGI:S100a8))	We found that 4T1 cells secrete S100A8/A9 proteins (Fig. 3F) and 4T1 supernatants are chemoattractants for MDSC (Fig. 3G).	SEN:10040296	18802069
BEL:20086302	path(MESHD:Neoplasms) increases r(MGI:S100a9)	TCM prevented the down-regulation of S100A9 mRNA expression during differentiation in vitro (Fig. 1 A).	SEN:10040302	18809714
BEL:20086310	path(MESHD:Neoplasms) increases p(MGI:S100a8)	Gr-1+ cells isolated after a 5-d culture of HPCs with GM-CSF and IL-4 in TCM expressed substantially more S100A8 and S100A9 proteins than did Gr-1_ cells (Fig. 1 C).	SEN:10040308	18809714
BEL:20086312	path(MESHD:Neoplasms) increases p(MGI:S100a9)	Gr-1+ cells isolated after a 5-d culture of HPCs with GM-CSF and IL-4 in TCM expressed substantially more S100A8 and S100A9 proteins than did Gr-1_ cells (Fig. 1 C).	SEN:10040308	18809714
BEL:20086356	tscript(p(MGI:Stat3)) increases r(MGI:S100a9)	Expression of the constitutively active STAT3 mutant STAT3C in ES cells maintained a high level of S100A9 expression after LIF withdrawal (Fig. 6, B and C).	SEN:10040336	18809714
BEL:20086358	r(MGI:Stat3) increases r(MGI:S100a9)	STAT3 depletion resulted in the down-regulation of S100A8 and S100A9 gene expression (Fig. 6 E), as well as the levels of both proteins (Fig. 6 F).	SEN:10040338	18809714
BEL:20086360	r(MGI:Stat3) increases r(MGI:S100a9)	Collectively, these data demonstrate that STAT3 up-regulates the expression of S100A8 and S100A9 both in vitro and in vivo.	SEN:10040340	18809714
BEL:20086362	r(MGI:S100a9) increases a(CHEBI:"reactive oxygen species")	Consistent with this hypothesis, amounts of ROS in the spleen and bone marrow were four- to fivefold greater in Gr-1+GFP+ cells from S100A9Tg mice than in Gr-1+GFP“ cells from wild-type and S100A9T mice (Fig. 7 A).	SEN:10040342	18809714
BEL:20086364	r(MGI:S100a9) increases a(CHEBI:"reactive oxygen species")	However, ROS levels in MDSCs from tumor-bearing S100A9KO mice were substantially lower than in tumor-bearing wild-type mice and were equivalent to ROS levels in naive wild-type mice (Fig. 7 B).	SEN:10040344	18809714
BEL:20086464	p(MGI:Il6) decreases p(MGI:Il1r1)	Both IL-6 and G-CSF treatment did not markedly change surface IL-4Ra amounts on BM cells; moreover, IL-6 had a detrimental effect on cell viability, thereby preventing any further functional characterization.	SEN:10040420	20605485
BEL:20086466	r(MGI:Csf3) increases r(MGI:Il1r1)	Despite the increased IL-4Ra expression following G-CSF treatment, this cytokine did not induce any appreciable imunosuppressive function in BM cells.	SEN:10040422	20605485
BEL:20086468	p(MGI:Csf2) increases r(MGI:Il1r1)	GM-CSF induced a significant increase (p = 0.028 versus untreated BM) of IL-4Ra expression, and BM cells cultured with this cytokine inhibited CTL activity in a dose-dependent fashion (Figures 1A and 1B).	SEN:10040424	20605485
BEL:20086488	r(MGI:Cebpb) increases p(MGI:Itgam)	When we analyzed the percentage of the different subsets of CD11b+Gr-1+ cells, percentages of CD11bhiGr-1hi and CD11bhiGr-1- cells were decreased in both C/EBPp-deficient strains, but subsets characterized by low and intermediate expression of the Gr-1 marker were significantly decreased only in fully ablated mice (Figure 3D).	SEN:10040432	20605485
BEL:20086500	p(MGI:Cebpb) increases p(MGI:Arg1)	Following separation of CD11b+ cells from MCA203 tumor infiltrate, we found that loss of C/EBPp caused a significant reduction in both arginase 1 (Arg1) and nitric oxide synthase 2 (Nos2) proteins (Figure 6A), two enzymes that were described as crucial components of MDSC inhibitory machinery (Bronte and Zanovello, 2005; Gabrilovich and Nagaraj, 2009).	SEN:10040442	20605485
BEL:20086502	p(MGI:Cebpb) increases p(MGI:Nos2)	Following separation of CD11b+ cells from MCA203 tumor infiltrate, we found that loss of C/EBPp caused a significant reduction in both arginase 1 (Arg1) and nitric oxide synthase 2 (Nos2) proteins (Figure 6A), two enzymes that were described as crucial components of MDSC inhibitory machinery (Bronte and Zanovello, 2005; Gabrilovich and Nagaraj, 2009).	SEN:10040442	20605485
BEL:20086508	p(HGNC:CSF3) increases r(HGNC:IL4R)	Cytokines were able to upregulate IL-4Ra expression, but a more pronounced effect was obtained by G-CSF+GM-CSF combination (Figure 7B and Figure S6B).	SEN:10040446	20605485
BEL:20086538	act(p(MGI:Nos2)) decreases bp(GOBP:"T cell proliferation")	Inhibition of iNOS with LMMA and of arginase I with nor-NOH completely abrogated suppressive activity of tumor-derived MDSC (Fig. 2 F).	SEN:10040466	20876310
BEL:20086540	act(p(MGI:Arg1)) decreases bp(GOBP:"T cell proliferation")	Inhibition of iNOS with LMMA and of arginase I with nor-NOH completely abrogated suppressive activity of tumor-derived MDSC (Fig. 2 F).	SEN:10040466	20876310
BEL:20086542	act(p(MGI:Arg1)) decreases bp(GOBP:"T cell proliferation")	Thus, MDSCs from the tumor use primarily arginase and NO to suppress T cell role, whereas splenic MDSCs use primarily ROS.	SEN:10040468	20876310
BEL:20086544	a(CHEBI:"nitric oxide") decreases bp(GOBP:"T cell proliferation")	Thus, MDSCs from the tumor use primarily arginase and NO to suppress T cell role, whereas splenic MDSCs use primarily ROS.	SEN:10040468	20876310
BEL:20086564	bp(GOBP:"response to hypoxia") increases r(MGI:Nos2)	In contrast, hypoxia dramatically up-regulated expression of argl and inos (Fig. 5 C).	SEN:10040480	20876310
BEL:20086566	bp(GOBP:"response to hypoxia") increases r(MGI:Arg1)	In contrast, hypoxia dramatically up-regulated expression of argl and inos (Fig. 5 C).	SEN:10040480	20876310
BEL:20086594	act(p(MGI:Hif1a)) increases r(MGI:Nos2)	DFO caused significant up-regulation of the expression of argl and inos and a decrease in the expression of NOX components p47phox andgp91phox (Fig. 6, D and E).	SEN:10040488	20876310
BEL:20086596	act(p(MGI:Hif1a)) increases r(MGI:Arg1)	DFO caused significant up-regulation of the expression of argl and inos and a decrease in the expression of NOX components p47phox andgp91phox (Fig. 6, D and E).	SEN:10040488	20876310
BEL:20086598	act(p(MGI:Hif1a)) decreases r(MGI:Ncf1)	DFO caused significant up-regulation of the expression of argl and inos and a decrease in the expression of NOX components p47phox andgp91phox (Fig. 6, D and E).	SEN:10040488	20876310
BEL:20086600	act(p(MGI:Hif1a)) decreases r(MGI:Cybb)	DFO caused significant up-regulation of the expression of argl and inos and a decrease in the expression of NOX components p47phox andgp91phox (Fig. 6, D and E).	SEN:10040488	20876310
BEL:20086602	act(p(MGI:Hif1a)) increases r(MGI:Arg1)	Expression of argl and inos in HIF-1a-positive MDSC was dramatically up-regulated after transfer into the tumor site (Fig. 6 I).	SEN:10040490	20876310
BEL:20086604	act(p(MGI:Hif1a)) increases r(MGI:Nos2)	Expression of argl and inos in HIF-1a-positive MDSC was dramatically up-regulated after transfer into the tumor site (Fig. 6 I).	SEN:10040490	20876310
BEL:20086608	act(p(MGI:Hif1a)) decreases a(CHEBI:"reactive oxygen species")	HIF-1a-deficient MDSCs had substantially higher ROS production than their WT counterparts (Fig. 6 K).	SEN:10040494	20876310
BEL:20086610	act(p(MGI:Hif1a)) increases p(MGI:Emr1)	Half of HIF-1a WT Gr-1- donor cells acquired the F4/80 marker of M$ and 20% became CD11c+ DCs (Fig. 7 A).	SEN:10040496	20876310
BEL:20086616	act(p(MGI:Hif1a)) increases p(MGI:Itgax)	In contrast, HIF-1a-deficient MDSC acquired CD11c marker, with only 20% of cells expressing F4/80 (Fig. 7 A).	SEN:10040498	20876310
BEL:20086620	act(p(MGI:Hif1a)) increases p(MGI:Nos2)	Hypoxia caused a dramatic up-regulation of arg1 and inos in HIF-1a WT MDSC, whereas a much smaller effect was observed in HIF-1a-deficient MDSC (Fig. 7 B).	SEN:10040502	20876310
BEL:20086622	act(p(MGI:Hif1a)) increases p(MGI:Arg1)	Hypoxia caused a dramatic up-regulation of arg1 and inos in HIF-1a WT MDSC, whereas a much smaller effect was observed in HIF-1a-deficient MDSC (Fig. 7 B).	SEN:10040502	20876310
BEL:20086628	p(MGI:Il1b) decreases p(MGI:Ly6c1)	Interestingly, in 4T1/IL-1p-tumor bearing mice the ratio of Lyc6low to Ly6Cneg MDSC was reversed, that is, this newly identified subpopulation of Ly6Cneg MDSC represented 75-90% of polymophonuclear (PMN)-MDSC in those mice (Figure 1C, D and Supplemental Figure 2A).	SEN:10040508	21110318
BEL:20086646	p(MGI:Il1b) decreases p(MGI:Cd27)	Using these markers we found a similar percentage of CD27+ NK cells in the bone marrow of all mice (Figure 4B), however, NK cells from 4T1/IL-1p-tumor bearing mice expressed 5-10-times less CD27 protein than NK cells from the other mice (Figure 4B).	SEN:10040522	21110318
BEL:20086648	p(MGI:Il1b) decreases p(MGI:Klrk1)	Ly6Cneg MDSC affect NKG2D expression by NK cells in vitro and in vivo. Further analyses showed a rapid down-modulation of NKG2D but not NKp46 expression by NK cells after injection of 4T1- and 4T1/IL-1p-tumor cells.	SEN:10040524	21110318
BEL:20086650	p(MGI:Il1b) decreases p(MGI:Klrk1)	The reduced expression of NKG2D occurred earlier and was more pronounced in 4T1/IL-ip-than in 4T1-tumor mice (Figure 5A and data not shown).	SEN:10040526	21110318
BEL:20086652	path(MESHD:"Breast Neoplasms") decreases p(MGI:Klrk1)	The reduced expression of NKG2D occurred earlier and was more pronounced in 4T1/IL-ip-than in 4T1-tumor mice (Figure 5A and data not shown).	SEN:10040526	21110318
BEL:20086674	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir223)	As shown in Figure 1c, with the differentiation of CD11b+Gr1+ cells from BMCs upon exposure to CT26 tumor, 1D8 tumor and tumor-associated factor PGE2, the expression of both pri-miR-223 and mature miR-223 was downregulated although there had a temporary up-regulation.	SEN:10040546	21213211
BEL:20086676	p(HGNC:PTGS2) decreases m(MGI:Mir223)	As shown in Figure 1c, with the differentiation of CD11b+Gr1+ cells from BMCs upon exposure to CT26 tumor, 1D8 tumor and tumor-associated factor PGE2, the expression of both pri-miR-223 and mature miR-223 was downregulated although there had a temporary up-regulation.	SEN:10040546	21213211
BEL:20086686	bp(GOBP:"response to tumor cell") increases r(MGI:Mef2c)	In contrast to miR-223 expression, CD11b+Gr1+ cells and both CD11b+Ly6G~Ly6C+ and CD11b+Ly6C+Ly6G+ subsets isolated from the spleens of mice bearing tumors had higher levels of expression of MEF2C than those from the spleens of disease-free mice (Fig. 3a).	SEN:10040556	21213211
BEL:20086688	bp(GOBP:"response to tumor cell") increases r(MGI:Mef2c)	Similarly, the expression of MEF2C was upregulated in the tumor-induced MDSCs (Fig. 3b) although there had a temporary downregulation.	SEN:10040558	21213211
BEL:20086690	p(HGNC:PTGS2) increases r(MGI:Mef2c)	Similarly, the expression of MEF2C was upregulated in the tumor-induced MDSCs (Fig. 3b) although there had a temporary downregulation.	SEN:10040558	21213211
BEL:20086710	m(MGI:Mir223) directlyDecreases r(MGI:Mef2c)	Meanwhile, miR-223-engineered cells had reduced MEF2C expression when compared to controls (Supporting Information Fig. S7).	SEN:10040574	21213211
BEL:20086716	p(MGI:Il6) increases tscript(p(MGI:Stat3))	In the lung, the concentration of IL-6 was increased, which aberrantly activated oncogenic Stat3 and increased expression of Stat3 downstream genes in epithelial tumor progenitor cells.	SEN:10040580	21378275
BEL:20086718	r(MGI:Mmp12) increases path(MESHD:Adenocarcinoma)	Spontaneous emphysema and lung adenocarcinoma were sequentially developed after MMP12 overexpression.	SEN:10040582	21378275
BEL:20086726	r(MGI:Mmp12) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	MMP12 suppresses T-cell proliferation and function in vivo The CD4+ T-lymphocyte population was significantly decreased in the spleen of doxycycline-treated bitransgenic mice (5.58%) compared with that in untreated ones (21.14%), while the CD8+ T-lymphocyte population was less affected (Figure 2A).	SEN:10040590	21378275
BEL:20086732	act(p(MGI:Mmp12)) decreases sec(p(MGI:Il2))	The culture medium showed decreased secretion of IL-2, IL-4, and IFN7 in the activated MMP12-treated samples (Figure 2F).	SEN:10040594	21378275
BEL:20086734	act(p(MGI:Mmp12)) decreases sec(p(MGI:Il4))	The culture medium showed decreased secretion of IL-2, IL-4, and IFN7 in the activated MMP12-treated samples (Figure 2F).	SEN:10040594	21378275
BEL:20086736	act(p(MGI:Mmp12)) decreases sec(p(MGI:Ifng))	The culture medium showed decreased secretion of IL-2, IL-4, and IFN7 in the activated MMP12-treated samples (Figure 2F).	SEN:10040594	21378275
BEL:20086742	act(p(MGI:Mmp12)) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	CD11b+/Gr-1+ cells from doxcycline-treated bitransgenic mice showed the strongest inhibition on proliferation of wild-type CD4+ T cells (Figure 3C).	SEN:10040598	21378275
BEL:20086744	act(p(MGI:Mmp12)) decreases sec(p(MGI:Il2))	This inhibition was further confirmed by a significant reduction of IL-2 and IL-4 secretion, implicating a functional impairment of CD4+ T cells by CD11b+/Gr-1+ cells from doxcycline-treated bitransgenic mice (Figure 3D).	SEN:10040600	21378275
BEL:20086746	act(p(MGI:Mmp12)) decreases sec(p(MGI:Il4))	This inhibition was further confirmed by a significant reduction of IL-2 and IL-4 secretion, implicating a functional impairment of CD4+ T cells by CD11b+/Gr-1+ cells from doxcycline-treated bitransgenic mice (Figure 3D).	SEN:10040600	21378275
BEL:20086756	act(p(MGI:Mmp12)) increases r(MGI:Il6)	Compared with doxycycline-untreated bitransgenic mice, the expression levels of IL-1p, IL-6, MIP-2, and TNF-a were abnormally increased in the plasma of doxycycline-treated bitransgenic mice (Figure 4A).	SEN:10040608	21378275
BEL:20086758	act(p(MGI:Mmp12)) increases r(MGI:Il1b)	Compared with doxycycline-untreated bitransgenic mice, the expression levels of IL-1p, IL-6, MIP-2, and TNF-a were abnormally increased in the plasma of doxycycline-treated bitransgenic mice (Figure 4A).	SEN:10040608	21378275
BEL:20086760	act(p(MGI:Mmp12)) increases p(MGI:Wdr26)	Compared with doxycycline-untreated bitransgenic mice, the expression levels of IL-1p, IL-6, MIP-2, and TNF-a were abnormally increased in the plasma of doxycycline-treated bitransgenic mice (Figure 4A).	SEN:10040608	21378275
BEL:20086762	act(p(MGI:Mmp12)) increases r(MGI:Tnf)	Compared with doxycycline-untreated bitransgenic mice, the expression levels of IL-1p, IL-6, MIP-2, and TNF-a were abnormally increased in the plasma of doxycycline-treated bitransgenic mice (Figure 4A).	SEN:10040608	21378275
BEL:20086818	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir20a)	The expression of miR-17-5p and miR-20a in tumor-associated MDSCs was found to be lower than in Gr1+CD11b+ cells isolated from the spleens of disease-free mice.	SEN:10040636	21383238
BEL:20086820	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir17)	The expression of miR-17-5p and miR-20a in tumor-associated MDSCs was found to be lower than in Gr1+CD11b+ cells isolated from the spleens of disease-free mice.	SEN:10040636	21383238
BEL:20086822	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir17)	Tumor-associated factor downregulates the expression of both miR-17-5p and miR-20a.	SEN:10040638	21383238
BEL:20086824	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir20a)	Tumor-associated factor downregulates the expression of both miR-17-5p and miR-20a.	SEN:10040638	21383238
BEL:20086826	m(MGI:Mir17) decreases p(MGI:Stat3)	STAT3 is regulated by miR-17-5p and miR-20a.	SEN:10040640	21383238
BEL:20086828	m(MGI:Mir20a) decreases p(MGI:Stat3)	STAT3 is regulated by miR-17-5p and miR-20a.	SEN:10040640	21383238
BEL:20086830	m(MGI:Mir17) decreases p(MGI:Stat3)	We found that miR17-5p or miR-20a affects STAT3 expression only at the protein level.	SEN:10040642	21383238
BEL:20086832	m(MGI:Mir20a) decreases p(MGI:Stat3)	We found that miR17-5p or miR-20a affects STAT3 expression only at the protein level.	SEN:10040642	21383238
BEL:20086834	m(MGI:Mir17) decreases p(MGI:Stat3)	As shown in Fig. 2, the levels of STAT3 protein in RAW 264.7 cells transfected with miR17-5p or miR-20a mimics were indeed lower than in negative control transfected cells, whereas the transcription level of STAT3 was not affected.	SEN:10040644	21383238
BEL:20086836	m(MGI:Mir20a) decreases p(MGI:Stat3)	As shown in Fig. 2, the levels of STAT3 protein in RAW 264.7 cells transfected with miR17-5p or miR-20a mimics were indeed lower than in negative control transfected cells, whereas the transcription level of STAT3 was not affected.	SEN:10040644	21383238
BEL:20086838	m(MGI:Mir20a) decreases r(MGI:Cybb)	As shown in Fig. 2, miR-17-5p and miR-20a also reduced the transcriptional and protein levels of p47phox and gp91 phox, two subunits of NADPH oxidase.	SEN:10040646	21383238
BEL:20086840	m(MGI:Mir20a) decreases r(MGI:Ncf1)	As shown in Fig. 2, miR-17-5p and miR-20a also reduced the transcriptional and protein levels of p47phox and gp91 phox, two subunits of NADPH oxidase.	SEN:10040646	21383238
BEL:20086842	m(MGI:Mir17) decreases r(MGI:Cybb)	As shown in Fig. 2, miR-17-5p and miR-20a also reduced the transcriptional and protein levels of p47phox and gp91 phox, two subunits of NADPH oxidase.	SEN:10040646	21383238
BEL:20086844	m(MGI:Mir17) decreases r(MGI:Ncf1)	As shown in Fig. 2, miR-17-5p and miR-20a also reduced the transcriptional and protein levels of p47phox and gp91 phox, two subunits of NADPH oxidase.	SEN:10040646	21383238
BEL:20086846	complex(m(MGI:Mir20a),tscript(p(MGI:Stat3))) decreases p(MGI:Stat3)	Thus, our results demonstrate that both miR-17-5p and miR-20a target the STAT3 3'UTR to reduce the expression of STAT3.	SEN:10040648	21383238
BEL:20086848	complex(m(MGI:Mir17),tscript(p(MGI:Stat3))) decreases p(MGI:Stat3)	Thus, our results demonstrate that both miR-17-5p and miR-20a target the STAT3 3'UTR to reduce the expression of STAT3.	SEN:10040648	21383238
BEL:20086854	tscript(p(MGI:Stat3)) increases a(CHEBI:"reactive oxygen species")	As a positive control, STAT3-targeted siRNAs also inhibit the expression of ROS and the production of H2O2 (Supplemental Fig. 3).	SEN:10040652	21383238
BEL:20086856	tscript(p(MGI:Stat3)) increases a(CHEBI:dioxidaniumyl)	As a positive control, STAT3-targeted siRNAs also inhibit the expression of ROS and the production of H2O2 (Supplemental Fig. 3).	SEN:10040652	21383238
BEL:20086858	m(MGI:Mir17) decreases a(CHEBI:"reactive oxygen species")	As shown in Fig. 3A and 3B, the transfection of miR-17-5p and miR-20a mimics reduces the expression of ROS and the production of H2O2 in the isolated tumor-associated MDSCs in the presence of PMA.	SEN:10040654	21383238
BEL:20086860	m(MGI:Mir17) decreases a(CHEBI:dioxidaniumyl)	As shown in Fig. 3A and 3B, the transfection of miR-17-5p and miR-20a mimics reduces the expression of ROS and the production of H2O2 in the isolated tumor-associated MDSCs in the presence of PMA.	SEN:10040654	21383238
BEL:20086862	m(MGI:Mir20a) decreases a(CHEBI:dioxidaniumyl)	As shown in Fig. 3A and 3B, the transfection of miR-17-5p and miR-20a mimics reduces the expression of ROS and the production of H2O2 in the isolated tumor-associated MDSCs in the presence of PMA.	SEN:10040654	21383238
BEL:20086864	m(MGI:Mir20a) decreases a(CHEBI:"reactive oxygen species")	As shown in Fig. 3A and 3B, the transfection of miR-17-5p and miR-20a mimics reduces the expression of ROS and the production of H2O2 in the isolated tumor-associated MDSCs in the presence of PMA.	SEN:10040654	21383238
BEL:20086898	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir17)	As shown in Fig. 5A, Gr1+CD11b+ cells isolated from the spleens of CT-26 tumor-bearing mice have lower levels of expression of both pri- and mature miR-17-5p and miR-20a than do Gr1+CD11b+ cells from the spleens of disease-free mice (p < 0.05).	SEN:10040668	21383238
BEL:20086900	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir20a)	As shown in Fig. 5A, Gr1+CD11b+ cells isolated from the spleens of CT-26 tumor-bearing mice have lower levels of expression of both pri- and mature miR-17-5p and miR-20a than do Gr1+CD11b+ cells from the spleens of disease-free mice (p < 0.05).	SEN:10040668	21383238
BEL:20086902	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir17)	As shown in Fig. 5B, tumor-associated factors can upregulate the expression of miR-17-5p and miR-20a, but the expression of miR-17-5p and miR-20a is downregulated after 6 h exposure to tumor supernatants.	SEN:10040670	21383238
BEL:20086904	bp(GOBP:"response to tumor cell") decreases m(MGI:Mir20a)	As shown in Fig. 5B, tumor-associated factors can upregulate the expression of miR-17-5p and miR-20a, but the expression of miR-17-5p and miR-20a is downregulated after 6 h exposure to tumor supernatants.	SEN:10040670	21383238
BEL:20086906	bp(GOBP:"response to tumor cell") increases p(MGI:Stat3)	Conversely, the expression of STAT3 was found to be upregulated after a temporary downregulation.	SEN:10040672	21383238
BEL:20086916	m(MGI:Mir17) increases a(CHEBI:"reactive oxygen species")	The role of miR-17-5p and miR-20a in the expression of ROS and production of H2O2 by CD11b+Ly6G+ can be blocked by miR-17-5p or miR-20a inhibitors.	SEN:10040678	21383238
BEL:20086918	m(MGI:Mir17) increases a(CHEBI:dioxidaniumyl)	The role of miR-17-5p and miR-20a in the expression of ROS and production of H2O2 by CD11b+Ly6G+ can be blocked by miR-17-5p or miR-20a inhibitors.	SEN:10040678	21383238
BEL:20086920	m(MGI:Mir20a) increases a(CHEBI:"reactive oxygen species")	The role of miR-17-5p and miR-20a in the expression of ROS and production of H2O2 by CD11b+Ly6G+ can be blocked by miR-17-5p or miR-20a inhibitors.	SEN:10040678	21383238
BEL:20086922	m(MGI:Mir20a) increases a(CHEBI:dioxidaniumyl)	The role of miR-17-5p and miR-20a in the expression of ROS and production of H2O2 by CD11b+Ly6G+ can be blocked by miR-17-5p or miR-20a inhibitors.	SEN:10040678	21383238
BEL:20086926	p(MGI:Fasl) increases act(p(MGI:Casp3))	Although control antibody-treated MDSCs from tumor-free and tumor-bearing mice had some background-cleaved caspase3 expression, Jo2 mAb-treated cells from both tumor-bearing and tumor-free mice had significantly higher levels of cleaved caspase3.	SEN:10040682	21450901
BEL:20086928	p(MGI:Fasl) increases act(p(MGI:Casp3))	Jo2-treated MDSCs also contained activated caspase3 as detected by Western blot analysis (Figure 3B).	SEN:10040684	21450901
BEL:20086930	p(MGI:Fasl) increases act(p(MGI:Casp3))	Ninety-two percent of Gr1+CD11b+ MDSCs treated with Jo2 mAb were strongly positive for cleaved caspase3, whereas only 5% of control mAb-treated cells were strongly positive.	SEN:10040686	21450901
BEL:20086956	p(MGI:Tnf) increases p(MGI:Il10)	These data indicate that during DMBA/TPA-induced squamous carcinogenesis TNF-a mediates tumor-promoting activity via regulatory B cells that repress antitumor immunity.	SEN:10040706	21670304
BEL:20086968	p(MGI:Tnf) decreases p(MGI:Ccl5)	There were no other significant differences in leukocyte infiltrate.. CCL5, a T-cell chemoattractant, was increased threefold in untreated Tnf-/- epidermis compared with wild-type epidermis (Fig. 2C, Left) and also increased in DMBA/TPA-treated Tnf-/-epidermis compared with wild-type (Fig. 2C, Center).	SEN:10040716	21670304
BEL:20086972	p(MGI:Tnf) decreases p(MGI:Ifng)	IFN-y mRNA was 10-fold higher in untreated Tnf-/- epidermis than in untreated wild-type epidermis (Fig. 2D, Left) and was higher at all time points during DMBA/TPA treatment (Fig. 2D, Center).	SEN:10040718	21670304
BEL:20086974	p(MGI:Tnf) decreases p(MGI:Ccl5)	CCL5 mRNA was lower in Tnf-/- epidermis after transfer of wild-type B cells, as was IFN-y mRNA at 10 wk (Fig. 2 C and D, Right).	SEN:10040720	21670304
BEL:20086978	p(MGI:Tnf) increases p(MGI:Il10)	LPS-stimulated CD19+ B cells isolated from Tnf mice produced less IL-10 and more total IL-12 (IL-12p70) than did CD19+ B cells from wild-type mice (Fig. 3C; P < 0.05).	SEN:10040724	21670304
BEL:20086980	p(MGI:Tnf) decreases p(MGI:Il12b)	LPS-stimulated CD19+ B cells isolated from Tnf mice produced less IL-10 and more total IL-12 (IL-12p70) than did CD19+ B cells from wild-type mice (Fig. 3C; P < 0.05).	SEN:10040724	21670304
BEL:20086990	p(MGI:Tnf) increases p(MGI:Cr2)	We found that Tnf mice are deficient for CD19+CD21high B cells compared with wild-type mice, both in terms of percentage of cells and absolute number (Fig. 4C; P < 0.01, Fig. S2B).	SEN:10040730	21670304
BEL:20086994	p(MGI:Tnf) decreases p(MGI:Ifng)	DMBA/TPA-treated Tnf mice had more IFN-y+ T cells in spleens (P < 0.05) than wild-type treated mice (Fig. 4D).	SEN:10040732	21670304
BEL:20087096	act(p(HGNC:PTGS2)) increases p(HGNC:IDO1)	This effect was abrogated by the addition of COX2 inhibitor during the generation of CM from cancer ascites cells.	SEN:10040800	21972293
BEL:20087098	act(p(HGNC:PTGS2)) increases r(HGNC:NOS2)	This effect was abrogated by the addition of COX2 inhibitor during the generation of CM from cancer ascites cells.	SEN:10040800	21972293
BEL:20087100	act(p(HGNC:PTGS2)) increases r(HGNC:IL10)	This effect was abrogated by the addition of COX2 inhibitor during the generation of CM from cancer ascites cells.	SEN:10040800	21972293
BEL:20087102	act(p(HGNC:PTGS2)) increases r(HGNC:IL4R)	This effect was abrogated by the addition of COX2 inhibitor during the generation of CM from cancer ascites cells.	SEN:10040800	21972293
BEL:20087136	bp(GOBP:"response to tumor cell") increases r(HGNC:PTGS2)	Whereas the MDSCs isolated from cancer patients expressed COX2 and secreted high levels of PGE2 (Figure 4B) compared with control CD11b+ cells from normal blood, their PGE2 secretion was blocked by celecoxib treatment (Figure 4B).	SEN:10040810	21972293
BEL:20087306	r(MGI:Inpp5d) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Factors from murine pancreatic cancer cells cause the down-regulation of SHIP-1 expression, which may potentially contribute to MDSC expansion, and the suppression of CD8+ T cell immune responses.	SEN:10040908	22132131
BEL:20087308	bp(GOBP:"response to tumor cell") decreases r(MGI:Inpp5d)	qRT-PCR and Western blot analyses revealed the in vivo down-regulation of SHIP-1 expression in splenocytes from TB mice.	SEN:10040910	22132131
BEL:20087310	bp(GOBP:"response to tumor cell") increases p(MGI:Bcl2)	Western blot analyses also detected reduced SHIP-1 activity, increased AKT-1 and BAD hyper-phosphorylation and up-regulation of BCL-2 expression in splenocytes from TB mice.	SEN:10040912	22132131
BEL:20087312	bp(GOBP:"response to tumor cell") decreases p(MGI:Inpp5d,pmod(P))	Western blot analyses also detected reduced SHIP-1 activity, increased AKT-1 and BAD hyper-phosphorylation and up-regulation of BCL-2 expression in splenocytes from TB mice.	SEN:10040912	22132131
BEL:20087314	bp(GOBP:"response to tumor cell") increases p(MGI:Akt1,pmod(P))	Western blot analyses also detected reduced SHIP-1 activity, increased AKT-1 and BAD hyper-phosphorylation and up-regulation of BCL-2 expression in splenocytes from TB mice.	SEN:10040912	22132131
BEL:20087316	bp(GOBP:"response to tumor cell") increases p(MGI:Bad,pmod(P))	Western blot analyses also detected reduced SHIP-1 activity, increased AKT-1 and BAD hyper-phosphorylation and up-regulation of BCL-2 expression in splenocytes from TB mice.	SEN:10040912	22132131
BEL:20087318	bp(GOBP:"response to tumor cell") decreases r(MGI:Inpp5d)	In vitro, qRT-PCR and Western blot analyses detected reduced SHIP-1 mRNA and protein expression in control splenocytes co-cultured with Panc 02.03 cells.	SEN:10040914	22132131
BEL:20087320	bp(GOBP:"response to tumor cell") decreases p(MGI:Inpp5d)	In vitro, qRT-PCR and Western blot analyses detected reduced SHIP-1 mRNA and protein expression in control splenocytes co-cultured with Panc 02.03 cells.	SEN:10040914	22132131
BEL:20087326	bp(GOBP:"response to tumor cell") increases p(MGI:Il6)	Results from the Inflammatory Cytometric Bead Analysis (CBA) Kit detected pro-inflammatory factors Interleukin-6 (IL-6), Interleukin-10 (IL-10) and Monocyte Chemoattractant Protein-1 (MCP-1) to a greater extent than Tumor Necrosis Factor (TNF), Interferon gamma (IFN-y and Interleukin-12p 70 (IL-12p70) in the supernatants of cultured murine Panc 02.03 cells (Figure 1a).	SEN:10040918	22132131
BEL:20087328	bp(GOBP:"response to tumor cell") increases p(MGI:Il10)	Results from the Inflammatory Cytometric Bead Analysis (CBA) Kit detected pro-inflammatory factors Interleukin-6 (IL-6), Interleukin-10 (IL-10) and Monocyte Chemoattractant Protein-1 (MCP-1) to a greater extent than Tumor Necrosis Factor (TNF), Interferon gamma (IFN-y and Interleukin-12p 70 (IL-12p70) in the supernatants of cultured murine Panc 02.03 cells (Figure 1a).	SEN:10040918	22132131
BEL:20087330	bp(GOBP:"response to tumor cell") increases p(MGI:Ccl2)	Results from the Inflammatory Cytometric Bead Analysis (CBA) Kit detected pro-inflammatory factors Interleukin-6 (IL-6), Interleukin-10 (IL-10) and Monocyte Chemoattractant Protein-1 (MCP-1) to a greater extent than Tumor Necrosis Factor (TNF), Interferon gamma (IFN-y and Interleukin-12p 70 (IL-12p70) in the supernatants of cultured murine Panc 02.03 cells (Figure 1a).	SEN:10040918	22132131
BEL:20087332	bp(GOBP:"response to tumor cell") decreases r(MGI:Inpp5d)	TB splenocytes have a reduction in SHIP-1 expression.	SEN:10040920	22132131
BEL:20087334	bp(GOBP:"response to tumor cell") decreases r(MGI:Inpp5d)	Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) results detected a decrease in SHIP-1 mRNA expression in TB compared to control splenocytes (Figure 3b).	SEN:10040922	22132131
BEL:20087336	bp(GOBP:"response to tumor cell") decreases act(p(MGI:Inpp5d))	TB splenocytes have reduced SHIP-1 activity.	SEN:10040924	22132131
BEL:20087338	bp(GOBP:"response to tumor cell") decreases p(MGI:Inpp5d,pmod(P))	Western blot analyses did not detect phosphorylation of tyrosine 1020 on SHIP-1, in splenocytes from TB compared to control mice (Figure 4a).	SEN:10040926	22132131
BEL:20087340	bp(GOBP:"response to tumor cell") increases act(p(MGI:Akt1))	TB splenocytes have increased AKT activity.	SEN:10040928	22132131
BEL:20087342	bp(GOBP:"response to tumor cell") increases p(MGI:Akt1,pmod(P,S,473))	Western Blot results revealed hyper-phosphorylation of AKT-1 at Ser473 in whole splenocytes from TB compared to control mice (Figure 4b).	SEN:10040930	22132131
BEL:20087344	bp(GOBP:"response to tumor cell") increases r(MGI:Bcl2)	TB splenocytes have increased BCL-2 expression.	SEN:10040932	22132131
BEL:20087346	bp(GOBP:"response to tumor cell") increases p(MGI:Bad,pmod(P,S,112))	Western Blot results showed hyperphosphorylation of BAD at Ser112 in splenocytes from TB mice compared to control mice (Figure 4c).	SEN:10040934	22132131
BEL:20087348	bp(GOBP:"response to tumor cell") increases r(MGI:Bcl2)	Western blot results revealed an up-regulation in BCL-2 expression in splenocytes from TB mice (Figure 4d) compared to control.	SEN:10040936	22132131
BEL:20087350	bp(GOBP:"response to tumor cell") decreases p(MGI:Inpp5d)	Murine Panc 02.03 cells down-regulate SHIP-1 expression in vitro.	SEN:10040938	22132131
BEL:20087352	bp(GOBP:"response to tumor cell") decreases r(MGI:Inpp5d)	qRT-PCR analysis revealed a significant decrease in SHIP-1 mRNA expression in control splenocytes co-cultured with Panc 02.03 cells compared to control splenocytes cultured alone (Figure 5a).	SEN:10040940	22132131
BEL:20087354	bp(GOBP:"response to tumor cell") decreases p(MGI:Inpp5d)	In addition, western blot results revealed greater than a a 2-fold reduction in SHIP-1 protein expression in control splenocytes cocultured with Panc 02.03 cells compared to control splenocytes cultured alone (Figure 5b).	SEN:10040942	22132131
BEL:20087356	bp(GOBP:"response to tumor cell") decreases p(MGI:Inpp5d)	These results correlate with our in vivo data and show that Panc 02.03 cells are able to suppress SHIP-1 mRNA and protein expression in vitro.	SEN:10040944	22132131
BEL:20087358	bp(GOBP:"response to tumor cell") decreases r(MGI:Inpp5d)	These results correlate with our in vivo data and show that Panc 02.03 cells are able to suppress SHIP-1 mRNA and protein expression in vitro.	SEN:10040944	22132131
BEL:20087386	act(p(MGI:Nos2)) increases p(MGI:Stat3,pmod(P))	L-NIL downregulates STAT3 activation and inhibits ROS production in MDSC.	SEN:10040962	22529296
BEL:20087388	act(p(MGI:Nos2)) increases a(CHEBI:"reactive oxygen species")	L-NIL downregulates STAT3 activation and inhibits ROS production in MDSC.	SEN:10040962	22529296
BEL:20087390	act(p(MGI:Nos2)) increases a(CHEBI:"reactive oxygen species")	However, ROS levels were dramatically upregulated in Transwell culture with MT-RET-1 cells (Fig. 2A, 2B), and upregulation of ROS was suppressed to levels below baseline by addition of L-NIL to coculture.	SEN:10040964	22529296
BEL:20087392	bp(GOBP:"response to tumor cell") increases a(CHEBI:"reactive oxygen species")	However, ROS levels were dramatically upregulated in Transwell culture with MT-RET-1 cells (Fig. 2A, 2B), and upregulation of ROS was suppressed to levels below baseline by addition of L-NIL to coculture.	SEN:10040964	22529296
BEL:20087396	bp(GOBP:"response to tumor cell") increases p(MGI:Stat3)	Coculture with MT-RET-1 cells also strongly upregulated levels of activated phospho-STAT3 in bone marrow-derived MDSC, and STAT3 activation was suppressed by addition of L-NIL (Fig. 2C).	SEN:10040966	22529296
BEL:20087398	bp(GOBP:"response to tumor cell") increases sec(p(MGI:Vegfa))	Release of VEGF from tumor cells has also been shown to be upregulated by iNOS expression.	SEN:10040968	22529296
BEL:20087400	p(MGI:Nos2) increases sec(p(MGI:Vegfa))	Release of VEGF from tumor cells has also been shown to be upregulated by iNOS expression.	SEN:10040968	22529296
BEL:20087402	act(p(MGI:Nos2)) increases sec(p(MGI:Vegfa))	VEGF release by MT-RET-1 cells was reduced >2-fold by L-NIL in vitro (Fig. 3A) without evidence of direct toxicity to tumor cells (Supplemental Fig. 1B)..	SEN:10040970	22529296
BEL:20087414	act(p(MGI:Nos2)) increases a(CHEBI:"reactive oxygen species")	ROS levels in MDSC from spleen of L-NIL-treated tumor-bearing mice were significantly reduced as compared with untreated mice (Fig. 6C).	SEN:10040980	22529296
BEL:20087416	act(p(HGNC:NOS2)) increases p(HGNC:STAT3,pmod(P,S,727))	Western blot analysis of total and phospho-STAT3 levels in MT-RET-1 tumors demonstrated robust phosphorylation of serine 727 and tyrosine 705 in tumors from untreated mice.	SEN:10040982	22529296
BEL:20087418	act(p(MGI:Nos2)) increases p(MGI:Stat3,pmod(P,Y,727))	Western blot analysis of total and phospho-STAT3 levels in MT-RET-1 tumors demonstrated robust phosphorylation of serine 727 and tyrosine 705 in tumors from untreated mice.	SEN:10040982	22529296
BEL:20087420	act(p(MGI:Nos2)) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	Treatment of both 4-d (data not shown) and 14-d MT-RET-1 tumors with L-NIL increased numbers of tumor-infiltrating and splenic CD4 and CD8 T cells in wild-type mice (Fig. 4B).	SEN:10040984	22529296
BEL:20087422	act(p(MGI:Nos2)) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Treatment of both 4-d (data not shown) and 14-d MT-RET-1 tumors with L-NIL increased numbers of tumor-infiltrating and splenic CD4 and CD8 T cells in wild-type mice (Fig. 4B).	SEN:10040984	22529296
BEL:20087424	act(p(MGI:Nos2)) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	Whereas splenic T cell levels were reduced in the tumor-bearing state, L-NIL treatment restored numbers of splenic CD4 and CD8 T cells to numbers comparable to those seen in tumor-free mice (3 X 106 CD4 and 2.5 X 106 CD8 T cells) and reversed the splenomegaly observed in many tumor-bearing mice (data not shown).	SEN:10040986	22529296
BEL:20087428	act(p(MGI:Nos2)) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	L-NIL treatment of iNOS-deficient mice led to robust recovery of splenic CD4 and CD8 T cell numbers (Fig. 4B), demonstrating that the failure of host iNOS ablation to restore T cell numbers in tumor-bearing mice is not due to upregulation of iNOS-independent compensatory mechanisms in iNOS KO mice.	SEN:10040990	22529296
BEL:20087430	act(p(MGI:Nos2)) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	L-NIL treatment of iNOS-deficient mice led to robust recovery of splenic CD4 and CD8 T cell numbers (Fig. 4B), demonstrating that the failure of host iNOS ablation to restore T cell numbers in tumor-bearing mice is not due to upregulation of iNOS-independent compensatory mechanisms in iNOS KO mice.	SEN:10040990	22529296
BEL:20087434	bp(GOBP:"response to tumor cell") increases m(MGI:Mir494)	In this study, we identified microRNA-494 (miR-494), whose expression was dramatically induced by tumor-derived factors, as an essential player in regulating the accumulation and activity of MDSCs by targeting of phosphatase and tensin homolog (PTEN) and activation of the Akt pathway.	SEN:10040994	22544933
BEL:20087444	bp(GOBP:"response to tumor cell") increases m(MGI:Mir494)	miR-494 is highly expressed in tumor-expanded MDSCs.	SEN:10041002	22544933
BEL:20087460	bp(GOBP:"response to tumor cell") increases m(MGI:Mir494)	As shown in Fig. 1C, significantly increased expression of miR-494 was detected in both subpopulations compared with their counterpart from tumor-free mice (granulocytic MDSCs, p < 0.01; monocytic MDSCs, p < 0.001).	SEN:10041006	22544933
BEL:20087464	p(MGI:Tgfb1) increases m(MGI:Mir494)	Tumor-derived factors, especially TG'F-fH, markedly induce the upregulation of miR-494 in MDSCs.	SEN:10041010	22544933
BEL:20087466	p(MGI:Tgfb1) increases m(MGI:Mir494)	As expected, we found that miR-494 expression was significantly induced by TCCM in a dose-dependent manner (Fig. 2A).	SEN:10041012	22544933
BEL:20087468	p(MGI:Tgfb1) increases m(MGI:Mir494)	As shown in Fig. 2B, we found that the expression of miR-494 in Gr-1+ CD11b+ cells was not affected by GM-CSF and IL-6, but interestingly, miR-494 expression was significantly induced by TGF-b1 treatment (p < 0.001).	SEN:10041014	22544933
BEL:20087470	p(MGI:Tgfb1) increases m(MGI:Mir494)	Moreover, the induction of miR-494 was partially blocked by anti-TGF-p1 mAb in cells stimulated with 4T1 TCCM (Fig. 2C), and the upregulation of miR-494 was impaired in Smad 3-deficient Gr-1+ CD11b+ cells isolated from the spleen of Smad 3_/_ mice (Fig. 2D).	SEN:10041016	22544933
BEL:20087482	m(MGI:Mir494) increases r(MGI:Mmp14)	As expected, the expression levels of ARG1, MMP2, MMP13, and MMP14 were significantly upregulated in lv-494-infected MDSCs compared with those in lv-ctrl-infected MDSCs (Fig. 4B); moreover, lv-sponge overtly blocked the induction in the expression of these molecules.	SEN:10041022	22544933
BEL:20087484	m(MGI:Mir494) increases r(MGI:Mmp13)	As expected, the expression levels of ARG1, MMP2, MMP13, and MMP14 were significantly upregulated in lv-494-infected MDSCs compared with those in lv-ctrl-infected MDSCs (Fig. 4B); moreover, lv-sponge overtly blocked the induction in the expression of these molecules.	SEN:10041022	22544933
BEL:20087486	m(MGI:Mir494) increases r(MGI:Tinagl1)	As expected, the expression levels of ARG1, MMP2, MMP13, and MMP14 were significantly upregulated in lv-494-infected MDSCs compared with those in lv-ctrl-infected MDSCs (Fig. 4B); moreover, lv-sponge overtly blocked the induction in the expression of these molecules.	SEN:10041022	22544933
BEL:20087488	m(MGI:Mir494) increases r(MGI:Mmp2)	As expected, the expression levels of ARG1, MMP2, MMP13, and MMP14 were significantly upregulated in lv-494-infected MDSCs compared with those in lv-ctrl-infected MDSCs (Fig. 4B); moreover, lv-sponge overtly blocked the induction in the expression of these molecules.	SEN:10041022	22544933
BEL:20087494	m(MGI:Mir494) decreases act(p(MGI:Arg1))	As shown in Fig. 4G, OT-1 CD8+ T cell proliferation was significantly suppressed by lv-494-infected MDSCs in comparison with lv-ctrl-infected MDSCs, and this suppressive activity could be partially blocked by an ARG1 inhibitor nor-NOHA.	SEN:10041028	22544933
BEL:20087496	act(p(MGI:Arg1)) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	As shown in Fig. 4G, OT-1 CD8+ T cell proliferation was significantly suppressed by lv-494-infected MDSCs in comparison with lv-ctrl-infected MDSCs, and this suppressive activity could be partially blocked by an ARG1 inhibitor nor-NOHA.	SEN:10041028	22544933
BEL:20087510	bp(GOBP:"response to tumor cell") decreases p(MGI:Pten)	Notably, the PTEN protein level was significantly downregulated in tumor-expanded MDSCs compared with that in Gr-1+ CD11b+ cells from tumor-free mice, whereas PTEN mRNA expression showed no difference (Fig. 6A).	SEN:10041038	22544933
BEL:20087512	m(HGNC:MIR494) decreases p(HGNC:PTEN)	When the reporter plasmids with miR-494 mimics or the scrambled oligonucleotide were cotransfected to HEK-293 cells, we observed that the miR-494 mimics markedly decreased the luciferase activity (Fig. 6B).	SEN:10041040	22544933
BEL:20087514	m(MGI:Mir494) decreases p(MGI:Pten)	Furthermore, transfection of lv-494 significantly decreased PTEN expression in MDSCs, thus suggesting that endogenous PTEN is targeted and regulated by miR-494 (Fig. 6C).. To confirm whether miR-494-induced activation of MDSCs was mediated by targeting of PTEN expression, we designed a lentiviral vector encoding 39-UTR-depleted PTEN to enforce the expression of PTEN in MDSCs.	SEN:10041042	22544933
BEL:20087516	p(MGI:Pten) decreases r(MGI:Mmp2)	Overexpression of PTEN in Gr-1+ CD11b+ cells did not affect the TDF-induced miR-494 up-regulation, whereas the increased expression of MMPs induced by TCCM were significantly blocked (Fig. 6D), and SDF-1/CXCL12-mediated MDSC migration was abrogated (Fig. 6E).	SEN:10041044	22544933
BEL:20087518	p(MGI:Pten) decreases r(MGI:Mmp14)	Overexpression of PTEN in Gr-1+ CD11b+ cells did not affect the TDF-induced miR-494 up-regulation, whereas the increased expression of MMPs induced by TCCM were significantly blocked (Fig. 6D), and SDF-1/CXCL12-mediated MDSC migration was abrogated (Fig. 6E).	SEN:10041044	22544933
BEL:20087522	bp(GOBP:"response to tumor cell") decreases r(MGI:Pten)	Significantly reduced PTEN expression was also detected in Gr-1+ CD11b+ cells after TCCM stimulation (Fig. 6G); this was inversely correlated with the phosphorylation levels of mTOR and NF-kB.	SEN:10041046	22544933
BEL:20087524	act(p(MGI:Akt1)) increases r(MGI:Mmp14)	As shown in Fig. 6H, the increased levels of MMPs induced by TCCM were completely abolished by LY294002, suggesting that the Akt activity is indispensable for the activation of MDSCs.	SEN:10041048	22544933
BEL:20087526	act(p(MGI:Akt1)) increases r(MGI:Mmp2)	As shown in Fig. 6H, the increased levels of MMPs induced by TCCM were completely abolished by LY294002, suggesting that the Akt activity is indispensable for the activation of MDSCs.	SEN:10041048	22544933
BEL:20087528	act(p(MGI:Nkap)) increases r(MGI:Mmp13)	BAY-117802 significantly blocked MMP13 expression but had a limited effect on the upregulation of MMP2 and MMP14, whereas rapamycin eliminated the expression of all MMPs.	SEN:10041050	22544933
BEL:20087530	p(MGI:Tgfb1) increases m(MGI:Mir494)	TGF-p1-induced miR-494 was involved in the negative regulation of PTEN expression.	SEN:10041052	22544933
BEL:20087532	m(MGI:Mir494) decreases p(MGI:Pten)	TGF-p1-induced miR-494 was involved in the negative regulation of PTEN expression.	SEN:10041052	22544933
BEL:20087564	p(MGI:Stat1) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Upon coculture with OVA-stimulated TCR transgenic OT-1 splenocytes, WT MO-MDSCs suppressed T-cell proliferation in a dose-dependent manner, while IFN-yR-/- and STAT-1-/-MO-MDSCs almost completely lost their suppressive capacity (Fig. 1A and Supporting Information Fig. 2A for CFSE dilution).	SEN:10041062	23878002
BEL:20087566	p(MGI:Ifng) increases p(MGI:Stat1,pmod(P))	Interestingly, when treating MO-MDSCs with recombinant IFN-y, only 72% of the population phosphorylates STAT-1, illustrating MO-MDSC heterogeneity and suggesting that only the IFN-y-responsive part of this population mediates suppression (Supporting Information Fig. 3).	SEN:10041064	23878002
BEL:20087574	p(MGI:Ifng) increases p(MGI:Stat1,pmod(P))	The relatively minor importance of IFN-y is not due to a lack of IFN-y responsiveness, since IFN-y treatment of PMN-MDSCs uniformly phosphorylates STAT-1 (Supporting Information Fig. 3).	SEN:10041068	23878002
BEL:20087608	p(MGI:Snap25) increases r(MGI:Fas)	Conversely, SNAP increased Fas expression, although never to the levels seen with MO-MDSCs, suggesting that NO is crucial but not sufficient to maximize Fas expression on CD8+ T cells.	SEN:10041096	23878002
BEL:20087636	p(MGI:Plcg2) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	We found that both PLC72_/~ PMN- and MO-MDSCs had greater immune-suppressive effects on CD8+ T cell proliferation than WT MDSCs in both antigen- and mitogen-driven T cell stimulatory conditions (Fig. 5, A and B).	SEN:10041118	24127488
BEL:20087638	p(MGI:Plcg2) decreases a(CHEBI:"reactive oxygen species")	WT PMN-MDSCs predominantly produced ROS, whereas WT MO-MDSCs mainly released nitrites (Fig. 5, C and D).	SEN:10041120	24127488
BEL:20087640	p(MGI:Plcg2) decreases a(CHEBI:"reactive oxygen species")	In contrast, PMN-MDSCs and MO-MDSCs from PLC72~7~ mice released both high levels of ROS and NO (Fig. 5, C and D).	SEN:10041122	24127488
BEL:20087642	p(MGI:Plcg2) decreases p(MGI:Ctnnb1)	Results show increased p-catenin protein levels in PLC^2-deficient MDSCs treated with PDBu compared with untreated cells (Fig. 6 B), indicating that PLC^2 can regulate p-catenin levels via DAG-dependent PKC activation.	SEN:10041124	24127488
BEL:20087656	p(MGI:Ctnnb1) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Consistent with this observation, the percentage of CD8+ T cells infiltrating the tumor was significantly increased in PLC^2cKO/p-cat.CA compared with PLC^2cKO (Fig. 7 E).	SEN:10041136	24127488
BEL:20087658	p(MGI:Plcg2) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	As expected from our previous result (Fig. 5 B), CD8+ T cell proliferation is strongly diminished by PLC^2cKO MDSCs compared with control.	SEN:10041138	24127488
BEL:20087668	bp(GOBP:"response to tumor cell") decreases r(MGI:Hes5)	Expression of Notch target genes hesl and hes5 was dramatically reduced in all 3 populations of cells isolated from TB mice as compared with the cells from naive mice (Fig. 1A and B).	SEN:10041144	24220241
BEL:20087670	bp(GOBP:"response to tumor cell") decreases r(MGI:Helt)	Expression of Notch target genes hesl and hes5 was dramatically reduced in all 3 populations of cells isolated from TB mice as compared with the cells from naive mice (Fig. 1A and B).	SEN:10041144	24220241
BEL:20087672	bp(GOBP:"response to tumor cell") decreases complex(p(MGI:Csl),p(MGI:Rbpj))	The CSL/ CBF1-specific binding in HPCs from TB mice was substantially lower than the binding in HPCs from control mice (Fig. 1D).	SEN:10041146	24220241
BEL:20087674	bp(GOBP:"response to tumor cell") decreases r(HGNC:HES1)	Three-day culture of human CD34+ HPC with TCM from breast carcinoma MCF7 and small cell lung cancer cell line 81M1 caused significant (P < 0.01) decrease in the expression of HES1 (Fig. 1H).	SEN:10041148	24220241
BEL:20087678	bp(GOBP:"response to tumor cell") decreases r(MGI:Hes1)	Significant reduction in the expression of hes1 was observed, whereas no differences were seen in the expression of notch1 and notch2 (Fig. 2D).	SEN:10041152	24220241
BEL:20087680	bp(GOBP:"response to tumor cell") decreases r(MGI:Dll3)	Dramatic downregulation of all studied Notch ligands (Jag1, Jag2, Dll1, 3, and 4) was found in bone marrow from CT26 TB mice as compared with naive tumor-free mice (Fig. 2E).	SEN:10041154	24220241
BEL:20087682	bp(GOBP:"response to tumor cell") decreases r(MGI:Jag2)	Dramatic downregulation of all studied Notch ligands (Jag1, Jag2, Dll1, 3, and 4) was found in bone marrow from CT26 TB mice as compared with naive tumor-free mice (Fig. 2E).	SEN:10041154	24220241
BEL:20087684	bp(GOBP:"response to tumor cell") decreases r(MGI:Jag1)	Dramatic downregulation of all studied Notch ligands (Jag1, Jag2, Dll1, 3, and 4) was found in bone marrow from CT26 TB mice as compared with naive tumor-free mice (Fig. 2E).	SEN:10041154	24220241
BEL:20087686	bp(GOBP:"response to tumor cell") decreases r(MGI:Dll4)	Dramatic downregulation of all studied Notch ligands (Jag1, Jag2, Dll1, 3, and 4) was found in bone marrow from CT26 TB mice as compared with naive tumor-free mice (Fig. 2E).	SEN:10041154	24220241
BEL:20087688	bp(GOBP:"response to tumor cell") decreases r(MGI:Hes1)	In the absence of TCM, Dll1 caused 6-fold increase in hes1 expression.	SEN:10041156	24220241
BEL:20087692	bp(GOBP:"response to tumor cell") increases p(MGI:Notch1,pmod(P,Y))	Culture of HPC with TCM resulted in an increase in serine phosphorylation of Notch1 (Fig. 4A), whereas no tyrosine phosphorylation was detected (data not shown).. Analysis of the structure of Notch suggested a number of serine residues in RAM domain, phosphorylation of which could affect binding of Notch1 with CSL.	SEN:10041160	24220241
BEL:20087694	bp(GOBP:"response to tumor cell") increases p(MGI:Notch1,pmod(P,S))	Culture of HPC with TCM resulted in an increase in serine phosphorylation of Notch1 (Fig. 4A), whereas no tyrosine phosphorylation was detected (data not shown).. Analysis of the structure of Notch suggested a number of serine residues in RAM domain, phosphorylation of which could affect binding of Notch1 with CSL.	SEN:10041160	24220241
BEL:20087696	bp(GOBP:"response to tumor cell") decreases p(MGI:Notch1,pmod(P,S))	However, after mutations in S1901 and T1898, Notch1 construct lost binding to CSL in MDSC (Fig. 4C) and was associated with substantially reduced level of serine phosphorylation in the presence of TCM (Fig. 4C).	SEN:10041162	24220241
BEL:20087698	p(MGI:Csnk2a2) increases r(MGI:Hes1)	We observed that MDSC transfected with control siRNA cultured with TCM had significantly (P < 0.01) lower hes1 expression than cells cultured in complete medium.	SEN:10041164	24220241
BEL:20087700	act(p(MGI:Csnk2a2)) increases p(MGI:Notch1,pmod(P,S))	Inhibition of CK2 abrogated serine phosphoryla- tion of ICN caused by TCM and restored interaction between ICN and CSL (Fig. 6B).. .	SEN:10041166	24220241
BEL:20087704	act(p(MGI:Csnk2a2)) decreases r(MGI:Hes1)	This was associated with significant increase in the expression of hes1 in these cells (Fig. 7C).	SEN:10041170	24220241
BEL:20087754	a(CHEBI:peroxynitrite) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Conversely, PTIO prevented the T cell suppression effect induced by Mo-MDSC in both tumor models, without having an effect in G-MDSC suppression (Fig. 3b).	SEN:10041198	24259296
BEL:20087756	act(p(MGI:Nos3)) increases a(CHEBI:peroxynitrite)	A significant prevention in the production of PNT by G-MDSC, but not by Mo-MDSC, was found in tumor-bearing gp91phox and eNOS null mice, as compared to MDSC from control mice (Fig. 4a).	SEN:10041200	24259296
BEL:20087758	act(p(MGI:Cybb)) increases a(CHEBI:peroxynitrite)	A significant prevention in the production of PNT by G-MDSC, but not by Mo-MDSC, was found in tumor-bearing gp91phox and eNOS null mice, as compared to MDSC from control mice (Fig. 4a).	SEN:10041200	24259296
BEL:20087760	a(CHEBI:peroxynitrite) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	4b and 4c), suggesting the fundamental role of eNOS and gp91phox in the PNT-linked suppression induced by G-MDSC.	SEN:10041202	24259296
BEL:20087770	bp(GOBP:"response to tumor cell") increases m(MGI:Mir21)	High levels of miR-155 and miR-21 also were detected in bone marrow and spleen MDSC isolated from tumor-bearing mice.	SEN:10041210	24391219
BEL:20087772	bp(GOBP:"response to tumor cell") increases m(MGI:Mir155)	High levels of miR-155 and miR-21 also were detected in bone marrow and spleen MDSC isolated from tumor-bearing mice.	SEN:10041210	24391219
BEL:20087774	bp(GOBP:"response to tumor cell") increases m(MGI:Mir155)	As shown in Fig. 2C, the levels of miR-155 and miR-21 were significantly higher in MDSC derived from the BM, spleen, or tumor tissue in tumor-bearing mice than those in control mice.	SEN:10041212	24391219
BEL:20087776	bp(GOBP:"response to tumor cell") increases m(MGI:Mir21)	As shown in Fig. 2C, the levels of miR-155 and miR-21 were significantly higher in MDSC derived from the BM, spleen, or tumor tissue in tumor-bearing mice than those in control mice.	SEN:10041212	24391219
BEL:20087802	act(p(HGNC:CSF1R)) increases act(p(HGNC:ALDH1A1))	e ALDH1 activity in human PC (N = 11); representative flow cytometry plot of human PC tumor gated on live EpCAM+ cells using Aldefluor assay.	SEN:10041226	24652403
BEL:20087804	act(p(MGI:Csf1r)) decreases r(MGI:Tnf)	Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).	SEN:10041228	24652403
BEL:20087806	act(p(MGI:Csf1r)) decreases r(MGI:Ifng)	Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).	SEN:10041228	24652403
BEL:20087808	act(p(MGI:Csf1r)) decreases r(MGI:Il12b)	Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).	SEN:10041228	24652403
BEL:20087810	act(p(MGI:Csf1r)) increases r(MGI:Arg1)	Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).	SEN:10041228	24652403
BEL:20087812	act(p(MGI:Csf1r)) increases r(MGI:Il6)	Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).	SEN:10041228	24652403
BEL:20087814	act(p(MGI:Csf1r)) increases p(MGI:Tgfb1)	Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).	SEN:10041228	24652403
BEL:20087816	act(p(MGI:Csf1r)) increases p(MGI:Il10)	Furthermore, GCSFR-/- mice exhibit a shift in the immune profile of PC tumors from a TH-2 to TH-1 immune response, characterized by increased expression of IFN-y, TNF-a and IL-12 with decreased expression of arginase-1, IL-6, TGF-P, IL-10 compared to WT mice (Fig. 2d).	SEN:10041228	24652403
BEL:20087832	bp(GOBP:"response to tumor cell") increases p(HGNC:ARG1)	These monocytes acquired a Mo-MDSC phenotype characterized by a significantly decreased expression of HLA-DR and increased expression of arginase-1 as well as the ability to suppress CD8+ T cell proliferation in vitro [29-32] (Fig. 4a-c).	SEN:10041236	24652403
BEL:20087860	p(MGI:Stat3,pmod(P)) increases r(HGNC:IL6)	While we found that IL-6 mRNA gene expression was significantly downregulated by STAT3 inhibition (Supplementary figure 11), IL-6 blockade using anti-IL-6 antibodies decreased but did not fully reverse the effect of Mo-MDSC on increasing the prevalence of ALDH1Bright CSCs.	SEN:10041248	24652403
BEL:20087872	p(MGI:Ripk2) decreases p(MGI:Zeb1)	Rip2-deficient tumors showed enhanced epithelial-to-mesenchymal transition, with elevated expression of zebl, zeb2, twist, and snail in the tumor microenvironment.	SEN:10041254	24733360
BEL:20087874	p(MGI:Ripk2) decreases p(MGI:Twist1)	Rip2-deficient tumors showed enhanced epithelial-to-mesenchymal transition, with elevated expression of zebl, zeb2, twist, and snail in the tumor microenvironment.	SEN:10041254	24733360
BEL:20087904	p(MGI:Ripk2) decreases p(MGI:Il1a)	The majority were associated with myeloid differentiation and chemotaxis, including G-CSF, M-CSF, IL-16, MCP-1, TREM-1, TIMP-1, and IL-1a with relative levels shown schematically [27-33] (Fig 4A).	SEN:10041276	24733360
BEL:20087906	p(MGI:Ripk2) decreases p(MGI:Trem1)	The majority were associated with myeloid differentiation and chemotaxis, including G-CSF, M-CSF, IL-16, MCP-1, TREM-1, TIMP-1, and IL-1a with relative levels shown schematically [27-33] (Fig 4A).	SEN:10041276	24733360
BEL:20087908	p(MGI:Ripk2) decreases p(MGI:Ccl2)	The majority were associated with myeloid differentiation and chemotaxis, including G-CSF, M-CSF, IL-16, MCP-1, TREM-1, TIMP-1, and IL-1a with relative levels shown schematically [27-33] (Fig 4A).	SEN:10041276	24733360
BEL:20087910	p(MGI:Ripk2) decreases p(MGI:Il16)	The majority were associated with myeloid differentiation and chemotaxis, including G-CSF, M-CSF, IL-16, MCP-1, TREM-1, TIMP-1, and IL-1a with relative levels shown schematically [27-33] (Fig 4A).	SEN:10041276	24733360
BEL:20087914	p(MGI:Ripk2) decreases p(MGI:Il4)	Increased levels of IL-4, G-CSF, and GM-CSF were observed in bladder tumors from Rip2-deficient compared to wild-type mice, while no differences were detected in IFNy and M-CSF expression, consistent with a tumor microenvironment fostering development of the tumor associated MDSCs (Fig 4C).	SEN:10041280	24733360
BEL:20087916	p(MGI:Ripk2) decreases p(MGI:Csf3)	Increased levels of IL-4, G-CSF, and GM-CSF were observed in bladder tumors from Rip2-deficient compared to wild-type mice, while no differences were detected in IFNy and M-CSF expression, consistent with a tumor microenvironment fostering development of the tumor associated MDSCs (Fig 4C).	SEN:10041280	24733360
BEL:20087918	p(MGI:Ripk2) increases p(MGI:Cdh1)	To investigate the influence ofRip2 in development of EMT, we examined expression of adhesion markers in intravesical tumors and observed decreased E-cadherin expression throughout the tumor with concomitant increased N-cadherin expression at the peripheral of the tumor in Rip2-deficient relative to wild-type mice (Fig 6A).	SEN:10041282	24733360
BEL:20087920	p(MGI:Ripk2) increases p(MGI:Cdh2)	To investigate the influence ofRip2 in development of EMT, we examined expression of adhesion markers in intravesical tumors and observed decreased E-cadherin expression throughout the tumor with concomitant increased N-cadherin expression at the peripheral of the tumor in Rip2-deficient relative to wild-type mice (Fig 6A).	SEN:10041282	24733360
BEL:20087922	p(MGI:Ripk2) increases act(p(MGI:Nfkbib))	Consistent with prior literature, we observed decreased canonical NF-kB activation exhibited by decreased p-IkB expression in Rip2-deficient tumors (Fig 6B), suggesting NF-kB independent mechanisms to account for EMT [39].	SEN:10041284	24733360
BEL:20087936	p(MGI:Ripk2) decreases p(MGI:Twist1)	We also examined expression of these EMT inducing genes in lungs containing metastases from Rip2 wild-type and -deficient mice, revealing a similar trend with statistical significance for increased twist expression in absence of Rip2 (Fig 6D).	SEN:10041288	24733360
BEL:20087982	p(HGNC:STAT3) increases p(HGNC:MAP3K14)	Blocking STAT3 activation with the small molecule inhibitor JSI-124 significantly inhibited the accumulation of NIK and IDO expression in MDSCs.	SEN:10041328	25063873
BEL:20087984	act(p(HGNC:MAP3K14)) increases p(HGNC:IDO1)	Knockdown of NIK in MDSCs suppressed IDO expression but not STAT3 activation.	SEN:10041330	25063873
BEL:20087986	complex(p(HGNC:RELB),p(HGNC:IDO1)) increases r(HGNC:IDO1)	RelB-p52 dimers were found to directly bind to the IDO promoter, leading to IDO expression in MDSCs.	SEN:10041332	25063873
BEL:20087988	act(p(HGNC:STAT3)) increases p(MGI:Ido1)	STAT3 activation-induced IDO expression is independent of direct binding of STAT3 to the promoter region of IDO gene.	SEN:10041334	25063873
BEL:20088008	p(HGNC:STAT3,pmod(P)) increases p(HGNC:RELB)	Blocking STAT3 activation by JSI-124 dramatically decreased the levels of p52 and RelB in nuclei (Fig. 2C, p < 0.05).	SEN:10041344	25063873
BEL:20088010	p(HGNC:STAT3,pmod(P)) increases p(HGNC:NFKB2)	Blocking STAT3 activation by JSI-124 dramatically decreased the levels of p52 and RelB in nuclei (Fig. 2C, p < 0.05).	SEN:10041344	25063873
BEL:20088012	act(p(HGNC:STAT3)) increases p(HGNC:STAT3,pmod(P))	The level of STAT3 phosphorylation in MDSCs was reduced at 30 min and completely suppressed at 4 h after treatment with JSI-124.	SEN:10041346	25063873
BEL:20088014	p(HGNC:STAT3,pmod(P)) increases p(HGNC:MAP3K14)	Consistently, the level of NIK in MDSCs started to decline at 1 h and was completely blocked at 8 h after JSI-124 treatment.	SEN:10041348	25063873
BEL:20088016	p(MGI:Stat3,pmod(P)) increases p(MGI:Ido1)	The level of IDO significantly decreased at 4 h after JSI-124 treatment (Fig. 3A).	SEN:10041350	25063873
BEL:20088018	p(HGNC:MAP3K14) increases p(HGNC:IDO1)	In NIK knockdown MDSCs, the level of IDO protein was reduced significantly, but the level of pSTAT3 protein was not affected (Fig. 3B, 3C).	SEN:10041352	25063873
BEL:20088020	p(HGNC:STAT3,pmod(P)) increases r(HGNC:MAP3K14)	In contrast, both IDO and NIK expression were reduced by JSI-124 treatment in MDSCs (Fig. 3A).	SEN:10041354	25063873
BEL:20088022	p(HGNC:STAT3,pmod(P)) increases r(HGNC:IDO1)	In contrast, both IDO and NIK expression were reduced by JSI-124 treatment in MDSCs (Fig. 3A).	SEN:10041354	25063873
BEL:20088024	complex(p(HGNC:RELB),p(HGNC:NFKB2)) directlyIncreases tscript(p(HGNC:IDO1))	RelB/p52 dimers directly bind to the IDO promoter to regulate IDO expression in MDSCs.	SEN:10041356	25063873
BEL:20088026	tscript(p(HGNC:IDO1)) increases r(HGNC:IDO1)	RelB/p52 dimers directly bind to the IDO promoter to regulate IDO expression in MDSCs.	SEN:10041356	25063873
BEL:20088036	p(MGI:Stat3,pmod(P)) increases r(MGI:Map3k14)	We isolated CD11b+ MDSCs from the spleen of JSI-124-treated mice and found decreased expression of p-STAT3, NIK, and IDO protein in CD11b+ MDSCs compared with those isolated from the controls (Fig. 6D).	SEN:10041366	25063873
BEL:20088038	p(MGI:Stat3,pmod(P)) increases p(MGI:Ido1)	We isolated CD11b+ MDSCs from the spleen of JSI-124-treated mice and found decreased expression of p-STAT3, NIK, and IDO protein in CD11b+ MDSCs compared with those isolated from the controls (Fig. 6D).	SEN:10041366	25063873
BEL:20088078	p(HGNC:IL6) increases p(HGNC:STAT3,pmod(P))	Furthermore, a specific IL-6-neutralizing Ab significantly decreased the levels of p-STAT3, NIK, and IDO in MDSCs (Fig. 7E, p < 0.05).	SEN:10041374	25063873
BEL:20088080	p(HGNC:IL6) increases p(HGNC:IDO1)	Furthermore, a specific IL-6-neutralizing Ab significantly decreased the levels of p-STAT3, NIK, and IDO in MDSCs (Fig. 7E, p < 0.05).	SEN:10041374	25063873
BEL:20088082	p(HGNC:IL6) increases p(HGNC:MAP3K14)	Furthermore, a specific IL-6-neutralizing Ab significantly decreased the levels of p-STAT3, NIK, and IDO in MDSCs (Fig. 7E, p < 0.05).	SEN:10041374	25063873
BEL:20088116	bp(GOBP:"response to tumor cell") increases p(MGI:Stat3,pmod(P))	Shown are the representative results from one of three independent experiments done in triplicate as in a. (c) Tumor-infiltrating NK cells (CD49b+) and granulocytes (Gr1+) from wild-type mice showed increased phospho-Stat3 compared with their splenic counterparts.	SEN:10041404	16288283
BEL:20088118	p(MGI:Stat3) decreases bp(GOBP:"myeloid dendritic cell activation")	Furthermore, examination of tumor-infiltrating DCs showed that expression of major histocompatibility complex (MHC) class II, CD80 and CD86 is considerably increased in Stat3-/- mice when compared to those from Stat3+/+ mice (Fig. 2d).	SEN:10041406	16288283
BEL:20088126	bp(GOBP:"response to tumor cell") increases p(MGI:Stat3,pmod(P))	Analysis of phosphorylated Stat3 by flow cytometry showed that Stat3 was also constitutively activated in tumor-infiltrating NK cells and neutrophils (Fig. 3c).	SEN:10041410	16288283
BEL:20088128	p(MGI:Il10) increases p(MGI:Stat3,pmod(P))	Flow cytometry and electrophoretic mobility shift assay (EMSA) indicated that IL-10 activates Stat3 in NK cells (CD49b+CD3-) and granulocytes (Gr1+; Supplementary Fig. 3 online).	SEN:10041412	16288283
BEL:20088130	p(MGI:Stat3) decreases r(MGI:Fasl)	Furthermore, our data showed that FasL expression was increased in Stat3-/-Gr1+CD11b+ neutrophils (Supplementary Fig. 4 online).	SEN:10041414	16288283
BEL:20088156	p(MGI:Cyp2a4) decreases tscript(p(MGI:Stat3))	We showed that CPA-7 inhibits Stat3 but not Statl and Stat5 in DC2.4 mouse DC line (Supplementary Fig. 6 online).	SEN:10041426	16288283
BEL:20088158	p(MGI:Cyp2a4) decreases tscript(p(MGI:Stat3))	Tumor-infiltrating DCs from the mice receiving CPA-7 24 h earlier showed considerably reduced phosphorylated Stat3 compared to vehicle-treated mice (Fig. 6b).	SEN:10041428	16288283
BEL:20088198	p(MGI:Tgfb1) increases bp(GOBP:"regulatory T cell differentiation")	Treatment of 1D11 also reduced the conversion of CD4+ T cells into Treg cells and subsequent Treg cell-mediated suppression of antitumor immunity.	SEN:10041456	17312132
BEL:20088200	p(MGI:Tgfb1) increases bp(GOBP:"regulatory T cell differentiation")	In summary, we havedemonstrated that tumor cells directly convert CD4+CD25_ T cells to Treg cells through production of high levels of TGF-^,suggesting a possible mechanism through which tumor cells evade the immune system.	SEN:10041458	17312132
BEL:20088202	bp(GOBP:"response to tumor cell") increases bp(GOBP:"regulatory T cell differentiation")	More importantly, Foxp3+CD25+ T cells were also detected at the tumor sites (Fig. 1B).	SEN:10041460	17312132
BEL:20088208	bp(GOBP:"response to tumor cell") increases bp(GOBP:"regulatory T cell differentiation")	These results suggest that coculture of purified CD4+CD25~ T cells with tumor cells TRAMP-C2, but not nontumorigenic NRP-152 cells, induces CD4+CD25+Foxp3+ T cells.	SEN:10041462	17312132
BEL:20088210	bp(GOBP:"response to tumor cell") increases bp(GOBP:"regulatory T cell differentiation")	Moreover, these results provide evidence that tumor cells can indeed directly convert CD4+CD25~ T cells into Treg cells.	SEN:10041464	17312132
BEL:20088212	bp(GOBP:"response to tumor cell") increases p(MGI:Foxp3)	In agreement with RT-PCR results, FACS analysis demonstrated increased protein expression levels of Foxp3 in T cells cultured in TRAMP-C2 CM (CM) as the Ctrl 25+ ; however, CD4+CD25~ T cells cultured with T cell medium (Ctrl) did not express Foxp3 (Fig. 2D, bottom panel).	SEN:10041466	17312132
BEL:20088214	bp(GOBP:"regulatory T cell differentiation") decreases sec(p(MGI:Il2))	T cells cultured with TRAMP-C2 CM (CM) produced virtually nondetectable amounts of IL-2, whereas T cells cultured with T cell medium (Ctrl) produced high levels of IL-2 (Fig. 3A).	SEN:10041468	17312132
BEL:20088216	bp(GOBP:"regulatory T cell differentiation") increases sec(p(MGI:Il10))	In addition, T cells cultured with CM produced high levels of IL-10 and TGF-0 as compared with T cells cultured with T cell medium (Fig. 3, B and C).	SEN:10041470	17312132
BEL:20088218	bp(GOBP:"regulatory T cell differentiation") increases sec(p(MGI:Tgfb1))	In addition, T cells cultured with CM produced high levels of IL-10 and TGF-0 as compared with T cells cultured with T cell medium (Fig. 3, B and C).	SEN:10041470	17312132
BEL:20088220	bp(GOBP:"regulatory T cell differentiation") decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	T cells cultured with tumor cell CM suppress CD4+CD25~ T cell proliferation Next, the suppressive ability of T cells cultured with CM was examined in an in vitro functional assay.	SEN:10041472	17312132
BEL:20088222	bp(GOBP:"regulatory T cell differentiation") decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	T cells cultured with CM derived from tumor cells TRAMP-C2 or RENCA (CM/25_) suppressed CD4+CD25~ T cell proliferation, whereas T cells cultured with T cell medium (Ctrl/25_) did not (Fig. 4, A, C, and D).	SEN:10041474	17312132
BEL:20088224	bp(GOBP:"response to tumor cell") increases sec(p(MGI:Tgfb1))	The results indicated that tumor cells produced high levels of TGF-^, whereas the nontumorigenic NRP-152 and irradiated TRAMP-C2 cells had significantly lower TGF-^ production (Fig. 4E).	SEN:10041476	17312132
BEL:20088226	act(p(MGI:Tgfb1)) increases sec(p(MGI:Il10))	Furthermore, neutralization of TGF-^ completely changed the profile of cytokine production of these T cells, and cells now expressed high levels of IL-2 and low levels of IL-10 and TGF-^ (Fig. 3).	SEN:10041478	17312132
BEL:20088228	act(p(MGI:Tgfb1)) increases sec(p(MGI:Tgfb1))	Furthermore, neutralization of TGF-^ completely changed the profile of cytokine production of these T cells, and cells now expressed high levels of IL-2 and low levels of IL-10 and TGF-^ (Fig. 3).	SEN:10041478	17312132
BEL:20088230	act(p(MGI:Tgfb1)) decreases sec(p(MGI:Il2))	Furthermore, neutralization of TGF-^ completely changed the profile of cytokine production of these T cells, and cells now expressed high levels of IL-2 and low levels of IL-10 and TGF-^ (Fig. 3).	SEN:10041478	17312132
BEL:20088234	p(MGI:Tgfb1) increases bp(GOBP:"regulatory T cell differentiation")	Taken together, these results have revealed a critical role of tumor-derived TGF-^ in conversion of CD4+CD25~ T cells into Treg cells.	SEN:10041482	17312132
BEL:20088242	p(MGI:Tgfb1) increases p(MGI:Foxp3)	However, immunofluorescence staining revealed that Foxp3 expression was absent in animals receiving 1D11 and present in animals receiving no treatment or control Ab 13C4 (Fig. 6A).	SEN:10041490	17312132
BEL:20088244	p(MGI:Tgfb1) increases bp(GOBP:"regulatory T cell differentiation")	These results suggest tumor-derived TGF-^ converts CD4+ T cells into CD4+CD25+Foxp3+ Treg cells in the tumor microenvironment and neutralization of TGF-^ using 1D11 abolished the conversion.	SEN:10041492	17312132
BEL:20088246	bp(GOBP:"regulatory T cell differentiation") increases tscript(p(HGNC:FOXP3))	The forkhead transcription factor Foxp3 is highly expressed in CD4+CD25+ regulatory T cells (Treg) and was recently identified as a key player in mediating their inhibitory functions.	SEN:10041494	17804750
BEL:20088248	p(HGNC:TGFB2) increases r(HGNC:FOXP3)	Foxp3 expression was induced by transforming growth factor-(32 (TGF-(32), but not TGF-(31 stimulation in these cells, and was partially suppressed following antibody-mediated neutralization of TGF-(32.	SEN:10041496	17804750
BEL:20088250	p(HGNC:FOXP3) decreases r(HGNC:IL8)	Down-regulation of Foxp3 with small interfering RNA (siRNA) in pancreatic carcinoma cells resulted in the up-regulation of interleukin 6 (IL-6) and IL-8 expression, providing evidence for a negative transcriptional activity of Foxp3 also in these epithelial cells.	SEN:10041498	17804750
BEL:20088252	p(HGNC:FOXP3) decreases r(HGNC:IL6)	Down-regulation of Foxp3 with small interfering RNA (siRNA) in pancreatic carcinoma cells resulted in the up-regulation of interleukin 6 (IL-6) and IL-8 expression, providing evidence for a negative transcriptional activity of Foxp3 also in these epithelial cells.	SEN:10041498	17804750
BEL:20088254	p(HGNC:FOXP3) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	Coculture of Foxp3-expressing tumor cells with naive T cells completely inhibited T-cell proliferation, but not activation, and this antiproliferative effect was partially abrogated following specific inhibition of Foxp3 expression.	SEN:10041500	17804750
BEL:20088256	bp(GOBP:"response to tumor cell") increases r(HGNC:FOXP3)	In an initial analysis of microdissected pancreatic carcinoma tissue using Affymetrix chip technology, Foxp3 was among the up-regulated genes in some tumor samples (26); (Fig. 1A).	SEN:10041502	17804750
BEL:20088258	bp(GOBP:"response to tumor cell") increases r(HGNC:FOXO3)	In accordance with the immunohistochemistry data pointing to FoxP3 expression in tumor cells (see above), Foxp3 expression was clearly detectable in several pancreatic carcinoma cell lines at both mRNA (Fig. 2A) and protein levels (Fig. 2B).	SEN:10041504	17804750
BEL:20088260	bp(GOBP:"response to tumor cell") increases p(HGNC:FOXP3)	In accordance with the immunohistochemistry data pointing to FoxP3 expression in tumor cells (see above), Foxp3 expression was clearly detectable in several pancreatic carcinoma cell lines at both mRNA (Fig. 2A) and protein levels (Fig. 2B).	SEN:10041504	17804750
BEL:20088262	p(HGNC:TGFB2) increases p(HGNC:FOXP3)	Treatment of PANC-89, Capan1, and Panc1 cells with TGF-h2 led to an up-regulation of the Foxp3 protein, which was moderate for PANC-89 and Capan1 and strong for Panc1 (Fig. 3A and D).	SEN:10041506	17804750
BEL:20088264	p(HGNC:TGFB2) increases r(HGNC:FOXP3)	RT-PCR analysis detected a 13-fold (mean value of four independent experiments) increase of Foxp3 mRNA expression in PANC-89 cells after a 48-h stimulation with TGF-h2, whereas no such effect was evident after stimulation with TGF-h1 (Fig. 3B).	SEN:10041508	17804750
BEL:20088266	p(HGNC:TGFB2) increases r(HGNC:FOXP3)	Moreover, the incubation of PANC-89 and Capan1 cells with anti-TGF-h2 antibody for 48 h clearly suppressed the Foxp3 signal (Fig. 3A ), suggesting that endogenously produced TGF-h2 maintains Foxp3 expression in pancreatic cancer cell cultures.	SEN:10041510	17804750
BEL:20088268	p(HGNC:FOXP3) decreases p(HGNC:IL8)	Specific down-regulation of Foxp3 in pancreatic carcinoma cells results in up-regulation of IL-6 and IL-8.	SEN:10041512	17804750
BEL:20088270	p(HGNC:FOXP3) decreases p(HGNC:IL6)	Specific down-regulation of Foxp3 in pancreatic carcinoma cells results in up-regulation of IL-6 and IL-8.	SEN:10041512	17804750
BEL:20088272	p(HGNC:FOXP3) decreases sec(p(HGNC:IL8))	A screen for changes in cytokine secretion in these cells using the Raybiotec Cytokine Array (Hoelzel Diagnostica) revealed an increase of IL-6 and IL-8 in the culture supernatant, whereas other cytokines remained unchanged (data not shown).	SEN:10041514	17804750
BEL:20088274	p(HGNC:FOXP3) decreases sec(p(HGNC:IL6))	A screen for changes in cytokine secretion in these cells using the Raybiotec Cytokine Array (Hoelzel Diagnostica) revealed an increase of IL-6 and IL-8 in the culture supernatant, whereas other cytokines remained unchanged (data not shown).	SEN:10041514	17804750
BEL:20088278	bp(GOBP:"response to tumor cell") decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	In the cocultures, Colo357, PANC-89, and PancTu1 tumor cells strongly inhibited the proliferation of anti-CD3/anti-CD28-stimulated T cells (Fig. 4D).	SEN:10041518	17804750
BEL:20088280	bp(GOBP:"CD4-positive, alpha-beta T cell proliferation") increases p(HGNC:TNFRSF18)	As shown in Fig. 5B, CD25 GITR and CD69 were up-regulated after anti-CD3/anti-CD28 stimulation, irrespective of the presence or absence of tumor cells.	SEN:10041520	17804750
BEL:20088282	bp(GOBP:"CD4-positive, alpha-beta T cell proliferation") increases p(HGNC:CD69)	As shown in Fig. 5B, CD25 GITR and CD69 were up-regulated after anti-CD3/anti-CD28 stimulation, irrespective of the presence or absence of tumor cells.	SEN:10041520	17804750
BEL:20088284	bp(GOBP:"CD4-positive, alpha-beta T cell proliferation") increases p(HGNC:ISG20)	As shown in Fig. 5B, CD25 GITR and CD69 were up-regulated after anti-CD3/anti-CD28 stimulation, irrespective of the presence or absence of tumor cells.	SEN:10041520	17804750
BEL:20088286	p(HGNC:FOXP3) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	When using these cells, we observed an ~ 45% recovery of T-cell proliferation in the coculture system (Fig. 5A).	SEN:10041522	17804750
BEL:20088304	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases bp(GOBP:"regulatory T cell differentiation")	TMV induce and promote proliferation of Treg	SEN:10041530	20661468
BEL:20088310	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases r(HGNC:CTLA4)	In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).	SEN:10041534	20661468
BEL:20088312	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases r(HGNC:TNFRSF18)	In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).	SEN:10041534	20661468
BEL:20088314	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases r(HGNC:FASLG)	In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).	SEN:10041534	20661468
BEL:20088316	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases r(HGNC:CCR7)	In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).	SEN:10041534	20661468
BEL:20088318	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases r(HGNC:TGFB1)	In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).	SEN:10041534	20661468
BEL:20088320	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases r(HGNC:PRF1)	In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).	SEN:10041534	20661468
BEL:20088322	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases r(HGNC:GZMB)	In cultures containing TMV, Treg expressing GITR, CTLA-4, FasL, CCR7, TGF-P1, Granzyme B, and perforin were increased (p<0.05 for all).	SEN:10041534	20661468
BEL:20088336	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases (bp(GOBP:"regulatory T cell differentiation") increases complex(p(HGNC:SMAD2,pmod(P)),p(HGNC:SMAD3,pmod(P))))	In addition, intracytoplasmic expression of phosphorylated SMAD2/3 and phosphorylated STAT3 in Treg was increased in the presence of TMV relative to Treg incubated in the absence of TMV (Figure 7C).	SEN:10041544	20661468
BEL:20088338	complex(p(HGNC:IL10),p(HGNC:TGFB1),p(HGNC:FASLG)) increases (bp(GOBP:"regulatory T cell differentiation") increases p(HGNC:STAT3,pmod(P)))	In addition, intracytoplasmic expression of phosphorylated SMAD2/3 and phosphorylated STAT3 in Treg was increased in the presence of TMV relative to Treg incubated in the absence of TMV (Figure 7C).	SEN:10041544	20661468
BEL:20088340	tscript(p(MGI:Tlr2)) decreases bp(GOBP:"regulatory T cell differentiation")	These results demonstrate that the TLR1/TLR2 agonist BLP may have a general tumor therapeutic property involving reciprocal downregulation of Treg and upregulation of CTL function.	SEN:10041546	21217015
BEL:20088342	tscript(p(MGI:Tlr1)) decreases bp(GOBP:"regulatory T cell differentiation")	These results demonstrate that the TLR1/TLR2 agonist BLP may have a general tumor therapeutic property involving reciprocal downregulation of Treg and upregulation of CTL function.	SEN:10041546	21217015
BEL:20088348	tscript(p(MGI:Tlr1)) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	CD8+ T cells isolated from BLP-treated tumor-bearing mice exhibited vigorous proliferation upon in vitro restimulation with 3LL tumor cells, whereas CD8+ T cells isolated from PBS-treated mice failed to do so (Fig. 2A).	SEN:10041550	21217015
BEL:20088350	tscript(p(MGI:Tlr2)) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	CD8+ T cells isolated from BLP-treated tumor-bearing mice exhibited vigorous proliferation upon in vitro restimulation with 3LL tumor cells, whereas CD8+ T cells isolated from PBS-treated mice failed to do so (Fig. 2A).	SEN:10041550	21217015
BEL:20088352	tscript(p(MGI:Tlr1)) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Whereas PBS-treated Tregs retained their function and effectively suppressed CTL proliferation, BLP-treated Tregs lost their suppressive function, resulting in a marked CTL expansion in vitro (Fig. 3B).	SEN:10041552	21217015
BEL:20088354	tscript(p(MGI:Tlr2)) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	Whereas PBS-treated Tregs retained their function and effectively suppressed CTL proliferation, BLP-treated Tregs lost their suppressive function, resulting in a marked CTL expansion in vitro (Fig. 3B).	SEN:10041552	21217015
BEL:20088356	tscript(p(MGI:Tlr2)) increases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	BLP-treated Tregs from WT but not TLR2_/_ mice lost their suppressive function, as demonstrated indirectly by the increased CTL numbers in the DLNs and the higher levels of serum IL-2 and IFN-g found in mice receiving BLP-treated WT as compared with TLR2_/_ Tregs, regardless of whether the cotransferred CTL were from either WT or TLR2_/_ mice (Fig. 4B, 4C).	SEN:10041554	21217015
BEL:20088358	tscript(p(MGI:Tlr2)) increases p(MGI:Il2)	BLP-treated Tregs from WT but not TLR2_/_ mice lost their suppressive function, as demonstrated indirectly by the increased CTL numbers in the DLNs and the higher levels of serum IL-2 and IFN-g found in mice receiving BLP-treated WT as compared with TLR2_/_ Tregs, regardless of whether the cotransferred CTL were from either WT or TLR2_/_ mice (Fig. 4B, 4C).	SEN:10041554	21217015
BEL:20088360	tscript(p(MGI:Tlr2)) increases p(MGI:Ifng)	BLP-treated Tregs from WT but not TLR2_/_ mice lost their suppressive function, as demonstrated indirectly by the increased CTL numbers in the DLNs and the higher levels of serum IL-2 and IFN-g found in mice receiving BLP-treated WT as compared with TLR2_/_ Tregs, regardless of whether the cotransferred CTL were from either WT or TLR2_/_ mice (Fig. 4B, 4C).	SEN:10041554	21217015
BEL:20088492	bp(GOBP:"response to tumor cell") increases r(MGI:Rorc)	The mRNA expression of Foxp3 and RORyt in the spleen was very low in the normal control group but significantly higher in the model control group (P < 0.05).	SEN:10041642	24949077
BEL:20088494	bp(GOBP:"response to tumor cell") increases r(MGI:Foxp3)	The mRNA expression of Foxp3 and RORyt in the spleen was very low in the normal control group but significantly higher in the model control group (P < 0.05).	SEN:10041642	24949077
BEL:20088500	bp(GOBP:"response to tumor cell") decreases p(MGI:Socs3)	SOCS3 protein expression was significantly downregulated in all groups except for the normal control group (P < 0.05).	SEN:10041646	24949077
BEL:20088502	bp(GOBP:"response to tumor cell") increases p(MGI:Stat3)	Jak2 and STAT3 protein expression was significantly higher in the model control group than in all other groups (P < 0.05).	SEN:10041648	24949077
BEL:20088504	bp(GOBP:"response to tumor cell") increases p(MGI:Jak2)	Jak2 and STAT3 protein expression was significantly higher in the model control group than in all other groups (P < 0.05).	SEN:10041648	24949077
BEL:20088506	act(p(MGI:Pik3ca)) increases bp(GOBP:"regulatory T cell differentiation")	We found that PI3K-Akt pathway inhibitors selectively inhibit Tregs with minimal effect on conventional T cells (Tconv).	SEN:10041650	25080445
BEL:20088508	act(p(MGI:Akt1)) increases bp(GOBP:"regulatory T cell differentiation")	We found that PI3K-Akt pathway inhibitors selectively inhibit Tregs with minimal effect on conventional T cells (Tconv).	SEN:10041650	25080445
BEL:20088518	act(p(MGI:Akt1)) decreases bp(GOBP:"CD8-positive, alpha-beta T cell proliferation")	In tumors treated with the combination of MK-2206 with the vaccine, a significantly higher number of CD8+ T cells were detected in comparison with that of the nontreated group (P < 0.001; Fig. 5B).	SEN:10041656	25080445
BEL:20088606	bp(GOBP:"regulatory T cell differentiation") increases r(HGNC:TAB1)	Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4+CD25+Treg/CD4+ cells in the blood and the expressions of Foxp3+, IL-10, TGF-p, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.	SEN:10041704	25168696
BEL:20088646	bp(GOBP:"response to tumor cell") increases bp(GOBP:"regulatory T cell differentiation")	LDR reduces CTLA-4 expression on the CD4+CD25+Treg cell surface and inhibits CD4+CD25+Treg cell suppression of CD4+CD25-T cells CD4+CD25-T cells significantly proliferated because of the effects of anti-CD3 and anti-CD28 stimulating factors.	SEN:10041718	25168696
BEL:20088650	bp(GOBP:"regulatory T cell differentiation") decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	LDR reduces CTLA-4 expression on the CD4+CD25+Treg cell surface and inhibits CD4+CD25+Treg cell suppression of CD4+CD25-T cells CD4+CD25-T cells significantly proliferated because of the effects of anti-CD3 and anti-CD28 stimulating factors.	SEN:10041718	25168696
BEL:20088652	bp(GOBP:"regulatory T cell differentiation") decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	This proliferation of CD4+CD25-T cells significantly decreased after the addition of antogenous CD4+CD25+T cells in a co-culture for 3 d, which indicates significant inhibition of CD4+CD25-T cell proliferation by the CD4+CD25+T cells.	SEN:10041720	25168696
BEL:20088654	p(HGNC:TAB1) decreases bp(GOBP:"CD4-positive, alpha-beta T cell proliferation")	After the addition of TGF-b or IL-10 blockers, CD4+CD25-T cell proliferation increased, and OD values increased from 0.54 ± 0.028 to 0.58 ±0.026 with no significant difference, although the addition of anti-TGF-P and anti-1L-10 decreased the inhibition function of CD4+CD25+T cells (Fig. 7D).	SEN:10041722	25168696
BEL:20088666	act(p(MGI:Hras)) increases r(MGI:Vegfa)	Hypoxia was capable of inducing VEGF mRNA in both immortalized and transformed endothelial cells (4.5-fold in cells expressing SV40 large T antigen alone or in combination with H-ras), but both baseline and induced VEGF mRNA expression was increased in cells containing activated ras (Fig. 4).	SEN:10041730	9023347
BEL:20088668	bp(GOBP:"response to hypoxia") increases r(MGI:Vegfa)	Hypoxia was capable of inducing VEGF mRNA in both immortalized and transformed endothelial cells (4.5-fold in cells expressing SV40 large T antigen alone or in combination with H-ras), but both baseline and induced VEGF mRNA expression was increased in cells containing activated ras (Fig. 4).	SEN:10041730	9023347
BEL:20088672	act(p(MGI:Pik3cg)) decreases p(MGI:Vegfa)	Treatment of cells with wortmannin, a steroidal inhibitor of phosphatidylinositol-3-kinase (15), resulted in a decreased level of VEGF under hypoxic conditions but the fold stimulation of VEGF mRNA was not changed (Fig. 5).	SEN:10041732	9023347
BEL:20088674	act(p(MGI:Hras)) increases p(MGI:Mmp2)	Cells with activated ras demonstrated high level of expression of 72-kDa metalloproteinase (MMP-2, gelatinase A), and 92-kDa metalloproteinase (MMP-9, gelatinase B) compared with cells containing SV40 large T antigen alone.	SEN:10041734	9023347
BEL:20088676	act(p(MGI:Hras)) increases p(MGI:Mmp9)	Cells with activated ras demonstrated high level of expression of 72-kDa metalloproteinase (MMP-2, gelatinase A), and 92-kDa metalloproteinase (MMP-9, gelatinase B) compared with cells containing SV40 large T antigen alone.	SEN:10041734	9023347
BEL:20088678	act(p(MGI:Pik3cg)) increases p(MGI:Mmp2)	Treatment of ras-containing cells with wortmannin resulted in a decrease in MMP expression (Fig. 6).	SEN:10041736	9023347
BEL:20088680	act(p(MGI:Pik3cg)) increases p(MGI:Mmp9)	Treatment of ras-containing cells with wortmannin resulted in a decrease in MMP expression (Fig. 6).	SEN:10041736	9023347
BEL:20088690	act(p(MGI:Pik3cg)) increases act(p(MGI:Vegfa))	Since wortmannin inhibits VEGF and MMP activity, but does not restore TIMP activity, tumor-igenesis is not expected to be fully suppressed.	SEN:10041744	9023347
BEL:20088698	bp(GOBP:"response to hypoxia") increases p(MGI:Vegfa)	Wortmannin could inhibit ras-mediated induction of VEGF, but it did not inhibit the hypoxic regulation of VEGF.	SEN:10041748	9023347
BEL:20088700	bp(GOBP:"response to hypoxia") increases p(MGI:Vegfa)	This suggests that the hypoxic regulation of VEGF is independent of phosphatidylinositol-3-kinase.	SEN:10041750	9023347
BEL:20088722	p(MGI:Mmp9) increases p(MGI:Col4a3)	Mice deficient in matrix metalloproteinase-9, which cleaves tumstatin efficiently from Col IVa3, have decreased circulating tumstatin and accelerated growth of tumor.	SEN:10041766	12842087
BEL:20088734	p(MGI:Col4a3) decreases path(MESHD:"Neovascularization, Pathologic")	We observed increased angiogenesis in the Col IVa3/tumstatin-deficient mice, as compared to the wild-type mice (Figure 2B).	SEN:10041774	12842087
BEL:20088738	p(MGI:Col4a3) decreases p(MGI:Kdr)	Col IVa3/tumstatin-deficient mice had increased circulating VEGFR2-positive endothelial cells (Figure 2D).	SEN:10041778	12842087
BEL:20088764	p(MGI:Hras) decreases p(MGI:Thbs1)	Here, we show that ras-transformed cancer cells can also induce TSP-1 down-regulation in their adjacent nontransformed stromal fibroblasts, but not in endothelial cells, in a paracrine and distance-dependent manner.	SEN:10041796	16204059
BEL:20088768	p(MGI:Hras) decreases p(MGI:Thbs1)	Indeed, MDF528 nontransformed dermal fibroblasts, like many other types of normal nonangiogenic cells (12), express copious amounts of TSP-1 (Fig. 1B, lane 1), which becomes undetectable in their H-ras -expressing counterparts (528ras1 cells; Fig. 1B, lane 2; refs.	SEN:10041800	16204059
BEL:20088772	p(MGI:Hras) decreases act(p(MGI:Thbs1))	Down-regulation of thrombospondin-1 promoter activity in nontumorigenic dermal fibroblasts exposed to tumor cell-derived soluble mediator(s).	SEN:10041802	16204059
BEL:20088774	p(MGI:Hras) decreases act(p(MGI:Thbs1))	Interestingly, exposure of MDF-EGFP/TSP-1 fibroblasts to conditioned medium derived rom H-ras-expressing 528ras1 cancer cells (528ras1 conditioned medium) induced a near complete inhibition of GFP fluorescence as indicated by both confocal microscopy and flow cytometry (Fig. 2C, left).	SEN:10041804	16204059
BEL:20088776	p(MGI:Hras) decreases p(MGI:Thbs1)	Again, this effect was paralleled by comparable decreases in TSP-1 mRNA and protein expression in these cells exposed to 528ras1 conditioned medium (Fig. 2C).	SEN:10041806	16204059
BEL:20088778	p(MGI:Hras) decreases r(MGI:Thbs1)	Again, this effect was paralleled by comparable decreases in TSP-1 mRNA and protein expression in these cells exposed to 528ras1 conditioned medium (Fig. 2C).	SEN:10041806	16204059
BEL:20088780	p(MGI:Kras) decreases act(p(MGI:Thbs1))	In addition to the aforementioned paracrine properties of 528ras1 cells, we observed that also conditioned medium of human colorectal cancer cells harboring a mutant K-ras oncogene (DLD-1), but not that of a DLD-1 variant with genetically disrupted K-ras allele (DKO-3 cells), efficiently suppressed the activity of the TSP-1 reporter gene in MDF-EGFP/ TSP-1 cells (Fig. 4A).	SEN:10041808	16204059
BEL:20088782	p(MGI:Hras) decreases p(MGI:Thbs1)	Once again, we observed that expression of TSP-1 by the nontransformed MDFB6 fibroblasts was precipitously down-regulated when these cells were incubated with B6ras conditioned medium (Fig. 5A).	SEN:10041810	16204059
BEL:20088784	p(MGI:Hras) decreases p(MGI:Thbs1)	A, immortalized dermal fibroblasts (MDFB6) down-regulate TSP-1 protein expression in the presence of conditioned medium from their H-ras-transformed counterparts (B6ras CM); quantification of representative Western blot.	SEN:10041812	16204059
BEL:20088786	p(MGI:Id1) decreases p(MGI:Thbs1)	B, absence of TSP-1 down-regulation in Id1-deficient dermal fibroblasts exposed to conditioned medium of ras-transformed (528ras1 CM and B6ras CM) and neu-transformed (528neu CM) tumor cells.	SEN:10041814	16204059
BEL:20088788	r(MGI:Hras) decreases r(MGI:Thbs1)	Paracrine effects of various ras-driven cancer cells were detected at the level of TSP-1 protein, mRNA, and promoter activity (Fig. 2C).	SEN:10041816	16204059
BEL:20088790	r(MGI:Hras) decreases p(MGI:Thbs1)	Paracrine effects of various ras-driven cancer cells were detected at the level of TSP-1 protein, mRNA, and promoter activity (Fig. 2C).	SEN:10041816	16204059
BEL:20088792	r(MGI:Hras) decreases act(p(MGI:Thbs1))	Paracrine effects of various ras-driven cancer cells were detected at the level of TSP-1 protein, mRNA, and promoter activity (Fig. 2C).	SEN:10041816	16204059
BEL:20088796	act(p(MGI:Sphk1)) decreases act(p(MGI:Thbs1))	In contrast, abrogation of TSP-1 suppression was observed (Fig. 6C) when MDF528 cells were incubated with dimethylsphingosine, a specific inhibitor of sphingosine kinase.	SEN:10041820	16204059
BEL:20088798	act(p(MGI:Sphk1)) decreases act(p(MGI:Thbs1))	Thus, suppression of TSP-1 promoter activity by fraction 2 of 528ras1 conditioned medium was moderately sensitive to pertussis toxin but was completely abolished by dimethylsphingosine.	SEN:10041822	16204059
BEL:20088806	p(MGI:Csf3) decreases p(MGI:Cxcl12)	Results G-CSF treatment increased WBCs and neutrophils in peripheral blood and reduced the bone marrow SDF-1 level We treated mice with N-terminal-mutated recombinant human G-CSF, nartograstim (8 ig kg_1), and examined the number of total WBCs and neutrophils in peripheral blood to confirm its biological effects.	SEN:10041826	16352631
BEL:20088808	p(MGI:Csf3) decreases a(MGI:Cxcl12)	G-CSF treatment did not change the serum SDF-1 level (Fig. 1B), but 4 Mechanism of tumor angiogenesis activated by G-CSF significantly reduced the bone marrow SDF-1 level (Fig. 1C) as previously shown (21).	SEN:10041828	16352631
BEL:20088814	p(MGI:Csf3) increases bp(GOBP:"blood vessel development")	G-CSF treatment induced the increase of vessel density in tumor tissues, but did not affect the proliferation of HUVECs Hematoxylin and eosin staining of the tumor tissues revealed hyper-neovascularization in tumors from G-CSF-treated mice (Fig. 3A and C; total of six G-CSF injections).	SEN:10041834	16352631
BEL:20088816	p(MGI:Csf3) increases bp(GOBP:"blood vessel development")	Compared with control mice, we found an increase of tumor vessel density in G-CSF-treated mice.	SEN:10041836	16352631
BEL:20088826	complex(p(MGI:Itgav),p(MGI:Itgb1)) increases path(MESHD:"Neovascularization, Pathologic")	These antagonists prevented monocyte stimulation of angiogenesis in vivo, macrophage colonization of tumors, and tumor angiogenesis.	SEN:10041844	16489015
BEL:20088830	bp(GOBP:"response to tumor cell") increases bp(GOBP:"macrophage chemotaxis")	In contrast to most normal tissues, tumors have a high macrophage content; an average of 199 + 33 F4/80+ macrophages per field can be observed in Lewis lung carcinoma tumors and an average of 61 + 1 F4/80+ macrophages per field can be observed in HT29 xenograft tumors grown in mice (Fig. 1A and B).	SEN:10041846	16489015
BEL:20088836	complex(p(MGI:Itgav),p(MGI:Itgb1)) increases bp(GOBP:"cell adhesion")	Integrin A4B1 mediates myeloid cell adhesion to endothelium in vitro.	SEN:10041850	16489015
BEL:20088838	p(HGNC:SSFA2) directlyIncreases complex(p(MGI:Itgav),p(MGI:Itgb1))	Antagonists of a4h1 blocked monocyte attachment to VCAM, indicating that integrin a4h1 is a functionally active receptor for both CS-1 fibronectin and VCAM (Supplementary Fig. S4).	SEN:10041852	16489015
BEL:20088840	p(HGNC:VCAM1) directlyIncreases complex(p(MGI:Itgav),p(MGI:Itgb1))	Antagonists of a4h1 blocked monocyte attachment to VCAM, indicating that integrin a4h1 is a functionally active receptor for both CS-1 fibronectin and VCAM (Supplementary Fig. S4).	SEN:10041852	16489015
BEL:20088842	complex(p(MGI:Itgav),p(MGI:Itgb1)) increases bp(GOBP:"macrophage chemotaxis")	Treatment with integrin a4h1 antagonists, but not other antagonists, significantly suppressed the number of F4/80+ macrophages within tumors (Fig. 6A and B).	SEN:10041854	16489015
BEL:20088848	complex(p(MGI:Itgav),p(MGI:Itgb1)) increases bp(GOBP:"blood vessel development")	These antagonists also reduced blood vessel density within treated tumors (Fig. 6C and D) and partially suppressed tumor growth (Supplementary Fig. S5).	SEN:10041856	16489015
BEL:20088858	r(MGI:Efemp1) decreases p(HGNC:MAPK14,pmod(P))	FBLN-3 expression in MB114 cells also prevented their activation of p38 MAPK, but not that of extracellular signal-regulated kinase 1/2 (ERK1/2), stimulated by VEGF (Fig. 2E).	SEN:10041864	16510581
BEL:20088860	r(MGI:Fbln5) decreases r(HGNC:MMP3)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088862	r(MGI:Efemp1) decreases r(HGNC:MMP2)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088864	p(HGNC:EFEMP1) decreases r(HGNC:MMP3)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088866	r(MGI:Fbln5) decreases r(HGNC:MMP2)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088868	r(MGI:Fbln5) increases r(HGNC:TIMP1)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088870	r(MGI:Fbln5) increases r(HGNC:TIMP3)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088872	r(MGI:Efemp1) increases r(HGNC:TIMP3)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088874	r(MGI:Efemp1) increases r(HGNC:TIMP1)	Figure 3A shows that relative to control cells, FBLN-3 and FBLN-5 both decreased MB114 cell expression of MMP-2 and MMP-3 while simultaneously increasing that of the MMP antagonists, TIMP-1 and TIMP-3.	SEN:10041866	16510581
BEL:20088876	r(MGI:Efemp1) increases r(HGNC:THBS1)	Although MB114 cell expression of TIMP-2 was unaffected by either FBLN-3 or FBLN-5, both FBLNs induced MB114 cell expression of the angiostatic molecule, TSP-1 (Fig. 3A).	SEN:10041868	16510581
BEL:20088878	r(MGI:Fbln5) increases r(HGNC:THBS1)	Although MB114 cell expression of TIMP-2 was unaffected by either FBLN-3 or FBLN-5, both FBLNs induced MB114 cell expression of the angiostatic molecule, TSP-1 (Fig. 3A).	SEN:10041868	16510581
BEL:20088880	r(MGI:Efemp1) increases r(HGNC:TIMP3)	Interestingly, although TIMP-3 expression was elevated basally in FBLN-5-expressing MB114 cells, only FBLN-3 stimulated TIMP-3 expression in tubulating MB114 cells (Fig. 3B).	SEN:10041870	16510581
BEL:20088882	r(MGI:Fbln5) decreases pep(p(HGNC:MMP2))	Gelatin zymography of MB114 cell conditioned medium confirmed that expression of either FBLN-3 or FBLN-5 significantly reduced MMP-2 protease activity in tubulating MB114 cells (Fig. 3C).	SEN:10041872	16510581
BEL:20088884	r(MGI:Efemp1) decreases pep(p(HGNC:MMP2))	Gelatin zymography of MB114 cell conditioned medium confirmed that expression of either FBLN-3 or FBLN-5 significantly reduced MMP-2 protease activity in tubulating MB114 cells (Fig. 3C).	SEN:10041872	16510581
BEL:20088886	p(MGI:Efemp1) decreases bp(GOBP:angiogenesis)	FBLN-3 and FBLN-5 antagonize angiogenesis in vivo.	SEN:10041874	16510581
BEL:20088888	p(MGI:Fbln5) decreases bp(GOBP:angiogenesis)	FBLN-3 and FBLN-5 antagonize angiogenesis in vivo.	SEN:10041874	16510581
BEL:20088894	r(MGI:Fbln5) decreases bp(GOBP:"cell migration")	Moreover, recombinant FBLN-3 and FBLN-5 (Fig. 4B) both inhibited human HMEC-1 endothelial cell migration to fibronectin (Fig. 4C), whereas FBLN-5, but not FBLN-3, mediated their adhesion in an RGD-dependent manner (Fig. 4D; refs.	SEN:10041878	16510581
BEL:20088896	r(MGI:Efemp1) decreases bp(GOBP:"cell migration")	Moreover, recombinant FBLN-3 and FBLN-5 (Fig. 4B) both inhibited human HMEC-1 endothelial cell migration to fibronectin (Fig. 4C), whereas FBLN-5, but not FBLN-3, mediated their adhesion in an RGD-dependent manner (Fig. 4D; refs.	SEN:10041878	16510581
BEL:20088900	p(HGNC:FGF2) increases path(MESHD:"Neovascularization, Pathologic")	Figure 5A shows that bFGF stimulated significant vascularization of implanted Matrigel plugs, which was quantified by measuring plug hemoglobin contents (Fig. 5A) and microvessel densities (Fig. 5B).	SEN:10041880	16510581
BEL:20088914	r(MGI:Efemp1) decreases bp(GOBP:"blood vessel development")	More importantly, tumors derived from FBLN-expressing MCA102 fibrosarcoma cells also exhibited significantly reduced blood vessel densities compared with tumors derived from control cells (Fig. 6D ).	SEN:10041890	16510581
BEL:20088916	p(MGI:Fbln5) decreases bp(GOBP:"blood vessel development")	More importantly, tumors derived from FBLN-expressing MCA102 fibrosarcoma cells also exhibited significantly reduced blood vessel densities compared with tumors derived from control cells (Fig. 6D ).	SEN:10041890	16510581
BEL:20088918	r(MGI:Efemp1) increases bp(GOBP:"necrotic cell death")	In addition, FBLN-3-expressing MCA102 tumors contained significantly enlarged regions of central and peripheral necrosis that were typically absent in their control counterparts.	SEN:10041892	16510581
BEL:20088922	bp(GOBP:"response to tumor cell") increases sec(p(HGNC:FGG,trunc(399)))	DLD-1 human colon cancer cells that secrete ;C or ;C399tr grew at similar levels in vitro but grew much slower in vivo than mock-transfected cells.	SEN:10041896	17018627
BEL:20088924	bp(GOBP:"response to tumor cell") increases sec(p(HGNC:FGG))	DLD-1 human colon cancer cells that secrete ;C or ;C399tr grew at similar levels in vitro but grew much slower in vivo than mock-transfected cells.	SEN:10041896	17018627
BEL:20088930	p(HGNC:FGG,trunc(399)) decreases path(MESHD:"Neovascularization, Pathologic")	The recombinant purified ;C399tr fragment markedly suppressed tumor growth, development of intra-tumoral vasculature, and tumor metastasis in vivo in the highly metastatic Met-1 breast cancer model.	SEN:10041898	17018627
BEL:20088934	p(HGNC:FGG,trunc(399)) increases act(p(HGNC:CASP3))	gC induced caspase-3 activation in 8 hours in these cells in Matrigel (Fig. 2C).	SEN:10041902	17018627
BEL:20088936	bp(GOBP:"response to tumor cell") increases sec(p(MGI:Fgg,trunc(399)))	DLD-1 colon carcinoma cells engineered to secrete ;C or ;C399tr grew slower than nonsecreting control cells in SCID mice.	SEN:10041904	17018627
BEL:20088938	sec(p(MGI:Fgg,trunc(399))) decreases bp(GOBP:"cell growth")	DLD-1 colon carcinoma cells engineered to secrete ;C or ;C399tr grew slower than nonsecreting control cells in SCID mice.	SEN:10041904	17018627
BEL:20088940	bp(GOBP:"response to tumor cell") increases sec(p(HGNC:FGG))	DLD-1 colon carcinoma cells engineered to secrete ;C or ;C399tr grew slower than nonsecreting control cells in SCID mice.	SEN:10041904	17018627
BEL:20088942	sec(p(HGNC:FGG)) decreases bp(GOBP:"cell growth")	DLD-1 colon carcinoma cells engineered to secrete ;C or ;C399tr grew slower than nonsecreting control cells in SCID mice.	SEN:10041904	17018627
BEL:20088948	p(HGNC:FGG,trunc(399)) decreases path(MESHD:"Neovascularization, Pathologic")	;C399tr blocked the tumor growth, intratumoral vascularization, and metastasis of the highly metastatic Met-1 breast cancer in nude mice.	SEN:10041908	17018627
BEL:20089040	p(HGNC:DLL4) increases r(HGNC:HELT)	Hesl and Heyl mRNA was significantly increased in U87 cells (DLL4 cells versus EV cells, P < 0.01 for both genes; Supplementary Fig. S1C).	SEN:10041972	18056450
BEL:20089042	p(HGNC:DLL4) increases r(HGNC:HEYL)	Hesl and Heyl mRNA was significantly increased in U87 cells (DLL4 cells versus EV cells, P < 0.01 for both genes; Supplementary Fig. S1C).	SEN:10041972	18056450
BEL:20089044	p(MGI:Dll4) increases r(MGI:Helt)	Similarly, expression of mouse Hesl (mHesl) and mHey2 was also increased in B16 cells (DLL4 cells versus EV cells, P < 0.05 for both genes).	SEN:10041974	18056450
BEL:20089046	p(MGI:Dll4) increases r(MGI:Heyl)	Similarly, expression of mouse Hesl (mHesl) and mHey2 was also increased in B16 cells (DLL4 cells versus EV cells, P < 0.05 for both genes).	SEN:10041974	18056450
BEL:20089058	p(MGI:Dll4) increases r(MGI:Helt)	For U87 xenograft tumors, mDLL4 expressed in tumor ECs and mHesl expressed in host stromal/endothelial cells were significantly increased in tumors overexpressing DLL4 (both P < 0.05).	SEN:10041980	18056450
BEL:20089060	p(MGI:Dll4) increases r(MGI:Helt)	In contrast, for B16 allograft tumors, all tested genes were significantly increased in DLL4-overexpressing tumors (P < 0.05).	SEN:10041982	18056450
BEL:20089062	p(MGI:Dll4) increases r(MGI:Hey1)	In contrast, for B16 allograft tumors, all tested genes were significantly increased in DLL4-overexpressing tumors (P < 0.05).	SEN:10041982	18056450
BEL:20089064	p(MGI:Dll4) increases r(MGI:Hey2)	In contrast, for B16 allograft tumors, all tested genes were significantly increased in DLL4-overexpressing tumors (P < 0.05).	SEN:10041982	18056450
BEL:20089066	p(MGI:Dll4) increases r(MGI:Efnb2)	In contrast, for B16 allograft tumors, all tested genes were significantly increased in DLL4-overexpressing tumors (P < 0.05).	SEN:10041982	18056450
BEL:20089072	p(MGI:Dll4) decreases bp(GOBP:"blood vessel development")	In contrast, DLL4-overexpressing tumors displayed decreased vessel density and vessel number, yet exhibited larger vessels with large lumina (Fig. 3A ).	SEN:10041984	18056450
BEL:20089076	p(MGI:Dll4) decreases bp(GOBP:"response to hypoxia")	Double staining for hypoxyprobe-1 (pimonidazole) and mCD31 showed much reduced regions of intratumoral hypoxia in DLL4-overexpressing U87 tumors, significantly less than those in EV control tumors (5% compared with 18%; P < 0.01; Fig. 3C).	SEN:10041988	18056450
BEL:20089078	p(MGI:Dll4) decreases p(MGI:Kdr)	As shown in Fig. 3D, in vivo expression of mouse VEGFR2 protein in the large vessels was lower in DLL4-overexpressing U87 tumors compared with those of EV control tumors, suggesting that the large vessels were particularly modulated by the DLL4 signal.	SEN:10041990	18056450
BEL:20089084	p(MGI:Dll4) decreases p(HGNC:CASP3)	Immunostaining for activated caspase-3, a marker of apoptosis, showed that the number of apoptotic cells was decreased in DLL4-overexpressing tumors compared with EV control tumors (P < 0.01; Fig. 3C).	SEN:10041994	18056450
BEL:20089088	bp(GOBP:"response to hypoxia") increases sec(p(HGNC:VEGFA))	Interestingly, hypoxia significantly increased VEGF production of PC3 (P < 0.05) but not U87 cells (P > 0.05) compared with normoxia.	SEN:10041998	18056450
BEL:20089096	complex(p(MGI:Dll4),p(MGI:Kdr)) decreases path(MESHD:"Neovascularization, Pathologic")	However, there were residual well-organized large vessels with regular shape and large lumina in DLL4-overexpressing tumors after bevacizumab treatment (Fig. 4D).	SEN:10042006	18056450
BEL:20089100	bp(GOBP:"response to tumor cell") decreases r(HGNC:FBLN5)	Along these lines, Oncomine analyses comparing the gene expression profiles of 40 breast carcinomas versus seven normal breast tissues also found FBLN5 messenger RNA expression to be reduced in mammary tumors as compared with their normal counterparts (Figure 1A).	SEN:10042010	18713838
BEL:20089102	bp(GOBP:"response to tumor cell") increases p(HGNC:FBLN5)	In stark contrast, we observed human breast cancers to contain abundant levels of FBLN5 protein, and in fact, to express more FBLN5 protein than did their normal counterparts (Figure 1B and C).	SEN:10042012	18713838
BEL:20089110	r(MGI:Fbln5) increases p(MGI:Acta2)	Indeed, actin cytoskeletal rearrangements (Figure 2B, red channel) were readily apparent in NMuMG that expressed FBLN5 (Figure 2B, green channel), which contrasted sharply with the normal cuboidal morphologies and cortical actin architectures exhibited by adjacent NMuMG cells that failed to express the FBLN5 transgene (Figure 2B).	SEN:10042018	18713838
BEL:20089116	p(MGI:Fbln5) increases bp(GOBP:"epithelial to mesenchymal transition")	Similarly, FBLN5 expression also enhanced the resting and TGF-P-stimulated EMT in 4T1 breast cancer cells (Figure 2C), suggesting that the oncogenic activities of FBLN5 are not restricted to NMuMG cells.	SEN:10042022	18713838
BEL:20089126	p(MGI:Tgfb1) increases r(MGI:Twist1)	Moreover, we found that EMT stimulated by TGF-P (Figure 2E) or the process of mammary tumorigenesis (Figure 2F) both induced Twist expression, and more importantly, that FBLN5 significantly enhanced resting and TGF-P-stimulated Twist expression in normal and malignant MECs (Figure 2E and F).	SEN:10042026	18713838
BEL:20089128	p(MGI:Fbln5) increases r(MGI:Twist1)	Moreover, we found that EMT stimulated by TGF-P (Figure 2E) or the process of mammary tumorigenesis (Figure 2F) both induced Twist expression, and more importantly, that FBLN5 significantly enhanced resting and TGF-P-stimulated Twist expression in normal and malignant MECs (Figure 2E and F).	SEN:10042026	18713838
BEL:20089140	p(MGI:Fbln5) increases bp(GOBP:"epithelial to mesenchymal transition")	Functionally, FBLN5 enhanced the EMT phenotype in normal (Figure 5A) and malignant (Figure 5B) MECs, as well as significantly augmented their tonic and TGF-P-stimulated invasion through synthetic basement membranes (Figure 5C; data not shown).	SEN:10042034	18713838
BEL:20089150	act(p(MGI:Mmp2)) decreases r(MGI:Cdh1)	As above, both transcriptional responses mediated by FBLN5 were reversed by treating the cells with the type I MMP-2/3 or MMP-2/9 inhibitors (Figure 5D and E).	SEN:10042040	18713838
BEL:20089152	act(p(MGI:Mmp2)) increases r(MGI:Twist1)	As above, both transcriptional responses mediated by FBLN5 were reversed by treating the cells with the type I MMP-2/3 or MMP-2/9 inhibitors (Figure 5D and E).	SEN:10042040	18713838
BEL:20089154	act(p(MGI:Mmp9)) increases r(MGI:Twist1)	As above, both transcriptional responses mediated by FBLN5 were reversed by treating the cells with the type I MMP-2/3 or MMP-2/9 inhibitors (Figure 5D and E).	SEN:10042040	18713838
BEL:20089164	p(MGI:Itga6) decreases p(MGI:Vegfa)	Mechanistically, endothelial a6-integrin deficiency elevated significantly VEGF-mediated angiogenesis both in vivo and ex vivo.	SEN:10042048	19967723
BEL:20089166	p(MGI:Itga6) increases p(MGI:Kdr)	In particular, a6-integrin-deficient endothelial cells displayed increased levels of VEGF-receptor 2 (VEGFR2) and VEGF-mediated downstream ERK1/2 activation.	SEN:10042050	19967723
BEL:20089168	p(MGI:Kdr) increases act(p(MGI:Mapk3))	In particular, a6-integrin-deficient endothelial cells displayed increased levels of VEGF-receptor 2 (VEGFR2) and VEGF-mediated downstream ERK1/2 activation.	SEN:10042050	19967723
BEL:20089170	bp(GOBP:"response to tumor cell") decreases p(HGNC:ITGA6)	Blood vessels associated with IDC showed a significant reduction in mean a6-integrin pixel intensity when compared with blood vessels from normal breast tissue (**p < 0.0001, Figure 1b).	SEN:10042052	19967723
BEL:20089176	p(MGI:Itga6) decreases bp(GOBP:"blood vessel development")	The results showed that there was a significant increase in tumour blood vessel density in a6fl/fl-Tie1Cre+ mice compared with a6fl/fl-Tie1Cre- controls (*p < 0.02, Figure 3b).	SEN:10042058	19967723
BEL:20089182	p(MGI:Itga6) increases bp(GOBP:"cell adhesion")	As predicted, the absence of a6-integrin reduced the ability of the a6-/— cells to adhere and migrate to Lm but did not affect the ability of these cells to adhere or migrate on Fn, Col or Vn (*p < 0.05, Figures 5c and 5d).	SEN:10042064	19967723
BEL:20089186	p(MGI:Itga6) decreases p(MGI:Mapk3,pmod(P))	Western blot analysis revealed that VEGF stimulated the phosphorylation of ERK1/2 in both a6fl/fl-Tie1Cre-and a6fl/fl-Tie1Cre+ endothelial cells and that the levels of phosphorylated ERK1/2 (pERK1/2) detected in a6fl/fl-Cre+ endothelial cells after a VEGF stimulus were dramatically higher than those detected in a6fl/flTie1Cre- endothelial cells (Figure 6b).	SEN:10042068	19967723
BEL:20089188	complex(p(MGI:Vegfa),p(MGI:Kdr)) increases p(MGI:Mapk3,pmod(P))	Furthermore, blockade of VEGFR2 using the function blocking monoclonal antibody to VEGFR2, DC101 [26], ablated these enhanced VEGF-mediated responses, demonstrating that the enhanced ERK1/2 phosphorylation was via VEGFR2 (Figure 6b).	SEN:10042070	19967723
BEL:20089194	p(HGNC:MMP2) increases p(HGNC:VEGFA,pmod(P))	MMP-2 transcriptional suppression decreased VEGF, phosphatidylinositol 3-kinase (PI3K) protein levels and AKT phosphorylation in lung cancer cells.	SEN:10042074	20027628
BEL:20089196	p(HGNC:MMP2) increases p(HGNC:AKT1,pmod(P))	MMP-2 transcriptional suppression decreased VEGF, phosphatidylinositol 3-kinase (PI3K) protein levels and AKT phosphorylation in lung cancer cells.	SEN:10042074	20027628
BEL:20089198	p(HGNC:MMP2) increases p(HGNC:HIF1A)	In addition, MMP-2 suppression decreased hypoxia inducible factor-1a (HIF-1a), a transcription factor for VEGF, as determined by electrophoretic mobility shift assay (EMSA).	SEN:10042076	20027628
BEL:20089202	p(MGI:Mmp2) increases p(MGI:Vegfa)	Moreover, A549 xenograft tissue sections from mice that treated with MMP-2 siRNA showed reduced expression of VEGF and the angiogenic marker, factor-VIII.	SEN:10042080	20027628
BEL:20089206	p(HGNC:MMP2) increases act(p(HGNC:MMP2))	MMP-2 gelatinolytic activity was higher in cells infected with PBS (mock) and Ad-SV.	SEN:10042082	20027628
BEL:20089208	p(HGNC:MMP2) increases p(HGNC:MMP2)	Further, we also show that Ad-MMP-2-Si inhibits MMP-2 protein and mRNA levels in NCI-H1299, another adenocarcinoma cell line (Supporting Information Fig. 1).	SEN:10042084	20027628
BEL:20089214	p(HGNC:MMP2) increases p(HGNC:VEGFA)	Ad-MMP-2-Si inhibits VEGF-mediated angiogenesis in vitro.	SEN:10042090	20027628
BEL:20089218	p(HGNC:MMP2) increases sec(p(HGNC:VEGFA))	MMP-2 inhibition decreased VEGF shedding into TCM as compared to mock and Ad-SV-infected cells.	SEN:10042092	20027628
BEL:20089220	p(HGNC:MMP2) increases sec(p(HGNC:VEGFA))	The extent of VEGF secretion into the TCM in Ad-MMP-2-Si-infected A549 cells was 2.01 ± 0.15 pg/lg (p < 0.01) as compared to 7.22 ± 0.84 pg/lg in Ad-SV-infected cells (Fig. 2b).	SEN:10042094	20027628
BEL:20089222	p(HGNC:MMP2) increases p(HGNC:KDR)	Western blot analysis indicated that VEGF and VEGFR-2 protein expression was decreased in Ad-MMP-2-Si-infected cells as compared to mock and Ad-SV-infected cells (Fig. 2c).	SEN:10042096	20027628
BEL:20089224	p(HGNC:MMP2) increases p(HGNC:VEGFA)	Western blot analysis indicated that VEGF and VEGFR-2 protein expression was decreased in Ad-MMP-2-Si-infected cells as compared to mock and Ad-SV-infected cells (Fig. 2c).	SEN:10042096	20027628
BEL:20089226	p(HGNC:MMP2) increases p(HGNC:KDR)	Ad-MMP-2-Si infection inhibited VEGF and VEGFR-2 expression by >85% (p < 0.01) and 65.00 ± 4.45% (p < 0.05), respectively.	SEN:10042098	20027628
BEL:20089228	p(HGNC:MMP2) increases p(HGNC:VEGFA)	Ad-MMP-2-Si infection inhibited VEGF and VEGFR-2 expression by >85% (p < 0.01) and 65.00 ± 4.45% (p < 0.05), respectively.	SEN:10042098	20027628
BEL:20089230	p(HGNC:MMP2) increases r(HGNC:KDR)	As shown in Figure 2d, Ad-MMP-2-Si infection inhibited VEGF and VEGFR-2 mRNA transcription by 89.65 ± 2.01% (p < 0.01) and 68.65 ± 2.44% (p < 0.05), respectively.	SEN:10042100	20027628
BEL:20089232	p(HGNC:MMP2) increases r(HGNC:VEGFA)	As shown in Figure 2d, Ad-MMP-2-Si infection inhibited VEGF and VEGFR-2 mRNA transcription by 89.65 ± 2.01% (p < 0.01) and 68.65 ± 2.44% (p < 0.05), respectively.	SEN:10042100	20027628
BEL:20089236	p(HGNC:MMP2) increases p(HGNC:VEGFA)	As shown in Figure 5, rhMMP-2 restored Ad-MMP-2-Si-mediated inhibition of VEGF expression from 15.55 ± 6.21% (p < 0.01) to 67.96 ± 4.01% (p < 0.01).	SEN:10042104	20027628
BEL:20089240	p(HGNC:MMP2) increases r(HGNC:VEGFA)	These results suggest that MMP-2 downregulation inhibits expression of VEGF at the mRNA transcription level in A549 cells.	SEN:10042108	20027628
BEL:20089242	p(HGNC:MMP2) increases p(HGNC:HIF1A)	Ad-MMP-2-Si inhibits HIF-1a expression and activity in A549 cells A key stimulus for increased VEGF expression in lung cancer is hypoxia.	SEN:10042110	20027628
BEL:20089244	p(HGNC:MMP2) increases act(p(HGNC:HIF1A))	Ad-MMP-2-Si inhibits HIF-1a expression and activity in A549 cells A key stimulus for increased VEGF expression in lung cancer is hypoxia.	SEN:10042110	20027628
BEL:20089246	bp(GOBP:"response to hypoxia") increases r(HGNC:HIF1A)	We could not detect HIF-1a expression under normoxic conditions; however, HIF-1 a was detected in A549 cells exposed to hypoxia (1% O2) for 12-16 hr.	SEN:10042112	20027628
BEL:20089248	p(HGNC:MMP2) increases p(HGNC:HIF1A)	As Figure 3a shows, Ad-MMP-2-Si infection inhibited HIF-1a expression by 96.13 ± 1.98% (p < 0.01) when compared to the controls.	SEN:10042114	20027628
BEL:20089250	p(HGNC:MMP2) increases r(HGNC:HIF1A)	As shown in Figure 3b, Ad-MMP-2-Si infection inhibited HIF-1a mRNA transcription by 81.21 ± 3.47% (p < 0.01) as compared to the controls.	SEN:10042116	20027628
BEL:20089252	p(HGNC:MMP2) increases act(p(HGNC:HIF1A))	As shown Figure 3c, HIF-1a activity substantially decreased in Ad-MMP-2-Si-infected A549 cells as compared to mock and Ad-SV infected cells.	SEN:10042118	20027628
BEL:20089256	p(HGNC:MMP2) increases p(HGNC:AKT1,pmod(P,S,473))	As shown in Figure 4a, Ad-MMP-2-Si infection inhibited the expression of PI3K and phosphorylation of AKT (Ser-473) by 94.7 ± 1.95% (p < 0.01) and 98.9 ± 1.02% (p < 0.01), respectively.	SEN:10042120	20027628
BEL:20089258	act(p(HGNC:AKT1)) increases p(HGNC:AKT1,pmod(P))	As shown in Figure 4b, ectopic expression of constitutively active-AKT restored AKT phosphorylation and VEGF expression in Ad-MMP-2-Si-infected A549 cells.	SEN:10042122	20027628
BEL:20089260	act(p(HGNC:AKT1)) increases r(HGNC:VEGFA)	As shown in Figure 4b, ectopic expression of constitutively active-AKT restored AKT phosphorylation and VEGF expression in Ad-MMP-2-Si-infected A549 cells.	SEN:10042122	20027628
BEL:20089266	p(HGNC:MMP2) increases p(HGNC:AKT1,pmod(P))	The addition of rhMMP-2 to Ad-MMP-2-Si-infected A549 cells restored PI3K expression (from 13.25 ± 2.36%; p < 0.01 to 40.11 ± 2.32%; p < 0.01), phospho-AKT (from 9.45 ± 4.21% p < 0.01 to 60.22 ± 3.33%; p < 0.01) and VEGF (from 15.55 ± 6.21%; p < 0.01 to 67.96 ± 4.01%; p < 0.01) in A549 cell line (Fig. 5a).	SEN:10042126	20027628
BEL:20089268	p(HGNC:MMP2) increases p(HGNC:VEGFA)	The addition of rhMMP-2 to Ad-MMP-2-Si-infected A549 cells restored PI3K expression (from 13.25 ± 2.36%; p < 0.01 to 40.11 ± 2.32%; p < 0.01), phospho-AKT (from 9.45 ± 4.21% p < 0.01 to 60.22 ± 3.33%; p < 0.01) and VEGF (from 15.55 ± 6.21%; p < 0.01 to 67.96 ± 4.01%; p < 0.01) in A549 cell line (Fig. 5a).	SEN:10042126	20027628
BEL:20089282	p(HGNC:MMP2) increases p(HGNC:AKT1,pmod(P))	Addition of rhMMP-2 markedly increased the phosphorylation of AKT and expression of PI3K and VEGF in mock and Ad-MMP-2-Si-infected cells (Fig. 6e) as compared to cells treated with Ad-MMP-2-Si only.	SEN:10042140	20027628
BEL:20089284	p(HGNC:MMP2) increases p(HGNC:VEGFA)	Addition of rhMMP-2 markedly increased the phosphorylation of AKT and expression of PI3K and VEGF in mock and Ad-MMP-2-Si-infected cells (Fig. 6e) as compared to cells treated with Ad-MMP-2-Si only.	SEN:10042140	20027628
BEL:20089288	p(HGNC:MMP2) increases r(HGNC:VEGFA)	Ad-MMP-2-Si treatment inhibits VEGF expression and reduces blood vessel density in vivo We next sought to determine the effect of Ad-MMP-2-Si treatment on VEGF expression and angiogenesis in vivo.	SEN:10042142	20027628
BEL:20089366	kin(p(MGI:Kdr)) increases bp(GOBP:"blood vessel development")	Although in LLC the vascular density remained unaffected, a significant decrease in vascular density had occurred in B16.F10 tumors (Fig. 2e and f).	SEN:10042186	22075979
BEL:20089368	kin(p(MGI:Kdr)) increases p(MGI:Pecam1)	Treatment significantly reduced the overall CD31-positive surface area of B16.F10 tumors by approximately 2-fold, which was confirmed by a 3-fold reduction in mRNA levels of the endothelial marker molecules CD31 and VE-cadherin in the tumor (Fig. 2g and h).	SEN:10042188	22075979
BEL:20089370	kin(p(MGI:Kdr)) increases r(MGI:Pecam1)	Treatment significantly reduced the overall CD31-positive surface area of B16.F10 tumors by approximately 2-fold, which was confirmed by a 3-fold reduction in mRNA levels of the endothelial marker molecules CD31 and VE-cadherin in the tumor (Fig. 2g and h).	SEN:10042188	22075979
BEL:20089372	kin(p(MGI:Kdr)) increases p(MGI:Cdh5)	Treatment significantly reduced the overall CD31-positive surface area of B16.F10 tumors by approximately 2-fold, which was confirmed by a 3-fold reduction in mRNA levels of the endothelial marker molecules CD31 and VE-cadherin in the tumor (Fig. 2g and h).	SEN:10042188	22075979
BEL:20089374	kin(p(MGI:Kdr)) increases r(MGI:Itgb3)	VEGFR2/EGFR inhibitor therapy significantly down-regulated mRNA expression of the proangiogenic/vascular destabilization molecules integrin p3 and Ang2 3-fold and significantly upregulated mRNA levels of the vascular stability molecules Tie2 and N-cadherin approximately 3-fold in LLC (Fig. 3).	SEN:10042190	22075979
BEL:20089376	kin(p(MGI:Kdr)) increases r(MGI:Angpt2)	VEGFR2/EGFR inhibitor therapy significantly down-regulated mRNA expression of the proangiogenic/vascular destabilization molecules integrin p3 and Ang2 3-fold and significantly upregulated mRNA levels of the vascular stability molecules Tie2 and N-cadherin approximately 3-fold in LLC (Fig. 3).	SEN:10042190	22075979
BEL:20089378	kin(p(MGI:Kdr)) decreases r(MGI:Tek)	VEGFR2/EGFR inhibitor therapy significantly down-regulated mRNA expression of the proangiogenic/vascular destabilization molecules integrin p3 and Ang2 3-fold and significantly upregulated mRNA levels of the vascular stability molecules Tie2 and N-cadherin approximately 3-fold in LLC (Fig. 3).	SEN:10042190	22075979
BEL:20089380	kin(p(MGI:Kdr)) decreases r(MGI:Cdh2)	VEGFR2/EGFR inhibitor therapy significantly down-regulated mRNA expression of the proangiogenic/vascular destabilization molecules integrin p3 and Ang2 3-fold and significantly upregulated mRNA levels of the vascular stability molecules Tie2 and N-cadherin approximately 3-fold in LLC (Fig. 3).	SEN:10042190	22075979
BEL:20089382	kin(p(MGI:Kdr)) increases p(MGI:Pdgfrb)	Furthermore, an approximately 1.5-fold decrease in PDGFRp expression was observed in LLC tumor vasculature upon vandetanib treatment, as well as a 9-fold upregulation of desmin, which, however, did not reach statistical significance (P = 0.08) because of interindividual variation between the mice.	SEN:10042192	22075979
BEL:20089384	kin(p(MGI:Kdr)) decreases p(MGI:Nos3)	In contrast, vandetanib treatment induced a 2.3-fold increase in eNOS mRNA in B16.F10 vasculature.	SEN:10042194	22075979
BEL:20089386	kin(p(MGI:Kdr)) increases p(MGI:Kdr)	Strikingly, VEGFR2 staining was strongly diminished after treatment in both LLC and B16.F10 tumors (Fig. 5a—l).	SEN:10042196	22075979
BEL:20089388	kin(p(MGI:Kdr)) increases p(MGI:Egfr)	Vandetanib treatment also reduced EGFR expression, although this reduction was less pronounced than for VEGFR2.	SEN:10042198	22075979
BEL:20089392	m(MGI:Mir190) decreases r(MGI:Timp3)	Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.	SEN:10042202	22952847
BEL:20089394	m(HGNC:MIR580) decreases r(MGI:Timp3)	Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.	SEN:10042202	22952847
BEL:20089396	m(HGNC:MIR588) decreases r(MGI:Timp3)	Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.	SEN:10042202	22952847
BEL:20089398	m(HGNC:MIR580) decreases r(MGI:Fgf2)	Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.	SEN:10042202	22952847
BEL:20089400	m(HGNC:MIR580) decreases r(MGI:Tgfa)	Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.	SEN:10042202	22952847
BEL:20089402	m(HGNC:MIR588) decreases r(MGI:Tgfa)	Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.	SEN:10042202	22952847
BEL:20089404	m(MGI:Mir190) decreases r(MGI:Tgfa)	Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha.	SEN:10042202	22952847
BEL:20089412	r(HGNC:MIR588) increases bp(GOBP:"cell proliferation")	Figure 2D shows the high rate of proliferative Ki67+ cells in a representative dormant miR-588 expressing A-GBM tumor at day 113 post injection.	SEN:10042206	22952847
BEL:20089420	m(MGI:Mir190) increases r(MGI:Amot)	We found that antiangiogenic and dormancy promoting genes, Angiomotin (AMOT-1) and Eph receptor A5 (EphA5), were both upregulated in all DmiR expressing A-GBM tumors as compared to the GFP-vector- control A-GBM cells (Figure 4).	SEN:10042214	22952847
BEL:20089422	m(MGI:Mir190) increases r(MGI:Epha5)	We found that antiangiogenic and dormancy promoting genes, Angiomotin (AMOT-1) and Eph receptor A5 (EphA5), were both upregulated in all DmiR expressing A-GBM tumors as compared to the GFP-vector- control A-GBM cells (Figure 4).	SEN:10042214	22952847
BEL:20089424	m(HGNC:MIR580) increases r(MGI:Epha5)	We found that antiangiogenic and dormancy promoting genes, Angiomotin (AMOT-1) and Eph receptor A5 (EphA5), were both upregulated in all DmiR expressing A-GBM tumors as compared to the GFP-vector- control A-GBM cells (Figure 4).	SEN:10042214	22952847
BEL:20089426	m(HGNC:MIR580) increases r(MGI:Amot)	We found that antiangiogenic and dormancy promoting genes, Angiomotin (AMOT-1) and Eph receptor A5 (EphA5), were both upregulated in all DmiR expressing A-GBM tumors as compared to the GFP-vector- control A-GBM cells (Figure 4).	SEN:10042214	22952847
BEL:20089428	m(HGNC:MIR588) increases r(HGNC:EPHA5)	We found that antiangiogenic and dormancy promoting genes, Angiomotin (AMOT-1) and Eph receptor A5 (EphA5), were both upregulated in all DmiR expressing A-GBM tumors as compared to the GFP-vector- control A-GBM cells (Figure 4).	SEN:10042214	22952847
BEL:20089430	m(HGNC:MIR588) increases r(MGI:Amot)	We found that antiangiogenic and dormancy promoting genes, Angiomotin (AMOT-1) and Eph receptor A5 (EphA5), were both upregulated in all DmiR expressing A-GBM tumors as compared to the GFP-vector- control A-GBM cells (Figure 4).	SEN:10042214	22952847
BEL:20089432	m(HGNC:MIR580) decreases p(MGI:Fgf2)	In contrast, genes involved in pro-angiogenic signaling, including tissue inhibitor of metalloprotei-nases 3 (TIMP-3), hypoxia-induced factor 1 alpha (HIF-1-alpha), basic fibroblast growth factor (bFGF, FGF2), and the K-ras tumor oncogene, were consistently downregulated in DmiR expressing A-GBM.	SEN:10042216	22952847
BEL:20089434	m(HGNC:MIR580) decreases p(MGI:Hif1a)	In contrast, genes involved in pro-angiogenic signaling, including tissue inhibitor of metalloprotei-nases 3 (TIMP-3), hypoxia-induced factor 1 alpha (HIF-1-alpha), basic fibroblast growth factor (bFGF, FGF2), and the K-ras tumor oncogene, were consistently downregulated in DmiR expressing A-GBM.	SEN:10042216	22952847
BEL:20089436	m(HGNC:MIR588) decreases p(MGI:Hif1a)	In contrast, genes involved in pro-angiogenic signaling, including tissue inhibitor of metalloprotei-nases 3 (TIMP-3), hypoxia-induced factor 1 alpha (HIF-1-alpha), basic fibroblast growth factor (bFGF, FGF2), and the K-ras tumor oncogene, were consistently downregulated in DmiR expressing A-GBM.	SEN:10042216	22952847
BEL:20089438	m(HGNC:MIR588) decreases p(MGI:Tgfa)	In contrast, genes involved in pro-angiogenic signaling, including tissue inhibitor of metalloprotei-nases 3 (TIMP-3), hypoxia-induced factor 1 alpha (HIF-1-alpha), basic fibroblast growth factor (bFGF, FGF2), and the K-ras tumor oncogene, were consistently downregulated in DmiR expressing A-GBM.	SEN:10042216	22952847
BEL:20089440	m(HGNC:MIR580) decreases p(MGI:Tgfa)	In contrast, genes involved in pro-angiogenic signaling, including tissue inhibitor of metalloprotei-nases 3 (TIMP-3), hypoxia-induced factor 1 alpha (HIF-1-alpha), basic fibroblast growth factor (bFGF, FGF2), and the K-ras tumor oncogene, were consistently downregulated in DmiR expressing A-GBM.	SEN:10042216	22952847
BEL:20089442	m(MGI:Mir190) decreases p(MGI:Tgfa)	In contrast, genes involved in pro-angiogenic signaling, including tissue inhibitor of metalloprotei-nases 3 (TIMP-3), hypoxia-induced factor 1 alpha (HIF-1-alpha), basic fibroblast growth factor (bFGF, FGF2), and the K-ras tumor oncogene, were consistently downregulated in DmiR expressing A-GBM.	SEN:10042216	22952847
BEL:20089444	m(HGNC:MIR588) decreases r(MGI:Prok2)	Importantly, we found Bv8 also known as prokineticin 2 (Prok2) to be markedly downregulated in all three DmiR expressing A-GBM (Figure 5A).	SEN:10042218	22952847
BEL:20089446	m(HGNC:MIR580) decreases r(MGI:Prok2)	Importantly, we found Bv8 also known as prokineticin 2 (Prok2) to be markedly downregulated in all three DmiR expressing A-GBM (Figure 5A).	SEN:10042218	22952847
BEL:20089454	bp(GOBP:"response to tumor cell") increases m(HGNC:MIR190A)	Over-expression of miR-580, miR-588 and miR-190 in fast-growing angiogenic glioblastoma.	SEN:10042226	22952847
BEL:20089456	bp(GOBP:"response to tumor cell") increases m(HGNC:MIR580)	Over-expression of miR-580, miR-588 and miR-190 in fast-growing angiogenic glioblastoma.	SEN:10042226	22952847
BEL:20089458	bp(GOBP:"response to tumor cell") increases m(HGNC:MIR588)	Over-expression of miR-580, miR-588 and miR-190 in fast-growing angiogenic glioblastoma.	SEN:10042226	22952847
BEL:20089468	p(MGI:Pld2) increases bp(GOBP:"blood vessel development")	In contrast, VEGF plugs in Pld1~-~ mice exhibited almost no vascularization (Fig. 2, A and B).	SEN:10042236	23131846
BEL:20089484	p(MGI:Pld1) increases p(MGI:Akt1,pmod(P,S,473))	PLD1 deficiency reduced basal phosphorylation of Ser473 in Akt and prevented VEGF-induced phosphorylation of Akt at Ser473 (Fig. 3, C and D).	SEN:10042240	23131846
BEL:20089488	p(MGI:Pld1) increases p(MGI:Mapk3,pmod(P))	Pldl-- endothelial cells similarly exhibited a 50% reduction in basal phosphorylation of ERK1/2 but otherwise exhibited similar kinetics to wild-type cells for VEGF-induced phosphorylation of ERK1/2.	SEN:10042242	23131846
BEL:20089494	p(MGI:Pld1) increases bp(GOBP:"blood vessel development")	Histological and quantitative analyses of the tumors revealed a 79% decrease in microvessels in the tumors that formed in FIPI-treated mice (Fig. 4C).	SEN:10042248	23131846
BEL:20089518	act(p(HGNC:MAPK3)) increases complex(p(HGNC:ITGAV),p(HGNC:ITGB3,pmod(P)))	Against this background, we conducted in vitro phosphorylation studies of the phosphorylation of in-tegrin avp3 dimer with activated ERK1 and found phosphorylation of the dimer (Fig. 3A) that was inhibited by the ERK inhibitor, FR180204.	SEN:10042272	23640055
BEL:20089528	a(CHEBI:"thyroid hormone") increases complex(p(HGNC:ITGAV),p(HGNC:PTGS2))	Integrin av bound to the COX-2 promoter in both OVCAR-3 and H522 cells in response to T4 (Fig. 4A)	SEN:10042278	23640055
BEL:20089536	a(CHEBI:"thyroid hormone") increases complex(p(HGNC:ITGAV),p(HGNC:NCOR1))	These results suggest that although T4 increased complex formation between integrin av and NCoR/SMRT, the association between NCoR/SMRT and DNA was unchanged.	SEN:10042282	23640055
BEL:20089538	a(CHEBI:"thyroid hormone") increases complex(p(HGNC:ITGAV),p(HGNC:NCOR2))	These results suggest that although T4 increased complex formation between integrin av and NCoR/SMRT, the association between NCoR/SMRT and DNA was unchanged.	SEN:10042282	23640055
BEL:20089540	a(CHEBI:"thyroid hormone") increases r(HGNC:PTGS2)	The transcription of COX-2, ERa, HIF-la, and TR$1 was increased in thyroid hormone-treated cells (Fig. 4B).	SEN:10042284	23640055
BEL:20089542	a(CHEBI:"thyroid hormone") increases r(MGI:Esr1)	The transcription of COX-2, ERa, HIF-la, and TR$1 was increased in thyroid hormone-treated cells (Fig. 4B).	SEN:10042284	23640055
BEL:20089544	a(CHEBI:"thyroid hormone") increases r(HGNC:HIF1A)	The transcription of COX-2, ERa, HIF-la, and TR$1 was increased in thyroid hormone-treated cells (Fig. 4B).	SEN:10042284	23640055
BEL:20089546	a(CHEBI:"thyroid hormone") increases r(HGNC:TAS2R14)	The transcription of COX-2, ERa, HIF-la, and TR$1 was increased in thyroid hormone-treated cells (Fig. 4B).	SEN:10042284	23640055
BEL:20089554	p(HGNC:TGFBI) decreases bp(GOBP:"cell migration")	TGFBI inhibited vitronectin-induced HUVEC migration on Boy-den chambers coated with vitronectin and this inhibition was reversed by treatment with the functional blocking monoclonal antibody against TGFBI (Fig. 1E, Supplementary Fig. 2B).	SEN:10042292	23792174
BEL:20089562	p(HGNC:FAS) increases complex(p(HGNC:FAS),complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	FAS1_D1234 protein, lacking the RGD motif and EMI domain, bound effectively to avp3 integrin with an affinity of 340 nM, indicating that the four repeats of the FAS1 domain coordinate with the RGD motif to achieve strong and specific binding to av(33 integrin.	SEN:10042298	23792174
BEL:20089564	p(HGNC:FAS) increases complex(p(HGNC:FAS),complex(p(HGNC:ITGAV),p(HGNC:ITGB3)))	Furthermore, upon deletion of FAS1 domains 1 and 2, affinity was decreased by 255-fold to 86.84 |aM, whereas deletion of FAS1 domains 3 and 4 only decreased binding affinity by 2.1-fold to 715 nM, implying that FAS1_D12 domains play a critical role in binding to avp3 integrin.	SEN:10042300	23792174
BEL:20089574	p(MGI:Tgfb1) decreases bp(GOBP:"blood vessel development")	Blood vessel density (vascular volume/tumor volume) was also reduced by 2.2-fold in the TGFBI-treated group (Fig. 5D).	SEN:10042308	23792174
BEL:20089590	p(HGNC:KDM5A) increases p(HGNC:HIF1A)	RBP2 stimulated the up-regulation of VEGF, which was dependent on HIF-1a, and activated the HIF-1a via phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway.	SEN:10042322	999999999
BEL:20089592	path(MESHD:"Carcinoma, Non-Small-Cell Lung") increases p(HGNC:KDM5A)	RBP2 was detected as being overexpressed in 52 (51%) of 102 NSCLC specimens according to the abovementioned criteria.	SEN:10042324	999999999
BEL:20089594	bp(GOBP:"response to tumor cell") increases r(HGNC:KDM5A)	2. RBP2 is overexpressed in human NSCLC cell lines.	SEN:10042326	999999999
BEL:20089596	bp(GOBP:"response to tumor cell") increases p(HGNC:KDM5A)	The protein level of RBP2 was up-regulated in lung cancer cell lines SK-MES-1, A549, SPCA-1 and H1975 compared to the human bronchial epithelial cell line BEAS2B (Fig. 3A).	SEN:10042328	999999999
BEL:20089598	p(HGNC:KDM5A) increases p(HGNC:VEGFA)	Down-regulation of RBP2 protein decreases the expression levels of VEGF in conditioned medium.	SEN:10042330	999999999
BEL:20089600	p(HGNC:KDM5A) increases p(HGNC:VEGFA)	The results demonstrated that the VEGF protein levels in the conditioned media of RBP2-siRNA1 (0.9960.11 ng/ml) and RBP2-siRNA2 (0.9460.14 ng/ml) H1975 cells were significantly lower than in the control siRNA H1975 cells (1.8760.10	SEN:10042332	999999999
BEL:20089604	p(HGNC:KDM5A) increases r(HGNC:VEGFA)	PRBP2 stimulates HIF-1a and VEGF mRNA and protein expression.	SEN:10042336	999999999
BEL:20089606	p(HGNC:KDM5A) increases p(HGNC:HIF1A)	PRBP2 stimulates HIF-1a and VEGF mRNA and protein expression.	SEN:10042336	999999999
BEL:20089608	p(HGNC:KDM5A) increases p(HGNC:VEGFA)	PRBP2 stimulates HIF-1a and VEGF mRNA and protein expression.	SEN:10042336	999999999
BEL:20089610	p(HGNC:KDM5A) increases r(HGNC:HIF1A)	PRBP2 stimulates HIF-1a and VEGF mRNA and protein expression.	SEN:10042336	999999999
BEL:20089612	p(HGNC:KDM5A) increases p(HGNC:HIF1A)	As shown in Fig. 5A, the enforced expression of RBP2 up-regulated the expression of the HIF-1 a protein in a time-dependent manner under normoxic conditions, and the peak value of HIF-1 a expression appeared at 36 hours after transfection was performed.	SEN:10042338	999999999
BEL:20089614	bp(GOBP:"response to tumor cell") increases r(HGNC:KDM5A)	RBP2 is overexpressed in human NSCLC cell lines SK-MES-1, A549, SPCA-1 and H1975 compared to the human bronchial epithelial cell line BEAS2B cells.	SEN:10042340	999999999
BEL:20089616	p(HGNC:KDM5A) increases p(HGNC:VEGFA)	As shown in Fig. 5B and Fig. 5C, the down-regulation of RBP2 in H1975 cells led to the decreased expression of HIF-1a and VEGF, whereas ectopic RBP2 expression in SK-MES-1 cells by pcDNA3-HA-RBP2 led to the up-regulation of HIF-1a and VEGF.	SEN:10042342	999999999
BEL:20089618	p(HGNC:KDM5A) increases p(HGNC:HIF1A)	As shown in Fig. 5B and Fig. 5C, the down-regulation of RBP2 in H1975 cells led to the decreased expression of HIF-1a and VEGF, whereas ectopic RBP2 expression in SK-MES-1 cells by pcDNA3-HA-RBP2 led to the up-regulation of HIF-1a and VEGF.	SEN:10042342	999999999
BEL:20089620	p(HGNC:KDM5A) increases r(HGNC:HIF1A)	The mRNA expression levels of HIF-1a (PsiRNA1 =0.006, PsiRNA2 = 0.001) and VEGF (PsiRNA1 =0.000, PsiRNA2 = 0.000) were significantly decreased in RBP2-depleted H1975 cells.	SEN:10042344	999999999
BEL:20089622	p(HGNC:KDM5A) increases r(HGNC:VEGFA)	The mRNA expression levels of HIF-1a (PsiRNA1 =0.006, PsiRNA2 = 0.001) and VEGF (PsiRNA1 =0.000, PsiRNA2 = 0.000) were significantly decreased in RBP2-depleted H1975 cells.	SEN:10042344	999999999
BEL:20089624	p(HGNC:KDM5A) increases r(HGNC:HIF1A)	Moreover, HIF-1a (P = 0.001) and VEGF (P = 0.000) were increased in RBP2-overexpressing SK-MES-1 cells compared to the control cells (Fig. 5D and Fig. 5E).	SEN:10042346	999999999
BEL:20089626	p(HGNC:KDM5A) increases r(HGNC:VEGFA)	Moreover, HIF-1a (P = 0.001) and VEGF (P = 0.000) were increased in RBP2-overexpressing SK-MES-1 cells compared to the control cells (Fig. 5D and Fig. 5E).	SEN:10042346	999999999
BEL:20089628	p(HGNC:HIF1A) increases r(HGNC:VEGFA)	As shown in Fig. 6A and Fig. 6B, knockdown of HIF-1a expression in ectopic RBP2-expressing SK-MES-1 cells led to the down-regulation of VEGF compared with the scramble non-specific control siRNA; up-regulation of HIF-1a expression in RBP2-depleted H1975 cells led to the up-regulation of VEGF.	SEN:10042348	999999999
BEL:20089630	p(HGNC:KDM5A) increases act(p(HGNC:AKT1))	Our results revealed that silencing RBP2 expression with either RBP2-siRNA1 or RBP2-siRNA2 in H1975 cells significantly decreased the phosphorylation of Akt, whereas the forced expression of RBP2 with pcDNA3-HA-RBP2 in SK-MES-1 cells increased the activity of Akt (Fig. 7A).	SEN:10042350	999999999
BEL:20089632	p(HGNC:KDM5A) increases p(HGNC:AKT1,pmod(P))	Our results revealed that silencing RBP2 expression with either RBP2-siRNA1 or RBP2-siRNA2 in H1975 cells significantly decreased the phosphorylation of Akt, whereas the forced expression of RBP2 with pcDNA3-HA-RBP2 in SK-MES-1 cells increased the activity of Akt (Fig. 7A).	SEN:10042350	999999999
BEL:20089634	p(HGNC:AKT1,pmod(P)) increases r(HGNC:HIF1A)	Moreover, when a constitutively active form of Akt in RBP2-siRNA2 H1975 cells was expressed, the expression of HIF-1a and VEGF were increased compared to the control; the PI3K/Akt inhibitor LY294002 significantly inhibited the expression of HIF-1a and VEGF in pcDNA3-HA-RBP2 SK-MES-1 cells (Fig. 7B).	SEN:10042352	999999999
BEL:20089636	p(HGNC:AKT1,pmod(P)) increases p(HGNC:VEGFA)	Moreover, when a constitutively active form of Akt in RBP2-siRNA2 H1975 cells was expressed, the expression of HIF-1a and VEGF were increased compared to the control; the PI3K/Akt inhibitor LY294002 significantly inhibited the expression of HIF-1a and VEGF in pcDNA3-HA-RBP2 SK-MES-1 cells (Fig. 7B).	SEN:10042352	999999999
BEL:20089642	p(HGNC:VEGFA) increases p(HGNC:AKT1,pmod(P))	As shown in Fig. 7D, in the presence of recombinant human VEGF-165 stimulation, the activation of Akt was increased in RBP2-depleted H1975 cells and RBP2-overexpressing SK-MES-1 cells (25 ng/mL, 30 minutes).	SEN:10042354	999999999
